PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hogan, MF; Ravnskjaer, K; Matsumura, S; Huising, MO; Hull, RL; Kahn, SE; Montminy, M				Hogan, Meghan F.; Ravnskjaer, Kim; Matsumura, Shigenobu; Huising, Mark O.; Hull, Rebecca L.; Kahn, Steven E.; Montminy, Marc			Hepatic Insulin Resistance Following Chronic Activation of the CREB Coactivator CRTC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CELL PROLIFERATION; FREE FATTY-ACIDS; GLUCOSE-METABOLISM; GENE-EXPRESSION; LIVER; TORC2; GLUCONEOGENESIS; OBESITY; MICE; ISLET	Under fasting conditions, increases in circulating concentrations of glucagon maintain glucose homeostasis via the induction of hepatic gluconeogenesis. Triggering of the cAMP pathway in hepatocytes stimulates the gluconeogenic program via the PKA-mediated phosphorylation of CREB and dephosphorylation of the cAMP-regulated CREB coactivators CRTC2 and CRTC3. In parallel, decreases in circulating insulin also increase gluconeogenic gene expression via the de-phosphorylation and activation of the forkhead transcription factor FOXO1. Hepatic gluconeogenesis is increased in insulin resistance where it contributes to the attendant hyperglycemia. Whether selective activation of the hepatic CREB/CRTC pathway is sufficient to trigger metabolic changes in other tissues is unclear, however. Modest hepatic expression of a phosphorylation-defective and therefore constitutively active CRTC2S171,275A protein increased gluconeogenic gene expression under fasting as well as feeding conditions. Circulating glucose concentrations were constitutively elevated in CRTC2S(171,275)A-expressing mice, leading to compensatory increases in circulating insulin concentrations that enhance FOXO1 phosphorylation. Despite accompanying decreases in FOXO1 activity, hepatic gluconeogenic gene expression remained elevated in CRTC2S(171,275)A mice, demonstrating that chronic increases inCRTC2activity in the liver are indeed sufficient to promote hepatic insulin resistance and to disrupt glucose homeostasis.	[Hogan, Meghan F.; Ravnskjaer, Kim; Matsumura, Shigenobu; Huising, Mark O.; Montminy, Marc] Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA; [Hogan, Meghan F.; Hull, Rebecca L.; Kahn, Steven E.] VA Puget Sound Hlth Care Syst, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98108 USA; [Hogan, Meghan F.; Hull, Rebecca L.; Kahn, Steven E.] Univ Washington, Seattle, WA 98108 USA; [Ravnskjaer, Kim] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Matsumura, Shigenobu] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Sakyo Ku, Kyoto 6068502, Japan; [Huising, Mark O.] Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA	Salk Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; University of Southern Denmark; Kyoto University; University of California System; University of California Davis	Montminy, M (corresponding author), Salk Inst Biol Studies, Peptide Biol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	montminy@salk.edu	Hogan, Meghan/AAD-4425-2020; Hull-Meichle, Rebecca L./CAG-5879-2022; Huising, Mark O./H-3885-2019; Matsumura, Shigenobu/Z-2088-2019; Regan, Clinton/E-6250-2012; Ravnskjaer, Kim/GRJ-3065-2022	Huising, Mark O./0000-0002-6594-2205; Ravnskjaer, Kim/0000-0002-5322-3887; Hogan, Meghan/0000-0002-5767-1599; Hull, Rebecca/0000-0001-9690-4087; Kahn, Steven/0000-0001-7307-9002	National Institutes of Health [R37DK083834, 5T32GM007240, 5R01DK088082]; Clayton Foundation for Medical Research; Kieckhefer Foundation; Leona M. and Harry B. Helmsley Charitable Trust Grant [2012-PG-MED002]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK083834, P30DK017047, R01DK088082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clayton Foundation for Medical Research; Kieckhefer Foundation; Leona M. and Harry B. Helmsley Charitable Trust Grant; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R37DK083834 (to M. M., M. F. H.); 5T32GM007240 (to M. F. H.); 5R01DK088082 (to R. L. H.); The Clayton Foundation for Medical Research (to M. M.), the Kieckhefer Foundation (to M. M.), the Leona M. and Harry B. Helmsley Charitable Trust Grant # 2012-PG-MED002 (to M. M., M. F. H.); and the Department of Veterans Affairs (S. E. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Alonso LC, 2007, DIABETES, V56, P1792, DOI 10.2337/db06-1513; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; El Ouaamari A, 2013, CELL REP, V3, P401, DOI 10.1016/j.celrep.2013.01.007; Garcia-Ocana A, 2000, J BIOL CHEM, V275, P1226, DOI 10.1074/jbc.275.2.1226; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; Hardy OT, 2012, CURR OPIN ENDOCRINOL, V19, P81, DOI 10.1097/MED.0b013e3283514e13; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hull R, 2005, DIABETOLOGIA, V48, P1350, DOI 10.1007/s00125-005-1772-9; Hull RL, 2003, DIABETES, V52, P372, DOI 10.2337/diabetes.52.2.372; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Le Lay J, 2009, CELL METAB, V10, P55, DOI 10.1016/j.cmet.2009.06.006; Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686; Luo Q, 2012, P NATL ACAD SCI USA, V109, P20865, DOI 10.1073/pnas.1219028109; Miller RA, 2011, J CLIN INVEST, V121, P2518, DOI 10.1172/JCI45942; Nagle CA, 2009, J LIPID RES, V50, pS74, DOI 10.1194/jlr.R800053-JLR200; Nielsen JH, 1999, J MOL MED-JMM, V77, P62; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Ravnskjaer K, 2013, J CLIN INVEST, V123, P4318, DOI 10.1172/JCI69035; Ryysy L, 2000, DIABETES, V49, P749, DOI 10.2337/diabetes.49.5.749; Saberi M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1137, DOI 10.1152/ajpendo.00158.2009; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Song Y, 2010, NATURE, V468, P933, DOI 10.1038/nature09564; Stoffers DA, 2000, DIABETES, V49, P741, DOI 10.2337/diabetes.49.5.741; Uebi T, 2010, AM J PHYSIOL-ENDOC M, V299, pE413, DOI 10.1152/ajpendo.00525.2009; van der Meulen T, 2015, NAT MED, V21, P769, DOI 10.1038/nm.3872; Wang XL, 2009, CELL METAB, V9, P428, DOI 10.1016/j.cmet.2009.04.001; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107	34	21	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25997	26006		10.1074/jbc.M115.679266	http://dx.doi.org/10.1074/jbc.M115.679266			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26342077	Green Published, hybrid			2022-12-26	WOS:000363527300021
J	Wang, T; Hurwitz, O; Shimada, SG; Qu, LT; Fu, K; Zhang, P; Ma, C; LaMotte, RH				Wang, Tao; Hurwitz, Olivia; Shimada, Steven G.; Qu, Lintao; Fu, Kai; Zhang, Pu; Ma, Chao; LaMotte, Robert H.			Chronic Compression of the Dorsal Root Ganglion Enhances Mechanically Evoked Pain Behavior and the Activity of Cutaneous Nociceptors in Mice	PLOS ONE			English	Article							PERIPHERAL NEUROPATHIC PAIN; C-FIBER NOCICEPTORS; SPARED NERVE INJURY; ELECTROPHYSIOLOGICAL CHANGES; THERMAL HYPERALGESIA; TACTILE ALLODYNIA; SPINAL NERVE; NEURONS; RAT; MODEL	Radicular pain in humans is usually caused by intraforaminal stenosis and other diseases affecting the spinal nerve, root, or dorsal root ganglion (DRG). Previous studies discovered that a chronic compression of the DRG (CCD) induced mechanical allodynia in rats and mice, with enhanced excitability of DRG neurons. We investigated whether CCD altered the pain-like behavior and also the responses of cutaneous nociceptors with unmyelinated axons (C-fibers) to a normally aversive punctate mechanical stimulus delivered to the hairy skin of the hind limb of the mouse. The incidence of a foot shaking evoked by indentation of the dorsum of foot with an aversive von Frey filament (tip diameter 200 mu m, bending force 20 mN) was significantly higher in the foot ipsilateral to the CCD surgery as compared to the contralateral side on post-operative days 2 to 8. Mechanically-evoked action potentials were electrophysiologically recorded from the L3 DRG, in vivo, from cell bodies visually identified as expressing a transgenically labeled fluorescent marker (neurons expressing either the receptor MrgprA3 or MrgprD). After CCD, 26.7% of MrgprA3(+) and 32.1% MrgprD(+) neurons exhibited spontaneous activity (SA), while none of the unoperated control neurons had SA. MrgprA3(+) and MrgprD(+) neurons in the compressed DRG exhibited, in comparison with neurons from unoperated control mice, an increased response to the punctate mechanical stimuli for each force applied (6, 20, 40, and 80 mN). We conclude that CCD produced both a behavioral hyperalgesia and an enhanced response of cutaneous C-nociceptors to aversive punctate mechanical stimuli.	[Wang, Tao; Ma, Chao] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Anat Histol & Embryol, Sch Basic Med,Peking Union Med Coll,Neurosci Ctr, Beijing 100730, Peoples R China; [Wang, Tao; Hurwitz, Olivia; Shimada, Steven G.; Qu, Lintao; Fu, Kai; Zhang, Pu; Ma, Chao; LaMotte, Robert H.] Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA; [Qu, Lintao] Johns Hopkins Univ, Dept Neurosurg, Neurosurg Pain Res Inst, Baltimore, MD USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Yale University; Johns Hopkins University	LaMotte, RH (corresponding author), Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA.	robert.lamotte@yale.edu	Wang, Tao/GYU-4584-2022; Ma, Chao/A-7803-2012	Ma, Chao/0000-0003-1346-6961	National Institutes of Health [NS047399, NS014624]; National Natural Science Foundation of China (NSFC) [81271239]; Institute of Basic Medical Sciences/Chinese Academy of Medical Sciences Dean's Fund [2011RC01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014624, P01NS047399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Institute of Basic Medical Sciences/Chinese Academy of Medical Sciences Dean's Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants to RHL from the National Institutes of Health (NS047399 and NS014624), and to CM from the National Natural Science Foundation of China (NSFC #81271239) and the Institute of Basic Medical Sciences/Chinese Academy of Medical Sciences Dean's Fund (2011RC01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briggs C A, 1995, Clin Anat, V8, P339, DOI 10.1002/ca.980080506; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen RG, 2011, NEUROSCI BULL, V27, P233, DOI 10.1007/s12264-011-1006-8; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Djouhri L, 2006, J NEUROSCI, V26, P1281, DOI 10.1523/JNEUROSCI.3388-05.2006; Djouhri L, 2012, PAIN, V153, P1824, DOI 10.1016/j.pain.2012.04.019; Fan N, 2011, J NEUROPHYSIOL, V106, P3067, DOI 10.1152/jn.00752.2011; Fan N, 2011, J NEUROPHYSIOL, V106, P211, DOI 10.1152/jn.00065.2011; Gu XP, 2008, ANESTHESIOLOGY, V108, P113, DOI 10.1097/01.anes.0000296073.16972.13; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Hu SJ, 1998, PAIN, V77, P15, DOI 10.1016/S0304-3959(98)00067-0; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Johanek LM, 2008, J NEUROSCI, V28, P7659, DOI 10.1523/JNEUROSCI.1760-08.2008; Kawakami M, 1996, SPINE, V21, P2101, DOI 10.1097/00007632-199609150-00009; LaMotte RH, 2009, J NEUROPHYSIOL, V101, P1430, DOI 10.1152/jn.91268.2008; LAMOTTE RH, 1991, J NEUROPHYSIOL, V66, P190, DOI 10.1152/jn.1991.66.1.190; Liu Q, 2012, J NEUROSCI, V32, P14532, DOI 10.1523/JNEUROSCI.3509-12.2012; Ma C, 2012, J NEUROPHYSIOL, V107, P357, DOI 10.1152/jn.00801.2011; Ma C, 2003, J NEUROPHYSIOL, V89, P1588, DOI 10.1152/jn.00855.2002; Ma C, 2007, J NEUROSCI, V27, P14059, DOI 10.1523/JNEUROSCI.3699-07.2007; Ma C, 2010, J NEUROSCI METH, V191, P60, DOI 10.1016/j.jneumeth.2010.06.010; Marziniak M, 2011, J AM ACAD DERMATOL, V65, P756, DOI 10.1016/j.jaad.2010.07.036; Misery L, 2014, NAT REV NEUROL, V10, P408, DOI 10.1038/nrneurol.2014.99; Namer B, 2008, J NEUROPHYSIOL, V100, P2062, DOI 10.1152/jn.90482.2008; OLMARKER K, 1993, SPINE, V18, P1425; Qu LT, 2014, BRAIN, V137, P1039, DOI 10.1093/brain/awu007; Rau KK, 2009, J NEUROSCI, V29, P8612, DOI 10.1523/JNEUROSCI.1057-09.2009; Ringkamp M, 1999, PAIN, V79, P143, DOI 10.1016/S0304-3959(98)00186-9; Ritter AM, 2001, EUR J NEUROSCI, V14, P411, DOI 10.1046/j.0953-816x.2001.01654.x; Shim B, 2005, NEUROSCIENCE, V132, P193, DOI 10.1016/j.neuroscience.2004.12.036; Sikand P, 2011, PAIN, V152, P2485, DOI 10.1016/j.pain.2011.06.001; Smith AK, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-61; Song XJ, 1999, J NEUROPHYSIOL, V82, P3347, DOI 10.1152/jn.1999.82.6.3347; Song Ying, 2013, Shengli Xuebao, V65, P533; TAKAHASHI Y, 1994, NEUROSCI LETT, V168, P85, DOI 10.1016/0304-3940(94)90422-7; TAL M, 1994, PAIN, V57, P375, DOI 10.1016/0304-3959(94)90013-2; Wooten M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5122; Zhang JM, 1999, J NEUROPHYSIOL, V82, P3359, DOI 10.1152/jn.1999.82.6.3359; Zhang JM, 2008, ANESTHESIOLOGY, V108, P5, DOI 10.1097/01.anes.0000296148.09016.d5; Ziegler EA, 1999, BRAIN, V122, P2245, DOI 10.1093/brain/122.12.2245; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	41	14	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137512	10.1371/journal.pone.0137512	http://dx.doi.org/10.1371/journal.pone.0137512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356638	Green Submitted, Green Published, gold			2022-12-26	WOS:000360965800052
J	Yepes, S; Torres, MM; Andrade, RE				Yepes, Sally; Mercedes Torres, Maria; Andrade, Rafael E.			Clustering of Expression Data in Chronic Lymphocytic Leukemia Reveals New Molecular Subdivisions	PLOS ONE			English	Article							GENOMIC ABERRATIONS; ENRICHMENT ANALYSIS; MUTATION STATUS; TCL1; RECEPTOR; PATTERN; GENES; MICROENVIRONMENT; PROLIFERATION; BIOMARKERS	Although the identification of inherent structure in chronic lymphocytic leukemia (CLL) gene expression data using class discovery approaches has not been extensively explored, the natural clustering of patient samples can reveal molecular subdivisions that have biological and clinical implications. To explore this, we preprocessed raw gene expression data from two published studies, combined the data to increase the statistical power, and performed unsupervised clustering analysis. The clustering analysis was replicated in 4 independent cohorts. To assess the biological significance of the resultant clusters, we evaluated their prognostic value and identified cluster-specific markers. The clustering analysis revealed two robust and stable subgroups of CLL patients in the pooled dataset. The subgroups were confirmed by different methodological approaches (non-negative matrix factorization NMF clustering and hierarchical clustering) and validated in different cohorts. The subdivisions were related with differential clinical outcomes and markers associated with the microenvironment and the MAPK and BCR signaling pathways. It was also found that the cluster markers were independent of the immunoglobulin heavy chain variable (IGVH) genes mutational status. These findings suggest that the microenvironment can influence the clinical behavior of CLL, contributing to prognostic differences. The workflow followed here provides a new perspective on differences in prognosis and highlights new markers that should be explored in this context.	[Yepes, Sally; Mercedes Torres, Maria] Univ Los Andes, Dept Ciencias Biol, Fac Ciencias, Bogota, Colombia; [Andrade, Rafael E.] Univ Los Andes, Fdn Santa Fe Bogota, Univ Hosp, Fac Med,Dept Patol, Bogota, Colombia	Universidad de los Andes (Colombia); Universidad de los Andes (Colombia)	Yepes, S (corresponding author), Univ Los Andes, Dept Ciencias Biol, Fac Ciencias, Bogota, Colombia.	sl.yepes233@uniandes.edu.co		Torres, Maria/0000-0001-7033-0097	Vicerectoria de Investigaciones; Facultad de Ciencias, Universidad de los Andes	Vicerectoria de Investigaciones; Facultad de Ciencias, Universidad de los Andes	Vicerectoria de Investigaciones and Facultad de Ciencias, Universidad de los Andes supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andritsos LA, 2010, HAEMATOLOGICA S2, V95; [Anonymous], 2014, R LANG ENV STAT COMP; Bichi R, 2002, P NATL ACAD SCI USA, V99, P6955, DOI 10.1073/pnas.102181599; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Burger JA, 2009, LEUKEMIA, V23, P43, DOI 10.1038/leu.2008.299; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Chuang HY, 2012, BLOOD, V120, P2639, DOI 10.1182/blood-2012-03-416461; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Fabris S, 2008, GENE CHROMOSOME CANC, V47, P781, DOI 10.1002/gcc.20579; Fabris S, 2013, AM J HEMATOL, V88, P24, DOI 10.1002/ajh.23340; Ferreira PG, 2014, GENOME RES, V24, P212, DOI 10.1101/gr.152132.112; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman R., ANNOTATE ANNOTATION; Hahne F, 2008, USE R, P1, DOI 10.1007/978-0-387-77240-0_1; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Haslinger C, 2004, J CLIN ONCOL, V22, P3937, DOI 10.1200/JCO.2004.12.133; Hastie T., 2014, PAMR PAM PREDICTION; Herishanu Y, 2011, BLOOD, V117, P563, DOI 10.1182/blood-2010-05-284984; Herling M, 2006, LEUKEMIA, V20, P280, DOI 10.1038/sj.leu.2404017; Herling M, 2007, AM J SURG PATHOL, V31, P1123, DOI 10.1097/PAS.0b013e31802e2201; Herling M, 2009, BLOOD, V114, P4675, DOI 10.1182/blood-2009-03-208256; Herold T, 2011, LEUKEMIA, V25, P1639, DOI 10.1038/leu.2011.125; Hoshida Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015543; Hoyer KK, 2005, J IMMUNOL, V175, P864, DOI 10.4049/jimmunol.175.2.864; Li FJ, 2008, BLOOD, V112, P179, DOI 10.1182/blood-2008-01-131359; Maechler M, 2014, CLUSTER CLUSTER 2NAL; McCall MN, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-369; Nahi H, 2008, BRIT J HAEMATOL, V141, P445, DOI 10.1111/j.1365-2141.2008.07046.x; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Parman C, AFFYQCREPORT QC REPO; Pede V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060275; Pekarsky Y, 2008, P NATL ACAD SCI USA, V105, P19643, DOI 10.1073/pnas.0810965105; Popal W, 2010, LEUKEMIA LYMPHOMA, V51, P1375, DOI 10.3109/10428194.2010.505064; Refaeli Y, 2008, PLOS BIOL, V6, P1208, DOI 10.1371/journal.pbio.0060152; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Ronchetti D, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-27; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Schwender H, 2012, SIGGENES MULTIPLE TE; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sivina M, 2012, LEUKEMIA, V26, P1812, DOI 10.1038/leu.2012.63; Szremska AP, 2003, BLOOD, V102, P4159, DOI 10.1182/blood-2003-03-0915; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Taminau J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-335; Therneau TM, 2014, PACKAGE SURVIVAL ANA; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vedeld HM, 2015, INT J CANCER, V136, P844, DOI 10.1002/ijc.29039; Villamor N, 2009, HAEMATOL-HEMATOL J, V94, P366; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Wang X, METADE MICROARRAY ME; Wang XB, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-52; Woyach JA, 2012, BLOOD, V120, P1175, DOI 10.1182/blood-2012-02-362624; Yu J, 2013, ONCOGENE, V32, P307, DOI 10.1038/onc.2012.54	56	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137132	10.1371/journal.pone.0137132	http://dx.doi.org/10.1371/journal.pone.0137132			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355846	Green Submitted, Green Published, gold			2022-12-26	WOS:000360965800030
J	Bremser, A; Brack, M; Izcue, A				Bremser, Anna; Brack, Maria; Izcue, Ana			Higher Sensitivity of Foxp3(+) Treg Compared to Foxp3(-) Conventional T Cells to TCR-Independent Signals for CD69 Induction	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; IMMUNOLOGICAL SELF-TOLERANCE; AUTOIMMUNE-DISEASE; FACTOR RECEPTOR; ACTIVATION; REQUIREMENT; RECOGNITION; STRENGTH; S1P(1)	T lymphocytes elicit specific responses after recognizing cognate antigen. However, antigen-experienced T cells can also respond to non-cognate stimuli, such as cytokines. CD4(+) Foxp3(+) regulatory T cells (Treg) exhibit an antigen-experienced-like phenotype. Treg can regulate T cell responses in an antigen-specific or bystander way, and it is still unclear as to which extent they rely on T cell receptor (TCR) signals. The study of the antigen response of Treg has been hampered by the lack of downstream readouts for TCR stimuli. Here we assess the effects of TCR signals on the expression of a classical marker of early T cell activation, CD69. Although it can be induced following cytokine exposure, CD69 is commonly used as a readout for antigen response on T cells. We established that upon in vitro TCR stimulation CD69 induction on Foxp3+ Treg cells was more dependent on signaling via soluble factors than on TCR activation. By contrast, expression of the activation marker Nur77 was only induced after TCR stimulation. Our data suggest that Treg are more sensitive to TCR-independent signals than Foxp3(-) cells, which could contribute to their bystander activity.	[Bremser, Anna; Brack, Maria; Izcue, Ana] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Bremser, Anna; Brack, Maria; Izcue, Ana] Univ Freiburg, Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency CCI, D-79106 Freiburg, Germany; [Bremser, Anna] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany	Max Planck Society; University of Freiburg; University of Freiburg	Izcue, A (corresponding author), Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany.	izcue@ie-freiburg.mpg.de		Izcue, Ana/0000-0002-7974-7451	Bundesministerium fur Bildung und Forschung [BMBF 01EO1303]; Max Planck Society	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck Society)	This study was supported by the Bundesministerium fur Bildung und Forschung (BMBF 01EO1303) (www.bmbf.de) and the Max Planck Society (www.mpg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alari-Pahissa E, 2012, J LEUKOCYTE BIOL, V92, P145, DOI 10.1189/jlb.1011499; Bankovich AJ, 2010, J BIOL CHEM, V285, P22328, DOI 10.1074/jbc.M110.123299; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Betts RJ, 2012, J VIROL, V86, P2817, DOI 10.1128/JVI.05685-11; Cebula A, 2013, NATURE, V497, P258, DOI 10.1038/nature12079; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; Cortes JR, 2014, J AUTOIMMUN, V55, P51, DOI 10.1016/j.jaut.2014.05.007; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Freeman BE, 2012, P NATL ACAD SCI USA, V109, P9971, DOI 10.1073/pnas.1203543109; Fu HM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4436; Grell M, 1998, P NATL ACAD SCI USA, V95, P570, DOI 10.1073/pnas.95.2.570; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Grinberg-Bleyer Y, 2010, J CLIN INVEST, V120, P4558, DOI 10.1172/JCI42945; Hickman SP, 2006, J IMMUNOL, V177, P2186, DOI 10.4049/jimmunol.177.4.2186; Larkin J, 2007, EUR J IMMUNOL, V37, P139, DOI 10.1002/eji.200636577; Lathrop SK, 2008, J EXP MED, V205, P3105, DOI 10.1084/jem.20081359; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Lieberman SM, 2012, EUR J IMMUNOL, V42, P1429, DOI 10.1002/eji.201142286; Liu G, 2009, NATURE IMMUNOLOGY, DOI [10.1038/ni.1835, DOI 10.1038/NI.1835]; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; LOPEZCABRERA M, 1995, J BIOL CHEM, V270, P21545, DOI 10.1074/jbc.270.37.21545; Mac Sharry J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098648; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; Mahmud SA, 2014, NAT IMMUNOL, V15, P473, DOI 10.1038/ni.2849; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Oh S, 2012, J IMMUNOL, V188, P4171, DOI 10.4049/jimmunol.1103598; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Radulovic K, 2012, J IMMUNOL, V188, P2001, DOI 10.4049/jimmunol.1100765; Read S, 1998, EUR J IMMUNOL, V28, P3435, DOI 10.1002/(SICI)1521-4141(199811)28:11<3435::AID-IMMU3435>3.3.CO;2-G; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Samy ET, 2005, J EXP MED, V202, P771, DOI 10.1084/jem.20041033; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Seddon B, 1999, J EXP MED, V189, P877, DOI 10.1084/jem.189.5.877; Sekar D, 2012, EUR J IMMUNOL, V42, P1585, DOI 10.1002/eji.201142093; Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885; Shinoda K, 2012, P NATL ACAD SCI USA, V109, P7409, DOI 10.1073/pnas.1118539109; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Vahl JC, 2014, IMMUNITY, V41, P722, DOI 10.1016/j.immuni.2014.10.012; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Weissler KA, 2014, IMMUNOL REV, V259, P11, DOI 10.1111/imr.12177	46	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137393	10.1371/journal.pone.0137393	http://dx.doi.org/10.1371/journal.pone.0137393			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352149	Green Published, gold, Green Submitted			2022-12-26	WOS:000360932800081
J	Castillo, Y; Tachibana, M; Nakatsu, Y; Watanabe, K; Shimizu, T; Watarai, M				Castillo, Yussaira; Tachibana, Masato; Nakatsu, Yukiko; Watanabe, Kenta; Shimizu, Takashi; Watarai, Masahisa			Combination of Zinc and All-Trans Retinoic Acid Promotes Protection against Listeria monocytogenes Infection	PLOS ONE			English	Article							VITAMIN-A; IMMUNE-RESPONSES; SUPPLEMENTATION; NUTRITION; CHILDREN; TRIAL	Zinc (Zn) is the second most abundant transition metal after iron. It plays a vital role in living organisms and affects multiple aspects of the immune system. All-trans retinoic acid (atRA) is an isomeric form of the vitamin A or retinol. It possesses the greatest biological activity of Vitamin A. Vitamin A and related retinoids influence many aspects of immunity. In this study, we demonstrated that treatment with a combination of Zn and atRA contributes to host resistance against infection by Listeria monocytogenes. Pretreatment with Zn and atRA enhanced resistance against L. monocytogenes infection in mice and treatment with both Zn and atRA showed a higher protective effect than treatment with either alone. Supplementation with Zn, atRA or their combination decreased the number of L. monocytogenes present in target organs. In vitro, supplementation increased the bacterial uptake by macrophage cells and reduced the replication of L. monocytogenes. Our results suggest that the combination of Zn and atRA has a great bacteriostatic impact on L. monocytogenes and its infection.	[Castillo, Yussaira; Tachibana, Masato; Nakatsu, Yukiko; Watanabe, Kenta; Shimizu, Takashi; Watarai, Masahisa] Yamaguchi Univ, United Grad Sch Vet Sci, Yamaguchi 7538515, Japan	Yamaguchi University	Watarai, M (corresponding author), Yamaguchi Univ, United Grad Sch Vet Sci, 1677-1 Yoshida, Yamaguchi 7538515, Japan.	watarai@yamaguchi-u.ac.jp			Japan Society for the Promotion of Science [26850181]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding: This work was supported by Japan Society for the Promotion of Science Grant Number 26850181 (MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonaventura P, 2015, AUTOIMMUN REV, V14, P277, DOI 10.1016/j.autrev.2014.11.008; Bottari NB, 2014, MICROB PATHOGENESIS, V74, P15, DOI 10.1016/j.micpath.2014.06.004; CHANDRA RK, 1992, LANCET, V340, P1124, DOI 10.1016/0140-6736(92)93151-C; Christian P, 1998, AM J CLIN NUTR, V68, p435S, DOI 10.1093/ajcn/68.2.435S; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Cossart P, 2014, FEBS LETT, V588, P2437, DOI 10.1016/j.febslet.2014.05.051; Crane JK, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-145; Dardenne M, 2002, EUR J CLIN NUTR, V56, pS20, DOI 10.1038/sj.ejcn.1601479; Fischer W. C., 2004, ANNU REV NUTR, V24, P255, DOI DOI 10.1146/ANNUREV.NUTR.23.011702.073054; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Harrison EH, 2012, BBA-MOL CELL BIOL L, V1821, P70, DOI 10.1016/j.bbalip.2011.06.002; Kartasurya MI, 2012, BRIT J NUTR, V108, P2251, DOI 10.1017/S0007114512000499; Lahiri A, 2014, GASTROENTEROLOGY, V147, P835, DOI 10.1053/j.gastro.2014.06.024; Lo HM, 2014, FOOD FUNCT, V5, P140, DOI 10.1039/c3fo60309a; Long KZ, 2006, AM J CLIN NUTR, V83, P693, DOI 10.1093/ajcn.83.3.693; Lorber B, 1997, CLIN INFECT DIS, V24, P1, DOI 10.1093/clinids/24.1.1; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; PORTNOY DA, 1992, INFECT IMMUN, V60, P1263, DOI 10.1128/IAI.60.4.1263-1267.1992; Rahman MM, 2002, AM J CLIN NUTR, V75, P92, DOI 10.1093/ajcn/75.1.92; Rink L, 2001, BIOMETALS, V14, P367, DOI 10.1023/A:1012986225203; SEMBA RD, 1994, CLIN INFECT DIS, V19, P489, DOI 10.1093/clinids/19.3.489; Simonyte Sandrita, 2003, Medicina (Kaunas), V39, P767; Smith J C Jr, 1980, Ann N Y Acad Sci, V355, P62, DOI 10.1111/j.1749-6632.1980.tb21328.x; Stephensen CB, 2001, ANNU REV NUTR, V21, P167, DOI 10.1146/annurev.nutr.21.1.167; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Todd WR, 1934, AM J PHYSIOL, V107, P146, DOI 10.1152/ajplegacy.1933.107.1.146; Villamor E, 2005, CLIN MICROBIOL REV, V18, P446, DOI 10.1128/CMR.18.3.446-464.2005; WEST KP, 1989, ANNU REV NUTR, V9, P63, DOI 10.1146/annurev.nu.09.070189.000431; Yamada H, 2007, J NUTR, V137, P2696, DOI 10.1093/jn/137.12.2696; Yang Y, 2011, NUTRITION, V27, P227, DOI 10.1016/j.nut.2009.11.024	30	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137463	10.1371/journal.pone.0137463	http://dx.doi.org/10.1371/journal.pone.0137463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26351852	gold, Green Published, Green Submitted			2022-12-26	WOS:000360932800089
J	Granados, ML; Hudson, LG; Samudio-Ruiz, SL				Granados, Michaela L.; Hudson, Laurie G.; Samudio-Ruiz, Sabrina L.			Contributions of the Epidermal Growth Factor Receptor to Acquisition of Platinum Resistance in Ovarian Cancer Cells	PLOS ONE			English	Article							CISPLATIN-INDUCED ACTIVATION; RANDOMIZED PHASE-III; DNA METHYLATION; MONOCLONAL-ANTIBODY; REDOX REGULATION; EGF-RECEPTOR; CHEMOTHERAPY; ERLOTINIB; CARBOPLATIN; DECITABINE	Acquisition of platinum resistance following first line platinum/taxane therapy is commonly observed in ovarian cancer patients and prevents clinical effectiveness. There are few options to prevent platinum resistance; however, demethylating agents have been shown to resensitize patients to platinum therapy thereby demonstrating that DNA methylation is a critical contributor to the development of platinum resistance. We previously reported the Epidermal Growth Factor Receptor (EGFR) is a novel regulator of DNA methyltransferase (DNMT) activity and DNA methylation. Others have shown that EGFR activation is linked to cisplatin treatment and platinum resistance. We hypothesized that cisplatin induced activation of the EGFR mediates changes in DNA methylation associated with the development of platinum resistance. To investigate this, we evaluated EGFR signaling and DNMT activity after acute cisplatin exposure. We also developed an in vitro model of platinum resistance to examine the effects of EGFR inhibition on acquisition of cisplatin resistance. Acute cisplatin treatment activates the EGFR and downstream signaling pathways, and induces an EGFR mediated increase in DNMT activity. Cisplatin resistant cells also showed increased DNMT activity and global methylation. EGFR inhibition during repeated cisplatin treatments generated cells that were more sensitive to cisplatin and did not develop increases in DNA methylation or DNMT activity compared to controls. These findings suggest that activation of EGFR during platinum treatment contributes to the development of platinum resistance. Furthermore, EGFR inhibition may be an effective strategy at attenuating the development of platinum resistance thereby enhancing the effectiveness of chemotherapeutic treatment in ovarian cancer.	[Granados, Michaela L.; Hudson, Laurie G.; Samudio-Ruiz, Sabrina L.] Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA	University of New Mexico	Samudio-Ruiz, SL (corresponding author), Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA.	SRuiz@salud.unm.edu			National Cancer Institute of the National Institutes of Health [K01CA172591]; NATIONAL CANCER INSTITUTE [K01CA172591] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R25HG007630] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number K01CA172591. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asadollahi R, 2010, GYNECOL ONCOL, V118, P81, DOI 10.1016/j.ygyno.2010.03.015; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Benhar M, 2002, ONCOGENE, V21, P8723, DOI 10.1038/sj.onc.1205980; Blank SV, 2010, GYNECOL ONCOL, V119, P451, DOI 10.1016/j.ygyno.2010.08.008; Chang XF, 2010, CANCER RES, V70, P2870, DOI 10.1158/0008-5472.CAN-09-3427; Chiarugi P, 2003, TRENDS BIOCHEM SCI, V28, P509, DOI 10.1016/S0968-0004(03)00174-9; Deavall DG, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/645460; Denis H, 2011, EMBO REP, V12, P647, DOI 10.1038/embor.2011.110; Erdlenbruch B, 2001, EUR J CLIN PHARMACOL, V57, P393, DOI 10.1007/s002280100319; Fang F, 2014, CLIN CANCER RES, V20, P6504, DOI 10.1158/1078-0432.CCR-14-1553; Fang F, 2014, ONCOTARGET, V5, P3579, DOI 10.18632/oncotarget.1961; Fang F, 2010, CANCER-AM CANCER SOC, V116, P4043, DOI 10.1002/cncr.25204; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gifford G, 2004, CLIN CANCER RES, V10, P4420, DOI 10.1158/1078-0432.CCR-03-0732; Glasspool RM, 2014, BRIT J CANCER, V110, P1923, DOI 10.1038/bjc.2014.116; Gui T, 2012, CANCER EPIDEMIOL, V36, P490, DOI 10.1016/j.canep.2012.06.005; Hahne JC, 2012, ONCOL REP, V28, P2023, DOI 10.3892/or.2012.2041; Hiraishi Y, 2008, PATHOL ONCOL RES, V14, P39, DOI 10.1007/s12253-008-9020-5; Hirte H, 2010, GYNECOL ONCOL, V118, P308, DOI 10.1016/j.ygyno.2010.05.005; Hirte HW, 2013, ONCOTARGETS THER, V6, DOI 10.2147/OTT.S30373; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Hudson LG, 2009, FUTURE ONCOL, V5, P323, DOI 10.2217/FON.09.10; Garces AHI, 2015, CANCER CHEMOTH PHARM, V75, P221, DOI 10.1007/s00280-014-2581-y; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Koti M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-549; Li M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-34; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064; Lu R, 2007, J BIOL CHEM, V282, P12249, DOI 10.1074/jbc.M608525200; Ludwig T, 2004, KIDNEY INT, V66, P196, DOI 10.1111/j.1523-1755.2004.00720.x; Ma L, 2014, ONCOL LETT, V8, P921, DOI 10.3892/ol.2014.2224; Matei D, 2012, CANCER RES, V72, P2197, DOI 10.1158/0008-5472.CAN-11-3909; Matei DE, 2010, GYNECOL ONCOL, V116, P195, DOI 10.1016/j.ygyno.2009.09.043; Meng F, 2013, BRIT J CANCER, V108, P579, DOI 10.1038/bjc.2013.10; Murphy M, 2011, DRUG RESIST UPDATE, V14, P177, DOI 10.1016/j.drup.2011.02.004; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Peng DJ, 2010, BIOCHEM BIOPH RES CO, V394, P600, DOI 10.1016/j.bbrc.2010.03.029; Pujade-Lauraine E, 2014, J CLIN ONCOL, V32, P1302, DOI 10.1200/JCO.2013.51.4489; Romero I, 2012, ENDOCRINOLOGY, V153, P1593, DOI 10.1210/en.2011-2123; Samudio-Ruiz S, 2014, MED CHEM; Samudio-Ruiz SL, 2012, EPIGENETICS-US, V7, P216, DOI 10.4161/epi.7.3.19273; Sheng Q, 2011, BRIT J CANCER, V104, P1241, DOI 10.1038/bjc.2011.62; Shi Z, 2009, ONCOL REP, V21, P483, DOI 10.3892/or_00000248; Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siwak DR, 2010, J ONCOL, V2010, DOI 10.1155/2010/568938; Tang Y, 2012, STEM CELLS, V30, P2645, DOI 10.1002/stem.1225; Truong TH, 2012, BIOCHEMISTRY-US, V51, P9954, DOI 10.1021/bi301441e; Vergote IB, 2014, J CLIN ONCOL, V32, P320, DOI 10.1200/JCO.2013.50.5669; Wang YN, 2014, CANCER RES, V74, P4922, DOI 10.1158/0008-5472.CAN-14-1022; Winograd-Katz SE, 2006, ONCOGENE, V25, P7381, DOI 10.1038/sj.onc.1209737; Yoshida T, 2008, FEBS LETT, V582, P4125, DOI 10.1016/j.febslet.2008.11.010; Yue P, 2012, ONCOGENE, V31, P2309, DOI 10.1038/onc.2011.409; Zeineldin R, 2010, J ONCOL, V2010, DOI 10.1155/2010/414676; Zeller C, 2012, ONCOGENE, V31, P4567, DOI 10.1038/onc.2011.611	55	24	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136893	10.1371/journal.pone.0136893	http://dx.doi.org/10.1371/journal.pone.0136893			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26351843	gold, Green Published, Green Submitted			2022-12-26	WOS:000360932800053
J	McCullough, LE; Miller, EE; Wang, Q; Li, JY; Liu, L; Li, H; Zhang, J; Smith, JS				McCullough, Lauren E.; Miller, Erline E.; Wang, Qiong; Li, Jia-yuan; Liu, Li; Li, Hui; Zhang, Jing; Smith, Jennifer S.			Cross-Sectional Associations between Body Size, Circulating Sex-Steroid Hormones and IGF Components among Healthy Chinese Women	PLOS ONE			English	Article							BREAST-CANCER RISK; GROWTH-FACTOR (IGF)-I; PROGESTERONE-RECEPTOR STATUS; PREMENOPAUSAL WOMEN; BINDING PROTEIN-3; MASS INDEX; ENERGY-BALANCE; INSULIN-RESISTANCE; POOLED ANALYSIS; FACTOR-I	The incidence of breast cancer has increased in Asian countries and rates of hormone receptor (HR) negative breast cancer exceed those of Western countries. Epidemiologic data suggest that the association between body size and BC risk may vary by HR status, and could differ geographically. While body size may influence BC risk by moderating the synthesis and metabolism of circulating sex-steroid hormones, insulin-like growth factor (IGF)-1 and related binding proteins, there is a dearth of literature among Asian women. We aimed to examine these specific associations in a sample of Chinese women. In Sichuan Province 143 women aged >= 40 years were recruited through outpatient services (20112012). Questionnaires, anthropometric measurements, and blood samples were utilized for data collection and linear regression was applied in data analyses. Among women <50 years we observed a non-monotonic positive association between body mass index (BMI) and 17 beta-estradiol, and a reversed J-shaped association between BMI and IGF-1 (p <= 0.05). We observed similar associations between waist-to-hip ratio and these markers. Our finding of augmented IGF-1 among women with low body mass may have implications for understanding breast tumor heterogeneity in diverse populations and should be evaluated in larger prospective studies with cancer outcomes.	[McCullough, Lauren E.; Miller, Erline E.; Li, Jia-yuan; Smith, Jennifer S.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Wang, Qiong; Li, Jia-yuan; Li, Hui] Sichuan Univ, Dept Epidemiol & Biostat, West China Sch Publ Hlth, Chengdu 610041, Peoples R China; [Liu, Li; Zhang, Jing] Chengdu Womens & Childrens Cent Hosp, Comprehens Guidance Ctr Womens Hlth, Chengdu 610015, Peoples R China; [McCullough, Lauren E.; Smith, Jennifer S.] Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill; Sichuan University	Li, JY (corresponding author), Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, 135 Dauer Dr, Chapel Hill, NC 27599 USA.	lijiayuan@scu.edu.cn	li, jia/GVT-7587-2022		Ministry of Education Fundamental Research Foundation for Central Universities, P.R. China [2010SCU21001]; National Cancer Institute [R25CA057726]	Ministry of Education Fundamental Research Foundation for Central Universities, P.R. China; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This work was funded by the Ministry of Education Fundamental Research Foundation for Central Universities, P.R. China (http://www.moe.edu.cn/publicfiles/business/htmlfiles/moe/moe_2792/index.html; Grant no. 2010SCU21001); National Cancer Institute (http://www.cancer.gov/researchandfunding; Grant no. R25CA057726). Funders had no role in the study.	Allen NE, 2003, CANCER CAUSE CONTROL, V14, P65, DOI 10.1023/A:1022518321634; Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Barnett JB, 2001, NUTR CANCER, V41, P47, DOI 10.1207/S15327914NC41-1&amp;2_6; Beckmann MW, 1997, J MOL MED, V75, P429, DOI 10.1007/s001090050128; Bernstein L, 2002, J MAMMARY GLAND BIOL, V7, P3, DOI 10.1023/A:1015714305420; Blackmore KM, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-15; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Chen WY, 2007, NAT CLIN PRACT ONCOL, V4, P415, DOI 10.1038/ncponc0851; COLDITZ GA, 1993, CANCER-AM CANCER SOC, V71, P1480, DOI 10.1002/cncr.2820710413; DeLellis K, 2004, CANCER EPIDEM BIOMAR, V13, P1444; Diorio C, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2093; Ellis MJ, 1998, BREAST CANCER RES TR, V52, P175, DOI 10.1023/A:1006127621512; Fair AM, 2007, CANCER DETECT PREV, V31, P214, DOI 10.1016/j.cdp.2007.04.003; Fowke JH, 2010, ENDOCR-RELAT CANCER, V17, P51, DOI 10.1677/ERC-09-0023; Freeman EW, 2010, MENOPAUSE, V17, P718, DOI [10.1097/gme.0b013e3181db9f8b, 10.1097/gme.0b013e3181cec85d]; Gennigens C, 2006, CRIT REV ONCOL HEMAT, V58, P124, DOI 10.1016/j.critrevonc.2005.10.003; Gram IT, 2006, INT J OBESITY, V30, P1623, DOI 10.1038/sj.ijo.0803324; Green M, 2008, ASIA-PAC J CLIN ONCO, V4, pS5, DOI 10.1111/j.1743-7563.2008.00191.x; Greenland S, 2002, INT J EPIDEMIOL, V31, P1030, DOI 10.1093/ije/31.5.1030; Harris Neil S, 2004, MLO Med Lab Obs, V36, P22; Harris NS, 2004, MLO MED LAB OBS, V36, P2; Henderson KD, 2006, CANCER EPIDEM BIOMAR, V15, P2298, DOI 10.1158/1055-9965.EPI-06-0344; Holmes MD, 2002, CANCER EPIDEM BIOMAR, V11, P862; Iwasaki M, 2007, ANN EPIDEMIOL, V17, P304, DOI 10.1016/j.annepidem.2006.09.003; Kaaks R, 2001, P NUTR SOC, V60, P91, DOI 10.1079/PNS200070; Kaaks R, 1996, CANCER CAUSE CONTROL, V7, P605, DOI 10.1007/BF00051703; Kalme T, 2003, J STEROID BIOCHEM, V86, P197, DOI 10.1016/S0960-0760(03)00268-1; Key TJ, 2013, LANCET ONCOL, V14, P1009, DOI 10.1016/S1470-2045(13)70301-2; Key TJ, 2001, P NUTR SOC, V60, P81, DOI 10.1079/PNS200068; Lahmann PH, 2004, INT J CANCER, V111, P762, DOI 10.1002/ijc.20315; Lorincz AM, 2006, ENDOCR-RELAT CANCER, V13, P279, DOI 10.1677/erc.1.00729; Lukanova A, 2004, EUR J ENDOCRINOL, V150, P161, DOI 10.1530/eje.0.1500161; Lukanova A, 2002, CANCER CAUSE CONTROL, V13, P509, DOI 10.1023/A:1016392129279; Maiti B, 2010, BREAST CANCER RES TR, V121, P479, DOI 10.1007/s10549-009-0591-y; Missmer SA, 2006, CANCER EPIDEM BIOMAR, V15, P972, DOI 10.1158/1055-9965.EPI-05-0848; Muti P, 2004, ANN NY ACAD SCI, V1028, P273, DOI 10.1196/annals.1322.031; Nagata C, 2011, CANCER CAUSE CONTROL, V22, P581, DOI 10.1007/s10552-011-9731-x; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Panzer C, 2006, J SEX MED, V3, P104, DOI 10.1111/j.1743-6109.2005.00198.x; Paxton RJ, 2013, J CLIN ENDOCR METAB, V98, pE485, DOI 10.1210/jc.2012-2782; Peacock SL, 1999, AM J EPIDEMIOL, V149, P339, DOI 10.1093/oxfordjournals.aje.a009818; Pichard C, 2008, MATURITAS, V60, P19, DOI 10.1016/j.maturitas.2008.03.002; Renehan AG, 2006, ENDOCR-RELAT CANCER, V13, P273, DOI 10.1677/erc.1.01219; Sachdev D, 2001, ENDOCR-RELAT CANCER, V8, P197, DOI 10.1677/erc.0.0080197; Selvin S., 2004, STAT ANAL EPIDEMIOLO; Setiawan VW, 2009, AM J EPIDEMIOL, V169, P1251, DOI 10.1093/aje/kwp036; Song QK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072175; Suzuki R, 2006, INT J CANCER, V119, P1683, DOI 10.1002/ijc.22034; Tehard B, 2006, INT J OBESITY, V30, P156, DOI 10.1038/sj.ijo.0803133; Tworoger SS, 2006, CANCER EPIDEM BIOMAR, V15, P2494, DOI 10.1158/1055-9965.EPI-06-0671; URSIN G, 1995, EPIDEMIOLOGY, V6, P137, DOI 10.1097/00001648-199503000-00009; van den Brandt PA, 2000, AM J EPIDEMIOL, V152, P514, DOI 10.1093/aje/152.6.514; Verkasalo PK, 2001, CANCER CAUSE CONTROL, V12, P47, DOI 10.1023/A:1008929714862; Vongpatanasin W, 2003, J AM COLL CARDIOL, V41, P1358, DOI 10.1016/S0735-1097(03)00156-6; Voskuil DW, 2001, CANCER CAUSE CONTROL, V12, P951, DOI 10.1023/A:1013708627664; Wang Q, 2011, DNA CELL BIOL, V30, P585, DOI 10.1089/dna.2010.1195; Wei SY, 2009, OBESITY, V17, P1070, DOI 10.1038/oby.2008.641; Yang XR, 2011, JNCI-J NATL CANCER I, V103, P250, DOI 10.1093/jnci/djq526; Yasui Y, 1999, CANCER CAUSE CONTROL, V10, P431, DOI 10.1023/A:1008970121595	60	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137686	10.1371/journal.pone.0137686	http://dx.doi.org/10.1371/journal.pone.0137686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352264	Green Published, Green Submitted, gold			2022-12-26	WOS:000360932800109
J	Meier, T; Senftleben, K; Deumelandt, P; Christen, O; Riedel, K; Langer, M				Meier, Toni; Senftleben, Karolin; Deumelandt, Peter; Christen, Olaf; Riedel, Katja; Langer, Martin			Healthcare Costs Associated with an Adequate Intake of Sugars, Salt and Saturated Fat in Germany: A Health Econometrical Analysis	PLOS ONE			English	Article							SODIUM CONSUMPTION; ECONOMIC BURDEN; GLOBAL BURDEN; RISK-FACTORS; CANCER RISK; DIETARY; OBESITY; SENSITIVITY; DISEASE; ADULTS	Non-communicable diseases (NCDs) represent not only the major driver for quality-restricted and lost life years; NCDs and their related medical treatment costs also pose a substantial economic burden on healthcare and intra-generational tax distribution systems. The main objective of this study was therefore to quantify the economic burden of unbalanced nutrition in Germany-in particular the effects of an excessive consumption of fat, salt and sugar-and to examine different reduction scenarios on this basis. In this study, the avoidable direct cost savings in the German healthcare system attributable to an adequate intake of saturated fatty acids (SFA), salt and sugar (mono- & disaccharides, MDS) were calculated. To this end, disease-specific healthcare cost data from the official Federal Health Monitoring for the years 2002-2008 and disease-related risk factors, obtained by thoroughly searching the literature, were used. A total of 22 clinical endpoints with 48 risk-outcome pairs were considered. Direct healthcare costs attributable to an unbalanced intake of fat, salt and sugar are calculated to be 16.8 billion EUR (CI95%: 6.3-24.1 billion EUR) in the year 2008, which represents 7% (CI95% 2%-10%) of the total treatment costs in Germany (254 billion EUR). This is equal to 205 EUR per person annually. The excessive consumption of sugar poses the highest burden, at 8.6 billion EUR (CI95%: 3.0-12.1); salt ranks 2nd at 5.3 billion EUR (CI95%: 3.2-7.3) and saturated fat ranks 3rd at 2.9 billion EUR (CI95%: 32 million-4.7 billion). Predicted direct healthcare cost savings by means of a balanced intake of sugars, salt and saturated fat are substantial. However, as this study solely considered direct medical treatment costs regarding an adequate consumption of fat, salt and sugars, the actual societal and economic gains, resulting both from direct and indirect cost savings, may easily exceed 16.8 billion EUR.	[Meier, Toni; Senftleben, Karolin; Deumelandt, Peter; Christen, Olaf] Univ Halle Wittenberg, Inst Agr & Nutr Sci, D-06108 Halle, Saale, Germany; [Riedel, Katja; Langer, Martin] BRAIN Biotechnol Res & Informat Network AG, Zwingenberg, Germany	Martin Luther University Halle Wittenberg	Meier, T (corresponding author), Univ Halle Wittenberg, Inst Agr & Nutr Sci, D-06108 Halle, Saale, Germany.	toni.meier@landw.uni-halle.de	MUÑOZ, ROSA ANA/H-3964-2018; Christen, Olaf/C-1093-2012; Meier, Toni/AAB-1704-2021	MUÑOZ, ROSA ANA/0000-0002-7504-2163; Meier, Toni/0000-0001-6056-0665	German Federal Ministry of Education and Research (BMBF) as part of the Strategic Alliance NatLifE [FKZ 031A206-B]; Biotechnology Research And Information Network AG (BRAIN AG)	German Federal Ministry of Education and Research (BMBF) as part of the Strategic Alliance NatLifE(Federal Ministry of Education & Research (BMBF)); Biotechnology Research And Information Network AG (BRAIN AG)	This study was partially funded by the German Federal Ministry of Education and Research (BMBF) as part of the Strategic Alliance NatLifE 2020 (grant no. FKZ 031A206-B) as well as by Biotechnology Research And Information Network AG (BRAIN AG). KR and ML are paid employees of BRAIN AG and they were involved in designing the study, data discussion, the decision to publish and the internal review of the manuscript.	Ajslev TA, 2011, INT J OBESITY, V35, P522, DOI 10.1038/ijo.2011.27; [Anonymous], GES KRANK DIAGN KRAN; [Anonymous], VERBR DEUTSCHL JAHR; [Anonymous], GES GES RECH KRANKH; [Anonymous], GES GES RECH GES VOL; Arab-Kohlmeier L, 1993, ERNAHRUNGSABHANGIGE, V27; Arnold M, 2015, LANCET ONCOL, V16, P36, DOI 10.1016/S1470-2045(14)71123-4; BARNARD ND, 1995, PREV MED, V24, P646, DOI 10.1006/pmed.1995.1100; Basu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057873; Behrens G, 2014, CAN MED ASSOC J, V186, pE457, DOI 10.1503/cmaj.140025; Bloom DE, 2011, GLOBAL EC BURDEN NON, DOI DOI 10.1192/BJP.184.5.393; Bonner G., 2003, J HYPERTONIE AUSTRIA, V7, P16; BOSTICK RM, 1994, CANCER CAUSE CONTROL, V5, P38, DOI 10.1007/BF01830725; Caudarella R, 2009, J Endocrinol Invest, V32, P15; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Deutsche Gesellschaft fur Ernahrung, 2012, 12 ERN 2012 DTSCH GE; Deutsche Gesellschaft fur Ernahrung, 2006, EV LEITL FETTK PRAV; Deutsche Gesellschaft fur Ernahrung, 2015, EV LEITL FETTZ PRAV; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; Gallus S, 2011, CANCER CAUSE CONTROL, V22, P33, DOI 10.1007/s10552-010-9665-8; Grant RL., 2014, BMJ, V348, pf7450, DOI [DOI 10.1136/BMJ.F7450, 10.1136/bmj.f7450]; Harbour R, 2001, BRIT MED J, V323, P334, DOI 10.1136/bmj.323.7308.334; Hauner H, 2012, DEUT MED WOCHENSCHR, V137, P389, DOI 10.1055/s-0031-1298916; He F. J., 2013, BMJ, V346; Hjerpsted J, 2011, AM J CLIN NUTR, V94, P1479, DOI 10.3945/ajcn.111.022426; Institute for Health Metrics and Evaluation, 2010, GLOB BURD DIS STUD 2; Joffres MR, 2007, CAN J CARDIOL, V23, P437, DOI 10.1016/S0828-282X(07)70780-8; Kastner T, 2012, P NATL ACAD SCI USA, V109, P6868, DOI 10.1073/pnas.1117054109; Lamarche B, 2014, APPL PHYSIOL NUTR ME, V39, P1409, DOI 10.1139/apnm-2014-0141; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Malhotra A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6340; Marshall TA, 2014, J EVID-BASED DENT PR, V14, P56, DOI 10.1016/j.jebdp.2014.04.018; Max Rubner-Institut, 2008, NAT VERZ 2 ERG 2; Meier T, 2015, ERNAHRUNGS UMSCHAU, V62, pM80, DOI 10.4455/eu.2015.005; Meier T, 2014, APPETITE, V74, P20, DOI 10.1016/j.appet.2013.11.006; Melander O, 2006, J HYPERTENS, V24, P1475, DOI 10.1097/01.hjh.0000239280.89819.bc; Mensink GBM, 2013, BUNDESGESUNDHEITSBLA, V56, P786, DOI 10.1007/s00103-012-1656-3; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Moynihan PJ, 2014, J DENT RES, V93, P8, DOI 10.1177/0022034513508954; Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nestel PJ, 2008, J AM COLL NUTR, V27, p735S, DOI 10.1080/07315724.2008.10719751; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Otto MCD, 2012, AM J CLIN NUTR, V96, P397, DOI 10.3945/ajcn.112.037770; Palar K, 2009, AM J HEALTH PROMOT, V24, P49, DOI 10.4278/ajhp.080826-QUAN-164; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Rocchini AP, 2000, NUTR METAB CARDIOVAS, V10, P287; Saldana TM, 2007, EPIDEMIOLOGY, V18, P501, DOI 10.1097/EDE.0b013e3180646338; Scheidt-Nave C, 2013, BUNDESGESUNDHEITSBLA, V56, P661, DOI 10.1007/s00103-013-1670-0; Schmid A, 2005, SOZ PRAVENTIV MED, V50, P87, DOI 10.1007/s00038-004-4067-x; Schulz M, 2002, J NUTR, V132, P1335, DOI 10.1093/jn/132.6.1335; Sieri S, 2008, AM J CLIN NUTR, V88, P1304, DOI 10.3945/ajcn.2008.26090; SIGN, 1999, SIGN PUBL, V39; SIGN, 2014, GUID DEV HDB SIGN 50; Soerensen KV, 2014, AM J CLIN NUTR, V99, P984, DOI 10.3945/ajcn.113.077735; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Sullivan PW, 2007, OBESITY, V15, P3150, DOI 10.1038/oby.2007.375; Trasande L, 2013, INT J OBESITY, V37, P16, DOI 10.1038/ijo.2012.132; Tsugane S, 2004, BRIT J CANCER, V90, P128, DOI 10.1038/sj.bjc.6601511; UnitedHealth Group, 2010, 5 UNITEDHEALTH CTR H; Wang XQ, 2009, WORLD J GASTROENTERO, V15, P2204, DOI 10.3748/wjg.15.2204; Warren JJ, 2009, COMMUNITY DENT ORAL, V37, P116, DOI 10.1111/j.1600-0528.2008.00447.x; Weinberger MH, 2001, HYPERTENSION, V37, P429, DOI 10.1161/01.HYP.37.2.429; Welte R, 2000, EUR J PUBLIC HEALTH, V10, P31, DOI 10.1093/eurpub/10.1.31; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x; Woo J, 2009, J HUM HYPERTENS, V23, P451, DOI 10.1038/jhh.2008.156; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization, 2013, 66 WORLD HL IN PRESS	70	28	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135990	10.1371/journal.pone.0135990	http://dx.doi.org/10.1371/journal.pone.0135990			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352606	Green Submitted, Green Published, gold			2022-12-26	WOS:000360932800021
J	Micheletti, D; Dettori, MT; Micali, S; Aramini, V; Pacheco, I; Linge, CD; Foschi, S; Banchi, E; Barreneche, T; Quilot-Turion, B; Lambert, P; Pascal, T; Iglesias, I; Carbo, J; Wang, LR; Ma, RJ; Li, XW; Gao, ZS; Nazzicari, N; Troggio, M; Bassi, D; Rossini, L; Verde, I; Laurens, F; Arus, P; Aranzana, MJ				Micheletti, Diego; Dettori, Maria Teresa; Micali, Sabrina; Aramini, Valeria; Pacheco, Igor; Linge, Cassia Da Silva; Foschi, Stefano; Banchi, Elisa; Barreneche, Teresa; Quilot-Turion, Benedicte; Lambert, Patrick; Pascal, Thierry; Iglesias, Ignasi; Carbo, Joaquim; Wang, Li-rong; Ma, Rui-juan; Li, Xiong-wei; Gao, Zhong-shan; Nazzicari, Nelson; Troggio, Michela; Bassi, Daniele; Rossini, Laura; Verde, Ignazio; Laurens, Francois; Arus, Pere; Jose Aranzana, Maria			Whole-Genome Analysis of Diversity and SNP-Major Gene Association in Peach Germplasm	PLOS ONE			English	Article							PRUNUS-PERSICA L.; POPULATION-STRUCTURE; LINKAGE DISEQUILIBRIUM; GENOTYPE DATA; FRUIT CROPS; BATSCH; MAP; SELECTION; VARIABILITY; MARKERS	Peach was domesticated in China more than four millennia ago and from there it spread world-wide. Since the middle of the last century, peach breeding programs have been very dynamic generating hundreds of new commercial varieties, however, in most cases such varieties derive from a limited collection of parental lines (founders). This is one reason for the observed low levels of variability of the commercial gene pool, implying that knowledge of the extent and distribution of genetic variability in peach is critical to allow the choice of adequate parents to confer enhanced productivity, adaptation and quality to improved varieties. With this aim we genotyped 1,580 peach accessions (including a few closely related Prunus species) maintained and phenotyped in five germplasm collections (four European and one Chinese) with the International Peach SNP Consortium 9K SNP peach array. The study of population structure revealed the subdivision of the panel in three main populations, one mainly made up of Occidental varieties from breeding programs (POP1OCB), one of Occidental landraces (POP2OCT) and the third of Oriental accessions (POP3OR). Analysis of linkage disequilibrium (LD) identified differential patterns of genome-wide LD blocks in each of the populations. Phenotypic data for seven monogenic traits were integrated in a genome-wide association study (GWAS). The significantly associated SNPs were always in the regions predicted by linkage analysis, forming haplotypes of markers. These diagnostic haplotypes could be used for marker-assisted selection (MAS) in modern breeding programs.	[Micheletti, Diego; Arus, Pere; Jose Aranzana, Maria] IRTA, Ctr Recerca Agrigen CSIC IRTA UAB UB, Campus UAB, Barcelona, Spain; [Dettori, Maria Teresa; Micali, Sabrina; Aramini, Valeria; Verde, Ignazio] IRTA, Ctr Recerca Agrigen CSIC IRTA UAB UB, Campus UAB, Barcelona, Spain; [Pacheco, Igor; Linge, Cassia Da Silva; Rossini, Laura] Ctr Ric Frutticoltura, Consiglio Ric Agr Analisi Econ Agr CRA, Rome, Italy; [Foschi, Stefano] Univ Milan, DiSAA, Milan, Italy; [Banchi, Elisa; Troggio, Michela] Ctr Ric Prod Vegetali, Cesena, FC, Italy; [Barreneche, Teresa] FEM, Res & Innovat Ctr, San Michele All Adige, Italy; [Barreneche, Teresa] INRA, Biol Fruit & Pathol, UMR 1332, Villenave Dornon, France; [Quilot-Turion, Benedicte; Lambert, Patrick; Pascal, Thierry] Univ Bordeaux, Biol Fruit & Pathol, UMR 1332, Villenave Dornon, France; [Iglesias, Ignasi] INRA, Domaine St Maurice, GAFL UR1052, F-84143 Montfavet, France; [Carbo, Joaquim] IRTA, Estacio Expt Lleida, Lleida, Spain; [Wang, Li-rong] IRTA, Estacio Expt Mas Badia, Girona, Spain; [Ma, Rui-juan] CAAS, Zhenzhou Fruit Res Inst, Zhengzhou, Peoples R China; [Li, Xiong-wei; Gao, Zhong-shan] Jiangsu Acad Agr Sci, Inst Hort, Nanjing, Jiangsu, Peoples R China; [Nazzicari, Nelson; Rossini, Laura] Zhejiang Univ, Dept Hort, Hangzhou 310003, Zhejiang, Peoples R China; [Laurens, Francois] Parco Tecnol Padano, Lodi, Italy; [Laurens, Francois] INRA, Inst Rech Hort & Semences, UMR 1345, Beaucouze, France; [Laurens, Francois] Univ Angers, Inst Rech Hort & Semences, QUASAV, PRES LUNAM,UMR 1345,SFR 4207, Angers, France; Inst Rech Hort & Semences, UMR 1345, Agrocampus Ouest, Angers, France; [Pacheco, Igor] Univ Chile, INTA, Santiago, Chile; [Micheletti, Diego] Fondazione Edmund Mach FEM, Res & Innovat Ctr, TN San Michele All Adige, Italy	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Milan; Fondazione Edmund Mach; INRAE; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; INRAE; IRTA; IRTA; Chinese Academy of Agricultural Sciences; Zhengzhou Fruit Research Institute, CAAS; Jiangsu Academy of Agricultural Sciences; Zhejiang University; INRAE; Universite d'Angers; Institut Agro; Agrocampus Ouest; Universite d'Angers; Universidad de Chile; Fondazione Edmund Mach	Aranzana, MJ (corresponding author), IRTA, Ctr Recerca Agrigen CSIC IRTA UAB UB, Barcelona, Spain.	mariajose.aranzana@irta.cat	micali, sabrina/ABU-4540-2022; Gao, zhongshan/C-2582-2008; Aranzana, Maria Jose/H-7799-2015; Bassi, Daniele/C-2952-2012; Cruz, Igor Pacheco/A-8507-2015; Cruz, Igor Pacheco/J-1193-2019; da Silva Linge, Cassia/C-9538-2019; Verde, Ignazio/K-6348-2019; Carbo, Joaquim/AAB-3350-2019; Rossini, Laura/J-7873-2012; nazzicari, nelson/ABE-1344-2021; Arús, Pere/F-6443-2015; Quilot-Turion, Bénédicte/AAT-2958-2020; Quilot-Turion, Bénédicte/H-9106-2016	Aranzana, Maria Jose/0000-0002-0240-8021; Cruz, Igor Pacheco/0000-0001-5057-0464; Cruz, Igor Pacheco/0000-0001-5057-0464; da Silva Linge, Cassia/0000-0003-4760-1359; Rossini, Laura/0000-0001-6509-9177; nazzicari, nelson/0000-0003-2710-9885; Arús, Pere/0000-0003-0939-8038; Quilot-Turion, Bénédicte/0000-0003-4095-1399; Quilot-Turion, Bénédicte/0000-0003-4095-1399; BARRENECHE, Teresa/0000-0002-7852-1418; Micheletti, Diego/0000-0001-9175-9853; Micali, Sabrina/0000-0002-2086-7467; Bassi, Daniele/0000-0002-8966-3534; Gao, zhongshan/0000-0001-6944-9955; Banchi, Elisa/0000-0002-6598-0447	EU [FP7-265582]; Ministero delle Politiche Agricole Alimentari e Forestali - Italy (MiPAAF) [DM14999/7303/08, DM 14658/7303/10]; Spanish Ministry of Science and Innovation [AGL2012-40228-C02-01]; INIA [RF2012-00024-C04-04]	EU(European Commission); Ministero delle Politiche Agricole Alimentari e Forestali - Italy (MiPAAF); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); INIA(Instituto de Investigacion Agropecuaria (INIA))	This work has been funded by the EU seventh Framework Programme (http://ec.europa.eu/research/fp7/index_en.cfm) through the project "FruitBreedomics: Integrated Approach for increasing breeding efficiency in fruit tree crops" (Grant #FP7-265582; http://fruitbreedomics.com/); by the Ministero delle Politiche Agricole Alimentari e Forestali - Italy (MiPAAF, http://www.politicheagricole.it) through the project "DRUPOMICS: Sequenziamento del genoma del pesco ed utilizzo della sequenza in programmi di miglioramento della qualita del frutto del pesco e della resistenza alle malattie" (Grant # DM14999/7303/08) and "ESPLORA: Esplorazione della biodiversita vegetale ed animale alla ricerca di alleli superiori da inserire nei programmi avanzati di miglioramento genetico a sostegno dell'agricoltura nazionale" (Grant #DM 14658/7303/10); by the Spanish Ministry of Science and Innovation (http://www.micinn.es/) through the project AGL2012-40228-C02-01 (uso de la secuencia genomica para la caracterizacion de la variabilidad intraclonal e interespecifica en Melocotonero y almendro) and by the INIA (http://www.inia.es/) through the Project RF2012-00024-C04-04 ("conservacion y caracterizacion de germoplasma introducido"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2002, ACTA HORTIC, P145, DOI 10.17660/ActaHortic.2002.575.14; Abbott A. G., 2008, The peach: botany, production and uses, P85, DOI 10.1079/9781845933869.0085; Ahmad R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-569; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Aranzana MJ, 2003, THEOR APPL GENET, V106, P1341, DOI 10.1007/s00122-002-1128-5; Arus P, 2005, PLANT BREEDING REV, P175; Benjamini Y, 2001, ANN STAT, V29, P1165; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; BYRNE DH, 1990, J HERED, V81, P68, DOI 10.1093/oxfordjournals.jhered.a110927; Cao K, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0415-1; Cao K, 2012, TREE GENET GENOMES, V8, P975, DOI 10.1007/s11295-012-0477-8; Dettori MT, 2001, GENOME, V44, P783, DOI 10.1139/g01-065; Dirlewanger E, 2007, TREE GENET GENOMES, V3, P1, DOI 10.1007/s11295-006-0053-1; Dirlewanger E, 2004, P NATL ACAD SCI USA, V101, P9891, DOI 10.1073/pnas.0307937101; Dirlewanger E, 1998, THEOR APPL GENET, V97, P888, DOI 10.1007/s001220050969; Eduardo I, 2014, TREE GENET GENOMES, V10, P1695, DOI 10.1007/s11295-014-0789-y; Eduardo I, 2013, TREE GENET GENOMES, V9, P189, DOI 10.1007/s11295-012-0546-z; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falchi R, 2013, PLANT J, V76, P175, DOI 10.1111/tpj.12283; Faust M., 1995, Horticultural Reviews, V17, P331, DOI 10.1002/9780470650585.ch10; Frett TJ, 2014, TREE GENET GENOMES, V10, P367, DOI 10.1007/s11295-013-0692-y; Hesse C. O., 1975, Advances in fruit breeding. Temperate fruits., P285; Jauregui B, 2001, THEOR APPL GENET, V102, P1169, DOI 10.1007/s001220000511; Aranzana MJ, 2012, TREE GENET GENOMES, V8, P1359, DOI 10.1007/s11295-012-0523-6; Aranzana MJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-69; Lambert P, 2011, TREE GENET GENOMES, V7, P1057, DOI 10.1007/s11295-011-0394-2; Li XW, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-84; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Mangin B, 2012, HEREDITY, V108, P285, DOI 10.1038/hdy.2011.73; Mnejja M, 2010, TREE GENET GENOMES, V6, P689, DOI 10.1007/s11295-010-0284-z; Monet R, 1996, AGRONOMIE, V16, P321, DOI 10.1051/agro:19960505; Ogundiwin EA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-587; Pacheco I, 2014, TREE GENET GENOMES, V10, P1223, DOI 10.1007/s11295-014-0756-7; Peace CP, 2005, MOL BREEDING, V16, P21, DOI 10.1007/s11032-005-0828-3; Pfaff CL, 2001, AM J HUM GENET, V68, P198, DOI 10.1086/316935; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Romeu JF, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-52; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; SCORZA R, 1985, J AM SOC HORTIC SCI, V110, P547; Soto-Cerda BJ, 2012, GENETIC DIVERSITY IN PLANTS, P29; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vendramin E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090574; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Xie RJ, 2010, SCI HORTIC-AMSTERDAM, V125, P622, DOI 10.1016/j.scienta.2010.05.015; Yamamoto T, 2005, J JPN SOC HORTIC SCI, V74, P204, DOI 10.2503/jjshs.74.204; Yang NN, 2013, TREE GENET GENOMES, V9, P573, DOI 10.1007/s11295-012-0580-x; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	49	67	74	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136803	10.1371/journal.pone.0136803	http://dx.doi.org/10.1371/journal.pone.0136803			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352671	Green Published, gold, Green Submitted			2022-12-26	WOS:000360932800049
J	Saba, ES; Gueyffier, L; Danjoy, ML; Vanhems, P; Pozzetto, B; Sobh, M; Pottel, H; Michallet, M; Zrein, MA				Saba, Esber S.; Gueyffier, Lucie; Danjoy, Marie-Laure; Vanhems, Philippe; Pozzetto, Bruno; Sobh, Mohamad; Pottel, Hans; Michallet, Mauricette; Zrein, Maan A.			Trypanosoma-Cruzi Cross-Reactive Antibodies Longitudinal Follow-Up: A Prospective Observational Study in Hematopoietic Stem Cell Transplantation	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; IMMUNE RECONSTITUTION; T-CELLS; TRANSMISSION; VACCINATION; MYELOMA; DONORS; RISK; CMV	Antibodies named TcCRA "Trypanosoma cruzi Cross Reactive Antibodies" were detected in 47% of blood donors from French population unexposed to the parasite. In order to evaluate the passive or active transmissibility of TcCRA and further characterize its role and etiology, we have conducted a study in a cohort of 47 patients who underwent allogeneic Hematopoietic Stem Cell Transplantations (allo-HSCT). Donors and recipients were tested for TcCRA prior to transplantation. Recipients were further tested during follow-up after transplantation. Demographical, clinical and biological data were collected. Our primary end-point was to assess the risk of TcCRA acquisition after transplantation. During this initial analysis, we observed no seroconversion in patients receiving cells from TcCRA negative donors (n = 23) but detected seroconversion in 4 out of 24 patients who received hematopoietic stem cells from positive donors. Here, we are discussing possible scenarios to explain TcCRA-immune status in recipient after transplantation.	[Saba, Esber S.; Gueyffier, Lucie; Danjoy, Marie-Laure; Zrein, Maan A.] INFYN Biomarkers, Lyon, France; [Vanhems, Philippe; Sobh, Mohamad; Michallet, Mauricette; Zrein, Maan A.] Hosp Civils Lyon, Lyon, France; [Saba, Esber S.; Pozzetto, Bruno] Fac Med Jacques Lisfranc, GIMAP EA3064, Labs Bacteriol Virol, St Etienne, France; [Pottel, Hans] Katholieke Univ Leuven, Interdisciplinary Res Ctr, Kortrijk, Belgium	CHU Lyon; KU Leuven	Zrein, MA (corresponding author), INFYN Biomarkers, Lyon, France.	mzrein@infynity-biomarkers.com	Pottel, Hans/AAD-9444-2019; ZREIN, Maan/C-7666-2018	Pottel, Hans/0000-0003-0074-8919; ZREIN, Maan/0000-0002-3301-4252; POZZETTO, Bruno/0000-0002-2603-8467; Saba, Esber/0000-0003-1525-6394	INFYNITY-Biomarkers	INFYNITY-Biomarkers	This study was funded by INFYNITY-Biomarkers. Esber S. Saba, Lucie Gueyffier, Marie-Laure Danjoy and Maan A. Zrein are employed by INFYNITY-Biomarkers. Infynity-Biomarkers provided support in the form of salaries for authors [Esber S. Saba, Lucie Gueyffier, Marie-Laure Danjoy, Maan A. Zrein], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abu-Khader A, 2013, EUR J HAEMATOL, V91, P534, DOI 10.1111/ejh.12187; Avigan D, 2001, BIOL BLOOD MARROW TR, V7, P171, DOI 10.1053/bbmt.2001.v7.pm11302551; Behzad-Behbahani A, 2005, TRANSPL P, V37, P3211, DOI 10.1016/j.transproceed.2005.07.007; Bemark M, 2012, CLIN EXP IMMUNOL, V167, P15, DOI 10.1111/j.1365-2249.2011.04469.x; Bosch M, 2012, CURR OPIN HEMATOL, V19, P324, DOI 10.1097/MOH.0b013e328353bc7d; Dykewicz CA, 2001, CLIN INFECT DIS, V33, P139, DOI 10.1086/321805; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Foglietta M, 2013, BONE MARROW TRANSPL, V48, P269, DOI 10.1038/bmt.2012.132; LUM LG, 1986, BLOOD, V67, P582; Neelapu S, 2005, BONE MARROW TRANSPL, V36, P315, DOI 10.1038/sj.bmt.1705057; Popgeorgiev N, 2013, J CLIN VIROL, V58, P722, DOI 10.1016/j.jcv.2013.10.001; Popgeorgiev N, 2013, J INFECT DIS, V208, P1042, DOI 10.1093/infdis/jit292; Saba ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074493; Scheinberg P, 2009, BLOOD, V114, P5071, DOI 10.1182/blood-2009-04-214684; Storek J, 2004, BONE MARROW TRANSPL, V33, P337, DOI 10.1038/sj.bmt.1704336; Thiele T, 2011, TRANSFUSION, V51, P2620, DOI 10.1111/j.1537-2995.2011.03203.x	16	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137240	10.1371/journal.pone.0137240	http://dx.doi.org/10.1371/journal.pone.0137240			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26351849	Green Published, Green Submitted, gold			2022-12-26	WOS:000360932800071
J	Ichikawa, K; Fujiwara, T; Nakayama, T				Ichikawa, Kayoko; Fujiwara, Takeo; Nakayama, Takeo			Effectiveness of Home Visits in Pregnancy as a Public Health Measure to Improve Birth Outcomes	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PRETERM BIRTH; PRENATAL-CARE; 1ST-TIME MOTHERS; WEIGHT INFANTS; BORN PRETERM; RISK-FACTORS; PROGRAM; METAANALYSIS; VISITATION	Background Birth outcomes, such as preterm birth, low birth weight (LBW), and small for gestational age (SGA), are crucial indicators of child development and health. Purpose To evaluate whether home visits from public health nurses for high-risk pregnant women prevent adverse birth outcomes. Methods In this quasi-experimental cohort study in Kyoto city, Japan, high-risk pregnant women were defined as teenage girls (range 14-19 years old), women with a twin pregnancy, women who registered their pregnancy late, had a physical or mental illness, were of single marital status, non-Japanese women who were not fluent in Japanese, or elderly primiparas. We collected data from all high-risk pregnant women at pregnancy registration interviews held at a public health centers between 1 July 2011 and 30 June 2012, as well as birth outcomes when delivered from the Maternal and Child Health Handbook (N = 964), which is a record of prenatal check-ups, delivery, child development and vaccinations. Of these women, 622 women were selected based on the home-visit program propensity score-matched sample (pair of N = 311) and included in the analysis. Data were analyzed between January and June 2014. Results In the propensity score-matched sample, women who received the home-visit program had lower odds of preterm birth (odds ratio [OR], 0.62; 95% confidence interval [CI], 0.39 to 0.98) and showed a 0.55-week difference in gestational age (95% CI: 0.18 to 0.92) compared to the matched controlled sample. Although the program did not prevent LBW and SGA, children born to mothers who received the program showed an increase in birth weight by 107.8 g (95% CI: 27.0 to 188.5). Conclusion Home visits by public health nurses for high-risk pregnant women in Japan might be effective in preventing preterm birth, but not SGA.	[Ichikawa, Kayoko; Nakayama, Takeo] Kyoto Univ, Sch Publ Hlth, Dept Hlth Informat, Kyoto, Japan; [Ichikawa, Kayoko; Fujiwara, Takeo] Natl Res Inst Child Hlth & Dev, Dept Social Med, Tokyo, Japan	Kyoto University; National Center for Child Health & Development - Japan	Fujiwara, T (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Social Med, Tokyo, Japan.	fujiwara-tk@ncchd.go.jp	NAKAYAMA, Takeo/HCH-0537-2022	Nakayama, Takeo/0000-0002-7918-6252	Ministry of Health and Labour Sciences Research [H23-Seisaku-Ippan-005]; Japan Health Foundation	Ministry of Health and Labour Sciences Research; Japan Health Foundation(Japan Health Foundation)	This study was partly supported by a grant from the Ministry of Health and Labour Sciences Research Grant (H23-Seisaku-Ippan-005) and the Japan Health Foundation 2014.	Adirim T, 2013, PEDIATRICS, V132, pS59, DOI 10.1542/peds.2013-1021C; Avellar SA, 2013, PEDIATRICS, V132, pS90, DOI 10.1542/peds.2013-1021G; Baron IS, 2012, NEUROPSYCHOL REV, V22, P438, DOI 10.1007/s11065-012-9210-5; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Brett KM, 1997, AM J PUBLIC HEALTH, V87, P199, DOI 10.2105/AJPH.87.2.199; Carabin H, 2005, PAEDIATR PERINAT EP, V19, P194, DOI 10.1111/j.1365-3016.2005.00651.x; Cooper BP, 2013, MATERN CHILD HLTH J, V17, P1158, DOI 10.1007/s10995-012-1101-0; DiFranza JR, 2004, PEDIATRICS, V113, P1007; Donovan EF, 2007, PEDIATRICS, V119, P1145, DOI 10.1542/peds.2006-2411; Filene JH, 2013, PEDIATRICS, V132, pS100, DOI 10.1542/peds.2013-1021H; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Goyal NK, 2013, PEDIATRICS, V132, pS118, DOI 10.1542/peds.2013-1021J; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Health Labour and Welfare Statistics Association, 2012, J HLTH WELFARE STAT; Hendler I, 2005, AM J OBSTET GYNECOL, V192, P882, DOI 10.1016/j.ajog.2004.09.021; Hertz-Picciotto I, 1998, EPIDEMIOLOGY, V9, P61; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Hobel CJ, 2008, CLIN OBSTET GYNECOL, V51, P333, DOI 10.1097/GRF.0b013e31816f2709; Hoffman S, 1996, PAEDIATR PERINAT EP, V10, P380, DOI 10.1111/j.1365-3016.1996.tb00063.x; Hokama T, 2009, ACTA PAEDIATR, V98, P242, DOI 10.1111/j.1651-2227.2008.01017.x; Issel LM, 2011, JOGNN-J OBST GYN NEO, V40, P157, DOI 10.1111/j.1552-6909.2011.01219.x; Japanese Nursing Association, 2014, MIDW IN JAP; Jongbloed-Pereboom M, 2012, NEUROSCI BIOBEHAV R, V36, P1314, DOI 10.1016/j.neubiorev.2012.02.005; Kitzman H, 1997, JAMA-J AM MED ASSOC, V278, P644, DOI 10.1001/jama.278.8.644; Lee E, 2009, AM J PREV MED, V36, P154, DOI 10.1016/j.amepre.2008.09.029; McGowan JE, 2011, PEDIATRICS, V127, P1111, DOI 10.1542/peds.2010-2257; MCLAUGHLIN FJ, 1992, PEDIATRICS, V89, P128; McNaughton DB, 2004, PUBLIC HEALTH NURS, V21, P207, DOI 10.1111/j.0737-1209.2004.021303.x; Ministry of Health Lavour and Welfare, 2014, REP COMM HLTH CAR HL; Nakamura Y, 2010, JPN MED ASS J, V53, P259; OLDS DL, 1986, PEDIATRICS, V77, P16; Peacock S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-17; Roman L, 2014, JAMA PEDIATR, V168, P220, DOI 10.1001/jamapediatrics.2013.4347; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Smith LK, 2007, ARCH DIS CHILD-FETAL, V92, pF11, DOI 10.1136/adc.2005.090308; Strathearn L, 2001, PEDIATRICS, V108, P142, DOI 10.1542/peds.108.1.142; Takimoto H, 2005, J OBSTET GYNAECOL RE, V31, P314, DOI 10.1111/j.1447-0756.2005.00294.x; Thompson JMD, 2006, PAEDIATR PERINAT EP, V20, P182, DOI 10.1111/j.1365-3016.2006.00711.x; van Noort-van der Spek IL, 2012, PEDIATRICS, V129, P745, DOI 10.1542/peds.2011-1728; Windham AM, 2004, CHILD ABUSE NEGLECT, V28, P645, DOI 10.1016/j.chiabu.2004.01.003; Wu SS, 2004, CHILD ABUSE NEGLECT, V28, P1253, DOI 10.1016/j.chiabu.2004.07.005; Xiong X, 2006, BJOG-INT J OBSTET GY, V113, P135, DOI 10.1111/j.1471-0528.2005.00827.x; Yorifuji T, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-162	44	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137307	10.1371/journal.pone.0137307	http://dx.doi.org/10.1371/journal.pone.0137307			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ8YQ	26348847	gold, Green Published, Green Submitted			2022-12-26	WOS:000360897600032
J	Kwon, GH; Kim, KA; Hwang, SS; Park, SY; Kim, HA; Choi, SY; Kim, JW				Kwon, Gene-hyuk; Kim, Kyung Ah; Hwang, Seong Su; Park, Soo Youn; Kim, Hyun A.; Choi, Sun Young; Kim, Ji Woong			Efficiency of Non-Contrast-Enhanced Liver Imaging Sequences Added to Initial Rectal MRI in Rectal Cancer Patients	PLOS ONE			English	Article							EXTRAMURAL VASCULAR INVASION; COLORECTAL-CANCER; CARCINOMA; ACCURACY; METASTASIS; T1	Purpose The purpose of this study was to estimate the value of addition of liver imaging to initial rectal magnetic resonance imaging (MRI) for detection of liver metastasis and evaluate imaging predictors of a high risk of liver metastasis on rectal MRI. Methods We enrolled 144 patients who from October 2010 to May 2013 underwent rectal MRI with T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) (b values = 50, 500, and 900 s/mm(2)) of the liver and abdominopelvic computed tomography (APCT) for the initial staging of rectal cancer. Two reviewers scored the possibility of liver metastasis on different sets of liver images (T2WI, DWI, and combined T2WI and DWI) and APCT and reached a conclusion by consensus for different analytic results. Imaging features from rectal MRI were also analyzed. The diagnostic performances of CT and an additional liver scan to detect liver metastasis were compared. Multivariate logistic regression to determine independent predictors of liver metastasis among rectal MRI features and tumor markers was performed. This retrospective study was approved by the Institutional Review Board, and the requirement for informed consent was waived. Results All sets of liver images were more effective than APCT for detecting liver metastasis, and DWI was the most effective. Perivascular stranding and anal sphincter invasion were statistically significant for liver metastasis (p = 0.0077 and p = 0.0471), while extramural vascular invasion based on MRI (mrEMVI) was marginally significant (p = 0.0534). Conclusion The addition of non-contrast-enhanced liver imaging, particularly DWI, to initial rectal MRI in rectal cancer patients could facilitate detection of liver metastasis without APCT. Perivascular stranding, anal sphincter invasion, and mrEMVI detected on rectal MRI were important imaging predictors of liver metastasis.	[Kwon, Gene-hyuk; Kim, Kyung Ah; Hwang, Seong Su; Park, Soo Youn; Kim, Hyun A.] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Radiol, Seoul, South Korea; [Choi, Sun Young] Ewha Womans Univ, Sch Med, Dept Radiol, Seoul, South Korea; [Choi, Sun Young] Ewha Womans Univ, Sch Med, Med Res Inst, Seoul, South Korea; [Kim, Ji Woong] Hanseo Univ, Dept Chiropract, Grad Sch Hlth Promot, Seosan, South Korea	Catholic University of Korea; Ewha Womans University; Ewha Womans University; Hanseo University	Kim, KA (corresponding author), Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Radiol, Seoul, South Korea.	bellenina@daum.net			St. Vincent's hospital [SVHR-2013-01]	St. Vincent's hospital	The financial support of the St. Vincent's hospital, research institute of medical science (SVHR-2013-01) for data analysis.	Adeyemo D, 2009, COLORECTAL DIS, V11, P259, DOI 10.1111/j.1463-1318.2008.01588.x; Akasu T, 2009, ANN SURG ONCOL, V16, P2787, DOI 10.1245/s10434-009-0613-3; [Anonymous], 2006, BMJ-BRIT MED J, V333, P779, DOI [10.1136/bmj.38937.646400.55, DOI 10.1136/BMJ.38937.646400.55]; Beets-Tan RGH, 2001, LANCET, V357, P497, DOI 10.1016/S0140-6736(00)04040-X; Chand M, 2014, BRIT J CANCER, V110, P19, DOI 10.1038/bjc.2013.603; Fang WL, 2005, HEPATO-GASTROENTEROL, V52, P1688; Galea N, 2013, J MAGN RESON IMAGING, V37, P1260, DOI 10.1002/jmri.23947; Heijnen LA, 2013, EUR RADIOL, V23, P3354, DOI 10.1007/s00330-013-2952-5; Kim MJ, 2003, J COMPUT ASSIST TOMO, V27, P48, DOI 10.1097/00004728-200301000-00010; Kim NK, 2000, ANN SURG ONCOL, V7, P732, DOI 10.1007/s10434-000-0732-3; Liang TY, 2012, CANCER IMAGING, V12, P290, DOI 10.1102/1470-7330.2012.0034; Lim GH, 2009, DIS COLON RECTUM, V52, P1487, DOI 10.1007/DCR.0013e3181a74d5e; Lim JS, 2004, KOREAN J RADIOL, V5, P225, DOI 10.3348/kjr.2004.5.4.225; Nascimbeni R, 2002, DIS COLON RECTUM, V45, P200, DOI 10.1007/s10350-004-6147-7; Smith NJ, 2008, BRIT J SURG, V95, P229, DOI 10.1002/bjs.5917; Smith NJ, 2008, AM J ROENTGENOL, V191, P1517, DOI 10.2214/AJR.08.1298; Yu SKT, 2014, EUR J CANCER, V50, P920, DOI 10.1016/j.ejca.2013.12.007	17	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137320	10.1371/journal.pone.0137320	http://dx.doi.org/10.1371/journal.pone.0137320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348217	Green Published, gold, Green Submitted			2022-12-26	WOS:000360897600036
J	Teeuw, WJ; Laine, ML; Bizzarro, S; Loos, BG				Teeuw, Wijnand J.; Laine, Marja L.; Bizzarro, Sergio; Loos, Bruno G.			A Lead ANRIL Polymorphism Is Associated with Elevated CRP Levels in Periodontitis: A Pilot Case-Control Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CORONARY-ARTERY-DISEASE; ALTERNATIVE PATHWAY; SYSTEMIC MARKERS; ATHEROSCLEROSIS; REPLICATION; ACTIVATION; VARIANTS; SMOKING; 9P21.3	Elevated high sensitive C-reactive protein (hsCRP) is a marker for systemic inflammation and a risk marker for atherosclerotic cardiovascular disease (ACVD), and has also been associated with periodontitis. Inter-individual variation for hsCRP in periodontitis has been shown. ANRIL is the strongest genetic susceptibility locus for both periodontitis and ACVD, and it is speculated that genetic variation in ANRIL may modulate inflammatory processes. Therefore, we explored the possible association between hsCRP plasma levels and a leading ANRIL single nucleotide polymorphism (SNP) in periodontitis patients and controls. 171 healthy subjects with North European descent (115 periodontitis and 56 controls) were included in this case-control study. hsCRP levels were determined and subjects were genotyped for the leading ANRIL SNP rs1333048. In a multivariate analysis, periodontitis, female gender, increasing BMI and homozygosity for the major allele (AA-genotype) of rs1333048 were significantly associated with elevated hsCRP plasma levels (p = 0.012, p = 0.004, p = 0.007 and p = 0.003, respectively). Periodontitis patients with rs1333048 AA-genotype showed higher levels of hsCRP than those carrying the minor C allele (median: 4.5 mg/L vs. 1.6 mg/L, p(adjusted) = 0.007). This study is the first to show that, in addition to gender and BMI, also a leading SNP in ANRIL is explanatory for inter-individual variation in hsCRP levels in periodontitis patients of North European descent.	[Teeuw, Wijnand J.] Univ Amsterdam, Dept Periodontol, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands; Vrije Univ Amsterdam, Amsterdam, Netherlands	Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Teeuw, WJ (corresponding author), Univ Amsterdam, Dept Periodontol, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands.	W.Teeuw@acta.nl	Laine, Marja Leena/ABF-2341-2021		University of Amsterdam	University of Amsterdam	The Department of Periodontology at ACTA, the Netherlands is supported in part by a grant of the University of Amsterdam for its participation in the focal point "Oral Infections and Inflammation". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. For the rest of the study, the authors did not receive specific funding. There was no additional external funding received for this study.	Bizzarro S, 2007, J CLIN PERIODONTOL, V34, P574, DOI 10.1111/j.1600-051X.2007.01095.x; Bochenek G, 2013, HUM MOL GENET, V22, P4516, DOI 10.1093/hmg/ddt299; Congrains A, 2012, ATHEROSCLEROSIS, V220, P449, DOI 10.1016/j.atherosclerosis.2011.11.017; Cunnington MS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000899; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Divaris K, 2012, J DENT RES, V91, pS21, DOI 10.1177/0022034512447951; Du Clos Terry W, 2013, ISRN Inflamm, V2013, P379040, DOI 10.1155/2013/379040; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Eke PI, 2012, J PERIODONTOL, V83, P1449, DOI 10.1902/jop.2012.110664; Ernst FD, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-119; Geluk CA, 2008, ATHEROSCLEROSIS, V196, P372, DOI 10.1016/j.atherosclerosis.2006.11.013; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helmersson J, 2005, ATHEROSCLEROSIS, V181, P201, DOI 10.1016/j.atherosclerosis.2004.11.026; Holers VM, 2008, IMMUNOL REV, V223, P300, DOI 10.1111/j.1600-065X.2008.00641.x; Hugoson A, 2008, J CLIN PERIODONTOL, V35, P405, DOI 10.1111/j.1600-051X.2008.01225.x; Incalcaterra E, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0329-5; Loos BG, 2005, J PERIODONTOL, V76, P2106, DOI 10.1902/jop.2005.76.11-S.2106; Loos BG, 2000, J PERIODONTOL, V71, P1528, DOI 10.1902/jop.2000.71.10.1528; Lopez R, 2015, VIRULENCE, V6, P249, DOI 10.1080/21505594.2015.1014266; Mihlan M, 2011, FASEB J, V25, P4198, DOI 10.1096/fj.11-186460; MOLD C, 1984, J IMMUNOL, V133, P882; Paraskevas S, 2008, J CLIN PERIODONTOL, V35, P277, DOI 10.1111/j.1600-051X.2007.01173.x; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pradeep AR, 2012, DIS MARKERS, V33, P207, DOI [10.3233/DMA-2012-0926, 10.1155/2012/173123]; Ridker PM, 2010, AM J CARDIOL, V106, P204, DOI 10.1016/j.amjcard.2010.03.018; Schaefer AS, 2015, CIRC-CARDIOVASC GENE, V8, P159, DOI 10.1161/CIRCGENETICS.114.000554; Schaefer AS, 2013, J CLIN PERIODONTOL, V40, P563, DOI 10.1111/jcpe.12092; Schaefer AS, 2011, J MED GENET, V48, P38, DOI 10.1136/jmg.2010.078998; Schaefer AS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000378; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Schwenk RW, 2012, J BIOL CHEM, V287, P37530, DOI 10.1074/jbc.M112.363630; Suankratay C, 1998, CLIN EXP IMMUNOL, V113, P353; Teeuw WJ, 2014, J CLIN PERIODONTOL, V41, P70, DOI 10.1111/jcpe.12171; van Greevenbroek MMJ, 2012, INT J CARDIOL, V154, P158, DOI 10.1016/j.ijcard.2010.09.017; Wannamethee SG, 2005, EUR HEART J, V26, P1765, DOI 10.1093/eurheartj/ehi183; Woloshin S, 2005, NEW ENGL J MED, V352, P1611, DOI 10.1056/NEJM200504143521525; Zieske AW, 2005, ARTERIOSCL THROM VAS, V25, P1237, DOI 10.1161/01.ATV.0000164625.93129.64	39	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137335	10.1371/journal.pone.0137335	http://dx.doi.org/10.1371/journal.pone.0137335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348353	Green Submitted, Green Published, gold			2022-12-26	WOS:000360897600037
J	Toth, I; Kiss, DS; Jocsak, G; Somogyi, V; Toronyi, E; Bartha, T; Frenyo, LV; Horvath, TL; Zsarnovszky, A				Toth, Istvan; Kiss, David S.; Jocsak, Gergely; Somogyi, Virag; Toronyi, Eva; Bartha, Tibor; Frenyo, Laszlo V.; Horvath, Tamas L.; Zsarnovszky, Attila			Estrogen- and Satiety State-Dependent Metabolic Lateralization in the Hypothalamus of Female Rats	PLOS ONE			English	Article							MITOCHONDRIAL METABOLISM; SUPRACHIASMATIC NUCLEI; UNILATERAL IMPLANT; ENDOCRINE CONTROL; NEUROPEPTIDE-Y; LH-RH; ASYMMETRY; BRAIN; ESTRADIOL; PROTEIN	Hypothalamus is the highest center and the main crossroad of numerous homeostatic regulatory pathways including reproduction and energy metabolism. Previous reports indicate that some of these functions may be driven by the synchronized but distinct functioning of the left and right hypothalamic sides. However, the nature of interplay between the hemispheres with regard to distinct hypothalamic functions is still unclear. Here we investigated the metabolic asymmetry between the left and right hypothalamic sides of ovariectomized female rats by measuring mitochondrial respiration rates, a parameter that reflects the intensity of cell and tissue metabolism. Ovariectomized (saline injected) and ovariectomized+estrogen injected animals were fed ad libitum or fasted to determine 1) the contribution of estrogen to metabolic asymmetry of hypothalamus; and 2) whether the hypothalamic asymmetry is modulated by the satiety state. Results show that estrogen-priming significantly increased both the proportion of animals with detected hypothalamic lateralization and the degree of metabolic difference between the hypothalamic sides causing a right-sided dominance during state 3 mitochondrial respiration (St3) in ad libitum fed animals. After 24 hours of fasting, lateralization in St3 values was clearly maintained; however, instead of the observed right-sided dominance that was detected in ad libitum fed animals here appeared in form of either right- or left-sidedness. In conclusion, our results revealed estrogen- and satiety state-dependent metabolic differences between the two hypothalamic hemispheres in female rats showing that the hypothalamic hemispheres drive the reproductive and satiety state related functions in an asymmetric manner.	[Toth, Istvan; Kiss, David S.; Jocsak, Gergely; Somogyi, Virag; Bartha, Tibor; Frenyo, Laszlo V.] Szent Istvan Univ, Fac Vet Sci, Dept Physiol & Biochem, Budapest, Hungary; [Toronyi, Eva] Semmelweis Univ, Dept Transplantat & Surg, H-1085 Budapest, Hungary; [Horvath, Tamas L.; Zsarnovszky, Attila] Yale Univ, Sch Med, Div Comparat Med, New Haven, CT USA; [Horvath, Tamas L.; Zsarnovszky, Attila] Szent Istvan Univ, Fac Agr & Environm Sci, Dept Anim Physiol & Anim Hlth, Godollo, Hungary	Hungarian University of Agriculture & Life Sciences; Semmelweis University; Yale University; Hungarian University of Agriculture & Life Sciences	Toth, I (corresponding author), Szent Istvan Univ, Fac Vet Sci, Dept Physiol & Biochem, Budapest, Hungary.	toth.istvan@aotk.szie.hu			Nemzeti Kutatasi, Fejlesztesi es Innovacios Hivatal [OTKA 104982, OTKA 72186]; Faculty of Veterinary Science [NKB 15930, KK UK-12021, KK PhD-15263]; Hungarian Ministry of Human Resources [9877-3/2015/FEKUT]	Nemzeti Kutatasi, Fejlesztesi es Innovacios Hivatal; Faculty of Veterinary Science; Hungarian Ministry of Human Resources	This work was supported by OTKA 104982 (Nemzeti Kutatasi, Fejlesztesi es Innovacios Hivatal; http://www.otka.hu/) to AZ, and OTKA 72186 (Nemzeti Kutatasi, Fejlesztesi es Innovacios Hivatal; http://www.otka.hu/) to TB (design, data collection, analysis); NKB 15930, KK UK-12021 (Faculty of Veterinary Science; http://www.univet.hu/hu/kiemeltegysegek/tkk/palyazatok-kutato-kar-2013-16/kutatokar/) (data collection); KK PhD-15263 (Faculty of Veterinary Science; http://www.univet.hu/hu/kiemeltegysegek/tkk/palyazatok-kutato-kar-2013-16/kutato-kar/) (preparation of the manuscript); and 9877-3/2015/FEKUT (grant of the Hungarian Ministry of Human Resources) (preparation of manuscript).	Ainslie DA, 2001, INT J OBESITY, V25, P1680, DOI 10.1038/sj.ijo.0801806; Aizawa H, 2013, ANAT SCI INT, V88, P1, DOI 10.1007/s12565-012-0158-6; Arnold S, 2012, J STEROID BIOCHEM, V131, P2, DOI 10.1016/j.jsbmb.2012.01.012; Arteaga-Lopez PR, 2003, ENDOCRINE, V21, P251, DOI 10.1385/ENDO:21:3:251; BAKALKIN GY, 1984, BRAIN RES, V296, P361, DOI 10.1016/0006-8993(84)90074-X; BETANCUR C, 1991, BRAIN BEHAV IMMUN, V5, P162, DOI 10.1016/0889-1591(91)90014-2; BORSONCHAZOT F, 1986, BRAIN RES, V382, P433, DOI 10.1016/0006-8993(86)91358-2; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Cakir I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008322; Clegg DJ, 2007, DIABETES, V56, P1051, DOI 10.2337/db06-0015; Cruz ME, 2014, ALCOHOL CLIN EXP RES, V38, P1611, DOI 10.1111/acer.12399; CRUZ ME, 1989, J ENDOCRINOL, V123, P437, DOI 10.1677/joe.0.1230437; de la Iglesia HO, 2000, SCIENCE, V290, P799, DOI 10.1126/science.290.5492.799; de la Iglesia HO, 2003, J NEUROSCI, V23, P7412; DELRUE C, 1994, BRAIN BEHAV IMMUN, V8, P137, DOI 10.1006/brbi.1994.1013; FUKUDA M, 1984, NEUROSCI LETT, V51, P365, DOI 10.1016/0304-3940(84)90404-X; GERENDAI I, 1978, NEUROSCI LETT, V9, P333, DOI 10.1016/0304-3940(78)90204-5; Grossmann A, 2013, NEUROBIOLOGY CYTOKIN, V16th, P302; Grundmann SJ, 2005, AM J PHYSIOL-REG I, V288, pR702, DOI 10.1152/ajpregu.00460.2004; Gupte AA, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/916585; Harris JA, 1996, NEUROSCI BIOBEHAV R, V20, P637, DOI 10.1016/0149-7634(95)00077-1; Hou GL, 2013, NEUROCHEM RES, V38, P453, DOI 10.1007/s11064-012-0954-3; INASE Y, 1992, BRAIN RES, V580, P338, DOI 10.1016/0006-8993(92)90964-B; Kann O, 2003, NEUROSCIENCE, V119, P87, DOI 10.1016/S0306-4522(03)00026-5; Kelly MJ, 2008, MOL CELL ENDOCRINOL, V290, P14, DOI 10.1016/j.mce.2008.04.014; KING TR, 1985, PHYSIOL BEHAV, V35, P955, DOI 10.1016/0031-9384(85)90265-3; Kiss DS, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-31; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Lopez E, 1997, ARCH MED RES, V28, P343; MITTLEMAN G, 1985, BEHAV BRAIN RES, V15, P263, DOI 10.1016/0166-4328(85)90182-2; Naftolin F, 2007, REPROD SCI, V14, P101, DOI 10.1177/1933719107301059; NANCE DM, 1984, BRAIN RES BULL, V13, P651, DOI 10.1016/0361-9230(84)90197-7; NANCE DM, 1983, BRAIN RES BULL, V10, P353, DOI 10.1016/0361-9230(83)90103-X; Ribolsi M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01010; ROY EJ, 1987, PHYSIOL BEHAV, V40, P267, DOI 10.1016/0031-9384(87)90219-8; Santollo J, 2008, BEHAV BRAIN RES, V191, P173, DOI 10.1016/j.bbr.2008.03.019; Stratton RC, 2010, J BIOL CHEM, V285, P27201, DOI 10.1074/jbc.M110.103630; Toth I, 2014, REPROD SCI, V21, P1492, DOI 10.1177/1933719114530188; Vanetsian G L, 2004, Neurosci Behav Physiol, V34, P703, DOI 10.1023/B:NEAB.0000036011.57653.fc; Xavier CH, 2009, NEUROSCIENCE, V164, P1360, DOI 10.1016/j.neuroscience.2009.09.018; Xavier CH, 2013, AM J PHYSIOL-REG I, V304, pR664, DOI 10.1152/ajpregu.00401.2012; ZHANG LM, 1995, NEUROREPORT, V6, P537, DOI 10.1097/00001756-199502000-00032; Zheng JB, 1999, J STEROID BIOCHEM, V68, P65, DOI 10.1016/S0960-0760(98)00161-7; Zheng JB, 1999, EUR J PHARMACOL, V368, P95, DOI 10.1016/S0014-2999(99)00012-6	44	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137462	10.1371/journal.pone.0137462	http://dx.doi.org/10.1371/journal.pone.0137462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339901	Green Published, gold, Green Submitted			2022-12-26	WOS:000360688200062
J	Gomez, JMT; Diaz-Gete, L; Martin-Cantera, C; Escurriola, MF; Moreno, ML; Leandro, RB; Quintero, AMG; Ballve, JL; Jimenez, MLC; Puig, EP; More, RC; Rueda, BG; Casajuana, M; Mendez-Aguirre, M; Bonias, DG; Maestre, SF; Fondevila, JS				Trujillo Gomez, Jose Manuel; Diaz-Gete, Laura; Martin-Cantera, Carlos; Fabregas Escurriola, Mireia; Lozano Moreno, Maribel; Buron Leandro, Raquel; Gomez Quintero, Ana Maria; Luis Ballve, Jose; Clemente Jimenez, Maria Lourdes; Puigdomenech Puig, Elisa; Casas More, Ramon; Garcia Rueda, Beatriz; Casajuana, Marc; Mendez-Aguirre, Marga; Garcia Bonias, David; Fernandez Maestre, Soraya; Sanchez Fondevila, Jessica			Intervention for Smokers through New Communication Technologies: What Perceptions Do Patients and Healthcare Professionals Have? A Qualitative Study	PLOS ONE			English	Article							SMOKING-CESSATION; E-MAIL; INTERNET; INFORMATION; PART	Background The use of information and communication technologies (ICTs) in the health service is increasing. In spite of limitations, such as lack of time and experience, the deployment of ICTs in the healthcare system has advantages which include patient satisfaction with secure messaging, and time saving benefits and utility for patients and health professionals. ICTs may be helpful as either interventions on their own or as complementary tools to help patients stop smoking. Objectives To gather opinions from both medical professionals and smokers about an email-based application that had been designed by our research group to help smoking cessation, and identify the advantages and disadvantages associated with interventions based on the utilization of ICTs for this purpose. Methods A qualitative, descriptive-interpretative study with a phenomenological perspective was performed to identify and interpret the discourses of the participating smokers and primary healthcare professionals. Data were obtained through two techniques: semi-structured individual interviews and discussion groups, which were recorded and later systematically and literally transcribed together with the interviewer's notes. Data were analyzed with the ATLAS TI 6.0 programme. Results Seven individual interviews and four focal groups were conducted. The advantages of the application based on the email intervention designed by our research group were said to be the saving of time in consultations and ease of access for patients who found work timetables and following a programme for smoking cessation incompatible. The disadvantages were thought to be a lack of personal contact with the healthcare professional, and the possibility of cheating/self-deception, and a greater probability of relapse on the part of the smokers. Conclusions Both patients and healthcare professionals viewed the email-based application to help patients stop smoking as a complementary aid to face-to-face consultations. Nevertheless, ICTs could not substitute personal contact in the smoking cessation programme.	[Trujillo Gomez, Jose Manuel] Ctr Salud Cuevas Almanzora, Serv Andaluz Salud, Almeria, Spain; [Trujillo Gomez, Jose Manuel; Martin-Cantera, Carlos; Puigdomenech Puig, Elisa; Casajuana, Marc; Sanchez Fondevila, Jessica] Primary Healthcare Univ Res Inst IDIAP Jordi Gol, Barcelona, Spain; [Diaz-Gete, Laura; Fernandez Maestre, Soraya] Inst Catala Salut, Ctr Atencio Primaria La Sagrera, Barcelona, Spain; [Martin-Cantera, Carlos; Lozano Moreno, Maribel] Inst Catala Salut, Ctr Atencio Primaria Passeig de St Joan, Barcelona, Spain; [Fabregas Escurriola, Mireia] Inst Catala Salut, Ctr Atencio Primaria La Marina, Barcelona, Spain; [Buron Leandro, Raquel; Gomez Quintero, Ana Maria] Inst Catala Salut, Ctr Atencio Primaria Turo, Barcelona, Spain; [Luis Ballve, Jose] Inst Catala Salut, Ctr Atencio Primaria Florida Nord, Lhospitalet De Llobregat, Spain; [Clemente Jimenez, Maria Lourdes] Ctr Salud Santo Grial, Serv Aragones Salud, Huesca, Spain; [Casas More, Ramon] Inst Catala Salut, Ctr Atencio Primaria St Antoni, Barcelona, Spain; [Garcia Rueda, Beatriz] Inst Catala Salut, Ctr Atencio Primaria Goretti Badia, Barcelona, Spain; [Garcia Bonias, David] Inst Catala Salut, Ctr Atencio Primaria Vallcarca St Gervasi, Barcelona, Spain		Gomez, JMT (corresponding author), Ctr Salud Cuevas Almanzora, Serv Andaluz Salud, Almeria, Spain.	aplaceinheaven@hotmail.com	Martin Cantera, Carlos/D-2693-2011	Martin Cantera, Carlos/0000-0003-0656-8126; Casajuana Closas, Marc/0000-0001-5653-996X	4a Convocatoria de moduls de recerca de l'ambit d'Atencio primaria de Barcelona ciutat	4a Convocatoria de moduls de recerca de l'ambit d'Atencio primaria de Barcelona ciutat	This work was supported by research grants from 4a Convocatoria de moduls de recerca de l'ambit d'Atencio primaria de Barcelona ciutat 2011.	Asociacion para la Investigacion de Medios de Comunicacion, 2014, EST GEN MED; Atherton H, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007978.pub2; Atherton H, 2010, J TELEMED TELECARE, V16, P172, DOI 10.1258/jtt.2010.004002; Civljak M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007078.pub4; Cobb NK, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.3.e17; Coleman T, 2000, BRIT J GEN PRACT, V50, P207; Diaz-Gete L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-364; Flynn D, 2009, INT J MED INFORM, V78, P588, DOI 10.1016/j.ijmedinf.2009.03.008; Frisby G, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.2.e8; Graham AL, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.987; Herbec A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1070; Hsiung RC., 2002, CASE STUDIES GUIDING, P150; Illiger K, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3799; INE, 2020, ENC EQ US TECN INF C; Instituto Nacional de Estadistica (INE), 2015, EST PROF SAN COL; Klatt C, 2008, AM J PREV MED, V35, pS471, DOI 10.1016/j.amepre.2008.09.001; Koehler N, 2013, J MTM, V2, P14, DOI DOI 10.7309/JMTM.2.1.3; Lenert L, 2004, J AM MED INFORM ASSN, V11, P235, DOI 10.1197/jamia.M1464; Meis TM, 2002, JCMC, V7, P1; Patt MR, 2003, J MED INTERNET RES, V5, DOI 10.2196/jmir.5.2.e9; Patten CA, 2006, PATIENT EDUC COUNS, V64, P249, DOI 10.1016/j.pec.2006.03.001; Poel FT, 2009, HEALTH EDUC RES, V24, P930, DOI 10.1093/her/cyp036; Polosa R, 2009, RESP CARE, V54, P1033; Puigdomenech E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/1471-2458-15-2; Richmond R, 2009, TOB CONTROL, V18, P176, DOI 10.1136/tc.2008.026393; Stadista, 2014, STAT PORT HOM SHAR M; Stadista. The Statistics Portal, 2014, STAT PORT NUMB MONTH; Wallwiener M, 2009, J TELEMED TELECARE, V15, P243, DOI 10.1258/jtt.2009.090111; World Health Organization Global Observatory for eHealth, 2011, ATLAS EHEALTH COUNTR, V1, P195; World Medical Association, 2013, WMA DECL HELS ETH PR	30	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137415	10.1371/journal.pone.0137415	http://dx.doi.org/10.1371/journal.pone.0137415			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340346	gold, Green Published, Green Submitted			2022-12-26	WOS:000360688200056
J	Chen, YJ; Xiang, J; Wang, ZQ; Xiao, YM; Zhang, DM; Chen, X; Li, HT; Liu, MN; Zhang, QJ				Chen, Yongjie; Xiang, Jing; Wang, Zhiqiang; Xiao, Yaming; Zhang, Dongmei; Chen, Xia; Li, Huiting; Liu, Meina; Zhang, Qiuju			Associations of Bone Mineral Density with Lean Mass, Fat Mass, and Dietary Patterns in Postmenopausal Chinese Women: A 2-Year Prospective Study	PLOS ONE			English	Article							BODY-MASS; MILK SUPPLEMENTATION; MAJOR DETERMINANT; PROXIMAL FEMUR; VITAMIN-D; CALCIUM; OSTEOPOROSIS; MENOPAUSE; TISSUE; FRACTURES	Objective To assess factors associated with bone mineral density (BMD) in postmenopausal women in a longitudinal study, and to examine the relative contribution of lean mass, fat mass, dietary patterns, and years since menopause to BMD. Methods Two hundred and eighty-two postmenopausal women were randomly selected from Hongqi Community Health Center, in Harbin City, China. All participants were followed up from 2009 to 2011. Dietary data were collected using a Food Frequency Questionnaire. BMD of the left hip, the lumbar spine, and the total body, and the body composition were measured by dual-energy X-ray absorptiometry at baseline and follow-up. Results Lean mass and fat mass were positively associated with BMD of the spine, hip, and the total body at both baseline and follow-up. The association between fat mass and BMD at the spine at baseline (P = 0.210) and at the spine (P = 0.116) and hip (P = 0.073) in the second year was not statistically significant when height was adjusted. Six dietary patterns were identified but only cereal grains-fruits pattern (P = 0.001 in the spine, P = 0.037 in hip) and milk-root vegetables pattern (P = 0.010 in hip) were associated with BMD of the spine and hip. The linear mixed model of follow-up data showed that lean mass, years since menopause, and age of menophania were the significant determinants of BMD of all sites. Moreover, lean mass was the best determinant of BMD (VIP = 1.936). Conclusion Lean mass, years since menopause, age of menophania and dietary patterns are the important determinants of BMD of the spine, hip, and the total body. Lean mass is the best determinant of BMD.	[Chen, Yongjie; Xiang, Jing; Xiao, Yaming; Liu, Meina; Zhang, Qiuju] Harbin Med Univ, Coll Publ Hlth, Dept Biostat, Harbin, Heilongjiang Pr, Peoples R China; [Wang, Zhiqiang] Univ Queensland, Sch Med, Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Zhang, Dongmei] First Peoples Hosp Tengzhou, Zaozhuang City, Shandong, Peoples R China; [Chen, Xia] Changsha Med Univ, Dept Epidemiol & Evidence Based Med, Coll Publ Hlth, Changsha, Hunan, Peoples R China; [Li, Huiting] Harbin Inst Technol Hosp, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Royal Brisbane & Women's Hospital; University of Queensland; Changsha Medical University; Harbin Institute of Technology	Liu, MN (corresponding author), Harbin Med Univ, Coll Publ Hlth, Dept Biostat, Harbin, Heilongjiang Pr, Peoples R China.	liumeina369@163.com; zqj81129@sina.com	zhang, qiu/GXG-5600-2022; Wang, Zhiqiang/A-5835-2010	Wang, Zhiqiang/0000-0002-5839-743X	National Major Scientific and Technological Special Project of China [2014ZX08011005]	National Major Scientific and Technological Special Project of China	This study was supported by the National Major Scientific and Technological Special Project of China (2014ZX08011005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.nmp.gov.cn/	Bates DW, 2002, JAMA-J AM MED ASSOC, V288, P1898, DOI 10.1001/jama.288.15.1898; Blain H, 2004, CALCIFIED TISSUE INT, V75, P32, DOI 10.1007/s00223-003-0192-4; Chee WSS, 2003, OSTEOPOROSIS INT, V14, P828, DOI 10.1007/s00198-003-1448-6; Chen Z, 1997, J BONE MINER RES, V12, P144, DOI 10.1359/jbmr.1997.12.1.144; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Da Shao H, 2015, J BONE MINER METAB, V33, P507, DOI 10.1007/s00774-014-0613-7; Douchi T, 2003, MATURITAS, V45, P185, DOI 10.1016/S0378-5122(03)00143-9; Dytfeld J, 2011, ARCH GERONTOL GERIAT, V53, pE237, DOI 10.1016/j.archger.2011.01.002; Fu X, 2011, OSTEOPOROSIS INT, V22, P113, DOI 10.1007/s00198-010-1210-9; GAMBACCIANI M, 1993, J CLIN ENDOCR METAB, V77, P1148, DOI 10.1210/jcem.77.5.8077305; Gnudi S, 2007, J BONE MINER METAB, V25, P326, DOI 10.1007/s00774-007-0758-8; Ho-Pham LT, 2014, J CLIN ENDOCR METAB, V99, P30, DOI 10.1210/jc.2013-3190; Ho-Pham LT, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-59; Hsu YH, 2006, AM J CLIN NUTR, V83, P146; Kameda T, 1997, J EXP MED, V186, P489, DOI 10.1084/jem.186.4.489; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Kruger MC, 2012, EUR J CLIN NUTR, V66, P856, DOI 10.1038/ejcn.2012.54; Lau EMC, 2001, J BONE MINER RES, V16, P1704, DOI 10.1359/jbmr.2001.16.9.1704; LEY CJ, 1992, AM J CLIN NUTR, V55, P950, DOI 10.1093/ajcn/55.5.950; Li GW, 2014, J BONE MINER METAB, P1; Li ST, 2013, AM J CLIN NUTR, V98, P1353, DOI 10.3945/ajcn.113.062844; Liu-Ambrose T, 2006, CALCIFIED TISSUE INT, V79, P145, DOI 10.1007/s00223-006-0098-z; Namwongprom S, 2013, INT J WOMENS HEALTH, V5, P87, DOI 10.2147/IJWH.S41884; Nguyen ND, 2007, J BONE MINER RES, V22, P1147, DOI [10.1359/jbmr.070412, 10.1359/JBMR.070412]; Ofluoglu D, 2005, CLIN RHEUMATOL, V24, P606, DOI 10.1007/s10067-005-1110-0; Ozdemir F, 2005, TOHOKU J EXP MED, V205, P277, DOI 10.1620/tjem.205.277; Park YW, 2001, OBES RES, V9, P381, DOI 10.1038/oby.2001.49; Piaseu Noppawan, 2001, Journal of the Medical Association of Thailand, V84, P772; RANNAR S, 1994, J CHEMOMETR, V8, P111, DOI 10.1002/cem.1180080204; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Sotunde OF, 2015, J NUTR HEALTH AGING, V19, P628, DOI 10.1007/s12603-015-0492-1; Taaffe DR, 2001, J BONE MINER RES, V16, P1343, DOI 10.1359/jbmr.2001.16.7.1343; Tobias RD, 1995, P ANN SAS US GROUP I; Woo J, 1997, NUTR RES, V17, P1633, DOI 10.1016/S0271-5317(97)00170-X; Woolf AD, 2003, BMJ-BRIT MED J, V327, P89, DOI 10.1136/bmj.327.7406.89; Yaegashi Y, 2008, EUR J EPIDEMIOL, V23, P219, DOI 10.1007/s10654-008-9225-7; Yang S, 2015, OSTEOPOROSIS INT, V26, P1381, DOI 10.1007/s00198-014-3009-6; Zhu K, 2015, BONE, V74, P146, DOI 10.1016/j.bone.2015.01.015; Zillikens MC, 2010, CALCIFIED TISSUE INT, V86, P116, DOI 10.1007/s00223-009-9319-6	39	19	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137097	10.1371/journal.pone.0137097	http://dx.doi.org/10.1371/journal.pone.0137097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335921	gold, Green Published, Green Submitted			2022-12-26	WOS:000360615400039
J	Miehe-Steier, A; Roscher, C; Reichelt, M; Gershenzon, J; Unsicker, SB				Miehe-Steier, Annegret; Roscher, Christiane; Reichelt, Michael; Gershenzon, Jonathan; Unsicker, Sybille B.			Light and Nutrient Dependent Responses in Secondary Metabolites of Plantago lanceolata Offspring Are Due to Phenotypic Plasticity in Experimental Grasslands	PLOS ONE			English	Article							IRIDOID GLYCOSIDES; CHEMICAL DEFENSE; MORPHOLOGICAL VARIATION; INVERTEBRATE HERBIVORY; QUANTITATIVE VARIATION; SPECIES RICHNESS; RESOURCE USE; GENERALIST; SPECIALIST; GROWTH	A few studies in the past have shown that plant diversity in terms of species richness and functional composition can modify plant defense chemistry. However, it is not yet clear to what extent genetic differentiation of plant chemotypes or phenotypic plasticity in response to diversity-induced variation in growth conditions or a combination of both is responsible for this pattern. We collected seed families of ribwort plantain (Plantago lanceolata) from six-year old experimental grasslands of varying plant diversity (Jena Experiment). The offspring of these seed families was grown under standardized conditions with two levels of light and nutrients. The iridoid glycosides, catalpol and aucubin, and verbascoside, a caffeoyl phenylethanoid glycoside, were measured in roots and shoots. Although offspring of different seed families differed in the tissue concentrations of defensive metabolites, plant diversity in the mothers' environment did not explain the variation in the measured defensive metabolites of P. lanceolata offspring. However secondary metabolite levels in roots and shoots were strongly affected by light and nutrient availability. Highest concentrations of iridoid glycosides and verbascoside were found under high light conditions, and nutrient availability had positive effects on iridoid glycoside concentrations in plants grown under high light conditions. However, verbascoside concentrations decreased under high levels of nutrients irrespective of light. The data from our greenhouse study show that phenotypic plasticity in response to environmental variation rather than genetic differentiation in response to plant community diversity is responsible for variation in secondary metabolite concentrations of P. lanceolata in the six-year old communities of the grassland biodiversity experiment. Due to its large phenotypic plasticity P. lanceolata has the potential for a fast and efficient adjustment to varying environmental conditions in plant communities of different species richness and functional composition.	[Miehe-Steier, Annegret; Reichelt, Michael; Gershenzon, Jonathan; Unsicker, Sybille B.] Max Planck Inst Chem Ecol, Jena, Germany; [Miehe-Steier, Annegret; Roscher, Christiane] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Roscher, Christiane] Helmholtz Ctr Environm Res, UFZ, Dept Community Ecol, Halle, Germany	Max Planck Society; Max Planck Society; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Unsicker, SB (corresponding author), Max Planck Inst Chem Ecol, Jena, Germany.	sunsicker@ice.mpg.de	Gershenzon, Jonathan/K-1331-2013; Unsicker, Sybille B./AAW-6968-2021	Gershenzon, Jonathan/0000-0002-1812-1551; Unsicker, Sybille B./0000-0002-9738-0075	MPI for Chemical Ecology; MPI for Biogeochemistry; IMPRS-gBGC; German Science Foundation [FOR 456/1451]	MPI for Chemical Ecology; MPI for Biogeochemistry; IMPRS-gBGC; German Science Foundation(German Research Foundation (DFG))	This experiment was funded by MPI for Chemical Ecology, MPI for Biogeochemistry and IMPRS-gBGC. The Jena Experiment is funded by the German Science Foundation (FOR 456/1451).	Alexander JM, 2012, J ECOL, V100, P771, DOI 10.1111/j.1365-2745.2011.01951.x; ARNONE JA, 1995, OECOLOGIA, V104, P72, DOI 10.1007/BF00365564; Barton KE, 2008, OIKOS, V117, P917, DOI 10.1111/j.0030-1299.2008.16324.x; Barton KE, 2006, OECOLOGIA, V150, P442, DOI 10.1007/s00442-006-0531-z; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baythavong BS, 2011, AM NAT, V178, P75, DOI 10.1086/660281; Bennett AE, 2007, ECOLOGY, V88, P210, DOI 10.1890/0012-9658(2007)88[210:MSDAPG]2.0.CO;2; Bessler H, 2012, PLANT SOIL, V358, P301, DOI 10.1007/s11104-012-1181-z; Biere A, 2004, OECOLOGIA, V140, P430, DOI 10.1007/s00442-004-1603-6; Bode RF, 2012, J ECOL, V100, P795, DOI 10.1111/j.1365-2745.2012.01958.x; BOWERS MD, 1988, J CHEM ECOL, V14, P319, DOI 10.1007/BF01022549; BOWERS MD, 1993, ECOLOGY, V74, P1778, DOI 10.2307/1939936; BOWERS MD, 1992, J CHEM ECOL, V18, P985, DOI 10.1007/BF00980057; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Darrow K, 1997, BIOCHEM SYST ECOL, V25, P1, DOI 10.1016/S0305-1978(96)00090-7; DUDT JF, 1994, ECOLOGY, V75, P86, DOI 10.2307/1939385; Eichmann R, 2008, J PLANT PHYSIOL, V165, P5, DOI 10.1016/j.jplph.2007.05.004; Ellenberg H., 1988, Vegetation ecology of Central Europe.; FAJER ED, 1992, AM NAT, V140, P707, DOI 10.1086/285436; Fritz C, 2006, PLANT J, V46, P533, DOI 10.1111/j.1365-313X.2006.02715.x; Gubsch M, 2011, PLANT CELL ENVIRON, V34, P895, DOI 10.1111/j.1365-3040.2011.02287.x; Harvey JA, 2005, J CHEM ECOL, V31, P287, DOI 10.1007/s10886-005-1341-1; Hemming JDC, 1999, J CHEM ECOL, V25, P1687, DOI 10.1023/A:1020805420160; Holeski LM, 2013, J CHEM ECOL, V39, P525, DOI 10.1007/s10886-013-0270-7; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Ingersoll CM, 2010, BOTANY, V88, P1007, DOI 10.1139/B10-072; Jamieson MA, 2012, CHEMOECOLOGY, V22, P1, DOI 10.1007/s00049-011-0087-1; Jarzomski CM, 2000, OIKOS, V88, P371, DOI 10.1034/j.1600-0706.2000.880216.x; Kawoosa T, 2010, FUNCT INTEGR GENOMIC, V10, P393, DOI 10.1007/s10142-009-0152-9; Kerchev PI, 2012, PLANT CELL ENVIRON, V35, P441, DOI 10.1111/j.1365-3040.2011.02399.x; Klotz S, 2003, SCHRREIHE VEGKD, V38, P1; Kluge G, 2000, BER DTSCH WETTERDIEN, V213, P1; Lampert EC, 2010, J CHEM ECOL, V36, P1101, DOI 10.1007/s10886-010-9849-4; Larbat R, 2012, PLANT BIOLOGY, V14, P760, DOI 10.1111/j.1438-8677.2012.00564.x; Li H, 2010, PHYTOCHEMISTRY, V71, P1690, DOI 10.1016/j.phytochem.2010.06.019; Lipowsky A, 2011, BASIC APPL ECOL, V12, P360, DOI 10.1016/j.baae.2011.03.005; Lorentzen S, 2008, PERSPECT PLANT ECOL, V10, P73, DOI 10.1016/j.ppees.2007.12.001; Marak HB, 2003, EVOLUTION, V57, P2519, DOI 10.1111/j.0014-3820.2003.tb01496.x; Marak HB, 2002, J CHEM ECOL, V28, P2429, DOI 10.1023/A:1021475800765; Marquard E, 2009, J ECOL, V97, P696, DOI 10.1111/j.1365-2745.2009.01521.x; McCloud ES, 1999, ENTOMOL EXP APPL, V93, P233, DOI 10.1023/A:1003806316904; MOLGAARD P, 1986, BIOCHEM SYST ECOL, V14, P113, DOI 10.1016/0305-1978(86)90095-5; MOLGAARD P, 1986, J ECOL, V74, P1127, DOI 10.2307/2260239; Moreira X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105438; Mraja A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028055; Nieminen M, 2003, J CHEM ECOL, V29, P823, DOI 10.1023/A:1022923514534; Niinemets U, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00262; Nunes-Nesi A, 2010, MOL PLANT, V3, P973, DOI 10.1093/mp/ssq049; Pellissier L, 2014, ECOGRAPHY, V37, P950, DOI 10.1111/ecog.00833; PEREYRA PC, 1988, J CHEM ECOL, V14, P917, DOI 10.1007/BF01018783; PUTTICK GM, 1988, J CHEM ECOL, V14, P335, DOI 10.1007/BF01022550; R Core Team, 2021, R LANGUAGE ENV STAT; REICHARDT PB, 1988, ACS SYM SER, V380, P130; Reudler JH, 2011, J CHEM ECOL, V37, P765, DOI 10.1007/s10886-011-9983-7; Reudler Talsma JH, 2008, J CHEM ECOL, V34, P1202, DOI 10.1007/s10886-008-9519-y; Rohmer M, 1999, NAT PROD REP, V16, P565, DOI 10.1039/a709175c; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2011, PLANT BIOLOGY, V13, P134, DOI 10.1111/j.1438-8677.2010.00338.x; Roscher C, 2011, ANN BOT-LONDON, V107, P965, DOI 10.1093/aob/mcr044; SAGAR GR, 1964, J ECOL, V52, P189, DOI 10.2307/2257792; Scherber C, 2006, OECOLOGIA, V147, P489, DOI 10.1007/s00442-005-0281-3; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; SHARMA N, 1992, ANN BOT-LONDON, V69, P7, DOI 10.1093/oxfordjournals.aob.a088309; SHOYAMA Y, 1987, PHYTOCHEMISTRY, V26, P983, DOI 10.1016/S0031-9422(00)82331-6; Smilanich AM, 2009, ECOL LETT, V12, P612, DOI 10.1111/j.1461-0248.2009.01309.x; Spehn EM, 2000, FUNCT ECOL, V14, P326, DOI 10.1046/j.1365-2435.2000.00437.x; Suomi J, 2003, ANAL BIOANAL CHEM, V376, P884, DOI 10.1007/s00216-003-2003-1; Unsicker SB, 2006, OECOLOGIA, V150, P233, DOI 10.1007/s00442-006-0511-3; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; Van Tienderen Peter H., 1996, Plant Species Biology, V11, P87; vanHinsberg A, 1997, J EVOLUTION BIOL, V10, P687, DOI 10.1007/s000360050049; VANTIENDEREN PH, 1990, EVOL TREND PLANT, V4, P35; Waterman P.G., 1989, P107; YOUNG KA, 1995, FUNCT ECOL, V9, P725, DOI 10.2307/2390245; Zuppinger-Dingley D, 2014, NATURE, V515, P108, DOI 10.1038/nature13869; Zuur Alain F., 2009, P1	76	21	21	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136073	10.1371/journal.pone.0136073	http://dx.doi.org/10.1371/journal.pone.0136073			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26336100	Green Published, Green Submitted, gold			2022-12-26	WOS:000360615400009
J	Neiman, J; Giuseffi, K; Smith, K; French, J; Waismel-Manor, I; Hibbing, J				Neiman, Jayme; Giuseffi, Karl; Smith, Kevin; French, Jeffrey; Waismel-Manor, Israel; Hibbing, John			Voting at Home Is Associated with Lower Cortisol than Voting at the Polls	PLOS ONE			English	Article							NEGATIVE AFFECT; VALIDATION; BEHAVIOR; PANAS	Previous research finds that voting is a socially stressful activity associated with increases in cortisol levels. Here we extend this research by investigating whether different voting modalities have differential effects on the stress response to voting. Results from a field experiment conducted during the 2012 presidential elections strongly suggest that traditional "at the polls" voting is more stressful, as measured by increases in cortisol levels, than voting at home by mail-in ballot or engaging in comparable non-political social activities. These findings imply that increased low-stress voting options such as mail-in ballots may increase political participation among individuals who are sensitive to social stressors.	[Neiman, Jayme] Univ No Iowa, Dept Polit Sci, Cedar Falls, IA 50614 USA; [Giuseffi, Karl; Smith, Kevin; Hibbing, John] Univ Nebraska, Dept Polit Sci, Lincoln, NE USA; [French, Jeffrey] Univ Nebraska, Dept Psychol, Omaha, NE 68182 USA; [Waismel-Manor, Israel] Univ Haifa, Sch Polit Sci, IL-31999 Haifa, Israel	University of Northern Iowa; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Haifa	Neiman, J (corresponding author), Univ No Iowa, Dept Polit Sci, Cedar Falls, IA 50614 USA.	jayme.neiman@uni.edu	waismel-manor, israel/GQA-3701-2022	waismel-manor, israel/0000-0001-6202-8111	Human and Social Dynamics initiative at the National Science Foundation [BCS-08-26828]	Human and Social Dynamics initiative at the National Science Foundation	This research was made possible by a grant (BCS-08-26828) from the Human and Social Dynamics initiative at the National Science Foundation (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Apicella CL, 2011, MAN IS NATURE POLITI, P261; Blanton H, 2012, POLIT COMMUN, V29, P447, DOI 10.1080/10584609.2012.736239; Clements AD, 1998, PSYCHONEUROENDOCRINO, V23, P613; French JA, 2014, PHYSIOL BEHAV, V133, P61, DOI 10.1016/j.physbeh.2014.05.004; Het S, 2012, PSYCHOSOM MED, V74, P23, DOI 10.1097/PSY.0b013e31823a4a25; Kudielka B. M., 2007, SOC NEUROSCI-UK, P56, DOI DOI 10.1007/978-1-4614-6852-3; Marcus G.E., 2010, SENTIMENTAL CITIZEN; McDermott R., 2011, MAN IS NATURE POLITI; Mcdermott R, 2007, ANN AM ACAD POLIT SS, V614, P15, DOI 10.1177/0002716207305268; Smyth J, 1998, PSYCHONEUROENDOCRINO, V23, P353, DOI 10.1016/S0306-4530(98)00008-0; Stanton SJ, 2010, PSYCHONEUROENDOCRINO, V35, P768, DOI 10.1016/j.psyneuen.2009.10.018; Susman EJ, 2007, DEV PSYCHOL, V43, P811, DOI 10.1037/0012-1649.43.4.811; Thompson ER, 2007, J CROSS CULT PSYCHOL, V38, P227, DOI 10.1177/0022022106297301; van Honk J, 2003, NEUROREPORT, V14, P1993, DOI 10.1097/00001756-200310270-00023; Wai ST, 2004, PSYCHIAT RES, V126, P197; Waismel-Manor I, 2011, EUR NEUROPSYCHOPHARM, V21, P789, DOI 10.1016/j.euroneuro.2011.03.003; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Young EA, 2004, BIOL PSYCHIAT, V56, P205, DOI 10.1016/j.biopsych.2004.05.011	18	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0135289	10.1371/journal.pone.0135289	http://dx.doi.org/10.1371/journal.pone.0135289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335591	Green Published, gold			2022-12-26	WOS:000360615400004
J	Matsui, K; Adelsberger, JW; Kemp, TJ; Baseler, MW; Ledgerwood, JE; Pinto, LA				Matsui, Ken; Adelsberger, Joseph W.; Kemp, Troy J.; Baseler, Michael W.; Ledgerwood, Julie E.; Pinto, Ligia A.			Circulating CXCR5(+)CD4(+) T Follicular-Like Helper Cell and Memory B Cell Responses to Human Papillomavirus Vaccines	PLOS ONE			English	Article							CXC CHEMOKINE RECEPTOR-5; TFH CELLS; MONONUCLEAR-CELLS; IMMUNITY; EXPRESS; SUBSET; VIRUS; BLOOD	Through the interaction of T follicular helper (Tfh) cells and B cells, efficacious vaccines can generate high-affinity, pathogen-neutralizing antibodies, and memory B cells. Using CXCR5, CXCR3, CCR6, CCR7, PD1, and ICOS as markers, Tfh-like cells can be identified in the circulation and be classified into three functionally distinct subsets that are PD1(+)ICOS(+), PD1(+)ICOS(-), or PD1(-)ICOS(-). We used these markers to identify different subsets of CXCR5(+)CD4(+) Tfh-like cells in response to highly immunogenic and efficacious vaccines for human papillomaviruses (HPV): Cervarix and Gardasil. In this small study, we used PBMC samples from 11 Gardasil recipients, and 8 Cervarix recipients from the Vaccine Research Center 902 Study to examine the induction of circulating Tfh-like cells and IgD-CD38(Hi)CD27(+) memory B cells by flow cytometry. PD1(+)ICOS(+) CXCR3(+)CCR6(-)CXCR5(+)CD4(+) (Tfh1-like) cells were induced and peaked on Day (D) 7 post-first vaccination, but not asmuch on D7 post-third vaccination. We also observed a trend toward increase in PD1(+)ICOS(+) CXCR3(-)CCR6(-)CXCR5(+)CD4(+) (Tfh2-like) cells for both vaccines, and PD1(+)ICOS(+) CXCR3(-)CCR6(+)CXCR5(+)CD4(+) (Tfh17-like) subset was induced by Cervarix post-first vaccination. There were alsominimal changes in the other cellular subsets. In addition, Cervarix recipients had more memory B cells post-first vaccination than did Gardasil recipients at D14 and D30. We found frequencies ofmemory B cells at D30 correlated with anti-HPV16 and 18 antibody titers from D30, and the induction levels of memory B cells at D30 and PD1(+)ICOS(+)Tfh1-like cells at D7 post-first vaccination correlated for Cervarix. Our study showed that induction of circulating CXCR5(+)CD4(+) Tfh-like subsets can be detected following immunization with HPV vaccines, and potentially be useful as a marker of immunogenicity of vaccines. However, further investigations should be extended to different cohorts with larger sample size to better understand the functions of these T cells, as well as their relationship with B cells and antibodies.	[Matsui, Ken; Kemp, Troy J.; Pinto, Ligia A.] Frederick Natl Lab Canc Res, Leidos Biomed Res Inc, Human Papillomavirus HPV Immunol Lab, Frederick, MD 21702 USA; [Adelsberger, Joseph W.; Baseler, Michael W.] Frederick Natl Lab Canc Res, Leidos Biomed Res Inc, AIDS Monitoring Lab, Clin Serv Program,Appl & Dev Directorate, Frederick, MD USA; [Ledgerwood, Julie E.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Pinto, LA (corresponding author), Frederick Natl Lab Canc Res, Leidos Biomed Res Inc, Human Papillomavirus HPV Immunol Lab, Frederick, MD 21702 USA.	pintol@mail.nih.gov			National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005047] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E.	Amanna IJ, 2006, IMMUNOL REV, V211, P320, DOI 10.1111/j.0105-2896.2006.00392.x; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Boswell KL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003853; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Buck Christopher B, 2007, Curr Protoc Cell Biol, VChapter 26, DOI 10.1002/0471143030.cb2601s37; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Chevalier N, 2011, J IMMUNOL, V186, P5556, DOI 10.4049/jimmunol.1002828; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Einstein MH, 2009, HUM VACCINES, V5, P705, DOI 10.4161/hv.5.10.9518; Giannini SL, 2006, VACCINE, V24, P5937, DOI 10.1016/j.vaccine.2006.06.005; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Herrin DM, 2014, HUM VACC IMMUNOTHER, V10, P3446, DOI 10.4161/hv.34408; Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Koyama S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000759; Lacey CJN, 2006, VACCINE, V24, P35, DOI 10.1016/j.vaccine.2006.06.015; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Markowitz LE, 2014, MMWR RECOMM REP, V63, P1; Martin JE, 2006, CLIN VACCINE IMMUNOL, V13, P1267, DOI 10.1128/CVI.00162-06; Matsui K, 2013, BRIT J HAEMATOL, V163, P81, DOI 10.1111/bjh.12475; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Pinto LA, 2005, CYTOM PART B-CLIN CY, V63B, P47, DOI 10.1002/cyto.b.20038; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Romanowski B, 2011, HUM VACCINES, V7, P161, DOI 10.4161/hv.7.2.13690; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schiller JT, 2012, VACCINE, V30, pF123, DOI 10.1016/j.vaccine.2012.04.108; Schmitt N, 2014, TRENDS IMMUNOL, V35, P436, DOI 10.1016/j.it.2014.06.002; Schmitt N, 2013, IMMUNITY, V39, P629, DOI 10.1016/j.immuni.2013.09.011; Stanley M, 2012, VACCINE, V30, pF83, DOI 10.1016/j.vaccine.2012.04.106; Stanley MA, 2014, EXPERT REV VACCINES, V13, P1027, DOI 10.1586/14760584.2014.935767; Suan D, 2015, IMMUNITY, V42, P704, DOI 10.1016/j.immuni.2015.03.002; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Tsai LM, 2014, IMMUNOL CELL BIOL, V92, P57, DOI 10.1038/icb.2013.68; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	44	32	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137195	10.1371/journal.pone.0137195	http://dx.doi.org/10.1371/journal.pone.0137195			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26333070	Green Submitted, Green Published, gold			2022-12-26	WOS:000360613800108
J	Smith, CL; Pivovarova, N; Reese, TS				Smith, Carolyn L.; Pivovarova, Natalia; Reese, Thomas S.			Coordinated Feeding Behavior in Trichoplax, an Animal without Synapses	PLOS ONE			English	Article							RHABDOCALYPTUS-DAWSONI LAMBE; HEXACTINELLID SPONGES; FIBER CELLS; GENOME; PLACOZOA; DICKINSONIA; SYSTEM	Trichoplax is a small disk-shaped marine metazoan that adheres to substrates and locomotes by ciliary gliding. Despite having only six cell types and lacking synapses Trichoplax coordinates a complex sequence of behaviors culminating in external digestion of algae. We combine live cell imaging with electron microscopy to show how this is accomplished. When Trichoplax glides over a patch of algae, its cilia stop beating so it ceases moving. A subset of one of the cell types, lipophils, simultaneously secretes granules whose content rapidly lyses algae. This secretion is accurately targeted, as only lipophils located near algae release granules. The animal pauses while the algal content is ingested, and then resumes gliding. Global control of gliding is coordinated with precise local control of lipophil secretion suggesting the presence of mechanisms for cellular communication and integration.	[Smith, Carolyn L.; Pivovarova, Natalia; Reese, Thomas S.] NINDS, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Smith, CL (corresponding author), NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	smithca@ninds.nih.gov			National Institutes of Neurological Diseases and Stroke, National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002972] Funding Source: NIH RePORTER	National Institutes of Neurological Diseases and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Neurological Diseases and Stroke, National Institutes of Health.	Alberts B, 2014, MOL BIOL CELL, DOI DOI 10.1201/9780203833445; Aono K, 2008, BIOL BULL-US, V215, P272, DOI 10.2307/25470711; Brasier MD, 2008, PALAEOGEOGR PALAEOCL, V270, P311, DOI 10.1016/j.palaeo.2008.07.018; Conzelmann M, 2011, P NATL ACAD SCI USA, V108, pE1174, DOI 10.1073/pnas.1109085108; FARBMAN AI, 1992, CELL BIOL OLFACTION; Gehling JG, 2005, EVOLVING FORM AND FUNCTION: FOSSILS AND DEVELOPMENT, P43; Gorr SU, 2005, J DENT RES, V84, P500, DOI 10.1177/154405910508400604; Grell K.G., 1991, P13; GRELL KG, 1972, Z MORPHOL TIERE, V73, P297, DOI 10.1007/BF00391925; GRELL KG, 1974, Z NATURFORSCH C, VC 29, P790; Guidi L, 2011, J MORPHOL, V272, P371, DOI 10.1002/jmor.10922; Hoef-Emden K, CRYPTOMONADS; Ivantsov AY, 2013, STRATIGR GEO CORREL+, V21, P252, DOI 10.1134/S0869593813030039; Ivantsov AY, 2011, PALEONTOL J+, V45, P237, DOI 10.1134/S0031030111030063; Jackson AM, 2009, INVERTEBR BIOL, V128, P205, DOI 10.1111/j.1744-7410.2009.00177.x; Jekely G, 2015, EVODEVO, V6, DOI 10.1186/2041-9139-6-1; Kana R, 2009, FEBS LETT, V583, P670, DOI 10.1016/j.febslet.2009.01.016; Liebeskind BJ, 2015, P NATL ACAD SCI USA, V112, pE846, DOI 10.1073/pnas.1501195112; MACHEMER H, 1972, J EXP BIOL, V57, P239; MACKIE GO, 1983, PHILOS T ROY SOC B, V301, P365, DOI 10.1098/rstb.1983.0028; MACKIE GO, 1983, PHILOS T ROY SOC B, V301, P401, DOI 10.1098/rstb.1983.0029; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; Pearse VB, 2007, INTEGR COMP BIOL, V47, P677, DOI 10.1093/icb/icm015; Pozzo-Miller LD, 1999, MICROSC RES TECHNIQ, V46, P370, DOI 10.1002/(SICI)1097-0029(19990915)46:6<370::AID-JEMT5>3.0.CO;2-3; Rompolas P, 2009, METHOD CELL BIOL, V93, P81, DOI 10.1016/S0091-679X(08)93004-1; RUTHMANN A, 1986, ZOOMORPHOLOGY, V106, P115, DOI 10.1007/BF00312113; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; SCHUCHERT P, 1993, ACTA ZOOL-STOCKHOLM, V74, P115, DOI 10.1111/j.1463-6395.1993.tb01227.x; SCHULSINGER F, 1991, Acta Psychiatrica Scandinavica Supplementum, P1; Signorovitch AY, 2006, BIOL BULL-US, V211, P149, DOI 10.2307/4134589; Smith CL, 2014, CURR BIOL, V24, P1565, DOI 10.1016/j.cub.2014.05.046; Sperling EA, 2010, EVOL DEV, V12, P201, DOI 10.1111/j.1525-142X.2010.00404.x; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Sternini C, 2008, CURR OPIN ENDOCRINOL, V15, P73, DOI 10.1097/MED.0b013e3282f43a73; THIEMANN M, 1989, ZOOMORPHOLOGY, V109, P89, DOI 10.1007/BF00312314; Ueda T, 1999, BIOSYSTEMS, V54, P65, DOI 10.1016/S0303-2647(99)00066-0; WENDEROTH H, 1986, Z NATURFORSCH C, V41, P343	37	66	69	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136098	10.1371/journal.pone.0136098	http://dx.doi.org/10.1371/journal.pone.0136098			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26333190	gold, Green Submitted, Green Published			2022-12-26	WOS:000360613800049
J	Dettin, M; Zamuner, A; Roso, M; Gloria, A; Iucci, G; Messina, GML; D'Amora, U; Marletta, G; Modesti, M; Castagliuolo, I; Brun, P				Dettin, Monica; Zamuner, Annj; Roso, Martina; Gloria, Antonio; Iucci, Giovanna; Messina, Grazia M. L.; D'Amora, Ugo; Marletta, Giovanni; Modesti, Michele; Castagliuolo, Ignazio; Brun, Paola			Electrospun Scaffolds for Osteoblast Cells: Peptide-Induced Concentration-Dependent Improvements of Polycaprolactone	PLOS ONE			English	Article							SELF-ASSEMBLING PEPTIDE; SURFACE; DIFFERENTIATION; NANOFIBERS; GELATIN; NEXAFS; TIO2; XPS; AU	The design of hybrid poly-e-caprolactone (PCL)-self-assembling peptides (SAPs) matrices represents a simple method for the surface functionalization of synthetic scaffolds, which is essential for cell compatibility. This study investigates the influence of increasing concentrations (2.5%, 5%, 10% and 15% w/w SAP compared to PCL) of three different SAPs on the physico-chemical/mechanical and biological properties of PCL fibers. We demonstrated that physico-chemical surface characteristics were slightly improved at increasing SAP concentrations: the fiber diameter increased; surface wettability increased with the first SAP addition (2.5%) and slightly less for the following ones; SAP-surface density increased but no change in the conformation was registered. These results could allow engineering matrices with structural characteristics and desired wettability according to the needs and the cell system used. The biological and mechanical characteristics of these scaffolds showed a particular trend at increasing SAP concentrations suggesting a prevailing correlation between cell behavior and mechanical features of the matrices. As compared with bare PCL, SAP enrichment increased the number of metabolic active h-osteoblast cells, fostered the expression of specific osteoblast-related mRNA transcripts, and guided calcium deposition, revealing the potential application of PCL-SAP scaffolds for the maintenance of osteoblast phenotype.	[Dettin, Monica; Zamuner, Annj; Roso, Martina; Modesti, Michele] Univ Padua, Dept Ind Engn, Padua, Italy; [Gloria, Antonio; D'Amora, Ugo] Natl Res Council Italy, Inst Polymers Composites & Biomat, Naples, Italy; [Iucci, Giovanna] Univ Roma Tre, Dept Phys, Rome, Italy; [Messina, Grazia M. L.; Marletta, Giovanni] Univ Catania, Dept Chem, Catania, Italy; [Castagliuolo, Ignazio; Brun, Paola] Univ Padua, Dept Mol Med, Padua, Italy	University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto per i Polimeri, Compositi e Biomateriali (IPCB-CNR); Roma Tre University; University of Catania; University of Padua	Dettin, M (corresponding author), Univ Padua, Dept Ind Engn, Padua, Italy.	monica.dettin@unipd.it	castagliuolo, ignazio/K-9963-2016; Marletta, Giovanni/F-3154-2012; D'Amora, Ugo/P-6304-2019	castagliuolo, ignazio/0000-0001-9888-7030; Marletta, Giovanni/0000-0002-6929-9499; D'Amora, Ugo/0000-0002-6142-059X; Modesti, Michele/0000-0002-5805-5587; Zamuner, Annj/0000-0002-8113-0346; Gloria, Antonio/0000-0001-5233-5687; IUCCI, Giovanna/0000-0002-6478-3759; roso, martina/0000-0001-6430-2751	Ministero dell'Istruzione, dell'Universita e della Ricerca Progetti di Rilevante iInteresse Nazionale [SH3K]; University of Padova Progetto di Ateneo [CPDA128452]	Ministero dell'Istruzione, dell'Universita e della Ricerca Progetti di Rilevante iInteresse Nazionale; University of Padova Progetto di Ateneo	This work has been supported by Ministero dell'Istruzione, dell'Universita e della Ricerca (http://www.istruzione.it/) Progetti di Rilevante iInteresse Nazionale 2010 (SH3K) (MD, MM, GI) and by University of Padova (http://www.unipd.it/) Progetto di Ateneo 2012 (CPDA128452) (MD, PB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, HDB XRAY PHOTOELECTR; Barbieri L, 2007, LANGMUIR, V23, P1723, DOI 10.1021/la0617964; Battocchio C, 2012, MAT SCI ENG C, V169, P36; Brun P, 2013, ACTA BIOMATER, V9, P6105, DOI 10.1016/j.actbio.2012.12.018; Brun P, 2011, ACTA BIOMATER, V7, P2526, DOI 10.1016/j.actbio.2011.02.025; Danesin R, 2012, BONE, V51, P851, DOI 10.1016/j.bone.2012.08.119; Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X; Dettin M, 1998, J PEPT SCI, V4, P436, DOI 10.1002/(SICI)1099-1387(199811)4:7<436::AID-PSC163>3.0.CO;2-C; FISHER LW, 1990, J BIOL CHEM, V265, P2347; Gelain F, 2010, J CONTROL RELEASE, V145, P231, DOI 10.1016/j.jconrel.2010.04.026; Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007; Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646; HARIS PI, 1995, BIOPOLYMERS, V37, P251, DOI 10.1002/bip.360370404; He LN, 2011, APPL SURF SCI, V257, P3547, DOI 10.1016/j.apsusc.2010.11.072; Heydarkhan-Hagvall S, 2008, BIOMATERIALS, V29, P2907, DOI 10.1016/j.biomaterials.2008.03.034; Iucci G, 2007, SURF SCI, V601, P3843, DOI 10.1016/j.susc.2007.04.024; LEBUGLE A, 1995, BBA-PROTEIN STRUCT M, V1248, P107, DOI 10.1016/0167-4838(95)00009-J; Li MY, 2006, J BIOMED MATER RES A, V79A, P963, DOI 10.1002/jbm.a.30833; Li MY, 2006, BIOMATERIALS, V27, P2705, DOI 10.1016/j.biomaterials.2005.11.037; Luna LG, 1968, MANUAL HISTOLOGIC ST, V3; Mahmoud ZN, 2011, BIOMATERIALS, V32, P3712, DOI 10.1016/j.biomaterials.2010.12.002; Marmur A, 2009, LANGMUIR, V25, P1277, DOI 10.1021/la802667b; Mattanavee W, 2009, ACS APPL MATER INTER, V1, P1076, DOI 10.1021/am900048t; Mit-uppatham C, 2004, MACROMOL CHEM PHYS, V205, P2327, DOI 10.1002/macp.200400225; Moraes C, 2014, LAB CHIP, V14, P2191, DOI 10.1039/c4lc00122b; Ortiz J, 2012, J BIOMED MATER RES A, V100A, P1770, DOI 10.1002/jbm.a.34103; Ozeki M, 2011, J BIOMATER APPL, V25, P663, DOI 10.1177/0885328209356328; Pathak JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131041; Polzonetti G, 2006, MAT SCI ENG C-BIO S, V26, P929, DOI 10.1016/j.msec.2005.09.062; Shekaran A, 2011, J BIOMED MATER RES A, V96A, P261, DOI 10.1002/jbm.a.32979; Son WK, 2004, POLYMER, V45, P2959, DOI [10.1016/j.polymer.2004.03.006, 10.1016/j.polymer.2004.02.006]; Tambralli A, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/2/025001; Tsai SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031200; Watts J. F., 1992, HIGH RESOLUTION XPS; Xie JW, 2009, ACS NANO, V3, P1151, DOI 10.1021/nn900070z; Yoo HS, 2009, ADV DRUG DELIVER REV, V61, P1033, DOI 10.1016/j.addr.2009.07.007; ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334; Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k	38	29	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137505	10.1371/journal.pone.0137505	http://dx.doi.org/10.1371/journal.pone.0137505			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26361004	Green Published, Green Submitted, gold			2022-12-26	WOS:000361043100047
J	Hao, PY; Wang, L; Niu, Z				Hao, Pengyu; Wang, Li; Niu, Zheng			Comparison of Hybrid Classifiers for Crop Classification Using Normalized Difference Vegetation Index Time Series: A Case Study for Major Crops in North Xinjiang, China	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; REMOTE-SENSING DATA; RANDOM FORESTS; IMAGE-ANALYSIS; MODIS; UNCERTAINTY; ALGORITHMS; TM; REQUIREMENTS; ACCURACY	A range of single classifiers have been proposed to classify crop types using time series vegetation indices, and hybrid classifiers are used to improve discriminatory power. Traditional fusion rules use the product of multi-single classifiers, but that strategy cannot integrate the classification output of machine learning classifiers. In this research, the performance of two hybrid strategies, multiple voting (M-voting) and probabilistic fusion (P-fusion), for crop classification using NDVI time series were tested with different training sample sizes at both pixel and object levels, and two representative counties in north Xinjiang were selected as study area. The single classifiers employed in this research included Random Forest (RF), Support Vector Machine (SVM), and See 5 (C 5.0). The results indicated that classification performance improved (increased the mean overall accuracy by 5%similar to 10%, and reduced standard deviation of overall accuracy by around 1%) substantially with the training sample number, and when the training sample size was small (50 or 100 training samples), hybrid classifiers substantially outperformed single classifiers with higher mean overall accuracy (1%similar to 2%). However, when abundant training samples (4,000) were employed, single classifiers could achieve good classification accuracy, and all classifiers obtained similar performances. Additionally, although object-based classification did not improve accuracy, it resulted in greater visual appeal, especially in study areas with a heterogeneous cropping pattern.	[Hao, Pengyu; Wang, Li; Niu, Zheng] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, State Key Lab Remote Sensing Sci, Beijing 100101, Peoples R China; [Hao, Pengyu] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, L (corresponding author), Chinese Acad Sci, Inst Remote Sensing & Digital Earth, State Key Lab Remote Sensing Sci, Beijing 100101, Peoples R China.	wangli@radi.ac.cn	niu, zheng/M-9923-2017; Wang, Li/P-9811-2018; HAO, Pengyu/P-1175-2014	Wang, Li/0000-0002-2929-4255; HAO, Pengyu/0000-0003-3711-6157	National Natural Science Foundation of China [41371358, 41301498]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This study was supported by the National Natural Science Foundation of China (41371358) and (41301498).	Agapiou A, 2014, INT J DIGIT EARTH, V7, P351, DOI 10.1080/17538947.2012.674159; Araya YH, GEO ENVIRONMENT AND, P233; Benz UC, 2004, ISPRS J PHOTOGRAMM, V58, P239, DOI 10.1016/j.isprsjprs.2003.10.002; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, BREIMAN CUTLERS RAND; Camps-Valls G, 2008, IEEE T GEOSCI REMOTE, V46, P1822, DOI 10.1109/TGRS.2008.916201; CCRSDA, TECHNICAL SPECIFICAT; Chander G, 2009, REMOTE SENS ENVIRON, V113, P893, DOI 10.1016/j.rse.2009.01.007; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Conrad C, 2013, GLOBAL PLANET CHANGE, V110, P88, DOI 10.1016/j.gloplacha.2013.08.002; De Rainville FM, 2014, PATTERN ANAL APPL, V17, P401, DOI 10.1007/s10044-012-0307-5; Dorren LKA, 2003, FOREST ECOL MANAG, V183, P31, DOI 10.1016/S0378-1127(03)00113-0; Du YZ, 2004, OPT ENG, V43, P1777, DOI 10.1117/1.1766301; Duro DC, 2012, REMOTE SENS ENVIRON, V118, P259, DOI 10.1016/j.rse.2011.11.020; Exelis, ENV VIS IM 2015; Exelis, FAST LIN OF SIGHT AT; Foody GM, 2004, REMOTE SENS ENVIRON, V93, P107, DOI 10.1016/j.rse.2004.06.017; Foody GM, 2004, PHOTOGRAMM ENG REM S, V70, P627, DOI 10.14358/PERS.70.5.627; Fry J.A., 2009, COMPLETION NATL LAND; Gallego J., 2008, BEST PRACTICES CROP; Gao Y, 2006, INT J REMOTE SENS, V27, P4039, DOI 10.1080/01431160600702632; Ghiyamat A, 2010, INT J REMOTE SENS, V31, P1837, DOI 10.1080/01431160902926681; Ghosh A, 2014, INT J APPL EARTH OBS, V26, P298, DOI 10.1016/j.jag.2013.08.011; Hao PY, 2014, REMOTE SENS-BASEL, V6, P7610, DOI 10.3390/rs6087610; Howard DM, 2014, PHOTOGRAMM ENG REM S, V80, P537, DOI 10.14358/PERS.80.6.537-549; Huang N, 2013, ECOL INDIC, V26, P117, DOI 10.1016/j.ecolind.2012.10.027; Huang WJ, 2013, SENSORS-BASEL, V13, P16023, DOI 10.3390/s131216023; Huang X, 2013, IEEE T GEOSCI REMOTE, V51, P257, DOI 10.1109/TGRS.2012.2202912; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Ju JC, 2008, REMOTE SENS ENVIRON, V112, P1196, DOI 10.1016/j.rse.2007.08.011; Kuhn M, 2014, C5 0 DECISION TREES; Low F, 2013, ISPRS J PHOTOGRAMM, V85, P102, DOI 10.1016/j.isprsjprs.2013.08.007; Low F, 2014, REMOTE SENS-BASEL, V6, P9034, DOI 10.3390/rs6099034; Long JA, 2013, GISCI REMOTE SENS, V50, P418, DOI 10.1080/15481603.2013.817150; Loosvelt L, 2012, IEEE T GEOSCI REMOTE, V50, P4185, DOI 10.1109/TGRS.2012.2189012; Loosvelt L, 2012, INT J APPL EARTH OBS, V19, P173, DOI 10.1016/j.jag.2012.05.011; Los SO, 2005, REMOTE SENS ENVIRON, V99, P400, DOI 10.1016/j.rse.2005.08.017; Lu D, 2007, INT J REMOTE SENS, V28, P823, DOI 10.1080/01431160600746456; Melgani F, 2004, IEEE T GEOSCI REMOTE, V42, P1778, DOI 10.1109/TGRS.2004.831865; Meyer D., MISC FUNCTIONS DEP S; Mountrakis G, 2011, ISPRS J PHOTOGRAMM, V66, P247, DOI 10.1016/j.isprsjprs.2010.11.001; NASS, 2014, CROPSPACE CROPL DAT; Ouyang ZT, 2011, ECOL INFORM, V6, P136, DOI 10.1016/j.ecoinf.2011.01.002; PAL NR, 1994, IEEE T FUZZY SYST, V2, P107, DOI 10.1109/91.277960; [庞素琳 PANG Su-lin], 2009, [系统工程理论与实践, Systems Engineering-Theory & Practice], V29, P94, DOI 10.1016/S1874-8651(10)60092-0; Pena-Barragan JM, 2011, REMOTE SENS ENVIRON, V115, P1301, DOI 10.1016/j.rse.2011.01.009; Petitjean F, 2012, IEEE T GEOSCI REMOTE, V50, P3081, DOI 10.1109/TGRS.2011.2179050; Potgieter AB, 2013, INT J APPL EARTH OBS, V23, P254, DOI 10.1016/j.jag.2012.09.009; Robertson LD, 2011, INT J REMOTE SENS, V32, P1505, DOI 10.1080/01431160903571791; Rodriguez-Galiano VF, 2012, ISPRS J PHOTOGRAMM, V67, P93, DOI 10.1016/j.isprsjprs.2011.11.002; RuleQuest, 2013, DAT MIN TOOLS SEE5 C; Shao Y, 2010, PHOTOGRAMM ENG REM S, V76, P73, DOI 10.14358/PERS.76.1.73; Space ADa, 2015, DMC CONST; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tong A, 2013, J APPL REMOTE SENS, V7, DOI 10.1117/1.JRS.7.073599; Vanonckelen S, 2013, INT J APPL EARTH OBS, V24, P9, DOI 10.1016/j.jag.2013.02.003; Vieira MA, 2012, REMOTE SENS ENVIRON, V123, P553, DOI 10.1016/j.rse.2012.04.011; Vintrou E, 2013, IEEE J-STARS, V6, P2132, DOI 10.1109/JSTARS.2013.2238507; Wardlow BD, 2008, REMOTE SENS ENVIRON, V112, P1096, DOI 10.1016/j.rse.2007.07.019; Wardlow BD, 2007, REMOTE SENS ENVIRON, V108, P290, DOI 10.1016/j.rse.2006.11.021; Zheng BJ, 2015, INT J APPL EARTH OBS, V34, P103, DOI 10.1016/j.jag.2014.07.002; Zhong LH, 2014, REMOTE SENS ENVIRON, V140, P1, DOI 10.1016/j.rse.2013.08.023; Zhou FQ, 2013, ISPRS J PHOTOGRAMM, V84, P114, DOI 10.1016/j.isprsjprs.2013.07.008; Zhu S, 2012, INT CONF AGRO-GEOINF, P603	65	23	25	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137748	10.1371/journal.pone.0137748	http://dx.doi.org/10.1371/journal.pone.0137748			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360597	gold, Green Submitted, Green Published			2022-12-26	WOS:000361043100080
J	Movahed, E; Munusamy, K; Tan, GMY; Looi, CY; Tay, ST; Wong, WF				Movahed, Elaheh; Munusamy, Komathy; Tan, Grace Min Yi; Looi, Chung Yeng; Tay, Sun Tee; Wong, Won Fen			Genome-Wide Transcription Study of Cryptococcus neoformans H99 Clinical Strain versus Environmental Strains	PLOS ONE			English	Article							SIDEROPHORE BIOSYNTHESIS; ENDOPLASMIC-RETICULUM; ASPERGILLUS-FUMIGATUS; CELL INTEGRITY; IRON UPTAKE; VIRULENCE; SEC2P; GENE; IDENTIFICATION; DEHYDROGENASE	The infection of Cryptococcus neoformans is acquired through the inhalation of desiccated yeast cells and basidiospores originated from the environment, particularly from bird's droppings and decaying wood. Three environmental strains of C. neoformans originated from bird droppings (H4, S48B and S68B) and C. neoformans reference clinical strain (H99) were used for intranasal infection in C57BL/6 mice. We showed that the H99 strain demonstrated higher virulence compared to H4, S48B and S68B strains. To examine if gene expression contributed to the different degree of virulence among these strains, a genome-wide microarray study was performed to inspect the transcriptomic profiles of all four strains. Our results revealed that out of 7,419 genes (22,257 probes) examined, 65 genes were significantly up-or down-regulated in H99 versus H4, S48B and S68B strains. The up-regulated genes in H99 strain include Hydroxymethylglutaryl-CoA synthase (MVA1), Mitochondrial matrix factor 1 (MMF1), Bud-site-selection protein 8 (BUD8), High affinity glucose transporter 3 (SNF3) and Rho GTPase-activating protein 2 (RGA2). Pathway annotation using DAVID bioinformatics resource showed that metal ion binding and sugar transmembrane transporter activity pathways were highly expressed in the H99 strain. We suggest that the genes and pathways identified may possibly play crucial roles in the fungal pathogenesis.	[Movahed, Elaheh; Munusamy, Komathy; Tan, Grace Min Yi; Tay, Sun Tee; Wong, Won Fen] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Looi, Chung Yeng] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya	Wong, WF (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	wonfen@um.edu.my	Tay, Sun Tee/N-2295-2019; Wong, Won Fen/D-3087-2012	Tay, Sun Tee/0000-0002-3120-6998; Wong, Won Fen/0000-0003-1082-1956	Malaysian Ministry of Higher Education [E000013-20001]; University of Malaya [RG525-13HTM]	Malaysian Ministry of Higher Education; University of Malaya(Universiti Malaya)	This work was supported by Malaysian Ministry of Higher Education (E000013-20001) and University of Malaya (RG525-13HTM). EM was supported by a postgraduate research fund (PPP) from University of Malaya.	Villar-Tajadura MA, 2008, MOL MICROBIOL, V70, P867, DOI 10.1111/j.1365-2958.2008.06447.x; Ardon O, 2001, J BIOL CHEM, V276, P43049, DOI 10.1074/jbc.M108701200; BISSON LF, 1987, J BACTERIOL, V169, P1656, DOI 10.1128/jb.169.4.1656-1662.1987; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Broad Institute of Harvard and MIT, CRYPT NEOF VAR GRUB; Caballero-Lima D, 2014, MOL MICROBIOL, V94, P828, DOI 10.1111/mmi.12799; CELENZA JL, 1988, P NATL ACAD SCI USA, V85, P2130, DOI 10.1073/pnas.85.7.2130; Chan MY, 2010, MYCOSES, V53, P26, DOI 10.1111/j.1439-0507.2008.01654.x; Choi KM, 2015, FEBS LETT, V589, P349, DOI 10.1016/j.febslet.2014.12.020; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cox GM, 2003, INFECT IMMUN, V71, P173, DOI 10.1128/IAI.71.1.173-180.2003; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; Diao FC, 2007, P NATL ACAD SCI USA, V104, P11706, DOI 10.1073/pnas.0700544104; Ding C, 2013, CELL HOST MICROBE, V13, P265, DOI 10.1016/j.chom.2013.02.002; Elkind NB, 2000, J CELL BIOL, V149, P95, DOI 10.1083/jcb.149.1.95; Ellerbroek PM, 2004, J IMMUNOL, V173, P7513, DOI 10.4049/jimmunol.173.12.7513; ELLIS DH, 1990, LANCET, V336, P923, DOI 10.1016/0140-6736(90)92283-N; Enache-Angoulvant A, 2007, J CLIN MICROBIOL, V45, P1261, DOI 10.1128/JCM.01839-06; Espinel-Ingroff A, 2012, ANTIMICROB AGENTS CH, V56, P5898, DOI 10.1128/AAC.01115-12; Fraser JA, 2013, MBIO, V4, DOI DOI 10.1128/MBI0.00408-13; GarciaHermoso D, 1997, J CLIN MICROBIOL, V35, P2683, DOI 10.1128/JCM.35.10.2683-2685.1997; Gerik KJ, 2005, MOL MICROBIOL, V58, P393, DOI 10.1111/j.1365-2958.2005.04843.x; Goldman DL, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e66; Haas H, 2003, APPL MICROBIOL BIOT, V62, P316, DOI 10.1007/s00253-003-1335-2; Harkins HA, 2001, MOL BIOL CELL, V12, P2497, DOI 10.1091/mbc.12.8.2497; Herrero AB, 2002, EUKARYOT CELL, V1, P420, DOI 10.1128/EC.1.3.420-431.2002; Heymann P, 2002, INFECT IMMUN, V70, P5246, DOI 10.1128/IAI.70.9.5246-5255.2002; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005; Hissen AHT, 2004, INFECT IMMUN, V72, P1402, DOI 10.1128/IAI.72.3.1402-1408.2004; Hu GG, 2008, MOL MICROBIOL, V69, P1456, DOI 10.1111/j.1365-2958.2008.06374.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUFFNAGLE GB, 1991, INFECT IMMUN, V59, P1423, DOI 10.1128/IAI.59.4.1423-1433.1991; Jain N, 2013, MOL MICROBIOL, V88, P713, DOI 10.1111/mmi.12216; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Kim JM, 2001, GENES CELLS, V6, P507, DOI 10.1046/j.1365-2443.2001.00443.x; Kim SY, 2010, FUNGAL GENET BIOL, V47, P782, DOI 10.1016/j.fgb.2010.06.005; Kosman DJ, 2003, MOL MICROBIOL, V47, P1185, DOI 10.1046/j.1365-2958.2003.03368.x; Krappmann AB, 2007, MOL BIOL CELL, V18, P3323, DOI 10.1091/mbc.E06-10-0899; Kraus PR, 2003, MOL MICROBIOL, V48, P1377, DOI 10.1046/j.1365-2958.2003.03508.x; Kronstad J, 2008, CELL HOST MICROBE, V4, P308, DOI 10.1016/j.chom.2008.09.003; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Lazera MS, 1996, J MED VET MYCOL, V34, P127; Lee YJ, 2012, J BIOL CHEM, V287, P44221, DOI 10.1074/jbc.M112.375360; Lesuisse E, 2001, MICROBIOL-UK, V147, P289, DOI 10.1099/00221287-147-2-289; Lian TS, 2005, MOL MICROBIOL, V55, P1452, DOI 10.1111/j.1365-2958.2004.04474.x; Litvintseva AP, 2009, INFECT IMMUN, V77, P3188, DOI 10.1128/IAI.00296-09; Maeng S, 2010, EUKARYOT CELL, V9, P360, DOI 10.1128/EC.00309-09; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Molin M, 2003, J BIOL CHEM, V278, P1415, DOI 10.1074/jbc.M203030200; Ngamskulrungroj P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016076; Ngamskulrungroj P, 2009, INFECT IMMUN, V77, P4584, DOI 10.1128/IAI.00565-09; Oxelmark E, 2000, MOL CELL BIOL, V20, P7784, DOI 10.1128/MCB.20.20.7784-7797.2000; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2005, FEMS IMMUNOL MED MIC, V45, P395, DOI 10.1016/j.femsim.2005.06.005; Price MS, 2011, MBIO, V2, DOI 10.1128/mBio.00103-11; Rodaki A, 2009, MOL BIOL CELL, V20, P4845, DOI 10.1091/mbc.E09-01-0002; Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242; Shingu-Vazquez M, 2011, EUKARYOT CELL, V10, P1376, DOI 10.1128/EC.05184-11; Stalder D, 2013, P NATL ACAD SCI USA, V110, P19995, DOI 10.1073/pnas.1320029110; Taheri N, 2000, EMBO J, V19, P6686, DOI 10.1093/emboj/19.24.6686; Tan GMY, 2015, SCI REP-UK, V5, DOI 10.1038/srep11046; Tangen KL, 2007, MICROBIOL-SGM, V153, P29, DOI 10.1099/mic.0.2006/000927-0; Tay ST, 2006, MED MYCOL, V44, P617, DOI 10.1080/13693780600857330; Tay ST, 2005, MYCOPATHOLOGIA, V159, P509, DOI 10.1007/s11046-005-3091-6; Theodoris G, 2001, FEMS MICROBIOL LETT, V197, P73, DOI 10.1016/S0378-1097(01)00088-X; Vellucci VF, 2007, FUNGAL GENET BIOL, V44, P979, DOI 10.1016/j.fgb.2006.12.003; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; Warringer J, 2006, YEAST, V23, P389, DOI 10.1002/yea.1363; WILLIAMSON PR, 1994, J BACTERIOL, V176, P656, DOI 10.1128/jb.176.3.656-664.1994; Wong WF, 2014, EUR J IMMUNOL, V44, P894, DOI 10.1002/eji.201343496; Wright LC, 2004, BIOCHEM J, V384, P377, DOI 10.1042/BJ20041079; Yu QL, 2012, MICROBIOL-SGM, V158, P2272, DOI 10.1099/mic.0.057232-0; Zahner JE, 1996, MOL CELL BIOL, V16, P1857; Zhang YQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000939; Zheng XD, 2007, EMBO J, V26, P3760, DOI 10.1038/sj.emboj.7601814; Zhu XD, 2003, MOL MICROBIOL, V47, P1007, DOI 10.1046/j.1365-2958.2003.03340.x	77	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137457	10.1371/journal.pone.0137457	http://dx.doi.org/10.1371/journal.pone.0137457			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360021	Green Published, gold, Green Submitted			2022-12-26	WOS:000361043100041
J	Logvinova, DS; Markov, DI; Nikolaeva, OP; Sluchanko, NN; Ushakov, DS; Levitsky, DI				Logvinova, Daria S.; Markov, Denis I.; Nikolaeva, Olga P.; Sluchanko, Nikolai N.; Ushakov, Dmitry S.; Levitsky, Dmitrii I.			Does Interaction between the Motor and Regulatory Domains of the Myosin Head Occur during ATPase Cycle? Evidence from Thermal Unfolding Studies on Myosin Subfragment 1	PLOS ONE			English	Article							ESSENTIAL LIGHT-CHAIN; SKELETAL-MUSCLE MYOSIN; BERYLLIUM FLUORIDE; MOLECULAR MOTOR; ENERGY-TRANSFER; SCALLOP MYOSIN; ALKALI LIGHT; FLUORESCENCE; ACTIN; COMPLEX	Myosin head (myosin subfragment 1, S1) consists of two major structural domains, the motor (or catalytic) domain and the regulatory domain. Functioning of the myosin head as a molecular motor is believed to involve a rotation of the regulatory domain (lever arm) relative to the motor domain during the ATPase cycle. According to predictions, this rotation can be accompanied by an interaction between the motor domain and the C-terminus of the essential light chain (ELC) associated with the regulatory domain. To check this assumption, we applied differential scanning calorimetry (DSC) combined with temperature dependences of fluorescence to study changes in thermal unfolding and the domain structure of S1, which occur upon formation of the ternary complexes S1-ADP-AlF(4)(-)and S1-ADP-BeFx that mimic S1 ATPase intermediate states S1**-ADP-P-i and S1*-ATP, respectively. To identify the thermal transitions on the DSC profiles (i.e. to assign them to the structural domains of S1), we compared the DSC data with temperature-induced changes in fluorescence of either tryptophan residues, located only in the motor domain, or recombinant ELC mutants (light chain 1 isoform), which were first fluorescently labeled at different positions in their C-terminal half and then introduced into the S1 regulatory domain. We show that formation of the ternary complexes S1-ADP-AlF4-and S1-ADP-BeFx significantly stabilizes not only the motor domain, but also the regulatory domain of the S1 molecule implying inter-domain interaction via ELC. This is consistent with the previously proposed concepts and also adds some new interesting details to the molecular mechanism of the myosin ATPase cycle.	[Logvinova, Daria S.; Markov, Denis I.; Sluchanko, Nikolai N.; Levitsky, Dmitrii I.] Russian Acad Sci, AN Bach Inst Biochem, Moscow, Russia; [Logvinova, Daria S.] Moscow MV Lomonosov State Univ, Dept Biochem, Sch Biol, Moscow, Russia; [Logvinova, Daria S.] Vyatka State Univ, Dept Biotechnol, Sch Biol, Kirov, Russia; [Nikolaeva, Olga P.; Levitsky, Dmitrii I.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; [Ushakov, Dmitry S.] Kings Coll London, London WC2R 2LS, England	Research Center of Biotechnology RAS; Russian Academy of Sciences; Lomonosov Moscow State University; Vyatka State University; Lomonosov Moscow State University; University of London; King's College London	Levitsky, DI (corresponding author), Russian Acad Sci, AN Bach Inst Biochem, Moscow, Russia.	Levitsky@inbi.ras.ru	Sluchanko, Nikolai/R-4110-2016; Ushakov, Dmitry/AAF-7914-2020	Sluchanko, Nikolai/0000-0002-8608-1416; Ushakov, Dmitry/0000-0001-7109-4217	Russian Foundation for Basic Research [15-04-03037]; Program "Molecular and Cell Biology" of the Presidium of the Russian Academy of Sciences	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Program "Molecular and Cell Biology" of the Presidium of the Russian Academy of Sciences(Russian Academy of Sciences)	This investigation was supported by the Russian Foundation for Basic Research (grant 15-04-03037 to DIL) and the Program "Molecular and Cell Biology" of the Presidium of the Russian Academy of Sciences (DIL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billington N, 2014, J MOL BIOL, V426, P894, DOI 10.1016/j.jmb.2013.11.028; BOBKOV AA, 1995, BIOCHEMISTRY-US, V34, P9708, DOI 10.1021/bi00030a008; BOBKOV AA, 1993, FEBS LETT, V332, P64, DOI 10.1016/0014-5793(93)80485-D; Borejdo J, 2001, BIOCHEMISTRY-US, V40, P3796, DOI 10.1021/bi002527u; Delbecq SP, 2013, FEBS LETT, V587, P1073, DOI 10.1016/j.febslet.2013.01.021; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Fischer S, 2005, P NATL ACAD SCI USA, V102, P6873, DOI 10.1073/pnas.0408784102; GOLITSINA NL, 1992, FEBS LETT, V303, P255, DOI 10.1016/0014-5793(92)80532-L; Golitsina NL, 1996, J MUSCLE RES CELL M, V17, P475, DOI 10.1007/BF00123363; GOODNO CC, 1982, METHOD ENZYMOL, V85, P116; HOLT JC, 1975, BIOCHEMISTRY-US, V14, P4609, DOI 10.1021/bi00692a008; Houdusse A, 2000, P NATL ACAD SCI USA, V97, P11238, DOI 10.1073/pnas.200376897; Houdusse A, 1996, STRUCTURE, V4, P21, DOI 10.1016/S0969-2126(96)00006-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levitsky D. I., 2004, The nature of biological systems as revealed by thermal methods, P127; LEVITSKY DI, 1992, EUR J BIOCHEM, V209, P829, DOI 10.1111/j.1432-1033.1992.tb17354.x; Levitsky DI, 1998, EUR J BIOCHEM, V251, P275, DOI 10.1046/j.1432-1327.1998.2510275.x; Levitsky DI, 1998, BIOCHEMISTRY-MOSCOW+, V63, P322; LEVITSKY DI, 1990, FEBS LETT, V264, P176, DOI 10.1016/0014-5793(90)80242-B; LOWEY S, 1993, NATURE, V365, P454, DOI 10.1038/365454a0; Markov DI, 2010, ACTA NATURAE, V2, P77, DOI 10.32607/20758251-2010-2-2-77-81; Markov DI, 2008, FEBS LETT, V582, P1407, DOI 10.1016/j.febslet.2008.03.035; Markov DI, 2010, INT J MOL SCI, V11, P4194, DOI 10.3390/ijms11114194; MARSH DJ, 1980, BIOCHEMISTRY-US, V19, P774, DOI 10.1021/bi00545a025; MARSH DJ, 1982, BIOCHEMISTRY-US, V21, P1925, DOI 10.1021/bi00537a035; Milligan RA, 1996, P NATL ACAD SCI USA, V93, P21, DOI 10.1073/pnas.93.1.21; Nelson MR, 1998, PROTEIN SCI, V7, P270; Nikolaeva OP, 2002, EUR J BIOCHEM, V269, P5678, DOI 10.1046/j.1432-1033.2002.03279.x; PHAN B, 1992, BIOCHEMISTRY-US, V31, P4787, DOI 10.1021/bi00135a007; Ponomarev MA, 2000, BIOCHEMISTRY-US, V39, P4527, DOI 10.1021/bi992420a; Privalov P L, 1986, Methods Enzymol, V131, P4; PRIVALOV PL, 1982, ADV PROTEIN CHEM, V35, P1, DOI 10.1016/S0065-3233(08)60468-4; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Shakirova L, 2007, J MUSCLE RES CELL M, V28, P67, DOI 10.1007/s10974-007-9108-7; TRAYER HR, 1988, BIOCHEMISTRY-US, V27, P5718, DOI 10.1021/bi00415a049; Turoverov KK, 2003, J FLUORESC, V13, P41, DOI 10.1023/A:1022366816812; TUROVEROV KK, 1976, FEBS LETT, V62, P4, DOI 10.1016/0014-5793(76)80003-8; Ushakov DS, 2011, J BIOL CHEM, V286, P842, DOI 10.1074/jbc.M110.149526; Uyeda TQP, 1996, P NATL ACAD SCI USA, V93, P4459, DOI 10.1073/pnas.93.9.4459; VANBUREN P, 1994, P NATL ACAD SCI USA, V91, P12403, DOI 10.1073/pnas.91.26.12403; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; WERBER MM, 1992, BIOCHEMISTRY-US, V31, P7190, DOI 10.1021/bi00146a023; ZAAGER S, 1988, J BIOL CHEM, V263, P13891	43	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137517	10.1371/journal.pone.0137517	http://dx.doi.org/10.1371/journal.pone.0137517			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356744	Green Published, gold, Green Submitted			2022-12-26	WOS:000360965800053
J	Shafiek, H; Fiorentino, F; Merino, JL; Lopez, C; Oliver, A; Segura, J; de Paul, I; Sibila, O; Agust, A; Cosio, BG				Shafiek, Hanaa; Fiorentino, Federico; Merino, Jose Luis; Lopez, Carla; Oliver, Antonio; Segura, Jaume; de Paul, Ivan; Sibila, Oriol; Agust, Alvar; Cosio, Borja G.			Using the Electronic Nose to Identify Airway Infection during COPD Exacerbations	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; EXHALED BREATH; BRONCHIAL INFLAMMATION; LUNG-CANCER; PNEUMONIA; DIAGNOSIS; DISCRIMINATION; IDENTIFICATION; RECOGNITION; BACTERIA	Background The electronic nose (e-nose) detects volatile organic compounds (VOCs) in exhaled air. We hypothesized that the exhaled VOCs print is different in stable vs. exacerbated patients with chronic obstructive pulmonary disease (COPD), particularly if the latter is associated with airway bacterial infection, and that the e-nose can distinguish them. Methods Smell-prints of the bacteria most commonly involved in exacerbations of COPD (ECOPD) were identified in vitro. Subsequently, we tested our hypothesis in 93 patients with ECOPD, 19 of them with pneumonia, 50 with stable COPD and 30 healthy controls in a cross-sectional case-controlled study. Secondly, ECOPD patients were re-studied after 2 months if clinically stable. Exhaled air was collected within a Tedlar bag and processed by a Cynarose 320 e-nose. Breath-prints were analyzed by Linear Discriminant Analysis (LDA) with "One Out" technique and Sensor logic Relations (SLR). Sputum samples were collected for culture. Results ECOPD with evidence of infection were significantly distinguishable from non-infected ECOPD (p = 0.018), with better accuracy when ECOPD was associated to pneumonia. The same patients with ECOPD were significantly distinguishable from stable COPD during follow-up (p = 0.018), unless the patient was colonized. Additionally, breath-prints from COPD patients were significantly distinguished from healthy controls. Various bacteria species were identified in culture but the e-nose was unable to identify accurately the bacteria smell-print in infected patients. Conclusion E-nose can identify ECOPD, especially if associated with airway bacterial infection or pneumonia.	[Shafiek, Hanaa; Fiorentino, Federico; Cosio, Borja G.] Hosp Univ Son Espases IdISPa, Dept Resp Med, Palma De Mallorca, Spain; [Shafiek, Hanaa] Univ Alexandria, Fac Med, Dept Chest Dis, Alexandria, Egypt; [Merino, Jose Luis; Segura, Jaume; de Paul, Ivan] UIB, GSE, Palma De Mallorca, Spain; [Lopez, Carla; Oliver, Antonio] Hosp Univ Son Espases IdISPa, Dept Microbiol, Palma De Mallorca, Spain; [Sibila, Oriol] Hosp Santa Creu & Sant Pau, IIB St Pau, Dept Resp Med, Barcelona, Spain; [Agust, Alvar] Univ Barcelona, IDIBAPS, Hosp Clin, Thorax Inst, Barcelona, Spain; [Agust, Alvar; Cosio, Borja G.] CIBERES, Madrid, Spain	Hospital Universitari Son Espases; Institut Investigacio Sanitaria Illes Balears (IdISBa); Egyptian Knowledge Bank (EKB); Alexandria University; Barcelona School of Economics; Universitat de les Illes Balears; Hospital Universitari Son Espases; Institut Investigacio Sanitaria Illes Balears (IdISBa); Hospital of Santa Creu i Sant Pau; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Cosio, BG (corresponding author), Hosp Univ Son Espases IdISPa, Dept Resp Med, Palma De Mallorca, Spain.	borja.cosio@ssib.es	Sibila, Oriol/T-4366-2017; G.Cosio, Borja/P-4963-2017; López-Causapé, Carla/AAG-5231-2019; Shafiek, Hanaa/HGC-3311-2022; Oliver, Antonio/V-5541-2019; Shafiek, Hanaa/AAM-7161-2021; Oliver, Antonio/E-4048-2012; López-Causapé, Carla/F-5414-2019	Sibila, Oriol/0000-0002-4833-6713; G.Cosio, Borja/0000-0002-6388-8209; López-Causapé, Carla/0000-0003-2228-2005; Oliver, Antonio/0000-0001-9327-1894; Shafiek, Hanaa/0000-0002-4716-4809; Oliver, Antonio/0000-0001-9327-1894; López-Causapé, Carla/0000-0003-2228-2005; Segura, Jaume/0000-0001-9742-2936; de Paul Bernal, Ivan/0000-0001-9526-3492	Instituto de Salud Carlos III [FIS PI12/02628]; Spanish Respiratory Society	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Respiratory Society	This project was supported by the Instituto de Salud Carlos III (FIS PI12/02628) and the Spanish Respiratory Society. The funding sources were used to cover fungible expenses and had no influence on the results.	ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Bathoorn E., 2009, INT J CHRONIC OBSTR, V4, P101; Boixeda R, 2012, INT J CHRONIC OBSTR, V7, P327, DOI 10.2147/COPD.S30568; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Corhay JL, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0115-0; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Dragonieri S, 2007, J ALLERGY CLIN IMMUN, V120, P856, DOI 10.1016/j.jaci.2007.05.043; Dragonieri S, 2009, LUNG CANCER, V64, P166, DOI 10.1016/j.lungcan.2008.08.008; Dutta R, 2002, BIOMED ENG ONLINE, V1, DOI 10.1186/1475-925X-1-4; FAGON JY, 1990, AM REV RESPIR DIS, V142, P1004, DOI 10.1164/ajrccm/142.5.1004; Fens N, 2013, CLIN EXP ALLERGY, V43, P705, DOI 10.1111/cea.12052; Fens N, 2009, AM J RESP CRIT CARE, V180, P1076, DOI 10.1164/rccm.200906-0939OC; Garcha DS, 2012, THORAX, V67, P1075, DOI 10.1136/thoraxjnl-2012-201924; Gessner C, 2005, RESP MED, V99, P1229, DOI 10.1016/j.rmed.2005.02.041; Gompertz S, 2001, EUR RESPIR J, V17, P1112, DOI 10.1183/09031936.01.99114901; Hanson CW, 2005, ANESTHESIOLOGY, V102, P63, DOI 10.1097/00000542-200501000-00013; Hockstein NG, 2004, LARYNGOSCOPE, V114, P1701, DOI 10.1097/00005537-200410000-00005; Huerta A, 2013, CHEST, V144, P1134, DOI 10.1378/chest.13-0488; Hurst JR, 2006, AM J RESP CRIT CARE, V173, P71, DOI 10.1164/rccm.200505-704OC; Joensen O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115584; Lai SY, 2002, LARYNGOSCOPE, V112, P975, DOI 10.1097/00005537-200206000-00007; Laszlo G, 2006, THORAX, V61, P744, DOI 10.1136/thx.2006.061648; Machado RF, 2005, AM J RESP CRIT CARE, V171, P1286, DOI 10.1164/rccm.200409-1184OC; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; McWilliams A, 2015, IEEE T BIOMED ENG; MONSO E, 1995, AM J RESP CRIT CARE, V152, P1316, DOI 10.1164/ajrccm.152.4.7551388; Moser B, 2005, RESP PHYSIOL NEUROBI, V145, P295, DOI 10.1016/j.resp.2004.02.002; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Pavlou A, 2002, LETT APPL MICROBIOL, V35, P366, DOI 10.1046/j.1472-765X.2002.01197.x; Ram FSF, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004403.pub2; ROCA J, 1986, B EUR PHYSIOPATH RES, V22, P217; Rodriguez-Roisin R, 2000, CHEST, V117, p398S, DOI 10.1378/chest.117.5_suppl_2.398S; Shykhon ME, 2004, J LARYNGOL OTOL, V118, P706, DOI 10.1258/0022215042244660; Sibila O, 2014, RESP MED; SMITH CB, 1976, J INFECT DIS, V134, P552, DOI 10.1093/infdis/134.6.552; Spencer S, 2003, THORAX, V58, P589, DOI 10.1136/thorax.58.7.589; Stolz D, 2007, CHEST, V131, P9, DOI 10.1378/chest.06-1500; Thaler ER, 2006, AM J RHINOL, V20, P170, DOI 10.1177/194589240602000209; Turner APF, 2004, NAT REV MICROBIOL, V2, P161, DOI 10.1038/nrmicro823; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Voelkel NF, 2000, CHEST, V117, p376S, DOI 10.1378/chest.117.5_suppl_2.376S; White AJ, 2003, THORAX, V58, P680, DOI 10.1136/thorax.58.8.680; Zhang HX, 2003, SENSOR ACTUAT B-CHEM, V96, P385, DOI 10.1016/S0925-4005(03)00574-4	44	47	47	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135199	10.1371/journal.pone.0135199	http://dx.doi.org/10.1371/journal.pone.0135199			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353114	Green Published, Green Submitted, gold			2022-12-26	WOS:000360932800007
J	Zhang, C; Phang, CW; Zeng, XH; Wang, XM; Xu, YJ; Huang, Y; Contractor, N				Zhang, Cheng; Phang, Chee Wei; Zeng, Xiaohua; Wang, Ximeng; Xu, Yunjie; Huang, Yun; Contractor, Noshir			Circadian Rhythms in Socializing Propensity	PLOS ONE			English	Article								Using large-scale interaction data from a virtual world, we show that people's propensity to socialize (forming new social connections) varies by hour of the day. We arrive at our results by longitudinally tracking people's friend-adding activities in a virtual world. Specifically, we find that people are most likely to socialize during the evening, at approximately 8 p.m. and 12 a.m., and are least likely to do so in the morning, at approximately 8 a.m. Such patterns prevail on weekdays and weekends and are robust to variations in individual characteristics and geographical conditions.	[Zhang, Cheng; Phang, Chee Wei; Wang, Ximeng; Xu, Yunjie] Fudan Univ, Dept Informat Management & Informat Syst, Shanghai 200433, Peoples R China; [Zeng, Xiaohua] City Univ Hong Kong, Coll Business, Hong Kong, Hong Kong, Peoples R China; [Huang, Yun; Contractor, Noshir] Northwestern Univ, Sch Commun, Evanston, IL USA	Fudan University; City University of Hong Kong; Northwestern University	Phang, CW (corresponding author), Fudan Univ, Dept Informat Management & Informat Syst, Shanghai 200433, Peoples R China.	phangcw@fudan.edu.cn	Contractor, Noshir/AAJ-8371-2020; Zhang, Cheng/P-6145-2019; Contractor, Noshir/B-7456-2009; Xu, Yunjie/E-9466-2011; Zhang, Cheng/A-1230-2009	Contractor, Noshir/0000-0002-9989-3018; Zhang, Cheng/0000-0002-8277-5138; Zeng, Xiaohua/0000-0003-2488-8203	Research Grants Council of the Hong Kong Special Administrative Region [CityU 11507514]; National Science Foundation of China [71372112, 71232008, 71102018]; Shanghai Social Science Fund [2013BGL003]	Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Social Science Fund	This work was supported by grants from the Research Grants Council of the Hong Kong Special Administrative Region (Grant CityU 11507514), the National Science Foundation of China (71372112, 71232008, 71102018) and the Shanghai Social Science Fund (2013BGL003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burt R.S., 1992, STRUCTURAL HOLES; Clary EG, 2002, J SOCIAL ISSUES, V58; Dodds PS, 2010, J HAPPINESS STUDIES, V11; Dy Jr Manuel B., 1994, CONT SOCIAL PHILOS; Forsling ML, 1998, EXP PHYSL, V83; Frank E, 2005, ARCH GEN PSYCHIAT, V62, P996, DOI 10.1001/archpsyc.62.9.996; Golder A, 2011, SCIENCE, V333; Golder S, P IEEE C SOC COMP 20; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Jaques E, 1982, THE FORM OF TIME; Jiang ZQ, 2010, PHYSICA A, V389, P807, DOI 10.1016/j.physa.2009.10.028; Jiang ZQ, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/48007; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; McPherson  M., 2001, ANN REV SOCIOLOGY, V27; Mislove A., P 5 INT AAAI C WEBL; MONK TH, 1991, PSYCHIAT RES, V36, P195, DOI 10.1016/0165-1781(91)90131-8; Nonaka I., 1995, KNOWLEDGE CREATION C; O'Connor B, P INT AAAI C WEBL SO; Ohta H, 1993, ESSAYS ML GREENHUT; Reisberg B, 2002, AM J ALZHEIMERS DIS, V17; Shen GH, 2008, BIPOLAR DISORDERS, V10; Tauber M, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-47; van Wingen GA, 2011, NEUROSCIENCE, V191, P38, DOI 10.1016/j.neuroscience.2011.04.042; Wellman B, 1996, SOCIAL NETWORKS, V18; West J. H., 2012, OPEN J PREVENTIVE ME, V2; Whelan DC, 2012, SOCIAL PSYCHOL PERSO, V3; Xie WJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05244	27	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136325	10.1371/journal.pone.0136325	http://dx.doi.org/10.1371/journal.pone.0136325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9KG	26353080	Green Published, gold, Green Submitted			2022-12-26	WOS:000360932800034
J	Hao, WR; Marsh, C; Friedman, A				Hao, Wenrui; Marsh, Clay; Friedman, Avner			A Mathematical Model of Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TGF-BETA; OXIDATIVE STRESS; LUNG; POLYMORPHISMS; INFLAMMATION; MACROPHAGES; MUTATIONS; TARGETS; IL-10	Idiopathic pulmonary fibrosis (IPF) is a disease of unknown etiology, and life expectancy of 3-5 years after diagnosis. The incidence rate in the United States is estimated as high as 15 per 100,000 persons per year. The disease is characterized by repeated injury to the alveolar epithelium, resulting in inflammation and deregulated repair, leading to scarring of the lung tissue, resulting in progressive dyspnea and hypoxemia. The disease has no cure, although new drugs are in clinical trials and two agents have been approved for use by the FDA. In the present paper we develop a mathematical model based on the interactions among cells and proteins that are involved in the progression of the disease. The model simulations are shown to be in agreement with available lung tissue data of human patients. The model can be used to explore the efficacy of potential drugs.	[Hao, Wenrui; Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Marsh, Clay] W Virginia Univ, Hlth Sci Ctr South, Morgantown, WV 26506 USA; [Friedman, Avner] Ohio State Univ, Dept Math, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; West Virginia University; University System of Ohio; Ohio State University	Hao, WR (corresponding author), Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA.	hao.50@mbi.osu.edu		HAO, WENRUI/0000-0002-6925-7424	Mathematical Biosciences Institute; National Science Foundation [DMS 0931642]	Mathematical Biosciences Institute; National Science Foundation(National Science Foundation (NSF))	This research has been supported by the Mathematical Biosciences Institute and the National Science Foundation under Grant DMS 0931642 (http://nsf.gov/awardsearch/showAward?AWD_ID=0931642).	ALLEVA DG, 1994, J IMMUNOL, V153, P1674; Armanios M, 2012, NEW ENGL J MED, V367, P384, DOI 10.1056/NEJMc1206730; Bargagli E, 2011, PULM MED, V2011, DOI 10.1155/2011/717130; Bergeron A, 2003, EUR RESPIR J, V22, P69, DOI 10.1183/09031936.03.00014703; Boorsma CE, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/769214; Bringardner BD, 2008, ANTIOXID REDOX SIGN, V10, P287, DOI 10.1089/ars.2007.1897; Camelo A, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00173; Cho JH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-8; Clarke DL, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-20; Crouser ED, 2009, AM J RESP CRIT CARE, V179, P929, DOI 10.1164/rccm.200803-490OC; Daniels CE, 2010, AM J RESP CRIT CARE, V181, P604, DOI 10.1164/rccm.200906-0964OC; Daniil ZD, 2008, PULM PHARMACOL THER, V21, P26, DOI 10.1016/j.pupt.2006.10.005; Day J, 2009, P NATL ACAD SCI USA, V106, P11246, DOI 10.1073/pnas.0904846106; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Gharib SA, 2014, J LEUKOCYTE BIOL, V95, P9, DOI 10.1189/jlb.1112587; Hao WR, 2014, P NATL ACAD SCI USA, V111, P16065, DOI 10.1073/pnas.1417789111; Hao WR, 2014, P NATL ACAD SCI USA, V111, P14193, DOI 10.1073/pnas.1413970111; Hao WR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090497; Herzog EL, 2010, EXP HEMATOL, V38, P548, DOI 10.1016/j.exphem.2010.03.004; Homer RJ, 2011, ARCH PATHOL LAB MED, V135, P780, DOI 10.1043/2010-0296-RA.1; IYONAGA K, 1994, HUM PATHOL, V25, P455, DOI 10.1016/0046-8177(94)90117-1; Jakubzick C, 2003, J IMMUNOL, V171, P2684, DOI 10.4049/jimmunol.171.5.2684; Jikov V. V., 1994, HOMOGENIZATION DIFFE; Kliment CR, 2010, FREE RADICAL BIO MED, V49, P707, DOI 10.1016/j.freeradbiomed.2010.04.036; Kuwano K, 2004, HISTOL HISTOPATHOL, V19, P867, DOI 10.14670/HH-19.867; Landsman L, 2007, J IMMUNOL, V179, P3488, DOI 10.4049/jimmunol.179.6.3488; Lomas NJ, 2012, INT J CLIN EXP PATHO, V5, P58; Malli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053658; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; McRitchie DI, 2000, CYTOKINE, V12, P644, DOI 10.1006/cyto.1999.0656; Murphy J, 2008, AM J RESP CELL MOL, V38, P380, DOI 10.1165/rcmb.2007-0224RC; Murray LA, 2011, INT J BIOCHEM CELL B, V43, P154, DOI 10.1016/j.biocel.2010.10.013; Nkyimbeng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073279; Noble PW, 2008, EUR RESPIR REV, V17, P123, DOI 10.1183/09059180.00010904; Nogee LM, 2002, CHEST, V121, p20S, DOI 10.1378/chest.121.3_suppl.20S; Ochs M, 2004, AM J RESP CRIT CARE, V169, P120, DOI 10.1164/rccm.200308-1107OC; OLIVER JC, 1993, LYMPHOKINE CYTOK RES, V12, P115; Orbe J, 2003, ATHEROSCLEROSIS, V167, P45, DOI 10.1016/S0021-9150(02)00392-1; Park SW, 2009, J KOREAN MED SCI, V24, P614, DOI 10.3346/jkms.2009.24.4.614; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; Rabinovich EI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033770; Raghu G, 2008, AM J RESP CRIT CARE, V178, P948, DOI 10.1164/rccm.200709-1446OC; Redente EF, 2014, AM J RESP CELL MOL, V50, P825, DOI 10.1165/rcmb.2013-0386OC; Sakai N, 2013, BBA-MOL BASIS DIS, V1832, P911, DOI 10.1016/j.bbadis.2013.03.001; Sanders YY, 2012, AM J RESP CRIT CARE, V186, P525, DOI 10.1164/rccm.201201-0077OC; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Selman Moises, 2006, Proc Am Thorac Soc, V3, P364, DOI 10.1513/pats.200601-003TK; Selman M, 2014, AM J RESP CRIT CARE, V189, P1161, DOI 10.1164/rccm.201312-2221PP; Stahl M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081382; Takeda Y, 2014, PATIENT PREFER ADHER, V8, P361, DOI 10.2147/PPA.S37233; Tatler Amanda L, 2012, Proc Am Thorac Soc, V9, P130, DOI 10.1513/pats.201201-003AW; Ulrich D, 2010, J PLAST RECONSTR AES, V63, P1015, DOI 10.1016/j.bjps.2009.04.021; Vasakova M, 2006, TISSUE ANTIGENS, V67, P229, DOI 10.1111/j.1399-0039.2006.00560.x; Vasakova M, 2013, HUM IMMUNOL, V74, P1346, DOI 10.1016/j.humimm.2013.07.011; Whittington HA, 2003, GENES IMMUN, V4, P258, DOI 10.1038/sj.gene.6363959; Xiao L, 2012, FRONT BIOSCI-LANDMRK, V17, P2667, DOI 10.2741/4077; Xue C, 2009, P NATL ACAD SCI USA, V106, P16782, DOI 10.1073/pnas.0909115106; Yang IV, 2015, TRANSL RES, V165, P48, DOI 10.1016/j.trsl.2014.03.011; Zoz DF, 2011, AM J MED SCI, V341, P435, DOI 10.1097/MAJ.0b013e31821a9d8e	59	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0135097	10.1371/journal.pone.0135097	http://dx.doi.org/10.1371/journal.pone.0135097			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348490	Green Published, gold, Green Submitted			2022-12-26	WOS:000360897600002
J	Jia, ZL; Zhang, X; Guan, NY; Bo, XC; Barnes, MR; Luo, ZG				Jia, Zhilong; Zhang, Xiang; Guan, Naiyang; Bo, Xiaochen; Barnes, Michael R.; Luo, Zhigang			Gene Ranking of RNA-Seq Data via Discriminant Non-Negative Matrix Factorization	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; ENRICHMENT ANALYSIS; PACKAGE; ALGORITHM	RNA-sequencing is rapidly becoming the method of choice for studying the full complexity of transcriptomes, however with increasing dimensionality, accurate gene ranking is becoming increasingly challenging. This paper proposes an accurate and sensitive gene ranking method that implements discriminant non-negative matrix factorization (DNMF) for RNA-seq data. To the best of our knowledge, this is the first work to explore the utility of DNMF for gene ranking. When incorporating Fisher's discriminant criteria and setting the reduced dimension as two, DNMF learns two factors to approximate the original gene expression data, abstracting the up-regulated or down-regulated metagene by using the sample label information. The first factor denotes all the genes' weights of two metagenes as the additive combination of all genes, while the second learned factor represents the expression values of two metagenes. In the gene ranking stage, all the genes are ranked as a descending sequence according to the differential values of the metagene weights. Leveraging the nature of NMF and Fisher's criterion, DNMF can robustly boost the gene ranking performance. The Area Under the Curve analysis of differential expression analysis on two benchmarking tests of four RNA-seq data sets with similar phenotypes showed that our proposed DNMF-based gene ranking method outperforms other widely used methods. Moreover, the Gene Set Enrichment Analysis also showed DNMF outweighs others. DNMF is also computationally efficient, substantially outperforming all other benchmarked methods. Consequently, we suggest DNMF is an effective method for the analysis of differential gene expression and gene ranking for RNA-seq data.	[Jia, Zhilong] Natl Univ Def Technol, Coll Sci, Dept Biol & Chem, Changsha, Hunan, Peoples R China; [Jia, Zhilong; Barnes, Michael R.] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Zhang, Xiang; Guan, Naiyang; Luo, Zhigang] Natl Univ Def Technol, Sci & Technol Parallel & Distributed Proc Lab, Coll Comp, Changsha, Hunan, Peoples R China; [Bo, Xiaochen] Inst Radiat Med, Beijing, Peoples R China	National University of Defense Technology - China; University of London; Queen Mary University London; National University of Defense Technology - China	Barnes, MR (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England.	m.r.barnes@qmul.ac.uk; zgluo@nudt.edu.cn	Jia, Zhilong/ABA-9776-2020	Jia, Zhilong/0000-0003-2370-5073; Barnes, Michael/0000-0001-9097-7381; Bo, Xiao-chen/0000-0003-1911-7922	Major Research Plan of The National Natural Science Foundation of China [U1435222]; Plan for interdisciplinary joint PhD students at NUDT; Plan for Innovative Graduate Student at NUDT [B140202]; National Institutes for Health Research (NIHR); China Scholarship Council; Medical Research Council [G1001516] Funding Source: researchfish; MRC [G1001516] Funding Source: UKRI	Major Research Plan of The National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Plan for interdisciplinary joint PhD students at NUDT; Plan for Innovative Graduate Student at NUDT; National Institutes for Health Research (NIHR); China Scholarship Council(China Scholarship Council); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is partly supported by Major Research Plan of The National Natural Science Foundation of China (under grant no. U1435222) to XB, Plan for interdisciplinary joint PhD students at NUDT to ZL and Plan for Innovative Graduate Student at NUDT (under grant no. B140202) to ZJ. MRB is funded by the National Institutes for Health Research (NIHR), and this work forms part of the portfolio of translational research of the NIHR Cardiovascular Biomedical Research Unit at Barts. And ZJ is funded by China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cheung VCK, 2005, P ANN INT IEEE EMBS, P4990, DOI 10.1109/IEMBS.2005.1615595; Devarajan K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000029; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Feng JX, 2012, BIOINFORMATICS, V28, P2782, DOI 10.1093/bioinformatics/bts515; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Horiuchi T, 2001, STROKE, V32, P218, DOI 10.1161/01.STR.32.1.218; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kim B., 2013, NEURAL INFORM PROCES; Kong W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S5-S7; Kotsia I, 2007, IEEE T INF FOREN SEC, V2, P588, DOI 10.1109/TIFS.2007.902017; Lee CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048238; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee SY, 2012, COGN NEURODYNAMICS, V6, P525, DOI 10.1007/s11571-012-9213-1; Li J, 2012, BIOSTATISTICS, V13, P523, DOI 10.1093/biostatistics/kxr031; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Mostafavi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068141; Ni SY, 2012, J COMPUT BIOL, V19, P766, DOI 10.1089/cmb.2012.0026; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tjioe E, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S14; Wang HQ, 2015, BIOINFORMATICS, V31, P572, DOI 10.1093/bioinformatics/btu679; Wang Y., 2004, P AS C COMP VIS CIT; Wang YX, 2013, IEEE T KNOWL DATA EN, V25, P1336, DOI 10.1109/TKDE.2012.51; Zafeiriou S, 2006, IEEE T NEURAL NETWOR, V17, P683, DOI 10.1109/TNN.2006.873291	32	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137782	10.1371/journal.pone.0137782	http://dx.doi.org/10.1371/journal.pone.0137782			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348772	Green Published, Green Submitted, gold			2022-12-26	WOS:000360897600058
J	Scharf, I; Braf, H; Ifrach, N; Rosenstein, S; Subach, A				Scharf, Inon; Braf, Hila; Ifrach, Naama; Rosenstein, Shai; Subach, Aziz			The Effects of Temperature and Diet during Development, Adulthood, and Mating on Reproduction in the Red Flour Beetle	PLOS ONE			English	Article							BENEFICIAL ACCLIMATION HYPOTHESIS; TRIBOLIUM-CASTANEUM; FLIGHT PERFORMANCE; THERMAL TOLERANCE; SEXUAL SELECTION; BODY-SIZE; PLASTICITY; POPULATION; GROWTH; PATTERNS	The effects of different temperatures and diets experienced during distinct life stages are not necessarily similar. The silver-spoon hypothesis predicts that developing under favorable conditions will always lead to better performing adults under all adult conditions. The environment-matching hypothesis suggests that a match between developmental and adult conditions will lead to the best performing adults. Similar to the latter hypothesis, the beneficial-acclimation hypothesis suggests that either developing or acclimating as adults to the test temperature will improve later performance under such temperature. We disentangled here between the effect of growth, adult, and mating conditions (temperature and diet) on reproduction in the red flour beetle (Tribolium castaneum), in reference to the reproduction success rate, the number of viable offspring produced, and the mean offspring mass 13 days after mating. The most influential stage affecting reproduction differed between the diet and temperature experiments: adult temperature vs. parental growth diet. Generally, a yeast-rich diet or warmer temperature improved reproduction, supporting the silver-spoon hypothesis. However, interactions between life stages made the results more complex, also fitting the environment-matching hypothesis. Warm growth temperature positively affected reproduction success, but only when adults were kept under the same warm temperature. When the parental growth and adult diets matched, the mean offspring mass was greater than in a mismatch between the two. Additionally, a match between warm adult temperature and warm off-spring growth temperature led to the largest offspring mass. These findings support the environment-matching hypothesis. Our results provide evidence for all these hypotheses and demonstrate that parental effects and plasticity may be induced by temperature and diet.	[Scharf, Inon; Braf, Hila; Ifrach, Naama; Rosenstein, Shai; Subach, Aziz] Tel Aviv Univ, Dept Zool, Fac Life Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University	Scharf, I (corresponding author), Tel Aviv Univ, Dept Zool, Fac Life Sci, IL-69978 Tel Aviv, Israel.	scharfi@post.tau.ac.il	Scharf, Inon/AAF-2343-2020	Scharf, Inon/0000-0002-8506-7161	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7) under REA grant [333442]	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7) under REA grant	This study was supported by the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement no [333442]. The funding agency supported scholarships for students and salaries for research assistants.	Alabi T, 2008, ECOL ENTOMOL, V33, P716, DOI 10.1111/j.1365-2311.2008.01020.x; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; [Anonymous], 2009, COLD SPRING HARB PRO, DOI DOI 10.1101/PDB.EMO126; Atkinson D, 1997, TRENDS ECOL EVOL, V12, P235, DOI 10.1016/S0169-5347(97)01058-6; Barrett ELB, 2009, P ROY SOC B-BIOL SCI, V276, P3257, DOI 10.1098/rspb.2009.0725; Bauerfeind SS, 2005, OIKOS, V111, P514, DOI 10.1111/j.0030-1299.2005.13888.x; Benton TG, 2008, J ANIM ECOL, V77, P1038, DOI 10.1111/j.1365-2656.2008.01434.x; Best AR, 2012, ANIM BEHAV, V83, P1483, DOI 10.1016/j.anbehav.2012.03.022; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; Bowler K, 2005, J THERM BIOL, V30, P125, DOI 10.1016/j.jtherbio.2004.09.001; Bowler K, 2008, BIOL REV, V83, P339, DOI 10.1111/j.1469-185X.2008.00046.x; Bubliy OA, 2012, FUNCT ECOL, V26, P245, DOI 10.1111/j.1365-2435.2011.01928.x; Buckman KA, 2013, J ECON ENTOMOL, V106, P499, DOI 10.1603/EC12276; Campbell JF, 2010, J ECON ENTOMOL, V103, P991, DOI 10.1603/EC09347; Colinet H, 2012, FUNCT ECOL, V26, P84, DOI 10.1111/j.1365-2435.2011.01898.x; Daglish GJ, 2006, J STORED PROD RES, V42, P328, DOI 10.1016/j.jspr.2005.04.003; Davis JM, 2008, Q REV BIOL, V83, P363, DOI 10.1086/592851; Dmitriew C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017399; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Fedina TY, 2008, BIOL REV, V83, P151, DOI 10.1111/j.1469-185X.2008.00037.x; Ferrer A, 2014, ENTOMOL EXP APPL, V151, P11, DOI 10.1111/eea.12163; Fischer K, 2003, P ROY SOC B-BIOL SCI, V270, P2051, DOI 10.1098/rspb.2003.2470; Frazier MR, 2008, J EXP BIOL, V211, P2116, DOI 10.1242/jeb.019422; Geister TL, 2007, BEHAV ECOL, V18, P658, DOI 10.1093/beheco/arm024; Gibbs M, 2010, PHYSIOL ENTOMOL, V35, P29, DOI 10.1111/j.1365-3032.2009.00706.x; Grazer V, 2013, THESIS ETH ZURICH SW; Halliday WD, 2014, J ZOOL, V294, P198, DOI 10.1111/jzo.12168; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Huey RB, 1999, AM ZOOL, V39, P323; Kingsolver JG, 2008, EVOL ECOL RES, V10, P251; Kleinteich A, 2015, OIKOS, V124, P130, DOI 10.1111/oik.01421; LLOYD M, 1968, ECOLOGY, V49, P245, DOI 10.2307/1934453; Marshall DJ, 2007, OIKOS, V116, P1957, DOI 10.1111/j.2007.0030-1299.16203.x; Mayhew PJ, 2001, TRENDS ECOL EVOL, V16, P165, DOI 10.1016/S0169-5347(00)02099-1; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Modlmeier AP, 2012, NATURWISSENSCHAFTEN, V99, P811, DOI 10.1007/s00114-012-0963-8; Monaghan P, 2008, PHILOS T R SOC B, V363, P1635, DOI 10.1098/rstb.2007.0011; Overgaard J, 2008, CRYOBIOLOGY, V56, P159, DOI 10.1016/j.cryobiol.2008.01.001; Park T, 1934, Q REV BIOL, V9, P36, DOI 10.1086/394454; Parthasarathy R, 2011, INSECT BIOCHEM MOLEC, V41, P294, DOI 10.1016/j.ibmb.2011.01.006; Philip BN, 2010, J INSECT PHYSIOL, V56, P679, DOI 10.1016/j.jinsphys.2009.12.003; Sabat P, 2000, J COMP PHYSIOL B, V170, P411, DOI 10.1007/s003600000118; Sbilordo SH, 2014, BIOL J LINN SOC, V112, P67, DOI 10.1111/bij.12262; Scharf I, 2015, EVOL BIOL, V42, P54, DOI 10.1007/s11692-014-9298-z; Scharf I, 2010, CLIM RES, V43, P115, DOI 10.3354/cr00907; Scharf I, 2009, OECOLOGIA, V160, P453, DOI 10.1007/s00442-009-1316-y; SIBLY R, 1986, J THEOR BIOL, V123, P311, DOI 10.1016/S0022-5193(86)80246-6; Stillwell RC, 2005, ECOLOGY, V86, P924, DOI 10.1890/04-0547; Stoks R, 2006, ECOLOGY, V87, P1566, DOI 10.1890/0012-9658(2006)87[1566:PCOCGI]2.0.CO;2; Teets NM, 2013, PHYSIOL ENTOMOL, V38, P105, DOI 10.1111/phen.12019; Terblanche JS, 2006, J EXP BIOL, V209, P1064, DOI 10.1242/jeb.02129; Thiery D, 2005, OECOLOGIA, V143, P548, DOI 10.1007/s00442-005-0022-7; Uller T, 2013, J EVOLUTION BIOL, V26, P2161, DOI 10.1111/jeb.12212; Van Allen BG, 2014, OIKOS, V123, P699, DOI 10.1111/oik.01240; Van Allen BG, 2013, AM NAT, V181, P596, DOI 10.1086/670127; Wheeler D, 1996, ANNU REV ENTOMOL, V41, P407, DOI 10.1146/annurev.en.41.010196.002203; Wilson RS, 2007, P R SOC B, V274, P1199, DOI 10.1098/rspb.2006.0401; Wilson RS, 2002, TRENDS ECOL EVOL, V17, P66, DOI 10.1016/S0169-5347(01)02384-9; Wong JWY, 2014, J EVOLUTION BIOL, V27, P2420, DOI 10.1111/jeb.12484; Woods HA, 2002, EVOLUTION, V56, P1863	60	33	35	1	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136924	10.1371/journal.pone.0136924	http://dx.doi.org/10.1371/journal.pone.0136924			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348929	Green Submitted, gold, Green Published			2022-12-26	WOS:000360897600015
J	Wojakowska, A; Marczak, L; Jelonek, K; Polanski, K; Widlak, P; Pietrowska, M				Wojakowska, Anna; Marczak, Lukasz; Jelonek, Karol; Polanski, Krzysztof; Widlak, Piotr; Pietrowska, Monika			An Optimized Method of Metabolite Extraction from Formalin-Fixed Paraffin-Embedded Tissue for GC/MS Analysis	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; PROTEIN-ANALYSIS; CHALLENGES; BIOMARKERS; PROTEOMICS; SPECIMENS; SECTIONS; FIXATION	Formalin-fixed paraffin-embedded (FFPE) tissue specimens constitute a highly valuable source of clinical material for retrospective molecular studies. However, metabolomic assessment of such archival material remains still in its infancy. Hence, there is an urgent need for efficient methods enabling extraction and profiling of metabolites present in FFPE tissue specimens. Here we demonstrate the methodology for isolation of primary metabolites from archival tissues; either fresh-frozen, formalin-fixed or formalin-fixed and paraffin-embedded specimens of mouse kidney were analysed and compared in this work. We used gas chromatography followed by mass spectrometry (GC/MS approach) to identify about 80 metabolites (including amino acids, saccharides, carboxylic acids, fatty acids) present in such archive material. Importantly, about 75% of identified compounds were detected in all three types of specimens. Moreover, we observed that fixation with formalin itself (and their duration) did not affect markedly the presence of particular metabolites in tissue-extracted material, yet fixation for 24h could be recommended as a practical standard. Paraffin embedding influenced efficiency of extraction, which resulted in reduced quantities of several compounds. Nevertheless, we proved applicability of FFPE specimens for non-targeted GS/MS-based profiling of tissue metabolome, which is of great importance for feasibility of metabolomics studies using retrospective clinical material.	[Wojakowska, Anna; Jelonek, Karol; Widlak, Piotr; Pietrowska, Monika] Maria Sklodowska Curie Mem Canc Ctr, Ctr Translat Res & Mol Biol Canc, PL-44100 Gliwice, Poland; [Wojakowska, Anna; Jelonek, Karol; Widlak, Piotr; Pietrowska, Monika] Inst Oncol, Gliwice Branch, PL-44100 Gliwice, Poland; [Marczak, Lukasz] Polish Acad Sci, Inst Bioorgan Chem, PL-61704 Poznan, Poland; [Polanski, Krzysztof] Univ Warwick, Warwick Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England	Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; University of Warwick	Pietrowska, M (corresponding author), Maria Sklodowska Curie Mem Canc Ctr, Ctr Translat Res & Mol Biol Canc, Wybrzeze Armii Krajowej 15, PL-44100 Gliwice, Poland.	m_pietrowska@io.gliwice.pl	Widlak, Piotr/AAL-8075-2021; Wojakowska, Anna/C-2075-2013; Marczak, Lukasz/C-9069-2011	Widlak, Piotr/0000-0001-5099-4726; Wojakowska, Anna/0000-0002-4541-1239; Marczak, Lukasz/0000-0001-8602-0077; Pietrowska, Monika/0000-0001-9317-7822; Jelonek, Karol/0000-0002-7233-7695; Polanski, Krzysztof/0000-0002-2586-9576	National Science Centre [UMO-2013/08/S/NZ2/00868, UMO2012/07/B/NZ4/01450]; ONKO;  [POIG. 02. 03. 01-24-099 / 13];  [POIG. 02.03.xx-xx-xxx / 13]	National Science Centre(National Science Centre, Poland); ONKO; ; 	This work was supported by the National Science Centre (grant No UMO-2013/08/S/NZ2/00868 and UMO2012/07/B/NZ4/01450). All the calculations were carried out using GeCONil infrastructure funded by grant POIG. 02. 03. 01-24-099 / 13 and ONKO. SYS infrastructure funded by grant POIG. 02.03.xx-xx-xxx / 13. The authors are grateful to Katarzyna Zorawska-Kulig for preparing the FFPE tissue sections.	Atkins D, 2004, J HISTOCHEM CYTOCHEM, V52, P893, DOI 10.1369/jhc.3A6195.2004; Denkert C, 2006, CANCER RES, V66, P10795, DOI 10.1158/0008-5472.CAN-06-0755; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; Ganti S, 2012, CANCER RES, V72, P3471, DOI 10.1158/0008-5472.CAN-11-3105; Hackett MJ, 2011, ANALYST, V136, P2941, DOI 10.1039/c0an00269k; Hughes C, 2014, ANAL METHODS-UK, V6, P1028, DOI 10.1039/c3ay41308j; Kelly AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025357; Khoury T, 2009, MODERN PATHOL, V22, P1457, DOI 10.1038/modpathol.2009.117; Klopfleisch R, 2011, HISTOL HISTOPATHOL, V26, P797, DOI 10.14670/HH-26.797; Maes E, 2013, AMINO ACIDS, V45, P205, DOI 10.1007/s00726-013-1494-0; Ng ESM, 2014, CANCER CHEMOTH PHARM, V73, P475, DOI 10.1007/s00280-013-2346-z; Nirmalan NJ, 2008, MOL BIOSYST, V4, P712, DOI 10.1039/b800098k; Reimel BA, 2009, CURR PROTEOMICS, V6, P63, DOI 10.2174/157016409787847420; Richter S, 2014, J CLIN ENDOCR METAB, V99, P3903, DOI 10.1210/jc.2014-2151; Sahm F, 2012, BRAIN PATHOL, V22, P26, DOI 10.1111/j.1750-3639.2011.00506.x; Shi S.-R., 2000, ANTIGEN RETRIEVAL TE, P17; Sprung RW, 2009, MOL CELL PROTEOMICS, V8, P1988, DOI 10.1074/mcp.M800518-MCP200; Steiner C, 2014, PROTEOMICS, V14, P441, DOI 10.1002/pmic.201300311; Tanca A, 2012, PROTEOM CLIN APPL, V6, P7, DOI 10.1002/prca.201100044; Xu H, 2008, J PROTEOME RES, V7, P1098, DOI 10.1021/pr7006768; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024	21	32	32	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136902	10.1371/journal.pone.0136902	http://dx.doi.org/10.1371/journal.pone.0136902			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348873	gold, Green Submitted, Green Published			2022-12-26	WOS:000360897600014
J	Cao, SN; Liu, P; Zhu, HY; Gong, HY; Yao, JF; Sun, YW; Geng, GF; Wang, T; Feng, SZ; Han, MZ; Zhou, JX; Xu, YF				Cao, Shannan; Liu, Peng; Zhu, Haiyan; Gong, Haiyan; Yao, Jianfeng; Sun, Yawei; Geng, Guangfeng; Wang, Tong; Feng, Sizhou; Han, Mingzhe; Zhou, Jiaxi; Xu, Yuanfu			Extracellular Acidification Acts as a Key Modulator of Neutrophil Apoptosis and Functions	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; NADPH OXIDASE; PERITONEAL-FLUID; RESPIRATORY BURST; INNATE IMMUNITY; PH-DECREASE; ACIDOSIS; SUPEROXIDE; MACROPHAGES; ACTIVATION	In human pathological conditions, the acidification of local environment is a frequent feature, such as tumor and inflammation. As the pH of microenvironment alters, the functions of immune cells are about to change. It makes the extracellular acidification a key modulator of innate immunity. Here we detected the impact of extracellular acidification on neutrophil apoptosis and functions, including cell death, respiratory burst, migration and phagocytosis. As a result, we found that under the acid environment, neutrophil apoptosis delayed, respiratory burst inhibited, polarization augmented, chemotaxis differed, endocytosis enhanced and bacteria killing suppressed. These findings suggested that extracellular acidification acts as a key regulator of neutrophil apoptosis and functions.	[Cao, Shannan; Liu, Peng; Zhu, Haiyan; Gong, Haiyan; Sun, Yawei; Geng, Guangfeng; Wang, Tong; Zhou, Jiaxi; Xu, Yuanfu] Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Cao, Shannan; Liu, Peng; Zhu, Haiyan; Gong, Haiyan; Sun, Yawei; Geng, Guangfeng; Wang, Tong; Zhou, Jiaxi; Xu, Yuanfu] Peking Union Med Coll, Tianjin, Peoples R China; [Yao, Jianfeng; Feng, Sizhou; Han, Mingzhe] Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Hematopoiet Stem Cell Transplantat Ctr, Tianjin, Peoples R China; [Yao, Jianfeng; Feng, Sizhou; Han, Mingzhe] Chinese Acad Med Sci, Tianjin, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Xu, YF (corresponding author), Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, State Key Lab Expt Hematol, Tianjin, Peoples R China.	xuyf@ihcams.ac.cn	zhu, xueqiong/U-1320-2019; Xu, Yuanfu/Z-1135-2019					Abou Alaiwa MH, 2014, P NATL ACAD SCI USA, V111, P18703, DOI 10.1073/pnas.1422091112; AUSTIN C, 1993, J PHYSIOL-LONDON, V466, P1; Bylund J, 2010, FREE RADICAL BIO MED, V49, P1834, DOI 10.1016/j.freeradbiomed.2010.09.016; COLOTTA F, 1992, BLOOD, V80, P2012; Jancic CC, 2012, CYTOKINE, V57, P258, DOI 10.1016/j.cyto.2011.11.013; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; EDLOW DW, 1971, P SOC EXP BIOL MED, V137, P1328; ENGIN K, 1995, INT J HYPERTHER, V11, P211, DOI 10.3109/02656739509022457; GABIG TG, 1979, BLOOD, V53, P1133; HENDERSON LM, 1988, BIOCHEM J, V251, P563, DOI 10.1042/bj2510563; ICHIHARA K, 1984, AM J PHYSIOL, V246, pH652, DOI 10.1152/ajpheart.1984.246.5.H652; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Kellum JA, 2004, CRIT CARE, V8, P331, DOI 10.1186/cc2900; Lam TI, 2013, P NATL ACAD SCI USA, V110, pE4362, DOI 10.1073/pnas.1313029110; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Latson KM, 2005, EQUINE VET J, V37, P342, DOI 10.2746/0425164054529319; LEE A, 1993, J LEUKOCYTE BIOL, V54, P283, DOI 10.1002/jlb.54.4.283; Lopez DH, 1999, IMMUNOLOGY, V98, P450, DOI 10.1046/j.1365-2567.1999.00884.x; Luo HBR, 2008, AM J HEMATOL, V83, P288, DOI 10.1002/ajh.21078; Martinez D, 2006, J IMMUNOL, V176, P1163, DOI 10.4049/jimmunol.176.2.1163; MatuteBello G, 1997, AM J RESP CRIT CARE, V156, P1969, DOI 10.1164/ajrccm.156.6.96-12081; Morgan D, 2005, J PHYSIOL-LONDON, V569, P419, DOI 10.1113/jphysiol.2005.094748; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Prasad A, 2011, NAT IMMUNOL, V12, P752, DOI 10.1038/ni.2052; Rajamaki K, 2013, J BIOL CHEM, V288, P13410, DOI 10.1074/jbc.M112.426254; Sakai J, 2012, IMMUNITY, V37, P1037, DOI 10.1016/j.immuni.2012.08.017; Sareila O, 2011, ANTIOXID REDOX SIGN, V15, P2197, DOI 10.1089/ars.2010.3635; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Scheel-Toellner D, 2004, BLOOD, V104, P2557, DOI 10.1182/blood-2004-01-0191; SIMCHOWITZ L, 1985, J CLIN INVEST, V76, P1079, DOI 10.1172/JCI112061; SIMMEN HP, 1993, AM J SURG, V166, P24, DOI 10.1016/S0002-9610(05)80576-8; TAKANAKA K, 1988, J BIOCHEM-TOKYO, V103, P656, DOI 10.1093/oxfordjournals.jbchem.a122324; Trevani AS, 1999, J IMMUNOL, V162, P4849; Van Hoogmoed L, 1999, J AM VET MED ASSOC, V214, P1032; Vogt S, 2007, J SURG RES, V139, P176, DOI 10.1016/j.jss.2006.07.041; WARD TT, 1978, AM J MED, V64, P933, DOI 10.1016/0002-9343(78)90446-1; WIKEHOOLEY JL, 1984, RADIOTHER ONCOL, V2, P343, DOI 10.1016/S0167-8140(84)80077-8; Xu YF, 2010, P NATL ACAD SCI USA, V107, P2950, DOI 10.1073/pnas.0912717107; Yang Ke-Ni, 2014, Cancer Biology Medicine, V11, P34, DOI 10.7497/j.issn.2095-3941.2014.01.003; ZIGMOND SH, 1981, J IMMUNOL, V126, P478	42	21	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137221	10.1371/journal.pone.0137221	http://dx.doi.org/10.1371/journal.pone.0137221			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340269	Green Published, gold			2022-12-26	WOS:000360688200035
J	Silvestrini, L; Rossi, B; Gallmetzer, A; Mathieu, M; Scazzocchio, C; Berardi, E; Strauss, J				Silvestrini, Lucia; Rossi, Beatrice; Gallmetzer, Andreas; Mathieu, Martine; Scazzocchio, Claudio; Berardi, Enrico; Strauss, Joseph			Interaction of Yna1 and Yna2 Is Required for Nuclear Accumulation and Transcriptional Activation of the Nitrate Assimilation Pathway in the Yeast Hansenula polymorpha	PLOS ONE			English	Article							GATA FACTOR AREA; IN-VIVO BINDING; NITROGEN REGULATORY PROTEIN; ENCODING NITRITE REDUCTASE; ASPERGILLUS-NIDULANS; NEUROSPORA-CRASSA; CHROMATIN-STRUCTURE; TRANSPORTER YNT1; GENE-EXPRESSION; MESSENGER-RNA	A few yeasts, including Hansenula polymorpha are able to assimilate nitrate and use it as nitrogen source. The genes necessary for nitrate assimilation are organised in this organism as a cluster comprising those encoding nitrate reductase (YNR1), nitrite reductase (YNI1), a high affinity transporter (YNT1), as well as the two pathway specific Zn(II)(2)Cys(2) transcriptional activators (YNA1, YNA2). Yna1p and Yna2p mediate induction of the systemand here we show that their functions are interdependent. Yna1p activates YNA2 as well as its own (YNA1) transcription thus forming a nitrate-dependent autoactivation loop. Using a split-YFP approach we demonstrate here that Yna1p and Yna2p form a heterodimer independently of the inducer and despite both Yna1p and Yna2p can occupy the target promoter as mono-or homodimer individually, these proteins are transcriptionally incompetent. Subsequently, the transcription factors target genes containing a conserved DNA motif (termed nitrate-UAS) determined in this work by in vitro and in vivo protein-DNA interaction studies. These events lead to a rearrangement of the chromatin landscape on the target promoters and are associated with the onset of transcription of these target genes. In contrast to other fungi and plants, in which nuclear accumulation of the pathway-specific transcription factors only occur in the presence of nitrate, Yna1p and Yna2p are constitutively nuclear in H. polymorpha. Yna2p is needed for this nuclear accumulation and Yna1p is incapable of strictly positioning in the nucleus without Yna2p. In vivo DNA footprinting and ChIP analyses revealed that the permanently nuclear Yna1p/Yna2p heterodimer only binds to the nitrate-UAS when the inducer is present. The nitrate-dependent up-regulation of one partner protein in the heterodimeric complex is functionally similar to the nitrate-dependent activation of nuclear accumulation in other systems.	[Silvestrini, Lucia; Gallmetzer, Andreas; Strauss, Joseph] BOKU Univ Nat Resources & Life Sci Vienna, Fungal Genet & Genom Unit, Div Microbial Genet & Pathogen Interact, Univ & Res Ctr Tulln, A-3430 Tulln Donau, Austria; [Silvestrini, Lucia; Rossi, Beatrice; Berardi, Enrico] Univ Politecn Marche, DiSA, Lab Genet Microb, I-60131 Ancona, Italy; [Rossi, Beatrice; Mathieu, Martine; Scazzocchio, Claudio] Univ Paris 11, CNRS, CEA, I2BC, F-91405 Orsay, France; [Scazzocchio, Claudio] Univ London Imperial Coll Sci Technol & Med, Dept Microbiol, London, England; [Strauss, Joseph] Univ & Res Ctr Tulln, Hlth & Environm Dept, Austrian Inst Technol GmbH AIT, A-3430 Tulln Donau, Austria	Marche Polytechnic University; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Imperial College London	Strauss, J (corresponding author), BOKU Univ Nat Resources & Life Sci Vienna, Fungal Genet & Genom Unit, Div Microbial Genet & Pathogen Interact, Univ & Res Ctr Tulln, Konrad Lorenz Str 24, A-3430 Tulln Donau, Austria.	joseph.strauss@boku.ac.at	Silvestrini, Lucia/GZG-9705-2022	Silvestrini, Lucia/0000-0002-0476-2358; Strauss, Joseph/0000-0003-0474-6267	Austrian Science Fund FWF [20630, F3703]; Universite-Sud; CNRS; Institute Universitaire de France	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Universite-Sud; CNRS(Centre National de la Recherche Scientifique (CNRS)); Institute Universitaire de France	Work at Vienna was supported by project P 20630 and Special Research Area project F3703 of the Austrian Science Fund FWF to JS, and work at Orsay was supported by the Universite-Sud, the CNRS and the Institute Universitaire de France.	Avila J, 2002, YEAST, V19, P537, DOI 10.1002/yea.847; AVILA J, 1995, FEBS LETT, V366, P137, DOI 10.1016/0014-5793(95)00511-7; Avila J, 1998, BIOCHEM J, V335, P647, DOI 10.1042/bj3350647; AXELROD JD, 1993, GENE DEV, V7, P857, DOI 10.1101/gad.7.5.857; BERARDI E, 1990, CURR GENET, V18, P169, DOI 10.1007/BF00312606; Berger H, 2006, MOL MICROBIOL, V59, P433, DOI 10.1111/j.1365-2958.2005.04957.x; Berger H, 2008, MOL MICROBIOL, V69, P1385, DOI 10.1111/j.1365-2958.2008.06359.x; Bernreiter A, 2007, MOL CELL BIOL, V27, P791, DOI 10.1128/MCB.00761-06; Bok JW, 2009, NAT CHEM BIOL, V5, P462, DOI 10.1038/nchembio.177; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; BRITO N, 1993, J BACTERIOL, V175, P6755, DOI 10.1128/jb.175.21.6755-6759.1993; Brito N, 1996, BIOCHEM J, V317, P89, DOI 10.1042/bj3170089; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; BURGER G, 1991, MOL CELL BIOL, V11, P5746, DOI 10.1128/MCB.11.11.5746; COSTANZO G, 1995, J BIOL CHEM, V270, P11091, DOI 10.1074/jbc.270.19.11091; Felsenfeld G, 1996, P NATL ACAD SCI USA, V93, P9384, DOI 10.1073/pnas.93.18.9384; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; Feng B, 1996, CURR GENET, V29, P537; Fitzgerald MX, 2006, STRUCTURE, V14, P725, DOI 10.1016/j.str.2005.11.025; Gallmetzer A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005297; GIETL C, 1994, P NATL ACAD SCI USA, V91, P3151, DOI 10.1073/pnas.91.8.3151; GLEESON MA, 1988, YEAST, V4, P293, DOI 10.1002/yea.320040407; Gomez D, 2002, MOL MICROBIOL, V44, P585, DOI 10.1046/j.1365-2958.2002.02939.x; Gonzalez R, 1997, NUCLEIC ACIDS RES, V25, P3955, DOI 10.1093/nar/25.19.3955; Kang HA, 2001, APPL MICROBIOL BIOT, V55, P734, DOI 10.1007/s002530100605; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; LU Q, 1994, J CELL BIOCHEM, V55, P83, DOI 10.1002/jcb.240550110; Machin F, 2004, YEAST, V21, P265, DOI 10.1002/yea.1075; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; Marchive C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2650; Martin Y, 2011, J BIOL CHEM, V286, P27225, DOI 10.1074/jbc.M111.265116; Mathieu M, 2005, MOL MICROBIOL, V56, P535, DOI 10.1111/j.1365-2958.2005.04559.x; Mo XK, 2003, CURR GENET, V42, P260, DOI 10.1007/s00294-002-0362-3; Morozov IY, 2001, MOL MICROBIOL, V42, P269, DOI 10.1046/j.1365-2958.2001.02636.x; Morse RH, 2003, BIOCHEM CELL BIOL, V81, P101, DOI 10.1139/o03-039; Muro-Pastor MI, 1999, EMBO J, V18, P1584, DOI 10.1093/emboj/18.6.1584; Narendja F, 2002, MOL MICROBIOL, V44, P573, DOI 10.1046/j.1365-2958.2002.02911.x; Navarro FJ, 2003, FEMS YEAST RES, V4, P149, DOI 10.1016/S1567-1356(03)00163-6; Navarro FJ, 2008, J BIOL CHEM, V283, P31208, DOI 10.1074/jbc.M802170200; Pal S, 2004, P NATL ACAD SCI USA, V101, P980, DOI 10.1073/pnas.0307612100; Perez MD, 1997, BIOCHEM J, V321, P397, DOI 10.1042/bj3210397; Sambrook J, 2001, MOLECULAR CLONING VO; Scazzocchio C, 2014, FUNGAL BIOLOGY AND B, V1; Schinko T, 2013, FUNGAL GENET BIOL, V54, P34, DOI 10.1016/j.fgb.2013.02.003; Schinko T, 2010, MOL MICROBIOL, V78, P720, DOI 10.1111/j.1365-2958.2010.07363.x; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Siverio JM, 2002, FEMS MICROBIOL REV, V26, P277, DOI 10.1016/S0168-6445(02)00100-6; Strauss J, 1998, MOL CELL BIOL, V18, P1339, DOI 10.1128/MCB.18.3.1339; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; SUDBERY PE, 1988, BIOCHEM SOC T, V16, P1081; Tao Y, 1999, CURR GENET, V36, P153, DOI 10.1007/s002940050485; Todd RB, 1997, FUNGAL GENET BIOL, V21, P388, DOI 10.1006/fgbi.1997.0993; Wolschek MF, 1998, NUCLEIC ACIDS RES, V26, P3862, DOI 10.1093/nar/26.16.3862; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; XIAO XD, 1995, BIOCHEMISTRY-US, V34, P8861, DOI 10.1021/bi00027a038; Xu M, 1998, MOL CELL BIOL, V18, P1201, DOI 10.1128/MCB.18.3.1201	56	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0135416	10.1371/journal.pone.0135416	http://dx.doi.org/10.1371/journal.pone.0135416			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335797	Green Published, Green Submitted, gold			2022-12-26	WOS:000360615400006
J	Cabet, E; Batonnet-Pichon, S; Delort, F; Gausseres, B; Vicart, P; Lilienbaum, A				Cabet, Eva; Batonnet-Pichon, Sabrina; Delort, Florence; Gausseres, Blandine; Vicart, Patrick; Lilienbaum, Alain			Antioxidant Treatment and Induction of Autophagy Cooperate to Reduce Desmin Aggregation in a Cellular Model of Desminopathy	PLOS ONE			English	Article							STRESS-INDUCED AUTOPHAGY; OXIDATIVE STRESS; SKELETAL-MUSCLE; MYOFIBRILLAR MYOPATHIES; MONITORING AUTOPHAGY; SIGNALING PATHWAYS; DISEASE; CELLS; MUTATIONS; RAC1	Desminopathies, a subgroup of myofibrillar myopathies (MFMs), the progressive muscular diseases characterized by the accumulation of granulofilamentous desmin-positive aggregates, result from mutations in the desmin gene (DES), encoding a muscle-specific intermediate filament. Desminopathies often lead to severe disability and premature death from cardiac and/or respiratory failure; no specific treatment is currently available. To identify drug-targetable pathophysiological pathways, we performed pharmacological studies in C2C12 myoblastic cells expressing mutant DES. We found that inhibition of the Rac1 pathway (a G protein signaling pathway involved in diverse cellular processes), antioxidant treatment, and stimulation of macroautophagy reduced protein aggregation by up to 75% in this model. Further, a combination of two or three of these treatments was more effective than any of them alone. These results pave the way towards the development of the first treatments for desminopathies and are potentially applicable to other muscle or brain diseases associated with abnormal protein aggregation.	[Cabet, Eva; Batonnet-Pichon, Sabrina; Delort, Florence; Vicart, Patrick; Lilienbaum, Alain] Univ Paris Diderot, Sorbonne Paris Cite, Physiopathol Striated Muscle Lab, Unit Funct & Adapt Biol,CNRS,UMR 8251, Paris, France; [Gausseres, Blandine] Univ Paris Diderot, Sorbonne Paris Cite, Biol & Pathol Endocrine Pancreas Lab, Unit Funct & Adapt Biol,CNRS,UMR 8251, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Lilienbaum, A (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Physiopathol Striated Muscle Lab, Unit Funct & Adapt Biol,CNRS,UMR 8251, Paris, France.	alain.lilienbaum@univ-paris-diderot.fr		Cabet, Eva/0000-0002-9113-3153	Universite Paris Diderot; Centre National de la Recherche Scientifique" (CNRS) [UMR8251]; Association Francaise contre les Myopathies (AFM) [15454]	Universite Paris Diderot; Centre National de la Recherche Scientifique" (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	This work was supported by Universite Paris Diderot http://www.univ-paris-diderot.fr PV, Centre National de la Recherche Scientifique" (CNRS) http://www.cnrs.fr UMR8251 PV, and Association Francaise contre les Myopathies (AFM) 15454 PV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Bar H, 2006, J MOL BIOL, V360, P1031, DOI 10.1016/j.jmb.2006.05.068; Bar H, 2005, P NATL ACAD SCI USA, V102, P15099, DOI 10.1073/pnas.0504568102; Barberi L, 2013, BIOGERONTOLOGY, V14, P273, DOI 10.1007/s10522-013-9429-4; BEHRENDT H, 1977, CELL TISSUE RES, V180, P303; Ben-Gedalya T, 2012, TRAFFIC, V13, P635, DOI 10.1111/j.1600-0854.2012.01330.x; Biol AJ, 2007, J NEUROPATH EXP NEUR, V66, P711, DOI 10.1097/nen.0b013e3181256b4c; Capetanaki Y, 2002, TRENDS CARDIOVAS MED, V12, P339, DOI 10.1016/S1050-1738(02)00184-6; Chen B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004374; Chen JL, 2009, AUTOPHAGY, V5, P244, DOI 10.4161/auto.5.2.7549; Claeys KG, 2013, HAND CLINIC, V113, P1337, DOI 10.1016/B978-0-444-59565-2.00005-8; Clemen CS, 2013, ACTA NEUROPATHOL, V125, P47, DOI 10.1007/s00401-012-1057-6; Dunlop RA, 2009, IUBMB LIFE, V61, P522, DOI 10.1002/iub.189; FERRANS VJ, 1973, J MOL CELL CARDIOL, V5, P247, DOI 10.1016/0022-2828(73)90065-5; Giordano S, 2014, REDOX BIOL, V2, P82, DOI 10.1016/j.redox.2013.12.013; Goldfarb LG, 2009, J CLIN INVEST, V119, P1806, DOI 10.1172/JCI38027; Goudeau B, 2001, HUM MUTAT, V18, P388, DOI 10.1002/humu.1210; Goudeau B, 2006, HUM MUTAT, V27, P906, DOI 10.1002/humu.20351; Gregersen N, 2006, ANNU REV GENOM HUM G, V7, P103, DOI 10.1146/annurev.genom.7.080505.115737; Huang CQ, 2010, AM J PHYSIOL-HEART C, V298, pH570, DOI 10.1152/ajpheart.00716.2009; Ishida H, 2007, J BIOL CHEM, V282, P11836, DOI 10.1074/jbc.M610106200; Janue A, 2007, BRAIN PATHOL, V17, P377, DOI 10.1111/j.1750-3639.2007.00087.x; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; Jordan SN, 2012, CYTOSKELETON, V69, P919, DOI 10.1002/cm.21071; Joseph JA, 1998, ANN NY ACAD SCI, V854, P268, DOI 10.1111/j.1749-6632.1998.tb09908.x; Kimura S, 2009, METHOD ENZYMOL, V452, P1, DOI 10.1016/S0076-6879(08)03601-X; Kley RA, 2013, AUTOPHAGY, V9, P422, DOI 10.4161/auto.22921; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kubota H, 2009, J BIOCHEM, V146, P609, DOI 10.1093/jb/mvp139; Lanneau D, 2010, THESCIENTIFICWORLDJO, V10, P1543, DOI 10.1100/tsw.2010.152; Launay N, 2006, EXP CELL RES, V312, P3570, DOI 10.1016/j.yexcr.2006.07.025; LAZARIDES E, 1976, P NATL ACAD SCI USA, V73, P4344, DOI 10.1073/pnas.73.12.4344; Lilienbaum A, CARDIOMYOPATHIES ASS; Madaro L, 2013, FASEB J, V27, P1990, DOI 10.1096/fj.12-215475; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Mitomi Y, 2012, J BIOL CHEM, V287, P34764, DOI 10.1074/jbc.M112.387035; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nicolescu P G, 1984, Morphol Embryol (Bucur), V30, P251; Olive M, 2013, CURR OPIN NEUROL, V26, P527, DOI 10.1097/WCO.0b013e328364d6b1; Parrini Maria Carla, 2012, Cell Logist, V2, P78; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Ramos FJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003802; Reimann J, 2003, NEUROPATH APPL NEURO, V29, P45, DOI 10.1046/j.1365-2990.2003.00428.x; Romero NB, 2013, HAND CLINIC, V113, P1299, DOI 10.1016/B978-0-444-59565-2.00002-2; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Schroder R, 2013, ACTA NEUROPATHOL, V125, P1, DOI 10.1007/s00401-012-1071-8; Segard BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076361; Selcen D, 2011, NEUROMUSCULAR DISORD, V21, P161, DOI 10.1016/j.nmd.2010.12.007; Shah SB, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/704061; Shah SB, 2004, BIOPHYS J, V86, P2993, DOI 10.1016/S0006-3495(04)74349-0; Su HB, 2010, CARDIOVASC RES, V85, P253, DOI 10.1093/cvr/cvp287; Tang GM, 2008, HUM MOL GENET, V17, P1540, DOI 10.1093/hmg/ddn042; Tannous P, 2008, P NATL ACAD SCI USA, V105, P9745, DOI 10.1073/pnas.0706802105; Trippier PC, 2013, J MED CHEM, V56, P3121, DOI 10.1021/jm3015926; van Spaendonck-Zwarts KY, 2011, CLIN GENET, V80, P354, DOI 10.1111/j.1399-0004.2010.01512.x; Wei YM, 2013, CELL PHYSIOL BIOCHEM, V31, P925, DOI 10.1159/000350111; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Winslow AR, 2011, AUTOPHAGY, V7, P429, DOI 10.4161/auto.7.4.14393; Winter DL, 2014, HISTOCHEM CELL BIOL, V141, P1, DOI 10.1007/s00418-013-1148-z; Wong ESP, 2008, HUM MOL GENET, V17, P2570, DOI 10.1093/hmg/ddn157	62	22	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137009	10.1371/journal.pone.0137009	http://dx.doi.org/10.1371/journal.pone.0137009			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26333167	Green Submitted, gold, Green Published			2022-12-26	WOS:000360613800089
J	Choi, SJ; Kim, MH; Jeon, J; Kim, OY; Choi, Y; Seo, J; Hong, SW; Lee, WH; Jeon, SG; Gho, YS; Jee, YK; Kim, YK				Choi, Seng Jin; Kim, Min-Hye; Jeon, Jinseong; Kim, Oh Youn; Choi, Youngwoo; Seo, Jihye; Hong, Sung-Wook; Lee, Won-Hee; Jeon, Seong Gyu; Gho, Yong Song; Jee, Young-Koo; Kim, Yoon-Keun			Active Immunization with Extracellular Vesicles Derived from Staphylococcus aureus Effectively Protects against Staphylococcal Lung Infections, Mainly via Th1 Cell-Mediated Immunity	PLOS ONE			English	Article							OUTER-MEMBRANE VESICLES; CLUMPING FACTOR-A; SURFACE-PROTEINS; VACCINE; ANTIBODIES; EPIDEMIOLOGY; PREVENTION; RESPONSES; EFFICACY; ANTIGENS	Staphylococcus aureus is an important pathogenic bacterium that causes various infectious diseases. Extracellular vesicles (EVs) released from S. aureus contain bacterial proteins, nucleic acids, and lipids. These EVs can induce immune responses leading to similar symptoms as during staphylococcal infection condition and have the potential as vaccination agent. Here, we show that active immunization (vaccination) with S. aureus-derived EVs induce adaptive immunity of antibody and T cell responses. In addition, these EVs have the vaccine adjuvant ability to induce protective immunity such as the up-regulation of co-stimulatory molecules and the expression of T cell polarizing cytokines in antigen-presenting cells. Moreover, vaccination with S. aureus EVs conferred protection against lethality induced by airway challenge with lethal dose of S. aureus and also pneumonia induced by the administration of sub-lethal dose of S. aureus. These protective effects were also found in mice that were adoptively transferred with splenic T cells isolated from S. aureus EV-immunized mice, but not in serum transferred mice. Furthermore, this protective effect of S. aureus EVs was significantly reduced by the absence of interferon-gamma, but not by the absence of interleukin-17. Together, the study herein suggests that S. aureus EVs are a novel vaccine candidate against S. aureus infections, mainly via Th1 cellular response.	[Choi, Seng Jin; Jeon, Jinseong; Kim, Oh Youn; Choi, Youngwoo; Seo, Jihye; Lee, Won-Hee; Jeon, Seong Gyu; Gho, Yong Song] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, South Korea; [Kim, Min-Hye; Kim, Yoon-Keun] Ewha Womans Univ, Sch Med, Dept Med, Seoul, South Korea; [Kim, Min-Hye; Kim, Yoon-Keun] Ewha Womans Med Ctr, Ewha Inst Convergence Med, Seoul, South Korea; [Hong, Sung-Wook] Acad Immunol & Microbiol AIM, Inst Basic Sci IBS, Pohang, South Korea; [Hong, Sung-Wook] Pohang Univ Sci & Technol POSTECH, Dept Integrat Biosci & Biotechnol, Pohang, South Korea; [Jee, Young-Koo] Dankook Univ, Coll Med, Dept Internal Med, Cheonan, South Korea	Pohang University of Science & Technology (POSTECH); Ewha Womans University; Ewha Womans University; Institute for Basic Science - Korea (IBS); Pohang University of Science & Technology (POSTECH); Dankook University	Jeon, SG (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, South Korea.	gene49@hanmail.net; juinea@ewha.ac.kr		Jeon, Jinseong/0000-0003-1829-7319; Jee, Young-Koo/0000-0001-5800-8038; Lee, Won Hee/0000-0003-0162-4176	Korea Drug Development Fund (KDDF) - MSIP; MOTIE; MOHW [KDDF-201212-05]; Korea Health Technology R & D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C2694]	Korea Drug Development Fund (KDDF) - MSIP(Korea Drug Development Fund (KDDF)); MOTIE(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); MOHW; Korea Health Technology R & D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by Korea Drug Development Fund (KDDF) funded by MSIP, MOTIE, and MOHW (Grant No. KDDF-201212-05) and a grant of the Korea Health Technology R & D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C2694).	Arrecubieta C, 2008, J INFECT DIS, V198, P571, DOI 10.1086/590210; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Bagnoli F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00016; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Baudner BC, 2009, PHARM RES-DORDR, V26, P1477, DOI 10.1007/s11095-009-9859-5; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Clarke SR, 2006, J INFECT DIS, V193, P1098, DOI 10.1086/501471; Cook J, 2009, HUM VACCINES, V5, P254, DOI 10.4161/hv.5.4.6765; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Dejonge M, 2007, J PEDIATR-US, V151, P260, DOI 10.1016/j.jpeds.2007.04.060; Dormitzer PR, 2011, IMMUNOL REV, V239, P167, DOI 10.1111/j.1600-065X.2010.00974.x; Dryla A, 2005, CLIN DIAGN LAB IMMUN, V12, P387, DOI 10.1128/CDLI.12.3.387-398.2005; EDWARDS SW, 1987, J GEN MICROBIOL, V133, P3591; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Galli G, 2009, P NATL ACAD SCI USA, V106, P7962, DOI 10.1073/pnas.0903181106; Harro CD, 2012, VACCINE, V30, P1729, DOI 10.1016/j.vaccine.2011.12.045; Hong SW, 2011, ALLERGY, V66, P351, DOI 10.1111/j.1398-9995.2010.02483.x; Jones T, 2009, CURR OPIN MOL THER, V11, P337; Josefsson E, 2001, J INFECT DIS, V184, P1572, DOI 10.1086/324430; Kamath AT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003683; Kim HK, 2011, FASEB J, V25, P3605, DOI 10.1096/fj.11-187963; Kim MR, 2012, ALLERGY, V67, P1271, DOI 10.1111/all.12001; Kim OY, 2013, J IMMUNOL, V190, P4092, DOI 10.4049/jimmunol.1200742; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Kwon SO, 2009, FEMS MICROBIOL LETT, V297, P150, DOI 10.1111/j.1574-6968.2009.01669.x; Lee EY, 2007, PROTEOMICS, V7, P3143, DOI [10.1002/pmic.200700196, 10.1002/pmic.200790083]; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; Lee IT, 2010, AM J PATHOL, V176, P1671, DOI 10.2353/ajpath.2010.090714; Levine MM, 2004, NAT IMMUNOL, V5, P460, DOI 10.1038/ni0504-460; Lin HY, 2010, INT IMMUNOPHARMACOL, V10, P883, DOI 10.1016/j.intimp.2010.04.026; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P402, DOI 10.1016/j.ijmm.2010.04.015; Otto M, 2010, EXPERT OPIN BIOL TH, V10, P1049, DOI 10.1517/14712598.2010.495115; Park KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011334; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Robbins JB, 2004, AM HEART J, V147, P593, DOI 10.1016/j.ahj.2004.01.012; Schaffer AC, 2008, INT J ANTIMICROB AG, V32, pS71, DOI 10.1016/j.ijantimicag.2008.06.009; Spellberg B, 2008, INFECT IMMUN, V76, P4574, DOI 10.1128/IAI.00700-08; Spellberg B, 2012, SEMIN IMMUNOPATHOL, V34, P335, DOI 10.1007/s00281-011-0293-5; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Tuchscherr LPN, 2008, INFECT IMMUN, V76, P5738, DOI 10.1128/IAI.00874-08; Verkaik NJ, 2009, J INFECT DIS, V199, P625, DOI 10.1086/596743; Vernachio JH, 2006, ANTIMICROB AGENTS CH, V50, P511, DOI 10.1128/AAC.50.2.511-518.2006; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208	48	54	59	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136021	10.1371/journal.pone.0136021	http://dx.doi.org/10.1371/journal.pone.0136021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26333035	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800047
J	Roth, R; Swanson, R; Izaguirre, G; Bock, SC; Gettins, PGW; Olson, ST				Roth, Ryan; Swanson, Richard; Izaguirre, Gonzalo; Bock, Susan C.; Gettins, Peter G. W.; Olson, Steven T.			Saturation Mutagenesis of the Antithrombin Reactive Center Loop P14 Residue Supports a Three-step Mechanism of Heparin Allosteric Activation Involving Intermediate and Fully Activated States	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR IXA; FACTOR-XA; CONFORMATIONAL ACTIVATION; PROTEINASE REACTIONS; RAPID INHIBITION; BETA-SHEET; HELIX-D; BINDING; SERPIN; EXOSITE	Past studies have suggested that a key feature of the mechanism of heparin allosteric activation of the anticoagulant serpin, antithrombin, is the release of the reactive center loop P14 residue from a native state stabilizing interaction with the hydrophobic core. However, more recent studies have indicated that this structural change plays a secondary role in the activation mechanism. To clarify this role, we expressed and characterized 15 antithrombin P14 variants. The variants exhibited basal reactivities with factors Xa and IXa, heparin affinities and thermal stabilities that were dramatically altered from wild type, consistent with the P14 mutations perturbing native state stability and shifting an allosteric equilibrium between native and activated states. Rapid kinetic studies confirmed that limiting rate constants for heparin allosteric activation of the mutants were altered in conjunction with the observed shifts of the allosteric equilibrium. However, correlations of the P14 mutations' effects on parameters reflecting the allosteric activation state of the serpin were inconsistent with a two-state model of allosteric activation and suggested multiple activated states. Together, these findings support a minimal three-state model of allosteric activation in which the P14 mutations perturb equilibria involving distinct native, intermediate, and fully activated states wherein the P14 residue retains an interaction with the hydrophobic core in the intermediate state but is released from the core in the fully activated state, and the bulk of allosteric activation has occurred in the intermediate.	Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA; [Roth, Ryan; Swanson, Richard; Izaguirre, Gonzalo; Olson, Steven T.] Univ Illinois, Dept Periodont, Chicago, IL 60612 USA; [Gettins, Peter G. W.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60612 USA; [Bock, Susan C.] Univ Utah, Dept Med, Salt Lake City, UT 84132 USA; [Bock, Susan C.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84132 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Olson, ST (corresponding author), 801 S Paulina St,MC 860, Chicago, IL 60612 USA.	stolson@uic.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R37 HL39888]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL039888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in wholeor in part, by National Institutes of Health Grant R37 HL39888 (to S. T. O.). The authors declare that they have no conflicts of interest with the contents of this article.	BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; Bedsted T, 2003, BIOCHEMISTRY-US, V42, P8143, DOI 10.1021/bi034363y; Dementiev A, 2013, J BIOL CHEM, V288, P33611, DOI 10.1074/jbc.M113.510727; Desai UR, 1998, J BIOL CHEM, V273, P7478, DOI 10.1074/jbc.273.13.7478; ERSDALBADJU E, 1995, BIOCHEM J, V310, P323, DOI 10.1042/bj3100323; Futamura A, 2000, J BIOL CHEM, V275, P4092, DOI 10.1074/jbc.275.6.4092; Gettins PGW, 2009, FEBS LETT, V583, P3397, DOI 10.1016/j.febslet.2009.10.005; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Hopfner KP, 1997, EMBO J, V16, P6626, DOI 10.1093/emboj/16.22.6626; Huntington JA, 2000, J BIOL CHEM, V275, P15377, DOI 10.1074/jbc.275.20.15377; Huntington JA, 1998, BIOCHEMISTRY-US, V37, P3272, DOI 10.1021/bi972182o; Huntington JA, 1996, BIOCHEMISTRY-US, V35, P8495, DOI 10.1021/bi9604643; Ishiguro K, 2000, J CLIN INVEST, V106, P873, DOI 10.1172/JCI10489; Izaguirre G, 2006, J BIOL CHEM, V281, P13424, DOI 10.1074/jbc.M600415200; Izaguirre G, 2003, J BIOL CHEM, V278, P51433, DOI 10.1074/jbc.M309266200; Izaguirre G, 2014, J BIOL CHEM, V289, P34049, DOI 10.1074/jbc.M114.611707; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Johnson DJD, 2010, P NATL ACAD SCI USA, V107, P645, DOI 10.1073/pnas.0910144107; Johnson DJD, 2003, BIOCHEMISTRY-US, V42, P8712, DOI 10.1021/bi034524y; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langdown J, 2009, J MOL BIOL, V386, P1278, DOI 10.1016/j.jmb.2009.01.028; Lawrence DA, 2000, J BIOL CHEM, V275, P5839, DOI 10.1074/jbc.275.8.5839; LAWRENCE DA, 1994, BIOCHEMISTRY-US, V33, P3643, DOI 10.1021/bi00178a022; Liu Y, 2014, BLOOD, V124, P142, DOI 10.1182/blood-2014-03-561027; MASCOTTI DP, 1995, BIOCHEMISTRY-US, V34, P2908, DOI 10.1021/bi00009a022; Meagher JL, 2000, J BIOL CHEM, V275, P2698, DOI 10.1074/jbc.275.4.2698; NORDENMAN B, 1977, EUR J BIOCHEM, V78, P195, DOI 10.1111/j.1432-1033.1977.tb11730.x; OLSON ST, 1992, J BIOL CHEM, V267, P12528; OLSON ST, 1991, J BIOL CHEM, V266, P6353; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Olson ST, 2010, BIOCHIMIE, V92, P1587, DOI 10.1016/j.biochi.2010.05.011; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Rezaie AR, 1998, J BIOL CHEM, V273, P16824, DOI 10.1074/jbc.273.27.16824; Richard B, 2008, J BIOL CHEM, V283, P14417, DOI 10.1074/jbc.M710327200; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schedin-Weiss S, 2010, ARCH BIOCHEM BIOPHYS, V504, P169, DOI 10.1016/j.abb.2010.08.021; Sturzebecher J, 1997, FEBS LETT, V412, P295, DOI 10.1016/S0014-5793(97)00811-9; Turk B, 1997, BIOCHEMISTRY-US, V36, P6682, DOI 10.1021/bi9702492; vanBoven HH, 1997, SEMIN HEMATOL, V34, P188	41	6	6	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28020	28036		10.1074/jbc.M115.678839	http://dx.doi.org/10.1074/jbc.M115.678839			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26359493	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000365761900001
J	Bamford, NC; Snarr, BD; Gravelat, FN; Little, DJ; Lee, MJ; Zacharias, CA; Chabot, JC; Geller, AM; Baptista, SD; Baker, P; Robinson, H; Howell, PL; Sheppard, DC				Bamford, Natalie C.; Snarr, Brendan D.; Gravelat, Fabrice N.; Little, Dustin J.; Lee, Mark J.; Zacharias, Caitlin A.; Chabot, Josee C.; Geller, Alexander M.; Baptista, Stefanie D.; Baker, Perrin; Robinson, Howard; Howell, P. Lynne; Sheppard, Donald C.			Sph3 Is a Glycoside Hydrolase Required for the Biosynthesis of Galactosaminogalactan in Aspergillus fumigatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EVOLUTIONARY CONSERVATION; CATALYTIC MECHANISM; CRYSTAL-STRUCTURE; BIOFILM FORMATION; ALGINATE LYASE; POLYSACCHARIDE; SEQUENCE; CONSURF; CLASSIFICATION; IDENTIFICATION	Aspergillus fumigatus is the most virulent species within the Aspergillus genus and causes invasive infections with high mortality rates. The exopolysaccharide galactosaminogalactan (GAG) contributes to the virulence of A. fumigatus. A co-regulated five-gene cluster has been identified and proposed to encode the proteins required for GAG biosynthesis. One of these genes, sph3, is predicted to encode a protein belonging to the spherulin 4 family, a protein family with no known function. Construction of an sph3-deficient mutant demonstrated that the gene is necessary for GAG production. To determine the role of Sph3 in GAG biosynthesis, we determined the structure of Aspergillus clavatus Sph3 to 1.25 angstrom. The structure revealed a (beta/alpha)(8) fold, with similarities to glycoside hydrolase families 18, 27, and 84. Recombinant Sph3 displayed hydrolytic activity against both purified and cell wall-associated GAG. Structural and sequence alignments identified three conserved acidic residues, Asp-166, Glu-167, and Glu-222, that are located within the putative active site groove. In vitro and in vivo mutagenesis analysis demonstrated that all three residues are important for activity. Variants of Asp-166 yielded the greatest decrease in activity suggesting a role in catalysis. This work shows that Sph3 is a glycoside hydrolase essential for GAG production and defines a new glycoside hydrolase family, GH135.	[Bamford, Natalie C.; Little, Dustin J.; Baker, Perrin; Howell, P. Lynne] Hosp Sick Children, Res Inst, Program Mol Struct & Funct, Toronto, ON M5G 0A4, Canada; [Bamford, Natalie C.; Little, Dustin J.; Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Snarr, Brendan D.; Gravelat, Fabrice N.; Lee, Mark J.; Zacharias, Caitlin A.; Chabot, Josee C.; Geller, Alexander M.; Baptista, Stefanie D.; Sheppard, Donald C.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H4A 3J1, Canada; [Snarr, Brendan D.; Gravelat, Fabrice N.; Lee, Mark J.; Zacharias, Caitlin A.; Chabot, Josee C.; Geller, Alexander M.; Baptista, Stefanie D.; Sheppard, Donald C.] McGill Univ, Dept Med, Montreal, PQ H4A 3J1, Canada; [Robinson, Howard] Brookhaven Natl Lab, Photon Sci Div, Upton, NY 11973 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; McGill University; McGill University; United States Department of Energy (DOE); Brookhaven National Laboratory	Howell, PL (corresponding author), Hosp Sick Children, Res Inst, Program Mol Struct & Funct, Toronto, ON M5G 0A4, Canada.	howell@sickkids.ca; don.sheppard@mcgill.ca	Sheppard, Donald/B-4637-2008	Sheppard, Donald/0000-0001-8877-880X; Bamford, Natalie/0000-0003-1959-856X; Gravelat, Fabrice/0000-0003-2416-9380	United States Department of Energy Office; National Institutes of Health from NCRR [P41RR012408]; National Institutes of Health from NIGMS [P41GM103473]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103473] Funding Source: NIH RePORTER	United States Department of Energy Office(United States Department of Energy (DOE)); National Institutes of Health from NCRR; National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Magee (University of Minnesota, St. Paul) for the Af293 strain, J. P. Latge (Institut Pasteur, Paris, France) for the anti-GAG antibody, and P. Yip (The Hospital for Sick Children, Toronto, Canada) for technical assistance. Beamline X29 at the National Synchrotron Light Source is supported by the United States Department of Energy Office and National Institutes of Health Grant P41RR012408 from NCRR and Grant P41GM103473 from NIGMS. Beamline 08B1-1 at the Canadian Light Source is supported by Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research, the National Research Council Canada, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anthon GE, 2001, J AGR FOOD CHEM, V49, P32, DOI 10.1021/jf000871s; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bakkevig K, 2005, J BACTERIOL, V187, P8375, DOI 10.1128/JB.187.24.8375-8384.2005; Bourne Y, 2004, J BIOL CHEM, V279, P527, DOI 10.1074/jbc.M308218200; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Colvin KM, 2013, J BACTERIOL, V195, P2329, DOI 10.1128/JB.02150-12; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fontaine T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002372; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; Geiser DM, 2007, STUD MYCOL, P1, DOI 10.3114/sim.2007.59.01; Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gravelat FN, 2008, INFECT IMMUN, V76, P3632, DOI 10.1128/IAI.01483-07; Gravelat FN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003575; Gravelat Fabrice N, 2012, Methods Mol Biol, V845, P119, DOI 10.1007/978-1-61779-539-8_8; Gravelat FN, 2010, CELL MICROBIOL, V12, P473, DOI 10.1111/j.1462-5822.2009.01408.x; Gresnigt MS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003936; Guce AI, 2010, J BIOL CHEM, V285, P3625, DOI 10.1074/jbc.M109.060145; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; Jain S, 2005, INFECT IMMUN, V73, P6429, DOI 10.1128/IAI.73.10.6429-6436.2005; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kaur S, 2014, MED MYCOL, V52, P2, DOI 10.3109/13693786.2013.819592; Kawano S, 2002, J BIOSCI BIOENG, V94, P275, DOI 10.1263/jbb.94.275; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Koseoglu VK, 2015, MOL MICROBIOL, V96, P728, DOI 10.1111/mmi.12966; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JE, 2001, STRUCTURE, V9, P941, DOI 10.1016/S0969-2126(01)00656-6; Lee M. J., 2015, MBIO; Lee MJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005187; Lee MJ, 2014, J BIOL CHEM, V289, P1243, DOI 10.1074/jbc.M113.522516; Lewis RE, 2013, MYCOSES, V56, P638, DOI 10.1111/myc.12081; Little DJ, 2015, J BIOL CHEM, V290, P22827, DOI 10.1074/jbc.M115.672469; Little DJ, 2014, P NATL ACAD SCI USA, V111, P11013, DOI 10.1073/pnas.1406388111; Little DJ, 2012, J BIOL CHEM, V287, P31126, DOI 10.1074/jbc.M112.390005; Loussert C, 2010, CELL MICROBIOL, V12, P405, DOI 10.1111/j.1462-5822.2009.01409.x; Mazur O, 2011, J BIOL CHEM, V286, P17601, DOI 10.1074/jbc.M111.227660; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Nakai T, 2013, J BACTERIOL, V195, P958, DOI 10.1128/JB.01473-12; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papanikolau Y, 2001, BIOCHEMISTRY-US, V40, P11338, DOI 10.1021/bi010505h; Parise G, 2007, J BACTERIOL, V189, P750, DOI 10.1128/JB.00953-06; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Payne CM, 2012, J BIOL CHEM, V287, P36322, DOI 10.1074/jbc.M112.402149; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Roberts SM, 2012, METHOD ENZYMOL, V510, P141, DOI 10.1016/B978-0-12-415931-0.00008-2; Robinet P, 2014, J IMMUNOL, V192, P5332, DOI 10.4049/jimmunol.1303180; Rohde H, 2010, EUR J CELL BIOL, V89, P103, DOI 10.1016/j.ejcb.2009.10.005; SAVARD L, 1989, BIOCHIM BIOPHYS ACTA, V1007, P264, DOI 10.1016/0167-4781(89)90146-2; Sloan GP, 2007, J BACTERIOL, V189, P8270, DOI 10.1128/JB.00785-07; Steiner S, 2013, EMBO J, V32, P354, DOI 10.1038/emboj.2012.315; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798; Whitney JC, 2013, TRENDS MICROBIOL, V21, P63, DOI 10.1016/j.tim.2012.10.001	67	49	53	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27438	27450		10.1074/jbc.M115.679050	http://dx.doi.org/10.1074/jbc.M115.679050			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26342082	Green Published, hybrid			2022-12-26	WOS:000365757500001
J	Nguyen, Y; Harvey, H; Sugiman-Marangos, S; Bell, SD; Buensuceso, RNC; Junop, MS; Burrows, LL				Nguyen, Ylan; Harvey, Hanjeong; Sugiman-Marangos, Seiji; Bell, Stephanie D.; Buensuceso, Ryan N. C.; Junop, Murray S.; Burrows, Lori L.			Structural and Functional Studies of the Pseudomonas aeruginosa Mninor Pilin, PilE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIN-COREGULATED PILUS; IV PILI; NEISSERIA-MENINGITIDIS; II SECRETION; MINOR PILINS; AMINO-ACID; PROTEIN-SECRETION; GONORRHOEAE; PREPILIN; REVEALS	Many bacterial pathogens, including Pseudomonas aeruginosa, use type IVa pili (T4aP) for attachment and twitching motility. T4aP are composed primarily of major pilin subunits, which are repeatedly assembled and disassembled to mediate function. A group of pilin-like proteins, the minor pilins FimU and PilVWXE, prime pilus assembly and are incorporated into the pilus. We showed previously that minor pilin PilE depends on the putative priming subcomplex PilVWX and the non-pilin protein PilY1 for incorporation into pili, and that with FimU, PilE may couple the priming subcomplex to the major pilin PilA, allowing for efficient pilus assembly. Here we provide further support for this model, showing interaction of PilE with other minor pilins and the major pilin. A 1.25 angstrom crystal structure of PilE(Delta 1-28) shows a typical type IV pilin fold, demonstrating how it may be incorporated into the pilus. Despite limited sequence identity, PilE is structurally similar to Neisseria meningitidis minor pilins PilX(Nm) and PilV(Nm), recently suggested via characterization of mCherry fusions to modulate pilus assembly from within the periplasm. A P. aeruginosa PilE-mCherry fusion failed to complement twitching motility or piliation of a pilE mutant. However, in a retraction-deficient strain where surface piliation depends solely on PilE, the fusion construct restored some surface piliation. PilE-mCherry was present in sheared surface fractions, suggesting that it was incorporated into pili. Together, these data provide evidence that PilE, the sole P. aeruginosa equivalent of PilX(Nm) and PilV(Nm), likely connects a priming subcomplex to the major pilin, promoting efficient assembly of T4aP.	[Nguyen, Ylan; Harvey, Hanjeong; Sugiman-Marangos, Seiji; Bell, Stephanie D.; Buensuceso, Ryan N. C.; Burrows, Lori L.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada; [Nguyen, Ylan; Harvey, Hanjeong; Sugiman-Marangos, Seiji; Bell, Stephanie D.; Buensuceso, Ryan N. C.; Burrows, Lori L.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8S 4K1, Canada; [Junop, Murray S.] Western Univ, Dept Biochem, London, ON N6A 3K7, Canada	McMaster University; McMaster University; Western University (University of Western Ontario)	Burrows, LL (corresponding author), 4H18 Hlth Sci Ctr, 1200 Main St West, Hamilton, ON L8N 3Z5, Canada.	burrowl@mcmaster.ca	Junop, Murray S/E-4160-2015	Junop, Murray S/0000-0001-6676-5717; Sugiman-Marangos, Seiji/0000-0002-8475-5456	Canadian Institutes of Health Research (CIHR) [MOP 86639, MOP 89903]; Cystic Fibrosis Canada; CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada; CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Operating Grants MOP 86639 (to L. L. B.) and MOP 89903 (to M. S. J.). This work was also supported by a Graduate Studentship from Cystic Fibrosis Canada and a Banting Scholarship from the CIHR (to Y. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Albers SV, 2009, EXTREMOPHILES, V13, P403, DOI 10.1007/s00792-009-0241-7; Asikyan ML, 2008, J BACTERIOL, V190, P7022, DOI 10.1128/JB.00938-08; Ayers M, 2010, FUTURE MICROBIOL, V5, P1203, DOI 10.2217/FMB.10.76; Belete B, 2008, J BACTERIOL, V190, P2023, DOI 10.1128/JB.01623-07; Brown DR, 2010, INFECT IMMUN, V78, P3053, DOI 10.1128/IAI.00099-10; Cehovin A, 2013, P NATL ACAD SCI USA, V110, P3065, DOI 10.1073/pnas.1218832110; Cisneros DA, 2012, MOL MICROBIOL, V86, P805, DOI 10.1111/mmi.12033; Cisneros DA, 2012, EMBO J, V31, P1041, DOI 10.1038/emboj.2011.454; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Durand E, 2003, J BACTERIOL, V185, P2749, DOI 10.1128/JB.185.9.2749-2758.2003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Giltner CL, 2011, ENVIRON MICROBIOL, V13, P250, DOI 10.1111/j.1462-2920.2010.02327.x; Giltner CL, 2010, J MOL BIOL, V398, P444, DOI 10.1016/j.jmb.2010.03.028; Hartung S, 2011, J BIOL CHEM, V286, P44254, DOI 10.1074/jbc.M111.297242; Harvey H, 2009, J BACTERIOL, V191, P6513, DOI 10.1128/JB.00943-09; Helaine S, 2005, MOL MICROBIOL, V55, P65, DOI 10.1111/j.1365-2958.2004.04372.x; Helaine S, 2007, P NATL ACAD SCI USA, V104, P15888, DOI 10.1073/pnas.0707581104; HOBBS M, 1993, MOL MICROBIOL, V10, P233, DOI 10.1111/j.1365-2958.1993.tb01949.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Imhaus AF, 2014, EMBO J, V33, P1767, DOI 10.15252/embj.201488031; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; JONSSON AB, 1992, P NATL ACAD SCI USA, V89, P3204, DOI 10.1073/pnas.89.8.3204; Karimova G, 2001, J MOL MICROB BIOTECH, V3, P73; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Li J, 2008, STRUCTURE, V16, P137, DOI 10.1016/j.str.2007.10.027; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morand PC, 2001, MOL MICROBIOL, V40, P846, DOI 10.1046/j.1365-2958.2001.02452.x; Otwinowski Z, 1997, METHODS ENZYMOL, V276, P307; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; RUSSELL MA, 1994, MOL MICROBIOL, V13, P973, DOI 10.1111/j.1365-2958.1994.tb00489.x; SASTRY PA, 1985, J BACTERIOL, V164, P571, DOI 10.1128/JB.164.2.571-577.1985; Siryaporn A, 2014, P NATL ACAD SCI USA, V111, P16860, DOI 10.1073/pnas.1415712111; STROM MS, 1991, J BIOL CHEM, V266, P1656; STROM MS, 1993, P NATL ACAD SCI USA, V90, P2404, DOI 10.1073/pnas.90.6.2404; Szabo Z, 2007, J BACTERIOL, V189, P772, DOI 10.1128/JB.01547-06; Takahashi H, 2012, INFECT IMMUN, V80, P4154, DOI 10.1128/IAI.00423-12; Winther-Larsen HC, 2005, MOL MICROBIOL, V56, P903, DOI 10.1111/j.1365-2958.2005.04591.x; Winther-Larsen HC, 2001, P NATL ACAD SCI USA, V98, P15276, DOI 10.1073/pnas.261574998; Wolfgang M, 1999, MOL MICROBIOL, V31, P1345, DOI 10.1046/j.1365-2958.1999.01269.x	48	17	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26856	26865		10.1074/jbc.M115.683334	http://dx.doi.org/10.1074/jbc.M115.683334			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26359492	Green Published, hybrid			2022-12-26	WOS:000364793600047
J	de Andrade, ED; Hennington, EA; de Siqueira, HR; Rolla, VC; Mannarino, C				de Andrade, Elizabeth da Trindade; Hennington, Elida Azevedo; de Siqueira, Helio Ribeiro; Rolla, Valeria Cavalcanti; Mannarino, Celina			Perspectives of Patients, Doctors and Medical Students at a Public University Hospital in Rio de Janeiro Regarding Tuberculosis and Therapeutic Adherence	PLOS ONE			English	Article							BARRIERS	Introduction The World Health Organization (WHO) identifies 8.7 million new cases of tuberculosis (TB) annually around the world. The unfavorable outcomes of TB treatment prevent the achievement of the WHO's cure target. Goal To evaluate existing intersections in the conceptions relative to the knowledge of TB, the experience of the illness and the treatment. Methods Doctors, medical students and patients were selected from a public university in Rio de Janeiro, Brazil, from 2011 to 2013. The data were obtained by semi-structured individual and focus group interviews, participant observation and a field journal. The inclusion of patients was interrupted due to saturation, and the inclusion of doctors and medical students stopped due to exhaustion. The theoretical background included symbolic Interactionism, and the analysis used rounded Theory. The analysis prioritized the actions/interactions axis. Results Twenty-three patients with pulmonary TB, seven doctors and 15 medical students were included. In the interviews, themes such as stigma, self-segregation, and difficulties in assistance emerged, in addition to defense mechanisms such as denial, rationalization, isolation and other mental mechanisms, including guilt, accountability and concealment of the disease. Aspects related to the assistance strategy, the social support network, bonding with the healthcare staff and the doctor-patient relationship were highlighted as adherence enablers. Doctors and students recommended an expansion of the theoretical and practical instruction on TB during medical students' education. The existence of health programs and policies was mentioned as a potential enabler of adherence. Conclusion The main concepts identified were the stigma, self-segregation, guilt, responsibility, concealment and emotional repercussions. In relation to the facilitation of therapeutic adherence, the concepts identified were the bonds with healthcare staff, the doctor-patient relationship, assistance and educational health strategies.	[de Andrade, Elizabeth da Trindade; Hennington, Elida Azevedo; Rolla, Valeria Cavalcanti; Mannarino, Celina] Natl Inst Infect Dis Evandro Chagas INI Fiocruz, Rio De Janeiro, Brazil; [Hennington, Elida Azevedo; Mannarino, Celina] Natl Inst Infect Dis Evandro Chagas INI Fiocruz, Educ, Rio De Janeiro, Brazil; [de Siqueira, Helio Ribeiro] State Univ Rio de Janeiro UERJ, Fac Med Sci, Rio De Janeiro, Brazil; [Rolla, Valeria Cavalcanti] Natl Inst Infect Dis Evandro Chagas INI Fiocruz, Clin Res Lab Mycobacteria, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz	de Andrade, ED (corresponding author), Natl Inst Infect Dis Evandro Chagas INI Fiocruz, Rio De Janeiro, Brazil.	bethtrind@gmail.com	Hennington, Elida Azevedo/AAK-3354-2020; Rolla, Valeria Cavalcanti/AAI-6078-2021	Hennington, Elida Azevedo/0000-0001-5280-8827; Rolla, Valeria Cavalcanti/0000-0002-0841-1408				Abebe G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013339; Abrão Carolina Borges, 2008, Rev. bras. educ. med., V32, P315, DOI 10.1590/S0100-55022008000300006; Abreu Neto Iron Pires de, 2006, Rev. bras. educ. med., V30, P154, DOI 10.1590/S0100-55022006000300006; [Anonymous], 2013, GLOB TUB CONTR; Backes MTS, 2011, ESC A NERY, V15; Fontanella BJ, 2008, CAD SAUDE PUBLICA, V24, P17, DOI 10.1590/S0102-311X2008000100003; Fontanella BJB, 2011, CAD SAUDE PUBLICA, V27, P389, DOI 10.1590/S0102-311X2011000200020; Bertazone Érika do Carmo, 2005, Rev. Latino-Am. Enfermagem, V13, P374; Blumer H., 1969, SYMB INTERACT; Brasil. Ministerio da Saude, 2013, B EPIDEMIOLOGICO, V44; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2010, MAN REC CONTR TUB BR; Chirinos NEC, 2011, TEXTO CONTEXTO ENFER, V20, P399, DOI 10.1590/S0104-07072011000300023; Chang SH, 2014, INT J TUBERC LUNG D, V18, P168, DOI 10.5588/ijtld.13.0181; Clementino FS, 2011, REV ENFERM UERJ, V19, P638; Corbin J, 2009, PESQUISA QUALITATIVA; Costa A, 2009, REV BRASILEIRA TERAP, V11, P329; Courtwright A, 2010, PUBLIC HEALTH REP, V125, P34, DOI 10.1177/00333549101250S407; DENZIN N., 2006, PLANEJAMENTO PESQUIS, V2; Ferreira-Santos E, 2010, ESTUDANTE MED PSICOL, P61; Goffman E., 2004, ESTIGMA NOTAS MANIPU, V4, DOI [10.4324/9781315182131-8, DOI 10.4324/9781315182131-8]; Hane F, 2007, INT J TUBERC LUNG D, V11, P539; Koifman L., 2001, Historia Ciencias, Saude - Manguinhos, V8, P49, DOI 10.1590/S0104-59702001000200003; Konradsen H, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.23644; Kuznetsov VN, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-712; Lakatos EM, 2009, METODOLOGIA CIENTIFI; Laperriere A, 2010, PESQUI QUAL ENFOQUES; Dias AAL, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-595; Mala G, 2013, J EVAL CLIN PRACT, V20, P88; Marra Carlo A, 2004, Health Qual Life Outcomes, V2, P58, DOI 10.1186/1477-7525-2-58; *MIN SAUD, 2012, B EP ESP TUB, P43; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Neves SC, 2010, ENSINO SAUDE AMBIENT, V3; Nico Lucélia Silva, 2007, Ciênc. saúde coletiva, V12, P789; Noyes J, 2007, J ADV NURS, V57, P227, DOI 10.1111/j.1365-2648.2006.04092.x; Onifade DA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-381; Sanou A, 2004, INT J TUBERC LUNG D, V8, P1479; Singh V, 2002, TROP MED INT HEALTH, V7, P693, DOI 10.1046/j.1365-3156.2002.00909.x; SOUZA SF, 2006, THESIS U FEDERAL SAN; Spitz L, 1997, CAD IPUB SAUDE MENTA, P85; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Thiam S, 2007, JAMA-J AM MED ASSOC, V297, P380, DOI 10.1001/jama.297.4.380; Valadares G, 2011, REV ENFERM UERJ, V19, P473; Watkins RE, 2004, INT J TUBERC LUNG D, V8, P218; WHO, 2012, GLOB TUB CONTR	44	2	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137572	10.1371/journal.pone.0137572	http://dx.doi.org/10.1371/journal.pone.0137572			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360291	gold, Green Published, Green Submitted			2022-12-26	WOS:000361043100054
J	Lee, SY; Lee, SH; Yang, EJ; Kim, EK; Kim, JK; Shin, DY; Cho, ML				Lee, Seon-Yeong; Lee, Seung Hoon; Yang, Eun-Ji; Kim, Eun-Kyung; Kim, Jae-Kyung; Shin, Dong-Yun; Cho, Mi-La			Metformin Ameliorates Inflammatory Bowel Disease by Suppression of the STAT3 Signaling Pathway and Regulation of the between Th17/Treg Balance	PLOS ONE			English	Article								Objective Metformin is used to treat type 2 diabetes. We sought to determine whether metformin reduces inflammation, by regulating p-signal transducer and activator of transcription 3 (STAT3) expression and T-helper 17 (Th17) cell proliferation, in a mouse model of inflammatory bowel disease (IBD). Methods IBD mice were administered metformin for 16 days and their tissues were analyzed. AMP-activated protein kinase (AMPK), the mammalian target of rapamycin (mTOR), p-STAT3 and p-STAT5 in the spleen and lymph nodes were detected using immunohistochemistry and confocal microscopy. Gene expression was determined using quantitative PCR assays, and protein expression levels were measured using western blotting and enzyme-linked immunosorbent assays. Human HT-29 cell proliferation was evaluated using MTT assays. Results Metformin reduced disease activity index scores and inhibited weight loss. Metformin also decreased the colonic histological score and inflammatory mediators and increased colon lengths increased. Treatment with metformin inhibited the expression of interleukin (IL)-17, p-STAT3, and p-mTOR. In contrast, metformin treatment increased expression levels of p-AMPK and Foxp3. In addition, expression of inflammatory cytokines decreased in a dose-dependent manner in inflamed human HT-29 cells cultured with metformin at various concentrations. Conclusions Metformin attenuates IBD severity and reduces inflammation through the inhibition of p-STAT3 and IL-17 expression. Our results have increased our understanding of this chronic inflammatory disease, and support the strategy of using p-STAT3 inhibitors to treat IBD.	[Lee, Seon-Yeong; Lee, Seung Hoon; Yang, Eun-Ji; Kim, Eun-Kyung; Kim, Jae-Kyung; Cho, Mi-La] Catholic Univ Korea, Catholic Res Inst Med Sci, Rheumatism Res Ctr, Seoul, South Korea; [Lee, Seon-Yeong; Cho, Mi-La] Catholic Univ, CRCID, Lab Immune Network, Seoul, South Korea; [Shin, Dong-Yun] Gachon Univ Med & Sci, Coll Pharm, 191 Hambakmoe Ro, Inchon 406799, South Korea	Catholic University of Korea; Catholic University of Korea; Gachon University	Shin, DY (corresponding author), Gachon Univ Med & Sci, Coll Pharm, 191 Hambakmoe Ro, Inchon 406799, South Korea.	dyshin21@naver.com; iammila@catholic.ac.kr			Korean Health Technology RAMP;D Project, Ministry for Health AMP; Welfare, Republic of Korea [HI14C3417]; Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea; Korea Health Technology RAMP;D Project through the Korea Health Industry Development Institute [HI14C1549]	Korean Health Technology RAMP;D Project, Ministry for Health AMP; Welfare, Republic of Korea; Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea; Korea Health Technology RAMP;D Project through the Korea Health Industry Development Institute	Funding for this work was provided by The Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea (HI14C3417), the Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea, and The Korea Health Technology R&D Project through the Korea Health Industry Development Institute (HI14C1549).	Capiralla H, 2012, FEBS J, V279, P3791, DOI 10.1111/j.1742-4658.2012.08739.x; Deng L, 2010, AM J PATHOL, V176, P952, DOI 10.2353/ajpath.2010.090622; Dignass A, 2012, J CROHNS COLITIS, V6, DOI [10.1016/j.crohns.2012.09.003, DOI 10.1016/J.CR0HNS.2012.09.003]; Eastaff-Leung N, 2010, J CLIN IMMUNOL, V30, P80, DOI 10.1007/s10875-009-9345-1; Galvez Julio, 2014, ISRN Inflamm, V2014, P928461, DOI 10.1155/2014/928461; Goodman WA, 2011, J IMMUNOL, V186, P3336, DOI 10.4049/jimmunol.1001455; Gu FM, 2011, MOL CANCER, P10; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Himmel ME, 2012, IMMUNOLOGY, V136, P115, DOI 10.1111/j.1365-2567.2012.03572.x; Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110; Isoda K, 2006, ARTERIOSCLER THROMB, V26; Izutani R, 1995, INFLAMM BOWEL DIS, V1; Jhun J, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/351856; Kitabayashi C, 2010, INT IMMUNOL, V22, P375, DOI 10.1093/intimm/dxq017; Koh SJ, 2014, J GASTROENTEROL HEPA, V29; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Marafini I, 2013, CURR DRUG TARGETS, V14, P1400, DOI 10.2174/13894501113149990157; Micic D, 2011, HORMONES ATHENS, V10; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Park CS, 2012, BIOCH PHARM, V84; Passerini L, 2008, INT IMMUNOL, V20, P421, DOI 10.1093/intimm/dxn002; Raza A, 2012, EXPERT REV CLIN IMMU, V8, P161, DOI [10.1586/ECI.11.96, 10.1586/eci.11.96]; REINECKER HC, 1993, CLIN EXP IMMUNOL, V94, P174; Rudensky AY, 2007, NAT IMMUNOL, V8; Sandborn WJ, LANCET, V369; Scaldaferri F, 2009, GASTROENTEROLOGY, V136; Selmi C, 2011, AUTOIMMUN REV, V10, P725, DOI 10.1016/j.autrev.2011.06.004; Shaw RJ, 2009, NAT REV CANC, V9; Son HJ, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/973986; van Heel DA, 2002, HUM MOL GENET, V11, P1281, DOI 10.1093/hmg/11.11.1281; Wruck CJ, ANN RHEUM DIS, V70; Yang EJ, 2014, PLOS ONE, V9; Yang XO, 2007, J BIOL CHEM, V282; Yu H, 2009, NAT REV CANC, V9; Zhou J, 2007, P NATL ACAD SCI US, V104; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	36	76	86	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0135858	10.1371/journal.pone.0135858	http://dx.doi.org/10.1371/journal.pone.0135858			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360050	gold, Green Submitted, Green Published			2022-12-26	WOS:000361043100005
J	Pallister, KB; Mason, S; Nygaard, TK; Liu, B; Griffith, S; Jones, J; Linderman, S; Hughes, M; Erickson, D; Voyich, JM; Davis, MF; Wilson, E				Pallister, Kyler B.; Mason, Sara; Nygaard, Tyler K.; Liu, Bin; Griffith, Shannon; Jones, Jennifer; Linderman, Susanne; Hughes, Melissa; Erickson, David; Voyich, Jovanka M.; Davis, Mary F.; Wilson, Eric			Bovine CCL28 Mediates Chemotaxis via CCR10 and Demonstrates Direct Antimicrobial Activity against Mastitis Causing Bacteria	PLOS ONE			English	Article							ANTIBODY-SECRETING CELLS; MAMMARY-GLAND; CHEMOKINE RECEPTORS; MUCOSAL TISSUES; CXC CHEMOKINES; CUTTING EDGE; IDENTIFICATION; ACCUMULATION; INVOLVEMENT; EXPRESSION	In addition to the well characterized function of chemokines in mediating the homing and accumulation of leukocytes to tissues, some chemokines also exhibit potent antimicrobial activity. Little is known of the potential role of chemokines in bovine mammary gland health and disease. The chemokine CCL28 has previously been shown to play a key role in the homing and accumulation of IgA antibody secreting cells to the lactating murine mammary gland. CCL28 has also been shown to act as an antimicrobial peptide with activity demonstrated against a wide range of pathogens including bacteria, fungi and protozoans. Here we describe the cloning and function of bovine CCL28 and document the concentration of this chemokine in bovine milk. Bovine CCL28 was shown to mediate cellular chemotaxis via the CCR10 chemokine receptor and exhibited antimicrobial activity against a variety of bovine mastitis causing organisms. The concentration of bovine CCL28 in milk was found to be highly correlated with the lactation cycle. Highest concentrations of CCL28 were observed soon after parturition, with levels decreasing over time. These results suggest a potential role for CCL28 in the prevention/resolution of bovine mastitis.	[Pallister, Kyler B.; Nygaard, Tyler K.; Griffith, Shannon; Jones, Jennifer; Voyich, Jovanka M.] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA; [Mason, Sara; Liu, Bin; Linderman, Susanne; Hughes, Melissa; Erickson, David; Davis, Mary F.; Wilson, Eric] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA	Montana State University System; Montana State University Bozeman; Brigham Young University	Wilson, E (corresponding author), Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA.	ericwilson@byu.edu		Erickson, David/0000-0001-6149-273X; Nygaard, Tyler/0000-0002-4736-0156; Mason, Sara/0000-0002-0684-2714; Linderman, Susanne/0000-0003-3297-3774	United States Department of Agriculture [2008-35204-04623]; National Center for Research Resources [NIH-RR020185]; National Institute of Allergy And Infectious Diseases [2R15AI072769-02A1]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI072769] Funding Source: NIH RePORTER	United States Department of Agriculture(United States Department of Agriculture (USDA)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Allergy And Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by the United States Department of Agriculture grant number 2008-35204-04623 to JMV; the National Center for Research Resources grant NIH-RR020185 to JMV; and the National Institute of Allergy And Infectious Diseases grant number 2R15AI072769-02A1 to EW.	Berri M, 2008, MOL IMMUNOL, V45, P271, DOI 10.1016/j.molimm.2007.04.026; Berri M, 2014, DEV COMP IMMUNOL, V44, P286, DOI 10.1016/j.dci.2014.01.005; Bourges D, 2004, SCAND J IMMUNOL, V60, P338, DOI 10.1111/j.0300-9475.2004.01479.x; Bourges D, 2008, MOL IMMUNOL, V45, P3354, DOI 10.1016/j.molimm.2008.04.017; Bradley AJ, 2002, VET J, V164, P116, DOI 10.1053/tvjl.2002.0724; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Distelhorst K, 2010, VET IMMUNOL IMMUNOP, V138, P134, DOI 10.1016/j.vetimm.2010.07.008; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Hieshima K, 2004, J IMMUNOL, V173, P3668, DOI 10.4049/jimmunol.173.6.3668; Hieshima K, 2003, J IMMUNOL, V170, P1452, DOI 10.4049/jimmunol.170.3.1452; Hu SM, 2011, P NATL ACAD SCI USA, V108, pE1035, DOI 10.1073/pnas.1100156108; Karlsson C, 2013, BLOOD, V121, P3838, DOI 10.1182/blood-2013-02-481192; Kerr DE, 2003, J ANIM SCI, V81, P38; Kotarsky K, 2010, MUCOSAL IMMUNOL, V3, P40, DOI 10.1038/mi.2009.115; Krijgsveld J, 2000, J BIOL CHEM, V275, P20374, DOI 10.1074/jbc.275.27.20374; Lazarus NH, 2003, J IMMUNOL, V170, P3799, DOI 10.4049/jimmunol.170.7.3799; Liu B, 2010, EUR J IMMUNOL, V40, P186, DOI 10.1002/eji.200939819; Morteau O, 2008, J IMMUNOL, V181, P6309, DOI 10.4049/jimmunol.181.9.6309; Ott TR, 2004, BIOCHEMISTRY-US, V43, P3670, DOI 10.1021/bi035895h; Pan JL, 2000, J IMMUNOL, V165, P2943, DOI 10.4049/jimmunol.165.6.2943; Prado GN, 2007, BIOCHEMISTRY-US, V46, P8961, DOI 10.1021/bi7004043; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Wang W, 2000, J BIOL CHEM, V275, P22313, DOI 10.1074/jbc.M001461200; Warnock RA, 2000, J EXP MED, V191, P77, DOI 10.1084/jem.191.1.77; Watkins HR, 2007, J PERIODONTOL, V78, P2356, DOI 10.1902/jop.2007.060504; Widdison S, 2011, ANIM GENET, V42, P341, DOI 10.1111/j.1365-2052.2011.02200.x; Widdison S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-439; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	32	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0138084	10.1371/journal.pone.0138084	http://dx.doi.org/10.1371/journal.pone.0138084			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359669	Green Published, gold, Green Submitted			2022-12-26	WOS:000361043100111
J	Zhang, Y; Liang, Q; Gao, RT; Hou, HB; Tan, WB; He, XS; Zhang, H; Yu, MD; Ma, LN; Xi, BD; Wang, XW				Zhang, Yuan; Liang, Qiong; Gao, Rutai; Hou, Haobo; Tan, Wenbing; He, Xiaosong; Zhang, Hui; Yu, Minda; Ma, Lina; Xi, Beidou; Wang, Xiaowei			Contamination of Phthalate Esters (PAEs) in Typical Wastewater-Irrigated Agricultural Soils in Hebei, North China	PLOS ONE			English	Article							SOLID-PHASE EXTRACTION; ORGANIC-CARBON; YELLOW-RIVER; FATE; RESIDUES; SAMPLES; AREAS	The Wangyang River (WYR) basin is a typical wastewater irrigation area in Hebei Province, North China. This study investigated the concentration and distribution of six priority phthalate esters (PAEs) in the agricultural soils in this area. Thirty-nine soil samples (0-20 cm) were collected along the WYR to assess the PAE residues in soils. Results showed that PAEs are ubiquitous environmental contaminants in the topsoil obtained from the irrigation area. The concentrations of Sigma(6)PAEs range from 0.191 mu g g(-1) dw to 0.457 mu g g(-1) dw with an average value of 0.294 mu g g(-1) dw. Di(2-ethylhexyl) phthalate (DEHP) and di-n-butyl phthalate (DnBP) are the dominant PAE species in the agricultural soils. Among the DEHP concentrations, the highest DEHP concentration was found at the sites close to the villages; this result suggested that dense anthropogenic activities and random garbage disposal in the rural area are possible sources of PAEs. The PAE concentrations were weakly and positively correlated with soil organic carbon and soil enzyme activities; thus, these factors can affect the distribution of PAEs. This study further showed that only dimethyl phthalate (DMP) concentrations exceeded the recommended allowable concentrations; no remediation measures are necessary to control the PAEs in the WYR area. However, the PAEs in the topsoil may pose a potential risk to the ecosystem and human health in this area. Therefore, the exacerbating PAE pollution should be addressed.	[Zhang, Yuan; Hou, Haobo] Wuhan Univ, Sch Resource & Environm Sci, Wuhan 430079, Peoples R China; [Liang, Qiong] Beijing Agr Univ, Coll Plant Sci & Technol, Beijing Key Lab New Tech Agr Applicat, Beijing 102206, Peoples R China; [Gao, Rutai; Tan, Wenbing; He, Xiaosong; Zhang, Hui; Yu, Minda; Ma, Lina; Xi, Beidou; Wang, Xiaowei] Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing 100012, Peoples R China	Wuhan University; Beijing University of Agriculture; Chinese Research Academy of Environmental Sciences	Xi, BD (corresponding author), Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing 100012, Peoples R China.	xibeidou@263.net	Wang, Xiaowei/AAJ-6512-2020		Major Science and Technology Program for Water Pollution Control and Treatment of China [2012ZX07203-003]; National Natural Science Funds [51325804]; Dabeinong Young Teachers Scientific Research Funds of Beijing University of Agriculture [14ZK001]; Free Exploration Foundation of State Key Laboratory of Environmental Criteria and Risk Assessment, Chinese Research Academy of Environmental Sciences [2014-GOT-019-N-26]	Major Science and Technology Program for Water Pollution Control and Treatment of China; National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Dabeinong Young Teachers Scientific Research Funds of Beijing University of Agriculture; Free Exploration Foundation of State Key Laboratory of Environmental Criteria and Risk Assessment, Chinese Research Academy of Environmental Sciences	This work was supported by the Major Science and Technology Program for Water Pollution Control and Treatment (No. 2012ZX07203-003) of China, National Natural Science Funds for Distinguished Young Scholar (No. 51325804), Dabeinong Young Teachers Scientific Research Funds of Beijing University of Agriculture (No. 14ZK001), and Free Exploration Foundation of State Key Laboratory of Environmental Criteria and Risk Assessment, Chinese Research Academy of Environmental Sciences (No. 2014-GOT-019-N-26).	[Anonymous], 1994, 4046 TAGM DEP ENV CO; Bandick AK, 1999, SOIL BIOL BIOCHEM, V31, P1471, DOI 10.1016/S0038-0717(99)00051-6; Cai QY, 2008, SCI TOTAL ENVIRON, V389, P209, DOI 10.1016/j.scitotenv.2007.08.026; Chai C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095701; Chen HQ, 2009, SOIL TILL RES, V106, P85, DOI 10.1016/j.still.2009.09.009; Chen Y, 2005, ENVIRON INT, V31, P778, DOI 10.1016/j.envint.2005.05.024; Chi J, 2009, CHEMOSPHERE, V77, P48, DOI 10.1016/j.chemosphere.2009.05.043; China National Environmental Protection Agency, 2008, ENV QUAL STAND SOILS; Dannenmann M, 2009, SOIL BIOL BIOCHEM, V41, P1622, DOI 10.1016/j.soilbio.2009.04.024; Fatoki OS, 2002, WATER AIR SOIL POLL, V140, P85, DOI 10.1023/A:1020134707450; Gao DW, 2014, CHEMOSPHERE, V95, P24, DOI 10.1016/j.chemosphere.2013.08.009; He W, 2013, SCI TOTAL ENVIRON, V461, P672, DOI [10.1016/j.scitotenv2013.05.049, 10.1016/j.scitotenv.2013.05.049]; Hu Xiongxing, 2007, ENV SCI MANAGEMENT, V32, P37; Jiang YH, 2014, CHEMOSPHERE, V112, P267, DOI 10.1016/j.chemosphere.2014.04.075; Joergensen RG, 1996, SOIL BIOL BIOCHEM, V28, P25, DOI 10.1016/0038-0717(95)00102-6; Kong SF, 2012, ENVIRON POLLUT, V170, P161, DOI 10.1016/j.envpol.2012.06.017; Liang Q, 2014, AGR WATER MANAGE, V135, P100, DOI 10.1016/j.agwat.2014.01.003; Mackintosh CE, 2006, ENVIRON SCI TECHNOL, V40, P3481, DOI 10.1021/es0519637; Mapanda F, 2005, AGR ECOSYST ENVIRON, V107, P151, DOI 10.1016/j.agee.2004.11.005; Meng XZ, 2014, SCI TOTAL ENVIRON, V476, P242, DOI 10.1016/j.scitotenv.2014.01.007; Niu LL, 2014, ENVIRON POLLUT, V195, P16, DOI 10.1016/j.envpol.2014.08.014; Penalver A, 2000, J CHROMATOGR A, V872, P191, DOI 10.1016/S0021-9673(99)01284-4; Schinner F., 1996, METHODS SOIL BIOL; Seth R, 1999, ENVIRON SCI TECHNOL, V33, P2390, DOI 10.1021/es980893j; Sha YJ, 2007, ENVIRON MONIT ASSESS, V124, P277, DOI 10.1007/s10661-006-9225-6; Staples CA, 1997, CHEMOSPHERE, V35, P667, DOI 10.1016/S0045-6535(97)00195-1; Tabatabai M. A., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P903; TAN GH, 1995, B ENVIRON CONTAM TOX, V54, P171, DOI 10.1007/BF00197427; Teil MJ, 2006, SCI TOTAL ENVIRON, V354, P212, DOI 10.1016/j.scitotenv.2004.12.083; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Vethaak AD, 2005, CHEMOSPHERE, V59, P511, DOI 10.1016/j.chemosphere.2004.12.053; Vieira FCB, 2007, SOIL TILL RES, V96, P195, DOI 10.1016/j.still.2007.06.007; Vitali M, 1997, ENVIRON INT, V23, P337, DOI 10.1016/S0160-4120(97)00035-4; Wang J, 2014, SCI TOTAL ENVIRON, V500, P113, DOI 10.1016/j.scitotenv.2014.08.092; Wang M, 2015, J SEP SCI, V38, P445, DOI 10.1002/jssc.201400991; Wang XL, 2013, ECOL ENG, V51, P10, DOI 10.1016/j.ecoleng.2012.12.079; Wang XJ, 2006, CHEMOSPHERE, V64, P1514, DOI 10.1016/j.chemosphere.2005.12.052; Xu N, 2007, CHEMOSPHERE, V69, P1419, DOI 10.1016/j.chemosphere.2007.04.070; Yang HJ, 2013, ENVIRON MONIT ASSESS, V185, P8489, DOI 10.1007/s10661-013-3190-7; Zeng F, 2008, ENVIRON POLLUT, V156, P425, DOI 10.1016/j.envpol.2008.01.045; Zhang Y, 2015, SCI TOTAL ENVIRON, V506, P118, DOI 10.1016/j.scitotenv.2014.10.075; Zhou QH, 2005, SOIL BIOL BIOCHEM, V37, P1454, DOI 10.1016/j.soilbio.2005.01.003	42	34	49	8	158	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137998	10.1371/journal.pone.0137998	http://dx.doi.org/10.1371/journal.pone.0137998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360905	Green Published, Green Submitted, gold			2022-12-26	WOS:000361043100106
J	D'Souza, K; Epureanu, BI; Pascual, M				D'Souza, Kiran; Epureanu, Bogdan I.; Pascual, Mercedes			Forecasting Bifurcations from Large Perturbation Recoveries in Feedback Ecosystems	PLOS ONE			English	Article							EARLY-WARNING SIGNALS; LEADING INDICATOR; ECOLOGY; SYSTEMS; SHIFTS; TIME	Forecasting bifurcations such as critical transitions is an active research area of relevance to the management and preservation of ecological systems. In particular, anticipating the distance to critical transitions remains a challenge, together with predicting the state of the system after these transitions are breached. In this work, a new model-less method is presented that addresses both these issues based on monitoring recoveries from large perturbations. The approach uses data from recoveries of the system from at least two separate parameter values before the critical point, to predict both the bifurcation and the post-bifurcation dynamics. The proposed method is demonstrated, and its performance evaluated under different levels of measurement noise, with two ecological models that have been used extensively in previous studies of tipping points and alternative steady states. The first one considers the dynamics of vegetation under grazing; the second, those of macrophyte and phytoplankton in shallow lakes. Applications of the method to more complex situations are discussed together with the kinds of empirical data needed for its implementation.	[D'Souza, Kiran] Ohio State Univ, Mech & Aerosp Engn Dept, Columbus, OH 43210 USA; [Epureanu, Bogdan I.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Pascual, Mercedes] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Pascual, Mercedes] Santa Fe Inst, Santa Fe, NM 87501 USA	University System of Ohio; Ohio State University; University of Michigan System; University of Michigan; University of Chicago; The Santa Fe Institute	D'Souza, K (corresponding author), Ohio State Univ, Mech & Aerosp Engn Dept, Columbus, OH 43210 USA.	dsouza.60@osu.edu	D'Souza, Kiran Xavier/J-6120-2014	D'Souza, Kiran Xavier/0000-0002-1144-2432	National Science Foundation [1334908]; Div Of Civil, Mechanical, & Manufact Inn [1334908] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by National Science Foundation, grant #1334908, http://www.nsf.gov/; BIE, KD, MP received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguas R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001767; Berglund N., 2002, STOCH DYNAM, V2, P327, DOI DOI 10.1142/S0219493702000455; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Boettiger C, 2012, J R SOC INTERFACE, V9, P2527, DOI 10.1098/rsif.2012.0125; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Chung KW, 2009, J SOUND VIB, V320, P163, DOI 10.1016/j.jsv.2008.07.019; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2010, THEOR ECOL-NETH, V3, P163, DOI 10.1007/s12080-009-0060-6; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; Gamarra JGP, 2000, ECOL LETT, V3, P114; Golomb D, 2001, PHYS REV LETT, V86, P4179, DOI 10.1103/PhysRevLett.86.4179; Grillo S, 2008, 2008 PROCEEDINGS OF THE 43RD INTERNATIONAL UNIVERSITIES POWER ENGINEERING CONFERENCE, VOLS 1-3, P356; Held H, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020972; Horsthemke W., 1984, NOISE INDUCED TRANSI; Kuehn C, 2011, PHYSICA D, V240, P1020, DOI 10.1016/j.physd.2011.02.012; Lade SJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002360; Lee E, 2011, J MATH ANAL APPL, V381, P732, DOI 10.1016/j.jmaa.2011.03.048; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Lim J, 2012, NONLINEAR DYNAM, V67, P2291, DOI 10.1007/s11071-011-0146-8; Lim J, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016203; Litt B, 2001, NEURON, V30, P51, DOI 10.1016/S0896-6273(01)00262-8; Livina VN, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028672; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; NOYMEIR I, 1975, J ECOL, V63, P459, DOI 10.2307/2258730; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 1998, POPULATION COMMUNITY, V22, P1; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Strogatz S. H., 2001, NONLINEAR DYNAMICS C; Van Geest GJ, 2007, ECOSYSTEMS, V10, P36, DOI 10.1007/s10021-006-9000-0; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; van Nes EH, 2002, AQUAT BOT, V72, P275, DOI 10.1016/S0304-3770(01)00206-6; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; Yang HL, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.154101; Zeng CH, 2012, ECOL MODEL, V233, P52, DOI 10.1016/j.ecolmodel.2012.03.025	37	23	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137779	10.1371/journal.pone.0137779	http://dx.doi.org/10.1371/journal.pone.0137779			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356503	gold, Green Published, Green Submitted			2022-12-26	WOS:000360965800081
J	Ho, CT; Chang, YJ; Yang, LX; Wei, PL; Liu, TZ; Liu, JJ				Ho, Chun-Te; Chang, Yu-Jia; Yang, Li-Xi; Wei, Po-Li; Liu, Tsan-Zon; Liu, Jun-Jen			A Novel Microtubule-Disrupting Agent Induces Endoplasmic Reticular Stress-Mediated Cell Death in Human Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							BIOLOGICAL EVALUATION; COLCHICINE; APOPTOSIS; MECHANISMS; INHIBITION; THIOCOLCHICINE; DERIVATIVES; PACLITAXEL; BINDING; PROTEIN	Here, we present evidence of a novel microtubule-disrupting agent, N-deacetyl-N-(chromone-2-carbonyl)-thiocolchicine (TCD), exhibiting potent antitumor activity (with IC50 values in the nanomolar range) against hepatocellular carcinoma cell lines. Cell cycle analysis revealed that TCD induced G2/M cell-cycle arrest in a dose-and time-dependent manner in both Hep-J5 and Mahlavu HCC cell lines. TCD also induced a decrease in mitochondrial membrane potential (Delta psi m) and caused DNA damage. Mechanistically, TCD activated protein kinase RNA-like endoplasmic reticular kinase and several transcription factors, including activating transcription factor (ATF) 6, ATF4, ATF3, and the CCAAT-enhancer binding protein homologous protein. These data clearly demonstrate that the antitumor activity of TCD is mechanistically linked to its capacity to trigger both intrinsic and extrinsic apoptotic cell death via endoplasmic reticular stress pathway. The potent antitumor activity of TCD was similarly demonstrated in a hepatocellular carcinoma xenograft model, where 5 and 10 mg/kg doses of TCD significantly arrested Hep-J5 and Mahlavu tumor growth. Our finding suggests that TCD is a promising therapeutic agent against hepatocellular carcinoma; further translational assessment of its clinical usage is warranted.	[Ho, Chun-Te; Liu, Jun-Jen] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Ho, Chun-Te; Liu, Jun-Jen] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan; [Chang, Yu-Jia; Wei, Po-Li; Liu, Tsan-Zon] Taipei Med Univ & Hosp, Ctr Canc, Translat Res Lab, Taipei, Taiwan; [Chang, Yu-Jia; Wei, Po-Li] Taipei Med Univ & Hosp, Dept Surg, Taipei, Taiwan; [Yang, Li-Xi] Calif Pacific Med Ctr, Res Inst, Radiobiol Lab, San Francisco, CA USA; [Yang, Li-Xi] St Marys Hosp, San Francisco, CA USA	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; California Pacific Medical Center; California Pacific Medical Center Research Institute	Liu, JJ (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.	jjliu_96@tmu.edu.tw	Liu, Jun-Jen/AAP-1788-2021	Chang, Yu-Jia/0000-0003-3978-3244	National Science Council [NSC 98-2320-B-038-008-MY3]; Ministry of Health and Welfare [DOH102-TD-N-111-006, MOHW103-TDU-N-211-133003]	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	JJL received the funding for this work from a National Science Council grant (NSC 98-2320-B-038-008-MY3); URL: http://statistics.most.gov.tw/was2/award/AsAwardMultiQuery.aspx?year=98&code=QS01&organ=&name=%E5%8A%89%E4%BF%8A%E4%BB%81; and a Ministry of Health and Welfare grant (DOH102-TD-N-111-006, MOHW103-TDU-N-211-133003); URL: https://rdsys.tmu.edu.tw/applyadmin/myview.aspx?hea=jjliu_96. The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the article.	BROSSI A, 1990, J MED CHEM, V33, P2311, DOI 10.1021/jm00171a001; Chen CY, 2007, J AGR FOOD CHEM, V55, P948, DOI 10.1021/jf0624594; Craig DH, 2008, J CLIN INVEST, V118, P3170, DOI 10.1172/JCI34279; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Gangjee A, 2007, J MED CHEM, V50, P3290, DOI 10.1021/jm070194u; Gotoh T, 2004, CELL DEATH DIFFER, V11, P390, DOI 10.1038/sj.cdd.4401369; GRIMM J, 1976, EUR J BIOCHEM, V64, P249, DOI 10.1111/j.1432-1033.1976.tb10294.x; Guan J, 1998, BIOORGAN MED CHEM, V6, P2127, DOI 10.1016/S0968-0896(98)00165-5; Hamed EA, 2010, J PEDIAT HEMATOL ONC, V32, P267, DOI 10.1097/MPH.0b013e3181d419d6; HASTIE SB, 1991, PHARMACOL THERAPEUT, V51, P377, DOI 10.1016/0163-7258(91)90067-V; Heald R, 2002, J CELL SCI, V115, P3; HSU ML, 1995, CANCER LETT, V94, P41, DOI 10.1016/0304-3835(95)03820-M; Huang YH, 2013, CANCER RES, V73, P2505, DOI 10.1158/0008-5472.CAN-12-2218; Huang YH, 2012, PLOS ONE, V5; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Joyce Margaret, 2009, Oncology (Williston Park), V23, P25; Karantanis E, 1994, Eur J Surg Oncol, V20, P653; Kim Sung-Kuk, 2013, Exp Mol Med, V45, pe19, DOI 10.1038/emm.2013.38; Knockaert L, 2011, FEBS J, V278, P4252, DOI 10.1111/j.1742-4658.2011.08357.x; Latiff ZA, 2010, J PEDIAT HEMATOL ONC, V32, P407, DOI 10.1097/MPH.0b013e3181e01584; Lee SH, 2005, ARCH PHARM, V338, P582, DOI 10.1002/ardp.200500148; Lim YS, 2014, GASTROENTEROLOGY, V147, P152, DOI 10.1053/j.gastro.2014.02.033; Lin ZY, 2013, LIFE SCI, V93, P323, DOI 10.1016/j.lfs.2013.07.002; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; Mane JY, 2008, J CHEM INF MODEL, V48, P1824, DOI 10.1021/ci800054n; Marzo I, 2013, BIOCHEM PHARMACOL, V86, P703, DOI 10.1016/j.bcp.2013.07.010; Nakajima Y, 2013, INT J MOL SCI, V14, P7771, DOI 10.3390/ijms14047771; Nicholson DW, 2000, NATURE, V407, P810, DOI 10.1038/35037747; Nimeiri HS, 2010, INVEST NEW DRUG, V28, P854, DOI 10.1007/s10637-009-9297-6; Oh JM, 2010, LIFE SCI, V87, P286, DOI 10.1016/j.lfs.2010.07.002; Okano JI, 2007, ONCOL REP, V17, P1195; Park EC, 2014, GASTROENTEROLOGY, V147, P860, DOI 10.1053/j.gastro.2014.06.039; Park MA, 2008, CANCER BIOL THER, V7, P1648, DOI 10.4161/cbt.7.10.6623; Park SH, 2010, EMBO REP, V11, P515, DOI 10.1038/embor.2010.92; Parker AL, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00153; Passarella D, 2008, BIOORGAN MED CHEM, V16, P6269, DOI 10.1016/j.bmc.2008.04.025; Patil MA, 2005, ONCOGENE, V24, P3737, DOI 10.1038/sj.onc.1208479; Perez EA, 2009, MOL CANCER THER, V8, P2086, DOI 10.1158/1535-7163.MCT-09-0366; Prota AE, 2014, P NATL ACAD SCI USA, V111, P13817, DOI 10.1073/pnas.1408124111; ROWINSKY EK, 1988, CANCER RES, V48, P4093; Saha MN, 2014, BRIT J CANCER, V110, P2224, DOI 10.1038/bjc.2014.164; Samarakoon R, 2009, CELL SIGNAL, V21, P986, DOI 10.1016/j.cellsig.2009.02.007; Sha SK, 2007, MOL CANCER THER, V6, P147, DOI 10.1158/1535-7163.MCT-06-0371; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Spratt JS, 1996, J SURG ONCOL, V61, P68, DOI 10.1002/1096-9098(199601)61:1<68::AID-JSO2930610102>3.0.CO;2-E; Tabrizian P, 2014, WORLD J GASTROENTERO, V20, P10223, DOI 10.3748/wjg.v20.i30.10223; Tozer GM, 2002, INT J EXP PATHOL, V83, P21, DOI 10.1046/j.1365-2613.2002.00211.x; Tung CY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-26; Uchida T, 1996, INT J CANCER, V67, P892	50	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0136340	10.1371/journal.pone.0136340	http://dx.doi.org/10.1371/journal.pone.0136340			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355599	Green Published, gold, Green Submitted			2022-12-26	WOS:000360965800012
J	Mall, R; Langone, R; Suykens, JAK				Mall, Raghvendra; Langone, Rocco; Suykens, Johan A. K.			Netgram: Visualizing Communities in Evolving Networks	PLOS ONE			English	Article								Real-world complex networks are dynamic in nature and change over time. The change is usually observed in the interactions within the network over time. Complex networks exhibit community like structures. A key feature of the dynamics of complex networks is the evolution of communities over time. Several methods have been proposed to detect and track the evolution of these groups over time. However, there is no generic tool which visualizes all the aspects of group evolution in dynamic networks including birth, death, splitting, merging, expansion, shrinkage and continuation of groups. In this paper, we propose Netgram: a tool for visualizing evolution of communities in time-evolving graphs. Netgram maintains evolution of communities over 2 consecutive time-stamps in tables which are used to create a query database using the sql outer-join operation. It uses a line-based visualization technique which adheres to certain design principles and aesthetic guidelines. Netgram uses a greedy solution to order the initial community information provided by the evolutionary clustering technique such that we have fewer line cross-overs in the visualization. This makes it easier to track the progress of individual communities in time evolving graphs. Netgram is a generic toolkit which can be used with any evolutionary community detection algorithm as illustrated in our experiments. We use Netgram for visualization of topic evolution in the NIPS conference over a period of 11 years and observe the emergence and merging of several disciplines in the field of information processing systems.	[Mall, Raghvendra; Langone, Rocco; Suykens, Johan A. K.] Katholieke Univ Leuven, ESAT STADIUS, B-3001 Leuven, Belgium	KU Leuven	Mall, R (corresponding author), Katholieke Univ Leuven, ESAT STADIUS, Kasteelpk Arenberg 10, B-3001 Leuven, Belgium.	raghvendra.mall@esat.kuleuven.be	Suykens, Johan A.K./C-9781-2014; Mall, Raghvendra/I-9470-2019	Suykens, Johan A.K./0000-0002-8846-6352; Mall, Raghvendra/0000-0003-1779-3150; Langone, Rocco/0000-0002-7583-7003	EU: ERC AdG A-DATADRIVE-B [290923]; Research Council KUL [GOA/10/-/09 MaNet]; CoE [PFV/10/002, BIL12/11T]; Flemish Government; FWO [G.0377.12, G.088114N]; IWT [100031]; iMinds Medical Information Technologies SBO Belgian Federal Science Policy Office [IUAP P7/19]; ERC (European Research Council); KU Leuven; BELSPO	EU: ERC AdG A-DATADRIVE-B; Research Council KUL(KU Leuven); CoE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Flemish Government(European Commission); FWO(FWO); IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); iMinds Medical Information Technologies SBO Belgian Federal Science Policy Office; ERC (European Research Council)(European Research Council (ERC)); KU Leuven(KU Leuven); BELSPO(Belgian Federal Science Policy Office)	This work was supported by EU: ERC AdG A-DATADRIVE-B (290923), Research Council KUL: GOA/10/-/09 MaNet, CoE PFV/10/002 (OPTEC), BIL12/11T; PhD/Postdoc grants-Flemish Government; FWO: projects: G.0377.12 (Structured systems), G.088114N (Tensor based data similarity); PhD/Postdoc grants; IWT: projects: SBO POM (100031); PhD/Postdoc grants; iMinds Medical Information Technologies SBO 2014-Belgian Federal Science Policy Office: IUAP P7/19 (DYSCO, Dynamical systems, control and optimization, 2012-2017). Johan Suykens received the funding. ERC (European Research Council): http://erc.europa.eu/. FWO (Fonds Wetenschappelijk Onderzoek): http://www.fwo.be/en/. KU Leuven: http://www.kuleuven.be/English. BELSPO (Belgian Federal Science Policy): https://www.belspo.be/belspo/index_en.stm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzate C, 2010, IEEE T PATTERN ANAL, V32, P335, DOI 10.1109/TPAMI.2008.292; [Anonymous], 2006, P 12 ACM SIGKDD INT, DOI DOI 10.1145/1150402.1150467; Bache Kevin, 2013, UCI MACHINE LEARNING; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Chi Y, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P153; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Crandall David, 2008, P 14 ACM SIGKDD INT, P160, DOI DOI 10.1145/1401890.1401914; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Greene D, 2010, P INT C ADV SOC NETW; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X, DOI 10.1371/journal.pbio.1001889]; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Lamirel JC, 2011, PAKDD WORKSH, P209; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056117; Langone R, 2014, 2014 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE AND DATA MINING (CIDM), P1, DOI 10.1109/CIDM.2014.7008141; Langone R, 2013, PHYSICA A, V392, P2588, DOI 10.1016/j.physa.2013.01.058; Lin YR, 2009, ACM T KNOWL DISCOV D, V3, DOI 10.1145/1514888.1514891; Mall Raghvendra, 2013, 2013 IEEE International Conference on Big Data, P385, DOI 10.1109/BigData.2013.6691599; Mall Raghvendra, 2013, Advances in Knowledge Discovery and Data Mining. 17th Pacific-Asia Conference, PAKDD 2013. Proceedings, P161, DOI 10.1007/978-3-642-37453-1_14; Mall R, 2014, 2014 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE AND DATA MINING (CIDM), P9, DOI 10.1109/CIDM.2014.7008142; Mall R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099966; Mall R, 2013, ENTROPY-SWITZ, V15, P1567, DOI 10.3390/e15051567; Mucha PJ, 2010, SCIENCE, V328, P876, DOI 10.1126/science.1184819; MURTAGH F, 1984, DISCRETE APPL MATH, V7, P191, DOI 10.1016/0166-218X(84)90066-0; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Pratt PJ, 2005, A GUIDE TO SQL; Robertson S, 2004, J DOC, V60, P503, DOI 10.1108/00220410410560582; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rosvall M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008694; Selcuk A. A., 2008, J NETWORK SECURITY, V6, P227; Sun JM, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P687; Tanahashi Y, 2015, IEEE T VIS COMPUT GR, V21, P730, DOI 10.1109/TVCG.2015.2392771; Tanahashi Y, 2012, IEEE T VIS COMPUT GR, V18, P2679, DOI 10.1109/TVCG.2012.212; Wang Q, 2013, DYNAMICS COMPLEX NET, V2, P159, DOI DOI 10.1007/978-1-4614-6729-8_9; Xie JR, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2501654.2501657; Xu KS, 2014, DATA MIN KNOWL DISC, V28, P304, DOI 10.1007/s10618-012-0302-x; Yu Clement, 1998, PRINCIPLES DATABASE	40	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137502	10.1371/journal.pone.0137502	http://dx.doi.org/10.1371/journal.pone.0137502			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356538	Green Published, gold, Green Submitted			2022-12-26	WOS:000360965800051
J	Moutardier, G; Gereva, S; Mills, SC; Adjeroud, M; Beldade, R; Ham, J; Kaku, R; Dumas, P				Moutardier, Gregoire; Gereva, Sompert; Mills, Suzanne C.; Adjeroud, Mehdi; Beldade, Ricardo; Ham, Jayven; Kaku, Rocky; Dumas, Pascal			Lime Juice and Vinegar Injections as a Cheap and Natural Alternative to Control COTS Outbreaks	PLOS ONE			English	Article							OF-THORNS STARFISH; GREAT-BARRIER-REEF; LYSOSOMAL MEMBRANE DAMAGE; RED RETENTION ASSAY; ACANTHASTER-PLANCI; CORAL-REEFS; SEA STAR; MYTILUS-GALLOPROVINCIALIS; POPULATION OUTBREAKS; EXTRACELLULAR PH	Outbreaks of the corallivorous crown-of-thorns seastar Acanthaster planci (COTS) represent one of the greatest disturbances to coral reef ecosystems in the Indo-Pacific, affecting not only coral reefs but also the coastal communities which rely on their resources. While injection approaches are increasingly used in an attempt to control COTS densities, most of them display severe drawbacks including logistical challenges, high residual environmental impacts or low cost-effectiveness. We tested a new alternative control method based upon acidic injections of cheap, 100% natural products. We investigated the lethal doses, intra- and inter-specific disease transmission and immune responses of COTS when injected with fresh lime juice (extracted from local Citrus arantifolia) and white spirit vinegar. High COTS mortality was achieved with small volumes: 10-20 ml per seastar induced death in 89%/97% of injected specimens after an average 34.3 h/29.8 h for lime juice and vinegar respectively. Highest efficiency was reached for both solutions with double shots of (2 x 10 ml) in two different areas on the body: 100% mortality occurred within 12-24 h, which is similar or faster compared with other current injection methods. Multiple immune measures suggested that death was very likely caused by pH stress from the acidic solutions rather than a bacterial infection. Contagion to either conspecifics or a variety of other reef species was not observed, even at COTS densities 15 times higher than the highest naturally reported. 10 to 20 I lime juice/vinegar could kill up to a thousand COTS at a cost of less than 0.05 USD per specimen; no permits or special handling procedures are required. We conclude that injections of lime juice and vinegar offer great advantages when compared to current best practises and constitute a cheap and natural option for all reefs affected by COTS.	[Moutardier, Gregoire; Dumas, Pascal] IRD, UMR ENTROPIE 9220, Noumea, New Caledonia; [Moutardier, Gregoire; Gereva, Sompert; Ham, Jayven; Kaku, Rocky; Dumas, Pascal] Fisheries Dept Vanuatu, Port Vila, Vanuatu; [Mills, Suzanne C.; Adjeroud, Mehdi; Beldade, Ricardo; Dumas, Pascal] Lab Excellence Corail, F-66860 Perpignan, France; [Mills, Suzanne C.; Beldade, Ricardo] UPVD, CRIOBE, USR 3278, CNRS,EPHE, F-66860 Perpignan, France; [Beldade, Ricardo] Univ Lisbon, Fac Ciencias, MARE Marine & Environm Sci Ctr, P-1749016 Lisbon, Portugal; [Adjeroud, Mehdi] Univ Perpignan, IRD, UMR ENTROPIE 9220, F-66860 Perpignan, France	Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universidade de Lisboa; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite Perpignan Via Domitia	Dumas, P (corresponding author), IRD, UMR ENTROPIE 9220, BP A5, Noumea, New Caledonia.	pascal-paul.dumas@ird.fr	Beldade, Ricardo/B-3724-2012; Mills, Suzanne/K-5538-2012; Adjeroud, Mehdi/J-6411-2016	Beldade, Ricardo/0000-0003-1911-0122; Mills, Suzanne/0000-0001-8948-3384; Adjeroud, Mehdi/0000-0002-6825-8759; Dumas, Pascal/0000-0001-7369-8989	Fisheries Department of Vanuatu [COT012]; Government of New Caledonia; LabEx Corail; Agence Nationale de la Recherche [ANR-11-JSV7-012-01]; Fundacao para a Ciencia e Tecnologia [SFRH/BPD/26901/2006]	Fisheries Department of Vanuatu; Government of New Caledonia; LabEx Corail; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This project was funded by grants from the Fisheries Department of Vanuatu (www.fisheries.gov.vu), grant #COT012. This was the main grant for this work, which covered fieldwork (Vanuatu) and functioning costs (hatchery and aquaculture facilities, technical staff, laboratory materials) of the study. Support was also provided by grants from the Government of New Caledonia (www.gouv.nc/portal/page/portal/gouv/), grant for project MANAO_2015, covered the hosting of Gregoire Moutardier at the Fisheries Department of Vanuatu during his MSc. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Support was also provided by grants from the LabEx Corail (www.labex-corail.fr/), grant for project DYNACANTH-2015, covered the field trip of Dr. Suzanne Mills in Vanuatu during the project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Support was also provided by grants from the Agence Nationale de la Recherche (ANR-11-JSV7-012-01 "Live and Let Die", Suzanne C. Mills) and the Fundacao para a Ciencia e Tecnologia (SFRH/BPD/26901/2006, Ricardo Beldade) provided additional support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 2009, CORAL REEFS, V28, P775, DOI 10.1007/s00338-009-0515-7; Antonova OA, 2009, BIOCHEMISTRY-MOSCOW+, V74, P605, DOI 10.1134/S0006297909060030; BAINTON DF, 1973, J CELL BIOL, V58, P249, DOI 10.1083/jcb.58.2.249; BARHAM EG, 1973, FISH B-NOAA, V71, P927; Bekri K, 2004, AQUAT TOXICOL, V66, P39, DOI 10.1016/j.aquatox.2003.07.001; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; BIRKELAND C, 1990, MAJOR MANAGEMENT PRO; Bos AR, 2013, OCEAN COAST MANAGE, V71, P116, DOI 10.1016/j.ocecoaman.2012.09.011; BRANHAM JM, 1971, SCIENCE, V172, P1155, DOI 10.1126/science.172.3988.1155; Brodie J, 2005, MAR POLLUT BULL, V51, P266, DOI 10.1016/j.marpolbul.2004.10.035; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; CAMERON AM, 1991, MAR ECOL PROG SER, V75, P251, DOI 10.3354/meps075251; Celliers Louis, 2006, Western Indian Ocean Journal of Marine Science, V5, P105; CHENEY D P, 1973, Micronesica, V9, P171; Chesher RH., 1969, ACANTHASTER PLANCI I; Ciacci C, 2009, COMP BIOCHEM PHYS B, V153, P365, DOI 10.1016/j.cbpb.2009.04.007; Coteur G, 2002, FISH SHELLFISH IMMUN, V12, P187, DOI 10.1006/fsim.2001.0366; De Dios Homer Hermes Y., 2015, Galaxea - Tokyo, V17, P23; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Dumas P, 2015, SPC FISHERIES NEWSLE, V146, P47; Dumas P, 2014, COMMUNITY BASED MANA; Fabricius KE, 2010, CORAL REEFS, V29, P593, DOI 10.1007/s00338-010-0628-z; Fraser N, 2000, BEST PRACTICES GUIDE; Friedman KJ, 2008, VANUATU COUNTRY REPO; GLYNN PW, 1984, B MAR SCI, V35, P54; Glynn PW., 1981, INT COR REEF S MAN P; Great Barrier Reef Marine Park Authority, 2004, CROWN OF THORNS STAR; Greenberg SS, 1989, IMMUNITY SURVIVAL; Hauton C, 1998, COMP BIOCHEM PHYS B, V119, P619, DOI 10.1016/S0305-0491(98)00036-4; Hoey J, 2004, STATE GREAT BARRIER; Johansson AC, 2010, APOPTOSIS, V15, P527, DOI 10.1007/s10495-009-0452-5; JOHNSON DB, 1990, CORAL REEFS, V9, P167, DOI 10.1007/BF00258231; Kanayama RK, 1970, ALOHA AINA DEP LAND, V1, P16; Kayal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047363; Kayal M, 2011, CORAL REEFS, V30, P827, DOI 10.1007/s00338-011-0763-1; KOBAYASHI TOSHIKAZU, 1963, JAPAN JOUR BACTERIOL, V18, P387; Koonjul MS, 2003, MAUR ANN M AGR SCI, P333; Kuroshio Biological Research Foundation, 2012, CROWN OF THORNS SEAS; Leray M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035456; LOWE DM, 1994, AQUAT TOXICOL, V30, P357, DOI 10.1016/0166-445X(94)00045-X; LOWE DM, 1992, MAR ECOL PROG SER, V91, P135, DOI 10.3354/meps091135; LOWE DM, 1995, AQUAT TOXICOL, V33, P105, DOI 10.1016/0166-445X(95)00015-V; Lowe DM, 1995, MAR ECOL PROG SER, V129, P189, DOI 10.3354/meps129189; MCCALL CE, 1969, J EXP MED, V129, P267, DOI 10.1084/jem.129.2.267; Mendonca VM, 2010, ZOOL STUD, V49, P108; Mills S, 2012, CORAL REEFS, V31, P603, DOI 10.1007/s00338-012-0883-2; Naviti W, 2000, REG S COR REEF PAC S; OHKUMA S, 1982, P NATL ACAD SCI-BIOL, V79, P2758, DOI 10.1073/pnas.79.9.2758; Ormond R.F.G., 1974, Proceedings int Coral Reef Symp, V2, P595; PEARSON RG, 1981, MAR ECOL PROG SER, V4, P105, DOI 10.3354/meps004105; Phillips RM, 2001, ANTICANCER RES, V21, P1795; Pratchett MS, 2014, OCEANOGR MAR BIOL, V52, P133; Pratchett MS, 1999, CORAL REEFS, V18, P272, DOI 10.1007/s003380050192; Rivera-Posada JA, 2011, DIS AQUAT ORGAN, V97, P85, DOI 10.3354/dao02401; Rivera-Posada J, 2013, MAR POLLUT BULL, V75, P133, DOI 10.1016/j.marpolbul.2013.07.053; Rivera-Posada J, 2012, J EXP MAR BIOL ECOL, V429, P1, DOI 10.1016/j.jembe.2012.06.008; ROMAN MR, 1993, LIMNOL OCEANOGR, V38, P1603, DOI 10.4319/lo.1993.38.8.1603; Sano M, 2000, MAR ECOL PROG SER, V198, P121, DOI 10.3354/meps198121; Schleyer M.H., 2003, Zoologische Verhandelingen (Leiden), V345, P387; Song L, 2007, J SHELLFISH RES, V26, P493, DOI 10.2983/0730-8000(2007)26[493:TAONRR]2.0.CO;2; SONG YL, 1994, DEV COMP IMMUNOL, V18, P201, DOI 10.1016/0145-305X(94)90012-4; Wang WN, 2009, COMP BIOCHEM PHYS C, V150, P428, DOI 10.1016/j.cbpc.2009.06.010; Wang WN, 2002, AQUAT TOXICOL, V60, P75, DOI 10.1016/S0166-445X(01)00271-5; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Yamamoto T., 2013, NATURALISTAE, V17, P63; Yanong RP, 2010, USE COPPER MARINE AQ; Zhou J, 2008, AQUACULTURE, V275, P356, DOI 10.1016/j.aquaculture.2007.12.005	67	12	13	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137605	10.1371/journal.pone.0137605	http://dx.doi.org/10.1371/journal.pone.0137605			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356840	Green Published, Green Submitted, gold			2022-12-26	WOS:000360965800069
J	Farnsworth, ML; Dickson, BG; Zachmann, LJ; Hegeman, EE; Cangelosi, AR; Jackson, TG; Scheib, AF				Farnsworth, Matthew L.; Dickson, Brett G.; Zachmann, Luke J.; Hegeman, Ericka E.; Cangelosi, Amanda R.; Jackson, Thomas G., Jr.; Scheib, Amanda F.			Short-Term Space-Use Patterns of Translocated Mojave Desert Tortoise in Southern California	PLOS ONE			English	Article							GOPHERUS-AGASSIZII; ENERGY DEVELOPMENT; HOME-RANGE; CONSERVATION; POPULATION; WILDLIFE; VARIABILITY; ECOSYSTEM; MOVEMENT; IMPACTS	Increasingly, renewable energy comprises a larger share of global energy production. Across the western United States, public lands are being developed to support renewable energy production. Where there are conflicts with threatened or endangered species, translocation can be used in an attempt to mitigate negative effects. For the threatened Mojave desert tortoise (Gopherus agassizii), we sought to compare habitat-and space-use patterns between short-distance translocated, resident, and control groups. We tested for differences in home range size based on utilization distributions and used linear mixed-effects models to compare space-use intensity, while controlling for demographic and environmental variables. In addition, we examined mean movement distances as well as home range overlap between years and for male and female tortoises in each study group. During the first active season post-translocation, home range size was greater and space-use intensity was lower for translocated tortoises than resident and control groups. These patterns were not present in the second season. In both years, there was no difference in home range size or space-use intensity between control and resident groups. Translocation typically resulted in one active season of questing followed by a second active season characterized by space-use patterns that were indistinguishable from control tortoises. Across both years, the number of times a tortoise was found in a burrow was positively related to greater space-use intensity. Minimizing the time required for translocated tortoises to exhibit patterns similar to non-translocated individuals may have strong implications for conservation by reducing exposure to adverse environmental conditions and predation. With ongoing development, our results can be used to guide future efforts aimed at understanding how translocation strategies influence patterns of animal space use.	[Farnsworth, Matthew L.; Dickson, Brett G.; Zachmann, Luke J.; Hegeman, Ericka E.; Cangelosi, Amanda R.] Conservat Sci Partners, Ft Collins, CO 80524 USA; [Jackson, Thomas G., Jr.] Kaweah Biol Consulting Inc, Three Rivers, CA USA; [Scheib, Amanda F.] Scheib Biol, Las Vegas, NV USA		Farnsworth, ML (corresponding author), Conservat Sci Partners, 5 Old Town Sq,Suite 205, Ft Collins, CO 80524 USA.	matt@csp-inc.org			NRG Energy Services; Google Inc.; BrightSource Energy	NRG Energy Services; Google Inc.(Google Incorporated); BrightSource Energy	Field data collection and analysis was funded by NRG Energy Services (www.nrg.com), Google Inc. (www.google.com), and BrightSource Energy (www.brightsourceenergy.com) through three limited liability companies: Solar Partners I, Solar Partners II, and Solar Partners VIII. The ISEGS is operated by NRG Energy Services. The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi SA, 2000, APPL ENERG, V65, P121, DOI 10.1016/S0306-2619(99)00077-X; Aiello CM, 2014, ANIM CONSERV, V17, P27, DOI 10.1111/acv.12147; Andersen MC, 2000, ECOL APPL, V10, P890, DOI 10.1890/1051-0761(2000)010[0890:RTMODT]2.0.CO;2; Anderson D. R., 2008, MODEL BASED INFERENC; Averill-Murray RC, 2012, BIOSCIENCE, V62, P893, DOI 10.1525/bio.2012.62.10.9; BAILEY SJ, 1995, J HERPETOL, V29, P361, DOI 10.2307/1564985; BERRY KH, 1986, HERPETOLOGICA, V42, P113; Beyer H. L, 2012, GEOSPATIAL MODELLING; Boarman William I., 1998, Herpetological Review, V29, P26; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Diggle PJ, 2002, ANAL LONGITUDINAL DA; Duda JJ, 1999, J WILDLIFE MANAGE, V63, P1181, DOI 10.2307/3802836; Esque Todd C., 2010, Endangered Species Research, V12, P167, DOI 10.3354/esr00298; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Field KJ, 2007, BIOL CONSERV, V136, P232, DOI 10.1016/j.biocon.2006.11.022; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Flather CH, 1998, BIOSCIENCE, V48, P365, DOI 10.2307/1313375; Franks Bryan R., 2011, Endangered Species Research, V13, P191, DOI 10.3354/esr00313; Freilich JE, 2000, CONSERV BIOL, V14, P1479, DOI 10.1046/j.1523-1739.2000.98360.x; Germano JM, 2015, FRONT ECOL ENVIRON, V13, P100, DOI 10.1890/140137; Grandmaison DD, 2010, J HERPETOL, V44, P581, DOI 10.1670/08-291.1; Hagerty BE, 2011, LANDSCAPE ECOL, V26, P267, DOI 10.1007/s10980-010-9550-6; Harless ML, 2009, COPEIA, P378, DOI 10.1643/CE-07-226; Hereford R, 2006, J ARID ENVIRON, V67, P13, DOI 10.1016/j.jaridenv.2006.09.019; Hinderle D, 2015, J WILDLIFE MANAGE, V79, P137, DOI 10.1002/jwmg.823; Horne JS, 2006, J WILDLIFE MANAGE, V70, P641, DOI 10.2193/0022-541X(2006)70[641:LCVLSC]2.0.CO;2; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jacobson MZ, 2009, ENERG ENVIRON SCI, V2, P148, DOI 10.1039/b809990c; JENNRICH RI, 1969, J THEOR BIOL, V22, P227, DOI 10.1016/0022-5193(69)90002-2; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Lovich JE, 1999, ENVIRON MANAGE, V24, P309, DOI 10.1007/s002679900235; Lovich JE, 2011, BIOSCIENCE, V61, P982, DOI 10.1525/bio.2011.61.12.8; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Miller KA, 2014, CONSERV BIOL, V28, P1045, DOI 10.1111/cobi.12254; Millspaugh JSJ, 2004, WILDLIFE SOC B, V32, P148, DOI 10.2193/0091-7648(2004)32[148:COTATT]2.0.CO;2; NAGY KA, 1986, HERPETOLOGICA, V42, P73; Northrup JM, 2013, ECOL LETT, V16, P112, DOI 10.1111/ele.12009; Nussear KE, 2012, J WILDLIFE MANAGE, V76, P1341, DOI 10.1002/jwmg.390; O'Connor Michael P., 1994, Herpetological Monographs, V8, P60, DOI 10.2307/1467070; PETERSON CC, 1994, BIOL CONSERV, V70, P101, DOI 10.1016/0006-3207(94)90277-1; Pinhiero J, 2014, LINEAR NONLINEAR MIX; REN21, 2013, REN GLOB FUT REP; REN21, 2014, REN 2014 GLOB STAT R; Riedle JD, 2008, COPEIA, P414, DOI 10.1643/CH-06-010; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; Willems EP, 2009, ECOLOGY, V90, P546, DOI 10.1890/08-0765.1; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Zimmerman Linda C., 1994, Herpetological Monographs, V0, P45, DOI 10.2307/1467069	49	15	15	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0134250	10.1371/journal.pone.0134250	http://dx.doi.org/10.1371/journal.pone.0134250			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352691	gold, Green Published, Green Submitted			2022-12-26	WOS:000360932800004
J	Maranhao, B; Biswas, P; Gottsch, ADH; Navani, M; Naeem, MA; Suk, J; Chu, J; Khan, SN; Poleman, R; Akram, J; Riazuddin, S; Lee, P; Riazuddin, SA; Hejtmancik, JF; Ayyagari, R				Maranhao, Bruno; Biswas, Pooja; Gottsch, Alexander D. H.; Navani, Mili; Naeem, Muhammad Asif; Suk, John; Chu, Justin; Khan, Sheen N.; Poleman, Rachel; Akram, Javed; Riazuddin, Sheikh; Lee, Pauline; Riazuddin, S. Amer; Hejtmancik, J. Fielding; Ayyagari, Radha			Investigating the Molecular Basis of Retinal Degeneration in a Familial Cohort of Pakistani Decent by Exome Sequencing	PLOS ONE			English	Article							GENOTYPE-PHENOTYPE CORRELATION; RETINITIS-PIGMENTOSA; CONGENITAL AMAUROSIS; MUTATIONS; DYSTROPHY; GENE; IDENTIFICATION; REVEALS; ALMS1	Purpose To define the molecular basis of retinal degeneration in consanguineous Pakistani pedigrees with early onset retinal degeneration. Methods A cohort of 277 individuals representing 26 pedigrees from the Punjab province of Pakistan was analyzed. Exomes were captured with commercial kits and sequenced on an Illumina HiSeq 2500. Candidate variants were identified using standard tools and analyzed using exomeSuite to detect all potentially pathogenic changes in genes implicated in retinal degeneration. Segregation analysis was performed by dideoxy sequencing and novel variants were additionally investigated for their presence in ethnicity-matched controls. Results We identified a total of nine causal mutations, including six novel variants in RPE65, LCA5, USH2A, CNGB1, FAM161A, CERKL and GUCY2D as the underlying cause of inherited retinal degenerations in 13 of 26 pedigrees. In addition to the causal variants, a total of 200 variants each observed in five or more unrelated pedigrees investigated in this study that were absent from the dbSNP, HapMap, 1000 Genomes, NHLBI ESP6500, and ExAC databases were identified, suggesting that they are common in, and unique to the Pakistani population. Conclusions We identified causal mutations associated with retinal degeneration in nearly half of the pedigrees investigated in this study through next generation whole exome sequencing. All novel variants detected in this study through exome sequencing have been cataloged providing a reference database of variants common in, and unique to the Pakistani population.	[Maranhao, Bruno; Biswas, Pooja; Navani, Mili; Suk, John; Chu, Justin; Poleman, Rachel; Lee, Pauline; Ayyagari, Radha] Univ Calif La Jolla, Dept Ophthalmol, La Jolla, CA USA; [Gottsch, Alexander D. H.; Riazuddin, S. Amer] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Naeem, Muhammad Asif; Khan, Sheen N.; Riazuddin, Sheikh; Riazuddin, S. Amer] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore, Pakistan; [Akram, Javed; Riazuddin, Sheikh] Univ Hlth Sci, Allama Iqbal Med Coll, Lahore, Pakistan; [Akram, Javed; Riazuddin, Sheikh] Shaheed Zulfiqar Ali Bhutto Med Univ, Natl Ctr Genet Dis, Islamabad, Pakistan; [Hejtmancik, J. Fielding] NEI, OGVF Branch, NIH, Bethesda, MD 20892 USA	University of California System; University of California San Diego; Johns Hopkins University; Johns Hopkins Medicine; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; University of Health Science - Pakistan; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Hejtmancik, JF (corresponding author), NEI, OGVF Branch, NIH, Bethesda, MD 20892 USA.	f3h@helix.nih.gov; rayyagari@ucsd.edu		Maranhao, Bruno/0000-0002-0224-5488; Naeem, Muhammad Asif/0000-0001-8547-6419	Foundation Fighting Blindness, Research to Prevent Blindness [NIH-EY21237, P30-EY22589]; NATIONAL EYE INSTITUTE [P30EY022589, R01EY021237, ZIAEY000272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER	Foundation Fighting Blindness, Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Foundation Fighting Blindness, Research to Prevent Blindness (to Department of Ophthalmology at UCSD, La Jolla, and Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD), NIH-EY21237, P30-EY22589.	Abu-Safieh L, 2013, GENOME RES, V23, P236, DOI 10.1101/gr.144105.112; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ali S, 2015, OPHTHALMOLOGY, V122, P429, DOI 10.1016/j.ophtha.2014.07.057; Ali S, 2011, MOL VIS, V17, P1373; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; [Anonymous], 2013, EX; Ayyagari R, 2005, INVEST OPHTH VIS SCI, V46, P3363, DOI 10.1167/iovs.05-0159; Bandah-Rozenfeld D, 2010, AM J HUM GENET, V87, P382, DOI 10.1016/j.ajhg.2010.07.022; Branham K, 2012, INVEST OPHTH VIS SCI, V53, P8232, DOI 10.1167/iovs.12-11025; BROWN MD, 1992, FASEB J, V6, P2791, DOI 10.1096/fasebj.6.10.1634041; Chassine T, 2015, BRIT J OPHTHALMOL, V99, P1360, DOI 10.1136/bjophthalmol-2014-306224; Chen YB, 2013, INVEST OPHTH VIS SCI, V54, P4351, DOI 10.1167/iovs.13-11606; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Daiger SP, 2013, CLIN GENET, V84, P132, DOI 10.1111/cge.12203; Di Gioia SA, 2012, HUM MOL GENET, V21, P5174, DOI 10.1093/hmg/dds368; Duncan JL, 2012, ARCH OPHTHALMOL-CHIC, V130, P1301, DOI 10.1001/archophthalmol.2012.1906; Farkas MH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-486; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fu Q, 2013, INVEST OPHTH VIS SCI, V54, P4158, DOI 10.1167/iovs.13-11672; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Hearn T, 2002, NAT GENET, V31, P79, DOI 10.1038/ng874; Huang XF, 2015, GENET MED, V17, P271, DOI 10.1038/gim.2014.138; Iqbal M, 2011, ARCH OPHTHALMOL-CHIC, V129, P1351, DOI 10.1001/archophthalmol.2011.267; Jinda W, 2014, INVEST OPHTH VIS SCI, V55, P2259, DOI 10.1167/iovs.13-13567; Kaul H, 2010, MOL VIS, V16, P511; Kaul H, 2010, MOL VIS, V16, P240; Khan MI, 2014, GENES-BASEL, V5, P176, DOI 10.3390/genes5010176; Khan Sadia Javed, 2007, J Pak Med Assoc, V57, P334; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Langmann T, 2010, AM J HUM GENET, V87, P376, DOI 10.1016/j.ajhg.2010.07.018; Li D, 2014, MOL VIS, V20, P1; Li L, 2010, AM J HUM GENET, V87, P400, DOI 10.1016/j.ajhg.2010.08.003; Maranhao B, 2014, GENOMICS, V103, P169, DOI 10.1016/j.ygeno.2014.02.006; McKibbin M, 2010, ARCH OPHTHALMOL-CHIC, V128, P107, DOI 10.1001/archophthalmol.2010.309; Naeem MA, 2012, INVEST OPHTH VIS SCI, V53, P1353, DOI 10.1167/iovs.11-8026; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Riazuddin SA, 2010, AM J HUM GENET, V87, P523, DOI 10.1016/j.ajhg.2010.08.013; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Simonelli F, 2007, INVEST OPHTH VIS SCI, V48, P4284, DOI 10.1167/iovs.07-0068; Wang X, 2011, HUM MUTAT, V32, P1450, DOI 10.1002/humu.21587; WELEBER RG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1531, DOI 10.1001/archopht.1993.01090110097033	42	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136561	10.1371/journal.pone.0136561	http://dx.doi.org/10.1371/journal.pone.0136561			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352687	gold, Green Published, Green Submitted			2022-12-26	WOS:000360932800040
J	Harhay, MO; Kizer, JR; Criqui, MH; Lima, JAC; Tracy, R; Bluemke, DA; Kawut, SM				Harhay, Michael O.; Kizer, Jorge R.; Criqui, Michael H.; Lima, Joao A. C.; Tracy, Russell; Bluemke, David A.; Kawut, Steven M.			Adipokines and the Right Ventricle: The MESA-RV Study	PLOS ONE			English	Article							HEART-FAILURE; CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS MESA; WEIGHT-LOSS; OBESITY; LEPTIN; HYPERTROPHY; ADIPONECTIN; MASS; INFLAMMATION	Objective Obesity is associated with changes in both right (RV) and left (LV) ventricular morphology, but the biological basis of this finding is not well established. We examined whether adipokine levels were associated with RV morphology and function in a population-based multiethnic sample free of clinical cardiovascular disease. Methods We examined relationships of leptin, resistin, TNF-alpha, and adiponectin with RV morphology and function (from cardiac MRI) in participants (n = 1,267) free of clinical cardiovascular disease from the Multi-Ethnic Study of Atherosclerosis (MESA)-RV study. Multivariable regressions (linear, quantile [25th and 75th] and generalized additive models [GAM]) were used to examine the independent association of each adipokine with RV mass, RV end-diastolic volume (RVEDV), RV end-systolic volume (RVESV), RV stroke volume (RVSV) and RV ejection fraction (RVEF). Results Higher leptin levels were associated with significantly lower levels of RV mass, RVEDV, RVESV and stroke volume, but not RVEF, after adjustment for age, gender, race, height and weight. These associations were somewhat attenuated but still significant after adjustment for traditional risk factors and covariates, and were completely attenuated when correcting for the respective LV measures. There were no significant interactions of age, gender, or race/ethnicity on the relationship between the four adipokines and RV structure or function. Conclusions Leptin levels are associated with favorable RV morphology in a multi-ethnic population free of cardiovascular disease, however these associations may be explained by a yet to be understood bi-ventricular process as this association was no longer present after adjustment for LV values. These findings complement the associations previously shown between adipokines and LV structure and function in both healthy and diseased patients. The mechanisms linking adipokines to healthy cardiovascular function require further investigation.	[Harhay, Michael O.; Kawut, Steven M.] Univ Penn, Perelman Sch Med, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA; [Harhay, Michael O.; Kawut, Steven M.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Harhay, Michael O.; Kawut, Steven M.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Kizer, Jorge R.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Criqui, Michael H.] Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA; [Lima, Joao A. C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Tracy, Russell] Univ Vermont, Sch Med, Dept Lab Med, Burlington, VT 05405 USA; [Bluemke, David A.] Natl Inst Biomed Imaging & Bioengn, Radiol & Imaging Sci, NIH, Ctr Clin, Bethesda, MD USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Diego; Johns Hopkins University; University of Vermont; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Kawut, SM (corresponding author), Univ Penn, Perelman Sch Med, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA.	kawut@upenn.edu	Bluemke, David/GYU-8169-2022	Bluemke, David/0000-0002-8323-8086; Harhay, Michael/0000-0002-0553-674X	National Institutes of Health [F31-HL127947, R01-HL086719, R01-HL077612, RO1-HL088451, N01-HC95159 - HC95165, N01-HC95169]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095159, N01HC095163, N01HC095169, N01HC095161, N01HC095160, N01HC095162, N01HC095164, N01HC095165] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL103844, R01HL086719, R01HL088451, F31HL127947, R01HL077612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541, P60DK020541] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090019] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CLINICAL CENTER	The following National Institutes of Health grants and contracts provided funding for this study: F31-HL127947 (to MOH), R01-HL086719, R01-HL077612, RO1-HL088451, N01-HC95159 - HC95165, N01-HC95169. The authors thank the MESA investigators, staff, and participants for their valuable contributions. A full list of participating MESA Investigators and institutions can be found at http://www.mesa-nhlbi.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison MA, 2013, AM J CARDIOL, V112, P726, DOI 10.1016/j.amjcard.2013.04.053; ALPERT MA, 1995, AM HEART J, V130, P1068, DOI 10.1016/0002-8703(95)90210-4; Barouch LA, 2003, CIRCULATION, V108, P754, DOI 10.1161/01.CIR.0000083716.82622.FD; Beltran-Sanchez H, 2013, J AM COLL CARDIOL, V62, P697, DOI 10.1016/j.jacc.2013.05.064; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bidulescu A, 2011, CIRC-HEART FAIL, V4, P747, DOI 10.1161/CIRCHEARTFAILURE.110.959742; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Chahal H, 2012, CHEST, V141, P388, DOI 10.1378/chest.11-0172; Chahal H, 2010, AM J CARDIOL, V106, P110, DOI 10.1016/j.amjcard.2010.02.022; Danias PG, 2003, J CARDIOV MAGN RESON, V5, P431, DOI 10.1081/JCMR-120022259; Di Blasio A, 2011, MENOPAUSE, V18, P77, DOI 10.1097/gme.0b013e3181e57813; ERIKSSON H, 1989, EUR HEART J, V10, P647, DOI 10.1093/oxfordjournals.eurheartj.a059542; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gardin JM, 2001, AM J CARDIOL, V87, P1051, DOI 10.1016/S0002-9149(01)01460-6; Gustafsson S, 2010, EUR J ENDOCRINOL, V162, P543, DOI 10.1530/EJE-09-1006; Hankinson JL, 2010, CHEST, V137, P138, DOI 10.1378/chest.09-0919; Hopkins TA, 2007, CARDIOVASC RES, V74, P11, DOI 10.1016/j.cardiores.2006.10.009; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kozakova M, 2008, J CLIN ENDOCR METAB, V93, P2811, DOI 10.1210/jc.2007-2580; Lieb W, 2009, AM J CARDIOL, V104, P602, DOI 10.1016/j.amjcard.2009.04.026; Lieb W, 2009, DIABETES CARE, V32, P612, DOI 10.2337/dc08-1596; McGaffin KR, 2008, CARDIOVASC RES, V77, P54, DOI 10.1093/cvr/cvm023; McManus DD, 2012, OBESITY, V20, P1882, DOI 10.1038/oby.2011.32; Natori S, 2006, AM J ROENTGENOL, V186, pS357, DOI 10.2214/AJR.04.1868; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pladevall M, 2003, J HYPERTENS, V21, P1467, DOI 10.1097/00004872-200308000-00009; Rajapurohitam V, 2003, CIRC RES, V93, P277, DOI 10.1161/01.RES.0000089255.37804.72; Rider OJ, 2011, HEART, V97, P203, DOI 10.1136/hrt.2009.185009; Rider OJ, 2010, OBESITY, V18, P2311, DOI 10.1038/oby.2010.64; Rider OJ, 2009, J AM COLL CARDIOL, V54, P718, DOI 10.1016/j.jacc.2009.02.086; Rothman KJ, 1990, NO ADJUSTMENTS ARE N; Smith SR, 2003, DIABETES, V52, P1611, DOI 10.2337/diabetes.52.7.1611; Turkbey EB, 2010, JACC-CARDIOVASC IMAG, V3, P266, DOI 10.1016/j.jcmg.2009.10.012; de Voorde J, 2013, METABOLISM, V62, P1513, DOI 10.1016/j.metabol.2013.06.004	35	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136818	10.1371/journal.pone.0136818	http://dx.doi.org/10.1371/journal.pone.0136818			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348768	Green Published, Green Submitted, gold			2022-12-26	WOS:000360897600013
J	Michel, L; Huguet-Lachon, A; Gourdon, G				Michel, Lise; Huguet-Lachon, Aline; Gourdon, Genevieve			Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development	PLOS ONE			English	Article							MYOTONIC-DYSTROPHY REGION; TRIPLET REPEAT; BINDING PROTEIN; CTG REPEATS; CUG REPEATS; EXPANSION; IDENTIFICATION; MISREGULATION; TRANSCRIPTION; EXPRESSION	Myotonic dystrophy type 1 (DM1) is caused by an unstable expanded CTG repeat located within the DMPK gene 3'UTR. The nature, severity and age at onset of DM1 symptoms are very variable in patients. Different forms of the disease are described, among which the congenital form (CDM) is the most severe. Molecular mechanisms of DM1 are well characterized for the adult form and involve accumulation of mutant DMPK RNA forming foci in the nucleus. These RNA foci sequester proteins from the MBNL family and deregulate CELF proteins. These proteins are involved in many cellular mechanisms such as alternative splicing, transcriptional, translational and post-translational regulation miRNA regulation as well as mRNA polyadenylation and localization. All these mechanisms can be impaired in DM1 because of the deregulation of CELF and MBNL functions. The mechanisms involved in CDM are not clearly described. In order to get insight into the mechanisms underlying CDM, we investigated if expanded RNA nuclear foci, one of the molecular hallmarks of DM1, could be detected in human DM1 fetal tissues, as well as in embryonic and neonatal tissues from transgenic mice carrying the human DMPK gene with an expanded CTG repeat. We observed very abundant RNA foci formed by sense DMPK RNA and, to a lesser extent, antisense DMPK RNA foci. Sense DMPK RNA foci clearly co-localized with MBNL1 and MBNL2 proteins. In addition, we studied DMPK sense and antisense expression during development in the transgenic mice. We found that DMPK sense and antisense transcripts are expressed from embryonic and fetal stages in heart, muscle and brain and are regulated during development. These results suggest that mechanisms underlying DM1 and CDM involved common players including toxic expanded RNA forming numerous nuclear foci at early stages during development.	[Michel, Lise; Huguet-Lachon, Aline; Gourdon, Genevieve] INSERM, UMR 1163, Paris, France; [Michel, Lise; Huguet-Lachon, Aline; Gourdon, Genevieve] Paris Descartes Sorbonne Paris Cite Univ, Imagine Inst, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Gourdon, G (corresponding author), INSERM, UMR 1163, Paris, France.	genevieve.gourdon@inserm.fr	Gourdon, Genevieve/F-2996-2013	Gourdon, Genevieve/0000-0002-3319-1347	National Research Agency under the "Investments for the Future" program [ANR-10-IAHU-01, ANR-10BLAN-1121-01]; French Ministry for Higher Education and Research; Fondation de la Recherche Medicale FRM [FDT20140930889]	National Research Agency under the "Investments for the Future" program(French National Research Agency (ANR)); French Ministry for Higher Education and Research; Fondation de la Recherche Medicale FRM(Fondation pour la Recherche Medicale)	This program has received a state subsidy managed by the National Research Agency under the "Investments for the Future" program bearing the reference ANR-10-IAHU-01 and under the program ANR-10BLAN-1121-01. L.M. was funded by a PhD fellowship from the French Ministry for Higher Education and Research and by the Fondation de la Recherche Medicale FRM FDT20140930889.	ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; Batra R, 2014, MOL CELL, V56, P311, DOI 10.1016/j.molcel.2014.08.027; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Brouwer JR, 2013, J NUCLEIC ACIDS, V2013, DOI 10.1155/2013/567435; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; Cleary JD, 2014, CURR OPIN GENET DEV, V26, P6, DOI 10.1016/j.gde.2014.03.002; Dasgupta T, 2012, WIRES RNA, V3, P104, DOI 10.1002/wrna.107; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Gladman JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072907; Gomes-Pereira M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030052; Gomes-Pereira M, 2011, TRENDS MOL MED, V17, P506, DOI 10.1016/j.molmed.2011.05.004; HAGEMAN ATM, 1993, J NEUROL SCI, V115, P95, DOI 10.1016/0022-510X(93)90072-7; Harper PS, 2001, MYOTONIC DYSTROPHY; Hernandez-Hernandez O, 2013, BRAIN, V136, P957, DOI 10.1093/brain/aws367; Holt I, 2009, AM J PATHOL, V174, P216, DOI 10.2353/ajpath.2009.080520; Huguet A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003043; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kanadia RN, 2003, GENE EXPR PATTERNS, V3, P459, DOI 10.1016/S1567-133X(03)00064-4; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kruse Bernd, 2008, Hum Mutat, V29, pE100, DOI 10.1002/humu.20791; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Ladd AN, 2005, DEV DYNAM, V233, P783, DOI 10.1002/dvdy.20382; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Liu YF, 2008, COMP BIOCHEM PHYS B, V151, P118, DOI 10.1016/j.cbpb.2008.06.005; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Margolis JM, 2006, HUM MOL GENET, V15, P1808, DOI 10.1093/hmg/ddl103; Mykowska A, 2011, NUCLEIC ACIDS RES, V39, P8938, DOI 10.1093/nar/gkr608; Onishi H, 2008, J NEUROSCI RES, V86, P1994, DOI 10.1002/jnr.21655; Rau F, 2011, NAT STRUCT MOL BIOL, V18, P840, DOI 10.1038/nsmb.2067; Seznec H, 2000, HUM MOL GENET, V9, P1185, DOI 10.1093/hmg/9.8.1185; Seznec H, 2001, HUM MOL GENET, V10, P2717, DOI 10.1093/hmg/10.23.2717; Sicot G, 2011, HUM MOL GENET, V20, pR116, DOI 10.1093/hmg/ddr343; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; Todd PK, 2014, DIS MODEL MECH, V7, P143, DOI 10.1242/dmm.012427; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	40	36	36	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137620	10.1371/journal.pone.0137620	http://dx.doi.org/10.1371/journal.pone.0137620			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339785	gold, Green Submitted, Green Published			2022-12-26	WOS:000360688200071
J	Chen, SQ; Han, JY; Liu, YQ				Chen, Suqin; Han, Junying; Liu, Yeqi			Dual Opposing Roles of Metallothionein Overexpression in C57BL/6J Mouse Pancreatic beta-Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; DIABETES-MELLITUS; INSULIN-RESISTANCE; GLUCOSE; CATALASE; GENE; PROTECTION; MICE; HYPERINSULINEMIA; POLYMORPHISMS	Background Growing evidence indicates that oxidative stress (OS), a persistent state of excess amounts of reactive oxygen species (ROS) along with reactive nitrogen species (RNS), plays an important role in insulin resistance, diabetic complications, and dysfunction of pancreatic beta-cells. Pancreatic beta-cells contain exceptionally low levels of antioxidant enzymes, rendering them susceptible to ROS-induced damage. Induction of antioxidants has been proposed to be a way for protecting beta-cells against oxidative stress. Compared to other antioxidants that act against particular beta-cell damages, metallothionein (MT) is the most effective in protecting beta-cells from several oxidative stressors including nitric oxide, peroxynitrite, hydrogen peroxide, superoxide and streptozotocin (STZ). We hypothesized that MT overexpression in pancreatic beta-cells would preserve beta-cell function in C57BL/6J mice, an animal model susceptible to high fat diet-induced obesity and type 2 diabetes. Research Design and Methods The pancreatic beta-cell specific MT overexpression was transferred to C57BL/6J background by backcrossing. We studied transgenic MT (MT-tg) mice and wild-type (WT) littermates at 8 weeks and 18 weeks of age. Several tests were performed to evaluate the function of islets, including STZ in vivo treatment, intraperitoneal glucose tolerance tests (IPGTT) and plasma insulin levels during IPGTT, pancreatic and islet insulin content measurement, insulin secretion, and islet morphology assessment. Gene expression in islets was performed by quantitative real-time PCR and PCR array analysis. Protein levels in pancreatic sections were evaluated by using immunohistochemistry. Results The transgenic MT protein was highly expressed in pancreatic islets. MT-tg overexpression significantly protected mice from acute STZ-induced ROS at 8 weeks of age; unexpectedly, however, MT-tg impaired glucose stimulated insulin secretion (GSIS) and promoted the development of diabetes. Pancreatic beta-cell function was significantly impaired, and islet morphology was also abnormal in MT-tg mice, and more severe damage was detected in males. The unique gene expression pattern and abnormal protein levels were observed in MT-tg islets. Conclusions MT overexpression protected beta-cells from acute STZ-induced ROS damages at young age, whereas it impaired GSIS and promoted the development of diabetes in adult C57BL/6J mice, and more severe damage was found in males.	[Chen, Suqin; Han, Junying; Liu, Yeqi] Childrens Hosp New Orleans, Res Inst Children, New Orleans, LA 70118 USA; [Chen, Suqin] Sun Yat Sen Univ, Zhongshan Med Coll, Dept Med Genet, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Yeqi] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA USA	Children's Hospital of New Orleans; Sun Yat Sen University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Chen, SQ (corresponding author), Childrens Hosp New Orleans, Res Inst Children, New Orleans, LA 70118 USA.	chensq@mail.sysu.edu.cn			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [1R01DK077624]; Research Institute for Children, Children's Hospital at New Orleans [6931]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077624] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Research Institute for Children, Children's Hospital at New Orleans; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, 1R01DK077624) and the Research Institute for Children, Children's Hospital at New Orleans (6931). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacci S, 2007, CURR OPIN CLIN NUTR, V10, P403, DOI 10.1097/MCO.0b013e3281e386c9; Chang YC, 2010, AM J TRANSL RES, V2, P316; Chen HN, 2005, DIABETES, V54, P1437, DOI 10.2337/diabetes.54.5.1437; Chen HN, 2001, DIABETES, V50, P2040, DOI 10.2337/diabetes.50.9.2040; Chiaverini N, 2010, FREE RADICAL RES, V44, P605, DOI 10.3109/10715761003692511; Collins S, 2012, BEST PRACT RES CL EN, V26, P753, DOI 10.1016/j.beem.2012.08.002; Di Paola R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019462; Fang N, 2014, METABOLISM, V63, P822, DOI 10.1016/j.metabol.2014.03.003; Fu YX, 1999, FREE RADICAL BIO MED, V27, P605, DOI 10.1016/S0891-5849(99)00104-5; Giacconi R, 2008, MOL GENET METAB, V94, P98, DOI 10.1016/j.ymgme.2007.12.006; Gorogawa S, 2002, DIABETES RES CLIN PR, V57, P1, DOI 10.1016/S0168-8227(02)00005-0; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; Han J, 2005, DIABETOLOGIA, V48, P1810, DOI 10.1007/s00125-005-1854-8; Harmon JS, 2009, ENDOCRINOLOGY, V150, P4855, DOI 10.1210/en.2009-0708; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Kaneto H, 1999, DIABETES, V48, P2398, DOI 10.2337/diabetes.48.12.2398; Kaneto H, 2009, CURR MED CHEM, V16, P3144, DOI 10.2174/092986709788802980; Kikumoto Y, 2010, BBA-MOL BASIS DIS, V1802, P240, DOI 10.1016/j.bbadis.2009.10.009; Kubisch HM, 1997, DIABETES, V46, P1563, DOI 10.2337/diabetes.46.10.1563; Kulkarni RN, 2003, DIABETES, V52, P1528, DOI 10.2337/diabetes.52.6.1528; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; Lei XG, 2011, ANTIOXID REDOX SIGN, V14, P489, DOI 10.1089/ars.2010.3416; Leloup C, 2006, DIABETES, V55, P2084, DOI 10.2337/db06-0086; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Li XY, 2006, DIABETES, V55, P1592, DOI 10.2337/db05-1357; Liew CW, 2010, J CLIN INVEST, V120, P2876, DOI 10.1172/JCI36849; Liu Q, 2014, J DIABETES INVEST, V5, P623, DOI 10.1111/jdi.12250; Liu YQ, 1998, J CLIN INVEST, V101, P1870, DOI 10.1172/JCI1211; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Lortz S, 2003, FREE RADICAL BIO MED, V34, P683, DOI 10.1016/S0891-5849(02)01371-0; Mandic SA, 2011, J BIOL CHEM, V286, P28026, DOI 10.1074/jbc.M111.235366; Maret W, 2008, EXP GERONTOL, V43, P363, DOI 10.1016/j.exger.2007.11.005; McClung JP, 2004, P NATL ACAD SCI USA, V101, P8852, DOI 10.1073/pnas.0308096101; Muscogiuri G, 2013, DIABETES, V62, P4201, DOI 10.2337/db13-0314; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Pi JB, 2010, TOXICOL APPL PHARM, V244, P77, DOI 10.1016/j.taap.2009.05.025; Robertson RP, 2009, TRENDS ENDOCRIN MET, V20, P388, DOI 10.1016/j.tem.2009.05.004; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Spinas GA, 1998, DIABETOLOGIA, V41, P292, DOI 10.1007/s001250050906; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Tanaka Y, 1999, P NATL ACAD SCI USA, V96, P10857, DOI 10.1073/pnas.96.19.10857; Thams P, 1999, EUR J ENDOCRINOL, V140, P87, DOI 10.1530/eje.0.1400087; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang XD, 2008, DIABETOLOGIA, V51, P1515, DOI 10.1007/s00125-008-1055-3; Xu B, 1999, FREE RADICAL BIO MED, V27, P830, DOI 10.1016/S0891-5849(99)00130-6; Yamamoto M, 2008, ANTIOXID REDOX SIGN, V10, P43, DOI 10.1089/ars.2007.1586; Yang L, 2008, AM J PHYSIOL-ENDOC M, V294, pE987, DOI 10.1152/ajpendo.90234.2008	49	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137583	10.1371/journal.pone.0137583	http://dx.doi.org/10.1371/journal.pone.0137583			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335571	Green Published, gold, Green Submitted			2022-12-26	WOS:000360615400068
J	Nunez, JCB; Seale, TP; Fraser, MA; Burton, TL; Fortson, TN; Hoover, D; Travis, J; Oleksiak, MF; Crawford, DL				Nunez, J. C. B.; Seale, T. P.; Fraser, M. A.; Burton, T. L.; Fortson, T. N.; Hoover, D.; Travis, J.; Oleksiak, M. F.; Crawford, D. L.			Population Genomics of the Euryhaline Teleost Poecilia latipinna	PLOS ONE			English	Article							CLIMATE-CHANGE; NUCLEOTIDE POLYMORPHISM; DROSOPHILA-MELANOGASTER; PHENOTYPIC PLASTICITY; GENETIC DIVERSITY; SPECIES RICHNESS; ECOSYSTEM; DNA; EVOLUTIONARY; SELECTION	Global climate change and increases in sea levels will affect coastal marine communities. The conservation of these ecologically important areas will be a challenge because of their wide geographic distribution, ecological diversity and species richness. To address this problem, we need to better understand how the genetic variation of the species in these communities is distributed within local populations, among populations and between distant regions. In this study we apply genotyping by sequencing (GBS) and examine 955 SNPs to determine Sailfin molly (Poecilia latipinna) genetic diversity among three geographically close mangrove salt marsh flats in the Florida Keys compared to populations in southern and northern Florida. The questions we are asking are whether there is sufficient genetic variation among isolated estuarine fish within populations and whether there are significant divergences among populations. Additionally, we want to know if GBS approaches agree with previous studies using more traditional molecular approaches. We are able to identify large genetic diversity within each saltmarsh community (pi approximate to 36%). Additionally, among the Florida Key populations and the mainland or between southern and northern Florida regions, there are significant differences in allele frequencies seen in population structure and evolutionary relationships among individuals. Surprisingly, even though the cumulative F-ST value using all 955 SNPs within the three Florida Key populations is small, there are 29 loci with significant F-ST values, and 11 of these were outliers suggestive of adaptive divergence. These data suggest that among the salt marsh flats surveyed here, there is significant genetic diversity within each population and small but significant differences among populations. Much of the genetic variation within and among populations found here with GBS is very similar to previous studies using allozymes and microsatellites. However, the meaningful difference between GBS and these previous measures of genetic diversity is the number of loci examined, which allows more precise delineations of population structure as well as facilitates identifying loci with excessive F-ST values that could indicate adaptive divergence.	[Nunez, J. C. B.; Seale, T. P.; Fraser, M. A.; Burton, T. L.; Fortson, T. N.; Oleksiak, M. F.; Crawford, D. L.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Hoover, D.; Travis, J.] Florida State Univ, Dept Biol, Tallahassee, FL 32306 USA	University of Miami; State University System of Florida; Florida State University	Crawford, DL (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	dcrawford@rsmas.miami.edu	Nunez, Joaquin C. B./L-5355-2015	Nunez, Joaquin C. B./0000-0002-3171-8918; Crawford, Douglas/0000-0002-6239-4012	University of Miami's Marine Science undergraduate program; National Science Foundation, Molecular and Cellular Biosciences [1158241]; Division Of Integrative Organismal Systems [1147042] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [1158241] Funding Source: National Science Foundation	University of Miami's Marine Science undergraduate program; National Science Foundation, Molecular and Cellular Biosciences; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Most of this research was supported by the University of Miami's Marine Science undergraduate program. Additional support for the adaptor primers was from National Science Foundation, Molecular and Cellular Biosciences 1158241 to MFO (http://www.nsf.gov/div/index.jsp?div=MCB).	Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Apodaca JJ, 2013, AM NAT, V181, P254, DOI 10.1086/668831; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Bierne N, 2013, MOL ECOL, V22, P2061, DOI 10.1111/mec.12241; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Catchen J, 2013, MOL ECOL, V22, P2864, DOI 10.1111/mec.12330; Cavanaugh KC, 2014, P NATL ACAD SCI USA, V111, P723, DOI 10.1073/pnas.1315800111; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Day JW, 2008, ESTUAR COAST, V31, P477, DOI 10.1007/s12237-008-9047-6; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Engelhardt KAM, 2001, NATURE, V411, P687, DOI 10.1038/35079573; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feller IC, 2010, ANNU REV MAR SCI, V2, P395, DOI 10.1146/annurev.marine.010908.163809; Gamfeldt L, 2005, ECOL LETT, V8, P696, DOI 10.1111/j.1461-0248.2005.00765.x; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Harte J, 2004, NATURE, V430, P33, DOI [10.1038/430003a, DOI 10.1038/430003A]; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hedrick PW, 2006, ANNU REV ECOL EVOL S, V37, P67, DOI 10.1146/annurev.ecolsys.37.091305.110132; Hermisson J, 2009, HEREDITY, V103, P283, DOI 10.1038/hdy.2009.101; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hofmann GE, 2010, ANNU REV PHYSIOL, V72, P127, DOI 10.1146/annurev-physiol-021909-135900; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Hyma KE, 2013, MOL ECOL, V22, P2917, DOI 10.1111/mec.12155; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2014, INTRO ADEGENET 1 41; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kemp SJ, 2008, MAR ECOL PROG SER, V371, P233, DOI 10.3354/meps07641; KREITMAN M, 1983, NATURE, V304, P412, DOI 10.1038/304412a0; KREITMAN ME, 1986, GENETICS, V114, P93; Leffler EM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001388; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lotterhos KE, 2014, MOL ECOL, V23, P2178, DOI 10.1111/mec.12725; LUDWIG MZ, 1995, MOL BIOL EVOL, V12, P1002; Narum SR, 2011, MOL ECOL RESOUR, V11, P184, DOI 10.1111/j.1755-0998.2011.02987.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Phillips PC, 1996, EVOLUTION, V50, P1334, DOI [10.2307/2410673, 10.1111/j.1558-5646.1996.tb02373.x]; Pritchard JK, 2000, GENETICS, V155, P945; Raj A, 2014, GENETICS, V197, P573, DOI 10.1534/genetics.114.164350; Reed DH, 2002, CONSERV BIOL, V17; Reusch TBH, 2006, ESTUARIES COASTS, V29, P159, DOI 10.1007/BF02784707; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Rey JR, 2012, WETL ECOL MANAG, V20, P197, DOI 10.1007/s11273-011-9235-1; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; SLATKIN M, 1991, GENETICS, V127, P627; SLATKIN M, 1995, GENETICS, V139, P457; Slatkin Montgomery, 1994, P3; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sternberg LDSL, 1994, ECOLOGICAL APLICATIO, V4, P144; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Travis Joseph, 1994, P205; TREXLER JC, 1988, EVOLUTION, V42, P1006, DOI 10.1111/j.1558-5646.1988.tb02519.x; TREXLER JC, 1990, EVOLUTION, V44, P157, DOI 10.1111/j.1558-5646.1990.tb04286.x; TREXLER JC, 1990, EVOLUTION, V44, P143, DOI 10.1111/j.1558-5646.1990.tb04285.x; Twilley R.R., 1985, COASTAL SHELF SCI, V20, P543, DOI DOI 10.1016/0272-7714(85)90106-4; Williams LM, 2011, MOL ECOL, V20, P5236, DOI 10.1111/j.1365-294X.2011.05360.x; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325	61	11	13	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137077	10.1371/journal.pone.0137077	http://dx.doi.org/10.1371/journal.pone.0137077			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335684	Green Submitted, Green Published, gold			2022-12-26	WOS:000360615400037
J	Snyder, SM; Howard, MO				Snyder, Susan M.; Howard, Matthew O.			Patterns of Inhalant Use among Incarcerated Youth	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; LATENT CLASS ANALYSIS; SUBSTANCE USE; ADOLESCENTS; PREVALENCE; DISORDERS; ALCOHOL; ADULTS	Inhalant use is especially prevalent among antisocial youth and can have serious health consequences. However, the extant literature has not investigated how use of various inhalants may co-occur among incarcerated youth. This study begins to address this gap in the literature by using latent class analyses to form distinct typologies of inhalant use. Study participants were residents (N = 723) of 27 Missouri Division of Youth Services facilities. Interviews assessed psychiatric symptoms, antisocial traits, delinquency, trauma, suicidality, and substance use behaviors. The mean age of the mostly male, ethnically diverse sample was 15.5 (S. D. = 1.2) years old. The study revealed the following classes of inhalant use: (1) severe polyinhalant use; (2) moderate polyinhalant use; (3) gas and permanent marker use; and (4) low-use. Compared to the low-use class, members of the severe polyinhalant use class had experienced more than double the rate of head injuries, the highest rates of traumatic experiences, and the highest rates of mental illness diagnoses. The gas and markers class had the highest rate of reporting hearing voices, followed by the severe polyinhalant use class, and the moderate polyinhalant use class. Results of this study underscore the need to address the high rate of head injuries and mental health diagnoses that contribute to severe polyinhalant use.	[Snyder, Susan M.] Georgia State Univ, Sch Social Work, Atlanta, GA 30303 USA; [Howard, Matthew O.] Univ N Carolina, Sch Social Work, Chapel Hill, NC USA	University System of Georgia; Georgia State University; University of North Carolina; University of North Carolina Chapel Hill	Snyder, SM (corresponding author), Georgia State Univ, Sch Social Work, Atlanta, GA 30303 USA.	ssnyder7@gsu.edu	Snyder, Susan M/AAN-2386-2021	Snyder, Susan M/0000-0002-6909-336X				[Anonymous], [No title captured]; Barnes GM, 2002, J DRUG ISSUES, V32, P153, DOI 10.1177/002204260203200107; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Collins LindaM., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; Derogatis LR, 1993, BSI BRIEF SYMPTOM IN; Elliott DS, 1989, MULTIPLE PROBLEM YOU; Freedenthal S, 2007, DRUG ALCOHOL DEPEN, V90, P81, DOI 10.1016/j.drugalcdep.2007.02.021; Garland EL, 2011, EXP CLIN PSYCHOPHARM, V19, P134, DOI 10.1037/a0022859; Grisso T., 2000, MASSACHUSETTS YOUTH; Hatcher L., 2003, STEP BY STEP BASIC S; Howard MO, 2008, DRUG ALCOHOL DEPEN, V93, P197, DOI 10.1016/j.drugalcdep.2007.08.023; Howard Matthew O, 2011, Addict Sci Clin Pract, V6, P18; Howard MO, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-8; Howard MO, 1999, ADDICT BEHAV, V24, P59, DOI 10.1016/S0306-4603(98)00039-2; Johnston L., 2015, MONITORING FUTURE NA; Kaba F, 2014, J ADOLESCENT HEALTH, V54, P615, DOI 10.1016/j.jadohealth.2013.12.013; Lanza S. T., 2003, HDB PSYCHOL RES METH, V2, P663, DOI [DOI 10.1002/0471264385.WEI0226, 10.1002/0471264385.wei0226]; Lilienfeld SO, 1996, J PERS ASSESS, V66, P488, DOI 10.1207/s15327752jpa6603_3; McCutcheon A.L., 2002, APPL LATENT CLASS AN, P56, DOI [10.1017/ CBO9780511499531.003, DOI 10.1017/CBO9780511499531.003]; Mitchell M. L., 2012, RES DESIGN EXPLAINED, V8th; National Institute on Drug Abuse, 2012, NAT I DRUG AB RES RE; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Newson R, 2003, STATA J, V3, P109, DOI 10.1177/1536867X0300300202; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; SCLOVE SL, 1987, PSYCHOMETRIKA, V52, P333, DOI 10.1007/BF02294360; Sickmund M, 2002, JUVENILE OFFENDERS R; Snyder S. M., 2013, J SOC SOC WORK RES, V4, P214, DOI [10.5243/jsswr.2013.15, DOI 10.5243/JSSWR.2013.15]; Snyder SM, SUBSTANCE A IN PRESS; Snyder SM, SUBST USE M IN PRESS; Snyder SM, 2015, SUBST USE MISUSE, V50, P226, DOI 10.3109/10826084.2014.966845; Snyder SM, 2014, J PSYCHOACTIVE DRUGS, V46, P188, DOI 10.1080/02791072.2014.914610; Snyder SM, 2013, CHILD YOUTH SERV REV, V35, P753, DOI 10.1016/j.childyouth.2013.01.021; Tofighi D, 2008, ADVANCES IN LATENT VARIABLE MIXTURE MODELS, P317; Vitacco MJ, 2003, ASSESSMENT, V10, P143, DOI 10.1177/1073191103010002005; Whitt A, 2012, J PSYCHOACTIVE DRUGS, V44, P365, DOI 10.1080/02791072.2012.736803; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Wu LT, 2007, DRUG ALCOHOL DEPEN, V88, P146, DOI 10.1016/j.drugalcdep.2006.10.012; Wu LT, 2006, DRUG ALCOHOL DEPEN, V85, P1, DOI 10.1016/j.drugalcdep.2006.01.017; Yang CC, 2006, COMPUT STAT DATA AN, V50, P1090, DOI 10.1016/j.csda.2004.11.004	41	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135303	10.1371/journal.pone.0135303	http://dx.doi.org/10.1371/journal.pone.0135303			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26333159	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800028
J	Lin, KY; Liao, SH; Liu, WC; Cheng, A; Lin, SW; Chang, SY; Tsai, MS; Kuo, CH; Wu, MR; Wang, HP; Hung, CC; Chang, SC				Lin, Kuan-Yin; Liao, Sih-Han; Liu, Wen-Chun; Cheng, Aristine; Lin, Shu-Wen; Chang, Sui-Yuan; Tsai, Mao-Song; Kuo, Ching-Hua; Wu, Mon-Ro; Wang, Hsiu-Po; Hung, Chien-Ching; Chang, Shan-Chwen			Cholelithiasis and Nephrolithiasis in HIV-Positive Patients in the Era of Combination Antiretroviral Therapy	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; RITONAVIR-BOOSTED ATAZANAVIR; C VIRUS-INFECTION; STONE DISEASE; UDP-GLUCURONOSYLTRANSFERASE; GALLSTONE DISEASE; POPULATION; EPIDEMIOLOGY; PREVALENCE; MANAGEMENT	Objectives This study aimed to describe the epidemiology and risk factors of cholelithiasis and nephrolithiasis among HIV-positive patients in the era of combination antiretroviral therapy. Methods We retrospectively reviewed the medical records of HIV-positive patients who underwent routine abdominal sonography for chronic viral hepatitis, fatty liver, or elevated aminotransferases between January 2004 and January 2015. Therapeutic drug monitoring of plasma concentrations of atazanavir was performed and genetic polymorphisms, including UDP-glucuronosyltransferase (UGT) 1A1*28 and multidrug resistance gene 1 (MDR1) G2677T/A, were determined in a subgroup of patients who received ritonavir-boosted or unboosted atazanavir-containing combination antiretroviral therapy. Information on demographics, clinical characteristics, and laboratory testing were collected and analyzed. Results During the 11-year study period, 910 patients who underwent routine abdominal sonography were included for analysis. The patients were mostly male (96.9%) with a mean age of 42.2 years and mean body-mass index of 22.9 kg/m(2) and 85.8% being on antiretroviral therapy. The anchor antiretroviral agents included non-nucleoside reverse-transcriptase inhibitors (49.3%), unboosted atazanavir (34.4%), ritonavir-boosted lopinavir (20.4%), and ritonavir-boosted atazanavir (5.5%). The overall prevalence of cholelithiasis and nephrolithiasis was 12.5% and 8.2%, respectively. Among 680 antiretroviral-experienced patients with both baseline and follow-up sonography, the crude incidence of cholelithiasis and nephrolithiasis was 4.3% and 3.7%, respectively. In multivariate analysis, the independent factors associated with incident cholelithiasis were exposure to ritonavir-boosted atazanavir for >2 years (adjusted odds ratio [AOR], 6.29; 95% confidence interval [CI], 1.12-35.16) and older age (AOR, 1.04; 95% CI, 1.00-1.09). The positive association between duration of exposure to ritonavir-boosted atazanavir and incident cholelithiasis was also found (AOR, per 1-year exposure, 1.49; 95% CI, 1.05-2.10). The associated factors with incident nephrolithiasis were hyperlipidemia (AOR, 3.97; 95% CI, 1.32-11.93), hepatitis B or C coinfection (AOR, 3.41; 95% CI, 1.09-10.62), and exposure to abacavir (AOR, 12.01; 95% CI, 1.54-93.54). Of 180 patients who underwent therapeutic drug monitoring of plasma atazanavir concentrations and pharmacogenetic investigations, we found that the atazanavir concentrations and UGT 1A1*28 and MDR1 G2677T/A polymorphisms were not statistically significantly associated with incident cholelithiasis and nephrolithiasis. Conclusions In HIV-positive patients in the era of combination antiretroviral therapy, a high prevalence of cholelithiasis and nephrolithiasis was observed, and exposure to ritonavir-boosted atazanavir for >2 years was associated with incident cholelithiasis.	[Lin, Kuan-Yin] Taipei City Hosp, Dept Internal Med, Div Infect Dis, Kun Ming Branch, Taipei, Taiwan; [Liao, Sih-Han; Cheng, Aristine] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Internal Med, Hsinchu, Taiwan; [Liu, Wen-Chun; Wu, Mon-Ro; Wang, Hsiu-Po; Hung, Chien-Ching; Chang, Shan-Chwen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Liu, Wen-Chun; Wu, Mon-Ro; Wang, Hsiu-Po; Hung, Chien-Ching; Chang, Shan-Chwen] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Lin, Shu-Wen] Natl Taiwan Univ Hosp, Dept Pharm, Taipei, Taiwan; [Lin, Shu-Wen] Natl Taiwan Univ, Grad Inst Clin Pharm, Taipei 10764, Taiwan; [Chang, Sui-Yuan] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Chang, Sui-Yuan] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Tsai, Mao-Song] Far Eastern Mem Hosp, Dept Internal Med, New Taipei City, Taiwan; [Kuo, Ching-Hua] Natl Taiwan Univ, Sch Pharm, Taipei 10764, Taiwan; [Hung, Chien-Ching] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Hung, Chien-Ching] China Med Univ, Taichung, Taiwan	Taipei City Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Far Eastern Memorial Hospital; National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Wang, HP (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	wanghp@ntu.edu.tw; hcc0401@ntu.edu.tw		LIAO, SIH-HAN/0000-0002-7339-2768; KUO, CHING-HUA/0000-0001-5722-0360; Cheng, Aristine/0000-0002-1182-7375; Hung, Chien-Ching/0000-0001-7345-0836; CHANG, SHAN-CHWEN/0000-0001-6505-4139; Lin, Kuan-Yin/0000-0001-6877-5345; CHANG, SUI-YUAN/0000-0002-6009-6724; LIN, SHU-WEN/0000-0002-9940-0850	Centers for Disease Control, Taiwan [DOH102-DC-1401, MOHW103-CDC-C-114-000405]; National Taiwan University Hospital [NTUH101S-1917]	Centers for Disease Control, Taiwan; National Taiwan University Hospital(National Taiwan University)	This study was supported by grants from the Centers for Disease Control, Taiwan (grant number DOH102-DC-1401 and MOHW103-CDC-C-114-000405 to C.-C. H.) and National Taiwan University Hospital (grant number NTUH101S-1917 to C.-C. H.). The funding source played no role in study design and conduct, data collection, analysis or interpretation, writing of the manuscript, or the decision to submit it for publication.	Acalovschi M, 2009, J VIRAL HEPATITIS, V16, P860, DOI 10.1111/j.1365-2893.2009.01141.x; Ahmed MH, 2014, RENAL FAILURE, V36, P957, DOI 10.3109/0886022X.2014.900424; [Anonymous], 2012, FULL PRESCRIPTION IN; AONO S, 1995, LANCET, V345, P958, DOI 10.1016/S0140-6736(95)90702-5; Boyd MA, 2006, J ANTIMICROB CHEMOTH, V57, P1161, DOI 10.1093/jac/dkl112; Cascorbi I, 2001, CLIN PHARMACOL THER, V69, P169, DOI 10.1067/mcp.2001.114164; Chan-Tack KM, 2007, AIDS, V21, P1215, DOI 10.1097/QAD.0b013e32813aee35; Chen JY, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-83; Collin F, 2007, THER DRUG MONIT, V29, P164, DOI 10.1097/ftd.0b013e318030839e; Colombo S, 2006, ANTIMICROB AGENTS CH, V50, P3801, DOI 10.1128/AAC.00098-06; Crixivan (Indinavir Sulfate), 2013, CRIX IND SULF FULL P; Foca E, 2012, DRUGS, V72, P1161, DOI 10.2165/11631070-000000000-00000; Hamada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069845; Hamada Y, 2012, CLIN INFECT DIS, V55, P1262, DOI 10.1093/cid/cis621; Huang WY, 2013, J UROLOGY, V189, P2158, DOI 10.1016/j.juro.2012.12.105; Lafaurie M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112836; Lee KY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088497; Malavaud B, 2000, ANTIVIR THER, V5, P3; Moe OW, 2006, LANCET, V367, P333, DOI 10.1016/S0140-6736(06)68071-9; Nishijima T, 2014, J ANTIMICROB CHEMOTH, V69, P3320, DOI 10.1093/jac/dku304; Nishijima T, 2014, J ANTIMICROB CHEMOTH, V69, P1385, DOI 10.1093/jac/dkt514; Nishijima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077268; Nkhoma E, 2014, J INT AIDS SOC, V17, P48, DOI 10.7448/IAS.17.4.19560; Park WB, 2010, CLIN INFECT DIS, V51, P101, DOI 10.1086/653427; [R. O. C.(Taiwan) Centers for Disease Control], 2013, GUIDELINES FOR DIAGN; Raheem OA, 2012, J ENDOUROL, V26, P1095, DOI 10.1089/end.2011.0639; Rakotondravelo S, 2012, CLIN INFECT DIS, V55, P1270, DOI 10.1093/cid/cis620; Ramachandran G, 2006, J CHROMATOGR B, V835, P131, DOI 10.1016/j.jchromb.2006.03.014; Romero Victoriano, 2010, Rev Urol, V12, pe86; Shaffer EA, 2006, BEST PRACT RES CL GA, V20, P981, DOI 10.1016/j.bpg.2006.05.004; SHEA JA, 1994, ARCH INTERN MED, V154, P2573, DOI 10.1001/archinte.154.22.2573; Smith-Bindman R, 2014, NEW ENGL J MED, V371, P1100, DOI 10.1056/NEJMoa1404446; Yasui T, 2008, UROLOGY, V71, P209, DOI 10.1016/j.urology.2007.09.034; Zhang DL, 2005, DRUG METAB DISPOS, V33, P1729, DOI 10.1124/dmd.105.005447	34	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137660	10.1371/journal.pone.0137660	http://dx.doi.org/10.1371/journal.pone.0137660			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360703	gold, Green Published, Green Submitted			2022-12-26	WOS:000361043100069
J	Ukaji, T; Lin, YZ; Banno, K; Okada, S; Umezawa, K				Ukaji, Tamami; Lin, Yinzhi; Banno, Kouji; Okada, Shoshiro; Umezawa, Kazuo			Inhibition of IGF-1-Mediated Cellular Migration and Invasion by Migracin A in Ovarian Clear Cell Carcinoma Cells	PLOS ONE			English	Article							CAPILLARY-TUBE FORMATION; PROTEIN-PROTEIN INTERACTION; STREPTOMYCES SP; ANGIOGENESIS INHIBITOR; COLORECTAL-CANCER; VASOHIBIN; GROWTH; METASTASIS; UCS15A; LUMINACINS	Previously we isolated migracin A from a Streptomyces culture filtrate as an inhibitor of cancer cell migration. In the present research, we found that migracin A inhibited migration and invasion of ovarian clear cell carcinoma ES-2 cells. In the course of our mechanistic study, migracin A was shown to enhance vasohibin-1 expression in an angiogenesis array. We also confirmed that it increased the mRNA expression of this protein. Moreover, overexpression of vasohibin-1 lowered the migration but not the invasion of ES-2 cells. Then, we looked for another target protein employing a motility array, and found that migracin A lowered the IGF-1 expression. Knockdown of IGF-1 by siRNA decreased the migration and invasion of ES-2 cells. Migracin A also decreased Akt phosphorylation involved in the downstream signaling. Crosstalk analysis indicated that overexpression of vasohibin-1 decreased the IGF-1 expression. On the other hand, it showed no direct anticancer activity in terms of the ES-2 growth in agar. Migracin A inhibited the migration and IGF-1 expression in not only ES-2 but also another ovarian clear cell carcinoma JHOC-5 cells. In addition, it also inhibited capillary tube formation of human umbilical vein endothelial cells. Since its cytotoxicity is very low, migracin A may be a candidate for an anti-metastasis agent not exhibiting prominent toxicity.	[Ukaji, Tamami; Lin, Yinzhi; Umezawa, Kazuo] Aichi Med Univ, Sch Med, Dept Mol Target Med, Nagakute, Aichi 4801195, Japan; [Banno, Kouji] Keio Univ, Sch Med, Dept Obstet & Gynecol, Shinjuku Ku, Tokyo 1608582, Japan; [Okada, Shoshiro] Aichi Med Univ, Sch Med, Dept Pharmacol, Nagakute, Aichi 4801195, Japan	Aichi Medical University; Keio University; Aichi Medical University	Umezawa, K (corresponding author), Aichi Med Univ, Sch Med, Dept Mol Target Med, 1-1 Yazako Karimata, Nagakute, Aichi 4801195, Japan.	umezawa@aichi-med-u.ac.jp			MEXT, KU [C 26350975]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities, KU	MEXT, KU; MEXT-Supported Program for the Strategic Research Foundation at Private Universities, KU	This work was supported by Grants-in-Aid for Scientific Research programs (C 26350975) from MEXT, (https://www.jsps.go.jp/j-grantsinaid), KU, and by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, (http://amu-strategy.org/), KU.	Andre F, 2004, ONCOGENE, V23, P1177, DOI 10.1038/sj.onc.1207238; Arai Y, 2013, J ANTIBIOT, V66, P225, DOI 10.1038/ja.2012.112; Bauer TW, 2005, ANN SURG, V241, P748, DOI 10.1097/01.sla.0000160699.59061.92; Chan JK, 2008, GYNECOL ONCOL, V109, P370, DOI 10.1016/j.ygyno.2008.02.006; Hashimoto S, 2006, P NATL ACAD SCI USA, V103, P7036, DOI 10.1073/pnas.0509166103; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Jiang H, 2012, MOL MED, V18, P1197, DOI 10.2119/molmed.2012.00075; Kern J, 2008, ARTERIOSCL THROM VAS, V28, P478, DOI 10.1161/ATVBAHA.107.160432; Kimura H, 2009, BLOOD, V113, P4810, DOI 10.1182/blood-2008-07-170316; King ER, 2011, GYNECOL ONCOL, V123, P13, DOI 10.1016/j.ygyno.2011.06.016; Li ZJ, 2013, WORLD J GASTROENTERO, V19, P7788, DOI 10.3748/wjg.v19.i43.7788; Maki RG, 2010, J CLIN ONCOL, V28, P4985, DOI 10.1200/JCO.2009.27.5040; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Naruse N, 2000, J ANTIBIOT, V53, P579, DOI 10.7164/antibiotics.53.579; Oneyama C, 2003, CHEM BIOL, V10, P443, DOI 10.1016/S1074-5521(03)00101-7; Oneyama C, 2002, ONCOGENE, V21, P2037, DOI 10.1038/sj.onc.1205271; Serin IS, 2008, GYNECOL ENDOCRINOL, V24, P117, DOI 10.1080/09513590801895559; Sharma SV, 2001, ONCOGENE, V20, P2068, DOI 10.1038/sj.onc.1204296; Shen JK, 2006, FASEB J, V20, P723, DOI 10.1096/fj.05-5046fje; Shibuya T, 2006, ARTERIOSCL THROM VAS, V26, P1051, DOI 10.1161/01.ATV.0000216747.66660.26; Shimizu K, 2005, BIOCHEM BIOPH RES CO, V327, P700, DOI 10.1016/j.bbrc.2004.12.073; Wakabayashi T, 2000, J ANTIBIOT, V53, P591, DOI 10.7164/antibiotics.53.591; Wang XS, 2010, PATHOLOGY, V42, P457, DOI 10.3109/00313025.2010.493864; Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152; Yuan L, 2015, CANCER LETT, V359, P136, DOI 10.1016/j.canlet.2015.01.003	25	11	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137663	10.1371/journal.pone.0137663	http://dx.doi.org/10.1371/journal.pone.0137663			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360832	Green Submitted, Green Published, gold			2022-12-26	WOS:000361043100070
J	Kabir, ME; Singh, H; Lu, R; Olde, B; Leeb-Lundberg, LMF; Bopassa, JC				Kabir, Mohammad E.; Singh, Harpreet; Lu, Rong; Olde, Bjorn; Leeb-Lundberg, L. M. Fredrik; Bopassa, Jean Chrisostome			G Protein-Coupled Estrogen Receptor 1 Mediates Acute Estrogen-Induced Cardioprotection via MEK/ERK/GSK-3 beta Pathway after Ischemia/Reperfusion	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; PERMEABILITY TRANSITION PORE; RAT-HEART; IN-VIVO; MOUSE HEART; BETA; KINASE; ALPHA; ACTIVATION; EXPRESSION	Three types of estrogen receptors (ER) exist in the heart, Esr1, Esr2 and the G protein-coupled estrogen receptor 1, Gper1. However, their relative importance in mediating estrogen protective action is unknown. We found that, in the male mouse ventricle, Gper1 transcripts are three-and seventeen-fold more abundant than Esr1 and Esr2 mRNAs, respectively. Analysis of the three ER knockouts (Esr1(-/-), Esr2(-/-) and Gper1(-/-)) showed that only the Gper1(-/-)hearts lost their ability to be protected by 40 nM estrogen as measured by heart function, infarct size and mitochondrial Ca2+ overload, an index of mitochondrial permeability transition pore (mPTP) activity. Analysis of Akt, ERK1/2 and GSK-3 beta salvage kinases uncovered Akt and ERK1/2 transient activation by estrogen whose phosphorylation increased during the first 5 min of non-ischemic perfusion. All these increase in phosphorylation effects were abrogated in Gper1(-/-). Inhibition of MEK1/2/ERK1/2 (1 mu M U0126) and PI3K/Akt (10 mu M LY294002) signaling showed that the MEK1/2/ERK1/2 pathway via GSK-3 beta exclusively was responsible for cardioprotection as an addition of U0126 prevented estrogen-induced GSK-3 beta increased phosphorylation, resistance to mitochondrial Ca2+-overload, functional recovery and protection against infarction. Further, inhibiting PKC translocation (1 mu M chelerythrin-chloride) abolished estrogen-induced cardioprotection. These data indicate that estrogen-Gper1 acute coupling plays a key role in cardioprotection against ischemia/reperfusion injury in male mouse via a cascade involving PKC translocation, ERK1/2/GSK-3 beta phosphorylation leading to the inhibition of the mPTP opening.	[Kabir, Mohammad E.; Bopassa, Jean Chrisostome] Univ Texas Hlth Sci Ctr San Antonio, Sch Med, Dept Physiol, San Antonio, TX 78229 USA; [Singh, Harpreet] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA; [Lu, Rong] Univ Calif Los Angeles, Dept Anesthesiol, Div Mol Med, Los Angeles, CA 90095 USA; [Olde, Bjorn; Leeb-Lundberg, L. M. Fredrik] Lund Univ, Dept Expt Med Sci, S-22184 Lund, Sweden	University of Texas System; University of Texas Health San Antonio; Drexel University; University of California System; University of California Los Angeles; Lund University	Bopassa, JC (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Sch Med, Dept Physiol, San Antonio, TX 78229 USA.	Bopassa@uthscsa.edu	Singh, Harpreet/M-9822-2019	Singh, Harpreet/0000-0002-6135-1897	American Heart Association (AHA) [09POST2190008]; Max and Minnie Tomerlin Voelcker fund; AHA National Scientist Development Grant [11SDG7230059]; Swedish Research Council	American Heart Association (AHA)(American Heart Association); Max and Minnie Tomerlin Voelcker fund; AHA National Scientist Development Grant; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the American Heart Association (AHA) Fellowship 09POST2190008 (JCB); Max and Minnie Tomerlin Voelcker fund (JCB); AHA National Scientist Development Grant 11SDG7230059 (HS); and a Swedish Research Council grant (LMFL-L).	Bell RM, 2003, J MOL CELL CARDIOL, V35, P185, DOI 10.1016/S0022-2828(02)00310-3; Booth EA, 2005, AM J PHYSIOL-HEART C, V289, pH2039, DOI 10.1152/ajpheart.00479.2005; Bopassa JC, 2006, CARDIOVASC RES, V69, P178, DOI 10.1016/j.cardiores.2005.07.014; Bopassa JC, 2010, AM J PHYSIOL-HEART C, V298, pH16, DOI 10.1152/ajpheart.00588.2009; CROSS MJ, 1995, J BIOL CHEM, V270, P25352, DOI 10.1074/jbc.270.43.25352; Deschamps AM, 2009, AM J PHYSL HEART CIR; Deschamps AM, 2010, TRENDS CARDIOVAS MED, V20, P73, DOI 10.1016/j.tcm.2010.05.001; Downey JM, 2007, HEART FAIL REV, V12, P181, DOI 10.1007/s10741-007-9025-2; Dupont S, 2000, DEVELOPMENT, V127, P4277; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Gomez L, 2008, CIRCULATION, V117, P2761, DOI 10.1161/CIRCULATIONAHA.107.755066; Grohe C, 1998, J ENDOCRINOL, V156, pR1, DOI 10.1677/joe.0.156R001; Hausenloy DJ, 2003, CARDIOVASC RES, V60, P617, DOI 10.1016/j.cardiores.2003.09.025; Holm A, 2012, MOL CELL BIOCHEM, V366, P239, DOI 10.1007/s11010-012-1301-3; Hsieh YC, 2007, AM J PATHOL, V170, P1210, DOI 10.2353/ajpath.2007.060883; Hunter JC, 2007, AM J PHYSIOL-REG I, V292, pR800, DOI 10.1152/ajpregu.00374.2006; Hutchens MP, 2010, ANESTHESIOLOGY, V112, P395, DOI 10.1097/ALN.0b013e3181c98da9; Jin ZQ, 2004, CIRCULATION, V110, P1980, DOI 10.1161/01.CIR.0000143632.06471.93; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Kuno A, 2007, J MOL CELL CARDIOL, V43, P262, DOI 10.1016/j.yjmcc.2007.05.016; Kurt AH, 2013, EUR J PHARMACOL, V702, P71, DOI 10.1016/j.ejphar.2013.01.020; Li JY, 2012, ANESTHESIOLOGY, V117, P836, DOI 10.1097/ALN.0b013e3182655e73; Lizotte E, 2009, CELL PHYSIOL BIOCHEM, V23, P75, DOI 10.1159/000204096; MARTENSSON UE, 2008, ENDOCRINOLOGY; Nilsson BO, 2011, BRIT J PHARMACOL, V163, P1131, DOI 10.1111/j.1476-5381.2011.01235.x; Nishino Y, 2008, CIRC RES, V103, P307, DOI 10.1161/CIRCRESAHA.107.169953; Node K, 1997, CIRCULATION, V96, P1953, DOI 10.1161/01.CIR.96.6.1953; Patel VH, 2010, INT J MOL MED, V26, P193, DOI 10.3892/ijmm_00000452; Patten RD, 2004, CIRC RES, V95, P692, DOI 10.1161/01.RES.0000144126.57786.89; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Rahman S, 2011, ANESTHESIOLOGY, V115, P242, DOI 10.1097/ALN.0b013e318223b8b9; Ropero AB, 2006, J MOL CELL CARDIOL, V41, P496, DOI 10.1016/j.yjmcc.2006.05.022; Siomboing X, 2001, FARMACO, V56, P859, DOI 10.1016/S0014-827X(01)01165-X; Solenkova NV, 2006, AM J PHYSIOL-HEART C, V290, pH441, DOI 10.1152/ajpheart.00589.2005; Sovershaev MA, 2006, AM J PHYSIOL-HEART C, V291, pH1554, DOI 10.1152/ajpheart.01171.2005; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Vornehm ND, 2009, SURGERY, V146, P145, DOI 10.1016/j.surg.2009.04.026; Wang MJ, 2006, CIRCULATION, V114, pI282, DOI 10.1161/CIRCULATIONAHA.105.001164; Weil BR, 2010, SURGERY, V148, P436, DOI 10.1016/j.surg.2010.03.011; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101	40	53	56	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0135988	10.1371/journal.pone.0135988	http://dx.doi.org/10.1371/journal.pone.0135988			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356837	gold, Green Published, Green Submitted			2022-12-26	WOS:000360965800009
J	Emanuele, AA; Garcia, GA				Emanuele, Anthony A.; Garcia, George A.			Mechanism of Action and Initial, In Vitro SAR of an Inhibitor of the Shigella flexneri Virulence Regulator VirF	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITORS; III SECRETION SYSTEM; H-NS; DNA-BINDING; TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; LARGE PLASMID; ICSA; PATHOGENESIS; INVASION	Shigella spp. are among the main causative agents of acute diarrheal illness and claim more than 1 million lives per year worldwide. There are multiple bacterial genes that control the pathogenesis of Shigella, but the virF gene may be the most important. This gene, located on the primary pathogenicity island of Shigella, encodes VirF, an AraC-family transcriptional activator that is responsible for initiating the pathogenesis cycle in Shigella. We have previously shown that it is possible to attenuate the virulence of Shigella flexneri via small molecule inhibition of VirF. In this study, we probed the mechanism of action of our small molecule inhibitors of VirF. To enable these studies, we have developed a homologous and efficient expression and purification system for VirF and have optimized two different in vitro VirF-DNA binding assays. We have determined that one of our HTS hit compounds inhibits VirF binding to DNA with a calculated K-i similar to the effective doses seen in our transcriptional activation and virulence screens. This is consistent with inhibition of DNA binding as the mechanism of action of this hit compound. We have also screened 15 commercially sourced analogs of this compound and deduced an initial SAR from the approximately 100-fold range in activities. Our four other HTS hit compounds do not inhibit DNA binding and yet they do block VirF activity. This suggests that multiple agents with different molecular mechanisms of inhibition of VirF could be developed. Pursuing hits with different mechanisms of action could be a powerful approach to enhance activity and to circumvent resistance that could develop to any one of these agents.	[Emanuele, Anthony A.; Garcia, George A.] Univ Michigan, Coll Pharm, Dept Med Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Garcia, GA (corresponding author), Univ Michigan, Coll Pharm, Dept Med Chem, Ann Arbor, MI 48109 USA.	gagarcia@umich.edu			National Institutes of Health [AI085179, GM007767]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI085179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the National Institutes of Health (AI085179 to GAG and GM007767, AAE trainee) for funding.	ADLER B, 1989, MOL MICROBIOL, V3, P627, DOI 10.1111/j.1365-2958.1989.tb00210.x; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Bowser TE, 2007, BIOORG MED CHEM LETT, V17, P5652, DOI 10.1016/j.bmcl.2007.07.072; Tran CN, 2011, NUCLEIC ACIDS RES, V39, P8122, DOI 10.1093/nar/gkr521; COLONNA B, 1995, J BACTERIOL, V177, P4703, DOI 10.1128/jb.177.16.4703-4712.1995; Emanuele AA, 2014, J ANTIBIOT, V67, P379, DOI 10.1038/ja.2014.10; Espina M, 2006, INFECT IMMUN, V74, P4391, DOI 10.1128/IAI.00440-06; Falconi M, 1998, EMBO J, V17, P7033, DOI 10.1093/emboj/17.23.7033; Garrity-Ryan LK, 2010, INFECT IMMUN, V78, P4683, DOI 10.1128/IAI.01305-09; Glass LS, 2010, BIOORG MED CHEM LETT, V20, P1685, DOI 10.1016/j.bmcl.2010.01.033; Hilbi H, 1998, J BIOL CHEM, V273, P32895, DOI 10.1074/jbc.273.49.32895; Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739; Hurt JK, 2010, J BIOMOL SCREEN, V15, P379, DOI 10.1177/1087057110362101; Jullien N, 2011, BIOTECHNIQUES, V51, P267, DOI 10.2144/000113751; Kim OK, 2009, J MED CHEM, V52, P5626, DOI 10.1021/jm9006577; Koppolu V, 2013, INFECT IMMUN, V81, P4220, DOI 10.1128/IAI.00919-13; MAKINO S, 1986, CELL, V46, P551, DOI 10.1016/0092-8674(86)90880-9; Martin RG, 2001, CURR OPIN MICROBIOL, V4, P132, DOI 10.1016/S1369-5274(00)00178-8; MAURELLI AT, 1984, INFECT IMMUN, V43, P397, DOI 10.1128/IAI.43.1.397-401.1984; May KL, 2008, J BACTERIOL, V190, P4666, DOI 10.1128/JB.00093-08; MILLS JA, 1992, INFECT IMMUN, V60, P175, DOI 10.1128/IAI.60.1.175-182.1992; NAKAYAMA S, 1995, J BACTERIOL, V177, P5062, DOI 10.1128/jb.177.17.5062-5069.1995; Nguyen B, 2004, BIOPHYS J, V86, P1028, DOI 10.1016/S0006-3495(04)74178-8; Porter ME, 1997, MOL GEN GENET, V256, P93, DOI 10.1007/s004380050550; Porter ME, 2002, J BACTERIOL, V184, P531, DOI 10.1128/JB.184.2.531-539.2002; PORTER ME, 1994, J BACTERIOL, V176, P4187, DOI 10.1128/JB.176.13.4187-4191.1994; SAKAI T, 1988, MOL MICROBIOL, V2, P589, DOI 10.1111/j.1365-2958.1988.tb00067.x; SANSONETTI PJ, 1991, VACCINE, V9, P416, DOI 10.1016/0264-410X(91)90128-S; SASAKAWA C, 1988, J BACTERIOL, V170, P2480, DOI 10.1128/jb.170.6.2480-2484.1988; Schleif R, 2003, BIOESSAYS, V25, P274, DOI 10.1002/bies.10237; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Skredenske JM, 2013, J BIOMOL SCREEN, V18, P588, DOI 10.1177/1087057112474690; TOBE T, 1995, J BACTERIOL, V177, P1094, DOI 10.1128/jb.177.4.1094-1097.1995; TOBE T, 1991, MOL MICROBIOL, V5, P887, DOI 10.1111/j.1365-2958.1991.tb00762.x; TOBE T, 1993, J BACTERIOL, V175, P6142, DOI 10.1128/JB.175.19.6142-6149.1993; Tse WC, 2004, ACCOUNTS CHEM RES, V37, P61, DOI 10.1021/ar030113y; Tse Winston C, 2005, Curr Protoc Nucleic Acid Chem, VChapter 8, DOI 10.1002/0471142700.nc0805s20; WHO-World Health Organization, 2014, ANTIMICROBIAL RESIST; Zumsteg AB, 2014, CELL HOST MICROBE, V15, P435, DOI 10.1016/j.chom.2014.03.001	40	9	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137410	10.1371/journal.pone.0137410	http://dx.doi.org/10.1371/journal.pone.0137410			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352269	Green Published, gold, Green Submitted			2022-12-26	WOS:000360932800082
J	Levy-Shraga, Y; Cohen, R; Ben Ami, M; Yeshayahu, Y; Temam, V; Modan-Moses, D				Levy-Shraga, Yael; Cohen, Rinat; Ben Ami, Michal; Yeshayahu, Yonatan; Temam, Vered; Modan-Moses, Dalit			Sun Exposure and Protection Habits in Pediatric Patients with a History of Malignancy	PLOS ONE			English	Article							VITAMIN-D INSUFFICIENCY; SKIN-CANCER PREVENTION; CHILDHOOD-CANCER; ADULT SURVIVORS; ULTRAVIOLET-RADIATION; ADOLESCENT CANCER; HEALTH BEHAVIORS; D DEFICIENCY; SUNLIGHT; CHILDREN	Background Survivors of childhood cancer are at high risk for developing non-melanoma skin cancer and therefore are firmly advised to avoid or minimize sun exposure and adopt skin protection measures. We aimed to compare sun exposure and protection habits in a cohort of pediatric patients with a history of malignancy to those of healthy controls. Methods Case-control study of 143 pediatric patients with a history of malignancy (aged 11.2 +/- 4.6y, Male = 68, mean interval from diagnosis 4.4 +/- 3.8y) and 150 healthy controls (aged 10.4 +/- 4.8y, Male = 67). Sun exposure and protection habits were assessed using validated questionnaires. Results Patients and controls reported similar sun exposure time during weekdays (94 +/- 82minutes/day vs. 81 +/- 65minutes/day; p = 0.83), while during weekends patients spent significantly less time outside compared to controls (103 +/- 85minutes/day vs. 124 +/- 87minutes/day; p = 0.02). Time elapsed from diagnosis positively correlated with time spent outside both during weekdays (r = 0.194, p = 0.02) and weekends (r = 0.217, p = 0.01), and there was a step-up in sun exposure starting three years after diagnosis. There was no significant difference regarding composite sun protection score between patients and controls. Age was positively correlated with number of sunburns per year and sun exposure for the purpose of tanning, and was negatively correlated with the use of sun protection measures. Conclusions Although childhood cancer survivors are firmly instructed to adopt sun protection habits, the adherence to these instructions is incomplete, and more attention should be paid to improve these habits throughout their lives. Since sunlight avoidance may results in vitamin D deficiency, dietary supplementation will likely be needed.	[Levy-Shraga, Yael; Ben Ami, Michal; Yeshayahu, Yonatan; Modan-Moses, Dalit] Chaim Sheba Med Ctr, Pediat Endocrinol Unit, Edmond & Lily Safra Childrens Hosp, IL-52621 Ramat Gan, Israel; [Cohen, Rinat] Meuhedet Hlth Serv, Primary Care Div, Tel Aviv, Israel; [Levy-Shraga, Yael; Ben Ami, Michal; Yeshayahu, Yonatan; Modan-Moses, Dalit] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Temam, Vered] Edmond & Lily Safra Childrens Hosp, Dept Pediat Hematol Oncol, Ramat Gan, Israel; [Temam, Vered] Edmond & Lily Safra Childrens Hosp, BMT, Ramat Gan, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Levy-Shraga, Y (corresponding author), Chaim Sheba Med Ctr, Pediat Endocrinol Unit, Edmond & Lily Safra Childrens Hosp, IL-52621 Ramat Gan, Israel.	yael.levy.shraga@gmail.com	Yeshayahu, Yonatan/Y-8019-2019	Yeshayahu, Yonatan/0000-0002-3864-9898	late Alter Jacob Israel and Layla environment and epidemiologic research Foundation; Israel Cancer association	late Alter Jacob Israel and Layla environment and epidemiologic research Foundation; Israel Cancer association	The study was supported by the late Alter Jacob Israel and Layla environment and epidemiologic research Foundation and the Israel Cancer association.	Armstrong BK, 2004, CANC PREV CANC CAUSE, V3, P89; Balk SJ, 2011, PEDIATRICS, V127, pE791, DOI [10.1542/peds.2010-3502, 10.1542/peds.2010-3501]; Banerjee P, 2003, MOL CELL BIOCHEM, V253, P247, DOI 10.1023/A:1026072118217; Branstrom R, 2010, CANCER EPIDEM BIOMAR, V19, P2199, DOI 10.1158/1055-9965.EPI-10-0196; Buchanan N, 2009, CANCER-AM CANCER SOC, V115, P4374, DOI 10.1002/cncr.24581; Choudhary A, 2013, PEDIATR BLOOD CANCER, V60, P1237, DOI 10.1002/pbc.24403; Dusza SW, 2012, PEDIATRICS, V129, P309, DOI 10.1542/peds.2011-0104; Esbenshade AJ, 2014, PEDIATR BLOOD CANCER, V61, P723, DOI 10.1002/pbc.24844; Glanz K, 2008, ARCH DERMATOL, V144, P217, DOI 10.1001/archdermatol.2007.46; Glanz K, 2010, AM J PUBLIC HEALTH, V100, P735, DOI 10.2105/AJPH.2008.155705; Helou M, 2014, J PEDIAT HEMATOL ONC, V36, P212, DOI 10.1097/MPH.0b013e31829f3754; Hennessy A, 2013, P NUTR SOC, V72, P433, DOI 10.1017/S002966511300339X; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Kaluski DN, 2003, ISR MED ASSOC J, V5, P277; Kyle RG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005137; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Larcombe I, 2002, BRIT J CANCER, V87, P1204, DOI 10.1038/sj.bjc.6600632; Linet Martha S., 2014, Journal of the National Cancer Institute Monographs, P26, DOI 10.1093/jncimonographs/lgu006; Macdonald HM, 2013, CALCIFIED TISSUE INT, V92, P163, DOI 10.1007/s00223-012-9634-1; Misra M, 2008, PEDIATRICS, V122, P398, DOI 10.1542/peds.2007-1894; Modan-Moses D, 2012, PEDIATR RES, V72, P620, DOI 10.1038/pr.2012.131; Mullin GE, 2007, NUTR CLIN PRACT, V22, P305, DOI 10.1177/0115426507022003305; Ordonez-Moran P, 2005, FRONT BIOSCI-LANDMRK, V10, P2723, DOI 10.2741/1731; Palesh O, 2014, SUPPORT CARE CANCER, V22, P2973, DOI 10.1007/s00520-014-2286-0; Perkins JL, 2005, J CLIN ONCOL, V23, P3733, DOI 10.1200/JCO.2005.06.237; Rebholz CE, 2012, BRIT J CANCER, V107, P234, DOI 10.1038/bjc.2012.250; Reichrath J, 2009, BRIT J DERMATOL, V161, P54, DOI 10.1111/j.1365-2133.2009.09450.x; Robien K, 2011, BONE MARROW TRANSPL, V46, P1472, DOI 10.1038/bmt.2010.326; Simmons J, 2013, PEDIATR BLOOD CANCER, V60, P2025, DOI 10.1002/pbc.24684; Tercyak KP, 2006, PEDIATR BLOOD CANCER, V47, P825, DOI 10.1002/pbc.20602; Tsur A, 2011, OSTEOPOROSIS INT, V22, P2895, DOI 10.1007/s00198-010-1492-y; van Ginkel PR, 2007, J NEURO-ONCOL, V85, P255, DOI 10.1007/s11060-007-9418-z; Wacker M, 2013, DERM-ENDOCRINOL, V5, DOI [10.4161/derm.24476, 10.4161/derm.24494]; Watt TC, 2012, J NATL CANCER I, V104, P1240, DOI 10.1093/jnci/djs298; Zeichner SB, 2014, CLIN BREAST CANCER	35	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137453	10.1371/journal.pone.0137453	http://dx.doi.org/10.1371/journal.pone.0137453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348212	gold, Green Submitted, Green Published			2022-12-26	WOS:000360897600045
J	Tanigawa, T; Shibata, R; Kondo, K; Katahira, N; Kambara, T; Inoue, Y; Nonoyama, H; Horibe, Y; Ueda, H; Murohara, T				Tanigawa, Tohru; Shibata, Rei; Kondo, Kazuhisa; Katahira, Nobuyuki; Kambara, Takahiro; Inoue, Yoko; Nonoyama, Hiroshi; Horibe, Yuichiro; Ueda, Hiromi; Murohara, Toyoaki			Soybean beta-Conglycinin Prevents Age-Related Hearing Impairment	PLOS ONE			English	Article							ADIPONECTIN; COCHLEA; TISSUE	Obesity-related complications are associated with the development of age-related hearing impairment. beta-Conglycinin (beta-CG), one of the main storage proteins in soy, offers multiple health benefits, including anti-obesity and anti-atherosclerotic effects. Here, to elucidate the potential therapeutic application of beta-CG, we investigated the effect of beta-CG on age-related hearing impairment. Male wild-type mice (age 6 months) were randomly divided into beta-CG-fed and control groups. Six months later, the body weight was significantly lower in beta-CG-fed mice than in the controls. Consumption of beta-CG rescued the hearing impairment observed in control mice. Cochlear blood flow also increased in beta-CG-fed mice, as did the expression of eNOS in the stria vascularis (SV), which protects vasculature. beta-CG consumption also ameliorated oxidative status as assessed by 4-HNE staining. In the SV, lipofuscin granules of marginal cells and vacuolar degeneration of microvascular pericytes were decreased in beta-CG-fed mice, as shown by transmission electron microscopy. beta-CG consumption prevented loss of spiral ganglion cells and reduced the frequencies of lipofuscin granules, nuclear invaginations, and myelin vacuolation. Our observations indicate that beta-CG ameliorates age-related hearing impairment by preserving cochlear blood flow and suppressing oxidative stress.	[Tanigawa, Tohru; Katahira, Nobuyuki; Nonoyama, Hiroshi; Horibe, Yuichiro; Ueda, Hiromi] Aichi Med Univ, Dept Otolaryngol, Nagakute, Aichi, Japan; [Shibata, Rei; Kondo, Kazuhisa; Kambara, Takahiro; Inoue, Yoko; Murohara, Toyoaki] Nagoya Univ, Dept Cardiol, Grad Sch Med, Nagoya, Aichi 4648601, Japan	Aichi Medical University; Nagoya University	Tanigawa, T (corresponding author), Aichi Med Univ, Dept Otolaryngol, Nagakute, Aichi, Japan.	tanigawa@aichi-med-u.ac.jp; rshibata@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014					Adams MR, 2004, J NUTR, V134, P511, DOI 10.1093/jn/134.3.511; Ahn JH, 2008, NEUROREPORT, V19, P1265, DOI 10.1097/WNR.0b013e328308b338; Aoyama T, 2001, BIOSCI BIOTECH BIOCH, V65, P1071, DOI 10.1271/bbb.65.1071; Cheng AG, 1999, BRAIN RES, V850, P234, DOI 10.1016/S0006-8993(99)01983-6; CULLEN JR, 1993, J LARYNGOL OTOL, V107, P179, DOI 10.1017/S0022215100122571; Dalton DS, 1998, DIABETES CARE, V21, P1540, DOI 10.2337/diacare.21.9.1540; Ferreira ES, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-11; Fujimoto C, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/582849; Guo YK, 2005, HEARING RES, V208, P54, DOI 10.1016/j.heares.2005.05.010; Hwang JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060730; Hwang JH, 2012, INT J AUDIOL, V51, P920, DOI 10.3109/14992027.2012.721933; JERGER J, 1995, J AM GERIATR SOC, V43, P928, DOI 10.1111/j.1532-5415.1995.tb05539.x; Jiang H, 2007, NEUROBIOL AGING, V28, P1605, DOI 10.1016/j.neurobiolaging.2006.06.025; Keithley EM, 2004, HEARING RES, V188, P21, DOI 10.1016/S0378-5955(03)00365-4; Kim TS, 2014, CLIN ENDOCRINOL, V80, P368, DOI 10.1111/cen.12184; Kinoshita M, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/325702; Kohno M, 2006, J ATHEROSCLER THROMB, V13, P247, DOI 10.5551/jat.13.247; Lamm K, 1996, Audiol Neurootol, V1, P148; Liu W, 2000, J CELL SCI, V113, P635; Liu XZ, 2007, J PATHOL, V211, P188, DOI 10.1002/path.2102; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Naganuma H, 2014, AURIS NASUS LARYNX, V41, P249, DOI 10.1016/j.anl.2013.12.004; Nishi T, 2003, J NUTR, V133, P352, DOI 10.1093/jn/133.2.352; Seidman MD, 2002, AGEING RES REV, V1, P331, DOI 10.1016/S1568-1637(02)00004-1; Someya S, 2007, NEUROBIOL AGING, V28, P1613, DOI 10.1016/j.neurobiolaging.2006.06.024; Suzuki K, 2000, LARYNGOSCOPE, V110, P1736, DOI 10.1097/00005537-200010000-00033; Tachibana N, 2010, BIOSCI BIOTECH BIOCH, V74, P1250, DOI 10.1271/bbb.100088; Tanigawa T, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.140; Vasilyeva ON, 2009, HEARING RES, V249, P44, DOI 10.1016/j.heares.2009.01.007; Velasquez Manuel T, 2007, Int J Med Sci, V4, P72; Zhu SS, 2008, ORL-J OTO-RHIN-LARYN, V70, P373, DOI 10.1159/000163033	31	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137493	10.1371/journal.pone.0137493	http://dx.doi.org/10.1371/journal.pone.0137493			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348726	Green Published, gold, Green Submitted			2022-12-26	WOS:000360897600049
J	Weller, S; Florentine, S; Sillitoe, J; Grech, C; McLaren, D; Chauhan, BS				Weller, Sandra; Florentine, Singarayer; Sillitoe, James; Grech, Charles; McLaren, David; Chauhan, Bhagirath Singh			Detecting the Seeds of Nassella neesiana in Large Round Hay Bales, by Means of Non-Destructive Core Sampling	PLOS ONE			English	Article							DISPERSAL; PASTURES; DYNAMICS; ECOLOGY; STORAGE; LOSSES; GRASS	In the last three decades or so there has been a significant increase in fodder trading, both in terms of the quantity of fodder traded and in terms of its economic value to the industry. Often, this fodder type may be supplied free of charge to graziers in distress due to circumstances that follow natural disasters such as bushfires, drought, and flood. However, because of the obvious urgency arising from these situations, it is suspected that much relief fodder may unintentionally pose an elevated risk for dispersal of weeds since it may be supplied from pasture not normally used for trade in fodder, and therefore is of unknown quality. Previous destructive method to detect weed propagules in bales of fodder are cumbersome, time consuming and of limited ecological and statistical value. Therefore, objective of this paper was to development of a convenient method to assess round pasture hay bales for the presence of weed propagules, to prevent unintentional spread of noxious species in hay bales. To examine this objective known quantity of seeds were added in a series of distributions to bales of seed free pasture hay, and a positive correlation for the amount of seed added per bale with that recovered in core samples was observed. Whilst the number of seeds detected per bale varied according to the distribution of seeds within the bales and the number of cores analysed, the absolute detection of seeds suggests that this sampling method is worthy of further examination. In addition, a pragmatic estimation of bale remnants after stock feeding has been investigated to more closely estimate the potential size of the remaining seed bank. The authors propose that development of this approach is timely, in the light of future climatic uncertainty driving extreme weather events that increase the need for relief fodder, which can be a potential vector for the spread of noxious weed seeds.	[Weller, Sandra; Florentine, Singarayer] Federat Univ Australia, Ctr Environm Management, Fac Sci & Technol, Mt Helen, Vic, Australia; [Sillitoe, James] Federat Univ, Res Serv, Mt Helen, Vic, Australia; [Grech, Charles; McLaren, David] Dept Environm & Primary Ind, Bundoora, Vic, Australia; [Chauhan, Bhagirath Singh] Univ Queensland, QAAFI, Toowoomba, Qld, Australia	Federation University Australia; Federation University Australia; University of Queensland	Florentine, S (corresponding author), Federat Univ Australia, Ctr Environm Management, Fac Sci & Technol, Mt Helen, Vic, Australia.	s.florentine@federation.edu.au	Florentine, Singarayer/Q-7198-2019; Florentine, Singarayer/ABA-7740-2020; Chauhan, Bhagirath/G-8892-2014	Florentine, Singarayer/0000-0002-5734-3421; Chauhan, Bhagirath/0000-0003-1540-4668; Weller, Sandra/0000-0003-4204-8582	Department of Environment and Primary Industries; Federation University Australia	Department of Environment and Primary Industries; Federation University Australia	This study was supported by the Department of Environment and Primary Industries to SF; Federation University Australia, PhD Scholarship to SW.	AFIA, 2007, AN AFIA LAB MAN REF, P8; Aljoe H, SAMPLING HAY STANDIN; BELYEA RL, 1985, J DAIRY SCI, V68, P3371, DOI 10.3168/jds.S0022-0302(85)81250-9; BOURDOT GW, 1992, NEW ZEAL J AGR RES, V35, P101; Bureau of Meterology, CLIM DAT ONL; Buskirk DD, 2003, J ANIM SCI, V81, P109; Clines J, 2005, P P CAL INV PLANTS C, P4; COBLE CG, 1987, BIOMASS, V14, P209, DOI 10.1016/0144-4565(87)90048-5; Collins M, 2000, HAY SAMPLING PRINCIP; Conn JS, 2010, INVAS PLANT SCI MANA, V3, P276, DOI 10.1614/IPSM-D-09-00041.1; DPI, INF IMP FODD NSW; DWLBC, BUYING FODD AR YOU G; FOREMAN DB, 1993, FLORA VICTORIA; Gardener M. R., 1998, BIOL NASSELLA NEESIA; Gardener MR, 2003, AUST J AGR RES, V54, P621, DOI 10.1071/AR01076; Invasive Species Council, VICT BUSHF COULD PAV; Kienzle LC, 1944, TOOL SAMPLING BALED, p[409, 592]; Marble VL, 1989, 19 CAL ALF S 6 7 DEC, P92; Martin P, 2009, AUSTR FODDER IND OVE; McIntyre GA, 1978, MEASUREMENT GRASSLAN, P8; McIntyre S, 2005, AUST J BOT, V53, P757, DOI 10.1071/BT05088; MCIVOR JG, 1987, AUST J EXP AGR, V27, P283, DOI 10.1071/EA9870283; MEYER JH, 1959, J ANIM SCI, V18, P1223, DOI 10.2527/jas1959.1841233x; NORDSKOG AW, 1945, J ANIM SCI, V4, P113, DOI 10.2527/jas1945.42113x; North American Weed Management Association, 2006, MIN CERT STAND N AM; Orloff S, 1999, 29 CAL ALF S 8 9 DEC, P120; PEART MH, 1979, J ECOL, V67, P843, DOI 10.2307/2259218; Schoenig S, 2007, CERTIFIED WEED FREE; Sheaffer CC, 2000, AGRON J, V92, P64, DOI 10.1007/s100870050008; Sindel BM, 2009, FINAL REPORT PATHWAY; Sinden Jack, 2005, Plant Protection Quarterly, V20, P25; STAMP NE, 1984, J ECOL, V72, P611, DOI 10.2307/2260070; THOMAS AG, 1984, J AUST I AGR SCI, V50, P103; Trounce B, 2007, WEED STRATEGIES FOLL; Vila M, 2000, J ECOL, V88, P479, DOI 10.1046/j.1365-2745.2000.00460.x; Weller S, 2015, CROP PROT, V70, P21, DOI 10.1016/j.cropro.2014.12.014; Weston PH, 1993, FLORA NEW S WALES, V4, P133; Wollner HJ, 1941, IND ENG CHEM, V13, P0883, DOI 10.1021/i560100a007	38	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137343	10.1371/journal.pone.0137343	http://dx.doi.org/10.1371/journal.pone.0137343			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348493	Green Published, Green Submitted, gold			2022-12-26	WOS:000360897600038
J	Durkin, J; Bissett, J; Pahlavani, M; Mooney, B; Buchwaldt, L				Durkin, Jonathan; Bissett, John; Pahlavani, Mohammadhadi; Mooney, Brent; Buchwaldt, Lone			IGS Minisatellites Useful for Race Differentiation in Colletotrichum lentis and a Likely Site of Small RNA Synthesis Affecting Pathogenicity	PLOS ONE			English	Article							INTERGENIC SPACER REGION; RIBOSOMAL-RNA; SCLEROTINIA-SCLEROTIORUM; RFLP ANALYSIS; TRUNCATUM; SEQUENCE; FUSARIUM; DNA; RDNA; IDENTIFICATION	Colletotrichum lentis is a fungal pathogen of lentil in Canada but rarely reported elsewhere. Two races, Ct0 and Ct1, have been identified using differential lines. Our objective was to develop a PCR-probe differentiating these races. Sequences of the translation elongation factor 1 alpha (tef1 alpha), RNA polymerase II subunit B2 (rpb2), ATP citrate lyase subunit A (acla), and internal transcribed spacer (ITS) regions were monomorphic, while the intergenic spacer (IGS) region showed length polymorphisms at two minisatellites of 23 and 39 nucleotides (nt). A PCR-probe (39F/R) amplifying the 39 nt minisatellite was developed which subsequently revealed 1-5 minisatellites with 1-12 repeats in C. lentis. The probe differentiated race Ct1 isolates having 7, 9 or 7+9 repeats from race Ct0 having primarily 2 or 4 repeats, occasionally 5, 6, or 8, but never 7 or 9 repeats. These isolates were collected between 1991 and 1999. In a 2012 survey isolates with 2 and 4 repeats increased from 34% to 67%, while isolated with 7 or 9 repeats decreased from 40 to 4%, likely because Ct1 resistant lentil varieties had been grown. The 39 nt repeat was identified in C. gloeosporioides, C. trifolii, Ascochyta lentis, Sclerotinia sclerotiorum and Botrytis cinerea. Thus, the 39F/R PCR probe is not species specific, but can differentiate isolates based on repeat number. The 23 nt minisatellite in C. lentis exists as three length variants with ten sequence variations differentiating race Ct0 having 14 or 19 repeats from race Ct1 having 17 repeats, except for one isolate. RNA-translation of 23 nt repeats forms hairpins and has the appropriate length to suggest that IGS could be a site of small RNA synthesis, a hypothesis that warrants further investigation. Small RNA from fungal plant pathogens able to silence genes either in the host or pathogen thereby aiding infection have been reported.	[Durkin, Jonathan; Mooney, Brent; Buchwaldt, Lone] Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada; [Bissett, John] Agr & Agri Food Canada, Eastern Cereal & Oilseed Res Ctr, Ottawa, ON, Canada; [Pahlavani, Mohammadhadi] Gorgan Univ Agr Sci, Dept Agron & Plant Breeding, Gorgan, Iran	Agriculture & Agri Food Canada; Agriculture & Agri Food Canada	Buchwaldt, L (corresponding author), Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada.	Lone.Buchwaldt@agr.gc.ca						Aminnejad M, 2009, AM EURASIAN J AGR EN, V6, P697; ANDERSON K. L., 1999, CAN PLANT DIS SURV, V79, P126; Appel DJ, 1996, MOL PLANT MICROBE IN, V9, P125, DOI 10.1094/MPMI-9-0125; Armstrong-Cho CL, 2006, MYCOL RES, V110, P951, DOI 10.1016/j.mycres.2006.06.002; Audas TE, 2012, MOL CELL, V45, P147, DOI 10.1016/j.molcel.2011.12.012; BALDRIDGE GD, 1992, J MOL EVOL, V35, P514, DOI 10.1007/BF00160212; Buchwaldt L, 2004, PHYTOPATHOLOGY, V94, P236, DOI 10.1094/PHYTO.2004.94.3.236; Buchwaldt L, 1996, PHYTOPATHOLOGY, V86, P1193, DOI 10.1094/Phyto-86-1193; Buchwaldt L, 2013, CAN J PLANT PATHOL, V35, P222, DOI 10.1080/07060661.2013.768296; Cannon PF, 2012, STUD MYCOL, P181, DOI 10.3114/sim0014; Chongo G, 1999, CAN J PLANT PATHOL, V21, P16, DOI 10.1080/07060661.1999.10600116; Clarkson JP, 2013, PLANT PATHOL, V62, P309, DOI 10.1111/j.1365-3059.2012.02635.x; Damm U, 2014, STUD MYCOL, P49, DOI 10.1016/j.simyco.2014.09.003; Diermeier SD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003786; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Ford R, 2004, AUSTRALAS PLANT PATH, V33, P559, DOI 10.1071/AP04058; Forseille L, 2011, CAN J PLANT PATHOL, V33, P512, DOI 10.1080/07060661.2011.619580; Gale LR, 2003, PLANT DIS, V87, P1433, DOI 10.1094/PDIS.2003.87.12.1433; Gossen BD, 2009, CAN J PLANT PATHOL, V31, P65, DOI 10.1080/07060660909507573; Grafenhan T, 2011, STUD MYCOL, P79, DOI 10.3114/sim.2011.68.04; Hinojo MJ, 2004, SYST APPL MICROBIOL, V27, P681, DOI 10.1078/0723202042369938; Hong SG, 2005, MYCOL RES, V109, P87, DOI 10.1017/S0953756204001388; Hoyos-Carvajal L, 2009, FUNGAL GENET BIOL, V46, P615, DOI 10.1016/j.fgb.2009.04.006; Kaiser WJ, 1998, PLANT DIS, V82, P128, DOI 10.1094/PDIS.1998.82.1.128C; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim HJ, 2001, J MICROBIOL, V39, P265; Kim Hyun-Jung, 2004, Mycobiology, V32, P119; KIM WK, 1992, CURR GENET, V22, P101, DOI 10.1007/BF00351468; Konstantinova P, 2004, INT J FOOD MICROBIOL, V95, P321, DOI 10.1016/j.ijfoodmicro.2003.12.010; Latunde-Dada AO, 2007, PLANT PATHOL, V56, P437, DOI 10.1111/j.1365-3059.2007.01576.x; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; Llorens A, 2006, ANTON LEEUW INT J G, V89, P465, DOI 10.1007/s10482-005-9045-7; Morrall RAA, 1997, CAN J PLANT PATHOL, V19, P197, DOI 10.1080/07060669709500554; MORRALL RAA, 1988, PLANT DIS, V72, P994, DOI 10.1094/PD-72-0994D; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; MOSS T, 1995, PROG NUCLEIC ACID RE, V50, P25, DOI 10.1016/S0079-6603(08)60810-7; Nagarajan Gopal, 2004, The Plant Pathology Journal, V20, P264; Nalim FA, 2009, PHYTOPATHOLOGY, V99, P462, DOI 10.1094/PHYTO-99-4-0462; Nunes CC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-288; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pecchia S, 2004, MYCOPATHOLOGIA, V157, P317, DOI 10.1023/B:MYCO.0000024185.66158.7e; Pecchia S, 1998, FEMS MICROBIOL LETT, V166, P21, DOI 10.1111/j.1574-6968.1998.tb13178.x; Pramateftaki PV, 2000, FUNGAL GENET BIOL, V29, P19, DOI 10.1006/fgbi.1999.1178; Qutob D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2354; Roose-Amsaleg C, 2002, MYCOL RES, V106, P918, DOI 10.1017/S0953756202006251; Shaikh R, 2013, GENET RESOUR CROP EV, V60, P193, DOI 10.1007/s10722-012-9825-7; Shiue CN, 2014, NUCLEIC ACIDS RES, V42, P5505, DOI 10.1093/nar/gku183; Silva DN, 2012, MOL ECOL, V21, P2655, DOI 10.1111/j.1365-294X.2012.05557.x; SOMMERVILLE J, 1984, NATURE, V310, P189, DOI 10.1038/310189a0; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOLMSOFF WJ, 1983, ANNU REV PHYTOPATHOL, V21, P317, DOI 10.1146/annurev.py.21.090183.001533; Vandenberg A, 2006, CAN J PLANT SCI, V86, P497, DOI 10.4141/P05-071; Vandenberg A, 2002, CAN J PLANT SCI, V82, P111, DOI 10.4141/P01-003; VENETTE JR, 1994, PLANT DIS, V78, P1216, DOI 10.1094/PD-78-1216D; Weiberg A, 2013, SCIENCE, V342, P118, DOI 10.1126/science.1239705; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Zhou JH, 2012, MOL GENET GENOMICS, V287, P275, DOI 10.1007/s00438-012-0678-8; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	60	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137398	10.1371/journal.pone.0137398	http://dx.doi.org/10.1371/journal.pone.0137398			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340001	Green Published, Green Submitted, gold			2022-12-26	WOS:000360688200053
J	Malcolm, HR; Blount, P				Malcolm, Hannah R.; Blount, Paul			Mutations in a Conserved Domain of E-coli MscS to the Most Conserved Superfamily Residue Leads to Kinetic Changes	PLOS ONE			English	Article							MECHANOSENSITIVE CHANNEL MSCS; BCNG ION CHANNELS; SMALL-CONDUCTANCE; SINGLE RESIDUE; MECHANISM; TENSION; IDENTIFICATION; PURIFICATION; PREFERENCE; FAMILIES	In Escherichia coli (E. coli) the mechanosensitive channel of small conductance, MscS, gates in response to membrane tension created from acute external hypoosmotic shock, thus rescuing the bacterium from cell lysis. E. coli MscS is the most well studied member of the MscS superfamily of channels, whose members are found throughout the bacterial and plant kingdoms. Homology to the pore lining helix and upper vestibule domain of E. coli MscS is required for inclusion into the superfamily. Although highly conserved, in the second half of the pore lining helix (TM3B), E. coli MscS has five residues significantly different from other members of the superfamily. In superfamilies such as this, it remains unclear why variations within such a homologous region occur: is it tolerance of alternate residues, or does it define functional variance within the superfamily? Point mutations (S114I/T, L118F, A120S, L123F, F127E/K/T) and patch clamp electrophysiology were used to study the effect of changing these residues in E. coli MscS on sensitivity and gating. The data indicate that variation at these locations do not consistently lead to wildtype channel phenotypes, nor do they define large changes in mechanosensation, but often appear to effect changes in the E. coli MscS channel gating kinetics.	[Malcolm, Hannah R.; Blount, Paul] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 76390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Blount, P (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 76390 USA.	Paul.Blount@utsouthwestern.edu		Malcolm, Hannah/0000-0001-9792-8494	Welch Foundation [I-1420]; Cancer Prevention & Research Institute of Texas (CPRIT) [RP100146]; National Institutes of Health [GM061028]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061028] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); Cancer Prevention & Research Institute of Texas (CPRIT); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant I-1420 of the Welch Foundation (Welch1.org), Grant RP100146 from the Cancer Prevention & Research Institute of Texas (CPRIT; http://www.cprit.state.tx.us/), and Grant GM061028 from the National Institutes of Health (NIH.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akitake B, 2005, J GEN PHYSIOL, V125, P143, DOI 10.1085/jgp.200409198; Akitake B, 2007, NAT STRUCT MOL BIOL, V14, P1141, DOI 10.1038/nsmb1341; Balleza D, 2009, EUR BIOPHYS J BIOPHY, V38, P1013, DOI 10.1007/s00249-009-0460-y; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Belyy V, 2010, NAT STRUCT MOL BIOL, V17, P451, DOI 10.1038/nsmb.1775; Blount P, 1999, Methods Enzymol, V294, P458; Blount P, 1999, TRENDS MICROBIOL, V7, P420, DOI 10.1016/S0966-842X(99)01594-2; Blount P, 1997, BIOL BULL, V192, P126, DOI 10.2307/1542585; Blount P, 1996, P NATL ACAD SCI USA, V93, P11652, DOI 10.1073/pnas.93.21.11652; Blount P, 1996, EMBO J, V15, P4798, DOI 10.1002/j.1460-2075.1996.tb00860.x; Booth IR, 2012, J BACTERIOL, V194, P4802, DOI 10.1128/JB.00576-12; Edwards MD, 2008, BIOPHYS J, V94, P3003, DOI 10.1529/biophysj.107.123448; Edwards MD, 2012, CHANNELS, V6, P272, DOI 10.4161/chan.20998; Haswell ES, 2008, CURR BIOL, V18, P730, DOI 10.1016/j.cub.2008.04.039; Haswell ES, 2011, STRUCTURE, V19, P1356, DOI 10.1016/j.str.2011.09.005; Iscla I, 2008, BIOPHYS J, V95, P2283, DOI 10.1529/biophysj.107.127423; Iscla I, 2011, FASEB J, V25, P694, DOI 10.1096/fj.10-170878; Kamaraju K, 2011, J GEN PHYSIOL, V138, P49, DOI 10.1085/jgp.201110606; Kloda A, 2002, EUR BIOPHYS J BIOPHY, V31, P14, DOI 10.1007/s002490100160; Kloda A, 2001, CELL BIOCHEM BIOPHYS, V34, P349, DOI 10.1385/CBB:34:3:349; Kloda A, 2008, INT J BIOCHEM CELL B, V40, P164, DOI 10.1016/j.biocel.2007.02.003; Koprowski P, 2003, J BIOL CHEM, V278, P11237, DOI 10.1074/jbc.M212073200; Koprowski P, 2011, J BIOL CHEM, V286, P877, DOI 10.1074/jbc.M110.176131; Lai JY, 2013, PROTEIN SCI, V22, P502, DOI 10.1002/pro.2222; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Maksaev G, 2012, P NATL ACAD SCI USA, V109, P19015, DOI 10.1073/pnas.1213931109; Maksaev G, 2011, J GEN PHYSIOL, V138, P641, DOI 10.1085/jgp.201110723; Malcolm HR, 2015, BBA-BIOMEMBRANES, V1848, P159, DOI 10.1016/j.bbamem.2014.10.022; Malcolm HR, 2012, EUR BIOPHYS J BIOPHY, V41, P1003, DOI 10.1007/s00249-012-0855-z; Malcolm HR, 2012, CHEMBIOCHEM, V13, P2037, DOI 10.1002/cbic.201200410; Malcolm HR, 2012, BIOCHEM BIOPH RES CO, V417, P972, DOI 10.1016/j.bbrc.2011.12.049; Malcolm HR, 2011, BIOPHYS J, V101, P345, DOI 10.1016/j.bpj.2011.05.058; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; Miller S, 2003, EMBO J, V22, P36, DOI 10.1093/emboj/cdg011; Nakayama Y, 2014, CELL CALCIUM, V56, P467, DOI 10.1016/j.ceca.2014.10.001; Nakayama Y, 2014, FEMS YEAST RES, V14, P992, DOI 10.1111/1567-1364.12181; Nakayama Y, 2013, BIOPHYS J, V105, P1366, DOI 10.1016/j.bpj.2013.06.054; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Petrov E, 2013, BIOPHYS J, V104, P1426, DOI 10.1016/j.bpj.2013.01.055; Pivetti CD, 2003, MICROBIOL MOL BIOL R, V67, P66, DOI 10.1128/MMBR.67.1.66-85.2003; Rowe I, 2014, J GEN PHYSIOL, V143, P543, DOI 10.1085/jgp.201311114; Schumann U, 2010, P NATL ACAD SCI USA, V107, P12664, DOI 10.1073/pnas.1001405107; Sukharev S, 2002, BIOPHYS J, V83, P290, DOI 10.1016/S0006-3495(02)75169-2; Vasquez V, 2008, SCIENCE, V321, P1210, DOI 10.1126/science.1159674; Vasquez V, 2008, J MOL BIOL, V378, P55, DOI 10.1016/j.jmb.2007.10.086; Vasquez V, 2007, BIOCHEMISTRY-US, V46, P6766, DOI 10.1021/bi700322k; Wang WJ, 2008, SCIENCE, V321, P1179, DOI 10.1126/science.1159262; Yoshimura K, 1999, BIOPHYS J, V77, P1960, DOI 10.1016/S0006-3495(99)77037-2	49	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0136756	10.1371/journal.pone.0136756	http://dx.doi.org/10.1371/journal.pone.0136756			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340270	Green Published, Green Submitted, gold			2022-12-26	WOS:000360688200015
J	Bhargava, A; Cotton, JA; Dixon, BR; Gedamu, L; Yates, RM; Buret, AG				Bhargava, Amol; Cotton, James A.; Dixon, Brent R.; Gedamu, Lashitew; Yates, Robin M.; Buret, Andre G.			Giardia duodenalis Surface Cysteine Proteases Induce Cleavage of the Intestinal Epithelial Cytoskeletal Protein Villin via Myosin Light Chain Kinase	PLOS ONE			English	Article							ENTAMOEBA-HISTOLYTICA; CATHEPSIN-B; BARRIER FUNCTION; IN-VITRO; ACTIN CYTOSKELETON; MOLECULAR CHARACTERIZATION; MICROTUBULE NETWORK; ESCHERICHIA-COLI; CELL MIGRATION; GROWTH-FACTOR	Giardia duodenalis infections are among the most common causes of waterborne diarrhoeal disease worldwide. At the height of infection, G. duodenalis trophozoites induce multiple pathophysiological processes within intestinal epithelial cells that contribute to the development of diarrhoeal disease. To date, our understanding of pathophysiological processes in giardiasis remains incompletely understood. The present study reveals a previously unappreciated role for G. duodenalis cathepsin cysteine proteases in intestinal epithelial pathophysiological processes that occur during giardiasis. Experiments first established that Giardia trophozoites indeed produce cathepsin B and L in strain-dependent fashion. Co-incubation of G. duodenalis with human enterocytes enhanced cathepsin production by Assemblage A (NF and S2 isolates) trophozoites, but not when epithelial cells were exposed to Assemblage B (GSM isolate) trophozoites. Direct contact between G. duodenalis parasites and human intestinal epithelial monolayers resulted in the degradation and redistribution of the intestinal epithelial cytoskeletal protein villin; these effects were abolished when parasite cathepsin cysteine proteases were inhibited. Interestingly, inhibition of parasite proteases did not prevent degradation of the intestinal tight junction-associated protein zonula occludens 1 (ZO-1), suggesting that G. duodenalis induces multiple pathophysiological processes within intestinal epithelial cells. Finally, this study demonstrates that G. duodenalis-mediated disruption of villin is, at least, in part dependent on activation of myosin light chain kinase (MLCK). Taken together, this study indicates a novel role for parasite cathepsin cysteine proteases in the pathophysiology of G. duodenalis infections.	[Bhargava, Amol; Cotton, James A.; Gedamu, Lashitew; Buret, Andre G.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Bhargava, Amol; Cotton, James A.; Buret, Andre G.] Univ Calgary, Inflammat Res Network, Calgary, AB, Canada; [Bhargava, Amol; Cotton, James A.; Gedamu, Lashitew; Buret, Andre G.] Univ Calgary, Host Parasite Interact, Calgary, AB, Canada; [Dixon, Brent R.] Hlth Canada, Bur Microbial Hazards, Food Directorate, Hlth Prod & Food Branch, Ottawa, ON K1A 0L2, Canada; [Yates, Robin M.] Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB, Canada; [Yates, Robin M.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; Health Canada; University of Calgary; University of Calgary	Buret, AG (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	aburet@ucalgary.ca	Yates, Robin/K-5032-2015	Yates, Robin/0000-0003-3122-1845	Natural Sciences and Engineering Research Council of Canada (NSERC) CREATE program [413888-2012]; NSERC Discovery grant [183681-2011]; NSERC graduate student scholarship; NSERC gradate student scholarship; Alberta Innovates Health Solutions (AIHS); Crohn's and colitis foundation of Canada (CCFC); Alberta Innovates [201400554] Funding Source: researchfish	Natural Sciences and Engineering Research Council of Canada (NSERC) CREATE program(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC graduate student scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC gradate student scholarship; Alberta Innovates Health Solutions (AIHS); Crohn's and colitis foundation of Canada (CCFC); Alberta Innovates	AGB's laboratory is funded in part by a training grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) CREATE program, grant #413888-2012 (URL: http://www.nserc-crsng.gc.ca/) and an NSERC Discovery grant, #183681-2011 (URL: http://www.nserc-crsng.gc.ca/). AB is a recipient of an NSERC graduate student scholarship. JAC is a recipient of an NSERC gradate student scholarship and a joint IBD studentship from Alberta Innovates Health Solutions (AIHS) and the Crohn's and colitis foundation of Canada (CCFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; AGGARWAL A, 1989, MOL BIOCHEM PARASIT, V32, P39, DOI 10.1016/0166-6851(89)90127-8; Ankarklev J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001780; Ankarklev J, 2010, NAT REV MICROBIOL, V8, P413, DOI 10.1038/nrmicro2317; Athman R, 2005, CELL MICROBIOL, V7, P1109, DOI 10.1111/j.1462-5822.2005.00535.x; Athman R, 2002, AM J PHYSIOL-GASTR L, V283, pG496, DOI 10.1152/ajpgi.00207.2002; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD526, DOI 10.1093/nar/gkn631; AVILA EE, 1993, EXP PARASITOL, V76, P232, DOI 10.1006/expr.1993.1028; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; BARRETT AJ, 1980, BIOCHEM J, V187, P909, DOI 10.1042/bj1870909; Battle SE, 2014, INFECT IMMUN, V82, P3713, DOI 10.1128/IAI.01523-13; Rodriguez-Fuentes GB, 2006, MEM I OSWALDO CRUZ, V101, P693, DOI 10.1590/S0074-02762006000600020; Bilenko N, 2004, EUR J EPIDEMIOL, V19, P877, DOI 10.1023/B:EJEP.0000040533.75646.9c; Bonnin A, 1999, EUR J CELL BIOL, V78, P794, DOI 10.1016/S0171-9335(99)80030-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURET A, 1992, GASTROENTEROLOGY, V103, P506, DOI 10.1016/0016-5085(92)90840-U; BURET A, 1990, J INFECT DIS, V162, P231, DOI 10.1093/infdis/162.1.231; Buret AG, 2002, PARASITOLOGY, V125, P11, DOI 10.1017/S0031182002001853; Busatti HGNO, 2009, BIOL-TARGETS THER, V3, P273; Caccio SM, 2008, MOL BIOCHEM PARASIT, V160, P75, DOI 10.1016/j.molbiopara.2008.04.006; Carabeo RA, 2002, INFECT IMMUN, V70, P3793, DOI 10.1128/IAI.70.7.3793-3803.2002; Chin AC, 2002, INFECT IMMUN, V70, P3673, DOI 10.1128/IAI.70.7.3673-3680.2002; Coklin T, 2007, VET PARASITOL, V150, P297, DOI 10.1016/j.vetpar.2007.09.014; Coradi ST, 2006, PARASITOL RES, V99, P131, DOI 10.1007/s00436-005-0124-5; Cotton JA, 2014, INFECT IMMUN, V82, P2772, DOI 10.1128/IAI.01771-14; Cotton JA, 2011, INT J PARASITOL, V41, P925, DOI 10.1016/j.ijpara.2011.05.002; de Carvalho TB, 2008, PARASITOL RES, V104, P185, DOI 10.1007/s00436-008-1185-z; de Carvalho TB, 2014, REV INST MED TROP SP, V56, P43, DOI 10.1590/S0036-46652014000100006; DEBEAUREGARD MAC, 1995, EMBO J, V14, P409, DOI 10.1002/j.1460-2075.1995.tb07017.x; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; DuBois KN, 2008, J BIOL CHEM, V283, P18024, DOI 10.1074/jbc.M802133200; DuBois KN, 2006, PARASITOL RES, V99, P313, DOI 10.1007/s00436-006-0149-4; Eckmann L, 2000, J IMMUNOL, V164, P1478, DOI 10.4049/jimmunol.164.3.1478; Elliott DA, 2000, INFECT IMMUN, V68, P2315, DOI 10.1128/IAI.68.4.2315-2322.2000; FAVENNEC L, 1990, PARASITOL RES, V76, P581, DOI 10.1007/BF00932566; FINLAY BB, 1990, J INFECT DIS, V162, P1096, DOI 10.1093/infdis/162.5.1096; Franzen O, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000560; Garcia-Rivera G, 1999, MOL MICROBIOL, V33, P556, DOI 10.1046/j.1365-2958.1999.01500.x; Goosney DL, 1999, EMERG INFECT DIS, V5, P216, DOI 10.3201/eid0502.990205; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Halliez MCM, 2013, WORLD J GASTROENTERO, V19, P8974, DOI 10.3748/wjg.v19.i47.8974; Heimer J, 2015, ACTA TROP, V145, P17, DOI 10.1016/j.actatropica.2015.01.011; Humen MA, 2011, CELL MICROBIOL, V13, P1683, DOI 10.1111/j.1462-5822.2011.01647.x; Ignatius R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001677; Jacobs T, 1998, MOL MICROBIOL, V27, P269, DOI 10.1046/j.1365-2958.1998.00662.x; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Khurana S, 2008, FEBS LETT, V582, P2128, DOI 10.1016/j.febslet.2008.02.040; Kissoon-Singh V, 2011, ADV EXP MED BIOL, V712, P62, DOI 10.1007/978-1-4419-8414-2_5; Koh WH, 2013, J PARASITOL, V99, P353, DOI 10.1645/GE-3021.1; Krumkamp R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003568; Lasek-Nesselquist E, 2010, INT J PARASITOL, V40, P1063, DOI 10.1016/j.ijpara.2010.02.015; Lauwaet T, 2003, J BIOL CHEM, V278, P22650, DOI 10.1074/jbc.M300142200; Lauwaet T, 2010, J ANTIMICROB CHEMOTH, V65, P531, DOI 10.1093/jac/dkp501; Lhocine N, 2015, CELL HOST MICROBE, V17, P164, DOI 10.1016/j.chom.2014.12.003; Lidell ME, 2006, P NATL ACAD SCI USA, V103, P9298, DOI 10.1073/pnas.0600623103; Louvard RAD, 2003, MOL BIOL CELL, V14, P4641, DOI 10.1091/mbc.E03-02-0091; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; Moncada DM, 2006, GASTROENTEROLOGY, V130, P721, DOI 10.1053/j.gastro.2005.11.012; Muller J, 2006, ANTIMICROB AGENTS CH, V50, P162, DOI 10.1128/AAC.50.1.162-170.2006; MUSIL D, 1991, EMBO J, V10, P2321, DOI 10.1002/j.1460-2075.1991.tb07771.x; OLSON ME, 1995, AM J VET RES, V56, P1470; Olson ME, 1997, CAN VET J, V38, P703; Palm D, 2005, MOL BIOCHEM PARASIT, V141, P199, DOI 10.1016/j.molbiopara.2005.03.005; Read CM, 2004, INFECT GENET EVOL, V4, P125, DOI 10.1016/j.meegid.2004.02.001; Ringqvist E, 2008, MOL BIOCHEM PARASIT, V159, P85, DOI 10.1016/j.molbiopara.2008.02.005; Ringqvist E, 2011, INT J PARASITOL, V41, P277, DOI 10.1016/j.ijpara.2010.09.011; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Savioli L, 2006, TRENDS PARASITOL, V22, P203, DOI 10.1016/j.pt.2006.02.015; Scott KGE, 2004, INFECT IMMUN, V72, P3536, DOI 10.1128/IAI.72.6.3536-3542.2004; Scott KGE, 2002, GASTROENTEROLOGY, V123, P1179, DOI 10.1053/gast.2002.36002; Solaymani-Mohammadi S, 2013, MUCOSAL IMMUNOL, V6, P369, DOI 10.1038/mi.2012.80; Somanna A, 2002, J BIOL CHEM, V277, P25305, DOI 10.1074/jbc.M203034200; Stadelmann B, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-256; Stadelmann B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045325; TCHOUPE JR, 1991, BIOCHIM BIOPHYS ACTA, V1076, P149, DOI 10.1016/0167-4838(91)90232-O; Teoh DA, 2000, J PARASITOL, V86, P800; Tomar A, 2006, J BIOL CHEM, V281, P31972, DOI 10.1074/jbc.M604323200; Troeger H, 2007, GUT, V56, P328, DOI 10.1136/gut.2006.100198; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Upcroft JA, 2001, ANTIMICROB AGENTS CH, V45, P1810, DOI 10.1128/AAC.45.6.1810-1814.2001; Veenemans J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001158; Walker' ME, 2008, MICROBES INFECT, V10, P1440, DOI 10.1016/j.micinf.2008.08.014; Wang L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002437; Wang YH, 2008, J BIOL CHEM, V283, P9454, DOI 10.1074/jbc.M707962200; Wang YH, 2007, AM J PHYSIOL-CELL PH, V292, pC1775, DOI 10.1152/ajpcell.00420.2006; Ward W, 1997, CELL, V89, P437, DOI 10.1016/S0092-8674(00)80224-X; Wensaas KA, 2012, GUT, V61, P214, DOI 10.1136/gutjnl-2011-300220; WILLIAMS AG, 1995, INT J PARASITOL, V25, P771, DOI 10.1016/0020-7519(94)00201-X; Xu FF, 2012, MOL BIOL EVOL, V29, P2895, DOI 10.1093/molbev/mss107; Yang WM, 2012, VIRUS RES, V163, P269, DOI 10.1016/j.virusres.2011.10.011; Yoder JS, 2010, MMWR SURVEILL SUMM, V59, P15	92	44	44	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136102	10.1371/journal.pone.0136102	http://dx.doi.org/10.1371/journal.pone.0136102			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334299	gold, Green Published, Green Submitted			2022-12-26	WOS:000360615400010
J	Lai, CT; Yao, WC; Lin, SY; Liu, HY; Chang, HW; Hu, FR; Chen, WL				Lai, Chun-Ting; Yao, Wei-Chieng; Lin, Szu-Yuan; Liu, Hsin-Yu; Chang, Huai-Wen; Hu, Fung-Rong; Chen, Wei-Li			Changes of Ocular Surface and the Inflammatory Response in a Rabbit Model of Short-Term Exposure Keratopathy	PLOS ONE			English	Article							DRY EYE DISEASE; INTENSIVE-CARE-UNIT; HERPES-ZOSTER OPHTHALMICUS; DESICCATING STRESS; SJOGRENS-SYNDROME; CYTOKINE PROFILES; MOUSE MODEL; TEAR FILM; EXPRESSION; ANTIBODY	Purpose To evaluate the ocular surface change and the inflammatory response in a rabbit model of short-term exposure keratopathy. Methods Short term exposure keratopathy by continuous eyelid opening was induced in New Zealand white rabbits for up to 4 hours. Ultrasound pachymetry was used to detect central total corneal thickness. In vivo confocal microscopy and impression cytology were performed to evaluate the morphology of ocular surface epithelium and the infiltration of inflammatory cells. Immunohistochemistry for macrophage, neutrophil, CD4(+) T cells, and CD8(+) T cells were performed to classify the inflammatory cells. Scanning electron microscopy(SEM) was performed to detect ocular surface change. The concentrations of IL-8, IL-17, Line and TNF-alpha were analyzed by multiplex immunobead assay. TUNEL staining was performed to detect cellular apoptosis. Results Significant decrease ofcentral total cornealthickness were found within the first 5 minutes and remained stable thereafter, while there were no changes of corneal epithelial thickness. No significant change of corneal, limbal and conjunctival epithelial morphology was found by in vivo confocal microscopy except the time dependent increase of superficial cellular defects in the central cornea. Impression cytology also demonstrated time dependent increase of sloughing superficial cells of the central cornea. Aggregations ofinflammatory cells were found at 1 hour in the limbal epithelium, 2 hours in the perilimbal conjunctival epithelium, and 3 hours in the peripheral corneal epithelium. In eyes receiving exposure for 4 hours, the infiltration of the inflammatory cells can still be detected at 8 hours after closing eyes. Immunohistochemical study demonstrated the cells to be macrophages, neutrophils, CD4-T cells and CD-8 T cells. SEM demonstrated time-depending increase of intercellular border and sloughing of superficial epithelial cells in corneal surface. Time dependent increase of IL-8, IL-17 and TNF-alpha in tear was found. TUNEL staining revealed some apoptotic cells in the corneal epithelium and superficial stroma at 3 hours after exposure. Conclusions Short term exposure keratopathy can cause significant changes to the ocular surface and inflammatory response. Decrease of central total corneal thickness, aggregation of inflammatory cells, and cornea epithelial cell and superficial keratocyte apoptosis were found no less than 4 hours following the insult.	[Lai, Chun-Ting; Liu, Hsin-Yu; Chang, Huai-Wen; Hu, Fung-Rong; Chen, Wei-Li] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Yao, Wei-Chieng] Min Sheng Gen Hosp, Dept Anesthesia, Taoyuan, Taiwan; [Lin, Szu-Yuan] Cathay Gen Hosp, Deparment Ophthalmol, Taipei, Taiwan; [Hu, Fung-Rong; Chen, Wei-Li] Natl Taiwan Univ Hosp, Ctr Corneal Tissue Engn & Stem Cell Biol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; Cathay General Hospital; National Taiwan University; National Taiwan University Hospital	Chen, WL (corresponding author), Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.	chenweili@ntu.edu.tw		CHEN, WEI-LI/0000-0002-1538-2414; HU, FUNG-RONG/0000-0002-2102-5317	National Taiwan University Hospital Plan Asia One; Department of Medical Research at the NTUH; National Taiwan University Hospital [100001]; Ministry of Science and Technology, Taiwan [NSC 103-2314-B-002-074-MY3]; Min-Sheng General Hospital [100001]	National Taiwan University Hospital Plan Asia One; Department of Medical Research at the NTUH; National Taiwan University Hospital(National Taiwan University); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Min-Sheng General Hospital	Supported, in part, by the National Taiwan University Hospital Plan Asia One and the Department of Medical Research at the NTUH, the Jointed Research Grant between National Taiwan University Hospital and Min-Sheng General Hospital 100001, and Grant NSC 103-2314-B-002-074-MY3 from the Ministry of Science and Technology, Taiwan.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Ang RT, 2001, CURR OPIN OPHTHALMOL, V12, P318, DOI 10.1097/00055735-200108000-00013; Asman P, 2003, ACTA OPHTHALMOL SCAN, V81, P437, DOI 10.1034/j.1600-0420.2003.00147.x; Barabino S, 2005, INVEST OPHTH VIS SCI, V46, P2766, DOI 10.1167/iovs.04-1326; Barabino S, 2012, PROG RETIN EYE RES, V31, P271, DOI 10.1016/j.preteyeres.2012.02.003; Barrera MJ, 2013, J AUTOIMMUN, V42, P7, DOI 10.1016/j.jaut.2013.02.001; Boehm N, 2011, INVEST OPHTH VIS SCI, V52, P7725, DOI 10.1167/iovs.11-7266; Bonini S, 2003, EYE, V17, P989, DOI 10.1038/sj.eye.6700616; Bron AJ, 2014, OCUL SURF, V12, pS1, DOI 10.1016/j.jtos.2014.02.002; Buratto L, 1997, Curr Opin Ophthalmol, V8, P59, DOI 10.1097/00055735-199708000-00009; Chauhan SK, 2009, J IMMUNOL, V182, P1247, DOI 10.4049/jimmunol.182.3.1247; Chen WL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094205; Chen YH, 2013, INVEST OPHTH VIS SCI, V54, P2457, DOI 10.1167/iovs.12-11121; COBO LM, 1988, CORNEA, V7, P50; COLLINS M, 1989, ACTA OPHTHALMOL, V67, P525; Corrales RM, 2007, CORNEA, V26, P579, DOI 10.1097/ICO.0b013e318033a729; Pereira MVC, 2010, SEMIN OPHTHALMOL, V25, P72, DOI 10.3109/08820538.2010.488578; DANJO Y, 1994, ACTA OPHTHALMOL, V72, P433; De Paiva CS, 2009, MUCOSAL IMMUNOL, V2, P243, DOI 10.1038/mi.2009.5; Dinakaran S, 2002, EUR J OPHTHALMOL, V12, P331, DOI 10.1177/112067210201200415; Dursun D, 2002, INVEST OPHTH VIS SCI, V43, P632; El Annan J, 2009, INVEST OPHTH VIS SCI, V50, P3802, DOI 10.1167/iovs.08-2417; Ellenberg D, 2010, PROG RETIN EYE RES, V29, P208, DOI 10.1016/j.preteyeres.2010.01.002; Elner Victor M, 2003, Arch Facial Plast Surg, V5, P427, DOI 10.1001/archfaci.5.5.427; Ezra DG, 2005, BRIT J OPHTHALMOL, V89, P1068, DOI 10.1136/bjo.2004.062406; Feltham MH, 2002, CLIN EXP OPHTHALMOL, V30, P99, DOI 10.1046/j.1442-6404.2002.00496.x; Foster KW, 2005, J AM ACAD DERMATOL, V53, P707, DOI 10.1016/j.jaad.2005.03.063; Freegard TJ, 1997, EYE, V11, P465, DOI 10.1038/eye.1997.127; Gire A, 2013, OPHTHAL PLAST RECONS, V29, pE38, DOI 10.1097/IOP.0b013e3182674069; Grixti A, 2012, OCUL SURF, V10, P26, DOI 10.1016/j.jtos.2011.10.001; Jammal H, 2012, J CRIT CARE, V27, P537, DOI 10.1016/j.jcrc.2012.02.005; JESTER JV, 1982, INVEST OPHTH VIS SCI, V22, P660; Ji YW, 2013, INVEST OPHTH VIS SCI, V54, P7557, DOI 10.1167/iovs.12-11515; Johnson ME, 2004, PROG RETIN EYE RES, V23, P449, DOI 10.1016/j.preteyeres.2004.04.003; Jones DT, 1998, ADV EXP MED BIOL, V438, P533; Joo CK, 1999, J CATARACT REFR SURG, V25, P1165, DOI 10.1016/S0886-3350(99)00117-0; Khanal S, 2009, OPTOMETRY VISION SCI, V86, P1235, DOI 10.1097/OPX.0b013e3181bc63cc; Komohara Y, 2006, J HISTOCHEM CYTOCHEM, V54, P763, DOI 10.1369/jhc.5A6871.2006; Lam H, 2009, AM J OPHTHALMOL, V147, P198, DOI 10.1016/j.ajo.2008.08.032; Lee SY, 2013, AM J OPHTHALMOL, V156, P247, DOI 10.1016/j.ajo.2013.04.003; Leinowitz H, 1998, CORNEAL DISORDERS CL, P2; Lenart S B, 2000, Am J Crit Care, V9, P188; Liesegang TJ, 1997, CORNEA, V16, P125; Maurice DM, 1984, EYE B, V1, P1; McGinnigle S, 2012, SURV OPHTHALMOL, V57, P293, DOI 10.1016/j.survophthal.2011.11.003; McHugh J, 2008, EYE, V22, P1465, DOI 10.1038/sj.eye.6702930; Moore JE, 2009, BRIT J OPHTHALMOL, V93, P66, DOI 10.1136/bjo.2007.131722; Moss SE, 2004, ARCH OPHTHALMOL-CHIC, V122, P369, DOI 10.1001/archopht.122.3.369; PFLUGFELDER SC, 1990, OPHTHALMOLOGY, V97, P985; PFLUGFELDER SC, 1986, OPHTHALMOLOGY, V93, P1513; Pflugfelder SC, 2008, CORNEA, V27, pS9, DOI 10.1097/ICO.0b013e31817f4075; Pflugfelder SC, 2013, EXP EYE RES, V117, P118, DOI 10.1016/j.exer.2013.08.013; Pflugfelder SC, 2009, OCUL SURF, V7, P67, DOI 10.1016/S1542-0124(12)70297-5; Rao NA, 2004, OPHTHALMOLOGY, P1105; Saritas TB, 2013, THESCIENTIFICWORLDJO, V2013, DOI [10.1155/2013/182038, DOI 10.1155/2013/182038]; Shaikh S, 2002, AM FAM PHYSICIAN, V66, P1723; Shan H, 2010, INT J OPHTHALMOL-CHI, V3, P346, DOI 10.3980/j.issn.2222-3959.2010.04.16; Shen MX, 2009, INVEST OPHTH VIS SCI, V50, P2722, DOI 10.1167/iovs.08-2704; Stern Michael E, 2004, Ocul Surf, V2, P124; Stevenson W, 2012, ARCH OPHTHALMOL-CHIC, V130, P90, DOI 10.1001/archophthalmol.2011.364; Tomlinson A, 2013, OCUL SURF, V11, P267, DOI 10.1016/j.jtos.2013.05.002; TSUBOTA K, 1995, ARCH OPHTHALMOL-CHIC, V113, P155, DOI 10.1001/archopht.1995.01100020037025; van der Wekken RJ, 2013, NETH J MED, V71, P204; Wei YH, 2013, J FORMOS MED ASSOC, V13, P358; Yeh S, 2003, INVEST OPHTH VIS SCI, V44, P124, DOI 10.1167/iovs.02-0581; Yoon KC, 2007, INVEST OPHTH VIS SCI, V48, P2561, DOI 10.1167/iovs.07-0002; Yoon KC, 2011, INVEST OPHTH VIS SCI, V52, P7267, DOI 10.1167/iovs.11-7231; Yoon KC, 2010, INVEST OPHTH VIS SCI, V51, P643, DOI 10.1167/iovs.09-3425; Yuan YM, 2010, AM J OPHTHALMOL, V149, P932, DOI 10.1016/j.ajo.2010.01.004; Zeng L, 1996, J PATHOL, V178, P207; Zheng XF, 2010, J CELL PHYSIOL, V222, P95, DOI 10.1002/jcp.21926	71	12	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137186	10.1371/journal.pone.0137186	http://dx.doi.org/10.1371/journal.pone.0137186			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334533	Green Published, Green Submitted, gold			2022-12-26	WOS:000360615400043
J	Cannistraro, VJ; Pondugula, S; Song, Q; Taylor, JS				Cannistraro, Vincent J.; Pondugula, Santhi; Song, Qian; Taylor, John-Stephen			Rapid Deamination of Cyclobutane Pyrimidine Dimer Photoproducts at TCG Sites in a Translationally and Rotationally Positioned Nucleosome in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMINE DNA GLYCOSYLASE; CHROMATIN-STRUCTURE; CORE PARTICLE; ANGSTROM RESOLUTION; ULTRAVIOLET-LIGHT; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; GAMMA-RADIATION; POLYMERASE ETA; UV-MUTAGENESIS	Sunlight-induced C to T mutation hot spots in skin cancers occur primarily at methylated CpG sites that coincide with sites of UV-induced cyclobutane pyrimidine dimer (CPD) formation. The C and 5-methyl-C in CPDs are not stable and deaminate to U and T, respectively, which leads to the insertion of A by the DNA damage bypass polymerase eta, thereby defining a probable mechanism for the origin of UV-induced C to T mutations. Deamination rates for T(m)CG CPDs have been found to vary 12-fold with rotational position in a nucleosome in vitro. To determine the influence of nucleosome structure on deamination rates in vivo, we determined the deamination rates of CPDs at TCG sites in a stably positioned nucleosome within the FOS promoter in HeLa cells. A procedure for in vivo hydroxyl radical footprinting with Fe-EDTA was developed, and, together with results from a cytosine methylation protection assay, we determined the translational and rotational positions of the TCG sites. Consistent with the in vitro observations, deamination was slower for one CPD located at an intermediate rotational position compared with two other sites located at outside positions, and all were much faster than for CPDs at non-TCG sites. Photoproduct formation was also highly suppressed at one site, possibly due to its interaction with a histone tail. Thus, it was shown that CPDs of TCG sites deaminate the fastest in vivo and that nucleosomes can modulate both their formation and deamination, which could contribute to the UV mutation hot spots and cold spots.	[Cannistraro, Vincent J.; Pondugula, Santhi; Song, Qian; Taylor, John-Stephen] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL)	Taylor, JS (corresponding author), Washington Univ, Dept Chem, St Louis, MO 63130 USA.	taylor@wustl.edu	Taylor, John-Stephen/AAA-3218-2020	Taylor, John-Stephen/0000-0002-8615-7257	National Cancer Institute, National Institutes of Health [R01 CA40463]; NATIONAL CANCER INSTITUTE [R01CA040463] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Cancer Institute, National Institutes of Health Grant R01 CA40463 (to J.-S. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Adilakshmi T, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl291; Andrews AJ, 2011, ANNU REV BIOPHYS, V40, P99, DOI 10.1146/annurev-biophys-042910-155329; Balasubramanian B, 1998, P NATL ACAD SCI USA, V95, P9738, DOI 10.1073/pnas.95.17.9738; Barrett TE, 1998, CELL, V92, P117, DOI 10.1016/S0092-8674(00)80904-6; Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; Blomquist P, 1996, J BIOL CHEM, V271, P153, DOI 10.1074/jbc.271.1.153; Burger A, 2003, MUTAT RES-FUND MOL M, V522, P145, DOI 10.1016/S0027-5107(02)00310-X; Bykov VJ, 1999, J INVEST DERMATOL, V112, P326, DOI 10.1046/j.1523-1747.1999.00523.x; Cannistraro VJ, 2009, J MOL BIOL, V392, P1145, DOI 10.1016/j.jmb.2009.07.048; Darst RP, 2013, NUCLEIC ACIDS RES, V41, P2993, DOI 10.1093/nar/gkt033; Darst RP, 2012, METHODS MOL BIOL, V833, P125, DOI 10.1007/978-1-61779-477-3_9; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Delmas AL, 2011, CARCINOGENESIS, V32, P1625, DOI 10.1093/carcin/bgr193; DEVRIES E, 1987, EMBO J, V6, P161, DOI 10.1002/j.1460-2075.1987.tb04734.x; DIXON WJ, 1991, METHOD ENZYMOL, V208, P380; FIX D, 1981, MOL GEN GENET, V182, P7, DOI 10.1007/BF00422759; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; Gaffney DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003036; GALE JM, 1987, P NATL ACAD SCI USA, V84, P6644, DOI 10.1073/pnas.84.19.6644; Hara R, 2003, MOL CELL BIOL, V23, P4121, DOI 10.1128/MCB.23.12.4121-4125.2003; HAYES JJ, 1991, P NATL ACAD SCI USA, V88, P6829, DOI 10.1073/pnas.88.15.6829; Herrera RE, 1997, CHROMOSOMA, V106, P284, DOI 10.1007/s004120050249; Ikehata H, 2014, DNA REPAIR, V22, P112, DOI 10.1016/j.dnarep.2014.07.012; Ikehata H, 2011, J RADIAT RES, V52, P115, DOI 10.1269/jrr.10175; KAPPEN LS, 1983, BIOCHEMISTRY-US, V22, P4872, DOI 10.1021/bi00290a002; Kladde MP, 1999, METHOD ENZYMOL, V304, P431; Komura J, 2003, BIOCHEMISTRY-US, V42, P15084, DOI 10.1021/bi034802t; Lee DH, 2003, J BIOL CHEM, V278, P10314, DOI 10.1074/jbc.M212696200; LEMAIRE DGE, 1993, BIOCHEMISTRY-US, V32, P2525, DOI 10.1021/bi00061a009; LJUNGMAN M, 1992, MOL CARCINOGEN, V5, P264, DOI 10.1002/mc.2940050406; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Morgan MT, 2007, J BIOL CHEM, V282, P27578, DOI 10.1074/jbc.M704253200; Mouret S, 2008, DNA REPAIR, V7, P704, DOI 10.1016/j.dnarep.2008.01.005; Mueller P R, 2001, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1503s56; Nabilsi NH, 2014, GENOME RES, V24, P329, DOI 10.1101/gr.161737.113; O'Donnell A, 2008, MOL CELL, V29, P780, DOI 10.1016/j.molcel.2008.01.019; Ottinger LM, 2000, J AM CHEM SOC, V122, P5901, DOI 10.1021/ja000285f; Pardo CE, 2015, METHODS MOL BIOL, V1288, P123, DOI 10.1007/978-1-4939-2474-5_9; Pardo CE, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq716; PEHRSON JR, 1989, P NATL ACAD SCI USA, V86, P9149, DOI 10.1073/pnas.86.23.9149; Peng W, 1996, BIOCHEMISTRY-US, V35, P10172, DOI 10.1021/bi960001x; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Pondugula S, 2008, J CELL BIOCHEM, V105, P330, DOI 10.1002/jcb.21849; Ryabinina OP, 2011, DNA REPAIR, V10, P1014, DOI 10.1016/j.dnarep.2011.07.015; Schieferstein U, 1996, BIOCHEMISTRY-US, V35, P7705, DOI 10.1021/bi953011r; SchildPoulter C, 1996, NUCLEIC ACIDS RES, V24, P4751, DOI 10.1093/nar/24.23.4751; SETLOW RB, 1966, SCIENCE, V153, P379, DOI 10.1126/science.153.3734.379; Singer VL, 1997, ANAL BIOCHEM, V249, P228, DOI 10.1006/abio.1997.2177; Song Q, 2014, NUCLEIC ACIDS RES, V42, P13122, DOI 10.1093/nar/gku1049; Song Q, 2012, J BIOL CHEM, V287, P8021, DOI 10.1074/jbc.M111.333591; SUQUET C, 1993, J BIOL CHEM, V268, P23755; Syed SH, 2010, P NATL ACAD SCI USA, V107, P9620, DOI 10.1073/pnas.1000309107; Tornaletti S, 1996, MOL CARCINOGEN, V17, P192, DOI 10.1002/(SICI)1098-2744(199612)17:4<192::AID-MC2>3.0.CO;2-G; Tu YQ, 1998, J MOL BIOL, V284, P297, DOI 10.1006/jmbi.1998.2176; Valota A, 2003, INT J RADIAT BIOL, V79, P643, DOI 10.1080/09553000310001596977; Vu B, 2006, BIOCHEMISTRY-US, V45, P9327, DOI 10.1021/bi0602009; Wells D., 1989, Nucleic Acids Research, V17, P311; Worthington EN, 2003, J BIOL CHEM, V278, P39143, DOI 10.1074/jbc.M305792200; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106	60	16	17	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26597	26609		10.1074/jbc.M115.673301	http://dx.doi.org/10.1074/jbc.M115.673301			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26354431	hybrid, Green Published			2022-12-26	WOS:000364793600026
J	Batabyal, S; Cervenka, G; Ha, JH; Kim, YT; Mohanty, S				Batabyal, Subrata; Cervenka, Gregory; Ha, Ji Hee; Kim, Young-tae; Mohanty, Samarendra			Broad-Band Activatable White-Opsin	PLOS ONE			English	Article							RESTORES VISUAL RESPONSES; ECTOPIC EXPRESSION; EXCITABLE CELLS; OPTICAL CONTROL; LIGHT; CHANNELRHODOPSIN-2; MICE	Currently, the use of optogenetic sensitization of retinal cells combined with activation/inhibition has the potential to be an alternative to retinal implants that would require electrodes inside every single neuron for high visual resolution. However, clinical translation of optogenetic activation for restoration of vision suffers from the drawback that the narrow spectral sensitivity of an opsin requires active stimulation by a blue laser or a light emitting diode with much higher intensities than ambient light. In order to allow an ambient light-based stimulation paradigm, we report the development of a 'white-opsin' that has broad spectral excitability in the visible spectrum. The cells sensitized with white-opsin showed excitability at an order of magnitude higher with white light compared to using only narrow-band light components. Further, cells sensitized with white-opsin produced a photocurrent that was five times higher than Channelrhodopsin-2 under similar photo-excitation conditions. The use of fast white-opsin may allow opsin-sensitized neurons in a degenerated retina to exhibit a higher sensitivity to ambient white light. This property, therefore, significantly lowers the activation threshold in contrast to conventional approaches that use intense narrow-band opsins and light to activate cellular stimulation.	[Batabyal, Subrata; Cervenka, Gregory; Mohanty, Samarendra] Univ Texas Arlington, Biophys & Physiol Lab, Arlington, TX 76019 USA; [Ha, Ji Hee] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA; [Kim, Young-tae] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA	University of Texas System; University of Texas Arlington; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Texas System; University of Texas Arlington	Mohanty, S (corresponding author), Univ Texas Arlington, Biophys & Physiol Lab, Arlington, TX 76019 USA.	smohanty@uta.edu			National Institutes of Health [NS084311]; National Science Foundation [1148541]; Office of President and Provost, The University of Texas at Arlington; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS084311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Office of President and Provost, The University of Texas at Arlington; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	SM would like to acknowledge support from the National Institutes of Health (NS084311), National Science Foundation (1148541), and Office of President and Provost, The University of Texas at Arlington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Buj R, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-18; BUSHMAN W, 1985, SCIENCE, V230, P906, DOI 10.1126/science.2932798; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Cao H, 2013, IEEE T BIO-MED ENG, V60, P225, DOI 10.1109/TBME.2012.2217395; Castonguay A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094633; Chow AY, 2002, J REHABIL RES DEV, V39, P313; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; Degenaar P, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/3/035007; Doroudchi MM, 2011, MOL THER, V19, P1220, DOI 10.1038/mt.2011.69; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Gu L, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3662887; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Mezer E, 2007, OPHTHALMIC GENET, V28, P9, DOI 10.1080/13816810701199423; Miller G, 2006, SCIENCE, V314, P1674, DOI 10.1126/science.314.5806.1674; Mohanty SK, 2008, BIOPHYS J, V95, P3916, DOI 10.1529/biophysj.108.130187; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Sugawara T, 2010, EYE, V24, P535, DOI 10.1038/eye.2009.176; Thyagarajan S, 2010, J NEUROSCI, V30, P8745, DOI 10.1523/JNEUROSCI.4417-09.2010; Tomita H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007679; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang Y, 2009, J NEUROSCI, V29, P9186, DOI 10.1523/JNEUROSCI.0184-09.2009; Zrenner E, 2002, SCIENCE, V295, P1022, DOI 10.1126/science.1067996	34	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0136958	10.1371/journal.pone.0136958	http://dx.doi.org/10.1371/journal.pone.0136958			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360377	Green Published, Green Submitted, gold			2022-12-26	WOS:000361043100019
J	Bekelis, K; Missios, S; Coy, S; Rahmani, R; Singer, RJ; MacKenzie, TA				Bekelis, Kimon; Missios, Symeon; Coy, Shannon; Rahmani, Redi; Singer, Robert J.; MacKenzie, Todd A.			Surgical Clipping versus Endovascular Intervention for the Treatment of Subarachnoid Hemorrhage Patients in New York State	PLOS ONE			English	Article							ANEURYSM TRIAL; STROKE; MORTALITY; ISAT	Object Randomized trials have demonstrated a survival benefit for endovascular treatment of ruptured cerebral aneurysms. We investigated the association of surgical clipping and endovascular coiling with outcomes in subarachnoid hemorrhage (SAH) patients in a real-world regional cohort. Methods We performed a cohort study involving patients with ruptured cerebral aneurysms, who underwent surgical clipping, or endovascular coiling from 2009-2013 and were registered in the Statewide Planning and Research Cooperative System (SPARCS) database. An instrumental variable analysis was used to investigate the association of treatment technique with outcomes. Results Of the 4,098 patients undergoing treatment, 2,585 (63.1%) underwent coiling, and 1,513 (36.9%) underwent clipping. Using an instrumental variable analysis, we did not identify a difference in inpatient mortality [marginal effect (ME), -0.56; 95% CI, -1.03 to 0.02], length of stay (LOS) (ME, 1.72; 95% CI, -3.39 to 6.84), or the rate of 30-day readmissions (ME, -0.30; 95% CI, -0.82 to 0.22) between the two treatment techniques for patients with SAH. Clipping was associated with a higher rate of discharge to rehabilitation (ME, 0.63; 95% CI, 0.24 to 1.01). In sensitivity analysis, mixed effect regression, and propensity score adjusted regression models demonstrated identical results. Conclusions Using a comprehensive all-payer cohort of patients in New York State presenting with aneurysmal SAH we did not identify an association of treatment method with mortality, LOS or 30-day readmission. Clipping was associated with a higher rate of discharge to rehabilitation.	[Bekelis, Kimon; Singer, Robert J.] Dartmouth Hitchcock Med Ctr, Sect Neurosurg, Lebanon, NH 03766 USA; [Missios, Symeon] Louisiana State Univ, Dept Neurosurg, Hlth Sci Ctr, Shreveport, LA 71105 USA; [Coy, Shannon; Rahmani, Redi] Geisel Sch Med Dartmouth, Hanover, NH USA; [MacKenzie, Todd A.] Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03766 USA; [MacKenzie, Todd A.] Dartmouth Hitchcock Med Ctr, Dept Community & Family Med, Lebanon, NH 03766 USA; [MacKenzie, Todd A.] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA	Dartmouth College; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College	Bekelis, K (corresponding author), Dartmouth Hitchcock Med Ctr, Sect Neurosurg, Lebanon, NH 03766 USA.	kbekelis@gmail.com	Rahmani, Redi/AAD-1811-2021; Bekelis, Kimon/Y-3402-2019	Rahmani, Redi/0000-0003-3161-2125; 	NIH (Dartmouth Clinical and Translational Science Institute) [UL1TR001086]	NIH (Dartmouth Clinical and Translational Science Institute)	Funding provided by NIH (Dartmouth Clinical and Translational Science Institute-UL1TR001086).	Bekelis K, 2014, VARIATION CARE SURG; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Feasby TE, 2007, ARCH NEUROL-CHICAGO, V64, P1496, DOI 10.1001/archneur.64.10.1496; Foster EM, 1997, SOC SCI RES, V26, P287; Garabedian LF, 2014, ANN INTERN MED, V161, P131, DOI 10.7326/M13-1887; Harbaugh RE, 2003, LANCET, V361, P783, DOI 10.1016/S0140-6736(03)12641-4; Health NYSDo, 2015, STAT PLANN RES COOP; Jalbert JJ, 2015, JAMA NEUROL; Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1; McDougall CG, 2012, J NEUROSURG, V116, P135, DOI 10.3171/2011.8.JNS101767; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Molyneux AJ, 2009, LANCET NEUROL, V8, P427, DOI 10.1016/S1474-4422(09)70080-8; Neuman MD, 2014, JAMA-J AM MED ASSOC, V311, P2508, DOI 10.1001/jama.2014.6499; NeuroPoint Alliance, 2015, NAT NEUR QUAL OUTC D; Qureshi AI, 2011, J NEUROSURG, V114, P834, DOI 10.3171/2010.6.JNS091486; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; Tan HJ, 2012, JAMA-J AM MED ASSOC, V307, P1629, DOI 10.1001/jama.2012.475; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; Xian Y, 2011, JAMA-J AM MED ASSOC, V305, P373, DOI 10.1001/jama.2011.22; Zacharia BE, 2014, STROKE, V45, P1447, DOI 10.1161/STROKEAHA.113.004412; Zacharia BE, 2011, STROKE, V42, P2844, DOI 10.1161/STROKEAHA.111.619767	21	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137946	10.1371/journal.pone.0137946	http://dx.doi.org/10.1371/journal.pone.0137946			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360422	Green Submitted, Green Published, gold			2022-12-26	WOS:000361043100103
J	Hassan, SS; Akram, M; King, EC; Dockrell, HM; Cliff, JM				Hassan, Syeda S.; Akram, Muhammad; King, Elizabeth C.; Dockrell, Hazel M.; Cliff, Jacqueline M.			PD-1, PD-L1 and PD-L2 Gene Expression on T-Cells and Natural Killer Cells Declines in Conjunction with a Reduction in PD-1 Protein during the Intensive Phase of Tuberculosis Treatment	PLOS ONE			English	Article							PROGRAMMED DEATH 1; B7 FAMILY; EXHAUSTION; PATHWAY; TOLERANCE; LIGANDS	Background The PD-1 axis is a cell intrinsic immunoregulatory pathway that mediates T cell exhaustion in chronic infection particularly in some viral infections. We hypothesized that PD-1, PD-L1 and PD-L2 would be highly expressed in untreated tuberculosis patients compared to controls due to their chronic infection and would decrease with successful TB treatment. Materials and Methods Untreated tuberculosis patients (n = 26) were recruited at diagnosis and followed up during treatment. Household contacts (n = 24) were recruited to establish baseline differences. Blood gene expression ex vivo was investigated using qRT-PCR. Flow cytometry was performed to establish protein expression patterns. Results PD-L1 gene expression was found to be elevated in active TB disease; however, this was not observed for PD-1 or PD-L2. The intensive phase of TB treatment was associated with a significant decline in PD-1, PD-L1 and PD-L2 gene expression. PD-1 protein expression on the surface of NK cells, CD8(+) and CD4(+) T cells was similar in patients with active TB disease compared to controls but declined with successful TB treatment, with the greatest decline occurring on the NK cells followed by CD8(+) T cells and then CD4(+) T cells. Granzyme B/PD-1 co-expression declined with successful intensive phase treatment. Conclusion Modulation of PD-1/PD-L1 pathway through TB treatment indicates changes in the peripheral T cell response caused by live Mycobacterium tuberculosis (Mtb) followed by the response to dead bacilli, antigen-release and immuno-pathology resolution. The PD-1 axis could be a host drug target for immunomodulatory treatments in the future.	[Hassan, Syeda S.; King, Elizabeth C.; Dockrell, Hazel M.; Cliff, Jacqueline M.] Univ London London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1E 7HT, England; [Akram, Muhammad] Gulab Devi Chest Hosp, Lahore, Pakistan	University of London; London School of Hygiene & Tropical Medicine	Hassan, SS (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Immunol & Infect, Keppel St, London WC1E 7HT, England.	syeda.hassan@lshtm.ac.uk		Cliff, Jackie/0000-0002-5653-1818; Dockrell, Hazel/0000-0003-1869-9107	University of London Central Research Fund [AR/CRF/B]; EDCTP [IP.2009.32040.011]	University of London Central Research Fund; EDCTP	This work was supported by the University of London Central Research Fund (Grant # AR/CRF/B), http://www.london.ac.uk/awards_pg.html. Salary support for JMC was provided by the EDCTP (Grant: IP.2009.32040.011), http://www.edctp.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez IB, 2010, J INFECT DIS, V202, P524, DOI 10.1086/654932; Bandaru A, 2014, EUR J IMMUNOL, V44, P2013, DOI 10.1002/eji.201343680; Barber DL, 2011, J IMMUNOL, V186, P1598, DOI 10.4049/jimmunol.1003304; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Djoba Siawaya JF, 2009, CLIN EXP IMMUNOL, V156, P69, DOI 10.1111/j.1365-2249.2009.03875.x; Dong HD, 1999, NAT MED, V5, P1365; Elliott TOJP, 2015, J INFECT DIS, V212, P1469, DOI 10.1093/infdis/jiv238; Greaves P, 2013, BLOOD, V121, P734, DOI 10.1182/blood-2012-10-385591; Hassan SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070063; Henao-Tamayo M, 2011, TUBERCULOSIS, V91, P308, DOI 10.1016/j.tube.2011.04.001; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jurado JO, 2008, J IMMUNOL, V181, P116, DOI 10.4049/jimmunol.181.1.116; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kulpa DA, 2013, SEMIN IMMUNOL, V25, P219, DOI 10.1016/j.smim.2013.02.002; Kumar NP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111098; Lazar-Molnar E, 2010, P NATL ACAD SCI USA, V107, P13402, DOI 10.1073/pnas.1007394107; McNab FW, 2011, EUR J IMMUNOL, V41, P1941, DOI 10.1002/eji.201141421; Nurieva R, 2006, EMBO J, V25, P2623, DOI 10.1038/sj.emboj.7601146; Jurado JO, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17428; Periasamy S, 2011, J INFECT DIS, V203, P1256, DOI 10.1093/infdis/jir011; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Qiu LY, 2008, J INFECT DIS, V198, P1514, DOI 10.1086/592448; Reiley WW, 2010, P NATL ACAD SCI USA, V107, P19408, DOI 10.1073/pnas.1006298107; Rozen S, 2000, Methods Mol Biol, V132, P365; Singh A, 2014, TUBERCULOSIS, V94, P197, DOI 10.1016/j.tube.2014.01.005; Singh A, 2013, J INFECT DIS, V208, P603, DOI 10.1093/infdis/jit206; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Tousif S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019864; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; World Health Organization, 2014, GLOB TUB REP; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x	35	41	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137646	10.1371/journal.pone.0137646	http://dx.doi.org/10.1371/journal.pone.0137646			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359860	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000361043100064
J	Zandona, E; Auer, SK; Kilham, SS; Reznick, DN				Zandona, Eugenia; Auer, Sonya K.; Kilham, Susan S.; Reznick, David N.			Contrasting Population and Diet Influences on Gut Length of an Omnivorous Tropical Fish, the Trinidadian Guppy (Poecilia reticulata)	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; PHENOTYPIC FLEXIBILITY; INTESTINE LENGTH; DIGESTIVE-SYSTEM; ORGAN SIZE; PLASTICITY; PREDATION; STREAM; FOOD; DIVERSITY	Phenotypic plasticity is advantageous for organisms that live in variable environments. The digestive system is particularly plastic, responding to changes in diet. Gut length is the result of a trade-off between maximum nutrient absorption and minimum cost for its maintenance and it can be influenced by diet and by evolutionary history. We assessed variation in gut length of Trinidadian guppies (Poecilia reticulata) as a function of diet, season, ontogeny, and local adaptation. Populations of guppies adapted to different predation levels have evolved different life history traits and have different diets. We sampled guppies from sites with low (LP) and high predation (HP) pressure in the Aripo and Guanapo Rivers in Trinidad. We collected fish during both the dry and wet season and assessed their diet and gut length. During the dry season, guppies from HP sites fed mostly on invertebrates, while guppies in the LP sites fed mainly on detritus. During the wet season, the diet of LP and HP populations became very similar. We did not find strong evidence of an ontogenetic diet shift. Gut length was negatively correlated with the proportion of invertebrates in diet across fish from all sites, supporting the hypothesis that guppy digestive systems adapt in length to changes in diet. Population of origin also had an effect on gut length, as HP and LP fish maintained different gut lengths even in the wet season, when their diets were very similar and individuals in both types of populations fed mostly on detritus. Thus, both environment and population of origin influenced guppies gut length, but population of origin seemed to have a stronger effect. Our study also showed that, even in omnivorous fish, gut length adapted to different diets, being more evident when the magnitude of difference between animal and plant material in the diet was very large.	[Zandona, Eugenia; Kilham, Susan S.] Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA; [Auer, Sonya K.; Reznick, David N.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	Drexel University; University of California System; University of California Riverside	Zandona, E (corresponding author), Univ Estado Rio de Janeiro, Dept Ecol, Inst Biol Roberto Alcantara Gomes, BR-20550011 Rio De Janeiro, RJ, Brazil.	eugenia.zandona@gmail.com	Zandona, Eugenia/B-3449-2013; Zandona, Eugenia/ABG-8207-2020; Zandona, Eugenia/GQH-9518-2022	Zandona, Eugenia/0000-0003-4754-5326; Zandona, Eugenia/0000-0003-4754-5326; Zandona, Eugenia/0000-0003-4754-5326; reznick, david/0000-0002-1144-0568	National Science Foundations Frontiers in Integrative Biological Research program [EF-0623632]; Betz Chair of Environmental Science at Drexel University; Joseph Mozino scholarship	National Science Foundations Frontiers in Integrative Biological Research program; Betz Chair of Environmental Science at Drexel University; Joseph Mozino scholarship	This research was funded by the National Science Foundations Frontiers in Integrative Biological Research program, grant no. EF-0623632 to DNR, the Betz Chair of Environmental Science at Drexel University and the Joseph Mozino scholarship awarded to EZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer SK, 2012, J ANIM ECOL, V81, P818, DOI 10.1111/j.1365-2656.2012.01964.x; Barboza PS, 2010, PHYSIOL BIOCHEM ZOOL, V83, P764, DOI 10.1086/650472; Bassar RD, 2013, AM NAT, V181, P25, DOI 10.1086/668590; Bassar RD, 2010, P NATL ACAD SCI USA, V107, P3616, DOI 10.1073/pnas.0908023107; Cant JP, 1996, J ANIM SCI, V74, P2541; Davis AM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-53; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; DUSSAULT GV, 1981, CAN J ZOOL, V59, P684, DOI 10.1139/z81-098; German DP, 2014, COMP BIOCHEM PHYS B, V168, P12, DOI 10.1016/j.cbpb.2013.11.006; German DP, 2006, MAR BIOL, V148, P1123, DOI 10.1007/s00227-005-0149-4; Ghalambor CK, 2004, AM NAT, V164, P38, DOI 10.1086/421412; Hayes AF, 2009, BEHAV RES METHODS, V41, P924, DOI 10.3758/BRM.41.3.924; Heatherly T, 2012, FLOW REGIME GUPPY IN; Hendry AP, 2006, J EVOLUTION BIOL, V19, P741, DOI 10.1111/j.1420-9101.2005.01061.x; Karasov W. H., 2007, PHYSL ECOLOGY ANIMAL; Karasov WH, 2011, ANNU REV PHYSIOL, V73, P69, DOI 10.1146/annurev-physiol-012110-142152; Kohler TJ, 2012, FRESHW SCI, V31, P1019, DOI 10.1899/11-141.1; Kotrschal A, 2014, FUNCT ECOL, V28, P878, DOI 10.1111/1365-2435.12230; KRAMER DL, 1995, ENVIRON BIOL FISH, V42, P129, DOI 10.1007/BF00001991; KRAMER DL, 1995, ENVIRON BIOL FISH, V42, P115, DOI 10.1007/BF00001990; Leung ASL, 2011, FRESHWATER BIOL, V56, P1193, DOI 10.1111/j.1365-2427.2010.02556.x; Levin SA, 2009, PRINCETON GUIDE ECOL; MAGURRAN AE, 1992, P ROY SOC B-BIOL SCI, V248, P117, DOI 10.1098/rspb.1992.0050; Maharaj LD, 1994, ECOLOGY SELECTED AQU; Merritt RW, 2007, INTRO AQUATIC INSECT; Naya DE, 2007, EVOL ECOL RES, V9, P1363; Naya DE, 2009, J EXP ZOOL PART A, V311A, P270, DOI 10.1002/jez.525; Olsson J, 2007, BIOL J LINN SOC, V90, P517, DOI 10.1111/j.1095-8312.2007.00742.x; Palkovacs EP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018879; Perez G. R, 1996, GUIA ESTUDIO MACROIN; Piersma T, 1997, TRENDS ECOL EVOL, V12, P134, DOI 10.1016/S0169-5347(97)01003-3; Piersma T, 2003, TRENDS ECOL EVOL, V18, P228, DOI 10.1016/S0169-5347(03)00036-3; Pringle CM, 1997, ECOLOGY, V78, P2432; Ramirez A, 2006, J N AM BENTHOL SOC, V25, P108, DOI 10.1899/0887-3593(2006)25[108:TASPIS]2.0.CO;2; REZNICK D, 1993, ECOLOGY, V74, P2011, DOI 10.2307/1940844; REZNICK D, 1982, EVOLUTION, V36, P1236, DOI 10.1111/j.1558-5646.1982.tb05493.x; REZNICK D, 1982, EVOLUTION, V36, P160, DOI 10.1111/j.1558-5646.1982.tb05021.x; Reznick D, 2001, AM NAT, V157, P126, DOI 10.1086/318627; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Reznick DN, 2012, EVOLUTION, V66, P2903, DOI 10.1111/j.1558-5646.2012.01650.x; REZNICK DN, 1987, EVOLUTION, V41, P1370, DOI 10.1111/j.1558-5646.1987.tb02474.x; Reznick DN, 1996, EVOLUTION, V50, P1651, DOI 10.1111/j.1558-5646.1996.tb03937.x; REZNICK DN, 1989, EVOLUTION, V43, P1285, DOI 10.1111/j.1558-5646.1989.tb02575.x; Sibly R.M., 1981, P109; Starck JM, 2003, ANIM BIOL, V53, P245, DOI 10.1163/157075603322539444; Starck JM, 2003, J EXP BIOL, V206, P1887, DOI 10.1242/jeb.00372; Starck JM, 1999, J EXP BIOL, V202, P3171; Sullam KE, 2015, OECOLOGIA, V177, P245, DOI 10.1007/s00442-014-3158-5; Wagner CE, 2009, FUNCT ECOL, V23, P1122, DOI 10.1111/j.1365-2435.2009.01589.x; Walsh MR, 2008, P NATL ACAD SCI USA, V105, P594, DOI 10.1073/pnas.0710051105; WHITE TCR, 1985, OECOLOGIA, V67, P596, DOI 10.1007/BF00790034; Winemiller KO, 1998, J FISH BIOL, V53, P267, DOI 10.1111/j.1095-8649.1998.tb01032.x; Zandona E, 2011, FUNCT ECOL, V25, P964, DOI 10.1111/j.1365-2435.2011.01865.x	53	37	38	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0136079	10.1371/journal.pone.0136079	http://dx.doi.org/10.1371/journal.pone.0136079			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360601	Green Published, gold, Green Submitted			2022-12-26	WOS:000361043100008
J	Ypsilantis, PP; Siddique, M; Sohn, HM; Davies, A; Cook, G; Goh, V; Montana, G				Ypsilantis, Petros-Pavlos; Siddique, Musib; Sohn, Hyon-Mok; Davies, Andrew; Cook, Gary; Goh, Vicky; Montana, Giovanni			Predicting Response to Neoadjuvant Chemotherapy with PET Imaging Using Convolutional Neural Networks	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CELL LUNG-CANCER; TEXTURAL FEATURES; PREOPERATIVE CHEMORADIOTHERAPY; ESOPHAGOGASTRIC JUNCTION; FRACTAL ANALYSIS; TUMOR RESPONSE; FDG-PET; ESOPHAGEAL; HETEROGENEITY	Imaging of cancer with F-18-fluorodeoxyglucose positron emission tomography (F-18-FDG PET) has become a standard component of diagnosis and staging in oncology, and is becoming more important as a quantitative monitor of individual response to therapy. In this article we investigate the challenging problem of predicting a patient's response to neoadjuvant chemotherapy from a single F-18-FDG PET scan taken prior to treatment. We take a "radiomics" approach whereby a large amount of quantitative features is automatically extracted from pretherapy PET images in order to build a comprehensive quantification of the tumor phenotype. While the dominant methodology relies on hand-crafted texture features, we explore the potential of automatically learning low-to high-level features directly from PET scans. We report on a study that compares the performance of two competing radiomics strategies: an approach based on state-of-the-art statistical classifiers using over 100 quantitative imaging descriptors, including texture features as well as standardized uptake values, and a convolutional neural network, 3S-CNN, trained directly from PET scans by taking sets of adjacent intra-tumor slices. Our experimental results, based on a sample of 107 patients with esophageal cancer, provide initial evidence that convolutional neural networks have the potential to extract PET imaging representations that are highly predictive of response to therapy. On this dataset, 3S-CNN achieves an average 80.7% sensitivity and 81.6% specificity in predicting non-responders, and outperforms other competing predictive models.	[Ypsilantis, Petros-Pavlos; Montana, Giovanni] Kings Coll London, Dept Biomed Engn, London SE1 7EH, England; [Siddique, Musib; Sohn, Hyon-Mok; Davies, Andrew; Cook, Gary; Goh, Vicky] Kings Coll London, Dept Canc Imaging, London SE1 7EH, England	University of London; King's College London; University of London; King's College London	Montana, G (corresponding author), Kings Coll London, Dept Biomed Engn, London SE1 7EH, England.	giovanni.montana@kcl.ac.uk	Goh, Vicky/AAG-2708-2020	Cook, Gary/0000-0002-8732-8134; Goh, Vicky/0000-0002-2321-8091	NIHR Biomedical Research Centre of Guys & St Thomas' NHS Trust; CRUK; EPSRC; Cancer Research UK [16463] Funding Source: researchfish	NIHR Biomedical Research Centre of Guys & St Thomas' NHS Trust; CRUK(Cancer Research UK); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cancer Research UK(Cancer Research UK)	Support was received from the NIHR Biomedical Research Centre of Guys & St Thomas' NHS Trust in partnership with Kings College London, and King's College London and UCL Comprehensive Cancer Imaging Centre funded by the CRUK and EPSRC in association with the MRC and DoH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADASUN M, 1989, IEEE T SYST MAN CYB, V19, P1264, DOI 10.1109/21.44046; Bergstra J., 2010, P 9 PYTH SCI C, P3, DOI DOI 10.25080/MAJORA-92BF1922-003; Bottou L., 2008, ADV NEURAL INFORM PR, V20, P161, DOI DOI 10.7751/mitpress/8996.003.0015; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brun E, 2002, HEAD NECK-J SCI SPEC, V24, P127, DOI 10.1002/hed.10037.abs; Castellano G, 2004, CLIN RADIOL, V59, P1061, DOI 10.1016/j.crad.2004.07.008; Chen CH, 2011, HDB PATTERN RECOGNIT; Cheng NM, 2013, J NUCL MED, V54, P1703, DOI 10.2967/jnumed.112.119289; Ciresan D, 2012, PROC CVPR IEEE, P3642, DOI 10.1109/CVPR.2012.6248110; Ciresan DC, 2013, LECT NOTES COMPUT SC, V8150, P411, DOI 10.1007/978-3-642-40763-5_51; CONNERS RW, 1980, IEEE T PATTERN ANAL, V2, P204, DOI 10.1109/TPAMI.1980.4767008; Cook GJR, 2014, CLIN TRANSL IMAGING, V2, P269, DOI 10.1007/s40336-014-0064-0; Cook GJR, 2013, J NUCL MED, V54, P19, DOI 10.2967/jnumed.112.107375; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; El Naqa I, 2009, PATTERN RECOGN, V42, P1162, DOI 10.1016/j.patcog.2008.08.011; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Galloway M., 1975, COMPUTER GRAPHICS IM, V4, P172, DOI DOI 10.1016/S0146-664X(75)80008-6; Glorot X., 2011, P 14 INT C ART INT S, P315; Ha S, 2014, J NUCL MED, V55; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hatt M, 2011, EUR J NUCL MED MOL I, V38, P1191, DOI 10.1007/s00259-011-1755-7; Hicks RJ, 2004, INT J RADIAT ONCOL, V60, P412, DOI 10.1016/j.ijrobp.2004.03.036; Hofstetter W, 2002, ANN SURG, V236, P376, DOI 10.1097/00000658-200209000-00014; Javeri H, 2009, CANCER-AM CANCER SOC, V115, P624, DOI 10.1002/cncr.24056; Juweid ME, 2006, NEW ENGL J MED, V354, P496, DOI 10.1056/NEJMra050276; Kalff V, 2006, J NUCL MED, V47, P14; Kalliokoski KK, 2001, EUR J NUCL MED, V28, P450, DOI 10.1007/s002590000458; Kelsen DP, 1998, NEW ENGL J MED, V339, P1979, DOI 10.1056/NEJM199812313392704; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Kunkel M, 2003, CANCER, V97, P1015, DOI 10.1002/cncr.11159; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lecun Y., 1989, GEN NETWORK DESIGN S; MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; Mandelbrot B. B., 1982, FRACTAL GEOMETRY NAT, DOI DOI 10.1002/ESP3290080415; Miller TR, 2003, J NUCL MED, V44, P192; Miwa K, 2014, EUR J RADIOL, V83, P715, DOI 10.1016/j.ejrad.2013.12.020; Peng CYJ, 2002, J EDUC RES, V96, P3, DOI 10.1080/00220670209598786; PENTLAND AP, 1984, IEEE T PATTERN ANAL, V6, P661, DOI 10.1109/TPAMI.1984.4767591; Rajendran JG, 2006, CLIN CANCER RES, V12, P5435, DOI 10.1158/1078-0432.CCR-05-1773; Ranzato MA, 1995, COMPUTER VISION PATT, P1; Rizk NP, 2009, J THORAC ONCOL, V4, P875, DOI 10.1097/JTO.0b013e3181a8cebf; Rohren EM, 2004, RADIOLOGY, V231, P305, DOI 10.1148/radiol.2312021185; SARKAR N, 1994, IEEE T SYST MAN CYB, V24, P115, DOI 10.1109/21.259692; Schollaert P, 2014, J GASTROINTEST SURG, V18, P894, DOI 10.1007/s11605-014-2488-2; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Thibault G., 2009, PROC PATTERN RECOGNI, P140; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Vaidya M, 2012, RADIOTHER ONCOL, V102, P239, DOI 10.1016/j.radonc.2011.10.014; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Vesselle H, 2000, CLIN CANCER RES, V6, P3837; Weber WA, 2001, J CLIN ONCOL, V19, P3058, DOI 10.1200/JCO.2001.19.12.3058; Willaime J, 2012, J NUCL MED, V53; Yan Xu, 2014, 2014 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), P1626, DOI 10.1109/ICASSP.2014.6853873; Ychou M, 2011, J CLIN ONCOL, V29, P1715, DOI 10.1200/JCO.2010.33.0597; Zhu W, 2012, BRIT J RADIOL, V85, pE694, DOI 10.1259/bjr/29946900	58	111	118	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137036	10.1371/journal.pone.0137036	http://dx.doi.org/10.1371/journal.pone.0137036			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355298	Green Published, Green Submitted, gold			2022-12-26	WOS:000360965800025
J	Gessner, DK; Grone, B; Couturier, A; Rosenbaum, S; Hillen, S; Becker, S; Erhardt, G; Reiner, G; Ringseis, R; Eder, K				Gessner, Denise K.; Groene, Birthe; Couturier, Aline; Rosenbaum, Susann; Hillen, Sonja; Becker, Sabrina; Erhardt, Georg; Reiner, Gerald; Ringseis, Robert; Eder, Klaus			Dietary Fish Oil Inhibits Pro-Inflammatory and ER Stress Signalling Pathways in the Liver of Sows during Lactation	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ACTIVATED RECEPTOR-ALPHA; POLYUNSATURATED FATTY-ACIDS; FACTOR E2-RELATED FACTOR-2; ACUTE-PHASE RESPONSE; C-REACTIVE PROTEIN; TRANSITION PERIOD; DAIRY-COWS; OXIDATIVE STRESS; KAPPA-B	Lactating sows have been shown to develop typical signs of an inflammatory condition in the liver during the transition from pregnancy to lactation. Hepatic inflammation is considered critical due to the induction of an acute phase response and the activation of stress signaling pathways like the endoplasmic reticulum (ER) stress-induced unfolded protein response (UPR), both of which impair animal's health and performance. Whether ER stress-induced UPR is also activated in the liver of lactating sows and whether dietary fish oil as a source of anti-inflammatory effects n-3 PUFA is able to attenuate hepatic inflammation and ER stress-induced UPR in the liver of sows is currently unknown. Based on this, two experiments with lactating sows were performed. The first experiment revealed that ER stress-induced UPR occurs also in the liver of sows during lactation. This was evident from the up-regulation of a set of genes regulated by the UPR and numerically increased phosphorylation of the ER stress-transducer PERK and PERK-mediated phosphorylation of eIF2 alpha and I kappa B. The second experiment showed that fish oil inhibits ER stress-induced UPR in the liver of lactating sows. This was demonstrated by decreased mRNA levels of a number of UPR-regulated genes and reduced phosphorylation of PERK and PERK-mediated phosphorylation of eIF2 alpha and I kappa B in the liver of the fish oil group. The mRNA levels of various nuclear factor-kappa B-regulated genes encoding inflammatory mediators and acute phase proteins in the liver of lactating sows were also reduced in the fish oil group. In line with this, the plasma levels of acute phase proteins were reduced in the fish oil group, although differences to the control group were not significant. In conclusion, ER stress-induced UPR is present in the liver of lactating sows and fish oil is able to inhibit inflammatory signaling pathways and ER stress-induced UPR in the liver.	[Gessner, Denise K.; Groene, Birthe; Couturier, Aline; Rosenbaum, Susann; Ringseis, Robert; Eder, Klaus] Univ Giessen, Inst Anim Nutr & Nutr Physiol, D-35392 Giessen, Germany; [Hillen, Sonja; Becker, Sabrina; Reiner, Gerald] Univ Giessen, Dept Vet Clin Sci, Swine Dis, D-35392 Giessen, Germany; [Erhardt, Georg] Univ Giessen, Inst Anim Breeding & Genet, D-35390 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen	Eder, K (corresponding author), Univ Giessen, Inst Anim Nutr & Nutr Physiol, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany.	klaus.eder@ernaehrung.uni-giessen.de	Ringseis, Robert/AAH-1509-2021		German Research Foundation (Deutsche Forschungsgemeinschaft) [ED 70/9-1]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	Funding: This study was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, grant number: ED 70/9-1, www.dfg.de) which financed the PhD position of SR and costs for the animal experiment and the analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO RJ, 1984, J DAIRY SCI, V67, P1707, DOI 10.3168/jds.S0022-0302(84)81496-4; Bossaert P, 2012, VET J, V192, P222, DOI 10.1016/j.tvjl.2011.06.004; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; COLLIER RJ, 1984, J ANIM SCI, V59, P498, DOI 10.2527/jas1984.592498x; Cray C, 2009, COMPARATIVE MED, V59, P517; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Delerive P, 2000, J BIOL CHEM, V275, P36703, DOI 10.1074/jbc.M004045200; Dewey KG, 1997, ANNU REV NUTR, V17, P19, DOI 10.1146/annurev.nutr.17.1.19; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; Eckersall PD, 1996, VET IMMUNOL IMMUNOP, V51, P377, DOI 10.1016/0165-2427(95)05527-4; Feillet-Coudray C, 2013, BRIT J NUTR, V110, P1789, DOI 10.1017/S0007114513001311; Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007; Gessner DK, 2016, J ANIM PHYSIOL AN N, V100, P337, DOI 10.1111/jpn.12324; Gessner DK, 2013, J DAIRY SCI, V96, P1038, DOI 10.3168/jds.2012-5967; Gessner DK, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0368-y; Gessner DK, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-18; GESSNER DK, 2014, BMC VET RES, V10; Gutgesell A, 2009, J MOL ENDOCRINOL, V43, P241, DOI 10.1677/JME-09-0064; Gutgesell A, 2009, METABOLISM, V58, P226, DOI 10.1016/j.metabol.2008.09.018; Heegaard PMH, 1998, COMP BIOCHEM PHYS B, V119, P365, DOI 10.1016/S0305-0491(97)00362-3; Hsu JM, 2004, J ANIM SCI, V82, P683; Hulten C, 2003, VET MICROBIOL, V95, P75, DOI 10.1016/S0378-1135(03)00136-6; Katoh N, 2002, J VET MED SCI, V64, P293, DOI 10.1292/jvms.64.293; Kovac G, 2008, ACTA VET-BEOGRAD, V58, P459, DOI 10.2298/AVB0806459K; Lee JS, 2012, TOXICOL LETT, V211, P29, DOI 10.1016/j.toxlet.2012.02.017; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Miles EA, 2012, BRIT J NUTR, V107, pS171, DOI 10.1017/S0007114512001560; Murata H, 2004, VET J, V168, P28, DOI 10.1016/S1090-0233(03)00119-9; Myhrstad MCW, 2011, INFLAMM RES, V60, P309, DOI 10.1007/s00011-010-0302-5; Papadopoulos GA, 2009, BRIT J NUTR, V101, P348, DOI 10.1017/S0007114508026160; Ringseis R, 2011, MOL NUTR FOOD RES, V55, pS193, DOI 10.1002/mnfr.201100040; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rooke JA, 2001, BRIT J NUTR, V86, P21, DOI 10.1079/BJN2001363; Rooke JA, 2001, BRIT J NUTR, V86, P461, DOI 10.1079/BJN2001422; Rosenbaum S, 2012, COMP BIOCHEM PHYS D, V7, P370, DOI 10.1016/j.cbd.2012.09.001; Rosenbaum S, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-59; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Salamano G, 2008, VET J, V177, P110, DOI 10.1016/j.tvjl.2007.03.015; Samali Afshin, 2010, Int J Cell Biol, V2010, P830307, DOI 10.1155/2010/830307; Schaap FG, 2013, BIOCHIMIE, V95, P692, DOI 10.1016/j.biochi.2012.10.019; Smith MS, 2002, FRONT NEUROENDOCRIN, V23, P225, DOI 10.1016/S0091-3022(02)00002-X; Smits RJ, 2011, J ANIM SCI, V89, P2731, DOI 10.2527/jas.2010-3593; TRAYHURN P, 1982, NATURE, V298, P59, DOI 10.1038/298059a0; TROTTIER NL, 1995, J ANIM SCI, V73, P1086; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WILLIAMSON DH, 1986, BIOCHEM SOC T, V14, P225, DOI 10.1042/bst0140225; Yan YQ, 2013, IMMUNITY, V38, P1154, DOI 10.1016/j.immuni.2013.05.015; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	50	13	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137684	10.1371/journal.pone.0137684	http://dx.doi.org/10.1371/journal.pone.0137684			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26351857	Green Submitted, Green Published, gold			2022-12-26	WOS:000360932800107
J	Kuuliala, K; Kuuliala, A; Koivuniemi, R; Oksanen, S; Hamalainen, M; Moilanen, E; Kautiainen, H; Leirisalo-Repo, M; Repo, H				Kuuliala, Krista; Kuuliala, Antti; Koivuniemi, Riitta; Oksanen, Suvi; Hamalainen, Mari; Moilanen, Eeva; Kautiainen, Hannu; Leirisalo-Repo, Marjatta; Repo, Heikki			Constitutive STAT3 Phosphorylation in Circulating CD4(+) T Lymphocytes Associates with Disease Activity and Treatment Response in Recent-Onset Rheumatoid Arthritis	PLOS ONE			English	Article							SIGNALING PROFILES; ACUTE-PANCREATITIS; UP-REGULATION; ACTIVATION; INFLAMMATION; LEUKOCYTES; CANCER; ADHESION; CELLS; IL-6	The aim of the present study was to examine constitutive signal transducer and activator of transcription 3 (STAT3) phosphorylation in circulating leukocytes as a candidate biomarker in rheumatoid arthritis (RA). 25 patients with recent-onset, untreated RA provided samples for whole blood flow cytometric determination of intracellular STAT3 phosphorylation, expressed as relative fluorescence units. The occurrence of constitutive STAT3 phosphorylation was evaluated by determining proportion of STAT3-phosphorylated cells among different leukocyte subtypes. Plasma levels of interleukin (IL)-6, IL-17 and IL-21 were measured by immunoassay, radiographs of hands and feet were examined and disease activity score (DAS28) was determined. Biomarkers were restudied and treatment response (according to European League Against Rheumatism) was determined after 12 months of treatment with disease-modifying antirheumatic drugs. At baseline, constitutive phosphorylation of STAT3 occurred in CD4(+) T cells of 14 (56%) patients, CD8(+) T cells of 13 (52%) patients, in CD19+ B cells of 7 (28%) patients, and in CD14(+) monocytes of 12 (48%) patients. STAT3 phosphorylation levels of CD4(+) T cells associated with DAS28, and those of all leukocyte subtypes studied associated with erosive disease. The presence of constitutive STAT3 phosphorylation in CD4(+) T lymphocytes, pSTAT3 fluorescence intensity of CD4(+) and CD8(+) T cells and C-reactive protein (CRP) levels at baseline associated with good treatment response. In conclusion, constitutive STAT3 phosphorylation in circulating CD4(+) T cells is common in recent-onset untreated RA and associates with good treatment response in patients characterized by high disease activity and the presence of systemic inflammation.	[Kuuliala, Krista; Kuuliala, Antti; Oksanen, Suvi; Leirisalo-Repo, Marjatta; Repo, Heikki] Helsinki Univ Hosp, Bacteriol & Immunol, Helsinki, Finland; [Kuuliala, Krista; Kuuliala, Antti; Koivuniemi, Riitta; Oksanen, Suvi; Kautiainen, Hannu; Leirisalo-Repo, Marjatta; Repo, Heikki] Univ Helsinki, Helsinki, Finland; [Koivuniemi, Riitta; Leirisalo-Repo, Marjatta] Helsinki Univ Hosp, Rheumatol, Helsinki, Finland; [Hamalainen, Mari; Moilanen, Eeva] Univ Tampere, Sch Med, Immunopharmacol Res Grp, FIN-33101 Tampere, Finland; [Hamalainen, Mari; Moilanen, Eeva] Tampere Univ Hosp, Tampere, Finland; [Kautiainen, Hannu] Helsinki Univ Hosp, Primary Hlth Care, Helsinki, Finland; [Kautiainen, Hannu] Helsinki Univ Hosp, Gen Practice, Helsinki, Finland; [Kautiainen, Hannu] Kuopio Univ Hosp, Unit Primary Hlth Care, SF-70210 Kuopio, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Tampere University; Tampere University; Tampere University Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Kuopio University Hospital; University of Eastern Finland	Kuuliala, K (corresponding author), Helsinki Univ Hosp, Bacteriol & Immunol, Helsinki, Finland.	krista.kuuliala@helsinki.fi		Hamalainen, Mari/0000-0002-6409-3758; Kuuliala, Antti/0000-0002-3190-207X	Paulo Foundation; Finnish Cultural Foundation; Helsinki University Central Hospital Research Funds; Finska Lakaresallskapet	Paulo Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Helsinki University Central Hospital Research Funds; Finska Lakaresallskapet	This work was supported by Paulo Foundation and Finnish Cultural Foundation (to KK); Helsinki University Central Hospital Research Funds (to MLR and HR); and Finska Lakaresallskapet (to MLR and HR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson AS, 2009, CURR OPIN IMMUNOL, V21, P161, DOI 10.1016/j.coi.2009.03.013; Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Alanara T, 2012, SCAND J RHEUMATOL, V41, P267, DOI 10.3109/03009742.2012.664649; Ally MMTM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/183653; Anderson AE, 2016, ANN RHEUM DIS, V75, P466, DOI 10.1136/annrheumdis-2014-205850; Attridge K, 2014, J IMMUNOL, V192, P2195, DOI 10.4049/jimmunol.1302082; Aziz MH, 2010, ONCOGENE, V29, P3100, DOI 10.1038/onc.2010.63; Baillet A, 2015, ARTHRIT CARE RES, V67, P905, DOI 10.1002/acr.22513; BARRERA P, 1995, BRIT J RHEUMATOL, V34, P747; BD Biosciences, PERM BUFFER III; Benedetti G, 2014, EUR J IMMUNOL, V44, P339, DOI 10.1002/eji.201344184; Caiello I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107886; CALAFAT J, 1993, BLOOD, V81, P3122; Caldwell CC, 2011, CRIT CARE, V15, DOI 10.1186/cc9397; Cho JY, 2008, BIOL PHARM BULL, V31, P726, DOI 10.1248/bpb.31.726; da Silva JC, 2013, CLINICS, V68, P766, DOI 10.6061/clinics/2013(06)07; de Hooge ASK, 2004, ARTHRITIS RHEUM-US, V50, P2014, DOI 10.1002/art.20302; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Eddahri F, 2009, BLOOD, V113, P2426, DOI 10.1182/blood-2008-04-154682; Engstad CS, 1997, THROMB HAEMOSTASIS, V77, P690; Frank DA, 1997, J CLIN INVEST, V100, P3140, DOI 10.1172/JCI119869; Fransen J, 2005, CLIN EXP RHEUMATOL, V23, pS93; Goldbach-Mansky R, 2005, ANN RHEUM DIS, V64, P715, DOI 10.1136/ard.2003.007039; GREENFIELD SM, 1993, GUT, V34, P252, DOI 10.1136/gut.34.2.252; Hakala Markku, 2009, Duodecim, V125, P2131; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; Isomaki P, 2015, RHEUMATOLOGY, V54, P1103, DOI 10.1093/rheumatology/keu430; Klimiuk PA, 2005, J RHEUMATOL, V32, P1666; Knudsen LS, 2008, J RHEUMATOL, V35, P1277; Kuuliala K, 2013, SCAND J CLIN LAB INV, V73, P494, DOI 10.3109/00365513.2013.811612; Kuuliala K, 2011, ARTHRITIS RHEUM-US, V63, pS1008; Kwok SK, 2012, ARTHRITIS RHEUM-US, V64, P740, DOI 10.1002/art.33390; Kyttaris VC, 2012, DRUG DES DEV THER, V6, P245, DOI 10.2147/DDDT.S25426; Leipe J, 2011, ANN RHEUM DIS, V70, P1453, DOI 10.1136/ard.2011.152074; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; Liu Y, 2011, IMMUNOLOGY, V132, P540, DOI 10.1111/j.1365-2567.2010.03399.x; Maecker HT, 2010, NAT IMMUNOL, V11, P975, DOI 10.1038/ni1110-975; MEHTA CR, 1995, STAT MED, V14, P2143, DOI 10.1002/sim.4780141908; Morishima N, 2005, J IMMUNOL, V175, P1686, DOI 10.4049/jimmunol.175.3.1686; Newhall KJ, 2010, CLIN CHEM, V56, P1483, DOI 10.1373/clinchem.2006.144618; Nowell MA, 2009, J IMMUNOL, V182, P613, DOI 10.4049/jimmunol.182.1.613; Nupponen I, 2013, SCAND J IMMUNOL, V78, P426, DOI 10.1111/sji.12094; Oiva J, 2013, PANCREATOLOGY, V13, P118, DOI 10.1016/j.pan.2013.01.010; Oiva J, 2010, CRIT CARE, V14, DOI 10.1186/cc9329; Ortiz MA, 2015, CLIN IMMUNOL, V158, P174, DOI 10.1016/j.clim.2015.03.025; Pratt AG, 2012, ANN RHEUM DIS, V71, P1374, DOI 10.1136/annrheumdis-2011-200968; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Sakaguchi M, 2012, J INVEST DERMATOL, V132, P1877, DOI 10.1038/jid.2012.45; SENGUPTA TK, 1995, J EXP MED, V181, P1015, DOI 10.1084/jem.181.3.1015; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Stjernberg-Salmela S, 2010, RHEUMATOLOGY, V49, P382, DOI 10.1093/rheumatology/kep327; Sun M, 2012, PROSTATE, V72, P82, DOI 10.1002/pros.21409; Tak PP, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/ar3096, 10.1186/1478-6354-13-S1-S5]; Todd DJ, 2011, ARTHRITIS RHEUM-US, V63, P894, DOI 10.1002/art.30213; van der Linden MPM, 2011, ARTHRITIS RHEUM-US, V63, P37, DOI 10.1002/art.30100; Wooten DK, 2000, J BIOL CHEM, V275, P26566, DOI 10.1074/jbc.M003495200; Ye H, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0590-9; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	58	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137385	10.1371/journal.pone.0137385	http://dx.doi.org/10.1371/journal.pone.0137385			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353115	gold, Green Published, Green Submitted			2022-12-26	WOS:000360932800079
J	Wellard, R; Erbe, C; Fouda, L; Blewitt, M				Wellard, Rebecca; Erbe, Christine; Fouda, Leila; Blewitt, Michelle			Vocalisations of Killer Whales (Orcinus orca) in the Bremer Canyon, Western Australia	PLOS ONE			English	Article							BRITISH-COLUMBIA; ACOUSTIC BEHAVIOR; CULTURAL TRANSMISSION; VANCOUVER-ISLAND; NORTH PACIFIC; ECHOLOCATION; WHISTLES; CALLS; WATERS; POPULATIONS	To date, there has been no dedicated study in Australian waters on the acoustics of killer whales. Hence no information has been published on the sounds produced by killer whales from this region. Here we present the first acoustical analysis of recordings collected off the Western Australian coast. Underwater sounds produced by Australian killer whales were recorded during the months of February and March 2014 and 2015 in the Bremer Canyon in Western Australia. Vocalisations recorded included echolocation clicks, burst-pulse sounds and whistles. A total of 28 hours and 29 minutes were recorded and analysed, with 2376 killer whale calls (whistles and burst-pulse sounds) detected. Recordings of poor quality or signal-to-noise ratio were excluded from analysis, resulting in 142 whistles and burst-pulse vocalisations suitable for analysis and categorisation. These were grouped based on their spectrographic features into nine Bremer Canyon (BC) "call types". The frequency of the fundamental contours of all call types ranged from 600 Hz to 29 kHz. Calls ranged from 0.05 to 11.3 seconds in duration. Biosonar clicks were also recorded, but not studied further. Surface behaviours noted during acoustic recordings were categorised as either travelling or social behaviour. A detailed description of the acoustic characteristics is necessary for species acoustic identification and for the development of passive acoustic tools for population monitoring, including assessments of population status, habitat usage, migration patterns, behaviour and acoustic ecology. This study provides the first quantitative assessment and report on the acoustic features of killer whales vocalisations in Australian waters, and presents an opportunity to further investigate this little-known population.	[Wellard, Rebecca; Erbe, Christine; Fouda, Leila] Curtin Univ, Ctr Marine Sci & Technol, Perth, WA 6845, Australia; [Blewitt, Michelle] Marine Environm Res Consultants, Sydney, NSW 2099, Australia; [Blewitt, Michelle] Univ Sydney, Inst Marine Sci, Sydney, NSW 2006, Australia	Curtin University; University of Sydney	Wellard, R (corresponding author), Curtin Univ, Ctr Marine Sci & Technol, GPO Box U1987, Perth, WA 6845, Australia.	becwellard@gmail.com	Erbe, Christine/H-4777-2012; Wellard, Rebecca/AAW-7310-2020; Erbe, Christine/AAA-3801-2021	Erbe, Christine/0000-0002-7884-9907; Wellard, Rebecca/0000-0001-8427-564X; Fouda, Leila/0000-0002-0723-3697	Busch Gardens Conservation Fund	Busch Gardens Conservation Fund	The 2015 data collection was supported by the Busch Gardens Conservation Fund (http://swbgconservationfund.org/). Authors who received the funding were CE and LF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au WWL, 2004, J ACOUST SOC AM, V115, P901, DOI 10.1121/1.1642628; Au WWL, 2000, SPR HDB AUD, V12, P364; Bannister J, 1996, ACTION PLAN AUSTR CE; BarrettLennard LG, 1996, ANIM BEHAV, V51, P553, DOI 10.1006/anbe.1996.0059; Bigg M., 1982, ASSESSMENT KILLER WH; Bigg M.A., 1987, KILLER WHALES STUDY; Bioacoustics Research Program, RAV PRO INT SOUND AN; Chatto Ray, 2000, Beagle, V16, P163; Deecke VB, 2005, ANIM BEHAV, V69, P395, DOI 10.1016/j.anbehav.2004.04.014; Deecke VB, 2000, ANIM BEHAV, V60, P629, DOI 10.1006/anbe.2000.1454; Ding Wang, 1995, P299; Erbe C, 2013, ACOUST AUST, V41, P113; Evans W, 1973, J ACOUST SOC AM, P191; Filatova OA, 2009, ACTA ETHOL, V12, P37, DOI 10.1007/s10211-009-0056-7; Filatova OA, 2012, J ACOUST SOC AM, V132, P3618, DOI 10.1121/1.4764874; Fllatova OA, 2007, BIOACOUSTICS, V16, P261; Foote AD, 2009, MOL ECOL, V18, P5207, DOI 10.1111/j.1365-294X.2009.04407.x; Ford J. K. B., 1987, CANADIAN DATA REPORT; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; FORD JKB, 1991, CAN J ZOOL, V69, P1454, DOI 10.1139/z91-206; FORD JKB, 1989, CAN J ZOOL, V67, P727, DOI 10.1139/z89-105; Ford JKB, 2002, ENCY MARINE MAMMALS; Gassmann M, 2013, J ACOUST SOC AM, V134, P3513, DOI 10.1121/1.4824162; Holt MM, 2011, J ACOUST SOC AM, V130, P3100, DOI 10.1121/1.3641446; KASAMATSU F, 1995, ANTARCT SCI, V7, P365, DOI 10.1017/S0954102095000514; LING J K, 1991, Transactions of the Royal Society of South Australia, V115, P95; MathWorks Inc, 2014, MATLAB; Miller PJO, 2006, J COMP PHYSIOL A, V192, P449, DOI 10.1007/s00359-005-0085-2; Miller PJO, 2004, ANIM BEHAV, V67, P1099, DOI 10.1016/j.anbehav.2003.06.017; MOORE S E, 1988, Rit Fiskideildar, V11, P225; Morrice M.G., 2004, KILLER WHALES ORCINU; Morrice MG, 2008, MAMMALS AUSTR, P860; Morrice MG, 2007, IWC SCI COMM ANCH US; Mustoe S, 2008, VICTORIAN NAT, V125, P76, DOI DOI 10.1371/J0URNAL.P0NE.0136535; Parker D, 1978, AUSTR WILDLIFE RES, P25; Pitman Robert L., 2003, Journal of Cetacean Research and Management, V5, P131; Pitman RL, 2011, POLAR BIOL, V34, P303, DOI 10.1007/s00300-010-0871-3; Richlen Michael F., 2008, Aquatic Mammals, V34, P448, DOI 10.1578/AM.34.4.2008.448; Riesch R, 2006, ANIM BEHAV, V71, P79, DOI 10.1016/j.anbehav.2005.03.026; Riesch R, 2011, BEHAV ECOL SOCIOBIOL, V65, P1377, DOI 10.1007/s00265-011-1148-8; Ross G.J., 2006, REV CONSERVATION STA; Samarra FIP, 2010, J ACOUST SOC AM, V128, pEL205, DOI 10.1121/1.3462235; Simon M, 2007, J ACOUST SOC AM, V121, P749, DOI 10.1121/1.2404922; Simonis AE, 2012, J ACOUST SOC AM, V131, pEL295, DOI 10.1121/1.3690963; STRAGER H, 1995, CAN J ZOOL, V73, P1037, DOI 10.1139/z95-124; Thiele D, 2000, DEEP-SEA RES PT II, V47, P2543, DOI 10.1016/S0967-0645(00)00035-7; Thiele D, 1999, ANTARCT SCI, V11, P48, DOI 10.1017/S0954102099000073; Thomsen F, 2002, NATURWISSENSCHAFTEN, V89, P404, DOI 10.1007/s00114-002-0351-x; Thomsen F, 2001, J ACOUST SOC AM, V109, P1240, DOI 10.1121/1.1349537; Tyack PL, 2000, SPR HDB AUD, V12, P156; Van Waerebeek Koen, 2010, Journal of Cetacean Research and Management, V11, P315; Weib BM, 2007, J ACOUST SOC AM, V122, P3710, DOI 10.1121/1.2799907; Williams R, 2006, BIOL CONSERV, V133, P301, DOI 10.1016/j.biocon.2006.06.010; Yurk H, 2002, ANIM BEHAV, V63, P1103, DOI 10.1006/anbe.2002.3012; [No title captured]	55	16	17	2	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136535	10.1371/journal.pone.0136535	http://dx.doi.org/10.1371/journal.pone.0136535			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352429	Green Submitted, Green Published, gold			2022-12-26	WOS:000360932800038
J	Kane, P; Zollman, KJS				Kane, Patrick; Zollman, Kevin J. S.			An Evolutionary Comparison of the Handicap Principle and Hybrid Equilibrium Theories of Signaling	PLOS ONE			English	Article							SIMPLE-MODEL; COST; TALK; GAME; COMMUNICATION; PREDATION; RELATIVES	The handicap principle has come under significant challenge both from empirical studies and from theoretical work. As a result, a number of alternative explanations for honest signaling have been proposed. This paper compares the evolutionary plausibility of one such alternative, the "hybrid equilibrium," to the handicap principle. We utilize computer simulations to compare these two theories as they are instantiated in Maynard Smith's Sir Philip Sidney game. We conclude that, when both types of communication are possible, evolution is unlikely to lead to handicap signaling and is far more likely to result in the partially honest signaling predicted by hybrid equilibrium theory.	[Kane, Patrick] Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA; [Zollman, Kevin J. S.] Carnegie Mellon Univ, Dept Philosophy, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University	Zollman, KJS (corresponding author), Carnegie Mellon Univ, Dept Philosophy, Pittsburgh, PA 15213 USA.	kzollman@andrew.cmu.edu		Zollman, Kevin/0000-0001-9776-1890	National Science Foundation [EF 1038456]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant No. EF 1038456. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, GAMES, DOI DOI 10.1016/j.paid.2008.09.031; Bergstrom CT, 1998, P NATL ACAD SCI USA, V95, P5100, DOI 10.1073/pnas.95.9.5100; Bergstrom CT, 2002, PHILOS T R SOC B, V357, P1595, DOI 10.1098/rstb.2002.1068; Bergstrom CT, 1997, PHILOS T ROY SOC B, V352, P609, DOI 10.1098/rstb.1997.0041; BORGIA G, 1993, AM NAT, V141, P729, DOI 10.1086/285502; Caro TM, 1995, BEHAV ECOL, V6, P442, DOI 10.1093/beheco/6.4.442; CHAPPELL MA, 1995, ANIM BEHAV, V49, P255, DOI 10.1016/0003-3472(95)80177-4; Crawford V, 1998, J ECON THEORY, V78, P286, DOI 10.1006/jeth.1997.2359; Cressman R, 2003, ECON LEARN SOC EVOL, P1; Gaunt AS, 1996, AUK, V113, P718, DOI 10.2307/4089004; Grafe TU, 2007, ETHOLOGY, V113, P772, DOI 10.1111/j.1439-0310.2007.01378.x; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Grose J, 2011, BIOL PHILOS, V26, P677, DOI 10.1007/s10539-011-9275-1; Haskell DG, 1999, ANIM BEHAV, V57, P893, DOI 10.1006/anbe.1998.1053; Hofbauer J, 1998, EVOLUTIONARY GAMES P; HORN AG, 1995, ANIM BEHAV, V50, P1171, DOI 10.1016/0003-3472(95)80033-6; Hurd PL, 1997, J THEOR BIOL, V184, P83, DOI 10.1006/jtbi.1996.0246; HURD PL, 1995, J THEOR BIOL, V174, P217, DOI 10.1006/jtbi.1995.0093; Huttegger SM, 2016, DYN GAMES APPL, V6, P347, DOI 10.1007/s13235-015-0159-x; Huttegger SM, 2013, BRIT J PHILOS SCI, V64, P637, DOI 10.1093/bjps/axs035; Huttegger SM, 2010, P ROY SOC B-BIOL SCI, V277, P1915, DOI 10.1098/rspb.2009.2105; JOHNSTONE RA, 1992, J THEOR BIOL, V156, P215, DOI 10.1016/S0022-5193(05)80674-5; Lachmann M, 2001, P NATL ACAD SCI USA, V98, P13189, DOI 10.1073/pnas.231216498; Leech SM, 1997, BEHAV ECOL, V8, P644, DOI 10.1093/beheco/8.6.644; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; McCarty JP, 1996, AUK, V113, P178, DOI 10.2307/4088944; Palagi E, 2009, AM J PHYS ANTHROPOL, V139, P182, DOI 10.1002/ajpa.20971; Pomiankowski A, 1998, EVOLUTION, V52, P928, DOI [10.1111/j.1558-5646.1998.tb03720.x, DOI 10.1111/J.1558-5646.1998.TB03720.X]; Rodriguez-Girones MA, 1998, P NATL ACAD SCI USA, V95, P4453, DOI 10.1073/pnas.95.8.4453; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Silk JB, 2000, ANIM BEHAV, V59, P423, DOI 10.1006/anbe.1999.1312; Smith CL, 2008, J EXP BIOL, V211, P2052, DOI 10.1242/jeb.017194; SMITH JM, 1991, ANIM BEHAV, V42, P1034, DOI 10.1016/S0003-3472(05)80161-7; Szamado S, 2000, ANIM BEHAV, V59, P221, DOI 10.1006/anbe.1999.1293; Szamado S, 1999, J THEOR BIOL, V198, P593, DOI 10.1006/jtbi.1999.0935; Szamado S, 2011, ANIM BEHAV, V81, P3, DOI 10.1016/j.anbehav.2010.08.022; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zahavi A, 1997, HANDICAP PRINCIPLE M; Zollman Kevin J. S., 2013, Biology Theory, V8, P127, DOI 10.1007/s13752-013-0107-1; Zollman KJS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.1878	41	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137271	10.1371/journal.pone.0137271	http://dx.doi.org/10.1371/journal.pone.0137271			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348617	Green Published, Green Submitted, gold			2022-12-26	WOS:000360897600030
J	Shiga, T; Althen, H; Cornella, M; Zarnowiec, K; Yabe, H; Escera, C				Shiga, Tetsuya; Althen, Heike; Cornella, Miriam; Zarnowiec, Katarzyna; Yabe, Hirooki; Escera, Carles			Deviance-Related Responses along the Auditory Hierarchy: Combined FFR, MLR and MMN Evidence	PLOS ONE			English	Article							MISMATCH NEGATIVITY MMN; STIMULUS-SPECIFIC ADAPTATION; FEATURE CONJUNCTIONS; BRAIN-STEM; ELECTROPHYSIOLOGICAL EVIDENCE; EVOKED-POTENTIALS; NOVELTY DETECTION; SENSORY MEMORY; REGULARITY; CORTEX	The mismatch negativity (MMN) provides a correlate of automatic auditory discrimination in human auditory cortex that is elicited in response to violation of any acoustic regularity. Recently, deviance-related responses were found at much earlier cortical processing stages as reflected by the middle latency response (MLR) of the auditory evoked potential, and even at the level of the auditory brainstem as reflected by the frequency following response (FFR). However, no study has reported deviance-related responses in the FFR, MLR and long latency response (LLR) concurrently in a single recording protocol. Amplitude-modulated (AM) sounds were presented to healthy human participants in a frequency oddball paradigm to investigate deviance-related responses along the auditory hierarchy in the ranges of FFR, MLR and LLR. AM frequency deviants modulated the FFR, the Na and Nb components of the MLR, and the LLR eliciting the MMN. These findings demonstrate that it is possible to elicit deviance-related responses at three different levels (FFR, MLR and LLR) in one single recording protocol, highlight the involvement of the whole auditory hierarchy in deviance detection and have implications for cognitive and clinical auditory neuroscience. Moreover, the present protocol provides a new research tool into clinical neuroscience so that the functional integrity of the auditory novelty system can now be tested as a whole in a range of clinical populations where the MMN was previously shown to be defective.	[Shiga, Tetsuya; Althen, Heike; Cornella, Miriam; Zarnowiec, Katarzyna; Escera, Carles] Univ Barcelona, Inst Brain Cognit & Behav IR3C, Barcelona, Catalonia, Spain; [Shiga, Tetsuya; Althen, Heike; Cornella, Miriam; Zarnowiec, Katarzyna; Escera, Carles] Univ Barcelona, Cognit Neurosci Res Grp, Dept Psychiat & Clin Psychobiol, Barcelona, Catalonia, Spain; [Shiga, Tetsuya; Yabe, Hirooki] Fukushima Med Univ, Dept Neuropsychiat, Fukushima, Japan	University of Barcelona; University of Barcelona; Fukushima Medical University	Shiga, T (corresponding author), Univ Barcelona, Inst Brain Cognit & Behav IR3C, Barcelona, Catalonia, Spain.	tetsuya3@fmu.ac.jp	Escera, Carles/A-8658-2010; Althen, Heike/E-2435-2016	Escera, Carles/0000-0001-8203-2951; Cornella, Miriam/0000-0002-2745-4518	Spanish Ministry of Economy and Knowledge [PSI2012-37174]; Excellence Research Group of the Generalitat de Catalunya [2014SGR-177]; ICREA Academia Distinguished Professorship award	Spanish Ministry of Economy and Knowledge(Spanish Government); Excellence Research Group of the Generalitat de Catalunya(Generalitat de Catalunya); ICREA Academia Distinguished Professorship award(ICREA)	This work was supported by the PSI2012-37174 grant from the Spanish Ministry of Economy and Knowledge, the 2014SGR-177 Excellence Research Group of the Generalitat de Catalunya, and the ICREA Academia Distinguished Professorship awarded to Carles Escera.	Alain C, 1998, BRAIN RES, V812, P23, DOI 10.1016/S0006-8993(98)00851-8; ALHO K, 1995, EAR HEARING, V16, P38, DOI 10.1097/00003446-199502000-00004; ALHO K, 1994, ELECTROEN CLIN NEURO, V91, P353, DOI 10.1016/0013-4694(94)00173-1; Alho K, 2012, EUR J NEUROSCI, V36, P2972, DOI 10.1111/j.1460-9568.2012.08219.x; Althen Heike, 2013, Tropical Medicine & International Health, V18, P3448, DOI 10.1111/ejn.12346; Althen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028522; Antunes FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014071; Bidelman GM, 2015, NEUROPSYCHOLOGIA, V68, P38, DOI 10.1016/j.neuropsychologia.2014.12.020; Bidelman GM, 2015, J NEUROSCI METH, V241, P94, DOI 10.1016/j.jneumeth.2014.12.019; Bidelman GM, 2014, NEUROBIOL AGING, V35, P2526, DOI 10.1016/j.neurobiolaging.2014.05.006; Bidelman GM, 2014, EUR J NEUROSCI, V40, P2662, DOI 10.1111/ejn.12627; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cacciaglia R, 2015, NEUROPSYCHOLOGIA, V68, P51, DOI 10.1016/j.neuropsychologia.2015.01.001; Chandrasekaran B, 2010, PSYCHOPHYSIOLOGY, V47, P236, DOI 10.1111/j.1469-8986.2009.00928.x; Cornella M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043604; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Deouell LY, 2007, J PSYCHOPHYSIOL, V21, P188, DOI 10.1027/0269-8803.21.34.188; Escera C, 2007, J PSYCHOPHYSIOL, V21, P251, DOI 10.1027/0269-8803.21.34.251; Escera C, 2014, BRAIN TOPOGR, V27, P527, DOI 10.1007/s10548-013-0328-4; Escera C, 2014, PSYCHOPHYSIOLOGY, V51, P111, DOI 10.1111/psyp.12156; Gil-Da-Costa R, 2013, P NATL ACAD SCI USA, V110, P15425, DOI 10.1073/pnas.1312264110; Gomes H, 1997, PSYCHOPHYSIOLOGY, V34, P712, DOI 10.1111/j.1469-8986.1997.tb02146.x; Grimm S, 2012, BIOL PSYCHOL, V89, P232, DOI 10.1016/j.biopsycho.2011.10.014; Grimm S, 2011, PSYCHOPHYSIOLOGY, V48, P377, DOI 10.1111/j.1469-8986.2010.01073.x; Haenschel C, 2005, J NEUROSCI, V25, P10494, DOI 10.1523/JNEUROSCI.1227-05.2005; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; Jackson AF, 2014, PSYCHOPHYSIOLOGY, V51, P1061, DOI 10.1111/psyp.12283; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; Kleiner M, 2007, PERCEPTION, V36, P14; Lepisto T, 2006, CLIN NEUROPHYSIOL, V117, P2161, DOI 10.1016/j.clinph.2006.06.709; Leung S, 2013, CLIN NEUROPHYSIOL, V124, P2397, DOI 10.1016/j.clinph.2013.06.001; Leung S, 2012, PSYCHOPHYSIOLOGY, V49, P933, DOI 10.1111/j.1469-8986.2012.01375.x; Maess B, 2007, NEUROIMAGE, V37, P561, DOI 10.1016/j.neuroimage.2007.05.040; Malmierca MS, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00111; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; Malone BJ, 2015, J NEUROSCI, V35, P5904, DOI 10.1523/JNEUROSCI.4833-14.2015; Mullen T., 2012, CLEANLINE EEGLAB PLU; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 2012, CLIN NEUROPHYSIOL, V123, P424, DOI 10.1016/j.clinph.2011.09.020; Naatanen R, 2004, CLIN NEUROPHYSIOL, V115, P140, DOI 10.1016/j.clinph.2003.04.001; Naatanen R, 2000, AUDIOL NEURO-OTOL, V5, P105, DOI 10.1159/000013874; Naatanen R, 2015, INT J PSYCHOPHYSIOL, V95, P338, DOI 10.1016/j.ijpsycho.2014.12.012; Naatanen R, 2011, BRAIN, V134, P3432, DOI 10.1093/brain/awr064; Nelken I, 2007, J PSYCHOPHYSIOL, V21, P214, DOI 10.1027/0269-8803.21.34.214; Opitz B, 2005, EUR J NEUROSCI, V21, P531, DOI 10.1111/j.1460-9568.2005.03839.x; PAAVILAINEN P, 1991, ELECTROEN CLIN NEURO, V78, P466, DOI 10.1016/0013-4694(91)90064-B; Pakarinen S, 2007, CLIN NEUROPHYSIOL, V118, P177, DOI 10.1016/j.clinph.2006.09.001; Pakarinen S, 2009, BIOL PSYCHOL, V82, P219, DOI 10.1016/j.biopsycho.2009.07.008; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Perez-Gonzalez D, 2005, EUR J NEUROSCI, V22, P2879, DOI 10.1111/j.1460-9568.2005.04472.x; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; PICTON TW, 1974, ELECTROEN CLIN NEURO, V36, P179, DOI 10.1016/0013-4694(74)90155-2; Recasens M, 2014, HUM BRAIN MAPP, V35, P5701, DOI 10.1002/hbm.22582; Recasens M, 2014, CEREB CORTEX, V24, P143, DOI 10.1093/cercor/bhs295; Sawada M, 2008, PSYCHIAT CLIN NEUROS, V62, P479, DOI 10.1111/j.1440-1819.2008.01835.x; Schonwiesner M, 2007, J NEUROPHYSIOL, V97, P2075, DOI 10.1152/jn.01083.2006; Schroger E, 2014, BRAIN TOPOGR, V27, P565, DOI 10.1007/s10548-013-0334-6; Schroger E, 1996, NEUROREPORT, V7, P3005, DOI 10.1097/00001756-199611250-00041; Slabu L, 2012, J NEUROSCI, V32, P1447, DOI 10.1523/JNEUROSCI.2557-11.2012; Slabu L, 2010, EUR J NEUROSCI, V32, P859, DOI 10.1111/j.1460-9568.2010.07324.x; Sonnadara RR, 2006, BRAIN RES, V1076, P187, DOI 10.1016/j.brainres.2005.12.093; Sussman E, 1998, BRAIN RES, V793, P95, DOI 10.1016/S0006-8993(98)00164-4; Taaseh N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023369; Takegata R, 1999, NEUROSCI LETT, V266, P109, DOI 10.1016/S0304-3940(99)00267-0; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; von der Behrens W, 2009, J NEUROSCI, V29, P13837, DOI 10.1523/JNEUROSCI.3475-09.2009; Widmann A, 2015, J NEUROSCI METH, V250, P34, DOI 10.1016/j.jneumeth.2014.08.002; Winkler I, 2007, J PSYCHOPHYSIOL, V21, P147, DOI 10.1027/0269-8803.21.34.147; Yu XJ, 2009, NAT NEUROSCI, V12, P1165, DOI 10.1038/nn.2373; Yvert B, 2005, NEUROIMAGE, V28, P140, DOI 10.1016/j.neuroimage.2005.05.056; Yvert B, 2001, CEREB CORTEX, V11, P411, DOI 10.1093/cercor/11.5.411	73	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136794	10.1371/journal.pone.0136794	http://dx.doi.org/10.1371/journal.pone.0136794			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348628	Green Published, gold, Green Submitted			2022-12-26	WOS:000360897600012
J	Madhavan, L; Daley, BF; Davidson, BL; Boudreau, RL; Lipton, JW; Cole-Strauss, A; Steece-Collier, K; Collier, TJ				Madhavan, Lalitha; Daley, Brian F.; Davidson, Beverly L.; Boudreau, Ryan L.; Lipton, Jack W.; Cole-Strauss, Allyson; Steece-Collier, Kathy; Collier, Timothy J.			Sonic Hedgehog Controls the Phenotypic Fate and Therapeutic Efficacy of Grafted Neural Precursor Cells in a Model of Nigrostriatal Neurodegeneration	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; STEM-CELLS; PARKINSONS-DISEASE; RAT MODEL; SUBVENTRICULAR ZONE; NEUROTROPHIC FACTOR; ADULT RATS; NEUROPROTECTION; TRANSPLANTATION	The expression of soluble growth and survival promoting factors by neural precursor cells (NPCs) is suggested to be a prominent mechanism underlying the protective and regenerative effects of these cells after transplantation. Nevertheless, how and to what extent specific NPC-expressed factors contribute to therapeutic effects is not well understood. Using RNA silencing, the current study investigated the roles of two donor NPC molecules, namely glial cell-line derived neurotrophic factor (GDNF) and sonic hedgehog (SHH), in the protection of substantia nigra dopamine neurons in rats treated with 6-hydroxydopamine (6-OHDA). Analyses indicate that as opposed to the knock-down of GDNF, SHH inhibition caused a profound decline in nigrostriatal neuroprotection. Further, SHH silencing also curbed endogenous neurogenesis and the migration of host brdU(+)/dcx(+) neural precursors into the striatum, which was present in the animals receiving control or GDNF silenced NPCs. A change in graft phenotype, mainly reflected by a reduced proportion of undifferentiated nestin(+) cells, as well as a significantly greater host microglial activity, suggested an important role for these processes in the attenuation of neuroprotection and neurogenesis upon SHH silencing. Overall these studies reveal core mechanisms fundamental to grafted NPC-based therapeutic effects, and delineate the particular contributions of two graft-expressed molecules, SHH and GDNF, in mediating midbrain dopamine neuron protection, and host plasticity after NPC transplantation.	[Madhavan, Lalitha] Univ Arizona, Dept Neurol, Tucson, AZ 85724 USA; [Davidson, Beverly L.] Childrens Hosp Philadelphia, Ctr Cell & Mol Therapy, Philadelphia, PA 19104 USA; [Boudreau, Ryan L.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Daley, Brian F.; Lipton, Jack W.; Cole-Strauss, Allyson; Steece-Collier, Kathy; Collier, Timothy J.] Michigan State Univ, Translat Sci & Mol Med, Grand Rapids, MI 49503 USA	University of Arizona; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Iowa; Michigan State University	Madhavan, L (corresponding author), Univ Arizona, Dept Neurol, Tucson, AZ 85724 USA.	lmadhavan@email.arizona.edu	Lipton, Jack/L-3631-2019	Lipton, Jack/0000-0003-0991-8275; Boudreau, Ryan/0000-0002-9800-5349; Davidson, Beverly/0000-0002-3715-6290	NIH [NS58830, NS055295]; Gardner Family Foundation at the University of Cincinnati; University of Arizona intramural funds; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS058830, R01NS055295] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gardner Family Foundation at the University of Cincinnati; University of Arizona intramural funds; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by: NIH grants NS58830 the Udall Center of Excellence in Parkinson's Disease Research at Michigan State University and NS055295 (TJC), Gardner Family Foundation at the University of Cincinnati (TJC and LM), and The University of Arizona intramural funds (LM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JK, 2009, PROG BRAIN RES, V175, P125, DOI 10.1016/S0079-6123(09)17508-8; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Angot E, 2008, STEM CELLS, V26, P2311, DOI 10.1634/stemcells.2008-0297; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Balordi F, 2007, J NEUROSCI, V27, P5936, DOI 10.1523/JNEUROSCI.1040-07.2007; Boudreau RL, 2012, METHOD ENZYMOL, V507, P275, DOI 10.1016/B978-0-12-386509-0.00014-4; Breunig JJ, 2011, NEURON, V70, P614, DOI 10.1016/j.neuron.2011.05.005; Catalin B, 2013, ROM J MORPHOL EMBRYO, V54, P467; Chechneva OV, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.446; Cusimano M, 2012, BRAIN, V135, P447, DOI 10.1093/brain/awr339; De Feo D, 2012, CURR OPIN NEUROL, V25, P322, DOI 10.1097/WCO.0b013e328352ec45; Drago D, 2013, BIOCHIMIE, V95, P2271, DOI 10.1016/j.biochi.2013.06.020; Gonzalez-Reyes LE, 2012, NEURON, V75, P306, DOI 10.1016/j.neuron.2012.05.018; Han SSW, 2002, EXP NEUROL, V177, P360, DOI 10.1006/exnr.2002.7995; Harper SQ, 2005, METH MOL B, V309, P219; Hayes L, 2013, DEV BIOL, V374, P115, DOI 10.1016/j.ydbio.2012.11.016; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; Kobayashi T, 2006, STROKE, V37, P2361, DOI 10.1161/01.STR.0000236025.44089.e1; Kordower JH, 2013, MOVEMENT DISORD, V28, P96, DOI 10.1002/mds.25344; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Laganiere J, 2010, J NEUROSCI, V30, P16469, DOI 10.1523/JNEUROSCI.2440-10.2010; Liu J, 2013, J CELL MOL MED, V17, P1434, DOI 10.1111/jcmm.12123; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Madhavan L, 2007, STEM CELLS; Madhavan L, 2012, EUR J NEUROSCI, V35, P883, DOI 10.1111/j.1460-9568.2012.08019.x; Madhavan L, 2010, NEUROPHARMACOLOGY, V58, P835, DOI 10.1016/j.neuropharm.2009.10.005; Madhavan L, 2009, J COMP NEUROL, V515, P102, DOI 10.1002/cne.22033; Miao NN, 1997, J NEUROSCI, V17, P5891; Mine Y, 2013, NEUROBIOL DIS, V52, P191, DOI 10.1016/j.nbd.2012.12.006; Mosher KI, 2012, NAT NEUROSCI, V15, P1485, DOI 10.1038/nn.3233; Mujtaba T, 2002, EXP NEUROL, V174, P48, DOI 10.1006/exnr.2001.7847; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; PARK D, 2010, STEM CELLS; Pluchino S, 2010, ARCH ITAL BIOL, V148, P173; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Spieles-Engemann AL, 2011, J PARKINSON DIS, V1, P123, DOI 10.3233/JPD-2011-11008; Tsuboi K, 2002, EXP NEUROL, V173, P95, DOI 10.1006/exnr.2001.7825; Yasuhara T, 2006, J NEUROSCI, V26, P12497, DOI 10.1523/JNEUROSCI.3719-06.2006; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009	40	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137136	10.1371/journal.pone.0137136	http://dx.doi.org/10.1371/journal.pone.0137136			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340267	Green Submitted, Green Published, gold			2022-12-26	WOS:000360688200025
J	Zhang, J; Gu, FF; Zhao, SY; Xiao, SZ; Wang, YC; Guo, XK; Ni, YX; Han, LZ				Zhang, Ji; Gu, Fei-Fei; Zhao, Sheng-Yuan; Xiao, Shu-Zhen; Wang, Yan-Chun; Guo, Xiao-Kui; Ni, Yu-Xing; Han, Li-Zhong			Prevalence and Molecular Epidemiology of Staphylococcus aureus among Residents of Seven Nursing Homes in Shanghai	PLOS ONE			English	Article							NASAL CARRIAGE; GENE-CLUSTER; COLONIZATION; INFECTIONS; STRAINS; MRSA; RESISTANCE; DIVERSITY; IMPACT	Background Residents in nursing homes (NHs) always represent potential reservoirs for Staphylococcus aureus and methicillin-resistant S. aureus (MRSA). To our knowledge, there is no epidemiological information up till now that describes the prevalence and molecular characteristics of S. aureus in nursing home residents in Shanghai, China. Methods Four hundred and ninety-one unique residents from 7 NHs were enrolled in this study. Specimens were collected among these residents including 491 nasal swabs, 487 axillary swabs and 119 skin swabs. S. aureus isolated and identified from the swabs was characterized according to antimicrobial susceptibility profiling, toxin gene prevalence, and multilocus sequence typing (MLST), spa and SCCmec typing. Results Among the 491 residents screened, S. aureus was isolated in 109 residents from 90 nasal swabs (90/491, 18.3%), 29 axillary swabs (29/487, 6.0%), and 22 skin swabs (22/119, 18.5%). Sixty-eight MRSA isolates were detected in 52 residents from 41 nasal carriers, 15 axillary carriers and 12 skin carriers. The overall prevalence rate of S. aureus and MRSA colonization was 22.2% and 10.6% respectively. Ten residents presented S. aureus in all three sample types and 12 residents presented S. aureus in two of the three sample types collected. Molecular analysis revealed CC1 (29.1%) to be the dominant clone in this study, followed by CC398 (19.9%), CC188 (13.5%) and CC5 (12.8%). The most common spa type was t127 (22.0%), followed by t14383 (12.8%) and t002 (10.6%). Conclusions A high prevalence of S. aureus and MRSA colonization was revealed in nursing home residents in Shanghai. CC1 was the most common clonal complex and t127 was the most common spa type among NH residents. The data provides an important baseline for future surveillance of S. aureus in NHs in Shanghai and other highly urbanized regions in China. Implementation of infection control strategies must be given high priority in NHs to fight such high prevalence of both MRSA and methicillin-susceptible S. aureus (MSSA).	[Zhang, Ji] Shanghai Peoples Hosp Putuo Dist, Dept Clin Lab, Shanghai, Peoples R China; [Gu, Fei-Fei; Zhao, Sheng-Yuan; Xiao, Shu-Zhen; Ni, Yu-Xing; Han, Li-Zhong] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Clin Microbiol, Shanghai 200030, Peoples R China; [Wang, Yan-Chun; Guo, Xiao-Kui] Shanghai Jiao Tong Univ, Sch Med, Dept Microbiol & Parasitol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Han, LZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Clin Microbiol, Shanghai 200030, Peoples R China.	hanlizhong1107@163.com	wang, yi/GVT-8516-2022; Wang, Yijun/GXW-1763-2022; Wang, Yixuan/GZK-6559-2022; wang, yixuan/GXW-2866-2022		National Natural Science Foundation of China [81472010]; Research Special Fund for Public Welfare Industry of Health [201002021]; Scientific Research Project of Independent Innovation of Shanghai Putuo District Health System [[Pu]KW11204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Special Fund for Public Welfare Industry of Health; Scientific Research Project of Independent Innovation of Shanghai Putuo District Health System	This study was supported by National Natural Science Foundation of China (No. 81472010), Research Special Fund for Public Welfare Industry of Health (No. 201002021) and Scientific Research Project of Independent Innovation of Shanghai Putuo District Health System ([Pu]KW11204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin NS, 2010, J HOSP INFECT, V76, P36, DOI 10.1016/j.jhin.2010.03.006; Baldwin NS, 2009, J AM GERIATR SOC, V57, P620, DOI 10.1111/j.1532-5415.2009.02181.x; Bradley SF, 2002, CLIN INFECT DIS, V34, P211, DOI 10.1086/338150; Brugnaro P, 2009, INFECTION, V37, P216, DOI 10.1007/s15010-008-8165-1; Budimir A, 2014, AM J INFECT CONTROL, V42, P1197, DOI 10.1016/j.ajic.2014.07.032; Chamchod F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029757; Chen X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072811; Chen X, 2012, BURNS, V38, P738, DOI 10.1016/j.burns.2011.12.023; Collery MM, 2009, J MED MICROBIOL, V58, P13, DOI 10.1099/jmm.0.005215-0; Conceicao T, 2012, MICROB DRUG RESIST, V18, P116, DOI 10.1089/mdr.2011.0182; Cox RA, 1999, J HOSP INFECT, V43, P115, DOI 10.1053/jhin.1999.0633; Cuny C, 2015, VET MICROBIOL, V177, P219, DOI 10.1016/j.vetmic.2015.02.031; Denis O, 2009, J ANTIMICROB CHEMOTH, V64, P1299, DOI 10.1093/jac/dkp345; Elias J, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-111; Franklin R., 2013, M100S23 ABMM, V33; Gu FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123557; Gu FF, 2015, SURG INFECT, V16, P97, DOI 10.1089/sur.2014.027; Han LZ, 2010, EMERG INFECT DIS, V16, P731, DOI 10.3201/eid1604.081324; Hudson LO, 2013, J CLIN MICROBIOL, V51, P3788, DOI 10.1128/JCM.01708-13; Hughes C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006354.pub4; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Lee BY, 2013, MED CARE, V51, P205, DOI 10.1097/MLR.0b013e3182836dc2; Lee BY, 2013, INFECT CONT HOSP EP, V34, P151, DOI 10.1086/669091; Lesse AJ, 2006, AM J INFECT CONTROL, V34, P642, DOI 10.1016/j.ajic.2006.06.008; Li Fenfang, 2010, Hawaii Med J, V69, P126; Li M, 2012, NAT MED, V18, P816, DOI 10.1038/nm.2692; Loeb MB, 2003, AM J EPIDEMIOL, V157, P40, DOI 10.1093/aje/kwf173; Murphy CR, 2013, INFECT CONT HOSP EP, V34, P325, DOI 10.1086/669519; Murphy CR, 2012, J AM GERIATR SOC, V60, P1012, DOI 10.1111/j.1532-5415.2012.03978.x; O'Sullivan NP, 2000, J HOSP INFECT, V45, P322, DOI 10.1053/jhin.2000.0758; Pfingsten-Wurzburg S, 2011, J HOSP INFECT, V78, P108, DOI 10.1016/j.jhin.2011.02.011; Qiao YH, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0582-4; Robert J, 2011, ANTIMICROB AGENTS CH, V55, P1734, DOI 10.1128/AAC.01221-10; Stark L, 2014, EPIDEMIOL INFECT, V142, P1310, DOI 10.1017/S0950268813002033; Suetens C, 2006, J AM GERIATR SOC, V54, P1854, DOI 10.1111/j.1532-5415.2006.00972.x; Tian SF, 2013, SCAND J INFECT DIS, V45, P915, DOI 10.3109/00365548.2013.830330; Verkade E, 2012, INFECT CONT HOSP EP, V33, P624, DOI 10.1086/665726; Verrall A, 2013, J HOSP INFECT, V83, P250, DOI 10.1016/j.jhin.2012.11.021; Zhao CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038577	39	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137593	10.1371/journal.pone.0137593	http://dx.doi.org/10.1371/journal.pone.0137593			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340648	Green Published, Green Submitted, gold			2022-12-26	WOS:000360688200069
J	Li Causi, E; Parikh, SC; Chudley, L; Layfield, DM; Ottensmeier, CH; Stevenson, FK; Di Genova, G				Li Causi, Eleonora; Parikh, Suraj C.; Chudley, Lindsey; Layfield, David M.; Ottensmeier, Christian H.; Stevenson, Freda K.; Di Genova, Gianfranco			Vaccination Expands Antigen-Specific CD4(+) Memory T Cells and Mobilizes Bystander Central Memory T Cells	PLOS ONE			English	Article							BONE-MARROW; SMALLPOX; EFFECTOR; HETEROGENEITY; IMMUNIZATION; STIMULATION; GENERATION; RESPONSES; IMMUNITY	CD4(+) T helper memory (Th-mem) cells influence both natural and vaccine-boosted immunity, but mechanisms for their maintenance remain unclear. Pro-survival signals from the common gamma-chain cytokines, in particular IL-7, appear important. Previously we showed in healthy volunteers that a booster vaccination with tetanus toxoid (TT) expanded peripheral blood TT-specific Th-mem cells as expected, but was accompanied by parallel increase of Thmem cells specific for two unrelated and non cross-reactive common recall antigens. Here, in a new cohort of healthy human subjects, we compare blood vaccine-specific and bystander Th-mem cells in terms of differentiation stage, function, activation and proliferative status. Both responses peaked 1 week post-vaccination. Vaccine-specific cytokine-producing Th-mem cells were predominantly effector memory, whereas bystander cells were mainly of central memory phenotype. Importantly, TT-specific Th-mem cells were activated (CD38(High) HLA-DR+), cycling or recently divided (Ki-67(+)), and apparently vulnerable to death (IL-7R alpha(Low) and Bcl-2 (Low)). In contrast, bystander Th-mem cells were resting (CD38(Low) HLA-DR- Ki-67(-)) with high expression of IL-7R alpha and Bcl-2. These findings allow a clear distinction between vaccine-specific and bystander Th-mem cells, suggesting the latter do not derive from recent proliferation but from cells mobilized from as yet undefined reservoirs. Furthermore, they reveal the interdependent dynamics of specific and bystander T-cell responses which will inform assessments of responses to vaccines.	[Li Causi, Eleonora; Parikh, Suraj C.; Chudley, Lindsey; Layfield, David M.; Ottensmeier, Christian H.; Stevenson, Freda K.; Di Genova, Gianfranco] Univ Southampton, Fac Med, Canc Sci Unit, Southampton SO9 5NH, Hants, England	University of Southampton	Di Genova, G (corresponding author), AstraZeneca R&D Oncol IMed, 33G197 Mereside,Alderley Pk, Macclesfield SK10 4TG, Cheshire, England.	g.digenova@outlook.com	Ottensmeier, Christian H/E-8131-2012; Ottensmeier, Christian/ABE-9056-2020	Ottensmeier, Christian H/0000-0003-3619-1657; Ottensmeier, Christian/0000-0003-3619-1657; Parikh, Suraj/0000-0002-1878-6510; Layfield, David/0000-0002-9224-8243; Stevenson, Freda/0000-0002-0933-5021	Leukaemia & Lymphoma Research [08028]; Cancer Research UK [15951, 20613] Funding Source: researchfish	Leukaemia & Lymphoma Research; Cancer Research UK(Cancer Research UK)	This study was supported by Leukaemia & Lymphoma Research https://leukaemialymphomaresearch.org.uk/ grant number 08028. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangs SC, 2009, J IMMUNOL, V182, P1962, DOI 10.4049/jimmunol.0802596; Cellerai C, 2007, EUR J IMMUNOL, V37, P1129, DOI 10.1002/eji.200636885; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Cohen GB, 2005, J IMMUNOL METHODS, V302, P103, DOI 10.1016/j.jim.2005.05.002; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Demkowicz WE, 1996, J VIROL, V70, P2627, DOI 10.1128/JVI.70.4.2627-2631.1996; Di Genova G, 2006, BLOOD, V107, P2806, DOI 10.1182/blood-2005-08-3255; Di Genova G, 2010, EUR J IMMUNOL, V40, P976, DOI 10.1002/eji.200940017; DONNENBERG AD, 1984, SCAND J IMMUNOL, V20, P279, DOI 10.1111/j.1365-3083.1984.tb01004.x; FERNANDEZ V, 1994, EUR J IMMUNOL, V24, P1808, DOI 10.1002/eji.1830240813; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Gonzalez-Garcia I, 2006, J IMMUNOL, V176, P4042, DOI 10.4049/jimmunol.176.7.4042; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Harari A, 2004, EUR J IMMUNOL, V34, P3525, DOI 10.1002/eji.200425324; Herndler-Brandstetter D, 2011, J IMMUNOL, V186, P6965, DOI 10.4049/jimmunol.1100243; Kohler S, 2012, EUR J IMMUNOL, V42, P2363, DOI 10.1002/eji.201142306; Mayer S, 2002, IMMUNOBIOLOGY, V205, P282, DOI 10.1078/0171-2985-00131; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Mitchell T, 1999, J IMMUNOL, V162, P4527; Odendahl M, 2005, BLOOD, V105, P1614, DOI 10.1182/blood-2004-07-2507; Okhrimenko A, 2014, P NATL ACAD SCI USA, V111, P9229, DOI 10.1073/pnas.1318731111; Osborne LC, 2010, CYTOKINE, V50, P105, DOI 10.1016/j.cyto.2009.09.008; Perona-Wright G, 2010, NAT IMMUNOL, V11, P520, DOI 10.1038/ni.1866; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 2009, EUR J IMMUNOL, V39, P2076, DOI 10.1002/eji.200939722; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Shinoda K, 2012, P NATL ACAD SCI USA, V109, P7409, DOI 10.1073/pnas.1118539109; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Taylor JJ, 2011, CURR OPIN IMMUNOL, V23, P319, DOI 10.1016/j.coi.2011.03.010; Tokoyoda K, 2010, NAT REV IMMUNOL, V10, P193, DOI 10.1038/nri2727; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Varga SM, 2001, J IMMUNOL, V166, P1554, DOI 10.4049/jimmunol.166.3.1554; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	35	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136717	10.1371/journal.pone.0136717	http://dx.doi.org/10.1371/journal.pone.0136717			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332995	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000360613800067
J	Itakura, M; Nakajima, H; Kubo, T; Semi, Y; Kume, S; Higashida, S; Kaneshige, A; Kuwamura, M; Harada, N; Kita, A; Azuma, YT; Yamaji, R; Inui, T; Takeuchi, T				Itakura, Masanori; Nakajima, Hidemitsu; Kubo, Takeya; Semi, Yuko; Kume, Satoshi; Higashida, Shusaku; Kaneshige, Akihiro; Kuwamura, Mitsuru; Harada, Naoki; Kita, Akinori; Azuma, Yasu-Taka; Yamaji, Ryoichi; Inui, Takashi; Takeuchi, Tadayoshi			Glyceraldehyde-3-phosphate Dehydrogenase Aggregates Accelerate Amyloid-beta Amyloidogenesis in Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; A-BETA; NUCLEAR TRANSLOCATION; MOUSE MODELS; GAPDH; ACTIVATION; PEPTIDE; ASSOCIATION; MECHANISM; TOXICITY	Alzheimer disease (AD) is a progressive neurodegenerative disorder characterized by loss of neurons and formation of pathological extracellular deposits induced by amyloid-beta peptide (A beta). Numerous studies have established A beta amyloidogenesis as a hallmark of AD pathogenesis, particularly with respect to mitochondrial dysfunction. We have previously shown that glycolytic glyceraldehyde-3-phosphate dehydrogenase (GAPDH) forms amyloid-like aggregates upon exposure to oxidative stress and that these aggregates contribute to neuronal cell death. Here, we report that GAPDH aggregates accelerate A beta amyloidogenesis and subsequent neuronal cell death both in vitro and in vivo. Co-incubation of A beta 40 with small amounts of GAPDH aggregates significantly enhanced A beta 40 amyloidogenesis, as assessed by in vitro thioflavin-T assays. Similarly, structural analyses using Congo red staining, circular dichroism, and atomic force microscopy revealed that GAPDH aggregates induced A beta 40 amyloidogenesis. In PC12 cells, GAPDH aggregates augmented A beta 40-induced cell death, concomitant with disruption of mitochondrial membrane potential. Furthermore, mice injected intracerebroventricularly with A beta 40 co-incubated withGAPDHaggregates exhibited A beta 40-induced pyramidal cell death and gliosis in the hippocampal CA3 region. These observations were accompanied by nuclear translocation of apoptosis-inducing factor and cytosolic release of cytochrome c from mitochondria. Finally, in the 3 x Tg-AD mouse model of AD, GAPDH/A beta co-aggregation and mitochondrial dysfunction were consistently detected in an age- dependent manner, and A beta aggregate formation was attenuated by GAPDH siRNA treatment. Thus, this study suggests that GAPDH aggregates accelerate A beta amyloidogenesis, subsequently leading to mitochondrial dysfunction and neuronal cell death in the pathogenesis of AD.	[Itakura, Masanori; Nakajima, Hidemitsu; Kubo, Takeya; Semi, Yuko; Higashida, Shusaku; Kaneshige, Akihiro; Kita, Akinori; Azuma, Yasu-Taka; Takeuchi, Tadayoshi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Lab Vet Pharmacol, Izumisano, Osaka 5988531, Japan; [Kuwamura, Mitsuru] Osaka Prefecture Univ, Lab Vet Pathol, Izumisano, Osaka 5988531, Japan; [Kume, Satoshi; Inui, Takashi] Osaka Prefecture Univ, Lab Biol Macromol, Osaka 5998531, Japan; [Harada, Naoki; Yamaji, Ryoichi] Osaka Prefecture Univ, Nutr Chem Lab, Osaka 5998531, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University	Nakajima, H (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Lab Vet Pharmacol, Izumisano, Osaka 5988531, Japan.	hnakajima@vet.osakafu-u.ac.jp	Harada, Naoki/AAP-2868-2020; Inui, Takashi/G-1069-2011	Harada, Naoki/0000-0003-3846-388X; Azuma, Yasu-Taka/0000-0002-3515-171X; Nakajima, Hidemitsu/0000-0002-0441-1929	Japan Society for the Promotion of Science [22580339, 25450428]; Japan Science and Technology Agency [AS232Z02185G, AS242Z02311Q]; Adaptable and Seamless Technology Transfer Program through target-driven RD;  [02120076]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Adaptable and Seamless Technology Transfer Program through target-driven RD; 	This work was supported in part by Grants-in-aid for Scientific Research 22580339 and 25450428 (to H. N.) from the Japan Society for the Promotion of Science, by Grants-in-aid from the Japan Science and Technology Agency for exploratory research in A-STEP AS232Z02185G and AS242Z02311Q (to H. N.), he Adaptable and Seamless Technology Transfer Program through target-driven R&D, and by Grant-in-aid for Scientific Research on Innovative Areas 02120076 (to T. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Allen M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.08.002; Bodles AM, 2000, EUR J BIOCHEM, V267, P2186, DOI 10.1046/j.1432-1327.2000.01219.x; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Butterfield DA, 2013, ANTIOXID REDOX SIGN, V19, P823, DOI 10.1089/ars.2012.5027; Butterfield DA, 2010, J ALZHEIMERS DIS, V20, P369, DOI 10.3233/JAD-2010-1375; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Cumming RC, 2005, FASEB J, V19, P2060, DOI 10.1096/fj.05-4195fje; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; Dong YF, 2011, FASEB J, V25, P2911, DOI 10.1096/fj.11-182873; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Foley AM, 2015, J ALZHEIMERS DIS, V44, P787, DOI 10.3233/JAD-142208; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; GANTER C, 1990, BIOCHEMISTRY-US, V29, P9395, DOI 10.1021/bi00492a013; Goto A, 2009, NEUROCHEM INT, V54, P330, DOI 10.1016/j.neuint.2008.12.012; Grace EA, 2002, NEUROSCIENCE, V114, P265, DOI 10.1016/S0306-4522(02)00241-5; Gursky O, 2000, BBA-PROTEIN STRUCT M, V1476, P93, DOI 10.1016/S0167-4838(99)00228-9; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; HARKANY T, 1995, BRAIN RES, V698, P270, DOI 10.1016/0006-8993(95)01013-L; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Hong H, 2004, LIFE SCI, V74, P2959, DOI 10.1016/j.lfs.2003.09.074; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Ishitani R, 2003, PROG NEURO-PSYCHOPH, V27, P291, DOI 10.1016/S0278-5846(03)00024-1; Ishitani R, 1998, MOL PHARMACOL, V53, P701, DOI 10.1124/mol.53.4.701; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Li Y, 2004, P NATL ACAD SCI USA, V101, P15688, DOI 10.1073/pnas.0403535101; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lin PI, 2006, NEUROLOGY, V67, P64, DOI 10.1212/01.wnl.0000223438.90113.4e; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; Moreira PI, 2010, BBA-MOL BASIS DIS, V1802, P2, DOI 10.1016/j.bbadis.2009.10.006; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Nakajima H, 2015, J BIOL CHEM, V290, P14493, DOI 10.1074/jbc.M114.635607; Nakajima H, 2009, BIOCHEM BIOPH RES CO, V390, P1066, DOI 10.1016/j.bbrc.2009.10.118; Nakajima H, 2009, J BIOL CHEM, V284, P34331, DOI 10.1074/jbc.M109.027698; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Ono K, 2005, BIOCHEM BIOPH RES CO, V336, P444, DOI 10.1016/j.bbrc.2005.08.148; Pagani Lucia, 2011, Int J Alzheimers Dis, V2011, P925050, DOI 10.4061/2011/925050; Perluigi M, 2010, J NEUROSCI RES, V88, P3498, DOI 10.1002/jnr.22500; Pierce A, 2008, J MOL BIOL, V382, P1195, DOI 10.1016/j.jmb.2008.07.088; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SIMMONS LK, 1994, MOL PHARMACOL, V45, P373; SLOVITER RS, 1989, J COMP NEUROL, V280, P183, DOI 10.1002/cne.902800203; Small DH, 2001, NAT REV NEUROSCI, V2, P595, DOI 10.1038/35086072; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; Tisdale EJ, 2001, J BIOL CHEM, V276, P2480, DOI 10.1074/jbc.M007567200; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Tsuchiya K, 2005, EUR J NEUROSCI, V21, P317, DOI 10.1111/j.1460-9568.2005.03870.x; Tsuchiya K, 2004, LIFE SCI, V74, P3245, DOI 10.1016/j.lfs.2003.11.029; Wang Q, 2005, FASEB J, V19, P869, DOI 10.1096/fj.04-3210fje; Wirths O, 2012, LIFE SCI, V91, P1148, DOI 10.1016/j.lfs.2012.02.001; Xu GL, 2013, HUM MOL GENET, V22, P2765, DOI 10.1093/hmg/ddt121; Yamaji R, 2003, BBA-MOL CELL RES, V1593, P269, DOI 10.1016/S0167-4889(02)00397-X; Yamaji R, 2005, BBA-GEN SUBJECTS, V1726, P261, DOI 10.1016/j.bbagen.2005.07.013; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	65	45	46	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26072	26087		10.1074/jbc.M115.669291	http://dx.doi.org/10.1074/jbc.M115.669291			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26359500	Green Published, hybrid			2022-12-26	WOS:000363527300028
J	Rhee, SH; Ma, EL; Lee, Y; Tache, Y; Pothoulakis, C; Im, E				Rhee, Sang Hoon; Ma, Elise L.; Lee, Yunna; Tache, Yvette; Pothoulakis, Charalabos; Im, Eunok			Corticotropin Releasing Hormone and Urocortin 3 Stimulate Vascular Endothelial Growth Factor Expression through the cAMP/CREB Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE-RECEPTOR-5 ENGAGEMENT; INTESTINAL INFLAMMATION; GENE-EXPRESSION; SPLICE VARIANT; RECEPTOR; VEGF; CELLS; HYPOXIA; ANGIOGENESIS	Colonic epithelium is the first line of defense against various pathological offenses in the gut. Previous studies have shown that the peptides of the corticotropin-releasing hormone (CRH) family modulate vascular endothelial growth factor (VEGF)-A production in other cells. Here we sought to investigate whether CRH and urocortin (Ucn) 3 regulate VEGF-A secretion in colonocytes through CRH receptors and to elucidate the underlying mechanism of action. CRH and Ucn 3 significantly increased the expression levels of VEGF-A mRNA and protein through CRH receptor 1 and 2, respectively, in human colonic epithelial cells and primary mouse intestinal epithelial cells. Underlying mechanisms involve activation of adenylyl cyclase with subsequent increase of intracellular cAMP level and increased DNA binding activity of transcription factor CREB on VEGF-A promoter region. Finally, genetic deficiency of CREB decreased intestinal inflammation and VEGF-A expression in a dextran sodium sulfate-induced colitis model. These results show that activation of CRH receptors by CRH ligands stimulates VEGF-A expression in intestinal epithelial cells through the cAMP/CREB pathway. Since VEGF-A boosts inflammatory responses through angiogenesis, these data suggest that CREB may be a key effector of CRH and Ucn 3-dependent inflammatory angiogenesis.	[Rhee, Sang Hoon; Ma, Elise L.; Tache, Yvette; Pothoulakis, Charalabos] Univ Calif Los Angeles, David Geffen Sch Med, Sect Inflammatory Bowel Dis, Los Angeles, CA 90095 USA; [Rhee, Sang Hoon; Ma, Elise L.; Tache, Yvette; Pothoulakis, Charalabos] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Inflammatory Bowel Dis, Div Digest Dis, Los Angeles, CA 90095 USA; [Lee, Yunna; Im, Eunok] Pusan Natl Univ, Coll Pharm, Busan 609735, South Korea	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pusan National University	Im, E (corresponding author), Pusan Natl Univ, Coll Pharm, Busan 609735, South Korea.	eoim@pusan.ac.kr	Regan, Clinton/E-6250-2012		Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A2057432]; National Institutes of Health [R01DK101671]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301, R01DK101671] Funding Source: NIH RePORTER	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A1A2057432, to E. I.) and by the National Institutes of Health (R01DK101671, to C. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Anton PM, 2004, P NATL ACAD SCI USA, V101, P8503, DOI 10.1073/pnas.0402693101; Bale TL, 2002, P NATL ACAD SCI USA, V99, P7734, DOI 10.1073/pnas.102187099; Bates DO, 2002, CANCER RES, V62, P4123; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Cao J, 2005, J IMMUNOL, V174, P7665, DOI 10.4049/jimmunol.174.12.7665; Carvalho AT, 2007, WORLD J GASTROENTERO, V13, P2166, DOI 10.3748/wjg.v13.i15.2166; Choi YJ, 2013, FASEB J, V27, P243, DOI 10.1096/fj.12-217596; Choi YJ, 2010, J BIOL CHEM, V285, P37570, DOI 10.1074/jbc.M110.158394; CLAFFEY KP, 1992, J BIOL CHEM, V267, P16317; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; GARRIDO C, 1993, GROWTH FACTORS, V8, P109, DOI 10.3109/08977199309046931; Grammatopoulos DK, 2012, BRIT J PHARMACOL, V166, P85, DOI 10.1111/j.1476-5381.2011.01631.x; Hao ZR, 2008, P NATL ACAD SCI USA, V105, P3939, DOI 10.1073/pnas.0712366105; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Hillhouse EW, 2006, ENDOCR REV, V27, P260, DOI 10.1210/er.2005-0034; Hsu SY, 2001, NAT MED, V7, P605, DOI 10.1038/87936; IKEDA E, 1995, J BIOL CHEM, V270, P19761, DOI 10.1074/jbc.270.34.19761; Im E, 2005, MOL BIOL CELL, V16, P3488, DOI 10.1091/mbc.E04-11-1029; Im E, 2006, EMBO J, V25, P2075, DOI 10.1038/sj.emboj.7601100; Im E, 2014, INTEST RES, V12, P96, DOI 10.5217/ir.2014.12.2.96; Im E, 2010, GASTROENTEROLOGY, V138, P2457, DOI 10.1053/j.gastro.2010.02.055; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Jeon SH, 2007, MOL CELLS, V23, P23; Kokkotou E, 2006, J IMMUNOL, V177, P3355, DOI 10.4049/jimmunol.177.5.3355; LABRIE F, 1982, SCIENCE, V216, P1007, DOI 10.1126/science.6281886; Lee JS, 2009, J NEUROSCI, V29, P8493, DOI 10.1523/JNEUROSCI.1321-09.2009; Levy AP, 1996, J BIOL CHEM, V271, P2746, DOI 10.1074/jbc.271.5.2746; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; McEvoy AN, 2002, ANN NY ACAD SCI, V966, P119, DOI 10.1111/j.1749-6632.2002.tb04209.x; Million M, 1999, AM J PHYSIOL-GASTR L, V276, pG1027, DOI 10.1152/ajpgi.1999.276.4.G1027; Mukhopadhyay D, 1997, MOL CELL BIOL, V17, P5629, DOI 10.1128/MCB.17.9.5629; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; Rhee SH, 2008, GASTROENTEROLOGY, V135, P518, DOI 10.1053/j.gastro.2008.04.022; Rhee SH, 2000, J BIOL CHEM, V275, P34035, DOI 10.1074/jbc.M007386200; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Rhee SH, 2004, J BIOL CHEM, V279, P25179, DOI 10.1074/jbc.M400967200; Scaldaferri F, 2009, GASTROENTEROLOGY, V136, P585, DOI 10.1053/j.gastro.2008.09.064; Tache Y, 2007, J CLIN INVEST, V117, P33, DOI 10.1172/JCI30085; Takahashi A, 2002, MOL CELL BIOL, V22, P4803, DOI 10.1128/MCB.22.13.4803-4814.2002; Tezval H, 2009, WORLD J UROL, V27, P825, DOI 10.1007/s00345-009-0417-x; Tezval H, 2009, PROSTATE, V69, P443, DOI 10.1002/pros.20892; Tolstanova G, 2009, J PHARMACOL EXP THER, V328, P749, DOI 10.1124/jpet.108.145128; Tsiolakidou G, 2008, DIGEST LIVER DIS, V40, P673, DOI 10.1016/j.dld.2008.02.010; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Wakahashi S, 2008, ENDOCRINE, V33, P144, DOI 10.1007/s12020-008-9071-0; Wang JJ, 2010, CANCER INVEST, V28, P146, DOI 10.3109/07357900903179617; Woolard J, 2004, CANCER RES, V64, P7822, DOI 10.1158/0008-5472.CAN-04-0934	50	14	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26194	26203		10.1074/jbc.M115.678979	http://dx.doi.org/10.1074/jbc.M115.678979			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26350463	Green Published, hybrid			2022-12-26	WOS:000363527300037
J	Aguilera, MA; Valdivia, N; Broitman, BR				Aguilera, Moises A.; Valdivia, Nelson; Broitman, Bernardo R.			Herbivore-Alga Interaction Strength Influences Spatial Heterogeneity in a Kelp-Dominated Intertidal Community	PLOS ONE			English	Article							ROCKY SHORES; NORTHERN CHILE; DURVILLAEA-ANTARCTICA; FUNCTIONAL REDUNDANCY; GEOGRAPHIC-VARIATION; POPULATION BIOLOGY; LIFE-HISTORIES; BOTTOM-UP; PATTERNS; MARINE	There is a general consensus that marine herbivores can affect algal species composition and abundance, but little empirical work exists on the role of herbivores as modifiers of the spatial structure of resource assemblages. Here, we test the consumption/bulldozing effects of the molluscan grazer Enoplochiton niger and its influence on the spatial structure of a low intertidal community dominated by the bull kelp Durvillaea antarctica and the kelp Lessonia spicata. Through field experiments conducted at a rocky intertidal shore in north-central Chile (similar to 30 degrees-32 degrees S), the edge of the grazer and algae geographic distributions, we estimated the strength and variability of consumptive effects of the grazer on different functional group of algae. We also used data from abundance field surveys to evaluate spatial co-occurrence patterns of the study species. Exclusion-enclosure experiments showed that E. niger maintained primary space available by preventing algal colonization, even of large brown algae species. The grazing activity of E. niger also reduced spatial heterogeneity of the ephemeral algal species, increasing bare space availability and variability through time in similar ways to those observed for the collective effect with other grazers. Overall, our result suggests that E. niger can be considered an important modifier of the spatial structure of the large brown algae-dominated community. Effects of E. niger on resource variability seem to be directly related to its foraging patterns, large body size, and population densities, which are all relevant factors for management and conservation of the large brown algae community. Our study thus highlights the importance of considering functional roles and identity of generalist consumers on spatial structure of the entire landscape.	[Aguilera, Moises A.; Broitman, Bernardo R.] Univ Catolica Norte, CEAZA, Larrondo 1281, Coquimbo, Chile; [Valdivia, Nelson] Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile	Universidad Catolica del Norte; Universidad Austral de Chile	Aguilera, MA (corresponding author), Univ Catolica Norte, CEAZA, Larrondo 1281, Coquimbo, Chile.	moises.aguilera@ceaza.cl	Aguilera, Moisés/AAC-2981-2020; Broitman, Bernardo R/D-6007-2013; Valdivia, Nelson/C-3613-2009	Aguilera, Moisés/0000-0002-3517-6255; Broitman, Bernardo R/0000-0001-6582-3188; Valdivia, Nelson/0000-0002-5394-2072	Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT) [11121360, 1090488, 1120988, 3100014, 1141037]; Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (MECESUP) [AUS0805]; UACH [S-2013-03]; CEAZA; Millennium Nucleus Center for the Study of Multiple-drivers on Marine Socio-Ecological Systems (MUSELS) by MINECON Project [NC120086]; Center for Marine Conservation [RC130024]	Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (MECESUP); UACH; CEAZA(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT Regional/CEAZA); Millennium Nucleus Center for the Study of Multiple-drivers on Marine Socio-Ecological Systems (MUSELS) by MINECON Project; Center for Marine Conservation	Research was supported by grants from the Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT) to MAA (grant #11121360), BRB (grants #1090488 and 1120988) and NV (grants #3100014 and 1141037), and by the Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (MECESUP) and UACH to NV (grants #AUS0805 and S-2013-03, respectively). Funds from CEAZA to MAA and BRB greatly appreciated. Finally, the Millennium Nucleus Center for the Study of Multiple-drivers on Marine Socio-Ecological Systems (MUSELS) by MINECON Project NC120086 and the Center for Marine Conservation RC130024 also supported the final stages of this project.	Adler PB, 2001, OECOLOGIA, V128, P465, DOI 10.1007/s004420100737; Aguilera MA, 2007, J EXP MAR BIOL ECOL, V349, P84, DOI 10.1016/j.jembe.2007.05.002; Aguilera MA, 2012, ECOLOGY, V93, P75, DOI 10.1890/11-0434.1; Aguilera MA, 2011, REV CHIL HIST NAT, V84, P241, DOI 10.4067/S0716-078X2011000200009; Aguilera MA, 2011, MAR ECOL PROG SER, V431, P119, DOI 10.3354/meps09100; Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Benedetti-Cecchi L, 2000, NATURE, V407, P370, DOI 10.1038/35030089; BenedettiCecchi L, 1997, J EXP MAR BIOL ECOL, V209, P171, DOI 10.1016/S0022-0981(96)02686-X; Berlow EL, 1999, ECOLOGY, V80, P2206, DOI 10.1890/0012-9658(1999)080[2206:QVITSO]2.0.CO;2; Blanchette CA, 2008, J BIOGEOGR, V35, P1593, DOI 10.1111/j.1365-2699.2008.01913.x; Botsford LW, 2007, MANAGEMENT FISHERIES, V277, P509; Broitman BR, 2011, REV CHIL HIST NAT, V84, P143, DOI 10.4067/S0716-078X2011000100011; Broitman BR, 2001, MAR ECOL PROG SER, V224, P21, DOI 10.3354/meps224021; Burrows MT, 1998, MAR ECOL PROG SER, V167, P1, DOI 10.3354/meps167001; Camus PA, 2001, REV CHIL HIST NAT, V74, P587, DOI 10.4067/S0716-078X2001000300008; CAMUS PA, 1994, J EXP MAR BIOL ECOL, V184, P171, DOI 10.1016/0022-0981(94)90003-5; Camus PA, 2008, MAR ECOL PROG SER, V361, P35, DOI 10.3354/meps07421; Chapman MG, 2008, MAR ECOL PROG SER, V354, P147, DOI 10.3354/meps07205; Coleman RA, 2006, OECOLOGIA, V147, P556, DOI 10.1007/s00442-005-0296-9; DAYTON PK, 1992, ECOL MONOGR, V62, P421, DOI 10.2307/2937118; DELLASANTINA P, 1995, MAR BIOL, V122, P265; Diaz ER, 2011, J ECOL, V99, P416, DOI 10.1111/j.1365-2745.2010.01779.x; Duffy JE, 2001, ECOLOGY, V82, P2417; DUGGINS DO, 1985, OECOLOGIA, V67, P183, DOI 10.1007/BF00384282; Elahi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078969; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Fox RJ, 2009, MAR ECOL PROG SER, V385, P261, DOI 10.3354/meps08059; Fraser CI, 2009, J PHYCOL, V45, P436, DOI 10.1111/j.1529-8817.2009.00658.x; HAWKINS SJ, 1983, OCEANOGR MAR BIOL, V21, P195; Hillebrand H, 2007, P NATL ACAD SCI USA, V104, P10904, DOI 10.1073/pnas.0701918104; Jenkins SR, 2005, MAR ECOL PROG SER, V287, P77, DOI 10.3354/meps287077; Jenkins SR, 2001, MAR ECOL PROG SER, V211, P193, DOI 10.3354/meps211193; Johansson CL, 2013, CORAL REEFS, V32, P963, DOI 10.1007/s00338-013-1044-y; Johnson MP, 2008, J EXP MAR BIOL ECOL, V365, P136, DOI 10.1016/j.jembe.2008.08.006; Johnson MP, 1997, MAR ECOL PROG SER, V160, P209, DOI 10.3354/meps160209; Jonsson PR, 2006, ECOLOGY, V87, P1169, DOI 10.1890/0012-9658(2006)87[1169:IBWAAG]2.0.CO;2; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Laska MS, 1998, ECOLOGY, V79, P461, DOI 10.2307/176946; Lauzon-Guay JS, 2010, MAR ECOL PROG SER, V403, P29, DOI 10.3354/meps08494; LUBCHENCO J, 1980, ECOLOGY, V61, P676, DOI 10.2307/1937433; Manly B.F.J., 2006, RANDOMIZATION BOOTST, V3rd, DOI DOI 10.1201/9781315273075; Milchunas DG, 1998, OIKOS, V83, P65, DOI 10.2307/3546547; Navarrete SA, 2003, OIKOS, V100, P251, DOI 10.1034/j.1600-0706.2003.11996.x; Navarrete SA, 1996, ECOL MONOGR, V66, P409, DOI 10.2307/2963488; Nielsen KJ, 2004, ECOL LETT, V7, P31, DOI 10.1046/j.1461-0248.2003.00542.x; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Olff H, 1999, NATURE, P400; Orostica MH, 2014, MAR ECOL PROG SER, V511, P71, DOI 10.3354/meps10931; Osenberg Craig W., 1996, P134; Osenberg CW, 1997, AM NAT, V150, P798, DOI 10.1086/286095; Owen-Smith N, 2014, ECOGRAPHY, V37, P416, DOI 10.1111/j.1600-0587.2013.00613.x; Paine RT, 2010, AM NAT, V176, P385, DOI 10.1086/656273; PAINE RT, 1992, NATURE, V355, P73, DOI 10.1038/355073a0; Poore AGB, 2012, ECOL LETT, V15, P912, DOI 10.1111/j.1461-0248.2012.01804.x; Price TD, 2009, P ROY SOC B-BIOL SCI, V276, P1429, DOI 10.1098/rspb.2008.1199; R Core Team, 2016, R FDN STAT COMP; Rivadeneira MM, 2005, J BIOGEOGR, V32, P203, DOI 10.1111/j.1365-2699.2004.01133.x; Rivadeneira MM, 2002, MAR ECOL PROG SER, V245, P123, DOI 10.3354/meps245123; Sala E, 2002, P NATL ACAD SCI USA, V99, P3678, DOI 10.1073/pnas.052028499; Sala E, 2011, MAR ECOL-EVOL PERSP, V32, P300, DOI 10.1111/j.1439-0485.2011.00471.x; Sanhueza AG, 2008, REV CHIL HIST NAT, V81, P533; SANTELICES B, 1990, HYDROBIOLOGIA, V192, P35, DOI 10.1007/BF00006226; Schiel DR, 2006, ANNU REV ECOL EVOL S, V37, P343, DOI 10.1146/annurev.ecolsys.37.091305.110251; Schmitz OJ, 2008, ANNU REV ECOL EVOL S, V39, P133, DOI 10.1146/annurev.ecolsys.39.110707.173418; Silliman BR, 2013, ANNU REV ECOL EVOL S, V44, P503, DOI 10.1146/annurev-ecolsys-110512-135753; Stafford R, 2007, MAR ECOL PROG SER, V342, P151, DOI 10.3354/meps342151; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; STENECK RS, 1982, MAR BIOL, V68, P299, DOI 10.1007/BF00409596; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; STIMSON J, 1973, ECOLOGY, V54, P1020, DOI 10.2307/1935568; Tapia FJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110841; Taylor DI, 2010, ECOLOGY, V91, P201, DOI 10.1890/08-1512.1; Tellier F, 2011, J PHYCOL, V47, P894, DOI 10.1111/j.1529-8817.2011.01019.x; Thiel M, 2000, HYDROBIOLOGIA, V440, P45, DOI 10.1023/A:1004188826443; UNDERWOOD AJ, 1981, OECOLOGIA, V48, P221, DOI 10.1007/BF00347968; Underwood AJ, 1998, OECOLOGIA, V117, P570, DOI 10.1007/s004420050694; Underwood AJ, 1998, J EXP MAR BIOL ECOL, V231, P291, DOI 10.1016/S0022-0981(98)00091-4; Vasquez JA, 1997, REV CHIL HIST NAT, V70, P41; Vasquez JA, 2012, J APPL PHYCOL, V24, P417, DOI 10.1007/s10811-012-9794-4; Von Ende C, 1993, DESIGN ANAL ECOLOGIC, P445; Vucetich JA, 2003, CONSERV GENET, V4, P639, DOI 10.1023/A:1025671831349; WESTERMEIER R, 1994, MAR ECOL PROG SER, V110, P187, DOI 10.3354/meps110187; Wieters EA, 2005, MAR ECOL PROG SER, V301, P43, DOI 10.3354/meps301043; Wieters EA, 2003, MAR ECOL PROG SER, V249, P93, DOI 10.3354/meps249093; Worm B, 2000, MAR ECOL PROG SER, V202, P283, DOI 10.3354/meps202283; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	87	20	20	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137287	10.1371/journal.pone.0137287	http://dx.doi.org/10.1371/journal.pone.0137287			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360294	gold, Green Published, Green Submitted			2022-12-26	WOS:000361043100030
J	Odahara, S; Uchiyama, K; Kubota, T; Ito, Z; Takami, S; Kobayashi, H; Saito, K; Koido, S; Ohkusa, T				Odahara, Shunichi; Uchiyama, Kan; Kubota, Takahiro; Ito, Zensho; Takami, Shinichiro; Kobayashi, Hiroko; Saito, Keisuke; Koido, Shigeo; Ohkusa, Toshifumi			A Prospective Study Evaluating Metabolic Capacity of Thiopurine and Associated Adverse Reactions in Japanese Patients with Inflammatory Bowel Disease (IBD)	PLOS ONE			English	Article							S-METHYLTRANSFERASE; 6-THIOGUANINE NUCLEOTIDE; CROHNS-DISEASE; DRUG-REACTIONS; GENETIC-BASIS; AZATHIOPRINE; 6-MERCAPTOPURINE; THERAPY; POLYMORPHISM; MAINTENANCE	Azathioprine (AZA) is frequently used in patients with inflammatory bowel disease (IBD). However, toxic adverse reactions frequently develop and limit the clinical benefits. Currently, the precise mechanisms underlying thiopurine-related toxicity are not well understood. To investigate the relationship between the extent of thiopurine metabolism and adverse reactions in Japanese IBD patients, we prospectively observed 48 IBD patients who received AZA. We analyzed the thiopurine S-methyltransferase (TPMT) and inosine triphosphate pyrophosphatase (ITPA) gene mutations and measured the concentrations of 6-thioguanine nucleotide (6-TGN) continuously for 52 weeks. All patients possessed wild-type TPMT gene sequences. The ITPA 94C>A mutation was detected in 19 patients (39.6%). Adverse reactions developed in 14 of the 48 patients (29.2%), including leukopenia in 10 patients (20.8%). In the leukopenia group, the percentages of patients with 94C>A were higher than those in the without-leukopenia group (70.0% vs. 31.6%, P < 0.05). The average concentrations of 6-TGN in the patients with 94C>A were generally higher than those in the patients without 94C>A, however, there were no significant differences. Only 3 out of 10 patients with leukopenia exhibited high 6-TGN levels (30.0%). No negative correlations between white blood cell (WBC) counts and 6-TGN concentrations were observed. The cumulative incidence of leukopenia were higher for patients with 94C>A. Seven out of 19 patients (36.8%) with the ITPA 94C>A mutation developed leukopenia; however, this mutation may not unequivocally increase the risk of developing leukopenia. In addition, there are factors other than increased 6-TGN levels that are involved in the onset of leukopenia.	[Odahara, Shunichi; Uchiyama, Kan; Ito, Zensho; Takami, Shinichiro; Kobayashi, Hiroko; Saito, Keisuke; Koido, Shigeo; Ohkusa, Toshifumi] Jikei Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med,Kashiwa Hosp, Chiba, Japan; [Kubota, Takahiro] Niigata Univ Pharm & Appl Life Sci, Dept Biopharmaceut, Fac Pharmaceut Sci, Niigata, Japan	Jikei University; Niigata University	Uchiyama, K (corresponding author), Jikei Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med,Kashiwa Hosp, Chiba, Japan.	uchikan@jikei.ac.jp	大草, 敏史/HGD-2376-2022		JSPS KAKENHI [24590204]; Grants-in-Aid for Scientific Research [24590204] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by JSPS KAKENHI Grant Number 24590204. There was no additional external funding received for this study.	Ansari A, 2002, ALIMENT PHARM THER, V16, P1743, DOI 10.1046/j.1365-2036.2002.01353.x; Appell ML, 2013, PHARMACOGENET GENOM, V23, P242, DOI 10.1097/FPC.0b013e32835f1cc0; Ban H, 2010, J GASTROENTEROL, V45, P1014, DOI 10.1007/s00535-010-0248-y; Ban H, 2008, INTERNAL MED, V47, P1645, DOI 10.2169/internalmedicine.47.1268; Blaker PA, 2013, BIOCHEM PHARMACOL, V86, P539, DOI 10.1016/j.bcp.2013.06.002; Colombel JF, 2000, GASTROENTEROLOGY, V118, P1025, DOI 10.1016/S0016-5085(00)70354-4; Cuffari C, 1996, GUT, V39, P401, DOI 10.1136/gut.39.3.401; de Boer NKH, 2007, AM J GASTROENTEROL, V102, P2747, DOI 10.1111/j.1572-0241.2007.01511.x; Derijks LJJ, 2006, ALIMENT PHARM THER, V24, P715, DOI 10.1111/j.1365-2036.2006.02980.x; Dubinsky MC, 2000, GASTROENTEROLOGY, V118, P705, DOI 10.1016/S0016-5085(00)70140-5; Gearry RB, 2005, J GASTROEN HEPATOL, V20, P1149, DOI 10.1111/j.1440-1746.2005.03832.x; Gisbert JP, 2008, AM J GASTROENTEROL, V103, P1783, DOI 10.1111/j.1572-0241.2008.01848.x; Hanai H, 2010, INFLAMM BOWEL DIS, V16, P1376, DOI 10.1002/ibd.21190; Hande S, 2006, INFLAMM BOWEL DIS, V12, P251, DOI 10.1097/01.MIB.0000206544.05661.9f; Hibi T, 2003, J GASTROENTEROL, V38, P740, DOI 10.1007/s00535-003-1139-2; Hiratsuka M, 2000, MUTAT RES-FUND MOL M, V448, P91, DOI 10.1016/S0027-5107(00)00004-X; Kubota T, 2004, THER DRUG MONIT, V26, P319, DOI 10.1097/00007691-200406000-00017; Kubota T, 2001, BRIT J CLIN PHARMACO, V51, P475, DOI 10.1046/j.1365-2125.2001.01371.x; Kumagai K, 2001, PHARMACOGENETICS, V11, P275, DOI 10.1097/00008571-200104000-00012; LENNARD L, 1983, J PHARM PHARMACOL, V35, P15, DOI 10.1111/j.2042-7158.1983.tb04255.x; Lichtenstein GR, 2006, GASTROENTEROLOGY, V130, P940, DOI 10.1053/j.gastro.2006.01.048; Lowenthal A, 2001, EUR J CLIN PHARMACOL, V57, P43, DOI 10.1007/s002280100267; Maeda T, 2005, MOL GENET METAB, V85, P271, DOI 10.1016/j.ymgme.2005.03.011; Marinaki AM, 2004, PHARMACOGENETICS, V14, P181, DOI 10.1097/00008571-200403000-00006; MCLEOD HL, 1994, CLIN PHARMACOL THER, V55, P15, DOI 10.1038/clpt.1994.4; Ohtsuka Y, 2010, J GASTROEN HEPATOL, V25, P1626, DOI 10.1111/j.1440-1746.2010.06364.x; Ooi CY, 2007, ALIMENT PHARM THER, V25, P941, DOI 10.1111/j.1365-2036.2007.03278.x; Osterman MT, 2006, GASTROENTEROLOGY, V130, P1047, DOI 10.1053/j.gastro.2006.01.046; Pike MG, 2001, J CHROMATOGR B, V757, P1, DOI 10.1016/S0378-4347(00)00513-2; Sumi S, 2002, HUM GENET, V111, P360, DOI 10.1007/s00439-002-0798-z; Takatsu N, 2009, J GASTROEN HEPATOL, V24, P1258, DOI 10.1111/j.1440-1746.2009.05917.x; Uchiyama K, 2009, J GASTROENTEROL, V44, P197, DOI 10.1007/s00535-008-2307-1; Zelinkova Z, 2006, CLIN GASTROENTEROL H, V4, P44, DOI 10.1016/j.cgh.2005.10.019	33	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137798	10.1371/journal.pone.0137798	http://dx.doi.org/10.1371/journal.pone.0137798			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360046	Green Submitted, Green Published, gold			2022-12-26	WOS:000361043100089
J	Tehrani, FR; Montazeri, SA; Hosseinpanah, F; Cheraghi, L; Erfani, H; Tohidi, M; Azizi, F				Tehrani, Fahimeh Ramezani; Montazeri, Seyed Ali; Hosseinpanah, Farhad; Cheraghi, Leila; Erfani, Hadi; Tohidi, Maryam; Azizi, Fereidoun			Trend of Cardio-Metabolic Risk Factors in Polycystic Ovary Syndrome: A Population-Based Prospective Cohort Study	PLOS ONE			English	Article							OLIGOMENORRHEA AND/OR HIRSUTISM; SELF-REPORTED SYMPTOMS; CARDIOVASCULAR-DISEASE RISK; INSULIN-RESISTANCE; FOLLOW-UP; POSTMENOPAUSAL WOMEN; WAIST CIRCUMFERENCE; YOUNG-WOMEN; PREVALENCE; PCOS	Objective To see the changes of cardio-metabolic risk factors overtime in polycystic ovary syndrome vs. control women. Methods This study was conducted on 637 participants (85 PCOS and 552 control reproductive aged, 18-45 years) of Tehran Lipid and Glucose Study (TLGS), an ongoing population-based cohort study with 12 years of follow-up. The cardiovascular risk factors of these groups were assessed in three-year intervals using standard questionnaires, history taking, anthropometric measures, and metabolic/endocrine evaluation. Generalized estimating equation was used to analyze the data. Results Overall mean of insulin (3.55, CI: 0.66-6.45), HOMA-IR (0.63, CI: 0.08-1.18), and HOMA-beta (45.90, CI: 0.86-90.93) were significantly higher in PCOS than in healthy women after adjustment for age, BMI, and baseline levels. However, the negative interaction (follow-up years x PCOS status) of PCOS and normal women converged overtime. Comparing third follow-up with first, insulin and HOMA-IR decreased 10.6% and 5%, respectively in PCOS women; and increased 6.7% and 14.6%, respectively in controls (P<0.05). The results did not show any significant result for other cardio-metabolic variables including WC, lipid profile, FPG, 2-h PG, SBP, and DBP. Conclusion While the insulin level and insulin resistance rate were higher in reproductive aged PCOS than in healthy women, the difference of these risk factors decreased overtime. Thus, the metabolic consequences of PCOS women in later life may be lower than those initially anticipated.	[Tehrani, Fahimeh Ramezani; Montazeri, Seyed Ali; Cheraghi, Leila; Erfani, Hadi] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Reprod Endocrinol Res Ctr, Tehran, Iran; [Hosseinpanah, Farhad] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Obes Res Ctr, Tehran, Iran; [Tohidi, Maryam] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran; [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran; [Montazeri, Seyed Ali; Erfani, Hadi] Shahid Beheshti Univ Med Sci, Publ Hlth, Sch Publ Hlth, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Tehrani, FR (corresponding author), Res Inst Endocrine Sci 24 Parvaneh, Yaman St,POB 19395-4763, Tehran, Iran.	ramezani@endocrine.ac.ir	Tohidi, Maryam/V-2261-2019; Tehrani, Fahimeh Ramezani/H-6133-2017; Erfani, Hadi/R-1463-2017; Azizi, Fereidoun/ABD-4136-2021; hosseinpanah, farhad/AAM-7277-2020	Tehrani, Fahimeh Ramezani/0000-0002-4609-065X; Erfani, Hadi/0000-0002-1655-6877; Azizi, Fereidoun/0000-0002-6470-2517; hosseinpanah, farhad/0000-0001-5235-9451	National Council of Scientific Research of the Islamic Republic of Iran	National Council of Scientific Research of the Islamic Republic of Iran	The National Council of Scientific Research of the Islamic Republic of Iran has approved and funded the TLGS as a national research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 2004, THE SEVENTH REPORT O; Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5; Azziz R, 2009, FERTIL STERIL, V91, P456, DOI 10.1016/j.fertnstert.2008.06.035; Baillargeon JP, 2007, FERTIL STERIL, V88, P886, DOI 10.1016/j.fertnstert.2006.12.055; Brown ZA, 2011, FERTIL STERIL, V96, P1259, DOI 10.1016/j.fertnstert.2011.09.002; Daan NMP, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.08.001; de Groot PCM, 2011, HUM REPROD UPDATE, V17, P495, DOI 10.1093/humupd/dmr001; Delavari A, 2009, DIABETES CARE, V32, P1092, DOI 10.2337/dc08-1800; Ehrmann DA, 2006, J CLIN ENDOCR METAB, V91, P48, DOI 10.1210/jc.2005-1329; Fauser BCJM, 2011, J CLIN ENDOCR METAB, V96, P3675, DOI 10.1210/jc.2011-2935; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gambineri A, 2012, DIABETES, V61, P2369, DOI 10.2337/db11-1360; Giles LC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-341; HATCH R, 1981, AM J OBSTET GYNECOL, V140, P815, DOI 10.1016/0002-9378(81)90746-8; Huang J, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-142; Hudecova M, 2012, CURR DIABETES REV, V8, P444, DOI 10.2174/157339912803529913; Hudecova M, 2011, FERTIL STERIL, V96, P1271, DOI 10.1016/j.fertnstert.2011.08.006; Lawson MA, 2008, J CLIN ENDOCR METAB, V93, P2089, DOI 10.1210/jc.2007-2656; Lunde O, 2007, GYNECOL ENDOCRINOL, V23, P704, DOI 10.1080/09513590701705189; Mani H, 2013, CLIN ENDOCRINOL, V78, P926, DOI 10.1111/cen.12068; Mason JB, 2011, AGING CELL, V10, P448, DOI 10.1111/j.1474-9726.2011.00691.x; Moran L, 2009, HUM REPROD UPDATE, V15, P477, DOI 10.1093/humupd/dmp008; Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001; Moran LJ, 2015, TRENDS ENDOCRINOL ME; Morgan CL, 2012, J CLIN ENDOCR METAB, V97, P3251, DOI 10.1210/jc.2012-1690; Morin-Papunen LC, 2000, HUM REPROD, V15, P1266, DOI 10.1093/humrep/15.6.1266; Perls TT, 1997, NATURE, V389, P133, DOI 10.1038/38148; Randeva HS, 2012, ENDOCR REV, V33, P812, DOI 10.1210/er.2012-1003; Schmidt J, 2011, J CLIN ENDOCR METAB, V96, P3794, DOI 10.1210/jc.2011-1677; Schmidt J, 2011, J CLIN ENDOCR METAB, V96, P2178, DOI 10.1210/jc.2010-2959; Shaw LJ, 2008, J CLIN ENDOCR METAB, V93, P1276, DOI 10.1210/jc.2007-0425; Skrha J, 2004, J CLIN ENDOCR METAB, V89, P135, DOI 10.1210/jc.2002-030024; Stepto NK, 2013, HUM REPROD, V28, P777, DOI 10.1093/humrep/des463; Talbott E, 1998, J CLIN EPIDEMIOL, V51, P415, DOI 10.1016/S0895-4356(98)00010-9; TALBOTT E, 1995, ARTERIOSCL THROM VAS, V15, P821, DOI 10.1161/01.ATV.15.7.821; Taponen S, 2003, J CLIN ENDOCR METAB, V88, P141, DOI 10.1210/jc.2002-020982; Taponen S, 2004, HUM REPROD, V19, P1083, DOI 10.1093/humrep/deh214; Taponen S, 2004, J CLIN ENDOCR METAB, V89, P2114, DOI 10.1210/jc.2003-031720; Teede HJ, 2006, ENDOCRINE, V30, P45, DOI 10.1385/ENDO:30:1:45; Tehrani FR, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-144; Tehrani FR, 2010, HUM REPROD, V25, P1775, DOI 10.1093/humrep/deq088; Tosi F, 2009, EUR J ENDOCRINOL, V161, P737, DOI 10.1530/EJE-09-0379; Twisk JWR, 2003, APPL LONGITUDINAL DA, Vxvi; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wang ET, 2011, J CLIN ENDOCR METAB, V96, pE114, DOI 10.1210/jc.2010-1709; Wang ET, 2011, OBSTET GYNECOL, V117, P6, DOI 10.1097/AOG.0b013e31820209bb; Wild S, 2000, CLIN ENDOCRINOL, V52, P595, DOI 10.1046/j.1365-2265.2000.01000.x; World Health Organization, 1996, RES MEN 1990S REP WH; Zadeh-Vakili A, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-18; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	52	42	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137609	10.1371/journal.pone.0137609	http://dx.doi.org/10.1371/journal.pone.0137609			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360602	Green Published, Green Submitted, gold			2022-12-26	WOS:000361043100056
J	Giannini, TC; Garibaldi, LA; Acosta, AL; Silva, JS; Maia, KP; Saraiva, AM; Guimaraes, PR; Kleinert, AMP				Giannini, Tereza C.; Garibaldi, Lucas A.; Acosta, Andre L.; Silva, Juliana S.; Maia, Kate P.; Saraiva, Antonio M.; Guimaraes, Paulo R., Jr.; Kleinert, Astrid M. P.			Native and Non-Native Supergeneralist Bee Species Have Different Effects on Plant-Bee Networks	PLOS ONE			English	Article							POLLINATION NETWORKS; CLIMATE-CHANGE; COEVOLUTIONARY NETWORKS; MUTUALISTIC NETWORKS; BIOLOGICAL INVASIONS; HABITAT LOSS; ARCHITECTURE; DIVERSITY; COMMUNITIES; NESTEDNESS	Supergeneralists, defined as species that interact with multiple groups of species in ecological networks, can act as important connectors of otherwise disconnected species subsets. In Brazil, there are two supergeneralist bees: the honeybee Apis mellifera, a non-native species, and Trigona spinipes, a native stingless bee. We compared the role of both species and the effect of geographic and local factors on networks by addressing three questions: 1) Do both species have similar abundance and interaction patterns (degree and strength) in plant-bee networks? 2) Are both species equally influential to the network structure (nestedness, connectance, and plant and bee niche overlap)? 3) How are these species affected by geographic (altitude, temperature, precipitation) and local (natural vs. disturbed habitat) factors? We analyzed 21 plant-bee weighted interaction networks, encompassing most of the main biomes in Brazil. We found no significant difference between both species in abundance, in the number of plant species with which each bee species interacts (degree), and in the sum of their dependencies (strength). Structural equation models revealed the effect of A. mellifera and T. spinipes, respectively, on the interaction network pattern (nestedness) and in the similarity in bee's interactive partners (bee niche overlap). It is most likely that the recent invasion of A. mellifera resulted in its rapid settlement inside the core of species that retain the largest number of interactions, resulting in a strong influence on nestedness. However, the long-term interaction between native T. spinipes and other bees most likely has a more direct effect on their interactive behavior. Moreover, temperature negatively affected A. mellifera bees, whereas disturbed habitats positively affected T. spinipes. Conversely, precipitation showed no effect. Being positively (T. spinipes) or indifferently (A. mellifera) affected by disturbed habitats makes these species prone to pollinate plant species in these areas, which are potentially poor in pollinators.	[Giannini, Tereza C.; Acosta, Andre L.; Maia, Kate P.; Guimaraes, Paulo R., Jr.; Kleinert, Astrid M. P.] Univ Sao Paulo, Inst Biociencias, Sao Paulo, SP, Brazil; [Giannini, Tereza C.] Inst Tecnol Vale Desenvolvimento Sustentado, Belem, Para, Brazil; [Garibaldi, Lucas A.] UNRN, Sede Andina, San Carlos De Bariloche, Rio Negro, Argentina; [Garibaldi, Lucas A.] Consejo Nacl Invest Cient & Tecn, San Carlos De Bariloche, Rio Negro, Argentina; [Silva, Juliana S.] Inst Fed Educ Ciencia Tecnol Mato Grosso, Cuiaba, Mato Grosso, Brazil; [Saraiva, Antonio M.] Univ Sao Paulo, Escola Politecn, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Instituto Tecnologico Vale Desenvolvimento Sustentavel; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto Federal de Mato Grosso (IFMT); Universidade de Sao Paulo	Giannini, TC (corresponding author), Univ Sao Paulo, Inst Biociencias, Sao Paulo, SP, Brazil.	giannini@usp.br	Saraiva, Antonio M/B-6350-2011; Acosta, Andre Luis/H-2036-2012; Giannini, Tereza Cristina/AAA-2958-2019; Guimarães-Junior, Paulo R/M-1298-2016; Garibaldi, Lucas A/D-7302-2013; Giannini, Tereza C/F-2676-2012; Maia, Kate P./B-1122-2013; Kleinert, Astrid M.P./A-1486-2008; Saraiva, Antonio/ABC-5330-2021; Guimaraes, Paulo R./E-1915-2016; Silva, Juliana Saragiotto/A-8182-2010	Saraiva, Antonio M/0000-0003-2283-1123; Acosta, Andre Luis/0000-0002-4244-9637; Giannini, Tereza Cristina/0000-0001-9830-1204; Maia, Kate P./0000-0002-2095-5731; Kleinert, Astrid M.P./0000-0003-0550-7452; Saraiva, Antonio/0000-0003-2283-1123; Guimaraes, Paulo R./0000-0001-9161-8305; Silva, Juliana Saragiotto/0000-0002-3711-6432; Garibaldi, Lucas Alejandro/0000-0003-0725-4049	National Counsel of Technological and Scientific Development [CNPq 472702/2013-0]; Sao Paulo Research Foundation [FAPESP 2004/15801-0, 2008/06704-1, 2011/12779-7, 2009/54422-8]; Mato Grosso (FAPEMAT) Research Foundation; Coordination for the Improvement of Higher Level Personnel (CAPES); Federal Institute of Education, Science and Technology of Mato Grosso (IFMT); Research Center on Biodiversity and Computing from University of Sao Paulo (NAP-Biocomp)	National Counsel of Technological and Scientific Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Mato Grosso (FAPEMAT) Research Foundation; Coordination for the Improvement of Higher Level Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Federal Institute of Education, Science and Technology of Mato Grosso (IFMT); Research Center on Biodiversity and Computing from University of Sao Paulo (NAP-Biocomp)	The authors thank the National Counsel of Technological and Scientific Development (CNPq 472702/2013-0), Sao Paulo (FAPESP 2004/15801-0, 2008/06704-1, 2011/12779-7, 2009/54422-8) and Mato Grosso (FAPEMAT) Research Foundations; Coordination for the Improvement of Higher Level Personnel (CAPES); Federal Institute of Education, Science and Technology of Mato Grosso (IFMT); and Research Center on Biodiversity and Computing from University of Sao Paulo (NAP-Biocomp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, PLOS BIOL, V6, P396, DOI 10.1371/journal.pbio.0060031; Aizen MA, 2012, SCIENCE, V335, P1486, DOI 10.1126/science.1215320; Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Almeida GF, 2008, THESIS U SAO PAULO; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Bartomeus I, 2008, OECOLOGIA, V155, P761, DOI 10.1007/s00442-007-0946-1; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Biesmeijer Jacobus C., 2005, Biota Neotropica, V5, P1; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Burkle LA, 2011, AM J BOT, V98, P528, DOI 10.3732/ajb.1000391; Butts C. T., 2008, J STAT SOFTW, V24, P1, DOI [10.18637/jss.v024.i06, DOI 10.18637/JSS.V024.I06, 10.18637/jss.v024.i02]; Canard EF, 2014, AM NAT, V183, P468, DOI 10.1086/675363; Canard E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038295; Carneiro LT, 2012, APIDOLOGIE, V43, P474, DOI 10.1007/s13592-011-0116-7; Catford JA, 2011, DIVERS DISTRIB, V17, P1099, DOI 10.1111/j.1472-4642.2011.00794.x; Chytry M, 2008, J APPL ECOL, V45, P448, DOI 10.1111/j.1365-2664.2007.01398.x; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; CORTOPASSILAURINO M, 1988, APIDOLOGIE, V19, P1, DOI 10.1051/apido:19880101; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; Davey CM, 2013, J ANIM ECOL, V82, P551, DOI 10.1111/1365-2656.12035; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Fortuna MA, 2006, ECOL LETT, V9, P278, DOI 10.1111/j.1461-0248.2005.00868.x; Fox J, 2006, STRUCT EQU MODELING, V13, P465, DOI 10.1207/s15328007sem1303_7; Fox J, 2012, SEM STRUCTURAL EQUAT; Freitas BM, 2009, APIDOLOGIE, V40, P332, DOI 10.1051/apido/2009012; Gianquitto T, 2014, AMERICA'S DARWIN: DARWINIAN THEORY AND U.S. LITERARY CULTURE, P1, DOI 10.1007/s13592-014-0316-z; Girao LC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000908; Goulson D, 2003, ANNU REV ECOL EVOL S, V34, P1, DOI 10.1146/annurev.ecolsys.34.011802.132355; Grace JB, 2010, ECOL MONOGR, V80, P67, DOI 10.1890/09-0464.1; Guimaraes PR, 2011, ECOL LETT, V14, P877, DOI 10.1111/j.1461-0248.2011.01649.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jaffe R, 2010, CONSERV BIOL, V24, P583, DOI 10.1111/j.1523-1739.2009.01331.x; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Jordano P., 2009, ECOLOGIA EVOLUCI ON, P17; Kleinert AMP, 2012, POLINIZADORES BRASIL, P175; Kleinert Astrid de Matos Peixoto, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/291519; Krebs C.J., 2014, ECOLOGICAL METHODOLO; Krishna A, 2008, OIKOS, V117, P1609, DOI 10.1111/j.1600-0706.2008.16540.x; Legendre P., 2012, DEV ENV MODELLING, V24, P265, DOI [10.1016/B978-0-444-42386-3.50001-0, DOI 10.1016/B978-0-444-42386-3.50001-0, 10.1016/B978-0-444-53868-0.50007-1, DOI 10.1016/B978-0-444-53868-0.50007-1]; Lever JJ, 2014, ECOL LETT, V17, P350, DOI 10.1111/ele.12236; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Lopezaraiza-Mikel ME, 2007, ECOL LETT, V10, P539, DOI 10.1111/j.1461-0248.2007.01055.x; Lurgi M, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00036; Lurgi M, 2012, PHILOS T R SOC B, V367, P2913, DOI 10.1098/rstb.2012.0238; Gonzalez AMM, 2010, ECOL COMPLEX, V7, P36, DOI 10.1016/j.ecocom.2009.03.008; Marvier M, 2004, RISK ANAL, V24, P869, DOI 10.1111/j.0272-4332.2004.00485.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Nieh JC, 2005, INSECT SOC, V52, P147, DOI 10.1007/s00040-004-0785-6; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Olesen JM, 2002, DIVERS DISTRIB, V8, P181, DOI 10.1046/j.1472-4642.2002.00148.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; R Core Team, R LANG ENV STAT COMP; Romanuk TN, 2009, PHILOS T R SOC B, V364, P1743, DOI 10.1098/rstb.2008.0286; ROUBIK DAVID W, 2009, Acta biol.Colomb., V14, P115; Sakagami S. F., 1967, Journal of the Faculty of Science Hokkaido University Zoology, V16, P253; Santos GMD, 2012, BIOL INVASIONS, V14, P2369, DOI 10.1007/s10530-012-0235-8; Schneider SS, 2004, ANNU REV ENTOMOL, V49, P351, DOI 10.1146/annurev.ento.49.061802.123359; Schweiger O, 2008, ECOLOGY, V89, P3472, DOI 10.1890/07-1748.1; Schweiger O, 2010, BIOL REV, V85, P777, DOI 10.1111/j.1469-185X.2010.00125.x; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Spiesman BJ, 2013, ECOLOGY, V94, P2688, DOI 10.1890/13-0977.1; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Traveset A, 2006, TRENDS ECOL EVOL, V21, P208, DOI 10.1016/j.tree.2006.01.006; Traveset A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3040; Valiente-Banuet A, 2015, FUNCT ECOL, V29, P299, DOI 10.1111/1365-2435.12356; Vazquez DP, 2009, ECOLOGY, V90, P2039, DOI 10.1890/08-1837.1; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; Vidal MM, 2014, ECOLOGY, V95, P3440, DOI 10.1890/13-1584.1; Vila M, 2009, P ROY SOC B-BIOL SCI, V276, P3887, DOI 10.1098/rspb.2009.1076; Villanueva R, 2004, APIDOLOGIE, V35, P481, DOI 10.1051/apido:2004041; Wilsey BJ, 2011, PERSPECT PLANT ECOL, V13, P265, DOI 10.1016/j.ppees.2011.07.002	77	52	53	3	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137198	10.1371/journal.pone.0137198	http://dx.doi.org/10.1371/journal.pone.0137198			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356234	Green Submitted, Green Published, gold			2022-12-26	WOS:000360965800033
J	Nyakatura, JA; Allen, VR; Laustroer, J; Andikfar, A; Danczak, M; Ullrich, HJ; Hufenbach, W; Martens, T; Fischer, MS				Nyakatura, John A.; Allen, Vivian R.; Laustroeer, Jonas; Andikfar, Amir; Danczak, Marek; Ullrich, Hans-Juergen; Hufenbach, Werner; Martens, Thomas; Fischer, Martin S.			A Three-Dimensional Skeletal Reconstruction of the Stem Amniote Orobates pabsti (Diadectidae): Analyses of Body Mass, Centre of Mass Position, and Joint Mobility	PLOS ONE			English	Article							ATLAS-AXIS COMPLEX; TERRESTRIAL LOCOMOTION; KINEMATICS; ARCHOSAURS; DINOSAURS; TETRAPODS; ORIGIN; MOTION; PANDERICHTHYS; PERSPECTIVES	Orobates pabsti, a basal diadectid from the lower Permian, is a key fossil for the understanding of early amniote evolution. Quantitative analysis of anatomical information suffers from fragmentation of fossil bones, plastic deformation due to diagenetic processes and fragile preservation within surrounding rock matrix, preventing further biomechanical investigation. Here we describe the steps taken to digitally reconstruct MNG 10181, the holotype specimen of Orobates pabsti, and subsequently use the digital reconstruction to assess body mass, position of the centre of mass in individual segments as well as the whole animal, and study joint mobility in the shoulder and hip joints. The shape of most fossil bone fragments could be recovered from micro-focus computed tomography scans. This also revealed structures that were hitherto hidden within the rock matrix. However, parts of the axial skeleton had to be modelled using relevant isolated bones from the same locality as templates. Based on the digital fossil, mass of MNG 10181 was estimated using a model of body shape that was varied within a plausible range to account for uncertainties of the dimension. In the mean estimate model the specimen had an estimated mass of circa 4 kg. Varying of the mass distribution amongst body segments further revealed that Orobates carried most of its weight on the hind limbs. Mostly unrestricted joint morphology further suggested that MNG 10181 was able to effectively generate propulsion with the pelvic limbs. The digital reconstruction is made available for future biomechanical studies.	[Nyakatura, John A.] Humboldt Univ, Bild Wissen Gestaltung Ein Interdisziplinares Lab, AG Morphol & Formengeschichte, D-10099 Berlin, Germany; [Nyakatura, John A.] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany; [Nyakatura, John A.; Allen, Vivian R.; Fischer, Martin S.] Univ Jena, Phyletischem Museum, Inst Spezielle Zool & Evolutionsbiol, Jena, Germany; [Allen, Vivian R.] Royal Vet Coll, Struct & Mot Lab, N Mymms, England; [Laustroeer, Jonas; Andikfar, Amir] Hsch Angew Wissensch, Dept Design, Hamburg, Germany; [Danczak, Marek; Ullrich, Hans-Juergen; Hufenbach, Werner] Tech Univ Dresden, Inst Leichtbau & Kunststofftech, D-01062 Dresden, Germany; [Martens, Thomas] Stiftung Schloss Friedenstein, Museum Nat, Gotha, Germany	Humboldt University of Berlin; Humboldt University of Berlin; Friedrich Schiller University of Jena; University of London; University of London Royal Veterinary College; Hochschule Angewandte Wissenschaft Hamburg; Technische Universitat Dresden	Nyakatura, JA (corresponding author), Humboldt Univ, Bild Wissen Gestaltung Ein Interdisziplinares Lab, AG Morphol & Formengeschichte, D-10099 Berlin, Germany.	john.nyakatura@hu-berlin.de	Nyakatura, John A./AAC-9807-2019	Nyakatura, John A./0000-0001-8088-8684; Hufenbach, Werner/0000-0002-5131-3483	Volkswagen Foundation [858587]	Volkswagen Foundation(Volkswagen)	This study was funded by the Volkswagen Foundation (http://www.volkswagenstiftung.de/; grant number: 858587 to MSF, TM, and JAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen V, 2013, NATURE, V497, P104, DOI 10.1038/nature12059; Allen V, 2009, ANAT REC, V292, P1442, DOI 10.1002/ar.20973; Arnold P, 2014, J ANAT, V225, P31, DOI 10.1111/joa.12187; ASHLEYROSS MA, 1994, J EXP BIOL, V193, P255; Baier DB, 2013, J ANAT, V223, P462, DOI 10.1111/joa.12102; BARCLAY OR, 1946, J EXP BIOL, V23, P177; Bates KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004532; Berman David S., 2004, Bulletin of Carnegie Museum of Natural History, V35, P1, DOI 10.2992/0145-9058(2004)35[1:ANDDOP]2.0.CO;2; Boisvert CA, 2005, NATURE, V438, P1145, DOI 10.1038/nature04119; Boisvert CA, 2008, NATURE, V456, P636, DOI 10.1038/nature07339; Carroll Robert L., 1995, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V17, P389; Clack JA, 2002, GAINING GROUND THE O; Clemente CJ, 2013, J EXP BIOL, V216, P3854, DOI 10.1242/jeb.089060; Eberth DA, 2000, PALAIOS, V15, P293, DOI 10.2307/3515538; Edwards JL, 1977, EVOLUTION TERRESTRIA, P553; GAUTHIER JA, 1988, PHYLOGENY CLASSIFICA, V1, P103; Holliday CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013120; Hutchinson JR, 2007, J THEOR BIOL, V246, P660, DOI 10.1016/j.jtbi.2007.01.023; Hutchinson JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026037; Hutchinson JR, 2004, J MORPHOL, V262, P441, DOI 10.1002/jmor.10240; Hutson JD, 2013, J EXP BIOL, V216, P275, DOI 10.1242/jeb.074229; Hutson JD, 2012, J EXP BIOL, V215, P2030, DOI 10.1242/jeb.069567; Karakasiliotis K, 2013, BIOL CYBERN, V107, P529, DOI 10.1007/s00422-012-0540-4; Kawano SM, 2013, INTEGR COMP BIOL, V53, P283, DOI 10.1093/icb/ict051; Krause TM, 2006, ABHANDLUNGEN BERICHT, V24, P199; Laurin Michel, 1997, P9, DOI 10.1016/B978-012676460-4/50003-2; Lutzner H, 2012, SCHRIFTENREIHE DTSCH, V61, P418, DOI 10.1127/sdgg/61/2012/418.(InGerman); Mallison H., 2010, PALAEONTOLOGIA ELECT, V13; Mallison H, 2010, ACTA PALAEONTOL POL, V55, P433, DOI 10.4202/app.2009.0075; Martens T, 2005, 65 ANN M SOC VERT PA, P89; Martens Thomas, 2001, Hallesches Jahrbuch fuer Geowissenschaften Reihe B Geologie Palaeontologie Mineralogie, V23, P45; Martens Thomas, 2009, Zeitschrift fuer Geologische Wissenschaften, V37, P81; Modesto S, 1992, J VERTEBR PALEONTOL, V11, p49A; Molnar J.L., 2012, PALAEONTOL ELECTRON, V15, P18; Motani R, 2001, PALEOBIOLOGY, V27, P735, DOI 10.1666/0094-8373(2001)027<0735:EBMFST>2.0.CO;2; Nyakatura JA, 2014, EVOL BIOL, V41, P175, DOI 10.1007/s11692-013-9266-z; Ogihara N, 2006, AM J PHYS ANTHROPOL, V130, P1, DOI 10.1002/ajpa.20332; Pierce SE, 2013, INTEGR COMP BIOL, V53, P209, DOI 10.1093/icb/ict022; Pierce SE, 2013, NATURE, V494, P226, DOI 10.1038/nature11825; Pierce SE, 2012, NATURE, V486, P523, DOI 10.1038/nature11124; Reisz RR, 1997, TRENDS ECOL EVOL, V12, P218, DOI 10.1016/S0169-5347(97)01060-4; Schmidt-Nielsen K., SCALING WHY IS ANIMA; Sellers WI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078733; Stevens KA, 1999, SCIENCE, V284, P798, DOI 10.1126/science.284.5415.798; SUAREZ RK, 1992, EXPERIENTIA, V48, P565, DOI 10.1007/BF01920240; SUMIDA SS, 1992, PHILOS T ROY SOC B, V336, P259, DOI 10.1098/rstb.1992.0060; SUMIDA SS, 1991, J PALEONTOL, V65, P973, DOI 10.1017/S002233600003328X; Sumida Stuart S., 1997, P353, DOI 10.1016/B978-012676460-4/50012-3; TAYLOR CR, 1980, J EXP BIOL, V86, P9; Voigt S, 2007, J VERTEBR PALEONTOL, V27, P553, DOI 10.1671/0272-4634(2007)27[553:FWTAOP]2.0.CO;2; Voigt S, 2011, PALAIOS, V26, P555, DOI 10.2110/palo.2011.p11-014r; Zaaf A, 2001, J EXP BIOL, V204, P1233	52	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137284	10.1371/journal.pone.0137284	http://dx.doi.org/10.1371/journal.pone.0137284			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355297	gold, Green Submitted, Green Published			2022-12-26	WOS:000360965800040
J	Kriangkum, J; Motz, SN; Mack, T; Beiggi, S; Baigorri, E; Kuppusamy, H; Belch, AR; Johnston, JB; Pilarski, LM				Kriangkum, Jitra; Motz, Sarah N.; Mack, Tanner; Beiggi, Sara; Baigorri, Eva; Kuppusamy, Hemalatha; Belch, Andrew R.; Johnston, James B.; Pilarski, Linda M.			Single-Cell Analysis and Next-Generation Immuno-Sequencing Show That Multiple Clones Persist in Patients with Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; IDENTIFICATION; EVOLUTION; CLL	The immunoglobulin heavy chain (IGH) gene rearrangement in chronic lymphocytic leukemia (CLL) provides a unique molecular signature; however, we demonstrate that 26/198 CLL patients (13%) had more than one IGH rearrangement, indicating the power of molecular technology over phenotypic analysis. Single-cell PCR analysis and next-generation immuno-sequencing identified IGH-defined clones. In 23% (18/79) of cases whose clones carried unmutated immunoglobulin heavy chain variable (IGHV) genes (U-CLL), IGH rearrangements were bialleic with one productive (P) and one non-productive (NP) allele. Two U-CLL were biclonal, each clone being monoallelic (P). In 119 IGHV-mutated (M-CLL) cases, one had biallelic rearrangements in their CLL (P/NP) and five had 2-4 distinct clones. Allelic exclusion was maintained in all B-clones analyzed. Based on single-cell PCR analysis, 5/11 partner clones (45%) reached levels of >5x10(9) cells/L, suggesting second CLL clones. Partner clones persisted over years. Conventional IGH characterization and next-generation sequencing of 13 CLL, 3 multiple myeloma, 2 Waldenstrom's macroglobulinemia and 3 age-matched healthy donors consistently identified the same rearranged IGH sequences. Most multiple clones occurred in M-CLL, perhaps indicative of weak clonal dominance, thereby associating with a good prognosis. In contrast, biallelic CLL occurred primarily in U-CLL thus being associated with poor prognosis. Extending beyond intraclonal diversity, molecular analysis of clonal evolution and apparent subclones in CLL may also reflect inter-clonal diversity.	[Kriangkum, Jitra; Motz, Sarah N.; Mack, Tanner; Baigorri, Eva; Kuppusamy, Hemalatha; Belch, Andrew R.; Pilarski, Linda M.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Kriangkum, Jitra; Motz, Sarah N.; Mack, Tanner; Baigorri, Eva; Kuppusamy, Hemalatha; Belch, Andrew R.; Pilarski, Linda M.] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Beiggi, Sara; Johnston, James B.] Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada	University of Alberta; University of Alberta	Pilarski, LM (corresponding author), Univ Alberta, Dept Oncol, Edmonton, AB, Canada.	lpilarsk@ualberta.ca						BREZINSCHEK HP, 1995, J IMMUNOL, V155, P190; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Chang H, 2006, AM J CLIN PATHOL, V126, P23, DOI 10.1309/0YYF17GFKFJFNP5G; CROSSEN PE, 1993, GENE CHROMOSOME CANC, V8, P49, DOI 10.1002/gcc.2870080109; Gonzalez-Campos J, 1997, ANN HEMATOL, V74, P243, DOI 10.1007/s002770050292; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Henriques A, 2014, HAEMATOLOGICA, V99, P897, DOI 10.3324/haematol.2013.098913; Henriques A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067751; Hsi ED, 2000, AM J CLIN PATHOL, V113, P798, DOI 10.1309/V8AN-A2XP-7TDV-HR0T; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kern W, 2014, BRIT J HAEMATOL, V164, P565, DOI 10.1111/bjh.12652; Kriangkum J, 2007, CLIN CANCER RES, V13, P2005, DOI 10.1158/1078-0432.CCR-06-2788; Kriangkum J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064927; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Lanasa MC, 2010, LEUKEMIA, V24, P133, DOI 10.1038/leu.2009.192; Landau DA, 2014, LEUKEMIA, V28, P34, DOI 10.1038/leu.2013.248; Landgren O, 2009, NEW ENGL J MED, V360, P659, DOI 10.1056/NEJMoa0806122; Langerak AW, 2011, LEUKEMIA, V25, P979, DOI 10.1038/leu.2011.49; Nieto WG, 2009, BLOOD, V114, P33, DOI 10.1182/blood-2009-01-197368; Plevova K, 2014, HAEMATOLOGICA, V99, P329, DOI 10.3324/haematol.2013.087593; Rassenti LZ, 1997, J EXP MED, V185, P1435, DOI 10.1084/jem.185.8.1435; Robins H, 2012, J IMMUNOL METHODS, V375, P14, DOI 10.1016/j.jim.2011.09.001; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Rossi D, 2014, BLOOD, V123, P2139, DOI 10.1182/blood-2013-11-539726; Sanchez ML, 2003, BLOOD, V102, P2994, DOI 10.1182/blood-2003-01-0045; Schuh A, 2012, BLOOD, V120, P4191, DOI 10.1182/blood-2012-05-433540; Souto-Carneiro MM, 2005, J IMMUNOL, V175, P7425, DOI 10.4049/jimmunol.175.11.7425; Stamatopoulos K, 1996, LEUKEMIA, V10, P1551; Taylor Brian J., 2005, V113, P121, DOI 10.1385/1-59259-916-8:121; Villamor N, 2013, SEMIN HEMATOL, V50, P286, DOI 10.1053/j.seminhematol.2013.09.005	31	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137232	10.1371/journal.pone.0137232	http://dx.doi.org/10.1371/journal.pone.0137232			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353109	gold, Green Published, Green Submitted			2022-12-26	WOS:000360932800070
J	Buisine, N; Ruan, XA; Bilesimo, P; Grimaldi, A; Alfama, G; Ariyaratne, P; Mulawadi, F; Chen, JQ; Sung, WK; Liu, ET; Demeneix, BA; Ruan, YJ; Sachs, LM				Buisine, Nicolas; Ruan, Xiaoan; Bilesimo, Patrice; Grimaldi, Alexis; Alfama, Gladys; Ariyaratne, Pramila; Mulawadi, Fabianus; Chen, Jieqi; Sung, Wing-Kin; Liu, Edison T.; Demeneix, Barbara A.; Ruan, Yijun; Sachs, Laurent M.			Xenopus tropicalis Genome Re-Scaffolding and Re-Annotation Reach the Resolution Required for In Vivo ChIA-PET Analysis	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; DRAFT GENOME; RNA-SEQ; SEQUENCE; IDENTIFICATION; METAMORPHOSIS; TRANSCRIPTOME; EVOLUTION; MODEL	Genome-wide functional analyses require high-resolution genome assembly and annotation. We applied ChIA-PET to analyze gene regulatory networks, including 3D chromosome interactions, underlying thyroid hormone (TH) signaling in the frog Xenopus tropicalis. As the available versions of Xenopus tropicalis assembly and annotation lacked the resolution required for ChIA-PET we improve the genome assembly version 4.1 and annotations using data derived from the paired end tag (PET) sequencing technologies and approaches (e.g., DNA-PET [gPET], RNA-PET etc.). The large insert (similar to 10Kb, similar to 17Kb) paired end DNA-PET with high throughput NGS sequencing not only significantly improved genome assembly quality, but also strongly reduced genome "fragmentation", reducing total scaffold numbers by similar to 60%. Next, RNA-PET technology, designed and developed for the detection of full-length transcripts and fusion mRNA in whole transcriptome studies (ENCODE consortia), was applied to capture the 5' and 3' ends of transcripts. These amendments in assembly and annotation were essential prerequisites for the ChIA-PET analysis of TH transcription regulation. Their application revealed complex regulatory configurations of target genes and the structures of the regulatory networks underlying physiological responses. Our work allowed us to improve the quality of Xenopus tropicalis genomic resources, reaching the standard required for ChIA-PET analysis of transcriptional networks. We consider that the workflow proposed offers useful conceptual and methodological guidance and can readily be applied to other non-conventional models that have low-resolution genome data.	[Buisine, Nicolas; Bilesimo, Patrice; Grimaldi, Alexis; Alfama, Gladys; Demeneix, Barbara A.; Sachs, Laurent M.] Museum Natl Hist Nat, UMR CNRS 7221, F-75231 Paris, France; [Ruan, Xiaoan; Liu, Edison T.; Ruan, Yijun] Jackson Lab Genom Med, Farmington, CT 06302 USA; [Ruan, Xiaoan; Liu, Edison T.; Ruan, Yijun] Univ Connecticut, Dept Genet & Dev Biol, Farmington, CT USA; [Ruan, Xiaoan; Ariyaratne, Pramila; Mulawadi, Fabianus; Chen, Jieqi; Sung, Wing-Kin; Liu, Edison T.; Ruan, Yijun] Genome Inst Singapore, Singapore, Singapore; [Bilesimo, Patrice] Watchfrog SAS, Evry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); Jackson Laboratory; University of Connecticut; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Ruan, YJ (corresponding author), Jackson Lab Genom Med, Farmington, CT 06302 USA.	Yijun.Ruan@jax.org; sachs@mnhn.fr	Sachs, Laurent/AAE-1504-2020	Sung, Wing-Kin/0000-0001-7806-7086	CRESCENDO [LSHM-CT-2005-01865]; TRIGGER [ANR-08-JCJC-0100-01]; IDEAL [259679]; Convention CIFRE [631/2006]; MERLION project [5.01.10]; ARC fellowship [SJ118-10]; NATIONAL CANCER INSTITUTE [R01CA186714] Funding Source: NIH RePORTER	CRESCENDO(European Commission); TRIGGER; IDEAL; Convention CIFRE; MERLION project; ARC fellowship(Australian Research Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded by the following grant: CRESCENDO, LSHM-CT-2005-01865, http:// www.tmpneo.com/site_crescendo/links.asp?rub=4 & TRIGGER, ANR-08-JCJC-0100-01, http://www.agence-nationale-recherche.fr/projet-anr/? tx_lwmsuivibilan_pi2[CODE]=ANR-08-JCJC-0100; IDEAL, 259679, http://ec.europa.eu/ research/health/medical-research/human-development-and-ageing/projects/ideal en.html; Convention CIFRE 631/2006; MERLION project 5.01.10; ARC fellowship SJ118-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Watchfrog S.A.S. provided support in form of salaries for author (P.B.), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The roles of this author are articulated in the 'author contributions' section.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Ariyaratne PN, 2011, BIOINFORMATICS, V27, P167, DOI 10.1093/bioinformatics/btq626; Bilesimo P, 2011, MOL ENDOCRINOL, V25, P225, DOI 10.1210/me.2010-0269; Bombarely A, 2012, MOL PLANT MICROBE IN, V25, P1523, DOI 10.1094/MPMI-06-12-0148-TA; Buchholz DR, 2015, DEV BIOL, V408, P188, DOI 10.1016/j.ydbio.2015.02.018; Buisine Nicolas, 2009, BMC Res Notes, V2, P257, DOI 10.1186/1756-0500-2-257; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Eckalbar WL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-49; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Furey TS, 2012, NAT REV GENET, V13, P840, DOI 10.1038/nrg3306; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Grimaldi AG, 2013, HIGH THROUGHPUT SEQU, P277; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; Huang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054732; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laudet V, 2011, CURR BIOL, V21, pR726, DOI 10.1016/j.cub.2011.07.030; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lin MF, 2007, GENOME RES, V17, P1823, DOI 10.1101/gr.6679507; Mardis ER, 2011, NATURE, V470, P198, DOI 10.1038/nature09796; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Nieuwkoop PD, 1967, NORMAL TABLE OF XENO; Reese MG, 2000, GENOME RES, V10, P483, DOI 10.1101/gr.10.4.483; Ruan XA, 2012, METHODS MOL BIOL, V809, P535, DOI 10.1007/978-1-61779-376-9_35; Ruan YJ, 2007, GENOME RES, V17, P828, DOI 10.1101/gr.6018607; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Shi YB, 1998, AMPHIBIAN METAMORPHO; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tata JR, 2006, MOL CELL ENDOCRINOL, V246, P10, DOI 10.1016/j.mce.2005.11.024; TATA JR, 1993, BIOESSAYS, V15, P239, DOI 10.1002/bies.950150404; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Wells DE, 2011, DEV BIOL, V354, P1, DOI 10.1016/j.ydbio.2011.03.022; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Yandell M, 2012, NAT REV GENET, V13, P329, DOI 10.1038/nrg3174; Yao F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046152; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910; Zhuo Y, 2012, J BACTERIOL, V194, P4749, DOI 10.1128/JB.00931-12	46	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137526	10.1371/journal.pone.0137526	http://dx.doi.org/10.1371/journal.pone.0137526			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348928	Green Submitted, Green Published, gold			2022-12-26	WOS:000360897600051
J	Chen, Y; Wong, LLN; Zhu, SF; Xi, X				Chen, Yuan; Wong, Lena L. N.; Zhu, Shufeng; Xi, Xin			A Structural Equation Modeling Approach to Examining Factors Influencing Outcomes with Cochlear Implant in Mandarin-Speaking Children	PLOS ONE			English	Article							SPEECH-PERCEPTION; LANGUAGE-DEVELOPMENT; DEAF-CHILDREN; SPOKEN LANGUAGE; AUDITORY DEVELOPMENT; RESIDUAL HEARING; AGE; VOCABULARY; PERFORMANCE; EXPERIENCE	Objective To examine the direct and indirect effects of demographical factors on speech perception and vocabulary outcomes of Mandarin-speaking children with cochlear implants (CIs). Methods 115 participants implanted before the age of 5 and who had used CI before 1 to 3 years were evaluated using a battery of speech perception and vocabulary tests. Structural equation modeling was used to test the hypotheses proposed. Results Early implantation significantly contributed to speech perception outcomes while having undergone a hearing aid trial (HAT) before implantation, maternal educational level (MEL), and having undergone universal newborn hearing screening (UNHS) before implantation had indirect effects on speech perception outcomes via their effects on age at implantation. In addition, both age at implantation and MEL had direct and indirect effects on vocabulary skills, while UNHS and HAT had indirect effects on vocabulary outcomes via their effects on age at implantation. Conclusion A number of factors had indirect and direct effects on speech perception and vocabulary outcomes in Mandarin-speaking children with CIs and these factors were not necessarily identical to those reported among their English-speaking counterparts.	[Chen, Yuan; Wong, Lena L. N.] Univ Hong Kong, Div Speech & Hearing Sci, Clin Hearing Sci CHearS Lab, Hong Kong, Hong Kong, Peoples R China; [Zhu, Shufeng] South Univ Sci & Technol China, Dept Elect & Elect Engn, Shenzhen, Peoples R China; [Xi, Xin] Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China	University of Hong Kong; Southern University of Science & Technology; Chinese People's Liberation Army General Hospital	Chen, Y (corresponding author), Univ Hong Kong, Div Speech & Hearing Sci, Clin Hearing Sci CHearS Lab, Hong Kong, Hong Kong, Peoples R China.	chenyuan@hku.hk		CHEN, Yuan/0000-0001-6706-0962; Wong, Lena L N/0000-0003-2245-8592	University Grant Council General Research Fund [HKU780109]	University Grant Council General Research Fund	This work was supported by the University Grant Council General Research Fund (#HKU780109).	Adunka OF, 2008, LARYNGOSCOPE, V118, P2044, DOI 10.1097/MLG.0b013e3181820900; BALANDA KP, 1988, AM STAT, V42, P111, DOI 10.2307/2684482; BENTLER PM, 1987, SOCIOL METHOD RES, V16, P78, DOI 10.1177/0049124187016001004; Blamey PJ, 2001, J SPEECH LANG HEAR R, V44, P264, DOI 10.1044/1092-4388(2001/022); Bornstein MH, 1998, J CHILD LANG, V25, P367, DOI 10.1017/S0305000998003456; Chen F, 2013, J ACOUST SOC AM, V134, pEL178, DOI 10.1121/1.4812820; Chen XQ, 2010, ACTA OTO-LARYNGOL, V130, P263, DOI 10.3109/00016480903150528; Chen Y, 2014, INT J PEDIATR OTORHI, V78, P1923, DOI 10.1016/j.ijporl.2014.08.025; Connor CM, 2006, EAR HEARING, V27, P628, DOI 10.1097/01.aud.0000240640.59205.42; Connor CM, 2000, J SPEECH LANG HEAR R, V43, P1185, DOI 10.1044/jslhr.4305.1185; Davidson Lisa S, 2011, Ear Hear, V32, p19S, DOI 10.1097/AUD.0b013e3181ffdb8b; Deggouj N, 2007, B-ENT, V3, P9; DesJardin JL, 2009, INT J AUDIOL, V48, P248, DOI 10.1080/14992020802607423; Eisenberg LS, 2002, EAR HEARING, V23, P450, DOI 10.1097/00003446-200210000-00007; El-Hakim H, 2002, ANN OTO RHINOL LARYN, V111, P102, DOI 10.1177/00034894021110S521; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Gantz BJ, 2000, ANN OTO RHINOL LARYN, V109, P33, DOI 10.1177/0003489400109S1214; Geers A, 2003, EAR HEARING, V24, p24S, DOI 10.1097/01.AUD.0000051687.99218.0F; Geers A, 2002, ANN OTO RHINOL LARYN, V111, P127, DOI 10.1177/00034894021110S525; Geers AE, 2002, LANG SPEECH HEAR SER, V33, DOI 10.1044/0161-1461(2002/015); Geers AE, 2003, EAR HEARING, V24, p46S, DOI 10.1097/01.AUD.0000051689.57380.1B; Hoff E, 2005, J COMMUN DISORD, V38, P271, DOI 10.1016/j.jcomdis.2005.02.003; Holt RF, 2005, EAR HEARING, V26, P132, DOI 10.1097/00003446-200504000-00003; Houston DM, 2010, OTOL NEUROTOL, V31, P1248, DOI 10.1097/MAO.0b013e3181f1cc6a; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hua Z, 2000, J CHILD LANG, V27, P3, DOI 10.1017/S030500099900402X; Li B, 2014, INT J PEDIATR OTORHI, V78, P1000, DOI 10.1016/j.ijporl.2014.03.020; Liang Qi, 2013, Cochlear Implants Int, V14 Suppl 1, pS26, DOI 10.1179/1467010013Z.00000000080; Lovas GS, 2011, FIRST LANG, V31, P83, DOI 10.1177/0142723709359241; Lu XP, 2013, RES DEV DISABIL, V34, P3526, DOI 10.1016/j.ridd.2013.07.010; Manrique M, 2004, ACTA OTO-LARYNGOL, V124, P55, DOI 10.1080/03655230410017148; Mondain M, 2002, INT J PEDIATR OTORHI, V63, P91, DOI 10.1016/S0165-5876(01)00638-3; Nicholas JG, 2007, J SPEECH LANG HEAR R, V50, P1048, DOI 10.1044/1092-4388(2007/073); Pisoni DB, 2004, SPR HDB AUD, V20, P377; Pisoni DB, 2003, EAR HEARING, V24, p106S, DOI 10.1097/01.AUD.0000051692.05140.8E; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; Schorr EA, 2006, VOLTA REV, V106, P365; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Sharma A, 2005, HEARING RES, V203, P134, DOI 10.1016/j.heares.2004.12.010; Sharma Anu, 2002, Ear and Hearing, V23, P532, DOI 10.1097/00003446-200212000-00004; Sininger YS, 2010, EAR HEARING, V31, P166, DOI 10.1097/AUD.0b013e3181c8e7b6; Spivak L, 2009, AM J AUDIOL, V18, P24, DOI 10.1044/1059-0889(2008/08-0015); Suhr D, 2006, THE BASICS OF STRUCT; Svirsky MA, 2000, PSYCHOL SCI, V11, P153, DOI 10.1111/1467-9280.00231; Tardif T, 2008, USERS GUIDE AND MANU; Teoh SW, 2004, LARYNGOSCOPE, V114, P1536; Waltzman S. B., 2006, COCHLEAR IMPLANTS; Waltzman SB, 2000, AM J OTOL, V21, P329, DOI 10.1016/S0196-0709(00)80040-X; [王慧琴 WANG HuiQin], 2007, [中国心理卫生杂志, Chinese Mental Health Journal], V21, P700; Wiley S, 2004, INT CONGR SER, V1273, P273, DOI 10.1016/j.ics.2004.08.089; Wong LLN, 2014, J SPEECH LANG HEAR R, V57, P1548, DOI 10.1044/2014_JSLHR-H-13-0024; Zheng Y, 2009, INT J AUDIOL, V48, P718, DOI 10.1080/14992020902902658; Zheng Y, 2009, EAR HEARING, V30, P600, DOI 10.1097/AUD.0b013e3181b4aba8; Zheng Y, 2009, AUDIOL NEURO-OTOL, V14, P214, DOI 10.1159/000189264; Zwolan T, 2009, PERSPECT HEARING HEA, V19, P4, DOI DOI 10.1044/HHDC19.1.4	55	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136576	10.1371/journal.pone.0136576	http://dx.doi.org/10.1371/journal.pone.0136576			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348360	Green Published, gold, Green Submitted			2022-12-26	WOS:000360897600010
J	Yeh, WC; Lai, CM				Yeh, Wei-Chang; Lai, Chyh-Ming			Accelerated Simplified Swarm Optimization with Exploitation Search Scheme for Data Clustering	PLOS ONE			English	Article							K-MEANS ALGORITHM; PARTICLE SWARM; FEATURE-SELECTION; EVOLUTIONARY; CONVERGENCE	Data clustering is commonly employed in many disciplines. The aim of clustering is to partition a set of data into clusters, in which objects within the same cluster are similar and dissimilar to other objects that belong to different clusters. Over the past decade, the evolutionary algorithm has been commonly used to solve clustering problems. This study presents a novel algorithm based on simplified swarm optimization, an emerging population- based stochastic optimization approach with the advantages of simplicity, efficiency, and flexibility. This approach combines variable vibrating search (VVS) and rapid centralized strategy (RCS) in dealing with clustering problem. VVS is an exploitation search scheme that can refine the quality of solutions by searching the extreme points nearby the global best position. RCS is developed to accelerate the convergence rate of the algorithm by using the arithmetic average. To empirically evaluate the performance of the proposed algorithm, experiments are examined using 12 benchmark datasets, and corresponding results are compared with recent works. Results of statistical analysis indicate that the proposed algorithm is competitive in terms of the quality of solutions.	[Yeh, Wei-Chang; Lai, Chyh-Ming] Natl Tsing Hua Univ, Dept Ind Engn & Engn Management, Hsinchu, Taiwan	National Tsing Hua University	Lai, CM (corresponding author), 101,Sect 2,Kuang Fu Rd, Hsinchu 30013, Taiwan.	chyh.ming.lai@gmail.com	YEH, WEI-CHANG/AAH-4172-2019	YEH, WEI-CHANG/0000-0001-7393-0768				Adib AB, 2005, J PHYS A-MATH GEN, V38, P8487, DOI 10.1088/0305-4470/38/40/001; Bae C, 2012, INT J INNOV COMPUT I, V8, P4391; Bandyopadhyay S, 2002, INFORM SCIENCES, V146, P221, DOI 10.1016/S0020-0255(02)00208-6; Banharnsakun A, 2013, NEUROCOMPUTING, V116, P355, DOI 10.1016/j.neucom.2012.02.047; Ben Ghalia M, 2008, MIDWEST SYMP CIRCUIT, P759, DOI 10.1109/MWSCAS.2008.4616910; Boutsidis C., 2010, ADV NEURAL INFORM PR, V23, P298; Chaves AA, 2010, COMPUT OPER RES, V37, P552, DOI 10.1016/j.cor.2008.09.011; Chuang LY, 2011, EXPERT SYST APPL, V38, P14555, DOI 10.1016/j.eswa.2011.05.027; Clerc M, 2002, IEEE T EVOLUT COMPUT, V6, P58, DOI 10.1109/4235.985692; Dean J, 2008, COMMUN ACM, V51, P107, DOI 10.1145/1327452.1327492; Derrac J, 2011, SWARM EVOL COMPUT, V1, P3, DOI 10.1016/j.swevo.2011.02.002; Dy JG, 2004, J MACH LEARN RES, V5, P845; Fahad A, 2014, IEEE T EMERG TOP COM, V2, P267, DOI 10.1109/TETC.2014.2330519; Hatamlou A, 2012, SWARM EVOL COMPUT, V6, P47, DOI 10.1016/j.swevo.2012.02.003; Hatamlou A, 2013, INFORM SCIENCES, V222, P175, DOI 10.1016/j.ins.2012.08.023; Hatamlou A, 2011, COMM COM INF SC, V241, P383; Johnson W., 1984, CONT MATH, V26, P189, DOI [10.1090/conm/026/737400, DOI 10.1090/CONM/026/737400]; Kang U, 2011, KNOWL INF SYST, V27, P303, DOI 10.1007/s10115-010-0305-0; Kao YT, 2008, EXPERT SYST APPL, V34, P1754, DOI 10.1016/j.eswa.2007.01.028; Karaboga D, 2011, APPL SOFT COMPUT, V11, P652, DOI 10.1016/j.asoc.2009.12.025; Krishna K, 1999, IEEE T SYST MAN CY B, V29, P433, DOI 10.1109/3477.764879; Kudo M, 2000, PATTERN RECOGN, V33, P25, DOI 10.1016/S0031-3203(99)00041-2; Liu YG, 2008, INFORM SCIENCES, V178, P2680, DOI 10.1016/j.ins.2008.01.022; Maulik U, 2000, PATTERN RECOGN, V33, P1455, DOI 10.1016/S0031-3203(99)00137-5; Mitra P, 2002, IEEE T PATTERN ANAL, V24, P301, DOI 10.1109/34.990133; Ng RT, 2002, IEEE T KNOWL DATA EN, V14, P1003, DOI 10.1109/TKDE.2002.1033770; Rashedi E, 2009, INFORM SCIENCES, V179, P2232, DOI 10.1016/j.ins.2009.03.004; SELIM SZ, 1991, PATTERN RECOGN, V24, P1003, DOI 10.1016/0031-3203(91)90097-O; SELIM SZ, 1984, IEEE T PATTERN ANAL, V6, P81, DOI 10.1109/TPAMI.1984.4767478; Shelokar PS, 2004, ANAL CHIM ACTA, V509, P187, DOI 10.1016/j.aca.2003.12.032; Tsai CY, 2011, EXPERT SYST APPL, V38, P6565, DOI 10.1016/j.eswa.2010.11.082; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141; Yeh WC, 2014, KNOWL-BASED SYST, V64, P1, DOI 10.1016/j.knosys.2014.03.011; Yeh WC, 2012, INFORM SCIENCES, V197, P65, DOI 10.1016/j.ins.2012.02.009; Yeh WC, 2012, IEEE T SYST MAN CY A, V42, P250, DOI 10.1109/TSMCA.2011.2157135; Yeh WC, 2009, EXPERT SYST APPL, V36, P8204, DOI 10.1016/j.eswa.2008.10.004; Zhang L, 2011, INFORM SCIENCES, V181, P4658, DOI 10.1016/j.ins.2010.11.005	37	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137246	10.1371/journal.pone.0137246	http://dx.doi.org/10.1371/journal.pone.0137246			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348483	Green Submitted, gold, Green Published			2022-12-26	WOS:000360897600029
J	Maus, F; Sakry, D; Biname, F; Karram, K; Rajalingam, K; Watts, C; Heywood, R; Kruger, R; Stegmuller, J; Werner, HB; Nave, KA; Kramer-Albers, EM; Trotter, J				Maus, Frank; Sakry, Dominik; Biname, Fabien; Karram, Khalad; Rajalingam, Krishnaraj; Watts, Colin; Heywood, Richard; Krueger, Rejko; Stegmueller, Judith; Werner, Hauke B.; Nave, Klaus-Armin; Kraemer-Albers, Eva-Maria; Trotter, Jacqueline			The NG2 Proteoglycan Protects Oligodendrocyte Precursor Cells against Oxidative Stress via Interaction with OMI/HtrA2	PLOS ONE			English	Article							SERINE-PROTEASE HTRA2/OMI; GLIAL PROGENITOR CELLS; FUNCTIONAL-ANALYSIS; MULTIPLE-SCLEROSIS; PDZ DOMAIN; DEATH; EXPRESSION; GLIOMA; GLIOBLASTOMA; INHIBITOR	The NG2 proteoglycan is characteristically expressed by oligodendrocyte progenitor cells (OPC) and also by aggressive brain tumours highly resistant to chemo-and radiation therapy. Oligodendrocyte-lineage cells are particularly sensitive to stress resulting in cell death in white matter after hypoxic or ischemic insults of premature infants and destruction of OPC in some types of Multiple Sclerosis lesions. Here we show that the NG2 proteoglycan binds OMI/HtrA2, a mitochondrial serine protease which is released from damaged mitochondria into the cytosol in response to stress. In the cytosol, OMI/HtrA2 initiates apoptosis by proteolytic degradation of anti-apoptotic factors. OPC in which NG2 has been downregulated by siRNA, or OPC from the NG2-knockout mouse show an increased sensitivity to oxidative stress evidenced by increased cell death. The proapoptotic protease activity of OMI/ HtrA2 in the cytosol can be reduced by the interaction with NG2. Human glioma expressing high levels of NG2 are less sensitive to oxidative stress than those with lower NG2 expression and reducing NG2 expression by siRNA increases cell death in response to oxidative stress. Binding of NG2 to OMI/HtrA2 may thus help protect cells against oxidative stress-induced cell death. This interaction is likely to contribute to the high chemo-and radioresistance of glioma.	[Maus, Frank; Sakry, Dominik; Biname, Fabien; Karram, Khalad; Kraemer-Albers, Eva-Maria; Trotter, Jacqueline] Johannes Gutenberg Univ Mainz, Dept Biol, Mol Cell Biol, D-55122 Mainz, Germany; [Rajalingam, Krishnaraj] Johannes Gutenberg Univ Mainz, Med Ctr Mainz, Inst Immunol, Res Ctr Immune Therapy, D-55122 Mainz, Germany; [Krueger, Rejko] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Clin & Expt Neurosci, Luxembourg, Luxembourg; [Krueger, Rejko] Ctr Hosp Luxembourg, Luxembourg, Luxembourg; [Krueger, Rejko] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, Tubingen, Germany; [Krueger, Rejko] Univ Tubingen, German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany; [Werner, Hauke B.; Nave, Klaus-Armin] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Karram, Khalad] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, D-55122 Mainz, Germany; [Watts, Colin; Heywood, Richard] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Stegmueller, Judith] Max Planck Inst Expt Med, Cellular & Mol Neurobiol, D-37075 Gottingen, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Luxembourg; Luxembourg Hospital Center; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Max Planck Society; Johannes Gutenberg University of Mainz; University of Cambridge; Max Planck Society	Trotter, J (corresponding author), Johannes Gutenberg Univ Mainz, Dept Biol, Mol Cell Biol, D-55122 Mainz, Germany.	trotter@uni-mainz.de	BINAME, Fabien/ABD-8279-2021; Eva-Maria, Kraemer-Albers/AAP-8805-2020; Maus, Frank/AAE-9241-2022	Eva-Maria, Kraemer-Albers/0000-0001-7994-1185; Biname, Fabien/0000-0002-9758-1512; Werner, Hauke/0000-0002-7710-5738; Krueger, Rejko/0000-0003-4258-6241; Sakry, Dominik/0000-0002-7144-7243	Deutsche Forschungsgemeinschaft [TR 1008/1-1, TR 1008/2-1, CRC TRR 128/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (TR 1008/1-1, TR 1008/2-1, CRC TRR 128/1).	Al-Mayhani MTF, 2011, NEURO-ONCOLOGY, V13, P830, DOI 10.1093/neuonc/nor088; Back SA, 2001, J NEUROSCI, V21, P1302; Barrantes-Freer A, 2013, J NEUROPATH EXP NEUR, V72, P307, DOI 10.1097/NEN.0b013e31828afdbd; Barritt DS, 2000, J CELL BIOCHEM, V79, P213, DOI 10.1002/1097-4644(20001101)79:2<213::AID-JCB50>3.0.CO;2-G; Biname F, 2013, J NEUROSCI, V33, P10858, DOI 10.1523/JNEUROSCI.5010-12.2013; Chatterjee N, 2008, J BIOL CHEM, V283, P8310, DOI 10.1074/jbc.M706074200; Chekenya M, 2008, ONCOGENE, V27, P5182, DOI 10.1038/onc.2008.157; Cilenti L, 2003, J BIOL CHEM, V278, P11489, DOI 10.1074/jbc.M212819200; Cuddapah VA, 2014, NAT REV NEUROSCI, V15, P455, DOI 10.1038/nrn3765; Cui QL, 2013, AM J PATHOL, V183, P516, DOI 10.1016/j.ajpath.2013.04.016; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Decker P, 2000, J BIOL CHEM, V275, P9043, DOI 10.1074/jbc.275.12.9043; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Fragoso G, 2004, J NEUROCHEM, V90, P392, DOI 10.1111/j.1471-4159.2004.02488.x; Guilfoyle MR, 2011, BRIT J CANCER, V104, P1810, DOI 10.1038/bjc.2011.153; Gupta S, 2004, J BIOL CHEM, V279, P45844, DOI 10.1074/jbc.M404940200; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Itoh T, 2003, J NEUROCHEM, V85, P1500, DOI 10.1046/j.1471-4159.2003.01795.x; Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052; Joo NE, 2014, DNA CELL BIOL, V33, P854, DOI 10.1089/dna.2014.2399; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Karram K, 2008, GENESIS, V46, P743, DOI 10.1002/dvg.20440; Khan FS, 2008, CELL DEATH DIFFER, V15, P1073, DOI 10.1038/cdd.2008.19; Khorchid A, 2002, GLIA, V40, P283, DOI 10.1002/glia.10123; Kilbride SM, 2013, ONCOGENE, V32, P2703, DOI 10.1038/onc.2012.348; Klupsch K, 2006, CELL DEATH DIFFER, V13, P2157, DOI 10.1038/sj.cdd.4401955; Kuninaka S, 2005, ONCOGENE, V24, P5287, DOI 10.1038/sj.onc.1208682; LEGRAND C, 1992, J BIOTECHNOL, V25, P231, DOI 10.1016/0168-1656(92)90158-6; LEVINE JM, 1994, J NEUROSCI, V14, P4716; Liddell JR, 2010, GLIA, V58, P1500, DOI 10.1002/glia.21024; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004; Martins LM, 2003, J BIOL CHEM, V278, P49417, DOI 10.1074/jbc.M308659200; Ness JK, 2001, DEV NEUROSCI-BASEL, V23, P203, DOI 10.1159/000046144; Niehaus A, 1999, J NEUROSCI, V19, P4948; NISHIYAMA A, 1995, MOL BIOL CELL, V6, P1819, DOI 10.1091/mbc.6.12.1819; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Sakry D, 2015, BRAIN RES; Sakry D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127222; Sakry D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001993; Savopoulos JW, 2000, PROTEIN EXPRES PURIF, V19, P227, DOI 10.1006/prep.2000.1240; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Stallcup WB, 2008, CELL ADHES MIGR, V2, P192, DOI 10.4161/cam.2.3.6279; Stegmuller J, 2002, J NEUROCYTOL, V31, P497, DOI 10.1023/A:1025743731306; Stegmuller J, 2003, J BIOL CHEM, V278, P3590, DOI 10.1074/jbc.M210010200; Stelzer S, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-27; Sugiarto S, 2011, CANCER CELL, V20, P328, DOI 10.1016/j.ccr.2011.08.011; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Svendsen A, 2011, ACTA NEUROPATHOL, V122, P495, DOI 10.1007/s00401-011-0867-2; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; Vande Walle L, 2008, CELL DEATH DIFFER, V15, P453, DOI 10.1038/sj.cdd.4402291; Virag L, 2013, MOL ASPECTS MED, V34, P1153, DOI 10.1016/j.mam.2013.01.007; Zhang YN, 2007, PROTEIN SCI, V16, P1738, DOI 10.1110/ps.072833207	55	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137311	10.1371/journal.pone.0137311	http://dx.doi.org/10.1371/journal.pone.0137311			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340347	Green Published, Green Submitted, gold			2022-12-26	WOS:000360688200046
J	Pugliese, F; Acerbi, A; Marocco, D				Pugliese, Francesco; Acerbi, Alberto; Marocco, Davide			Emergence of Leadership in a Group of Autonomous Robots	PLOS ONE			English	Article							DECISION-MAKING; EVOLUTION; COMMUNICATION; PERSONALITY; ORIGINS; MODEL; SIZE	In this paper we examine the factors contributing to the emergence of leadership in a group, and we explore the relationship between the role of the leader and the behavioural capabilities of other individuals. We use a simulation technique where a group of foraging robots must coordinate to choose between two identical food zones in order to forage collectively. Behavioural and quantitative analysis indicate that a form of leadership emerges, and that groups with a leader are more effective than groups without. Moreover, we show that the most skilled individuals in a group tend to be the ones that assume a leadership role, supporting biological findings. Further analysis reveals the emergence of different "styles" of leadership (active and passive).	[Pugliese, Francesco] Italian Natl Inst Stat, Dept Natl Accounts & Econ Stat, Rome, Italy; [Acerbi, Alberto] Univ Bristol, Dept Archaeol & Anthropol, Bristol, Avon, England; [Acerbi, Alberto] Eindhoven Univ Technol, Sch Innovat Sci, Philosophy & Eth, NL-5600 MB Eindhoven, Netherlands; [Marocco, Davide] Univ Plymouth, Sch Comp & Math, Plymouth PL4 8AA, Devon, England	University of Bristol; Eindhoven University of Technology; University of Plymouth	Pugliese, F (corresponding author), Italian Natl Inst Stat, Dept Natl Accounts & Econ Stat, Rome, Italy.	francesco.pugliese@istat.it	marocco, davide/GNM-7611-2022	MAROCCO, DAVIDE/0000-0001-5185-1313; Acerbi, Alberto/0000-0001-5827-8003				Acerbi A., 2009, Proceedings 2009 International Joint Conference on Neural Networks (IJCNN 2009 - Atlanta), P20, DOI 10.1109/IJCNN.2009.5178607; Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Ame JM, 2006, P NATL ACAD SCI USA, V103, P5835, DOI 10.1073/pnas.0507877103; BARNARD CJ, 1980, ANIM BEHAV, V28, P295, DOI 10.1016/S0003-3472(80)80032-7; Bornstein G, 2002, GAME ECON BEHAV, V41, P1, DOI 10.1016/S0899-8256(02)00012-X; CHAPMAN CA, 1995, BEHAV ECOL SOCIOBIOL, V36, P59, DOI 10.1007/BF00175729; Collignon B, 2009, P ROYAL SOC LONDON B; Conradt L, 2009, AM NAT, V173, P304, DOI 10.1086/596532; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; de Greeff J, 2014, INTEL ROBOT AUTON AG, P179; Dyer JRG, 2008, ANIM BEHAV, V75, P461, DOI 10.1016/j.anbehav.2007.05.010; Fischhoff IR, 2007, ANIM BEHAV, V73, P825, DOI 10.1016/j.anbehav.2006.10.012; Franks NR, 2006, NATURE, V439, P153, DOI 10.1038/439153a; Gigliotta O, 2010, ARTIFICIAL LIFE AND EVOLUTIONARY COMPUTATION, P167, DOI 10.1142/9789814287456_0015; Giraldeau LA, 1999, TRENDS ECOL EVOL, V14, P102, DOI 10.1016/S0169-5347(98)01542-0; Guilford T, 1996, P ROY SOC B-BIOL SCI, V263, P153, DOI 10.1098/rspb.1996.0024; Harcourt JL, 2009, CURR BIOL, V19, P248, DOI 10.1016/j.cub.2008.12.051; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; HOLLAND JH, 1992, SCI AM, V267, P66, DOI 10.1038/scientificamerican0792-66; Jacoby G, 2008, EL COMP ENG 2008 CCE; Judge TA, 2000, J APPL PSYCHOL, V85, P751, DOI 10.1037/0021-9010.85.5.751; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; Konig B, 1997, NATURWISSENSCHAFTEN, V84, P95, DOI 10.1007/s001140050356; Leca JB, 2003, ANIM BEHAV, V66, P1045, DOI 10.1006/anbe.2003.2276; LINDAUER M, 1957, NATURE, V179, P63, DOI 10.1038/179063a0; Lusseau D, 2009, BEHAV ECOL SOCIOBIOL, V63, P1067, DOI 10.1007/s00265-009-0740-7; Ma KHS, 2008, INT J COMPUT SCI NET, V8, P302; Miglino O, 1995, Artif Life, V2, P417, DOI 10.1162/artl.1995.2.4.417; Mondada F., 1999, PROC 1 INT KHEPERA W, P7; Nolfi S, 2002, TRENDS COGN SCI, V6, P31, DOI 10.1016/S1364-6613(00)01812-X; Noonan MP, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001940; ORIANS GH, 1969, AM NAT, V103, P589, DOI 10.1086/282628; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Simpson SA, 2005, J ACOUST SOC AM, V118, P2775, DOI 10.1121/1.2062650; Tarpy DR, 2009, ETHOL ECOL EVOL, V21, P147, DOI 10.1080/08927014.2009.9522503; Van Vugt M, 2008, AM PSYCHOL, V63, P182, DOI 10.1037/0003-066X.63.3.182; Van Vugt M, 2006, PERS SOC PSYCHOL REV, V10, P354, DOI 10.1207/s15327957pspr1004_5; VANSCHAIK CP, 1983, BEHAVIOUR, V87, P120, DOI 10.1163/156853983X00147; Venayagamoorthy GK, 2004, IEEE IND APPLIC SOC, P1200; VINACKE WE, 1964, SOCIOMETRY, V27, P25, DOI 10.2307/2785800; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447; Wright J, 2003, J ANIM ECOL, V72, P1003, DOI 10.1046/j.1365-2656.2003.00771.x	44	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137234	10.1371/journal.pone.0137234	http://dx.doi.org/10.1371/journal.pone.0137234			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ6BA	26340449	Green Published, Green Submitted, gold			2022-12-26	WOS:000360688200037
J	Zhou, M; Peng, X; Mao, C; Tian, JH; Zhang, SW; Xu, F; Tu, JJ; Liu, S; Hu, M; Yu, GY				Zhou, Miao; Peng, Xin; Mao, Chi; Tian, Jia-he; Zhang, Shu-wen; Xu, Fang; Tu, Jing-jing; Liu, Sheng; Hu, Min; Yu, Guang-yan			The Value of SPECT/CT in Monitoring Prefabricated Tissue-Engineered Bone and Orthotopic rhBMP-2 Implants for Mandibular Reconstruction	PLOS ONE			English	Article							MORPHOGENETIC PROTEIN-2; CLINICAL-APPLICATIONS; MATRIX; GROWTH; CELLS; RESORPTION	Bone tissue engineering shows good prospects for mandibular reconstruction. In recent studies, prefabricated tissue-engineered bone (PTEB) by recombinant human bone morphogenetic proteins (rhBMPs) applied in vivo has found to be an effective alternative for autologous bone grafts. However, the optimal time to transfer PTEB for mandibular reconstruction is still not elucidated. Thus, here in an animal experiment of rhesus monkey, the suitable transferring time for PTEB to reconstruct mandibular defects was evaluated by Tc-99m-MDP SPECT/CT, and its value in monitoring orthotopic rhBMP-2 implants for mandibular reconstruction was also evaluated. The result of SPECT/CT showed higher Tc-99m-MDP uptake, indicating osteoinductivity, in rhBMP-2 incorporated demineralized freeze-dried bone allograft (DFDBA) and coralline hydroxyapatite (CHA) implants than those without BMP stimulation. Tc-99m-MDP uptake of rhBMP-2 implant peaked at 8 weeks following implantation while CT showed the density of these implants increased after 13 weeks' prefabrication. Histology confirmed that mandibular defects were repaired successfully with PTEB or orthotopically rhBMP-2 incorporated CHA implants, in accordance with SPECT/CT findings. Collectively, data shows Tc-99m-MDP SPECT/CT is a sensitive and noninvasive tool to monitor osteoinductivity and bone regeneration of PTEB and orthotopic implants. The PTEB achieved peak osteoinductivity and bone density at 8 to 13 weeks following ectopic implantation, which would serve as a recommendable time frame for its transfer to mandibular reconstruction.	[Zhou, Miao; Peng, Xin; Mao, Chi; Yu, Guang-yan] Peking Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Beijing 100871, Peoples R China; [Zhou, Miao] Guangzhou Med Univ, Guangzhou Inst Oral Dis, Key Lab Oral Med, Stomatol Hosp, Guangzhou, Guangdong, Peoples R China; [Tian, Jia-he; Zhang, Shu-wen] Chinese Peoples Liberat Army Gen Hosp, Dept Nucl Med, Beijing, Peoples R China; [Xu, Fang; Tu, Jing-jing] Zhejiang Univ Technol, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China; [Liu, Sheng] Sun Yat Sen Univ, Dept Nucl Med, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Hu, Min] Chinese Peoples Liberat Army Gen Hosp, Dept Oral & Maxillofacial Surg, Beijing, Peoples R China	Peking University; Guangzhou Medical University; Chinese People's Liberation Army General Hospital; Zhejiang University of Technology; Sun Yat Sen University; Chinese People's Liberation Army General Hospital	Hu, M (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Oral & Maxillofacial Surg, Beijing, Peoples R China.	humin48@vip.163.com; gyyu@263.net			Beijing Municipal Science and Technology Commission [D090600704040291]; National Nature Science Foundation of China [81000421]; International Team for Implantology [881_2012]; Guangdong Provincial Department of Science and Technology [2013B021800314]	Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Team for Implantology; Guangdong Provincial Department of Science and Technology	This project was financially supported by the Beijing Municipal Science and Technology Commission (No. D090600704040291, http://www.bjkw.gov.cn/, PI:GYY), the National Nature Science Foundation of China (No. 81000421, http://www.nsfc.gov.cn/, PI:MZ), International Team for Implantology (No. 881_2012, http://www.iti.org/, PI:MZ) and Guangdong Provincial Department of Science and Technology (No. 2013B021800314, www.gdstc.gov.cn, PI:MZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASPENBERG P, 1992, ACTA ORTHOP SCAND, V63, P619; BAUER FCH, 1984, CLIN ORTHOP RELAT R, P139; Hardwick JCH, 2004, GASTROENTEROLOGY, V126, P111, DOI 10.1053/j.gastro.2003.10.067; Keidar Z, 2003, SEMIN NUCL MED, V33, P205, DOI 10.1053/snuc.2003.127310; Kempen DHR, 2009, J CONTROL RELEASE, V134, P169, DOI 10.1016/j.jconrel.2008.11.023; Kusafuka K, 1998, VIRCHOWS ARCH, V432, P247, DOI 10.1007/s004280050162; Langenfeld EM, 2003, CARCINOGENESIS, V24, P1445, DOI 10.1093/carcin/bgg100; LEITHA T, 1995, EUR J NUCL MED, V22, P308, DOI 10.1007/BF00941846; Mesimaki K, 2009, INT J ORAL MAX SURG, V38, P201, DOI 10.1016/j.ijom.2009.01.001; NILSSON OS, 1990, CLIN ORTHOP RELAT R, P280; O'Connor MK, 2006, SEMIN NUCL MED, V36, P258, DOI 10.1053/j.semnuclmed.2006.05.005; Ronga M, 2013, INJURY, V44, pS34, DOI 10.1016/S0020-1383(13)70008-1; Wang L, 2011, CANCER BIOL THER, V11, P457, DOI 10.4161/cbt.11.5.14372; Warnke PH, 2006, BIOMATERIALS, V27, P3163, DOI 10.1016/j.biomaterials.2006.01.050; Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3; Zhao M, 1998, J ORAL PATHOL MED, V27, P293; Zhou J, 2010, BIOMATERIALS, V31, P1171, DOI 10.1016/j.biomaterials.2009.10.043; Zhou M, 2010, BIOMATERIALS, V31, P4935, DOI 10.1016/j.biomaterials.2010.02.072	18	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137167	10.1371/journal.pone.0137167	http://dx.doi.org/10.1371/journal.pone.0137167			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340447	Green Submitted, gold, Green Published			2022-12-26	WOS:000360688200027
J	Chow, WZ; Lim, SH; Ong, LY; Yong, YK; Takebe, Y; Kamarulzaman, A; Tee, KK				Chow, Wei Zhen; Lim, Sin How; Ong, Lai Yee; Yong, Yean Kong; Takebe, Yutaka; Kamarulzaman, Adeeba; Tee, Kok Keng			Impact of HIV-1 Subtype on the Time to CD4+T-Cell Recovery in Combination Antiretroviral Therapy (cART)-Experienced Patients	PLOS ONE			English	Article							DISEASE PROGRESSION; SEX-DIFFERENCES; VIRAL LOAD; INFECTION; VIRUS; PATHOGENESIS; DECLINE; COHORTS; PLASMA; AIDS	Human immunodeficiency virus type 1 (HIV-1) subtypes have been shown to differ in the rate of clinical progression. We studied the association between HIV-1 subtypes and the rate of CD4+ T-cell recovery in a longitudinal cohort of patients on combination antiretroviral therapy (cART). We studied 103 patients infected with CRF01_AE (69%) and subtype B (31%) who initiated cART between 2006 and 2013. Demographic data, CD4+ T-cell counts and HIV-1 viral load were abstracted from patient medical charts. Kaplan-Meier was used to estimate the time to CD4+ T-cell count increase to >= 350 between subtypes and effects of covariates were analysed using Cox proportional hazards. An 87% of the study population were male adults (mean age of 38.7 years old). Baseline CD4+ T-cell counts and viral loads, age at cART initiation, sex, ethnicity and co-infection did not differ significantly between subtypes. A shorter median time for CD4+ T-cell count increase to >= 350 cells/mu L was observed for CRF01_AE (546 days; 95% confidence interval [CI], 186-906 days; P = .502) compared to subtype B (987 days; 95% CI, 894-1079 days). In multivariate analysis, female sex was significantly associated with a 2.7 times higher chance of achieving CD4+ T-cell recovery (adjusted hazard ratio [HR], 2.75; 95% CI, 1.21-6.22; P = .025) and both baseline CD4+ T-cell count (P = .001) and viral load (P = .001) were important predictors for CD4+ T-cell recovery. Immunological recovery correlated significantly with female sex, baseline CD4+ T-cell counts and viral load but not subtype.	[Chow, Wei Zhen; Lim, Sin How; Ong, Lai Yee; Yong, Yean Kong; Takebe, Yutaka; Kamarulzaman, Adeeba; Tee, Kok Keng] Univ Malaya, Fac Med, Dept Med, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia; [Takebe, Yutaka] Natl Inst Infect Dis, AIDS Res Ctr, Shinjuku Ku, Tokyo 1628640, Japan	Universiti Malaya; National Institute of Infectious Diseases (NIID)	Tee, KK (corresponding author), Univ Malaya, Fac Med, Dept Med, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia.	k2tee@um.edu.my	Yong, Yean Kong/Q-5318-2016; Yong, Yean/B-9202-2017; Lim, Sin How/AAC-8004-2020; Lim, Sin How/L-7168-2017; Tee, Kok Keng/A-8148-2008; KAMARULZAMAN, ADEEBA/B-5216-2010	Yong, Yean/0000-0002-8409-6251; Lim, Sin How/0000-0002-8727-4826; Tee, Kok Keng/0000-0002-7923-5448; 	IAS-NIDA fellowship; Ministry of Education, Malaysia: High Impact Research [E-000001-20001]; High Impact Research [H-500001-00-A000012-000001]	IAS-NIDA fellowship; Ministry of Education, Malaysia: High Impact Research; High Impact Research	This work was supported in part by IAS-NIDA fellowship to S.H.L., grants from the Ministry of Education, Malaysia: High Impact Research E-000001-20001 to A.K., and High Impact Research H-500001-00-A000012-000001 to K.K.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2014, J INFECT DIS, V209, pS86, DOI 10.1093/infdis/jiu175; BENTWICH Z, 1995, IMMUNOL TODAY, V16, P187, DOI 10.1016/0167-5699(95)80119-7; Bhargava M, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18944; Chang JJ, 2013, J INFECT DIS, V208, P830, DOI 10.1093/infdis/jit262; Chow WZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062560; Collazos J, 2007, AIDS, V21, P835, DOI 10.1097/QAD.0b013e3280b0774a; Cornelissen M, 2012, CLIN INFECT DIS, V54, P539, DOI 10.1093/cid/cir849; Dorak MT, 2003, J INFECT DIS, V188, P856, DOI 10.1086/378071; Easterbrook PJ, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-4; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; Frater J, 2014, AIDS, V28, P699, DOI 10.1097/QAD.0000000000000130; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Kanki PJ, 1999, J INFECT DIS, V179, P68, DOI 10.1086/314557; Kiwanuka N, 2008, J INFECT DIS, V197, P707, DOI 10.1086/527416; Lee LK, 2012, CLIN INFECT DIS, V54, P1818, DOI 10.1093/cid/cis312; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mlisana K, 2014, CLIN INFECT DIS, V59, P1322, DOI 10.1093/cid/ciu573; Ng OT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015738; Nicastri E, 2005, AIDS, V19, P577, DOI 10.1097/01.aids.0000163934.22273.06; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Scherrer AU, 2011, CLIN INFECT DIS, V53, P1143, DOI 10.1093/cid/cir669; Seng Remonie, 2015, AIDS, V29, P595, DOI 10.1097/QAD.0000000000000571; Touloumi G, 2013, CLIN INFECT DIS, V56, P888, DOI 10.1093/cid/cis1000; Williams JP, 2014, ELIFE, V3, DOI 10.7554/eLife.03821	26	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137281	10.1371/journal.pone.0137281	http://dx.doi.org/10.1371/journal.pone.0137281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335136	Green Published, gold, Green Submitted			2022-12-26	WOS:000360615400048
J	Lopes-Pacheco, M; Boinot, C; Sabirzhanova, I; Morales, MM; Guggino, WB; Cebotaru, L				Lopes-Pacheco, Miqueias; Boinot, Clement; Sabirzhanova, Inna; Morales, Marcelo M.; Guggino, William B.; Cebotaru, Liudmila			Combination of Correctors Rescue Delta F508-CFTR by Reducing Its Association with Hsp40 and Hsp27	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; IN-VITRO; CFTR; MUTATION; DEGRADATION; MUTANT; PROTEOSTASIS; TRANSPORT; CHAPERONE	Correcting the processing of Delta F508-CFTR, the most common mutation in cystic fibrosis, is the major goal in the development of new therapies for this disease. Here, we determined whether Delta F508 could be rescued by a combination of small-molecule correctors, and identified the mechanism by which correctors rescue the trafficking mutant of cystic fibrosis transmembrane conductance regulator (CFTR). We transfected COS-7 cells with Delta F508, created HEK-293 stably expressing Delta F508, and utilized CFBE41o(-) cell lines stably transduced with Delta F508. As shown previously, Delta F508 expressed less protein, was unstable at physiological temperature, and rapidly degraded. When the cells were treated with the combination C18 + C4 the mature C-band was expressed at the cell surface. After treatment with C18 + C4, we saw a lower rate of protein disappearance after translation was stopped with cycloheximide. To understand how this rescue occurs, we evaluated the change in the binding of proteins involved in endoplasmic reticulum-associated degradation, such as Hsp27 (HspB1) and Hsp40 (DnaJ). We saw a dramatic reduction in binding to heat shock proteins 27 and 40 following combined corrector therapy. siRNA experiments confirmed that a reduction in Hsp27 or Hsp40 rescued CFTR in the Delta F508 mutant, but the rescue was not additive or synergistic with C4 + 18 treatment, indicating these correctors shared a common pathway for rescue involving a network of endoplasmic reticulum-associated degradation proteins.	[Lopes-Pacheco, Miqueias; Boinot, Clement; Sabirzhanova, Inna; Guggino, William B.; Cebotaru, Liudmila] Johns Hopkins Univ, Dept Med, Baltimore, MD 21205 USA; [Lopes-Pacheco, Miqueias; Boinot, Clement; Sabirzhanova, Inna; Guggino, William B.; Cebotaru, Liudmila] Johns Hopkins Univ, Dept Physiol, Baltimore, MD 21205 USA; [Lopes-Pacheco, Miqueias; Morales, Marcelo M.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil	Johns Hopkins University; Johns Hopkins University; Universidade Federal do Rio de Janeiro	Cebotaru, L (corresponding author), Wood Basic Sci Bldg,Rm 414,725 N Wolfe St, Baltimore, MD 21205 USA.	lcebotaru@jhmi.edu	Lopes-Pacheco, Miquéias/AAM-7432-2020; Lopes-Pacheco, Miquéias/I-1290-2017	Lopes-Pacheco, Miquéias/0000-0002-7444-9359; Lopes-Pacheco, Miquéias/0000-0002-7444-9359	United States CF Foundation; National Council for Scientific and Technological Development (CNPq/Program Science without Borders), Brazil	United States CF Foundation; National Council for Scientific and Technological Development (CNPq/Program Science without Borders), Brazil	This work was supported by the United States CF Foundation and the National Council for Scientific and Technological Development (CNPq/Program Science without Borders), Brazil (to M. L. -P.). The authors declare that they have no conflicts of interest with the contents of this article.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Ahner A, 2007, MOL BIOL CELL, V18, P806, DOI 10.1091/mbc.E06-05-0458; Ahner A, 2013, MOL BIOL CELL, V24, P74, DOI 10.1091/mbc.E12-09-0678; Amaral MD, 2013, CURR PHARM DESIGN, V19, P3497; Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Balch W. E., 2011, COLD SPRING HARBOR P, V3; Cebotaru L, 2008, J BIOL CHEM, V283, P21926, DOI 10.1074/jbc.M709156200; Cebotaru L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085183; Cebotaru L, 2013, J BIOL CHEM, V288, P10505, DOI 10.1074/jbc.M112.420489; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Cohen-Cymberknoh M, 2011, AM J RESP CRIT CARE, V183, P1463, DOI 10.1164/rccm.201009-1478CI; Farinha CM, 2002, BIOCHEM J, V366, P797, DOI 10.1042/BJ20011717; Hoelen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015458; Illek B, 2010, CELL PHYSIOL BIOCHEM, V26, P983, DOI 10.1159/000324011; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Mickle JE, 1998, CLIN CHEST MED, V19, P443, DOI 10.1016/S0272-5231(05)70092-7; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; RICH DP, 1993, RECEPTOR CHANNEL, V1, P221; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; RIORDAN JR, 1989, SCIENCE, V245, P1066; Roth DM, 2011, CURR OPIN CELL BIOL, V23, P126, DOI 10.1016/j.ceb.2010.11.001; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106	33	29	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25636	25645		10.1074/jbc.M115.671925	http://dx.doi.org/10.1074/jbc.M115.671925			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26336106	Green Published, hybrid			2022-12-26	WOS:000362962800036
J	Buss, LW; Anderson, CP; Perry, EK; Buss, ED; Bolton, EW				Buss, Leo W.; Anderson, Christopher P.; Perry, Elena K.; Buss, Evan D.; Bolton, Edward W.			Nutrient Distribution and Absorption in the Colonial Hydroid Podocoryna carnea Is Sequentially Diffusive and Directional	PLOS ONE			English	Article							HYDRACTINIA-SYMBIOLONGICARPUS CNIDARIA; STEADY STATE GROWTH; TISSUE DYNAMICS; CELL MOVEMENTS; CAMPANULARIA FLEXUOSA; NUTRITIVE ENDOCYTOSIS; DIGESTIVE CELLS; STOLON; LITTORALIS; PHYSIOLOGY	The distribution and absorption of ingested protein was characterized within a colony of Podocoryna carnea when a single polyp was fed. Observations were conducted at multiple spatial and temporal scales at three different stages of colony ontogeny with an artificial food item containing Texas Red conjugated albumin. Food pellets were digested and all tracer absorbed by digestive cells within the first 2-3 hours post-feeding. The preponderance of the label was located in the fed polyp and in a transport-induced diffusion pattern surrounding the fed polyp. After 6 hours post-feeding particulates re-appeared in the gastrovascular system and their absorption increased the area over which the nutrients were distributed, albeit still in a pattern that was centered on the fed polyp. At later intervals, tracer became concentrated in some stolon tips, but not in others, despite the proximity of these stolons either to the fed polyp or to adjacent stolons receiving nutrients. Distribution and absorption of nutrients is sequentially diffusive and directional.	[Buss, Leo W.; Anderson, Christopher P.; Perry, Elena K.; Buss, Evan D.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Buss, Leo W.] Smithsonian Marine Stn, Ft Pierce, FL USA; [Bolton, Edward W.] Yale Univ, Dept Geol & Geophys, New Haven, CT USA	Yale University; Smithsonian Institution; Smithsonian National Museum of Natural History; Yale University	Buss, LW (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	leo.buss@yale.edu		Perry, Elena/0000-0002-7151-1479				AFZELIUS BA, 1965, Z ZELLFORSCH MIK ANA, V67, P24, DOI 10.1007/BF00339274; Beloussov L.V., 1973, Publications Seto Mar Biol Lab, V20, P315; BELOUSSOV LV, 1989, J EXP ZOOL, V249, P258, DOI 10.1002/jez.1402490304; BELOUSSOV LV, 1972, J EMBRYOL EXP MORPH, V27, P317; BERRILL NJ, 1949, Q J MICROSC SCI, V90, P235; BERRILL NJ, 1949, J MORPHOL, V84, P1, DOI 10.1002/jmor.1050840102; Beutler R, 1924, J COMP PHYSL, V1, P1; Bird R. B., 2002, INTERPHASE TRANSPORT; BLACKSTONE NW, 1991, BIOL BULL, V180, P394, DOI 10.2307/1542340; BOARDMAN RS, 1973, ANIMAL COLONIES; BRAVERMAN M, 1971, J MORPHOL, V135, P131, DOI 10.1002/jmor.1051350202; BRAVERMAN M, 1968, J MORPHOL, V126, P95, DOI 10.1002/jmor.1051260106; Braverman M, 1966, CNIDARIA THEIR EVOLU, P169; Braverman M, 1974, ANN REV OCEANOGRAPHY, V12, P129; Brien P., 1951, Bulletin de la Societe Zoologique de France, V76, P277; Brien P., 1949, Bulletin Biologique de la France et de la Belgique, V83, P293; Bumann D, 2008, INVERTEBR BIOL, V127, P368, DOI 10.1111/j.1744-7410.2008.00135.x; BURNETT AL, 1961, J EXP ZOOL, V146, P21, DOI 10.1002/jez.1401460105; Buss LW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072221; Buss LW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048914; Buss LW, 2001, EVOLUTIONARY PATTERNS: GROWTH, FORM, AND TEMPO IN THE FOSSIL RECORD, P3; Cadavid LF, 2004, GENETICS, V167, P357, DOI 10.1534/genetics.167.1.357; CAMPBELL RD, 1967, J EMBRYOL EXP MORPH, V17, P607; CAMPBELL RD, 1967, J EXP ZOOL, V164, P379, DOI 10.1002/jez.1401640308; CAMPBELL RD, 1967, DEV BIOL, V15, P487, DOI 10.1016/0012-1606(67)90039-5; CAMPBELL RD, 1967, J MORPHOL, V121, P19, DOI 10.1002/jmor.1051210103; CARTWRIGHT P, 2006, J EXP ZOOL PART B, V306, P1; Cook CB, 1979, CYTOBIOS, V89, P17; CROWELL S, 1957, J EXP ZOOL, V134, P63, DOI 10.1002/jez.1401340104; DONALDSON S, 1974, AM ZOOL, V14, P735; Dudgeon S, 1999, BIOL BULL, V196, P1, DOI 10.2307/1543161; Dudgeon SR, 2011, ADV MAR BIOL, V59, P107, DOI 10.1016/B978-0-12-385536-7.00003-0; GAUTHIER GF, 1963, J EXP ZOOL, V152, P13, DOI 10.1002/jez.1401520104; HALE LJ, 1964, J EMBRYOL EXP MORPH, V12, P517; Hale LJ, 1960, Q J MICROSC SCI, V101, P39; Hamann O, 1882, JENA Z NATURISS, V15, P473; HUNDGEN M, 1978, MAR BIOL, V45, P79, DOI 10.1007/BF00388979; Jackson J. B. C., 1985, POPULATION BIOL EVOL; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Kosevich I. A., 2006, Russian Journal of Developmental Biology, V37, P90, DOI 10.1134/S1062360406020056; Kuhn A., 1914, ERG FORTSCHR ZOOL, P1; LARWOOD G, 1979, BIOL SYSTEMATICS COL; LENHOFF HM, 1961, EXP CELL RES, V23, P335, DOI 10.1016/0014-4827(61)90043-X; LENTZ T, 1966, CELL BIOL HYDRA; LENTZ TL, 1965, J ULTRA MOL STRUCT R, V13, P192, DOI 10.1016/S0022-5320(65)80096-X; LUNGER PD, 1963, J ULTRA MOL STRUCT R, V9, P362, DOI 10.1016/S0022-5320(63)80012-X; McConnell CH, 1931, J MORPHOL, V52, P249, DOI 10.1002/jmor.1050520112; MCNEIL PL, 1981, J CELL SCI, V49, P311; MCNEIL PL, 1984, TISSUE CELL, V16, P519, DOI 10.1016/0040-8166(84)90028-4; Metschnikoff E, 1880, ZOOL ANZ, V3, P261; Mokady O, 1998, P NATL ACAD SCI USA, V95, P3673, DOI 10.1073/pnas.95.7.3673; OVERTON J, 1963, J CELL BIOL, V17, P661, DOI 10.1083/jcb.17.3.661; Parker J, 1879, P ROY SOC LONDON, V30, P61; Powell AE, 2007, GENETICS, V177, P2101, DOI 10.1534/genetics.107.075689; Powell AE, 2011, G3-GENES GENOM GENET, V1, P499, DOI 10.1534/g3.111.001149; Rees J, 1970, COMP BIOCH PHYSL, V1970, P309; SHOSTAK S, 1967, DEV BIOL, V15, P451, DOI 10.1016/0012-1606(67)90037-1; SHOSTAK S, 1967, SCIENCE, V155, P1567, DOI 10.1126/science.155.3769.1567; SLAUTTERBACK DB, 1967, J CELL SCI, V2, P563; Steinmetz PRH, 2012, NATURE, V487, P231, DOI 10.1038/nature11180; STREHLER BL, 1961, GERONTOLOGY, V5, P1; TRIPP KARL, 1928, ZEITSCHR WISS ZOOL [KORSCHELT FESTBAND], V132, P476; WYTTENBACH CR, 1973, J EXP ZOOL, V186, P79, DOI 10.1002/jez.1401860111; WYTTENBACH CR, 1973, J MORPHOL, V139, P363, DOI 10.1002/jmor.1051390306; WYTTENBACH CR, 1968, J EXP ZOOL, V167, P333, DOI 10.1002/jez.1401670306; WYTTENBACH CR, 1974, AM ZOOL, V14, P699	66	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0136814	10.1371/journal.pone.0136814	http://dx.doi.org/10.1371/journal.pone.0136814			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359660	Green Published, gold, Green Submitted			2022-12-26	WOS:000361043100015
J	Nelson, BS; Donovan, JM; Takahashi, TT				Nelson, Brian S.; Donovan, Jeff M.; Takahashi, Terry T.			A Neural Model of Auditory Space Compatible with Human Perception under Simulated Echoic Conditions	PLOS ONE			English	Article							INTERAURAL TIME; SOUND LOCALIZATION; INFERIOR COLLICULUS; LOW-FREQUENCY; PRECEDENCE; SENSITIVITY; ENVELOPE; CUES; DOMINANCE; LATERALIZATION	In a typical auditory scene, sounds from different sources and reflective surfaces summate in the ears, causing spatial cues to fluctuate. Prevailing hypotheses of how spatial locations may be encoded and represented across auditory neurons generally disregard these fluctuations and must therefore invoke additional mechanisms for detecting and representing them. Here, we consider a different hypothesis in which spatial perception corresponds to an intermediate or sub-maximal firing probability across spatially selective neurons within each hemisphere. The precedence or Haas effect presents an ideal opportunity for examining this hypothesis, since the temporal superposition of an acoustical reflection with sounds arriving directly from a source can cause otherwise stable cues to fluctuate. Our findings suggest that subjects' experiences may simply reflect the spatial cues that momentarily arise under various acoustical conditions and how these cues are represented. We further suggest that auditory objects may acquire "edges" under conditions when interaural time differences are broadly distributed.	[Nelson, Brian S.; Donovan, Jeff M.; Takahashi, Terry T.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Oregon	Nelson, BS (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	bsnelson@uoregon.edu			University of Oregon Academic Support Account; NIDCD [R01-DC003925]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003925] Funding Source: NIH RePORTER	University of Oregon Academic Support Account; NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported in part by the University of Oregon Academic Support Account; the present experiments are also based on prior work in the owl supported by a grant from the NIDCD: Grant No. R01-DC003925.	Akeroyd MA, 2001, J ACOUST SOC AM, V110, P2516, DOI 10.1121/1.1412442; Baxter CS, 2013, J NEUROPHYSIOL, V109, P924, DOI 10.1152/jn.00755.2012; Best V, 2004, J ACOUST SOC AM, V115, P324, DOI 10.1121/1.1632484; Bianchi F, 2013, JARO-J ASSOC RES OTO, V14, P767, DOI 10.1007/s10162-013-0406-z; BLAUERT J, 1988, ACUSTICA, V66, P267; BLAUERT J, 1986, J ACOUST SOC AM, V79, P806, DOI 10.1121/1.393471; Blauert J., 1997, SPATIAL HEARING PSYC; Braasch J., 2003, Acoustical Science and Technology, V24, P293, DOI 10.1250/ast.24.293; Braasch J, 2013, J ACOUST SOC AM, V134, P420, DOI 10.1121/1.4807829; Brown AD, 2015, JARO-J ASSOC RES OTO, V16, P1, DOI 10.1007/s10162-014-0496-2; Brown AD, 2013, J ACOUST SOC AM, V133, P2883, DOI 10.1121/1.4796113; Butts DA, 2006, PLOS BIOL, V4, P639, DOI 10.1371/journal.pbio.0040092; Cazettes F, 2014, ELIFE, V3, DOI 10.7554/eLife.04854; Delgutte B, 1999, J NEUROPHYSIOL, V81, P2833, DOI 10.1152/jn.1999.81.6.2833; Dietz M, 2015, J ACOUST SOC AM, V137, pEL137, DOI 10.1121/1.4905891; Dietz M, 2014, J NEUROPHYSIOL, V111, P1973, DOI 10.1152/jn.00681.2013; Dizon RM, 2006, J ACOUST SOC AM, V119, P2947, DOI 10.1121/1.2189451; DOMNITZ RH, 1977, J ACOUST SOC AM, V61, P1586, DOI 10.1121/1.381472; Donovan JM, 2012, J ACOUST SOC AM, V132, P3912, DOI 10.1121/1.4764877; Faller C, 2004, J ACOUST SOC AM, V116, P3075, DOI 10.1121/1.1791872; GABRIEL KJ, 1981, J ACOUST SOC AM, V69, P1394, DOI 10.1121/1.385821; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; HAAS H, 1951, ACUSTICA, V1, P49; Hall DA, 2005, J NEUROPHYSIOL, V94, P3181, DOI 10.1152/jn.00271.2005; Harper NS, 2004, NATURE, V430, P682, DOI 10.1038/nature02768; Hartung K, 2001, J ACOUST SOC AM, V110, P1505, DOI 10.1121/1.1390339; HOUTGAST T, 1994, HEARING RES, V72, P29, DOI 10.1016/0378-5955(94)90202-X; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Joris P, 2007, TRENDS NEUROSCI, V30, P70, DOI 10.1016/j.tins.2006.12.004; JORIS PX, 1995, J NEUROPHYSIOL, V73, P1043, DOI 10.1152/jn.1995.73.3.1043; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; Joris PX, 2003, J NEUROSCI, V23, P6345; Litovsky RY, 1999, J ACOUST SOC AM, V106, P1633, DOI 10.1121/1.427914; Litovsky RY, 2001, J ACOUST SOC AM, V109, P346, DOI 10.1121/1.1328792; Maki K, 2005, J ACOUST SOC AM, V118, P872, DOI 10.1121/1.1944647; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; Meffin H, 2009, J ACOUST SOC AM, V126, P2437, DOI 10.1121/1.3238239; Nelson BS, 2010, NEURON, V67, P643, DOI 10.1016/j.neuron.2010.07.014; Nelson BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003598; PERROTT D R, 1987, Journal of Auditory Research, V27, P59; POLLACK I, 1959, J ACOUST SOC AM, V31, P1250, DOI 10.1121/1.1907852; RAJAN R, 1990, J NEUROPHYSIOL, V64, P872, DOI 10.1152/jn.1990.64.3.872; SHINNCUNNINGHAM BG, 1995, J ACOUST SOC AM, V98, P164, DOI 10.1121/1.413752; Slaney M, 1993, APPLE COMPUT PERCEPT, V35; Stecker GC, 2014, J ACOUST SOC AM, V135, P3541, DOI 10.1121/1.4876179; Tollin DJ, 1998, J ACOUST SOC AM, V104, P3030, DOI 10.1121/1.423884; Tollin DJ, 1999, J ACOUST SOC AM, V105, P838, DOI 10.1121/1.426273; Tollin DJ., 1998, P NATO ADV STUD I CO, P77; Trahiotis C, 2002, HEARING RES, V168, P55, DOI 10.1016/S0378-5955(02)00357-X; von Bekesy G, 1930, PHYS Z, V31, P824; Wagner H, 2007, J NEUROSCI, V27, P4191, DOI 10.1523/JNEUROSCI.5250-06.2007; WALLACH H, 1949, AM J PSYCHOL, V62, P315, DOI 10.2307/1418275; WENSTRUP JJ, 1986, J NEUROSCI, V6, P962; WISE LZ, 1985, J NEUROPHYSIOL, V54, P185, DOI 10.1152/jn.1985.54.2.185; Yost WA, 2013, J ACOUST SOC AM, V133, P2301, DOI 10.1121/1.4792155; ZUREK PM, 1980, J ACOUST SOC AM, V67, P952, DOI 10.1121/1.383974	56	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137900	10.1371/journal.pone.0137900	http://dx.doi.org/10.1371/journal.pone.0137900			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355676	Green Published, gold, Green Submitted			2022-12-26	WOS:000360965800088
J	Okolicsanyi, RK; Camilleri, ET; Oikari, LE; Yu, C; Cool, SM; van Wijnen, AJ; Griffiths, LR; Haupt, LM				Okolicsanyi, Rachel K.; Camilleri, Emily T.; Oikari, Lotta E.; Yu, Chieh; Cool, Simon M.; van Wijnen, Andre J.; Griffiths, Lyn R.; Haupt, Larisa M.			Human Mesenchymal Stem Cells Retain Multilineage Differentiation Capacity Including Neural Marker Expression after Extended In Vitro Expansion	PLOS ONE			English	Article							HUMAN-BONE-MARROW; III BETA-TUBULIN; CD44 VARIANT ISOFORMS; STROMAL CELLS; PROGENITOR CELLS; PERIPHERAL-BLOOD; SELF-RENEWAL; ADULT; CULTURES; NESTIN	The suitability of human mesenchymal stem cells (hMSCs) in regenerative medicine relies on retention of their proliferative expansion potential in conjunction with the ability to differentiate toward multiple lineages. Successful utilisation of these cells in clinical applications linked to tissue regeneration requires consideration of biomarker expression, time in culture and donor age, as well as their ability to differentiate towards mesenchymal (bone, cartilage, fat) or non-mesenchymal (e. g., neural) lineages. To identify potential therapeutic suitability we examined hMSCs after extended expansion including morphological changes, potency (stemness) and multilineage potential. Commercially available hMSC populations were expanded in vitro for > 20 passages, equating to > 60 days and > 50 population doublings. Distinct growth phases (A-C) were observed during serial passaging and cells were characterised for stemness and lineage markers at representative stages (Phase A: P+ 5, approximately 13 days in culture; Phase B: P+ 7, approximately 20 days in culture; and Phase C: P+ 13, approximately 43 days in culture). Cell surface markers, stem cell markers and lineage-specific markers were characterised by FACS, ICC and Q-PCR revealing MSCs maintained their multilineage potential, including neural lineages throughout expansion. Co-expression of multiple lineage markers along with continued CD45 expression in MSCs did not affect completion of osteogenic and adipogenic specification or the formation of neurospheres. Improved standardised isolation and characterisation of MSCs may facilitate the identification of biomarkers to improve therapeutic efficacy to ensure increased reproducibility and routine production of MSCs for therapeutic applications including neural repair.	[Okolicsanyi, Rachel K.; Oikari, Lotta E.; Yu, Chieh; Griffiths, Lyn R.; Haupt, Larisa M.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Genom Res Ctr, Brisbane, Qld 4001, Australia; [Camilleri, Emily T.; van Wijnen, Andre J.] Mayo Clin, Dept Orthoped Surg & Biochem & Mol Biol, Rochester, MN USA; [Cool, Simon M.] ASTAR, Inst Med Biol, Glycotherapeut Grp, Singapore, Singapore	Queensland University of Technology (QUT); Mayo Clinic; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Haupt, LM (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Genom Res Ctr, Brisbane, Qld 4001, Australia.	larisa.haupt@qut.edu.au	Haupt, Larisa M/C-6066-2017; Cool, Simon/W-1257-2018; van Wijnen, Andre J./AAG-3578-2019; Oikari, Lotta/AAZ-2508-2020; Cool, Simon McKenzie/AAG-4346-2021	Haupt, Larisa M/0000-0002-7735-8110; Cool, Simon/0000-0001-8543-3056; van Wijnen, Andre J./0000-0002-4458-0946; Oikari, Lotta/0000-0001-7821-8622; Okolicsanyi, Rachel/0000-0002-3488-4559; Yu, Chieh/0000-0003-3712-5491; Camilleri, Emily/0000-0001-8982-6770	Australian Postgraduate Award; Estate of the late Clem Jones, AO; National Institutes of Health [R01 AR049069]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069] Funding Source: NIH RePORTER	Australian Postgraduate Award(Australian Government); Estate of the late Clem Jones, AO; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by an Australian Postgraduate Award stipend (RKO), and the support of the Estate of the late Clem Jones, AO (LMH and LRG). In addition, we appreciate the philanthropic support of William and Karen Eby (AJvW and ETC), as well as a grant from the National Institutes of Health (R01 AR049069 to AJvW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2006, INT J MOL MED, V18, P233; Ahmed S, 2009, CELL ADHES MIGR, V3, P412, DOI 10.4161/cam.3.4.8803; Alexanian AR, 2005, EXP CELL RES, V310, P383, DOI 10.1016/j.yexcr.2005.08.015; ARCH R, 1992, SCIENCE, V257, P682, DOI 10.1126/science.1496383; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Bieback Karen, 2007, Curr Stem Cell Res Ther, V2, P310, DOI 10.2174/157488807782793763; Blake JA, 2014, DEVELOPMENT, V141, P737, DOI 10.1242/dev.091785; Cai N, 2012, CEREBELLUM, V11, P181, DOI 10.1007/s12311-011-0294-x; CASTROMALASPINA H, 1980, BLOOD, V56, P289; Choi MR, 2012, EXP MOL MED, V44, P503, DOI 10.3858/emm.2012.44.8.057; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; DALESSANDRO JS, 1994, GROWTH FACTORS, V11, P45, DOI 10.3109/08977199409015050; Deschaseaux F, 2003, BRIT J HAEMATOL, V122, P506, DOI 10.1046/j.1365-2141.2003.04469.x; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dudakovic A, 2014, J CELL BIOCHEM, V115, P1816, DOI 10.1002/jcb.24852; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Fernandez M, 1997, BONE MARROW TRANSPL, V20, P265, DOI 10.1038/sj.bmt.1700890; Ferrandina G, 2006, CLIN CANCER RES, V12, P2774, DOI 10.1158/1078-0432.CCR-05-2715; Fitzgerald KA, 1999, J IMMUNOL, V162, P4920; Foudah D, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/987678; Foudah D, 2013, CELL MOL BIOL LETT, V18, P163, DOI 10.2478/s11658-013-0083-2; Foudah D, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/820821; FOX SB, 1994, CANCER RES, V54, P4539; Gilyarov A V, 2008, Neurosci Behav Physiol, V38, P165, DOI 10.1007/s11055-008-0025-z; Gronthos S, 1999, J BONE MINER RES, V14, P47, DOI 10.1359/jbmr.1999.14.1.47; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Haupt LM, 2009, CURR CANCER THER REV, V5, P256, DOI 10.2174/157339409789712672; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hermann Andreas, 2006, Expert Opin Biol Ther, V6, P653, DOI 10.1517/14712598.6.7.653; Ichikawa H, 1999, BRAIN RES, V838, P205, DOI 10.1016/S0006-8993(99)01710-2; Igura K, 2004, CYTOTHERAPY, V6, P543, DOI 10.1080/14653240410005366-1; Jones M, 2000, J BIOL CHEM, V275, P7964, DOI 10.1074/jbc.275.11.7964; Jouhilahti EM, 2008, J HISTOCHEM CYTOCHEM, V56, P1113, DOI 10.1369/jhc.2008.952002; Kassem M, 2008, CELL TISSUE RES, V331, P157, DOI 10.1007/s00441-007-0509-0; Katsetos CD, 2003, CELL MOTIL CYTOSKEL, V55, P77, DOI 10.1002/cm.10116; Katsetos CD, 2003, J CHILD NEUROL, V18, P851, DOI 10.1177/088307380301801205; Kishaba Y, 2010, PATHOL INT, V60, P378, DOI 10.1111/j.1440-1827.2010.02532.x; KOOPMAN G, 1993, J EXP MED, V177, P897, DOI 10.1084/jem.177.4.897; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Krupkova O, 2010, NEOPLASMA, V57, P291, DOI 10.4149/neo_2010_04_291; Le Blanc K, 2005, BIOL BLOOD MARROW TR, V11, P321, DOI 10.1016/j.bbmt.2005.01.005; Lee S, 2005, EUR J CELL BIOL, V84, P453, DOI 10.1016/j.ejcb.2004.11.001; Lei T, 2013, DOMEST ANIM ENDOCRIN, V45, P28, DOI 10.1016/j.domaniend.2013.03.003; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018; MACKAY CR, 1994, J CELL BIOL, V124, P71, DOI 10.1083/jcb.124.1.71; Maslova O. O., 2012, Biopolymers and Cell, V28, P190; Minguell JJ, 2001, EXP BIOL MED, V226, P507, DOI 10.1177/153537020122600603; Naruse M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053109; Okolicsanyi RK, 2014, DEV BIOL; P Mafi, 2011, Open Orthop J, V5, P253, DOI 10.2174/1874325001105010253; Parte S, 2011, STEM CELLS DEV, V20, P1451, DOI 10.1089/scd.2010.0461; Penninger JM, 2001, NAT IMMUNOL, V2, P389, DOI 10.1038/87687; Piras F, 2010, ONCOL REP, V23, P17, DOI 10.3892/or_00000601; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Qin S, 2012, MOL CELL BIOL, V32, P4297, DOI 10.1128/MCB.00838-12; Ragni E, 2013, INT J BIOCHEM CELL B, V45, P2456, DOI 10.1016/j.biocel.2013.07.024; Reading L, 2000, BONE SUPPL, V26; Rogers I, 2004, BEST PRACT RES CL OB, V18, P893, DOI 10.1016/j.bpobgyn.2004.06.004; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Samsonraj RM, 2015, STEM CELLS, V33, P1878, DOI 10.1002/stem.1982; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sansom SN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000511; Sarruf DA, 2009, ENDOCRINOLOGY, V150, P707, DOI 10.1210/en.2008-0899; Schipani E., 2008, ADULT MESENCHYMAL ST; Scott CE, 2010, NAT NEUROSCI, V13, P1181, DOI 10.1038/nn.2646; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Shields LE, 1998, AM J OBSTET GYNECOL, V178, P931, DOI 10.1016/S0002-9378(98)70526-5; SIENA S, 1989, BLOOD, V74, P1905; SINGER JW, 1987, BLOOD, V70, P464; TAVASSOLI M, 1991, P SOC EXP BIOL MED, V196, P367; Tondreau T, 2001, BLOOD, V98, p125B; Verdi J, 2014, NEURAL REGEN RES, V9, P845, DOI 10.4103/1673-5374.131601; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Weiss JM, 1997, J CELL BIOL, V137, P1137, DOI 10.1083/jcb.137.5.1137; Wetzig A, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-54; Wu HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090883; Yu G, 2010, CYTOTHERAPY, V12, P538, DOI 10.3109/14653241003649528	81	48	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137255	10.1371/journal.pone.0137255	http://dx.doi.org/10.1371/journal.pone.0137255			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356539	Green Submitted, Green Published, gold			2022-12-26	WOS:000360965800036
J	Uchida, T; Miftahussurur, M; Pittayanon, R; Vilaichone, R; Wisedopas, N; Ratanachu-ek, T; Kishida, T; Moriyama, M; Yamaoka, Y; Mahachai, V				Uchida, Tomohisa; Miftahussurur, Muhammad; Pittayanon, Rapat; Vilaichone, Rathakorn; Wisedopas, Naruemon; Ratanachu-ek, Thawee; Kishida, Tetsuko; Moriyama, Masatsugu; Yamaoka, Yoshio; Mahachai, Varocha			Helicobacter pylori Infection in Thailand: A Nationwide Study of the CagA Phenotype	PLOS ONE			English	Article							GASTRIC-MUCOSAL ATROPHY; HIGH PREVALENCE; GENE; IMMUNOHISTOCHEMISTRY; MECHANISMS; DIVERSITY; GENOTYPE; DISEASE; CANCER	Background The risk to develop gastric cancer in Thailand is relatively low among Asian countries. In addition, the age-standardized incidence rate (ASR) of gastric cancer in Thailand varies with geographical distribution; the ASR in the North region is 3.5 times higher than that in the South region. We hypothesized that the prevalence of H. pylori infection and diversity of CagA phenotype contributes to the variety of gastric cancer risk in various regions of Thailand. Methods We conducted a nationwide survey within Thailand. We determined H. pylori infection prevalence by detecting H. pylori, using histochemical and immunohistochemical methods. The anti-CagA antibody and anti-East-Asian type CagA antibody (alpha-EAS Ab), which showed high accuracy in several East Asian countries, were used to determine CagA phenotype. Results Among 1,546 patients from four regions, including 17 provinces, the overall prevalence of H. pylori infection was 45.9% (710/1,546). Mirroring the prevalence of H. pylori infection, histological scores were the lowest in the South region. Of the 710 H. pylori-positive patients, 93.2%(662) were immunoreactive with the anti-CagA antibody. CagA-negative strain prevalence in the South region was significantly higher than that in other regions (17.9%; 5/28; p < 0.05). Overall, only 77 patients (11.6%) were immunoreactive with the alpha-EAS Ab. There were no differences in the alpha-EAS Ab immunoreactive rate across geographical regions. Conclusions This is the first study using immunohistochemistry to confirm H. pylori infections across different regions in Thailand. The prevalence of East-Asian type CagA H. pylori in Thailand was low. The low incidence of gastric cancer in Thailand may be attributed to the low prevalence of precancerous lesions. The low incidence of gastric cancer in the South region might be associated with the lower prevalence of H. pylori infection, precancerous lesions, and CagA-positive H. pylori strains, compared with that in the other regions.	[Uchida, Tomohisa] Oita Univ, Fac Med, Dept Mol Pathol, Yufu City, Oita, Japan; [Miftahussurur, Muhammad; Yamaoka, Yoshio] Oita Univ, Fac Med, Dept Environm & Prevent Med, Yufu City, Oita, Japan; [Miftahussurur, Muhammad] Airlangga Univ, Inst Trop Dis, Surabaya, Indonesia; [Pittayanon, Rapat] Chulalongkorn Univ, Div Gastroenterol, Bangkok, Thailand; [Vilaichone, Rathakorn] Thammasat Univ Hosp, Gastroenterol Unit, Pathum Thani, Thailand; [Wisedopas, Naruemon] Chulalongkorn Univ Hosp, Dept Pathol, Bangkok, Thailand; [Ratanachu-ek, Thawee] Rajavithi Hosp, Dept Surg, Bangkok, Thailand; [Kishida, Tetsuko] Oita Univ, Fac Med, Dept Forens Med, Yufu City, Oita, Japan; [Moriyama, Masatsugu] Oita Univ, Fac Med, Dept Mol Pathol, Yufu City, Oita, Japan; [Yamaoka, Yoshio] Baylor Coll Med, Dept Med Gastroenterol, Houston, TX 77030 USA; [Yamaoka, Yoshio] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Mahachai, Varocha] Bangkok Med Ctr, Gastrointestinal & Liver Ctr, Bangkok, Thailand	Oita University; Oita University; Airlangga University; Chulalongkorn University; Thammasat University; Chulalongkorn University; Rajavithi Hospital; Oita University; Oita University; Baylor College of Medicine; Baylor College of Medicine	Yamaoka, Y (corresponding author), Oita Univ, Fac Med, Dept Environm & Prevent Med, Hasama Machi, Yufu City, Oita, Japan.	yyamaoka@oita-u.ac.jp; vmahachai@gmail.com	Miftahussurur, Muhammad/AAB-6151-2021; Vilaichone, Ratha-korn/ABA-1118-2020	Yamaoka, Yoshio/0000-0002-1222-5819; Miftahussurur, Muhammad/0000-0003-1415-6033	National Institutes of Health [DK62813]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24406015, 24659200, 25293104, 26640114, 24590418]; Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits; Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency (JST); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits; Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency (JST); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This report is based on work supported in part by grants from the National Institutes of Health (DK62813) (YY), and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (24406015, 24659200, 25293104, and 26640114) (YY), and (24590418) (TU). This work was also supported by the Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits (YY), and the Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency (JST) (YY).	Atisook K, 2003, HELICOBACTER, V8, P132, DOI 10.1046/j.1523-5378.2003.00134.x; Bodger K, 2001, HELICOBACTER, V6, P216, DOI 10.1046/j.1523-5378.2001.00031.x; Bornschein J, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-10; Bui XT, 2009, J CLIN MICROBIOL, V47, P4021, DOI 10.1128/JCM.00504-09; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Duncan SS, 2012, J BACTERIOL, V194, P1593, DOI 10.1128/JB.06340-11; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Goh KL, 2011, HELICOBACTER, V16, P1, DOI 10.1111/j.1523-5378.2011.00874.x; Goh KL, 2001, EUR J GASTROEN HEPAT, V13, P177, DOI 10.1097/00042737-200102000-00014; Graham DY, 2007, T ROY SOC TROP MED H, V101, P849, DOI 10.1016/j.trstmh.2007.06.006; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hatakeyama M, 2011, CANCER SCI, V102, P36, DOI 10.1111/j.1349-7006.2010.01743.x; Hirai I, 2010, MICROBES INFECT, V12, P227, DOI 10.1016/j.micinf.2009.12.007; Jonkers D, 1997, J INFECTION, V35, P149, DOI 10.1016/S0163-4453(97)91611-X; Kanada R, 2008, PATHOL INT, V58, P218, DOI 10.1111/j.1440-1827.2008.02214.x; Lam TN, 2009, CLIN VACCINE IMMUNOL, V16, P1687, DOI 10.1128/CVI.00200-09; Megraud F, 2007, CLIN MICROBIOL REV, V20, P280, DOI 10.1128/CMR.00033-06; Mitacek EJ, 2008, NUTR CANCER, V60, P196, DOI 10.1080/01635580701649636; Miura M, 2009, INT J CANCER, V125, P2497, DOI 10.1002/ijc.24740; Miwa H, 2002, AM J GASTROENTEROL, V97, P1106, DOI 10.1111/j.1572-0241.2002.05663.x; Myint T, 2015, WORLD J GASTROENTERO, V21, P629, DOI 10.3748/wjg.v21.i2.629; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Rugge M, 2007, GUT, V56, P631, DOI 10.1136/gut.2006.106666; Sahara S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-223; Salaun L, 2004, MICROBIOL-SGM, V150, P817, DOI 10.1099/mic.0.26993-0; Shiota S, 2013, J MED MICROBIOL, V62, P1571, DOI 10.1099/jmm.0.060905-0; Shiota S, 2010, FUTURE MICROBIOL, V5, P1885, DOI 10.2217/FMB.10.135; Sugimoto M, 2009, CLIN MICROBIOL INFEC, V15, P835, DOI 10.1111/j.1469-0691.2009.02769.x; Suzuki H, 2009, GASTRIC CANCER, V12, P79, DOI 10.1007/s10120-009-0507-x; Trang VT, 2009, J AGR FOOD CHEM, V57, P11343, DOI 10.1021/jf9026876; Uchida T, 2007, CANCER SCI, V98, P521, DOI 10.1111/j.1349-7006.2007.00415.x; Vilaichone RK, 2013, WORLD J GASTROENTERO, V19, P2806, DOI 10.3748/wjg.v19.i18.2806; Vilaichone RK, 2004, HELICOBACTER, V9, P453, DOI 10.1111/j.1083-4389.2004.00260.x; Yamaoka Y, 1998, J CLIN MICROBIOL, V36, P2258, DOI 10.1128/JCM.36.8.2258-2263.1998; Yamaoka Y, 2010, NAT REV GASTRO HEPAT, V7, P629, DOI 10.1038/nrgastro.2010.154	36	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0136775	10.1371/journal.pone.0136775	http://dx.doi.org/10.1371/journal.pone.0136775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355839	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000360965800015
J	Carter, G; Schoeppler, D; Manthey, M; Knornschild, M; Denzinger, A				Carter, Gerald; Schoeppler, Diana; Manthey, Marie; Knoernschild, Mirjam; Denzinger, Annette			Distress Calls of a Fast-Flying Bat (Molossus molossus) Provoke Inspection Flights but Not Cooperative Mobbing	PLOS ONE			English	Article							ALARM CALLS; PREDATOR; CHIROPTERA; BEHAVIOR; RESPONSES; CONSPECIFICS; VESPERTILIONIDAE; NONLINEARITIES; RESPONSIVENESS; SCREAMS	Many birds and mammals produce distress calls when captured. Bats often approach speakers playing conspecific distress calls, which has led to the hypothesis that bat distress calls promote cooperative mobbing. An alternative explanation is that approaching bats are selfishly assessing predation risk. Previous playback studies on bat distress calls involved species with highly maneuverable flight, capable of making close passes and tight circles around speakers, which can look like mobbing. We broadcast distress calls recorded from the velvety free-tailed bat, Molossus molossus, a fast-flying aerial-hawker with relatively poor maneuverability. Based on their flight behavior, we predicted that, in response to distress call playbacks, M. molossus would make individual passing inspection flights but would not approach in groups or approach within a meter of the distress call source. By recording responses via ultrasonic recording and infrared video, we found that M. molossus, and to a lesser extent Saccopteryx bilineata, made more flight passes during distress call playbacks compared to noise. However, only the more maneuverable S. bilineata made close approaches to the speaker, and we found no evidence of mobbing in groups. Instead, our findings are consistent with the hypothesis that single bats approached distress calls simply to investigate the situation. These results suggest that approaches by bats to distress calls should not suffice as clear evidence for mobbing.	[Carter, Gerald] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Schoeppler, Diana; Manthey, Marie; Denzinger, Annette] Univ Tubingen, Inst Neurobiol, Anim Physiol, Tubingen, Germany; [Knoernschild, Mirjam] Univ Ulm, Inst Evolutionary Ecol & Conservat Genom, D-89069 Ulm, Germany; [Knoernschild, Mirjam] Smithsonian Trop Res Inst, Balboa, Panama	University System of Maryland; University of Maryland College Park; Eberhard Karls University of Tubingen; Ulm University; Smithsonian Institution; Smithsonian Tropical Research Institute	Carter, G (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	gcarter@umd.edu		Knornschild, Mirjam/0000-0003-0448-9600	UMD-UT collaboration program of the University of Maryland; University of Tuebingen	UMD-UT collaboration program of the University of Maryland; University of Tuebingen	This project was funded by the UMD-UT collaboration program of the University of Maryland and the University of Tuebingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, JMP VERS 12; Arnal LH, 2015, CURR BIOL, V25, P2051, DOI 10.1016/j.cub.2015.06.043; August P.V., 1979, P151; AUGUST PV, 1985, SOUTHWEST NAT, V30, P371, DOI 10.2307/3671269; Blumstein DT, 2009, ETHOLOGY, V115, P1074, DOI 10.1111/j.1439-0310.2009.01691.x; Branch CL, 2012, BEHAV ECOL, V23, P854, DOI 10.1093/beheco/ars041; Breviglieri CPB, 2013, OECOLOGIA, V173, P905, DOI 10.1007/s00442-013-2677-9; Caro Tim, 2005, pXIII; Carter Gerald G., 2013, P225; CONOVER MR, 1994, BEHAVIOUR, V131, P19, DOI 10.1163/156853994X00190; de Toledo Luis Felipe, 2009, South American Journal of Herpetology, V4, P25, DOI 10.2994/057.004.0104; Dechmann DKN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009012; Denzinger A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00164; DUGATKIN LA, 1992, ANN ZOOL FENN, V29, P233; FENTON MB, 1976, CAN J ZOOL, V54, P1443, DOI 10.1139/z76-167; FITZGIBBON CD, 1994, BEHAV ECOL SOCIOBIOL, V34, P139; FRANKENBERG E, 1975, ISRAEL J ZOOL, V24, P43; Frommolt Karl-Heinz, 1999, Bioacoustics, V10, P219; Griesser M, 2008, CURR BIOL, V18, P69, DOI 10.1016/j.cub.2007.11.069; Griesser M, 2009, P R SOC B, V276, P2887, DOI 10.1098/rspb.2009.0551; HAUSER MD, 1986, BEHAV ECOL SOCIOBIOL, V19, P65, DOI 10.1007/BF00303844; HILL GE, 1986, ANIM BEHAV, V34, P590, DOI 10.1016/S0003-3472(86)80128-2; HOGSTEDT G, 1983, AM NAT, V121, P562, DOI 10.1086/284083; Holland RA, 2011, ACTA CHIROPTEROL, V13, P399, DOI 10.3161/150811011X624875; Jung K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085279; Karp D, 2014, ETHOLOGY, V120, P189, DOI 10.1111/eth.12195; Knoernschild M, 2010, CAN J ZOOL, V88, P589, DOI 10.1139/Z10-028; Knoernschild Mirjam, 2012, Chiroptera Neotropical, V18, P1132; Laiolo P, 2004, P ROY SOC B-BIOL SCI, V271, pS513, DOI 10.1098/rsbl.2004.0239; Lemasson A, 2008, BEHAV ECOL SOCIOBIOL, V62, P1027, DOI 10.1007/s00265-007-0530-z; Lima SL, 2013, BIOL REV, V88, P626, DOI 10.1111/brv.12021; Lucan RK, 2013, MAMMALIA, V77, P235, DOI 10.1515/mammalia-2012-0067; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2315, DOI 10.1098/rspb.2001.1773; Mora EC, 2004, J COMP PHYSIOL A, V190, P561, DOI 10.1007/s00359-004-0519-2; Nagel J, 2006, THESIS U W ONTARIO; Naguib M, 1999, BEHAV ECOL, V10, P636, DOI 10.1093/beheco/10.6.636; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; PERRONE M, 1980, WILSON BULL, V92, P404; PITCHER TJ, 1986, J FISH BIOL, V28, P439, DOI 10.1111/j.1095-8649.1986.tb05181.x; Rendall D, 2009, J ACOUST SOC AM, V125, P1792, DOI 10.1121/1.3068453; Russ JM, 2005, ANIM BEHAV, V70, P397, DOI 10.1016/j.anbehav.2004.11.006; Russ JM, 2004, ANIM BEHAV, V67, P1005, DOI 10.1016/j.anbehav.2003.09.003; Russ JM, 1998, ANIM BEHAV, V55, P705, DOI 10.1006/anbe.1997.0665; RYAN JM, 1985, J MAMMAL, V66, P179, DOI 10.2307/1380980; Slaughter EI, 2013, ETHOLOGY, V119, P309, DOI 10.1111/eth.12066; STATON MA, 1978, AM NAT, V112, P327, DOI 10.1086/283275; Templeton CN, 2005, SCIENCE, V308, P1934, DOI 10.1126/science.1108841; Townsend SW, 2011, BIOL LETTERS, V7, P47, DOI 10.1098/rsbl.2010.0537; Voigt CC, 2012, J COMP PHYSIOL B, V182, P415, DOI 10.1007/s00360-011-0627-6; Wise KK, 1999, BEHAVIOUR, V136, P935, DOI 10.1163/156853999501658; Zuberbuhler K, 2001, BEHAV ECOL SOCIOBIOL, V50, P414, DOI 10.1007/s002650100383	51	22	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136146	10.1371/journal.pone.0136146	http://dx.doi.org/10.1371/journal.pone.0136146			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353118	Green Published, Green Submitted, gold			2022-12-26	WOS:000360932800025
J	Moreno-Ramos, OA; Olivares, AM; Haider, NB; de Autismo, LC; Lattig, MC				Moreno-Ramos, Oscar A.; Maria Olivares, Ana; Haider, Neena B.; Colombiana de Autismo, Liga; Claudia Lattig, Maria			Whole-Exome Sequencing in a South American Cohort Links ALDH1A3, FOXN1 and Retinoic Acid Regulation Pathways to Autism Spectrum Disorders	PLOS ONE			English	Article							DE-NOVO MUTATIONS; SYNONYMOUS VARIANTS; GENE-EXPRESSION; GENOME; DNA; IDENTIFICATION; INDIVIDUALS; FRAMEWORK; PATTERNS; RISK	Autism spectrum disorders (ASDs) are a range of complex neurodevelopmental conditions principally characterized by dysfunctions linked to mental development. Previous studies have shown that there are more than 1000 genes likely involved in ASD, expressed mainly in brain and highly interconnected among them. We applied whole exome sequencing in Colombian-South American trios. Two missense novel SNVs were found in the same child: ALDH1A3 (RefSeq NM_000693: c.1514T>C (p.I505T)) and FOXN1 (RefSeq NM_003593: c. 146C>T (p.S49L)). Gene expression studies reveal that Aldh1a3 and Foxn1 are expressed in similar to E13.5 mouse embryonic brain, as well as in adult piriform cortex (PC; similar to P30). Conserved Retinoic Acid Response Elements (RAREs) upstream of human ALDH1A3 and FOXN1 and in mouse Aldh1a3 and Foxn1 genes were revealed using bioinformatic approximation. Chromatin immunoprecipitation (ChIP) assay using Retinoid Acid Receptor B (Rarb) as the immunoprecipitation target suggests RA regulation of Aldh1a3 and Foxn1 in mice. Our results frame a possible link of RA regulation in brain to ASD etiology, and a feasible non-additive effect of two apparently unrelated variants in ALDH1A3 and FOXN1 recognizing that every result given by next generation sequencing should be cautiously analyzed, as it might be an incidental finding.	[Moreno-Ramos, Oscar A.; Claudia Lattig, Maria] Univ Los Andes, Fac Ciencias, Dept Ciencias Biol, Bogota, Colombia; [Maria Olivares, Ana; Haider, Neena B.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Schepens Eye Res Inst,Dept Ophthalmol, Boston, MA USA; [Colombiana de Autismo, Liga] Liga Colombiana Autismo LICA, Bogota, Colombia	Universidad de los Andes (Colombia); Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute	Lattig, MC (corresponding author), Univ Los Andes, Fac Ciencias, Dept Ciencias Biol, Bogota, Colombia.	mlattig@uniandes.edu.co		lattig, claudia/0000-0003-2113-9266				Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aldahmesh MA, 2013, CLIN GENET, V84, P128, DOI 10.1111/cge.12184; Amorosi S, 2008, CLIN GENET, V73, P380, DOI 10.1111/j.1399-0004.2008.00977.x; Amorosi S, 2010, J NEUROL SCI, V298, P121, DOI 10.1016/j.jns.2010.08.066; Moreno-Ramos OA, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-59; Balmer JE, 2005, J STEROID BIOCHEM, V96, P347, DOI 10.1016/j.jsbmb.2005.05.005; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Bonhomme D, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00006; Bredenkamp N, 2014, DEVELOPMENT, V141, P1627, DOI 10.1242/dev.103614; Buske OJ, 2013, BIOINFORMATICS, V29, P1843, DOI 10.1093/bioinformatics/btt308; Buxbaum JD, 2012, NEURON, V76, P1052, DOI 10.1016/j.neuron.2012.12.008; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chatzi C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000609; Chen LZ, 2009, BLOOD, V113, P567, DOI 10.1182/blood-2008-05-156265; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Constantino JN, 2003, ARCH GEN PSYCHIAT, V60, P524, DOI 10.1001/archpsyc.60.5.524; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fares-Taie L, 2013, AM J HUM GENET, V92, P265, DOI 10.1016/j.ajhg.2012.12.003; Haider NB, 2001, HUM MOL GENET, V10, P1619, DOI 10.1093/hmg/10.16.1619; Haider NB, 2009, EXP EYE RES, V89, P365, DOI 10.1016/j.exer.2009.04.006; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao WL, 2005, EUR J NEUROSCI, V21, P3262, DOI 10.1111/j.1460-9568.2005.04178.x; Liao WL, 2005, DEV DYNAM, V232, P887, DOI 10.1002/dvdy.20281; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Mahony S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r2; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Mizee MR, 2013, J NEUROSCI, V33, P1660, DOI 10.1523/JNEUROSCI.1338-12.2013; Molotkova N, 2007, DEV BIOL, V303, P601, DOI 10.1016/j.ydbio.2006.11.035; Mory A, 2014, EUR J HUM GENET, V22, P419, DOI 10.1038/ejhg.2013.157; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nowell CS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002348; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Onore C, 2012, BRAIN BEHAV IMMUN, V26, P383, DOI 10.1016/j.bbi.2011.08.007; Ozonoff S, 2011, PEDIATRICS, V128, pE488, DOI 10.1542/peds.2010-2825; Perea CS, 2012, J AFFECT DISORDERS, V136, P767, DOI 10.1016/j.jad.2011.09.043; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Roos L, 2013, CLIN GENET; Rousso DL, 2008, NEURON, V59, P226, DOI 10.1016/j.neuron.2008.06.025; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sandin S, 2014, JAMA-J AM MED ASSOC, V311, P1770, DOI 10.1001/jama.2014.4144; Sarachana T, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-14; Semerci CN, 2014, BRIT J OPHTHALMOL, V98, P832, DOI 10.1136/bjophthalmol-2013-304058; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Suckow MA, 2007, CANCER IMMUNOL IMMUN, V56, P1275, DOI 10.1007/s00262-006-0278-8; Vorstman JAS, 2011, MOL PSYCHIATR, V16, P442, DOI 10.1038/mp.2010.26; Wagner E, 2002, CEREB CORTEX, V12, P1244, DOI 10.1093/cercor/12.12.1244; Yahyavi M, 2013, HUM MOL GENET, V22, P3250, DOI 10.1093/hmg/ddt179; Zaroff CM, 2012, SOC PSYCH PSYCH EPID, V47, P395, DOI 10.1007/s00127-011-0350-3	64	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135927	10.1371/journal.pone.0135927	http://dx.doi.org/10.1371/journal.pone.0135927			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352270	Green Published, gold, Green Submitted			2022-12-26	WOS:000360932800019
J	Brage, S; Westgate, K; Franks, PW; Stegle, O; Wright, A; Ekelund, U; Wareham, NJ				Brage, Soren; Westgate, Kate; Franks, Paul W.; Stegle, Oliver; Wright, Antony; Ekelund, Ulf; Wareham, Nicholas J.			Estimation of Free-Living Energy Expenditure by Heart Rate and Movement Sensing: A Doubly-Labelled Water Study	PLOS ONE			English	Article							ASSESS PHYSICAL-ACTIVITY; MEASUREMENT ERROR; CALORIMETRIC VALIDATION; RELATIVE IMPORTANCE; BODY-COMPOSITION; SEDENTARY TIME; MOTION SENSOR; VALIDITY; INTENSITY; ACCELEROMETRY	Background Accurate assessment of energy expenditure (EE) is important for the study of energy balance and metabolic disorders. Combined heart rate (HR) and acceleration (ACC) sensing may increase precision of physical activity EE (PAEE) which is the most variable component of total EE (TEE). Objective To evaluate estimates of EE using ACC and HR data with or without individual calibration against doubly-labelled water (DLW) estimates of EE. Design 23 women and 23 men (22-55 yrs, 48-104 kg, 8-46% body fat) underwent 45-min resting EE (REE) measurement and completed a 20-min treadmill test, an 8-min step test, and a 3-min walk test for individual calibration. ACC and HR were monitored and TEE measured over 14 days using DLW. Diet-induced thermogenesis (DIT) was calculated from food-frequency questionnaire. PAEE (TEE divided by REE divided by DIT) and TEE were compared to estimates from ACC and HR using bias, root mean square error (RMSE), and correlation statistics. Results Mean(SD) measured PAEE and TEE were 66(25) kJ.day(-1).kg(-1), and 12(2.6) MJ.day(-1), respectively. Estimated PAEE from ACC was 54(15) kJ.day(-1).kg(-1) (p<0.001), with RMSE 24 kJ.day(-1).kg(-1) and correlation r = 0.52. PAEE estimated from HR and ACC+HR with treadmill calibration were 67(42) and 69(25) kJ.day(-1).kg(-1) (bias non-significant), with RMSE 34 and 20 kJ.day(-1).kg(-1) and correlations r = 0.58 and r = 0.67, respectively. Similar results were obtained with step-calibrated and walk-calibrated models, whereas non-calibrated models were less precise (RMSE: 37 and 24 kJ.day(-1).kg(-1), r = 0.40 and r = 0.55). TEE models also had high validity, with biases <5%, and correlations r = 0.71 (ACC), r = 0.66-0.76 (HR), and r = 0.76-0.83 (ACC+HR). Conclusions Both accelerometry and heart rate may be used to estimate EE in adult European men and women, with improved precision if combined and if heart rate is individually calibrated.	[Brage, Soren; Westgate, Kate; Franks, Paul W.; Wright, Antony; Ekelund, Ulf; Wareham, Nicholas J.] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England; [Franks, Paul W.] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Stegle, Oliver] Univ Cambridge, Dept Phys, Cambridge, England; [Stegle, Oliver] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Wright, Antony] MRC Human Nutr Res, Cambridge, England	University of Cambridge; Lund University; University of Cambridge; European Molecular Biology Laboratory (EMBL); UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Brage, S (corresponding author), Univ Cambridge, MRC Epidemiol Unit, Cambridge, England.	soren.brage@mrc-epid.cam.ac.uk	Stegle, Oliver/AAU-9177-2020; Ekelund, Ulf/AAE-8471-2019; Franks, Paul/AAA-3300-2020; Brage, Soren/C-6415-2013	Stegle, Oliver/0000-0002-8818-7193; Ekelund, Ulf/0000-0003-2115-9267; Brage, Soren/0000-0002-1265-7355; Franks, Paul/0000-0002-0520-7604; Westgate, Kate/0000-0002-0283-3562	Medical Research Council [MC_UU_12015/3]; Wellcome Trust; Unilever UK; Medical Research Council [MC_U106179473, MC_U105960384, MC_UU_12015/1, MC_U106179471] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10135] Funding Source: researchfish; MRC [MC_UU_12015/3, MC_U105960384, MC_UU_12015/1, MC_U106179473] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Unilever UK(Unilever); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study received funding from Medical Research Council (MC_UU_12015/3), Wellcome Trust, Unilever UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Assah FK, 2008, DIABETOLOGIA, V51, P1399, DOI 10.1007/s00125-008-1033-9; Assah FK, 2011, INT J EPIDEMIOL, V40, P112, DOI 10.1093/ije/dyq098; Assah FK, 2011, DIABETES CARE, V34, P491, DOI 10.2337/dc10-0990; AVONS P, 1988, EUR J CLIN NUTR, V42, P185; Bingham SA, 1997, INT J EPIDEMIOL, V26, pS137, DOI 10.1093/ije/26.suppl_1.S137; BLACK AE, 1993, J AM DIET ASSOC, V93, P572, DOI 10.1016/0002-8223(93)91820-G; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bouten CVC, 1996, J APPL PHYSIOL, V81, P1019, DOI 10.1152/jappl.1996.81.2.1019; Brage S, 2006, EUR J APPL PHYSIOL, V96, P517, DOI 10.1007/s00421-005-0112-6; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Brage S, 2004, J APPL PHYSIOL, V96, P343, DOI 10.1152/japplphysiol.00703.2003; Brage S, 2013, ICAMPAM AMH C P 2013; Brage S, 2007, J APPL PHYSIOL, V103, P682, DOI 10.1152/japplphysiol.00092.2006; Calabro MA, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0119-7; CAVAGNA GA, 1976, J PHYSIOL-LONDON, V262, P639, DOI 10.1113/jphysiol.1976.sp011613; CEESAY SM, 1989, BRIT J NUTR, V61, P175, DOI 10.1079/BJN19890107; Chen KY, 1997, J APPL PHYSIOL, V83, P2112, DOI 10.1152/jappl.1997.83.6.2112; Christensen DL, 2012, AM J HUM BIOL, V24, P723, DOI 10.1002/ajhb.22303; COLE TJ, 1992, AM J PHYSIOL, V263, pE965, DOI 10.1152/ajpendo.1992.263.5.E965; Cooper AJM, 2014, DIABETOLOGIA, V57, P73, DOI 10.1007/s00125-013-3069-8; COWARD WA, 1988, EUR J CLIN NUTR, V42, P207; COWARD WA, 1988, P NUTR SOC, V47, P209, DOI 10.1079/PNS19880037; Crouter SE, 2008, EUR J CLIN NUTR, V62, P704, DOI 10.1038/sj.ejcn.1602766; Dahl-Petersen IK, 2013, DIABETES RES CLIN PR, V102, P242, DOI 10.1016/j.diabres.2013.10.004; Davidson L, 1997, BRIT J NUTR, V78, P695, DOI 10.1079/BJN19970188; Day NE, 2004, INT J EPIDEMIOL, V33, P1373, DOI 10.1093/ije/dyh138; den Hoed M, 2013, AM J CLIN NUTR, V98, P1317, DOI 10.3945/ajcn.113.069849; Franks PW, 2002, BRIT J NUTR, V88, P307, DOI 10.1079/BJN2002663; Fraser GE, 2004, ANN EPIDEMIOL, V14, P287, DOI 10.1016/j.annepidem.2003.08.008; GOLDBERG GR, 1988, EUR J CLIN NUTR, V42, P137; Golubic R, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-58; HASKELL WL, 1993, MED SCI SPORT EXER, V25, P109, DOI 10.1249/00005768-199301000-00015; Helmerhorst HJF, 2009, DIABETES, V58, P1776, DOI 10.2337/db08-1773; Henry CJK, 2005, PUBLIC HEALTH NUTR, V8, P1133, DOI 10.1079/PHN2005801; Hoffman DJ, 2000, AM J CLIN NUTR, V72, P1025; Hustvedt BE, 2004, BRIT J NUTR, V92, P1001, DOI 10.1079/BJN20041272; Jakes RW, 2004, INT J EPIDEMIOL, V33, P1382, DOI 10.1093/ije/dyh181; Jarisch A, 1927, SKAND ARCH PHYSIOL, V51, P235, DOI 10.1111/j.1748-1716.1927.tb00223.x; Jequier E, 2002, INT J OBESITY, V26, pS12, DOI 10.1038/sj.ijo.0802123; Johansson HP, 2006, BRIT J NUTR, V95, P631, DOI 10.1079/BJN20051527; Kashiwazaki H, 1999, J NUTR SCI VITAMINOL, V45, P79, DOI 10.3177/jnsv.45.79; Kipnis V, 1997, AM J EPIDEMIOL, V146, P842, DOI 10.1093/oxfordjournals.aje.a009202; KLAKEG CH, 1955, AM HEART J, V49, P614, DOI 10.1016/0002-8703(55)90080-6; KLEIN PD, 1984, HUM NUTR-CLIN NUTR, V38C, P95; Kumahara H, 2004, BRIT J NUTR, V91, P235, DOI 10.1079/BJN20031033; Leenders NYJM, 2001, MED SCI SPORT EXER, V33, P1233; LIVINGSTONE MBE, 1990, AM J CLIN NUTR, V52, P59, DOI 10.1093/ajcn/52.1.59; Luke A, 1997, MED SCI SPORT EXER, V29, P144, DOI 10.1097/00005768-199701000-00021; Masse LC, 2004, J APPL PHYSIOL, V96, P1357, DOI 10.1152/japplphysiol.00901.2003; Peters T, 2012, EUR J EPIDEMIOL, V27, P15, DOI 10.1007/s10654-011-9625-y; Plasqui G, 2005, OBES RES, V13, P1363, DOI 10.1038/oby.2005.165; Rafamantanantsoa HH, 2002, J NUTR SCI VITAMINOL, V48, P517, DOI 10.3177/jnsv.48.517; Rennie K, 2000, EUR J CLIN NUTR, V54, P409, DOI 10.1038/sj.ejcn.1600973; Rietjens GJWM, 2001, INT J SPORTS MED, V22, P291, DOI 10.1055/s-2001-14342; Ritz P, 1996, AM J PHYSIOL-ENDOC M, V270, pE164, DOI 10.1152/ajpendo.1996.270.1.E164; SCHOELLER DA, 1986, AM J PHYSIOL, V250, pR823, DOI 10.1152/ajpregu.1986.250.5.R823; SCHOELLER DA, 1986, AM J PHYSIOL, V251, pR1137, DOI 10.1152/ajpregu.1986.251.6.R1137; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; SEALE JL, 1993, J APPL PHYSIOL, V74, P402, DOI 10.1063/1.354123; SPURR GB, 1988, AM J CLIN NUTR, V48, P552, DOI 10.1093/ajcn/48.3.552; Stegle O, 2008, IEEE T BIO-MED ENG, V55, P2143, DOI 10.1109/TBME.2008.923118; Strath SJ, 2005, MED SCI SPORT EXER, V37, pS563, DOI 10.1249/01.mss.0000185650.68232.3f; Strath SJ, 2002, MED SCI SPORT EXER, V34, P888, DOI 10.1097/00005768-200205000-00025; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Tate DF, 2003, JAMA-J AM MED ASSOC, V289, P1833, DOI 10.1001/jama.289.14.1833; Thompson D, 2006, J NUTR, V136, P1037, DOI 10.1093/jn/136.4.1037; Villars C, 2012, J APPL PHYSIOL, V113, P1763, DOI 10.1152/japplphysiol.01413.2011; Wareham NJ, 2000, AM J EPIDEMIOL, V152, P132, DOI 10.1093/aje/152.2.132; Wareham NJ, 2000, INT J EPIDEMIOL, V29, P655, DOI 10.1093/ije/29.4.655; Wareham NJ, 1998, INT J OBESITY, V22, pS30; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Westerterp Klaas R, 2004, Nutr Metab (Lond), V1, P5; Wickstrom G, 2000, SCAND J WORK ENV HEA, V26, P363, DOI 10.5271/sjweh.555; Withers RT, 1998, J APPL PHYSIOL, V85, P238, DOI 10.1152/jappl.1998.85.1.238; Wong MY, 1999, STAT MED, V18, P2831, DOI 10.1002/(SICI)1097-0258(19991115)18:21<2831::AID-SIM282>3.3.CO;2-V	75	81	81	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137206	10.1371/journal.pone.0137206	http://dx.doi.org/10.1371/journal.pone.0137206			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26349056	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000360897600025
J	Hung, DZ; Yang, HJ; Li, YF; Lin, CL; Chang, SY; Sung, FC; Tai, SCW				Hung, Dong-Zong; Yang, Hao-Jan; Li, Yu-Fen; Lin, Cheng-Li; Chang, Shih-Yu; Sung, Fung-Chang; Tai, Sally C. W.			The Long-Term Effects of Organophosphates Poisoning as a Risk Factor of CVDs: A Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION INCIDENCE; SUDDEN CARDIAC DEATH; VENTRICULAR-ARRHYTHMIAS; AGRICULTURAL HEALTH; SARIN VAPOR; TOXICITY; EXPOSURE; RATS; POLYMORPHISM; ASSOCIATION	Background Organophosphorus pesticides are widely used throughout the world. Because of their ease of availability, organophosphorus compounds are commonly used for self-poisoning in developing countries. The acute effects of exposure to organophosphorus pesticides are well known, but the chronic effects are unclear. Recent studies suggest that abnormalities of the central and peripheral nervous systems persisted for up to 5 years after acute poisoning due to a single large dose of organophosphates (OPs). However, the long-term effects on cardiovascular diseases are poorly understood. Methodology/Principal Findings An OPs-exposed cohort (N = 7,561) and an age-and gender-matched control cohort (N = 30,244), both identified from the National Health Insurance Research Database, were compared. We utilized the multivariable Cox proportional model to estimate the risks of developing arrhythmia, coronary artery disease (CAD) and congestive heart failure (CHF). The patients with acute poisoning from OPs had higher incidence rates of arrhythmia (5.89 vs. 3.61 per 1,000 person-years), CAD (9.10 vs. 6.88 per 1,000 person-years), and CHF (3.89 vs. 2.98 per 1,000 person-years) compared with that of the non-OPs poisoning cohort, with a crude subhazard ratio (SHR) of 1.40, 1.13, and 1.12, respectively. Additionally, a significantly higher risk of arrhythmia was observed in the OPs poisoning cohort (adjusted SHR = 1.25) compared with the non-OPs poisoning cohort, particularly in male patients (adjusted SHR = 1.33) and those under 49 years of age (adjusted SHR = 3.16). After accounting for the competing risks of death, there was a higher risk of arrhythmia and CAD during a three year follow-up period (adjusted SHR = 1.50 for arrhythmia; adjusted SHR = 1.10 for CAD). We also found an adjusted SHR of 1.36 associated with developing CHF after 6 years of follow-up for OPs poisoning cohort. Conclusions Acute OPs poisoning may continuously impact human health through mechanisms that are unclear. Any supportive measurements that could contribute to a reduction in the risk of heart disease may be beneficial in cases of OPs poisoning survivors.	[Hung, Dong-Zong; Tai, Sally C. W.] China Med Univ Hosp, Dept Emergency, Toxicol Ctr, Taichung, Taiwan; [Hung, Dong-Zong; Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Yang, Hao-Jan; Chang, Shih-Yu] Chung Shan Med Univ, Sch Publ Hlth, Taichung, Taiwan; [Yang, Hao-Jan; Chang, Shih-Yu] Chung Shan Med Univ Hosp, Dept Family & Community Med, Taichung, Taiwan; [Li, Yu-Fen] China Med Univ, Inst Biostat, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Sung, Fung-Chang] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Sung, Fung-Chang] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan	Chang, SY (corresponding author), Chung Shan Med Univ, Sch Publ Hlth, Taichung, Taiwan.	sychang@csmu.edu.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004, MOHW104-TDU-B-212-113002]	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004) and (MOHW104-TDU-B-212-113002). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghabiklooei A, 2013, PAK J PHARM SCI, V26, P1247; Allon N, 2005, TOXICOL SCI, V87, P385, DOI 10.1093/toxsci/kfi263; Allon N, 2011, TOXICOL APPL PHARM, V253, P31, DOI 10.1016/j.taap.2011.03.007; Barrios V, 2008, REV ESP CARDIOL, V61, P1159, DOI 10.1016/S1885-5857(09)60030-X; Ben Amara I, 2013, ENVIRON TOXICOL, V28, P630, DOI 10.1002/tox.20759; Bird S., 2014, UPTODATE, V14, P339; Blanc-Lapierre A, 2013, AM J EPIDEMIOL, V177, P1086, DOI 10.1093/aje/kws346; Bruyndonckx R B, 2002, Eur J Emerg Med, V9, P238, DOI 10.1097/00063110-200209000-00006; Chugh SS, 2008, PROG CARDIOVASC DIS, V51, P213, DOI 10.1016/j.pcad.2008.06.003; Dayton SB, 2010, J OCCUP ENVIRON MED, V52, P693, DOI 10.1097/JOM.0b013e3181e66d25; Eddleston M, 2008, LANCET, V371, P597, DOI 10.1016/S0140-6736(07)61202-1; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fukushima Hidetada, 2010, Chudoku Kenkyu, V23, P41; Furlong CE, 2007, J BIOCHEM MOL TOXIC, V21, P197, DOI 10.1002/jbt.20181; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Jayasinghe SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037987; Karki P., 2004, SMJ Singapore Medical Journal, V45, P385; London L, 1997, ENVIRON RES, V73, P132, DOI 10.1006/enrs.1997.3715; Lotti M, 2006, MUSCLE NERVE, V34, P499, DOI 10.1002/mus.20620; Lotti Marcello, 2005, Toxicol Rev, V24, P37, DOI 10.2165/00139709-200524010-00003; LUDOMIRSKY A, 1982, AM J CARDIOL, V49, P1654, DOI 10.1016/0002-9149(82)90242-9; Lyzhnikov E A, 1975, Kardiologiia, V15, P126; MCDONOUGH JH, 1995, NEUROTOXICOLOGY, V16, P123; Mills KT, 2009, AM J EPIDEMIOL, V170, P892, DOI 10.1093/aje/kwp214; Mostafalou S, 2013, TOXICOL APPL PHARM, V268, P157, DOI 10.1016/j.taap.2013.01.025; Velmurugan G, 2013, TOXICOLOGY, V307, P103, DOI 10.1016/j.tox.2012.11.022; Voetsch B, 2002, STROKE, V33, P1459, DOI 10.1161/01.STR.0000016928.60995.BD; World Heart Federation, CARD DIS RISK FACT; Xiao ZJ, 2009, ACTA NEUROL BELG, V109, P205; Xiong XM, 2010, PROG BIOCHEM BIOPHYS, V37, P1232, DOI 10.3724/SP.J.1206.2010.00332; Yanagisawa N, 2006, J NEUROL SCI, V249, P76, DOI 10.1016/j.jns.2006.06.007; Zipes DP, 2006, CIRCULATION, V114, pE385, DOI 10.1161/CIRCULATIONAHA.106.178233	32	51	53	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137632	10.1371/journal.pone.0137632	http://dx.doi.org/10.1371/journal.pone.0137632			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339906	Green Published, Green Submitted, gold			2022-12-26	WOS:000360688200072
J	Perry, LK; Perlman, M; Lupyan, G				Perry, Lynn K.; Perlman, Marcus; Lupyan, Gary			Iconicity in English and Spanish and Its Relation to Lexical Category and Age of Acquisition	PLOS ONE			English	Article							SOUND-SYMBOLISM; SIGN-LANGUAGE; WINDOW	Signed languages exhibit iconicity (resemblance between form and meaning) across their vocabulary, and many non-Indo-European spoken languages feature sizable classes of iconic words known as ideophones. In comparison, Indo-European languages like English and Spanish are believed to be arbitrary outside of a small number of onomatopoeic words. In three experiments with English and two with Spanish, we asked native speakers to rate the iconicity of similar to 600 words from the English and Spanish MacArthur-Bates Communicative Developmental Inventories. We found that iconicity in the words of both languages varied in a theoretically meaningful way with lexical category. In both languages, adjectives were rated as more iconic than nouns and function words, and corresponding to typological differences between English and Spanish in verb semantics, English verbs were rated as relatively iconic compared to Spanish verbs. We also found that both languages exhibited a negative relationship between iconicity ratings and age of acquisition. Words learned earlier tended to be more iconic, suggesting that iconicity in early vocabulary may aid word learning. Altogether these findings show that iconicity is a graded quality that pervades vocabularies of even the most "arbitrary" spoken languages. The findings provide compelling evidence that iconicity is an important property of all languages, signed and spoken, including Indo-European languages.	[Perry, Lynn K.] Univ Miami, Coral Gables, FL 33124 USA; [Perlman, Marcus; Lupyan, Gary] Univ Wisconsin, Madison, WI USA	University of Miami; University of Wisconsin System; University of Wisconsin Madison	Perry, LK (corresponding author), Univ Miami, Coral Gables, FL 33124 USA.	lkp36@miami.edu	Perlman, Marcus/K-6972-2018	Perlman, Marcus/0000-0002-1269-3882; Lupyan, Gary/0000-0001-8441-7433; Perry, Lynn/0000-0001-6976-3741	National Science Foundation, Integrated NSF Support Promoting Interdisciplinary Research and Education (INSPIRE) [1344279]; Division Of Behavioral and Cognitive Sci [1344279] Funding Source: National Science Foundation	National Science Foundation, Integrated NSF Support Promoting Interdisciplinary Research and Education (INSPIRE); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Funding was provided by the National Science Foundation, Integrated NSF Support Promoting Interdisciplinary Research and Education (INSPIRE) Award 1344279 awarded to GL.	Ahlner F., 2010, SIGN SYST STUD, V38, P298, DOI [10.12697/SSS.2010.38.1-4.11, DOI 10.12697/SSS.2010.38.1-4.11]; Armstrong D.F., 2007, GESTURAL ORIGIN LANG; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Beavers J, 2010, J LINGUIST, V46, P331, DOI 10.1017/S0022226709990272; Bentley M, 1933, AM J PSYCHOL, V45, P76, DOI 10.2307/1414187; Bergen BK, 2004, LANGUAGE, V80, P290, DOI 10.1353/lan.2004.0056; Berlin B, 1994, EVIDENCE PERVASIVE S, P76, DOI DOI 10.1017/CBO9780511751806.006; BROWN R W, 1955, J Abnorm Psychol, V50, P388, DOI 10.1037/h0046820; Cuskley C, OXFORD HDB SYNAESTHE, P869; Cuskley C., 2013, PUBLIC J SEMIOTICS, V5, P39, DOI DOI 10.37693/pjos.2013.5.9651; Davies Mark, 2017, FREQUENCY DICT SPANI; Diffloth G., 1972, 8 REG M CHIC LING SO, P440; Dingemanse M, TRENDS COGN IN PRESS; Dingemanse M, 2014, PRAGMAT SOC, V5, P384, DOI 10.1075/ps.5.3.04din; Dingemanse M, 2012, LANG LINGUIST COMPAS, V6, P654, DOI 10.1002/lnc3.361; Farmer TA, 2006, P NATL ACAD SCI USA, V103, P12203, DOI 10.1073/pnas.0602173103; FENSON L, 1994, MONOGR SOC RES CHILD, V59, pR5; FRISHBERG N, 1975, LANGUAGE, V51, P696, DOI 10.2307/412894; GEBELS G, 1969, J VERB LEARN VERB BE, V8, P310, DOI 10.1016/S0022-5371(69)80083-6; HOCKETT CF, 1978, AM SPEECH, V53, P243, DOI 10.2307/455140; HOCKETT CF, 1960, SCI AM, V203, P88, DOI 10.1038/scientificamerican0960-88; Imai M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0298; Imai M, 2008, COGNITION, V109, P54, DOI 10.1016/j.cognition.2008.07.015; Jackson-Maldonado D, 2003, USERS GUIDE TECHNICA; Jorgensen RN, 2010, J CHILD LANG, V37, P419, DOI 10.1017/S0305000909009544; Kantartzis K, 2011, COGNITIVE SCI, V35, P575, DOI 10.1111/j.1551-6709.2010.01169.x; La Polla R., 1994, SOUND SYMBOLISM; Lupyan G, 2015, LANG COGN, V7, P167, DOI 10.1017/langcog.2014.21; Masuda K., 2007, INSISTENT IMAGES, V5, P57; Monaghan P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0299; Nielsen A, 2012, LANG COGN, V4, P115, DOI 10.1515/langcog-2012-0007; Nuckolls JanisB., 2003, P 11 ANN S LANG SOC; Nygaard LC, 2009, COGNITIVE SCI, V33, P127, DOI 10.1111/j.1551-6709.2008.01007.x; Padden C, 2013, GESTURE, V13, P287, DOI 10.1075/gest.13.3.03pad; Perlman M., 2014, COGN SCI; Perlman M, GESTURE IN PRESS; Perniss P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0300; PINKER S, 1990, BEHAV BRAIN SCI, V13, P707, DOI 10.1017/S0140525X00081061; Plato, 1999, CRATYLUS; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; Reppen R., 2005, AM NATL CORPUS ANC 2; Saussure F. de., 1983, COURSE GEN LINGUISTI; Shintel H, 2006, J MEM LANG, V55, P167, DOI 10.1016/j.jml.2006.03.002; Signs Morris C., 2011, LANGUAGE BEHAV; Strickland B, 2015, P NATL ACAD SCI USA, V112, P5968, DOI 10.1073/pnas.1423080112; TANZ C, 1971, LANG SPEECH, V14, P266, DOI 10.1177/002383097101400307; Taub S.F., 2001, LANGUAGE BODY ICONIC; Thompson RL, 2012, PSYCHOL SCI, V23, P1443, DOI 10.1177/0956797612459763; Tomasello M, 2008, JEAN NICOD LECT, P1; Ultan R., 1978, SIZE SOUND SYMBOLISM; Urban M, 2011, FOLIA LINGUIST, V45, P199, DOI 10.1515/FLIN.2011.007; Vigliocco G, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0292; Vinson DP, 2008, BEHAV RES METHODS, V40, P1079, DOI 10.3758/BRM.40.4.1079; Voeltz F.K. Erhard, 2001, IDEOPHONES; Wilcox S., 2009, ANN REV COGN LING, V7, P89, DOI [DOI 10.1075/ARCL.7.04WIL, 10.1075/arcl.7.04wil]; WILSON M, 1988, BEHAV RES METH INSTR, V20, P6, DOI 10.3758/BF03202594; Yoshida H, 2012, J COGN DEV, V13, P232, DOI 10.1080/15248372.2011.573515	57	95	95	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137147	10.1371/journal.pone.0137147	http://dx.doi.org/10.1371/journal.pone.0137147			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CQ6BA	26340349	gold, Green Published, Green Submitted			2022-12-26	WOS:000360688200026
J	Serrano, E; Martinez, AB; Arruga, D; Perez-Pe, R; Sanchez-Ferrer, A; Muino-Blanco, T; Cebrian-Perez, JA				Serrano, Edith; Martinez, Ana B.; Arruga, Diana; Perez-Pe, Rosaura; Sanchez-Ferrer, Alvaro; Muino-Blanco, Teresa; Cebrian-Perez, Jose A.			New Insights into the Phylogeny and Gene Context Analysis of Binder of Sperm Proteins (BSPs)	PLOS ONE			English	Article							SEMINAL PLASMA-PROTEINS; SINGLE-STEP METHOD; MAJOR PROTEINS; RNA ISOLATION; LOCALIZATION; PURIFICATION; EXPRESSION; MEMBRANE; DAMAGE	Seminal plasma (SP) proteins support the survival of spermatozoa acting not only at the plasma membrane but also by inhibition of capacitation, resulting in higher fertilizing ability. Among SP proteins, BSP (binder of sperm) proteins are the most studied, since they may be useful for the improvement of semen diluents, storage and subsequent fertilization results. However, an updated and detailed phylogenetic analysis of the BSP protein superfamily has not been carried out with all the sequences described in the main databases. The update view shows for the first time an equally distributed number of sequences between the three families: BSP, and their homologs 1 (BSPH1) and 2 (BSPH2). The BSP family is divided in four subfamilies, BSP1 subfamily being the predominant, followed by subfamilies BSP3, BSP5 and BSP2. BSPH proteins were found among placental mammals (Eutheria) belonging to the orders Proboscidea, Primates, Lagomorpha, Rodentia, Chiroptera, Perissodactyla and Cetartiodactyla. However, BSPH2 proteins were also found in the Scandentia order and Metatheria clade. This phylogenetic analysis, when combined with a gene context analysis, showed a completely new evolutionary scenario for the BSP superfamily of proteins with three defined different gene patterns, one for BSPs, one for BSPH1/BSPH2/ELSPBP1 and another one for BSPH1/BSPH2 without ELSPBP1. In addition, the study has permitted to define concise conserved blocks for each family (BSP, BSPH1 and BSPH2), which could be used for a more reliable assignment for the incoming sequences, for data curation of current databases, and for cloning new BSPs, as the one described in this paper, ram seminal vesicle 20 kDa protein (RSVP20, Ovis aries BSP5b).	[Serrano, Edith; Arruga, Diana; Perez-Pe, Rosaura; Muino-Blanco, Teresa; Cebrian-Perez, Jose A.] Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Inst Univ Invest Ciencias Ambientables Aragon IUC, Fac Veterinaria, E-50013 Zaragoza, Spain; [Martinez, Ana B.; Sanchez-Ferrer, Alvaro] Univ Murcia, Dept Biochem & Mol Biol A, Fac Biol, E-30100 Murcia, Spain; [Martinez, Ana B.; Sanchez-Ferrer, Alvaro] Murcia Biomed Res Inst IMIB Arrixaca, Murcia 30120, Spain	University of Zaragoza; University of Murcia	Sanchez-Ferrer, A (corresponding author), Univ Murcia, Dept Biochem & Mol Biol A, Fac Biol, Reg Campus Int Excellence Campus Mare Nostrum, E-30100 Murcia, Spain.	alvaro@um.es; pcebrian@unizar.es	PEREZ-PE, ROSAURA/L-1924-2014; Sánchez-Ferrer, Alvaro/M-1631-2014	PEREZ-PE, ROSAURA/0000-0002-2312-6402; Sánchez-Ferrer, Alvaro/0000-0001-7266-4402; Cebrian Perez, Jose Alvaro/0000-0001-9842-6197; Muino Blanco, Maria Teresa/0000-0003-1306-8517	MINECO-FEDER [AGL2011-25850, AGL 2013-43328-P, BIO2010-22225-C02-01, BIO2013-45336-R]; Direccion General de Aragon [A-26FSE]; FPI fellowship [BES-2012-053094]	MINECO-FEDER; Direccion General de Aragon(Gobierno de Aragon); FPI fellowship(Spanish Government)	This work was supported by grants MINECO-FEDER (AGL2011-25850 and AGL 2013-43328-P), Direccion General de Aragon (A-26FSE), and MINECO-FEDER (BIO2010-22225-C02-01 and BIO2013-45336-R). E.S. was financed by the FPI fellowship BES-2012-053094, and A.B.M. is holder of a predoctoral research contract associated with BIO2013-45336-R.	Austin C.R., 1985, P121; Barrios B, 2005, J ANDROL, V26, P539, DOI 10.2164/jandrol.04172; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DESNOYERS L, 1992, J BIOL CHEM, V267, P10149; Fan JJ, 2006, GENE, V375, P63, DOI 10.1016/j.gene.2006.02.025; Fernandez-Juan M, 2006, J ANDROL, V27, P588, DOI 10.2164/jandrol.05187; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Lefebvre J, 2009, MOL HUM REPROD, V15, P105, DOI 10.1093/molehr/gan077; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; MANJUNATH P, 1987, BIOSCIENCE REP, V7, P231, DOI 10.1007/BF01124794; MANJUNATH P, 1989, J BIOL CHEM, V264, P16853; Manjunath P, 2002, BIOL REPROD, V67, P1250, DOI 10.1095/biolreprod67.4.1250; Manjunath P, 1988, MOL BIOL BRAIN ENDOC, P259; Manjunath P, 2009, BIOL REPROD, V80, P394, DOI 10.1095/biolreprod.108.074088; Mendoza N, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105650; Nauc V, 2000, BIOL REPROD, V63, P1058, DOI 10.1095/biolreprod63.4.1058; Perez-Pe R, 2002, MOL REPROD DEV, V61, P226, DOI 10.1002/mrd.1152; Perez-Pe R, 2001, INT J ANDROL, V24, P352, DOI 10.1046/j.1365-2605.2001.00315.x; Perez-Pe R, 2001, THERIOGENOLOGY, V56, P425, DOI 10.1016/S0093-691X(01)00574-X; Plante G, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.114272; Plante G, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.096644; Serrano E, 2013, GENE, V519, P271, DOI 10.1016/j.gene.2013.02.016; Therien I, 2005, MOL REPROD DEV, V71, P97, DOI 10.1002/mrd.20287; Tian X, 2009, BIOL REPROD, V80, P616, DOI 10.1095/biolreprod.108.073684; Wah DA, 2002, STRUCTURE, V10, P505, DOI 10.1016/S0969-2126(02)00751-7; Yanagimachi R., 1994, Zygote, V2, P371	31	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137008	10.1371/journal.pone.0137008	http://dx.doi.org/10.1371/journal.pone.0137008			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26333091	Green Published, gold, Green Submitted			2022-12-26	WOS:000360613800088
J	Nemeth, B; Doczi, J; Csete, D; Kacso, G; Ravasz, D; Adams, D; Kiss, G; Nagy, AM; Horvath, G; Tretter, L; Mocsai, A; Csepanyi-Komi, R; Iordanov, I; Adam-Vizi, V; Chinopoulos, C				Nemeth, Beata; Doczi, Judit; Csete, Daniel; Kacso, Gergely; Ravasz, Dora; Adams, Daniel; Kiss, Gergely; Nagy, Adam M.; Horvath, Gergo; Tretter, Laszlo; Mocsai, Attila; Csepanyi-Koemi, Roland; Iordanov, Iordan; Adam-Vizi, Vera; Chinopoulos, Christos			Abolition of mitochondrial substrate-level phosphorylation by itaconic acid produced by LPS-induced Irg1 expression in cells of murine macrophage lineage	FASEB JOURNAL			English	Article						succinate-CoA ligase; cadA; lipopolysaccharide	IMMUNE-RESPONSIVE GENE-1; SUCCINYL-COA SYNTHETASE; ISOCITRATE LYASE; ACTIVATED MACROPHAGES; COENZYME-A; METABOLISM; ATP; PROTEIN; INHIBITION; DEHYDROGENASE	Itaconate is a nonamino organic acid exhibiting antimicrobial effects. It has been recently identified in cells of macrophage lineage as a product of an enzyme encoded by immunoresponsive gene 1 (Irg1), acting on the citric acid cycle intermediate cis-aconitate. In mitochondria, itaconate can be converted by succinate-coenzyme A (CoA) ligase to itaconyl-CoA at the expense of ATP (or GTP), and is also a weak competitive inhibitor of complex II. Here, we investigated specific bioenergetic effects of increased itaconate production mediated by LPS-induced stimulation of Irg1 in murine bone marrow-derived macrophages (BMDM) and RAW-264.7 cells. In rotenone-treatedmacrophage cells, stimulation by LPS led to impairment in substrate-level phosphorylation (SLP) of in situ mitochondria, deduced by a reversal in the directionality of the adenine nucleotide translocase operation. In RAW-264.7 cells, the LPS-induced impairment in SLP was reversed by short-interfering RNA(siRNA)-but not scrambled siRNA-treatment directed against Irg1. LPS dose-dependently inhibited oxygen consumption rates (61-91%) and elevated glycolysis rates (>21%) in BMDM but not RAW-264.7 cells, studied under various metabolic conditions. In isolated mouse liver mitochondria treated with rotenone, itaconate dose-dependently (0.5-2 mM) reversed the operation of adenine nucleotide translocase, implying impairment in SLP, an effect that was partially mimicked by malonate. However, malonate yielded greater ADP-induced depolarizations (3-19%) than itaconate. We postulate that itaconate abolishes SLP due to 1) a "CoA trap" in the form of itaconyl-CoA that negatively affects the upstream supply of succinyl-CoA from the a-ketoglutarate dehydrogenase complex; 2) depletion of ATP (or GTP), which are required for the thioesterification by succinate-CoA ligase; and 3) inhibition of complex II leading to a buildup of succinate which shifts succinate-CoA ligase equilibrium toward ATP (or GTP) utilization. Our results support the notion that Irg1-expressing cells of macrophage lineage lose the capacity of mitochondrial SLP for producing itaconate during mounting of an immune defense.	[Nemeth, Beata; Doczi, Judit; Kacso, Gergely; Ravasz, Dora; Adams, Daniel; Kiss, Gergely; Nagy, Adam M.; Horvath, Gergo; Tretter, Laszlo; Iordanov, Iordan; Adam-Vizi, Vera; Chinopoulos, Christos] Semmelweis Univ, Dept Med Biochem, H-1094 Budapest, Hungary; [Csete, Daniel; Mocsai, Attila; Csepanyi-Koemi, Roland] Semmelweis Univ, Dept Physiol, H-1094 Budapest, Hungary; [Nemeth, Beata; Doczi, Judit; Kacso, Gergely; Ravasz, Dora; Adams, Daniel; Kiss, Gergely; Chinopoulos, Christos] Hungarian Acad Sci, Lendulet Neurobiochem Res Grp, Budapest, Hungary; [Csete, Daniel; Mocsai, Attila] Hungarian Acad Sci, Lendulet Inflammat Physiol Res Grp, Budapest, Hungary; [Nagy, Adam M.; Horvath, Gergo; Tretter, Laszlo; Adam-Vizi, Vera] Hungarian Acad Sci, Neurochem Lab, Budapest, Hungary; [Iordanov, Iordan] Hungarian Acad Sci, Lendulet Ion Channel Res Grp, Budapest, Hungary	Semmelweis University; Semmelweis University; Hungarian Academy of Sciences; Hungarian Academy of Sciences; Hungarian Academy of Sciences; Hungarian Academy of Sciences	Chinopoulos, C (corresponding author), Semmelweis Univ, Dept Med Biochem, Tuzolto St 37-47, H-1094 Budapest, Hungary.	chinopoulos.christos@eok.sote.hu	Horvath, Gergo/E-6656-2016; Tretter, Laszlo/ACI-2689-2022; Iordanov, Iordan/O-1892-2019; Csepanyi-Komi, Roland/B-2954-2010	Horvath, Gergo/0000-0001-5386-9509; Iordanov, Iordan/0000-0001-8251-5857; Chinopoulos, Christos/0000-0003-0183-4149; Adam-Vizi, Vera/0000-0002-8350-8701; Csepanyi-Komi, Roland/0000-0001-6825-7142; Kacso, Gergely/0000-0003-0428-3645; Ravasz, Dora/0000-0002-0510-3282	Lendulet program of the Hungarian Academy of Sciences [LP2013-66]; Wellcome Trust [087782]; MTA-SE Lendulet Grant [LP2012-39/2012]; Orszagos Tudomanyos Kutatasi Alapprogram (OTKA) [81983]; Hungarian Academy of Sciences [02001]; Hungarian Brain Research Program [KTIA_13_NAP-A-III/6]; MTA-SE Lendulet Neurobiochemistry Research Division [95003]; OTKA NNF [78905]; OTKA NNF2 [85658]; OTKA K [100918]	Lendulet program of the Hungarian Academy of Sciences; Wellcome Trust(Wellcome TrustEuropean Commission); MTA-SE Lendulet Grant; Orszagos Tudomanyos Kutatasi Alapprogram (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian Brain Research Program; MTA-SE Lendulet Neurobiochemistry Research Division; OTKA NNF(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); OTKA NNF2; OTKA K(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The authors thank Dr. Erzsebet Marothy-Toth for helpful discussions and Drs. Karsten Hiller and Thekla Cordes for generously providing the pCMV6-FLAG-Irg1 plasmid. This work was supported by the Lendulet program of the Hungarian Academy of Sciences (LP2013-66) and the Wellcome Trust International Senior Research Fellowship Grant 087782 (to A.M.), the MTA-SE Lendulet Grant LP2012-39/2012 (to Laszlo Csanady), the Orszagos Tudomanyos Kutatasi Alapprogram (OTKA) Grant 81983, the Hungarian Academy of Sciences Grant 02001, the Hungarian Brain Research Program KTIA_13_NAP-A-III/6 (to V.A.-V.), and Grants MTA-SE Lendulet Neurobiochemistry Research Division 95003, OTKA NNF 78905, OTKA NNF2 85658, and OTKA K 100918 (to C.C.).	Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Abramov AY, 2005, PHILOS T R SOC B, V360, P2309, DOI 10.1098/rstb.2005.1766; ADLER J, 1957, J BIOL CHEM, V229, P865; AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Berg IA, 2002, FEMS MICROBIOL LETT, V216, P49, DOI 10.1111/j.1574-6968.2002.tb11413.x; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; BOOTH AN, 1952, J BIOL CHEM, V195, P697; Chinopoulos C, 2011, J NEUROSCI RES, V89, P1897, DOI 10.1002/jnr.22659; Chinopoulos C, 2011, FEBS LETT, V585, P1255, DOI 10.1016/j.febslet.2011.04.004; Chinopoulos C, 2010, FASEB J, V24, P2405, DOI 10.1096/fj.09-149898; Chinopoulos C, 2009, BIOPHYS J, V96, P2490, DOI 10.1016/j.bpj.2008.12.3915; Cordes T, 2015, ANNU REV NUTR, V35, P451, DOI 10.1146/annurev-nutr-071714-034243; Degrandi D, 2009, J INTERF CYTOK RES, V29, P55, DOI 10.1089/jir.2008.0013; DERVARTANIAN DV, 1964, BIOCHIM BIOPHYS ACTA, V92, P233, DOI 10.1016/0926-6569(64)90182-8; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; FRANKE W, 1957, LIEBIGS ANN CHEM, V608, P168; Garedew A, 2010, CELL DEATH DIFFER, V17, P1540, DOI 10.1038/cdd.2010.27; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P11735, DOI 10.1073/pnas.89.24.11735; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HILLIER S, 1981, J BACTERIOL, V145, P452, DOI 10.1128/JB.145.1.452-458.1981; HILZ H, 1958, BIOCHEM Z, V329, P476; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hoentjen F, 2005, BLOOD, V105, P689, DOI 10.1182/blood-2004-04-1309; Hunger-Glaser I, 1999, MOL BIOCHEM PARASIT, V100, P53, DOI 10.1016/S0166-6851(99)00032-8; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Kiss G, 2014, FASEB J, V28, P1682, DOI 10.1096/fj.13-243030; Kiss G, 2013, FASEB J, V27, P2392, DOI 10.1096/fj.12-220202; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Kvitvang HFN, 2011, ANAL CHEM, V83, P2705, DOI 10.1021/ac103245b; LABBE RF, 1965, BIOCHIM BIOPHYS ACTA, V111, P403, DOI 10.1016/0304-4165(65)90050-4; Lee Y, 2004, EUR J BIOCHEM, V271, P1094, DOI 10.1111/j.1432-1033.2004.04011.x; Liu Y, 2012, MOL MED REP, V6, P1343, DOI 10.3892/mmr.2012.1072; MCFADDEN BA, 1977, J BACTERIOL, V131, P136, DOI 10.1128/JB.131.1.136-144.1977; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008; Mookerjee SA, 2015, BBA-BIOENERGETICS, V1847, P171, DOI 10.1016/j.bbabio.2014.10.005; Nolte JC, 2014, APPL ENVIRON MICROB, V80, P166, DOI 10.1128/AEM.03075-13; Okabe M, 2009, APPL MICROBIOL BIOT, V84, P597, DOI 10.1007/s00253-009-2132-3; OTTAWAY JH, 1981, INT J BIOCHEM, V13, P401, DOI 10.1016/0020-711X(81)90111-7; PATEL TR, 1978, EXP PARASITOL, V44, P262, DOI 10.1016/0014-4894(78)90107-8; Riboldi E, 2013, INT IMMUNOL, V25, P67, DOI 10.1093/intimm/dxs110; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Sakai A, 2004, NUTRITION, V20, P997, DOI 10.1016/j.nut.2004.08.007; SANADI DR, 1954, BIOCHIM BIOPHYS ACTA, V14, P434, DOI 10.1016/0006-3002(54)90205-X; Shin JH, 2011, J PROTEOME RES, V10, P2238, DOI 10.1021/pr101054m; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Steiger MG, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00023; Strelko CL, 2011, J AM CHEM SOC, V133, P16386, DOI 10.1021/ja2070889; Sugimoto M, 2012, METABOLOMICS, V8, P624, DOI 10.1007/s11306-011-0353-9; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tavakoli S, 2013, J NUCL MED, V54, P1661, DOI 10.2967/jnumed.112.119099; Theodoulou FL, 2014, BIOCHEM SOC T, V42, P1025, DOI 10.1042/BST20140176; Traves PG, 2012, J IMMUNOL, V188, P1402, DOI 10.4049/jimmunol.1101781; Tyler D. D., 1967, METHOD ENZYMOL, V10, P75, DOI DOI 10.1016/0076-6879(67)10014-1; WANG SF, 1961, J BIOL CHEM, V236, P26; Weinberg JM, 2000, P NATL ACAD SCI USA, V97, P2826, DOI 10.1073/pnas.97.6.2826; Wibom C, 2010, J PROTEOME RES, V9, P2909, DOI 10.1021/pr901088r; Willke T, 2001, APPL MICROBIOL BIOT, V56, P289, DOI 10.1007/s002530100685; Xaus J, 2000, BLOOD, V95, P3823; Xiao W, 2011, MOL CELL BIOCHEM, V353, P177, DOI 10.1007/s11010-011-0784-7; Xu LY, 2012, AM J PHYSIOL-ENDOC M, V302, pE788, DOI 10.1152/ajpendo.00337.2011; Zeng W, 2015, CANCER LETT, V356, P263, DOI 10.1016/j.canlet.2014.01.032; Zhu LN, 2015, INT REV IMMUNOL, V34, P82, DOI 10.3109/08830185.2014.969421	65	82	82	0	39	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					286	300		10.1096/fj.15-279398	http://dx.doi.org/10.1096/fj.15-279398			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26358042				2022-12-26	WOS:000367621000028
J	Fischer, M; Hopkins, AP; Severi, E; Hawkhead, J; Bawdon, D; Watts, AG; Hubbard, RE; Thomas, GH				Fischer, Marcus; Hopkins, Adam P.; Severi, Emmanuele; Hawkhead, Judith; Bawdon, Daniel; Watts, Andrew G.; Hubbard, Roderick E.; Thomas, Gavin H.			Tripartite ATP-independent Periplasmic (TRAP) Transporters Use an Arginine-mediated Selectivity Filter for High Affinity Substrate Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACYTOPLASMIC-SOLUTE-RECEPTOR; TREPONEMA-PALLIDUM LIPOPROTEINS; SIALIC-ACID TRANSPORTER; HAEMOPHILUS-INFLUENZAE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURES; VIRULENCE FACTOR; PROTEIN; FAMILY; SYSTEMS	Tripartite ATP-independent periplasmic (TRAP) transporters are secondary transporters that have evolved an obligate dependence on a substrate-binding protein (SBP) to confer unidirectional transport. Different members of the DctP family of TRAP SBPs have binding sites that recognize a diverse range of organic acid ligands but appear to only share a common electrostatic interaction between a conserved arginine and a carboxylate group in the ligand. We investigated the significance of this interaction using the sialic acid-specific SBP, SiaP, from the Haemophilus influenzae virulence-related SiaPQM TRAP transporter. Using in vitro, in vivo, and structural methods applied to SiaP, we demonstrate that the coordination of the acidic ligand moiety of sialic acid by the conserved arginine (Arg-147) is essential for the function of the transporter as a high affinity scavenging system. However, at high substrate concentrations, the transporter can function in the absence of Arg-147 suggesting that this bi-molecular interaction is not involved in further stages of the transport cycle. As well as being required for high affinity binding, we also demonstrate that the Arg-147 is a strong selectivity filter for carboxylate-containing substrates in TRAP transporters by engineering the SBP to recognize a non-carboxylate-containing substrate, sialylamide, through water-mediated interactions. Together, these data provide biochemical and structural support that TRAP transporters function predominantly as high affinity transporters for carboxylate-containing substrates.	[Fischer, Marcus; Severi, Emmanuele; Hubbard, Roderick E.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5YW, N Yorkshire, England; [Hopkins, Adam P.; Hawkhead, Judith; Bawdon, Daniel; Thomas, Gavin H.] Univ York, Dept Biol, Area 10, York YO10 5YW, N Yorkshire, England; [Watts, Andrew G.] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England	University of York - UK; University of York - UK; University of Bath	Thomas, GH (corresponding author), Univ York, Dept Biol, Area 10, POB 373, York YO10 5YW, N Yorkshire, England.	gavin.thomas@york.ac.uk	Fischer, Marcus/M-9841-2018; Thomas, Gavin Hugh/E-5753-2011	Fischer, Marcus/0000-0002-7179-2581; Thomas, Gavin Hugh/0000-0002-9763-1313; Watts, Andrew/0000-0003-4299-2717; Hopkins, Adam/0000-0002-1731-0350	Biotechnology and Biological Sciences Research Council [BBC509807, BBF0147591]; Wild Fund; BBSRC [BB/F014759/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C509807/1, BB/F014759/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wild Fund; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grants BBC509807 and BBF0147591 (to G. H. T.), and funding from the Wild Fund (to M. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Akiyama N, 2009, J MOL BIOL, V392, P559, DOI 10.1016/j.jmb.2009.07.043; Allen S, 2005, INFECT IMMUN, V73, P5291, DOI 10.1128/IAI.73.9.5291-5300.2005; ANDREWS PR, 1984, J MED CHEM, V27, P1648, DOI 10.1021/jm00378a021; Bouchet V, 2003, P NATL ACAD SCI USA, V100, P8898, DOI 10.1073/pnas.1432026100; Brautigam CA, 2012, J MOL BIOL, V420, P70, DOI 10.1016/j.jmb.2012.04.001; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Deka RK, 2012, J MOL BIOL, V416, P678, DOI 10.1016/j.jmb.2012.01.015; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Fischer M, 2010, TRENDS MICROBIOL, V18, P471, DOI 10.1016/j.tim.2010.06.009; Forward JA, 1997, J BACTERIOL, V179, P5482, DOI 10.1128/jb.179.17.5482-5493.1997; Gonin S, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-11; Herrou J, 2007, J MOL BIOL, V373, P954, DOI 10.1016/j.jmb.2007.08.006; Hopkins AP, 2013, FEMS MICROBIOL LETT, V347, P14, DOI 10.1111/1574-6968.12213; Jenkins GA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-48; Johnston JW, 2008, J BIOL CHEM, V283, P855, DOI 10.1074/jbc.M706603200; Kuhlmann SI, 2008, BIOCHEMISTRY-US, V47, P9475, DOI 10.1021/bi8006719; Lecher J, 2009, J MOL BIOL, V389, P58, DOI 10.1016/j.jmb.2009.03.077; Muller A, 2006, J BIOL CHEM, V281, P22212, DOI 10.1074/jbc.M603463200; Mulligan C, 2011, FEMS MICROBIOL REV, V35, P68, DOI 10.1111/j.1574-6976.2010.00236.x; Mulligan C, 2009, P NATL ACAD SCI USA, V106, P1778, DOI 10.1073/pnas.0809979106; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Paulsen IT, 2000, J MOL BIOL, V301, P75, DOI 10.1006/jmbi.2000.3961; Poretsky RS, 2010, ENVIRON MICROBIOL, V12, P616, DOI 10.1111/j.1462-2920.2009.02102.x; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Rucktooa P, 2007, J MOL BIOL, V370, P93, DOI 10.1016/j.jmb.2007.04.047; Severi E, 2005, MOL MICROBIOL, V58, P1173, DOI 10.1111/j.1365-2958.2005.04901.x; Severi E, 2008, J BIOL CHEM, V283, P4841, DOI 10.1074/jbc.M707822200; Severi E, 2010, FEMS MICROBIOL LETT, V304, P47, DOI 10.1111/j.1574-6968.2009.01881.x; Sowell SM, 2011, ISME J, V5, P856, DOI 10.1038/ismej.2010.168; Vetting MW, 2015, BIOCHEMISTRY-US, V54, P909, DOI 10.1021/bi501388y; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Williams TJ, 2014, TRENDS MICROBIOL, V22, P248, DOI 10.1016/j.tim.2014.03.004; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winnen B, 2003, RES MICROBIOL, V154, P457, DOI 10.1016/S0923-2508(03)00126-8; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	36	20	20	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27113	27123		10.1074/jbc.M115.656603	http://dx.doi.org/10.1074/jbc.M115.656603			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26342690	Green Published, hybrid			2022-12-26	WOS:000364794000021
J	Bacik, JP; Klesmith, JR; Whitehead, TA; Jarboe, LR; Unkefer, CJ; Mark, BL; Michalczyk, R				Bacik, John-Paul; Klesmith, Justin R.; Whitehead, Timothy A.; Jarboe, Laura R.; Unkefer, Clifford J.; Mark, Brian L.; Michalczyk, Ryszard			Producing Glucose 6-Phosphate from Cellulosic Biomass STRUCTURAL INSIGHTS INTO LEVOGLUCOSAN BIOCONVERSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGNOCELLULOSIC BIOMASS; ORGANIC-MATTER; KINASE; DYNAMICS; TRIS; PURIFICATION; SPECIFICITY; INTEGRATION; KINETICS; AEROSOL	The most abundant carbohydrate product of cellulosic biomass pyrolysis is the anhydrosugar levoglucosan (1,6-anhydro-beta-D-glucopyranose), which can be converted to glucose 6-phosphate by levoglucosan kinase (LGK). In addition to the canonical kinase phosphotransfer reaction, the conversion requires cleavage of the 1,6-anhydro ring to allow ATP-dependent phosphorylation of the sugar O6 atom. Using x-ray crystallography, we show that LGK binds two magnesium ions in the active site that are additionally coordinated with the nucleotide and water molecules to result in ideal octahedral coordination. To further verify the metal binding sites, we co-crystallized LGK in the presence of manganese instead of magnesium and solved the structure de novo using the anomalous signal from four manganese atoms in the dimeric structure. The first metal is required for catalysis, whereas our work suggests that the second is either required or significantly promotes the catalytic rate. Although the enzyme binds its sugar substrate in a similar orientation to the structurally related 1,6-anhydro-N-acetylmuramic acid kinase (AnmK), it forms markedly fewer bonding interactions with the substrate. In this orientation, the sugar is in an optimal position to couple phosphorylation with ring cleavage. We also observed a second alternate binding orientation for levoglucosan, and in these structures, ADP was found to bind with lower affinity. These combined observations provide an explanation for the high Km of LGK for levoglucosan. Greater knowledge of the factors that contribute to the catalytic efficiency of LGK can be used to improve applications of this enzyme for levoglucosan-derived biofuel production.	[Bacik, John-Paul; Unkefer, Clifford J.; Michalczyk, Ryszard] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA; [Klesmith, Justin R.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Whitehead, Timothy A.] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA; [Whitehead, Timothy A.] Michigan State Univ, Dept Biosyst & Agr Engn, E Lansing, MI 48824 USA; [Jarboe, Laura R.] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA; [Mark, Brian L.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada	United States Department of Energy (DOE); Los Alamos National Laboratory; Michigan State University; Michigan State University; Michigan State University; Iowa State University; University of Manitoba	Bacik, JP (corresponding author), Los Alamos Natl Lab, Biosci Div, TA03,Bldg 4200,MS T007, Los Alamos, NM 87545 USA.	jbacik@lanl.gov		Bacik, John-Paul/0000-0001-9315-5332; Klesmith, Justin/0000-0003-2908-9355; Mark, Brian/0000-0002-7344-1355; Michalczyk, Ryszard/0000-0001-8839-6473	Natural Sciences and Engineering Research Council of Canada (NSERC); National Research Council; Canadian Institutes of Health Research; University of Saskatchewan; U. S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, NIGMS [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER; Office Of The Director [1101284] Funding Source: National Science Foundation	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan; U. S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank Shaun Labiuk, Pavel Afonine, and the Canadian Light Source as well as the staff at the SLAC National Accelerator Laboratory for assistance in data collection and processing. We thank the Los Alamos National Laboratory Principal Associate Directorate for Science, Technology and Engineering for institutional investment in key equipment that enabled NMR measurements reported here. The Canadian Light Source is supported by Natural Sciences and Engineering Research Council of Canada (NSERC), the National Research Council, Canadian Institutes of Health Research, and the University of Saskatchewan. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U. S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, NIGMS (including Grant P41GM103393). We also thank Brian Broom-Peltz for technical assistance and Dr. Virginia A. Unkefer for help with editing the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bacik JP, 2014, J BIOL CHEM, V289, P4504, DOI 10.1074/jbc.M113.521633; Bacik JP, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.198317; Bai J, 2013, CHEMOSPHERE, V93, P2004, DOI 10.1016/j.chemosphere.2013.07.021; Bao ZQ, 2011, STRUCTURE, V19, P675, DOI 10.1016/j.str.2011.02.016; Bernstein BE, 1997, NATURE, V385, P275, DOI 10.1038/385275a0; Chen JCH, 2012, P NATL ACAD SCI USA, V109, P15301, DOI 10.1073/pnas.1208341109; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chuang MT, 2013, ATMOS ENVIRON, V78, P72, DOI 10.1016/j.atmosenv.2012.06.056; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Dai JH, 2009, WORLD J MICROB BIOT, V25, P1589, DOI 10.1007/s11274-009-0048-9; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Desmarais WT, 2002, STRUCTURE, V10, P1063, DOI 10.1016/S0969-2126(02)00810-9; Downing M., 2011, US BILLION TON UPDAT; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ghalanbor Z, 2008, PROTEIN PEPTIDE LETT, V15, P212, DOI 10.2174/092986608783489616; GordonWeeks R, 1997, PLANT PHYSIOL, V114, P901, DOI 10.1104/pp.114.3.901; GUPTA RK, 1983, BIOCHEM BIOPH RES CO, V117, P210, DOI 10.1016/0006-291X(83)91562-0; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; HIRAI M, 1977, BIOCHIM BIOPHYS ACTA, V480, P357, DOI 10.1016/0005-2744(77)90028-6; Hopmans EC, 2013, ORG GEOCHEM, V58, P86, DOI 10.1016/j.orggeochem.2013.02.003; Hurley JH, 1996, ANNU REV BIOPH BIOM, V25, P137; Jacobsen DM, 2012, J AM CHEM SOC, V134, P15357, DOI 10.1021/ja304419t; Jarboe LR, 2011, APPL MICROBIOL BIOT, V91, P1519, DOI 10.1007/s00253-011-3495-9; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kehrwald N, 2012, TELLUS B, V64, DOI 10.3402/tellusb.v64i0.18196; KITAMURA Y, 1991, AGR BIOL CHEM TOKYO, V55, P523, DOI 10.1080/00021369.1991.10870618; Knicker H, 2013, GEODERMA, V197, P43, DOI 10.1016/j.geoderma.2012.12.021; Kupfer R, 2001, BIOCHEMISTRY-US, V40, P11490, DOI 10.1021/bi010914d; Lai CY, 2014, ATMOS ENVIRON, V91, P32, DOI 10.1016/j.atmosenv.2014.03.054; Layton DS, 2011, BIORESOURCE TECHNOL, V102, P8318, DOI 10.1016/j.biortech.2011.06.011; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Levine J.S., 1991, EOS TRANSAC AM GEOPH, DOI DOI 10.1029/90E000289; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mullaugh KM, 2014, CHEMOSPHERE, V107, P51, DOI 10.1016/j.chemosphere.2014.03.014; NAKAHARA K, 1994, BIOSCI BIOTECH BIOCH, V58, P2193, DOI 10.1271/bbb.58.2193; Ning JY, 2008, WORLD J MICROB BIOT, V24, P15, DOI 10.1007/s11274-007-9432-5; Nishimasu H, 2007, J BIOL CHEM, V282, P9923, DOI 10.1074/jbc.M610678200; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Phitsuwan P, 2013, BIOMASS BIOENERG, V58, P390, DOI 10.1016/j.biombioe.2013.08.027; Regni C, 2004, STRUCTURE, V12, P55, DOI 10.1016/j.str.2003.11.015; Sachett LG, 2011, EUR J MED CHEM, V46, P5212, DOI 10.1016/j.ejmech.2011.08.016; SALAS M, 1965, J BIOL CHEM, V240, P561; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; Tsai YI, 2013, ATMOS ENVIRON, V78, P93, DOI 10.1016/j.atmosenv.2012.09.040; Uehara T, 2005, J BACTERIOL, V187, P3643, DOI 10.1128/JB.187.11.3643-3649.2005; Vancampenhout K, 2012, SOIL BIOL BIOCHEM, V50, P40, DOI 10.1016/j.soilbio.2012.03.005; Vicente A, 2013, ATMOS ENVIRON, V71, P295, DOI 10.1016/j.atmosenv.2013.01.062; Wallner P, 2013, INT J HYG ENVIR HEAL, V216, P280, DOI 10.1016/j.ijheh.2012.05.001; Zhuang XL, 2002, PROTEIN EXPRES PURIF, V26, P71, DOI 10.1016/S1046-5928(02)00501-6; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	52	13	16	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26638	26648		10.1074/jbc.M115.674614	http://dx.doi.org/10.1074/jbc.M115.674614			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26354439	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000364793600029
J	Rosas-Aguirre, A; Speybroeck, N; Llanos-Cuentas, A; Rosanas-Urgell, A; Carrasco-Escobar, G; Rodriguez, H; Gamboa, D; Contreras-Mancilla, J; Alava, F; Soares, IS; Remarque, E; D'Alessandro, U; Erhart, A				Rosas-Aguirre, Angel; Speybroeck, Niko; Llanos-Cuentas, Alejandro; Rosanas-Urgell, Anna; Carrasco-Escobar, Gabriel; Rodriguez, Hugo; Gamboa, Dionicia; Contreras-Mancilla, Juan; Alava, Freddy; Soares, Irene S.; Remarque, Edmond; D'Alessandro, Umberto; Erhart, Annette			Hotspots of Malaria Transmission in the Peruvian Amazon: Rapid Assessment through a Parasitological and Serological Survey	PLOS ONE			English	Article							PLASMODIUM-VIVAX-MALARIA; FALCIPARUM; COMMUNITIES; PREVALENCE; ENDEMICITY; PATTERNS; VECTOR; REGION; AREAS	Background With low and markedly seasonal malaria transmission, increasingly sensitive tools for better stratifying the risk of infection and targeting control interventions are needed. A cross-sectional survey to characterize the current malaria transmission patterns, identify hotspots, and detect recent changes using parasitological and serological measures was conducted in three sites of the Peruvian Amazon. Material and Methods After full census of the study population, 651 participants were interviewed, clinically examined and had a blood sample taken for the detection of malaria parasites (microscopy and PCR) and antibodies against P. vivax (PvMSP1(19), PvAMA1) and P. falciparum (PfGLURP, PfAMA1) antigens by ELISA. Risk factors for malaria infection (positive PCR) and malaria exposure (seropositivity) were assessed by multivariate survey logistic regression models. Age-specific seroprevalence was analyzed using a reversible catalytic conversion model based on maximum likelihood for generating seroconversion rates (SCR, lambda). SaTScan was used to detect spatial clusters of serology-positive individuals within each site. Results The overall parasite prevalence by PCR was low, i.e. 3.9% for P. vivax and 6.7% for P. falciparum, while the seroprevalence was substantially higher, 33.6% for P. vivax and 22.0% for P. falciparum, with major differences between study sites. Age and location (site) were significantly associated with P. vivax exposure; while location, age and outdoor occupation were associated with P. falciparum exposure. P. falciparum seroprevalence curves showed a stable transmission throughout time, while for P. vivax transmission was better described by a model with two SCRs. The spatial analysis identified well-defined clusters of P. falciparum seropositive individuals in two sites, while it detected only a very small cluster of P. vivax exposure. Conclusion The use of a single parasitological and serological malaria survey has proven to be an efficient and accurate method to characterize the species specific heterogeneity in malaria transmission at micro-geographical level as well as to identify recent changes in transmission.	[Rosas-Aguirre, Angel; Llanos-Cuentas, Alejandro; Carrasco-Escobar, Gabriel; Gamboa, Dionicia; Contreras-Mancilla, Juan] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima 31, Peru; [Rosas-Aguirre, Angel; Speybroeck, Niko] Catholic Univ Louvain, Res Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium; [Rosas-Aguirre, Angel; Rosanas-Urgell, Anna; Erhart, Annette] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Rodriguez, Hugo; Alava, Freddy] Iquitos, Reg Salud Loreto, Loreto 160, Peru; [Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Dept Ciencias Celulares & Mol, Lima 31, Peru; [Soares, Irene S.] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, BR-05508900 Sao Paulo, Brazil; [Remarque, Edmond] Biomed Primate Res Ctr, Dept Parasitol, NL-2280 GH Rijswijk, Netherlands; [D'Alessandro, Umberto] MRC Unit, Dis Control & Eliminat, Fajara 220, Gambia; [D'Alessandro, Umberto] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	Universidad Peruana Cayetano Heredia; Universite Catholique Louvain; Institute of Tropical Medicine (ITM); Universidad Peruana Cayetano Heredia; Universidade de Sao Paulo; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Rosas-Aguirre, A (corresponding author), Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima 31, Peru.	angelrosasa@gmail.com	Rosanas-Urgell, Anna/D-3193-2015; Remarque, Ed/AAE-8643-2020; Aguirre, Angel Rosas/A-5054-2016; Soares, Irene Silva/C-5974-2012; Gamboa, Dionicia/CAF-2097-2022; Soares, Irene/GQF-1984-2022	Rosanas-Urgell, Anna/0000-0002-0432-5203; Aguirre, Angel Rosas/0000-0002-3271-7028; Soares, Irene Silva/0000-0002-3336-6856; Gamboa, Dionicia/0000-0002-1420-7729; Carrasco-Escobar, Gabriel/0000-0002-6945-0419; ALAVA AREVALO, FREDDY FRANCO/0000-0002-1402-2556; Speybroeck, Niko/0000-0003-3322-3502; Contreras Mancilla, Juan Jose/0000-0003-0447-0926; Llanos-Cuentas, Alejandro/0000-0002-7567-5534	Directorate General for Development Cooperation (DGCD) of the Belgian Government	Directorate General for Development Cooperation (DGCD) of the Belgian Government	The study was funded by the Directorate General for Development Cooperation (DGCD) of the Belgian Government within the Third Framework Agreement of the Institutional Collaboration between the Institute of Tropical Medicine "Alexander von Humboldt" - Universidad Peruana Cayetano Heredia, Lima and the Institute of Tropical Medicine in Antwerp, Belgium (FA3-II project, 2011-2013)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo-Herrera M, 2012, ACTA TROP, V121, P303, DOI 10.1016/j.actatropica.2011.06.008; Arnold BF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093684; Barbosa S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003109; Bautista CT, 2006, AM J TROP MED HYG, V75, P1216, DOI 10.4269/ajtmh.2006.75.1216; Bejon P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021711; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Bousema T, 2010, EMERG INFECT DIS, V16, P392, DOI 10.3201/eid1603.090732; Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27; Chuquiyauri R, 2012, ACTA TROP, V121, P292, DOI 10.1016/j.actatropica.2011.11.003; Cook J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-86; Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137; Cook J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-169; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001; Cunha MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113357; da Silva-Nunes M, 2012, ACTA TROP, V121, P281, DOI 10.1016/j.actatropica.2011.10.001; DiCiccio TJ, 1996, STAT SCI, V11, P189; Dolo A, 2005, AM J TROP MED HYG, V72, P243, DOI 10.4269/ajtmh.2005.72.243; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Elissa N, 2003, ACTA TROP, V85, P355, DOI 10.1016/S0001-706X(02)00266-8; Elliott SR, 2014, F1000PRIME REP, V6, DOI 10.12703/P6-100; Faber BW, 2008, VACCINE, V26, P6143, DOI 10.1016/j.vaccine.2008.08.055; Gagnon AS, 2002, INT J BIOMETEOROL, V46, P81, DOI 10.1007/s00484-001-0119-6; Grietens KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050294; Griffing SM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-303; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Hui S L, 1998, Stat Methods Med Res, V7, P354, DOI 10.1191/096228098671192352; Instituto Nacional de Estadistica e Informatica, 2014, AN EST AMB 2013; Kulldorff, 2010, SATSCAN SOFTWARE SPA; Kulldorff M, 2011, SATSCAN USER GUIDE V; Maheu-Giroux M, 2010, ACTA TROP, V115, P112, DOI 10.1016/j.actatropica.2010.02.011; Maki S, 2001, ENVIRON CONSERV, V28, P199, DOI 10.1017/S0376892901000212; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Ministerio de Salud del Peru, 2013, B EPIDEMIOL, V22, P1088; Muench H., CATALYTIC MODELS EPI, P8928; Okell LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020179; Organismo Andino de Salud-PAMAFRO, 2009, COMP LECC APR; Paganotti GM, 2006, PARASITOLOGY, V132, P607, DOI 10.1017/S0031182005009601; Parekh FK, 2007, AM J TROP MED HYG, V77, P451, DOI 10.4269/ajtmh.2007.77.451; Parker BS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-178; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; QGIS developer team, 2014, QGIS US GUID REL 2 6; Reinbold-Wasson DD, 2012, AM J TROP MED HYG, V86, P459, DOI 10.4269/ajtmh.2012.11-0547; Rodrigues MHC, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-39; Rodriguesa MHC, 2005, INT J PARASITOL, V35, P185, DOI 10.1016/j.ijpara.2004.11.003; Rosas-Aguirre A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-339; Rosas-Aguirre Angel, 2011, Rev. perú. med. exp. salud publica, V28, P228, DOI 10.1590/s1726-46342011000200009; Rosas-Aguirre Ángel, 2010, Rev. perú. med. exp. salud publica, V27, P540, DOI 10.1590/s1726-46342010000400008; Roshanravan B, 2003, AM J TROP MED HYG, V69, P45, DOI 10.4269/ajtmh.2003.69.45; Rubio J M, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS199; Snounou Georges, 2002, Methods Mol Med, V72, P189, DOI 10.1385/1-59259-271-6:189; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467; Supargiyono S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-444; THEISEN M, 1995, CLIN DIAGN LAB IMMUN, V2, P30, DOI 10.1128/CDLI.2.1.30-34.1995; Tusting LS, 2014, ADV PARASIT, V84, P151, DOI 10.1016/B978-0-12-800099-1.00003-X; Vinetz JM, 2002, AM J TROP MED HYG, V66, P639, DOI 10.4269/ajtmh.2002.66.639; Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005	60	41	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137458	10.1371/journal.pone.0137458	http://dx.doi.org/10.1371/journal.pone.0137458			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356311	Green Published, Green Accepted, gold			2022-12-26	WOS:000360965800049
J	Sips, FLP; Nyman, E; Adiels, M; Hilbers, PAJ; Stralfors, P; van Riel, NAW; Cedersund, G				Sips, Fianne L. P.; Nyman, Elin; Adiels, Martin; Hilbers, Peter A. J.; Stralfors, Peter; van Riel, Natal A. W.; Cedersund, Gunnar			Model-Based Quantification of the Systemic Interplay between Glucose and Fatty Acids in the Postprandial State	PLOS ONE			English	Article							HEPATIC INSULIN-RESISTANCE; NUCLEAR-MAGNETIC-RESONANCE; DIACYLGLYCEROL ACTIVATION; OBESE-PATIENTS; METABOLISM; LIVER; MEAL; TRIGLYCERIDE; MECHANISMS; CYCLE	In metabolic diseases such as Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease, the systemic regulation of postprandial metabolite concentrations is disturbed. To understand this dysregulation, a quantitative and temporal understanding of systemic postprandial metabolite handling is needed. Of particular interest is the intertwined regulation of glucose and non-esterified fatty acids (NEFA), due to the association between disturbed NEFA metabolism and insulin resistance. However, postprandial glucose metabolism is characterized by a dynamic interplay of simultaneously responding regulatory mechanisms, which have proven difficult to measure directly. Therefore, we propose a mathematical modelling approach to untangle the systemic interplay between glucose and NEFA in the postprandial period. The developed model integrates data of both the perturbation of glucose metabolism by NEFA as measured under clamp conditions, and postprandial time-series of glucose, insulin, and NEFA. The model can describe independent data not used for fitting, and perturbations of NEFA metabolism result in an increased insulin, but not glucose, response, demonstrating that glucose homeostasis is maintained. Finally, the model is used to show that NEFA may mediate up to 30-45% of the postprandial increase in insulin-dependent glucose uptake at two hours after a glucose meal. In conclusion, the presented model can quantify the systemic interactions of glucose and NEFA in the postprandial state, and may therefore provide a new method to evaluate the disturbance of this interplay in metabolic disease.	[Sips, Fianne L. P.; Hilbers, Peter A. J.; van Riel, Natal A. W.] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Nyman, Elin; Cedersund, Gunnar] Linkoping Univ, Dept Biomed Engn, SE-58185 Linkoping, Sweden; [Nyman, Elin] CVMD iMED DMPK AstraZeneca R&D, S-43183 Molndal, Sweden; [Adiels, Martin] Univ Gothenburg, Hlth Metr Sahlgrenska Acad, Gothenburg, Sweden; [Stralfors, Peter; Cedersund, Gunnar] Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden	Eindhoven University of Technology; Linkoping University; AstraZeneca; University of Gothenburg; Linkoping University	Sips, FLP (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Postbus 513, NL-5600 MB Eindhoven, Netherlands.	f.l.p.sips@tue.nl	van Riel, Natal/J-5319-2013; Nyman, Elin/I-3363-2019	van Riel, Natal/0000-0001-9375-4730; Nyman, Elin/0000-0002-4261-0291; Stralfors, Peter/0000-0002-1196-1806	European Union [305707]; Linkoping Initiative within Life Science Technologies; Ostergotland County Council; Swedish Research Council; AstraZeneca	European Union(European Commission); Linkoping Initiative within Life Science Technologies; Ostergotland County Council; Swedish Research Council(Swedish Research CouncilEuropean Commission); AstraZeneca(AstraZeneca)	This study was supported by the European Union's Seventh Programme for research, technological development and demonstration under grant agreement No 305707, the Linkoping Initiative within Life Science Technologies, the Ostergotland County Council, and the Swedish Research Council. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AstraZeneca provided support in the form of salary for author EN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Adiels M, 2012, ATHEROSCLEROSIS, V222, P222, DOI 10.1016/j.atherosclerosis.2012.02.001; Ajmera I, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.30; Aryangat AV, 2010, VASC HEALTH RISK MAN, V6, P145; Basu R, 2003, AM J PHYSIOL-ENDOC M, V284, pE55, DOI 10.1152/ajpendo.00190.2001; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; BEVILACQUA S, 1987, METABOLISM, V36, P502, DOI 10.1016/0026-0495(87)90051-5; BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Bonora E, 2001, DIABETOLOGIA, V44, P2107, DOI 10.1007/s001250100020; Boren J, 2012, J INTERN MED, V271, P166, DOI 10.1111/j.1365-2796.2011.02497.x; Boston RC, 2008, AM J PHYSIOL-REG I, V294, pR1140, DOI 10.1152/ajpregu.00749.2007; Brannmark C, 2013, J BIOL CHEM, V288, P9867, DOI 10.1074/jbc.M112.432062; Campbell PJ, 2006, AM J PHYSIOL 1, V263, pE1063; Cassader M, 2001, LIPIDS, V36, P1117, DOI 10.1007/s11745-001-0822-5; Cedersund G, 2012, FEBS J, V279, P3513, DOI 10.1111/j.1742-4658.2012.08725.x; Cobelli C, 2014, IEEE T BIO-MED ENG, V61, P1577, DOI 10.1109/TBME.2014.2310514; Dalla Man C, 2006, IEEE T BIO-MED ENG, V53, P2472, DOI 10.1109/TBME.2006.883792; Farmer TG, 2008, J DRUG DELIV SCI TEC, V18, P387, DOI 10.1016/S1773-2247(08)50076-1; FERRANNINI E, 1983, J CLIN INVEST, V72, P1737, DOI 10.1172/JCI111133; Fielding B, 2011, P NUTR SOC, V70, P342, DOI 10.1017/S002966511100084X; Frayn KN, 2003, BIOCHEM SOC T, V31, P1115, DOI 10.1042/BST0311115; Galbo T, 2013, AGING-US, V5, P582, DOI 10.18632/aging.100585; Heath RB, 2007, AM J PHYSIOL-ENDOC M, V292, pE732, DOI 10.1152/ajpendo.00409.2006; Hijmans BS, 2015, FASEB J, V29, P1153, DOI 10.1096/fj.14-254656; Hodson L, 2009, AM J PHYSIOL-ENDOC M, V296, pE64, DOI 10.1152/ajpendo.90730.2008; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Jacome-Sosa MM, 2014, CURR OPIN LIPIDOL, V25, P213, DOI 10.1097/MOL.0000000000000080; Jelic K, 2009, ANN BIOMED ENG, V37, P1897, DOI 10.1007/s10439-009-9738-6; Johanson EH, 2004, J INTERN MED, V255, P273, DOI 10.1046/j.1365-2796.2003.01281.x; Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Kirkman MS, 2006, DIABETES CARE, V29, P2095, DOI 10.2337/dc06-0061; Kotronen A, 2008, GASTROENTEROLOGY, V135, P122, DOI 10.1053/j.gastro.2008.03.021; Krssak M, 2004, DIABETES, V53, P3048, DOI 10.2337/diabetes.53.12.3048; Kruszynska YT, 1997, DIABETES, V46, P1586, DOI 10.2337/diabetes.46.10.1586; Lambert JE, 2014, GASTROENTEROLOGY, V146, P726, DOI 10.1053/j.gastro.2013.11.049; Lambert JE, 2012, BBA-MOL CELL BIOL L, V1821, P721, DOI 10.1016/j.bbalip.2012.01.006; Lefebvre P, 1998, DIABETIC MED, V15, pS63, DOI 10.1002/(SICI)1096-9136(1998120)15:4+<S63::AID-DIA737>3.3.CO;2-Z; Lewis GF, 1997, DIABETES, V46, P1111, DOI 10.2337/diabetes.46.7.1111; Lewis GF, 1998, AM J PHYSIOL-ENDOC M, V275, pE177, DOI 10.1152/ajpendo.1998.275.1.E177; Man CD, 2007, IEEE T BIO-MED ENG, V54, P1740, DOI 10.1109/TBME.2007.893506; Marmarelis V, 2014, LECT N BIOENG, pV; McQuaid SE, 2011, DIABETES, V60, P47, DOI 10.2337/db10-0867; Mooradian AD, 2009, NAT CLIN PRACT ENDOC, V5, P150, DOI 10.1038/ncpendmet1066; Nyman E, 2014, J BIOL CHEM, V289, P33215, DOI 10.1074/jbc.M114.608927; Nyman E, 2011, J BIOL CHEM, V286, P26028, DOI 10.1074/jbc.M110.188987; Ost A, 2010, MOL MED, V16, P235, DOI 10.2119/molmed.2010.00023; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Petersen KF, 2001, METABOLISM, V50, P598, DOI 10.1053/meta.2001.22561; Pratt AC, 2015, MATH BIOSCI, V262, P167, DOI 10.1016/j.mbs.2014.12.012; RANDLE PJ, 1963, LANCET, V1, P785; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Robertson MD, 2002, AM J CLIN NUTR, V75, P505, DOI 10.1093/ajcn/75.3.505; Roden M, 2001, RECENT PROG HORM RES, V56, P219, DOI 10.1210/rp.56.1.219; Roden M, 2000, DIABETES, V49, P701, DOI 10.2337/diabetes.49.5.701; Roy A, 2006, DIABETES TECHNOL THE, V8, P617, DOI 10.1089/dia.2006.8.617; Salinari S, 2007, AM J PHYSIOL-ENDOC M, V292, pE1890, DOI 10.1152/ajpendo.00563.2006; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Shah P, 2002, DIABETES, V51, P301, DOI 10.2337/diabetes.51.2.301; Smith JMD, 2009, OBESITY, V17, P632, DOI 10.1038/oby.2008.604; Staehr P, 2003, DIABETES, V52, P260, DOI 10.2337/diabetes.52.2.260; Szendroedi J, 2014, P NATL ACAD SCI USA, V111, P9597, DOI 10.1073/pnas.1409229111; Taylor R, 1996, J CLIN INVEST, V97, P126, DOI 10.1172/JCI118379; Tiemann CA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003166; van Oostrom AJ, 2004, AM J CLIN NUTR, V79, P510	65	9	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0135665	10.1371/journal.pone.0135665	http://dx.doi.org/10.1371/journal.pone.0135665			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356502	Green Submitted, Green Published, gold			2022-12-26	WOS:000360965800006
J	Bender, J; Engeholm, M; Ederer, MS; Breu, J; Moller, TC; Michalakis, S; Rasko, T; Wanker, EE; Biel, M; Martinez, KL; Wurst, W; Deussing, JM				Bender, Julia; Engeholm, Maik; Ederer, Marion S.; Breu, Johannes; Moller, Thor C.; Michalakis, Stylianos; Rasko, Tamas; Wanker, Erich E.; Biel, Martin; Martinez, Karen L.; Wurst, Wolfgang; Deussing, Jan M.			Corticotropin-Releasing Hormone Receptor Type 1 (CRHR1) Clustering with MAGUKs Is Mediated via Its C-Terminal PDZ Binding Motif	PLOS ONE			English	Article							5-HT2A SEROTONIN RECEPTORS; D-ASPARTATE RECEPTORS; PROTEIN-KINASE-A; INTRACELLULAR LOOP; DENDRITIC SPINES; PSD-95 FAMILY; DOMAIN; COMPLEX; ANXIETY; STRESS	The corticotropin-releasing hormone receptor type 1 (CRHR1) plays an important role in orchestrating neuroendocrine, behavioral, and autonomic responses to stress. To identify molecules capable of directly modulating CRHR1 signaling, we performed a yeast-two-hybrid screen using the C-terminal intracellular tail of the receptor as bait. We identified several members of the membrane-associated guanylate kinase (MAGUK) family: postsynaptic density protein 95 (PSD95), synapse-associated protein 97 (SAP97), SAP102 and membrane associated guanylate kinase, WWand PDZ domain containing 2 (MAGI2). CRHR1 is co-expressed with the identified MAGUKs and with the additionally investigated PSD93 in neurons of the adult mouse brain and in primary hippocampal neurons, supporting the probability of a physiological interaction in vivo. The C-terminal PDZ (PSD-95, discs large, zona occludens 1) binding motif of CRHR1 is essential for its physical interaction with MAGUKs, as revealed by the CRHR1-STAVA mutant, which harbors a functionally impaired PDZ binding motif. The imitation of a phosphorylation at Thr413 within the PDZ binding motif also disrupted the interaction with MAGUKs. In contrast, distinct PDZ domains within the identified MAGUKs are involved in the interactions. Expression of CRHR1 in primary neurons demonstrated its localization throughout the neuronal plasma membrane, including the excitatory post synapse, where the receptor co-localized with PSD95 and SAP97. The co-expression of CRHR1 and respective interacting MAGUKs in HEK293 cells resulted in a clustered subcellular co-localization which required an intact PDZ binding motif. In conclusion, our study characterized the PDZ binding motif-mediated interaction of CRHR1 with multiple MAGUKs, which directly affects receptor function.	[Bender, Julia; Ederer, Marion S.; Deussing, Jan M.] Max Planck Inst Psychiat, Dept Stress Neurobiol & Neurogenet, Mol Neurogenet, Munich, Germany; [Engeholm, Maik; Breu, Johannes] Max Planck Inst Psychiat, Munich, Germany; [Moller, Thor C.; Martinez, Karen L.] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Moller, Thor C.; Martinez, Karen L.] Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark; [Michalakis, Stylianos; Biel, Martin] Univ Munich, CIPSM, Munich, Germany; [Michalakis, Stylianos; Biel, Martin] Univ Munich, Dept Pharm, Ctr Drug Res, Munich, Germany; [Rasko, Tamas; Wanker, Erich E.] Max Delbruck Ctr Mol Med, Berlin, Germany; [Wurst, Wolfgang] German Res Ctr Environm Hlth, Inst Dev Genet, Helmholtz Ctr Munich, Neuherberg, Germany; [Wurst, Wolfgang] German Ctr Neurodegenerat Dis Helmholtz Assoc, Munich, Germany; [Wurst, Wolfgang] Tech Univ Munchen Weihenstephan, Lehrstuhl Entwicklungsgenet Helmholtz Zentram M, Neuherberg, Germany	Max Planck Society; Max Planck Society; University of Copenhagen; University of Copenhagen; University of Munich; University of Munich; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Deussing, JM (corresponding author), Max Planck Inst Psychiat, Dept Stress Neurobiol & Neurogenet, Mol Neurogenet, Munich, Germany.	deussing@psych.mpg.de	Michalakis, Stylianos/M-4677-2019; Martinez, Karen/W-3709-2019; Michalakis, Stylianos/W-2094-2018; martinez, karen L/J-5933-2013; Deussing, Jan M/ABB-5993-2021; Biel, Martin/G-1175-2014; Møller, Thor C/T-9452-2018	Michalakis, Stylianos/0000-0001-5092-9238; Martinez, Karen/0000-0003-0932-8080; Michalakis, Stylianos/0000-0001-5092-9238; martinez, karen L/0000-0003-0932-8080; Biel, Martin/0000-0002-9974-3052; Møller, Thor C/0000-0002-2256-577X; Wurst, Wolfgang/0000-0003-4422-7410; Deussing, Jan/0000-0002-9329-5252; Wanker, Erich/0000-0001-8072-1630	German Federal Ministry of Education and Research [01ZX1314H]; program for medical genome research within the framework of the NGFN-Plus [FKZ: 01GS08151]; Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); program for medical genome research within the framework of the NGFN-Plus; Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association	This work was partially supported by the German Federal Ministry of Education and Research (http://www.bmbf.de/en/), within the framework of the e:Med research and funding concept (IntegraMent: Integrated Understanding of Causes and Mechanisms in Mental Disorders; FKZ 01ZX1314H), by the program for medical genome research within the framework of the NGFN-Plus (FKZ: 01GS08151) and by the Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama KT, 2013, J BIOL CHEM, V288, P6438, DOI 10.1074/jbc.M112.412478; Andres AL, 2013, J NEUROSCI, V 33, P16945, DOI 10.1523/JNEUROSCI.1445-13.2013; Arborelius L, 1999, J ENDOCRINOL, V160, P1, DOI 10.1677/joe.0.1600001; Becamel C, 2004, J BIOL CHEM, V279, P20257, DOI 10.1074/jbc.M312106200; Chen Y, 2004, NEUROSCIENCE, V126, P533, DOI 10.1016/j.neuroscience.2004.03.036; Chen Y, 2013, MOL PSYCHIATR, V18, P485, DOI 10.1038/mp.2012.17; Chen YC, 2008, J NEUROSCI, V28, P2903, DOI 10.1523/JNEUROSCI.0225-08.2008; Chen YC, 2010, P NATL ACAD SCI USA, V107, P13123, DOI 10.1073/pnas.1003825107; Chetkovich DM, 2002, J NEUROSCI, V22, P5791; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Dunn HA, 2014, MOL PHARMACOL, V86, P275, DOI 10.1124/mol.114.093476; Dunn HA, 2013, J BIOL CHEM, V288, P15023, DOI 10.1074/jbc.M113.473660; Fiorentini M, 2013, ACTA CRYSTALLOGR D, V69, P587, DOI 10.1107/S0907444912051839; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Gardiol D, 2002, J GEN VIROL, V83, P283, DOI 10.1099/0022-1317-83-2-283; Gerrow K, 2006, NEURON, V49, P547, DOI 10.1016/j.neuron.2006.01.015; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Graf C, 2012, MOL CELL ENDOCRINOL, V362, P29, DOI 10.1016/j.mce.2012.05.007; Grammatopoulos D, 1996, J CLIN ENDOCR METAB, V81, P745, DOI 10.1210/jc.81.2.745; Grammatopoulos DK, 2002, TRENDS ENDOCRIN MET, V13, P436, DOI 10.1016/S1043-2760(02)00670-7; Grant SGN, 2012, CURR OPIN NEUROBIOL, V22, P522, DOI 10.1016/j.conb.2012.02.002; Gutknecht E, 2009, MOL PHARMACOL, V75, P648, DOI 10.1124/mol.108.050427; Hauger RL, 2009, ANN NY ACAD SCI, V1179, P120, DOI 10.1111/j.1749-6632.2009.05011.x; Hirao K, 2000, J BIOL CHEM, V275, P2966, DOI 10.1074/jbc.275.4.2966; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Justice NJ, 2008, J COMP NEUROL, V511, P479, DOI 10.1002/cne.21848; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Koch S, 2012, HUM MOL GENET, V21, P4486, DOI 10.1093/hmg/dds290; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kovalovsky D, 2002, MOL ENDOCRINOL, V16, P1638, DOI 10.1210/me.16.7.1638; Kristiansen LV, 2005, SCHIZOPHR RES, V78, P87, DOI 10.1016/j.schres.2005.06.012; Kurakin A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000953; Lauks J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039420; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Lida J, 2004, MOL CELL NEUROSCI, V27, P497, DOI 10.1016/j.mcn.2004.08.006; Lim IA, 2002, J BIOL CHEM, V277, P21697, DOI 10.1074/jbc.M112339200; Mack V, 2001, SCIENCE, V292, P2501, DOI 10.1126/science.1059365; Magalhaes AC, 2010, NAT NEUROSCI, V13, P622, DOI 10.1038/nn.2529; Moller TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063352; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Muller MB, 2003, NAT NEUROSCI, V6, P1100, DOI 10.1038/nn1123; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Niethammer M, 1996, J NEUROSCI, V16, P2157; Oakley RH, 2007, AM J PHYSIOL-REG I, V293, pR209, DOI 10.1152/ajpregu.00099.2006; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Papadopoulou N, 2004, MOL ENDOCRINOL, V18, P624, DOI 10.1210/me.2003-0365; Petralia RS, 2010, NEUROSCIENCE, V167, P68, DOI 10.1016/j.neuroscience.2010.01.022; Punn A, 2012, J BIOL CHEM, V287, P8974, DOI 10.1074/jbc.M111.272161; Refojo D, 2005, P NATL ACAD SCI USA, V102, P6183, DOI 10.1073/pnas.0502070102; Refojo D, 2011, SCIENCE, V333, P1903, DOI 10.1126/science.1202107; Reul Johannes M H M, 2002, Dialogues Clin Neurosci, V4, P31; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Szidonya L, 2008, J ENDOCRINOL, V196, P435, DOI 10.1677/JOE-07-0573; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; von Ossowski I, 2006, FEBS J, V273, P5219, DOI 10.1111/j.1742-4658.2006.05521.x; Xia Z, 2003, NEUROSCIENCE, V122, P907, DOI 10.1016/S0306-4522(03)00589-X; Xia ZQ, 2003, J BIOL CHEM, V278, P21901, DOI 10.1074/jbc.M301905200	64	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136768	10.1371/journal.pone.0136768	http://dx.doi.org/10.1371/journal.pone.0136768			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352593	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000360932800048
J	Cooper, R; Wang, CL; Singh, N				Cooper, Richard; Wang, Changlu; Singh, Narinderpal			Mark-Release-Recapture Reveals Extensive Movement of Bed Bugs (Cimex lectularius L.) within and between Apartments	PLOS ONE			English	Article							TRAUMATIC INSEMINATION; AGGREGATION BEHAVIOR; HEMIPTERA CIMICIDAE; SEXUAL CONFLICT; CARBON-DIOXIDE; CHEMICAL LURE; INFESTATION; RESPONSES; BIOLOGY; TRAP	Understanding movement and dispersal of the common bed bug (Cimex lectularius L.) under field conditions is important in the control of infestations and for managing the spread of bed bugs to new locations. We investigated bed bug movement within and between apartments using mark-release-recapture (m-r-r) technique combined with apartment-wide monitoring using pitfall-style interceptors. Bed bugs were collected, marked, and released in six apartments. The distribution of marked and unmarked bed bugs in these apartments and their 24 neighboring units were monitored over 32 days. Extensive movement of marked bed bugs within and between apartments occurred regardless of the number of bed bugs released or presence/absence of a host. Comparison of marked and unmarked bed bug distributions confirms that the extensive bed bug activity observed was not an artifact of the m-r-r technique used. Marked bed bugs were recovered in apartments neighboring five of six m-r-r apartments. Their dispersal rates at 14 or 15 d were 0.0-5.0%. The estimated number of bed bugs per apartment in the six m-r-r apartments was 2,433-14,291 at 4-7 d after release. Longevity of bed bugs in the absence of a host was recorded in a vacant apartment. Marked large nymphs (3rd -5th instar), adult females, and adult males continued to be recovered up to 57, 113, and 134 d after host absence, respectively. Among the naturally existing unmarked bed bugs, unfed small nymphs (1st -2nd instar) were recovered up to 134 d; large nymphs and adults were still found at 155 d when the study ended. Our findings provide important insight into the behavioral ecology of bed bugs in infested apartments and have significant implications in regards to eradication programs and managing the spread of bed bugs within multi-occupancy dwellings.	[Cooper, Richard; Wang, Changlu; Singh, Narinderpal] Rutgers State Univ, Dept Entomol, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick	Cooper, R (corresponding author), Rutgers State Univ, Dept Entomol, New Brunswick, NJ 08903 USA.	rcooper@aesop.rutgers.edu	Wang, Changlu/P-1381-2014		Norm Ehmann Urban Pest Management Award; New Jersey Agricultural Experiment Station; USDA-National Institute for Food and Agriculture, Hatch Multistate [NJ08127]; Oregon and Washington State Pest Management Associations; USDA NIFA	Norm Ehmann Urban Pest Management Award; New Jersey Agricultural Experiment Station; USDA-National Institute for Food and Agriculture, Hatch Multistate; Oregon and Washington State Pest Management Associations; USDA NIFA(United States Department of Agriculture (USDA))	This project was partially funded by the Norm Ehmann Urban Pest Management Award and the New Jersey Agricultural Experiment Station and by the USDA-National Institute for Food and Agriculture, Hatch Multistate project number NJ08127. The Norm Ehmann Award was funded by the Oregon and Washington State Pest Management Associations and was managed by Washington State University. The Hatch Multistate Project is through the New Jersey Agricultural Experiment Station which is funded by USDA NIFA. None of the funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aak A, 2014, PHYSIOL ENTOMOL, V39, P199, DOI 10.1111/phen.12062; Anderson JF, 2009, MED VET ENTOMOL, V23, P99, DOI 10.1111/j.1365-2915.2008.00790.x; BELL WJ, 1990, ANNU REV ENTOMOL, V35, P447, DOI 10.1146/annurev.en.35.010190.002311; Booth W, 2012, J MED ENTOMOL, V49, P535, DOI 10.1603/ME11256; Cooper R, 2014, J ECON ENTOMOL, V107, P2171, DOI 10.1603/EC14195; Cooper RA, 2016, PEST MANAG SCI, V72, P45, DOI 10.1002/ps.3982; Doggett S. L., 2008, 6th International Conference on Urban Pests, Budapest, Hungary, 13-16 July 2008, P407; GRIFFITHS D, 1980, J ANIM ECOL, V49, P99, DOI 10.2307/4279; Haynes KF, 2008, PESTWORLD        MAR, P5; How YF, 2010, J MED ENTOMOL, V47, P305, DOI 10.1603/ME10004; Johnson CG, 1937, P ZOOL SOC LOND A-GE, V107, P107; Johnson CG, 1941, J HYG-CAMBRIDGE, V41, P345, DOI 10.1017/S0022172400012560; Kemper H, 1936, Z KLEINTIERK PELZTIE, V12, P1; KEMPER HEINRICH, 1930, ZEITSCHR WISS BIOL ABT A MORPH U OKOL TIERE, V19, P160, DOI 10.1007/BF00412294; Lehnert M., 2013, THESIS CLEMSON U; Marx R., 1955, Zeitschrift fuer Parasitenkunde, V17, P41; MELLANBY KENNETH, 1939, PARASITOLOGY, V31, P200, DOI 10.1017/S0031182000012762; National Pest Management Association, 2011, BEST MAN PRACT BED B; Naylor R., 2012, THESIS U SHEFFIELD; Olson JF, 2009, J INSECT PHYSIOL, V55, P580, DOI 10.1016/j.jinsphys.2009.03.001; Omori N., 1941, Journal of the Medical Association of Formosa, V60, P555; Pfiester Margie, 2009, American Entomologist, V55, P244; Pfiester M, 2009, J MED ENTOMOL, V46, P1015, DOI 10.1603/033.046.0506; Pinto L. J., 2007, BED BUG HDB COMPLETE; Polanco Andrea M., 2011, Insects, V2, P232, DOI 10.3390/insects2020232; Potter M. F., 2013, Pest Control Technology, V41, P72; Potter MF, 2013, PEST CONTROL TECHNOL, V41, P80; Potter MF, 2013, PEST CONTROL TECHNOL, V41, P78; Potter MF, 2013, PEST CONTROL TECHNOL, V41, P76; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; Reis MD, 2011, INSECTS, V2, P185; RIVNAY EZEKIEL, 1932, PARASITOLOGY, V24, P121, DOI 10.1017/S0031182000020461; Romero A, 2010, J INSECT PHYSIOL, V56, P1516, DOI 10.1016/j.jinsphys.2010.04.025; Romero A, 2009, J MED ENTOMOL, V46, P51, DOI 10.1603/033.046.0107; Saenz VL, 2012, J MED ENTOMOL, V49, P865, DOI 10.1603/ME11202; Singh N, 2012, PSYCHE; Singh N, 2013, J ECON ENTOMOL, V106, P1802, DOI 10.1603/EC13075; STRADLIN.DJ, 1970, J ANIM ECOL, V39, P575, DOI 10.2307/2855; Stutt AD, 2001, P NATL ACAD SCI USA, V98, P5683, DOI 10.1073/pnas.101440698; Usinger R., 1966, MONOGRAPH CIMICIDAE, V7; Wang C., 2012, P POST DEM TRACK, P4; Wang CL, 2011, J ECON ENTOMOL, V104, P274, DOI 10.1603/EC10141; Wang CL, 2010, J ECON ENTOMOL, V103, P172, DOI 10.1603/EC09230; Wang CL, 2009, J MED ENTOMOL, V46, P566, DOI 10.1603/033.046.0322	44	39	40	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136462	10.1371/journal.pone.0136462	http://dx.doi.org/10.1371/journal.pone.0136462			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352145	Green Published, Green Submitted, gold			2022-12-26	WOS:000360932800036
J	Nassal, MMJ; Wan, XP; Laurita, KR; Cutler, MJ				Nassal, Michelle M. J.; Wan, Xiaoping; Laurita, Kenneth R.; Cutler, Michael J.			Atrial SERCA2a Overexpression Has No Affect on Cardiac Alternans but Promotes Arrhythmogenic SR Ca2+ Triggers	PLOS ONE			English	Article							REPOLARIZATION ALTERNANS; INTRACELLULAR CALCIUM; ACTION-POTENTIALS; FIBRILLATION; MYOCYTES; MECHANISM; REFRACTORINESS; DYSFUNCTION; SIMULATION; INSIGHTS	Background Atrial fibrillation (AF) is the most common arrhythmia in humans, yet; treatment has remained sub-optimal due to poor understanding of the underlying mechanisms. Cardiac alternans precede AF episodes, suggesting an important arrhythmia substrate. Recently, we demonstrated ventricular SERCA2a overexpression suppresses cardiac alternans and arrhythmias. Therefore, we hypothesized that atrial SERCA2a overexpression will decrease cardiac alternans and arrhythmias. Methods Adult rat isolated atrial myocytes where divided into three treatment groups 1) Control, 2) SERCA2a overexpression (Ad. SERCA2a) and 3) SERCA2a inhibition (Thapsigargin, 1 mu m). Intracellular Ca2+ was measured using Indo-1AM and Ca2+ alternans (Ca-ALT) was induced with a standard ramp pacing protocol. Results As predicted, SR Ca2+ reuptake was enhanced with SERCA2a overexpression (p < 0.05) and reduced with SERCA2a inhibition (p < 0.05). Surprisingly, there was no difference in susceptibility to Ca-ALT with either SERCA2a overexpression or inhibition when compared to controls (p = 0.73). In contrast, SERCA2a overexpression resulted in increased premature SR Ca2+ (SCR) release compared to control myocytes (28% and 0%, p < 0.05) and concomitant increase in SR Ca2+ load (p < 0.05). Based on these observations we tested in-vivo atrial arrhythmia inducibility in control and Ad. SERCA2a animals using an esophageal atrial burst pacing protocol. There were no inducible atrial arrhythmias in Ad. GFP (n = 4) animals though 20% of Ad. SERCA2a (n = 5) animals had inducible atrial arrhythmias (p = 0.20). Conclusions Our findings suggest that unlike the ventricle, SERCA2a is not a key regulator of cardiac alternans in the atrium. Importantly, SERCA2a overexpression in atrial myocytes can increase SCR, which may be arrhythmogenic.	[Nassal, Michelle M. J.; Wan, Xiaoping; Laurita, Kenneth R.; Cutler, Michael J.] Case Western Reserve Univ, Heart & Vasc Res Ctr, Cleveland, OH 44106 USA; [Nassal, Michelle M. J.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Cutler, Michael J.] Intermt Heart Inst, Salt Lake City, UT USA	Case Western Reserve University; Case Western Reserve University	Cutler, MJ (corresponding author), Case Western Reserve Univ, Heart & Vasc Res Ctr, Cleveland, OH 44106 USA.	Michael.Cutler@imail.org			National Institutes of Health [T32CM007250, T32HL105338]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL105338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants T32CM007250 and T32HL105338.	Bers DM, 2014, ANNU REV PHYSIOL, V76, P107, DOI 10.1146/annurev-physiol-020911-153308; Bosch RF, 1999, CARDIOVASC RES, V44, P121, DOI 10.1016/S0008-6363(99)00178-9; Brette F, 2003, CIRC RES, V92, P1182, DOI 10.1161/01.RES.0000074908.17214.FD; Burstein B, 2009, CIRC RES, V105, P1213, DOI 10.1161/CIRCRESAHA.108.183400; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Cutler MJ, 2009, CIRC-ARRHYTHMIA ELEC, V2, P686, DOI 10.1161/CIRCEP.109.863118; De Jong AM, 2013, J CELL MOL MED, V17, P743, DOI 10.1111/jcmm.12064; del Monte F, 2004, P NATL ACAD SCI USA, V101, P5622, DOI 10.1073/pnas.0305778101; Dibb KM, 2009, CIRC-HEART FAIL, V2, P482, DOI 10.1161/CIRCHEARTFAILURE.109.852228; Gong YF, 2007, CIRCULATION, V115, P2094, DOI 10.1161/CIRCULATIONAHA.106.656504; Gyorke I, 1998, BIOPHYS J, V75, P2801, DOI 10.1016/S0006-3495(98)77723-9; Heijman J, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00030; Hiromoto K, 2005, CIRC J, V69, P1368, DOI 10.1253/circj.69.1368; Laurita KR, 2003, CIRC RES, V92, P668, DOI 10.1161/01.RES.0000062468.25308.27; Lenaerts I, 2009, CIRC RES, V105, P876, DOI 10.1161/CIRCRESAHA.109.206276; Li QC, 2012, BIOPHYS J, V102, P1471, DOI 10.1016/j.bpj.2012.03.007; Liang X, 2008, CARDIOLOGY, V111, P102, DOI 10.1159/000119697; Lugo CA, 2014, AM J PHYSIOL-HEART C, V306, pH1540, DOI 10.1152/ajpheart.00515.2013; Narayan SM, 2011, CIRCULATION, V123, P2922, DOI 10.1161/CIRCULATIONAHA.110.977827; Narayan SM, 2002, CIRCULATION, V106, P1968, DOI 10.1161/01.CIR.0000037062.35762.B4; Pastore JM, 2000, CIRC RES, V87, P1157, DOI 10.1161/01.RES.87.12.1157; Schlotthauer K, 2000, CIRC RES, V87, P774, DOI 10.1161/01.RES.87.9.774; Shkryl VM, 2012, AM J PHYSIOL-HEART C, V302, pH2310, DOI 10.1152/ajpheart.00079.2012; Tsai CT, 2011, J AM COLL CARDIOL, V58, P2106, DOI 10.1016/j.jacc.2011.07.039; Van Wagoner DR, 1999, CIRC RES, V85, P428, DOI 10.1161/01.RES.85.5.428; Vest JA, 2005, CIRCULATION, V111, P2025, DOI 10.1161/01.CIR.0000162461.67140.4C; Walden AP, 2009, J MOL CELL CARDIOL, V46, P463, DOI 10.1016/j.yjmcc.2008.11.003; Wan XP, 2005, J MOL CELL CARDIOL, V39, P419, DOI 10.1016/j.yjmcc.2005.06.004; Xie WJ, 2013, J MOL CELL CARDIOL, V64, P120, DOI 10.1016/j.yjmcc.2013.09.003; Yeh YH, 2008, CIRC-ARRHYTHMIA ELEC, V1, P93, DOI 10.1161/CIRCEP.107.754788	30	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137359	10.1371/journal.pone.0137359	http://dx.doi.org/10.1371/journal.pone.0137359			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352986	Green Published, Green Submitted, gold			2022-12-26	WOS:000360932800078
J	No, YR; Lee, SJ; Kumar, A; Yun, CC				No, Yi Ran; Lee, Sei-Jung; Kumar, Ajay; Yun, C. Chris			HIF1 alpha-Induced by Lysophosphatidic Acid Is Stabilized via Interaction with MIF and CSN5	PLOS ONE			English	Article							MIGRATION-INHIBITORY FACTOR; HYPOXIA-INDUCIBLE FACTOR; FACTOR GENE; CANCER; EXPRESSION; SURVIVAL; COLITIS; PROTEIN; MICE; P53	Macrophage migration inhibitory factor (MIF) is a cytokine that has broad effects on immune system and inflammatory response. A growing body of evidence implicates the role of MIF in tumor growth and metastasis. Lysophosphatidic acid (LPA), a bioactive lipid mediator, regulates colon cancer cell proliferation, invasion, and survival through LPA(2) receptor. Loss of LPA(2) results in decreased expression of MIF in a rodent model of colon cancer, but the mechanism of MIF regulation by LPA is yet to be determined. In this study, we show that LPA transcriptionally regulates MIF expression in colon cancer cells. MIF knockdown decreased LPA-mediated proliferation of HCT116 human adenocarcinoma cells without altering the basal proliferation rates. Conversely, extracellular recombinant MIF stimulated cell proliferation, suggesting that the effect of MIF may in part be mediated through activation of surface receptor. We have shown recently that LPA increases hypoxia-inducible factor 1 alpha (HIF1 alpha) expression. We found that MIF regulation by LPA was ablated by knockdown of HIF1 alpha, indicating that MIF is a transcriptional target of HIF1 alpha. Conversely, knockdown of MIF ablated an increase in HIF1 alpha expression in LPA-treated cells, suggesting a reciprocal relationship between HIF1 alpha and MIF. LPA stimulated co-immunoprecipitation of HIF1 alpha and MIF, indicating that their association is necessary for stabilization of HIF1 alpha. It has been shown previously that CSN9 signalosome subunit 5 (CSN5) interacts with HIF1 alpha to stabilize HIF1 alpha under aerobic conditions. We found that LPA did not alter expression of CSN5, but stimulated its interaction with HIF1 alpha and MIF. Depletion of CSN5 mitigated the association between HIF1 alpha and MIF, indicating that CSN5 acts as a physical link. We suggest that HIF1 alpha, MIF, and CSN5 form a ternary complex whose formation is necessary to prevent degradation of HIF1 alpha under aerobic conditions.	[No, Yi Ran; Lee, Sei-Jung; Kumar, Ajay; Yun, C. Chris] Emory Univ, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA; [Yun, C. Chris] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University	Yun, CC (corresponding author), Emory Univ, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA.	ccyun@emory.edu	Kumar, Ajay/AER-0947-2022; Lee, Sei-Jung/V-8772-2019		National Institutions of Health [R01DK071597]; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071597] Funding Source: NIH RePORTER	National Institutions of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: This work was supported by National Institutions of Health grant R01DK071597 and a Senior Research Award from the Crohn's and Colitis Foundation of America to C.C.Y.	Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Bae MK, 2002, J BIOL CHEM, V277, P9, DOI 10.1074/jbc.C100442200; Bai FW, 2012, J BIOL CHEM, V287, P30653, DOI 10.1074/jbc.M112.385583; Baugh JA, 2006, BIOCHEM BIOPH RES CO, V347, P895, DOI 10.1016/j.bbrc.2006.06.148; Bemis L, 2004, GENE DEV, V18, P739, DOI 10.1101/gad.1180104; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; del Vecchio MT, 2000, PROSTATE, V45, P51, DOI 10.1002/1097-0045(20000915)45:1<51::AID-PROS6>3.0.CO;2-9; Fingerle-Rowson G, 2009, MOL CELL BIOL, V29, P1922, DOI 10.1128/MCB.01907-08; Han I, 2008, CLIN ORTHOP RELAT R, V466, P2107, DOI 10.1007/s11999-008-0333-1; He PJ, 2011, MOL BIOL CELL, V22, P3812, DOI 10.1091/mbc.E11-04-0328; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Koong AC, 2000, CANCER RES, V60, P883; Kotch LE, 1999, DEV BIOL, V209, P254, DOI 10.1006/dbio.1999.9253; Larsen M, 2008, CANCER LETT, V265, P239, DOI 10.1016/j.canlet.2008.02.012; Lee SJ, 2013, J BIOL CHEM, V288, P25244, DOI 10.1074/jbc.M113.489708; Legendre H, 2003, MODERN PATHOL, V16, P491, DOI 10.1097/01.MP.0000068235.45178.C1; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lin SB, 2010, AM J PHYSIOL-GASTR L, V299, pG1128, DOI 10.1152/ajpgi.00321.2010; Lin SB, 2009, GASTROENTEROLOGY, V136, P1711, DOI 10.1053/j.gastro.2009.01.002; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Maaser C, 2002, GASTROENTEROLOGY, V122, P667, DOI 10.1053/gast.2002.31891; Meyer-Siegler KL, 2007, GENES IMMUN, V8, P646, DOI 10.1038/sj.gene.6364427; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Nemajerova A, 2007, EMBO J, V26, P987, DOI 10.1038/sj.emboj.7601564; Nishihira J, 2012, ANN NY ACAD SCI, V1271, P53, DOI 10.1111/j.1749-6632.2012.06735.x; Nohara H, 2004, J GASTROENTEROL, V39, P242, DOI 10.1007/s00535-003-1284-7; Oda S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002215; Ohkawara T, 2005, CLIN EXP IMMUNOL, V140, P241, DOI 10.1111/j.1365-2249.2005.02771.x; Ohkawara T, 2002, GASTROENTEROLOGY, V123, P256, DOI 10.1053/gast.2002.34236; Ren Y, 2005, ANN SURG, V242, P55, DOI 10.1097/01.sla.0000168555.97710.bb; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Simpson KD, 2012, J IMMUNOL, V189, P5533, DOI 10.4049/jimmunol.1201161; Sun B, 2005, CLIN CANCER RES, V11, P1050; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Wilson JM, 2005, GASTROENTEROLOGY, V129, P1485, DOI 10.1053/j.gastro.2005.07.061; Winner M, 2007, CANCER RES, V67, P186, DOI 10.1158/0008-5472.CAN-06-3292; Yao KS, 2005, CLIN CANCER RES, V11, P7264, DOI 10.1158/1078-0432.CCR-05-0135; Yun CC, 2015, EXP CELL RES, V333, P201, DOI 10.1016/j.yexcr.2014.11.013; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458	48	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137513	10.1371/journal.pone.0137513	http://dx.doi.org/10.1371/journal.pone.0137513			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352431	gold, Green Published, Green Submitted			2022-12-26	WOS:000360932800092
J	Pertesi, M; Galia, P; Nazaret, N; Vallee, M; Garderet, L; Leleu, X; Avet-Loiseau, H; Foll, M; Byrnes, G; Lachuer, J; Mckay, JD; Dumontet, C				Pertesi, Maroulio; Galia, Perrine; Nazaret, Nicolas; Vallee, Maxime; Garderet, Laurent; Leleu, Xavier; Avet-Loiseau, Herve; Foll, Matthieu; Byrnes, Graham; Lachuer, Joel; Mckay, James D.; Dumontet, Charles			Rare Circulating Cells in Familial Waldenstrom Macroglobulinemia Displaying the MYD88 L265P Mutation Are Enriched by Epstein-Barr Virus Immortalization	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; M MONOCLONAL GAMMOPATHY; DNA-SEQUENCING DATA; LYMPHOPROLIFERATIVE DISORDERS; READ ALIGNMENT; LYMPHOCYTES-B; EXPRESSION; FRAMEWORK; VARIANTS; LINES	The MYD88 L265P is a recurrent somatic mutation in neoplastic cells from patients with Waldenstrom Macroglobulinemia (WM). We identified the MYD88 L265P mutation in three individuals from unrelated families, but its presence did not explain the disease segregation within these WM pedigrees. We observed the mutation in these three individuals at high allele fractions in DNA extracted from EBV-immortalized Lymphoblastoid cell lines established from peripheral blood (LCL), but at much lower allele fractions in DNA extracted directly from peripheral blood, suggesting that this mutation is present in a clonal cell sub-population rather than of germ-line origin. Furthermore, we observed that the MYD88 L265P mutation is enriched in WM families, detected in 40.5% of patients with familial WM or MGUS (10/22 WM, 5/15 MGUS), compared to 3.5% of patients with familial MM or MGUS (0/72 MM, 4/41 MGUS) (p = 10(-7)). The mutant allele frequency increased with passages in vitro after immortalization with Epstein-Barr virus (EBV) consistent with the MYD88 L265P described gain-of-function proposed for this mutation. The MYD88 L265P mutation appears to be frequently present in circulating cells in patients with WM, and MGUS, and these cells are amenable to immortalization by EBV.	[Pertesi, Maroulio; Vallee, Maxime; Foll, Matthieu; Mckay, James D.] Int Agcy Res Canc, Genet Canc Susceptibil, F-69372 Lyon, France; [Galia, Perrine; Dumontet, Charles] Hosp Civils Lyon, Pierre Benite, France; [Galia, Perrine; Dumontet, Charles] CRCL, CNRS 5286, INSERM 1052, Lyon, France; [Galia, Perrine; Dumontet, Charles] Univ Lyon, Lyon, France; [Galia, Perrine; Nazaret, Nicolas; Lachuer, Joel; Dumontet, Charles] ProfilExpert, Lyon, France; [Garderet, Laurent] INSERM, UMR S Proliferat & Differentiat Stem Cells 938, Paris, France; [Garderet, Laurent] Hop St Antoine, AP HP, Dept Hematol & Therapie Cellulaire, F-75571 Paris, France; [Garderet, Laurent] Univ Paris 06, Sorbonne Univ, Paris, France; [Leleu, Xavier] CHRU Lille, Hop Huriez, Serv Malad Sang, F-59037 Lille, France; [Leleu, Xavier] Inst Rech Canc IRCL, Facteurs Persistance Cellules Leucem, Ctr Rech, INSERM,U837, Lille, France; [Avet-Loiseau, Herve] CRCT INSERM U1037, Inst Univ Canc Toulouse Oncopole, Unite Genom Myelome, Toulouse, France; [Byrnes, Graham] Int Agcy Res Canc, Biostat, F-69372 Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC); CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre de Recherche en cancerologie (CRCL); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); World Health Organization; International Agency for Research on Cancer (IARC)	Dumontet, C (corresponding author), Hosp Civils Lyon, Pierre Benite, France.	charles.dumontet@chu-lyon.fr	Foll, Matthieu/A-8561-2014; Avet-Loiseau, Herve/P-8872-2014	Foll, Matthieu/0000-0001-9006-8436; Avet-Loiseau, Herve/0000-0002-3050-0140; Byrnes, Graham/0000-0003-3893-7539; lachuer, joel/0000-0002-5209-5094; Vallee, Maxime/0000-0002-3616-9508; Dumontet, Charles/0000-0003-1875-134X	Institut National du Cancer (INCA) [2010-077]; Fondation Francaise pour la Recherche contre le Mylome et les Gammapathies (FFRMG)	Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France); Fondation Francaise pour la Recherche contre le Mylome et les Gammapathies (FFRMG)	The work was funded from the Institut National du Cancer (INCA, Projet Transla 2010-077, CD) and the Fondation Francaise pour la Recherche contre le Mylome et les Gammapathies (FFRMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; DOYLE MG, 1993, LEUKEMIA, V7, P1858; HAMMERSCHMIDT W, 1989, NATURE, V340, P393, DOI 10.1038/340393a0; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jimenez C, 2014, APPL IMMUNOHISTO M M, V22, P768, DOI 10.1097/PAI.0000000000000020; Kriangkum J, 2004, BLOOD, V104, P2134, DOI 10.1182/blood-2003-11-4024; Kristinsson SY, 2008, BLOOD, V112, P3052, DOI 10.1182/blood-2008-06-162768; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kyle RA, 2013, CL LYMPH MYELOM LEUK, V13, P184, DOI 10.1016/j.clml.2013.02.005; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee JE, 2010, CELL PROLIFERAT, V43, P378, DOI 10.1111/j.1365-2184.2010.00687.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mori N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080088; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; SMITH BR, 1983, BLOOD, V61, P911; Steingrimsson V, 2015, BLOOD, V125, P2174, DOI 10.1182/blood-2015-01-622068; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; SZEKELY L, 1995, ONCOGENE, V10, P1869; Toffart AC, 2014, LUNG CANCER, V83, P182, DOI 10.1016/j.lungcan.2013.12.003; Treon SP, 2006, ANN ONCOL, V17, P488, DOI 10.1093/annonc/mdj111; Treon SP, 2012, NEW ENGL J MED, V367, P826, DOI 10.1056/NEJMoa1200710; Walsh DE, 2001, J BIOL CHEM, V276, P35494, DOI 10.1074/jbc.M103543200; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Xu L, 2013, BLOOD, V121, P2051, DOI 10.1182/blood-2012-09-454355	27	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136505	10.1371/journal.pone.0136505	http://dx.doi.org/10.1371/journal.pone.0136505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352266	Green Published, Green Submitted, gold			2022-12-26	WOS:000360932800037
J	Seibert, AM; Koblitz, JC; Denzinger, A; Schnitzler, HU				Seibert, Anna-Maria; Koblitz, Jens C.; Denzinger, Annette; Schnitzler, Hans-Ulrich			Bidirectional Echolocation in the Bat Barbastella barbastellus: Different Signals of Low Source Level Are Emitted Upward through the Nose and Downward through the Mouth	PLOS ONE			English	Article							DIRECTIONALITY; TACTICS; DETECT; RANGE; MOTHS	The Barbastelle bat (Barbastella barbastellus) preys almost exclusively on tympanate moths. While foraging, this species alternates between two different signal types. We investigated whether these signals differ in emission direction or source level (SL) as assumed from earlier single microphone recordings. We used two different settings of a 16-microphone array to determine SL and sonar beam direction at various locations in the field. Both types of search signals had low SLs (81 and 82 dB SPL rms re 1 m) as compared to other aerial-hawking bats. These two signal types were emitted in different directions; type 1 signals were directed downward and type 2 signals upward. The angle between beam directions was approximately 70 degrees. Barbastelle bats are able to emit signals through both the mouth and the nostrils. As mouth and nostrils are roughly perpendicular to each other, we conclude that type 1 signals are emitted through the mouth while type 2 signals and approach signals are emitted through the nose. We hypothesize that the "stealth" echolocation system of B. barbastellus is bifunctional. The more upward directed nose signals may be mainly used for search and localization of prey. Their low SL prevents an early detection by eared moths but comes at the expense of a strongly reduced detection range for the environment below the bat. The more downward directed mouth signals may have evolved to compensate for this disadvantage and may be mainly used for spatial orientation. We suggest that the possibly bifunctional echolocation system of B. barbastellus has been adapted to the selective foraging of eared moths and is an excellent example of a sophisticated sensory arms race between predator and prey.	[Seibert, Anna-Maria; Koblitz, Jens C.; Denzinger, Annette; Schnitzler, Hans-Ulrich] Univ Tubingen, Inst Neurobiol, Anim Physiol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Seibert, AM (corresponding author), Univ Tubingen, Inst Neurobiol, Anim Physiol, Morgenstelle 28, D-72076 Tubingen, Germany.	anni.seibert@googlemail.com			Werner Reichardt Centre for Integrative Neuroscience (CIN) at the Eberhard Karls University of Tubingen [S.51.40001.2]; Deutsche Forschungsgemeinschaft (DFG) [SFB 550, Schn 138/27-1, EXC 307]	Werner Reichardt Centre for Integrative Neuroscience (CIN) at the Eberhard Karls University of Tubingen; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was funded by the Werner Reichardt Centre for Integrative Neuroscience (CIN) at the Eberhard Karls University of Tubingen (S.51.40001.2). The CIN is an Excellence Cluster funded by the Deutsche Forschungsgemeinschaft (DFG) within the framework of the Excellence Initiative (EXC 307). This study was also funded by the Deutsche Forschungsgemeinschaft (SFB 550 and Schn 138/27-1). Furthermore we acknowledge support by the Deutsche Forschungsgemeinschaft and the Open Access Publishing Fund of the University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlen I., 1981, Sveriges Lantbruksuniversitet Institutionen for Viltekologi Rapport, P1; Ahlen I., 1990, IDENTIFICATION BATS; Barataud M, 2001, VESPERE, V2, P95; Barataud M, 2004, RHINOLOPHE, V17, P87; Denzinger A, 2001, J COMP PHYSIOL A, V187, P521, DOI 10.1007/s003590100223; Denzinger A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00164; Dietz C., 2007, HDB FLEDERMAUSE EURO; FENTON MB, 1979, J COMP PHYSIOL, V132, P77, DOI 10.1007/BF00617734; Goerlitz HR, 2010, CURR BIOL, V20, P1568, DOI 10.1016/j.cub.2010.07.046; GRINNELL AD, 1977, J COMP PHYSIOL, V116, P63, DOI 10.1007/BF00605517; Holderied MW, 2003, P ROY SOC B-BIOL SCI, V270, P2293, DOI 10.1098/rspb.2003.2487; Jakobsen L, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00089; Koblitz JC, 2009, 5 AN SON S KYOT JAP; KOLB ANTON, 1965, Z VERGLEICHENDE PHYSIOL, V49, P412, DOI 10.1007/BF00298111; Madsen PT, 2007, DEEP-SEA RES PT I, V54, P1421, DOI 10.1016/j.dsr.2007.04.020; Miller LA, 2001, BIOSCIENCE, V51, P570, DOI 10.1641/0006-3568(2001)051[0570:HSIDAA]2.0.CO;2; Parsons S, 2000, J EXP BIOL, V203, P2641; Plank M, 2012, J ZOOL, V286, P154, DOI 10.1111/j.1469-7998.2011.00859.x; Pye J. D., 1960, Journal of Laryngology and Otology, V74, P718, DOI 10.1017/S0022215100057170; Rydell J, 1996, ECOGRAPHY, V19, P62, DOI 10.1111/j.1600-0587.1996.tb00155.x; Rydell J., 2012, FAUNA FLORA STOCKHOL, V197, P38; Rydell Jens, 1997, Mammalian Species, V557, P1; Schnitzler Hans-Ulrich, 1998, P183; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Seibert AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060752; Sierro A, 1997, ACTA OECOL, V18, P91, DOI 10.1016/S1146-609X(97)80067-7; Sierro A, 1999, J ZOOL, V248, P429, DOI 10.1111/j.1469-7998.1999.tb01042.x; Stilz P, 2006, J ACOUST SOC AM, V120, P3324; Stilz WP, 2012, J ACOUST SOC AM, V132, P1765, DOI 10.1121/1.4733537; Surlykke A., 1988, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, P551; Surlykke A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002036; Vaughan Nancy, 1997, Bioacoustics, V7, P189; VOLLETH M, 1985, GENETICA, V66, P231, DOI 10.1007/BF00128044; Waters DA, 2003, PHYSIOL ENTOMOL, V28, P237, DOI 10.1111/j.1365-3032.2003.00355.x	34	16	16	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135590	10.1371/journal.pone.0135590	http://dx.doi.org/10.1371/journal.pone.0135590			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352271	Green Published, Green Submitted, gold			2022-12-26	WOS:000360932800010
J	Schaub, NJ; Le Beux, C; Miao, JJ; Linhardt, RJ; Alauzun, JG; Laurencin, D; Gilbert, RJ				Schaub, Nicholas J.; Le Beux, Clementine; Miao, Jianjun; Linhardt, Robert J.; Alauzun, Johan G.; Laurencin, Danielle; Gilbert, Ryan J.			The Effect of Surface Modification of Aligned Poly-L-Lactic Acid Electrospun Fibers on Fiber Degradation and Neurite Extension	PLOS ONE			English	Article							SPINAL-CORD REPAIR; SCHWANN-CELL MIGRATION; NERVE REGENERATION; PLASMA TREATMENT; ENGINEERED NANOFIBERS; PERIPHERAL-NERVE; AXONAL GROWTH; STEM-CELLS; SCAFFOLDS; OUTGROWTH	The surface of aligned, electrospun poly-L-lactic acid (PLLA) fibers was chemically modified to determine if surface chemistry and hydrophilicity could improve neurite extension from chick dorsal root ganglia. Specifically, diethylenetriamine (DTA, for amine functionalization), 2-(2-aminoethoxy) ethanol (AEO, for alcohol functionalization), or GRGDS (cell adhesion peptide) were covalently attached to the surface of electrospun fibers. Water contact angle measurements revealed that surface modification of electrospun fibers significantly improved fiber hydrophilicity compared to unmodified fibers (p < 0.05). Scanning electron microscopy (SEM) of fibers revealed that surface modification changed fiber topography modestly, with DTA modified fibers displaying the roughest surface structure. Degradation of chemically modified fibers revealed no change in fiber diameter in any group over a period of seven days. Unexpectedly, neurites from chick DRG were longest on fibers without surface modification (1651 +/- 488 mu m) and fibers containing GRGDS (1560 +/- 107 mu m). Fibers modified with oxygen plasma (1240 +/- 143 mu m) or DTA (1118 +/- 82 mu m) produced shorter neurites than the GRGDS or unmodified fibers, but were not statistically shorter than unmodified and GRGDS modified fibers. Fibers modified with AEO (844 +/- 151 mu m) were significantly shorter than unmodified and GRGDS modified fibers (p<0.05). Based on these results, we conclude that fiber hydrophilic enhancement alone on electrospun PLLA fibers does not enhance neurite outgrowth. Further work must be conducted to better understand why neurite extension was not improved on more hydrophilic fibers, but the results presented here do not recommend hydrophilic surface modification for the purpose of improving neurite extension unless a bioactive ligand is used.	[Schaub, Nicholas J.; Miao, Jianjun; Linhardt, Robert J.; Gilbert, Ryan J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Schaub, Nicholas J.; Linhardt, Robert J.; Gilbert, Ryan J.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA; [Le Beux, Clementine; Alauzun, Johan G.; Laurencin, Danielle] Univ Montpellier, Inst Charles Gerhardt Montpellier, CNRS, UMR 5253,ENSCM, F-34095 Montpellier 05, France; [Miao, Jianjun; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Montpellier; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Gilbert, RJ (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.	gilber2@rpi.edu	Alauzun, Johan/B-2461-2010	Alauzun, Johan/0000-0002-6531-0750; Laurencin, Danielle/0000-0002-7445-0528	NSF CAREER Award [1105125]; University of Montpellier; Rensselaer Polytechnic Institute	NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); University of Montpellier; Rensselaer Polytechnic Institute	This work was supported by NSF CAREER Award 1105125 to RJG and a Partnership University Fund between the University of Montpellier and the Rensselaer Polytechnic Institute.	Alilain WJ, 2011, NATURE, V475, P196, DOI 10.1038/nature10199; Badami AS, 2006, BIOMATERIALS, V27, P596, DOI 10.1016/j.biomaterials.2005.05.084; Bashur CA, 2009, TISSUE ENG PT A, V15, P2435, DOI 10.1089/ten.tea.2008.0295; Binder C, 2013, J BIOMED MATER RES B, V101, P1200, DOI 10.1002/jbm.b.32931; Bockelmann J, 2011, TISSUE ENG PT A, V17, P475, DOI 10.1089/ten.TEA.2010.0369; Cao HQ, 2010, J BIOMED MATER RES A, V93A, P1151, DOI 10.1002/jbm.a.32609; Chen JP, 2011, ACTA BIOMATER, V7, P234, DOI 10.1016/j.actbio.2010.08.015; Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510; Chew SY, 2007, ADV FUNCT MATER, V17, P1288, DOI 10.1002/adfm.200600441; Chow WN, 2007, NEURON GLIA BIOL, V3, P119, DOI 10.1017/S1740925X07000580; Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004; Corey JM, 2008, ACTA BIOMATER, V4, P863, DOI 10.1016/j.actbio.2008.02.020; Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285; Daud MFB, 2012, BIOMATERIALS, V33, P5901, DOI 10.1016/j.biomaterials.2012.05.008; Delgado-Rivera R, 2009, MATRIX BIOL, V28, P137, DOI 10.1016/j.matbio.2009.02.001; Downing TL, 2012, J CONTROL RELEASE, V161, P910, DOI 10.1016/j.jconrel.2012.05.034; Fischer MJE, 2010, METHODS MOL BIOL, V627, P55, DOI 10.1007/978-1-60761-670-2_3; Gelain F, 2011, ACS NANO, V5, P227, DOI 10.1021/nn102461w; Gilbert Ryan J., 2011, Critical Reviews in Biomedical Engineering, V39, P125, DOI 10.1615/CritRevBiomedEng.v39.i2.30; GURRATH M, 1992, EUR J BIOCHEM, V210, P911, DOI 10.1111/j.1432-1033.1992.tb17495.x; He J, 2012, FRONT MATER SCI, V6, P1, DOI 10.1007/s11706-012-0157-5; He LM, 2010, ACTA BIOMATER, V6, P2960, DOI 10.1016/j.actbio.2010.02.039; Hurtado A, 2011, BIOMATERIALS, V32, P6068, DOI 10.1016/j.biomaterials.2011.05.006; Khorasani MT, 2008, RADIAT PHYS CHEM, V77, P280, DOI 10.1016/j.radphyschem.2007.05.013; Kijenska-Gawronska E, 2012, J BIOMED MATER RES B, V100B, P1093, DOI 10.1002/jbm.b.32676; Klinkhammer K, 2010, J MATER SCI-MATER M, V21, P2637, DOI 10.1007/s10856-010-4112-7; Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014; Leach MK, 2011, JOVE-J VIS EXP, DOI 10.3791/2389; Lee S, 2013, NAT PROTOC, V8, P771, DOI 10.1038/nprot.2013.039; Lee S, 2012, NAT METHODS, V9, P917, DOI 10.1038/nmeth.2105; Lee YS, 2011, POLYMERS-BASEL, V3, P413, DOI 10.3390/polym3010413; Lee YS, 2013, J NEUROSCI, V33, P10591, DOI 10.1523/JNEUROSCI.1116-12.2013; Liu T, 2012, TISSUE ENG PT A, V18, P1057, DOI [10.1089/ten.tea.2011.0430, 10.1089/ten.TEA.2011.0430]; Liu T, 2012, J BIOMED MATER RES A, V100A, P236, DOI 10.1002/jbm.a.33271; Liu XA, 2010, J BIOMED MATER RES A, V94A, P1004, DOI 10.1002/jbm.a.32675; Liu Y, 2009, J BIOMED MATER RES A, V90A, P1092, DOI 10.1002/jbm.a.32165; Martins A, 2009, SMALL, V5, P1195, DOI 10.1002/smll.200801648; Mukhatyar VJ, 2011, BIOMATERIALS, V32, P3958, DOI 10.1016/j.biomaterials.2011.02.015; Neal RA, 2012, J BIOMED MATER RES A, V100A, P406, DOI 10.1002/jbm.a.33204; Neal RA, 2009, TISSUE ENG PART C-ME, V15, P11, DOI 10.1089/ten.tec.2007.0366; Nisbet DR, 2008, J BIOMAT SCI-POLYM E, V19, P623, DOI 10.1163/156856208784089652; Nisbet DR, 2009, BIOMATERIALS, V30, P4573, DOI 10.1016/j.biomaterials.2009.05.011; Park SY, 2015, J TISSUE ENG REGEN M, V9, P66, DOI 10.1002/term.1615; PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294; Prabhakaran MP, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/45/455102; Qu J, 2013, J BIOMED MATER RES A, V101, P2667, DOI 10.1002/jbm.a.34551; Schaub NJ, 2013, BIONANOSCIENCE, V3, P329, DOI 10.1007/s12668-013-0100-y; Schaub NJ, 2013, ACS APPL MATER INTER, V5, P10173, DOI 10.1021/am402827g; Schaub NJ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046026; Schense JC, 2000, NAT BIOTECHNOL, V18, P415, DOI 10.1038/74473; Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009; Teraoka F, 2006, DENT MATER J, V25, P560, DOI 10.4012/dmj.25.560; Valmikinathan CM, 2009, BIOMACROMOLECULES, V10, P1084, DOI 10.1021/bm8012499; von Burkersroda F, 2002, BIOMATERIALS, V23, P4221, DOI 10.1016/S0142-9612(02)00170-9; Wang G, 2010, VITRO CELL DEV BIOL, V47, P234; Wang HB, 2010, ACTA BIOMATER, V6, P2970, DOI 10.1016/j.actbio.2010.02.020; Wang HB, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016001; Xie JW, 2009, ACS NANO, V3, P1151, DOI 10.1021/nn900070z; Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051; Yao L, 2009, J BIOMED MATER RES B, V90B, P483, DOI 10.1002/jbm.b.31308; Yu WW, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-68; Zamani F, 2014, J BIOMED MATER RES A, V102, P506, DOI 10.1002/jbm.a.34703; Zuidema JM, 2014, BIOMATERIALS, V35, P1439, DOI 10.1016/j.biomaterials.2013.10.079	63	27	28	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0136780	10.1371/journal.pone.0136780	http://dx.doi.org/10.1371/journal.pone.0136780			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340351	Green Published, gold, Green Submitted			2022-12-26	WOS:000360688200016
J	Tabe, Y; Kojima, K; Yamamoto, S; Sekihara, K; Matsushita, H; Davis, RE; Wang, ZQ; Ma, WC; Ishizawa, J; Kazuno, S; Kauffman, M; Shacham, S; Fujimura, T; Ueno, T; Miida, T; Andreeff, M				Tabe, Yoko; Kojima, Kensuke; Yamamoto, Shinichi; Sekihara, Kazumasa; Matsushita, Hiromichi; Davis, Richard Eric; Wang, Zhiqiang; Ma, Wencai; Ishizawa, Jo; Kazuno, Saiko; Kauffman, Michael; Shacham, Sharon; Fujimura, Tsutomu; Ueno, Takashi; Miida, Takashi; Andreeff, Michael			Ribosomal Biogenesis and Translational Flux Inhibition by the Selective Inhibitor of Nuclear Export (SINE) XPO1 Antagonist KPT-185	PLOS ONE			English	Article							MANTLE CELL LYMPHOMA; RESPONSIVE TRANSCRIPTION FACTOR; GENE-EXPRESSION; CANCER CELLS; CYCLIN D1; PROLIFERATION; PROTEIN; CRM1; KINASE; SIGNAL	Mantle cell lymphoma (MCL) is an aggressive B-cell lymphoma characterized by the aberrant expression of several growth-regulating, oncogenic effectors. Exportin 1 (XPO1) mediates the nucleocytoplasmic transport of numerous molecules including oncogenic growth-regulating factors, RNAs, and ribosomal subunits. In MCL cells, the small molecule KPT-185 blocks XPO1 function and exerts anti-proliferative effects. In this study, we investigated the molecular mechanisms of this putative anti-tumor effect on MCL cells using cell growth/viability assays, immunoblotting, gene expression analysis, and absolute quantification proteomics. KPT-185 exhibited a p53-independent anti-lymphoma effect on MCL cells, by suppression of oncogenic mediators (e.g., XPO1, cyclin D1, c-Myc, PIM1, and Bcl-2 family members), repression of ribosomal biogenesis, and downregulation of translation/chaperone proteins (e.g., PIM2, EEF1A1, EEF2, and HSP70) that are part of the translational/transcriptional network regulated by heat shock factor 1. These results elucidate a novel mechanism in which ribosomal biogenesis appears to be a key component through which XPO1 contributes to tumor cell survival. Thus, we propose that the blockade of XPO1 could be a promising, novel strategy for the treatment of MCL and other malignancies overexpressing XPO1.	[Tabe, Yoko; Kojima, Kensuke; Ishizawa, Jo; Andreeff, Michael] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Sect Mol Hematol & Therapy, Houston, TX 77030 USA; [Tabe, Yoko; Yamamoto, Shinichi; Sekihara, Kazumasa; Miida, Takashi] Juntendo Univ, Biomed Res Ctr, Grad Sch Med, Dept Clin Lab Med, Tokyo, Japan; [Yamamoto, Shinichi; Sekihara, Kazumasa] Juntendo Univ, Grad Sch Med, Biomed Res Ctr, Leading Ctr Dev & Res Canc Med, Tokyo, Japan; [Matsushita, Hiromichi] Tokai Univ Med, Dept Lab Med, Shibuya, Kanagawa, Japan; [Davis, Richard Eric; Wang, Zhiqiang; Ma, Wencai] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA; [Kazuno, Saiko; Fujimura, Tsutomu; Ueno, Takashi] Juntendo Univ, Grad Sch Med, Biomed Res Ctr, Lab Prote & Biomol Sci, Tokyo, Japan; [Kauffman, Michael; Shacham, Sharon] Karyopharm Therapeut Inc, Natick, MA USA	University of Texas System; UTMD Anderson Cancer Center; Juntendo University; Juntendo University; University of Texas System; UTMD Anderson Cancer Center; Juntendo University	Andreeff, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Sect Mol Hematol & Therapy, Houston, TX 77030 USA.	mandreef@mdanderson.org	松下, 弘道/AEX-6164-2022; Miida, Takashi/A-5589-2012	松下, 弘道/0000-0002-1629-6630; Miida, Takashi/0000-0002-4294-8030; Fujimura, Tsutomu/0000-0003-1744-7725	Foundation of Strategic Research Projects in Private Universities from the MEXT, Japan [S1311011]; National Institutes of Health [CA055164, CA083639, CA136411, CA100632, CA016672]; Paul and Mary Haas Chair in Genetics; NATIONAL CANCER INSTITUTE [P01CA055164, P50CA100632, P50CA136411, P50CA083639, P30CA016672] Funding Source: NIH RePORTER	Foundation of Strategic Research Projects in Private Universities from the MEXT, Japan; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul and Mary Haas Chair in Genetics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Grant-in-Aid for Scientific Research (C), Japan and by Grant-in-Aid (S1311011) from the Foundation of Strategic Research Projects in Private Universities from the MEXT, Japan (to Y.T.), the National Institutes of Health awards (CA055164, CA083639, CA136411, CA100632 and the MD Anderson's Cancer Center Support Grant CA016672), and by the Paul and Mary Haas Chair in Genetics to (M.A.). Karyopharm Therapeutics Inc. also provided support in the form of salaries for M. Kauffman and S. Shacham, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amin HM, 2003, ARCH PATHOL LAB MED, V127, P424; Azmi AS, 2013, HAEMATOLOGICA, V98, P1098, DOI 10.3324/haematol.2012.074781; Bachmann M, 2004, J BIOL CHEM, V279, P48319, DOI 10.1074/jbc.M404440200; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Benzeno S, 2004, J BIOL CHEM, V279, P56061, DOI 10.1074/jbc.M411910200; Bernard M, 2001, LEUKEMIA, V15, P1785, DOI 10.1038/sj.leu.2402272; BODRUG SE, 1994, EMBO J, V13, P2124, DOI 10.1002/j.1460-2075.1994.tb06488.x; Culjkovic B, 2006, J CELL BIOL, V175, P415, DOI 10.1083/jcb.200607020; de Billy E, 2012, ONCOTARGET, V3, P741; Ding LH, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn234; Donati G, 2012, CANCER RES, V72, P1602, DOI 10.1158/0008-5472.CAN-11-3992; Donati G, 2011, J CELL SCI, V124, P3017, DOI 10.1242/jcs.086074; Ekins S, 2006, XENOBIOTICA, V36, P877, DOI 10.1080/00498250600861660; Etchin J, 2013, LEUKEMIA, V27, P66, DOI 10.1038/leu.2012.219; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Flinn I, 2014, ASCO M, V32, P8518; Fukasawa M, 2010, BIOCHEM BIOPH RES CO, V391, P1166, DOI 10.1016/j.bbrc.2009.11.115; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gaubatz S, 2001, MOL CELL BIOL, V21, P1384, DOI 10.1128/MCB.21.4.1384-1392.2001; Glen A, 2008, J PROTEOME RES, V7, P897, DOI 10.1021/pr070378x; Gomez-Abad C, 2011, BLOOD, V118, P5517, DOI 10.1182/blood-2011-03-344374; Gravina GL, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0085-1; Grimm T, 2006, NUCLEIC ACIDS RES, V34, P3030, DOI 10.1093/nar/gkl378; HAMAMOTO T, 1983, J ANTIBIOT, V36, P646, DOI 10.7164/antibiotics.36.646; Herbrich SM, 2013, J PROTEOME RES, V12, P594, DOI 10.1021/pr300624g; Hinnebusch AG, 2012, MOL CELL, V46, P717, DOI 10.1016/j.molcel.2012.06.001; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Iadevaia V, 2010, ONCOGENE, V29, P5490, DOI 10.1038/onc.2010.279; Kojima K, 2013, BLOOD, V121, P4166, DOI 10.1182/blood-2012-08-447581; Lapalombella R, 2012, BLOOD, V120, P4621, DOI 10.1182/blood-2012-05-429506; Li J, 2009, CANCER SCI, V100, P2255, DOI 10.1111/j.1349-7006.2009.01325.x; Liu F, 2013, EUR J HAEMATOL, V90, P51, DOI 10.1111/ejh.12030; Longworth J, 2012, J PROTEOME RES, V11, P5959, DOI 10.1021/pr300692t; Ma WC, 2010, CANCER EPIDEM BIOMAR, V19, P2445, DOI 10.1158/1055-9965.EPI-10-0565; Martin P, 2008, ANN ONCOL, V19, P1327, DOI 10.1093/annonc/mdn045; Milella M, 2001, J CLIN INVEST, V108, P851, DOI 10.1172/JCI200112807; Mutka SC, 2009, CANCER RES, V69, P510, DOI 10.1158/0008-5472.CAN-08-0858; Nagy B, 2003, BRIT J HAEMATOL, V120, P434, DOI 10.1046/j.1365-2141.2003.04121.x; Naud JF, 2007, NAT CELL BIOL, V9, P873, DOI 10.1038/ncb0807-873; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Perez-Galan P, 2011, BLOOD, V117, P26, DOI 10.1182/blood-2010-04-189977; Quintanilla-Martinez L, 2003, BLOOD, V101, P3181, DOI 10.1182/blood-2002-01-0263; Rahal R, 2014, NAT MED, V20, P87, DOI 10.1038/nm.3435; Santagata S, 2013, SCIENCE, V341, P250, DOI 10.1126/science.1238303; Savona M, 2013, BLOOD, V122; Sengupta J, 2010, J CELL BIOL, V189, P1079, DOI 10.1083/jcb.201001124; Tabe Y, 2014, ACTA HAEMATOL-BASEL, V131, P59, DOI 10.1159/000353164; Tai YT, 2014, LEUKEMIA, V28, P155, DOI 10.1038/leu.2013.115; Tong XM, 2009, P NATL ACAD SCI USA, V106, P21660, DOI 10.1073/pnas.0911316106; Tong YG, 2009, J MOL ENDOCRINOL, V43, P179, DOI 10.1677/JME-08-0176; Topisirovic I, 2009, EMBO J, V28, P1087, DOI 10.1038/emboj.2009.53; Verhaegen M, 2006, CANCER RES, V66, P11348, DOI 10.1158/0008-5472.CAN-06-1748; Wang Shumin, 2014, Biomed Res Int, V2014, P507353, DOI 10.1155/2014/507353; Xu DR, 2012, MOL BIOL CELL, V23, P3673, DOI 10.1091/mbc.E12-01-0045; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Yoshimura M, 2014, CANCER SCI, V105, P795, DOI 10.1111/cas.12430; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Zhang KJ, 2013, EXP HEMATOL, V41, P67, DOI 10.1016/j.exphem.2012.09.002; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024	60	21	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137210	10.1371/journal.pone.0137210	http://dx.doi.org/10.1371/journal.pone.0137210			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340096	Green Submitted, Green Published, gold			2022-12-26	WOS:000360688200034
J	Tomioka, K; Okamoto, N; Kurumatani, N; Hosoi, H				Tomioka, Kimiko; Okamoto, Nozomi; Kurumatani, Norio; Hosoi, Hiroshi			Association of Psychosocial Conditions, Oral Health, and Dietary Variety with Intellectual Activity in Older Community-Dwelling Japanese Adults	PLOS ONE			English	Article							LEVEL FUNCTIONAL-CAPACITY; LIFE SOCIAL ACTIVITY; PERIODONTAL-DISEASE; INFLAMMATORY MARKERS; PHYSICAL PERFORMANCE; LONGITUDINAL CHANGES; RISK INDICATORS; ELDERLY ADULTS; RELATIVE RISK; MORTALITY	Background This study examined the factors related to intellectual activity in community-dwelling elderly persons. Methods Self-administered questionnaires mailed to all people aged >= 65 years in a dormitory suburb in Japan (n = 15,210). The response rate was 72.2%. Analytical subjects (n = 8,910) were those who lived independently and completely answered questions about independent and dependent variables and covariates. Independent variables included psychosocial conditions (i.e., social activities, hobbies, and a sense that life is worth living (ikigai)), oral health (i.e., dental health behaviors and oral function evaluated by chewing difficulties, swallowing difficulties, and oral dryness), and dietary variety measured using the dietary variety score (DVS). A dependent variable was intellectual activity measured using the Tokyo Metropolitan Institute of Gerontology Index of Competence. Covariates included age, gender, family structure, pensions, body mass index, alcohol, smoking, medical history, self-rated health, medications, cognitive function, depression, and falling. Logistic regression was used to estimate the odds ratio (OR) for poor intellectual activity. Results Poor intellectual activity was reported by 28.9% of the study population. After adjustment for covariates and independent variables, poor intellectual activity was significantly associated with nonparticipation in social activities (OR = 1.90, 95% CI = 1.61-2.24), having neither hobbies nor ikigai (3.13, 2.55-3.84), having neither regular dental visits nor daily brushing (1.70, 1.35-2.14), the poorest oral function (1.61, 1.31-1.98), and the lowest DVS quartile (1.96, 1.70-2.26). Conclusion These results indicate that psychosocial conditions, oral health, and dietary variety are independently associated with intellectual activity in elderly persons. The factors identified in this study may be used in community health programs for maintaining the intellectual activity ability of the elderly.	[Tomioka, Kimiko; Kurumatani, Norio; Hosoi, Hiroshi] Nara Med Univ, Nara Prefectural Hlth Res Ctr, Kashihara, Nara 634, Japan; [Okamoto, Nozomi; Kurumatani, Norio] Nara Med Univ, Dept Community Hlth & Epidemiol, Kashihara, Nara 634, Japan	Nara Medical University; Nara Medical University	Tomioka, K (corresponding author), Nara Med Univ, Nara Prefectural Hlth Res Ctr, Kashihara, Nara 634, Japan.	tkimiko@naramed-u.ac.jp			center administrative expense from Nara Medical University	center administrative expense from Nara Medical University	This work was supported by center administrative expense from Nara Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon T, 1999, AGE AGEING, V28, P429, DOI 10.1093/ageing/28.5.429; Amano H, 2005, J AM GERIATR SOC, V53, P2128, DOI 10.1111/j.1532-5415.2005.00536.x; American Academy of Periodontology, 1992, GLOSSARY OF PERIODON; [Anonymous], 2003, GERIATR GERONTOL INT; Attin T, 2005, Oral Health Prev Dent, V3, P135; Bernstein MA, 2002, J AM DIET ASSOC, V102, P1096, DOI 10.1016/S0002-8223(02)90246-4; Buchman AS, 2009, ARCH INTERN MED, V169, P1139, DOI 10.1001/archinternmed.2009.135; Campbell WW, 2007, J AM COLL NUTR, V26, p696S, DOI 10.1080/07315724.2007.10719650; Cesari M, 2003, AM J CARDIOL, V92, P522, DOI 10.1016/S0002-9149(03)00718-5; Cesari M, 2004, J GERONTOL A-BIOL, V59, P242; Cesari M, 2004, AM J CLIN NUTR, V79, P289; Cesari M, 2012, J GERONTOL A-BIOL, V67, P671, DOI 10.1093/gerona/glr246; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; D'Aiuto F, 2004, J PERIODONTAL RES, V39, P236, DOI 10.1111/j.1600-0765.2004.00731.x; de Leon CFM, 2003, AM J EPIDEMIOL, V157, P633, DOI 10.1093/aje/kwg028; Drewnowski A, 1997, J AM DIET ASSOC, V97, P266, DOI 10.1016/S0002-8223(97)00070-9; Ekuni D, 2011, NEUROMOL MED, V13, P197, DOI 10.1007/s12017-011-8151-0; Fujiwara Y, 2003, ARCH GERONTOL GERIAT, V36, P141, DOI 10.1016/S0167-4943(02)00081-X; Fujiwara Y., 2002, GERIATR GERONTOL INT, V2, P57; Fujiwara Y, 2009, INT J GERIATR PSYCH, V24, P547, DOI 10.1002/gps.2148; Fushiki Y, 2012, J EPIDEMIOL, V22, P340, DOI 10.2188/jea.JE20110057; GRANGER CV, 1979, ARCH PHYS MED REHAB, V60, P145; Haga H, 1997, FACT RES INTERV GER, P53; Hoyl MT, 1999, J AM GERIATR SOC, V47, P873, DOI 10.1111/j.1532-5415.1999.tb03848.x; Imai E, 2014, J AM GERIATR SOC, V62, P426, DOI 10.1111/jgs.12690; Ishida R, 2006, STRESS HEALTH, V22, P275, DOI 10.1002/smi.1095; Ishizaki T, 2000, J AM GERIATR SOC, V48, P1424, DOI 10.1111/j.1532-5415.2000.tb02632.x; Iwasa H, 2009, INT J GERIATR PSYCH, V24, P1192, DOI 10.1002/gps.2245; James BD, 2011, J GERONTOL A-BIOL, V66, P467, DOI 10.1093/gerona/gly231; Kajikawa M, 2014, CIRC J, V78, P950, DOI 10.1253/circj.CJ-13-1330; Kanamori S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099638; Klein R, 2014, JAMA OPHTHALMOL, V132, P446, DOI 10.1001/jamaophthalmol.2013.7671; Kondo N, 2008, PREV MED, V46, P457, DOI 10.1016/j.ypmed.2007.12.007; Kono A, 2004, J GERONTOL A-BIOL, V59, P275; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; Koyano W., 1987, JPN J PUBLIC HLTH, V34, P109; Kumagai Shu, 2003, Nihon Koshu Eisei Zasshi, V50, P1117; Lachman ME, 1998, PSYCHOL AGING, V13, P553, DOI 10.1037/0882-7974.13.4.553; Lawton MP, 1972, RES PLANNING ACTION, P122; Lee L, 2001, PUBLIC HEALTH, V115, P133, DOI 10.1016/S0033-3506(01)00432-2; Li XJ, 2000, CLIN MICROBIOL REV, V13, P547, DOI 10.1128/CMR.13.4.547-558.2000; Listl S, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-70; Liu L, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0053-3; LOCKER D, 1993, J DENT RES, V72, P9, DOI 10.1177/00220345930720011501; Marshall TA, 2001, J NUTR, V131, P2192, DOI 10.1093/jn/131.8.2192; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Miura H, 2007, J ORAL REHABIL, V34, P422, DOI 10.1111/j.1365-2842.2007.01741.x; Moriya S, 2013, GERODONTOLOGY, V30, P133, DOI 10.1111/j.1741-2358.2012.00654.x; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Mortazavi H, 2014, ANN MED HEALTH SCI R, V4, P503, DOI 10.4103/2141-9248.139284; Murata C, 2006, ARCH GERONTOL GERIAT, V43, P369, DOI 10.1016/j.archger.2006.01.002; Nakanishi N, 1998, SCAND J SOC MED, V26, P198, DOI 10.1177/14034948980260031001; Nakanishi N, 2005, J AM GERIATR SOC, V53, P54, DOI 10.1111/j.1532-5415.2005.53010.x; Nakanishi N, 1999, AGE AGEING, V28, P323, DOI 10.1093/ageing/28.3.323; Ohara Y, 2015, GERIATR GERONTOL INT, V15, P755, DOI 10.1111/ggi.12345; Osterberg T, 2002, Gerodontology, V19, P95, DOI 10.1111/j.1741-2358.2002.00095.x; Rudberg MA, 1996, J GERONTOL A-BIOL, V51, pM189, DOI 10.1093/gerona/51A.5.M189; Saito E, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-93; Sbaraglia M, 2002, J PUBLIC HEALTH DENT, V62, P51, DOI 10.1111/j.1752-7325.2002.tb03421.x; Shinkai S., 2003, GERIATR GERONTOL INT, V3, pS31, DOI [10.1111/j.1444-0594.2003.00094.x, DOI 10.1111/J.1444-0594.2003.00094.X]; Sone T, 2008, PSYCHOSOM MED, V70, P709, DOI 10.1097/PSY.0b013e31817e7e64; Takata Y, 2008, GERODONTOLOGY, V25, P147, DOI 10.1111/j.1741-2358.2007.00203.x; Takata Y, 2007, GERONTOLOGY, V53, P46, DOI 10.1159/000095934; Takeuchi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061741; Teixeira FB, 2014, INT J MED SCI, V11, P209, DOI 10.7150/ijms.6801; Tsubota-Utsugi M, 2011, J AM GERIATR SOC, V59, P1993, DOI 10.1111/j.1532-5415.2011.03633.x; Weaver JD, 2002, NEUROLOGY, V59, P371, DOI 10.1212/WNL.59.3.371; Worthington HV, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004625.pub4; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	69	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137656	10.1371/journal.pone.0137656	http://dx.doi.org/10.1371/journal.pone.0137656			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR0WB	26360380	Green Published, gold, Green Submitted			2022-12-26	WOS:000361043100067
J	Cui, HY; Wang, YB; Jiang, Q; Chen, SP; Ma, JY; Sun, W				Cui, Haiying; Wang, Yunbo; Jiang, Qi; Chen, Shiping; Ma, Jian-Ying; Sun, Wei			Carbon Isotope Composition of Nighttime Leaf-Respired CO2 in the Agricultural-Pastoral Zone of the Songnen Plain, Northeast China	PLOS ONE			English	Article							DIURNAL-VARIATION; NICOTIANA-SYLVESTRIS; DARK RESPIRATION; METABOLIC ORIGIN; LEAVES; DELTA-C-13; DISCRIMINATION; FRACTIONATION; DYNAMICS; C-13	Variations in the carbon isotope signature of leaf dark-respired CO2 (delta C-13(R)) within a single night is a widely observed phenomenon. However, it is unclear whether there are plant functional type differences with regard to the amplitude of the nighttime variation in delta C-13(R). These differences, if present, would be important for interpreting the short-term variations in the stable carbon signature of ecosystem respiration and the partitioning of carbon fluxes. To assess the plant functional type differences relating to the magnitude of the nighttime variation in delta C-13(R) and the respiratory apparent fractionation, we measured the delta C-13(R), the leaf gas exchange, and the delta C-13 of the respiratory substrates of 22 species present in the agricultural-pastoral zone of the Songnen Plain, northeast China. The species studied were grouped into C-3 and C-4 plants, trees, grasses, and herbs. A significant nocturnal shift in delta C-13(R) was detected in 20 of the studied species, with the magnitude of the shift ranging from 1 parts per thousand to 5.8 parts per thousand. The magnitude of the nighttime variation in delta C-13(R) was strongly correlated with the daytime cumulative carbon assimilation, which suggests that variation in delta C-13(R) were influenced, to some extent, by changes in the contribution of malate decarboxylation to total respiratory CO2 flux. There were no differences in the magnitude of the nighttime variation in delta C-13(R) between the C-3 and C-4 plants, as well as among the woody plants, herbs and graminoids. Leaf respired CO2 was enriched in C-13 compared to biomass, soluble carbohydrates and lipids; however the magnitude of enrichment differed between 8 pm and 4 am, which were mainly caused by the changes in delta C-13(R). We also detected the plant functional type differences in respiratory apparent fractionation relative to biomass at 4 am, which suggests that caution should be exercised when using the delta C-13 of bulk leaf material as a proxy for the delta C-13 of leaf-respired CO2.	[Cui, Haiying; Wang, Yunbo; Jiang, Qi; Sun, Wei] NE Normal Univ, Key Lab Vegetat Ecol, Minist Educ, Inst Grassland Sci, Changchun 130024, Jilin Province, Peoples R China; [Chen, Shiping] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing 100093, Peoples R China; [Ma, Jian-Ying] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi 830011, Peoples R China	Northeast Normal University - China; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Sun, W (corresponding author), NE Normal Univ, Key Lab Vegetat Ecol, Minist Educ, Inst Grassland Sci, Changchun 130024, Jilin Province, Peoples R China.	sunwei@nenu.edu.cn	Chen, Shiping/AAH-9751-2019	Cui, Haiying/0000-0003-4993-2231	National Natural Science Foundation of China [31270445]; State Key Laboratory of Vegetation and Environmental Change [LVEC2012kf01]; Program for New Century Excellent Talents in University [NCET-12-0814]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Vegetation and Environmental Change; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This research was supported by National Natural Science Foundation of China (31270445), the State Key Laboratory of Vegetation and Environmental Change (LVEC2012kf01), and Program for New Century Excellent Talents in University (NCET-12-0814). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badeck FW, 2005, RAPID COMMUN MASS SP, V19, P1381, DOI 10.1002/rcm.1912; Barbour MM, 2007, PLANT CELL ENVIRON, V30, P469, DOI 10.1111/j.1365-3040.2007.01634.x; Barbour MM, 2011, NEW PHYTOL, V190, P990, DOI 10.1111/j.1469-8137.2010.03635.x; Bowling DR, 2008, NEW PHYTOL, V178, P24, DOI 10.1111/j.1469-8137.2007.02342.x; Bowling DR, 2001, GLOBAL CHANGE BIOL, V7, P127, DOI 10.1046/j.1365-2486.2001.00400.x; Duranceau M, 1999, PLANT CELL ENVIRON, V22, P515, DOI 10.1046/j.1365-3040.1999.00420.x; Duranceau M, 2001, AUST J PLANT PHYSIOL, V28, P65, DOI 10.1071/PP00068; Gessler A, 2009, NEW PHYTOL, V181, P374, DOI 10.1111/j.1469-8137.2008.02672.x; Ghashghaie J, 2001, PLANT CELL ENVIRON, V24, P505, DOI 10.1046/j.1365-3040.2001.00699.x; Ghashghaie J, 2014, NEW PHYTOL, V201, P751, DOI 10.1111/nph.12563; Ghashghaie Jaleh, 2003, Phytochemistry Reviews, V2, P145, DOI 10.1023/B:PHYT.0000004326.00711.ca; Gottlicher S, 2006, RAPID COMMUN MASS SP, V20, P653, DOI 10.1002/rcm.2352; Griffis TJ, 2005, AGR FOREST METEOROL, V132, P1, DOI 10.1016/j.agrformet.2005.06.005; Hobbie EA, 2004, NEW PHYTOL, V161, P371, DOI 10.1111/j.1469-8137.2004.00970.x; Hymus GJ, 2005, NEW PHYTOL, V167, P377, DOI 10.1111/j.1469-8137.2005.01475.x; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045205; Knohl A, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002301; Lloyd J, 1996, AUST J PLANT PHYSIOL, V23, P371, DOI 10.1071/PP9960371; MELZER E, 1987, PLANT PHYSIOL, V84, P58, DOI 10.1104/pp.84.1.58; MELZER E, 1987, J BIOL CHEM, V262, P8159; Ocheltree TW, 2004, J EXP BOT, V55, P2599, DOI 10.1093/jxb/erh263; PARK R, 1961, PLANT PHYSIOL, V36, P133, DOI 10.1104/pp.36.2.133; Prater JL, 2006, PLANT CELL ENVIRON, V29, P202, DOI 10.1111/j.1365-3040.2005.01413.x; Priault P, 2009, NEW PHYTOL, V181, P400, DOI 10.1111/j.1469-8137.2008.02665.x; ROSSMANN A, 1991, PLANT PHYSIOL, V96, P609, DOI 10.1104/pp.96.2.609; Scartazza A, 2004, OECOLOGIA, V140, P340, DOI 10.1007/s00442-004-1588-1; Schnyder H, 2005, PLANT BIOLOGY, V7, P592, DOI 10.1055/s-2005-872872; Shimoda S, 2009, AGR FOREST METEOROL, V149, P603, DOI 10.1016/j.agrformet.2008.10.007; Sun W, 2012, PLANT CELL ENVIRON, V35, P567, DOI 10.1111/j.1365-3040.2011.02436.x; Sun W, 2010, OECOLOGIA, V164, P297, DOI 10.1007/s00442-010-1643-z; Sun W, 2009, PLANT CELL ENVIRON, V32, P1390, DOI 10.1111/j.1365-3040.2009.02006.x; Tcherkez G, 2003, PLANT PHYSIOL, V131, P237, DOI 10.1104/pp.013078; Wanek W, 2001, RAPID COMMUN MASS SP, V15, P1136, DOI 10.1002/rcm.353; Wang YB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127695; Wegener F, 2010, FUNCT PLANT BIOL, V37, P849, DOI 10.1071/FP09224; Werner C, 2012, BIOGEOSCIENCES, V9, P3083, DOI 10.5194/bg-9-3083-2012; Werner C, 2011, BIOGEOSCIENCES, V8, P2437, DOI 10.5194/bg-8-2437-2011; Werner C, 2007, RAPID COMMUN MASS SP, V21, P1352, DOI 10.1002/rcm.2970; Werner C, 2009, RAPID COMMUN MASS SP, V23, P2428, DOI 10.1002/rcm.4036; Werner RA, 2011, NEW PHYTOL, V191, P10, DOI 10.1111/j.1469-8137.2011.03741.x; Wingate L, 2010, NEW PHYTOL, V188, P576, DOI 10.1111/j.1469-8137.2010.03384.x; Xu CY, 2004, NEW PHYTOL, V163, P499, DOI 10.1111/j.1469-8137.2004.01153.x	42	13	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137575	10.1371/journal.pone.0137575	http://dx.doi.org/10.1371/journal.pone.0137575			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356083	gold, Green Published, Green Submitted			2022-12-26	WOS:000360965800062
J	Xu, L; Jiang, CQ; Cheng, KK; Yeung, SLRA; Sen Zhang, W; Lam, TH; Schooling, CM				Xu, Lin; Jiang, Chao Qiang; Cheng, Kar Keung; Yeung, Shiu Lun Ryan Au; Sen Zhang, Wei; Lam, Tai Hing; Schooling, Catherine Mary			Alcohol Use and Gamma-Glutamyltransferase Using a Mendelian Randomization Design in the Guangzhou Biobank Cohort Study	PLOS ONE			English	Article							ALKALINE-PHOSPHATASE; CONSUMPTION; ENZYMES; POPULATION; DEPENDENCE; DISEASE; MARKERS; RISK; MEN	Background Observational studies and small intervention studies suggest alcohol raises gamma-glutamyltransferase (GGT). We used Mendelian randomization to assess the causal effect of alcohol use on GGT in older Chinese people. Methods An instrumental variable (IV) analysis in 2,321 men and 2,757 women aged 50+ years from phase 3 of the Guangzhou Biobank Cohort Study with ALDH2 (rs671) genotyped, alcohol use and GGT available was used to assess the causal effect of alcohol use on GGT. Rs671 was used as an IV and F-statistics was used to test for weak instrument hypothesis. An F-statistic of >= 10 indicates the IV is not weak. Results In men, the F-statistic for rs671 on alcohol use was 70. Using IV analysis alcohol use increased GGT by 10.60 U/L per alcohol unit (10 gram ethanol) per day (95% confidence interval (CI) 6.58 to 14.62). The estimate was lower in observational multivariate regression: 3.48 U/L GGT per alcohol unit per day (95% CI 2.84 to 4.11) adjusted for age, education, physical activity and smoking. In women, rs671 was not associated with alcohol or GGT and the F-statistic was 7 precluding IV analysis. Conclusion In Mendelian randomization, we found confirmative evidence that alcohol use increases GGT among Southern Chinese men. Moreover, we found that the ALDH2 variant rs671 was not associated with GGT among Southern Chinese women who generally consume very low levels of alcohol. Taken together our findings strongly suggest that alcohol increases GGT, although we cannot rule out the possibility that other unknown factors may cause a different relation between alcohol and GGT in other populations.	[Xu, Lin; Yeung, Shiu Lun Ryan Au; Lam, Tai Hing; Schooling, Catherine Mary] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Jiang, Chao Qiang; Sen Zhang, Wei] Guangzhou 12 Hosp, Guangzhou 510620, Guangdong, Peoples R China; [Cheng, Kar Keung] Univ Birmingham, Publ Hlth Epidemiol & Biostat, Birmingham, W Midlands, England; [Schooling, Catherine Mary] CUNY Hunter Coll, Sch Urban Publ Hlth, New York, NY 10021 USA	University of Hong Kong; University of Birmingham; City University of New York (CUNY) System; Hunter College (CUNY)	Lam, TH (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	hrmrlth@hkucc.hku.hk	Cheng, Kar/AAL-8899-2021; SL, Au Yeung/ABD-3938-2021; Lam, Tai Hing/C-4317-2009	Cheng, Kar/0000-0002-1516-1857; SL, Au Yeung/0000-0001-6136-1836; Schooling, Mary/0000-0001-9933-5887; Lam, Tai Hing/0000-0002-2033-9971	University of Hong Kong Foundation for Development and Research, Hong Kong; University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau, Guangzhou, China; Guangzhou Science and Technology Committee, Guangzhou, China; University of Birmingham, Birmingham, UK; Hong Kong Health and Health Services Research Fund [06070981]; Bureau of Guangzhou Science and Technology [2013J4100031]; Key technology collaboration project - Bureau of Guangzhou Science and Technology [2012J5100041]; Natural Science Foundation of Guangdong Province, China	University of Hong Kong Foundation for Development and Research, Hong Kong(University of Hong Kong); University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau, Guangzhou, China; Guangzhou Science and Technology Committee, Guangzhou, China; University of Birmingham, Birmingham, UK; Hong Kong Health and Health Services Research Fund; Bureau of Guangzhou Science and Technology; Key technology collaboration project - Bureau of Guangzhou Science and Technology; Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported by the University of Hong Kong Foundation for Development and Research, Hong Kong; The University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau, and Guangzhou Science and Technology Committee, Guangzhou, China; and The University of Birmingham, Birmingham, UK. This sub-study was supported by the Hong Kong Health and Health Services Research Fund (Grant 06070981), the Bureau of Guangzhou Science and Technology (Grant 2013J4100031), the Key technology collaboration project funded by the Bureau of Guangzhou Science and Technology (Grant number: 2012J5100041) and Natural Science Foundation of Guangdong Province, China. The authors have indicated no financial conflicts of interest.	Belfrage P, 1972, ACTA MED SCAND, V552, P1; Bouchard C., 1996, GENETIC EPIDEMIOLOGY, P470; Brien SE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d636; Chick J, 2000, ALCOHOL ALCOHOLISM, V35, P587, DOI 10.1093/alcalc/35.6.587; Didelez V, 2007, STAT METHODS MED RES, V16, P309, DOI 10.1177/0962280206077743; FREER DE, 1977, CLIN CHEM, V23, P830; FRIMPONG NA, 1989, AM J CLIN NUTR, V50, P987, DOI 10.1093/ajcn/50.5.987; GJERDE H, 1987, BRIT J ADDICT, V82, P1027; GLUUD C, 1981, EUR J CLIN INVEST, V11, P171, DOI 10.1111/j.1365-2362.1981.tb01837.x; Hao W, 1999, ADDICTION, V94, P1467, DOI 10.1046/j.1360-0443.1999.941014673.x; Jiang CQ, 2013, INT J CARDIOL, V164, P349, DOI 10.1016/j.ijcard.2011.07.046; Jiang CQ, 2006, INT J EPIDEMIOL, V35, P844, DOI 10.1093/ije/dyl131; Lawlor DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114294; Lee DH, 2002, ANN EPIDEMIOL, V12, P90, DOI 10.1016/S1047-2797(01)00252-6; Macgregor S, 2009, HUM MOL GENET, V18, P580, DOI 10.1093/hmg/ddn372; NAKAJIMA T, 1994, AM J CLIN NUTR, V60, P87, DOI 10.1093/ajcn/60.1.87; NISHIMURA M, 1982, BIOCHEM PHARMACOL, V31, P377; PAPOZ L, 1981, JAMA-J AM MED ASSOC, V245, P1748; PERSSON J, 1989, ALCOHOL, V6, P403, DOI 10.1016/0741-8329(89)90011-6; Randell E, 1998, J CLIN LAB ANAL, V12, P92, DOI 10.1002/(SICI)1098-2825(1998)12:2<92::AID-JCLA4>3.3.CO;2-D; Rutherford SL, 2000, BIOESSAYS, V22, P1095, DOI 10.1002/1521-1878(200012)22:12&lt;1095::AID-BIES7&gt;3.0.CO;2-A; Salujha S K, 2014, Ind Psychiatry J, V23, P44, DOI 10.4103/0972-6748.144956; Schooling CM, 2009, J EPIDEMIOL COMMUN H, V63, P121, DOI 10.1136/jech.2008.077602; Schooling CM, 2013, J AM COLL CARDIOL, V61, P1931, DOI 10.1016/j.jacc.2012.12.049; Silva ISS, 2004, J GASTROEN HEPATOL, V19, P314, DOI 10.1111/j.1440-1746.2003.03256.x; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Steenland K, 1996, AM J EPIDEMIOL, V143, P202; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227; Yeung SLA, 2013, J EPIDEMIOL COMMUN H, V67, P1054, DOI 10.1136/jech-2013-202807; Yeung SLA, 2012, AM J EPIDEMIOL, V175, P1021, DOI 10.1093/aje/kwr462; Yeung SLA, 2014, ANN EPIDEMIOL, V24, P606, DOI 10.1016/j.annepidem.2014.05.015; Yeung SLA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068054; Yeung SLA, 2013, INT J EPIDEMIOL, V42, P318, DOI 10.1093/ije/dys221	34	10	10	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137790	10.1371/journal.pone.0137790	http://dx.doi.org/10.1371/journal.pone.0137790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356841	Green Published, gold			2022-12-26	WOS:000360965800084
J	Zhang, P; Tang, J; Sun, WJ; Yu, YQ; Zhang, W				Zhang, Ping; Tang, Jie; Sun, Wenjuan; Yu, Yongqiang; Zhang, Wen			Differential Effects of Conservational Management on SOC Accumulation in the Grasslands of China	PLOS ONE			English	Article							SOIL ORGANIC-CARBON; LAND-USE CHANGE; VERTICAL-DISTRIBUTION; TERRESTRIAL ECOSYSTEMS; NITROGEN DYNAMICS; CLIMATE-CHANGE; SEQUESTRATION; STORAGE; IMPACTS; TURNOVER	Conservational management practices in grasslands have been considered one of the efficient options to enhance the soil organic carbon (SOC) accumulation. However, the SOC changes after the conservational management practices vary significantly under different grassland vegetation types and the environmental conditions. At present, it is not clear how the SOC accumulation changes along the soil profile if conservational management practice was adopted. In this study, we collected 663 paired observational data of SOC changes with and without conservational management practices in grasslands of China from 176 published literatures that has both the surface (0. 20 cm) and subsurface (to 40 cm depth) SOC measurements. The differences of SOC density (SOCD) between pre. management and post. management in the vertical soil layers were analyzed in order to establish a quantitative relationship of the SOC changes between the subsurface and the surface. The results revealed that in all grasslands, conservational management practices benefits the SOC accumulation by enhancing 0.43. 1.14 Mg C ha(-1) yr(-1). But the SOC increment weakened downwards along the soil profile. While the surface SOC was enhanced by 17% after conservational management, the subsurface SOC was enhanced by only 7%. The SOC accumulation was closely correlated with restoration duration, pre-management SOCD and the environmental factors and differed greatly among different grasslands and the practices adopted. The alpine and mountain grassland showed a higher annual SOC increment than the temperate grassland with the annual rate of 1.62 and 0.72 Mg C ha(-1) yr(-1), respectively. The SOC increment caused by the artificial plantation and the grazing exclusion conservational management was more than 2-fold that of the cropland abandonment and the extensive utilization. With the quantitative relationship of the SOC changes between soil layers, we provide a methodological option to estimate SOC changes to layers deeper than the recommendation of IPCC when only the surface layer SOC increment is available.	[Zhang, Ping; Tang, Jie] Jilin Univ, Minist Educ, Key Lab Groundwater Resources & Environm, Changchun 130021, Peoples R China; [Zhang, Ping; Yu, Yongqiang; Zhang, Wen] Chinese Acad Sci, Inst Atmospher Phys, LAPC, Beijing 100029, Peoples R China; [Sun, Wenjuan] Chinese Acad Sci, Inst Bot, LVEC, Beijing 100093, Peoples R China	Jilin University; Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Chinese Academy of Sciences; Institute of Botany, CAS	Zhang, W (corresponding author), Chinese Acad Sci, Inst Atmospher Phys, LAPC, Beijing 100029, Peoples R China.	zhw@mail.iap.ac.cn	Zhang, Wen/AAH-6060-2020; LAPC, IAP/AAI-6991-2020; IAP, LAPC/AAI-6390-2020; Yu, Yongqiang/C-9661-2011	Zhang, Wen/0000-0001-6670-3057; LAPC, IAP/0000-0002-0025-3484; IAP, LAPC/0000-0002-6195-7362; Yu, Yongqiang/0000-0002-9345-2211; sun, wenjuan/0000-0002-9667-1882	National Basic Research Program of China [2010CB950604]; National Science Foundation of China [41471444, 41471152]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Basic Research Program of China (2010CB950604) and National Science Foundation of China (41471444, 41471152).	An SS, 2009, APPL SOIL ECOL, V41, P286, DOI 10.1016/j.apsoil.2008.12.001; Bagchi S, 2010, ECOL LETT, V13, P959, DOI 10.1111/j.1461-0248.2010.01486.x; Bai WM, 2010, GLOBAL CHANGE BIOL, V16, P1306, DOI 10.1111/j.1365-2486.2009.02019.x; Baker JM, 2007, AGR ECOSYST ENVIRON, V118, P1, DOI 10.1016/j.agee.2006.05.014; Batjes NH, 2004, DEV SUSTAINABILITY, V6, P133, DOI DOI 10.1023/B:ENVI.0000003633.14591.fd; Batlle-Bayer L, 2010, AGR ECOSYST ENVIRON, V137, P47, DOI 10.1016/j.agee.2010.02.003; Beier C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003381; Bell MJ, 2009, GEODERMA, V152, P74, DOI 10.1016/j.geoderma.2009.05.020; Blanco H, 2008, PRINCIPLES SOIL CONS, P449; Chen LD, 2007, ECOL RES, V22, P641, DOI 10.1007/s11284-006-0065-1; Conant RT, 2011, FRONT ECOL ENVIRON, V9, P169, DOI 10.1890/090153; Conant RT, 2003, BIOL FERT SOILS, V38, P386, DOI 10.1007/s00374-003-0652-z; Conant RT, 2004, ENVIRON MANAGE, V33, P467, DOI 10.1007/s00267-003-9104-7; Conant RT, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001661; Conant RT, 2001, ECOL APPL, V11, P343, DOI 10.1890/1051-0761(2001)011[0343:GMACIG]2.0.CO;2; Covaleda S, 2006, ORG GEOCHEM, V37, P1943, DOI 10.1016/j.orggeochem.2006.09.001; De Deyn GB, 2009, J ECOL, V97, P864, DOI 10.1111/j.1365-2745.2009.01536.x; Don A, 2009, J PLANT NUTR SOIL SC, V172, P53, DOI 10.1002/jpln.200700158; Dubeux JCB, 2006, SOIL BIOL BIOCHEM, V38, P2705, DOI 10.1016/j.soilbio.2006.04.021; Foote RL, 2010, ECOSYSTEMS, V13, P795, DOI 10.1007/s10021-010-9355-0; Fornara DA, 2009, ECOLOGY, V90, P408, DOI 10.1890/08-0325.1; Garcia-Pausas J, 2007, BIOGEOCHEMISTRY, V82, P279, DOI 10.1007/s10533-007-9071-9; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Han JG, 2008, RANGELAND J, V30, P233, DOI 10.1071/RJ08009; He NP, 2009, GEODERMA, V150, P302, DOI 10.1016/j.geoderma.2009.02.004; Hobbie SE, 2000, GLOBAL CHANGE BIOL, V6, P196, DOI 10.1046/j.1365-2486.2000.06021.x; Homann PS, 2007, BIOGEOCHEMISTRY, V85, P303, DOI 10.1007/s10533-007-9139-6; Huang Y, 2010, SCI CHINA LIFE SCI, V53, P766, DOI 10.1007/s11427-010-4022-4; IPCC, 2014, 2013 SUPPLEMENT 2006; Jenkinson DS, 2008, EUR J SOIL SCI, V59, P400, DOI 10.1111/j.1365-2389.2008.01026.x; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Jones MB, 2004, NEW PHYTOL, V164, P423, DOI 10.1111/j.1469-8137.2004.01201.x; Knops JMH, 2000, ECOLOGY, V81, P88, DOI 10.1890/0012-9658(2000)081[0088:DOSNAC]2.0.CO;2; Knops JMH, 2009, SOIL SCI SOC AM J, V73, P2096, DOI 10.2136/sssaj2009.0058; Krishnan P, 2007, CURR SCI INDIA, V93, P706; Kuzyakov Y, 2000, J PLANT NUTR SOIL SC, V163, P421, DOI 10.1002/1522-2624(200008)163:4<421::AID-JPLN421>3.0.CO;2-R; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2003, CRIT REV PLANT SCI, V22, P151, DOI 10.1080/713610854; Lal R, 2001, ADV AGRON, V71, P145, DOI 10.1016/S0065-2113(01)71014-0; Lal R., 1998, POTENTIAL US CROPLAN, P128; Lal R, 1999, GLOBALGLOBAL CHANGEN, V37, P4; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; Liu JY, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021649; Lorenz K, 2005, ADV AGRON, V88, P35, DOI 10.1016/S0065-2113(05)88002-2; Ma W, 2006, CARBON STORAGE TEMPE, P34; Ma WH, 2008, SCI CHINA SER C, V51, P263, DOI 10.1007/s11427-008-0029-5; Matamala R, 2003, SCIENCE, V302, P1385, DOI 10.1126/science.1089543; Matamala R, 2008, ECOL APPL, V18, P1470, DOI 10.1890/07-1609.1; McLauchlan KK, 2006, GEODERMA, V136, P289, DOI 10.1016/j.geoderma.2006.03.053; Ogle SM, 2003, GLOBAL CHANGE BIOL, V9, P1521, DOI 10.1046/j.1365-2486.2003.00683.x; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Post WM, 2000, GLOBAL CHANGE BIOL, V6, P317, DOI 10.1046/j.1365-2486.2000.00308.x; Reeder JD, 1998, SOIL TILL RES, V47, P339, DOI 10.1016/S0167-1987(98)00122-6; Ren Hai, 2007, Landscape and Ecological Engineering, V3, P1, DOI 10.1007/s11355-006-0018-4; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Silver WL, 2010, RANGELAND ECOL MANAG, V63, P128, DOI 10.2111/REM-D-09-00106.1; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Smith P, 2000, SOIL USE MANAGE, V16, P1, DOI 10.1111/j.1475-2743.2000.tb00162.x; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Sommer R, 2000, PLANT SOIL, V219, P231, DOI 10.1023/A:1004772301158; Song GH, 2005, BIOGEOCHEMISTRY, V74, P47, DOI 10.1007/s10533-004-2222-3; Soussana JF, 2004, SOIL USE MANAGE, V20, P219, DOI 10.1079/SUM2003234; State Environmental Protection Administration, 2008, REP STAT ENV CHIN, P54; Sun WJ, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI [10.1029/2009GB003484, 10.1029/2009GB003727]; Tan ZX, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002536; Torok P, 2012, J NAT CONSERV, V20, P41, DOI 10.1016/j.jnc.2011.07.006; Wang CT, 2009, LAND DEGRAD DEV, V20, P187, DOI 10.1002/ldr.879; Wang SL, 2004, ENVIRON MANAGE, V33, pS200, DOI 10.1007/s00267-003-9130-5; Wang SP, 2011, AGR ECOSYST ENVIRON, V142, P329, DOI 10.1016/j.agee.2011.06.002; Wiesmeier M, 2009, SOIL TILL RES, V104, P299, DOI 10.1016/j.still.2009.04.005; Wright AL, 2004, SOIL BIOL BIOCHEM, V36, P1809, DOI 10.1016/j.soilbio.2004.05.004; Wu GL, 2010, PLANT SOIL, V333, P469, DOI 10.1007/s11104-010-0363-9; Wu HB, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001844; Wu L, 2008, J ENVIRON QUAL, V37, P663, DOI 10.2134/jeq2007.0196; Yang Y, 2008, CARBON NITROGEN STOR, P74; Yang YH, 2007, BIOGEOCHEMISTRY, V84, P131, DOI 10.1007/s10533-007-9109-z; Yang YH, 2009, GLOBAL CHANGE BIOL, V15, P2723, DOI 10.1111/j.1365-2486.2009.01924.x; Zhang K, 2010, LAND DEGRAD DEV, V21, P13, DOI 10.1002/ldr.954; Zhou ZY, 2007, BIOGEOCHEMISTRY, V82, P127, DOI 10.1007/s10533-006-9058-y	79	3	3	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137280	10.1371/journal.pone.0137280	http://dx.doi.org/10.1371/journal.pone.0137280			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356845	Green Published, gold, Green Submitted			2022-12-26	WOS:000360965800039
J	Iannitti, T; Graham, A; Dolan, S				Iannitti, Tommaso; Graham, Annette; Dolan, Sharron			Adiponectin-Mediated Analgesia and AntiInflammatory Effects in Rat	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; PARAVENTRICULAR NUCLEUS; NEUROPATHIC PAIN; SPINAL-CORD; EXPRESSION; INFLAMMATION; NEURONS; MODULATION; MECHANISMS; OBESITY	The adipose tissue-derived protein, adiponectin, has significant anti-inflammatory properties in a variety of disease conditions. Recent evidence that adiponectin and its receptors (AdipoR1 and AdipoR2) are expressed in central nervous system, suggests that it may also have a central modulatory role in pain and inflammation. This study set out to investigate the effects of exogenously applied recombinant adiponectin (via intrathecal and intraplantar routes; 10-5000 ng) on the development of peripheral inflammation (paw oedema) and pain hypersensitivity in the rat carrageenan model of inflammation. Expression of adiponectin, AdipoR1 and AdipoR2 mRNA and protein was characterised in dorsal spinal cord using real-time polymerase chain reaction (PCR) and Western blotting. AdipoR1 and AdipoR2 mRNA and protein were found to be constitutively expressed in dorsal spinal cord, but no change in mRNA expression levels was detected in response to carrageenan-induced inflammation. Adiponectin mRNA, but not protein, was detected in dorsal spinal cord, although levels were very low. Intrathecal administration of adiponectin, both pre-and 3 hours post-carrageenan, significantly attenuated thermal hyperalgesia and mechanical hypersensitivity. Intrathecal administration of adiponectin post-carrageenan also reduced peripheral inflammation. Intraplantar administration of adiponectin pre-carrageenan dose-dependently reduced thermal hyperalgesia but had no effect on mechanical hypersensitivity and peripheral inflammation. These results show that adiponectin functions both peripherally and centrally at the spinal cord level, likely through activation of AdipoRs to modulate pain and peripheral inflammation. These data suggest that adiponectin receptors may be a novel therapeutic target for pain modulation.	[Iannitti, Tommaso; Graham, Annette; Dolan, Sharron] Glasgow Caledonian Univ, Dept Life Sci, Sch Hlth & Life Sci, Glasgow G4 0BA, Lanark, Scotland	Glasgow Caledonian University	Iannitti, T (corresponding author), Univ Sheffield, Sheffield Inst Translat Neurosci SITraN, 385A Glossop Rd, Sheffield S10 2HQ, S Yorkshire, England.	tommaso.iannitti@gmail.com		Dolan, Sharron/0000-0001-9053-6105	Glasgow Caledonian University	Glasgow Caledonian University	This study was funded by a Glasgow Caledonian University PhD Scholarship.	Ajuwon KM, 2005, AM J PHYSIOL-REG I, V288, pR1220, DOI 10.1152/ajpregu.00397.2004; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Beloeil H, 2006, ANESTHESIOLOGY, V105, P139, DOI 10.1097/00000542-200607000-00023; Biddlestone L, 2007, BRIT J PHARMACOL, V151, P285, DOI 10.1038/sj.bjp.0707220; Brochu-Gaudreau K, 2010, ENDOCRINE, V37, P11, DOI 10.1007/s12020-009-9278-8; Churi SB, 2008, J PAIN, V9, P639, DOI 10.1016/j.jpain.2008.02.002; Coope A, 2008, FEBS LETT, V582, P1471, DOI 10.1016/j.febslet.2008.03.037; Cui J, 2011, CLIN NEPHROL, V75, P26, DOI 10.2379/CNP75026; Dolan S, 2003, PAIN, V106, P501, DOI 10.1016/j.pain.2003.09.017; Fantuzzi G, 2013, CYTOKINE, V64, P1, DOI 10.1016/j.cyto.2013.06.317; Fry M, 2006, J NEUROSCI, V26, P9695, DOI 10.1523/JNEUROSCI.2014-06.2006; Hong SJ, 2006, CIRC J, V70, P414, DOI 10.1253/circj.70.414; Hoyda TD, 2007, J PHYSIOL-LONDON, V585, P805, DOI 10.1113/jphysiol.2007.144519; Hoyda TD, 2010, ENDOCRINOLOGY, V151, P3154, DOI 10.1210/en.2009-1390; Hoyda TD, 2009, BRAIN RES, V1256, P76, DOI 10.1016/j.brainres.2008.12.012; Huber JD, 2006, AM J PHYSIOL-HEART C, V290, pH732, DOI 10.1152/ajpheart.00747.2005; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Iannitti T, 2012, EXP PHYSIOL, V97, P1236, DOI 10.1113/expphysiol.2011.064220; Kilkenny C, 2012, VET CLIN PATH, V41, P27, DOI 10.1111/j.1939-165X.2012.00418.x; Kitagawa J, 2006, EUR J NEUROSCI, V24, P1976, DOI 10.1111/j.1460-9568.2006.05065.x; Klein I, 2011, BRAIN RES, V1423, P1, DOI 10.1016/j.brainres.2011.09.019; Kudriashova E Iu, 2002, Tsitologiia, V44, P285; Landskroner-Eiger S, 2009, CLIN CANCER RES, V15, P3265, DOI 10.1158/1078-0432.CCR-08-2649; Lawson K, 2006, CURR PHARM DESIGN, V12, P459, DOI 10.2174/138161206775474477; Lee SW, 2008, SCAND J RHEUMATOL, V37, P260, DOI 10.1080/03009740801910346; Maddineni S, 2005, ENDOCRINOLOGY, V146, P4250, DOI 10.1210/en.2005-0254; Maruyoshi H, 2005, CIRC J, V69, P1154, DOI 10.1253/circj.69.1154; Morgenweck J, 2010, NEUROPHARMACOLOGY, V58, P337, DOI 10.1016/j.neuropharm.2009.10.008; Morinigo R, 2006, OBES SURG, V16, P745, DOI 10.1381/096089206777346736; Ouchi N, 2007, CLIN CHIM ACTA, V380, P24, DOI 10.1016/j.cca.2007.01.026; Peterlin BL, 2008, NEUROLOGY, V70, P1905, DOI 10.1212/01.wnl.0000312278.40250.6e; Phillips SA, 2010, CURR OPIN PHARMACOL, V10, P676, DOI 10.1016/j.coph.2010.08.002; Psilopanagioti A, 2009, NEUROENDOCRINOLOGY, V89, P38, DOI 10.1159/000151396; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Rasmussen MS, 2006, OBESITY, V14, P28, DOI 10.1038/oby.2006.5; Rodriguez-Pacheco F, 2007, ENDOCRINOLOGY, V148, P401, DOI 10.1210/en.2006-1019; Roza C, 2008, PAIN, V138, P537, DOI 10.1016/j.pain.2008.01.031; SEKUT L, 1994, J LAB CLIN MED, V124, P813; Takahashi Y, 2011, ANESTH ANALG, V113, P398, DOI 10.1213/ANE.0b013e31821b220c; Takemura Yukihiro, 2007, Curr Atheroscler Rep, V9, P238, DOI 10.1007/s11883-007-0025-4; Thundyil J, 2012, BRIT J PHARMACOL, V165, P313, DOI 10.1111/j.1476-5381.2011.01560.x; Wang Y, 2008, BIOCHEM J, V409, P623, DOI 10.1042/BJ20071492; Xu W, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-49; Yamaguchi N, 2005, FEBS LETT, V579, P6821, DOI 10.1016/j.febslet.2005.11.019; Zhou YH, 2005, GENE EXPR PATTERNS, V5, P711, DOI 10.1016/j.modgep.2005.02.002	46	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136819	10.1371/journal.pone.0136819	http://dx.doi.org/10.1371/journal.pone.0136819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352808	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000360932800050
J	Peet, ED; McCoy, DC; Danaei, G; Ezzati, M; Fawzi, W; Jarvelin, MR; Pillas, D; Fink, G				Peet, Evan D.; McCoy, Dana C.; Danaei, Goodarz; Ezzati, Majid; Fawzi, Wafaie; Jarvelin, Marjo-Riitta; Pillas, Demetris; Fink, Gunther			Early Childhood Development and Schooling Attainment: Longitudinal Evidence from British, Finnish and Philippine Birth Cohorts	PLOS ONE			English	Article							CHILDREN; NUTRITION; HEIGHT; GROWTH; INTERVENTIONS; INFLAMMATION; INTELLIGENCE; EXPERIENCE; EDUCATION; HEALTH	Background While recent literature has highlighted the importance of early childhood development for later life outcomes, comparatively little is known regarding the relative importance of early physical and cognitive development in predicting educational attainment cross-culturally. Methods We used prospective data from three birth cohorts: the Northern Finland Birth Cohort of 1986 (NFBC1986), the 1970 British Cohort Study (BCS1970), and the Cebu Longitudinal Health and Nutrition Survey of 1983 (CLHNS) to assess the association of height-for-age z-score (HAZ) and cognitive development measured prior to age 8 with schooling attainment. Multivariate linear regression models were used to estimate baseline and adjusted associations. Results Both physical and cognitive development were highly predictive of adult educational attainment conditional on parental characteristics. The largest positive associations between physical development and schooling were found in the CLHNS (beta = 0.53, 95%-CI: [0.32, 0.74]) with substantially smaller associations in the BCS1970 (beta = 0.10, 95% CI [0.04, 0.16]) and the NFBC1986 (beta = 0.06, 95% CI [-0.05, 0.16]). Strong associations between cognitive development and educational attainment were found for all three cohorts (NFBC1986: beta = 0.22, 95%-CI: [0.12, 0.31], BCS1970: beta = 0.58, 95%-CI: [0.52, 0.64], CLHNS: beta = 1.08, 95%-CI: [0.88, 1.27]). Models jointly estimating educational associations of physical and cognitive development demonstrated weaker associations for physical development and minimal changes for cognitive development. Conclusion The results indicate that although physical and cognitive early development are both important predictors of educational attainment, cognitive development appears to play a particularly important role. The large degree of heterogeneity in the observed effect sizes suggest that the importance of early life physical growth and cognitive development is highly dependent on socioeconomic and institutional contexts.	[Peet, Evan D.; Danaei, Goodarz; Fawzi, Wafaie; Fink, Gunther] Harvard Univ, Dept Global Hlth & Populat, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Peet, Evan D.] RAND Corp, Pittsburgh, PA USA; [McCoy, Dana C.] Harvard Univ, Grad Sch Educ, Cambridge, MA 02138 USA; [Ezzati, Majid; Jarvelin, Marjo-Riitta; Pillas, Demetris] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, MRC PHE Ctr Environm & Hlth, Sch Publ Hlth, London, England; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland	Harvard University; Harvard T.H. Chan School of Public Health; RAND Corporation; Harvard University; Imperial College London; University of Oulu; University of Oulu; University of Oulu	Peet, ED (corresponding author), Harvard Univ, Dept Global Hlth & Populat, TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	epeet@rand.org		Jarvelin, Marjo-Riitta/0000-0002-2149-0630	Saving Brains Program; Grand Challenges Canada; Aga Khan Foundation; Bernard van Leer Foundation; Bill and Melinda Gates Foundation; Maria Cecilia Souto Vidigal Foundation; Norlien Foundation; World Vision Canada	Saving Brains Program; Grand Challenges Canada(CGIAR); Aga Khan Foundation; Bernard van Leer Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Maria Cecilia Souto Vidigal Foundation; Norlien Foundation; World Vision Canada	This work was supported by the Saving Brains Program in partnership with Grand Challenges Canada, Aga Khan Foundation, Bernard van Leer Foundation, Bill and Melinda Gates Foundation, Maria Cecilia Souto Vidigal Foundation, Norlien Foundation, and World Vision Canada.	Adair LS, 2011, INT J EPIDEMIOL, V40, P619, DOI 10.1093/ije/dyq085; Anderson LM, 2003, AM J PREV MED, V24, P32, DOI 10.1016/S0749-3797(02)00655-4; Banerjee AV, 2006, UNDERSTANDING POVERT, DOI [10.1093/0195305191.003.0006, DOI 10.1093/0195305191.003.0006]; Card D, 2001, ECONOMETRICA, V69, P1127, DOI 10.1111/1468-0262.00237; Case Anne, 2006, J POLITICAL EC, V16, P499; Centre for Longitudinal Studies (CLS), 2014, 1970 BRITISH COHORT; Crimmins EM, 2006, P NATL ACAD SCI USA, V103, P498, DOI 10.1073/pnas.0501470103; Cunha F, 2010, ECONOMETRICA, V78, P883, DOI 10.3982/ECTA6551; Daniels MC, 2004, J NUTR, V134, P1439, DOI 10.1093/jn/134.6.1439; Davie R, 1972, FROM BIRTH TO SEVEN; DUNCAN GJ, 1994, CHILD DEV, V65, P296, DOI 10.1111/j.1467-8624.1994.tb00752.x; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Feranil AB., 2008, ASIA PACIFIC POPULAT, V23, P39; Glewwe P, 2001, J PUBLIC ECON, V81, P345, DOI 10.1016/S0047-2727(00)00118-3; Grantham-McGregor S, 2002, LANCET, V359, P542, DOI 10.1016/S0140-6736(02)07719-X; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; GUTHRIE GM, 1977, J SOC PSYCHOL, V102, P3, DOI 10.1080/00224545.1977.9713233; Harris, 1963, CHILDRENS DRAWINGS M; Heckman JJ, 2006, J LABOR ECON, V24, P411, DOI 10.1086/504455; Hertzman C, 1999, ANN NY ACAD SCI, V896, P85, DOI 10.1111/j.1749-6632.1999.tb08107.x; Hertzman C, 2010, ANNU REV PUBL HEALTH, V31, P329, DOI 10.1146/annurev.publhealth.012809.103538; Jarvelin MR, 1997, PAEDIATR PERINAT EP, V11, P298, DOI 10.1111/j.1365-3016.1997.tb00007.x; Komlos J, 1994, LIVING STANDARDS EC; Leroy JL, 2013, AM J CLIN NUTR, V98, P854, DOI 10.3945/ajcn.113.066647; Leung Janet T Y, 2011, Int J Adolesc Med Health, V23, P109; Lochner L, 2004, AM ECON REV, V94, P155, DOI 10.1257/000282804322970751; Lundeen EA, 2014, AM J CLIN NUTR, V100, P821, DOI 10.3945/ajcn.114.084368; LYNN R, 1989, BRIT J EDUC PSYCHOL, V59, P372, DOI 10.1111/j.2044-8279.1989.tb03112.x; MOOCK PR, 1986, J DEV ECON, V20, P33, DOI 10.1016/0304-3878(86)90004-0; Moretti E, 2004, J ECONOMETRICS, V121, P175, DOI 10.1016/j.jeconom.2003.10.015; Nores M, 2010, ECON EDUC REV, V29, P271, DOI 10.1016/j.econedurev.2009.09.001; Pirkola J, 2010, DIABETES CARE, V33, P1115, DOI 10.2337/dc09-1871; Psacharopoulos G., 2004, EDUC ECON, V12, P111, DOI [DOI 10.1080/0964529042000239140, 10.1080/0964529042000239140]; Stein AD, 2005, FOOD NUTR BULL, V26, P46; Strauss J, 1998, J ECON LIT, V36, P766; Vulliamy G, 1997, S COMP AN CURR CHANG; Walker SP, 2005, LANCET, V366, P1804, DOI 10.1016/S0140-6736(05)67574-5; Walker SP, 2007, J NUTR, V137, P2464, DOI 10.1093/jn/137.11.2464; Wiggins D., 2014, HANDLING ATTRITION N	39	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137219	10.1371/journal.pone.0137219	http://dx.doi.org/10.1371/journal.pone.0137219			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9KG	26352937	Green Published, Green Submitted, gold			2022-12-26	WOS:000360932800069
J	Pickett, EJ; Thomson, DL; Li, TA; Xing, S				Pickett, Evan J.; Thomson, David L.; Li, Teng A.; Xing, Shuang			Jensen's Inequality and the Impact of Short-Term Environmental Variability on Long-Term Population Growth Rates	PLOS ONE			English	Article							CLIMATE-CHANGE; TEMPERATURE; EXTINCTION; STOCHASTICITY; DEMOGRAPHY; TRENDS; WINTER	It is well established in theory that short-term environmental fluctuations could affect the long-term growth rates of wildlife populations, but this theory has rarely been tested and there remains little empirical evidence that the effect is actually important in practice. Here we develop models to quantify the effects of daily, seasonal, and yearly temperature fluctuations on the average population growth rates, and we apply them to long-term data on the endangered Black-faced Spoonbill (Platalea minor); an endothermic species whose population growth rates follow a concave relationship with temperature. We demonstrate for the first time that the current levels of temperature variability, particularly seasonal variability, are already large enough to substantially reduce long-term population growth rates. As the climate changes, our results highlight the importance of considering the ecological effects of climate variability and not just average conditions.	[Pickett, Evan J.; Thomson, David L.; Li, Teng A.; Xing, Shuang] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Thomson, David L.] UAE Univ, Coll Sci, Dept Biol, Al Ain, U Arab Emirates	University of Hong Kong; United Arab Emirates University	Thomson, DL (corresponding author), Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China.	dthomson@hku.hk	Xing, Shuang/AAL-7991-2020		RGC-GRF from the Hong Kong Research Grants Council [HKU778512]	RGC-GRF from the Hong Kong Research Grants Council	This work has been supported financially with RGC-GRF grant HKU778512 to DLT from the Hong Kong Research Grants Council (http://www.ugc.edu.hk/eng/rgc/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2012, AM NAT, V179, P178, DOI 10.1086/663677; Boyce MS, 2006, TRENDS ECOL EVOL, V21, P141, DOI 10.1016/j.tree.2005.11.018; BOYCE MS, 1977, THEOR POPUL BIOL, V12, P366, DOI 10.1016/0040-5809(77)90050-8; Carey G., 2002, WATERBIRD COUNT HDB; CAWTHORNE RA, 1980, BIRD STUDY, V27, P163, DOI 10.1080/00063658009476675; COHEN D, 1968, J ECOL, V56, P219, DOI 10.2307/2258075; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Doak DF, 2005, AM NAT, V166, pE14, DOI 10.1086/430642; Drake JM, 2005, P ROY SOC B-BIOL SCI, V272, P1823, DOI 10.1098/rspb.2005.3148; Frazier MR, 2006, AM NAT, V168, P512, DOI 10.1086/506977; Giorgi F, 2004, CLIM DYNAM, V23, P839, DOI 10.1007/s00382-004-0467-0; Huey RB, 2001, AM NAT, V158, P204, DOI 10.1086/321314; Jensen JLWV, 1906, ACTA MATH-DJURSHOLM, V30, P175, DOI 10.1007/BF02418571; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; KARL TR, 1993, B AM METEOROL SOC, V74, P1007, DOI 10.1175/1520-0477(1993)074<1007:ANPORG>2.0.CO;2; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; LEWONTIN RC, 1969, P NATL ACAD SCI USA, V62, P1056, DOI 10.1073/pnas.62.4.1056; Lundberg P, 2000, TRENDS ECOL EVOL, V15, P460, DOI 10.1016/S0169-5347(00)01981-9; McKechnie AE, 2010, BIOL LETTERS, V6, P253, DOI 10.1098/rsbl.2009.0702; Morris WF, 2008, ECOLOGY, V89, P19, DOI 10.1890/07-0774.1; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Powell LA, 2007, CONDOR, V109, P949, DOI 10.1650/0010-5422(2007)109[949:AVODPU]2.0.CO;2; Preston KL, 2012, BIOL CONSERV, V152, P280, DOI 10.1016/j.biocon.2012.03.011; R Core Team, 2021, R LANGUAGE ENV STAT; Robb GN, 2008, BIOL LETTERS, V4, P220, DOI 10.1098/rsbl.2007.0622; Ruel JJ, 1999, TRENDS ECOL EVOL, V14, P361, DOI 10.1016/S0169-5347(99)01664-X; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Schneider SH, 2002, WILDLIFE RESPONSES C; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Ueng YT, 2006, WATERBIRDS, V29, P185, DOI 10.1675/1524-4695(2006)29[185:DOTBSW]2.0.CO;2; Ueta M, 2002, IBIS, V144, P340, DOI 10.1046/j.1474-919X.2002.00037.x; van de Pol M, 2010, ECOLOGY, V91, P1192, DOI 10.1890/09-0410.1; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	34	6	6	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136072	10.1371/journal.pone.0136072	http://dx.doi.org/10.1371/journal.pone.0136072			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352857	Green Published, gold, Green Submitted			2022-12-26	WOS:000360932800023
J	Ayepola, OO; Olasupo, NA; Egwari, LO; Becker, K; Schaumburg, F				Ayepola, Olayemi O.; Olasupo, Nurudeen A.; Egwari, Louis O.; Becker, Karsten; Schaumburg, Frieder			Molecular Characterization and Antimicrobial Susceptibility of Staphylococcus aureus Isolates from Clinical Infection and Asymptomatic Carriers in Southwest Nigeria	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; EPIDEMIOLOGY; IDENTIFICATION; PREVALENCE; RESISTANCE; CARRIAGE; STRAINS; TOXIN; AGR	Few reports from Africa suggest that resistance pattern, virulence factors and genotypes differ between Staphylococcus aureus from nasal carriage and clinical infection. We therefore compared antimicrobial resistance, selected virulence factors and genotypes of S. aureus from nasal carriage and clinical infection in Southwest Nigeria. Non-duplicate S. aureus isolates were obtained from infection (n = 217) and asymptomatic carriers (n = 73) during a cross sectional study in Lagos and Ogun States, Nigeria from 2010-2011. Susceptibility testing was performed using Vitek automated systems. Selected virulence factors were detected by PCR. The population structure was assessed using spa typing. The spa clonal complexes (spa-CC) were deduced using the Based Upon Repeat Pattern algorithm (BURP). Resistance was higher for aminoglycosides in clinical isolates while resistances to quinolones and tetracycline were more prevalent in carrier isolates. The Panton-Valentine leukocidin (PVL) was more frequently detected in isolates from infection compared to carriage (80.2 vs 53.4%; p< 0.001, chi(2)-test). Seven methicillin resistant S. aureus isolates were associated with spa types t002, t008, t064, t194, t8439, t8440 and t8441. The predominant spa types among the methicillin-susceptible S. aureus isolates were t084 (65.5%), t2304 (4.4%) and t8435 (4.1%). spa-CC 084 was predominant among isolates from infection (80.3%, n = 167) and was significantly associated with PVL (OR = 7.1, 95% CI: 3.913.2, p< 0.001, chi(2-)test). In conclusion, PVL positive isolates were more frequently detected among isolates from infection compared to carriage and are associated with spa-CC 084.	[Ayepola, Olayemi O.; Egwari, Louis O.] Covenant Univ, Dept Biol Sci, Ota, Ogun State, Nigeria; [Olasupo, Nurudeen A.] Lagos State Univ, Dept Microbiol, Ojo, Lagos State, Nigeria; [Becker, Karsten; Schaumburg, Frieder] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany	Covenant University; Lagos State University; University of Munster	Ayepola, OO (corresponding author), Covenant Univ, Dept Biol Sci, Ota, Ogun State, Nigeria.	ola.ayepola@covenantuniversity.edu.ng	Schaumburg, Frieder/E-4464-2016; Ayepola, Olayemi/C-6922-2016; Olasupo, Nurudeen/CAH-0407-2022; Becker, Karsten/O-2302-2018	Becker, Karsten/0000-0002-6391-1341; Olasupo, Nurudeen/0000-0002-9222-2959	Covenant University; European Molecular Biology Organization (EMBO) [ASTF 18.00-2011]	Covenant University; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	Covenant University www.covenantuniversity.edu.ng OOA, European Molecular Biology Organization (EMBO) www.embo.org ASTF 18.00-2011 OOA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker K, 2003, J CLIN MICROBIOL, V41, P1434, DOI 10.1128/JCM.41.4.1434-1439.2003; BRAKSTAD OG, 1992, J CLIN MICROBIOL, V30, P1654, DOI 10.1128/JCM.30.7.1654-1660.1992; Breurec S, 2011, CLIN MICROBIOL INFEC, V17, P633, DOI 10.1111/j.1469-0691.2010.03320.x; Cremieux AC, 2014, J INFECT DIS, V209, P1773, DOI 10.1093/infdis/jit840; Egyir B, 2015, J GLOB ANTIMICROB RE, V3, P26, DOI 10.1016/j.jgar.2014.11.006; Goerke C, 2005, INT J MED MICROBIOL, V295, P67, DOI [10.1016/j.ijmm.2005.01.004, 10.1016/j.imm.2005.01.004]; Holden MTG, 2013, GENOME RES, V23, P653, DOI 10.1101/gr.147710.112; Kaase M, 2008, CLIN MICROBIOL INFEC, V14, P614, DOI 10.1111/j.1469-0691.2008.01997.x; Kaspar U, 2016, ENVIRON MICROBIOL, V18, P2130, DOI 10.1111/1462-2920.12891; Kolawole DO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068721; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Kraef C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00060; Lina G, 2003, APPL ENVIRON MICROB, V69, P18, DOI 10.1128/AEM.69.1.18-23.2003; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Mellmann A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-98; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240, DOI 10.1128/JCM.29.10.2240-2244.1991; Naber KG, 2008, EUR UROL, V54, P1164, DOI 10.1016/j.eururo.2008.05.010; Otto M, 2014, CURR OPIN MICROBIOL, V17, P32, DOI 10.1016/j.mib.2013.11.004; Otto M, 2014, INT J MED MICROBIOL, V304, P164, DOI 10.1016/j.ijmm.2013.11.019; Schaumburg F, 2014, CLIN MICROBIOL INFEC, V20, P589, DOI 10.1111/1469-0691.12690; Schaumburg F, 2013, EPIDEMIOL INFECT, V141, P1717, DOI 10.1017/S0950268812002270; Schaumburg F, 2011, CLIN MICROBIOL INFEC, V17, P1507, DOI 10.1111/j.1469-0691.2011.03534.x; Schaumburg F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001150; Shallcross LJ, 2013, LANCET INFECT DIS, V13, P43, DOI 10.1016/S1473-3099(12)70238-4; Shittu A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-286; Shittu AO, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-92; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9	28	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137531	10.1371/journal.pone.0137531	http://dx.doi.org/10.1371/journal.pone.0137531			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348037	gold, Green Published, Green Submitted			2022-12-26	WOS:000360897600053
J	Liao, CT; Fan, KH; Kang, CJ; Lin, CY; Chang, JTC; Tsang, NM; Huang, BS; Chao, YK; Lee, LY; Hsueh, C; Wang, HM; Liau, CT; Hsu, CL; Hsieh, CH; Ng, SH; Lin, CH; Tsao, CK; Fang, TJ; Huang, SF; Chang, KP; Yen, TC				Liao, Chun-Ta; Fan, Kang-Hsing; Kang, Chung-Jan; Lin, Chien-Yu; Chang, Joseph Tung-Chieh; Tsang, Ngan-Ming; Huang, Bing-Shen; Chao, Yin-Kai; Lee, Li-Yu; Hsueh, Chuen; Wang, Hung-Ming; Liau, Chi-Ting; Hsu, Cheng-Lung; Hsieh, Chia-Hsun; Ng, Shu-Hang; Lin, Chih-Hung; Tsao, Chung-Kan; Fang, Tuan-Jen; Huang, Shiang-Fu; Chang, Kai-Ping; Yen, Tzu-Chen			Clinical Outcomes of Patients with Resected Oral Cavity Cancer and Simultaneous Second Primary Malignancies	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ESOPHAGEAL CANCER; PRIMARY-TUMORS; NECK-CANCER; HEAD; SURVIVAL	Objectives Simultaneous second primary tumors (SSPT) are not uncommon in patients with oral cavity squamous cell carcinoma (OSCC) living in areas where the habit of betel quid chewing is widespread. We sought to identify the main prognostic factors in OSCC patients with SSPT and incorporate them into a risk stratification scheme. Methods A total of 1822 consecutive patients with primary OSCC treated between January 1996 and February 2014 were analyzed for the presence of SSPT. The 18-month and 5-year overall survival (OS) rates served as the main outcome measures. Results Of the 1822 patients, 77 (4%) were found to have SSPT (i.e, two malignancies identified within one month of each other). The 18-month and 5-year OS rates in patients without SSPT and with SSPT were 82% and 69%, and 72% and 53%, respectively (p = 0.0063). Patients with SSPT were further divided into patients with either esophageal cancer or hepatocellular carcinoma (eso-HCC subgroup, n = 8) and other tumors (NO eso-HCC subgroup, n = 69). After multivariate analysis, neck nodal extracapsular spread (ECS, n = 18) and the presence of eso-HCC were identified as independent adverse prognostic factors. The 18-month OS rates of SSPT patients with both eso-HCC and ECS (n = 5) vs. the remaining patients (n = 72) were 0% and 78%, respectively (p < 0.0001). Conclusion OSCC patients with neck nodal ECS and esophageal cancer or hepatocellular carcinoma as SSPT have a dismal short-term prognosis.	[Liao, Chun-Ta; Kang, Chung-Jan; Fang, Tuan-Jen; Huang, Shiang-Fu; Chang, Kai-Ping] Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Taoyuan, Taiwan; [Liao, Chun-Ta; Fan, Kang-Hsing; Kang, Chung-Jan; Lin, Chien-Yu; Chang, Joseph Tung-Chieh; Tsang, Ngan-Ming; Huang, Bing-Shen; Chao, Yin-Kai; Lee, Li-Yu; Hsueh, Chuen; Wang, Hung-Ming; Liau, Chi-Ting; Hsu, Cheng-Lung; Hsieh, Chia-Hsun; Ng, Shu-Hang; Lin, Chih-Hung; Tsao, Chung-Kan; Fang, Tuan-Jen; Huang, Shiang-Fu; Chang, Kai-Ping; Yen, Tzu-Chen] Chang Gung Univ, Taoyuan, Taiwan; [Liao, Chun-Ta; Fan, Kang-Hsing; Kang, Chung-Jan; Lin, Chien-Yu; Chang, Joseph Tung-Chieh; Tsang, Ngan-Ming; Huang, Bing-Shen; Chao, Yin-Kai; Lee, Li-Yu; Hsueh, Chuen; Wang, Hung-Ming; Liau, Chi-Ting; Hsu, Cheng-Lung; Hsieh, Chia-Hsun; Ng, Shu-Hang; Lin, Chih-Hung; Tsao, Chung-Kan; Fang, Tuan-Jen; Huang, Shiang-Fu; Chang, Kai-Ping; Yen, Tzu-Chen] Chang Gung Mem Hosp, Head & Neck Oncol Grp, Taoyuan, Taiwan; [Fan, Kang-Hsing; Lin, Chien-Yu; Chang, Joseph Tung-Chieh; Tsang, Ngan-Ming; Huang, Bing-Shen] Chang Gung Mem Hosp, Dept Radiat Oncol, Taoyuan, Taiwan; [Chao, Yin-Kai] Chang Gung Mem Hosp, Dept Thorac & Cardiovasc Surg, Taoyuan, Taiwan; [Lee, Li-Yu; Hsueh, Chuen] Chang Gung Mem Hosp, Dept Pathol, Taoyuan, Taiwan; [Wang, Hung-Ming; Liau, Chi-Ting; Hsu, Cheng-Lung; Hsieh, Chia-Hsun] Chang Gung Mem Hosp, Dept Med Oncol, Taoyuan, Taiwan; [Ng, Shu-Hang] Chang Gung Mem Hosp, Dept Diagnost Radiol, Taoyuan, Taiwan; [Lin, Chih-Hung; Tsao, Chung-Kan] Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Taoyuan, Taiwan; [Yen, Tzu-Chen] Chang Gung Mem Hosp, Dept Nucl Med, Taoyuan, Taiwan; [Yen, Tzu-Chen] Chang Gung Mem Hosp, Mol Imaging Ctr, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Yen, TC (corresponding author), Chang Gung Mem Hosp, Head & Neck Oncol Grp, Taoyuan, Taiwan.	yen1110@adm.cgmh.org.tw	Hsieh, Jason Chia-Hsun/G-5059-2010; Fan, K/GXH-3734-2022; Li-yu, Lee/G-5055-2010; Chao, YinKai/ABE-7827-2020	Hsieh, Jason Chia-Hsun/0000-0002-5547-409X; Hsueh, Chuen/0000-0001-7860-5964; Chao, Yin Kai/0000-0001-8649-8783; Fang, TuanJen/0000-0002-7805-3458; Fan, Kang-Hsing/0000-0002-0910-7803				[Anonymous], 2011, CANC REGISTRY ANN RE; Boute P, 2014, EUR ANN OTORHINOLARY, V131, P283, DOI 10.1016/j.anorl.2013.10.003; Fan KH, 2010, INT J RADIAT ONCOL, V77, P1024, DOI 10.1016/j.ijrobp.2009.06.064; Fukuzawa K, 1999, CANCER LETT, V144, P145, DOI 10.1016/S0304-3835(99)00223-2; Hsu SH, 2013, HEAD NECK-J SCI SPEC, V35, P1801, DOI 10.1002/hed.23242; Liao CT, 2007, ORAL ONCOL, V43, P811, DOI 10.1016/j.oraloncology.2006.10.003; Liao CT, 2013, ORAL ONCOL, V49, P230, DOI 10.1016/j.oraloncology.2012.09.010; Liao CT, 2011, INT J RADIAT ONCOL, V81, P930, DOI 10.1016/j.ijrobp.2010.07.1988; Liao CT, 2009, INT J RADIAT ONCOL, V74, P1054, DOI 10.1016/j.ijrobp.2008.09.045; Liao CT, 2015, J CANC RES PRACT, V2, P103; Lim H, 2015, GUT LIVER, V9, P159, DOI 10.5009/gnl13401; Lin CY, 2010, INT J RADIAT ONCOL, V78, P1011, DOI 10.1016/j.ijrobp.2009.09.074; Morita M, 2013, ANN SURG ONCOL, V20, P2434, DOI 10.1245/s10434-013-2875-z; Qaisi M, 2014, J ORAL MAXIL SURG, V72, P1511, DOI 10.1016/j.joms.2014.03.012; Wang HM, 2004, CANCER-AM CANCER SOC, V101, P1818, DOI 10.1002/cncr.20561	15	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136918	10.1371/journal.pone.0136918	http://dx.doi.org/10.1371/journal.pone.0136918			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335067	Green Published, gold, Green Submitted			2022-12-26	WOS:000360615400032
J	Sokhi, DS; Oxenham, C; Coates, R; Forbes, M; Gupta, NK; Blackburn, DJ				Sokhi, Dilraj Singh; Oxenham, Chantal; Coates, Rebecca; Forbes, Mhairi; Gupta, Nadi K.; Blackburn, Daniel J.			Four-Stage Audit Demonstrating Increased Uptake of HIV Testing in Acute Neurology Admissions Using Staged Practical Interventions	PLOS ONE			English	Article							MEDICAL ADMISSIONS; CARE; GUIDELINES; UNIT; TRANSMISSION; INFECTION; BARRIERS	Background UK National Guidelines (UKNG) advise HIV testing in clinically indicated neurological presentations. We audited the impact of our practical strategies to increase uptake of HIV testing at a regional acute neurology admissions unit. Methods We audited HIV testing in 4 periods over 2 years: before we designed a UKNG-based "HIV testing in Neurology" protocol ("pre-protocol"); after dissemination of the protocol alone ("post-protocol"); post-protocol dissemination combined with both a tailored departmental admissions clerking proforma to prompt for HIV testing & consenting, and regular focussed tutorials to doctors on HIV testing in neurological patients ("post-proforma"); and finally one year after the post-proforma period ("+1 year"). We also looked at the total number of HIV tests sent from the unit during the two-year period. We assessed significance using Fisher's exact test. Results 47.8% of all acute neurology non-stroke admissions were eligible for HIV testing during all the audit periods. Testing rates were as follows: pre-protocol 21.9%; post-protocol 36.6%; post-proforma 83.3%; and at +1 year 65.4% (p<0.05 for both post-protocol and +1 year when compared to pre-protocol). Documentation of consent for HIV testing improved from 25% to 67.6% with the HIV-tailored clerking proforma. The total number of HIV tests requested from the unit doubled in the post-proforma period compared to pre-protocol ( p<0.05). Conclusion In conclusion: the combination of an HIV testing protocol, a tailored departmental clerking proforma and regular focussed teaching to doctors on indications for HIV testing led to a sustained increase in HIV testing uptake in our regional acute neurology admissions unit.	[Sokhi, Dilraj Singh; Oxenham, Chantal; Coates, Rebecca; Forbes, Mhairi; Blackburn, Daniel J.] Sheffield Teaching Hosp NHS Fdn Trust, Royal Hallamshire Hosp, Dept Clin Neurol, Sheffield S10 4JF, S Yorkshire, England; [Gupta, Nadi K.] Sheffield Teaching Hosp NHS Fdn Trust, Royal Hallamshire Hosp, Dept Genitourinary Med, Sheffield S10 4JF, S Yorkshire, England; [Blackburn, Daniel J.] Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Sokhi, DS (corresponding author), Sheffield Teaching Hosp NHS Fdn Trust, Royal Hallamshire Hosp, Dept Clin Neurol, Doctors Off L16, Glossop Rd, Sheffield S10 4JF, S Yorkshire, England.	Dilraj.Sokhi@doctors.net.uk	Blackburn, Daniel J/B-7355-2011	blackburn, daniel/0000-0001-8886-1283				Aghaizu A, 2013, GILL ON DELPECH VC C; Alston C, 2013, CLIN MED, V13, P114, DOI 10.7861/clinmedicine.13-1-114; Anand Kuljeet Singh, 2014, J Int Assoc Provid AIDS Care, V13, P409, DOI 10.1177/2325957414531620; [Anonymous], 2006, 2005 2006 MORT AUD; [Anonymous], 2009, HIV UK 2009 REP; Benjamin LA, 2012, LANCET NEUROL, V11, P878, DOI 10.1016/S1474-4422(12)70205-3; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Buetikofer S., 2014, SWISS MED WKLY, V144, DOI [10.4414/SMW.2014.13961, DOI 10.4414/SMW.2014.13961]; Burns F, 2013, HIV MED, V14, P10, DOI 10.1111/hiv.12056; Casalino E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046437; Chan SY, 2011, INT J STD AIDS, V22, P187, DOI 10.1258/ijsa.2010.010304; Chua AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034663; Deblonde J, 2010, EUR J PUBLIC HEALTH, V20, P422, DOI 10.1093/eurpub/ckp231; Dodd MC, 2013, THORAX, V68, P1072, DOI 10.1136/thoraxjnl-2012-202871; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Ellis S, 2011, CLIN MED, V11, P541, DOI 10.7861/clinmedicine.11-6-541; Socias ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069517; Gendelman HEG, 2011, NEUROLOGY AIDS; Hartney T, 2012, EVIDENCE RESOURCES C; Haukoos JS, 2010, JAMA-J AM MED ASSOC, V304, P284, DOI 10.1001/jama.2010.953; Health Protection Agency, 2011, TIM TEST HIV EXP HIV; Hickman SJ, 2008, NEURO-OPHTHALMOLOGY, V32, P237, DOI 10.1080/01658100802391905; Krentz HB, 2004, HIV MED, V5, P93, DOI 10.1111/j.1468-1293.2004.00193.x; Lucas SB, 2008, CLIN MED, V8, P250, DOI 10.7861/clinmedicine.8-3-250; May MT, 2014, AIDS, V28, P1193, DOI 10.1097/QAD.0000000000000243; McLaren JS, 2001, QJM-INT J MED, V94, P615, DOI 10.1093/qjmed/94.11.615; Mitchell L, 2011, INT J STD AIDS, V22, P753, DOI 10.1258/ijsa.2009.009244; Page I, 2011, J ROY COLL PHYS EDIN, V41, P9, DOI 10.4997/JRCPE.2011.103; Palfreeman A., 2008, UKNATIONAL GUIDELINE; Palfreeman A, 2013, SEX TRANSM INFECT, V89, P308, DOI 10.1136/sextrans-2011-050401; Peck L, 2010, QJM-INT J MED, V103, P147, DOI 10.1093/qjmed/hcp185; Perry NH, 2010, HIV MED, V11; Phillips D, 2014, SEX TRANSM INFECT, V90, P185, DOI 10.1136/sextrans-2013-051302; Price H, 2009, INT J STD AIDS, V20, P56, DOI 10.1258/ijsa.2008.008326; Ratcliffe L, 2011, POSTGRAD MED J, V87, P170, DOI 10.1136/pgmj.2010.109801; Rayment M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039530; Reynolds SJ, 2011, AIDS, V25, P473, DOI 10.1097/QAD.0b013e3283437c2b; Sokhi D, 2013, HIV MED S, V4, P12; Solomon T, 2012, J INFECTION, V64, P347, DOI 10.1016/j.jinf.2011.11.014; SOPHID, 2011, SURV PREV HIV INF DI; Thornton AC, 2012, SEX TRANSM INFECT, V88, P601, DOI 10.1136/sextrans-2012-050584; van Sighem A, 2010, AIDS, V24, P1527, DOI 10.1097/QAD.0b013e32833a3946	42	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0134574	10.1371/journal.pone.0134574	http://dx.doi.org/10.1371/journal.pone.0134574			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335351	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000360615400002
J	Titmarsh, HF; Gow, AG; Kilpatrick, S; Cartwright, JA; Milne, EM; Philbey, AW; Berry, J; Handel, I; Mellanby, RJ				Titmarsh, Helen F.; Gow, Adam G.; Kilpatrick, Scott; Cartwright, Jennifer A.; Milne, Elspeth M.; Philbey, Adrian W.; Berry, Jacqueline; Handel, Ian; Mellanby, Richard J.			Low Vitamin D Status Is Associated with Systemic and Gastrointestinal Inflammation in Dogs with a Chronic Enteropathy	PLOS ONE			English	Article							SERUM 25(OH)D CONCENTRATIONS; CONGESTIVE-HEART-FAILURE; C-REACTIVE PROTEIN; D SUPPLEMENTATION; 25-HYDROXYVITAMIN D; HYPOVITAMINOSIS D; BOWEL-DISEASE; PROINFLAMMATORY CYTOKINES; 1,25-DIHYDROXYVITAMIN D-3; OXIDATIVE STRESS	Introduction Vitamin D deficiency, as assessed by serum concentrations of 25 hydroxyvitamin D (25 (OH)D), has been linked to the development of over-zealous and inappropriate inflammation in humans. However, the relationship between vitamin D status and inflammation in dogs is ill-defined. Chronic enteropathies (CE) are frequently diagnosed in client owned dogs, have a wide range of serum 25(OH)D concentrations, and represent a spontaneous model in which to probe the relationship between vitamin D and inflammation. The hypothesis of this study was that vitamin D status would be negatively associated with systemic and gastrointestinal inflammation in dogs with a CE. The aim of this study was to examine the relationship between serum 25(OH)D concentrations and markers of systemic and gastrointestinal inflammation in a cohort of dogs with CE. Methods and Materials Serum 25(OH)D concentrations, together with neutrophil, monocyte, eosinophil and lymphocyte counts, duodenal histopathology scores, serum IL-2, IL-6, IL-8 and TNF alpha concentrations and were measured in 39 dogs with histologically confirmed CE. A linear regression model examined the relationship between serum 25(OH)D status and measures of inflammation. Results Serum 25(OH)D concentrations were negatively associated with neutrophil and monocyte counts, duodenal histopathology scores and serum IL-2 and IL-8 concentrations. Dogs with low serum 25(OH)D concentrations typically had an inflammatory signature characterised by high monocyte and neutrophil numbers together with low lymphocyte numbers. There is a need to establish whether low vitamin D status is a cause or consequence of inflammation.	[Titmarsh, Helen F.; Gow, Adam G.; Kilpatrick, Scott; Cartwright, Jennifer A.; Milne, Elspeth M.; Philbey, Adrian W.; Handel, Ian; Mellanby, Richard J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin EH25 9RG, Midlothian, Scotland; [Titmarsh, Helen F.; Gow, Adam G.; Kilpatrick, Scott; Cartwright, Jennifer A.; Milne, Elspeth M.; Philbey, Adrian W.; Handel, Ian; Mellanby, Richard J.] Univ Edinburgh, Roslin Inst, Roslin EH25 9RG, Midlothian, Scotland; [Berry, Jacqueline] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester Royal Infirm, Vitamin Res Lab D,Endocrinol & Diabet,Inst Human, Manchester M13 9WL, Lancs, England	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Manchester	Mellanby, RJ (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin EH25 9RG, Midlothian, Scotland.	Richard.Mellanby@ed.ac.uk	Gow, Adam/H-6623-2019	Gow, Adam/0000-0002-4297-8870; Kilpatrick, Scott/0000-0002-1469-757X; Mellanby, Richard John/0000-0002-3467-7007	Wellcome Trust Intermediate Clinical Fellowship	Wellcome Trust Intermediate Clinical Fellowship(Wellcome Trust)	Richard Mellanby is supported by a Wellcome Trust Intermediate Clinical Fellowship.	Abou-Raya A, 2013, J RHEUMATOL, V40, P265, DOI 10.3899/jrheum.111594; Alvarez JA, 2013, EUR J CLIN NUTR, V67, P264, DOI 10.1038/ejcn.2012.217; Bang UC, 2011, ENDOCR RES, V36, P135, DOI 10.3109/07435800.2011.554937; Barker T, 2013, EUR J APPL PHYSIOL, V113, P1523, DOI 10.1007/s00421-012-2582-7; Barth JH, 2012, ANN CLIN BIOCHEM, V49, P399, DOI 10.1258/acb.2011.011195; Bellia A, 2013, INTERN EMERG MED, V8, P33, DOI 10.1007/s11739-011-0559-x; Berry J, 2000, 25 HYDROXYVITAMIN D, P797; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Cannell JJ, 2014, DERM-ENDOCRINOL, V6, DOI 10.4161/19381980.2014.983401; Carlson Nathan, 2013, Perm J, V17, P19, DOI 10.7812/TPP/13-007; Chambers ES, 2014, IMMUNOLOGY, V143, P52, DOI 10.1111/imm.12289; Charrad M, 2014, J STAT SOFTW, V61, P1; Chen YZ, 2014, INFLAMM BOWEL DIS, V20, P1910, DOI 10.1097/MIB.0000000000000158; Christakos S, 2003, J CELL BIOCHEM, V88, P695, DOI 10.1002/jcb.10423; Codoner-Franch P, 2012, J PEDIATR-US, V161, P848, DOI 10.1016/j.jpeds.2012.04.046; Czifra G, 2014, RHEUMATOL INT, V34, P717, DOI 10.1007/s00296-013-2751-y; Day MJ, 2008, J COMP PATHOL, V138, pS1, DOI 10.1016/j.jcpa.2008.01.001; Cavalcante IGD, 2015, EXP GERONTOL, V66, P10, DOI 10.1016/j.exger.2015.03.011; De Vita F, 2014, AGE, V36, DOI 10.1007/s11357-014-9694-4; Di Filippo P, 2015, INT ARCH ALLERGY IMM, V166, P91, DOI 10.1159/000371350; Friis H, 2008, J NUTR, V138, P2474, DOI 10.3945/jn.108.094979; Froicu M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-5; Garg M, 2013, INFLAMM BOWEL DIS, V19, P2634, DOI 10.1097/01.MIB.0000436957.77533.b2; Gerber B, 2003, AM J VET RES, V64, P1161, DOI 10.2460/ajvr.2003.64.1161; Gow AG, 2011, J SMALL ANIM PRACT, V52, P410, DOI 10.1111/j.1748-5827.2011.01082.x; Grzanka A, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-2; Harishankar M, 2014, INT IMMUNOPHARMACOL, V23, P148, DOI 10.1016/j.intimp.2014.08.021; Henriksen VT, 2014, MED HYPOTHESES, V82, P134, DOI 10.1016/j.mehy.2013.11.020; Hidaka M, 2013, EUR J PHARMACOL, V721, P305, DOI 10.1016/j.ejphar.2013.09.014; Hopkins MH, 2011, CANCER PREV RES, V4, P1645, DOI 10.1158/1940-6207.CAPR-11-0105; Jeong MS, 2014, ANN DERMATOL, V26, P296, DOI 10.5021/ad.2014.26.3.296; Karim Y, 2013, INT IMMUNOPHARMACOL, V17, P693, DOI 10.1016/j.intimp.2013.08.010; Khoo AL, 2011, CYTOKINE, V55, P294, DOI 10.1016/j.cyto.2011.04.016; Kilpatrick S, 2014, VET J, V200, P197, DOI 10.1016/j.tvjl.2014.01.007; Korf H, 2012, IMMUNOBIOLOGY, V217, P1292, DOI 10.1016/j.imbio.2012.07.018; Kraus MS, 2014, J VET INTERN MED, V28, P109, DOI 10.1111/jvim.12239; Laird E, 2014, J CLIN ENDOCR METAB, V99, P1807, DOI 10.1210/jc.2013-3507; Li YC, 2015, J STEROID BIOCHEM, V148, P179, DOI 10.1016/j.jsbmb.2015.01.011; Maechler M., 2015, CLUSTER ANAL BASICS; Martineau AR, 2007, J IMMUNOL, V178, P7190, DOI 10.4049/jimmunol.178.11.7190; Matilainen JM, 2010, J STEROID BIOCHEM, V121, P142, DOI 10.1016/j.jsbmb.2010.03.020; MAWER EB, 1985, CLIN SCI, V68, P135, DOI 10.1042/cs0680135; MAWER EB, 1990, CLIN CHIM ACTA, V190, P199, DOI 10.1016/0009-8981(90)90174-Q; MAZZUCCHELLI L, 1994, AM J PATHOL, V144, P997; Mellanby RJ, 2005, J SMALL ANIM PRACT, V46, P345, DOI 10.1111/j.1748-5827.2005.tb00331.x; Nissou MF, 2014, J ALZHEIMERS DIS, V42, P789, DOI 10.3233/JAD-140411; Patel S, 2007, ARTHRITIS RHEUM, V56, P2143, DOI 10.1002/art.22722; Peterson CA, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-10; Poudel-Tandukar K, 2013, AIDS RES HUM RETROV, V29, P528, DOI [10.1089/aid.2012.0120, 10.1089/AID.2012.0120]; Prietl B, 2013, NUTRIENTS, V5, P2502, DOI 10.3390/nu5072502; Raftery T, 2015, DIGEST DIS SCI, V60, P2427, DOI 10.1007/s10620-015-3620-1; Reid D, 2011, AM J CLIN NUTR, V93, P1006, DOI 10.3945/ajcn.110.008490; Robinson AB, 2014, LUPUS SCI MED, V1, DOI 10.1136/lupus-2014-000011; Rosa CT, 2013, J VET INTERN MED, V27, P1159, DOI 10.1111/jvim.12161; Rosen CJ, 2012, ENDOCR REV, V33, P456, DOI 10.1210/er.2012-1000; Schleithoff SS, 2006, AM J CLIN NUTR, V83, P754, DOI 10.1093/ajcn/83.4.754; Selting KA, 2016, VET COMP ONCOL, V14, P295, DOI 10.1111/vco.12101; Shih EM, 2016, PEDIATR DIABETES, V17, P36, DOI 10.1111/pedi.12238; Sinha-Hikim I, 2015, HORM METAB RES, V47, P280, DOI 10.1055/s-0034-1383652; Spoo JW, 2015, J VET INTERN MED, V29, P519, DOI 10.1111/jvim.12546; Stubbs JR, 2010, J AM SOC NEPHROL, V21, P353, DOI 10.1681/ASN.2009040451; SWAIN SL, 1991, CURR OPIN IMMUNOL, V3, P304, DOI 10.1016/0952-7915(91)90028-Y; Szkaradkiewicz A, 2009, ARCH IMMUNOL THER EX, V57, P291, DOI 10.1007/s00005-009-0031-z; Team RC, 2014, LANG ENV STAT COMP R; Waldron JL, 2013, J CLIN PATHOL, V66, P620, DOI 10.1136/jclinpath-2012-201301; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Yang LL, 2013, CLIN TRANSL GASTROEN, V4, DOI 10.1038/ctg.2013.1; Zhu Y, 2005, EUR J IMMUNOL, V35, P217, DOI 10.1002/eji.200425491	68	33	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137377	10.1371/journal.pone.0137377	http://dx.doi.org/10.1371/journal.pone.0137377			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26333093	gold, Green Published, Green Submitted			2022-12-26	WOS:000360613800128
J	Molina, ML; Giudici, AM; Poveda, JA; Fernandez-Ballester, G; Montoya, E; Renart, ML; Fernandez, AM; Encinar, JA; Riquelme, G; Morales, A; Gonzalez-Ros, JM				Luisa Molina, M.; Marcela Giudici, A.; Poveda, Jose A.; Fernandez-Ballester, Gregorio; Montoya, Estefania; Lourdes Renart, M.; Fernandez, Asia M.; Encinar, Jose A.; Riquelme, Gloria; Morales, Andres; Gonzalez-Ros, Jose M.			Competing Lipid-Protein and Protein-Protein Interactions Determine Clustering and Gating Patterns in the Potassium Channel from Streptomyces lividans (KcsA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE NATIVE ELECTROPHORESIS; K+ CHANNEL; FORCE-FIELD; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MOLECULAR-BASIS; BINDING-SITES; SWISS-MODEL; PATCH-CLAMP; MEMBRANE	There is increasing evidence to support the notion that membrane proteins, instead of being isolated components floating in a fluid lipid environment, can be assembled into supramolecular complexes that take part in a variety of cooperative cellular functions. The interplay between lipid-protein and protein-protein interactions is expected to be a determinant factor in the assembly and dynamics of such membrane complexes. Here we report on a role of anionic phospholipids in determining the extent of clustering of KcsA, a model potassium channel. Assembly/disassembly of channel clusters occurs, at least partly, as a consequence of competing lipid-protein and protein-protein interactions at nonannular lipid binding sites on the channel surface and brings about profound changes in the gating properties of the channel. Our results suggest that these latter effects of anionic lipids are mediated via the Trp67-Glu71-Asp80 inactivation triad within the channel structure and its bearing on the selectivity filter.	[Luisa Molina, M.; Marcela Giudici, A.; Poveda, Jose A.; Fernandez-Ballester, Gregorio; Montoya, Estefania; Lourdes Renart, M.; Fernandez, Asia M.; Encinar, Jose A.; Gonzalez-Ros, Jose M.] Univ Miguel Hernandez, Inst Biol Mol & Celular, Alicante 03202, Spain; [Riquelme, Gloria] Univ Chile, Fac Med, Inst Ciencias Biomed, Santiago 1027, Chile; [Morales, Andres] Univ Alicante, Dept Fisiol Genet & Microbiol, E-03080 Alicante, Spain	Universidad Miguel Hernandez de Elche; Universidad de Chile; Universitat d'Alacant	Gonzalez-Ros, JM (corresponding author), Univ Miguel Hernandez, Inst Biol Mol & Celular, Alicante 03202, Spain.	gonzalez.ros@umh.es	Encinar, José A/F-2946-2013; Carvajal, Asia Fernandez/G-8877-2015; Encinar, José Antonio/AAE-9141-2020; Morales, Andrés/M-5128-2015; Gallego, María Luisa Molina/K-4810-2017; Poveda Larrosa, Jose Antonio/H-5925-2015	Encinar, José A/0000-0002-7219-3863; Encinar, José Antonio/0000-0002-7219-3863; Morales, Andrés/0000-0002-1526-3327; Gallego, María Luisa Molina/0000-0001-9190-6948; Montoya, Estefania/0000-0003-2866-4733; Gonzalez Ros, Jose Manuel/0000-0002-4804-6855; Renart, Maria Lourdes/0000-0002-6717-4756; Giudici, Ana Marcela/0000-0002-3753-4861; Fernandez-Carvajal, Asia/0000-0003-2741-1427; Poveda Larrosa, Jose Antonio/0000-0003-0722-3752	Spanish Ministerio de Ciencia e Innovacion [BFU2011-25920, BFU2012-31359]; Consolider-Ingenio Grant [CSD2-2008-00005]; Ministerio de Ciencia e Innovacion Jose Castillejo Program	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consolider-Ingenio Grant; Ministerio de Ciencia e Innovacion Jose Castillejo Program(Ministry of Science and Innovation, Spain (MICINN))	This work was supported in part by grants from the Spanish Ministerio de Ciencia e Innovacion Grants BFU2011-25920 and BFU2012-31359 and Consolider-Ingenio 2010 Grant CSD2-2008-00005. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by funds from the Ministerio de Ciencia e Innovacion Jose Castillejo Program for short research stays.	Barrera FN, 2008, BIOCHEMISTRY-US, V47, P2123, DOI 10.1021/bi700778c; Blunck R, 2006, J GEN PHYSIOL, V128, P569, DOI 10.1085/jgp.200609638; Botelho AV, 2006, BIOPHYS J, V91, P4464, DOI 10.1529/biophysj.106.082776; Cao Y, 2011, NATURE, V471, P336, DOI 10.1038/nature09731; Chakrapani S, 2007, J GEN PHYSIOL, V130, P479, DOI 10.1085/jgp.200709844; Cheng MH, 2009, J PHYS CHEM B, V113, P6964, DOI 10.1021/jp900714b; Chiantia S, 2005, LANGMUIR, V21, P6317, DOI 10.1021/la050115m; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cordero-Morales JF, 2011, BIOPHYS J, V100, P2387, DOI 10.1016/j.bpj.2011.01.073; Demmers JAA, 2003, FEBS LETT, V541, P28, DOI 10.1016/S0014-5793(03)00282-5; Deol SS, 2006, BIOPHYS J, V90, P822, DOI 10.1529/biophysj.105.071407; Dibb KM, 2003, J BIOL CHEM, V278, P49537, DOI 10.1074/jbc.M307723200; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Goforth RL, 2003, J GEN PHYSIOL, V121, P477, DOI 10.1085/jgp.200308797; Grage SL, 2011, BIOPHYS J, V100, P1252, DOI 10.1016/j.bpj.2011.01.023; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamill OP, 1991, CEREB CORTEX, V1, P48, DOI 10.1093/cercor/1.1.48; Hegermann J, 2006, MICROBIOL-SGM, V152, P2831, DOI 10.1099/mic.0.29002-0; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; Imai S, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.401265; Iwamoto M, 2013, P NATL ACAD SCI USA, V110, P749, DOI 10.1073/pnas.1217323110; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303; Giudici AM, 2013, BBA-BIOMEMBRANES, V1828, P193, DOI 10.1016/j.bbamem.2012.09.020; Marius P, 2005, BIOPHYS J, V89, P4081, DOI 10.1529/biophysj.105.070755; Marius P, 2008, BIOPHYS J, V94, P1689, DOI 10.1529/biophysj.107.117507; Marius P, 2012, BBA-BIOMEMBRANES, V1818, P90, DOI 10.1016/j.bbamem.2011.09.017; MCCORMICK JI, 1988, J BIOL CHEM, V263, P8111; Meuser D, 1999, FEBS LETT, V462, P447, DOI 10.1016/S0014-5793(99)01579-3; Molina ML, 2008, J BIOL CHEM, V283, P18076, DOI 10.1074/jbc.M710132200; Molina ML, 2006, J BIOL CHEM, V281, P18837, DOI 10.1074/jbc.M600342200; Molina ML, 2004, BIOCHEMISTRY-US, V43, P14924, DOI 10.1021/bi048889+; Mueller NS, 2012, MOL MEMBR BIOL, V29, P186, DOI 10.3109/09687688.2012.687461; NEUHOFF V, 1985, ELECTROPHORESIS, V6, P427, DOI 10.1002/elps.1150060905; Nicke A, 1999, J RECEPT SIGNAL TR R, V19, P493, DOI 10.3109/10799899909036667; Raja M, 2009, BIOPHYS CHEM, V142, P46, DOI 10.1016/j.bpc.2009.03.005; RIQUELME G, 1990, BIOCHEMISTRY-US, V29, P11215, DOI 10.1021/bi00503a009; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SCHREMPF H, 1995, EMBO J, V14, P5170, DOI 10.1002/j.1460-2075.1995.tb00201.x; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Seeger HM, 2009, J PHYS CHEM B, V113, P16654, DOI 10.1021/jp907505m; Spira F, 2012, NAT CELL BIOL, V14, P640, DOI 10.1038/ncb2487; Splitt H, 2000, FEBS LETT, V472, P83, DOI 10.1016/S0014-5793(00)01429-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Triano I, 2010, BIOCHEMISTRY-US, V49, P5397, DOI 10.1021/bi1003712; UNDROVINAS AI, 1992, CIRC RES, V71, P1231, DOI 10.1161/01.RES.71.5.1231; Uysal S, 2009, P NATL ACAD SCI USA, V106, P6644, DOI 10.1073/pnas.0810663106; Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/bi026215y; van Dalen A, 2002, FEBS LETT, V525, P33, DOI 10.1016/S0014-5793(02)03061-2; Vinothkumar KR, 2006, J BIOL CHEM, V281, P4795, DOI 10.1074/jbc.M508993200; Weingarth M, 2013, J AM CHEM SOC, V135, P3983, DOI 10.1021/ja3119114; Zakharian E, 2004, BIOCHEM BIOPH RES CO, V322, P1059, DOI 10.1016/j.bbrc.2004.08.027; Zakharian E, 2004, BIOCHEM BIOPH RES CO, V316, P429, DOI 10.1016/j.bbrc.2004.02.069; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	64	17	17	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25745	25755		10.1074/jbc.M115.669598	http://dx.doi.org/10.1074/jbc.M115.669598			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26336105	Green Published, hybrid			2022-12-26	WOS:000362962800045
J	Jin, DH; Park, SE; Lee, J; Kim, KM; Kim, S; Kim, DH; Park, J				Jin, Dong-Hao; Park, Seong-Eun; Lee, Jeeyun; Kim, Kyung-Mi; Kim, Sung; Kim, Duk-Hwan; Park, Joobae			Copy Number Gains at 8q24 and 20q11-q13 in Gastric Cancer Are More Common in Intestinal-Type than Diffuse-Type	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; HER2 GENE AMPLIFICATION; C-MYC; PROTEIN EXPRESSION; TRANSCRIPTION FACTOR; IDENTIFICATION; CARCINOMA; FHIT; ADENOCARCINOMA; PROGRESSION	The present study was aimed at discovering DNA copy number alterations (CNAs) involved in the carcinogenesis of stomach and at understanding their clinicopathological significances in the Korean population. DNA copy numbers were analyzed using Agilent 244K or 400K array comparative genomic hybridization (aCGH) in fresh-frozen tumor and matched normal tissues from 40 gastric cancer patients. Some of the detected CNA regions were validated using multiplex ligation-dependent probe amplification (MLPA) in six of the 40 patients and customized Agilent 60K aCGH in an independent set of 48 gastric cancers. The mRNA levels of genes at common CNA regions were analyzed using quantitative real-time PCR. Copy number gains were more common than losses across the entire genome in tumor tissues compared to matched normal tissues. The mean number of alterations per case was 64 for gains and 40 for losses, and the median aberration length was 44016 bp for gains and 4732 bp for losses. Copy number gains were frequently detected at 7p22.1 (20%), 8q24.21 (27%-30%), 8q24.3 (22%-48%), 13q34 (20%-31%), and 20q11-q13 (25%-30%), and losses at 3p14.2 (43%), 4q35.2 (27%), 6q26 (23%), and 17p13.3 (20%-23%). CNAs at 7p22.1, 13q34, and 17p13.3 have not been reported in other populations. Most of the copy number losses were associated with down-regulation of mRNA levels, but the correlation between copy number gains and mRNA expression levels varied in a gene-dependent manner. In addition, copy number gains tended to occur more commonly in intestinal-type cancers than in diffuse-type cancers. In conclusion, the present study suggests that copy number gains at 8q24 and 20q11-q13 and losses at 3p14.2 may be common events in gastric cancer but CNAs at 7p22.1, 13q34, and 17p13.3 may be Korean-specific.	[Jin, Dong-Hao; Park, Seong-Eun; Kim, Duk-Hwan; Park, Joobae] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon 135710, South Korea; [Lee, Jeeyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med, Seoul 135710, South Korea; [Kim, Kyung-Mi] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul 135710, South Korea; [Kim, Sung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul 135710, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, DH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon 135710, South Korea.	dukhwan.kim@samsung.com; jb.park@skku.edu	Lee, Jee Yun/C-9646-2011; Kim, Sung/G-4114-2014		National R&D Program for Cancer Control, Ministry for Health and Welfare [1120270]; Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C1979]	National R&D Program for Cancer Control, Ministry for Health and Welfare; Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This work was supported by grants from the National R&D Program for Cancer Control, Ministry for Health and Welfare (# 1120270) and from the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare (HI14C1979), Republic of Korea.	Baffa R, 1998, CANCER RES, V58, P4708; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Boussioutas A, 2001, INTERN MED J, V31, P296, DOI 10.1046/j.1445-5994.2001.00057.x; Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; Calcagno DQ, 2006, WORLD J GASTROENTERO, V12, P6207, DOI 10.3748/wjg.v12.i38.6207; Calcagno DQ, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-141; Cheng L, 2012, CANCER LETT, V326, P105, DOI 10.1016/j.canlet.2012.07.031; Cheng L, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-14; Chung KY, 2011, HEPATOLOGY, V54, P307, DOI 10.1002/hep.24372; Dang CV, 1999, EXP CELL RES, V253, P63, DOI 10.1006/excr.1999.4686; de Souza CR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064420, DOI 10.1371/J0URNAL.P0NE.0064420]; Diosdado B, 2010, CLIN CANCER RES, V16, P1391, DOI 10.1158/1078-0432.CCR-09-1773; Fan BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029824; Gemma A, 1997, CANCER RES, V57, P1435; Gogusev J, 1999, HUM GENET, V105, P444, DOI 10.1007/s004390051129; Gumireddy K, 2013, EMBO J, V32, P2672, DOI 10.1038/emboj.2013.188; Hayashi H, 2015, ONCOGENE, V34, P199, DOI 10.1038/onc.2013.547; Jorgensen JT, 2012, J CANCER, V3, P137, DOI 10.7150/jca.4090; Killian A, 2006, GENE CHROMOSOME CANC, V45, P874, DOI 10.1002/gcc.20351; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Koizumi Y, 1997, CLIN CANCER RES, V3, P1067; Kokkola A, 1998, CANCER GENET CYTOGEN, V107, P32, DOI 10.1016/S0165-4608(98)00092-2; Lee J, 2012, J CLIN ONCOL, V30, P268, DOI 10.1200/JCO.2011.39.1953; Lips EH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-314; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Matsushita K, 2006, CANCER RES, V66, P1409, DOI 10.1158/0008-5472.CAN-04-4459; Myllykangas S, 2008, INT J CANCER, V123, P817, DOI 10.1002/ijc.23574; Nelson MA, 2006, CANCER BIOL THER, V5, P407, DOI 10.4161/cbt.5.4.2512; Oh EK, 2012, INT J ONCOL, V41, P2038, DOI 10.3892/ijo.2012.1644; Ohta M, 1996, CELL, V84, P587, DOI 10.1016/S0092-8674(00)81034-X; Park CH, 2010, J SURG ONCOL, V102, P454, DOI 10.1002/jso.21585; Ramakrishna M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009983; Roa JC, 2005, REV MED CHILE, V133, P874; Rocco A, 2003, J CANCER RES CLIN, V129, P84, DOI 10.1007/s00432-002-0409-3; Rohrmoser M, 2007, MOL CELL BIOL, V27, P3682, DOI 10.1128/MCB.00172-07; Rossi E, 2011, HUM PATHOL, V42, P1937, DOI 10.1016/j.humpath.2011.02.016; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Shlien A, 2010, CURR OPIN ONCOL, V22, P55, DOI 10.1097/CCO.0b013e328333dca4; Siprashvili Z, 1997, P NATL ACAD SCI USA, V94, P13771, DOI 10.1073/pnas.94.25.13771; Sonoda A, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-25; Sung CO, 2013, CANCER GENET-NY, V206, P145, DOI 10.1016/j.cancergen.2013.04.002; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Tsukamoto Y, 2008, J PATHOL, V216, P471, DOI 10.1002/path.2424; Varis A, 2002, CANCER RES, V62, P2625; White SJ, 2007, CYTOGENET GENOME RES, V118, P19, DOI 10.1159/000106437; Xu AG, 2001, WORLD J GASTROENTERO, V7, P403; Yan B, 2010, J CLIN PATHOL, V63, P839, DOI 10.1136/jcp.2010.076570; Yano T, 2006, ONCOL REP, V15, P65; Yun SH, 2014, PLOS ONE, V3, P1, DOI DOI 10.1038/0NC.2013.472; Zhang L, 2010, MOL CELL BIOCHEM, V344, P125, DOI 10.1007/s11010-010-0536-0	51	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137657	10.1371/journal.pone.0137657	http://dx.doi.org/10.1371/journal.pone.0137657			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360582	gold, Green Submitted, Green Published			2022-12-26	WOS:000361043100068
J	Sarkar, A; Brenk, R				Sarkar, Aurijit; Brenk, Ruth			To Hit or Not to Hit, That Is the Question - Genome-wide Structure-Based Druggability Predictions for Pseudomonas aeruginosa Proteins	PLOS ONE			English	Article							LIGAND-BINDING-SITES; DRUG DISCOVERY; TARGETS; IDENTIFICATION; CAVITIES; POCKETS; DESIGN; INFORMATION; INHIBITORS; LIBRARY	Pseudomonas aeruginosa is a Gram-negative bacterium known to cause opportunistic infections in immune-compromised or immunosuppressed individuals that often prove fatal. New drugs to combat this organism are therefore sought after. To this end, we subjected the gene products of predicted perturbative genes to structure-based druggability predictions using DrugPred. Making this approach suitable for large-scale predictions required the introduction of new methods for calculation of descriptors, development of a workflow to identify suitable pockets in homologous proteins and establishment of criteria to obtain valid druggability predictions based on homologs. We were able to identify 29 perturbative proteins of P. aeruginosa that may contain druggable pockets, including some of them with no or no drug-like inhibitors deposited in ChEMBL. These proteins form promising novel targets for drug discovery against P. aeruginosa.	[Sarkar, Aurijit; Brenk, Ruth] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee, Scotland; [Brenk, Ruth] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55122 Mainz, Germany; [Brenk, Ruth] Univ Bergen, Dept Biomed, Bergen, Norway	University of Dundee; Johannes Gutenberg University of Mainz; University of Bergen	Brenk, R (corresponding author), Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dow St, Dundee, Scotland.	ruth.brenk@uib.no	Sarkar, Aurijit/AAW-3417-2020	Brenk, Ruth/0000-0002-6204-5488; Sarkar, Aurijit/0000-0003-3735-6345	European Commission; Aeropath	European Commission(European CommissionEuropean Commission Joint Research Centre); Aeropath	This work was funded by the European Commission Seventh Framework Programme (FP7/2007-2013; Aeropath, http://ec.europa.eu/research/fp7/index_en.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero F, 2008, NAT REV DRUG DISCOV, V7, P900, DOI 10.1038/nrd2684; Alphey MS, 2013, ACS CHEM BIOL, V8, P387, DOI 10.1021/cb300426u; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; An JH, 2005, MOL CELL PROTEOMICS, V4, P752, DOI 10.1074/mcp.M400159-MCP200; Bickerton GR, 2012, NAT CHEM, V4, P90, DOI [10.1038/nchem.1243, 10.1038/NCHEM.1243]; Blankenfeldt W, 2000, EMBO J, V19, P6652, DOI 10.1093/emboj/19.24.6652; Brady GP, 2000, J COMPUT AID MOL DES, V14, P383, DOI 10.1023/A:1008124202956; Brown D, 2003, DRUG DISCOV TODAY, V8, P1067, DOI 10.1016/S1359-6446(03)02902-7; Brylinski M, 2008, P NATL ACAD SCI USA, V105, P129, DOI 10.1073/pnas.0707684105; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; de Jonge BLM, 2013, ANTIMICROB AGENTS CH, V57, P6005, DOI 10.1128/AAC.01661-13; Desaphy J, 2012, J CHEM INF MODEL, V52, P2287, DOI 10.1021/ci300184x; Fauman EB, 2011, CURR OPIN CHEM BIOL, V15, P463, DOI 10.1016/j.cbpa.2011.05.020; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Hajduk PJ, 2005, J MED CHEM, V48, P2518, DOI 10.1021/jm049131r; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Henrich S, 2010, J MOL RECOGNIT, V23, P209, DOI 10.1002/jmr.984; Hopkins AL, 2011, CURR TOP MED CHEM, V11, P1292; Huang BD, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-19; Huang N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010109; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Krasowski A, 2011, J CHEM INF MODEL, V51, P2829, DOI 10.1021/ci200266d; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; McGovern SL, 2003, J MED CHEM, V46, P2895, DOI 10.1021/jm0300330; Moynie L, 2013, ACTA CRYSTALLOGR F, V69, P25, DOI 10.1107/S1744309112044739; Nayal M, 2006, PROTEINS, V63, P892, DOI 10.1002/prot.20897; Nisius B, 2012, J BIOTECHNOL, V159, P123, DOI 10.1016/j.jbiotec.2011.12.005; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Patel MN, 2013, NAT REV DRUG DISCOV, V12, P35, DOI 10.1038/nrd3913; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Perola E, 2012, J CHEM INF MODEL, V52, P1027, DOI 10.1021/ci200613b; Peters KP, 1996, J MOL BIOL, V256, P201, DOI 10.1006/jmbi.1996.0077; Schmidt T, 2014, DRUG DISCOV TODAY, V19, P890, DOI 10.1016/j.drudis.2013.10.027; Schmidtke P, 2010, J MED CHEM, V53, P5858, DOI 10.1021/jm100574m; SCHWEITZER BI, 1990, FASEB J, V4, P2441, DOI 10.1096/fasebj.4.8.2185970; Seco J, 2009, J MED CHEM, V52, P2363, DOI 10.1021/jm801385d; Shanmugham B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059126; SHARP KA, 1991, SCIENCE, V252, P106, DOI 10.1126/science.2011744; Sheridan RP, 2010, J CHEM INF MODEL, V50, P2029, DOI 10.1021/ci100312t; Tripathi A, 2010, PROTEINS, V78, P825, DOI 10.1002/prot.22608; Uddin R, 2014, COMPUT BIOL CHEM, V48, P55, DOI 10.1016/j.compbiolchem.2013.11.005; Volkamer A, 2014, FUTURE MED CHEM, V6, P319, DOI 10.4155/fmc.14.3; Volkamer A, 2012, J CHEM INF MODEL, V52, P360, DOI 10.1021/ci200454v; Wang CY, 2006, CLIN MICROBIOL INFEC, V12, P63, DOI 10.1111/j.1469-0691.2005.01305.x; Weisel M, 2007, CHEM CENT J, V1, DOI 10.1186/1752-153X-1-7; Zhang J, 2012, CURR MED CHEM, V19, P2038, DOI 10.2174/092986712800167374	52	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137279	10.1371/journal.pone.0137279	http://dx.doi.org/10.1371/journal.pone.0137279			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360059	Green Published, gold, Green Submitted			2022-12-26	WOS:000361043100029
J	Dosemeci, A; Toy, D; Reese, TS; Tao-Cheng, JH				Dosemeci, Ayse; Toy, Dana; Reese, Thomas S.; Tao-Cheng, Jung-Hwa			AIDA-1 Moves out of the Postsynaptic Density Core under Excitatory Conditions	PLOS ONE			English	Article							DOMAIN-ASSOCIATED PROTEIN-1; NEURONS; SYNGAP; MANNER	AIDA-1 is highly enriched in postsynaptic density (PSD) fractions and is considered a major component of the PSD complex. In the present study, immunogold electron microscopy was applied to determine localization as well as the activity-induced redistribution of AIDA-1 at the PSD using two antibodies that recognize two different epitopes. In cultured rat hippocampal neurons under basal conditions, immunogold label for AIDA-1 is mostly located within the dense core of the PSD, with a median distance of similar to 30 nm from the postsynaptic membrane. Under excitatory conditions, such as depolarization with high K+ (90 mM, 2 min) or application of NMDA (50 mu M, 2 min), AIDA-1 label density at the PSD core is reduced to 40% of controls and the median distance of label from the postsynaptic membrane increases to similar to 55 nm. The effect of excitatory conditions on the postsynaptic distribution of AIDA-1 is reversed within 30 minutes after returning to control conditions. The reversible removal of AIDA-1 from the PSD core under excitatory conditions is similar to the redistribution of another abundant PSD protein, SynGAP. Both SynGAP-alpha1 and AIDA-1 are known to bind PSD-95. Activity-induced transient translocation of these abundant proteins from the PSD core could promote structural flexibility, vacate sites on PSD-95 for the insertion of other components and thus may create a window for synaptic modification.	[Dosemeci, Ayse; Toy, Dana; Reese, Thomas S.] NINDS, Neurobiol Lab, NIH, Bethesda, MD 20892 USA; [Tao-Cheng, Jung-Hwa] NINDS, EM Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Dosemeci, A (corresponding author), NINDS, Neurobiol Lab, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	dosemeca@mail.nih.gov			Intramural Research Program of the National Institute of Neurological Disorders and Stroke, National Institutes of Health, USA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003113] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Neurological Disorders and Stroke, National Institutes of Health, USA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke, National Institutes of Health, USA.	Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Dosemeci A, 2000, J NEUROSCI, V20, P3076, DOI 10.1523/JNEUROSCI.20-09-03076.2000; Dosemeci A, 2001, P NATL ACAD SCI USA, V98, P10428, DOI 10.1073/pnas.181336998; Dosemeci A, 2007, MOL CELL PROTEOMICS, V6, P1749, DOI 10.1074/mcp.M700040-MCP200; Dosemeci A, 2013, BIOCHEM BIOPH RES CO, V430, P245, DOI 10.1016/j.bbrc.2012.10.131; Ghersi E, 2004, J BIOL CHEM, V279, P49105, DOI 10.1074/jbc.M405329200; Jacob AL, 2010, J COMP NEUROL, V518, P3221, DOI 10.1002/cne.22394; Jordan BA, 2007, NAT NEUROSCI, V10, P427, DOI 10.1038/nn1867; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Lowenthal MS, 2015, J PROTEOME RES, V14, P2528, DOI 10.1021/acs.jproteome.5b00109; Mulholland PJ, 2012, ALCOHOL, V46, P569, DOI 10.1016/j.alcohol.2012.04.004; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Tao-Cheng JH, 2014, NEUROSCIENCE, V266, P80, DOI 10.1016/j.neuroscience.2014.01.066; Tao-Cheng JH, 2010, NEUROSCIENCE, V168, P11, DOI 10.1016/j.neuroscience.2010.03.041; Tao-Cheng JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118750; Tindi JO, 2015, J NEUROSCI, V35, P8986, DOI 10.1523/JNEUROSCI.4029-14.2015; Yang Y, 2011, NEUROSCIENCE, V192, P132, DOI 10.1016/j.neuroscience.2011.06.061; Yang YL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054736, 10.1371/journal.pone.0055384, 10.1371/journal.pone.0067755]	19	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137216	10.1371/journal.pone.0137216	http://dx.doi.org/10.1371/journal.pone.0137216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356309	Green Submitted, Green Published, gold			2022-12-26	WOS:000360965800034
J	Ray, A; Vasudevan, S; Sengupta, S				Ray, Anasuya; Vasudevan, Smreti; Sengupta, Suparna			6-Shogaol Inhibits Breast Cancer Cells and Stem Cell-Like Spheroids by Modulation of Notch Signaling Pathway and Induction of Autophagic Cell Death	PLOS ONE			English	Article							MAMMARY STEM/PROGENITOR CELLS; GINGER; IDENTIFICATION; PROLIFERATION; ACTIVATION; MECHANISMS; CARCINOMA; GROWTH; TUMORS	Cancer stem cells (CSCs) pose a serious obstacle to cancer therapy as they can be responsible for poor prognosis and tumour relapse. In this study, we have investigated inhibitory activity of the ginger-derived compound 6-shogaol against breast cancer cells both in monolayer and in cancer-stem cell-like spheroid culture. The spheroids were generated from adherent breast cancer cells. 6-shogaol was effective in killing both breast cancer monolayer cells and spheroids at doses that were not toxic to noncancerous cells. The percentages of CD44(+) CD24(-)/(low) cells and the secondary sphere content were reduced drastically upon treatment with 6-shogaol confirming its action on CSCs. Treatment with 6-shogaol caused cytoplasmic vacuole formation and cleavage of microtubule associated protein Light Chain3 (LC3) in both monolayer and spheroid culture indicating that it induced autophagy. Kinetic analysis of the LC3 expression and a combination treatment with chloroquine revealed that the autophagic flux instigated cell death in 6-shogaol treated breast cancer cells in contrast to the autophagy inhibitor chloroquine. Furthermore, 6-shogaol-induced cell death got suppressed in the presence of chloroquine and a very low level of apoptosis was exhibited even after prolonged treatment of the compound, suggesting that autophagy is the major mode of cell death induced by 6-shogaol in breast cancer cells. 6-shogaol reduced the expression levels of Cleaved Notch1 and its target proteins Hes1 and Cyclin D1 in spheroids, and the reduction was further pronounced in the presence of a gamma-secretase inhibitor. Secondary sphere formation in the presence of the inhibitor was also further reduced by 6-shogaol. Together, these results indicate that the inhibitory action of 6-shogaol on spheroid growth and sustainability is conferred through gamma-secretase mediated down-regulation of Notch signaling. The efficacy of 6-shogaol in monolayer and cancer stem cell-like spheroids raise hope for its therapeutic benefit in breast cancer treatment.	[Ray, Anasuya; Vasudevan, Smreti; Sengupta, Suparna] Rajiv Gandhi Ctr Biotechnol, Div Canc Res, Thiruvananthapuram 695014, Kerala, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Sengupta, S (corresponding author), Rajiv Gandhi Ctr Biotechnol, Div Canc Res, Thiruvananthapuram 695014, Kerala, India.	sengupta_suparna@hotmail.com		Sengupta, Suparna/0000-0003-3639-4630	Woman Scientist Scheme, Department of Science and Technology, Govt. of India [SR/WOS-A/LS-326/2009]; Rajiv Gandhi Centre for Biotechnology	Woman Scientist Scheme, Department of Science and Technology, Govt. of India; Rajiv Gandhi Centre for Biotechnology	The work was supported by the following: grant no. SR/WOS-A/LS-326/2009; Woman Scientist Scheme, Department of Science and Technology, Govt. of India (http://dst.gov.in/scientific-programme/women-scientists.htm) to AR; and Rajiv Gandhi Centre for Biotechnology (http://rgcb.res.in/) core funding to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bak MJ, 2012, MOLECULES, V17, P8037, DOI 10.3390/molecules17078037; Banerjee SK, 2002, NUTR J, V1, DOI 10.1186/1475-2891-1-4; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brennan K, 2003, BREAST CANCER RES, V5, P69, DOI 10.1186/bcr559; Carew JS, 2011, J BIOL CHEM, V286, P6602, DOI 10.1074/jbc.M110.151324; Chen CY, 2007, J AGR FOOD CHEM, V55, P948, DOI 10.1021/jf0624594; Dievart A, 1999, ONCOGENE, V18, P5973, DOI 10.1038/sj.onc.1202991; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Gan FF, 2011, APOPTOSIS, V16, P856, DOI 10.1007/s10495-011-0611-3; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Hu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039664; Hung JY, 2009, J AGR FOOD CHEM, V57, P9809, DOI 10.1021/jf902315e; Ishiguro K, 2008, FEBS LETT, V582, P3531, DOI 10.1016/j.febslet.2008.09.027; Ishiguro K, 2007, BIOCHEM BIOPH RES CO, V362, P218, DOI 10.1016/j.bbrc.2007.08.012; Kakarala M, 2010, BREAST CANCER RES TR, V122, P777, DOI 10.1007/s10549-009-0612-x; Klarer AC, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-2; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Li YY, 2010, CLIN CANCER RES, V16, P2580, DOI 10.1158/1078-0432.CCR-09-2937; Ling H, 2010, BRIT J PHARMACOL, V161, P1763, DOI 10.1111/j.1476-5381.2010.00991.x; Liu SL, 2005, BREAST CANCER RES, V7, P86, DOI 10.1186/bcr1021; Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570; Miele L, 2006, CURR MOL MED, V6, P905, DOI 10.2174/156652406779010830; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pahlke G, 2006, J AGR FOOD CHEM, V54, P7075, DOI 10.1021/jf0612530; Ponti D, 2006, EUR J CANCER, V42, P1219, DOI 10.1016/j.ejca.2006.01.031; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Ray A, 2011, INT J ONCOL, V39, P797, DOI 10.3892/ijo.2011.1093; Shukla Y, 2007, FOOD CHEM TOXICOL, V45, P683, DOI 10.1016/j.fct.2006.11.002; Subramaniam D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030590; Tan BS, 2013, CANCER LETT, V336, P127, DOI 10.1016/j.canlet.2013.04.014; Verschooten L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048264; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zick SM, 2008, CANCER EPIDEM BIOMAR, V17, P1930, DOI 10.1158/1055-9965.EPI-07-2934	42	56	60	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137614	10.1371/journal.pone.0137614	http://dx.doi.org/10.1371/journal.pone.0137614			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355461	Green Published, Green Submitted, gold			2022-12-26	WOS:000360965800071
J	Loos, CMJ; Klarenbeek, P; van Oostenbrugge, RJ; Staals, J				Loos, Caroline M. J.; Klarenbeek, Pim; van Oostenbrugge, Robert J.; Staals, Julie			Association between Perivascular Spaces and Progression of White Matter Hyperintensities in Lacunar Stroke Patients	PLOS ONE			English	Article							SMALL-VESSEL DISEASE; AMBULATORY BLOOD-PRESSURE; VIRCHOW-ROBIN SPACES; SILENT BRAIN INFARCTS; MRI; LESIONS; BARRIER; ADULTS	Objectives Perivascular spaces are associated with MRI markers of cerebral small vessel disease, including white matter hyperintensities. Although perivascular spaces are considered to be an early MRI marker of cerebral small vessel disease, it is unknown whether they are associated with further progression of MRI markers, especially white matter hyperintensities. We determined the association between perivascular spaces and progression of white matter hyperintensities after 2-year follow-up in lacunar stroke patients. Methods In 118 lacunar stroke patients we obtained brain MRI and 24-hour ambulatory blood pressure measurements at baseline, and a follow-up brain MRI 2 years later. We visually graded perivascular spaces and white matter hyperintensities at baseline. Progression of white matter hyperintensities was assessed using a visual white matter hyperintensity change scale. Associations with white matter hyperintensity progression were tested with binary logistic regression analysis. Results Extensive basal ganglia perivascular spaces were associated with progression of white matter hyperintensities (OR 4.29; 95% CI: 1.28-14.32; p < 0.05), after adjustment for age, gender, 24-hour blood pressure and vascular risk factors. This association lost significance after additional adjustment for baseline white matter hyperintensities. Centrum semiovale perivascular spaces were not associated with progression of white matter hyperintensities. Conclusions Our study shows that extensive basal ganglia perivascular spaces are associated with progression of white matter hyperintensities in cerebral small vessel disease. However, this association was not independent of baseline white matter hyperintensities. Therefore, presence of white matter hyperintensities at baseline remains an important determinant of further progression of white matter hyperintensities in cerebral small vessel disease.	[Loos, Caroline M. J.; van Oostenbrugge, Robert J.; Staals, Julie] Maastricht Univ, Dept Neurol, Med Ctr, Maastricht, Netherlands; [Loos, Caroline M. J.; van Oostenbrugge, Robert J.; Staals, Julie] Univ Maastricht, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Klarenbeek, Pim] Zuyderland Hosp, Dept Neurol, Heerlen, Netherlands	Maastricht University; Maastricht University	Loos, CMJ (corresponding author), Maastricht Univ, Dept Neurol, Med Ctr, Maastricht, Netherlands.	c.loos@mumc.nl	Loos, Caroline M.J./AAC-9952-2022		Dutch Pearl String Initiative	Dutch Pearl String Initiative	This project was supported by the Dutch Pearl String Initiative (C.M.J. Loos). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham HMA, 2016, J CEREBR BLOOD F MET, V36, P132, DOI 10.1038/jcbfm.2015.121; Charidimou A, 2015, STROKE, V46, P1707, DOI 10.1161/STROKEAHA.115.009090; de Leeuw FE, 1999, ANN NEUROL, V46, P827, DOI 10.1002/1531-8249(199912)46:6<827::AID-ANA4>3.0.CO;2-H; de Leeuw FE, 2002, BRAIN, V125, P765, DOI 10.1093/brain/awf077; Dharmashankar K, 2010, CURR HYPERTENS REP, V12, P448, DOI 10.1007/s11906-010-0150-2; Donnan G, 2002, SUBCORTICAL STROKE, P27; Doubal FN, 2010, STROKE, V41, P450, DOI 10.1161/STROKEAHA.109.564914; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Firbank MJ, 2007, J NEUROL, V254, P713, DOI 10.1007/s00415-006-0238-4; Gottesman RF, 2010, STROKE, V41, P3, DOI 10.1161/STROKEAHA.109.566992; Gouw AA, 2008, CEREBROVASC DIS, V25, P247, DOI 10.1159/000113863; Gouw AA, 2008, STROKE, V39, P1414, DOI 10.1161/STROKEAHA.107.498535; Guo XX, 2009, HYPERTENSION, V54, P57, DOI 10.1161/HYPERTENSIONAHA.109.129700; Klarenbeek P, 2013, STROKE, V44, P2995, DOI 10.1161/STROKEAHA.113.002545; Klarenbeek P, 2013, J NEUROL, V260, P115, DOI 10.1007/s00415-012-6598-z; Marcus J, 2011, STROKE, V42, P2639, DOI 10.1161/STROKEAHA.111.617571; Prins ND, 2004, NEUROLOGY, V62, P1533, DOI 10.1212/01.WNL.0000123264.40498.B6; Rouhl RPW, 2008, J NEUROL, V255, P692, DOI 10.1007/s00415-008-0777-y; Schwartz GL, 2007, HYPERTENSION, V49, P1228, DOI 10.1161/HYPERTENSIONAHA.106.078691; Staals J, 2009, STROKE, V40, P3264, DOI 10.1161/STROKEAHA.109.558049; Verhaaren BFJ, 2013, HYPERTENSION, V61, P1354, DOI 10.1161/HYPERTENSIONAHA.111.00430; Vermeer SE, 2007, LANCET NEUROL, V6, P611, DOI 10.1016/S1474-4422(07)70170-9; Vermeer SE, 2002, STROKE, V33, P21, DOI 10.1161/hs0102.101629; Wardlaw JM, 2010, J NEUROL SCI, V299, P66, DOI 10.1016/j.jns.2010.08.042; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7; Wardlaw JM, 2009, ANN NEUROL, V65, P194, DOI 10.1002/ana.21549; Yakushiji Y, 2014, NEUROLOGY, V83, P2116, DOI 10.1212/WNL.0000000000001054; Yamamoto Y, 2009, STROKE, V40, P2004, DOI 10.1161/STROKEAHA.108.528299; Yao M, 2014, CEREBROVASC DIS, V37, P155, DOI 10.1159/000356982; Zhu YC, 2010, STROKE, V41, P2483, DOI 10.1161/STROKEAHA.110.591586	31	22	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137323	10.1371/journal.pone.0137323	http://dx.doi.org/10.1371/journal.pone.0137323			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352265	Green Published, gold, Green Submitted			2022-12-26	WOS:000360932800073
J	Lu, J; Yoshimura, K; Goto, K; Lee, C; Hamura, K; Kwon, O; Tamanoi, F				Lu, Jie; Yoshimura, Kohei; Goto, Koichi; Lee, Craig; Hamura, Ken; Kwon, Ohyun; Tamanoi, Fuyuhiko			Nanoformulation of Geranylgeranyltransferase-I Inhibitors for Cancer Therapy: Liposomal Encapsulation and pH-Dependent Delivery to Cancer Cells	PLOS ONE			English	Article							MESOPOROUS SILICA NANOPARTICLES; DRUG-DELIVERY; FARNESYLTRANSFERASE INHIBITORS; TRANSFERASE INHIBITORS; PROTEIN TRANSFERASE; POLYMERIC MICELLES; LUNG-CANCER; H-RAS; K-RAS; N-RAS	Small molecule inhibitors against protein geranylgeranyltransferase-I such as P61A6 have been shown to inhibit proliferation of a variety of human cancer cells and exhibit antitumor activity in mouse models. Development of these inhibitors could be dramatically accelerated by conferring tumor targeting and controlled release capability. As a first step towards this goal, we have encapsulated P61A6 into a new type of liposomes that open and release cargos only under low pH condition. These low pH-release type liposomes were prepared by adjusting the ratio of two types of phospholipid derivatives. Loading of geranylgeranyltransferase-I inhibitor (GGTI) generated liposomes with average diameter of 50-100 nm. GGTI release in solution was sharply dependent on pH values, only showing release at pH lower than 6. Release of cargos in a pH-dependent manner inside the cell was demonstrated by the use of a proton pump inhibitor Bafilomycin A1 that Increased lysosomal pH and inhibited the release of a dye carried in the pH-liposome. Delivery of GGTI to human pancreatic cancer cells was demonstrated by the inhibition of protein geranylgeranylation inside the cell and this effect was blocked by Bafilomycin A1. In addition, GGTI delivered by pH-liposomes induced proliferation inhibition, G1 cell cycle arrest that is associated with the expression of cell cycle regulator p21(CIP1/WAF1). Proliferation inhibition was also observed with various lung cancer cell lines. Availability of nanoformulated GGTI opens up the possibility to combine with other types of inhibitors. To demonstrate this point, we combined the liposomal-GGTI with farnesyltransferase inhibitor (FTI) to inhibit K-Ras signaling in pancreatic cancer cells. Our results show that the activated K-Ras signaling in these cells can be effectively inhibited and that synergistic effect of the two drugs is observed. Our results suggest a new direction in the use of GGTI for cancer therapy.	[Lu, Jie; Tamanoi, Fuyuhiko] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Yoshimura, Kohei; Hamura, Ken] NOF CORP, DDS Res Lab, Kawasaki, Kanagawa 2100865, Japan; [Goto, Koichi] Sojo Univ, Grad Sch Engn, Div Appl Life Sci, Kumamoto, Japan; [Lee, Craig; Kwon, Ohyun] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Sojo University; University of California System; University of California Los Angeles	Tamanoi, F (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	fuyut@microbio.ucla.edu			NIH [CA41996, R01GM071779, P41GM081282]; NOF, Inc; NATIONAL CANCER INSTITUTE [R01CA041996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071779, P41GM081282] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NOF, Inc; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This work was supported by NIH grant CA41996 (to FT) and R01GM071779 and P41GM081282 (to OK), https://grants.nih.gov/grants/giwelcome.htm. A part of the work carried out in this paper was supported by a sponsored research agreement with NOF, Inc (to FT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman D, 2014, TRENDS CELL BIOL, V24, P472, DOI 10.1016/j.tcb.2014.06.001; Adnane J, 1998, MOL CELL BIOL, V18, P6962, DOI 10.1128/MCB.18.12.6962; Barar J, 2013, BIOIMPACTS, V3, P149, DOI 10.5681/bi.2013.036; Basso AD, 2006, J LIPID RES, V47, P15, DOI 10.1194/jlr.R500012-JLR200; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; BOS JL, 1989, CANCER RES, V49, P4682; Bozzuto G, 2015, INT J NANOMED, V10, P975, DOI 10.2147/IJN.S68861; Braude E. A., 1955, DETERMINATION ORGANI; Cabral H, 2014, J CONTROL RELEASE, V190, P465, DOI 10.1016/j.jconrel.2014.06.042; Castellano S, 2007, J AM CHEM SOC, V129, P5843, DOI 10.1021/ja070274n; Chan LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026135; Chandrasekaran S, 2014, INT J MOL SCI, V15, P20209, DOI 10.3390/ijms151120209; Dai WM, 2005, CURR MED CHEM, V12, P1947, DOI 10.2174/0929867054546591; Dawidczyk CM, 2014, J CONTROL RELEASE, V187, P133, DOI 10.1016/j.jconrel.2014.05.036; DeSolms SJ, 2003, J MED CHEM, V46, P2973, DOI 10.1021/jm020587n; Doll RJ, 2004, CURR OPIN DRUG DISC, V7, P478; Douroumis D, 2013, CRIT REV BIOTECHNOL, V33, P229, DOI 10.3109/07388551.2012.685860; Eloy JO, 2014, COLLOID SURFACE B, V123, P345, DOI 10.1016/j.colsurfb.2014.09.029; Galdiero S, 2014, J PEPT SCI, V20, P468, DOI 10.1002/psc.2649; Gau CL, 2005, MOL CANCER THER, V4, P918, DOI 10.1158/1535-7163.MCT-04-0347; Gelb MH, 2006, NAT CHEM BIOL, V2, P518, DOI 10.1038/nchembio818; Gurudevan S, 2013, CURR GENE THER, V13, P322, DOI 10.2174/156652321305131212123558; Head Julia E, 2003, Expert Opin Emerg Drugs, V8, P163, DOI 10.1517/eoed.8.1.163.21041; Hwang AA, 2014, SMALL; JAMES GL, 1995, J BIOL CHEM, V270, P6221, DOI 10.1074/jbc.270.11.6221; Kohli AG, 2014, J CONTROL RELEASE, V190, P274, DOI 10.1016/j.jconrel.2014.04.047; Kraft JC, 2014, J PHARM SCI-US, V103, P29, DOI 10.1002/jps.23773; Kusama T, 2006, INT J ONCOL, V29, P217; Kuthati Y, 2013, J NANOSCI NANOTECHNO, V13, P2399, DOI 10.1166/jnn.2013.7363; Lee ES, 2003, J CONTROL RELEASE, V91, P103, DOI 10.1016/S0168-3659(03)00239-6; Lerner EC, 1997, ONCOGENE, V15, P1283, DOI 10.1038/sj.onc.1201296; Li ZX, 2012, CHEM SOC REV, V41, P2590, DOI 10.1039/c1cs15246g; Lobell RB, 2001, CANCER RES, V61, P8758; Lu J, 2009, MOL CANCER THER, V8, P1218, DOI 10.1158/1535-7163.MCT-08-1122; Maeda H., 2015, ADV DRUG DELIV REV; Matsumura Y, 2014, JPN J CLIN ONCOL, V44, P515, DOI 10.1093/jjco/hyu046; Mazet JL, 1999, FEBS LETT, V460, P235, DOI 10.1016/S0014-5793(99)01355-1; Ozpolat B, 2014, ADV DRUG DELIVER REV, V66, P110, DOI 10.1016/j.addr.2013.12.008; Perez-Herrero E, 2015, EUR J PHARM BIOPHARM; Prabhu RH, 2015, INT J NANOMED, V10, P1001, DOI 10.2147/IJN.S56932; Rowell CA, 1997, J BIOL CHEM, V272, P14093, DOI 10.1074/jbc.272.22.14093; Sakaguchi N, 2008, BIOCONJUGATE CHEM, V19, P1040, DOI 10.1021/bc7004736; Sjogren AKM, 2007, J CLIN INVEST, V117, P1294, DOI 10.1172/JCI30868; Sun JZ, 2003, CANCER RES, V63, P8922; Tetlow AL, 2013, ENZYMES, V33, P1, DOI [10.1016/B978-0-12-416749-0.00001-4, 10.1016/B978-0-12-420146-0.00008-1]; Unzueta U, 2015, TRENDS BIOTECHNOL; Vogt A, 1997, J BIOL CHEM, V272, P27224, DOI 10.1074/jbc.272.43.27224; Watanabe M, 2008, J BIOL CHEM, V283, P9571, DOI 10.1074/jbc.M706229200; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Yachi K, 1996, BIOPHARM DRUG DISPOS, V17, P589, DOI 10.1002/(SICI)1099-081X(199610)17:7<589::AID-BDD976>3.3.CO;2-4; Yanes RE, 2012, THER DELIV, V3, P389, DOI [10.4155/tde.12.9, 10.4155/TDE.12.9]; Yokoyama M, 2014, J DRUG TARGET, V22, P576, DOI 10.3109/1061186X.2014.934688; Yuba E, 2014, BIOMATERIALS, V35, P3091, DOI 10.1016/j.biomaterials.2013.12.024; Yuba E, 2013, BIOMATERIALS, V34, P5711, DOI 10.1016/j.biomaterials.2013.04.007; Zimonjic DB, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-198	55	9	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137595	10.1371/journal.pone.0137595	http://dx.doi.org/10.1371/journal.pone.0137595			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352258	gold, Green Submitted, Green Published			2022-12-26	WOS:000360932800100
J	Melmaiee, K; Anderson, M; Elavarthi, S; Guenzi, A; Canaan, P				Melmaiee, Kalpalatha; Anderson, Michael; Elavarthi, Sathya; Guenzi, Arron; Canaan, Patricia			Transcriptional Analysis of Resistance to Low Temperatures in Bermudagrass Crown Tissues	PLOS ONE			English	Article							PLANT COLD-ACCLIMATION; ARABIDOPSIS-THALIANA; FREEZING TOLERANCE; GENE-EXPRESSION; DEHYDRIN EXPRESSION; OPHIOSPHAERELLA-HERPOTRICHA; SEEDED BERMUDAGRASS; SIGNALING PATHWAYS; CAMELLIA-SINENSIS; RESPONSE PATHWAY	Bermudagrass (Cynodon dactylon L pers.) is one of the most geographically adapted and utilized of the warm-season grasses. However, bermudagrass adaptation to the Northern USA is limited by freeze damage and winterkill. Our study provides the first large-scale analyses of gene expression in bermudagrass regenerative crown tissues during cold acclimation. We compared gene expression patterns in crown tissues from highly cold tolerant "MSU" and susceptible "Zebra" genotypes exposed to near-freezing temperatures. Suppressive subtractive hybridization was used to isolate putative cold responsive genes Approximately, 3845 transcript sequences enriched for cold acclimation were deposited in the GenBank. A total of 4589 ESTs (3184 unigenes) including 744 ESTs associated with the bermudagrass disease spring dead spot were printed on microarrays and hybridized with cold acclimated complementary Deoxyribonucleic acid (cDNA). A total of 587 differentially expressed unigenes were identified in this study. Of these only 97 (17%) showed significant NCBI matches. The overall expression pattern revealed 40% more down- than up-regulated genes, which was particularly enhanced in MSU compared to Zebra. Among the up-regulated genes 68% were uniquely expressed in MSU (36%) or Zebra (32%). Among the down-regulated genes 40% were unique to MSU, while only 15% to Zebra. Overall expression intensity was significantly higher in MSU than in Zebra (p value <= 0.001) and the overall number of genes expressed at 28 days was 2.7 fold greater than at 2 days. These changes in expression patterns reflect the strong genotypic and temporal response to cold temperatures. Additionally, differentially expressed genes from this study can be utilized for developing molecular markers in bermudagrass and other warm season grasses for enhancing cold hardiness.	[Melmaiee, Kalpalatha; Anderson, Michael; Elavarthi, Sathya; Guenzi, Arron] Oklahoma State Univ, Dept Plant & Soil Sci, Stillwater, OK 74078 USA; [Canaan, Patricia] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater	Anderson, M (corresponding author), Oklahoma State Univ, Dept Plant & Soil Sci, Stillwater, OK 74078 USA.	michael.anderson@okstate.edu	Anderson, Michael/I-3309-2019	Anderson, Michael/0000-0002-2319-2282; Elavarthi, Sathya/0000-0002-6719-4669	 [200312-253]; Office of Integrative Activities [1301765] Funding Source: National Science Foundation	; Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by www.usga.org (200312-253).	Alonso AP, 2007, METAB ENG, V9, P419, DOI 10.1016/j.ymben.2007.06.002; Anderson J, 2002, CROP SCI, V42, P975, DOI 10.2135/cropsci2002.0975; ANDERSON JA, 1988, HORTSCIENCE, V23, P748; Anderson JA, 2002, CROP SCI, V42, P190, DOI 10.2135/cropsci2002.0190; Anderson JV, 2005, PLANT CELL ENVIRON, V28, P1567, DOI 10.1111/j.1365-3040.2005.01393.x; Artus NN, 1996, P NATL ACAD SCI USA, V93, P13404, DOI 10.1073/pnas.93.23.13404; Ayoubi P, 2002, NUCLEIC ACIDS RES, V30, P4761, DOI 10.1093/nar/gkf585; Baird JH, 1998, PLANT DIS, V82, P771, DOI 10.1094/PDIS.1998.82.7.771; Baud S, 2004, J EXP BOT, V55, P397, DOI 10.1093/jxb/erh047; Benedict C, 2006, PLANT PHYSIOL, V141, P1219, DOI 10.1104/pp.106.083527; Choi DW, 1999, THEOR APPL GENET, V98, P1234, DOI 10.1007/s001220051189; Daher Z, 2010, PROTEOMICS, V10, P2123, DOI 10.1002/pmic.200900345; de los Reyes BG, 2001, THEOR APPL GENET, V103, P297, DOI 10.1007/s001220100569; Degenkolbe T, 2012, PLANT J, V72, P972, DOI 10.1111/tpj.12007; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fujiki Y, 2000, PLANT PHYSIOL, V124, P1139, DOI 10.1104/pp.124.3.1139; Gatschet MJ, 1996, CROP SCI, V36, P712, DOI 10.2135/cropsci1996.0011183X003600030032x; GATSCHET MJ, 1994, J AM SOC HORTIC SCI, V119, P477, DOI 10.21273/JASHS.119.3.477; Giolo M, 2013, HORTSCIENCE, V48, P780, DOI 10.21273/HORTSCI.48.6.780; Gulick PJ, 2005, GENOME, V48, P913, DOI 10.1139/g05-039; Guy C, 2006, PHYSIOL PLANTARUM, V126, P1, DOI [10.1111/j.1399-3054.2006.00628.x, 10.1111/j.1399-3054.2005.00628.x]; HARLAN J R, 1970, East African Agricultural and Forestry Journal, V36, P220; HARLAN JR, 1969, CROP SCI, V9, P774, DOI 10.2135/cropsci1969.0011183X000900060031x; Hewezi T, 2006, J EXP BOT, V57, P3109, DOI 10.1093/jxb/erl080; Hur J, 2004, PLANT SCI, V167, P417, DOI 10.1016/j.plantsci.2004.04.009; Ismail AM, 1999, P NATL ACAD SCI USA, V96, P13566, DOI 10.1073/pnas.96.23.13566; Isopp H, 2000, PLANT CELL ENVIRON, V23, P597, DOI 10.1046/j.1365-3040.2000.00583.x; Ivashuta S, 2002, PLANT J, V31, P615, DOI 10.1046/j.1365-313X.2002.01383.x; Janska A, 2010, PLANT BIOLOGY, V12, P395, DOI 10.1111/j.1438-8677.2009.00299.x; Jarzabek M, 2009, CRYOBIOLOGY, V58, P268, DOI 10.1016/j.cryobiol.2009.01.007; JOHNSTON RA, 1975, CROP SCI, V15, P445, DOI 10.2135/cropsci1975.0011183X001500030050x; Knight H, 1997, PLANT J, V12, P1067, DOI 10.1046/j.1365-313X.1997.12051067.x; Kobayashi F, 2005, J EXP BOT, V56, P887, DOI 10.1093/jxb/eri081; Koehler G., 2007, Current Topics in Phytochemistry, Volume 8, P73; Kojima M, 2007, PLANT SCI, V172, P36, DOI 10.1016/j.plantsci.2006.07.009; KOSTER KL, 1988, PLANT PHYSIOL, V88, P829, DOI 10.1104/pp.88.3.829; Kvint K, 2003, CURR OPIN MICROBIOL, V6, P140, DOI 10.1016/S1369-5274(03)00025-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lupas AN, 2006, J STRUCT BIOL, V156, P1, DOI 10.1016/j.jsb.2006.07.009; Melmaiee K, 2007, FUNCTIONAL GENOMICS; Neuhaus HE, 2000, ANNU REV PLANT PHYS, V51, P111, DOI 10.1146/annurev.arplant.51.1.111; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Oh SA, 1996, PLANT MOL BIOL, V30, P739, DOI 10.1007/BF00019008; Oliveira IC, 1997, PLANT PHYSIOL BIOCH, V35, P185; Ouellet F., 2013, COLD ACCLIMATION FRE; Parmentier-Line CM, 2002, PLANT SCI, V162, P273, DOI 10.1016/S0168-9452(01)00563-5; Pinhero RG, 2007, PHYSIOL PLANTARUM, V130, P230, DOI 10.1111/j.1399-3054.2007.00911.x; RESTREPOHARTWIG MA, 1994, J VIROL, V68, P2388, DOI 10.1128/JVI.68.4.2388-2397.1994; Rorat T, 2006, CELL MOL BIOL LETT, V11, P536, DOI 10.2478/s11658-006-0044-0; Samala S, 1998, CROP SCI, V38, P188, DOI 10.2135/cropsci1998.0011183X003800010031x; Sandve SR, 2011, PLANT SCI, V180, P69, DOI 10.1016/j.plantsci.2010.07.011; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Sidebottom C, 2000, NATURE, V406, P256, DOI 10.1038/35018639; SMIRNOFF N, 1993, NEW PHYTOL, V125, P27, DOI 10.1111/j.1469-8137.1993.tb03863.x; Stitt M, 2002, CURR OPIN PLANT BIOL, V5, P199, DOI 10.1016/S1369-5266(02)00258-3; Strand A, 2003, PLANT CELL ENVIRON, V26, P523, DOI 10.1046/j.1365-3040.2003.00983.x; Strand A, 1997, PLANT J, V12, P605, DOI 10.1046/j.1365-313X.1997.00605.x; Svensson JT, 2006, PLANT PHYSIOL, V141, P257, DOI 10.1104/pp.105.072645; Tao DL, 1998, CRYOBIOLOGY, V37, P38, DOI 10.1006/cryo.1998.2096; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; VONKAMPEN J, 1995, PLANTA, V197, P528, DOI 10.1007/BF00196675; Vyas D, 2005, PLANT PHYSIOL BIOCH, V43, P383, DOI 10.1016/j.plaphy.2005.02.016; Wang XC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-415; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Xiao HG, 2006, PLANT CELL REP, V25, P968, DOI 10.1007/s00299-006-0151-4; Yu Jing, 2005, Acta Genetica Sinica, V32, P789; Zachariassen KE, 2000, CRYOBIOLOGY, V41, P257, DOI 10.1006/cryo.2000.2289; Zhang XL, 2008, J EXP BOT, V59, P4045, DOI 10.1093/jxb/ern245; Zhang XZ, 2008, J AM SOC HORTIC SCI, V133, P542, DOI 10.21273/JASHS.133.4.542; Zhang XZ, 2006, CROP SCI, V46, P2598, DOI 10.2135/cropsci2006.02.0108; Zhang XZ, 2011, CROP SCI, V51, P838, DOI 10.2135/cropsci2010.06.0345; Zhang Y, 2006, CROP SCI, V46, P497, DOI 10.2135/cropsci2004.0572; Zhang Y, 2006, PHYSIOL MOL PLANT P, V68, P105, DOI 10.1016/j.pmpp.2006.07.003	76	4	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136433	10.1371/journal.pone.0136433	http://dx.doi.org/10.1371/journal.pone.0136433			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348040	gold, Green Submitted, Green Published			2022-12-26	WOS:000360897600008
J	Narwani, A; Alexandrou, MA; Herrin, J; Vouaux, A; Zhou, C; Oakley, TH; Cardinale, BJ				Narwani, Anita; Alexandrou, Markos A.; Herrin, James; Vouaux, Alaina; Zhou, Charles; Oakley, Todd H.; Cardinale, Bradley J.			Common Ancestry Is a Poor Predictor of Competitive Traits in Freshwater Green Algae	PLOS ONE			English	Article							PHYLOGENETIC LIMITING SIMILARITY; PHYTOPLANKTON RESPONSES; EVOLUTIONARY HISTORY; RESOURCE COMPETITION; SPECIES INTERACTIONS; COMMUNITY ECOLOGY; FUNCTIONAL TRAITS; RELATEDNESS; DIVERSITY; PATTERNS	Phytoplankton species traits have been used to successfully predict the outcome of competition, but these traits are notoriously laborious to measure. If these traits display a phylogenetic signal, phylogenetic distance (PD) can be used as a proxy for trait variation. We provide the first investigation of the degree of phylogenetic signal in traits related to competition in freshwater green phytoplankton. We measured 17 traits related to competition and tested whether they displayed a phylogenetic signal across a molecular phylogeny of 59 species of green algae. We also assessed the fit of five models of trait evolution to trait variation across the phylogeny. There was no significant phylogenetic signal for 13 out of 17 ecological traits. For 7 traits, a non-phylogenetic model provided the best fit. For another 7 traits, a phylogenetic model was selected, but parameter values indicated that trait variation evolved recently, diminishing the importance of common ancestry. This study suggests that traits related to competition in freshwater green algae are not generally well-predicted by patterns of common ancestry. We discuss the mechanisms by which the link between phylogenetic distance and phenotypic differentiation may be broken.	[Narwani, Anita] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, CH-8600 Dubendorf, Switzerland; [Alexandrou, Markos A.; Oakley, Todd H.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Narwani, Anita; Herrin, James; Vouaux, Alaina; Zhou, Charles; Cardinale, Bradley J.] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of California System; University of California Santa Barbara; University of Michigan System; University of Michigan	Narwani, A (corresponding author), Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, BU-G11 Uberlandstr 133, CH-8600 Dubendorf, Switzerland.	anita.narwani@eawag.ch	Cardinale, Bradley J/I-7076-2013	Oakley, Todd/0000-0002-4478-915X; Narwani, Anita/0000-0003-4561-0163	US National Science Foundation [DEB-1046121]; Division Of Environmental Biology [1046307, 1046121] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by the US National Science Foundation's DIMENSIONS of Biodiversity program grant to BJC and THO (DEB-1046121) (http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=503446). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2009, P NATL ACAD SCI USA, V106, P18067, DOI 10.1073/pnas.0904862106; Alexandrou MA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1745; Becks L, 2012, ECOL LETT, V15, P492, DOI 10.1111/j.1461-0248.2012.01763.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cadotte MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019363; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cahill JF, 2008, PERSPECT PLANT ECOL, V10, P41, DOI 10.1016/j.ppees.2007.10.001; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Cavender-Bares J, 2006, ECOLOGY, V87, pS109, DOI 10.1890/0012-9658(2006)87[109:PSOFPC]2.0.CO;2; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Cooper N, 2010, J EVOLUTION BIOL, V23, P2529, DOI 10.1111/j.1420-9101.2010.02144.x; Cottingham KL, 1998, ECOL APPL, V8, P508, DOI 10.2307/2641090; Dybzinski R, 2007, AM NAT, V170, P305, DOI 10.1086/519857; Eaton A.D., 1998, STANDARD METHODS EXA, V20th; Edwards KF, 2013, ECOLOGY, V94, P1626, DOI 10.1890/12-1459.1; Edwards KF, 2012, LIMNOL OCEANOGR, V57, P554, DOI 10.4319/lo.2012.57.2.0554; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Faith DP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0011; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Fritschie KJ, 2014, ECOLOGY, V95, P1407, DOI 10.1890/13-0986.1; Fritz SA, 2010, P ROY SOC B-BIOL SCI, V277, P2435, DOI 10.1098/rspb.2010.0030; Gerhold P, 2015, FUNCT ECOL, V29, P600, DOI 10.1111/1365-2435.12425; Godoy O, 2014, ECOL LETT, V17, P836, DOI 10.1111/ele.12289; GROVER JP, 1989, LIMNOL OCEANOGR, V34, P341, DOI 10.4319/lo.1989.34.2.0341; GROVER JP, 1994, AM NAT, V143, P258, DOI 10.1086/285603; GROVER JP, 1989, LIMNOL OCEANOGR, V34, P349, DOI 10.4319/lo.1989.34.2.0349; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hertz PE, 2013, EVOLUTION, V67, P2101, DOI 10.1111/evo.12072; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Huisman J, 2001, AM NAT, V157, P488, DOI 10.1086/319929; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; Huisman J, 2001, ECOL LETT, V4, P408, DOI 10.1046/j.1461-0248.2001.00256.x; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Huynen MA, 1998, P NATL ACAD SCI USA, V95, P5849, DOI 10.1073/pnas.95.11.5849; Jones LE, 2009, PHILOS T R SOC B, V364, P1579, DOI 10.1098/rstb.2009.0004; Kelly S, 2014, DIVERS DISTRIB, V20, P600, DOI 10.1111/ddi.12188; Kilham SS, 1998, HYDROBIOLOGIA, V377, P147, DOI 10.1023/A:1003231628456; Klausmeier CA, 2008, ECOL RES, V23, P479, DOI 10.1007/s11284-008-0470-8; Litchman E, 2007, ECOL LETT, V10, P1170, DOI 10.1111/j.1461-0248.2007.01117.x; Litchman E, 2010, HYDROBIOLOGIA, V653, P15, DOI 10.1007/s10750-010-0341-5; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Loladze I, 2011, ECOL LETT, V14, P244, DOI 10.1111/j.1461-0248.2010.01577.x; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Low-Decarie E, 2011, GLOBAL CHANGE BIOL, V17, P2525, DOI 10.1111/j.1365-2486.2011.02402.x; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; Martiny AC, 2013, ISME J, V7, P830, DOI 10.1038/ismej.2012.160; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P1340, DOI 10.1111/j.1462-2920.2009.01860.x; Martiny AC, 2009, P NATL ACAD SCI USA, V106, P10787, DOI 10.1073/pnas.0902532106; Miller TE, 2005, AM NAT, V165, P439, DOI 10.1086/428681; Mouquet N, 2012, BIOL REV, V87, P769, DOI 10.1111/j.1469-185X.2012.00224.x; Munkemuller T, 2012, METHODS ECOL EVOL, V3, P743, DOI 10.1111/j.2041-210X.2012.00196.x; Nakov T, 2014, LIMNOL OCEANOGR, V59, P79, DOI 10.4319/lo.2014.59.1.0079; Narwani A, 2013, ECOL LETT, V16, P1373, DOI 10.1111/ele.12182; Ndiribe C, 2014, J PLANT ECOL, V7, P439, DOI 10.1093/jpe/rtt064; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Perronne R, 2014, PLANT ECOL EVOL, V147, P165, DOI 10.5091/plecevo.2014.885; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Revell LJ, 2008, SYST BIOL, V57, P591, DOI 10.1080/10635150802302427; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; RHEE GY, 1978, LIMNOL OCEANOGR, V23, P10, DOI 10.4319/lo.1978.23.1.0010; Roncal J, 2012, BIOL J LINN SOC, V106, P528, DOI 10.1111/j.1095-8312.2012.01879.x; Savage JA, 2012, ECOLOGY, V93, pS138, DOI 10.1890/11-0406.1; Schwaderer AS, 2011, LIMNOL OCEANOGR, V56, P589, DOI 10.4319/lo.2011.56.2.0589; Seppala J, 1998, HYDROBIOLOGIA, V363, P207; Smith KL, 2011, EVOLUTION, V65, P976, DOI 10.1111/j.1558-5646.2010.01211.x; Sommer U, 1995, LIMNOL OCEANOGR, V40, P1271, DOI 10.4319/lo.1995.40.7.1271; SOMMER U, 1984, LIMNOL OCEANOGR, V29, P633, DOI 10.4319/lo.1984.29.3.0633; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Strauss SY, 2006, P NATL ACAD SCI USA, V103, P5841, DOI 10.1073/pnas.0508073103; Tan JQ, 2012, ECOLOGY, V93, P1164, DOI 10.1890/11-1557.1; TILMAN D, 1977, ECOLOGY, V58, P338, DOI 10.2307/1935608; TILMAN D, 1981, ECOLOGY, V62, P802, DOI 10.2307/1937747; Tilman D., 1982, Monographs in Population Biology, pi; Venail PA, 2014, J ECOL, V102, P1288, DOI 10.1111/1365-2745.12271; Violle C, 2011, ECOL LETT, V14, P782, DOI 10.1111/j.1461-0248.2011.01644.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767; Yoshida T, 2007, PLOS BIOL, V5, P1868, DOI 10.1371/journal.pbio.0050235; Young JN, 2012, PHILOS T R SOC B, V367, P483, DOI 10.1098/rstb.2011.0145	84	17	18	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137085	10.1371/journal.pone.0137085	http://dx.doi.org/10.1371/journal.pone.0137085			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348482	Green Submitted, Green Published, gold			2022-12-26	WOS:000360897600020
J	Guan, WJ; Gao, YH; Li, HM; Yuan, JJ; Chen, RC; Zhong, NS				Guan, Wei-jie; Gao, Yong-hua; Li, Hui-min; Yuan, Jing-jing; Chen, Rong-chang; Zhong, Nan-shan			Impacts of Co-Existing Chronic Rhinosinusitis on Disease Severity and Risks of Exacerbations in Chinese Adults with Bronchiectasis	PLOS ONE			English	Article							CYSTIC FIBROSIS BRONCHIECTASIS; QUALITY-OF-LIFE; SINONASAL DISEASE; UNITED AIRWAYS; NASAL POLYPS; GUANGZHOU	Background Mounting evidence supports the notion of "one airway, one disease." Objective To determine whether chronic rhinosinusitis (CRS) poses adverse impacts on Chinese adults with bronchiectasis. Methods We enrolled 148 consecutive adults with clinically stable bronchiectasis. CRS diagnosed based on the 2012 (EPOS)-O-3 criteria. We systematically evaluated the bronchiectasis etiology, radiology, lung function, sputum bacteriology, airway inflammatory biomarkers, Bronchiectasis Severity Index, cough sensitivity and healthcare resource utilization. All patients were prospectively followed-up for 1 year to examine the frequency of bronchiectasis exacerbations (BEs). Results Forty-seven patients (31.8%) were diagnosed as having CRS. Bronchiectasis etiologies did not vary statistically between CRS and no-CRS group. There was a trend towards non-statistically higher Bronchiectasis Severity Index [6.4 +/- 3.4 vs. 5.0(6.0), P = 0.19], a higher proportion of patients with BEs needing hospitalization before enrollment (48.9% vs. 29.7%, P = 0.13), poorer FVC [78.2 +/- 19.8% vs. 82.2(16.8)%, P = 0.54] and FEV1 [68.2 +/- 24.8% vs. 74.8(21.2)%, P = 0.29], a higher prevalence of Pseudomonas aeruginosa isolated (36.2% vs. 26.7%, P = 0.27) or colonized in sputum (36.2% vs. 21.8%, P = 0.12) and greater capsaicin cough sensitivity [C2: 3.9(123.0) mu mol/L vs. 11.7(123.0) mu mol/L, P = 0.81; C5: 62.5(996.0) mu mol/L vs. 250.0(973.0) mu mol/L, P = 0.32]. Patients with CRS had significantly greater risks of experiencing BEs during follow-up (P = 0.02 for negative binominal regression test). Conclusion Chinese adults with bronchiectasis appear to have a lower prevalence of CRS than that in western countries. There was a trend towards greater adverse impacts on bronchiectasis in patients with CRS. Studies with greater sample sizes might help to resolve this issue. In future clinical practice, physicians should be vigilant to the screening of concomitant CRS in bronchiectasis so as to better improve patient's healthcare. Our findings may be of clinical significance in that proper treatment of upper airway symptoms due to CRS will be the prevention of infection or re-infection of the tracheobronchial tree, which should be addressed for the future management of bronchiectasis.	[Guan, Wei-jie; Li, Hui-min; Yuan, Jing-jing; Chen, Rong-chang; Zhong, Nan-shan] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis,Natl Clin Res Ctr Resp Dis, Guangzhou, Guangdong, Peoples R China; [Gao, Yong-hua] Zhengzhou Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Zhengzhou 450052, Henan, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Zhengzhou University	Chen, RC (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis,Natl Clin Res Ctr Resp Dis, Guangzhou, Guangdong, Peoples R China.	chenrc@vip.163.com; nanshan@vip.163.com	Guan, Wei-jie/K-8257-2019		Changjiang Scholars and Innovative Research Team in University [ITR0961]; National Key Technology R&D Program of the 12th National Five-year Development Plan [2012BAI05B01]; National Key Scientific & Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer [2013BAI09B09]; National Natural Science Foundation [81400010]; Scientific Research Projects for Medical Doctors and Researchers from Overseas, Guangzhou Medical University [2014C21]	Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Key Technology R&D Program of the 12th National Five-year Development Plan(National Key Technology R&D Program); National Key Scientific & Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Scientific Research Projects for Medical Doctors and Researchers from Overseas, Guangzhou Medical University	Profs. Zhong and Chen declared that they had received Changjiang Scholars and Innovative Research Team in University ITR0961, The National Key Technology R&D Program of the 12th National Five-year Development Plan 2012BAI05B01 and National Key Scientific & Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer No. 2013BAI09B09. All other authors declared no potential conflict of interest. Dr. Guan has received National Natural Science Foundation No. 81400010 and 2014 Scientific Research Projects for Medical Doctors and Researchers from Overseas, Guangzhou Medical University No. 2014C21. None of the funding sources had any role in the study.	Angrill J, 2002, THORAX, V57, P15, DOI 10.1136/thorax.57.1.15; Barker AF, 2014, LANCET RESP MED, V2, P738, DOI 10.1016/S2213-2600(14)70165-1; Bilton D, 2014, THORAX, V69, P1073, DOI 10.1136/thoraxjnl-2014-205587; Bousquet J, 2012, J ALLERGY CLIN IMMUN, V130, P1049, DOI 10.1016/j.jaci.2012.07.053; Brodt AM, 2014, EUR RESPIR J, V44, P382, DOI 10.1183/09031936.00018414; Chalmers JD, 2015, EUR RESPIR J, V45, P1446, DOI 10.1183/09031936.00119114; Chalmers JD, 2014, AM J RESP CRIT CARE, V189, P576, DOI 10.1164/rccm.201309-1575OC; Chalmers JD, 2012, AM J RESP CRIT CARE, V186, P657, DOI 10.1164/rccm.201203-0487OC; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Guan WJ, 2015, INT J TUBERC LUNG D, V19, P610, DOI 10.5588/ijtld.14.0613; Guan WJ, 2015, RESPIROLOGY, V20, P739, DOI 10.1111/resp.12528; Guan WJ, 2015, ANN AM THORAC SOC, V12, P657, DOI 10.1513/AnnalsATS.201406-280OC; Guan WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113057; Guilemany JM, 2006, RESP MED, V100, P1997, DOI 10.1016/j.rmed.2006.02.016; Guilemany JM, 2009, ALLERGY, V64, P1524, DOI 10.1111/j.1398-9995.2009.02011.x; Guilemany JM, 2009, ALLERGY, V64, P790, DOI 10.1111/j.1398-9995.2008.01892.x; Liu YP, 2015, RESPIROLOGY, V20, P312, DOI 10.1111/resp.12452; Loebinger MR, 2009, THORAX, V64, P1096, DOI 10.1136/thx.2008.112870; Guilemany JM, 2011, RESP MED, V105, P44, DOI 10.1016/j.rmed.2010.10.019; Metaxas EI, 2015, CAN RESPIR J, V22, P163, DOI 10.1155/2015/783682; Mutalithas K, 2008, RESP MED, V102, P1140, DOI 10.1016/j.rmed.2008.03.011; Pasteur MC, 2000, AM J RESP CRIT CARE, V162, P1277, DOI 10.1164/ajrccm.162.4.9906120; Philpott CM, 2008, J LARYNGOL OTOL, V122, P11, DOI 10.1017/S0022215107009140; Quittner AL, 2015, THORAX, V70, P12, DOI 10.1136/thoraxjnl-2014-205918; Taylor SL, 2015, ANN AM THORAC SOC, V12, P701, DOI 10.1513/AnnalsATS.201411-513OC; Tsang KWT, 1998, AM J RESP CRIT CARE, V158, P723, DOI 10.1164/ajrccm.158.3.9710090; Wilkinson M, 2014, COCHRANE DB SYST REV, V5, DOI DOI 10.1002/14651858.CD001289.PUB2; Wu QB, 2014, RESPIROLOGY, V19, P321, DOI 10.1111/resp.12233	28	17	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137348	10.1371/journal.pone.0137348	http://dx.doi.org/10.1371/journal.pone.0137348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340660	gold, Green Published, Green Submitted			2022-12-26	WOS:000360688200049
J	Parente-Rocha, JA; Parente, AFA; Baeza, LC; Bonfim, SMRC; Hernandez, O; McEwen, JG; Bailao, AM; Taborda, CP; Borges, CL; Soares, CMD				Parente-Rocha, Juliana Alves; Alves Parente, Ana Flavia; Baeza, Lilian Cristiane; Rondon Caixeta Bonfim, Sheyla Maria; Hernandez, Orville; McEwen, Juan G.; Bailao, Alexandre Melo; Taborda, Carlos Pelleschi; Borges, Clayton Luiz; de Almeida Soares, Celia Maria			Macrophage Interaction with Paracoccidioides brasiliensis Yeast Cells Modulates Fungal Metabolism and Generates a Response to Oxidative Stress	PLOS ONE			English	Article							NITROSATIVE STRESS; NANOUPLC-MSE; GENE; MULTIPLICATION; ANTIOXIDANT; ACTIVATION; MECHANISMS; PHAGOCYTES; EXPRESSION; AUTOPHAGY	Macrophages are key players during Paracoccidioides brasiliensis infection. However, the relative contribution of the fungal response to counteracting macrophage activity remains poorly understood. In this work, we evaluated the P. brasiliensis proteomic response to macrophage internalization. A total of 308 differentially expressed proteins were detected in P. brasiliensis during infection. The positively regulated proteins included those involved in alternative carbon metabolism, such as enzymes involved in gluconeogenesis, beta-oxidation of fatty acids and amino acids catabolism. The down-regulated proteins during P. brasiliensis internalization in macrophages included those related to glycolysis and protein synthesis. Proteins involved in the oxidative stress response in P. brasiliensis yeast cells were also up-regulated during macrophage infection, including superoxide dismutases (SOD), thioredoxins (THX) and cytochrome c peroxidase (CCP). Antisense knockdown mutants evaluated the importance of CCP during macrophage infection. The results suggested that CCP is involved in a complex system of protection against oxidative stress and that gene silencing of this component of the antioxidant system diminished the survival of P. brasiliensis in macrophages and in a murine model of infection.	[Parente-Rocha, Juliana Alves; Alves Parente, Ana Flavia; Baeza, Lilian Cristiane; Rondon Caixeta Bonfim, Sheyla Maria; Bailao, Alexandre Melo; Borges, Clayton Luiz; de Almeida Soares, Celia Maria] Univ Fed Goias, Inst Ciencias Biol, Lab Biol Mol, Goiania, Go, Brazil; [Hernandez, Orville; McEwen, Juan G.] CIB, Unidad Biol Celular & Mol, Medellin, Colombia; [Hernandez, Orville] Univ Antioquia, Escuela Microbiol, Grp Invest MICROBA, Medellin, Colombia; [McEwen, Juan G.] Univ Antioquia, Fac Med, Medellin, Colombia; [Taborda, Carlos Pelleschi] Univ Sao Paulo, Lab Micol, Dept Microbiol, Inst Ciencias Biomed, Sao Paulo, Brazil; [Alves Parente, Ana Flavia] Univ Fed Amazonas, Dept Ciencias Fisiol, Manaus, Amazonas, Brazil	Universidade Federal de Goias; Universidad de Antioquia; Universidad de Antioquia; Universidade de Sao Paulo; Universidade Federal de Amazonas	Soares, CMD (corresponding author), Lab Biol Mol, Campus Samambaia,S-N ICB2,Sala 206, BR-74690900 Goiania, Go, Brazil.		Taborda, Carlos Pelleschi/AAH-7031-2020; Parente-Rocha, Juliana/GNP-7393-2022; McEwen, Juan/AAG-6621-2021; Bailao, Alexandre Melo/H-1272-2013; Taborda, Carlos P/K-1660-2016; Baeza, Lilian Cristiane/F-2916-2018; BORGES, CLAYTON LUIZ/GQB-5595-2022	Bailao, Alexandre Melo/0000-0001-7754-4047; Taborda, Carlos P/0000-0001-9928-9809; Baeza, Lilian Cristiane/0000-0003-4119-9573; McEwen, Juan Guillermo/0000-0001-8594-9087	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa de Goias (FAPEG)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa de Goias (FAPEG)(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG))	This work at Universidade Federal de Goias was funded by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa de Goias (FAPEG). LCB is a post-doctoral fellow from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/PNPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailao AM, 2006, MICROBES INFECT, V8, P2686, DOI 10.1016/j.micinf.2006.07.019; Bookout Angie L, 2006, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1508s73; Brown AJP, 2009, CURR OPIN MICROBIOL, V12, P384, DOI 10.1016/j.mib.2009.06.007; BRUMMER E, 1988, J IMMUNOL, V140, P2786; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; BRUMMER E, 1989, INFECT IMMUN, V57, P2289, DOI 10.1128/IAI.57.8.2289-2294.1989; BRUMMER E, 1988, INT J IMMUNOPHARMACO, V10, P945, DOI 10.1016/0192-0561(88)90041-0; Campos EG, 2005, GENET MOL RES, V4, P409; da Fonseca CA, 2001, MICROBES INFECT, V3, P535, DOI 10.1016/S1286-4579(01)01409-5; Tavares AHFP, 2007, MICROBES INFECT, V9, P583, DOI 10.1016/j.micinf.2007.01.024; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Ferrari CKB, 2011, ARCH IMMUNOL THER EX, V59, P441, DOI 10.1007/s00005-011-0144-z; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Giles SS, 2005, FUNGAL GENET BIOL, V42, P20, DOI 10.1016/j.fgb.2004.09.003; Grahl N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002145; Grossklaus DD, 2013, MICROBES INFECT, V15, P347, DOI 10.1016/j.micinf.2012.12.002; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Khalfan WA, 2002, CURR OPIN CELL BIOL, V14, P468, DOI 10.1016/S0955-0674(02)00343-5; Lacaz C, 1994, PARACOCCIDIOIDOMYCOS, P1; Lima PD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002855; Bailao EFLC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002856; Martin DW, 2012, MICROBIOL-SGM, V158, P1767, DOI 10.1099/mic.0.059584-0; Matthews K, 2013, MOL MICROBIOL, V89, P1167, DOI 10.1111/mmi.12334; Matute DR, 2006, J CLIN MICROBIOL, V44, P2153, DOI 10.1128/JCM.02540-05; Matute DR, 2006, MOL BIOL EVOL, V23, P65, DOI 10.1093/molbev/msj008; MCEWEN JG, 1987, AM J TROP MED HYG, V36, P603, DOI 10.4269/ajtmh.1987.36.603; Menino Joao F, 2012, Methods Mol Biol, V845, P187, DOI 10.1007/978-1-61779-539-8_12; MOSCARDIBACCHI M, 1994, J MED MICROBIOL, V40, P159, DOI 10.1099/00222615-40-3-159; Murad AM, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-82; Murad AM, 2011, J SEP SCI, V34, P2618, DOI 10.1002/jssc.201100238; Parente AFA, 2015, MICROBES INFECT, V17, P575, DOI 10.1016/j.micinf.2015.03.012; Sambrook J., 2001, MOL CLONING LAB MANU; San-Blas G, 2002, MED MYCOL, V40, P225, DOI 10.1080/mmy.40.3.225.242; Schmidt M, 2013, MICROBIOL-SGM, V159, P2364, DOI 10.1099/mic.0.070516-0; Shi YY, 2013, J MED MICROBIOL, V62, P1226, DOI 10.1099/jmm.0.056903-0; Steinberg BE, 2007, P NATL ACAD SCI USA, V104, P9523, DOI 10.1073/pnas.0700783104; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Xu LS, 2013, MOL PLANT MICROBE IN, V26, P431, DOI 10.1094/MPMI-07-12-0177-R	38	50	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137619	10.1371/journal.pone.0137619	http://dx.doi.org/10.1371/journal.pone.0137619			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360774	Green Submitted, Green Published, gold			2022-12-26	WOS:000361043100057
J	Gutierrez-Exposito, C; Ramirez, F; Afan, I; Forero, MG; Hobson, KA				Gutierrez-Exposito, Carlos; Ramirez, Francisco; Afan, Isabel; Forero, Manuela G.; Hobson, Keith A.			Toward a Deuterium Feather Isoscape for Sub-Saharan Africa: Progress, Challenges and the Path Ahead	PLOS ONE			English	Article							STABLE HYDROGEN; MIGRATORY CONNECTIVITY; ISOTOPES; PRECIPITATION; TECHNOLOGY; ORIGINS; BIRDS	A key challenge to the application of continent-wide feather isoscapes for geographic assignment of migrant birds is the lack of ground-truthed samples. This is especially true for long-distance Palearctic-Afrotropical migrants. We used spatially-explicit information on the delta H-2 composition of archived feathers from Green-backed/Grey-backed Camaroptera, to create a feather delta H-2 isoscape for sub-Saharan Africa. We sampled from 34 out of 41 sub-Saharan countries, totaling 205 sampling localities. Feather samples were obtained from museum collections (n = 224, from 1950 to 2014) for delta H-2 assay. Region, altitude, annual rainfall and seasonal patterns in precipitation were revealed as relevant explanatory variables for spatial patterns in feather delta H-2. Predicted feather delta H-2 values ranged from -4.0% to -63.3%, with higher values observed in the Great Rift Valley and South Africa, and lower values in central Africa. Our feather isoscape differed fromthat modelled previously using a precipitation delta H-2 isoscape and an assumed feather-to-precipitation calibration, but the relatively low model goodness fit (F-10,F-213 = 5.98, p< 0.001, R-2 = 0.18) suggests that other, non-controlled variables might be driving observed geographic patterns in feather delta H-2 values. Additional ground-truthing studies are therefore recommended to improve the accuracy of the African feather delta H-2 isoscape.	[Gutierrez-Exposito, Carlos; Ramirez, Francisco; Forero, Manuela G.] Estac Biol Donana CSIC, Dept Biol Conservac, Seville, Spain; [Afan, Isabel] Estac Biol Donana CSIC, Lab SIG & Teledetecc LAST EBD, Seville, Spain; [Hobson, Keith A.] Environm Canada, Saskatoon, SK, Canada	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Environment & Climate Change Canada	Gutierrez-Exposito, C (corresponding author), Estac Biol Donana CSIC, Dept Biol Conservac, Seville, Spain.	carlines@ebd.csic.es	Hobson, Keith/Q-9306-2019; Gutiérrez-Expósito, Carlos/H-3478-2016; Afán, Isabel/F-4783-2015; Ramírez, Francisco/I-3553-2014	Gutiérrez-Expósito, Carlos/0000-0002-2907-7998; Afán, Isabel/0000-0003-3874-0461; Ramírez, Francisco/0000-0001-9670-486X	National Science and Engineering Council of Canada (NSERC) [103367]; Environment Canada; Spanish Ministry of Economy and Competitiveness, through the Severo Ochoa Programme for Centres of Excellence in RDI [SEV-2012-0262]	National Science and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Environment Canada(CGIAR); Spanish Ministry of Economy and Competitiveness, through the Severo Ochoa Programme for Centres of Excellence in RDI	Support was provided by a National Science and Engineering Council of Canada (NSERC) grant 103367 to CGE and an Environment Canada operating grant to KAH. Sampling costs were supported by the Spanish Ministry of Economy and Competitiveness, through the Severo Ochoa Programme for Centres of Excellence in R&D&I (SEV-2012-0262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannerman DA, 1939, BIRDS TROPICAL W AFR; Barton K., 2014, MUMIN MULTIMODEL INF; Bowen GJ, 2010, ANNU REV EARTH PL SC, V38, P161, DOI 10.1146/annurev-earth-040809-152429; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Bridge ES, 2014, ECOL INDIC, V45, P266, DOI 10.1016/j.ecolind.2014.04.027; Bridge ES, 2013, J FIELD ORNITHOL, V84, P121, DOI 10.1111/jofo.12011; Bridge ES, 2011, BIOSCIENCE, V61, P689, DOI 10.1525/bio.2011.61.9.7; Clark I., 1997, ENV ISOTOPES HYDROGE; CRAIG AJFK, 1983, OSTRICH, V54, P220, DOI 10.1080/00306525.1983.9634475; del Hoyo J, 2006, HDB BIRDS WORLD VOL, V11; FOGDEN MPL, 1979, J ZOOL, V189, P233; Gelman A., 2014, ARM DATA ANAL USING; Gunnarsson G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035679; Hallworth MT, 2015, SCI REP-UK, V5, DOI 10.1038/srep11069; Hastings D. A., 1999, GLOBAL LAND ONE KILO; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hobson KA, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00018.1; Hobson KA, 2004, OECOLOGIA, V141, P477, DOI 10.1007/s00442-004-1671-7; Hobson KA, 2008, TERR ECOL SER, V2, P1; Hobson Keith A., 2013, Animal Migration, V1, P8, DOI 10.2478/ami-2012-0002; Hobson KA, 2014, J FIELD ORNITHOL, V85, P237, DOI 10.1111/jofo.12065; Hobson KA, 2014, ACTA ORNITHOL, V49, P57, DOI 10.3161/000164514X682896; Hobson KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045005; Hobson KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035137; Hobson KA, 2009, J GEOCHEM EXPLOR, V102, P167, DOI 10.1016/j.gexplo.2009.02.007; IAEA/WMO, 2014, GNIP DAT; International Atomic Energy Agency (IAEA), 1992, IAEA TECHN REP SER, V331; Lobo JM, 2007, EUROPEAN DISTRIBUTED; Mackworth-Praed CW, 1960, AFRICA HDB BIRDS 1, V2; Mazerolle DF, 2005, OECOLOGIA, V144, P541, DOI 10.1007/s00442-005-0031-6; Mu QZ, 2011, REMOTE SENS ENVIRON, V115, P1781, DOI 10.1016/j.rse.2011.02.019; Oppel S, 2011, J AVIAN BIOL, V42, P342, DOI 10.1111/j.1600-048X.2011.05252.x; Pain DJ, 2004, OECOLOGIA, V138, P168, DOI 10.1007/s00442-003-1416-z; PAYNE RB, 1969, CONDOR, V71, P140, DOI 10.2307/1366075; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Prochazka P, 2013, J AVIAN BIOL, V44, P541, DOI 10.1111/j.1600-048X.2013.00185.x; Reichlin TS, 2013, OECOLOGIA, V171, P591, DOI 10.1007/s00442-012-2418-5; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Terzer S, 2013, HYDROL EARTH SYST SC, V17, P1; Urban EK, 1997, BIRDS AFRICA, V5; Vander Zanden HB, 2014, METHODS ECOL EVOL, V5, P891, DOI 10.1111/2041-210X.12229; Walsh R. P. D., 1981, Weather, V36, P201, DOI 10.1002/j.1477-8696.1981.tb05400.x; Wassenaar L. I., 2003, ISOT ENVIRON HEALT S, V39, P1; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wunder MB, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P251, DOI 10.1007/978-90-481-3354-3_12	47	8	9	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0135938	10.1371/journal.pone.0135938	http://dx.doi.org/10.1371/journal.pone.0135938			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356677	gold, Green Published, Green Submitted			2022-12-26	WOS:000360965800008
J	Hauquier, F; Suja, LD; Gutt, J; Veit-Kohler, G; Vanreusel, A				Hauquier, Freija; Suja, Laura Duran; Gutt, Julian; Veit-Koehler, Gritta; Vanreusel, Ann			Different Oceanographic Regimes in the Vicinity of the Antarctic Peninsula Reflected in Benthic Nematode Communities	PLOS ONE			English	Article							NATIONAL-PARK BERCHTESGADEN; OLIGOTROPHIC LAKE KONIGSSEE; SOUTH SHETLAND ISLANDS; DEEP-SEA NEMATODES; CLIMATE-CHANGE; MEIOFAUNA DISTRIBUTION; MARINE NEMATODES; ABYSSAL-PLAIN; DRAKE PASSAGE; SHELF WATERS	Marine free-living nematode communities were studied at similar depths (similar to 500 m) at two sides of the Antarctic Peninsula, characterised by different environmental and oceanographic conditions. At the Weddell Sea side, benthic communities are influenced by cold deep-water formation and seasonal sea-ice conditions, whereas the Drake Passage side experiences milder oceanic conditions and strong dynamics of the Antarctic Circumpolar Current. This resulted in different surface primary productivity, which contrasted with observed benthic pigment patterns and varied according to the area studied: chlorophyll a concentrations (as a proxy for primary production) were high in the Weddell Sea sediments, but low in the surface waters above; this pattern was reversed in the Drake Passage. Differences between areas were largely mirrored by the nematode communities: nematode densities peaked in Weddell stations and showed deeper vertical occurrence in the sediment, associated with deeper penetration of chlorophyll a and indicative of a strong benthopelagic coupling. Generic composition showed some similarities across both areas, though differences in the relative contribution of certain genera were noted, together with distinct community shifts with depth in the sediment at all locations.	[Hauquier, Freija; Suja, Laura Duran; Vanreusel, Ann] Univ Ghent, Marine Biol Res Grp, B-9000 Ghent, Belgium; [Gutt, Julian] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany; [Veit-Koehler, Gritta] German Ctr Marine Biodivers Res, Wilhelmshaven, Germany	Ghent University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Hauquier, F (corresponding author), Univ Ghent, Marine Biol Res Grp, B-9000 Ghent, Belgium.	freija.hauquier@ugent.be		Hauquier, Freija/0000-0002-6606-2162; Gutt, Julian/0000-0003-3773-9370	Research Foundation of Flanders [FWO11/ASP/256]; Belgian Science Policy (BELSPO/BRAIN) [BR/132/A1/vERSO]	Research Foundation of Flanders(FWO); Belgian Science Policy (BELSPO/BRAIN)	FH is a fellow with the Research Foundation of Flanders (no.FWO11/ASP/256; http://www.fwo.be/en/). The presented work contributes to project no. BR/132/A1/vERSO of the Belgian Science Policy (BELSPO/BRAIN; http://www.belspo.be/belspo/index_en.stm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan EL, 2013, ECOL EVOL, V3, P2994, DOI 10.1002/ece3.678; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Arntz WE, 2005, SCI MAR, V69, P237, DOI 10.3989/scimar.2005.69s2237; ARNTZ WE, 1994, OCEANOGR MAR BIOL, V32, P241; Aronson RB, 2001, AM ZOOL, V41, P27, DOI 10.1668/0003-1569(2001)041[0027:GCCATO]2.0.CO;2; Arrigo KR, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004551; Arrigo KR, 2004, ANTARCT SCI, V16, P471, DOI 10.1017/S0954102004002263; Arrigo KR, 1998, J GEOPHYS RES-OCEANS, V103, P15587, DOI 10.1029/98JC00930; Bain O, 2014, HDB ZOOLOGY; Barker PF, 2004, EARTH-SCI REV, V66, P143, DOI 10.1016/j.earscirev.2003.10.003; Barker PF, 2001, EARTH-SCI REV, V55, P1, DOI 10.1016/S0012-8252(01)00055-1; Barnes DKA, 2008, CLIM RES, V37, P149, DOI 10.3354/cr00760; Barnes DKA, 2006, GLOBAL ECOL BIOGEOGR, V15, P121, DOI 10.1111/j.1466-822x.2006.00216.x; BARNETT PRO, 1984, OCEANOL ACTA, V7, P399; BATHMANN UV, 1991, DEEP-SEA RES, V38, P1341, DOI 10.1016/0198-0149(91)90031-A; Boeckner MJ, 2009, HYDROBIOLOGIA, V624, P91, DOI 10.1007/s10750-008-9669-5; Mendes CRB, 2013, POLAR BIOL, V36, P537, DOI 10.1007/s00300-012-1282-4; Brandt A, 2007, PHILOS T R SOC B, V362, P39, DOI 10.1098/rstb.2006.1952; BRANDT A, 1993, POLAR BIOL, V13, P565; BRANDT A, 1995, MAR ECOL PROG SER, V121, P39, DOI 10.3354/meps121039; Brandt A, 2007, NATURE, V447, P307, DOI 10.1038/nature05827; Clarke A, 2005, TRENDS ECOL EVOL, V20, P1, DOI 10.1016/j.tree.2004.10.004; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; Clarke A, 2007, PHILOS T R SOC B, V362, P149, DOI 10.1098/rstb.2006.1958; Clarke A, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000886; Clarke A, 2008, J EXP MAR BIOL ECOL, V366, P48, DOI 10.1016/j.jembe.2008.07.008; Crame JA, 1999, SCI MAR, V63, P1; Damerau M, 2012, POLAR BIOL, V35, P1073, DOI 10.1007/s00300-012-1155-x; Danovaro R, 2013, DEEP-SEA RES PT II, V92, P97, DOI 10.1016/j.dsr2.2013.03.035; Dayton P.K., 1990, P631; De Grisse A.T., 1969, MEDEDELINGEN RIJKSFA, V34, P351, DOI DOI 10.1163/156854199508559; de Skowronski RSP, 2002, POLAR BIOL, V25, P126, DOI 10.1007/s003000100320; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; Diaz A, 2011, DEEP-SEA RES PT II, V58, P205, DOI 10.1016/j.dsr2.2010.10.012; Fabiano M, 1999, POLAR BIOL, V22, P115, DOI 10.1007/s003000050398; Figuerola B, 2014, J SEA RES, V85, P1, DOI 10.1016/j.seares.2013.09.003; Galeron J, 2001, PROG OCEANOGR, V50, P303, DOI 10.1016/S0079-6611(01)00059-3; Gambi C, 2003, DEEP-SEA RES PT I, V50, P103, DOI 10.1016/S0967-0637(02)00143-7; Giere O, 2009, MEIOBENTHOLOGY MICRO, DOI 10.1007/978-3-540-68661-3; Glover AG, 2008, DEEP-SEA RES PT II, V55, P2491, DOI 10.1016/j.dsr2.2008.06.008; Gordon AL, 2001, J GEOPHYS RES-OCEANS, V106, P9005, DOI 10.1029/2000JC000281; Gorley C.K., 2006, GETTING STARTED PRIM; Grebmeier J.M., 1991, Journal of Marine Systems, V2, P495, DOI 10.1016/0924-7963(91)90049-Z; Guilini K, 2013, PROG OCEANOGR, V110, P80, DOI 10.1016/j.pocean.2013.01.002; Guilini K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018912; Gutt J, 2015, GLOBAL CHANGE BIOL, V21, P1434, DOI 10.1111/gcb.12794; Gutt Julian, 2013, Berichte zur Polar- und Meeresforschung, V665, P3; Hauquier F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022240; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; Heip C., 1982, Helminthologia (Bratislava), V51, P1; Heip Carlo H. R., 1998, Oceanis, V24, P61; HERMAN RL, 1992, POLAR BIOL, V12, P313; Higgins R.P., 1988, P1; Ingels J, 2006, POLAR BIOL, V29, P936, DOI 10.1007/s00300-006-0135-4; Ingels J, 2012, ECOL EVOL, V2, P453, DOI 10.1002/ece3.96; Ingels J, 2010, MAR ECOL PROG SER, V406, P121, DOI 10.3354/meps08535; JENSEN P, 1988, DEEP-SEA RES, V35, P1173, DOI 10.1016/0198-0149(88)90008-8; JENSEN P, 1987, MAR ECOL PROG SER, V35, P187, DOI 10.3354/meps035187; Jiang MS, 2013, DEEP-SEA RES PT II, V90, P15, DOI 10.1016/j.dsr2.2013.02.029; JUMARS PA, 1984, AM ZOOL, V24, P45; Kang SH, 2001, J PLANKTON RES, V23, P333, DOI 10.1093/plankt/23.4.333; Knefelkamp B, 2007, J EXP MAR BIOL ECOL, V345, P61, DOI 10.1016/j.jembe.2007.01.008; Lawver LA, 2003, PALAEOGEOGR PALAEOCL, V198, P11, DOI 10.1016/S0031-0182(03)00392-4; Lins L, 2014, DEEP-SEA RES PT II, V108, P60, DOI 10.1016/j.dsr2.2014.05.003; Lins L, 2015, PROG OCEANOGR, V134, P356, DOI 10.1016/j.pocean.2015.03.006; Lizotte MP, 2001, AM ZOOL, V41, P57, DOI 10.1668/0003-1569(2001)041[0057:TCOSIA]2.0.CO;2; Lochte K, 1997, DEEP-SEA RES PT II, V44, P321, DOI 10.1016/S0967-0645(96)00081-1; Lockhart SJ, 2008, CCAMLR SCI, V15, P167; Maar M, 2011, J MARINE SYST, V85, P57, DOI 10.1016/j.jmarsys.2010.11.006; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; Mermillod-Blondin F, 2006, AQUAT SCI, V68, P434, DOI 10.1007/s00027-006-0858-x; Moens T, 2006, FRESHWATER NEMATODES: ECOLOGY AND TAXONOMY, P105, DOI 10.1079/9780851990095.0105; Moline MA, 2004, GLOBAL CHANGE BIOL, V10, P1973, DOI 10.1111/j.1365-2486.2004.00825.x; Montes-Hugo M, 2009, SCIENCE, V323, P1470, DOI 10.1126/science.1164533; Moore JK, 2000, J GEOPHYS RES-OCEANS, V105, P28709, DOI 10.1029/1999JC000043; Moran XAG, 2001, DEEP-SEA RES PT I, V48, P405, DOI 10.1016/S0967-0637(00)00042-X; Peck LS, 2004, FUNCT ECOL, V18, P625, DOI 10.1111/j.0269-8463.2004.00903.x; Pennak RW, 1988, ECOLOGY FRESHWATER M, P39; Piepenburg D, 2002, POLAR BIOL, V25, P146, DOI 10.1007/s003000100322; Platt H.M., 1980, Systematics Association Special Volume Series, P729; Platt HM, 1983, NEW SERIES SYNOPSES, V28, P307; Platt HM, 1998, SYNOPSES BRIT FAUNA, V38; Portnova D, 2011, MAR ECOL-EVOL PERSP, V32, P24, DOI 10.1111/j.1439-0485.2010.00403.x; Prezelin BB, 2004, J MAR RES, V62, P419, DOI 10.1357/0022240041446173; R Core Team, 2021, R LANGUAGE ENV STAT; Rack W, 2004, ANN GLACIOL-SER, V39, P505, DOI 10.3189/172756404781814005; Raes M, 2010, GLOBAL CHANGE BIOL, V16, P1618, DOI 10.1111/j.1365-2486.2009.02137.x; Sane E, 2011, J SEA RES, V65, P94, DOI 10.1016/j.seares.2010.07.005; SanVicente CS, 1997, POLAR BIOL, V18, P415; Schratzberger M, 2006, J SEA RES, V55, P113, DOI 10.1016/j.seares.2005.07.002; Schroder M, 2002, DEEP-SEA RES PT II, V49, P4767, DOI 10.1016/S0967-0645(02)00158-3; Sebastian S, 2007, DEEP-SEA RES PT II, V54, P1727, DOI 10.1016/j.dsr2.2007.07.004; Sharma J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014491, DOI 10.1371/journal.pone.0014491]; SHIRAYAMA Y, 1990, Journal of the Oceanographical Society of Japan, V46, P118, DOI 10.1007/BF02123438; Smale DA, 2008, ECOGRAPHY, V31, P289, DOI 10.1111/j.0906-7590.2008.05456.x; Smith CR, 2006, DEEP-SEA RES PT II, V53, P875, DOI 10.1016/j.dsr2.2006.02.001; Smith WO, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004251; SMITH WO, 1986, BIOSCIENCE, V36, P251, DOI 10.2307/1310215; Suzuki H, 2001, POLAR BIOL, V24, P697, DOI 10.1007/s003000100271; Thomson MRA, 2004, DEEP-SEA RES PT II, V51, P1467, DOI 10.1016/j.dsr2.2004.06.021; Traunspurger W, 1996, ARCH HYDROBIOL, V135, P393; Traunspurger W, 1996, ARCH HYDROBIOL, V135, P557; Traunspurger Walter, 1992, Spixiana, V15, P233; Van Gaever S, 2004, J MAR BIOL ASSOC UK, V84, P547, DOI 10.1017/S0025315404009555h; Vanaverbeke J, 2014, NEMYS WORLD DATABASE; Vanhove S, 1999, MAR ECOL PROG SER, V181, P237, DOI 10.3354/meps181237; Vanhove S, 2004, DEEP-SEA RES PT II, V51, P1665, DOI 10.1016/j.dsr2.2004.06.029; VANHOVE S, 1995, MAR ECOL PROG SER, V127, P65, DOI 10.3354/meps127065; Vanreusel A, 1997, MAR ECOL PROG SER, V157, P207, DOI 10.3354/meps157207; Vanreusel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012449; Vanreusel A, 2010, MAR ECOL-EVOL PERSP, V31, P6, DOI 10.1111/j.1439-0485.2009.00352.x; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Veit-Kohler G, 2011, DEEP-SEA RES PT II, V58, P1983, DOI 10.1016/j.dsr2.2011.05.008; VERARDO DJ, 1990, DEEP-SEA RES, V37, P157, DOI 10.1016/0198-0149(90)90034-S; VIDEAU C, 1994, J MARINE SYST, V5, P235, DOI 10.1016/0924-7963(94)90049-3; Vincx Magda, 1996, P187; VITIELLO P, 1974, ANN I OCEANOGR PARIS, V50, P145; Watson AJ, 2013, NATURE, V501, P408, DOI 10.1038/nature12432; WEBB DG, 1993, J EXP MAR BIOL ECOL, V166, P151, DOI 10.1016/0022-0981(93)90215-A; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910; WIESER W., 1953, ARKIV ZOOL, V4, P439; Wing SR, 2012, ECOLOGY, V93, P314, DOI 10.1890/11-0996.1; Witbaard R, 2001, PROG OCEANOGR, V50, P423, DOI 10.1016/S0079-6611(01)00064-7; Zhou M, 2010, DEEP-SEA RES PT I, V57, P1039, DOI 10.1016/j.dsr.2010.05.012	124	14	14	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137527	10.1371/journal.pone.0137527	http://dx.doi.org/10.1371/journal.pone.0137527			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355457	Green Published, gold, Green Submitted			2022-12-26	WOS:000360965800056
J	Kelly, H; Downing, T; Tuite, NL; Smith, TJ; Kerin, MJ; Dwyer, RM; Clancy, E; Barry, T; Reddington, K				Kelly, Helena; Downing, Tim; Tuite, Nina L.; Smith, Terry J.; Kerin, Michael J.; Dwyer, Rolsin M.; Clancy, Eoin; Barry, Thomas; Reddington, Kate			Cross Platform Standardisation of an Experimental Pipeline for Use in the Identification of Dysregulated Human Circulating MiRNAs	PLOS ONE			English	Article							GENE-EXPRESSION; NORMALIZATION METHODS; MICRORNA EXPRESSION; QUANTITATIVE PCR; DOWN-REGULATION; QUALITY-CONTROL; RNA; CANCER; BIOMARKERS; BLOOD	Introduction Micro RNAs (miRNAs) are a class of highly conserved small non-coding RNAs that play an important part in the post-transcriptional regulation of gene expression. A substantial number of miRNAs have been proposed as biomarkers for diseases. While reverse transcriptase Real-time PCR (RT-qPCR) is considered the gold standard for the evaluation and validation of miRNA biomarkers, small RNA sequencing is now routinely being adopted for the identification of dysregulated miRNAs. However, in many cases where putative miRNA biomarkers are identified using small RNA sequencing, they are not substantiated when RT-qPCR is used for validation. To date, there is a lack of consensus regarding optimal methodologies for miRNA detection, quantification and standardisation when different platform technologies are used. Materials and Methods In this study we present an experimental pipeline that takes into consideration sample collection, processing, enrichment, and the subsequent comparative analysis of circulating small ribonucleic acids using small RNA sequencing and RT-qPCR. Results, Discussion, Conclusions Initially, a panel of miRNAs dysregulated in circulating blood from breast cancer patients compared to healthy women were identified using small RNA sequencing. MiR-320a was identified as the most dysregulated miRNA between the two female cohorts. Total RNA and enriched small RNA populations (<30 bp) isolated from peripheral blood from the same female cohort samples were then tested for using a miR-320a RT-qPCR assay. When total RNA was analysed with this miR-320a RT-qPCR assay, a 2.3-fold decrease in expression levels was observed between blood samples from healthy controls and breast cancer patients. However, upon enrichment for the small RNA population and subsequent analysis of miR-320a using RT-qPCR, its dysregulation in breast cancer patients was more pronounced with an 8.89-fold decrease in miR-320a expression. We propose that the experimental pipeline outlined could serve as a robust approach for the identification and validation of small RNA biomarkers for disease.	[Kelly, Helena; Tuite, Nina L.; Barry, Thomas; Reddington, Kate] Natl Univ Ireland, NADRL, Microbiol, Sch Nat Sci, Galway, Ireland; [Downing, Tim] Dublin City Univ, Sch Biotechnol, Dublin 9, Ireland; [Smith, Terry J.; Clancy, Eoin] Natl Univ Ireland, Sch Nat Sci, MDRG, Galway, Ireland; [Smith, Terry J.; Clancy, Eoin] Natl Univ Ireland, Biomed Diagnost Inst BDI Programme, Galway, Ireland; [Kerin, Michael J.; Dwyer, Rolsin M.] Natl Univ Ireland Galway, Discipline Surg, Sch Med, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Dublin City University; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Barry, T (corresponding author), Natl Univ Ireland, NADRL, Microbiol, Sch Nat Sci, Galway, Ireland.	Thomas.barry@nuigalway.ie	Dwyer, Roisin M/C-6654-2013; Reddington, Kate/J-7868-2015	Dwyer, Roisin M/0000-0002-5854-0339; Downing, Tim/0000-0002-8385-6730; Smith, Terry/0000-0002-4956-3299; Kerin, Michael/0000-0003-4164-5561; Reddington, Kate/0000-0002-9559-5638	Science Foundation Ireland [10/CE/B1821]; Breast Cancer Research; European Union's Seventh Programme for research, technological development and demonstration	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Breast Cancer Research; European Union's Seventh Programme for research, technological development and demonstration	EC and TS have been supported during the time this work was carried out by Science Foundation Ireland under Grant No. 10/CE/B1821. MJK and RMD are supported by Breast Cancer Research. NLT, TB, and KR are supported under European Union's Seventh Programme for research, technological development and demonstration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baker M, 2010, NAT METHODS, V7, P687, DOI 10.1038/nmeth0910-687; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Becker C, 2010, METHODS, V50, P237, DOI 10.1016/j.ymeth.2010.01.010; Benes V, 2010, METHODS, V50, P244, DOI 10.1016/j.ymeth.2010.01.026; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Chal V, 2005, J CLIN LAB ANAL, V19, P182, DOI 10.1002/jcla.20075; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cheng C, 2014, TUMOR BIOL, V35, P4177, DOI 10.1007/s13277-013-1546-9; Cheng ZA, 2013, J CLIN IMMUNOL, V33, P567, DOI 10.1007/s10875-012-9834-5; Chevillet JR, 2014, MOLECULES, V19, P6080, DOI 10.3390/molecules19056080; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garmire LX, 2012, RNA, V18, P1279, DOI 10.1261/rna.030916.111; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grosshans H, 2008, NATURE, V451, P414, DOI 10.1038/451414a; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hanna JA, 2012, BIOTECHNIQUES, V52, P235, DOI 10.2144/000113837; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hicks S. C., 2014, USE QUANTILE NORMALI, P12203; Huang A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085201; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Keller A, 2014, MULT SCLER J, V20, P295, DOI 10.1177/1352458513496343; Kim JH, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-76; Kim YK, 2012, MOL CELL, V46, P893, DOI 10.1016/j.molcel.2012.05.036; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Kratz A, 2014, NAT BIOTECHNOL, V32, P882, DOI 10.1038/nbt.3015; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Lawless N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057543; Leidner RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057841; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li Q, 2014, ONCOGENE, V33, P2589, DOI 10.1038/onc.2013.226; Li W, 2009, ANAL BIOANAL CHEM, V394, P1117, DOI 10.1007/s00216-008-2570-2; Lopez JP, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0109-x; Lu C, 2007, METHODS, V43, P110, DOI 10.1016/j.ymeth.2007.05.002; Luo HE, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0527-7; Luo XY, 2011, CANCER EPIDEM BIOMAR, V20, P1272, DOI 10.1158/1055-9965.EPI-11-0035; Mar-Aguilar F, 2013, DIS MARKERS, V34, P163, DOI [10.1155/2013/259454, 10.3233/DMA-120957]; Martins PAD, 2010, CURR DRUG TARGETS, V11, P900, DOI 10.2174/138945010791591322; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Meyer CA, 2014, NAT REV GENET, V15, P709, DOI 10.1038/nrg3788; Meyer M., 2010, COLD SPRING HARB PRO; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moldovan L, 2014, J CELL MOL MED, V18, P371, DOI 10.1111/jcmm.12236; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Patnaik SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046045; Pieter M, 2014, NATURE METHODS; Redshaw N, 2013, BIOTECHNIQUES, V54, P155, DOI 10.2144/000114002; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roth C, 2011, MOL ONCOL, V5, P281, DOI 10.1016/j.molonc.2011.02.002; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Shang C, 2014, MOL BIOL REP, V41, P2521, DOI 10.1007/s11033-014-3110-0; Shapira I, 2014, BRIT J CANCER, V110, P976, DOI 10.1038/bjc.2013.795; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Silahtaroglu A, 2010, ESSAYS BIOCHEM, V48, P165, DOI [10.1042/BSE0480165, 10.1042/bse0480165]; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; Sun JY, 2012, BIOCHEM BIOPH RES CO, V420, P787, DOI 10.1016/j.bbrc.2012.03.075; Svec D, 2015, BIOMOLECULAR DETECTI; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wu YY, 2014, ANGIOGENESIS, V17, P247, DOI 10.1007/s10456-013-9394-1; Yang HP, 2014, ONCOL LETT, V8, P1043, DOI 10.3892/ol.2014.2298; Yin JQ, 2008, TRENDS BIOTECHNOL, V26, P70, DOI 10.1016/j.tibtech.2007.11.007; Yuan YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073604; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang R, 2009, J GENET GENOMICS, V36, P1, DOI 10.1016/S1673-8527(09)60001-1; Zhao H, 2013, CARCINOGENESIS; Zhou XB, 2013, RNA, V19, P733, DOI 10.1261/rna.037895.112	79	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137389	10.1371/journal.pone.0137389	http://dx.doi.org/10.1371/journal.pone.0137389			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355751	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000360965800044
J	Taktikos, J; Lin, YT; Stark, H; Biais, N; Zaburdaev, V				Taktikos, Johannes; Lin, Yen Ting; Stark, Holger; Biais, Nicolas; Zaburdaev, Vasily			Pili-Induced Clustering of N-gonorrhoeae Bacteria	PLOS ONE			English	Article							CORTICAL PLAQUE-FORMATION; TWITCHING MOTILITY; NEISSERIA-GONORRHOEAE; IV PILI; EPITHELIAL-CELLS; BIOFILMS; CYTOPROTECTION; MICROSCOPY; RETRACTION; MECHANISM	Type IV pili (Tfp) are prokaryotic retractable appendages known to mediate surface attachment, motility, and subsequent clustering of cells. Tfp are the main means of motility for Neisseria gonorrhoeae, the causative agent of gonorrhea. Tfp are also involved in formation of the microcolonies, which play a crucial role in the progression of the disease. While motility of individual cells is relatively well understood, little is known about the dynamics of N. gonorrhoeae aggregation. We investigate how individual N. gonorrhoeae cells, initially uniformly dispersed on flat plastic or glass surfaces, agglomerate into spherical microcolonies within hours. We quantify the clustering process by measuring the area fraction covered by the cells, number of cell aggregates, and their average size as a function of time. We observe that the microcolonies are also able to move but their mobility rapidly vanishes as the size of the colony increases. After a certain critical size they become immobile. We propose a simple theoretical model which assumes a pili-pili interaction of cells as the main clustering mechanism. Numerical simulations of the model quantitatively reproduce the experimental data on clustering and thus suggest that the agglomeration process can be entirely explained by the Tfp-mediated interactions. In agreement with this hypothesis mutants lacking pili are not able to form colonies. Moreover, cells with deficient quorum sensing mechanism show similar aggregation as the wild-type bacteria. Therefore, our results demonstrate that pili provide an essential mechanism for colony formation, while additional chemical cues, for example quorum sensing, might be of secondary importance.	[Taktikos, Johannes; Zaburdaev, Vasily] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Taktikos, Johannes; Stark, Holger] Tech Univ Berlin, Inst Theoret Phys, Berlin, Germany; [Taktikos, Johannes; Lin, Yen Ting; Zaburdaev, Vasily] Max Planck Inst Phys Komplexer Syst, Dresden, Germany; [Biais, Nicolas] CUNY Brooklyn Coll, Dept Biol, Brooklyn, NY 11210 USA	Harvard University; Technical University of Berlin; Max Planck Society; City University of New York (CUNY) System; Brooklyn College (CUNY)	Biais, N (corresponding author), CUNY Brooklyn Coll, Dept Biol, Brooklyn, NY 11210 USA.	nicolas@mechano-micro-biology.org; vzaburd@pks.mpg.de	Lin, Yen Ting/ABB-8491-2020; Zaburdaev, Vasily/B-8194-2017	Lin, Yen Ting/0000-0001-6893-8423; Zaburdaev, Vasily/0000-0001-8234-3442	Deutsche Forschungsgemeinschaft (DFG) through the Research Training Group GRK 1558 "Nonequilibrium Collective Dynamics in Condensed Matter and Biological Systems"; NIH [AI116566]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC2AI116566] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG) through the Research Training Group GRK 1558 "Nonequilibrium Collective Dynamics in Condensed Matter and Biological Systems"; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JT, HS, and VZ acknowledge financial support by the Deutsche Forschungsgemeinschaft (DFG) through the Research Training Group GRK 1558 "Nonequilibrium Collective Dynamics in Condensed Matter and Biological Systems." NB would like to acknowledge support from grant AI116566 from NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Biais N, 2008, PLOS BIOL, V6, P907, DOI 10.1371/journal.pbio.0060087; Brenner MP, 1998, BIOPHYS J, V74, P1677, DOI 10.1016/S0006-3495(98)77880-4; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Dewenter L, 2015, INTEGR BIOL-UK, V7, P1161, DOI 10.1039/c5ib00018a; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; HENRICHSEN J, 1983, ANNU REV MICROBIOL, V37, P81, DOI 10.1146/annurev.mi.37.100183.000501; Higashi DL, 2007, INFECT IMMUN, V75, P4743, DOI 10.1128/IAI.00687-07; Higashi DL, 2009, MICROBIOL-SGM, V155, P4084, DOI 10.1099/mic.0.032656-0; Holz C, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.178104; Howie HL, 2005, PLOS BIOL, V3, P627, DOI 10.1371/journal.pbio.0030100; Lee SW, 2005, CELL MICROBIOL, V7, P1271, DOI 10.1111/j.1462-5822.2005.00551.x; Lushnikov PM, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061904; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Marathe R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4759; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Merz AJ, 1999, MOL MICROBIOL, V32, P1316, DOI 10.1046/j.1365-2958.1999.01459.x; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Morikawa R, 2014, JPS C P, V1; MORSE SA, 1978, INFECT IMMUN, V21, P87, DOI 10.1128/IAI.21.1.87-95.1978; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Park HSM, 2001, MOL MICROBIOL, V42, P293, DOI 10.1046/j.1365-2958.2001.02629.x; Peruani F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.098102; Seminara A, 2012, P NATL ACAD SCI USA, V109, P1116, DOI 10.1073/pnas.1109261108; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Taktikos J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.051901; Ulrich LE, 2009, NUCLEIC ACIDS RES, V38; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Weber C, 2014, KINETIC DESCRI UNPUB; Wu YL, 2007, PLOS COMPUT BIOL, V3, P2546, DOI 10.1371/journal.pcbi.0030253; Zaburdaev V, 2014, BIOPHYS J, V107, P1523, DOI 10.1016/j.bpj.2014.07.061	35	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137661	10.1371/journal.pone.0137661	http://dx.doi.org/10.1371/journal.pone.0137661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355966	Green Published, gold			2022-12-26	WOS:000360965800076
J	Russell, KA; Gibson, TWG; Chong, A; Co, C; Koch, TG				Russell, Keith A.; Gibson, Thomas W. G.; Chong, Andrew; Co, Carmon; Koch, Thomas G.			Canine Platelet Lysate Is Inferior to Fetal Bovine Serum for the Isolation and Propagation of Canine Adipose Tissue- and Bone Marrow-Derived Mesenchymal Stromal Cells	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; STEM-CELLS; IN-VITRO; EXPANSION; THERAPY; DIFFERENTIATION; SUBSTITUTE; EXPRESSION; CULTURE	Background Mesenchymal stromal cells (MSC) are increasingly investigated for their clinical utility in dogs. Fetal bovine serum (FBS) is a common culture supplement used for canine MSC expansion. However, FBS content is variable, its clinical use carries risk of an immune response, and its cost is increasing due to global demand. Platelet lysate (PL) has proven to be a suitable alternative to FBS for expansion of human MSC. Hypothesis and Objectives We hypothesized that canine adipose tissue (AT) and bone marrow (BM) MSC could be isolated and expanded equally in PL and FBS at conventionally-used concentrations with differentiation of these MSC unaffected by choice of supplement. Our objectives were to evaluate the use of canine PL in comparison with FBS at four stages: 1) isolation, 2) proliferation, 3) spontaneous differentiation, and 4) directed differentiation. Results 1) Medium with 10% PL was unable to isolate MSC. 2) MSC, initially isolated in FBS-supplemented media, followed a dose-dependent response with no significant difference between PL and FBS cultures at up to 20% (AT) or 30% (BM) enrichment. Beyond these respective peaks, proliferation fell in PL cultures only, while a continued dose-dependent proliferation response was noted in FBS cultures. 3) Further investigation indicated PL expansion culture was inducing spontaneous adipogenesis in concentrations as low as 10% and as early as 4 days in culture. 4) MSC isolated in FBS, but expanded in either FBS or PL, maintained ability to undergo directed adipogenesis and osteogenesis, but not chondrogenesis. Conclusions/Significance Canine PL did not support establishment of MSC colonies from AT and BM, nor expansion of MSC, which appear to undergo spontaneous adipogenesis in response to PL exposure. In vivo studies are warranted to determine if concurrent use of MSC with any plateletderived products such as platelet- rich plasma are associated with synergistic, neutral or antagonistic effects.	[Russell, Keith A.; Chong, Andrew; Co, Carmon; Koch, Thomas G.] Univ Guelph, Dept Biomed Sci, Ontario Vet Coll, Guelph, ON N1G 2W1, Canada; [Gibson, Thomas W. G.] Univ Guelph, Clin Studies, Ontario Vet Coll, Guelph, ON N1G 2W1, Canada; [Koch, Thomas G.] Aarhus Univ, Orthopaed Res Lab, Aarhus, Denmark	University of Guelph; University of Guelph; Aarhus University	Russell, KA (corresponding author), Univ Guelph, Dept Biomed Sci, Ontario Vet Coll, Guelph, ON N1G 2W1, Canada.	karussell.edu@gmail.com	Russell, Keith/HHS-2364-2022	Russell, Keith/0000-0002-1704-2966	Morris Animal Foundation [D12CA-313]; Pet-Trust Research Foundation, Ontario Veterinary College; Dean's Office, Ontario Veterinary College; Department of Biomedical Sciences at the University of Guelph	Morris Animal Foundation; Pet-Trust Research Foundation, Ontario Veterinary College; Dean's Office, Ontario Veterinary College; Department of Biomedical Sciences at the University of Guelph	This project was supported by the Morris Animal Foundation, grant ID# D12CA-313; Pet-Trust Research Foundation, Ontario Veterinary College; The Dean's Office, Ontario Veterinary College and the Department of Biomedical Sciences at the University of Guelph. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSOGG ACG, 1993, AM J VET RES, V54, P635; Allan D, 2012, REGENERATIVE THERAPY, P217, DOI [10.1007/978-1-61779-471-1, DOI 10.1007/978-1-61779-471-1]; Berg LC, 2009, VET COMP ORTHOPAED, V22, P363, DOI 10.3415/VCOT-08-10-0107; Bernardo ME, 2007, J CELL PHYSIOL, V211, P121, DOI 10.1002/jcp.20911; Bieback K, 2008, TRANSFUS MED HEMOTH, V35, P286, DOI 10.1159/000141567; Bieback K, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/193519; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Brindley DA, 2012, REGEN MED, V7, P7, DOI [10.2217/rme.11.112, 10.2217/RME.11.112]; Brinkhof B, 2006, ANAL BIOCHEM, V356, P36, DOI 10.1016/j.ab.2006.06.001; Buechli ME, 2013, STEM CELLS DEV, V22, P1288, DOI 10.1089/scd.2012.0411; Capelli C, 2007, BONE MARROW TRANSPL, V40, P785, DOI 10.1038/sj.bmt.1705798; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Co C, 2014, OSTEOARTHR CARTILAGE, V22, P472, DOI 10.1016/j.joca.2013.12.021; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391; Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010; Kadiyala S, 1997, CELL TRANSPLANT, V6, P125, DOI 10.1016/S0963-6897(96)00279-5; Kisiel AH, 2012, AM J VET RES, V73, P1305, DOI 10.2460/ajvr.73.8.1305; Koch TG, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-26; Neupane M, 2008, TISSUE ENG PT A, V14, P1007, DOI [10.1089/ten.tea.2007.0207, 10.1089/tea.2007.0207]; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rendu F, 2001, PLATELETS, V12, P261, DOI 10.1080/09537100120068170; Russell KA, 2016, EQUINE VET J, V48, P261, DOI 10.1111/evj.12440; Schallmoser K, 2007, TRANSFUSION, V47, P1436, DOI 10.1111/j.1537-2995.2007.01220.x; Schallmoser Katharina, 2013, Methods Mol Biol, V946, P349, DOI 10.1007/978-1-62703-128-8_22; Sekiya I, 2004, J BONE MINER RES, V19, P256, DOI 10.1359/JBMR.0301220; Seo MS, 2009, J VET SCI, V10, P181, DOI 10.4142/jvs.2009.10.3.181; Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.ymthe.2004.02.012	29	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136621	10.1371/journal.pone.0136621	http://dx.doi.org/10.1371/journal.pone.0136621			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353112	Green Submitted, Green Published, gold			2022-12-26	WOS:000360932800043
J	Afroz, T; Luo, ML; Beisel, CL				Afroz, Taliman; Luo, Michelle L.; Beisel, Chase L.			Impact of Residual Inducer on Titratable Expression Systems	PLOS ONE			English	Article							P-BAD PROMOTER; ESCHERICHIA-COLI; GENE-EXPRESSION; ARABAD PROMOTER; RIBOSWITCHES; RNAS; TRANSPORTER; PROTEIN	Inducible expression systems are widely employed for the titratable control of gene expression, yet molecules inadvertently present in the growth medium or synthesized by the host cells can alter the response profile of some of these systems. Here, we explored the quantitative impact of these residual inducers on the apparent response properties of inducible systems. Using a simple mathematical model, we found that the presence of residual inducer shrinks the apparent dynamic range and causes the apparent Hill coefficient to converge to one. We also found that activating systems were more sensitive than repressing systems to the presence of residual inducer and the response parameters were most heavily dependent on the original Hill coefficient. Experimental interrogation of common titratable systems based on an L-arabinose inducible promoter or a thiamine pyrophosphate-repressing riboswitch in Escherichia coli confirmed the predicted trends. We finally found that residual inducer had a distinct effect on "all-or-none" systems, which exhibited increased sensitivity to the added inducer until becoming fully induced. Our findings indicate that residual inducer or repressor alters the quantitative response properties of titratable systems, impacting their utility for scientific discovery and pathway engineering.	[Afroz, Taliman; Luo, Michelle L.; Beisel, Chase L.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Beisel, CL (corresponding author), N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.	cbeisel@ncsu.edu	Beisel, Chase L/D-4823-2015	Beisel, Chase L/0000-0003-0650-9943	National Institutes of Health [1R56AI103557-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI103557] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (1R56AI103557-01A1 to CLB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afroz T, 2015, ACS SYNTH BIOL, V4, P141, DOI 10.1021/sb400162z; Afroz T, 2014, MOL MICROBIOL, V93, P1093, DOI 10.1111/mmi.12695; Afroz T, 2013, CHEM ENG SCI, V103, P79, DOI 10.1016/j.ces.2013.02.017; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Beisel CL, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.62; Brautaset T, 2009, MICROB BIOTECHNOL, V2, P15, DOI 10.1111/j.1751-7915.2008.00048.x; Buchler NE, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.30; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; Lakaye B, 2004, J BIOL CHEM, V279, P17142, DOI 10.1074/jbc.M313569200; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; LOBELL RB, 1990, SCIENCE, V250, P528, DOI 10.1126/science.2237403; Mandin P, 2009, MOL MICROBIOL, V72, P551, DOI 10.1111/j.1365-2958.2009.06665.x; Mizuguchi H, 2002, J GENE MED, V4, P240, DOI 10.1002/jgm.261; Morgan-Kiss RM, 2002, P NATL ACAD SCI USA, V99, P7373, DOI 10.1073/pnas.122227599; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Qi L, 2012, NUCLEIC ACIDS RES, V40, P5775, DOI 10.1093/nar/gks168; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Sharma V, 2008, J AM CHEM SOC, V130, P16310, DOI 10.1021/ja805203w; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; Topp S, 2010, APPL ENVIRON MICROB, V76, P7881, DOI 10.1128/AEM.01537-10; VOGLER AP, 1989, J BACTERIOL, V171, P6586, DOI 10.1128/jb.171.12.6586-6592.1989; WEICKERT MJ, 1993, MOL MICROBIOL, V10, P245, DOI 10.1111/j.1365-2958.1993.tb01950.x; Wieland M, 2009, ANGEW CHEM INT EDIT, V48, P2715, DOI 10.1002/anie.200805311; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145	31	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137421	10.1371/journal.pone.0137421	http://dx.doi.org/10.1371/journal.pone.0137421			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348036	Green Submitted, Green Published, gold			2022-12-26	WOS:000360897600044
J	Imohl, M; van der Linden, M				Imoehl, Matthias; van der Linden, Mark			Antimicrobial Susceptibility of Invasive Streptococcus pyogenes Isolates in Germany during 2003-2013	PLOS ONE			English	Article							MACROLIDE RESISTANCE; EMM TYPES; INFECTIONS; DISEASE; PHENOTYPES	A nationwide laboratory-based surveillance study of invasive S. pyogenes infections was conducted in Germany. Invasive isolates (n = 1,281) were obtained between 2003 and 2013. All isolates were susceptible to penicillin, cefotaxime and vancomycin. Tetracycline showed the highest rate of resistant or intermediate resistant isolates with 9.8%, followed by macrolides (4.0%), trimethoprim/sulfamethoxazole (SXT) (1.9%), levofloxacin (1.3%), chloramphenicol (0.9%) and clindamycin (0.7%). The most prominent trends were the appearance of levofloxacin non-susceptible isolates since 2011, and an increase of SXT non-susceptibility since 2012.	[Imoehl, Matthias] Univ Hosp RWTH Aachen, Inst Med Microbiol, Aachen, Germany; Univ Hosp RWTH Aachen, Natl Reference Ctr Streptococci, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Imohl, M (corresponding author), Univ Hosp RWTH Aachen, Inst Med Microbiol, Aachen, Germany.	mimoehl@ukaachen.de	Imöhl, Matthias/P-5014-2014; van der Linden, Mark/B-9305-2009	Imöhl, Matthias/0000-0002-8372-0251; van der Linden, Mark/0000-0002-6574-4313	European Commission's Directorate-General for Research's Fifth Framework Programme [QLK2.CT.2002.01398]	European Commission's Directorate-General for Research's Fifth Framework Programme	This study was supported, in part, by the European Commission's Directorate-General for Research's Fifth Framework Programme (QLK2.CT.2002.01398). All other resources used were supplied by the RWTH Aachen Universitiy and the Robert Koch-Institut.	Bley C, 2011, INT J ANTIMICROB AG, V37, P425, DOI 10.1016/j.ijantimicag.2011.01.019; Bowen AC, 2012, J CLIN MICROBIOL, V50, P4067, DOI 10.1128/JCM.02195-12; BREIMAN RF, 1993, JAMA-J AM MED ASSOC, V269, P390, DOI 10.1001/jama.1993.03500030088038; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Clinical and Laboratory Standards Institute, 2014, PERF STAND ANT SUSC; Creti R, 2007, J CLIN MICROBIOL, V45, P2249, DOI 10.1128/JCM.00513-07; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; EUCAST, 2014, BREAKP TABL INT MICS; Friaes A, 2013, INT J MED MICROBIOL, V303, P505, DOI 10.1016/j.ijmm.2013.07.004; Giovanetti E, 1999, ANTIMICROB AGENTS CH, V43, P1935, DOI 10.1128/AAC.43.8.1935; Imohl M, 2010, FEMS IMMUNOL MED MIC, V58, P389, DOI 10.1111/j.1574-695X.2010.00652.x; Lamagni T L, 2005, Euro Surveill, V10, P179; Luca-Harari B, 2008, J CLIN MICROBIOL, V46, P79, DOI 10.1128/JCM.01626-07; Martin J, 2011, EURO SURVEILL, V16; Meehan M, 2013, EUROSURVEILLANCE, P18; Meisal R, 2010, J CLIN MICROBIOL, V48, P842, DOI 10.1128/JCM.01312-09; Montes M, 2011, EUR J CLIN MICROBIOL, V30, P1295, DOI 10.1007/s10096-011-1226-x; Nir-Paz R, 2006, INT J ANTIMICROB AG, V28, P313, DOI 10.1016/j.ijantimicag.2006.07.005; Plainvert C, 2012, CLIN MICROBIOL INFEC, V18, P702, DOI 10.1111/j.1469-0691.2011.03624.x; PODBIELSKI A, 1991, MED MICROBIOL IMMUN, V180, P213; SEPPALA H, 1993, J ANTIMICROB CHEMOTH, V32, P885, DOI 10.1093/jac/32.6.885; Siljander T, 2010, EUR J CLIN MICROBIOL, V29, P1229, DOI 10.1007/s10096-010-0989-9; Silva-Costa C, 2015, EXPERT REV ANTI-INFE, V13, P615, DOI 10.1586/14787210.2015.1023292; Stevens DL, 2014, CLIN INFECT DIS, V59, pE10, DOI [10.1093/cid/ciu296, 10.1093/cid/ciu444]; Szczypa K, 2006, J CLIN MICROBIOL, V44, P3975, DOI 10.1128/JCM.01163-06; Vikerfors A, 2009, SCAND J INFECT DIS, V41, P823, DOI 10.3109/00365540903179749; Weisblum B, 1998, DRUG RESIST UPDATE, V1, P29, DOI 10.1016/S1368-7646(98)80212-4; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577; Zakikhany K, 2011, EUROSURVEILLANCE, P16	29	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137313	10.1371/journal.pone.0137313	http://dx.doi.org/10.1371/journal.pone.0137313			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340445	Green Submitted, Green Published, gold			2022-12-26	WOS:000360688200047
J	Xie, NZ; Du, QS; Li, JX; Huang, RB				Xie, Neng-Zhong; Du, Qi-Shi; Li, Jian-Xiu; Huang, Ri-Bo			Exploring Strong Interactions in Proteins with Quantum Chemistry and Examples of Their Applications in Drug Design	PLOS ONE			English	Article							CATION-PI INTERACTIONS; DENSITY-FUNCTIONAL THEORY; COUPLED-CLUSTER SINGLES; INTERACTION ENERGIES; HEPATITIS-C; VIRUS P7; BINDING; MODEL; INHIBITORS; CHANNEL	Objectives Three strong interactions between amino acid side chains (salt bridge, cation-p, and amide bridge) are studied that are stronger than (or comparable to) the common hydrogen bond interactions, and play important roles in protein-protein interactions. Methods Quantum chemical methods MP2 and CCSD(T) are used in calculations of interaction energies and structural optimizations. Results The energies of three types of amino acid side chain interactions in gaseous phase and in aqueous solutions are calculated using high level quantum chemical methods and basis sets. Typical examples of amino acid salt bridge, cation-p, and amide bridge interactions are analyzed, including the inhibitor design targeting neuraminidase (NA) enzyme of influenza A virus, and the ligand binding interactions in the HCV p7 ion channel. The inhibition mechanism of the M2 proton channel in the influenza A virus is analyzed based on strong amino acid interactions. Conclusion (1) The salt bridge interactions between acidic amino acids (Glu(-) and Asp(-)) and alkaline amino acids (Arg(+), Lys(+) and His(+)) are the strongest residue-residue interactions. However, this type of interaction may be weakened by solvation effects and broken by lower pH conditions. (2) The cation-interactions between protonated amino acids (Arg(+), Lys(+) and His(+)) and aromatic amino acids (Phe, Tyr, Trp and His) are 2.5 to 5-fold stronger than common hydrogen bond interactions and are less affected by the solvation environment. (3) The amide bridge interactions between the two amide-containing amino acids (Asn and Gln) are three times stronger than hydrogen bond interactions, which are less influenced by the pH of the solution. (4) Ten of the twenty natural amino acids are involved in salt bridge, or cation-, or amide bridge interactions that often play important roles in protein-protein, protein-peptide, protein-ligand, and protein-DNA interactions.	[Xie, Neng-Zhong; Du, Qi-Shi; Li, Jian-Xiu; Huang, Ri-Bo] Guangxi Acad Sci, Natl Engn Res Ctr Nonfood Biorefinery, State Key Lab Nonfood Biomass & Enzyme Technol, Nanning 530007, Guangxi, Peoples R China; [Li, Jian-Xiu; Huang, Ri-Bo] Guangxi Univ, Life Sci & Biotechnol Coll, Nanning 530004, Guangxi, Peoples R China; [Du, Qi-Shi] Gordon Life Sci Inst, Belmont, MA 02478 USA	Guangxi University; Gordon Life Science Institute	Du, QS (corresponding author), Guangxi Acad Sci, Natl Engn Res Ctr Nonfood Biorefinery, State Key Lab Nonfood Biomass & Enzyme Technol, 98 Daling Rd, Nanning 530007, Guangxi, Peoples R China.	duqishi@foxmail.com; rbhuang@gxas.ac.cn			National Science Foundation of China (NSFC) [31370716, 31360207]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by the National Science Foundation of China (NSFC http://www.nsfc.gov.cn/) to QSD (31370716) and the National Science Foundation of China (NSFC http://www.nsfc.gov.cn/) to RBH (31360207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amovilli C, 1998, ADV QUANTUM CHEM, V32, P227, DOI 10.1016/S0065-3276(08)60416-5; ANDERSON DE, 1990, BIOCHEMISTRY-US, V29, P2403, DOI 10.1021/bi00461a025; Barrett GC, 1998, AMINO ACIDS PEPTIDES, P48; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Beene DL, 2002, BIOCHEMISTRY-US, V41, P10262, DOI 10.1021/bi020266d; Chan CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021624; Charbonneau DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076675; Cheng JG, 2008, SCI CHINA SER B, V51, P768, DOI 10.1007/s11426-008-0087-3; Chu XK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002608; Cossi M, 1998, J CHEM PHYS, V109, P6246, DOI 10.1063/1.477265; Crowley PB, 2005, PROTEINS, V59, P231, DOI 10.1002/prot.20417; DITCHFIELD R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Du QS, 2007, J CHEM THEORY COMPUT, V3, P1665, DOI 10.1021/ct700026d; Du QS, 2007, BIOCHEM BIOPH RES CO, V362, P525, DOI 10.1016/j.bbrc.2007.08.025; Du QS, 2012, J CHEM INF MODEL, V52, P996, DOI 10.1021/ci300066y; Du QS, 2012, J MOL GRAPH MODEL, V34, P38, DOI 10.1016/j.jmgm.2011.12.002; Du QS, 2012, J COMPUT CHEM, V33, P153, DOI 10.1002/jcc.21951; Du QS, 2006, J COMPUT CHEM, V27, P685, DOI 10.1002/jcc.20369; Du QS, 2005, J CHEM INF MODEL, V45, P347, DOI 10.1021/ci049707l; Eldar-Finkelman H, 2009, CURR PHARM DESIGN, V15, P2463, DOI 10.2174/138161209788682253; Foresman JB, 1996, J PHYS CHEM-US, V100, P16098, DOI 10.1021/jp960488j; Foster TL, 2011, HEPATOLOGY, V54, P79, DOI 10.1002/hep.24371; Gold V., 2014, COMPENDIUM CHEM TERM, V528; Gresh N, 2004, J COMPUT CHEM, V25, P823, DOI 10.1002/jcc.20012; Grunenberg J, 2004, J AM CHEM SOC, V126, P16310, DOI 10.1021/ja046282a; Gu RX, 2011, J AM CHEM SOC, V133, P10817, DOI 10.1021/ja1114198; Halgren TA, 1996, J COMPUT CHEM, V17, P520, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<520::AID-JCC2>3.0.CO;2-W; Heyd J, 2003, J CHEM PHYS, V118, P8207, DOI 10.1063/1.1564060; Jensen F, 2007, INTRO COMPUTATIONAL, P159; Jurecka P, 2006, PHYS CHEM CHEM PHYS, V8, P1985, DOI 10.1039/b600027d; Jurecka P, 2007, J COMPUT CHEM, V28, P555, DOI 10.1002/jcc.20570; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Keskin O, 2008, CURR PHARM BIOTECHNO, V9, P67, DOI 10.2174/138920108783955191; Kober L, 2013, BIOTECHNOL BIOENG, V110, P1164, DOI 10.1002/bit.24776; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; LEE TJ, 1988, CHEM PHYS LETT, V150, P406, DOI 10.1016/0009-2614(88)80427-5; Liao SM, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-44; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Marshall MS, 2009, J PHYS CHEM A, V113, P13438, DOI 10.1021/jp906086x; MIERTUS S, 1981, CHEM PHYS, V55, P117, DOI 10.1016/0301-0104(81)85090-2; Mihm U, 2006, ANTIVIR THER, V11, P507; Morgado C, 2007, PHYS CHEM CHEM PHYS, V9, P448, DOI 10.1039/b615263e; Nagy PI, 2010, J PHYS CHEM B, V114, P16436, DOI 10.1021/jp103313s; Nayek A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093862; Nelson D.L., 2008, PRINCIPLES BIOCH; Nissink JWM, 2002, PROTEINS, V49, P457, DOI 10.1002/prot.10232; OuYang B, 2013, NATURE, V498, P521, DOI 10.1038/nature12283; PABO CO, 1984, ANNU REV BIOCHEM, V53, P293, DOI 10.1146/annurev.bi.53.070184.001453; Palazzo AF, 2007, PLOS BIOL, V5, P2862, DOI 10.1371/journal.pbio.0050322; Pielak RM, 2011, BBA-BIOMEMBRANES, V1808, P522, DOI 10.1016/j.bbamem.2010.04.015; PURVIS GD, 1982, J CHEM PHYS, V76, P1910, DOI 10.1063/1.443164; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Roy D, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4755990; Scalmani G., 2016, GAUSSIAN 09; Scheiner S, 1997, J AM CHEM SOC, p[119, 12952]; Scheraga HA, 2007, ANNU REV PHYS CHEM, V58, P57, DOI 10.1146/annurev.physchem.58.032806.104614; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; SCUSERIA GE, 1989, J CHEM PHYS, V90, P3700, DOI 10.1063/1.455827; SCUSERIA GE, 1988, J CHEM PHYS, V89, P7382, DOI 10.1063/1.455269; Silva PJ, 2012, THEORETICAL CHEMISTR, V132, P1307; Smith BJ, 2001, PROTEIN SCI, V10, P689, DOI 10.1110/ps.41801; StGelais C, 2009, J VIROL, V83, P7970, DOI 10.1128/JVI.00521-09; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Tomii K, 1996, PROTEIN ENG, V9, P27, DOI 10.1093/protein/9.1.27; van Mourik T, 2002, J CHEM PHYS, V116, P9620, DOI 10.1063/1.1476010; von Lilienfeld OA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.153004; VOSKO SH, 1980, CAN J PHYS, V58, P1200, DOI 10.1139/p80-159; Wang Q, 2013, P NATL ACAD SCI USA, V110, P20545, DOI 10.1073/pnas.1312788110; Wimley WC, 1996, P NATL ACAD SCI USA, V93, P2985, DOI 10.1073/pnas.93.7.2985; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768	73	31	31	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137113	10.1371/journal.pone.0137113	http://dx.doi.org/10.1371/journal.pone.0137113			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339784	Green Published, gold, Green Submitted			2022-12-26	WOS:000360688200021
J	Itakura, Y; Kohsaka, H; Ohyama, T; Zlatic, M; Pulver, SR; Nose, A				Itakura, Yuki; Kohsaka, Hiroshi; Ohyama, Tomoko; Zlatic, Marta; Pulver, Stefan R.; Nose, Akinao			Identification of Inhibitory Premotor Interneurons Activated at a Late Phase in a Motor Cycle during Drosophila Larval Locomotion	PLOS ONE			English	Article							TARGETED GENE-EXPRESSION; SYNAPTIC-TRANSMISSION; FLUORESCENT PROTEINS; PATTERN GENERATORS; NEURAL CIRCUITS; CENTRAL NEURONS; SPINAL-CORD; BODY-WALL; GLUTAMATE; ORGANIZATION	Rhythmic motor patterns underlying many types of locomotion are thought to be produced by central pattern generators (CPGs). Our knowledge of how CPG networks generate motor patterns in complex nervous systems remains incomplete, despite decades of work in a variety of model organisms. Substrate borne locomotion in Drosophila larvae is driven by waves of muscular contraction that propagate through multiple body segments. We use the motor circuitry underlying crawling in larval Drosophila as a model to try to understand how segmentally coordinated rhythmic motor patterns are generated. Whereas muscles, motoneurons and sensory neurons have been well investigated in this system, far less is known about the identities and function of interneurons. Our recent study identified a class of glutamatergic premotor interneurons, PMSIs (period-positive median segmental interneurons), that regulate the speed of locomotion. Here, we report on the identification of a distinct class of glutamatergic premotor interneurons called Glutamatergic Ventro-Lateral Interneurons (GVLIs). We used calcium imaging to search for interneurons that show rhythmic activity and identified GVLIs as interneurons showing wave-like activity during peristalsis. Paired GVLIs were present in each abdominal segment A1-A7 and locally extended an axon towards a dorsal neuropile region, where they formed GRASP-positive putative synaptic contacts with motoneurons. The interneurons expressed vesicular glutamate transporter (vGluT) and thus likely secrete glutamate, a neurotransmitter known to inhibit motoneurons. These anatomical results suggest that GVLIs are premotor interneurons that locally inhibit motoneurons in the same segment. Consistent with this, optogenetic activation of GVLIs with the red-shifted channelrhodopsin, CsChrimson ceased ongoing peristalsis in crawling larvae. Simultaneous calcium imaging of the activity of GVLIs and motoneurons showed that GVLIs' wave-like activity lagged behind that of motoneurons by several segments. Thus, GVLIs are activated when the front of a forward motor wave reaches the second or third anterior segment. We propose that GVLIs are part of the feedback inhibition system that terminates motor activity once the front of the motor wave proceeds to anterior segments.	[Itakura, Yuki; Kohsaka, Hiroshi; Nose, Akinao] Univ Tokyo, Dept Complex Sci & Engn, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Ohyama, Tomoko; Zlatic, Marta; Pulver, Stefan R.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Nose, Akinao] Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo; Howard Hughes Medical Institute; University of Tokyo	Pulver, SR (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	pulvers@janelia.hhmi.org; nose@k.u-tokyo.ac.jp	Kohsaka, Hiroshi/AAT-4177-2021	Kohsaka, Hiroshi/0000-0003-1087-9680; Zlatic, Marta/0000-0002-3149-2250; Pulver, Stefan/0000-0001-5170-7522; Itakura, Yuki/0000-0001-7513-0529	MEXT/JSPS KAKENHI Grant [22115002, 221S0003, 15H04255]; Janelia Research Campus (Howard Hughes Medical Institute)	MEXT/JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Janelia Research Campus (Howard Hughes Medical Institute)	This work was supported by a MEXT/JSPS KAKENHI Grant Numbers, 22115002 (to A.N.) and 221S0003 (to A.N. and Y.I.), and 15H04255 (to A.N.). The work was also supported by Janelia Research Campus (Howard Hughes Medical Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; [Anonymous], 1983, ANIMAL BEHAV, V31, P282; Berni J, 2012, CURR BIOL, V22, P1861, DOI 10.1016/j.cub.2012.07.048; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cao G, 2013, CELL, V154, P904, DOI 10.1016/j.cell.2013.07.027; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Clyne JD, 2008, CELL, V133, P354, DOI 10.1016/j.cell.2008.01.050; Combes D, 2004, J PHYSIOL-LONDON, V559, P17, DOI 10.1113/jphysiol.2004.069542; Cully DF, 1996, J BIOL CHEM, V271, P20187, DOI 10.1074/jbc.271.33.20187; DELCOMYN F, 1980, SCIENCE, V210, P492, DOI 10.1126/science.7423199; Esengil H, 2008, MOL BIOSYST, V4, P300, DOI 10.1039/b718447f; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Fox LE, 2006, J NEUROSCI, V26, P1486, DOI 10.1523/JNEUROSCI.4749-05.2006; Fujioka M, 2003, DEVELOPMENT, V130, P5385, DOI 10.1242/dev.00770; Gjorgjieva J, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00024; Gomez-Marin A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1455; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; GRILLNER S, 1985, SCIENCE, V228, P143, DOI 10.1126/science.3975635; GRILLNER S, 1974, EXP BRAIN RES, V20, P459; Heckscher ES, 2012, J NEUROSCI, V32, P12460, DOI 10.1523/JNEUROSCI.0222-12.2012; Hughes CL, 2007, MOL CELL NEUROSCI, V35, P383, DOI 10.1016/j.mcn.2007.04.001; Iyengar BG, 2011, GENES BRAIN BEHAV, V10, P883, DOI 10.1111/j.1601-183X.2011.00729.x; Iyengar BG, 2006, J COMP NEUROL, V499, P583, DOI 10.1002/cne.21133; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kitamoto T, 2002, J NEUROGENET, V16, P205, DOI 10.1080/01677060216295; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Kohsaka H, 2014, CURR BIOL, V24, P2632, DOI 10.1016/j.cub.2014.09.026; Lahiri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023180; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; Landgraf M, 2003, DEV BIOL, V260, P207, DOI 10.1016/S0012-1606(03)00215-X; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Li HH, 2014, CELL REP, V8, P897, DOI 10.1016/j.celrep.2014.06.065; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Liu WW, 2013, P NATL ACAD SCI USA, V110, P10294, DOI 10.1073/pnas.1220560110; MacKay-Lyons M, 2002, PHYS THER, V82, P69, DOI 10.1093/ptj/82.1.69; Mahr A, 2006, GENE EXPR PATTERNS, V6, P299, DOI 10.1016/j.modgep.2005.07.006; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Marley Richard, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.prot065656; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Nern A, 2011, P NATL ACAD SCI USA, V108, P14198, DOI 10.1073/pnas.1111704108; Nose A, 1997, DEVELOPMENT, V124, P1433; Ohyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071706; Parmentier ML, 1996, J NEUROSCI, V16, P6687; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Rohrbough J, 2002, J NEUROPHYSIOL, V88, P847, DOI 10.1152/jn.2002.88.2.847; Sanyal S, 2009, GENE EXPR PATTERNS, V9, P371, DOI 10.1016/j.gep.2009.01.002; Skinner FK, 1998, CURR OPIN NEUROBIOL, V8, P725, DOI 10.1016/S0959-4388(98)80114-1; Suster ML, 2002, NATURE, V416, P174, DOI 10.1038/416174a; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; WALLEN P, 1984, J PHYSIOL-LONDON, V347, P225, DOI 10.1113/jphysiol.1984.sp015063; WILSON DM, 1961, J EXP BIOL, V38, P471; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	61	27	27	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136660	10.1371/journal.pone.0136660	http://dx.doi.org/10.1371/journal.pone.0136660			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335437	Green Published, Green Submitted, gold			2022-12-26	WOS:000360615400019
J	Cattin, ME; Wang, J; Weldrick, JJ; Roeske, CL; Mak, E; Thorn, SL; DaSilva, JN; Wang, YB; Lusis, AJ; Burgon, PG				Cattin, Marie-Elodie; Wang, Jessica; Weldrick, Jonathan J.; Roeske, Cassandra L.; Mak, Esther; Thorn, Stephanie L.; DaSilva, Jean N.; Wang, Yibin; Lusis, Aldon J.; Burgon, Patrick G.			Deletion of MLIP (Muscle-enriched A-type Lamin-interacting Protein) Leads to Cardiac Hyperactivation of Akt/Mammalian Target of Rapamycin (mTOR) and Impaired Cardiac Adaptation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PTEN; MAMMALIAN TARGET; TRANSGENIC MICE; GLUCOSE-UPTAKE; HEART-FAILURE; IN-VIVO; HYPERTROPHY; KINASE; DISEASE; AKT	Aging and diseases generally result from tissue inability to maintain homeostasis through adaptation. The adult heart is particularly vulnerable to disequilibrium in homeostasis because its regenerative abilities are limited. Here, we report that MLIP (muscle enriched A-type lamin-interacting protein), a unique protein of unknown function, is required for proper cardiac adaptation. Mlip(-/-) mice exhibited normal cardiac function despite myocardial metabolic abnormalities and cardiac-specific overactivation of Akt/mTOR pathways. Cardiac-specific MLIP overexpression led to an inhibition of Akt/mTOR, providing evidence of a direct impact of MLIP on these key signaling pathways. Mlip(-/-) hearts showed an impaired capacity to adapt to stress (isoproterenol-induced hypertrophy), likely because of deregulated Akt/mTOR activity. Genome-wide association studies showed a genetic association between Mlip and early response to cardiac stress, supporting the role of MLIP in cardiac adaptation. Together, these results revealed that MLIP is required for normal myocardial adaptation to stress through integrated regulation of the Akt/mTOR pathways.	[Cattin, Marie-Elodie; Weldrick, Jonathan J.; Roeske, Cassandra L.; Mak, Esther; Thorn, Stephanie L.; DaSilva, Jean N.; Burgon, Patrick G.] Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada; [Wang, Jessica] Univ Calif Los Angeles, Dept Med, Div Cardiol, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Wang, Yibin] Univ Calif Los Angeles, Dept Anesthesiol Physiol & Med, Div Cardiol, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Lusis, Aldon J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Div Cardiol, Human Genet & Med,David Geffen Sch Med, Los Angeles, CA 90095 USA; [Weldrick, Jonathan J.; Thorn, Stephanie L.; DaSilva, Jean N.; Burgon, Patrick G.] Univ Ottawa, Dept Cellular & Mol Med, Fac Med, Ottawa, ON K1N 6N5, Canada; [Weldrick, Jonathan J.; Thorn, Stephanie L.; DaSilva, Jean N.; Burgon, Patrick G.] Univ Ottawa, Dept Med Cardiol, Fac Med, Ottawa, ON K1N 6N5, Canada	University of Ottawa; University of Ottawa Heart Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Ottawa; University of Ottawa	Burgon, PG (corresponding author), Univ Ottawa, Inst Heart, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.	pburgon@ottawaheart.ca	Thorn, Stephanie/AAD-6988-2022; Wang, Jessica/O-1805-2014; Regan, Clinton/E-6250-2012; Burgon, Patrick/ABB-1027-2021	Wang, Jessica/0000-0001-7348-0509; Wang, Yibin/0000-0003-0852-0767	Canadian Institutes of Health Research [MOP119470]; Heart and Stroke Foundation of Canada [000007]; National Institutes of Health [HL123295, HL114437]; University of Ottawa Cardiac Research Endowed Fellowship; University of Ottawa Heart Institute Foundation; University of Ottawa's Faculty of Medicine Cardiac Endowment Funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123295, R01HL114437] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Ottawa Cardiac Research Endowed Fellowship; University of Ottawa Heart Institute Foundation; University of Ottawa's Faculty of Medicine Cardiac Endowment Funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by Canadian Institutes of Health Research Grant MOP119470 (to P. G. B.), Heart and Stroke Foundation of Canada Grant 000007 (to P. G. B.), and National Institutes of Health Grants HL123295 and HL114437 (to A. J. L.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a University of Ottawa Cardiac Research Endowed Fellowship.; Supported by a Graduate Award from the University of Ottawa Heart Institute Foundation and the University of Ottawa's Faculty of Medicine Cardiac Endowment Funds.	Ahmady E, 2011, J BIOL CHEM, V286, P19702, DOI 10.1074/jbc.M110.165548; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Bertrand AT, 2011, BIOCHEM SOC T, V39, P1687, DOI 10.1042/BST20110670; Buss SJ, 2009, J AM COLL CARDIOL, V54, P2435, DOI 10.1016/j.jacc.2009.08.031; Chen X, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/868753; Choi JC, 2012, J BIOL CHEM, V287, P40513, DOI 10.1074/jbc.M112.404541; Choi JC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003875; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Dorn GW, 2010, PHYSIOL REV, V90, P1013, DOI 10.1152/physrev.00001.2010; Farber CR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002038; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley SA, 2014, BIOCHEM J, V459, P275, DOI 10.1042/BJ20131344; Hayasaka M, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12254; Hershberger RE, 2010, GENET MED, V12, P655, DOI 10.1097/GIM.0b013e3181f2481f; Huang ZP, 2012, CIRC RES, V110, P818, DOI 10.1161/CIRCRESAHA.111.259663; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Kelleher AR, 2013, AM J PHYSIOL-ENDOC M, V304, pE229, DOI 10.1152/ajpendo.00409.2012; Kim AS, 2009, ACTA PHYSIOL, V196, P37, DOI 10.1111/j.1748-1716.2009.01978.x; Lee CT, 2014, CAN J PHYSIOL PHARM, V92, P307, DOI 10.1139/cjpp-2013-0107; Li J, 2014, CELL METAB, V19, P373, DOI 10.1016/j.cmet.2014.01.001; Liu L, 2012, AM J TRANSL RES, V4, P175; Lundby A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003506; Lyon RC, 2015, CIRC RES, V116, P1462, DOI 10.1161/CIRCRESAHA.116.304937; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Palermo J, 1996, CIRC RES, V78, P504, DOI 10.1161/01.RES.78.3.504; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Ramos FJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003802; Rau CD, 2015, CURR OPIN CARDIOL, V30, P222, DOI 10.1097/HCO.0000000000000160; Rau CD, 2015, CIRC-CARDIOVASC GENE, V8, P40, DOI 10.1161/CIRCGENETICS.113.000732; Schiekofer S, 2006, PHYSIOL GENOMICS, V27, P156, DOI 10.1152/physiolgenomics.00234.2005; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Sciarretta S, 2014, CIRC RES, V114, P549, DOI 10.1161/CIRCRESAHA.114.302022; Shende P, 2011, CIRCULATION, V123, P1073, DOI 10.1161/CIRCULATIONAHA.110.977066; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Song XX, 2010, AM J PHYSIOL-CELL PH, V299, pC1256, DOI 10.1152/ajpcell.00338.2010; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steinbusch LKM, 2011, CELL MOL LIFE SCI, V68, P2525, DOI 10.1007/s00018-011-0690-x; Sussman MA, 2011, PHYSIOL REV, V91, P1023, DOI 10.1152/physrev.00024.2010; Thorn SL, 2013, J NUCL MED, V54, P1637, DOI 10.2967/jnumed.112.110114; Thorn SL, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-48; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xu SH, 2014, AGING DIS, V5, P263, DOI 10.14336/AD.2014.0500263; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008; Zhang WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026581; Zhu Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054221, 10.1371/journal.pone.0071727]; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	52	18	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26699	U404		10.1074/jbc.M115.678433	http://dx.doi.org/10.1074/jbc.M115.678433			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26359501	Green Published, hybrid			2022-12-26	WOS:000364793600033
J	Katsuma, S; Sugano, Y; Kiuchi, T; Shimada, T				Katsuma, Susumu; Sugano, Yudai; Kiuchi, Takashi; Shimada, Toru			Two Conserved Cysteine Residues Are Required for the Masculinizing Activity of the Silkworm Masc Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING; SEQUENCE ALIGNMENT; INTERACTING RNA; MESSENGER-RNA; W-CHROMOSOME; IDENTIFICATION; SEX	We have recently discovered that the Masculinizer (Masc) gene encodes a CCCH tandem zinc finger protein, which controls both masculinization and dosage compensation in the silkworm Bombyx mori. In this study, we attempted to identify functional regions or residues that are required for the masculinizing activity of the Masc protein. We constructed a series of plasmids that expressed the Masc derivatives and transfected them into a B. mori ovary-derived cell line, BmN-4. To assess the masculinizing activity of the Masc derivatives, we investigated the splicing patterns of B. mori doublesex (Bmdsx) and the expression levels of B. mori IGF-II mRNA-binding protein, a splicing regulator of Bmdsx, in Masc cDNA-transfected BmN-4 cells. We found that two zinc finger domains are not required for the masculinizing activity. We also identified that the C-terminal 288 amino acid residues are sufficient for the masculinizing activity of the Masc protein. Further detailed analyses revealed that two cysteine residues, Cys-301 and Cys-304, in the highly conserved region among lepidopteran Masc proteins are essential for the masculinizing activity in BmN-4 cells. Finally, we showed that Masc is a nuclear protein, but its nuclear localization is not tightly associated with the masculinizing activity.	[Katsuma, Susumu; Sugano, Yudai; Kiuchi, Takashi; Shimada, Toru] Univ Tokyo, Dept Agr & Environm Biol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Katsuma, S (corresponding author), Univ Tokyo, Dept Agr & Environm Biol, Grad Sch Agr & Life Sci, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	katsuma@ss.ab.a.u-tokyo.ac.jp	Shimada, Toru/AAZ-2703-2021; Kiuchi, Takashi/AAG-4913-2020; Shimada, Toru/A-2033-2011	Shimada, Toru/0000-0002-5791-0000; Kiuchi, Takashi/0000-0003-3616-1650; Shimada, Toru/0000-0002-5791-0000; Katsuma, Susumu/0000-0001-7096-3038	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry Grant [26034A]; KAKENHI Grant [15H02482]	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry Grant; KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry Grant 26034A (to S. K.) and KAKENHI Grant 15H02482 (to S. K., T. K., and T. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe H, 2008, GENETICA, V133, P269, DOI 10.1007/s10709-007-9210-1; Abe H, 2005, CYTOGENET GENOME RES, V110, P144, DOI 10.1159/000084946; Blackshear PJ, 2014, J INTERF CYTOK RES, V34, P297, DOI 10.1089/jir.2013.0150; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Fukui T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005048; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hasimoto H., 1933, JPN J GENET, V8, P245; IMANISHI S, 1988, Journal of Sericultural Science of Japan, V57, P184; Ishihara G, 2013, VIRUS RES, V174, P52, DOI 10.1016/j.virusres.2013.02.014; Iwasaki YW, 2015, ANNU REV BIOCHEM, V84, P405, DOI 10.1146/annurev-biochem-060614-034258; Kawamoto M, 2015, GENE, V560, P50, DOI 10.1016/j.gene.2015.01.036; Kawaoka S, 2011, RNA, V17, P2144, DOI 10.1261/rna.027565.111; Kawaoka S, 2011, RNA, V17, P1401, DOI 10.1261/rna.2709411; Kawaoka S, 2009, RNA, V15, P1258, DOI 10.1261/rna.1452209; Kelly SM, 2010, J BIOL CHEM, V285, P26022, DOI 10.1074/jbc.M110.141127; Kiuchi T, 2014, NATURE, V509, P633, DOI 10.1038/nature13315; Lee J, 2015, INSECT MOL BIOL, V24, P561, DOI 10.1111/imb.12181; Pomeranz MC, 2010, PLANT PHYSIOL, V152, P151, DOI 10.1104/pp.109.145656; Qu J, 2014, PLANT J, V78, P452, DOI 10.1111/tpj.12485; Suzuki MG, 2010, MOL CELL BIOL, V30, P5776, DOI 10.1128/MCB.00444-10; Suzuki MG, 2005, EVOL DEV, V7, P58, DOI 10.1111/j.1525-142X.2005.05007.x; Suzuki MG, 2003, DEV GENES EVOL, V213, P345, DOI 10.1007/s00427-003-0334-8; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka Y, 1916, J COLL AGR SAPPORO, V6, P1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	27	22	22	3	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26114	26124		10.1074/jbc.M115.685362	http://dx.doi.org/10.1074/jbc.M115.685362			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26342076	Green Published, hybrid			2022-12-26	WOS:000363527300031
J	Trefely, S; Khoo, PS; Krycer, JR; Chaudhuri, R; Fazakerley, DJ; Parker, BL; Sultani, G; Lee, J; Stephan, JP; Torres, E; Jung, K; Kuijl, C; James, DE; Junutula, JR; Stockli, J				Trefely, Sophie; Khoo, Poh-Sim; Krycer, James R.; Chaudhuri, Rima; Fazakerley, Daniel J.; Parker, Benjamin L.; Sultani, Ghazal; Lee, James; Stephan, Jean-Philippe; Torres, Eric; Jung, Kenneth; Kuijl, Coenraad; James, David E.; Junutula, Jagath R.; Stoeckli, Jacqueline			Kinome Screen Identifies PFKFB3 and Glucose Metabolism as Important Regulators of the Insulin/Insulin-like Growth Factor (IGF)-1 Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITION; INSULIN-RESISTANCE; SKELETAL-MUSCLE; GLUCOSE-TRANSPORTER-4 TRANSLOCATION; INDUCIBLE 6-PHOSPHOFRUCTO-2-KINASE; FRUCTOSE 2,6-BISPHOSPHATE; MYOSIN-II; IGF-I; AKT; GLUT4	The insulin/insulin-like growth factor (IGF)-1 signaling pathway (ISP) plays a fundamental role in long term health in a range of organisms. Protein kinases including Akt and ERK are intimately involved in the ISP. To identify other kinases that may participate in this pathway or intersect with it in a regulatory manner, we performed a whole kinome (779 kinases) siRNA screen for positive or negative regulators of the ISP, using GLUT4 translocation to the cell surface as an output for pathway activity. We identified PFKFB3, a positive regulator of glycolysis that is highly expressed in cancer cells and adipocytes, as a positive ISP regulator. Pharmacological inhibition of PFKFB3 suppressed insulin-stimulated glucose uptake, GLUT4 translocation, and Akt signaling in 3T3-L1 adipocytes. In contrast, overexpression of PFKFB3 in HEK293 cells potentiated insulin-dependent phosphorylation of Akt and Akt substrates. Furthermore, pharmacological modulation of glycolysis in 3T3-L1 adipocytes affected Akt phosphorylation. These data add to an emerging body of evidence that metabolism plays a central role in regulating numerous biological processes including the ISP. Our findings have important implications for diseases such as type 2 diabetes and cancer that are characterized by marked disruption of both metabolism and growth factor signaling.	[Trefely, Sophie; Khoo, Poh-Sim; Sultani, Ghazal] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Lee, James; Stephan, Jean-Philippe; Torres, Eric; Jung, Kenneth; Kuijl, Coenraad; Junutula, Jagath R.] Genentech Inc, San Francisco, CA 94080 USA; [Krycer, James R.; Chaudhuri, Rima; Fazakerley, Daniel J.; Parker, Benjamin L.; James, David E.; Stoeckli, Jacqueline] Univ Sydney, Sch Mol Biosci, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [James, David E.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	Garvan Institute of Medical Research; Roche Holding; Genentech; University of Sydney; University of Sydney	James, DE (corresponding author), Univ Sydney, Sydney Med Sch, Sch Mol Biosci, Charles Perkins Ctr, Sydney, NSW 2006, Australia.	david.james@sydney.edu.au; jagathjr@gmail.com; jacqueline.stoeckli@sydney.edu.au	Trefely, Sophie/AAL-9434-2020; Stoeckli, Jacqueline/Z-4443-2019; Junutula, Jagath Reddy/ABD-4753-2020; Stoeckli, Jacqueline/D-7053-2016; Fazakerley, Daniel/J-2652-2019	Stoeckli, Jacqueline/0000-0002-6446-7350; Junutula, Jagath Reddy/0000-0002-5942-4428; Stoeckli, Jacqueline/0000-0002-6446-7350; Fazakerley, Daniel/0000-0001-8241-2903; Trefely, Sophie/0000-0003-3816-6869; Kuijl, Coen/0000-0003-4378-1428; James, David/0000-0001-5946-5257; Krycer, James/0000-0003-1536-7270	National Health and Medical Research Council (NHMRC) [GNT1068469, GNT1086850]; Australian Postgraduate Award scholarships	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award scholarships	This work was supported in part by National Health and Medical Research Council (NHMRC) project Grants GNT1068469 (to J. S.) and GNT1086850 (to D. E. J.). The contents of the published material are solely the responsibility of the individual authors and do not reflect the views of NHMRC.; Supported by Australian Postgraduate Award scholarships.	Abe Y, 2006, BIOCHEM BIOPH RES CO, V344, P377, DOI 10.1016/j.bbrc.2006.03.071; Abe Y, 2001, J BIOL CHEM, V276, P44003, DOI 10.1074/jbc.M105669200; Ahmed K, 2010, CELL METAB, V11, P311, DOI 10.1016/j.cmet.2010.02.012; Atsumi T, 2005, DIABETES, V54, P3349, DOI 10.2337/diabetes.54.12.3349; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brewer PD, 2011, J BIOL CHEM, V286, P26287, DOI 10.1074/jbc.M111.253880; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Bulow MH, 2014, SCI REP-UK, V4, DOI 10.1038/srep04048; Cai TQ, 2008, BIOCHEM BIOPH RES CO, V377, P987, DOI 10.1016/j.bbrc.2008.10.088; CHALLISS RAJ, 1983, BIOSCIENCE REP, V3, P675, DOI 10.1007/BF01172878; Chan TO, 2012, CELL CYCLE, V11, P475, DOI 10.4161/cc.11.3.19059; Chesney J, 1999, P NATL ACAD SCI USA, V96, P3047, DOI 10.1073/pnas.96.6.3047; Clem B, 2008, MOL CANCER THER, V7, P110, DOI 10.1158/1535-7163.MCT-07-0482; Clem BF, 2013, MOL CANCER THER, V12, P1461, DOI 10.1158/1535-7163.MCT-13-0097; Cordero-Espinoza L, 2013, J BIOL CHEM, V288, P36020, DOI 10.1074/jbc.M113.510289; Davey JR, 2012, TRAFFIC, V13, P1429, DOI 10.1111/j.1600-0854.2012.01397.x; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; De Saedeleer CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046571; Doherty JR, 2014, CANCER RES, V74, P908, DOI 10.1158/0008-5472.CAN-13-2034; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Facchin S, 2007, CELL MOL LIFE SCI, V64, P2680, DOI 10.1007/s00018-007-7179-7; Fox JEM, 2000, J PHYSIOL-LONDON, V529, P285, DOI 10.1111/j.1469-7793.2000.00285.x; Fulcher FK, 2008, EXP CELL RES, V314, P3264, DOI 10.1016/j.yexcr.2008.08.007; Garcia-Guerra L, 2010, DIABETES, V59, P2407, DOI 10.2337/db10-0771; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; HALESTRAP AP, 1976, BIOCHEM J, V156, P181, DOI 10.1042/bj1560181; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hernandez R, 2001, FEBS LETT, V494, P225, DOI 10.1016/S0014-5793(01)02353-5; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hodson L, 2013, DIABETES, V62, P1417, DOI 10.2337/db12-1032; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Hoy AJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE67, DOI 10.1152/ajpendo.90945.2008; HUE L, 1987, BIOCHEM J, V245, P313, DOI 10.1042/bj2450313; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Huo YQ, 2012, J BIOL CHEM, V287, P21492, DOI 10.1074/jbc.M112.370379; Huo YQ, 2010, J BIOL CHEM, V285, P3713, DOI 10.1074/jbc.M109.058446; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; Klarer AC, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-2; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Krook A, 1998, DIABETES, V47, P1281, DOI 10.2337/diabetes.47.8.1281; Lalioti V, 2009, P NATL ACAD SCI USA, V106, P4249, DOI 10.1073/pnas.0900218106; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Li YF, 2005, MOL CELL BIOCHEM, V277, P117, DOI 10.1007/s11010-005-5535-1; Lim J, 2010, GENE DEV, V24, P1496, DOI 10.1101/gad.1904610; Lin K, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002618; Liu F, 2009, BIOCHEM J, V418, P413, DOI 10.1042/BJ20082051; Lodeiro M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004686; Lu XM, 2013, INT J MOL MED, V31, P740, DOI 10.3892/ijmm.2013.1241; MacIver NJ, 2008, J LEUKOCYTE BIOL, V84, P949, DOI 10.1189/jlb.0108024; Mehta A, 2009, MOL CELL BIOCHEM, V329, P3, DOI 10.1007/s11010-009-0114-5; Nosaka K, 2001, BBA-GENE STRUCT EXPR, V1517, P293, DOI 10.1016/S0167-4781(00)00247-5; Okada S, 2008, J BIOL CHEM, V283, P35455, DOI 10.1074/jbc.M806531200; Owen O. E., 1981, U.S Patent, Patent No. 4254222; Park S, 2005, INT J VEHICLE DES, V37, P1, DOI 10.1504/IJVD.2005.006092; Prabhu AV, 2013, FEBS LETT, V587, P983, DOI 10.1016/j.febslet.2013.02.040; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; Rock CO, 2000, J BIOL CHEM, V275, P1377, DOI 10.1074/jbc.275.2.1377; ROTHMAN DL, 1992, J CLIN INVEST, V89, P1069, DOI 10.1172/JCI115686; Ruan GX, 2013, J BIOL CHEM, V288, P21161, DOI 10.1074/jbc.M113.474619; Sabater D, 2014, SCI REP-UK, V4, DOI 10.1038/srep03663; Sakakibara R, 1997, J BIOCHEM-TOKYO, V122, P122; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schoors S, 2014, CELL METAB, V19, P37, DOI 10.1016/j.cmet.2013.11.008; Seo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024179; Seton-Rogers S, 2014, NAT REV DRUG DISCOV, V13, DOI 10.1038/nrd4267; Shewan AM, 2000, BIOCHEM J, V350, P99, DOI 10.1042/0264-6021:3500099; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Spielman LJ, 2014, J NEUROIMMUNOL, V273, P8, DOI 10.1016/j.jneuroim.2014.06.004; Steimle PA, 2005, BIOCHEM BIOPH RES CO, V331, P1560, DOI 10.1016/j.bbrc.2005.04.082; Stockli J, 2008, MOL ENDOCRINOL, V22, P2703, DOI 10.1210/me.2008-0111; Stockli J, 2015, DIABETES, V64, P1914, DOI 10.2337/db13-1489; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Tan SX, 2015, J BIOL CHEM, V290, P11337, DOI 10.1074/jbc.M114.623686; Tan SX, 2012, J BIOL CHEM, V287, P6128, DOI 10.1074/jbc.M111.318238; Tan SX, 2010, BIOCHEM J, V432, P191, DOI 10.1042/BJ20100750; Telang S, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-95; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Turban S, 2011, FEBS LETT, V585, P269, DOI 10.1016/j.febslet.2010.12.022; Usui I, 2004, EMBO J, V23, P2821, DOI 10.1038/sj.emboj.7600297; Valiente M, 2005, J BIOL CHEM, V280, P28936, DOI 10.1074/jbc.M504761200; VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191; Vijayakumar MV, 2010, J BIOSCIENCES, V35, P525, DOI 10.1007/s12038-010-0060-0; Wani R, 2011, P NATL ACAD SCI USA, V108, P10550, DOI 10.1073/pnas.1011665108; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; WEILAND M, 1991, J CELL PHYSIOL, V149, P428, DOI 10.1002/jcp.1041490311; Wheeler DB, 2004, NAT METHODS, V1, P127, DOI 10.1038/NMETH711; WILSON CM, 1995, FEBS LETT, V368, P19, DOI 10.1016/0014-5793(95)00589-2; Xie N., 2015, AM J RESP CRIT CARE, DOI [10.1164/rccm.201504-0780OC, DOI 10.1164/RCCM.201504-0780OC]; Xintaropoulou C, 2015, ONCOTARGET, V6, P25677, DOI 10.18632/oncotarget.4499; Xu YM, 2014, ARTERIOSCL THROM VAS, V34, P1231, DOI 10.1161/ATVBAHA.113.303041; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yao JE, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-95; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60	104	37	37	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25834	25846		10.1074/jbc.M115.658815	http://dx.doi.org/10.1074/jbc.M115.658815			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26342081	hybrid, Green Published			2022-12-26	WOS:000363527300005
J	Sasaki, N; Itakura, Y; Toyoda, M				Sasaki, Norihiko; Itakura, Yoko; Toyoda, Masashi			Ganglioside GM1 Contributes to the State of Insulin Resistance in Senescent Human Arterial Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATHEROSCLEROSIS; RECEPTOR; OVEREXPRESSION; INHIBITION; MECHANISMS; YOUNG	Vascular endothelial cells (ECs) play central roles in physiologically important functions of blood vessels and contribute to the maintenance of vascular integrity. Therefore, it is considered that the impairment of EC functions leads to the development of vascular diseases. However, the molecular mechanisms of the EC dysfunctions that accompany senescence and aging have not yet been clarified. The carbohydrate antigens carried by glycoconjugates (e.g. glycoproteins, glycosphingolipids, and proteoglycans) mainly present on the cell surface serve not only as marker molecules but also as functional molecules. In this study, we have investigated the abundance and functional roles of glycosphingolipids in human ECs during senescence and aging. Among glycosphingolipids, ganglioside GM1 was highly expressed in abundance on the surface of replicatively and prematurely senescent ECs and also of ECs derived from an elderly subject. Insulin signaling, which regulates important functions of ECs, is impaired in senescent and aged ECs. Actually, by down-regulating GM1 on senescent ECs and overloading exogenous GM1 onto non-senescent ECs, we showed that an increased abundance of GM1 functionally contributes to the impairment of insulin signaling in ECs. Taken together, these findings provide the first evidence that GM1 increases in abundance on the cell surface of ECs under the conditions of cellular senescence and aging and causes insulin resistance in ECs. GM1 may be an attractive target for the detection, prevention, and therapy of insulin resistance and related vascular diseases, particularly in older people.	[Sasaki, Norihiko; Itakura, Yoko; Toyoda, Masashi] Tokyo Metropolitan Inst Gerontol, Res Team Geriatr Med Vasc Med, Itabashi Ku, Tokyo 1730015, Japan	Tokyo Metropolitan Institute of Gerontology	Toyoda, M (corresponding author), Tokyo Metropolitan Inst Gerontol, Res Team Geriatr Med Vasc Med, Itabashi Ku, Sakaecho 35-2, Tokyo 1730015, Japan.	mtoyoda@tmig.or.jp	Itakura, Yoko/AAM-5166-2020		Japan Society for the Promotion of Science KAKENHI [24890298]; Terumo Life Science Foundation (general subsidy)	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Terumo Life Science Foundation (general subsidy)	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant 24890298, grant-in-aid for young scientists (start-up), grant-in-aid for scientific research (C), and grant-in-aid for challenging exploratory research, and Terumo Life Science Foundation (2013 general subsidy). The authors declare that they have no conflicts of interest with the contents of this article.	Aerts JM, 2003, PHILOS T R SOC B, V358, P905, DOI 10.1098/rstb.2003.1273; Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Bietrix F, 2010, ARTERIOSCL THROM VAS, V30, P931, DOI 10.1161/ATVBAHA.109.201673; Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Bremer E G, 1984, Adv Exp Med Biol, V174, P381; Cai H, 2005, CARDIOVASC RES, V68, P26, DOI 10.1016/j.cardiores.2005.06.021; Cai Y, 2014, MOL CELL BIOCHEM, V391, P117, DOI 10.1007/s11010-014-1993-7; Dong Y, 2010, CANCER SCI, V101, P2039, DOI 10.1111/j.1349-7006.2010.01613.x; Favero G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/801896; Frippiat C, 2001, J BIOL CHEM, V276, P2531, DOI 10.1074/jbc.M006809200; Furukawa K, 2011, NEUROCHEM RES, V36, P1578, DOI 10.1007/s11064-011-0494-2; HAKOMORI S, 1995, J BIOCHEM, V118, P1091, DOI 10.1093/oxfordjournals.jbchem.a124992; Hewitt G, 2013, METHODS MOL BIOL, V1048, P31, DOI 10.1007/978-1-62703-556-9_4; Jiang L, 2014, BBA-BIOMEMBRANES, V1838, P1255, DOI 10.1016/j.bbamem.2014.01.003; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; Kubota T, 2011, CELL METAB, V13, P294, DOI 10.1016/j.cmet.2011.01.018; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lingwood CA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004788; Ma H, 2006, CARDIOVASC RES, V69, P57, DOI 10.1016/j.cardiores.2005.08.019; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Mitsuda T, 2002, J BIOL CHEM, V277, P11239, DOI 10.1074/jbc.M107756200; Muniyappa R, 2007, CURR OPIN CLIN NUTR, V10, P523, DOI 10.1097/MCO.0b013e32819f8ecd; OHSAWA T, 1989, MECH AGEING DEV, V50, P169, DOI 10.1016/0047-6374(89)90012-2; Rajendran P, 2013, INT J BIOL SCI, V9, P1057, DOI 10.7150/ijbs.7502; Rask-Madsen C, 2010, CELL METAB, V11, P379, DOI 10.1016/j.cmet.2010.03.013; Sasaki A, 2003, J BIOL CHEM, V278, P27896, DOI 10.1074/jbc.M212200200; Tagami S, 2002, J BIOL CHEM, V277, P3085, DOI 10.1074/jbc.M103705200; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719	31	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25475	25486		10.1074/jbc.M115.684274	http://dx.doi.org/10.1074/jbc.M115.684274			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26338710	Green Published, hybrid			2022-12-26	WOS:000362962800023
J	Baldauf, C; Jeschke, A; Kanbach, V; Catala-Lehnen, P; Baumhoer, D; Gerull, H; Buhs, S; Amling, M; Nollau, P; Harroch, S; Schinke, T				Baldauf, Christina; Jeschke, Anke; Kanbach, Vincent; Catala-Lehnen, Philip; Baumhoer, Daniel; Gerull, Helwe; Buhs, Sophia; Amling, Michael; Nollau, Peter; Harroch, Sheila; Schinke, Thorsten			The Protein Tyrosine Phosphatase Rptp zeta Suppresses Osteosarcoma Development in Trp53-Heterozygous Mice	PLOS ONE			English	Article							GRADE CENTRAL OSTEOSARCOMA; GROWTH-FACTOR MIDKINE; GENE-EXPRESSION; DIFFERENTIATED OSTEOBLASTS; P53 MUTATIONS; COPY-NUMBER; IN-VITRO; BETA; CANCER; INACTIVATION	Osteosarcoma (OS), a highly aggressive primary bone tumor, belongs to the most common solid tumors in growing children. Since specific molecular targets for OS treatment remain to be identified, surgical resection combined with multimodal (neo-) adjuvant chemotherapy is still the only way to help respective individuals. We have previously identified the protein tyrosine phosphatase Rptp zeta as a marker of terminally differentiated osteoblasts, which negatively regulates their proliferation in vitro. Here we have addressed the question if Rptp zeta can function as a tumor suppressor protein inhibiting OS development in vivo. We therefore analyzed the skeletal phenotype of mice lacking Ptprz1, the gene encoding Rptp zeta on a tumor-prone genetic background, i.e. Trp53-heterozygosity. By screening a large number of 52 week old Trp53-heterozygous mice by contact radiography we found that Ptprz1-deficiency significantly enhanced OS development with 19% of the mice being affected. The tumors in Ptprz1-deficient Trp53-heterozygous mice were present in different locations (spine, long bones, ribs), and their OS nature was confirmed by undecalcified histology. Likewise, cell lines derived from the tumors were able to undergo osteogenic differentiation ex vivo. A comparison between Ptprz1-heterozygous and Ptprz1-deficient cultures further revealed that the latter ones displayed increased proliferation, a higher abundance of tyrosine-phosphorylated proteins and resistance towards the influence of the growth factor Midkine. Our findings underscore the relevance of Rptp zeta as an attenuator of proliferation in differentiated osteoblasts and raise the possibility that activating Rptp zeta-dependent signaling could specifically target osteoblastic tumor cells.	[Baldauf, Christina; Jeschke, Anke; Kanbach, Vincent; Catala-Lehnen, Philip; Amling, Michael; Schinke, Thorsten] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, D-20246 Hamburg, Germany; [Baumhoer, Daniel] Univ Basel Hosp, Bone Tumor Reference Ctr, CH-4031 Basel, Switzerland; [Baumhoer, Daniel] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland; [Gerull, Helwe; Buhs, Sophia; Nollau, Peter] Univ Med Ctr Hamburg Eppendorf, Res Inst Childrens Canc Ctr, D-20246 Hamburg, Germany; [Gerull, Helwe; Buhs, Sophia; Nollau, Peter] Univ Med Ctr Hamburg Eppendorf, Clin Pediat Hematol & Oncol, D-20246 Hamburg, Germany; [Harroch, Sheila] Inst Pasteur, Dept Neurosci, F-75624 Paris, France	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Basel; University of Basel; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Schinke, T (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, D-20246 Hamburg, Germany.	schinke@uke.de		Catala-Lehnen, Philip/0000-0001-5475-6741	Deutsche Forschungsgemeinschaft [AM103/10-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding: This work was supported by a grant from the Deutsche Forschungsgemeinschaft (AM103/10-3; www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers J, 2013, J CELL BIOL, V200, P537, DOI 10.1083/jcb.201207142; Allison Daniel C., 2012, Sarcoma, V2012, P704872, DOI 10.1155/2012/704872; Anninga JK, 2011, EUR J CANCER, V47, P2431, DOI 10.1016/j.ejca.2011.05.030; Bacci G, 2003, CANCER, V97, P3068, DOI 10.1002/cncr.11456; BARNEA G, 1994, CELL, V76, P205, DOI 10.1016/0092-8674(94)90328-X; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Botter SM, 2014, CURR OPIN PHARMACOL, V16, P15, DOI 10.1016/j.coph.2014.02.002; Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232; Chen X, 2014, CELL REP, V7, P104, DOI 10.1016/j.celrep.2014.03.003; Cleton-Jansen AM, 2009, BRIT J CANCER, V101, P1909, DOI 10.1038/sj.bjc.6605405; David JP, 2005, J CLIN INVEST, V115, P664, DOI 10.1172/JCI200522877; Diamantopoulou Z, 2012, J BIOL CHEM, V287, P40339, DOI 10.1074/jbc.M112.405852; Faissner A, 2006, ADV EXP MED BIOL, V557, P25; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Gokgoz N, 2001, CANCER, V92, P2181, DOI 10.1002/1097-0142(20011015)92:8<2181::AID-CNCR1561>3.0.CO;2-3; GRIGORIADIS AE, 1993, J CELL BIOL, V122, P685, DOI 10.1083/jcb.122.3.685; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harroch S, 2000, MOL CELL BIOL, V20, P7706, DOI 10.1128/MCB.20.20.7706-7715.2000; Harroch S, 2002, NAT GENET, V32, P411, DOI 10.1038/ng1004; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kadomatsu K, 2013, J BIOCHEM, V153, P511, DOI 10.1093/jb/mvt035; Kansara M, 2014, NAT REV CANCER, V14, P722, DOI 10.1038/nrc3838; Kansara M, 2009, J CLIN INVEST, V119, P837, DOI 10.1172/JCI37175; Kleihues P, 1997, AM J PATHOL, V150, P1; Klein MJ, 2006, AM J CLIN PATHOL, V125, P555, DOI 10.1309/UC6KQHLD9LV2KENN; Kresse SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048262; Kresse SH, 2009, GENE CHROMOSOME CANC, V48, P679, DOI 10.1002/gcc.20675; Kuijjer ML, 2013, INT J CANCER, V133, P2512, DOI 10.1002/ijc.28124; Kuijjer ML, 2012, GENE CHROMOSOME CANC, V51, P696, DOI 10.1002/gcc.21956; Lamprianou S, 2011, P NATL ACAD SCI USA, V108, P17498, DOI 10.1073/pnas.1108774108; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Lietman Steven A, 2010, Cleve Clin J Med, V77 Suppl 1, pS8, DOI 10.3949/ccjm.77.s1.02; Lockwood WW, 2011, J MOL DIAGN, V13, P289, DOI 10.1016/j.jmoldx.2010.11.020; Machida Kazuya, 2012, Genes Cancer, V3, P353, DOI 10.1177/1947601912459048; Maeda N, 1999, J BIOL CHEM, V274, P12474, DOI 10.1074/jbc.274.18.12474; Maehara H, 2007, BIOCHEM BIOPH RES CO, V358, P757, DOI 10.1016/j.bbrc.2007.04.183; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Man TK, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-45; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Mirabello L, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv101; Musselman JRB, 2012, INT J MOL EPIDEMIOL, V3, P286; Nishiwaki T, 1998, J BIOCHEM-TOKYO, V123, P458; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Ottaviano L, 2010, GENE CHROMOSOME CANC, V49, P40, DOI 10.1002/gcc.20717; Pakos EE, 2009, EUR J CANCER, V45, P2367, DOI 10.1016/j.ejca.2009.03.005; Pariser H, 2005, BIOCHEM BIOPH RES CO, V335, P232, DOI 10.1016/j.bbrc.2005.07.060; Pasic I, 2010, CANCER RES, V70, P160, DOI 10.1158/0008-5472.CAN-09-1902; Peles E, 1998, TRENDS BIOCHEM SCI, V23, P121, DOI 10.1016/S0968-0004(98)01195-5; Sadikovic B, 2009, HUM MOL GENET, V18, P1962, DOI 10.1093/hmg/ddp117; Sadikovic B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002834; Savage SA, 2013, NAT GENET, V45, P799, DOI 10.1038/ng.2645; Savage Sharon A., 2011, Sarcoma, V2011, P548151, DOI 10.1155/2011/548151; Schinke T, 2008, BONE, V42, P524, DOI 10.1016/j.bone.2007.11.009; Schulze J, 2011, J BONE MINER RES, V26, P704, DOI 10.1002/jbmr.269; Schweigel H, 2013, PROTEOMICS, V13, P1016, DOI 10.1002/pmic.201200353; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Sueyoshi T, 2012, CANCER LETT, V316, P23, DOI 10.1016/j.canlet.2011.10.013; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Yang JL, 2011, CANCER-AM CANCER SOC, V117, P4925, DOI 10.1002/cncr.26116	63	7	7	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137745	10.1371/journal.pone.0137745	http://dx.doi.org/10.1371/journal.pone.0137745			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360410	Green Submitted, Green Published, gold			2022-12-26	WOS:000361043100079
J	Grams, ST; Kimoto, KYM; Azevedo, EMD; Lanca, M; de Albuquerque, ALP; de Brito, CMM; Yamaguti, WP				Grams, Samantha Torres; Mota Kimoto, Karen Yumi; de Oliveira Azevedo, Elen Moda; Lanca, Marina; Pereira de Albuquerque, Andre Luis; Moran de Brito, Christina May; Yamaguti, Wellington Pereira			Unidirectional Expiratory Valve Method to Assess Maximal Inspiratory Pressure in Individuals without Artificial Airway	PLOS ONE			English	Article							RESPIRATORY PRESSURES; REFERENCE VALUES; MANEUVERS; TESTS; AGE	Introduction Maximal Inspiratory Pressure (MIP) is considered an effective method to estimate strength of inspiratory muscles, but still leads to false positive diagnosis. Although MIP assessment with unidirectional expiratory valve method has been used in patients undergoing mechanical ventilation, no previous studies investigated the application of this method in subjects without artificial airway. Objectives This study aimed to compare the MIP values assessed by standard method (MIPsta) and by unidirectional expiratory valve method (MIPuni) in subjects with spontaneous breathing without artificial airway. MIPuni reproducibility was also evaluated. Methods This was a crossover design study, and 31 subjects performed MIPsta and MIPuni in a random order. MIPsta measured MIP maintaining negative pressure for at least one second after forceful expiration. MIPuni evaluated MIP using a unidirectional expiratory valve attached to a face mask and was conducted by two evaluators (A and B) at two moments (Tests 1 and 2) to determine interobserver and intraobserver reproducibility of MIP values. Intraclass correlation coefficient (ICC[2,1]) was used to determine intraobserver and interobserver reproducibility. Results The mean values for MIPuni were 14.3% higher (-117.3 +/- 24.8 cmH(2)O) than the mean values for MIPsta (-102.5 +/- 23.9 cmH(2)O) (p<0.001). Interobserver reproducibility assessment showed very high correlation for Test 1 (ICC[2,1] = 0.91), and high correlation for Test 2 (ICC[2,1] = 0.88). The assessment of the intraobserver reproducibility showed high correlation for evaluator A (ICC[2,1] = 0.86) and evaluator B (ICC[2,1] = 0.77). Conclusions MIPuni presented higher values when compared with MIPsta and proved to be reproducible in subjects with spontaneous breathing without artificial airway.	[Grams, Samantha Torres; Mota Kimoto, Karen Yumi; de Oliveira Azevedo, Elen Moda; Lanca, Marina; Pereira de Albuquerque, Andre Luis; Moran de Brito, Christina May; Yamaguti, Wellington Pereira] HSL, Dept Rehabil, Sao Paulo, SP, Brazil; [Pereira de Albuquerque, Andre Luis] HSL, NAT, Dept Pulm Funct, Sao Paulo, SP, Brazil		Yamaguti, WP (corresponding author), HSL, Dept Rehabil, Sao Paulo, SP, Brazil.	wellington.psyamaguti@hsl.org.br	Brito, Christina M/I-7269-2012; Albuquerque, Andre L P/C-8835-2012	Albuquerque, Andre L P/0000-0003-3486-5240				Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; BLACK LF, 1969, AM REV RESPIR DIS, V99, P696; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Caruso P, 1999, CHEST, V115, P1096, DOI 10.1378/chest.115.4.1096; Costa D, 2010, J BRAS PNEUMOL, V36, P306, DOI 10.1590/S1806-37132010000300007; FEELEY TW, 1975, NEW ENGL J MED, V292, P903, DOI 10.1056/NEJM197504242921707; Fiore Junior Julio Flavio, 2004, J. bras. pneumol., V30, P515, DOI 10.1590/S1806-37132004000600005; FIZ JA, 1989, THORAX, V44, P419, DOI 10.1136/thx.44.5.419; Fregonezi GAD, 2005, CHEST, V128, P1524, DOI 10.1378/chest.128.3.1524; Gayraud J, 2010, PEDIATR PULM, V45, P552, DOI 10.1002/ppul.21204; Gosselink R, 2011, EUR RESPIR J, V37, P416, DOI 10.1183/09031936.00031810; Grant S, 1999, CHEST, V116, P1208, DOI 10.1378/chest.116.5.1208; Lin Suh-Jen, 2012, Cardiopulm Phys Ther J, V23, P29; MARINI J J, 1986, Journal of Critical Care, V1, P32, DOI 10.1016/S0883-9441(86)80114-9; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Munro, 1997, STAT METHODS HLTH CA; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P719, DOI 10.1590/S0100-879X1999000600007; Parreira VF, 2007, BRAZ J PHYS THER, V11, P361, DOI 10.1590/S1413-35552007000500006; Parreira VF, 2012, BRAZ J PHYS THER, V16, P225, DOI 10.1590/S1413-35552012000300008; Pereira Carlos Alberto de Castro, 2007, J. bras. pneumol., V33, P397, DOI 10.1590/S1806-37132007000400008; SAHN SA, 1973, CHEST, V63, P1002, DOI 10.1378/chest.63.6.1002; SMYTH RJ, 1984, CHEST, V86, P568, DOI 10.1378/chest.86.4.568; Souza RB, 2002, J PNEUMOL S3, V28, P155; Steier J, 2007, THORAX, V62, P975, DOI 10.1136/thx.2006.072884; Terzano C, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-8; TRUWIT JD, 1992, CHEST, V102, P1216, DOI 10.1378/chest.102.4.1216; Tzanis G, 2011, BMC ANESTHESIOL, V11, DOI 10.1186/1471-2253-11-14; Wen AS, 1997, CHEST, V111, P802, DOI 10.1378/chest.111.3.802; Wohlgemuth M, 2003, EUR RESPIR J, V22, P1001, DOI 10.1183/09031936.03.00028103; Yamaguti WPS, 2004, REV BRAS TER INTENSI, V16, P142	30	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137825	10.1371/journal.pone.0137825	http://dx.doi.org/10.1371/journal.pone.0137825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360255	Green Published, gold, Green Submitted			2022-12-26	WOS:000361043100090
J	Kreisinger, J; Cizkova, D; Kropackova, L; Albrecht, T				Kreisinger, Jakub; Cizkova, Dagmar; Kropackova, Lucie; Albrecht, Tomas			Cloacal Microbiome Structure in a Long-Distance Migratory Bird Assessed Using Deep 16sRNA Pyrosequencing	PLOS ONE			English	Article							GUT MICROBIOME; GASTROINTESTINAL MICROBIOTA; EVOLUTION; BACTERIA; DIVERSITY; DIET; WILD; ASSEMBLAGES; COMMUNITIES; POPULATIONS	Effects of vertebrate-associated microbiota on physiology and health are of significant interest in current biological research. Most previous studies have focused on host-microbiota interactions in captive-bred mammalian models. These interactions and their outcomes are still relatively understudied, however, in wild populations and non-mammalian taxa. Using deep pyrosequencing, we described the cloacal microbiome (CM) composition in free living barn swallows Hirundo rustica, a long-distance migratory passerine bird. Barn swallow CM was dominated by bacteria of the Actinobacteria, Proteobacteria and Firmicutes phyla. Bacteroidetes, which represent an important proportion of the digestive tract microbiome in many vertebrate species, was relatively rare in barn swallow CM (< 5%). CM composition did not differ between males and females. A significant correlation of CM within breeding pair members is consistent with the hypothesis that cloacal contact during within-pair copulation may promote transfer of bacterial assemblages. This effect on CM composition had a relatively low effect size, however, possibly due to the species' high level of sexual promiscuity.	[Kreisinger, Jakub; Cizkova, Dagmar; Albrecht, Tomas] Acad Sci Czech Republ, Inst Vertebrate Biol, Studenec Res Facil, CS-60365 Brno, Czech Republic; [Kreisinger, Jakub; Kropackova, Lucie; Albrecht, Tomas] Charles Univ Prague, Fac Sci, Dept Zool, CR-12844 Prague 2, Czech Republic; [Kreisinger, Jakub] Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, I-38010 San Michele All Adige, TN, Italy	Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; Charles University Prague; Fondazione Edmund Mach	Kreisinger, J (corresponding author), Acad Sci Czech Republ, Inst Vertebrate Biol, Studenec Res Facil, Kvetna 8, CS-60365 Brno, Czech Republic.	jakubkreisinger@seznam.cz	Kreisinger, Jakub/H-4020-2011; Schmiedová, Lucie/S-3351-2017; Albrecht, Tomas/A-1130-2011	Schmiedová, Lucie/0000-0003-2180-5281; Albrecht, Tomas/0000-0002-9213-0034; Cizkova, Dagmar/0000-0001-5031-7792	Czech Science foundation [P506/12/2472, 14-16596P]; OPVK [CZ.1.07/2.3.00/20.0303]; Czech Academy of Sciences ("Operacni Program pro Vzdelavani a Konkurenceschopnost") [RVO:68081766]; SVV ("Specificky Vysokoskolsky Vyzkum") [260 087/2014]	Czech Science foundation(Grant Agency of the Czech Republic); OPVK; Czech Academy of Sciences ("Operacni Program pro Vzdelavani a Konkurenceschopnost"); SVV ("Specificky Vysokoskolsky Vyzkum")	Field works were funded by Czech Science foundation project P506/12/2472 (http://www.gacr.cz/). Wet-lab procedures and data analyses were funded by Czech Science foundation project 14-16596P. Jakub Kreisinger and Dagmar Cizkova were partially supported by OPVK CZ.1.07/2.3.00/20.0303 and by institutional funding of the Czech Academy of Sciences RVO:68081766 ("Operacni Program pro Vzdelavani a Konkurenceschopnost", http://www.ivb.cz/projekty-nextgenproject-technologie-nove-generace-v-evolucni-genetice.html). Lucie Kropackova was supported by SVV 260 087/2014 ("Specificky Vysokoskolsky Vyzkum", http://www.cuni.cz/UK-3362.html). All these funders are non-commercial. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Banks JC, 2009, ENVIRON MICROBIOL, V11, P577, DOI 10.1111/j.1462-2920.2008.01816.x; Bendtsen KMB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046231; Benskin CMH, 2010, MOL ECOL, V19, P5531, DOI 10.1111/j.1365-294X.2010.04892.x; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Bunge J, 2012, BIOINFORMATICS, V28, P1045, DOI 10.1093/bioinformatics/bts075; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cepak J, 2008, ATLAS MIGRACE PTAKU; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Chervonsky AV, 2012, CURR OPIN IMMUNOL, V24, P255, DOI 10.1016/j.coi.2012.03.002; Cho EJ, 2013, ANN LAB MED, V33, P145, DOI 10.3343/alm.2013.33.2.145; Cordaux R, 2007, APPL ENVIRON MICROB, V73, P5045, DOI 10.1128/AEM.00378-07; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cunningham EJA, 2003, BEHAV ECOL, V14, P326, DOI 10.1093/beheco/14.3.326; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dewar ML, 2013, MICROBIOLOGYOPEN, V2, P195, DOI 10.1002/mbo3.66; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; Gareau MG, 2011, GUT, V60, P307, DOI 10.1136/gut.2009.202515; Godoy-Vitorino F, 2012, RES MICROBIOL, V163, P211, DOI 10.1016/j.resmic.2012.01.001; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Hannigan GD, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015362; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Koch H, 2011, MICROB ECOL, V62, P121, DOI 10.1007/s00248-011-9854-3; Kokko H, 2002, EVOLUTION, V56, P1091; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Kreisinger J, 2014, MOL ECOL, V23, P5048, DOI 10.1111/mec.12909; Kulkarni S, 2007, BEHAV PROCESS, V74, P88, DOI 10.1016/j.beproc.2006.10.005; Laskemoen T, 2013, BEHAV ECOL SOCIOBIOL, V67, P301, DOI 10.1007/s00265-012-1450-0; Lee JH, 2012, J MICROBIOL, V50, P181, DOI 10.1007/s12275-012-1214-6; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lombardo MP, 2008, BEHAV ECOL SOCIOBIOL, V62, P479, DOI 10.1007/s00265-007-0428-9; Lombardo MP, 1999, BEHAV ECOL, V10, P333, DOI 10.1093/beheco/10.3.333; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lucas FS, 2005, J AVIAN BIOL, V36, P510, DOI 10.1111/j.0908-8857.2005.03479.x; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Mathis D, 2011, CELL HOST MICROBE, V10, P297, DOI 10.1016/j.chom.2011.09.007; May A, 2014, BIOINFORMATICS, V30, P1530, DOI 10.1093/bioinformatics/btu085; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Moller AP., 1994, SEXUAL SELECTION BAR; Moran NA, 2005, APPL ENVIRON MICROB, V71, P3302, DOI 10.1128/AEM.71.6.3302-3310.2005; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nelson TM, 2013, ENVIRON MICROBIOL, V15, P1132, DOI 10.1111/1462-2920.12022; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Poiani A, 2000, AUK, V117, P1061, DOI 10.1642/0004-8038(2000)117[1061:STDAPC]2.0.CO;2; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; R Core Team, 2021, R LANGUAGE ENV STAT; Roggenbuck M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6498; Rubolini D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048955; Safran RJ, 2008, CURR BIOL, V18, pR461, DOI 10.1016/j.cub.2008.03.031; Saino N, 1997, FUNCT ECOL, V11, P604, DOI 10.1046/j.1365-2435.1997.00131.x; Saino N, 2004, P ROY SOC B-BIOL SCI, V271, P681, DOI 10.1098/rspb.2003.2656; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Shaw DJ, 1995, PARASITOLOGY, V111, pS111, DOI 10.1017/S0031182000075855; Skraban J, 2013, VET MICROBIOL, V165, P416, DOI 10.1016/j.vetmic.2013.04.014; SMITH HG, 1992, CONDOR, V94, P750, DOI 10.2307/1369260; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Toth EM, 2008, INT J SYST EVOL MICR, V58, P976, DOI 10.1099/ijs.0.65324-0; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Videnska P, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-140; Waite DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035803; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022339; White J, 2010, ECOL LETT, V13, P1515, DOI 10.1111/j.1461-0248.2010.01542.x; Xu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056565; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347	78	53	53	1	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137401	10.1371/journal.pone.0137401	http://dx.doi.org/10.1371/journal.pone.0137401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360776	gold, Green Published, Green Submitted			2022-12-26	WOS:000361043100033
J	Louise, C; Vidal, PO; Suesdek, L				Louise, Caroline; Vidal, Paloma Oliveira; Suesdek, Lincoln			Microevolution of Aedes aegypti	PLOS ONE			English	Article							DIPTERA-CULICIDAE POPULATIONS; GENETIC-STRUCTURE; MOSQUITO VECTOR; WING GEOMETRY; DENGUE; PHYLOGEOGRAPHY; ANOPHELES; SOFTWARE; NUMBER; SHAPE	Scientific research into the epidemiology of dengue frequently focuses on the microevolution and dispersion of the mosquito Aedes aegypti. One of the world's largest urban agglomerations infested by Ae. aegypti is the Brazilian megalopolis of Sao Paulo, where >26,900 cases of dengue were reported until June 2015. Unfortunately, the dynamics of the genetic variability of Ae. aegypti in the Sao Paulo area have not been well studied. To reduce this knowledge gap, we assessed the morphogenetic variability of a population of Ae. aegypti from a densely urbanised neighbourhood of Sao Paulo. We tested if allelic patterns could vary over a short term and if wing shape could be a predictor of the genetic variation. Over a period of 14 months, we examined the variation of genetic (microsatellites loci) and morphological (wing geometry) markers in Ae. aegypti. Polymorphisms were detected, as revealed by the variability of 20 microsatellite loci (115 alleles combined; overall F-st = 0.0358) and 18 wing landmarks (quantitative estimator Q(st) = 0.4732). These levels of polymorphism are higher than typically expected to an exotic species. Allelic frequencies of the loci changed over time and temporal variation in the wing shape was even more pronounced, permitting high reclassification levels of chronological samples. In spite of the fact that both markers underwent temporal variation, no correlation was detected between their dynamics. We concluded that microevolution was detected despite the short observational period, but the intensities of change of the markers were discrepant. Wing shape failed from predicting allelic temporal variation. Possibly, natural selection (Q(st)>F-st) or variance of expressivity of wing phenotype are involved in this discrepancy. Other possibly influential factors on microevolution of Ae. aegypti are worth searching. Additionally, the implications of the rapid evolution and high polymorphism of this mosquito vector on the efficacy of control methods have yet to be investigated.	[Louise, Caroline; Vidal, Paloma Oliveira; Suesdek, Lincoln] Inst Butantan, Lab Parasitol, Sao Paulo, SP, Brazil; [Louise, Caroline; Suesdek, Lincoln] Univ Sao Paulo, Inst Med Trop, Programa Posgrad Med Trop, Sao Paulo, SP, Brazil; [Vidal, Paloma Oliveira] Univ Sao Paulo, Inst Ciencias Biomed, Programa Posgrad Biol Relacao Patogenohosp, BR-05508 Sao Paulo, SP, Brazil	Instituto Butantan; Universidade de Sao Paulo; Universidade de Sao Paulo	Suesdek, L (corresponding author), Inst Butantan, Lab Parasitol, Sao Paulo, SP, Brazil.	lincoln.suesdek@butantan.gov.br	Suesdek, Lincoln/C-7943-2013	Suesdek, Lincoln/0000-0001-6829-738X	FAPESP [2011/18962-8, 2010/15039-1]; CAPES [23038.005274/2011-24, 1275/2011]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by FAPESP Grants 2011/18962-8 (CL) and 2010/15039-1 (POV) and CAPES Grants #23038.005274/2011-24 and #1275/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mendonca BAA, 2014, ACTA TROP, V134, P80, DOI 10.1016/j.actatropica.2014.02.014; Belkhir K, 1996, 5171 CNRS UMR U MONT; Bookstein FL, 1991, MORPHOMETRIC TOOLS L; Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469; Brown JE, 2013, J MED ENTOMOL, V50, P294, DOI 10.1603/ME12173; Wilke ABB, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0468-8; Calle DA, 2002, MEM I OSWALDO CRUZ, V97, P1191, DOI 10.1590/S0074-02762002000800021; Campos M, 2012, ECOL EVOL, V2, P2794, DOI 10.1002/ece3.392; Cator LJ, 2009, SCIENCE, V323, P1077, DOI 10.1126/science.1166541; Chambers EW, 2007, J HERED, V98, P202, DOI 10.1093/jhered/esm015; Delatte H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002111; Demari-Silva B, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-174; Dujardin JP, 2008, INFECT GENET EVOL, V8, P875, DOI 10.1016/j.meegid.2008.07.011; Dujardin JP, 2006, THE CLICK PACKAGE; Endersby NM, 2011, J MED ENTOMOL, V48, P999, DOI 10.1603/ME10264; Epstein PR, 2000, SCI AM, V283, P50, DOI 10.1038/scientificamerican0800-50; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fonseca DM, 2010, MOL ECOL, V19, P1559, DOI 10.1111/j.1365-294X.2010.04576.x; Forattini OP, 2002, CULICIDOLOGIA MED; Gloria-Soria A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003029; Henry A, 2010, INFECT GENET EVOL, V10, P207, DOI 10.1016/j.meegid.2009.12.001; Herrera F, 2006, MEM I OSWALDO CRUZ, V101, P625, DOI 10.1590/S0074-02762006000600008; Huber K, 2001, MOL ECOL NOTES, V1, P219, DOI 10.1046/j.1471-8278.2001.00077.x; Jirakanjanakit N, 2007, TROP MED INT HEALTH, V12, P1354, DOI 10.1111/j.1365-3156.2007.01919.x; Jirakanjanakit N, 2008, INFECT GENET EVOL, V8, P414, DOI 10.1016/j.meegid.2007.05.004; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; KLACZKO LB, 1990, NATURE, V346, P321, DOI 10.1038/346321a0; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; Monteiro FA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003167; Motoki MT, 2012, INFECT GENET EVOL, V12, P1246, DOI 10.1016/j.meegid.2012.04.002; NEI M, 1974, GENETICS, V76, P379; Olanratmanee P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001913; Paupy C, 2012, INFECT GENET EVOL, V12, P1260, DOI 10.1016/j.meegid.2012.04.012; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., 2014, FIGTREE V1 4 0 TREE; Rasheed SB, 2013, MED VET ENTOMOL, V27, P430, DOI 10.1111/mve.12001; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; ROHLF F, 2005, TPSREGR; Rohlf F.J., 2010, TPSUTIL; Rohlf FJ, 2018, TPSDIG; Rohlf FJ, 2010, TPSRELW; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vargas REM, 2013, INFECT GENET EVOL, V13, P242, DOI 10.1016/j.meegid.2012.08.008; Vidal PO, 2012, INFECT GENET EVOL, V12, P591, DOI 10.1016/j.meegid.2011.11.013; Vidal PO, 2012, MEM I OSWALDO CRUZ, V107, P1030, DOI 10.1590/S0074-02762012000800011; da Costa-Ribeiro MCV, 2006, MEM I OSWALDO CRUZ, V101, P917, DOI 10.1590/S0074-02762006000800015; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitlock MC, 1999, GENET RES, V74, P215, DOI 10.1017/S0016672399004127	53	35	36	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137851	10.1371/journal.pone.0137851	http://dx.doi.org/10.1371/journal.pone.0137851			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360876	gold, Green Submitted, Green Published			2022-12-26	WOS:000361043100094
J	Alsharari, SD; King, JR; Nordman, JC; Muldoon, PP; Jackson, A; Zhu, AZX; Tyndale, RF; Kabbani, N; Damaj, MI				Alsharari, Shakir D.; King, Justin R.; Nordman, Jacob C.; Muldoon, Pretal P.; Jackson, Asti; Zhu, Andy Z. X.; Tyndale, Rachel F.; Kabbani, Nadine; Damaj, M. Imad			Effects of Menthol on Nicotine Pharmacokinetic, Pharmacology and Dependence in Mice	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTORS; CIGARETTE SMOKERS; SMOKING-CESSATION; AFRICAN-AMERICAN; UP-REGULATION; INHIBITION; ABSTINENCE	Although menthol, a common flavoring additive to cigarettes, has been found to impact the addictive properties of nicotine cigarettes in smokers little is known about its pharmacological and molecular actions in the brain. Studies were undertaken to examine whether the systemic administration of menthol would modulate nicotine pharmacokinetics, acute pharmacological effects (antinociception and hypothermia) and withdrawal in male ICR mice. In addition, we examined changes in the brain levels of nicotinic receptors of rodents exposed to nicotine and menthol. Administration of i. p. menthol significantly decreased nicotine's clearance (2-fold decrease) and increased its AUC compared to i. p. vehicle treatment. In addition, menthol pretreatment prolonged the duration of nicotine-induced antinociception and hypothermia (2.5 mg/kg, s. c.) for periods up to 180 min post-nicotine administration. Repeated administration of menthol with nicotine increased the intensity of mecamylamine-precipitated withdrawal signs in mice exposed chronically to nicotine. The potentiation of withdrawal intensity by menthol was accompanied by a significant increase in nicotine plasma levels in these mice. Western blot analyses of alpha 4 and beta 2 nAChR subunit expression suggests that chronic menthol impacts the levels and distribution of these nicotinic subunits in various brain regions. In particular, co-administration of menthol and nicotine appears to promote significant increase in beta 2 and alpha 4 nAChR subunit expression in the hippocampus, prefrontal cortex and striatum of mice. Surprisingly, chronic injections of menthol alone to mice caused an upregulation of beta 2 and alpha 4 nAChR subunit levels in these brain regions. Because the addition of menthol to tobacco products has been suggested to augment their addictive potential, the current findings reveal several new pharmacological molecular adaptations that may contribute to its unique addictive profile.	[Alsharari, Shakir D.] King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, Riyadh, Saudi Arabia; [Alsharari, Shakir D.; Muldoon, Pretal P.; Jackson, Asti; Damaj, M. Imad] Virginia Commonwealth Univ, Med Coll Virginia, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; [King, Justin R.; Nordman, Jacob C.; Kabbani, Nadine] George Mason Univ, Krasnow Inst Adv Study, Dept Mol Neurosci, Fairfax, VA 22030 USA; [Zhu, Andy Z. X.; Tyndale, Rachel F.] Univ Toronto, Dept Pharmacol & Toxicol & Psychiat, Campbell Family Mental Hlth Res Inst, CAMH, Toronto, ON, Canada	King Saud University; Virginia Commonwealth University; George Mason University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Kabbani, N (corresponding author), George Mason Univ, Krasnow Inst Adv Study, Dept Mol Neurosci, Fairfax, VA 22030 USA.	nkabbani@gmu.edu	AlSharari, Shakir/AAC-9103-2020	Nordman, Jacob/0000-0003-2513-7831; Tyndale, Rachel/0000-0003-1297-2053	National Institute on Drug Abuse [DA-05274, DA020830]; Endowed Chair in Addiction for the Department of Psychiatry; Canadian Institutes of Health Research [MOP86471, TMH109787]; Centre for Addiction and Mental Health (CAMH) foundation; Canada Foundation for Innovation [20289, 16014]; Ontario Ministry of Research and Innovation; Virginia Foundation for Healthy Youth; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA020830, P30DA033934, T32DA007027] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Endowed Chair in Addiction for the Department of Psychiatry; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Centre for Addiction and Mental Health (CAMH) foundation; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Virginia Foundation for Healthy Youth; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute on Drug Abuse grant # DA-05274 (MID), DA020830 (RFT), http://www.drugabuse.gov/; the Endowed Chair in Addiction for the Department of Psychiatry (RFT), http://www.psychiatry.utoronto.ca/endowed-chairs/; Canadian Institutes of Health Research (MOP86471 and TMH109787) (RFT), http://www.cihr-irsc.gc.ca/e/193.html; Centre for Addiction and Mental Health (CAMH) foundation (RFT), www.camh.ca; the Canada Foundation for Innovation (#20289 and #16014) (RFT), http://www.innovation.ca/; the Ontario Ministry of Research and Innovation (RFT), https://www.ontario.ca/ministry-research-innovation; and Virginia Foundation for Healthy Youth (NK), http://www.vfhy.org/.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Ashoor A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067674; Bagdas D, 2014, NEUROPHARMACOLOGY, V85, P67, DOI 10.1016/j.neuropharm.2014.05.006; Benowitz NL, 2008, CLIN PHARMACOL THER, V83, P531, DOI 10.1038/clpt.2008.3; Benowitz NL, 2004, J PHARMACOL EXP THER, V310, P1208, DOI 10.1124/jpet.104.066902; Brody AL, 2013, INT J NEUROPSYCHOPH, V16, P957, DOI 10.1017/S1461145712001022; Cosgrove KP, 2009, ARCH GEN PSYCHIAT, V66, P666, DOI 10.1001/archgenpsychiatry.2009.41; Dessirier JM, 2001, PHYSIOL BEHAV, V73, P25, DOI 10.1016/S0031-9384(01)00431-0; Gandhi KK, 2009, INT J CLIN PRACT, V63, P360, DOI 10.1111/j.1742-1241.2008.01969.x; Govind AP, 2009, BIOCHEM PHARMACOL, V78, P756, DOI 10.1016/j.bcp.2009.06.011; Hans M, 2012, CHEM SENSES, V37, P463, DOI 10.1093/chemse/bjr128; Hogg RC, 2003, REV PHYSIOL BIOCH P, V147, P1, DOI 10.1007/s10254-003-0005-1; Isola R, 1999, BRAIN RES, V850, P189, DOI 10.1016/S0006-8993(99)02131-9; Jackson KJ, 2008, J PHARMACOL EXP THER, V325, P302, DOI 10.1124/jpet.107.132977; Kabbani N, 2007, P NATL ACAD SCI USA, V104, P20570, DOI 10.1073/pnas.0710314104; Kramlinger VM, 2012, CHEM-BIOL INTERACT, V197, P87, DOI 10.1016/j.cbi.2012.03.009; MacDougall JM, 2003, CHEM RES TOXICOL, V16, P988, DOI 10.1021/tx0340551; Okuyemi KS, 2007, ADDICTION, V102, P1979, DOI 10.1111/j.1360-0443.2007.02010.x; Pan R, 2012, J PHARMACOL EXP THER, V343, P661, DOI 10.1124/jpet.112.196717; Pletcher MJ, 2006, ARCH INTERN MED, V166, P1915, DOI 10.1001/archinte.166.17.1915; Ruskin D, 2008, NICOTINE TOB RES, V10, P1753, DOI 10.1080/14622200802443734; Turner JR, 2011, NICOTINE TOB RES, V13, P48, DOI 10.1093/ntr/ntq206; Williams JM, 2007, NICOTINE TOB RES, V9, P873, DOI 10.1080/14622200701484995; Willis DN, 2011, FASEB J, V25, P4434, DOI 10.1096/fj.11-188383	24	59	59	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137070	10.1371/journal.pone.0137070	http://dx.doi.org/10.1371/journal.pone.0137070			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355604	Green Published, Green Submitted, gold			2022-12-26	WOS:000360965800027
J	Zong, JW; Zhao, TT; Ma, QH; Liang, LS; Wang, GX				Zong, Jian-Wei; Zhao, Tian-Tian; Ma, Qing-Hua; Liang, Li-Song; Wang, Gui-Xi			Assessment of Genetic Diversity and Population Genetic Structure of Corylus mandshurica in China Using SSR Markers	PLOS ONE			English	Article							AVELLANA L. CULTIVARS; MICROSATELLITE MARKERS; LINKAGE MAP; HAZELNUT; SOFTWARE; TRANSFERABILITY; GERMPLASM; ALLELES; SHANXI; NUMBER	Corylus mandshurica, also known as pilose hazelnut, is an economically and ecologically important species in China. In this study, ten polymorphic simple sequence repeat (SSR) markers were applied to evaluate the genetic diversity and population structure of 348 C. mandshurica individuals among 12 populations in China. The SSR markers expressed a relatively high level of genetic diversity (Na = 15.3, Ne = 5.6604, I = 1.8853, Ho = 0.6668, and He = 0.7777). According to the coefficient of genetic differentiation (F-st = 0.1215), genetic variation within the populations (87.85%) were remarkably higher than among populations (12.15%). The average gene flow (Nm = 1.8080) significantly impacts the genetic structure of C. mandshurica populations. The relatively high gene flow (Nm = 1.8080) among wild C. mandshurica may be caused by wind-pollinated flowers, highly nutritious seeds and self-incompatible mating system. The UPGMA (unweighted pair group method of arithmetic averages) dendrogram was divided into two main clusters. Moreover, the results of STRUCTURE analysis suggested that C. mandshurica populations fell into two main clusters. Comparison of the UPGMA dendrogram and the Bayesian STRUCTURE analysis showed general agreement between the population subdivisions and the genetic relationships among populations of C. mandshurica. Group I accessions were located in Northeast China, while Group II accessions were in North China. It is worth noting that a number of genetically similar populations were located in the same geographic region. The results further showed that there was obvious genetic differentiation among populations from Northeast China to North China. Results from the Mantel test showed a weak but still significant positive correlation between Nei's genetic distance and geographic distance (km) among populations (r = 0.419, P = 0.005), suggesting that genetic differentiation in the 12 C. mandshurica populations might be related to geographic distance. These data provide comprehensive information for the development of conservation strategies of these valuable hazelnut resources.	[Zong, Jian-Wei; Zhao, Tian-Tian; Ma, Qing-Hua; Liang, Li-Song; Wang, Gui-Xi] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; [Zong, Jian-Wei] Pingdingshan Univ, Coll Resource & Environm Sci, Pingdingshan, Henan Province, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Pingdingshan University	Zhao, TT (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China.	Zhaotian1984@163.com; Wanggx0114@126.com		Zhao, Tiantian/0000-0003-2700-5314	Beijing Municipal Natural Science Foundation [6144030]; Special Fund from State Forestry Administration in the Public Interest [201304710]; Special Fund for Basic Scientific Research Business of Central Public Research Institutes [RIF2013-10]	Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Special Fund from State Forestry Administration in the Public Interest; Special Fund for Basic Scientific Research Business of Central Public Research Institutes	This work was supported by Beijing Municipal Natural Science Foundation (Grant No. 6144030, http://www.bjnsf.org/), the Special Fund from State Forestry Administration in the Public Interest (Grant No. 201304710, http://www.forestry.gov.cn/), and Special Fund for Basic Scientific Research Business of Central Public Research Institutes (Grant No. RIF2013-10, http://rif.caf.ac.cn/).	Bacchetta L, 2015, GENET RESOUR CROP EV, V62, P649, DOI 10.1007/s10722-014-0173-7; Bai WN, 2010, NEW PHYTOL, V188, P892, DOI 10.1111/j.1469-8137.2010.03407.x; Bassil NV, 2005, J AM SOC HORTIC SCI, V130, P543, DOI 10.21273/JASHS.130.4.543; Bassil NV, 2005, ACTA HORTIC, V686, P105, DOI DOI 10.17660/ACTAHORTIC.2005.686.13; Boccacci P, 2006, GENOME, V49, P598, DOI 10.1139/G06-017; Boccacci P, 2005, MOL ECOL NOTES, V5, P934, DOI 10.1111/j.1471-8286.2005.01121.x; Boccacci P, 2008, HORTSCIENCE, V43, P667, DOI 10.21273/HORTSCI.43.3.667; Boccacci P, 2010, SCI HORTIC-AMSTERDAM, V124, P128, DOI 10.1016/j.scienta.2009.12.015; Cheng Lili, 2009, Scientia Silvae Sinicae, V45, P22; Di XiaoiaoYao, 2014, Plant Omics, V7, P213; Doyle J. J., 1987, PHYTOCHEM B, P11; Editorial Board of flora of China, 1979, FLORA CHINA; Erfatpour M, 2011, AUST J CROP SCI, V5, P1286; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fritsch Peter, 1996, P54; Futuyma D. J., 1998, EVOLUTIONARY BIOL; Gerber S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085130; Gokirmak T, 2005, ACTA HORTIC, P141; Gurcan K, 2010, MOL BREEDING, V26, P551, DOI 10.1007/s11032-010-9464-7; Gurcan K, 2010, J AM SOC HORTIC SCI, V135, P159, DOI 10.21273/JASHS.135.2.159; Gurcan K, 2010, PLANT BREEDING, V129, P422, DOI 10.1111/j.1439-0523.2009.01753.x; Hamrick J. L., 1990, PLANT POPULATION GEN; KIMURA M, 1964, GENETICS, V49, P725; Levin D. A., 1974, EVOL BIOL, V7, P139, DOI DOI 10.1007/978-1-4615-6944-2_5; Li Shiming, 2010, MODERN MANAGEMENT SC, V12, P1; Liu HJ, 2013, J CHIN CERE OILS ASS, V28, P41; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Mayr Ernst, 1997, EVOLUTION DIVERSITY; Mehlenbacher SA, 2006, GENOME, V49, P122, DOI 10.1139/G05-091; Mohammadzedeh M, 2014, SCI HORTIC-AMSTERDAM, V167, P17, DOI 10.1016/j.scienta.2013.12.025; Muehlbauer MF, 2014, J AM SOC HORTIC SCI, V139, P399, DOI 10.21273/JASHS.139.4.399; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Rowland LJ, 2014, MOL BREEDING, V34, P2033, DOI 10.1007/s11032-014-0161-9; Sathuvalli VR, 2011, TREE GENET GENOMES, V7, P337, DOI 10.1007/s11295-010-0335-5; Sathuvalli VR, 2012, GENET RESOUR CROP EV, V59, P1055, DOI 10.1007/s10722-011-9743-0; Sharma PC, 2007, TRENDS BIOTECHNOL, V25, P490, DOI 10.1016/j.tibtech.2007.07.013; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; SLATKIN M, 1985, EVOLUTION, V39, P53, DOI 10.2307/2408516; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Valentini N, 2014, SCI HORTIC-AMSTERDAM, V165, P303, DOI 10.1016/j.scienta.2013.11.027; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang GX, 1992, SHANXI FOREST; Wang Y., 2008, THESIS BEIJING FORES; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Wu Z, 1995, VEGETATION IN CHINA; Zhang Peng-Fei, 2014, Plant Science Journal, V32, P131, DOI 10.3724/SP.J.1142.2014.20131; [张艳波 ZHANG Yanbo], 2007, [吉林农业科学, Journal of Jilin Agricultural Sciences], V32, P56; [赵娣 Zhao Di], 2012, [中国农学通报, Chinese Agricultural Science Bulletin], V28, P87	50	27	29	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137528	10.1371/journal.pone.0137528	http://dx.doi.org/10.1371/journal.pone.0137528			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355595	Green Published, Green Submitted, gold			2022-12-26	WOS:000360965800057
J	Bennabi, M; Delorme, R; Oliveira, J; Fortier, C; Lajnef, M; Boukouaci, W; Feugeas, JP; Marzais, F; Gaman, A; Charron, D; Ghaleh, B; Krishnamoorthy, R; Leboyer, M; Tamouza, R				Bennabi, Meriem; Delorme, Richard; Oliveira, Jose; Fortier, Catherine; Lajnef, Mohamed; Boukouaci, Wahid; Feugeas, Jean-Paul; Marzais, Francois; Gaman, Alexandru; Charron, Dominique; Ghaleh, Bijan; Krishnamoorthy, Rajagopal; Leboyer, Marion; Tamouza, Ryad			Dectin-1 Polymorphism: A Genetic Disease Specifier in Autism Spectrum Disorders?	PLOS ONE			English	Article							AUTOIMMUNE-DISEASES; INNATE IMMUNITY; FAMILY-HISTORY; CHILDREN; RECEPTOR; SYMPTOMS; RISK; HOSPITALIZATION; ABNORMALITIES; ASSOCIATION	Introduction In autism spectrum disorders (ASD), complex gene-environment interactions contribute to disease onset and progress. Given that gastro-intestinal dysfunctions are common in ASD, we postulated involvement of microbial dysbiosis in ASD and investigated, under a case-control design, the influence of DNA polymorphisms in the CLEC7A gene that encodes a pivotal fungal sensor, Dectin-1. Material and methods DNAs from 478 ASD patients and 351 healthy controls (HC) were analyzed for the CLEC7A rs16910631G/A and rs2078178 A/G single nucleotide polymorphisms (SNPs). Differences in the distribution of allele, genotype and haplotype by Chi-square testing and nonparametric analysis by Kruskal-Wallis/Mann-Whitney tests, where appropriate, were performed. The free statistical package R. 2.13 software was used for the statistical analysis. Results We found that the CLEC7A rs2078178 G allele and GG genotype were more prevalent in HC as compared to ASD but failed to reach statistical significance for the latter (pc = 0.01, 0.06 respectively). However, after phenotype-based stratification, the CLEC7A rs2078178 G allele and GG genotype were found to be significantly more frequent in the Asperger group as compared to other ASD subsets (pc = 0.02, 0.01), a finding reinforced by haplotype analysis (rs2078178/rs16910631 G-G/G-G) (pc = 0.002). Further, intellectual quotient (IQ)-based stratification of ASD patients revealed that IQ values increase linearly along the CLEC7A rs2078178 AA, AG and GG genotypes (p = 0.05) and in a recessive manner (GG vs. AA+AG p = 0.02), further confirmed by haplotype distribution (CLEC7A rs2078178-16910631; A-G/A-G, A-G/G-G and G-G/G-G, p = 0.02, G-G/G-G vs. others, p = 0.01). Conclusion Our data suggest that the genetic diversity of CLEC7A gene influences the ASD phenotype by behaving as a disease specifier and imply that the genetic control of innate immune response could determine the ASD phenotype.	[Bennabi, Meriem; Oliveira, Jose; Boukouaci, Wahid; Krishnamoorthy, Rajagopal; Tamouza, Ryad] Hop St Louis, INSERM, U1160, Paris, France; [Bennabi, Meriem; Oliveira, Jose; Lajnef, Mohamed; Gaman, Alexandru; Leboyer, Marion] Hop Henri Mondor, INSERM, U955, Psychiat Genet, F-94010 Creteil, France; [Bennabi, Meriem; Oliveira, Jose; Lajnef, Mohamed; Gaman, Alexandru; Krishnamoorthy, Rajagopal; Leboyer, Marion; Tamouza, Ryad] Fdn FondaMental, Creteil, France; [Delorme, Richard] Hop Robert Debre, DHU Protect, Serv Psychiat Enfant & Adolescent, F-75019 Paris, France; [Delorme, Richard] Inst Pasteur, Dept Genet Humaine & Fonct Cognit, Paris, France; [Fortier, Catherine; Marzais, Francois; Charron, Dominique; Tamouza, Ryad] Hop St Louis, Lab Jean Dausset, Paris, France; [Fortier, Catherine; Marzais, Francois; Charron, Dominique; Tamouza, Ryad] Hop St Louis, LabEx Transplantex, Paris, France; [Feugeas, Jean-Paul] Hop Bichat Claude Bernard, INSERM, U1137, F-75877 Paris, France; [Feugeas, Jean-Paul; Charron, Dominique; Tamouza, Ryad] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Ghaleh, Bijan] Hop Univ Henri Mondor, Ctr Ressources Biol, Creteil, France; [Leboyer, Marion] Hop Univ Henri Mondor, AP HP, Pole Psychiat, DHU PePSY, Creteil, France; [Leboyer, Marion] Univ Paris Est, Fac Med, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Tamouza, R (corresponding author), Hop St Louis, INSERM, U1160, Paris, France.	tamouza.ryad@gmail.com	Oliveira, José/P-8459-2019; Leboyer, Marion/AAW-3648-2021; Tamouza, Ryad/AGQ-6644-2022	Oliveira, José/0000-0003-3475-4794; Leboyer, Marion/0000-0001-5473-3697; Delorme, Richard/0000-0002-5614-3663; Charron, Dominique/0000-0001-7689-8038; Ghaleh, Bijan/0000-0003-0061-5462				Adams JB, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-22; Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y; Buie T, 2010, PEDIATRICS, V125, pS1, DOI 10.1542/peds.2009-1878C; Cao Xinyi, 2013, Shanghai Arch Psychiatry, V25, P342, DOI 10.3969/j.issn.1002-0829.2013.06.003; Centers for disease and prevention, 2014, 63 MMWR SURV SUMM CE, P1; Comi AM, 1999, J CHILD NEUROL, V14, P388, DOI 10.1177/088307389901400608; Croen LA, 2005, ARCH PEDIAT ADOL MED, V159, P151, DOI 10.1001/archpedi.159.2.151; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Grigorenko EL, 2008, PEDIATRICS, V122, pE438, DOI 10.1542/peds.2007-3604; Guerini FR, 2015, BRAIN BEHAV IMMUN, V44, P207, DOI 10.1016/j.bbi.2014.10.002; Horvath K, 1999, J PEDIATR-US, V135, P559, DOI 10.1016/S0022-3476(99)70052-1; Huguet G, 2013, ANNU REV GENOM HUM G, V14, P191, DOI 10.1146/annurev-genom-091212-153431; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jyonouchi H, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0187-2; Jyonouchi H, 2011, J NEUROIMMUNOL, V238, P73, DOI 10.1016/j.jneuroim.2011.07.001; Jyonouchi H, 2010, EXPERT REV CLIN IMMU, V6, P397, DOI [10.1586/eci.10.18, 10.1586/ECI.10.18]; Kang DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068322; Krigsman A., 2010, AUTISM INSIGHTS, V2, P1; Lauritsen MB, 2013, EUR CHILD ADOLES PSY, V22, pS37, DOI 10.1007/s00787-012-0359-5; Leblond CS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004580; Lee BK, 2015, BRAIN BEHAV IMMUN, V44, P100, DOI 10.1016/j.bbi.2014.09.001; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Luther K, 2007, CELL MICROBIOL, V9, P368, DOI 10.1111/j.1462-5822.2006.00796.x; McLean MH, 2015, GUT, V64, P332, DOI [10.1136/gutjnl-2014-308514, 10.1136/gutjnl-2013-306499]; Niehus R, 2006, J DEV BEHAV PEDIATR, V27, pS120, DOI 10.1097/00004703-200604002-00010; Oliveira J, 2014, J AFFECT DISORDERS, V165, P135, DOI 10.1016/j.jad.2014.04.059; Oliveira J, 2014, J AFFECT DISORDERS, V152, P395, DOI 10.1016/j.jad.2013.09.043; Pagan C, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.120; Saijo S, 2011, INT IMMUNOL, V23, P467, DOI 10.1093/intimm/dxr046; Schippa S, 2014, NUTRIENTS, V6, P5786, DOI 10.3390/nu6125786; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sweeten TL, 2003, PEDIATRICS, V112, pE420, DOI 10.1542/peds.112.5.e420; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; Valicenti-McDermott M, 2006, J DEV BEHAV PEDIATR, V27, pS128, DOI 10.1097/00004703-200604002-00011; Wang Harold Z., 2013, Frontiers in Genetics, V4, P195, DOI 10.3389/fgene.2013.00195; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536; Winter SE, 2013, EMBO REP, V14, P319, DOI 10.1038/embor.2013.27; Wu SQ, 2015, NEUROSCI BIOBEHAV R, V55, P322, DOI 10.1016/j.neubiorev.2015.05.004; Yokota K, 2001, GENE, V272, P51, DOI 10.1016/S0378-1119(01)00528-5; Zerbo O, 2013, J AUTISM DEV DISORD	43	12	13	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137339	10.1371/journal.pone.0137339	http://dx.doi.org/10.1371/journal.pone.0137339			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352598	gold, Green Submitted, Green Published			2022-12-26	WOS:000360932800075
J	Edwards, HM; Canavati, SE; Rang, C; Ly, P; Sovannaroth, S; Canier, L; Khim, N; Menard, D; Ashton, RA; Meek, SR; Roca-Feltrer, A				Edwards, Hannah M.; Canavati, Sara E.; Rang, Chandary; Ly, Po; Sovannaroth, Siv; Canier, Lydie; Khim, Nimol; Menard, Didier; Ashton, Ruth A.; Meek, Sylvia R.; Roca-Feltrer, Arantxa			Novel Cross-Border Approaches to Optimise Identification of Asymptomatic and Artemisinin-Resistant Plasmodium Infection in Mobile Populations Crossing Cambodian Borders	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; NEW-GUINEAN CHILDREN; FALCIPARUM POPULATIONS; MALARIA TRANSMISSION; CHALLENGES; PARASITE; DISEASE; MOVEMENT; SPREAD; THREAT	Background Human population movement across country borders presents a real challenge for malaria control and elimination efforts in Cambodia and its neighbouring countries. To quantify Plasmodium infection among the border-crossing population, including asymptomatic and artemisinin resistant (AR) parasites, three official border crossing points, one from each of Cambodia's borders with Thailand, Laos and Vietnam, were selected for sampling. Methods and Findings A total of 3206 participants (of 4110 approached) were recruited as they crossed the border, tested for malaria and interviewed. By real-time polymerase chain reaction (RT-PCR), 5.4% of all screened individuals were found to harbour Plasmodium parasites. The proportion was highest at the Laos border (11.5%). Overall there were 97 P. vivax (55.7%), 55 P. falciparum (31.6%), two P. malariae (1.1%) and 20 mixed infections (11.5%). Of identified infections, only 20% were febrile at the time of screening. Of the 24 P. falciparum samples where a further PCR was possible to assess AR, 15 (62.5%) had mutations in the K13 propeller domain gene, all from participants at the Laos border point. Malaria rapid diagnostic test (RDT) pLDH/HRP-2 identified a positivity rate of 3.2% overall and sensitivity compared to RT-PCR was very low (43.1%). Main individual risk factors for infection included sex, fever, being a forest-goer, poor knowledge of malaria prevention methods and previous malaria infection. Occupation, day of the week and time of crossing (morning vs. afternoon) also appeared to play an important role in predicting positive cases. Conclusions This study offers a novel approach to identify asymptomatic infections and monitor AR parasite flow among mobile and migrant populations crossing the borders. Similar screening activities are recommended to identify other hot borders and characterise potential hot spots of AR. Targeted "customised" interventions and surveillance activities should be implemented in these sites to accelerate elimination efforts in the region.	[Edwards, Hannah M.; Canavati, Sara E.; Rang, Chandary; Ashton, Ruth A.; Meek, Sylvia R.; Roca-Feltrer, Arantxa] Malaria Consortium, Phnom Penh, Cambodia; [Ly, Po; Sovannaroth, Siv] Natl Ctr Parasitol Entomol & Malaria Control CNM, Phnom Penh, Cambodia; [Canier, Lydie; Khim, Nimol; Menard, Didier] Inst Pasteur Cambodia, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia	National Center Parasitology, Entomology & Malaria Control; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia	Roca-Feltrer, A (corresponding author), Malaria Consortium, Phnom Penh, Cambodia.	a.roca@malariaconsortium.org	Menard, Didier/O-3294-2013; Roca-Feltrer, Arantxa/AAW-6986-2020; Ashton, Ruth/GPS-9349-2022; Ashton, Ruth/S-7822-2019	Menard, Didier/0000-0003-1357-4495; Ashton, Ruth/0000-0002-7248-7730	UKaid from the UK Government	UKaid from the UK Government	This study was funded by UKaid from the UK Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, PAR CONF MAL DIAGN R; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; ASEAN, 2008, ASEAN EC COMM BLUEPR; Bhumiratana A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/363417; Bourgeois N, 2010, CLIN MICROBIOL INFEC, V16, P1305, DOI 10.1111/j.1469-0691.2009.02933.x; Cambodian National Institute of Statistics, 2008, GEN POP CENS 2008 AG; Canier L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-405; CNM, 2011, NAT STRAT PLAN EL MA; Delacollette C, 2009, SE ASIAN J TROP MED, V40, P674; Dysoley L, 2010, CAMBODIA MALARIA SUR; Golassa L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-352; Harris I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-254; Khamsiriwatchara A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-120; Kitvatanachai Sirima, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P48; Lin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009047; Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/eri.13.45, 10.1586/ERI.13.45]; Lynch C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001040; Martens P, 2000, EMERG INFECT DIS, V6, P103, DOI 10.3201/eid0602.000202; McMorrow ML, 2011, CLIN MICROBIOL INFEC, V17, P1624, DOI 10.1111/j.1469-0691.2011.03639.x; Meatherall B, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-377; Mharakurwa S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-89; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; Mita T, 2011, J INFECT DIS, V204, P1980, DOI 10.1093/infdis/jir664; Mouatcho JC, 2013, J MED MICROBIOL, V62, P1491, DOI 10.1099/jmm.0.052506-0; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Pindolia DK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-205; PROTHERO RM, 1977, INT J EPIDEMIOL, V6, P259, DOI 10.1093/ije/6.3.259; PROTHERO RM, 1961, B WORLD HEALTH ORGAN, V24, P405; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Singhasivanon P, 2013, SE ASIAN J TROP MED, V44, P166; StataCorp, 2011, STAT STAT SOFTW REL; Wangroongsarb P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-117; WHO F CDC TDR, 2012, MAL RAP DIAGN TEST P	34	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0124300	10.1371/journal.pone.0124300	http://dx.doi.org/10.1371/journal.pone.0124300			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352262	Green Submitted, Green Published, gold			2022-12-26	WOS:000360932800001
J	Heu, CC; Kurtti, TJ; Nelson, CM; Munderloh, UG				Heu, Chan C.; Kurtti, Timothy J.; Nelson, Curtis M.; Munderloh, Ulrike G.			Transcriptional Analysis of the Conjugal Transfer Genes of Rickettsia bellii RML 369-C	PLOS ONE			English	Article							HOST CELL-INTERACTIONS; TIME QUANTITATIVE PCR; MESSENGER-RNA DECAY; CHICKEN-EMBRYO; IN-VITRO; PLASMID; PROTEIN; EVOLUTION; QUANTIFICATION; IDENTIFICATION	Rickettsia bellii is an obligate intracellular bacterium that is one of the few rickettsiae that encode a complete set of conjugative transfer (tra) genes involved in bacterial conjugation and has been shown to exhibit pili-like structures. The reductive genomes of rickettsiae beg the question whether the tra genes are nonfunctional or functioning to enhance the genetic plasticity and biology of rickettsiae. We characterized the transcriptional dynamics of R. bellii tra genes in comparison to genes transcribed stably and above the background level to understand when and at what levels the tra genes are active or whether the tra genes are degenerative. We determined that the best reference genes, out of 10 tested, were methionyl tRNA ligase (metG) or a combination of metG and ribonucleoside diphosphate reductase 2 subunit beta (nrdF), using statistical algorithms from two different programs: Normfinder and BestKeeper. To validate the use of metG with other rickettsial genes exhibiting variable transcriptional patterns we examined its use with sca2 and rickA, genes involved in actin based motility. Both were shown to be up-regulated at different times of replication in Vero cells, showing variable and stable transcription levels of rickA and sca2, respectively. traATi was up-regulated at 72 hours post inoculation in the tick cell line ISE6, but showed no apparent changes in the monkey cell line Vero and mouse cell line L929. The transcription of tra genes was positively correlated with one another and up-regulated from 12 to 72 hours post inoculation (HPI) when compared to RBE_0422 (an inactivated transposase-derivative found within the tra cluster). Thus, the up-regulation of the tra genes indicated that the integrity and activity of each gene were intact and may facilitate the search for the optimal conditions necessary to demonstrate conjugation in rickettsiae.	[Heu, Chan C.; Kurtti, Timothy J.; Nelson, Curtis M.; Munderloh, Ulrike G.] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Heu, CC (corresponding author), Univ Minnesota, Dept Entomol, 219 Hodson Hall,1980 Folwell Ave, St Paul, MN 55108 USA.	heuxx012@umn.edu		Heu, Chan/0000-0002-5235-288X	UGM, National Institutes of Health [5RO1AI081690]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081690] Funding Source: NIH RePORTER	UGM, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by UGM, National Institutes of Health, funding number 5RO1AI081690.	AltMorbe J, 1996, J BACTERIOL, V178, P4248, DOI 10.1128/jb.178.14.4248-4257.1996; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anthony KG, 1999, J BACTERIOL, V181, P5149, DOI 10.1128/JB.181.17.5149-5159.1999; Audette GF, 2007, MICROBIOL-SGM, V153, P442, DOI 10.1099/mic.0.2006/001917-0; Baldridge GD, 2008, APPL ENVIRON MICROB, V74, P645, DOI 10.1128/AEM.02262-07; Baldridge GD, 2010, APPL ENVIRON MICROB, V76, P1718, DOI 10.1128/AEM.02988-09; Bellanger X, 2014, FEMS MICROBIOL REV, V38, P720, DOI 10.1111/1574-6976.12058; Blanc G, 2007, GENOME RES, V17, P1657, DOI 10.1101/gr.6742107; Blanc G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030014; Cardwell MM, 2009, INFECT IMMUN, V77, P5272, DOI 10.1128/IAI.00201-09; Cho BK, 2008, P NATL ACAD SCI USA, V105, P19462, DOI 10.1073/pnas.0807227105; Dam P, 2007, NUCLEIC ACIDS RES, V35, P288, DOI 10.1093/nar/gkl1018; Eremeeva ME, 2003, J CLIN MICROBIOL, V41, P5466, DOI 10.1128/JCM.41.12.5466-5472.2003; Felsheim RF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008361; FIRTH N, 1992, MOL GEN GENET, V232, P145, DOI 10.1007/BF00299147; Francia MV, 2004, FEMS MICROBIOL REV, V28, P79, DOI 10.1016/j.femsre.2003.09.001; Frost LS, 1998, MICROBIOL-SGM, V144, P2579, DOI 10.1099/00221287-144-9-2579; Galletti MFBM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077388; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Gaywee J, 2002, INFECT IMMUN, V70, P6346, DOI 10.1128/IAI.70.11.6346-6354.2002; Gillespie JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004833; Gillespie JJ, 2015, GENOME BIOL EVOL, V7, P35, DOI 10.1093/gbe/evu262; Gillespie JJ, 2012, J BACTERIOL, V194, P376, DOI 10.1128/JB.06244-11; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Haglund CM, 2010, NAT CELL BIOL, V12, P1057, DOI 10.1038/ncb2109; Haglund CM, 2011, RICKETTSIA SCA2 IS B; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hernandez-Lopez A, 2013, GENOME BIOL EVOL, V5, P2305, DOI 10.1093/gbe/evt178; HOPPS HE, 1959, J IMMUNOL, V82, P161; HOWARD MT, 1995, J BIOL CHEM, V270, P28381; Koraimann G, 1996, MOL GEN GENET, V250, P466; Kristoffersen SM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r30; Kurtti TJ, 2015, INT J SYST EVOL MICR; Lang S, 2011, MOL MICROBIOL, V82, P1071, DOI 10.1111/j.1365-2958.2011.07872.x; Lawley TD, 2003, FEMS MICROBIOL LETT, V224, P1, DOI 10.1016/S0378-1097(03)00430-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANNING PA, 1981, P NATL ACAD SCI-BIOL, V78, P7487, DOI 10.1073/pnas.78.12.7487; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Mao XZ, 2014, NUCLEIC ACIDS RES, V42, pD654, DOI 10.1093/nar/gkt1048; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marrero J, 2005, DEV CELL, V8, P963, DOI 10.1016/j.devcel.2005.05.004; Matson SW, 2005, J BACTERIOL, V187, P697, DOI 10.1128/JB.187.2.697-706.2005; Matson SW, 2001, J BIOL CHEM, V276, P2372, DOI 10.1074/jbc.M008728200; MUNDERLOH UG, 1989, EXP APPL ACAROL, V7, P219, DOI 10.1007/BF01194061; Munderloh UG, 1999, J CLIN MICROBIOL, V37, P2518, DOI 10.1128/JCM.37.8.2518-2524.1999; NELSON WC, 1995, J BIOL CHEM, V270, P28374; Ogata H, 2005, ANN NY ACAD SCI, V1063, P26, DOI 10.1196/annals.1355.004; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Oliver JD, 2013, APPL ENVIRON MICROB; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ragonese H, 2007, MOL MICROBIOL, V63, P1173, DOI 10.1111/j.1365-2958.2006.05576.x; Reed SCO, 2014, CURR BIOL, V24, P98, DOI 10.1016/j.cub.2013.11.025; Sears KT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002856; SILVERMAN DJ, 1980, INFECT IMMUN, V29, P778; Weinert LA, 2009, P R SOC B, V276, P3619, DOI 10.1098/rspb.2009.0875; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; WISSEMAN CL, 1975, INFECT IMMUN, V11, P1391, DOI 10.1128/IAI.11.6.1391-1401.1975; WISSEMAN CL, 1976, INFECT IMMUN, V14, P1052, DOI 10.1128/IAI.14.4.1052-1064.1976; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382	60	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137214	10.1371/journal.pone.0137214	http://dx.doi.org/10.1371/journal.pone.0137214			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352829	Green Published, Green Submitted, gold			2022-12-26	WOS:000360932800068
J	Wu, YX; Kang, XJ; Zheng, HY; Liu, HY; Liu, JQ				Wu, Yixuan; Kang, Xiangjin; Zheng, Haiyan; Liu, Haiying; Liu, Jianqiao			Effect of Paternal Age on Reproductive Outcomes of In Vitro Fertilization	PLOS ONE			English	Article							OLDER; FATHERS; COUPLES; MEN	Although the adverse effects of maternal aging on reproductive outcomes have been investigated widely, there is no consensus on the impact of paternal age. Therefore, we investigated the effect of paternal age on reproductive outcomes in a retrospective analysis of 9,991 in vitro fertilization (IVF) cycles performed at the Reproductive Medicine Center of the Third Affiliated Hospital of Guangzhou Medical University (China) between January 2007 and October 2013. Samples were grouped according to maternal age [<30 (3,327 cycles), 30-34 (4,587 cycles), and 35-38 (2,077 cycles)] and then subgrouped according to paternal age (<30, 30-32, 33-35, 36-38, 39-41, and >= 42). The groups did not differ in terms of fertilization rate, numbers of viable and high-quality embryos and miscarriage rate when controlling maternal age (P > 0.05). Chi-squared analysis revealed that there were no differences in implantation and pregnancy rates among the different paternal age groups when maternal age was <30 and 35-38 years (P > 0.05). However, implantation and pregnancy rates decreased with paternal age in the 31-34 y maternal age group (P <0.05). Our study indicates that paternal age has no impact on fertilization rate, embryo quality at the cleavage stage and miscarriage rate. For the 30-34 y maternal age group, the implantation rate decreased with increased paternal age, with the pregnancy rate in this group being significantly higher in the paternal <30 y and 30-32 y age groups, compared with those in the 3638 y and 39-41 y groups.	[Wu, Yixuan; Kang, Xiangjin; Zheng, Haiyan; Liu, Haiying; Liu, Jianqiao] Guangzhou Med Univ, Affiliated Hosp 3, Dept Reprod Med, Guangzhou, Guangdong, Peoples R China; [Wu, Yixuan] Key Lab Reprod Med Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Wu, Yixuan] Key Lab Major Obstet Dis Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Wu, Yixuan] Guangdong Higher Educ Inst, Key Lab Reprod & Genet, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Liu, JQ (corresponding author), Guangzhou Med Univ, Affiliated Hosp 3, Dept Reprod Med, Guangzhou, Guangdong, Peoples R China.	ljq88gz@163.com			National Natural Science Foundation of China [81401254]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grant: the National Natural Science Foundation of China (No. 81401254), grant recipient XJK, http://www.nsfc.gov.cn/. Role of funder: data collection, decision to publish.	Aboulghar M, 2007, REPROD BIOMED ONLINE, V14, P588, DOI 10.1016/S1472-6483(10)61050-4; Begueria R, 2014, HUM REPROD, V29, P2114, DOI 10.1093/humrep/deu189; Bellver J, 2008, REPROD BIOMED ONLINE, V17, P595, DOI 10.1016/S1472-6483(10)60305-7; de La Rochebrochard E, 2003, AM J OBSTET GYNECOL, V189, P901, DOI 10.1067/S0002-9378(03)00753-1; de La Rochebrochard E, 2002, HUM REPROD, V17, P1649, DOI 10.1093/humrep/17.6.1649; de la Rochebrochard E, 2006, FERTIL STERIL, V85, P1420, DOI 10.1016/j.fertnstert.2005.11.040; Ferreira RC, 2010, FERTIL STERIL, V93, P1870, DOI 10.1016/j.fertnstert.2008.12.043; Ford WCL, 2000, HUM REPROD, V15, P1703, DOI 10.1093/humrep/15.8.1703; Frattarelli JL, 2008, FERTIL STERIL, V90, P97, DOI 10.1016/j.fertnstert.2007.06.009; Gu LJ, 2012, J ASSIST REPROD GEN, V29, P331, DOI 10.1007/s10815-012-9719-9; Hellstrom WJG, 2006, J ANDROL, V27, P421, DOI 10.2164/jandrol.05156; Klonoff-Cohen HS, 2004, AM J OBSTET GYNECOL, V191, P507, DOI 10.1016/j.ajog.2004.01.035; Luna M, 2009, FERTIL STERIL, V92, P1772, DOI 10.1016/j.fertnstert.2009.05.036; Paulson RJ, 2001, AM J OBSTET GYNECOL, V184, P818, DOI 10.1067/mob.2001.113852; Robertshaw I, 2014, REPROD SCI, V21, P590, DOI 10.1177/1933719113506497; Sloter E, 2004, FERTIL STERIL, V81, P925, DOI 10.1016/j.fertnstert.2003.07.043; Tsai YR, 2013, TAIWAN J OBSTET GYNE, V52, P351, DOI 10.1016/j.tjog.2013.06.001; Whitcomb BW, 2011, FERTIL STERIL, V95, P147, DOI 10.1016/j.fertnstert.2010.06.039	18	10	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135734	10.1371/journal.pone.0135734	http://dx.doi.org/10.1371/journal.pone.0135734			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352861	gold, Green Published, Green Submitted			2022-12-26	WOS:000360932800014
J	Xiao, CF; Robertson, RM				Xiao, Chengfeng; Robertson, R. Meldrum			Locomotion Induced by Spatial Restriction in Adult Drosophila	PLOS ONE			English	Article							OPEN-FIELD ARENA; LAYING HENS; BEHAVIOR; STEREOTYPIES; MELANOGASTER; MUTANTS; WHITE; SEROTONIN; DOPAMINE; WELFARE	Drosophila adults display an unwillingness to enter confined spaces but the behaviors induced by spatial restriction in Drosophila are largely unknown. We developed a protocol for high-throughput analysis of locomotion and characterized features of locomotion in a restricted space. We observed intense and persistent locomotion of flies in small circular arenas (diameter 1.27 cm), whereas locomotion was greatly reduced in large circular arenas (diameter 3.81 cm). The increased locomotion induced by spatial restriction was seen in male flies but not female flies, indicating sexual dimorphism of the response to spatial restriction. In large arenas, male flies increased locomotion in arenas previously occupied by male but not female individuals. In small arenas, such pre-conditioning had no effect on male flies, which showed intense and persistent locomotion similar to that seen in fresh arenas. During locomotion with spatial restriction, wildtype Canton-S males traveled slower and with less variation in speed than the mutant w1118 carrying a null allele of white gene. In addition, wildtype flies showed a stronger preference for the boundary than the mutant in small arenas. Genetic analysis with a series of crosses revealed that the white gene was not associated with the phenotype of boundary preference in wildtype flies.	[Xiao, Chengfeng; Robertson, R. Meldrum] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Robertson, RM (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	robertrm@queensu.ca	Robertson, Robert M/B-2482-2009; Xiao, Chengfeng/B-1432-2014	Robertson, Robert M/0000-0002-2666-7861; Xiao, Chengfeng/0000-0002-2301-1365	RGPIN [40930-09]; Natural Sciences and Engineering Research Council of Canada (NSERC)	RGPIN; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by RGPIN 40930-09, the Natural Sciences and Engineering Research Council of Canada (NSERC) (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN SH, 1978, SCIENCE, V201, P373, DOI 10.1126/science.566471; ADAMS MR, 1988, LAB ANIM SCI, V38, P279; Balcombe JP, 2006, LAB ANIM-UK, V40, P217, DOI 10.1258/002367706777611488; BAXTER MR, 1994, VET REC, V134, P614, DOI 10.1136/vr.134.24.614; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Borycz J, 2008, J EXP BIOL, V211, P3454, DOI 10.1242/jeb.021162; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; BURNET B, 1988, HEREDITY, V61, P111, DOI 10.1038/hdy.1988.96; Chen A, 2013, GENETICS, V193, P159, DOI 10.1534/genetics.112.142042; COLE BJ, 1995, ANIM BEHAV, V50, P1317, DOI 10.1016/0003-3472(95)80047-6; Colomb Julien, 2014, F1000Res, V3, P176, DOI 10.12688/f1000research.4263.2; Colomb J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042247; CONNOLLY K, 1967, ANIM BEHAV, V15, P149, DOI 10.1016/S0003-3472(67)80026-5; CRASKE MG, 1992, BEHAV RES THER, V30, P569, DOI 10.1016/0005-7967(92)90002-X; EWING ARTHUR W., 1963, ANIMAL BEHAVIOUR, V11, P369, DOI 10.1016/S0003-3472(63)80128-1; Garner JP, 2002, BEHAV BRAIN RES, V136, P83, DOI 10.1016/S0166-4328(02)00111-0; Gatti S, 2000, CURR BIOL, V10, P667, DOI 10.1016/S0960-9822(00)00517-0; Gross AN, 2012, BEHAV BRAIN RES, V234, P61, DOI 10.1016/j.bbr.2012.06.007; HOTTA Y, 1976, P NATL ACAD SCI USA, V73, P4154, DOI 10.1073/pnas.73.11.4154; JENSEN P, 1984, APPL ANIM BEHAV SCI, V12, P93, DOI 10.1016/0168-1591(84)90099-6; Kain JS, 2012, P NATL ACAD SCI USA, V109, P19834, DOI 10.1073/pnas.1211988109; Krushinski LV, 1962, ANIMAL BEHAV ITS NOR; Langen M, 2011, NEUROSCI BIOBEHAV R, V35, P345, DOI 10.1016/j.neubiorev.2010.02.004; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; LEVIS R, 1985, SCIENCE, V229, P558, DOI 10.1126/science.2992080; Liu LZ, 2007, GENETICS, V175, P1197, DOI 10.1534/genetics.106.068411; Maimon G, 2008, CURR BIOL, V18, P464, DOI 10.1016/j.cub.2008.02.054; Manoli DS, 2013, CURR OPIN NEUROBIOL, V23, P330, DOI 10.1016/j.conb.2013.04.005; Martin JR, 1999, J COMP PHYSIOL A, V184, P73, DOI 10.1007/s003590050307; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; MASON GJ, 1991, ANIM BEHAV, V41, P1015, DOI 10.1016/S0003-3472(05)80640-2; MASON GJ, 1991, BEHAV PROCESS, V25, P103, DOI 10.1016/0376-6357(91)90013-P; Mendes CS, 2013, ELIFE, V2, DOI 10.7554/eLife.00231; MILLER RE, 1969, SCIENCE, V165, P1027, DOI 10.1126/science.165.3897.1027; Pendleton RG, 2002, BEHAV GENET, V32, P89, DOI 10.1023/A:1015279221600; PIRROTTA V, 1984, EMBO J, V3, P563, DOI 10.1002/j.1460-2075.1984.tb01847.x; Riemensperger T, 2013, CELL REP, V5, P952, DOI 10.1016/j.celrep.2013.10.032; Seelig JD, 2010, NAT METHODS, V7, P535, DOI [10.1038/NMETH.1468, 10.1038/nmeth.1468]; Shields Sara, 2013, Animals (Basel), V3, P386, DOI 10.3390/ani3020386; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; Soibam B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046570; Soibam B, 2012, BRAIN BEHAV, V2, P97, DOI 10.1002/brb3.36; Tactacan GB, 2009, POULTRY SCI, V88, P698, DOI 10.3382/ps.2008-00369; Valente D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001083; van Swinderen B, 2006, J NEUROBIOL, V66, P1195, DOI 10.1002/neu.20300	47	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135825	10.1371/journal.pone.0135825	http://dx.doi.org/10.1371/journal.pone.0135825			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26351842	Green Published, Green Submitted, gold			2022-12-26	WOS:000360932800017
J	Alex, A; Li, AR; Zeng, XX; Tate, RE; McKee, ML; Capen, DE; Zhang, Z; Tanzi, RE; Zhou, C				Alex, Aneesh; Li, Airong; Zeng, Xianxu; Tate, Rebecca E.; McKee, Mary L.; Capen, Diane E.; Zhang, Zhan; Tanzi, Rudolph E.; Zhou, Chao			A Circadian Clock Gene, Cry, Affects Heart Morphogenesis and Function in Drosophila as Revealed by Optical Coherence Microscopy	PLOS ONE			English	Article							CARDIAC DYSFUNCTION; EXPRESSION; CRYPTOCHROME; PHOTORECEPTOR; TOMOGRAPHY; RHYTHMS; DISEASE; PROTEIN; SYSTEM; LEADS	Circadian rhythms are endogenous, entrainable oscillations of physical, mental and behavioural processes in response to local environmental cues such as daylight, which are present in the living beings, including humans. Circadian rhythms have been related to cardiovascular function and pathology. However, the role that circadian clock genes play in heart development and function in a whole animal in vivo are poorly understood. The Drosophila cryptochrome (dCry) is a circadian clock gene that encodes a major component of the circadian clock negative feedback loop. Compared to the embryonic stage, the relative expression levels of dCry showed a significant increase (>100-fold) in Drosophila during the pupa and adult stages. In this study, we utilized an ultrahigh resolution optical coherence microscopy (OCM) system to perform non-invasive and longitudinal analysis of functional and morphological changes in the Drosophila heart throughout its post-embryonic lifecycle for the first time. The Drosophila heart exhibited major morphological and functional alterations during its development. Notably, heart rate (HR) and cardiac activity period (CAP) of Drosophila showed significant variations during the pupa stage, when heart remodeling took place. From the M-mode (2D + time) OCM images, cardiac structural and functional parameters of Drosophila at different developmental stages were quantitatively determined. In order to study the functional role of dCry on Drosophila heart development, we silenced dCry by RNAi in the Drosophila heart and mesoderm, and quantitatively measured heart morphology and function in those flies throughout its development. Silencing of dCry resulted in slower HR, reduced CAP, smaller heart chamber size, pupal lethality and disrupted posterior segmentation that was related to increased expression of a posterior compartment protein, wingless. Collectively, our studies provided novel evidence that the circadian clock gene, dCry, plays an essential role in heart morphogenesis and function.	[Alex, Aneesh; Zeng, Xianxu; Zhou, Chao] Lehigh Univ, Dept Elect & Comp Engn, Bethlehem, PA 18015 USA; [Alex, Aneesh; Zeng, Xianxu; Zhou, Chao] Lehigh Univ, Ctr Photon & Nanoelect, Bethlehem, PA 18015 USA; [Li, Airong; Tate, Rebecca E.; Tanzi, Rudolph E.] Massachusetts Gen Hosp, Dept Neurol, Genet & Aging Res Unit, Boston, MA 02129 USA; [Li, Airong; Tate, Rebecca E.; Tanzi, Rudolph E.] Harvard Univ, Sch Med, Boston, MA 02129 USA; [Zeng, Xianxu; Zhang, Zhan] Zhengzhou Univ, Affiliated Hosp 3, Dept Pathol, Zhengzhou 450000, Henan, Peoples R China; [McKee, Mary L.; Capen, Diane E.] Massachusetts Gen Hosp, Program Membrane Biol, Boston, MA 02115 USA; [McKee, Mary L.; Capen, Diane E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Zhou, Chao] Lehigh Univ, Bioengn Program, Bethlehem, PA 18015 USA	Lehigh University; Lehigh University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Zhengzhou University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Lehigh University	Tanzi, RE (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Genet & Aging Res Unit, Boston, MA 02129 USA.	tanzi@helix.mgh.harvard.edu; chaozhou@lehigh.edu	Zhou, Chao/A-1327-2007; Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454; Alex, Aneesh/0000-0001-8652-307X; Zhou, Chao/0000-0002-8679-3413	National Institutes of Health [R00EB010071, R15EB019704, R03AR063271, R01AG014713, R01MH060009]; National Science Foundation [1455613]; Cure Alzheimer's Fund; Massachusetts General Hospital ECOR Award; Boston Area Diabetes and Endocrinology Research Centre [DK 57521]; Centre for the Study of Inflammatory Bowel Disease [DK 43351]; Lehigh University Start-up Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR063271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R15EB019704, R00EB010071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014713, P50AG005134] Funding Source: NIH RePORTER; Direct For Biological Sciences [1455613] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Cure Alzheimer's Fund; Massachusetts General Hospital ECOR Award; Boston Area Diabetes and Endocrinology Research Centre; Centre for the Study of Inflammatory Bowel Disease; Lehigh University Start-up Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Lehigh University Start-up Fund, National Institutes of Health [R00EB010071 to C.Z., R15EB019704 to C.Z. and A.L., R03AR063271 to A.L., and R01AG014713 and R01MH060009 to R.E. Tanzi], National Science Foundation [1455613 to C.Z. and A. L.], the Cure Alzheimer's Fund [to R.E. Tanzi], and a Massachusetts General Hospital ECOR Award [to A.L.]. The Microscopy Core Facility at the MGH Program in Membrane Biology receives support from the Boston Area Diabetes and Endocrinology Research Centre [DK 57521] and the Centre for the Study of Inflammatory Bowel Disease [DK 43351]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AD, 2003, OPT LETT, V28, P2064, DOI 10.1364/OL.28.002064; Alayari NN, 2009, JOVE-J VIS EXP, pe1423, DOI DOI 10.3791/1423; Anea CB, 2009, CIRCULATION, V119, P1510, DOI 10.1161/CIRCULATIONAHA.108.827477; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Bodmer R, 1998, DEV GENET, V22, P181, DOI 10.1002/(SICI)1520-6408(1998)22:3<181::AID-DVG1>3.0.CO;2-2; Boppart SA, 1997, P NATL ACAD SCI USA, V94, P4256, DOI 10.1073/pnas.94.9.4256; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Curran KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002749; DiTacchio L, 2011, SCIENCE, V333, P1881, DOI 10.1126/science.1206022; Dolezelova E, 2007, GENETICS, V177, P329, DOI 10.1534/genetics.107.076513; Drexler W, 2008, BIOL MED PHYS BIOMED, P1, DOI 10.1007/978-3-540-77550-8; Dulcis D, 2005, J NEUROSCI, V25, P271, DOI 10.1523/JNEUROSCI.2906-04.2005; Durgan DJ, 2006, J BIOL CHEM, V281, P24254, DOI 10.1074/jbc.M601704200; Eisenberg LM, 2006, DEV BIOL, V293, P305, DOI 10.1016/j.ydbio.2006.02.014; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; FERCHER AF, 1995, OPT COMMUN, V117, P43, DOI 10.1016/0030-4018(95)00119-S; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Ha M, 2005, J OCCUP HEALTH, V47, P89, DOI 10.1539/joh.47.89; HIDALGO A, 1994, CURR BIOL, V4, P1087, DOI 10.1016/S0960-9822(00)00247-5; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Ishikawa T, 1999, GENES CELLS, V4, P57, DOI 10.1046/j.1365-2443.1999.00237.x; IZATT JA, 1994, OPT LETT, V19, P590, DOI 10.1364/OL.19.000590; Layalle S, 2011, DEVELOPMENT, V138, P2315, DOI 10.1242/dev.057059; Lefta M, 2012, AM J PHYSIOL-HEART C, V303, pH475, DOI 10.1152/ajpheart.00238.2012; Leibetseder V, 2009, CHRONOBIOL INT, V26, P621, DOI 10.1080/07420520902924939; Li A, 2011, CURR ALZHEIMER RES, V8, P313, DOI 10.2174/156720511795563746; Li AR, 2013, HUM MOL GENET, V22, P3798, DOI 10.1093/hmg/ddt230; Liu LB, 2011, NAT MED, V17, P1010, DOI 10.1038/nm.2409; Molina MR, 2001, MECH DEVELOP, V109, P51, DOI 10.1016/S0925-4773(01)00509-3; Monier B, 2005, DEVELOPMENT, V132, P5283, DOI 10.1242/dev.02091; Neely GG, 2010, CELL, V141, P142, DOI 10.1016/j.cell.2010.02.023; Paternostro G, 2001, CIRC RES, V88, P1053, DOI 10.1161/hh1001.090857; Peterson LM, 2012, BIOMED OPT EXPRESS, V3, P3022, DOI 10.1364/BOE.3.003022; Portaluppi F, 2012, SLEEP MED REV, V16, P151, DOI 10.1016/j.smrv.2011.04.003; Rizki T.M., 1978, P397; Slama K., 2010, EUROPEAN J ENTOMOLOG; Slama L, 2005, J INSECT PHYSIOL, V51, P489, DOI 10.1016/j.jinsphys.2004.11.016; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; STURTEVANT MA, 1995, DEVELOPMENT, V121, P785; Sullivan W, 2008, DROSOPHILA PROTOCOLS; Tao Y, 2007, SEMIN CELL DEV BIOL, V18, P3, DOI 10.1016/j.semcdb.2006.12.001; Tsai MT, 2013, J BIOPHOTONICS, V6, P708, DOI 10.1002/jbio.201200164; Udo R, 2004, BIOCHEM BIOPH RES CO, V318, P893, DOI 10.1016/j.bbrc.2004.04.113; Wager-Smith K, 2000, NAT GENET, V26, P23, DOI 10.1038/79134; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103; WU XS, 1995, DEV BIOL, V169, P619, DOI 10.1006/dbio.1995.1174; Yazdanfar S, 1997, OPT EXPRESS, V1, P424, DOI 10.1364/OE.1.000424; Yelbuz TM, 2002, CIRCULATION, V106, P2771, DOI 10.1161/01.CIR.0000042672.51054.7B; Young ME, 2006, AM J PHYSIOL-HEART C, V290, pH1, DOI 10.1152/ajpheart.00582.2005; Zeitouni B, 2007, PLOS GENET, V3, P1907, DOI 10.1371/journal.pgen.0030174; Zhou C, 2010, CANCER RES, V70, P10071, DOI 10.1158/0008-5472.CAN-10-2968; Zikova M, 2003, P NATL ACAD SCI USA, V100, P12189, DOI 10.1073/pnas.2133156100	58	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137236	10.1371/journal.pone.0137236	http://dx.doi.org/10.1371/journal.pone.0137236			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348211	gold, Green Published, Green Submitted			2022-12-26	WOS:000360897600027
J	Pant, SD; Karlskov-Mortensen, P; Jacobsen, MJ; Cirera, S; Kogelman, LJA; Bruun, CS; Mark, T; Jorgensen, CB; Grarup, N; Appel, EVR; Galjatovic, EAA; Hansen, T; Pedersen, O; Guerin, M; Huby, T; Lesnik, P; Meuwissen, THE; Kadarmideen, HN; Fredholm, M				Pant, Sameer D.; Karlskov-Mortensen, Peter; Jacobsen, Mette J.; Cirera, Susanna; Kogelman, Lisette J. A.; Bruun, Camilla S.; Mark, Thomas; Jorgensen, Claus B.; Grarup, Niels; Appel, Emil V. R.; Galjatovic, Ehm A. A.; Hansen, Torben; Pedersen, Oluf; Guerin, Maryse; Huby, Thierry; Lesnik, Philipppe; Meuwissen, Theo H. E.; Kadarmideen, Haja N.; Fredholm, Merete			Comparative Analyses of QTLs Influencing Obesity and Metabolic Phenotypes in Pigs and Humans	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; LINKAGE DISEQUILIBRIUM; ADIPOSE-TISSUE; CHOLESTEROL; GENE; RECEPTOR; ALPHA; LOCI; EXPRESSION	The pig is a well-known animal model used to investigate genetic and mechanistic aspects of human disease biology. They are particularly useful in the context of obesity and metabolic diseases because other widely used models (e.g. mice) do not completely recapitulate key pathophysiological features associated with these diseases in humans. Therefore, we established a F2 pig resource population (n = 564) designed to elucidate the genetics underlying obesity and metabolic phenotypes. Segregation of obesity traits was ensured by using breeds highly divergent with respect to obesity traits in the parental generation. Several obesity and metabolic phenotypes were recorded (n = 35) from birth to slaughter (242 +/- 48 days), including body composition determined at about two months of age (63 +/- 10 days) via dual-energy x-ray absorptiometry (DXA) scanning. All pigs were genotyped using Illumina Porcine 60k SNP Beadchip and a combined linkage disequilibrium-linkage analysis was used to identify genome-wide significant associations for collected phenotypes. We identified 229 QTLs which associated with adiposity-and metabolic phenotypes at genome-wide significant levels. Subsequently comparative analyses were performed to identify the extent of overlap between previously identified QTLs in both humans and pigs. The combined analysis of a large number of obesity phenotypes has provided insight in the genetic architecture of the molecular mechanisms underlying these traits indicating that QTLs underlying similar phenotypes are clustered in the genome. Our analyses have further confirmed that genetic heterogeneity is an inherent characteristic of obesity traits most likely caused by segregation or fixation of different variants of the individual components belonging to cellular pathways in different populations. Several important genes previously associated to obesity in human studies, along with novel genes were identified. Altogether, this study provides novel insight that may further the current understanding of the molecular mechanisms underlying human obesity.	[Pant, Sameer D.; Karlskov-Mortensen, Peter; Jacobsen, Mette J.; Cirera, Susanna; Kogelman, Lisette J. A.; Bruun, Camilla S.; Mark, Thomas; Jorgensen, Claus B.; Kadarmideen, Haja N.; Fredholm, Merete] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Copenhagen, Denmark; [Grarup, Niels; Appel, Emil V. R.; Galjatovic, Ehm A. A.; Hansen, Torben; Pedersen, Oluf] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark; [Guerin, Maryse; Huby, Thierry; Lesnik, Philipppe] Integrat Biol Atherosclerosis Team, INSERM, UMR S 1166, F-75013 Paris, France; [Guerin, Maryse; Huby, Thierry; Lesnik, Philipppe] Univ Paris 06, Sorbonne Univ, Integrat Biol Atherosclerosis Team, UMR S 1166, F-75013 Paris, France; [Guerin, Maryse; Huby, Thierry; Lesnik, Philipppe] Hop La Pitie Salpetriere, Inst Cardiometab & Nutr ICAN, Paris, France; [Meuwissen, Theo H. E.] Norwegian Univ Life Sci, Inst Anim & Agr Sci, As, Norway	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Norwegian University of Life Sciences	Kadarmideen, HN (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Copenhagen, Denmark.	hajak@sund.ku.dk; mf@sund.ku.dk	Pant, Sameer Dinkar/D-1448-2017; Karlskov-Mortensen, Peter/C-3030-2013; Grarup, Niels/K-2807-2015; Lesnik, Philippe/AAD-7393-2020; Kogelman, Lisette/Y-5883-2019; Guerin, Maryse/N-5794-2017; Pedersen, Oluf/AAG-8015-2020; Pedersen, Oluf/Z-1731-2019; Cirera, Susanna/K-8540-2017; Lesnik, Philippe F/F-7803-2011; Huby, Thierry/E-6768-2017; HUBY, Thierry/N-4820-2019; Jorgensen, Claus B./GXH-7925-2022	Pant, Sameer Dinkar/0000-0002-0672-4478; Karlskov-Mortensen, Peter/0000-0002-2491-2763; Grarup, Niels/0000-0001-5526-1070; Lesnik, Philippe/0000-0002-6909-7715; Pedersen, Oluf/0000-0002-3321-3972; Huby, Thierry/0000-0001-6634-551X; HUBY, Thierry/0000-0001-6634-551X; Jorgensen, Claus B./0000-0003-4749-5306; Fredholm, Merete/0000-0002-3563-7648; Kogelman, Lisette/0000-0001-9782-7810; Kadarmideen, Haja/0000-0001-6294-382X; Cirera, Susanna/0000-0001-8105-1579; Jacobsen, Mette Juul/0000-0001-9264-7554; GUERIN, Maryse/0000-0003-0150-1360	Ministry of Science and Technology; Danish Council for Strategic Research [0603-00457B]; Danish Research Council for Independent Research [DFF 1335-00127]; EU-FP7 Marie Curie Actions-Career Integration Grant [CIG293511]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Research Council for Independent Research(Det Frie Forskningsrad (DFF)); EU-FP7 Marie Curie Actions-Career Integration Grant	This study was supported by a grant from the Ministry of Science and Technology to the "UNIK Project for Food Fitness and Pharma for Health", by the Danish Council for Strategic Research to the BioChild project (0603-00457B), and by the Danish Research Council for Independent Research (DFF 1335-00127). HNK was supported by EU-FP7 Marie Curie Actions-Career Integration Grant (CIG293511). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Arai A, 2002, J BIOL CHEM, V277, P24453, DOI 10.1074/jbc.M202216200; Arner P, 2005, DIABETOLOGIA, V48, P2203, DOI 10.1007/s00125-005-1956-3; Badke YM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-24; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Bitsch F, 2003, ANAL BIOCHEM, V323, P139, DOI 10.1016/j.ab.2003.08.029; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Chang YC, 2010, OBESITY, V18, P7, DOI 10.1038/oby.2009.198; Chen GJ, 2012, EUR J HUM GENET, V20, P463, DOI 10.1038/ejhg.2011.206; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; Ding H, 2012, INT SCI INDEX, V6; Edwards DRV, 2013, HUM GENET, V132, P323, DOI 10.1007/s00439-012-1246-3; Estrada IA, 2012, CIRC RES, V111, P1166, DOI 10.1161/CIRCRESAHA.112.275743; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Fox CS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S18; Fox CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002695; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gilmour AR, 2009, ASREML USER GUIDE RE; GUERIN M, 1994, ARTERIOSCLER THROMB, V14, P199, DOI 10.1161/01.ATV.14.2.199; Heinritz SN, 2013, NUTR RES REV, V26, P191, DOI 10.1017/S0954422413000152; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Irvin MR, 2011, PHARMACOGENET GENOM, V21, P798, DOI 10.1097/FPC.0b013e32834b68f9; Johansen T, 2001, COMPARATIVE MED, V51, P150; Johansson A, 2010, OBESITY, V18, P803, DOI 10.1038/oby.2009.359; JONES DP, 1971, J CLIN INVEST, V50, P259, DOI 10.1172/JCI106490; Kallen JA, 2002, STRUCTURE, V10, P1697, DOI 10.1016/S0969-2126(02)00912-7; Kathiresan S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S17; Kempen KPG, 1998, EUR J CLIN INVEST, V28, P1030; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kogelman Lisette J. A., 2013, Frontiers in Genetics, V4, P29, DOI 10.3389/fgene.2013.00029; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Lowe JK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000365; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Makowski L, 2005, CURR OPIN LIPIDOL, V16, P543, DOI 10.1097/01.mol.0000180166.08196.07; Melen E, 2013, CLIN EXP ALLERGY, V43, P463, DOI 10.1111/cea.12054; Melka MG, 2012, J CLIN ENDOCR METAB, V97, pE145, DOI 10.1210/jc.2011-1801; Meuwissen T, 2010, GENETICS, V185, P1441, DOI 10.1534/genetics.110.113936; Nofer JR, 2003, J BIOL CHEM, V278, P53055, DOI 10.1074/jbc.M305673200; Pathak P, 2013, J BIOL CHEM, V288, P37154, DOI 10.1074/jbc.M113.485987; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Soleimani M, 2013, KIDNEY INT, V84, P657, DOI 10.1038/ki.2013.138; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang KS, 2012, GENE, V500, P80, DOI 10.1016/j.gene.2012.03.046; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Willson TM, 2002, STRUCTURE, V10, P1605, DOI 10.1016/S0969-2126(02)00916-4; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhang JF, 2004, P NATL ACAD SCI USA, V101, P10703, DOI 10.1073/pnas.0403652101; Zou LY, 2013, FASEB J, V27	57	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137356	10.1371/journal.pone.0137356	http://dx.doi.org/10.1371/journal.pone.0137356			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348622	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000360897600039
J	Leigh-Brown, S; Goncalves, A; Thybert, D; Stefflova, K; Watt, S; Flicek, P; Brazma, A; Marioni, JC; Odom, DT				Leigh-Brown, Sarah; Goncalves, Angela; Thybert, David; Stefflova, Klara; Watt, Stephen; Flicek, Paul; Brazma, Alvis; Marioni, John C.; Odom, Duncan T.			Regulatory Divergence of Transcript Isoforms in a Mammalian Model System	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; HOUSE MOUSE; POLYADENYLATION; GENOME; EVOLUTION; DNA; TISSUES; BINDING; CIS	Phenotypic differences between species are driven by changes in gene expression and, by extension, by modifications in the regulation of the transcriptome. Investigation of mammalian transcriptome divergence has been restricted to analysis of bulk gene expression levels and gene-internal splicing. Using allele-specific expression analysis in inter-strain hybrids of Mus musculus, we determined the contribution of multiple cellular regulatory systems to transcriptome divergence, including: alternative promoter usage, transcription start site selection, cassette exon usage, alternative last exon usage, and alternative polyadenylation site choice. Between mouse strains, a fifth of genes have variations in isoform usage that contribute to transcriptomic changes, half of which alter encoded amino acid sequence. Virtually all divergence in isoform usage altered the post-transcriptional regulatory instructions in gene UTRs. Furthermore, most genes with isoform differences between strains contain changes originating from multiple regulatory systems. This result indicates widespread cross-talk and coordination exists among different regulatory systems. Overall, isoform usage diverges in parallel with and independently to gene expression evolution, and the cis and trans regulatory contribution to each differs significantly.	[Leigh-Brown, Sarah; Odom, Duncan T.] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England; [Goncalves, Angela; Thybert, David; Flicek, Paul; Brazma, Alvis; Marioni, John C.] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Goncalves, Angela; Watt, Stephen; Odom, Duncan T.] Wellcome Trust Sanger Inst, Cambridge, England; [Stefflova, Klara] CALTECH, Div Biol, Pasadena, CA 91125 USA	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; California Institute of Technology	Marioni, JC (corresponding author), European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge, England.	marioni@ebi.ac.uk; Duncan.odom@cruk.cam.ac.uk		Flicek, Paul/0000-0002-3897-7955; Odom, Duncan/0000-0001-6201-5599; Brazma, Alvis/0000-0001-5988-7409; Thybert, David/0000-0001-7806-7318; Barsi, Klara/0000-0001-9338-0468; Marioni, John/0000-0001-9092-0852; Goncalves, Angela/0000-0002-3890-7658	European Research Council; EMBO Young Investigators Program; Hutchinson Whampoa; Cancer Research UK; University of Cambridge; European Molecular Biology Laboratory; Wellcome Trust [WT095908, WT098051]; European Commission [261123]; Cancer Research UK [20412, 15603] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); EMBO Young Investigators Program(European Molecular Biology Organization (EMBO)); Hutchinson Whampoa; Cancer Research UK(Cancer Research UK); University of Cambridge(University of Cambridge); European Molecular Biology Laboratory; Wellcome Trust(Wellcome Trust); European Commission(European CommissionEuropean Commission Joint Research Centre); Cancer Research UK(Cancer Research UK)	This work was supported by the European Research Council (DTO) (http://erc.europa.eu/); EMBO Young Investigators Program (DTO) (http://www.embo.org/funding-awards/young-investigators); Hutchinson Whampoa (DTO) (http://www.hutchison-whampoa.com/en/global/home.php); Cancer Research UK (DTO, SLB, KS, SW) (http://www.cancerresearchuk.org/); University of Cambridge (SLB, KS, DTO, AG) (http://www.cam.ac.uk/); European Molecular Biology Laboratory (AG, DT, AB, PF, JCM) (http://www.embl.org/); Wellcome Trust WT095908 and WT098051 (DT, PF, DTO) (http://www.wellcome.ac.uk/); and FP7 HEALTH grant from the European Commission GEUVADIS grant agreement 261123 (AG, AB) (http://www.geuvadis.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Since performing the experimental work and writing this manuscript, SLB has taken paid employment at Abcam, a Biotech firm selling reagents to research scientists. Abcam had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auboeuf D, 2002, SCIENCE, V298, P416, DOI 10.1126/science.1073734; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Bartolomei MS, 2011, COLD SPRING HARB PER, V3; Beaudoing E, 2001, GENOME RES, V11, P1520, DOI 10.1101/gr.190501; Bentley DL, 2014, NAT REV GENET, V15, P163, DOI 10.1038/nrg3662; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Braunschweig U, 2013, CELL, V152, P1252, DOI 10.1016/j.cell.2013.02.034; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; DeVeale B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002600; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Evsyukova I, 2013, RNA, V19, P103, DOI 10.1261/rna.035410.112; Gao QS, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145970; Geraldes A, 2011, MOL ECOL, V20, P4722, DOI 10.1111/j.1365-294X.2011.05285.x; Goncalves A, 2012, GENOME RES, V22, P2376, DOI 10.1101/gr.142281.112; Gonzalez-Porta M, 2012, GENOME RES, V22, P528, DOI 10.1101/gr.121947.111; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Lalonde E, 2011, GENOME RES, V21, P545, DOI 10.1101/gr.111211.110; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Le Sommer C, 2005, MOL CELL BIOL, V25, P9595, DOI 10.1128/MCB.25.21.9595-9607.2005; Li Y, 2010, GENETICS, V186, P405, DOI 10.1534/genetics.110.119677; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Mahony S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r84; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; McManus CJ, 2014, GENOME RES, V24, P786, DOI 10.1101/gr.161521.113; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Reyes A, 2013, P NATL ACAD SCI USA, V110, P15377, DOI 10.1073/pnas.1307202110; Rigo F, 2009, RNA, V15, P823, DOI 10.1261/rna.1409209; Smith DJ, 2008, MOL CELL, V30, P657, DOI 10.1016/j.molcel.2008.04.013; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Turro E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r13; Veraldi KL, 2001, MOL CELL BIOL, V21, P1228, DOI 10.1128/MCB.21.4.1228-1238.2001; Voolstra C, 2007, GENOME RES, V17, P42, DOI 10.1101/gr.5683806; Waks Z, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.32; Watanabe H, 2004, NATURE, V429, P382, DOI 10.1038/nature02564; Wittkopp PJ, 2008, NAT GENET, V40, P346, DOI 10.1038/ng.77; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Yang H, 2007, NAT GENET, V39, P1100, DOI 10.1038/ng2087; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100	53	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137367	10.1371/journal.pone.0137367	http://dx.doi.org/10.1371/journal.pone.0137367			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339903	Green Published, Green Accepted, gold			2022-12-26	WOS:000360688200052
J	Li, Y; Zhang, Q; Zhang, FF; Liu, RX; Liu, H; Chen, F				Li, Yue; Zhang, Qian; Zhang, Fangfei; Liu, Ruoxi; Liu, He; Chen, Feng			Analysis of the Microbiota of Black Stain in the Primary Dentition	PLOS ONE			English	Article							DENTAL-CARIES; PRIMARY TEETH; SCHOOLCHILDREN; PREVALENCE; CHILDREN; PERIODONTITIS; BACTERIA	Black tooth stain is a characteristic extrinsic discoloration commonly seen on the cervical enamel following the contour of the gingiva. To investigate the relationship between black tooth stain and the oral microbiota, we used 16S rRNA gene sequencing to compare the microbial composition of dental plaque and saliva among caries-free children with and without black stain. Dental plaque and saliva, as well as black stain, were sampled from 10 children with and 15 children without black stain. Data were analyzed using the pipeline tool MOTHUR. Student's t-test was used to compare alpha diversities and the Mann-Whitney U test to compare the relative abundances of the microbial taxa. A total of 10 phyla, 19 classes, 32 orders, 61 families and 102 genera were detected in these samples. Shannon and Simpson diversity were found to be significantly lower in saliva samples of children with black stain. Microbial diversity was reduced in the black stain compared to the plaque samples. Actinomyces, Cardiobacterium, Haemophilus, Corynebacterium, Tannerella and Treponema were more abundant and Campylobacter less abundant in plaque samples of children with black stain. Principal component analysis demonstrated clustering among the dental plaque samples from the control group, while the plaque samples from the black stain group were not and appeared to cluster into two subgroups. Alterations in oral microbiota may be associated with the formation of black stain.	[Li, Yue; Zhang, Fangfei; Liu, He] Peking Univ, Sch Stomatol, Dept Pediat Dent, Beijing 100871, Peoples R China; [Zhang, Qian; Liu, Ruoxi; Chen, Feng] Peking Univ, Sch Stomatol, Cent Lab, Beijing 100871, Peoples R China	Peking University; Peking University	Liu, H (corresponding author), Peking Univ, Sch Stomatol, Dept Pediat Dent, Beijing 100871, Peoples R China.	heliu69@126.com; moleculecf@gmail.com			National Natural Science Foundation of China [81200762]; Peking University School of Stomatology [PKUSS20110301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking University School of Stomatology	This work was funded by the National Natural Science Foundation of China (81200762 to FC) and Peking University School of Stomatology (PKUSS20110301 to FC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Franca-Pinto CC, 2012, CARIES RES, V46, P170, DOI 10.1159/000337280; Martin JMG, 2013, PEDIATR INT, V55, P355, DOI 10.1111/ped.12066; Gasparetto André, 2003, Braz. Dent. J., V14, P157, DOI 10.1590/S0103-64402003000300003; Han XY, 2005, J CLIN MICROBIOL, V43, P2370, DOI 10.1128/JCM.43.5.2370-2374.2005; Heinrich-Weltzien R, 2014, CARIES RES, V48, P118, DOI 10.1159/000353469; Heinrich-Weltzien R, 2009, COMMUNITY DENT ORAL, V37, P182, DOI 10.1111/j.1600-0528.2008.00458.x; Hutchison CA, 2007, NUCLEIC ACIDS RES, V35, P6227, DOI 10.1093/nar/gkm688; Kemp PF, 2004, FEMS MICROBIOL ECOL, V47, P161, DOI 10.1016/S0168-6496(03)00257-5; Koch MJ, 2001, J DENT CHILD, V68, P353; Li Y, 2014, ISME J, V8, P1879, DOI 10.1038/ismej.2014.28; MELLANBY M, 1957, BRIT MED J, V2, P318, DOI 10.1136/bmj.2.5040.318; Murphy TF, 2003, CURR OPIN INFECT DIS, V16, P129, DOI 10.1097/00001432-200304000-00009; Pushpanjali K, 2004, Oral Health Prev Dent, V2, P33; REID JS, 1976, J DENT RES, V55, P1130, DOI 10.1177/00220345760550062401; REID JS, 1977, J DENT RES, V56, P895, DOI 10.1177/00220345770560081001; Ronay V, 2011, ORAL HLTH PREV DENT, V9, P37; Saba C, 2006, J Clin Pediatr Dent, V30, P219; Sakai VT, 2007, INT J PAEDIATR DENT, V17, P192, DOI 10.1111/j.1365-263X.2006.00813.x; Sarkonen N, 2001, J CLIN MICROBIOL, V39, P3955, DOI 10.1128/JCM.39.11.3955-3961.2001; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sela MN, 2001, CRIT REV ORAL BIOL M, V12, P399, DOI 10.1177/10454411010120050301; SLOTS J, 1974, SCAND J DENT RES, V82, P484; Soukos NS, 2005, ANTIMICROB AGENTS CH, V49, P1391, DOI 10.1128/AAC.49.4.1391-1396.2005; Tek M, 2013, HEAD FACE MED, V9, DOI 10.1186/1746-160X-9-25; Tomita S, 2013, MICROB PATHOGENESIS, V61-62, P11, DOI 10.1016/j.micpath.2013.04.006; Tsuzukibashi O, 2014, J MICROBIOL METH, V104, P67, DOI 10.1016/j.mimet.2014.06.005; Unno T, 2015, J MICROBIOL BIOTECHN	27	24	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137030	10.1371/journal.pone.0137030	http://dx.doi.org/10.1371/journal.pone.0137030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340752	Green Published, gold, Green Submitted			2022-12-26	WOS:000360688200020
J	Xing, JJ; Liu, XF; Xiong, XM; Huang, L; Lao, CY; Yang, M; Gao, S; Huang, QY; Yang, W; Zhu, YF; Zhang, DH				Xing, Ji-Juan; Liu, Xiu-Fen; Xiong, Xiao-Ming; Huang, Li; Lao, Cheng-Yi; Yang, Mei; Gao, Shan; Huang, Qiong-Yan; Yang, Wei; Zhu, Yun-Feng; Zhang, Di-Hua			Effects of Combined Spinal-Epidural Analgesia during Labor on Postpartum Electrophysiological Function of Maternal Pelvic Floor Muscle: A Randomized Controlled Trial	PLOS ONE			English	Article							PRESSURE MEASUREMENTS; VAGINAL DELIVERY; REDUCE; RISK; PAIN	Objective Combined spinal-epidural analgesia (CSEA) is sometimes used for difficult births, but whether it contributes to postpartum pelvic muscle disorder is unclear. This randomized controlled trial examined whether CSEA given during labor affects the electrophysiological index of postpartum pelvic floor muscle function. Methods A consecutive sample of primiparous women who delivered vaginally at term were randomly assigned to a CSEA group (n = 143) and control group (n = 142) between June 2013 and June 2014. All were assessed 6-8 weeks later for electrophysiological function of pelvic floor muscle. Results The two groups were similar in the degree of muscle strength, muscle fatigue, and pelvic dynamic pressure of pelvic floor muscle. The CSEA and control groups showed similar proportions of women with normal muscle strength (score >= 4) in type I pelvic fibers (23.1% vs. 14.1%, P = 0.051) and type II pelvic fibers (28.0% vs. 24.6%, P = 0.524). The groups also contained similar proportions of women who showed no fatigue in type I fibers (54.5% vs. 48.6%, P = 0.315) or type II fibers (88.8% vs. 87.3%, P = 0.699). Similarly low proportions of women in the CSEA group and control group showed normal pelvic dynamic pressure 11.2% vs. 7.7%, P = 0.321). However, women in the CSEA group spent significantly less time in labor than those in the control group (7.25 vs. 9.52 h, P <0.001). Conclusions CSEA did not affect the risk of postpartum pelvic muscle disorder in this cohort of primiparous women who gave birth vaginally. A significant shorter duration of labour was observed in the CSEA-group.	[Xing, Ji-Juan; Lao, Cheng-Yi; Huang, Qiong-Yan; Yang, Wei; Zhu, Yun-Feng] Maternal & Child Hlth Hosp Nanning City, Dept Anesthesia, Nanning 530011, Peoples R China; [Liu, Xiu-Fen; Huang, Li] Peking Univ, Affiliated Hosp 1, Pain Management Dept, Beijing 100034, Peoples R China; [Xiong, Xiao-Ming] Maternal & Child Hlth Hosp Nandan Cty, Dept Obstet & Gynecol, Hechi 547200, Peoples R China; [Yang, Mei; Gao, Shan] Maternal & Child Hlth Hosp Nanning City, Matern Care Dept, Nanning 530011, Peoples R China; [Zhang, Di-Hua] Maternal & Child Hlth Hosp Nanning City, Child Care Dept, Nanning 530011, Peoples R China	Peking University	Zhu, YF (corresponding author), Maternal & Child Hlth Hosp Nanning City, Dept Anesthesia, Nanning 530011, Peoples R China.	xingjijuan123@163.com; 1069052046@qq.com			Scientific and Technological Key Project of Nanning City [20133189]	Scientific and Technological Key Project of Nanning City	This work was supported by the Scientific and Technological Key Project of Nanning City (no. 20133189).	Ashton-Miller JA, 2009, ANNU REV BIOMED ENG, V11, P163, DOI 10.1146/annurev-bioeng-061008-124823; BO K, 1990, NEUROUROL URODYNAM, V9, P479, DOI 10.1002/nau.1930090504; BO K, 1992, NEUROUROL URODYNAM, V11, P107, DOI 10.1002/nau.1930110205; Bo K, 1990, NEUROUROL URODYNAM, V9, P395; Caroci AD, 2010, J CLIN NURS, V19, P2424, DOI 10.1111/j.1365-2702.2010.03289.x; Costantini S, 2006, ULTRASOUND OBST GYN, V27, P183, DOI 10.1002/uog.2663; Ding T, 2014, ANESTH ANALG, V119, P383, DOI 10.1213/ANE.0000000000000107; Feng BB, 2013, CLIN EXP OBSTET GYN, V40, P574; Frawley HC, 2006, INT UROGYNECOL J, V17, P365, DOI 10.1007/s00192-005-0016-3; Gambling D, 2013, ANESTH ANALG, V116, P636, DOI 10.1213/ANE.0b013e31827e4e29; Gou WL, 2003, DELIVERY; Handa VL, 2011, OBSTET GYNECOL, V118, P777, DOI 10.1097/AOG.0b013e3182267f2f; Long Yan, 2007, Zhonghua Fu Chan Ke Za Zhi, V42, P808; Lovett RW, 1916, J AMER MED ASSOC, V66, P729; Memon H, 2012, CURR OPIN OBSTET GYN, V24, P349, DOI 10.1097/GCO.0b013e328357628b; Oliveira LS, 2014, SAO PAULO MED J, V132, P231, DOI 10.1590/1516-3180.2014.1324710; Panayi DC, 2009, CURR OPIN OBSTET GYN, V21, P97, DOI 10.1097/GCO.0b013e328321e44b; Qaseem A, 2006, ANN INTERN MED, V144, P575, DOI 10.7326/0003-4819-144-8-200604180-00008; Rofaeel A, 2007, CAN J ANAESTH, V54, P15, DOI 10.1007/BF03021894; Salvesen KA, 2004, BMJ-BRIT MED J, V329, P378, DOI 10.1136/bmj.38163.724306.3A; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Shan XM, 2012, CHIN J CLIN OBSTET G, V13, P92; Simmons SW, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003401.pub2; Simmons Scott W, 2012, Cochrane Database Syst Rev, V10, pCD003401, DOI 10.1002/14651858.CD003401.pub3; Singh N, 2014, ANN CARD ANAESTH, V17, P177, DOI 10.4103/0971-9784.129892; Torrisi G, 2012, EUR J OBSTET GYN R B, V160, P110, DOI 10.1016/j.ejogrb.2011.10.010; Tsen LC, 1999, ANESTHESIOLOGY, V91, P920, DOI 10.1097/00000542-199910000-00010; Van de Velde M, 2004, ANESTH ANALG, V98, P1153, DOI 10.1213/01.ANE.0000101980.34587.66; Wang SS, 2014, CONT MED, V20, P97; Wisner KL, 2014, ANESTH ANALG, V119, P219, DOI 10.1213/ANE.0000000000000322; Yao ZC, 2014, NURS PRAC RES, V11, P6	31	8	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137267	10.1371/journal.pone.0137267	http://dx.doi.org/10.1371/journal.pone.0137267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340002	Green Published, Green Submitted, gold			2022-12-26	WOS:000360688200043
J	Bronzwaer, ASGT; Ouweneel, DM; Stok, WJ; Westerhof, BE; van Lieshout, JJ				Bronzwaer, Anne-Sophie G. T.; Ouweneel, Dagmar M.; Stok, Wim J.; Westerhof, Berend E.; van Lieshout, Johannes J.			Arterial Pressure Variation as a Biomarker of Preload Dependency in Spontaneously Breathing Subjects - A Proof of Principle	PLOS ONE			English	Article							MECHANICALLY VENTILATED PATIENTS; PREDICTING FLUID RESPONSIVENESS; STROKE VOLUME VARIATION; PULSE PRESSURE; CARDIAC-OUTPUT; CENTRAL HYPOVOLEMIA; CRITICALLY-ILL; TIDAL VOLUME; HEAD-UP; TILT	Objective Pulse (PPV) and systolic pressure variation (SPV) quantify variations in arterial pressure related to heart-lung interactions and have been introduced as biomarkers of preload dependency to guide fluid treatment in mechanically ventilated patients. However, respiratory intrathoracic pressure changes during spontaneous breathing are considered too small to affect preload and stroke volume sufficiently for the detection by PPV and/or SPV. This study addressed the effects of paced breathing and/or an external respiratory resistance on PPV and SPV in detecting preload dependency in spontaneously breathing subjects. Methods In 10 healthy subjects, hemodynamic and respiratory parameters were evaluated during progressive central hypovolemia (head-up tilt). Breathing conditions were varied by manipulating breathing frequency and respiratory resistance. Subjects responding with a reduction in stroke volume index >= 15% were classified as having developed preload dependency. The ability for PPV and SPV to predict preload dependency was expressed by the area under the ROC curve (AUC). Results A breathing frequency at 6/min increased the PPV (16 +/- 5% vs. 10 +/- 3%, p<0.001) and SPV (9 +/- 3% vs. 5 +/- 2%, p<0.001) which was further enhanced by an expiratory resistance (PPV: 19 +/- 3%, p = 0.025 and SPV: 10 +/- 2%, p = 0.047). These respiratory modifications, compared to free breathing, enhanced the predictive value of PPV with higher accuracy (AUC: 0.92 vs. 0.46). Conclusion Under conditions of progressive central hypovolemia, the application of an external respiratory resistance at a breathing frequency of 6/min enhanced PPV and SPV and is worth further study for detection of preload dependency from arterial pressure variations in non-ventilated subjects.	[Bronzwaer, Anne-Sophie G. T.; van Lieshout, Johannes J.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands; [Ouweneel, Dagmar M.] Univ Amsterdam, Acad Med Ctr, AMC Heart Ctr, NL-1105 AZ Amsterdam, Netherlands; [Stok, Wim J.; van Lieshout, Johannes J.] Univ Amsterdam, Acad Med Ctr, Dept Anat Embryol & Physiol, NL-1105 AZ Amsterdam, Netherlands; [Bronzwaer, Anne-Sophie G. T.; Ouweneel, Dagmar M.; Stok, Wim J.; Westerhof, Berend E.; van Lieshout, Johannes J.] Univ Amsterdam, Acad Med Ctr, Ctr Heart Failure Res, Lab Clin Cardiovasc Physiol, NL-1105 AZ Amsterdam, Netherlands; [Westerhof, Berend E.] Edwards Lifesci BMEYE, Amsterdam, Netherlands; [van Lieshout, Johannes J.] Univ Nottingham, Sch Med, MRC Arthrit Res UK Ctr Musculoskeletal Ageing Res, Queens Med Ctr,Sch Life Sci, Nottingham, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Edwards Lifesciences; University of Nottingham	van Lieshout, JJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands.	j.j.vanlieshout@amc.uva.nl	Van Lieshout, Johannes/P-5499-2019; van Lieshout, Johannes J/B-6674-2011	Van Lieshout, Johannes/0000-0002-3646-2122; van Lieshout, Johannes J/0000-0002-3646-2122; Ouweneel, Dagmar/0000-0003-3857-7000				Bartels SA, 2011, J CLIN MONIT COMPUT, V25, P315, DOI 10.1007/s10877-011-9310-4; Bendjelid K, 2003, INTENS CARE MED, V29, P352, DOI 10.1007/s00134-002-1615-9; Bogert LWJ, 2010, ANAESTHESIA, V65, P1119, DOI 10.1111/j.1365-2044.2010.06511.x; Bronzwaer ASGT, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00157; Bundgaard-Nielsen M, 2009, BR J ANAESTH; Convertino VA, 2007, CRIT CARE MED, V35, P1145, DOI 10.1097/01.CCM.0000259464.83188.2C; Dahl MK, 2009, CRIT CARE, V13, DOI 10.1186/cc7760; De Backer D, 2005, INTENS CARE MED, V31, P517, DOI 10.1007/s00134-005-2586-4; De Backer D, 2009, ANESTHESIOLOGY, V110, P1092, DOI 10.1097/ALN.0b013e31819db2a1; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Gisolf J, 2004, AVIAT SPACE ENVIR MD, V75, P1086; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harms MPM, 2003, EXP PHYSIOL, V88, P611, DOI 10.1113/eph8802580; Heenen S, 2006, CRIT CARE, V10, DOI 10.1186/cc4970; Hofer Christoph K, 2011, Acta Anaesthesiol Taiwan, V49, P59, DOI 10.1016/j.aat.2011.05.001; Idris AH, 2007, RESP CARE, V52, P177; Jans O, 2012, BRIT J ANAESTH, V108, P436, DOI 10.1093/bja/aer403; Kim HK, 2008, CRIT CARE MED, V36, P2858, DOI 10.1097/CCM.0b013e3181865aea; Lansdorp B, 2011, BRJ ANAESTH; LENFANT C, 1967, J APPL PHYSIOL, V22, P675, DOI 10.1152/jappl.1967.22.4.675; Marik PE, 2009, CRIT CARE MED, V37, P2642, DOI 10.1097/CCM.0b013e3181a590da; MATZEN S, 1991, CLIN PHYSIOL, V11, P411, DOI 10.1111/j.1475-097X.1991.tb00813.x; Michard F, 2002, CHEST, V121, P2000, DOI 10.1378/chest.121.6.2000; Michard F, 2000, AM J RESP CRIT CARE, V162, P134, DOI 10.1164/ajrccm.162.1.9903035; Monnet X, 2007, CURR OPIN CRIT CARE, V13, P549, DOI 10.1097/MCC.0b013e3282ec68b2; MORENO AH, 1967, AM J PHYSIOL, V213, P455, DOI 10.1152/ajplegacy.1967.213.2.455; Muller L, 2010, INTENS CARE MED, V36, P496, DOI 10.1007/s00134-009-1686-y; Pinsky MR, 2007, CURR OPIN CRIT CARE, V13, P528, DOI 10.1097/MCC.0b013e3282efad97; Preisman S, 2005, BRIT J ANAESTH, V95, P746, DOI 10.1093/bja/aei262; PRIBAN IP, 1963, J PHYSIOL-LONDON, V166, P425, DOI 10.1113/jphysiol.1963.sp007114; Secher N H, 2011, CLIN FLUID THERAPY P, P166; Shum HP, 2011, J CRIT CARE, V26, P613, DOI 10.1016/j.jcrc.2011.02.008; Soubrier S, 2007, INTENS CARE MED, V33, P1117, DOI 10.1007/s00134-007-0644-9; Vallee F, 2009, INTENS CARE MED, V35, P1004, DOI 10.1007/s00134-009-1478-4; van Lieshout JJ, 2005, ACTA ANAESTH SCAND, V49, P1287, DOI 10.1111/j.1399-6576.2005.00841.x; Westerdahl E, 2001, J REHABIL MED, V33, P79; Zollei E, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-40	37	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137364	10.1371/journal.pone.0137364	http://dx.doi.org/10.1371/journal.pone.0137364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335939	Green Submitted, Green Published, gold			2022-12-26	WOS:000360615400055
J	Janganan, TK; Chen, GY; Chen, DL; Menino, JF; Rodrigues, F; Borges-Walmsley, MI; Walmsley, AR				Janganan, Thamarai K.; Chen, Gongyou; Chen, Daliang; Menino, Joao F.; Rodrigues, Fernando; Borges-Walmsley, Maria I.; Walmsley, Adrian R.			A G beta protein and the TupA Co-Regulator Bind to Protein Kinase A Tpk2 to Act as Antagonistic Molecular Switches of Fungal Morphological Changes	PLOS ONE			English	Article							TRANSCRIPTIONAL CO-REPRESSOR; CANDIDA-ALBICANS SFL1; KELCH-REPEAT PROTEINS; STALK-LIKE STRUCTURES; SACCHAROMYCES-CEREVISIAE; CYCLIC-AMP; G-ALPHA; ADENYLATE-CYCLASE; PARACOCCIDIOIDES-BRASILIENSIS; COUPLED RECEPTOR	The human pathogenic fungus Paracoccidioides brasiliensis (Pb) undergoes a morphological transition from a saprobic mycelium to pathogenic yeast that is controlled by the cAMP-signaling pathway. There is a change in the expression of the G beta-protein PbGpb1, which interacts with adenylate cyclase, during this morphological transition. We exploited the fact that the cAMP-signaling pathway of Saccharomyces cerevisiae does not include a G beta-protein to probe the functional role of PbGpb1. We present data that indicates that PbGpb1 and the transcriptional regulator PbTupA both bind to the PKA protein PbTpk2. PbTPK2 was able to complement a TPK2 Delta strain of S. cerevisiae, XPY5a/alpha, which was defective in pseudohyphal growth. Whilst PbGPB1 had no effect on the parent S. cerevisiae strain, MLY61a/alpha, it repressed the filamentous growth of XPY5a/alpha transformed with PbTPK2, behaviour that correlated with a reduced expression of the floculin FLO11. In vitro, PbGpb1 reduced the kinase activity of PbTpk2, suggesting that inhibition of PbTpk2 by PbGpb1 reduces the level of expression of Flo11, antagonizing the filamentous growth of the cells. In contrast, expressing the co-regulator PbTUPA in XPY5a/alpha cells transformed with PbTPK2, but not untransformed cells, induced hyperfilamentous growth, which could be antagonized by co-transforming the cells with PbGPB1. PbTUPA was unable to induce the hyperfilamentous growth of a FLO8 Delta strain, suggesting that PbTupA functions in conjunction with the transcription factor Flo8 to control Flo11 expression. Our data indicates that P. brasiliensis PbGpb1 and PbTupA, both of which have WD/beta-propeller structures, bind to PbTpk2 to act as antagonistic molecular switches of cell morphology, with PbTupA and PbGpb1 inducing and repressing filamentous growth, respectively. Our findings define a potential mechanism for controlling the morphological switch that underpins the virulence of dimorphic fungi.	[Janganan, Thamarai K.; Chen, Gongyou; Chen, Daliang; Borges-Walmsley, Maria I.; Walmsley, Adrian R.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Menino, Joao F.; Rodrigues, Fernando] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal; [Menino, Joao F.] Univ Minho, ICVS PT Govt Associate Lab 3Bs, Braga, Portugal	Durham University; Universidade do Minho; Universidade do Minho	Borges-Walmsley, MI (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	i.borgeswalmsley@me.com	Janganan, Thamarai/AAQ-8705-2020; CHEN, Gongyou/AAA-9694-2019; Rodrigues, Fernando/T-5299-2018	CHEN, Gongyou/0000-0003-1979-2880; Rodrigues, Fernando/0000-0001-8436-9398; Menino, Joao/0000-0003-3778-1747	Wellcome Trust [069445]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants from the Wellcome Trust 069445, and GC and DC were the recipients of Wellcome Trust travelling fellowships. (Wellcome.ac.uk.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alspaugh JA, 2002, EUKARYOT CELL, V1, P75, DOI 10.1128/EC.1.1.75-84.2002; Bahn YS, 2007, EUKARYOT CELL, V6, P2376, DOI 10.1128/EC.00318-07; Barrales RR, 2008, GENETICS, V178, P145, DOI 10.1534/genetics.107.081315; Batlle M, 2003, J CELL SCI, V116, P701, DOI 10.1242/jcs.00266; Bauer J, 2007, EUKARYOT CELL, V6, P1736, DOI 10.1128/EC.00236-07; Baum S, 2004, BIOCHEM J, V380, P823, DOI 10.1042/BJ20031962; Bockmuhl DP, 2001, MOL MICROBIOL, V42, P1243, DOI 10.1046/j.1365-2958.2001.02688.x; Borba CD, 2002, MYCOSES, V45, P174, DOI 10.1046/j.1439-0507.2002.00752.x; Borges-Walmsley MI, 2002, TRENDS MICROBIOL, V10, P80, DOI 10.1016/S0966-842X(01)02292-2; Braun BR, 2000, GENETICS, V156, P31; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; Braun BR, 2001, EMBO J, V20, P4753, DOI 10.1093/emboj/20.17.4753; CAMERON S, 1988, CELL, V53, P555, DOI 10.1016/0092-8674(88)90572-7; Cao F, 2006, MOL BIOL CELL, V17, P295, DOI 10.1091/mbc.E05-06-0502; Chen DL, 2007, MOL MICROBIOL, V65, P761, DOI 10.1111/j.1365-2958.2007.05824.x; Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; Conlan RS, 1999, J BIOL CHEM, V274, P205, DOI 10.1074/jbc.274.1.205; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; D'Souza CA, 2001, MOL CELL BIOL, V21, P3179, DOI 10.1128/MCB.21.9.3179-3191.2001; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; Edwards AS, 2000, CURR OPIN CELL BIOL, V12, P217, DOI 10.1016/S0955-0674(99)00085-X; Engelberg D, 1998, J BACTERIOL, V180, P3992, DOI 10.1128/JB.180.15.3992-3996.1998; Feliciello A, 2001, J MOL BIOL, V308, P99, DOI 10.1006/jmbi.2001.4585; Garcia-Sanchez S, 2005, MOL BIOL CELL, V16, P2913, DOI 10.1091/mbc.E05-01-0071; Gerbasi VR, 2004, MOL CELL BIOL, V24, P8276, DOI 10.1128/MCB.24.18.8276-8287.2004; GERST JE, 1991, MOL CELL BIOL, V11, P1248, DOI 10.1128/MCB.11.3.1248; Goes T, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003173; GOLD S, 1994, GENE DEV, V8, P2805, DOI 10.1101/gad.8.23.2805; Gorner W, 2002, EMBO J, V21, P135, DOI 10.1093/emboj/21.1.135; Grosse C, 2008, APPL ENVIRON MICROB, V74, P4923, DOI 10.1128/AEM.00470-08; Harashima T, 2002, MOL CELL, V10, P163, DOI 10.1016/S1097-2765(02)00569-5; Hirschman JE, 1999, MOL CELL BIOL, V19, P7705; Hoffman CS, 2005, EUKARYOT CELL, V4, P495, DOI 10.1128/EC.4.3.495-503.2005; Hwang CS, 2003, MOL MICROBIOL, V47, P1029, DOI 10.1046/j.1365-2958.2003.03353.x; Ivey FD, 2005, P NATL ACAD SCI USA, V102, P6108, DOI 10.1073/pnas.0502270102; Kadosh D, 2001, MOL CELL BIOL, V21, P2496, DOI 10.1128/MCB.21.7.2496-2505.2001; Kafadar KA, 2004, EUKARYOT CELL, V3, P1147, DOI 10.1128/EC.3.5.1147-1153.2004; Kennedy EJ, 2008, J BIOL CHEM, V283, P1084, DOI 10.1074/jbc.M704028200; Khalaf RA, 2001, GENETICS, V157, P1503; Kido M, 2002, J BIOL CHEM, V277, P3117, DOI 10.1074/jbc.M109526200; Klein BS, 2007, CURR OPIN MICROBIOL, V10, P314, DOI 10.1016/j.mib.2007.04.002; Klosterman SJ, 2007, ADV GENET, V57, P1, DOI 10.1016/S0065-2660(06)57001-4; Kraakman L, 1999, MOL MICROBIOL, V32, P1002, DOI 10.1046/j.1365-2958.1999.01413.x; Lee N, 2003, ANNU REV PHYTOPATHOL, V41, P399, DOI 10.1146/annurev.phyto.41.052002.095728; Lemaire K, 2004, MOL CELL, V16, P293, DOI 10.1016/j.molcel.2004.10.004; Li Y, 2007, EUKARYOT CELL, V6, P2112, DOI 10.1128/EC.00199-07; Liebmann B, 2004, INFECT IMMUN, V72, P5193, DOI 10.1128/IAI.72.9.5193-5203.2004; Liu H, 2007, EMBO J, V26, P690, DOI 10.1038/sj.emboj.7601536; Lo WS, 1998, MOL BIOL CELL, V9, P161, DOI 10.1091/mbc.9.1.161; Lorenz MC, 1997, EMBO J, V16, P7008, DOI 10.1093/emboj/16.23.7008; Malave TM, 2006, BIOCHEM CELL BIOL, V84, P437, DOI 10.1139/O06-073; MATSUMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P2355, DOI 10.1073/pnas.79.7.2355; MBONYI K, 1990, MOL CELL BIOL, V10, P4518, DOI 10.1128/MCB.10.9.4518; MEDOFF J, 1981, J BACTERIOL, V145, P1452, DOI 10.1128/JB.145.3.1452-1455.1981; Menino Joao F, 2012, Methods Mol Biol, V845, P187, DOI 10.1007/978-1-61779-539-8_12; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Murad AMA, 2001, EMBO J, V20, P4742, DOI 10.1093/emboj/20.17.4742; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; NIKAWA J, 1987, GENE DEV, V1, P931, DOI 10.1101/gad.1.9.931; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Pan XW, 2000, CURR OPIN MICROBIOL, V3, P567, DOI 10.1016/S1369-5274(00)00142-9; Pan XW, 2002, MOL CELL BIOL, V22, P3981, DOI 10.1128/MCB.22.12.3981-3993.2002; Pan XW, 1999, MOL CELL BIOL, V19, P4874; PARIS S, 1985, MYCOPATHOLOGIA, V92, P115, DOI 10.1007/BF00444093; Peeters T, 2007, TRENDS BIOCHEM SCI, V32, P547, DOI 10.1016/j.tibs.2007.09.011; Peeters T, 2006, P NATL ACAD SCI USA, V103, P13034, DOI 10.1073/pnas.0509644103; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Robertson LS, 1998, P NATL ACAD SCI USA, V95, P13783, DOI 10.1073/pnas.95.23.13783; Rocha CRC, 2001, MOL BIOL CELL, V12, P3631, DOI 10.1091/mbc.12.11.3631; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; San-Blas G, 2002, MED MYCOL, V40, P225, DOI 10.1080/mmy.40.3.225.242; SASS P, 1986, P NATL ACAD SCI USA, V83, P9303, DOI 10.1073/pnas.83.24.9303; Sastri M, 2005, P NATL ACAD SCI USA, V102, P349, DOI 10.1073/pnas.0408608102; Scherz R, 2001, J BACTERIOL, V183, P5402, DOI 10.1128/JB.183.18.5402-5413.2001; Sezen B, 2009, GENE DEV, V23, P1559, DOI 10.1101/gad.524209; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Slessareva JE, 2006, SCIENCE, V314, P1412, DOI 10.1126/science.1134041; Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; Song WJ, 1998, EMBO J, V17, P5757, DOI 10.1093/emboj/17.19.5757; Storlazzi A, 1999, Mol Cell Biol Res Commun, V2, P172, DOI 10.1006/mcbr.1999.0169; THEVELEIN JM, 1985, J GEN MICROBIOL, V131, P3199; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; Todd RB, 2003, MOL MICROBIOL, V48, P85, DOI 10.1046/j.1365-2958.2003.03426.x; Torres I, 2014, FEMS YEAST RES, V14, P270, DOI 10.1111/1567-1364.12099; Tudisca V, 2010, EUR J CELL BIOL, V89, P339, DOI 10.1016/j.ejcb.2009.08.005; TZAMARIAS D, 1994, NATURE, V369, P758, DOI 10.1038/369758a0; UNO I, 1985, P NATL ACAD SCI USA, V82, P7855, DOI 10.1073/pnas.82.23.7855; Valerius O, 2007, MOL CELL PROTEOMICS, V6, P1968, DOI 10.1074/mcp.M700184-MCP200; Versele M, 1999, EMBO J, V18, P5577, DOI 10.1093/emboj/18.20.5577; Versele M, 2001, EMBO REP, V2, P574, DOI 10.1093/embo-reports/kve132; WILSON RB, 1988, MOL CELL BIOL, V8, P505, DOI 10.1128/MCB.8.1.505; Xue Y, 1998, EMBO J, V17, P1996, DOI 10.1093/emboj/17.7.1996; Zeller CE, 2007, J BIOL CHEM, V282, P25168, DOI 10.1074/jbc.M702569200; Zhao W, 2006, INFECT IMMUN, V74, P4865, DOI 10.1128/IAI.00565-06; ZOLLER MJ, 1988, J BIOL CHEM, V263, P9142	99	1	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136866	10.1371/journal.pone.0136866	http://dx.doi.org/10.1371/journal.pone.0136866			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334875	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000360615400030
J	Junek, T; Vymyslicka, PJ; Hozdecka, K; Hejcmanova, P				Junek, Tomas; Vymyslicka, Pavla Junkova; Hozdecka, Katerina; Hejcmanova, Pavla			Application of Spatial and Closed Capture-Recapture Models on Known Population of the Western Derby Eland (Taurotragus derbianus derbianus) in Senegal	PLOS ONE			English	Article							CAMERA-TRAP; DENSITY-ESTIMATION; ABUNDANCE; SIZE; WILDLIFE; DESIGNS; BIASES; RANGE	Camera trapping with capture-recapture analyses has provided estimates of the abundances of elusive species over the last two decades. Closed capture-recapture models (CR) based on the recognition of individuals and incorporating natural heterogeneity in capture probabilities are considered robust tools; however, closure assumption is often questionable and the use of an M-h jackknife estimator may fail in estimations of real abundance when the heterogeneity is high and data is sparse. A novel, spatially explicit capture-recapture (SECR) approach based on the location-specific capture histories of individuals overcomes the limitations of closed models. We applied both methods on a closed population of 16 critically endangered Western Derby elands in the fenced 1,060-ha Fathala reserve, Senegal. We analyzed the data from 30 cameras operating during a 66-day sampling period deployed in two densities in grid and line arrays. We captured and identified all 16 individuals in 962 trap-days. Abundances were estimated in the programs CAPTURE (models M-0, Mh and Mh Chao) and R, package secr (basic Null and Finite mixture models), and compared with the true population size. We specified 66 days as a threshold in which SECR provides an accurate estimate in all trapping designs within the 7-times divergent density from 0.004 to 0.028 camera trap/ha. Both SECR models showed uniform tendency to overestimate abundance when sampling lasted shorter with no major differences between their outputs. Unlike the closed models, SECR performed well in the line patterns, which indicates promising potential for linear sampling of properly defined habitats of non-territorial and identifiable herbivores in dense wooded savanna conditions. The CR models provided reliable estimates in the grid and we confirmed the advantage of Mh Chao estimator over Mh jackknife when data appeared sparse. We also demonstrated the pooling of trapping occasions with an increase in the capture probabilities, avoiding violation of results.	[Junek, Tomas; Vymyslicka, Pavla Junkova] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague 16521 6, Suchdol, Czech Republic; [Hozdecka, Katerina; Hejcmanova, Pavla] Czech Univ Life Sci Prague, Fac Trop AgriSci, Dept Anim Sci & Food Proc, Prague 16521 6, Suchdol, Czech Republic	Czech University of Life Sciences Prague; Czech University of Life Sciences Prague	Junek, T (corresponding author), Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Kamycka 129, Prague 16521 6, Suchdol, Czech Republic.	tjunek@fzp.czu.cz	Hejcmanová, Pavla/AAD-4910-2021; Vymyslická, Pavla Jůnková/ABH-9466-2020	Hejcmanová, Pavla/0000-0001-9547-4302; Vymyslická, Pavla Jůnková/0000-0001-6915-1876	grant CIGA [20134220]; Czech University of Life Sciences Prague; Postdok CZU [CZ.1.07/2.3.00/30.0040]; Czech University of Life Sciences Prague (CIGA) [20134217]	grant CIGA; Czech University of Life Sciences Prague; Postdok CZU; Czech University of Life Sciences Prague (CIGA)	The project was financially supported by the grant CIGA, reg. No. 20134220 (principal investigator Tomas Junek), provided by the Czech University of Life Sciences Prague and Postdok CZU (ESF and MEYS CZ.1.07/2.3.00/30.0040), principal investigator Pavla Junkova Vymyslicka, provided by the Czech University of Life Sciences Prague (http://www.czu.cz/en/), and Grant of Czech University of Life Sciences Prague (CIGA, reg. number 20134217, principal investigator Pavla Junkova Vymyslicka). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anile S, 2014, J ZOOL, V293, P252, DOI 10.1111/jzo.12141; [Anonymous], 1991, USERS GUIDE INTERACT; Barnes RFW, 1999, MAMMAL REV, V29, P175, DOI 10.1046/j.1365-2907.1999.00044.x; Barrier NF, 2013, APPL PHOTOGRAPHIC CA, V8, P388; Bengsen AJ, 2011, J WILDLIFE MANAGE, V75, P1222, DOI 10.1002/jwmg.132; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Brandlova K., 2013, W DERBY ELAND TAUROT; BURNHAM KP, 1978, BIOMETRIKA, V65, P625, DOI 10.2307/2335915; Burton AC, 2011, BIOL CONSERV, V144, P2344, DOI 10.1016/j.biocon.2011.06.014; Cassey P, 1999, ENVIRONMETRICS, V10, P261, DOI 10.1002/(SICI)1099-095X(199905/06)10:3<261::AID-ENV351>3.0.CO;2-O; CHAO A, 1989, BIOMETRICS, V45, P427, DOI 10.2307/2531487; Chao A, 1987, ESTIMATING POPULATIO; Cooch E, 2009, PROGRAM MARK GENTLE, P1; Dawson DK, 2009, J APPL ECOL, V46, P1201, DOI 10.1111/j.1365-2664.2009.01731.x; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; Dumond M, 2015, WILDLIFE SOC B, V9999, P1; Efford MG, 2013, OIKOS, V122, P918, DOI 10.1111/j.1600-0706.2012.20440.x; Efford MG, 2011, ECOLOGY, V92, P2202, DOI 10.1890/11-0332.1; Foster RJ, 2012, J WILDLIFE MANAGE, V76, P224, DOI 10.1002/jwmg.275; Gerber BD, 2015, ECOL APPL, V25, P695, DOI 10.1890/14-0960.1; Gompper M, 2006, WILDLIFE SOC, V34; Harmsen BJ, 2011, POPUL ECOL, V53, P253, DOI 10.1007/s10144-010-0211-z; Harmsen BJ, 2010, BIOTROPICA, V42, P126, DOI 10.1111/j.1744-7429.2009.00544.x; Heilbrun RD, 2006, WILDLIFE SOC B, V34, P69, DOI 10.2193/0091-7648(2006)34[69:EBAUAT]2.0.CO;2; Henschel P, 2010, CATNEWS, P2006; Henschel P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083500; HILLMAN JC, 1988, AFR J ECOL, V26, P135, DOI 10.1111/j.1365-2028.1988.tb00964.x; Howe EJ, 2013, POPUL ECOL, V55, P595, DOI 10.1007/s10144-013-0389-y; Ivan JS, 2013, ECOLOGY, V94, P817, DOI 10.1890/12-0102.1; Jachmann H, 2002, J APPL ECOL, V39, P841, DOI 10.1046/j.1365-2664.2002.00752.x; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; Karanth KU, 1998, ECOLOGY, V79, P2852; Kelly MJ, 2008, J MAMMAL, V89, P408, DOI 10.1644/06-MAMM-A-424R.1; Kendall WL, 1999, ECOLOGY, V80, P2517, DOI 10.1890/0012-9658(1999)080[2517:ROCCRM]2.0.CO;2; Kolackova K, 2011, WILDLIFE BIOL, V17, P299, DOI 10.2981/10-019; Larrucea ES, 2007, J WILDLIFE MANAGE, V71, P1682, DOI 10.2193/2006-407; Li XY, 2014, POPUL ECOL, V56, P251, DOI 10.1007/s10144-013-0405-2; Maffei L, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P119, DOI 10.1007/978-4-431-99495-4_8; Marnewick K, 2008, S AFR J WILDL RES, V38, P59, DOI 10.3957/0379-4369-38.1.59; Marques TA, 2012, J ORNITHOL, V152, pS445, DOI 10.1007/s10336-010-0535-7; MENKENS GE, 1988, ECOLOGY, V69, P1952, DOI 10.2307/1941172; Nezerkova P, 2004, SOIL CONSERVATION; Nezerkova-Hejcmanova P, 2005, BELG J BOT, V138, P119; O'Brien TG, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P71, DOI 10.1007/978-4-431-99495-4_6; Ogutu JO, 2006, J ZOOL, V269, P149, DOI 10.1111/j.1469-7998.2006.00055.x; Ogutu JO, 2012, BIODIVERS CONSERV, V21, P1033, DOI 10.1007/s10531-012-0239-9; Otis DL., 1982, CAPTURE RECAPTURE RE; Redfern JV, 2002, S AFR J SCI, V98, P455; Renaud PC, 2006, INVENTAIRE AERIEN TE, P74; Rovero F, 2013, HYSTRIX, V24, P148, DOI 10.4404/hystrix-24.2-6316; Royle JA, 2013, ECOLOGY, V94, P287, DOI 10.1890/12-0413.1; Schipper J., 2007, SMALL CARNIVORE CONS, V36, P38; Sharma RK, 2010, ANIM CONSERV, V13, P94, DOI 10.1111/j.1469-1795.2009.00305.x; Silver SC, 2004, ORYX, V38, P148, DOI 10.1017/S0030605304000286; Tchamba MN, 1996, BIOL CONSERV, V75, P35, DOI 10.1016/0006-3207(95)00040-2; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Tobler MW, 2013, BIOL CONSERV, V159, P109, DOI 10.1016/j.biocon.2012.12.009; Treves A, 2010, BIOL CONSERV, V143, P521, DOI 10.1016/j.biocon.2009.11.025; Trolle M, 2003, J MAMMAL, V84, P607, DOI 10.1644/1545-1542(2003)084<0607:EOODIT>2.0.CO;2; Vanderhoff E. Natasha, 2011, Mastozool. neotrop., V18, P271; Wallace R. B., 2003, Mastozoologia Neotropical, V10, P133; Wang SW, 2009, BIOL CONSERV, V142, P606, DOI 10.1016/j.biocon.2008.11.023; Weingarth K, 2012, WALDOKOLOGIE LANDSCH, P1	63	7	7	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136525	10.1371/journal.pone.0136525	http://dx.doi.org/10.1371/journal.pone.0136525			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334997	Green Published, gold, Green Submitted			2022-12-26	WOS:000360615400015
J	Hoefler, A; Athenstaedt, U; Corcoran, K; Ebner, F; Ischebeck, A				Hoefler, Andreas; Athenstaedt, Ursula; Corcoran, Katja; Ebner, Franz; Ischebeck, Anja			Coping with Self-Threat and the Evaluation of Self-Related Traits: An fMRI Study	PLOS ONE			English	Article							ESTEEM; ACTIVATION; ATTENTION; VALENCE	A positive view of oneself is important for a healthy lifestyle. Self-protection mechanisms such as suppressing negative self-related information help us to maintain a positive view of ourselves. This is of special relevance when, for instance, a negative test result threatens our positive self-view. To date, it is not clear which brain areas support self-protective mechanisms under self-threat. In the present functional magnetic resonance imaging (fMRI) study the participants (N = 46) received a (negative vs. positive) performance test feedback before entering the scanner. In the scanner, the participants were instructed to ascribe personality traits either to themselves or to a famous other. Our results showed that participants responded slower to negative self-related traits compared to positive self-related traits. High self-esteem individuals responded slower to negative traits compared to low self-esteem individuals following a self-threat. This indicates that high self-esteem individuals engage more in self-enhancing strategies after a threat by inhibiting negative self-related information more successfully than low self-esteem individuals. This behavioral pattern was mirrored in the fMRI data as dACC correlated positively with trait self-esteem. Generally, ACC activation was attenuated under threat when participants evaluated self-relevant traits and even more for negative self-related traits. We also found that activation in the ACC was negatively correlated with response times, indicating that greater activation of the ACC is linked to better access (faster response) to positive self-related traits and to impaired access (slower response) to negative self-related traits. These results confirm the ACC function as important in managing threatened self-worth but indicate differences in trait self-esteem levels. The fMRI analyses also revealed a decrease in activation within the left Hippocampus and the right thalamus under threat. This indicates that a down-regulation of activation in these regions might also serve as coping mechanism in dealing with self-threat.	[Hoefler, Andreas; Athenstaedt, Ursula; Corcoran, Katja; Ischebeck, Anja] Graz Univ, Dept Psychol, Graz, Austria; [Ischebeck, Anja] BioTechMed Graz, Neurosci, Graz, Austria; [Ebner, Franz] Med Univ Graz, Dept Neuroradiol, Graz, Austria	University of Graz; Medical University of Graz	Hoefler, A (corresponding author), Graz Univ, Dept Psychol, Graz, Austria.	andreas.hoefler@uni-graz.at		Ischebeck, Anja/0000-0002-3493-2848; Corcoran, Katja/0000-0003-1838-9141				Alicke M. D., 2011, HDB SELF ENHANCEMENT; Altstotter-Gleich C., 2000, MOGLICHKEITEN OPERAT; Beer J. S., 2011, HDB SELF ENHANCEMENT, P49; Brett M, 2001, NEUROIMAGE, V13, pS85; D'Argembeau A, 2005, BRIT J PSYCHOL, V96, P457, DOI 10.1348/000712605X53218; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fazio R. H., 1990, J PERS SOC PSYCHOL, V50, P229; Ferring D, 1996, DIAGNOSTICA, V42, P284; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Guillery RW, 1998, TRENDS NEUROSCI, V21, P28, DOI 10.1016/S0166-2236(97)01157-0; HEATHERTON TF, 1991, J PERS SOC PSYCHOL, V60, P895, DOI 10.1037/0022-3514.60.6.895; Hosoda M, 2000, PERCEPT MOTOR SKILL, V90, P1283, DOI 10.2466/PMS.90.3.1283-1294; Hughes BL, 2013, J COGNITIVE NEUROSCI, V25, P613, DOI 10.1162/jocn_a_00343; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Korn CW, 2012, J NEUROSCI, V32, P16832, DOI 10.1523/JNEUROSCI.3016-12.2012; Krendl AC, 2008, PSYCHOL SCI, V19, P168, DOI 10.1111/j.1467-9280.2008.02063.x; Leary MR, 2009, PERS SOC PSYCHOL REV, V13, P151, DOI 10.1177/1088868309342595; Leary MR, 2000, ADV EXP SOC PSYCHOL, V32, P1, DOI 10.1016/S0065-2601(00)80003-9; MARKUS H, 1986, J PERS SOC PSYCHOL, V51, P858, DOI 10.1037/0022-3514.51.4.858; MARKUS H, 1977, J PERS SOC PSYCHOL, V35, P63, DOI 10.1037/0022-3514.35.2.63; McGregor I, 2006, PSYCHOL INQ, V17, P299, DOI 10.1080/10478400701366977; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Onoda K, 2010, SOC COGN AFFECT NEUR, V5, P385, DOI 10.1093/scan/nsq002; Pauly K, 2013, SOC COGN AFFECT NEUR, V8, P878, DOI 10.1093/scan/nss086; Penny W.D., 2004, HUMAN BRAIN FUNCTION, P843; Peukert D., 2010, BIOSPEKTRUM, V16, P639; Portas CM, 1998, J NEUROSCI, V18, P8979; Schmitz TW, 2004, NEUROIMAGE, V22, P941, DOI 10.1016/j.neuroimage.2004.02.018; Sedikides C, 2009, SOC PERSONAL PSYCHOL, V3, P1055, DOI 10.1111/j.1751-9004.2009.00220.x; Sheldon KM, 1997, J PERS SOC PSYCHOL, V73, P1380, DOI 10.1037/0022-3514.73.6.1380; Sherman S.M., 2001, EXPLORING THALAMUS, V1st Edn; Somerville LH, 2010, CEREB CORTEX, V20, P3005, DOI 10.1093/cercor/bhq049; Talairach J., 1988, COPLANAR STEREOTAXIC; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; vanDellen MR, 2011, PERS SOC PSYCHOL REV, V15, P51, DOI 10.1177/1088868310372950; Watson LA, 2008, BRIT J PSYCHOL, V99, P143, DOI 10.1348/000712607X248689; Wheeler C. S., 2007, PERSONALITY SOCIAL P, V11, P324; Wonderlic Inc, 1996, WOND PERS TEST WPT G; Yoshimura S, 2009, BRAIN COGNITION, V69, P218, DOI 10.1016/j.bandc.2008.07.010	42	11	14	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136027	10.1371/journal.pone.0136027	http://dx.doi.org/10.1371/journal.pone.0136027			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26333130	Green Published, Green Submitted, gold			2022-12-26	WOS:000360613800048
J	Login, FH; Wolf-Watz, H				Login, Frederic H.; Wolf-Watz, Hans			YscU/FlhB of Yersinia pseudotuberculosis Harbors a C-terminal Type III Secretion Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEINS; SALMONELLA-TYPHIMURIUM; SUBSTRATE-SPECIFICITY; NEEDLE COMPLEX; ORDER TRANSITION; MESSENGER-RNA; YOP PROTEINS; YSCU; ENTEROCOLITICA; BACTERIAL	All type III secretion systems (T3SS) harbor a member of the YscU/FlhB family of proteins that is characterized by an auto-proteolytic process that occurs at a conserved cytoplasmic NPTH motif. We have previously demonstrated that YscU(CC), the C-terminal peptide generated by auto-proteolysis of Yersinia pseudotuberculosis YscU, is secreted by the T3SS when bacteria are grown in Ca2+ -depleted medium at 37 degrees C. Here, we investigated the secretion of this early T3S-substrate and showed that YscU(CC) encompasses a specific C-terminal T3S signal within the 15 last residues (U-15). U-15 promoted C-terminal secretion of reporter proteins like GST and YopE lacking its native secretion signal. Similar to the "classical" N-terminal secretion signal, U-15 interacted with the ATPase YscN. Although U-15 is critical for YscU(CC) secretion, deletion of the C-terminal secretion signal of YscU(CC) did neither affect Yop secretion nor Yop translocation. However, these deletions resulted in increased secretion of YscF, the needle subunit. Thus, these results suggest that YscU via its C-terminal secretion signal is involved in regulation of the YscF secretion.	Umea Univ, Dept Mol Biol, Umea Ctr Microbial Res, SE-90187 Umea, Sweden; Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea Ctr Microbial Res, SE-90187 Umea, Sweden	Umea University; Umea University	Wolf-Watz, H (corresponding author), Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden.	hans.wolf-watz@molbiol.umu.se			Swedish Research Council; Umea Centre for Microbial Research (UCMR), Umea University, Sweden; Nordic EMBL partnership for Molecular Medicine Sweden (MIMS)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Umea Centre for Microbial Research (UCMR), Umea University, Sweden; Nordic EMBL partnership for Molecular Medicine Sweden (MIMS)	This work was supported by the Swedish Research Council, The Nordic EMBL partnership for Molecular Medicine Sweden (MIMS) and the Umea Centre for Microbial Research (UCMR), Umea University, Sweden. The authors declare that they have no conflicts of interest with the contents of this article.	Agrain C, 2005, MOL MICROBIOL, V56, P54, DOI 10.1111/j.1365-2958.2005.04534.x; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; ALLAOUI A, 1994, J BACTERIOL, V176, P4534, DOI 10.1128/JB.176.15.4534-4542.1994; Allison SE, 2014, J BIOL CHEM, V289, P23734, DOI 10.1074/jbc.M114.578476; Anderson DM, 1997, SCIENCE, V278, P1140, DOI 10.1126/science.278.5340.1140; Arnold R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000376; Bjornfot AC, 2009, J BACTERIOL, V191, P4259, DOI 10.1128/JB.01730-08; BOLIN I, 1985, INFECT IMMUN, V48, P234; Botteaux A, 2010, MICROBIOL-SGM, V156, P2807, DOI 10.1099/mic.0.039651-0; Chen L, 2013, CELL REP, V3, P709, DOI 10.1016/j.celrep.2013.02.025; Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003; Feldman MF, 2003, FEMS MICROBIOL LETT, V219, P151, DOI 10.1016/S0378-1097(03)00042-9; Feldman MF, 2002, MOL MICROBIOL, V46, P1183, DOI 10.1046/j.1365-2958.2002.03241.x; Ferris HU, 2005, J BIOL CHEM, V280, P41236, DOI 10.1074/jbc.M509438200; Frost S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049349; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; Kimura SR, 2001, BIOPHYS J, V80, P635, DOI 10.1016/S0006-3495(01)76044-4; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; KUTSUKAKE K, 1994, J BACTERIOL, V176, P7625, DOI 10.1128/JB.176.24.7625-7629.1994; Lara-Tejero M, 2011, SCIENCE, V331, P1188, DOI 10.1126/science.1201476; Lavander M, 2002, J BACTERIOL, V184, P4500, DOI 10.1128/JB.184.16.4500-4509.2002; Lloyd SA, 2002, MOL MICROBIOL, V43, P51, DOI 10.1046/j.1365-2958.2002.02738.x; Lloyd SA, 2001, MOL MICROBIOL, V39, P520, DOI 10.1046/j.1365-2958.2001.02271.x; Lountos GT, 2009, PROTEIN SCI, V18, P467, DOI 10.1002/pro.56; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Metcalf KJ, 2014, APPL ENVIRON MICROB, V80, P5927, DOI 10.1128/AEM.01330-14; Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000; Panthel K, 2008, INT J MED MICROBIOL, V298, P99, DOI 10.1016/j.ijmm.2007.07.002; PORTNOY DA, 1984, INFECT IMMUN, V43, P108, DOI 10.1128/IAI.43.1.108-114.1984; PORTNOY DA, 1981, J BACTERIOL, V148, P877, DOI 10.1128/JB.148.3.877-883.1981; Radics J, 2014, NAT STRUCT MOL BIOL, V21, P82, DOI 10.1038/nsmb.2722; Riordan KE, 2008, J BACTERIOL, V190, P6204, DOI 10.1128/JB.00467-08; Riordan KE, 2008, MOL MICROBIOL, V68, P1485, DOI 10.1111/j.1365-2958.2008.06247.x; Rodgers L, 2008, J BIOL CHEM, V283, P20857, DOI 10.1074/jbc.M802339200; ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x; ROSQVIST R, 1990, MOL MICROBIOL, V4, P657, DOI 10.1111/j.1365-2958.1990.tb00635.x; Schesser K, 1996, J BACTERIOL, V178, P7227, DOI 10.1128/jb.178.24.7227-7233.1996; Schraidt O, 2011, SCIENCE, V331, P1192, DOI 10.1126/science.1199358; Sorg I, 2007, EMBO J, V26, P3015, DOI 10.1038/sj.emboj.7601731; Sorg JA, 2006, P NATL ACAD SCI USA, V103, P16490, DOI 10.1073/pnas.0605974103; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; Thomas NA, 2005, MOL MICROBIOL, V57, P1762, DOI 10.1111/j.1365-2958.2005.04802.x; Vinatzer BA, 2005, MOL PLANT MICROBE IN, V18, P877, DOI 10.1094/MPMI-18-0877; Wang YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059754; Wang YJ, 2011, BIOINFORMATICS, V27, P777, DOI 10.1093/bioinformatics/btr021; Weise CF, 2014, BIOPHYS J, V107, P1950, DOI 10.1016/j.bpj.2014.09.005; Wilharm G, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-27; Williams AW, 1996, J BACTERIOL, V178, P2960, DOI 10.1128/jb.178.10.2960-2970.1996; Yang Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S47; Zarivach R, 2008, NATURE, V453, P124, DOI 10.1038/nature06832; Zolkiewski M, 2006, MOL MICROBIOL, V61, P1094, DOI 10.1111/j.1365-2958.2006.05309.x	53	5	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26282	26291		10.1074/jbc.M114.633677	http://dx.doi.org/10.1074/jbc.M114.633677			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26338709	Green Published, hybrid			2022-12-26	WOS:000363527300044
J	Park, Y; Han, GS; Mileykovskaya, E; Garrett, TA; Carman, GM				Park, Yeonhee; Han, Gil-Soo; Mileykovskaya, Eugenia; Garrett, Teresa A.; Carman, George M.			Altered Lipid Synthesis by Lack of Yeast Pah1 Phosphatidate Phosphatase Reduces Chronological Life Span	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MEMBRANE GROWTH; PROTEIN-KINASE-C; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-SYNTHESIS; TRIACYLGLYCEROL-METABOLISM; OXIDATIVE-PHOSPHORYLATION; ADENOSINE-TRIPHOSPHATASE; SUPEROXIDE-DISMUTASE; MITOCHONDRIAL ATPASE; MEDIATED REGULATION	In Saccharomyces cerevisiae, Pah1 phosphatidate phosphatase, which catalyzes the dephosphorylation of phosphatidate to yield diacylglycerol, plays a crucial role in the synthesis of the storage lipid triacylglycerol. This evolutionarily conserved enzyme also plays a negative regulatory role in controlling de novo membrane phospholipid synthesis through its consumption of phosphatidate. We found that the pah1 Delta mutant was defective in the utilization of non-fermentable carbon sources but not in oxidative phosphorylation; the mutant did not exhibit major changes in oxygen consumption rate, mitochondrial membrane potential, F1F0-ATP synthase activity, or gross mitochondrial morphology. The pah1 Delta mutant contained an almost normal complement of major mitochondrial phospholipids with some alterations in molecular species. Although oxidative phosphorylation was not compromised in the pah1 Delta mutant, the cellular levels of ATP in quiescent cells were reduced by 2-fold, inversely correlating with a 4-fold increase in membrane phospholipids. In addition, the quiescent pah1 Delta mutant cells had 3-fold higher levels of mitochondrial superoxide and cellular lipid hydroperoxides, had reduced activities of superoxide dismutase 2 and catalase, and were hypersensitive to hydrogen peroxide. Consequently, the pah1 Delta mutant had a shortened chronological life span. In addition, the loss of Tsa1 thioredoxin peroxidase caused a synthetic growth defect with the pah1 Delta mutation. The shortened chronological life span of the pah1 Delta mutant along with its growth defect on non-fermentable carbon sources and hypersensitivity to hydrogen peroxide was suppressed by the loss of Dgk1 diacylglycerol kinase, indicating that the underpinning of pah1 Delta mutant defects was the excess synthesis of membrane phospholipids.	[Park, Yeonhee; Han, Gil-Soo; Carman, George M.] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Dept Food Sci, New Brunswick, NJ 08901 USA; [Park, Yeonhee; Han, Gil-Soo; Carman, George M.] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Mileykovskaya, Eugenia] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Garrett, Teresa A.] Vassar Coll, Dept Chem, Poughkeepsie, NY 12604 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Texas System; University of Texas Health Science Center Houston; Vassar College	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu		Mileykovskaya, Eugenia/0000-0002-8775-4467	National Institutes of Health Grant from USPHS [GM028140]; National Science Foundation Major Research Instrumentation Award [1039659]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028140, R37GM028140] Funding Source: NIH RePORTER	National Institutes of Health Grant from USPHS; National Science Foundation Major Research Instrumentation Award(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM028140 (to G. M. C.) from the USPHS. This work was also supported by National Science Foundation Major Research Instrumentation Award 1039659 (to T. A. G). The authors declare that they have no conflicts of interest with the contents of this article.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; ANGUS WW, 1972, ARCH BIOCHEM BIOPHYS, V151, P483, DOI 10.1016/0003-9861(72)90525-5; Arnold I, 1999, J BIOL CHEM, V274, P36, DOI 10.1074/jbc.274.1.36; ATKINSON KD, 1980, J BACTERIOL, V141, P558, DOI 10.1128/JB.141.2.558-564.1980; Baba T, 2014, J BIOL CHEM, V289, P11497, DOI 10.1074/jbc.M113.531921; Baile MG, 2014, J BIOL CHEM, V289, P1768, DOI 10.1074/jbc.M113.525733; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; BEERS RF, 1952, J BIOL CHEM, V195, P133; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonawitz ND, 2006, MOL CELL BIOL, V26, P4818, DOI 10.1128/MCB.02360-05; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Bozzola J. J, 1999, ELECT MICROSCOPY PRI; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulat E, 2011, J BIOL CHEM, V286, P33819, DOI 10.1074/jbc.M111.269779; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CHAE HZ, 1993, J BIOL CHEM, V268, P16815; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chang YF, 2008, PROG LIPID RES, V47, P333, DOI 10.1016/j.plipres.2008.03.004; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Choi HS, 2010, J BIOL CHEM, V285, P11526, DOI 10.1074/jbc.M110.100727; Connerth M, 2012, SCIENCE, V338, P815, DOI 10.1126/science.1225625; Csaki LS, 2013, PROG LIPID RES, V52, P305, DOI 10.1016/j.plipres.2013.04.001; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Donkor J, 2009, J BIOL CHEM, V284, P29968, DOI 10.1074/jbc.M109.023663; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Fakas S, 2011, J BIOL CHEM, V286, P1464, DOI 10.1074/jbc.M110.194308; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Garrett TA, 2009, J LIPID RES, V50, P1589, DOI 10.1194/jlr.M800549-JLR200; Gaspar ML, 2011, J BIOL CHEM, V286, P1696, DOI 10.1074/jbc.M110.172296; Genova ML, 2015, ANTIOXID REDOX SIGN, V23, P208, DOI 10.1089/ars.2014.6214; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Goldsteins G, 2008, J BIOL CHEM, V283, P8446, DOI 10.1074/jbc.M706111200; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2004, J BIOL CHEM, V279, P5338, DOI 10.1074/jbc.M311779200; HANSON BA, 1980, J LIPID RES, V21, P309; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; HENRY SA, 1973, J BACTERIOL, V116, P1293, DOI 10.1128/JB.116.3.1293-1303.1973; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HOSAKA K, 1984, BIOCHIM BIOPHYS ACTA, V796, P110; Hsieh LS, 2015, J BIOL CHEM, V290, P11467, DOI 10.1074/jbc.M115.648659; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Jesch SA, 2010, J BIOL CHEM, V285, P41947, DOI 10.1074/jbc.M110.188607; JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N; Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kim HB, 2010, MOL CELL BIOL, V30, P3126, DOI 10.1128/MCB.01671-09; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lindegaard B, 2007, INT J OBESITY, V31, P449, DOI 10.1038/sj.ijo.0803434; Liu J, 2013, AGING CELL, V12, P833, DOI 10.1111/acel.12107; Longo VD, 1999, ARCH BIOCHEM BIOPHYS, V365, P131, DOI 10.1006/abbi.1999.1158; Lussier M, 1997, GENETICS, V147, P435; MACINO G, 1979, J BIOL CHEM, V254, P4617; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Michot C, 2013, BBA-MOL BASIS DIS, V1832, P2103, DOI 10.1016/j.bbadis.2013.07.021; Mul JD, 2011, J BIOL CHEM, V286, P26781, DOI 10.1074/jbc.M110.197947; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nadra K, 2012, MOL CELL BIOL, V32, P4794, DOI 10.1128/MCB.00512-12; Natter K, 2013, BBA-MOL CELL BIOL L, V1831, P314, DOI 10.1016/j.bbalip.2012.09.003; NIKI E, 1991, AM J CLIN NUTR, V53, pS201, DOI 10.1093/ajcn/53.1.201S; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Parrella E, 2008, METHODS, V46, P256, DOI 10.1016/j.ymeth.2008.10.004; Pascual F, 2014, J BIOL CHEM, V289, P9811, DOI 10.1074/jbc.M114.550103; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; PULLMAN ME, 1960, J BIOL CHEM, V235, P3322; Qi WJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002836; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; Rose MD., 1990, METHODS YEAST GENETI; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Ruiz C, 1999, YEAST, V15, P1001; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Skipski V P, 1975, Methods Enzymol, V35, P396, DOI 10.1016/0076-6879(75)35178-1; SOMLO M, 1968, EUR J BIOCHEM, V5, P276, DOI 10.1111/j.1432-1033.1968.tb00368.x; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Su WM, 2014, J BIOL CHEM, V289, P34699, DOI 10.1074/jbc.M114.614883; Su WM, 2014, J BIOL CHEM, V289, P18818, DOI 10.1074/jbc.M114.581462; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; TODD RD, 1980, J BIOL CHEM, V255, P5461; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Xu Z, 2012, J LIPID RES, V53, P522, DOI 10.1194/jlr.M022798; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang PX, 2014, CELL METAB, V20, P267, DOI 10.1016/j.cmet.2014.05.003; Zhong Q, 2004, J BIOL CHEM, V279, P32294, DOI 10.1074/jbc.M403275200	117	34	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25382	25394		10.1074/jbc.M115.680314	http://dx.doi.org/10.1074/jbc.M115.680314			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26338708	Green Published, hybrid			2022-12-26	WOS:000362962800016
J	Buchholz, S; Tietze, H; Kowarik, I; Schirmel, J				Buchholz, Sascha; Tietze, Hedwig; Kowarik, Ingo; Schirmel, Jens			Effects of a Major Tree Invader on Urban Woodland Arthropods	PLOS ONE			English	Article							ROBINIA-PSEUDOACACIA; SPECIES-DIVERSITY; INVASIVE PLANTS; ALIEN; COMMUNITIES; ASSEMBLAGES; IMPACTS; URBANIZATION; BIODIVERSITY; VEGETATION	Biological invasions are a major threat to biodiversity; however, the degree of impact can vary depending on the ecosystem and taxa. Here, we test whether a top invader at a global scale, the tree Robinia pseudoacacia (black locust or false acacia), which is known to profoundly change site conditions, significantly affects urban animal diversity. As a first multitaxon study of this kind, we analyzed the effects of Robinia dominance on 18 arthropod taxa by pairwise comparisons of woodlands in Berlin, Germany, that were dominated by R. pseudoacacia or the native pioneer tree Betula pendula. As a negative effect, abundances of five arthropod taxa decreased (Chilopoda, Formicidae, Diptera, Heteroptera, Hymenoptera); 13 others were not affected. Woodland type affected species composition of carabids and functional groups in spiders, but surprisingly did not decrease alpha and beta diversity of carabid and spider assemblages or the number of endangered species. Tree invasion thus did not induce biotic homogenization at the habitat scale. We detected no positive effects of alien dominance. Our results illustrate that invasions by a major tree invader can induce species turnover in ground-dwelling arthropods, but do not necessarily reduce arthropod species abundances or diversity and might thus contribute to the conservation of epigeal invertebrates in urban settings. Considering the context of invasion impacts thus helps to set priorities in managing biological invasions and can illustrate the potential of novel ecosystems to maintain urban biodiversity.	[Buchholz, Sascha; Tietze, Hedwig; Kowarik, Ingo] Tech Univ Berlin, Dept Ecol, Berlin, Germany; [Buchholz, Sascha; Kowarik, Ingo] Berlin Brandenburg Inst Adv Biodivers Res BBIB, D-14195 Berlin, Germany; [Schirmel, Jens] Univ Koblenz Landau, Inst Environm Sci, Landau, Germany	Technical University of Berlin; University of Koblenz & Landau	Buchholz, S (corresponding author), Tech Univ Berlin, Dept Ecol, Berlin, Germany.	sascha.buchholz@tu-berlin.de	Schirmel, Jens/I-3467-2012	Schirmel, Jens/0000-0003-0330-3376				Agosti D, 2000, BIOL DIVERSITY HDB S; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1996, SPIDERS BRITAIN NO E; Bartz R, 2010, CONSERV BIOL, V24, P675, DOI 10.1111/j.1523-1739.2009.01385.x; Blackburn TM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001850; Briggs J. C., 2013, ENV SKEPTICS CRITICS, V2, P73; Brown JH, 2001, OECOLOGIA, V126, P321, DOI 10.1007/s004420000536; Buchholz S, 2013, INSECT SCI, V20, P662, DOI 10.1111/j.1744-7917.2012.01556.x; Bultman TL, 2008, BIOL INVASIONS, V10, P749, DOI 10.1007/s10530-007-9168-z; Castro-Diez P, 2009, BIOL INVASIONS, V11, P1973, DOI 10.1007/s10530-008-9374-3; Castro-Diez P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100254; Cierjacks A, 2013, J ECOL, V101, P1623, DOI 10.1111/1365-2745.12162; DAISIE (Delivering Alien Invasive Species Inventories for Europe), 2013, HDB ALIEN SPECIES EU; de Groot M, 2007, BIOL CONSERV, V136, P612, DOI 10.1016/j.biocon.2007.01.005; Entling W, 2007, GLOBAL ECOL BIOGEOGR, V16, P440, DOI 10.1111/j.1466-8238.2006.00305.x; Fischer LK, 2009, J BIOGEOGR, V36, P2251, DOI 10.1111/j.1365-2699.2009.02173.x; Gotelli NJ, 2011, MYRMECOL NEWS, V15, P13; Hejda M, 2009, J ECOL, V97, P393, DOI 10.1111/j.1365-2745.2009.01480.x; Irmler Ulrich, 2004, Faunistisch-Oekologische Mitteilungen Supplement, V32, P1; Jager H, 2007, BIOL CONSERV, V140, P297, DOI 10.1016/j.biocon.2007.08.014; Jeschke JM, 2014, CONSERV BIOL, V28, P1188, DOI 10.1111/cobi.12299; Jones EL, 2012, EUR J ENTOMOL, V109, P463, DOI 10.14411/eje.2012.060; KENNEDY CEJ, 1984, J ANIM ECOL, V53, P455, DOI 10.2307/4528; Kielhorn K-H., 2005, LANDESBEAUFTRAGTE NA; Kleinbauer I, 2010, BIOL CONSERV, V143, P382, DOI 10.1016/j.biocon.2009.10.024; Kowarik I, 2005, WILD URBAN WOODLANDS: NEW PERSPECTIVES FOR URBAN FORESTRY, P287, DOI 10.1007/3-540-26859-6_18; Kowarik I, 2013, PRESLIA, V85, P113; Kowarik I, 2011, ENVIRON POLLUT, V159, P1974, DOI 10.1016/j.envpol.2011.02.022; Kuhn I, 2006, BIOL CONSERV, V127, P292, DOI 10.1016/j.biocon.2005.06.033; Lambdon PW, 2008, PRESLIA, V80, P101; Liu Jian, 2012, NeoBiota, P27; Lundholm JT, 2010, J APPL ECOL, V47, P966, DOI 10.1111/j.1365-2664.2010.01857.x; Masaka K, 2013, FOREST SCI, V59, P589, DOI 10.5849/forsci.11-106; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Moron D, 2009, BIOL CONSERV, V142, P1322, DOI 10.1016/j.biocon.2008.12.036; Muff P, 2009, INSECT CONSERV DIVER, V2, P36, DOI 10.1111/j.1752-4598.2008.00037.x; MULLER-MOTZFELD G., 2006, KALER MITTELEUROPAS, V2; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Pataki D. E., 2006, CLIMATIC CHANGE, V12, P1, DOI DOI 10.1111/J.1365-2486.2006.01242.X; Pearce JL, 2004, BIODIVERS CONSERV, V13, P1305, DOI 10.1023/B:BIOC.0000019403.26948.55; Platen R, 2005, LANDESBEAUFTRAGTE NA; Platen Ralph, 1995, Verhandlungen der Gesellschaft fuer Oekologie, V24, P431; Powell KI, 2013, SCIENCE, V339, P316, DOI 10.1126/science.1226817; Pysek P, 2008, TRENDS ECOL EVOL, V23, P237, DOI 10.1016/j.tree.2008.02.002; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; Rejmanek M., 2005, VEGETATION ECOLOGY, DOI DOI 10.1002/9781118452592.CH13; Ricciardi A, 2013, ECOL MONOGR, V83, P263, DOI 10.1890/13-0183.1; Richardson DM, 2011, DIVERS DISTRIB, V17, P788, DOI 10.1111/j.1472-4642.2011.00782.x; Roberts M. J., 1987, SPIDERGREAT BRITAI, VII; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sattler T, 2011, LANDSCAPE URBAN PLAN, V103, P347, DOI 10.1016/j.landurbplan.2011.08.008; Sax DF, 2002, GLOBAL ECOL BIOGEOGR, V11, P49, DOI 10.1046/j.1466-822X.2001.00262.x; Schirmel J, 2013, BIOL INVASIONS, V15, P1089, DOI 10.1007/s10530-012-0352-4; Schirmel J, 2011, BIOL INVASIONS, V13, P605, DOI 10.1007/s10530-010-9852-2; Schlaepfer MA, 2011, CONSERV BIOL, V25, P428, DOI 10.1111/j.1523-1739.2010.01646.x; Schlick-Steiner BC, 2006, INSECT SOC, V53, P274, DOI 10.1007/s00040-006-0869-6; Schweiger O, 2010, BIOL REV, V85, P777, DOI 10.1111/j.1469-185X.2010.00125.x; SEIFERT B, 2007, AMEISEN MITTEL NORDE; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Sitzia T, 2012, FOREST ECOL MANAG, V285, P85, DOI 10.1016/j.foreco.2012.08.016; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Thomas CD, 2013, NATURE, V502, P7, DOI 10.1038/502007a; Topp W, 2008, BIOL INVASIONS, V10, P381, DOI 10.1007/s10530-007-9137-6; Trentanovi G, 2013, DIVERS DISTRIB, V19, P738, DOI 10.1111/ddi.12028; Venables WN., 2002, MODERN APPL STAT S 4; Vergnes A, 2014, BIODIVERS CONSERV, V23, P1859, DOI 10.1007/s10531-014-0689-3; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Vitkova M, 2015, SCI TOTAL ENVIRON, V505, P315, DOI 10.1016/j.scitotenv.2014.09.104; Von Holle B, 2006, BIODIVERS CONSERV, V15, P2197, DOI 10.1007/s10531-004-6906-8; Von Holle B, 2013, OECOLOGIA, V172, P915, DOI 10.1007/s00442-012-2543-1; Wei XR, 2009, AFR J BIOTECHNOL, V8, P2984; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; 조광진, 2005, Journal of Ecology and Environment, V28, P15; [No title captured]	75	23	23	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137723	10.1371/journal.pone.0137723	http://dx.doi.org/10.1371/journal.pone.0137723			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359665	Green Submitted, Green Published, gold			2022-12-26	WOS:000361043100075
J	Hedna, K; Hakkarainen, KM; Gyllensten, H; Jonsson, AK; Sundell, KA; Petzold, M; Hagg, S				Hedna, Khedidja; Hakkarainen, Katja M.; Gyllensten, Hanna; Jonsson, Anna K.; Sundell, Karolina Andersson; Petzold, Max; Hagg, Staffan			Adherence to Antihypertensive Therapy and Elevated Blood Pressure: Should We Consider the Use of Multiple Medications?	PLOS ONE			English	Article							HYPERTENSION TREATMENT; DRUG ADHERENCE; PERSISTENCE; NONADHERENCE; OUTCOMES	Background Although a majority of patients with hypertension require a multidrug therapy, this is rarely considered when measuring adherence from refill data. Moreover, investigating the association between refill non-adherence to antihypertensive therapy (AHT) and elevated blood pressure (BP) has been advocated. Objective Identify factors associated with non-adherence to AHT, considering the multidrug therapy, and investigate the association between non-adherence to AHT and elevated BP. Methods A retrospective cohort study including patients with hypertension, identified from a random sample of 5025 Swedish adults. Two measures of adherence were estimated by the proportion of days covered method (PDC >= 80%): (1) Adherence to any antihypertensive medication and, (2) adherence to the full AHT regimen. Multiple logistic regressions were performed to investigate the association between sociodemographic factors (age, sex, education, income), clinical factors (user profile, number of antihypertensive medications, healthcare use, cardiovascular comorbidities) and non-adherence. Moreover, the association between non-adherence (long-term and a month prior to BP measurement) and elevated BP was investigated. Results Non-adherence to any antihypertensive medication was higher among persons < 65 years (Odds Ratio, OR 2.75 [95% CI, 1.18-6.43]) and with the lowest income (OR 2.05 [95% CI, 1.01-4.16]). Non-adherence to the full AHT regimen was higher among new users (OR 2.04 [95% CI, 1.32-3.15]), persons using specialized healthcare (OR 1.63, [95% CI, 1.14-2.32]), and having multiple antihypertensive medications (OR 1.85 [95% CI, 1.25-2.75] and OR 5.22 [95% CI, 3.48-7.83], for 2 and >= 3 antihypertensive medications, respectively). Non-adherence to any antihypertensive medication a month prior to healthcare visit was associated with elevated BP. Conclusion Sociodemographic factors were associated with non-adherence to any antihypertensive medication while clinical factors with non-adherence to the full AHT regimen. These differing findings support considering the use of multiple antihypertensive medications when measuring refill adherence. Monitoring patients' refill adherence prior to healthcare visit may facilitate interpreting elevated BP.	[Hedna, Khedidja; Hagg, Staffan] Linkoping Univ, Dept Drug Res Clin Pharmacol, Linkoping, Sweden; [Hedna, Khedidja; Hakkarainen, Katja M.; Gyllensten, Hanna] Nord Sch Publ Hlth NHV, Gothenburg, Sweden; [Hakkarainen, Katja M.] EPID Res, Espoo, Finland; [Gyllensten, Hanna] Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, Stockholm, Sweden; [Jonsson, Anna K.] Linkoping Univ, Dept Clin Pharmacol, Linkoping, Sweden; [Jonsson, Anna K.] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Sundell, Karolina Andersson] Univ Gothenburg, Sect Social Med, Gothenburg, Sweden; [Petzold, Max] Univ Gothenburg, Ctr Appl Biostat, Gothenburg, Sweden; [Hagg, Staffan] Futurum, Jonkoping Cty Council, Jonkoping, Sweden	Linkoping University; Karolinska Institutet; Linkoping University; Linkoping University; University of Gothenburg; University of Gothenburg; Futurum	Hedna, K (corresponding author), Linkoping Univ, Dept Drug Res Clin Pharmacol, Linkoping, Sweden.	khedidja.hedna@liu.se	Hägg, Staffan/G-5612-2013; Gyllensten, Hanna/H-7378-2016	Hägg, Staffan/0000-0002-5137-8420; Gyllensten, Hanna/0000-0001-6890-5162; fuchs, flavio/0000-0002-1191-0523	National Corporation of Swedish Pharmacies; Linkoping University; Ostergotland County Council	National Corporation of Swedish Pharmacies; Linkoping University; Ostergotland County Council	The project was funded through unrestricted grants from The National Corporation of Swedish Pharmacies, Linkoping University and Ostergotland County Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basak R, 2014, J MANAG CARE SPEC PH, V20, P815, DOI 10.18553/jmcp.2014.20.8.815; Bramley TJ, 2006, J MANAGE CARE PHARM, V12, P239, DOI 10.18553/jmcp.2006.12.3.239; Brookhart MA, 2007, AM J EPIDEMIOL, V166, P348, DOI 10.1093/aje/kwm070; Burnier M, 2013, HYPERTENSION, V62, P218, DOI 10.1161/HYPERTENSIONAHA.113.00687; Chapman RH, 2005, ARCH INTERN MED, V165, P1147, DOI 10.1001/archinte.165.10.1147; Choudhry NK, 2014, AM HEART J, V167, P51, DOI 10.1016/j.ahj.2013.09.014; Choudhry NK, 2011, ARCH INTERN MED, V171, P814, DOI 10.1001/archinternmed.2010.495; Choudhry NK, 2009, AM J MANAG CARE, V15, P457; De Smet PAGM, 2004, DRUGS, V64, P1779, DOI 10.2165/00003495-200464160-00005; Fischer MA, 2010, J GEN INTERN MED, V25, P284, DOI 10.1007/s11606-010-1253-9; Fung V, 2007, CLIN THER, V29, P972, DOI 10.1016/j.clinthera.2007.05.010; Granger BB, 2011, CURR OPIN CARDIOL, V26, P279, DOI 10.1097/HCO.0b013e328347c150; Hansen RA, 2009, ANN PHARMACOTHER, V43, P413, DOI 10.1345/aph.1L496; Hasford J, 2007, EUR J CLIN PHARMACOL, V63, P1055, DOI 10.1007/s00228-007-0340-2; Ishisaka DY, 2012, J AM SOC HYPERTENS, V6, P201, DOI 10.1016/j.jash.2012.02.004; Jones I, 1998, BRIT J GEN PRACT, V48, P903; Kirkman MS, 2015, DIABETES CARE, V38, P604, DOI 10.2337/dc14-2098; Krueger KP, 2005, ADV THER, V22, P313, DOI 10.1007/BF02850081; Lagu T, 2009, AM J MANAG CARE, V15, P24; Lim Gregory B, 2013, Nat Rev Cardiol, V10, P59, DOI 10.1038/nrcardio.2012.194; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Marshall IJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e3953; Ninomiya T, 2013, BMJ-BRIT MED J, V347, pf5680; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pladevall M, 2004, DIABETES CARE, V27, P2800, DOI 10.2337/diacare.27.12.2800; Raebel MA, 2013, MED CARE, V51, pS11, DOI 10.1097/MLR.0b013e31829b1d2a; Svensson S, 2000, INT J CARDIOL, V76, P157, DOI 10.1016/S0167-5273(00)00374-0; Turner BJ, 2008, ANN INTERN MED, V148, P578, DOI 10.7326/0003-4819-148-8-200804150-00002; Vinker S, 2008, EXPERT OPIN PHARMACO, V9, P1271, DOI 10.1517/14656566.9.8.1271 ; Wamala S, 2007, INT J QUAL HEALTH C, V19, P134, DOI 10.1093/intqhc/mzm011; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Wolf-Maier K, 2004, HYPERTENSION, V43, P10, DOI 10.1161/01.HYP.0000103630.72812.10; World Health Organization, 2003, ADH LONG TERM THER	34	41	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137451	10.1371/journal.pone.0137451	http://dx.doi.org/10.1371/journal.pone.0137451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359861	Green Published, gold, Green Submitted			2022-12-26	WOS:000361043100040
J	Chiu, TY; Chiang, HJK; Huang, RY; Jiang, JHR; Fages, F				Chiu, Tai-Yin; Chiang, Hui-Ju K.; Huang, Ruei-Yang; Jiang, Jie-Hong R.; Fages, Francois			Synthesizing Configurable Biochemical Implementation of Linear Systems from Their Transfer Function Specifications	PLOS ONE			English	Article							DNA STRAND DISPLACEMENT; BRANCH MIGRATION; DESIGN; COMPUTATION; CIRCUITS; KINETICS; CONSTRUCTION; CASCADES; NETWORK; DEVICES	The ability to engineer synthetic systems in the biochemical context is constantly being improved and has a profound societal impact. Linear system design is one of the most pervasive methods applied in control tasks, and its biochemical realization has been proposed by Oishi and Klavins and advanced further in recent years. However, several technical issues remain unsolved. Specifically, the design process is not fully automated from specification at the transfer function level, systems once designed often lack dynamic adaptivity to environmental changes, matching rate constants of reactions is not always possible, and implementation may be approximative and greatly deviate from the specifications. Building upon the work of Oishi and Klavins, this paper overcomes these issues by introducing a design flow that transforms a transfer-function specification of a linear system into a set of chemical reactions, whose input-output response precisely conforms to the specification. This system is implementable using the DNA strand displacement technique. The underlying configurability is embedded into primitive components and template modules, and thus the entire system is adaptive. Simulation of DNA strand displacement implementation confirmed the feasibility and superiority of the proposed synthesis flow.	[Chiu, Tai-Yin] Natl Taiwan Univ, Dept Phys, Taipei 10764, Taiwan; [Chiu, Tai-Yin; Chiang, Hui-Ju K.; Huang, Ruei-Yang; Jiang, Jie-Hong R.] Natl Taiwan Univ, Grad Inst Elect Engn, Taipei 10764, Taiwan; [Chiang, Hui-Ju K.; Fages, Francois] Inria Paris Rocquencourt, EPI Lifeware, Rocquencourt, France; [Jiang, Jie-Hong R.] Natl Taiwan Univ, Dept Elect Engn, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Jiang, JHR (corresponding author), Natl Taiwan Univ, Grad Inst Elect Engn, Taipei 10764, Taiwan.	jhjiang@ntu.edu.tw	Fages, Francois/F-7137-2015; Jiang, Jie-Hong R./P-1759-2014		Ministry of Science and Technology, Taiwan	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	Funding: The Ministry of Science and Technology, Taiwan, provided support in the form of salaries for authors Tai-Yin Chiu, Hui-Ju Chiang, Ruei-Yang Huang, and Jie-Hong R. Jiang, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Amir Y, 2014, NAT NANOTECHNOL, V9, P353, DOI [10.1038/NNANO.2014.58, 10.1038/nnano.2014.58]; Bath J, 2007, NAT NANOTECHNOL, V2, P275, DOI 10.1038/nnano.2007.104; Cardelli L, 2013, MATH STRUCT COMP SCI, V23, P247, DOI 10.1017/S0960129512000102; Cardelli L, 2009, LECT NOTES COMPUT SC, V5877, P12, DOI 10.1007/978-3-642-10604-0_2; Chandran H, 2011, LECT NOTES COMPUT SC, V6937, P64, DOI 10.1007/978-3-642-23638-9_8; Daniel R, 2013, NATURE, V497, P619, DOI 10.1038/nature12148; Densmore D, 2012, IEEE DES TEST COMPUT, V29, P7, DOI 10.1109/MDT.2012.2193370; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gopalkrishnan N, 2011, FDN NAN M FNANO; GREEN C, 1981, NUCLEIC ACIDS RES, V9, P1905, DOI 10.1093/nar/9.8.1905; Green SJ, 2006, BIOPHYS J, V91, P2966, DOI 10.1529/biophysj.106.084681; Gyorgy A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003486; HOLLOMAN WK, 1975, P NATL ACAD SCI USA, V72, P2394, DOI 10.1073/pnas.72.6.2394; KLONOWSKI W, 1983, BIOPHYS CHEM, V18, P73, DOI 10.1016/0301-4622(83)85001-7; Lakin MR, 2012, J R SOC INTERFACE, V9, P1470, DOI 10.1098/rsif.2011.0800; Lakin MR, 2012, J R SOC INTERFACE, V9, P470, DOI 10.1098/rsif.2011.0343; Lakin MR, 2011, BIOINFORMATICS, V27, P3211, DOI 10.1093/bioinformatics/btr543; Li QQ, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e5; Oishi K, 2011, IET SYST BIOL, V5, P252, DOI 10.1049/iet-syb.2010.0056; Padirac A, 2013, CURR OPIN BIOTECH, V24, P575, DOI 10.1016/j.copbio.2012.11.011; Padirac A, 2012, P NATL ACAD SCI USA, V109, pE3212, DOI 10.1073/pnas.1212069109; PANYUTIN IG, 1994, P NATL ACAD SCI USA, V91, P2021, DOI 10.1073/pnas.91.6.2021; PHILLIPS A, 2009, J R SOC INTERFACE S4, V6, DOI DOI 10.1098/RSIF.2009.0072.FOCUS; Qian L, 2011, NATURE, V475, P368, DOI 10.1038/nature10262; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; ROBINSON BH, 1987, BIOPHYS J, V51, P611, DOI 10.1016/S0006-3495(87)83386-6; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Sohka T, 2009, P NATL ACAD SCI USA, V106, P10135, DOI 10.1073/pnas.0901246106; Soloveichik D, 2010, P NATL ACAD SCI USA, V107, P5393, DOI 10.1073/pnas.0909380107; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; WEINSTOCK PH, 1990, NUCLEIC ACIDS RES, V18, P4207, DOI 10.1093/nar/18.14.4207; Yordanov B, 2014, ACS SYNTH BIOL, V3, P600, DOI 10.1021/sb400169s; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Yurke B., 2003, Genetic Programming and Evolvable Machines, V4, P111, DOI 10.1023/A:1023928811651; Zhang DY, 2007, SCIENCE, V318, P1121, DOI 10.1126/science.1148532; Zhang DY, 2011, NAT CHEM, V3, P103, DOI [10.1038/nchem.957, 10.1038/NCHEM.957]; Zhang DY, 2009, J AM CHEM SOC, V131, P17303, DOI 10.1021/ja906987s	38	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137442	10.1371/journal.pone.0137442	http://dx.doi.org/10.1371/journal.pone.0137442			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352855	Green Published, Green Submitted, gold			2022-12-26	WOS:000360932800086
J	Kalderstam, J; Eden, P; Ohlsson, M				Kalderstam, Jonas; Eden, Patrik; Ohlsson, Mattias			Finding Risk Groups by Optimizing Artificial Neural Networks on the Area under the Survival Curve Using Genetic Algorithms	PLOS ONE			English	Article								We investigate a new method to place patients into risk groups in censored survival data. Properties such as median survival time, and end survival rate, are implicitly improved by optimizing the area under the survival curve. Artificial neural networks (ANN) are trained to either maximize or minimize this area using a genetic algorithm, and combined into an ensemble to predict one of low, intermediate, or high risk groups. Estimated patient risk can influence treatment choices, and is important for study stratification. A common approach is to sort the patients according to a prognostic index and then group them along the quartile limits. The Cox proportional hazards model (Cox) is one example of this approach. Another method of doing risk grouping is recursive partitioning (Rpart), which constructs a decision tree where each branch point maximizes the statistical separation between the groups. ANN, Cox, and Rpart are compared on five publicly available data sets with varying properties. Cross-validation, as well as separate test sets, are used to validate the models. Results on the test sets show comparable performance, except for the smallest data set where Rpart's predicted risk groups turn out to be inverted, an example of crossing survival curves. Cross-validation shows that all three models exhibit crossing of some survival curves on this small data set but that the ANN model manages the best separation of groups in terms of median survival time before such crossings. The conclusion is that optimizing the area under the survival curve is a viable approach to identify risk groups. Training ANNs to optimize this area combines two key strengths from both prognostic indices and Rpart. First, a desired minimum group size can be specified, as for a prognostic index. Second, the ability to utilize non-linear effects among the covariates, which Rpart is also able to do.	[Kalderstam, Jonas; Eden, Patrik; Ohlsson, Mattias] Lund Univ, Dept Astron & Theoret Phys, Lund, Sweden	Lund University	Kalderstam, J (corresponding author), Lund Univ, Dept Astron & Theoret Phys, Lund, Sweden.	jonask@thep.lu.se		Ohlsson, Mattias/0000-0003-1145-4297	Swedish Foundation for Strategic Research	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	Funding: Funding provided by the Swedish Foundation for Strategic Research (http://www.createhealth.lth.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed FE, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-29; Amato F, 2013, J APPL BIOMED, V11, P47, DOI 10.2478/v10136-012-0031-x; [Anonymous], 2014, R LANG ENV STAT COMP; Banerjee M, 2000, CANCER, V89, P404, DOI 10.1002/1097-0142(20000715)89:2<404::AID-CNCR28>3.0.CO;2-M; Bishop C. M, 2006, PATTERN RECOGNITION; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Breslow NE, 1999, J R STAT SOC C-APPL, V48, P457, DOI 10.1111/1467-9876.00165; COX DR, 1972, J R STAT SOC B, V34, P187; Dispenzieri A, 2012, MAYO CLIN PROC, V87, P517, DOI 10.1016/j.mayocp.2012.03.009; Goldberg D.E., 1989, GENETIC ALGORITHMS S; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Kalderstam J, 2013, ARTIF INTELL MED, V58, P125, DOI 10.1016/j.artmed.2013.03.001; Lisboa PJ, 2006, NEURAL NETWORKS, V19, P408, DOI 10.1016/j.neunet.2005.10.007; Lisboa PJG, 2002, NEURAL NETWORKS, V15, P11, DOI 10.1016/S0893-6080(01)00111-3; LOPRINZI CL, 1994, J CLIN ONCOL, V12, P601, DOI 10.1200/JCO.1994.12.3.601; MOERTEL CG, 1990, NEW ENGL J MED, V322, P352, DOI 10.1056/NEJM199002083220602; Montana D. J., 1989, IJCAI-89 Proceedings of the Eleventh International Joint Conference on Artificial Intelligence, P762; SEGAL MR, 1988, BIOMETRICS, V44, P35, DOI 10.2307/2531894; Therneau T, 2015, RPART RECURSIVE PART; Therneau T. M., 2014, PACKAGE SURVIVAL; Therneau T.M., 2000, MODELING SURVIVAL DA; Van Belle V, 2007, P 3 INT C COMP INT M, P1; Van Belle V, 2013, NEUROCOMPUTING, V112, P200, DOI 10.1016/j.neucom.2012.12.049	24	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137597	10.1371/journal.pone.0137597	http://dx.doi.org/10.1371/journal.pone.0137597			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352405	Green Submitted, gold, Green Published			2022-12-26	WOS:000360932800101
J	Mwilambwe-Tshilobo, L; Davis, AJO; Aizenberg, M; Geffen, MN				Mwilambwe-Tshilobo, Laetitia; Davis, Andrew J. O.; Aizenberg, Mark; Geffen, Maria N.			Selective Impairment in Frequency Discrimination in a Mouse Model of Tinnitus	PLOS ONE			English	Article							PURE-TONE TRAUMA; ACOUSTIC TRAUMA; PERCEPTION; MECHANISMS; PLASTICITY; RATS; EPIDEMIOLOGY; NEUROSCIENCE; HEARING; CORTEX	Tinnitus is an auditory disorder, which affects millions of Americans, including active duty service members and veterans. It is manifested by a phantom sound that is commonly restricted to a specific frequency range. Because tinnitus is associated with hearing deficits, understanding how tinnitus affects hearing perception is important for guiding therapies to improve the quality of life in this vast group of patients. In a rodent model of tinnitus, prolonged exposure to a tone leads to a selective decrease in gap detection in specific frequency bands. However, whether and how hearing acuity is affected for sounds within and outside those frequency bands is not well understood. We induced tinnitus in mice by prolonged exposure to a loud mid-range tone, and behaviorally assayed whether mice exhibited a change in frequency discrimination acuity for tones embedded within the mid-frequency range and high-frequency range at 1, 4, and 8 weeks post-exposure. A subset of tone-exposed mice exhibited tinnitus-like symptoms, as demonstrated by selective deficits in gap detection, which were restricted to the high frequency range. These mice exhibited impaired frequency discrimination both for tones in the mid-frequency range and high-frequency range. The remaining tone exposed mice, which did not demonstrate behavioral evidence of tinnitus, showed temporary deficits in frequency discrimination for tones in the mid-frequency range, while control mice remained unimpaired. Our findings reveal that the high frequency-specific deficits in gap detection, indicative of tinnitus, are associated with impairments in frequency discrimination at the frequency of the presumed tinnitus.	[Mwilambwe-Tshilobo, Laetitia; Davis, Andrew J. O.; Aizenberg, Mark; Geffen, Maria N.] Univ Penn, Dept Otorhinolaryngol HNS, Philadelphia, PA 19104 USA	University of Pennsylvania	Geffen, MN (corresponding author), Univ Penn, Dept Otorhinolaryngol HNS, Philadelphia, PA 19104 USA.	mgeffen@med.upenn.edu		Aizenberg, Mark/0000-0002-0010-0453	Klingenstein Award in Neuroscience; Burroughs Wellcome Career Award at the Scientific Interface; NIDCD NIH [R03DC013660]; PA Lions Hearing Research Fellowship; NIH [R01DC014700]; Human Frontiers in Science Foundation; NARSAD; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC014479, R03DC013660] Funding Source: NIH RePORTER	Klingenstein Award in Neuroscience(Klingenstein Philanthropies); Burroughs Wellcome Career Award at the Scientific Interface(Burroughs Wellcome Fund); NIDCD NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); PA Lions Hearing Research Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers in Science Foundation; NARSAD(NARSAD); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding: Klingenstein Award in Neuroscience to MNG (http://www.klingfund.org). Burroughs Wellcome Career Award at the Scientific Interface to MNG: (http://www.bwfund.org/). NIDCD NIH R03DC013660 to MNG. PA Lions Hearing Research Fellowship to MNG. NIH R01DC014700 to MNG. Human Frontiers in Science Foundation Young Investigator Award to MNG. NARSAD Young Investigator Award to MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjamian P, 2009, HEARING RES, V253, P15, DOI 10.1016/j.heares.2009.04.001; Ahmad N, 2004, DRUG AGING, V21, P297, DOI 10.2165/00002512-200421050-00002; Aizenberg M, 2013, NAT NEUROSCI, V16, P994, DOI 10.1038/nn.3443; Araneda R, 2015, RESTOR NEUROL NEUROS, V33, P67, DOI 10.3233/RNN-140433; Brozoski TJ, 2005, HEARING RES, V206, P227, DOI 10.1016/j.heares.2004.12.013; Clause A, 2011, J NEUROSCI METH, V200, P63, DOI 10.1016/j.jneumeth.2011.05.027; Dong SY, 2010, EUR J NEUROSCI, V31, P1616, DOI 10.1111/j.1460-9568.2010.07183.x; Eggermont JJ, 2006, ACTA OTO-LARYNGOL, V126, P9, DOI 10.1080/03655230600895259; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2013, HEARING RES, V295, P140, DOI 10.1016/j.heares.2012.01.005; Folmer RL, 1999, OTOLARYNG HEAD NECK, V121, P48, DOI 10.1016/S0194-5998(99)70123-3; Hallam RS, 2004, INT J AUDIOL, V43, P218, DOI 10.1080/14992020400050030; Heller AJ, 2003, OTOLARYNG CLIN N AM, V36, P239, DOI 10.1016/S0030-6665(02)00160-3; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Komiya H, 2000, ACTA OTO-LARYNGOL, V120, P750; Lobarinas E, 2013, HEARING RES, V295, P150, DOI 10.1016/j.heares.2012.06.001; Longenecker RJ, 2011, JARO-J ASSOC RES OTO, V12, P647, DOI 10.1007/s10162-011-0276-1; Moller AR, 2007, PROG BRAIN RES, V166, P3, DOI 10.1016/S0079-6123(07)66001-4; Norena A, 2002, AUDIOL NEURO-OTOL, V7, P358, DOI 10.1159/000066156; Norena AJ, 2003, J NEUROPHYSIOL, V90, P2387, DOI 10.1152/jn.00139.2003; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Rossiter S, 2006, J SPEECH LANG HEAR R, V49, P150, DOI 10.1044/1092-4388(2006/012); Saunders JC, 2007, J COMMUN DISORD, V40, P313, DOI 10.1016/j.jcomdis.2007.03.006; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Thai-Van H, 2003, BRAIN, V126, P2235, DOI 10.1093/brain/awg228; Turner J, 2012, J NEUROSCI RES, V90, P1480, DOI 10.1002/jnr.22827; Turner JG, 2008, AM J AUDIOL, V17, pS185, DOI 10.1044/1059-0889(2008/08-0006); Turner JG, 2007, PROG BRAIN RES, V166, P147, DOI 10.1016/S0079-6123(07)66013-0; Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007; Wienbruch C, 2006, NEUROIMAGE, V33, P180, DOI 10.1016/j.neuroimage.2006.06.023; Yang SC, 2011, P NATL ACAD SCI USA, V108, P14974, DOI 10.1073/pnas.1107998108; Zhang JS, 2011, JARO-J ASSOC RES OTO, V12, P185, DOI 10.1007/s10162-010-0246-z	34	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137749	10.1371/journal.pone.0137749	http://dx.doi.org/10.1371/journal.pone.0137749			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352864	gold, Green Published, Green Submitted			2022-12-26	WOS:000360932800113
J	Su, HH; Cheng, YM; Wang, ZY; Li, Z; Stanley, D; Yang, YZ				Su, Honghua; Cheng, Yuming; Wang, Zhongyang; Li, Zhong; Stanley, David; Yang, Yizhong			Silk Gland Gene Expression during Larval-Pupal Transition in the Cotton Leaf Roller Sylepta derogata (Lepidoptera: Pyralidae)	PLOS ONE			English	Article							PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN; CLONING	The cotton leaf roller, Sylepta derogata, is a silk-producing insect pest. While young larvae feed on the underside of leaves, the older ones roll cotton leaves and feed on the leaf edges, which defoliates cotton plants. The larvae produce silk to stabilize the rolled leaf and to balloon from used to new leaves. Despite the significance of silk in the biology of pest insect species, there is virtually no information on the genes involved in their silk production. This is a substantial knowledge gap because some of these genes may be valuable targets for developing molecular pest management technologies. We addressed the gap by posing the hypothesis that silk gland gene expression changes during the transition from larvae to pupae. We tested our hypothesis using RNA-seq to investigate changes in silk gland gene expression at three developmental stages, 5th instar larvae (silk producing; 15,445,926 clean reads), prepupae (reduced silk producing; 13,758,154) and pupae (beyond silk producing; 16,787,792). We recorded 60,298 unigenes and mapped 50,158 (larvae), 48,415 (prepupae) and 46,623 (pupae) of them to the NCBI database. Most differentially expressed genes in the 5th instar larvae/prepupae libraries were relevant to nucleotide synthesis and maintenance of silk gland function. We identified down-regulated transcriptional factors and several genes involved in silk formation in the three libraries and verified the expression pattern of eight genes by qPCR. The developmental-and tissue-specific expression patterns of the fibroin light chain gene showed it was highly expressed during the larval silk-producing stage. We recorded highest expression of this gene in the larval silk gland, compared to other tissues, including midgut, hindgut, epidermis, Malpighian tubes, hemolymph and fat body. These data are a genetic resource to guide selection of key genes that may be targeted for in planta and other gene-silencing technologies for sustainable cotton agriculture.	[Su, Honghua; Cheng, Yuming; Li, Zhong; Yang, Yizhong] Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou 225009, Jiangsu, Peoples R China; [Wang, Zhongyang] Yangzhou Termite Control Ctr, Yangzhou 225001, Jiangsu, Peoples R China; [Stanley, David] USDA ARS, Biol Control Insects Res Lab, Columbia, MO 65203 USA	Yangzhou University; United States Department of Agriculture (USDA)	Yang, YZ (corresponding author), Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou 225009, Jiangsu, Peoples R China.	yzyang@yzu.edu.cn			major science and technology project - Ministry of Agriculture of the People's Republic of China [2014ZX08012004-007]; Yangzhou Termite Control Center	major science and technology project - Ministry of Agriculture of the People's Republic of China; Yangzhou Termite Control Center	This research was supported by a major science and technology project to create new crop varieties using gene transfer technology (Biosafety Monitoring Technique of Genetically Modified Organisms: 2014ZX08012004-007) funded by Ministry of Agriculture of the People's Republic of China. Co-author Zhongyang Wang is employed by Yangzhou Termite Control Center. Yangzhou Termite Control Center provided support in the form of salary for author Zhongyang Wang, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Chaitanya RK, 2010, GEN COMP ENDOCR, V167, P113, DOI 10.1016/j.ygcen.2010.02.007; Chen CX, 2015, J ENV ENTOM IN PRESS; Di JX, 2007, JIANGSU AGR SCI, V5, P82; Hou Y, 2007, INSECT BIOCHEM MOLEC, V37, P486, DOI 10.1016/j.ibmb.2007.02.011; Kamimura M, 2007, ARCH INSECT BIOCHEM, V65, P143, DOI 10.1002/arch.20186; Klapwijk MJ, 2013, ECOL EVOL, V3, P4183, DOI 10.1002/ece3.717; Kontogiannatos D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073834; Li H, 2014, ONCOGENE, V33, P4589, DOI 10.1038/onc.2013.408; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Park J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105717; Pelosi P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00320; Qiao HL, 2013, J INSECT PHYSIOL, V59, P667, DOI 10.1016/j.jinsphys.2013.04.004; Reumer A, 2009, DEV COMP IMMUNOL, V33, P1186, DOI 10.1016/j.dci.2009.06.010; SEHNAL F, 1990, INT J INSECT MORPHOL, V19, P79, DOI 10.1016/0020-7322(90)90022-H; Shimizu K, 2007, INSECT BIOCHEM MOLEC, V37, P713, DOI 10.1016/j.ibmb.2007.03.016; Statzner B, 1999, WATER RESOUR RES, V35, P3495, DOI 10.1029/1999WR900196; Sun W, 2012, INT J BIOL SCI, V8, P125, DOI 10.7150/ijbs.8.125; Takiya S, 2009, J BIOCHEM, V146, P103, DOI 10.1093/jb/mvp053; Tootle TL, 2008, DEVELOPMENT, V135, P839, DOI 10.1242/dev.017590; Tootle TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019943; Wang Meng-Qing, 2004, Entomological Knowledge, V41, P90; Wang XM, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/419343; Xiong YH, 2013, INT J BIOL SCI, V9, P370, DOI 10.7150/ijbs.5929; Xu J, 2010, J ECON ENTOMOL, V103, P1166, DOI 10.1603/EC09265; Yang HJ, 2011, ARCH INSECT BIOCHEM, V78, P17, DOI 10.1002/arch.20436; Zhao JM, 2011, P NATL ACAD SCI USA, V108, P14246, DOI 10.1073/pnas.1018075108; Zhao XQ, 2014, J BIOL CHEM; Zheng YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111369	28	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136868	10.1371/journal.pone.0136868	http://dx.doi.org/10.1371/journal.pone.0136868			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352931	Green Published, gold, Green Submitted			2022-12-26	WOS:000360932800051
J	Bullone, M; Beauchamp, G; Godbout, M; Martin, JG; Lavoie, JP				Bullone, Michela; Beauchamp, Guy; Godbout, Mireille; Martin, James G.; Lavoie, Jean-Pierre			Endobronchial Ultrasound Reliably Quantifies Airway Smooth Muscle Remodeling in an Equine Asthma Model	PLOS ONE			English	Article							BRONCHIAL WALL; LUNG-FUNCTION; HEAVES; ULTRASONOGRAPHY; DISEASE; HORSES; HYPERTROPHY; HYPERPLASIA; OBSTRUCTION; THICKNESS	Endobronchial ultrasonography (EBUS) revealed differences in the thickness of the layer representing subepithelial tissues (L2) between human asthmatics and controls, but whether this measurement correlates with airway smooth muscle (ASM) remodeling in asthma is unknown. In this study, we sought to determine the ability of EBUS to predict histological ASM remodeling in normal and equine asthmatic airways. We studied 109 isolated bronchi from the lungs of 13 horses. They underwent EBUS examination using a 30 MHz radial probe before being processed for histology. ASM remodeling parameters were evaluated in EBUS images (L2 thickness, L2 area, L2 area/internal perimeter [Pi] and L2 area/Pi(2)) and histological cuts (ASM area/Pi(2)), and compared. EBUS was then performed ex vivo on the lungs of 4 horses with heaves, an asthma-like condition of horses, and 7 controls to determine whether central bronchial remodeling could be detected with this technique. An optimized approach was developed based on data variability within airways, subjects, and groups, and then validated in 7 horses (3 controls, 4 with heaves) that underwent EBUS in vivo. L2 area was significantly associated to ASM area in isolated lungs (p<0.0001), in the absence of significant bias related to the airway size. Bronchial size significantly affected EBUS ASM-related parameters, except for L2 area/Pi(2). L2 area/Pi(2) was increased in the airways of asthmatic horses compared to controls, both ex vivo and in vivo (p<0.05). Bronchial histology confirmed our findings (A(ASM)/Pi(2) was increased in asthmatic horses compared to controls, p<0.05). In both horses with heaves and controls, L2 was composed of ASM for the outer 75% of its thickness and by ECM for the remaining inner 25%. In conclusion, EBUS reliably allows assessment of asthma-associated ASM remodeling of central airways in a non-invasive way.	[Bullone, Michela; Beauchamp, Guy; Godbout, Mireille; Lavoie, Jean-Pierre] Univ Montreal, Fac Vet Med, Dept Clin Sci, St Hyacinthe, PQ J2S 7C6, Canada; [Martin, James G.] McGill Univ, Meakins Christie Labs, Dept Med, Montreal, PQ, Canada	Universite de Montreal; McGill University	Lavoie, JP (corresponding author), Univ Montreal, Fac Vet Med, Dept Clin Sci, St Hyacinthe, PQ J2S 7C6, Canada.	jean-pierre.lavoie@umontreal.ca	Bullone, Michela/K-5175-2018	Bullone, Michela/0000-0002-9094-6734; Martin, James/0000-0001-7574-5363	Canadian Institutes of Health [R0017988]; Canadian Foundation for Innovation [29172]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	This study was supported by the Canadian Institutes of Health (#R0017988) and by the Canadian Foundation for Innovation (#29172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo BB, 2008, EUR RESPIR J, V32, P61, DOI 10.1183/09031936.00147807; Baba M, 2002, LUNG CANCER-J IASLC, V35, P65, DOI 10.1016/S0169-5002(01)00284-7; Bolliger CT, 2002, EUR RESPIR J, V19, P356, DOI 10.1183/09031936.02.00204602; Bullone M, 2014, J APPL PHYSIOL, V117, P806, DOI 10.1152/japplphysiol.00468.2014; EBINA M, 1993, AM REV RESPIR DIS, V148, P720, DOI 10.1164/ajrccm/148.3.720; EBINA M, 1990, AM REV RESPIR DIS, V141, P1322, DOI 10.1164/ajrccm/141.5_Pt_1.1322; EBINA M, 1990, AM REV RESPIR DIS, V141, P1327, DOI 10.1164/ajrccm/141.5_Pt_1.1327; Elliot JG, 2015, RESPIROLOGY, V20, P66, DOI 10.1111/resp.12384; Ernst A, 2003, CHEST, V123, P1693, DOI 10.1378/chest.123.5.1693; Falcone F, 2003, RESPIRATION, V70, P179, DOI 10.1159/000070066; Herszberg B, 2006, J ALLERGY CLIN IMMUN, V118, P382, DOI 10.1016/j.jaci.2006.03.044; Hirota N, 2013, CHEST, V144, P1026, DOI 10.1378/chest.12-3073; HURTER T, 1992, THORAX, V47, P565, DOI 10.1136/thx.47.7.565; James A, 2000, EUR RESPIR J, V15, P782, DOI 10.1034/j.1399-3003.2000.15d25.x; James AL, 2009, EUR RESPIR J, V34, P1040, DOI 10.1183/09031936.00181608; James AL, 2002, AM J RESP CRIT CARE, V166, P1590, DOI 10.1164/rccm.2108069; James AL, 1988, AM REV RESPIR DIS, V138, P139; James AL, 2012, AM J RESP CRIT CARE, V185, P1058, DOI 10.1164/rccm.201110-1849OC; Jones RL, 2014, AM J RESP CELL MOL, V50, P246, DOI 10.1165/rcmb.2013-0029OC; Kaminska M, 2009, J ALLERGY CLIN IMMUN, V124, P45, DOI 10.1016/j.jaci.2009.03.049; Kita T, 2010, J BRONCHOL INTERN PU, V17, P301, DOI 10.1097/LBR.0b013e3181f9f09b; Koblinger K, 2011, J VET INTERN MED, V25, P1118, DOI 10.1111/j.1939-1676.2011.00788.x; Kurimoto N, 1999, CHEST, V115, P1500, DOI 10.1378/chest.115.6.1500; LAMBERT RK, 1993, J APPL PHYSIOL, V74, P2771, DOI 10.1152/jappl.1993.74.6.2771; Leclere M, 2011, RESPIROLOGY, V16, P1027, DOI 10.1111/j.1440-1843.2011.02033.x; Leclere M, 2011, AM J RESP CELL MOL, V45, P181, DOI 10.1165/rcmb.2010-0300OC; Oliver MN, 2007, AM J RESP CELL MOL, V37, P264, DOI 10.1165/rcmb.2006-0418OC; Pepe C, 2005, J ALLERGY CLIN IMMUN, V116, P544, DOI 10.1016/j.jaci.2005.06.011; Robinson NE, 2000, EQUINE VET J, V32, P393, DOI 10.2746/042516400777591147; Setlakwe EL, 2014, AM J PHYSIOL-LUNG C, V307, pL252, DOI 10.1152/ajplung.00019.2014; Shaw TJ, 2004, EUR RESPIR J, V23, P813, DOI 10.1183/09031936.04.00119904; Soja J, 2009, CHEST, V136, P797, DOI 10.1378/chest.08-2759; Sumi Y, 2007, CLIN EXP ALLERGY, V37, P1781, DOI 10.1111/j.1365-2222.2007.02828.x	33	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136284	10.1371/journal.pone.0136284	http://dx.doi.org/10.1371/journal.pone.0136284			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348727	Green Submitted, Green Published, gold			2022-12-26	WOS:000360897600004
J	Caldwell, J; Wang, W; Zandstra, PW				Caldwell, Julia; Wang, Weijia; Zandstra, Peter W.			Proportional-Integral-Derivative (PID) Control of Secreted Factors for Blood Stem Cell Culture	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; GROWTH-FACTOR-BETA; INTERACTION NETWORKS; EXPANSION; RECONSTITUTION; HEMATOPOIESIS	Clinical use of umbilical cord blood has typically been limited by the need to expand hematopoietic stem and progenitor cells (HSPC) ex vivo. This expansion is challenging due to the accumulation of secreted signaling factors in the culture that have a negative regulatory effect on HSPC output. Strategies for global regulation of these factors through dilution have been developed, but do not accommodate the dynamic nature or inherent variability of hematopoietic cell culture. We have developed a mathematical model to simulate the impact of feedback control on in vitro hematopoiesis, and used it to design a proportional-integral-derivative (PID) control algorithm. This algorithm was implemented with a fed-batch bioreactor to regulate the concentrations of secreted factors. Controlling the concentration of a key target factor, TGF-beta 1, through dilution limited the negative effect it had on HSPCs, and allowed global control of other similarly-produced inhibitory endogenous factors. The PID control algorithm effectively maintained the target soluble factor at the target concentration. We show that feedback controlled dilution is predicted to be a more cost effective dilution strategy compared to other open-loop strategies, and can enhance HSPC expansion in short term culture. This study demonstrates the utility of secreted factor process control strategies to optimize stem cell culture systems, and motivates the development of multi-analyte protein sensors to automate the manufacturing of cell therapies.	[Caldwell, Julia; Wang, Weijia; Zandstra, Peter W.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Zandstra, Peter W.] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Zandstra, Peter W.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada; [Zandstra, Peter W.] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Zandstra, PW (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	peter.zandstra@utoronto.ca	Wang, Weijia/O-6061-2017	Wang, Weijia/0000-0002-0270-8366	Leukemia and Lymphoma Society of Canada grant [493946]; Canadian Stem Cell Network grant [492019]; Natural Science and Engineering Research Council Discovery grant [456382]; Ontario Stem Cell Initiative post-doctoral fellowship	Leukemia and Lymphoma Society of Canada grant; Canadian Stem Cell Network grant; Natural Science and Engineering Research Council Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Stem Cell Initiative post-doctoral fellowship	This work was funded by a Leukemia and Lymphoma Society of Canada grant (493946, www.llscanada.org) to PWZ, a Canadian Stem Cell Network grant (492019, www.stemcellnetwork.ca) to PWZ, and a Natural Science and Engineering Research Council Discovery grant (456382, www.nserc-crsng.gc.ca) to PWZ. WW was supported by an Ontario Stem Cell Initiative (www.oirm.ca) post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; CASHMAN JD, 1990, BLOOD, V75, P96; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Csaszar E, 2014, BIOTECHNOL BIOENG, V111, P1258, DOI 10.1002/bit.25163; Csaszar E, 2012, CELL STEM CELL, V10, P218, DOI 10.1016/j.stem.2012.01.003; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Durand EM, 2010, CURR OPIN HEMATOL, V17, P308, DOI 10.1097/MOH.0b013e32833a888c; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; Fortunel NO, 2000, BLOOD, V96, P2022; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; Gluckman E, 2009, BONE MARROW TRANSPL, V44, P621, DOI 10.1038/bmt.2009.280; Kirouac DC, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.71; Kirouac DC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.49; Koller MR, 1998, BONE MARROW TRANSPL, V21, P653, DOI 10.1038/sj.bmt.1701157; Lim M, 2007, BIOTECHNOL ADV, V25, P353, DOI 10.1016/j.biotechadv.2007.02.002; LYONS RM, 1988, J CELL BIOL, V106, P1659, DOI 10.1083/jcb.106.5.1659; Madlambayan GJ, 2005, EXP HEMATOL, V33, P1229, DOI 10.1016/j.exphem.2005.05.018; Ming K, 2015, ACS NANO, V9, P3060, DOI 10.1021/nn5072792; Mostafa SS, 2001, EXP HEMATOL, V29, P873, DOI 10.1016/S0301-472X(01)00658-0; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Politikos I, 2014, BLOOD, V124, P3201, DOI 10.1182/blood-2014-07-589176; Prouix C, 2004, BIOTECHNOL BIOENG, V88, P675, DOI 10.1002/bit.20288; Qiao W, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145141; Sage AT, 2014, ACCOUNTS CHEM RES, V47, P2417, DOI 10.1021/ar500130m; Yang H, 2002, STEM CELLS, V20, P320, DOI 10.1634/stemcells.20-4-320; Young GD, 2004, J BIOL CHEM, V279, P38032, DOI 10.1074/jbc.M405658200; Zhang CC, 2005, BLOOD, V105, P4314, DOI 10.1182/blood-2004-11-4418; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119	30	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137392	10.1371/journal.pone.0137392	http://dx.doi.org/10.1371/journal.pone.0137392			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348930	Green Published, gold, Green Submitted			2022-12-26	WOS:000360897600042
J	Schutt, SD; Fu, JN; Nguyen, H; Bastian, D; Heinrichs, J; Wu, YX; Liu, C; McDonald, DG; Pidala, J; Yu, XZ				Schutt, Steven D.; Fu, Jianing; Nguyen, Hung; Bastian, David; Heinrichs, Jessica; Wu, Yongxia; Liu, Chen; McDonald, Daniel G.; Pidala, Joseph; Yu, Xue-Zhong			Inhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in Mice	PLOS ONE			English	Article							BRUTONS TYROSINE KINASE; CD4(+) T-CELLS; B-CELLS; DONOR CD4(+); BRONCHIOLITIS OBLITERANS; TRANSCRIPTION FACTOR; CHRONIC GVHD; ACTIVATION; TRANSPLANTS; PHOSPHORYLATION	Bruton's Tyrosine Kinase (BTK) and IL-2 Inducible T-cell Kinase (ITK) are enzymes responsible for the phosphorylation and activation of downstream effectors in the B-cell receptor (BCR) signaling and T cell receptor (TCR) signaling pathways, respectively. Ibrutinib is an FDA-approved potent inhibitor of both BTK and ITK that impairs B-cell and T-cell function. CD4 T cells and B cells are essential for the induction of chronic graft-versus-host disease (cGVHD). We evaluated these targets by testing the ability of Ibrutinib to prevent or ameliorate cGVHD, which is one of the major complications for patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). We found that Ibrutinib significantly alleviated cGVHD across four different mouse models, accompanied by increased long-term survival and reduced clinical score. The clinical improvements in Ibrutinib-treated recipients were associated with decreased serum-autoantibodies, costimulatory molecule activation, B-cell proliferation, and glomerulonephritis compared to vehicle controls. Ibrutinib was also able to alleviate the clinical manifestations in acute GVHD (aGVHD), where the recipients were given grafts with or without B cells, suggesting that an inhibitory effect of Ibrutinib on T cells contributes to a reduction in both aGVHD and cGVHD pathogenesis. An effective prophylactic regimen is still lacking to both reduce the incidence and severity of human cGVHD following allo-HSCT. Our study shows that Ibrutinib is an effective prophylaxis against several mouse models of cGVHD with minimal toxicity and could be a promising strategy to combat human cGVHD clinically.	[Schutt, Steven D.; Fu, Jianing; Nguyen, Hung; Bastian, David; Heinrichs, Jessica; Wu, Yongxia; Yu, Xue-Zhong] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Fu, Jianing] Univ S Florida, Canc Biol PhD Program, Tampa, FL USA; [Fu, Jianing] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; [Liu, Chen] Univ Florida, Pathol Immunol & Lab Med, Gainesville, FL USA; [McDonald, Daniel G.] Med Univ S Carolina, Dept Radiat Oncol, Charleston, SC 29425 USA; [Pidala, Joseph] Univ S Florida, H Lee Moffitt Canc Ctr, Blood & Bone Marrow Transplant Dept, Tampa, FL 33682 USA; [Yu, Xue-Zhong] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA	Medical University of South Carolina; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of Florida; Medical University of South Carolina; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Medical University of South Carolina	Yu, XZ (corresponding author), Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA.	yux@musc.edu	Nguyen, Hung D/AAN-5364-2021; Fu, Jianing/F-4031-2014; Nguyen, Hung/F-9211-2016	Nguyen, Hung D/0000-0001-9416-5137; Fu, Jianing/0000-0003-1500-5405; Nguyen, Hung/0000-0002-7929-4392; Yu, Xue-Zhong/0000-0002-1751-2884; Schutt, Steven/0000-0002-2069-2556	 [CA169116];  [CA143812]; NATIONAL CANCER INSTITUTE [R01CA169116, R01CA143812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118305] Funding Source: NIH RePORTER	; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the following: CA169116, http://www.cancer.gov/; and CA143812, http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala A, 2003, INT J EXP PATHOL, V84, P1, DOI 10.1046/j.1365-2613.2003.00235.x; Allen JL, 2014, BLOOD, V123, P2108, DOI 10.1182/blood-2013-10-533562; Anderson BE, 2005, BLOOD, V105, P2227, DOI 10.1182/blood-2004-08-3032; Anderson BE, 2003, J CLIN INVEST, V112, P101, DOI 10.1172/JCI200317601; AUGUST A, 1994, P NATL ACAD SCI USA, V91, P9347, DOI 10.1073/pnas.91.20.9347; Byrd JC, 2014, NEW ENGL J MED, V371, P213, DOI 10.1056/NEJMoa1400376; Chu YW, 2008, BIOL BLOOD MARROW TR, V14, P365, DOI 10.1016/j.bbmt.2007.12.002; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; DeNucci CC, 2010, J IMMUNOL, V184, P2458, DOI 10.4049/jimmunol.0902407; Huu DL, 2013, BLOOD, V121, P3274, DOI 10.1182/blood-2012-11-465658; Dubovsky JA, 2014, J CLIN INVEST, V124, P4867, DOI 10.1172/JCI75328; Dubovsky JA, 2013, BLOOD, V122, P2539, DOI 10.1182/blood-2013-06-507947; Flynn R, 2014, BLOOD, V123, P3988, DOI 10.1182/blood-2014-03-562231; Fu JN, 2015, J IMMUNOL, V194, P388, DOI 10.4049/jimmunol.1401618; Gibson S, 1996, J IMMUNOL, V156, P2716; Gomez-Rodriguez J, 2014, J EXP MED, V211, P529, DOI 10.1084/jem.20131459; Hata D, 1998, J BIOL CHEM, V273, P10979, DOI 10.1074/jbc.273.18.10979; Jain N, 2013, NAT MED, V19, P1632, DOI 10.1038/nm.3393; Kansu E, 2001, BLOOD, V98, P3868, DOI 10.1182/blood.V98.13.3868; Kapur R, 2008, HAEMATOL-HEMATOL J, V93, P1702, DOI 10.3324/haematol.13311; KAWAKAMI Y, 1994, MOL CELL BIOL, V14, P5108, DOI 10.1128/MCB.14.8.5108; Levade M, 2014, BLOOD, V124, P3991, DOI 10.1182/blood-2014-06-583294; Liang Y, 2008, BLOOD, V111, P954, DOI 10.1182/blood-2007-05-089573; Lopez-Herrera G, 2014, J LEUKOCYTE BIOL, V95, P243, DOI 10.1189/jlb.0513307; Miller AT, 2004, IMMUNITY, V21, P67, DOI 10.1016/j.immuni.2004.06.009; Mohamed AJ, 1999, SCAND J IMMUNOL, V49, P113; Ogawa Y, 2003, INVEST OPHTH VIS SCI, V44, P1888, DOI 10.1167/iovs.02-0699; Satterthwaite AB, 2000, IMMUNOL REV, V175, P120, DOI 10.1034/j.1600-065X.2000.017504.x; Schroeder MA, 2011, DIS MODEL MECH, V4, P318, DOI 10.1242/dmm.006668; SINGH RR, 1995, J EXP MED, V181, P2017, DOI 10.1084/jem.181.6.2017; Socie G, 2014, BLOOD, V124, P374, DOI 10.1182/blood-2014-01-514752; Srinivasan M, 2012, BLOOD, V119, P1570, DOI 10.1182/blood-2011-07-364414; Tschetter JR, 2000, J IMMUNOL, V165, P5987, DOI 10.4049/jimmunol.165.10.5987; US Food & Drug Administration, 2013, HIGHL PRESCR INF; Valenzuela JO, 2009, J CLIN INVEST, V119, P3774, DOI 10.1172/JCI39692; Vogelsang GB, 2001, BLOOD, V97, P1196, DOI 10.1182/blood.V97.5.1196; Weil D, 1997, BLOOD, V90, P4332, DOI 10.1182/blood.V90.11.4332.4332_4332_4340; Westermann J, 2003, LAB INVEST, V83, P459, DOI 10.1097/01.LAB.0000062852.80567.90; Woods ML, 2001, EMBO J, V20, P1232, DOI 10.1093/emboj/20.6.1232; Wu T, 2013, J IMMUNOL, V191, P488, DOI 10.4049/jimmunol.1300657; Young JS, 2012, J IMMUNOL, V189, P222, DOI 10.4049/jimmunol.1200677; Yu Y, 2013, EUR J IMMUNOL, V43, P2327, DOI 10.1002/eji.201243282; Yu Y, 2011, BLOOD, V118, P5011, DOI 10.1182/blood-2011-03-340315; Zhang CY, 2006, BLOOD, V107, P2993, DOI 10.1182/blood-2005-09-3623; Zhao DC, 2011, J IMMUNOL, V186, P856, DOI 10.4049/jimmunol.1002195	45	60	64	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137641	10.1371/journal.pone.0137641	http://dx.doi.org/10.1371/journal.pone.0137641			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348529	gold, Green Published, Green Submitted			2022-12-26	WOS:000360897600056
J	Yang, YQ; Li, X; Yang, SH; Zhou, YL; Dong, C; Ren, J; Sun, XD; Yang, YP				Yang, Yunqiang; Li, Xiong; Yang, Shihai; Zhou, Yanli; Dong, Chao; Ren, Jian; Sun, Xudong; Yang, Yongping			Comparative Physiological and Proteomic Analysis Reveals the Leaf Response to Cadmium-Induced Stress in Poplar (Populus yunnanensis)	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ARABIDOPSIS-THALIANA; OXIDATIVE DAMAGE; ABIOTIC STRESS; PLANTS; DROUGHT; ROOTS; EXPRESSION; TOLERANCE; LEAVES	Excess amounts of heavy metals are important environmental pollutants with significant ecological and nutritional effects. Cdmium (Cd) is of particular concern because of its widespread occurrence and high toxicity. We conducted physiological and proteomic analyses to improve our understanding of the responses of Populus yunnanensis to Cd stress. The plantlets experienced two apparent stages in their response to Cd stress. During the first stage, transiently induced defense-response molecules, photosynthesis-and energy-associated proteins, antioxidant enzymes and heat shock proteins (HSPs) accumulated to enhance protein stability and establish a new cellular homeostasis. This activity explains why plant photosynthetic capability during this period barely changed. During the second stage, a decline of ribulose-1, 5-bisphosphate carboxylase (RuBisCO) and HSP levels led to imbalance of the plant photosynthetic system. Additionally, the expression of Mitogen-activated protein kinase 3 (MPK3), Mitogen-activated protein kinase 6 (MPK6) and a homeobox-leucine zipper protein was higher in the second stage. Higher expression of caffeoyl-CoA O-methyltransferase (CCoAOMT) may regulate plant cell wall synthesis for greater Cd storage. These genes may be candidates for further research and use in genetic manipulation of poplar tolerance to Cd stress.	[Yang, Yunqiang; Li, Xiong; Zhou, Yanli; Dong, Chao; Sun, Xudong; Yang, Yongping] Chinese Acad Sci, Key Lab Plant Divers & Biogeog East Asia, Kunming Inst Bot, Kunming 650204, Peoples R China; [Yang, Yunqiang; Li, Xiong; Zhou, Yanli; Dong, Chao; Sun, Xudong; Yang, Yongping] Chinese Acad Sci, Plant Germplasm & Genom Ctr, Kunming Inst Bot, Kunming 650201, Peoples R China; [Yang, Yunqiang; Li, Xiong; Zhou, Yanli; Dong, Chao; Sun, Xudong; Yang, Yongping] Chinese Acad Sci, Inst Tibetan Plateau Res, Kunming Inst Bot, Kunming 650201, Peoples R China; [Yang, Shihai] Chinese Acad Sci, Key Lab Tibetan Environm Changes & Land Surface P, Inst Tibetan Plateau Res, Beijing 100085, Peoples R China; [Ren, Jian] Yunnan Agr Univ, Dept Grassland Sci, Kunming 650201, Peoples R China; [Li, Xiong; Yang, Shihai; Zhou, Yanli; Dong, Chao] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; Yunnan Agricultural University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Sun, XD (corresponding author), Chinese Acad Sci, Key Lab Plant Divers & Biogeog East Asia, Kunming Inst Bot, Kunming 650204, Peoples R China.	sunxundong@mail.kib.ac.cn; yangyp@mail.kib.ac.cn	Yang, Shihai/J-1593-2012; Sun, Xudong/HHN-3905-2022	Yang, Shihai/0000-0002-6497-968X; 	National Natural Science Foundation of China (NSFC) [41271058]; Major State Basic Research Development Program of China [2010CB951704]; National Science Foundation of China [31260167]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (NSFC) (No. 41271058), the Major State Basic Research Development Program of China (Nos. 2010CB951704), and the National Science Foundation of China (No. 31260167).	Ali GM, 2006, J PROTEOME RES, V5, P396, DOI 10.1021/pr050291g; Benavides María P., 2005, Braz. J. Plant Physiol., V17, P21, DOI 10.1590/S1677-04202005000100003; Broin M, 2002, PLANT CELL, V14, P1417, DOI 10.1105/tpc.001644; Chen LH, 2011, J EXP BOT, V62, P5037, DOI 10.1093/jxb/err203; Chen Q, 2013, PLANT PHYSIOL BIOCH, V70, P504, DOI 10.1016/j.plaphy.2013.06.015; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Costa P, 1998, PLANT MOL BIOL, V38, P587, DOI 10.1023/A:1006006132120; Das P, 1997, ENVIRON POLLUT, V98, P29, DOI 10.1016/S0269-7491(97)00110-3; Desikan R, 2005, BIOL SCI SER, P169, DOI 10.1002/9780470988565.ch7; Duan BL, 2008, PHYSIOL PLANTARUM, V134, P257, DOI 10.1111/j.1399-3054.2008.01128.x; Duan BL, 2005, PHYSIOL PLANTARUM, V124, P476, DOI 10.1111/j.1399-3054.2005.00535.x; Gong HJ, 2005, PLANT SCI, V169, P313, DOI 10.1016/j.plantsci.2005.02.023; Gratao PL, 2005, FUNCT PLANT BIOL, V32, P481, DOI 10.1071/FP05016; Gratao PL, 2009, ENVIRON EXP BOT, V67, P387, DOI 10.1016/j.envexpbot.2009.06.017; Guo CL, 2013, PLANT MOL BIOL REP, V31, P1012, DOI 10.1007/s11105-013-0569-0; Herbette S, 2006, BIOCHIMIE, V88, P1751, DOI 10.1016/j.biochi.2006.04.018; HERNANDEZ JA, 1995, PLANT SCI, V105, P151, DOI 10.1016/0168-9452(94)04047-8; HOWDEN R, 1995, PLANT PHYSIOL, V107, P1059, DOI 10.1104/pp.107.4.1059; Jiang H, 2013, CHEMOSPHERE, V91, P1213, DOI 10.1016/j.chemosphere.2013.01.041; Jonak C, 2004, PLANT PHYSIOL, V136, P3276, DOI 10.1104/pp.104.045724; KEY JL, 1981, P NATL ACAD SCI-BIOL, V78, P3526, DOI 10.1073/pnas.78.6.3526; Kieffer P, 2008, PROTEOMICS, V8, P2514, DOI 10.1002/pmic.200701110; Kieffer P, 2009, J PROTEOME RES, V8, P400, DOI 10.1021/pr800561r; Kieffer P, 2009, J PROTEOMICS, V72, P379, DOI 10.1016/j.jprot.2009.01.014; Kirkham MB, 2006, GEODERMA, V137, P19, DOI 10.1016/j.geoderma.2006.08.024; Li L, 2013, PHYSIOL PLANTARUM, V147, P477, DOI 10.1111/j.1399-3054.2012.01676.x; Li X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107605; Li ZW, 2005, PLANT SOIL, V271, P165, DOI 10.1007/s11104-004-2296-7; Lin CW, 2005, PLANT PHYSIOL BIOCH, V43, P963, DOI 10.1016/j.plaphy.2005.10.001; Liu CP, 2007, BIOL PLANTARUM, V51, P116, DOI 10.1007/s10535-007-0023-y; Liu CF, 2011, PLANT SOIL, V344, P131, DOI 10.1007/s11104-011-0733-y; Liu XM, 2010, PHYTOCHEMISTRY, V71, P614, DOI 10.1016/j.phytochem.2010.01.005; Lombi E, 2002, PLANT PHYSIOL, V128, P1359, DOI 10.1104/pp.010731; Lukacova Z, 2013, PLANT GROWTH REGUL, V70, P89, DOI 10.1007/s10725-012-9781-4; Pietrini F, 2003, PLANT PHYSIOL, V133, P829, DOI 10.1104/pp.103.026518; Pietrzykowska M, 2014, PLANT CELL, V26, P3646, DOI 10.1105/tpc.114.127373; Prasad MNV, 1995, ENVIRON EXP BOT, V35, P525, DOI 10.1016/0098-8472(95)00024-0; Ranocha P, 2002, PLANT PHYSIOL, V129, P145, DOI 10.1104/pp.010988; Raven E L, 2000, Subcell Biochem, V35, P317; Roelofs D, 2008, FUNCT ECOL, V22, P8, DOI 10.1111/j.1365-2435.2007.01312.x; Rushton PJ, 1998, CURR OPIN PLANT BIOL, V1, P311, DOI 10.1016/1369-5266(88)80052-9; Sanita di Toppi L, 1999, ENVIRON EXP BOT, V41, P105, DOI 10.1016/S0098-8472(98)00058-6; Schnoor J, 2004, ENVIRON SCI TECHNOL, V38, p53A, DOI 10.1021/es040368m; Senthil KM, 2010, PLANT PHYSIOL BIOCH, V48, P35; SHOWALTER AM, 1993, PLANT CELL, V5, P9, DOI 10.1105/tpc.5.1.9; Vincent D, 2005, PLANT PHYSIOL, V137, P949, DOI 10.1104/pp.104.050815; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wang XQ, 2009, PLANT PHYSIOL, V149, P1739, DOI 10.1104/pp.108.131714; Weast RC, 1988, CRC HDB CHEM PHYS; Windhof A., 2011, RUBISCO FOLDING OLIG; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xu LX, 2013, ENVIRON EXP BOT, V89, P28, DOI 10.1016/j.envexpbot.2012.12.001; Yamaguchi H, 2010, J EXP BOT, V61, P423, DOI 10.1093/jxb/erp313; Yang JL, 2013, NEW PHYTOL, V197, P815, DOI 10.1111/nph.12057; Zhang A, 2010, J EXP BOT, V61, P4399, DOI 10.1093/jxb/erq243; Zhang XL, 2012, RICE SCI, V19, P86, DOI 10.1016/S1672-6308(12)60026-2; Zhao CR, 2010, SOIL SCI PLANT NUTR, V56, P150, DOI 10.1111/j.1747-0765.2009.00440.x; Zhou YQ, 2010, ECOTOXICOLOGY, V19, P69, DOI 10.1007/s10646-009-0389-z	59	23	24	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137396	10.1371/journal.pone.0137396	http://dx.doi.org/10.1371/journal.pone.0137396			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26349064	Green Published, Green Submitted, gold			2022-12-26	WOS:000360897600043
J	Etienne, L; Blanchard, E; Boyer, A; Desvignes, V; Gaillard, J; Meunier, JC; Roingeard, P; Hourioux, C				Etienne, Loic; Blanchard, Emmanuelle; Boyer, Audrey; Desvignes, Virginie; Gaillard, Julien; Meunier, Jean-Christophe; Roingeard, Philippe; Hourioux, Christophe			The Replacement of 10 Non-Conserved Residues in the Core Protein of JFH-1 Hepatitis C Virus Improves Its Assembly and Secretion	PLOS ONE			English	Article							SIGNAL PEPTIDE PEPTIDASE; CELL-CULTURE SYSTEM; LIPID DROPLETS; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE DOMAIN; STRUCTURAL PROTEINS; INFECTIOUS VIRUS; VIRAL GENOME; PARTICLES; RNA	Hepatitis C virus (HCV) assembly is still poorly understood. It is thought that trafficking of the HCV core protein to the lipid droplet (LD) surface is essential for its multimerization and association with newly synthesized HCV RNA to form the viral nucleocapsid. We carried out a mapping analysis of several complete HCV genomes of all genotypes, and found that the genotype 2 JFH-1 core protein contained 10 residues different from those of other genotypes. The replacement of these 10 residues of the JFH-1 strain sequence with the most conserved residues deduced fromsequence alignments greatly increased virus production. Confocal microscopy of themodified JFH-1 strain in cell culture showed that themutated JFH-1 core protein, C10M, was presentmostly at the endoplasmic reticulum(ER) membrane, but not at the surface of the LDs, even though its trafficking to these organelles was possible. The non-structural 5A protein of HCV was also redirected to ER membranes and colocalized with the C10Mcore protein. Using a Semliki forest virus vector to overproduce core protein, we demonstrated that the C10M core protein was able to form HCV-like particles, unlike the native JFH-1 core protein. Thus, the substitution of a few selected residues in the JFH-1 core protein modified the subcellular distribution and assembly properties of the protein. These findings suggest that the early steps of HCV assembly occur at the ER membrane rather than at the LD surface. The C10M-JFH-1 strain will be a valuable tool for further studies of HCV morphogenesis.	[Etienne, Loic; Blanchard, Emmanuelle; Boyer, Audrey; Desvignes, Virginie; Meunier, Jean-Christophe; Roingeard, Philippe; Hourioux, Christophe] Univ Tours, Fac Med, INSERM, U966, Tours, France; [Etienne, Loic; Blanchard, Emmanuelle; Boyer, Audrey; Desvignes, Virginie; Gaillard, Julien; Meunier, Jean-Christophe; Roingeard, Philippe; Hourioux, Christophe] CHRU Tours, Tours, France; [Blanchard, Emmanuelle; Gaillard, Julien; Roingeard, Philippe; Hourioux, Christophe] Univ Tours, PPF ASB, Plate Forme Microscopies, Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; Universite de Tours	Hourioux, C (corresponding author), Univ Tours, Fac Med, INSERM, U966, Tours, France.	hourioux@med.univ-tours.fr			Agence nationale de recherches sur le sida et les hepatites virales; Ligue contre le cancer	Agence nationale de recherches sur le sida et les hepatites virales(ANRSFrench National Research Agency (ANR)); Ligue contre le cancer(Ligue nationale contre le cancer)	This study was supported by the Agence nationale de recherches sur le sida et les hepatites virales, (http://www.anrs.fr/), Ligue contre le cancer, (http://www.ligue-cancer.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Goughoulte M, 2006, J GEN VIROL, V87, P855, DOI 10.1099/vir.0.81664-0; Aizaki H, 2003, VIROLOGY, V314, P16, DOI 10.1016/S0042-6822(03)00383-0; Aoki Y, 1998, VIROLOGY, V250, P140, DOI 10.1006/viro.1998.9361; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005; Blanchard E, 2003, J VIROL, V77, P10131, DOI 10.1128/JVI.77.18.10131-10138.2003; Blanchard E, 2002, J VIROL, V76, P4073, DOI 10.1128/JVI.76.8.4073-4079.2002; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Boson B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002144; Boulant S, 2005, J VIROL, V79, P11353, DOI 10.1128/JVI.79.17.11353-11365.2005; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200; Boyer A, 2014, J BIOL CHEM, V289, P18904, DOI 10.1074/jbc.M113.538256; Camus G, 2013, J BIOL CHEM, V288, P9915, DOI 10.1074/jbc.M112.434910; Chatel-Chaix L, 2014, J VIROL, V88, P5907, DOI 10.1128/JVI.03404-13; Cocquerel L, 1998, J VIROL, V72, P2183, DOI 10.1128/JVI.72.3.2183-2191.1998; Cocquerel L, 1999, J VIROL, V73, P2641, DOI 10.1128/JVI.73.4.2641-2649.1999; Counihan NA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002302; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; Galli A, 2013, J GEN VIROL, V94, P2221, DOI 10.1099/vir.0.053868-0; Gawlik K, 2014, IMMUNOL RES, V60, P1, DOI 10.1007/s12026-014-8494-3; Gawlik K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088866; Helle F, 2010, J VIROL, V84, P11905, DOI 10.1128/JVI.01548-10; Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913; Hourioux C, 2007, GUT, V56, P1302, DOI 10.1136/gut.2006.108647; Hourioux C, 2007, CELL MICROBIOL, V9, P1014, DOI 10.1111/j.1462-5822.2006.00848.x; Jirasko V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001233; Kim S, 2014, HEPATOLOGY, V60, P1838, DOI 10.1002/hep.27197; Lappalainen S, 2013, HUM VACC IMMUNOTHER, V9, P1991, DOI 10.4161/hv.25249; Lee J-Y, 2014, J VIROL; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lindenbach BD, 2013, NAT REV MICROBIOL, V11, P688, DOI 10.1038/nrmicro3098; Lindenbach BD, 2013, CURR TOP MICROBIOL, V369, P199, DOI 10.1007/978-3-642-27340-7_8; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Mateu G, 2008, VIROLOGY, V376, P397, DOI 10.1016/j.virol.2008.03.027; Matsumoto M, 1996, VIROLOGY, V218, P43, DOI 10.1006/viro.1996.0164; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928; OKAMOTO H, 1991, J GEN VIROL, V72, P2697, DOI 10.1099/0022-1317-72-11-2697; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Popescu CI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001278; Popescu CI, 2010, BIOL CELL, V102, P63, DOI 10.1042/BC20090125; Roingeard P, 2008, HISTOCHEM CELL BIOL, V130, P561, DOI 10.1007/s00418-008-0447-2; Rouille Y, 2006, J VIROL, V80, P2832, DOI 10.1128/JVI.80.6.2832-2841.2006; Salloum S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003513; Sharma KK, 2012, NUCLEIC ACIDS RES, V40, P2540, DOI 10.1093/nar/gkr1140; Sharma KK, 2010, NUCLEIC ACIDS RES, V38, P3632, DOI 10.1093/nar/gkq094; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Steinmann E, 2013, J VIROL, V87, P13297, DOI 10.1128/JVI.01708-13; Tan S-L, 2006, ASSEMBLE INTERACT PL; Targett-Adams P, 2008, J BIOL CHEM, V283, P16850, DOI 10.1074/jbc.M802273200; Vogt DA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003302; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162	57	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137182	10.1371/journal.pone.0137182	http://dx.doi.org/10.1371/journal.pone.0137182			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339783	Green Published, gold, Green Submitted			2022-12-26	WOS:000360688200031
J	Cieslik, M; Czapski, GA; Strosznajder, JB				Cieslik, Magdalena; Czapski, Grzegorz A.; Strosznajder, Joanna B.			The Molecular Mechanism of Amyloid beta 42 Peptide Toxicity: The Role of Sphingosine Kinase-1 and Mitochondrial Sirtuins	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; OXIDATIVE STRESS; CELL-DEATH; P53; ALPHA; SIRT1; SPHINGOSINE-1-PHOSPHATE; DEFICIENCY; PATHWAY	Our study focused on the relationship between amyloid beta 1-42 (A beta), sphingosine kinases (SphKs) and mitochondrial sirtuins in regulating cell fate. SphK1 is a key enzyme involved in maintaining sphingolipid rheostat in the brain. Deregulation of the sphingolipid metabolism may play a crucial role in the pathogenesis of Alzheimer's disease (AD). Mitochondrial function and mitochondrial deacetylases, i.e. sirtuins (Sirt3,-4,-5), are also important for cell viability. In this study, we evaluated the interaction between A beta(1-42), SphKs and Sirts in cell survival/death, and we examined several compounds to indicate possible target(s) for a strategy protecting against cytotoxicity of A beta(1-42). PC12 cells were subjected to A beta(1-42) oligomers and SphK inhibitor SKI II for 24-96 h. Our data indicated that A beta(1-42) enhanced SphK1 expression and activity after 24 h, but down-regulated them after 96 h and had no effect on Sphk2. A beta(1-42) and SKI II induced free radical formation, disturbed the balance between pro-and anti-apoptotic proteins and evoked cell death. Simultaneously, up-regulation of anti-oxidative enzymes catalase and superoxide dismutase 2 was observed. Moreover, the total protein level of glycogen synthase kinase-3 beta was decreased. A beta(1-42) significantly increased the level of mitochondrial proteins: apoptosis-inducing factor AIF and Sirt3, -4, -5. By using several pharmacologically active compounds we showed that p53 protein plays a significant role at very early stages of A beta(1-42) toxicity. However, during prolonged exposure to A beta(1-42), the activation of caspases, MEK/ERK, and alterations in mitochondrial permeability transition pores were additional factors leading to cell death. Moreover, SphK product, sphingosine-1-phosphate (S1P), and Sirt activators and antioxidants, resveratrol and quercetin, significantly enhanced viability of cells subjected to A beta(1-42). Our data indicated that p53 protein and inhibition of SphKs may be early key events responsible for cell death evoked by A beta 1-42. We suggest that activation of S1P-dependent signalling and Sirts may offer a promising cytoprotective strategy.	[Cieslik, Magdalena; Czapski, Grzegorz A.; Strosznajder, Joanna B.] Polish Acad Sci, Dept Cellular Signalling, Mossakowski Med Res Ctr, Warsaw, Poland	Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Strosznajder, JB (corresponding author), Polish Acad Sci, Dept Cellular Signalling, Mossakowski Med Res Ctr, Warsaw, Poland.	jstrosznajder@imdik.pan.pl	Czapski, Grzegorz/D-6151-2016	Strosznajder, Joanna/0000-0002-6213-1212; Czapski, Grzegorz/0000-0002-7541-1571; Cieslik, Magdalena/0000-0002-7604-4371	National Science Centre [2013/09/B/NZ3/01350, 5870/B/PO1/2011/40]	National Science Centre(National Science Centre, Poland)	This study was supported by The National Science Centre (http://www.ncn.gov.pl) Grants 2013/09/B/NZ3/01350 and 5870/B/PO1/2011/40 to J.B.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrabi SA, 2008, ANN NY ACAD SCI, V1147, P233, DOI 10.1196/annals.1427.014; Asle-Rousta M, 2013, J MOL NEUROSCI, V50, P524, DOI 10.1007/s12031-013-9979-6; Aubry S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120352; Bonda DJ, 2011, LANCET NEUROL, V10, P275, DOI 10.1016/S1474-4422(11)70013-8; Buizza L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.13; Ceccom J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-12; Cedazo-Minguez A, 2003, J NEUROCHEM, V87, P1152, DOI 10.1046/j.1471-4159.2003.02088.x; Cheng Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.254; Cieslik M, 2013, NEUROCHEM INT, V62, P626, DOI 10.1016/j.neuint.2013.02.016; Couttas TA, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-9; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; Czapski GA, 2011, FEBS LETT, V585, P1243, DOI 10.1016/j.febslet.2011.03.058; Czubowicz K, 2014, MOL NEUROBIOL, V50, P26, DOI 10.1007/s12035-013-8606-4; de Moura MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106028; Donmez G, 2012, J NEUROSCI, V32, P124, DOI 10.1523/JNEUROSCI.3442-11.2012; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Fonteh AN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125597; Fornai F, 2007, BRAIN RES, V1129, P174, DOI 10.1016/j.brainres.2006.10.071; Gandy K Alexa Orr, 2013, Handb Exp Pharmacol, P275, DOI 10.1007/978-3-7091-1511-4_14; Gassowska M, 2014, NEUROCHEM RES, V39, P645, DOI 10.1007/s11064-014-1240-3; Green KN, 2008, J NEUROSCI, V28, P11500, DOI 10.1523/JNEUROSCI.3203-08.2008; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Han XL, 2002, J NEUROCHEM, V82, P809, DOI 10.1046/j.1471-4159.2002.00997.x; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004; He XX, 2010, NEUROBIOL AGING, V31, P398, DOI 10.1016/j.neurobiolaging.2008.05.010; Hemmati F, 2013, BEHAV BRAIN RES, V252, P415, DOI 10.1016/j.bbr.2013.06.016; Herskovits AZ, 2013, CELL RES, V23, P746, DOI 10.1038/cr.2013.70; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Hooper C, 2007, NEUROSCI LETT, V418, P34, DOI 10.1016/j.neulet.2007.03.026; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jesko H, 2014, FOLIA NEUROPATHOL, V52, P70, DOI 10.5114/fn.2014.41745; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Jimenez S, 2011, J BIOL CHEM, V286, P18414, DOI 10.1074/jbc.M110.209718; Karaca I, 2014, J BIOL CHEM, V289, P16761, DOI 10.1074/jbc.M113.535500; Kazmierczak A, 2011, NEUROCHEM INT, V58, P206, DOI 10.1016/j.neuint.2010.11.018; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kim Taehyun, 2011, Int J Alzheimers Dis, V2011, P857368, DOI 10.4061/2011/857368; Kincaid B, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00048; Kitagishi Y, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt265; Koczor CA, 2012, AM J PATHOL, V180, P2276, DOI 10.1016/j.ajpath.2012.01.045; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li F, 2012, CURR PHARM DESIGN, V18, P27, DOI 10.2174/138161212798919075; Li NJ, 2010, CLIN BIOCHEM, V43, P992, DOI 10.1016/j.clinbiochem.2010.04.072; MASLIAH E, 1991, J NEUROSCI, V11, P2759; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Nakanishi A, 2015, INT J MOL SCI, V16, P2879, DOI 10.3390/ijms16022879; Nassif M, 2007, NEUROCHEM INT, V50, P229, DOI 10.1016/j.neuint.2006.08.008; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Perry G, 1999, NEUROREPORT, V10, P2411, DOI 10.1097/00001756-199908020-00035; Pyszko J, 2014, MOL NEUROBIOL, V50, P38, DOI 10.1007/s12035-013-8622-4; Pyszko JA, 2014, FOLIA NEUROPATHOL, V52, P260, DOI 10.5114/fn.2014.45567; Sery O, 2013, FOLIA NEUROPATHOL, V51, P1, DOI 10.5114/fn.2013.34190; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Strosznajder JB, 2012, MOL NEUROBIOL, V46, P78, DOI 10.1007/s12035-012-8258-9; Takasugi N, 2011, J NEUROSCI, V31, P6850, DOI 10.1523/JNEUROSCI.6467-10.2011; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; van Echten-Deckert G, 2014, CELL PHYSIOL BIOCHEM, V34, P148, DOI 10.1159/000362991; Yang Y, 2014, NEUROCHEM RES, V39, P932, DOI 10.1007/s11064-014-1290-6; Yuyama K, 2014, BBA-MOL CELL BIOL L, V1841, P793, DOI 10.1016/j.bbalip.2013.08.002	65	34	36	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137193	10.1371/journal.pone.0137193	http://dx.doi.org/10.1371/journal.pone.0137193			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334640	Green Submitted, Green Published, gold			2022-12-26	WOS:000360615400044
J	Moncrieff, S; Moncan, M; Scialpi, F; Ditzel, M				Moncrieff, Sophie; Moncan, Matthieu; Scialpi, Flavia; Ditzel, Mark			Regulation of hedgehog Ligand Expression by the N-End Rule Ubiquitin-Protein Ligase Hyperplastic Discs and the Drosophila GSK3 beta Homologue, Shaggy	PLOS ONE			English	Article							CUBITUS INTERRUPTUS; SUBSTRATE RECOGNITION; SIGNALING PATHWAYS; STRUCTURAL BASIS; EYE DEVELOPMENT; IMAGINAL DISC; GENE HEDGEHOG; EDD; WINGLESS; DEGRADATION	Hedgehog (Hh) morphogen signalling plays an essential role in tissue development and homeostasis. While much is known about the Hh signal transduction pathway, far less is known about the molecules that regulate the expression of the hedgehog (hh) ligand itself. Here we reveal that Shaggy (Sgg), the Drosophila melanogaster orthologue of GSK3 beta, and the N-end Rule Ubiquitin-protein ligase Hyperplastic Discs (Hyd) act together to co-ordinate Hedgehog signalling through regulating hh ligand expression and Cubitus interruptus (Ci) expression. Increased hh and Ci expression within hyd mutant clones was effectively suppressed by sgg RNAi, placing sgg downstream of hyd. Functionally, sgg RNAi also rescued the adult hyd mutant head phenotype. Consistent with the genetic interactions, we found Hyd to physically interact with Sgg and Ci. Taken together we propose that Hyd and Sgg function to co-ordinate hh ligand and Ci expression, which in turn influences important developmental signalling pathways during imaginal disc development. These findings are important as tight temporal/spatial regulation of hh ligand expression underlies its important roles in animal development and tissue homeostasis. When deregulated, hh ligand family misexpression underlies numerous human diseases (e.g., colorectal, lung, pancreatic and haematological cancers) and developmental defects (e.g., cyclopia and polydactyly). In summary, our Drosophila-based findings highlight an apical role for Hyd and Sgg in initiating Hedgehog signalling, which could also be evolutionarily conserved in mammals.	[Moncrieff, Sophie; Moncan, Matthieu; Scialpi, Flavia; Ditzel, Mark] Univ Edinburgh, MRC Inst Genet & Mol Med, Edinburgh CRUK Canc Res Ctr, Western Gen Hosp, Edinburgh EH4 2XR, Midlothian, Scotland	University of Edinburgh	Ditzel, M (corresponding author), Univ Edinburgh, MRC Inst Genet & Mol Med, Edinburgh CRUK Canc Res Ctr, Western Gen Hosp, Crewe Rd South, Edinburgh EH4 2XR, Midlothian, Scotland.	mark.ditzel@ed.ac.uk			Biotechnology and Biological Science Research Council New Investigator Award [BB/H0128691/1]; Medical Research Council [RA1734]; ERASMUS undergraduate placement award; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010949] Funding Source: NIH RePORTER; BBSRC [BB/H012869/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H012869/1] Funding Source: researchfish	Biotechnology and Biological Science Research Council New Investigator Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERASMUS undergraduate placement award; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Science Research Council New Investigator Award BB/H0128691/1 (MD, FS), the Medical Research Council RA1734 (SM) and an ERASMUS undergraduate placement award (MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NE, 2007, CURR OPIN GENET DEV, V17, P287, DOI 10.1016/j.gde.2007.05.005; Baker NE, 2009, DEV BIOL, V335, P356, DOI 10.1016/j.ydbio.2009.09.008; Bejarano F, 2007, EMBO REP, V8, P778, DOI 10.1038/sj.embor.7401003; Benavides M, 2013, BBA-MOL CELL RES, V1833, P21, DOI 10.1016/j.bbamcr.2012.10.007; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Blanco J, 2009, DEV BIOL, V329, P104, DOI 10.1016/j.ydbio.2009.02.027; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Ditzel M, 2008, MOL CELL, V32, P540, DOI 10.1016/j.molcel.2008.09.025; Fuja TJ, 2004, CANCER RES, V64, P942, DOI 10.1158/0008-5472.CAN-03-2100; Gallet A, 2003, DEV CELL, V4, P191, DOI 10.1016/S1534-5807(03)00031-5; Gradilla AC, 2013, CURR OPIN GENET DEV, V23, P363, DOI 10.1016/j.gde.2013.04.011; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Hay-Koren A, 2011, MOL BIOL CELL, V22, P399, DOI 10.1091/mbc.E10-05-0440; Henderson MJ, 2002, J BIOL CHEM, V277, P26468, DOI 10.1074/jbc.M203527200; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Kent D, 2006, DEVELOPMENT, V133, P2001, DOI 10.1242/dev.02370; Klein T, 2001, CURR OPIN GENET DEV, V11, P470, DOI 10.1016/S0959-437X(00)00219-7; Kozlov G, 2007, J BIOL CHEM, V282, P35787, DOI 10.1074/jbc.M705655200; Lee JD, 2002, DEVELOPMENT, V129, P5697, DOI 10.1242/dev.00159; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Legent Kevin, 2008, V469, P141, DOI 10.1007/978-1-60327-469-2_12; Lim NS, 2006, J BIOL CHEM, V281, P14376, DOI 10.1074/jbc.M600307200; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; MANSFIELD E, 1994, DEV BIOL, V165, P507, DOI 10.1006/dbio.1994.1271; Matta-Camacho E, 2012, ACTA CRYSTALLOGR F, V68, P1158, DOI 10.1107/S1744309112036937; Matta-Camacho E, 2010, NAT STRUCT MOL BIOL, V17, P1182, DOI 10.1038/nsmb.1894; Maurange C, 2002, GENE DEV, V16, P2672, DOI 10.1101/gad.242702; Meissner B, 2013, BLOOD, V121, P3161, DOI 10.1182/blood-2013-01-478834; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; MOTZNY CK, 1995, MECH DEVELOP, V52, P137, DOI 10.1016/0925-4773(95)00397-J; Munoz MA, 2007, CELL CYCLE, V6, P3070, DOI 10.4161/cc.6.24.5021; O'Brien PM, 2008, BRIT J CANCER, V98, P1085, DOI 10.1038/sj.bjc.6604281; Ohshima R, 2007, GENES CELLS, V12, P1339, DOI 10.1111/j.1365-2443.2007.01138.x; Okamoto K, 2013, NATURE, V494, P502, DOI 10.1038/nature11873; Ou CY, 2002, GENE DEV, V16, P2403, DOI 10.1101/gad.1011402; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Papadopoulou D, 2004, MOL CELL BIOL, V24, P4909, DOI 10.1128/MCB.24.11.4909-4919.2004; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Reid MA, 2013, MOL CELL, V50, P200, DOI 10.1016/j.molcel.2013.02.008; Roignant JY, 2009, INT J DEV BIOL, V53, P795, DOI 10.1387/ijdb.072483jr; Royet J, 1997, DEVELOPMENT, V124, P4793; Saunders DN, 2004, MOL CELL BIOL, V24, P7225, DOI 10.1128/MCB.24.16.7225-7234.2004; Scialpi F, 2015, J BIOL CHEM, V290, P12585, DOI 10.1074/jbc.M114.625673; Smits VA, 2012, CELL CYCLE, V11; Sriram SM, 2011, NAT REV MOL CELL BIO, V12, P735, DOI 10.1038/nrm3217; Su H, 2011, MOL CELL, V43, P97, DOI 10.1016/j.molcel.2011.06.013; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; TABATA T, 1992, GENE DEV, V6, P2635, DOI 10.1101/gad.6.12b.2635; Terriente-Felix A, 2011, DEV BIOL, V350, P382, DOI 10.1016/j.ydbio.2010.12.003; Tokusumi Y, 2010, DEVELOPMENT, V137, P3561, DOI 10.1242/dev.053728; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004; Zhang TY, 2014, P NATL ACAD SCI USA, V111, P12091, DOI 10.1073/pnas.1400230111	56	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136760	10.1371/journal.pone.0136760	http://dx.doi.org/10.1371/journal.pone.0136760			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334301	Green Published, gold, Green Submitted			2022-12-26	WOS:000360615400026
J	Wojdyla, JA; Cutts, E; Kaminska, R; Papadakos, G; Hopper, JTS; Stansfeld, PJ; Staunton, D; Robinson, CV; Kleanthous, C				Wojdyla, Justyna A.; Cutts, Erin; Kaminska, Renata; Papadakos, Grigorios; Hopper, Jonathan T. S.; Stansfeld, Phillip J.; Staunton, David; Robinson, Carol V.; Kleanthous, Colin			Structure and Function of the Escherichia coli Tol-Pal Stator Protein TolR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAGELLAR MOTOR; SECONDARY STRUCTURE; TERMINAL DOMAIN; KEY RESIDUES; FORCE-FIELD; ORGANIZATION; ELECTROSTATICS; RECOGNITION; ACTIVATION; EXPRESSION	TolR is a 15-kDa inner membrane protein subunit of the Tol-Pal complex in Gram-negative bacteria, and its function is poorly understood. Tol-Pal is recruited to cell division sites where it is involved in maintaining the integrity of the outer membrane. TolR is related to MotB, the peptidoglycan (PG)-binding stator protein from the flagellum, suggesting it might serve a similar role in Tol-Pal. The only structure thus far reported for TolR is of the periplasmic domain from Haemophilus influenzae in which N- and C-terminal residues had been deleted (TolR(62-133), Escherichia coli numbering). H. influenzae TolR(62-133) is a symmetrical dimer with a large deep cleft at the dimer interface. Here, we present the 1.7-angstrom crystal structure of the intact periplasmic domain of E. coli TolR (TolR(36-142)). E. coli TolR(36-142) is also dimeric, but the architecture of the dimer is radically different from that of TolR(62-133) due to the intertwining of its N and C termini. TolR monomers are rotated similar to 180 degrees relative to each other as a result of this strand swapping, obliterating the putative PG-binding groove seen in TolR(62-133). We found that removal of the strand-swapped regions (TolR(60-133)) exposes cryptic PG binding activity that is absent in the full-length domain. We conclude that to function as a stator in the Tol-Pal complex dimeric TolR must undergo large scale structural remodeling reminiscent of that proposed for MotB, where the N- and C-terminal sequences unfold in order for the protein to both reach and bind the PG layer similar to 90 angstrom away from the inner membrane.	[Wojdyla, Justyna A.; Cutts, Erin; Kaminska, Renata; Papadakos, Grigorios; Stansfeld, Phillip J.; Staunton, David; Kleanthous, Colin] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Hopper, Jonathan T. S.; Robinson, Carol V.] Univ Oxford, Dept Chem, Oxford OX1 3TA, England	University of Oxford; University of Oxford	Kleanthous, C (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	colin.kleanthous@bioch.ox.ac.uk	Stansfeld, Phill/C-6213-2011; Stansfeld, Phillip James/AAA-9228-2020	Stansfeld, Phill/0000-0001-8800-7669; Stansfeld, Phillip James/0000-0001-8800-7669; Kaminska, Renata/0000-0001-7252-379X; Papadakos, Grigorios/0000-0002-8666-0880; Cutts, Erin E./0000-0003-3290-4293; robinson, carol/0000-0001-7829-5505	Diamond Light Source; Wellcome Trust; Clarendon Fund (Oxford University); Biotechnology and Biological Sciences Research Council of the United Kingdom [BB/G020671/1]; BBSRC [BB/G020671/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G020671/2] Funding Source: researchfish	Diamond Light Source; Wellcome Trust(Wellcome TrustEuropean Commission); Clarendon Fund (Oxford University); Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Diamond Light Source. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Wellcome Trust and the Clarendon Fund (Oxford University).; Supported by Grant BB/G020671/1 from Biotechnology and Biological Sciences Research Council of the United Kingdom. To whom correspondence should be addressed. Tel.: 44-1865-613370; Fax: 44-1865-613213; E-mail: colin.kleanthous@bioch.ox.ac.uk.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Bonsor DA, 2007, J AM CHEM SOC, V129, P4800, DOI 10.1021/ja070153n; Bonsor DA, 2009, EMBO J, V28, P2846, DOI 10.1038/emboj.2009.224; Braun TF, 2001, BIOCHEMISTRY-US, V40, P13051, DOI 10.1021/bi011264g; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cascales E, 2001, MOL MICROBIOL, V42, P795, DOI 10.1046/j.1365-2958.2001.02673.x; Cascales E, 2000, MOL MICROBIOL, V38, P904, DOI 10.1046/j.1365-2958.2000.02190.x; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Clavel T, 1996, MOL MICROBIOL, V19, P19, DOI 10.1046/j.1365-2958.1996.343880.x; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dennis JJ, 1996, J BACTERIOL, V178, P7059, DOI 10.1128/jb.178.24.7059-7068.1996; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dubuisson JF, 2005, MICROBIOL-SGM, V151, P3337, DOI 10.1099/mic.0.28237-0; Edwards D., 1993, ESCHERICHIA COLI BAC, P369; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Gaspar JA, 2000, MOL MICROBIOL, V38, P262, DOI 10.1046/j.1365-2958.2000.02094.x; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Germon P, 2001, J BACTERIOL, V183, P4110, DOI 10.1128/JB.183.14.4110-4114.2001; Goemaere EL, 2007, J BIOL CHEM, V282, P17749, DOI 10.1074/jbc.M701002200; Goemaere EL, 2007, J MOL BIOL, V366, P1424, DOI 10.1016/j.jmb.2006.12.020; GUIHARD G, 1994, J BIOL CHEM, V269, P5874; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; Journet L, 1999, J BACTERIOL, V181, P4476, DOI 10.1128/JB.181.15.4476-4484.1999; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaimer C, 2012, CURR OPIN MICROBIOL, V15, P751, DOI 10.1016/j.mib.2012.10.005; Kim EA, 2008, BIOCHEMISTRY-US, V47, P11332, DOI 10.1021/bi801347a; Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454; Kojima S, 2009, MOL MICROBIOL, V73, P710, DOI 10.1111/j.1365-2958.2009.06802.x; Krewulak KD, 2011, BIOCHEM CELL BIOL, V89, P87, DOI [10.1139/o10-141, 10.1139/O10-141]; Laue T. M., 1992, ANAL ULTRACENTIFUGAT, P990; MacKinnon SS, 2013, STRUCTURE, V21, P638, DOI 10.1016/j.str.2013.01.019; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Morimoto YV, 2014, BIOMOLECULES, V4, P217, DOI 10.3390/biom4010217; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Neill J, 2011, ACTA CRYSTALLOGR D, V67, P1009, DOI 10.1107/S0907444911041102; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Parsons LM, 2008, BIOCHEMISTRY-US, V47, P3131, DOI 10.1021/bi702283x; Parsons LM, 2006, BIOCHEMISTRY-US, V45, P2122, DOI 10.1021/bi052227i; Paterson GK, 2009, MICROBIOL-SGM, V155, P220, DOI 10.1099/mic.0.021576-0; Roujeinikova A, 2008, P NATL ACAD SCI USA, V105, P10348, DOI 10.1073/pnas.0803039105; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stansfeld PJ, 2013, STRUCTURE, V21, P810, DOI 10.1016/j.str.2013.03.005; Sturgis JN, 2001, J MOL MICROB BIOTECH, V3, P113; Ursinus A, 2004, J BACTERIOL, V186, P6728, DOI 10.1128/JB.186.20.6728-6737.2004; Zhang XYZ, 2009, J BIOL CHEM, V284, P4275, DOI 10.1074/jbc.M805257200	58	16	17	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26675	26687		10.1074/jbc.M115.671586	http://dx.doi.org/10.1074/jbc.M115.671586			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26354441	hybrid, Green Published			2022-12-26	WOS:000364793600031
J	Rajendran, VM; Kumar, NSN; Tse, CM; Binder, HJ				Rajendran, Vazhaikkurichi M.; Kumar, Navalpur S. Nanda; Tse, Chung M.; Binder, Henry J.			Na-H Exchanger Isoform-2 (NHE2) Mediates Butyrate-dependent Na+ Absorption in Dextran Sulfate Sodium (DSS)-induced Colitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; ILEAL BRUSH-BORDER; DIFFERENTIAL REGULATION; ULCERATIVE-COLITIS; CHLORIDE TRANSPORT; MEMBRANE-VESICLES; PLASMA-MEMBRANE; DOWN-REGULATION; UP-REGULATION; K+ SECRETION	Diarrhea associated with ulcerative colitis (UC) occurs primarily as a result of reduced Na+ absorption. Although colonic Na+ absorption is mediated by both epithelial Na+ channels (ENaC) and Na-H exchangers (NHE), inhibition of NHE-mediated Na+ absorption is the primary cause of diarrhea in UC. As there are conflicting observations reported on NHE expression in human UC, the present study was initiated to identify whether NHE isoforms (NHE2 and NHE3) expression is altered and how Na+ absorption is regulated in DSS-induced inflammation in rat colon, a model that has been used to study UC. Western blot analyses indicate that neither NHE2 nor NHE3 expression is altered in apical membranes of inflamed colon. Na+ fluxes measured in vitro under voltage clamp conditions in controls demonstrate that both HCO3--dependent and butyrate-dependent Na+ absorption are inhibited by S3226 (NHE3-inhibitor), but not by HOE694 (NHE2-inhibitor) in normal animals. In contrast, in DSS-induced inflammation, butyrate-, but not HCO3--dependent Na+ absorption is present and is inhibited by HOE694, but not by S3226. These observations indicate that in normal colon NHE3 mediates both HCO3--dependent and butyrate-dependent Na+ absorption, whereas DSS-induced inflammation activates NHE2, which mediates butyrate-dependent (but not HCO3--dependent) Na+ absorption. In in vivo loop studies HCO3--Ringer and butyrate-Ringer exhibit similar rates of water absorption in normal rats, whereas in DSS-induced inflammation luminal butyrate- Ringer reversed water secretion observed with HCO3--Ringer to fluid absorption. Lumen butyrate-Ringer incubation activated NHE3-mediated Na+ absorption in DSS-induced colitis. These observations suggest that the butyrate activation of NHE2 would be a potential target to control UC-associated diarrhea.	[Rajendran, Vazhaikkurichi M.; Kumar, Navalpur S. Nanda] W Virginia Univ, Sch Med, Dept Biochem & Mol Biol, Morgantown, WV 26506 USA; [Tse, Chung M.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Binder, Henry J.] Yale Univ, Dept Internal Med, New Haven, CT 06520 USA	West Virginia University; Johns Hopkins University; Yale University	Rajendran, VM (corresponding author), W Virginia Univ, Sch Med, One Med Ctr Dr,POB 9142, Morgantown, WV 26506 USA.	vrajendran@hsc.wvu.edu			National Institutes of Health Grant from NIDDK [DK-018777]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104791, R01DK018777] Funding Source: NIH RePORTER	National Institutes of Health Grant from NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-018777 from the NIDDK (to V. M. R.). The authors declare that they do not have any conflict of interest with the content of this article.	Amasheh S, 2004, GASTROENTEROLOGY, V126, P1711, DOI 10.1053/j.gastro.2004.03.010; Biemesderfer D, 1997, AM J PHYSIOL-RENAL, V273, pF289, DOI 10.1152/ajprenal.1997.273.2.F289; Binder HJ, 2010, ANNU REV PHYSIOL, V72, P297, DOI 10.1146/annurev-physiol-021909-135817; Binder HJ, 2005, J CLIN GASTROENTEROL, V39, pS53, DOI 10.1097/01.mcg.0000155521.81382.3a; Binder HJ, 1991, LARGE INTESTINE PHYS, P141; Breuer RI, 1997, GUT, V40, P485, DOI 10.1136/gut.40.4.485; BUGAUT M, 1987, COMP BIOCHEM PHYS B, V86, P439, DOI 10.1016/0305-0491(87)90433-0; Chen T, 2015, J BIOL CHEM, V290, P1952, DOI 10.1074/jbc.M114.590174; CHO JH, 1994, AM J PHYSIOL, V267, pC796, DOI 10.1152/ajpcell.1994.267.3.C796; COUNILLON L, 1993, MOL PHARMACOL, V44, P1041; DELCASTILLO JR, 1991, AM J PHYSIOL, V261, pG1005, DOI 10.1152/ajpgi.1991.261.6.G1005; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Donowitz M, 2013, MOL ASPECTS MED, V34, P236, DOI 10.1016/j.mam.2012.05.001; Donowitz M, 2009, J EXP BIOL, V212, P1638, DOI 10.1242/jeb.028605; FORBUSH B, 1983, ANAL BIOCHEM, V128, P159, DOI 10.1016/0003-2697(83)90356-1; Greig E, 2000, ANN NY ACAD SCI, V915, P327; HARIG JM, 1989, NEW ENGL J MED, V320, P23, DOI 10.1056/NEJM198901053200105; Hecht G, 2004, AM J PHYSIOL-GASTR L, V287, pG370, DOI 10.1152/ajpgi.00432.2003; Hodges K, 2008, CELL MICROBIOL, V10, P1735, DOI 10.1111/j.1462-5822.2008.01163.x; Hodges K, 2006, AM J PHYSIOL-GASTR L, V291, pG959, DOI 10.1152/ajpgi.00274.2005; Ikuma M, 1999, AM J PHYSIOL-GASTR L, V276, pG539, DOI 10.1152/ajpgi.1999.276.2.G539; Kanthesh BM, 2013, AM J PHYSIOL-CELL PH, V305, pC972, DOI 10.1152/ajpcell.00165.2013; KNICKELBEIN R, 1985, AM J PHYSIOL, V249, pG236, DOI 10.1152/ajpgi.1985.249.2.G236; KNICKELBEIN R, 1983, AM J PHYSIOL, V245, pG504, DOI 10.1152/ajpgi.1983.245.4.G504; Krishnan S, 2003, AM J PHYSIOL-CELL PH, V285, pC1246, DOI 10.1152/ajpcell.00598.2002; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McNamara BP, 2001, J CLIN INVEST, V107, P621, DOI 10.1172/JCI11138; Moe OW, 1999, J AM SOC NEPHROL, V10, P2412; Musch MW, 2001, AM J PHYSIOL-GASTR L, V280, pG687, DOI 10.1152/ajpgi.2001.280.4.G687; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; RAJENDRAN VM, 1994, J MEMBRANE BIOL, V141, P51; RAJENDRAN VM, 1990, J BIOL CHEM, V265, P8408; Saemann MD, 2000, FASEB J, V14, P2380; Sandle GI, 2012, AM J PHYSIOL-CELL PH, V303, pC328, DOI 10.1152/ajpcell.00099.2012; SANDLE GI, 1990, GASTROENTEROLOGY, V99, P97, DOI 10.1016/0016-5085(90)91235-X; Sarker R, 2011, AM J PHYSIOL-CELL PH, V300, pC771, DOI 10.1152/ajpcell.00119.2010; Schwark JR, 1998, PFLUG ARCH EUR J PHY, V436, P797, DOI 10.1007/s004240050704; Soergel K H, 1989, Acta Vet Scand Suppl, V86, P107; STIEGER B, 1986, J MEMBRANE BIOL, V91, P19, DOI 10.1007/BF01870211; Subramanya SB, 2007, AM J PHYSIOL-GASTR L, V293, pG857, DOI 10.1152/ajpgi.00462.2006; Sullivan S, 2009, INFLAMM BOWEL DIS, V15, P261, DOI 10.1002/ibd.20743; Vidyasagar S, 2002, J PHYSIOL-LONDON, V539, P163, DOI 10.1113/jphysiol.2001.013056; Weber TE, 2006, VET IMMUNOL IMMUNOP, V113, P139, DOI 10.1016/j.vetimm.2006.04.006; Yang LM, 2006, J BIOL CHEM, V281, P9859, DOI 10.1074/jbc.M512046200; Yeruva S, 2010, INFLAMM BOWEL DIS, V16, P1149, DOI 10.1002/ibd.21183; Yip RGC, 1999, LIFE SCI, V66, P91, DOI 10.1016/S0024-3205(99)00314-8	47	11	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25487	25496		10.1074/jbc.M115.654277	http://dx.doi.org/10.1074/jbc.M115.654277			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26350456	hybrid, Green Published			2022-12-26	WOS:000362962800024
J	Lv, J; Liu, DD; Ma, J; Wang, XY; Zhang, J				Lv, Jun; Liu, Dongdong; Ma, Jing; Wang, Xiaoying; Zhang, Jue			Graph Theoretical Analysis of BOLD Functional Connectivity during Human Sleep without EEG Monitoring	PLOS ONE			English	Article							SMALL-WORLD NETWORKS; EYE-MOVEMENT SLEEP; COMPLEX BRAIN NETWORKS; CEREBRAL-CORTEX; ORGANIZATION; CONSCIOUSNESS; STIMULATION; INSIGHTS; SYSTEMS; PET	Background Functional brain networks of human have been revealed to have small-world properties by both analyzing electroencephalogram (EEG) and functional magnetic resonance imaging (fMRI) time series. Methods & Results In our study, by using graph theoretical analysis, we attempted to investigate the changes of paralimbic-limbic cortex between wake and sleep states. Ten healthy young people were recruited to our experiment. Data from 2 subjects were excluded for the reason that they had not fallen asleep during the experiment. For each subject, blood oxygen level dependency (BOLD) images were acquired to analyze brain network, and peripheral pulse signals were obtained continuously to identify if the subject was in sleep periods. Results of fMRI showed that brain networks exhibited stronger small-world characteristics during sleep state as compared to wake state, which was in consistent with previous studies using EEG synchronization. Moreover, we observed that compared with wake state, paralimbic-limbic cortex had less connectivity with neocortical system and centrencephalic structure in sleep. Conclusions In conclusion, this is the first study, to our knowledge, has observed that small-world properties of brain functional networks altered when human sleeps without EEG synchronization. Moreover, we speculate that paralimbic-limbic cortex organization owns an efficient defense mechanism responsible for suppressing the external environment interference when humans sleep, which is consistent with the hypothesis that the paralimbic-limbic cortex may be functionally disconnected from brain regions which directly mediate their interactions with the external environment. Our findings also provide a reasonable explanation why stable sleep exhibits homeostasis which is far less susceptible to outside world.	[Lv, Jun; Wang, Xiaoying; Zhang, Jue] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China; [Liu, Dongdong] Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China; [Ma, Jing] Peking Univ, Dept Pulm Med, Hosp 1, Beijing 100871, Peoples R China; [Wang, Xiaoying] Peking Univ, Dept Radiol, Hosp 1, Beijing 100871, Peoples R China; [Zhang, Jue] Peking Univ, Coll Engn, Beijing 100871, Peoples R China	Peking University; Capital Medical University; Peking University; Peking University; Peking University	Wang, XY (corresponding author), Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China.	cjr.wangxiaoying@vip.163.com; zhangjue@pku.edu.cn		Lyu, Jun/0000-0003-1989-1360				Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; [Anonymous], [No title captured]; AUSTIN MP, 1992, J AFFECT DISORDERS, V26, P31, DOI 10.1016/0165-0327(92)90032-2; Balkin TJ, 2002, BRAIN, V125, P2308, DOI 10.1093/brain/awf228; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Santana MTCG, 2010, EPILEPSY RES, V89, P327, DOI 10.1016/j.eplepsyres.2010.02.006; Dang-Vu TT, 2010, SLEEP, V33, P1589, DOI 10.1093/sleep/33.12.1589; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Ferri R, 2008, CLIN NEUROPHYSIOL, V119, P2026, DOI 10.1016/j.clinph.2008.04.294; Ferri R, 2007, CLIN NEUROPHYSIOL, V118, P449, DOI 10.1016/j.clinph.2006.10.021; Grachev ID, 1997, PSYCHIAT CLIN NEUROS, V51, P315, DOI 10.1111/j.1440-1819.1997.tb03205.x; Greene R, 2004, NEUROMOL MED, V5, P59, DOI 10.1385/NMM:5:1:059; He H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038195; Hobson JA, 2002, NAT REV NEUROSCI, V3, P679, DOI 10.1038/nrn915; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Lago-Fernandez LF, 2000, PHYS REV LETT, V84, P2758, DOI 10.1103/PhysRevLett.84.2758; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leistedt SJJ, 2009, HUM BRAIN MAPP, V30, P2207, DOI 10.1002/hbm.20662; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Maderwald S, 2010, P INT SOC MAG RES ME, P1299; Malliani, 1995, CRIT CARE MED, V23, P1795; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Masuda N, 2004, BIOL CYBERN, V90, P302, DOI 10.1007/s00422-004-0471-9; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Nofzinger EA, 2002, BRAIN, V125, P1105, DOI 10.1093/brain/awf103; Parker DJ, 2002, APPL RADIOL, V14, P65; Reddy CG, 2010, J NEUROSURG, V112, P1301, DOI 10.3171/2009.7.JNS09404; Spoormaker VI, 2011, PHILOS T R SOC A, V369, P3708, DOI 10.1098/rsta.2011.0078; Spoormaker VI, 2010, J NEUROSCI, V30, P11379, DOI 10.1523/JNEUROSCI.2015-10.2010; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vafaee MS, 2004, NEUROIMAGE, V22, P966, DOI 10.1016/j.neuroimage.2004.02.019; Wang L, 2009, HUM BRAIN MAPP, V30, P638, DOI 10.1002/hbm.20530; Zhang Y, 2013, MAGN RESON IMAGING, V31, P1105, DOI 10.1016/j.mri.2013.01.006	39	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137297	10.1371/journal.pone.0137297	http://dx.doi.org/10.1371/journal.pone.0137297			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360464	Green Submitted, Green Published, gold			2022-12-26	WOS:000361043100031
J	Hagberg, A; Lemons, N				Hagberg, Aric; Lemons, Nathan			Fast Generation of Sparse Random Kernel Graphs	PLOS ONE			English	Article							EFFICIENT GENERATION; MODEL; NETWORKS	The development of kernel-based inhomogeneous random graphs has provided models that are flexible enough to capture many observed characteristics of real networks, and that are also mathematically tractable. We specify a class of inhomogeneous random graph models, called random kernel graphs, that produces sparse graphs with tunable graph properties, and we develop an efficient generation algorithm to sample random instances from this model. As real-world networks are usually large, it is essential that the run-time of generation algorithms scales better than quadratically in the number of vertices n. We show that for many practical kernels our algorithm runs in time at most O(n(logn)(2)). As a practical example we show how to generate samples of power-law degree distribution graphs with tunable assortativity.	[Hagberg, Aric] Los Alamos Natl Lab, Ctr Nonlinear Studies, Div Theoret, Los Alamos, NM 87545 USA; [Lemons, Nathan] Los Alamos Natl Lab, Div Theoret, Appl Math & Plasma Phys, Los Alamos, NM 87544 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Lemons, N (corresponding author), Los Alamos Natl Lab, Div Theoret, Appl Math & Plasma Phys, Los Alamos, NM 87544 USA.	nlemons@lanl.gov			Department of Energy at Los Alamos National Laboratory through the Laboratory Directed Research and Development Program [DE-AC52-06NA25396]	Department of Energy at Los Alamos National Laboratory through the Laboratory Directed Research and Development Program	This work was funded by the Department of Energy at Los Alamos National Laboratory under contract DE-AC52-06NA25396 through the Laboratory Directed Research and Development Program.	Aiello W, 2001, EXP MATH, V10, P53, DOI 10.1080/10586458.2001.10504428; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Barrett C, 2006, INTERACTIVE COMPUTAT, P353; Batagelj V, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036113; Bayati M, 2010, ALGORITHMICA, V58, P860, DOI 10.1007/s00453-009-9340-1; BENDER EA, 1978, J COMB THEORY A, V24, P296, DOI 10.1016/0097-3165(78)90059-6; Blitzstein J, 2011, INTERNET MATH, V6, P489, DOI 10.1080/15427951.2010.557277; Bollobas B., 2001, RANDOM GRAPHS; Bollobas B., 1980, EUROPEAN J COMBIN, V1, P311, DOI [10.1016/S0195-6698(80)80030-8, DOI 10.1016/S0195-6698(80)80030-8]; Bollobas B, 2007, RANDOM STRUCT ALGOR, V31, P3, DOI 10.1002/rsa.20168; Bollobas B, 2011, RANDOM STRUCT ALGOR, V38, P269, DOI 10.1002/rsa.20322; Chakrabarti D, 2004, SIAM PROC S, P442; Chung F., 2002, ANN COMB, V6, P125, DOI [10.1007/PL00012580, 10.1007/PL00012580.pdf, DOI 10.1007/PL00012580.PDF]; Durrett R, 2010, P NATL ACAD SCI USA, V107, P4491, DOI 10.1073/pnas.0914402107; ERDOS P, 1960, B INT STATIST INST, V38, P343; GILBERT EN, 1959, ANN MATH STAT, V30, P1141, DOI 10.1214/aoms/1177706098; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Hay M, 2010, VLDB J, V19, P797, DOI 10.1007/s00778-010-0210-x; Janson S, 2010, RANDOM STRUCT ALGOR, V36, P26, DOI 10.1002/rsa.20297; Kannan R, 1999, RANDOM STRUCT ALGOR, V14, P293, DOI 10.1002/(SICI)1098-2418(199907)14:4<293::AID-RSA1>3.0.CO;2-G; Kolda TG, 2014, SIAM J SCI COMPUT, V36, pC424, DOI 10.1137/130914218; Litvak N, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.022801; Miller JC, 2011, LECT NOTES COMPUT SC, V6732, P115; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Ray Jaideep, 2012, Algorithms and Models for the Web Graph. Proceedings 9th International Workshop, WAW 2012, P153, DOI 10.1007/978-3-642-30541-2_12; Seshadhri C, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056109; Soderberg B, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.066121; Vespignani A, 2012, NAT PHYS, V8, P32, DOI 10.1038/nphys2160	30	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0135177	10.1371/journal.pone.0135177	http://dx.doi.org/10.1371/journal.pone.0135177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356296	Green Published, Green Submitted, gold			2022-12-26	WOS:000360965800004
J	Jhunjhunwala, S; Aresta-DaSilva, S; Tang, K; Alvarez, D; Webber, MJ; Tang, BC; Lavin, DM; Veiseh, O; Doloff, JC; Bose, S; Vegas, A; Ma, ML; Sahay, G; Chiu, A; Bader, A; Langan, E; Siebert, S; Li, J; Greiner, DL; Newburger, PE; von Andrian, UH; Langer, R; Anderson, DG				Jhunjhunwala, Siddharth; Aresta-DaSilva, Stephanie; Tang, Katherine; Alvarez, David; Webber, Matthew J.; Tang, Benjamin C.; Lavin, Danya M.; Veiseh, Omid; Doloff, Joshua C.; Bose, Suman; Vegas, Arturo; Ma, Minglin; Sahay, Gaurav; Chiu, Alan; Bader, Andrew; Langan, Erin; Siebert, Sean; Li, Jie; Greiner, Dale L.; Newburger, Peter E.; von Andrian, Ulrich H.; Langer, Robert; Anderson, Daniel G.			Neutrophil Responses to Sterile Implant Materials	PLOS ONE			English	Article							ACUTE INFLAMMATORY RESPONSES; EXTRACELLULAR TRAPS; BONE-MARROW; MAST-CELLS; MECHANISMS; RELEASE; PROFILE	In vivo implantation of sterile materials and devices results in a foreign body immune response leading to fibrosis of implanted material. Neutrophils, one of the first immune cells to be recruited to implantation sites, have been suggested to contribute to the establishment of the inflammatory microenvironment that initiates the fibrotic response. However, the precise numbers and roles of neutrophils in response to implanted devices remains unclear. Using a mouse model of peritoneal microcapsule implantation, we show 30-500 fold increased neutrophil presence in the peritoneal exudates in response to implants. We demonstrate that these neutrophils secrete increased amounts of a variety of inflammatory cytokines and chemokines. Further, we observe that they participate in the foreign body response through the formation of neutrophil extracellular traps (NETs) on implant surfaces. Our results provide new insight into neutrophil function during a foreign body response to peritoneal implants which has implications for the development of biologically compatible medical devices.	[Jhunjhunwala, Siddharth; Aresta-DaSilva, Stephanie; Tang, Katherine; Webber, Matthew J.; Tang, Benjamin C.; Lavin, Danya M.; Veiseh, Omid; Doloff, Joshua C.; Bose, Suman; Vegas, Arturo; Ma, Minglin; Sahay, Gaurav; Chiu, Alan; Bader, Andrew; Langan, Erin; Siebert, Sean; Li, Jie; Langer, Robert; Anderson, Daniel G.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Langer, Robert; Anderson, Daniel G.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Langer, Robert; Anderson, Daniel G.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Langer, Robert; Anderson, Daniel G.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Jhunjhunwala, Siddharth; Aresta-DaSilva, Stephanie; Tang, Katherine; Webber, Matthew J.; Tang, Benjamin C.; Lavin, Danya M.; Veiseh, Omid; Doloff, Joshua C.; Bose, Suman; Vegas, Arturo; Ma, Minglin; Sahay, Gaurav; Chiu, Alan; Bader, Andrew; Langan, Erin; Siebert, Sean; Li, Jie; Langer, Robert; Anderson, Daniel G.] Boston Childrens Hosp, Dept Anesthesiol, Boston, MA 02115 USA; [Alvarez, David; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Greiner, Dale L.] Univ Massachusetts, Sch Med, Diabet Ctr Excellence, Dept Mol Med, Worcester, MA 01605 USA; [Newburger, Peter E.] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01605 USA; [Newburger, Peter E.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [von Andrian, Ulrich H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Anderson, DG (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dgander@mit.edu	Webber, Matthew J/D-4847-2011; Veiseh, Omid/GLS-9547-2022; Bose, Suman/A-1794-2009; Jhunjhunwala, Siddharth/K-1526-2013; Veiseh, Omid/N-1137-2019	Veiseh, Omid/0000-0003-1153-8079; Jhunjhunwala, Siddharth/0000-0001-8046-2288; Webber, Matthew/0000-0003-3111-6228; Tang, Benjamin/0000-0002-3807-0480; Doloff, Joshua/0000-0002-4323-3264; Newburger, Peter/0000-0002-8615-673X	Mazumdar-Shaw International Oncology Fellowship; JDRF [17-2007-1063]; Leona M. and Harry B. Helmsley Charitable Trust Foundation [09PG-T1D027]; NIH [EB000244, EB000351, DE013023, CA151884, PO1AI111595, U19AI095261, 5T32 HL066987]; NATIONAL CANCER INSTITUTE [U54CA151884] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI095261, R01AI111595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000244, R01EB000244, R01EB000351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016516, R01DE013023] Funding Source: NIH RePORTER	Mazumdar-Shaw International Oncology Fellowship; JDRF(Juvenile Diabetes Research Foundation); Leona M. and Harry B. Helmsley Charitable Trust Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Mazumdar-Shaw International Oncology Fellowship to SJ; JDRF: Grant 17-2007-1063 to RL and DGA; Leona M. and Harry B. Helmsley Charitable Trust Foundation: Grant 09PG-T1D027 to RL and DGA; NIH: Grants EB000244, EB000351, DE013023, and CA151884 to RL and DGA; NIH: Grants PO1AI111595, U19AI095261 to UHvA. DA was supported by NIH (5T32 HL066987). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Dang TT, 2013, BIOMATERIALS, V34, P5792, DOI 10.1016/j.biomaterials.2013.04.016; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Grainger DW, 2013, NAT BIOTECHNOL, V31, P507, DOI 10.1038/nbt.2600; Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231; Itou T, 2006, CLIN VACCINE IMMUNOL, V13, P575, DOI 10.1128/CVI.13.5.575-583.2006; KAW JL, 1982, JPN J EXP MED, V52, P261; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Labow RS, 2001, J CELL PHYSIOL, V186, P95, DOI 10.1002/1097-4652(200101)186:1<95::AID-JCP1008>3.0.CO;2-0; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; Lakschevitz FS, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.37; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Le SJ, 2010, DIFFERENTIATION, V79, P232, DOI 10.1016/j.diff.2010.03.001; Lee PY, 2013, J LEUKOCYTE BIOL, V94, P585, DOI 10.1189/jlb.0113014; Lee PY, 2011, J IMMUNOL, V186, P1747, DOI 10.4049/jimmunol.1001328; Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955; Mooney JE, 2010, AM J PATHOL, V176, P369, DOI 10.2353/ajpath.2010.090545; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Pashuck ET, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002717; PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835; Ratner, 2012, BIOMATERIALS SCI; Ratner BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5371; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841; TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147; Tang LP, 1999, MOL MED, V5, P351, DOI 10.1007/BF03402124; Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841; Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023; Ye QS, 2010, BIOMATERIALS, V31, P9192, DOI 10.1016/j.biomaterials.2010.08.049; Zdolsek J, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-31; ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305	38	59	63	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137550	10.1371/journal.pone.0137550	http://dx.doi.org/10.1371/journal.pone.0137550			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355958	Green Published, gold, Green Submitted			2022-12-26	WOS:000360965800061
J	Baranowski, DS; Kotkowiak, W; Kierzek, R; Pasternak, A				Baranowski, Daniel Sylwester; Kotkowiak, Weronika; Kierzek, Ryszard; Pasternak, Anna			Hybridization Properties of RNA Containing 8-Methoxyguanosine and 8-Benzyloxyguanosine	PLOS ONE			English	Article							DIVISION PROTEIN FTSZ; GLYCOSIDIC CONFORMATION; STRUCTURAL BASIS; CELL; OLIGONUCLEOTIDES; 2-DEOXYADENOSINE; PHOSPHORAMIDITES; INHIBITION; NUCLEOSIDE; GUANOSINE	Modified nucleobase analogues can serve as powerful tools for changing physicochemical and biological properties of DNA or RNA. Guanosine derivatives containing bulky substituents at 8 position are known to adopt syn conformation of N-glycoside bond. On the contrary, in RNA the anti conformation is predominant in Watson-Crick base pairing. In this paper two 8-substituted guanosine derivatives, 8-methoxyguanosine and 8-benzyloxyguanosine, were synthesized and incorporated into oligoribonucleotides to investigate their influence on the thermodynamic stability of RNA duplexes. The methoxy and benzyloxy substituents are electron-donating groups, decreasing the rate of depurination in the monomers, as confirmed by N-glycoside bond stability assessments. Thermodynamic stability studies indicated that substitution of guanosine by 8-methoxy- or 8-benzyloxyguanosine significantly decreased the thermodynamic stability of RNA duplexes. Moreover, the presence of 8-substituted guanosine derivatives decreased mismatch discrimination. Circular dichroism spectra of modified RNA duplexes exhibited patterns typical for A-RNA geometry.	[Baranowski, Daniel Sylwester; Kotkowiak, Weronika; Kierzek, Ryszard; Pasternak, Anna] Polish Acad Sci, Inst Bioorgan Chem, PL-61704 Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Pasternak, A (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Noskowskiego 12-14, PL-61704 Poznan, Poland.	apa@ibch.poznan.pl	Pasternak, Anna/H-9411-2013	Kotkowiak, Weronika/0000-0002-9776-0924; Kierzek, Ryszard/0000-0002-7644-0016; Pasternak, Anna/0000-0002-9666-4148; Baranowski, Daniel/0000-0002-4346-4804	National Science Center [2012/05/D/ST5/03599]; Polish Ministry of Science and Higher Education under KNOW program	National Science Center(National Science Centre, Poland); Polish Ministry of Science and Higher Education under KNOW program	Funding: This work was supported by the National Science Center [grant number 2012/05/D/ST5/03599 to AP]. This publication was also supported by the Polish Ministry of Science and Higher Education, under the KNOW program.	Bianco C, 1997, CLIN CANCER RES, V3, P439; Bramsen JB, 2010, NUCLEIC ACIDS RES, V38, P5761, DOI 10.1093/nar/gkq341; Cavalieri E, 2012, IUBMB LIFE, V64, P169, DOI 10.1002/iub.586; Chang KY, 1997, J MOL BIOL, V269, P52, DOI 10.1006/jmbi.1997.1021; Chen LS, 2002, NUCLEOS NUCLEOT NUCL, V21, P599, DOI 10.1081/NCN-120015071; Childs-Disney JL, 2007, ACS CHEM BIOL, V2, P745, DOI 10.1021/cb700174r; Davis AR, 2011, NUCLEIC ACIDS RES, V39, P1081, DOI 10.1093/nar/gkq793; DIAS E, 1994, J AM CHEM SOC, V116, P4479, DOI 10.1021/ja00089a048; Eason RG, 1996, NUCLEIC ACIDS RES, V24, P890, DOI 10.1093/nar/24.5.890; Ewald B, 2008, ONCOGENE, V27, P6522, DOI 10.1038/onc.2008.316; Fabrega C, 2001, NUCLEOS NUCLEOT NUCL, V20, P251, DOI 10.1081/NCN-100002085; Kim SN, 2000, BIOCHEM BIOPH RES CO, V273, P404, DOI 10.1006/bbrc.2000.2949; Kotkowiak W, 2014, BIOCHEM J, V464, P203, DOI 10.1042/BJ20141023; LAAYOUN A, 1994, TETRAHEDRON LETT, V35, P4989, DOI 10.1016/S0040-4039(00)73300-4; Langkjaer N, 2009, BIOORGAN MED CHEM, V17, P5420, DOI 10.1016/j.bmc.2009.06.045; LIN TS, 1985, J MED CHEM, V28, P1194, DOI 10.1021/jm00147a012; Liu XJ, 2004, J AM CHEM SOC, V126, P9196, DOI 10.1021/ja048936l; Madela K, 2012, FUTURE MED CHEM, V4, P625, DOI [10.4155/FMC.12.10, 10.4155/fmc.12.10]; Marcelo F, 2013, J AM CHEM SOC, V135, P16418, DOI 10.1021/ja405515r; MCBRIDE LJ, 1983, TETRAHEDRON LETT, V24, P245, DOI 10.1016/S0040-4039(00)81376-3; McDowell JA, 1996, BIOCHEMISTRY-US, V35, P14077, DOI 10.1021/bi9615710; Messias AC, 2004, ACCOUNTS CHEM RES, V37, P279, DOI 10.1021/ar030034m; MOLLER A, 1984, BIOCHEMISTRY-US, V23, P54, DOI 10.1021/bi00296a009; Pasternak A, 2011, ORG BIOMOL CHEM, V9, P3591, DOI 10.1039/c0ob01085e; Proctor DJ, 2003, J AM CHEM SOC, V125, P2390, DOI 10.1021/ja029176m; Rose SD, 2013, REAL-TIME PCR: ADVANCED TECHNOLOGIES AND APPLICATIONS, P171; Schaaper R M, 1982, Basic Life Sci, V20, P199; Schaffner-Barbero C, 2010, BIOCHEMISTRY-US, V49, P10458, DOI 10.1021/bi101577p; Scuotto M, 2015, NUCLEIC ACIDS RES, V43, P7702, DOI 10.1093/nar/gkv789; Szombati Z, 2012, CHEMBIOCHEM, V13, P700, DOI 10.1002/cbic.201100573; TAYLOR CW, 1992, ANTI-CANCER DRUG, V3, P485, DOI 10.1097/00001813-199210000-00007; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Yajima R, 2007, CHEM BIOL, V14, P23, DOI 10.1016/j.chembiol.2006.11.004	33	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137674	10.1371/journal.pone.0137674	http://dx.doi.org/10.1371/journal.pone.0137674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353054	Green Published, gold, Green Submitted			2022-12-26	WOS:000360932800106
J	Shao, ML; Zhang, X; Rao, ZM; Xu, MJ; Yang, TW; Li, H; Xu, ZH				Shao, Minglong; Zhang, Xian; Rao, Zhiming; Xu, Meijuan; Yang, Taowei; Li, Hui; Xu, Zhenghong			Enhanced Production of Androst-1,4-Diene-3,17-Dione by Mycobacterium neoaurum JC-12 Using Three-Stage Fermentation Strategy	PLOS ONE			English	Article							GENE-ENCODING 3-KETOSTEROID-DELTA(1)-DEHYDROGENASE; MICROBIAL TRANSFORMATION; SOYBEAN PHYTOSTEROLS; BIOTRANSFORMATION; CHOLESTEROL; ANDROSTA-1,4-DIENE-3,17-DIONE; BIOCONVERSION; 4-ANDROSTENE-3,17-DIONE; ANDROSTENEDIONE; STEROLS	To improve the androst-1,4-diene-3,17-dione (ADD) production from phytosterol by Mycobacterium neoaurum JC-12, fructose was firstly found favorable as the initial carbon source to increase the biomass and eliminate the lag phase of M. neoaurum JC-12 in the phytosterol transformation process. Based on this phenomenon, two-stage fermentation by using fructose as the initial carbon source and feeding glucose to maintain strain metabolism was designed. By applying this strategy, the fermentation duration was decreased from 168 h to 120 h with the ADD productivity increased from 0.071 g/(L.h) to 0.108 g/(L.h). Further, three-stage fermentation by adding phytosterol to improve ADD production at the end of the two-stage fermentation was carried out and the final ADD production reached 18.6 g/L, which is the highest reported ADD production using phytosterol as substrate. Thus, this strategy provides a possible way in enhancing the ADD production in pharmaceutical industry.	[Shao, Minglong; Zhang, Xian; Rao, Zhiming; Xu, Meijuan; Yang, Taowei] Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Lab Appl Microorganisms & Metab Engn,Sch Biotechn, Wuxi 214122, Jiangsu, Peoples R China; [Li, Hui; Xu, Zhenghong] Jiangnan Univ, Sch Pharmaceut Sci, Lab Pharmaceut Engn, Wuxi 214122, Jiangsu, Peoples R China	Jiangnan University; Jiangnan University	Rao, ZM (corresponding author), Jiangnan Univ, Sch Biotechnol, 1800 Lihu Ave, Wuxi 214122, Jiangsu, Peoples R China.	raozhm@jiangnan.edu.cn	Xu, Meijuan/C-1790-2012		National Basic Research Program of China (973 Program) [2012CB725202]; High-Tech Research and Development Programs of China [2011AA02A211]; National Natural Science Foundation of China [21276110]; Fundamental Research Funds for the Central Universities [JUSRP51306A]; 111 Project [111-2-06]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Basic Research Program of China (973 Program)(National Basic Research Program of China); High-Tech Research and Development Programs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); 111 Project(Ministry of Education, China - 111 Project); Priority Academic Program Development of Jiangsu Higher Education Institutions	Funding: This work was supported by the National Basic Research Program of China (973 Program) (2012CB725202), the High-Tech Research and Development Programs of China (2011AA02A211), the National Natural Science Foundation of China (21276110), the Fundamental Research Funds for the Central Universities (JUSRP51306A), the 111 Project (111-2-06) and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borrego S, 2000, TISSUE CELL, V32, P494, DOI 10.1016/S0040-8166(00)80005-1; Carvalho F, 2009, BIORESOURCE TECHNOL, V100, P4050, DOI 10.1016/j.biortech.2009.03.044; Chaudhari PN, 2010, BIOTECHNOL LETT, V32, P695, DOI 10.1007/s10529-010-0206-z; Claudino MJC, 2008, BIORESOURCE TECHNOL, V99, P2304, DOI 10.1016/j.biortech.2007.05.007; Dias ACP, 2002, BIORESOURCE TECHNOL, V82, P253, DOI 10.1016/S0960-8524(01)00187-0; Fernandes P, 2007, BIORESOURCE TECHNOL, V98, P2335, DOI 10.1016/j.biortech.2006.10.006; Fernandes P, 2003, ENZYME MICROB TECH, V32, P688, DOI 10.1016/S0141-0229(03)00029-2; Gulla V, 2010, J CHEM TECHNOL BIOT, V85, P1135, DOI 10.1002/jctb.2410; Heipieper HJ, 2007, APPL MICROBIOL BIOT, V74, P961, DOI 10.1007/s00253-006-0833-4; Huang CL, 2006, ENZYME MICROB TECH, V39, P296, DOI 10.1016/j.enzmictec.2005.10.017; LEE CY, 1993, APPL MICROBIOL BIOT, V38, P447; Li Y, 2007, LETT APPL MICROBIOL, V44, P563, DOI 10.1111/j.1472-765X.2007.02134.x; Lin YL, 2009, BIORESOURCE TECHNOL, V100, P1864, DOI 10.1016/j.biortech.2008.09.040; Liu YC, 2011, WORLD J MICROB BIOT, V27, P759, DOI 10.1007/s11274-010-0513-5; Lo CK, 2002, J IND MICROBIOL BIOT, V28, P280, DOI 10.1038/sj/jim/7000243; Mahato SB, 1997, STEROIDS, V62, P332, DOI 10.1016/S0039-128X(96)00251-6; Malaviya A, 2008, BIORESOURCE TECHNOL, V99, P6725, DOI 10.1016/j.biortech.2008.01.039; Manosroi A, 2008, J STEROID BIOCHEM, V108, P132, DOI 10.1016/j.jsbmb.2007.05.032; Molchanova MA, 2007, RUSS J BIOORG CHEM+, V33, P354, DOI 10.1134/S1068162007030132; Olivares A, 2011, WORLD J MICROB BIOT, V27, P2513, DOI 10.1007/s11274-011-0720-8; Perez C, 2006, J IND MICROBIOL BIOT, V33, P719, DOI 10.1007/s10295-006-0148-6; ROY PK, 1991, INDIAN J BIOCHEM BIO, V28, P150; Saab HB, 2013, J IND MICROBIOL BIOT, V40, P1315, DOI 10.1007/s10295-013-1315-1; Sallam LAR, 2005, PROCESS BIOCHEM, V40, P203, DOI 10.1016/j.procbio.2003.12.006; Sharma P, 2012, ANN MICROBIOL, V62, P1651, DOI 10.1007/s13213-012-0422-y; Shen YB, 2012, J IND MICROBIOL BIOT, V39, P1253, DOI 10.1007/s10295-012-1130-0; Shen YB, 2011, APPL MICROBIOL BIOT, V90, P1995, DOI 10.1007/s00253-011-3214-6; Sripalakit P, 2006, J MOL CATAL B-ENZYM, V41, P49, DOI 10.1016/j.molcatb.2006.04.007; Wang M, 2009, J MOL CATAL B-ENZYM, V59, P58, DOI 10.1016/j.molcatb.2008.12.017; Wang ZF, 2002, J CHEM TECHNOL BIOT, V77, P1349, DOI 10.1002/jctb.728; Wang ZL, 2008, J IND MICROBIOL BIOT, V35, P645, DOI 10.1007/s10295-008-0345-6; Wang ZL, 2006, PROCESS BIOCHEM, V41, P557, DOI 10.1016/j.procbio.2005.09.014; Wei W, 2010, APPL ENVIRON MICROB, V76, P4578, DOI 10.1128/AEM.00448-10; Wu Y, 2014, STEROIDS, V84, P70, DOI 10.1016/j.steroids.2014.03.007; Yao K, 2013, METAB ENG, V15, P75, DOI 10.1016/j.ymben.2012.10.005; Ye Q, 2010, APPL MICROBIOL BIOT, V87, P517, DOI 10.1007/s00253-010-2536-0; Zehentgruber D, 2010, J BIOTECHNOL, V146, P179, DOI 10.1016/j.jbiotec.2010.01.019; Zhang LT, 2009, APPL BIOCHEM BIOTECH, V159, P642, DOI 10.1007/s12010-008-8499-2; Zhang WQ, 2013, J STEROID BIOCHEM, V135, P36, DOI 10.1016/j.jsbmb.2012.12.016; ZURKOWSK.P, 1964, CLIN CHEM, V10, P481	40	25	31	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137658	10.1371/journal.pone.0137658	http://dx.doi.org/10.1371/journal.pone.0137658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352898	Green Published, Green Submitted, gold			2022-12-26	WOS:000360932800105
J	Skinner, B; Guy, SJ				Skinner, Brian; Guy, Stephen J.			A Method for Using Player Tracking Data in Basketball to Learn Player Skills and Predict Team Performance	PLOS ONE			English	Article								Player tracking data represents a revolutionary new data source for basketball analysis, in which essentially every aspect of a player's performance is tracked and can be analyzed numerically. We suggest a way by which this data set, when coupled with a network-style model of the offense that relates players' skills to the team's success at running different plays, can be used to automatically learn players' skills and predict the performance of untested 5-man lineups in a way that accounts for the interaction between players' respective skill sets. After developing a general analysis procedure, we present as an example a specific implementation of our method using a simplified network model. While player tracking data is not yet available in the public domain, we evaluate our model using simulated data and show that player skills can be accurately inferred by a simple statistical inference scheme. Finally, we use the model to analyze games from the 2011 playoff series between the Memphis Grizzlies and the Oklahoma City Thunder and we show that, even with a very limited data set, the model can consistently describe a player's interactions with a given lineup based only on his performance with a different lineup.	[Skinner, Brian] Univ Minnesota, Fine Theoret Phys Inst, Minneapolis, MN 55455 USA; [Skinner, Brian] MIT, Cambridge, MA 02139 USA; [Guy, Stephen J.] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27599 USA; [Guy, Stephen J.] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; Massachusetts Institute of Technology (MIT); University of North Carolina; University of North Carolina Chapel Hill; University of Minnesota System; University of Minnesota Twin Cities	Skinner, B (corresponding author), Univ Minnesota, Fine Theoret Phys Inst, Minneapolis, MN 55455 USA.	skinner1@mit.edu; sjguy@cs.umn.edu		Guy, Stephen/0000-0001-8986-5817; Skinner, Brian/0000-0003-0774-3563				Carlin B. P., 2011, BAYESIAN METHODS DAT; Engelmann J., 2011, MIT SLOAN SPORTS AN; Fewell JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047445; Franks A, 2014, ARXIV14050231STAT; Goldsberry K, 2013, MIT SLOAN SPORTS AN; Lowe Z., 2013, 7 WAYS NBAS NEW CAME; Maheswaran R., 2012, P 6 ANN MIT SLOAN SP; Malinowski E., 2011, INSIDE NBAS DATA DRI; Maymin P, 2013, MIT SLOAN SPORTS AN; Miller A., 2014, ARXIV14010942STAT; Oliver D., 2004, BASKETBALL PAPER RUL; Piette J., 2011, MIT SLOAN SPORTS AN, P1; Reich BJ, 2006, AM STAT, V60, P3, DOI 10.1198/000313006X90305; Shirley K., 2007, NEW ENGL S STAT SPOR; Skinner B., 2013, SIGNIFICANCE, V10, P25, DOI [10.1111/j.1740-9713.2013.00662.x, DOI 10.1111/J.1740-9713.2013.00662.X]; Skinner B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030776; Skinner B, 2010, J QUANT ANAL SPORTS, V6, DOI 10.2202/1559-0410.1217; Strumbelj E, 2012, INT J FORECASTING, V28, P532, DOI 10.1016/j.ijforecast.2011.01.004; Weil S., 2011, MIT SLOAN SPORTS AN	19	11	12	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136393	10.1371/journal.pone.0136393	http://dx.doi.org/10.1371/journal.pone.0136393			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26351846	Green Published, gold, Green Submitted			2022-12-26	WOS:000360932800035
J	Sobral, G; Sues, HD; Muller, J				Sobral, Gabriela; Sues, Hans-Dieter; Mueller, Johannes			Anatomy of the Enigmatic Reptile Elachistosuchus huenei Janensch, 1949 (Reptilia: Diapsida) from the Upper Triassic of Germany and Its Relevance for the Origin of Sauria	PLOS ONE			English	Article							MISSING DATA; PHYLOGENETIC ANALYSES; INCOMPLETE TAXA; INTERRELATIONSHIPS; DINOSAURIA; BRAINCASE; THEROPODA; ACCURACY; SKELETON; FOSSILS	The holotype and only known specimen of the enigmatic small reptile Elachistosuchus huenei Janensch, 1949 from the Upper Triassic (Norian) Arnstadt Formation of Saxony-Anhalt (Germany) is redescribed using mu CT scans of the material. This re-examination revealed new information on the morphology of this taxon, including previously unknown parts of the skeleton such as the palate, braincase, and shoulder girdle. Elachistosuchus is diagnosed especially by the presence of the posterolateral process of the frontal, the extension of the maxillary tooth row to the posterior margin of the orbit, the free posterior process of the jugal, and the notched anterior margin of the interclavicle. Phylogenetic analyses using two recently published character-taxon matrices recovered conflicting results for the phylogenetic position of Elachistosuchus-either as an archosauromorph, as a lepidosauromorph or as a more basal, non-saurian diapsid. These different placements highlight the need of a thorough revision of critical taxa and new character sets used for inferring neodiapsid relationships.	[Sobral, Gabriela; Mueller, Johannes] Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde Berlin, Berlin, Germany; [Sues, Hans-Dieter] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA	Leibniz Institut fur Evolutions und Biodiversitatsforschung; Smithsonian Institution; Smithsonian National Museum of Natural History	Sobral, G (corresponding author), Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde Berlin, Berlin, Germany.	Gabriela.Sobral@mfn-berlin.de	Sobral, Gabriela/AAX-4093-2020; Müller, Johannes/A-6293-2017	Sobral, Gabriela/0000-0002-5001-4406; Müller, Johannes/0000-0001-5801-856X; Sues, Hans-Dieter/0000-0002-9911-7254	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Deutscher Akademischer Austauschdienst [BEX 3474/09-7]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD))	GS was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br) and the Deutscher Akademischer Austauschdienst (www.daad.de): BEX 3474/09-7.	Abel RL, 2012, PALAEONTOL ELECTRON, V15; [Anonymous], [No title captured]; Balanoff AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113559; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; BERMAN D S, 1982, Annals of Carnegie Museum, V51, P423; Canoville A, 2010, BIOL J LINN SOC, V100, P384, DOI 10.1111/j.1095-8312.2010.01431.x; Chen XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102361; Clark James M., 1993, Journal of Vertebrate Paleontology, V13, P48; Cobbett A, 2007, SYST BIOL, V56, P753, DOI 10.1080/10635150701627296; CURRIE P J, 1981, Palaeontologia Africana, V24, P99; Dilkes DW, 1998, PHILOS T ROY SOC B, V353, P501, DOI 10.1098/rstb.1998.0225; Evans S.E., 1989, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1989, P577; Evans S.E., 1987, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1987, P193; Evans S.E., 1986, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V173, P181; EVANS SE, 1981, ZOOL J LINN SOC-LOND, V73, P81, DOI 10.1111/j.1096-3642.1981.tb01580.x; EVANS SE, 1980, ZOOL J LINN SOC-LOND, V70, P203, DOI 10.1111/j.1096-3642.1980.tb00852.x; Evans Susan E., 2009, Palaeontologia Polonica, P145; Evans Susan E., 2009, Palaeontologia Polonica, P179; Ezcurra MD, 2015, PALAEONTOLOGY, V58, P141, DOI 10.1111/pala.12130; Ezcurra MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089165; Ezcurra MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086864; FRASER NC, 1988, PHILOS T ROY SOC B, V321, P125, DOI 10.1098/rstb.1988.0092; Gardner NM, 2010, PALAEONTOL ELECTRON, V13; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; GOW C E, 1975, Palaeontologia Africana, V18, P89; Hahn G., 1973, Palaeontographica Abt A, V142, P1; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; HOELZER GA, 1994, TRENDS ECOL EVOL, V9, P104, DOI 10.1016/0169-5347(94)90207-0; Jaekel O, 1913, PALAEONTOL Z, V1, P155; Jalil NE, 1997, J VERTEBR PALEONTOL, V17, P506, DOI 10.1080/02724634.1997.10010998; Janensch W., 1949, Neues Jahrbuch fuer Mineralogie Geologie und Palaeontologie Stuttgart, VB 8, P225; Kearney M, 2002, SYST BIOL, V51, P369, DOI 10.1080/10635150252899824; Kearney M, 2003, J VERTEBR PALEONTOL, V23, P263, DOI 10.1671/0272-4634(2003)023[0263:PDTMDI]2.0.CO;2; Kodandaramaiah U, 2010, MOL PHYLOGENET EVOL, V54, P386, DOI 10.1016/j.ympev.2009.08.012; Kuhn O., 1939, Palaeontologische Zeitschrift Berlin, V21, P258; M?ller J., 2004, RECENT ADV ORIGIN EA, P379; Maddison WP, 2011, MESQUITE MODULAR SYS; Miyashita T, 2011, J ANAT, V219, P661, DOI 10.1111/j.1469-7580.2011.01427.x; Modesto SP, 2002, J VERTEBR PALEONTOL, V22, P851, DOI 10.1671/0272-4634(2002)022[0851:AENDRF]2.0.CO;2; Muller J, 2005, CAN J EARTH SCI, V42, P1347, DOI 10.1139/E05-030; Nosotti Stefania, 2007, Memorie della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V35, P1; Oelrich T. M., 1956, Miscellaneous Publications Museum of Zoology University of Michigan, V94, P1; Pardo JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108542; Pol D, 2009, CLADISTICS, V25, P515, DOI 10.1111/j.1096-0031.2009.00258.x; Reisz R.R., 1981, University of Kansas Publications of the Museum of Natural History, P1; Reisz RR, 2011, P ROY SOC B-BIOL SCI, V278, P3731, DOI 10.1098/rspb.2011.0439; Rieppel O., 1989, Journal of Vertebrate Paleontology, V9, P373; Romer A. S., 1940, GEOLOGICAL SOC AM SP, V28, P1, DOI DOI 10.1130/SPE28-P1; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sampson SD, 2007, J VERTEBR PALEONTOL, V27, P32, DOI 10.1671/0272-4634(2007)27[32:CAOMCT]2.0.CO;2; Sen K, 2003, J ASIAN EARTH SCI, V21, P663, DOI 10.1016/S1367-9120(02)00110-4; Shavit L, 2007, MOL BIOL EVOL, V24, P2400, DOI 10.1093/molbev/msm178; Sobral G, 2012, J VERTEBR PALEONTOL, V32, P1090, DOI 10.1080/02724634.2012.693554; STORRS GW, 1993, J GEOL SOC LONDON, V150, P1103, DOI 10.1144/gsjgs.150.6.1103; Vaughn PP, 1955, B MUS COMP ZOOL HARV, V114, P36; WALKER AD, 1966, NATURE, V211, P583, DOI 10.1038/211583a0; Ware JL, 2008, SYST ENTOMOL, V33, P429, DOI 10.1111/j.1365-3113.2008.00424.x; WHITESIDE DI, 1986, PHILOS T ROY SOC B, V312, P379, DOI 10.1098/rstb.1986.0014; Wiens JJ, 2005, SYST BIOL, V54, P731, DOI 10.1080/10635150500234583; Wiens JJ, 2003, J VERTEBR PALEONTOL, V23, P297, DOI 10.1671/0272-4634(2003)023[0297:ITICAP]2.0.CO;2; Wiens JJ, 2011, SYST BIOL, V60, P719, DOI 10.1093/sysbio/syr025; WILLISTON S. W., 1925, OSTEOLOGY REPTILES; Witmer LM, 2009, ANAT REC, V292, P1266, DOI 10.1002/ar.20983	63	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135114	10.1371/journal.pone.0135114	http://dx.doi.org/10.1371/journal.pone.0135114			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352985	gold, Green Published, Green Submitted			2022-12-26	WOS:000360932800006
J	Chen, W; Zheng, HL; Teng, HK; Wang, YL; Zhang, YX; Zhao, CL; Liao, Y				Chen, Wei; Zheng, Huaili; Teng, Houkai; Wang, Yili; Zhang, Yuxin; Zhao, Chuanliang; Liao, Yong			Enhanced Coagulation-Flocculation Performance of Iron-Based Coagulants: Effects of PO43- and SiO32- Modifiers	PLOS ONE			English	Article							SILICATE SULFATE PFSIS; COMPOSITE COAGULANT; FERRIC SULFATE; POLYFERRIC SULFATE; WASTE-WATER; TITANIUM TETRACHLORIDE; DEWATERING PROPERTIES; FLOC CHARACTERISTICS; METAL-SALTS; BEHAVIOR	PO43- and SiO32- are often used as modifier to improve stability and aggregating ability of the iron-base coagulants, however, there are few reports about their detailed comparison between the coagulation performance and mechanisms. In this study, three coagulants-polyferric phosphoric sulfate (PFPS), polysilicon ferric sulfate (PFSS), and polyferric sulfate (PFS) were synthesized; their structure and morphology were characterized by Fourier transformed infrared (FT-IR) spectroscopy, X-ray diffraction (XRD) and Scanning electron microscope (SEM). Alkali titration and Ferron species analysis were employed to investigate the hydrolysis performance and species distribution. Jar test was conducted to measure their coagulation behaviors at different dosage, pH, and temperatures in which the flocs properties were measured. The results showed that a number of new compounds were formed due to the presence of PO43- and SiO32-. Moreover, PFPS and PFSS had similar level in Fe-a as well as Fe-b. Among them, PFPS produced more multi-core iron atoms polymer and content of Fe-b, and the formed flocs were larger and denser. It exhibited superior coagulation performance in terms of turbidity reduction, UV254 removal and residual ferric concentration. Jar test and floc breakage/regrowth experiments indicated other than charge neutrality, the dominated mechanism involved in PFSS was the adsorption between polysilicic acid and solution particle, while PFPS was sweeping, entrapment/adsorption resulting from larger polymer colloid of Fe-P chemistry bond.	[Chen, Wei; Zheng, Huaili; Zhao, Chuanliang; Liao, Yong] Chongqing Univ, State Minist Educ, Three Gorges Reservoir Reg Ecoenvironm, Key Lab, Chongqing 630044, Peoples R China; [Chen, Wei; Zheng, Huaili; Zhao, Chuanliang; Liao, Yong] Chongqing Univ, Natl Ctr Int Res Low Carbon & Green Bldg, Chongqing 630044, Peoples R China; [Teng, Houkai] Tianjin Chem Res & Design Inst, Natl Res Ctr Ind Water Treatment Engn & Technol, Tianjin, Peoples R China; [Wang, Yili] Beijing Forestry Univ, Res Ctr Water Pollut Source Control & Ecoremedia, Beijing, Peoples R China; [Zhang, Yuxin] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China	Chongqing University; Chongqing University; Beijing Forestry University; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Chen, W (corresponding author), Chongqing Univ, State Minist Educ, Three Gorges Reservoir Reg Ecoenvironm, Key Lab, Chongqing 630044, Peoples R China.	chenwei0835@foxmail.com; zhl@cqu.edu.cn	Zhang, Yu Xin/D-1524-2009	Zhang, Yu Xin/0000-0003-4698-5645	National Natural Science Foundation of China [21477010]; "Graduate Student Research Innovation Project" of Chongqing University [CYB14045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Graduate Student Research Innovation Project" of Chongqing University	Funding provided by National Natural Science Foundation of China (Project No. 21477010), URLs: http://www.nsfc.gov.cn/, received by Huaili Zheng, contribution to the preparation of manuscript and 2014 "Graduate Student Research Innovation Project" of Chongqing University (Project No. CYB14045), URLs: http://www.nsfc.gov.cn/, received by Wei Chen, contribution to the data collection and analysis.	Bache DH, 1997, WATER SCI TECHNOL, V36, P49, DOI 10.2166/wst.1997.0084; Cheng WP, 2002, CHEMOSPHERE, V47, P963, DOI 10.1016/S0045-6535(02)00052-8; Cotton F. A., 1999, ADV INORGANIC CHEM; Dong HY, 2014, DESALINATION, V335, P102, DOI 10.1016/j.desal.2013.12.018; DOUSMA J, 1978, J COLLOID INTERF SCI, V64, P154, DOI 10.1016/0021-9797(78)90345-4; Duan JM, 2003, ADV COLLOID INTERFAC, V100, P475, DOI 10.1016/S0001-8686(02)00067-2; El Samrani AG, 2004, WATER RES, V38, P756, DOI 10.1016/j.watres.2003.10.002; Fu Y, 2007, J NON-CRYST SOLIDS, V353, P2206, DOI 10.1016/j.jnoncrysol.2007.02.038; Fu Y, 2009, CHEM ENG J, V149, P1, DOI 10.1016/j.cej.2007.03.020; Huang X, 2014, CHEM ENG J, V245, P173, DOI 10.1016/j.cej.2014.02.018; Hussain S, 2013, CHEM ENG J, V225, P394, DOI 10.1016/j.cej.2013.03.119; Istv'an L., 1993, WATER SCI TECHNOL, V27, P242; Jiang JQ, 1998, WATER RES, V32, P930, DOI 10.1016/S0043-1354(97)83364-7; Kang L, 1995, J ENV ENG, V27, P249; KRATOHVIL S, 1967, J COLLOID INTERF SCI, V24, P47, DOI 10.1016/0021-9797(67)90275-5; Lan W, 2009, J HAZARD MATER, V162, P174, DOI 10.1016/j.jhazmat.2008.05.032; Lei GY, 2009, DESALINATION, V247, P518, DOI 10.1016/j.desal.2008.06.026; Li R, 2013, CHEM ENG J, V223, P869, DOI 10.1016/j.cej.2013.03.010; Li R, 2013, DESALINATION, V319, P85, DOI 10.1016/j.desal.2013.03.024; MORRIS JK, 1984, J AM WATER WORKS ASS, V76, P74; Moussas PA, 2008, SEP PURIF TECHNOL, V63, P475, DOI 10.1016/j.seppur.2008.06.009; Moussas PA, 2009, WATER RES, V43, P3511, DOI 10.1016/j.watres.2009.05.015; Mpofu P, 2004, J COLLOID INTERF SCI, V271, P145, DOI 10.1016/j.jcis.2003.09.042; Niu XX, 2011, J ENVIRON SCI-CHINA, V23, P1122, DOI 10.1016/S1001-0742(10)60537-2; Rong HY, 2014, CHEM ENG J, V243, P169, DOI 10.1016/j.cej.2013.12.005; Rong HY, 2013, J HAZARD MATER, V252, P330, DOI 10.1016/j.jhazmat.2013.03.011; Song S, 2006, WATER RES, V40, P364, DOI 10.1016/j.watres.2005.09.046; Sun CZ, 2012, CHEM ENG J, V185, P29, DOI 10.1016/j.cej.2011.04.056; Sun F, 2013, SEP PURIF TECHNOL, V115, P123, DOI 10.1016/j.seppur.2013.05.004; Sun T, 2010, CHEM ENG J, V163, P48, DOI 10.1016/j.cej.2010.07.037; Tang HX, 1994, CHEM WATER WASTEWATE, VIII, P57; Tran T, 2006, J MEMBRANE SCI, V280, P560, DOI 10.1016/j.memsci.2006.02.013; Tzoupanos ND, 2009, COLLOID SURFACE A, V342, P30, DOI 10.1016/j.colsurfa.2009.03.054; Wang DS, 2000, COLLOID SURFACE A, V166, P27, DOI 10.1016/S0927-7757(99)00420-3; Wang DS, 2001, WATER RES, V35, P3418, DOI 10.1016/S0043-1354(01)00034-3; Wang JP, 2013, WATER RES, V47, P2643, DOI 10.1016/j.watres.2013.01.050; Wei JC, 2009, WATER RES, V43, P724, DOI 10.1016/j.watres.2008.11.004; Yang Hai-yan, 2004, J Zhejiang Univ Sci, V5, P721, DOI 10.1631/jzus.2004.0721; Ye CQ, 2007, COLLOID SURFACE A, V294, P163, DOI 10.1016/j.colsurfa.2006.08.005; Yu WZ, 2010, WATER RES, V44, P3959, DOI 10.1016/j.watres.2010.04.032; Zeng K, 2007, HYDROMETALLURGY CHIN; Zhao YX, 2014, DESALINATION, V335, P70, DOI 10.1016/j.desal.2013.12.016; Zhao YX, 2013, CHEM ENG J, V233, P70, DOI 10.1016/j.cej.2013.08.017; Zheng HL, 2011, SPECTROSC SPECT ANAL, V31, P551, DOI 10.3964/j.issn.1000-0593(2011)02-0551-04; Zheng HL, 2013, CHEM ENG J, V234, P318, DOI 10.1016/j.cej.2013.08.098; Zheng HL, 2011, DESALINATION, V269, P148, DOI 10.1016/j.desal.2010.10.054; Zhu GC, 2012, DESALINATION, V285, P315, DOI 10.1016/j.desal.2011.10.019; Zhu GC, 2011, CHEM ENG J, V178, P50, DOI 10.1016/j.cej.2011.10.008; Zouboulis AI, 2008, J HAZARD MATER, V155, P459, DOI 10.1016/j.jhazmat.2007.11.108; Zouboulis AI, 2008, DESALINATION, V224, P307, DOI 10.1016/j.desal.2007.06.012	50	15	15	5	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137116	10.1371/journal.pone.0137116	http://dx.doi.org/10.1371/journal.pone.0137116			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339902	gold, Green Published, Green Submitted			2022-12-26	WOS:000360688200022
J	Matsunaga, E; Higuchi, Y; Mori, K; Yairo, N; Oka, T; Shinozuka, S; Tashiro, K; Izumi, M; Kuhara, S; Takegawa, K				Matsunaga, Emiko; Higuchi, Yujiro; Mori, Kazuki; Yairo, Nao; Oka, Takuji; Shinozuka, Saki; Tashiro, Kosuke; Izumi, Minoru; Kuhara, Satoru; Takegawa, Kaoru			Identification and Characterization of a Novel Galactofuranose-Specific beta-D-Galactofuranosidase from Streptomyces Species	PLOS ONE			English	Article							ALPHA-L-ARABINOFURANOSIDASE; UDP-GALACTOPYRANOSE MUTASE; ASPERGILLUS-NIDULANS; GENOME SEQUENCE; NIGER; BIOSYNTHESIS; GALACTOMANNAN; PENICILLIUM; KAWACHII; PROTEIN	beta-D-galactofuranose (Galf) is a component of polysaccharides and glycoconjugates and its transferase has been well analyzed. However, no beta-D-galactofuranosidase (Galf-ase) gene has been identified in any organism. To search for a Galf-ase gene we screened soil samples and discovered a strain, identified as a Streptomyces species by the 16S ribosomal RNA gene analysis, that exhibits Galf-ase activity for 4-nitrophenyl beta-D-galactofuranoside (pNP-beta-D-Galf) in culture supernatants. By draft genome sequencing of the strain, named JHA19, we found four candidate genes encoding Galf-ases. Using recombinant proteins expressed in Escherichia coli, we found that three out of four candidates displayed the activity of not only Galf-ase but also alpha-L-arabinofuranosidase (Araf-ase), whereas the other one showed only the Galf-ase activity. This novel Galf-specific hydrolase is encoded by ORF1110 and has an optimum pH of 5.5 and a Km of 4.4 mM for the substrate pNP-beta-D-Galf. In addition, this enzyme was able to release galactose residue from galactomannan prepared from the filamentous fungus Aspergillus fumigatus, suggesting that natural polysaccharides could be also substrates. By the BLAST search using the amino acid sequence of ORF1110 Galf-ase, we found that there are homolog genes in both prokaryotes and eukaryotes, indicating that Galf-specific Galf-ases widely exist in microorganisms.	[Matsunaga, Emiko; Higuchi, Yujiro; Mori, Kazuki; Yairo, Nao; Tashiro, Kosuke; Kuhara, Satoru; Takegawa, Kaoru] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Fukuoka 812, Japan; [Oka, Takuji] Sojo Univ, Fac Biotechnol & Life Sci, Dept Appl Microbial Technol, Kumamoto, Japan; [Shinozuka, Saki; Izumi, Minoru] Okayama Univ, Grad Sch Environm & Life Sci, Okayama, Japan	Kyushu University; Sojo University; Okayama University	Takegawa, K (corresponding author), Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, 6-10-1 Hakozaki, Fukuoka 812, Japan.	takegawa@agr.kyushu-u.ac.jp	Mori, Kazuki/M-2670-2018	Mori, Kazuki/0000-0003-3238-2472; Higuchi, Yujiro/0000-0001-7309-291X; Oka, Takuji/0000-0002-5691-654X	JSPS [26292054, 26892022]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by JSPS KAKENHI (https://www.jsps.go.jp/english/index.html) Grant Numbers 26292054 to K. Takegawa and 26892022 to YH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afroz S, 2011, FUNGAL GENET BIOL, V48, P896, DOI 10.1016/j.fgb.2011.06.001; Alam MK, 2012, FUNGAL GENET BIOL, V49, P1033, DOI 10.1016/j.fgb.2012.08.010; Chlubnova I, 2012, CARBOHYD RES, V356, P44, DOI 10.1016/j.carres.2012.04.002; COUSIN MA, 1989, J APPL BACTERIOL, V66, P311, DOI 10.1111/j.1365-2672.1989.tb02484.x; Crous JM, 1996, APPL MICROBIOL BIOT, V46, P256, DOI 10.1007/s002530050813; Damveld RA, 2008, GENETICS, V178, P873, DOI 10.1534/genetics.107.073148; El-Ganiny AM, 2010, FUNGAL GENET BIOL, V47, P629, DOI 10.1016/j.fgb.2010.03.002; El-Ganiny AM, 2008, FUNGAL GENET BIOL, V45, P1533, DOI 10.1016/j.fgb.2008.09.008; Engel J, 2009, J BIOL CHEM, V284, P33859, DOI 10.1074/jbc.M109.070219; FLIPPHI MJA, 1993, CURR GENET, V24, P525, DOI 10.1007/BF00351717; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Futagami T, 2011, EUKARYOT CELL, V10, P1586, DOI 10.1128/EC.05224-11; Gielkens M, 1999, MICROBIOL-UK, V145, P735, DOI 10.1099/13500872-145-3-735; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1415, DOI 10.1271/bbb.70080; Komachi Y, 2013, MOL MICROBIOL, V90, P1054, DOI 10.1111/mmi.12416; Koseki T, 2003, J BIOSCI BIOENG, V96, P232, DOI 10.1016/S1389-1723(03)80187-1; Kudoh A, 2015, GLYCOBIOLOGY, V25, P74, DOI 10.1093/glycob/cwu091; Lamarre C, 2009, CELL MICROBIOL, V11, P1612, DOI 10.1111/j.1462-5822.2009.01352.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Latge JP, 2009, MED MYCOL, V47, pS104, DOI 10.1080/13693780802258832; LATGE JP, 1994, INFECT IMMUN, V62, P5424; Leitao EA, 2003, GLYCOBIOLOGY, V13, P681, DOI 10.1093/glycob/cwg089; Marino C, 1998, GLYCOBIOLOGY, V8, P901, DOI 10.1093/glycob/8.9.901; Matsumura K, 2004, J BIOSCI BIOENG, V98, P77, DOI 10.1263/jbb.98.77; Morelle W, 2005, EUKARYOT CELL, V4, P1308, DOI 10.1128/EC.4.7.1308-1316.2005; Nikodinovic J, 2003, BIOTECHNIQUES, V35, P932, DOI 10.2144/03355bm05; Peltier P, 2008, CARBOHYD RES, V343, P1897, DOI 10.1016/j.carres.2008.02.010; RAMLI N, 1995, BIOSCI BIOTECH BIOCH, V59, P1856, DOI 10.1271/bbb.59.1856; REISS E, 1979, INFECT IMMUN, V25, P357, DOI 10.1128/IAI.25.1.357-365.1979; Richards MR, 2009, CHEMBIOCHEM, V10, P1920, DOI 10.1002/cbic.200900208; RIETSCHELBERST M, 1977, J BIOL CHEM, V252, P3219; Schmalhorst PS, 2008, EUKARYOT CELL, V7, P1268, DOI 10.1128/EC.00109-08; SCHWABE K, 1978, CARBOHYD RES, V67, P541, DOI 10.1016/S0008-6215(00)84146-4; Shi H, 2014, BIOTECHNOL LETT, V36, P1321, DOI 10.1007/s10529-014-1493-6; Tefsen B, 2012, BIOL CHEM, V393, P767, DOI 10.1515/hsz-2012-0134; Tefsen B, 2012, GLYCOBIOLOGY, V22, P456, DOI 10.1093/glycob/cwr144; VANBRUGGENVANDERLUGT AW, 1992, J BACTERIOL, V174, P6096; VARELA O, 1986, CARBOHYD RES, V155, P247, DOI 10.1016/S0008-6215(00)90153-8; Wallis GLF, 1999, BBA-GEN SUBJECTS, V1472, P576, DOI 10.1016/S0304-4165(99)00188-9; Wallis GLF, 2001, BBA-GEN SUBJECTS, V1525, P19, DOI 10.1016/S0304-4165(00)00150-1; Wallis GLF, 2001, EUR J BIOCHEM, V268, P4134, DOI 10.1046/j.1432-1327.2001.02322.x; Yuen KY, 2001, J CLIN MICROBIOL, V39, P3830, DOI 10.1128/JCM.39.11.3830-3837.2001; Zhao G, 2014, GENOME ANNOUNC, V2, P100; Zhao GZ, 2012, EUKARYOT CELL, V11, P1178, DOI 10.1128/EC.00160-12	44	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137230	10.1371/journal.pone.0137230	http://dx.doi.org/10.1371/journal.pone.0137230			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340350	Green Published, gold, Green Submitted			2022-12-26	WOS:000360688200036
J	Mori, J; Kawabata, A; Tang, HM; Tadagaki, K; Mizuguchi, H; Kuroda, K; Mori, Y				Mori, Junko; Kawabata, Akiko; Tang, Huamin; Tadagaki, Kenjiro; Mizuguchi, Hiroyuki; Kuroda, Kazumichi; Mori, Yasuko			Human Herpesvirus-6 U14 Induces Cell-Cycle Arrest in G2/M Phase by Associating with a Cellular Protein, EDD	PLOS ONE			English	Article							ADENOVIRUS VECTORS; HYPERPLASTIC-DISCS; E2F1/RB PATHWAYS; VIRAL ENVELOPE; CODING CONTENT; T-CELLS; HUMAN-HERPESVIRUS-6; GENE; P53; INFECTION	The human herpesvirus-6 (HHV-6) infection induces cell-cycle arrest. In this study, we found that the HHV-6-encoded U14 protein induced cell-cycle arrest at G2/M phase via an association with the cellular protein EDD, a mediator of DNA-damage signal transduction. In the early phase of HHV-6 infection, U14 colocalized with EDD dots in the nucleus, and similar colocalization was also observed in cells transfected with a U14 expression vector. When the carboxyl-terminal region of U14 was deleted, no association of U14 and EDD was observed, and the percentage of cells in G2/M decreased relative to that in cells expressing wild-type U14, indicating that the C-terminal region of U14 and the U14-EDD association are critical for the cell-cycle arrest induced by U14. These results indicate that U14 is a G2/M checkpoint regulator encoded by HHV-6.	[Mori, Junko; Kawabata, Akiko; Tang, Huamin; Mori, Yasuko] Kobe Univ, Grad Sch Med, Div Clin Virol, Kobe, Hyogo 6500017, Japan; [Tang, Huamin] Nanjing Med Univ, Dept Immunol, Nanjing 210029, Jiangsu, Peoples R China; [Tadagaki, Kenjiro] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Biochem & Mol Biol, Kyoto 6028566, Japan; [Mizuguchi, Hiroyuki] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biochem & Mol Biol, Osaka 5650871, Japan; [Kuroda, Kazumichi] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Microbiol, Tokyo 1738610, Japan; [Mori, Yasuko] Natl Inst Biomed Innovat, Lab Virol & Vaccinol, Osaka 5670085, Japan	Kobe University; Nanjing Medical University; Kyoto Prefectural University of Medicine; Osaka University; Nihon University; National Institute of Health Sciences - Japan	Mori, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Clin Virol, Kobe, Hyogo 6500017, Japan.	ymori@med.kobe-u.ac.jp			Japan Society for the Promotion of Science (JSPS)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (JSPS).	Ablashi D, 2014, ARCH VIROL, V159, P863, DOI 10.1007/s00705-013-1902-5; Akkapaiboon P, 2004, J VIROL, V78, P7969, DOI 10.1128/JVI.78.15.7969-7983.2004; Callaghan MJ, 1998, ONCOGENE, V17, P3479, DOI 10.1038/sj.onc.1202249; Clark DA, 2002, INT J HEMATOL, V76, P246, DOI 10.1007/BF03165124; Davy C, 2007, VIROLOGY, V368, P219, DOI 10.1016/j.virol.2007.05.043; De Bolle L, 2004, FEBS LETT, V560, P25, DOI 10.1016/S0014-5793(04)00035-3; Dominguez G, 1999, J VIROL, V73, P8040, DOI 10.1128/JVI.73.10.8040-8052.1999; Fehr AR, 2013, J VIROL, V87, P8818, DOI 10.1128/JVI.00088-13; GOMPELS UA, 1995, VIROLOGY, V209, P29, DOI 10.1006/viro.1995.1228; Henderson MJ, 2006, J BIOL CHEM, V281, P39990, DOI 10.1074/jbc.M602818200; Henderson MJ, 2002, J BIOL CHEM, V277, P26468, DOI 10.1074/jbc.M203527200; Isegawa Y, 1999, J VIROL, V73, P8053, DOI 10.1128/JVI.73.10.8053-8063.1999; Izumi T, 2010, P NATL ACAD SCI USA, V107, P20798, DOI 10.1073/pnas.1008076107; Kawabata A, 2012, VIROLOGY, V429, P21, DOI 10.1016/j.virol.2012.03.027; Kawabata K, 2005, MOL THER, V12, P547, DOI 10.1016/j.ymthe.2005.04.015; Kofod-Olsen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059223; Koshizuka T, 2010, VIROLOGY, V405, P280, DOI 10.1016/j.virol.2010.06.016; Li LY, 2014, ARCH VIROL, V159, P365, DOI 10.1007/s00705-013-1826-0; Li LY, 2012, J MED VIROL, V84, P657, DOI 10.1002/jmv.23226; Li LY, 2011, J VIROL, V85, P6774, DOI 10.1128/JVI.02577-10; Ling SY, 2011, J BIOL CHEM, V286, P14972, DOI 10.1074/jbc.M110.182527; Mizuguchi H, 2002, GENE, V285, P69, DOI 10.1016/S0378-1119(02)00410-9; Mlechkovich G, 2007, J VIROL, V81, P13499, DOI 10.1128/JVI.01496-07; Mori Y, 2003, J VIROL, V77, P4992, DOI 10.1128/JVI.77.8.4992-4999.2003; Mori Y, 1998, VIROLOGY, V249, P129, DOI 10.1006/viro.1998.9305; Mori Y, 2003, J VIROL, V77, P2452, DOI 10.1128/JVI.77.4.2452-2458.2003; Mori Y, 2009, CELL MICROBIOL, V11, P1001, DOI 10.1111/j.1462-5822.2009.01312.x; Munoz MA, 2007, CELL CYCLE, V6, P3070, DOI 10.4161/cc.6.24.5021; Nakamura T, 2008, J PROTEOME RES, V7, P1007, DOI 10.1021/pr7005878; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OKUNO T, 1989, J CLIN MICROBIOL, V27, P651, DOI 10.1128/JCM.27.4.651-653.1989; Oster B, 2008, J GEN VIROL, V89, P87, DOI 10.1099/vir.0.83136-0; Oster B, 2005, J VIROL, V79, P1961, DOI 10.1128/JVI.79.3.1961-1965.2005; Oster B, 2008, J GEN VIROL, V89, P1106, DOI 10.1099/vir.0.83262-0; Oster B, 2006, J CLIN VIROL, V37, pS63, DOI 10.1016/S1386-6532(06)70014-2; Ota M, 2014, MICROBIOL IMMUNOL, V58, P119, DOI 10.1111/1348-0421.12121; Reitsma JM, 2011, CELL HOST MICROBE, V9, P103, DOI 10.1016/j.chom.2011.01.006; Sakurai F, 2005, GENE THER, V12, P1424, DOI 10.1038/sj.gt.3302562; Schleimann MH, 2014, VIROLOGY, V452, P254, DOI 10.1016/j.virol.2014.01.028; Sharon E, 2014, P NATL ACAD SCI USA, V111, P451, DOI 10.1073/pnas.1308854110; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Takemoto M, 2005, J VIROL, V79, P13037, DOI 10.1128/JVI.79.20.13037-13046.2005; Takemoto M, 2004, J GEN VIROL, V85, P869, DOI 10.1099/vir.0.19626-0; YAMANISHI K, 1988, LANCET, V1, P1065; Zerr DM, 2005, CLIN INFECT DIS, V40, P932, DOI 10.1086/428060; Zhao RY, 2005, CELL RES, V15, P143, DOI 10.1038/sj.cr.7290279	46	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137420	10.1371/journal.pone.0137420	http://dx.doi.org/10.1371/journal.pone.0137420			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340541	gold, Green Published, Green Submitted			2022-12-26	WOS:000360688200058
J	Tundup, S; Srivastava, L; Norberg, T; Watford, W; Harn, D				Tundup, Smanla; Srivastava, Leena; Norberg, Thomas; Watford, Wendy; Harn, Donald			A Neoglycoconjugate Containing the Human Milk Sugar LNFPIII Drives Anti-Inflammatory Activation of Antigen Presenting Cells in a CD14 Dependent Pathway	PLOS ONE			English	Article							N-FUCOPENTAOSE-III; HOST IMMUNE-RESPONSES; DC-SIGN; ALTERNATIVE ACTIVATION; DENDRITIC CELLS; KAPPA-B; IN-VIVO; MACROPHAGES; POLARIZATION; RECEPTORS	The milk pentasaccharide LNFPIII has therapeutic action for metabolic and autoimmune diseases and prolongs transplant survival in mice when presented as a neoglycoconjugate. Within LNFPIII is the Lewis(x) trisaccharide, expressed by many helminth parasites. In humans, LNFPIII is found in human milk and also known as stage-specific embryonic antigen-1. LNFPIII-NGC drives alternative activation of macrophages and dendritic cells via NF kappa B activation in a TLR4 dependent mechanism. However, the connection between LNFPIII-NGC activation of APCs, TLR4 signaling and subsequent MAP kinase signaling leading to anti-inflammatory activation of APCs remains unknown. In this study we determined that the innate receptor CD14 was essential for LNFPIII-NGC induction of both ERK and NFkB activation in APCs. Induction of ERK activation by LNFPIII-NGC was completely dependent on CD14/TLR4-Ras-Raf1/TPL2-MEK axis in bone marrow derived dendritic cells (BMDCs). In addition, LNFPIII-NGC preferentially induced the production of Th2 "favoring" chemokines CCL22 and matrix metalloprotease protein-9 in a CD14 dependent manner in BMDCs. In contrast, LNFPIII-NGC induces significantly lower levels of Th1 "favoring" chemokines, MIP1 alpha, MIP1 beta and MIP-2 compared to levels in LPS stimulated cells. Interestingly, NGC of the identical human milk sugar LNnT, minus the alpha 1-3 linked fucose, failed to activate APCs via TLR4/MD2/CD14 receptor complex, suggesting that the alpha 1-3 linked fucose in LNFPIII and not on LNnT, is required for this process. Using specific chemical inhibitors of the MAPK pathway, we found that LNFPIII-NGC induction of CCL22, MMP9 and IL-10 production was dependent on ERK activation. Over all, this study suggests that LNFPIII-NGC utilizes CD14/TLR4-MAPK (ERK) axis in modulating APC activation to produce anti-inflammatory chemokines and cytokines in a manner distinct from that seen for the pro-inflammatory PAMP LPS. These pathways may explain the in vivo therapeutic effect of LNFPIII-NGC treatment for inflammation based diseases.	[Tundup, Smanla; Srivastava, Leena; Watford, Wendy; Harn, Donald] Univ Georgia, Dept Infect Dis, Coll Vet Med, Athens, GA 30602 USA; [Harn, Donald] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Norberg, Thomas] Uppsala Univ, Dept Biochem & Organ Chem, Uppsala, Sweden; [Tundup, Smanla] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Uppsala University; University of Chicago	Harn, D (corresponding author), Univ Georgia, Dept Infect Dis, Coll Vet Med, Athens, GA 30602 USA.	dharn@uga.edu		Watford, Wendy/0000-0003-4261-5399	National Institute of Health [5R01AI056484]; University of Georgia Research Funds; Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056484] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Georgia Research Funds; Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Health (Grant 5R01AI056484 to D.H.), University of Georgia Research Funds, and the Georgia Research Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atochina O, 2006, EXP DERMATOL, V15, P461, DOI 10.1111/j.1600-0625.2006.00431.x; Atochina O, 2005, CLIN DIAGN LAB IMMUN, V12, P1041, DOI 10.1128/CDLI.12.9.1041-1049.2005; Atochina O, 2008, IMMUNOLOGY, V125, P111, DOI 10.1111/j.1365-2567.2008.02826.x; Baumann CL, 2010, J EXP MED, V207, P2689, DOI 10.1084/jem.20101111; Bhargava P, 2012, NAT MED, V18, P1665, DOI 10.1038/nm.2962; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Dutta P, 2010, TRANSPLANTATION, V90, P1071, DOI 10.1097/TP.0b013e3181f8f296; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Gros A, 2012, CLIN CANCER RES, V18, P5212, DOI 10.1158/1078-0432.CCR-12-1108; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; HARN DA, 1987, J IMMUNOL, V138, P1571; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kaiser F, 2009, J EXP MED, V206, P1863, DOI 10.1084/jem.20091059; KO AI, 1990, P NATL ACAD SCI USA, V87, P4159, DOI 10.1073/pnas.87.11.4159; Koning N, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00112; Larghi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045279; Lee CG, 2001, J EXP MED, V194, P809, DOI 10.1084/jem.194.6.809; Lee HK, 2006, IMMUNITY, V24, P153, DOI 10.1016/j.immuni.2005.12.012; Lo SK, 1997, BLOOD, V89, P307, DOI 10.1182/blood.V89.1.307.307_307_314; Lopez-Pelaez M, 2011, EUR J IMMUNOL, V41, P1733, DOI 10.1002/eji.201041101; Martinez FO, 2011, EUR J IMMUNOL, V41, P1531, DOI 10.1002/eji.201141670; Naarding MA, 2005, J CLIN INVEST, V115, P3256, DOI 10.1172/JCI25105; Okano M, 2001, J IMMUNOL, V167, P442, DOI 10.4049/jimmunol.167.1.442; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; SPOONCER E, 1984, J BIOL CHEM, V259, P4792; Srivastava L, 2014, INFECT IMMUN, V82, P1891, DOI 10.1128/IAI.01293-13; Terrazas CA, 2013, FASEB J, V27, P4547, DOI 10.1096/fj.13-228932; Thomas PG, 2005, J IMMUNOL, V175, P2082, DOI 10.4049/jimmunol.175.4.2082; Thomas PG, 2003, J IMMUNOL, V171, P5837, DOI 10.4049/jimmunol.171.11.5837; Tundup S, 2014, INFECT IMMUN, V82, P3240, DOI 10.1128/IAI.01780-14; Tundup S, 2012, ANN NY ACAD SCI, V1253, pE1, DOI 10.1111/j.1749-6632.2012.06618.x; van Stijn CMW, 2010, MOL IMMUNOL, V47, P1544, DOI 10.1016/j.molimm.2010.01.014; VELUPILLAI P, 1994, P NATL ACAD SCI USA, V91, P18, DOI 10.1073/pnas.91.1.18; Watford WT, 2010, J IMMUNOL, V184, P105, DOI 10.4049/jimmunol.0803730; Zhu B, 2012, CLIN IMMUNOL, V142, P351, DOI 10.1016/j.clim.2011.12.006	37	18	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137495	10.1371/journal.pone.0137495	http://dx.doi.org/10.1371/journal.pone.0137495			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340260	Green Published, gold, Green Submitted			2022-12-26	WOS:000360688200065
J	Villar, M; Ayllon, N; Kocan, KM; Bonzon-Kulichenko, E; Alberdi, P; Blouin, EF; Weisheit, S; Mateos-Hernandez, L; Cabezas-Cruz, A; Bell-Sakyi, L; Vancova, M; Bily, T; Meyer, DF; Sterba, J; Contreras, M; Rudenko, N; Grubhoffer, L; Vazquez, J; de la Fuente, J				Villar, Margarita; Ayllon, Nieves; Kocan, Katherine M.; Bonzon-Kulichenko, Elena; Alberdi, Pilar; Blouin, Edmour F.; Weisheit, Sabine; Mateos-Hernandez, Lourdes; Cabezas-Cruz, Alejandro; Bell-Sakyi, Lesley; Vancova, Marie; Bily, Tomas; Meyer, Damien F.; Sterba, Jan; Contreras, Marinela; Rudenko, Nataliia; Grubhoffer, Libor; Vazquez, Jesus; de la Fuente, Jose			Identification and Characterization of Anaplasma phagocytophilum Proteins Involved in Infection of the Tick Vector, Ixodes scapularis	PLOS ONE			English	Article							IV SECRETION SYSTEM; GENE-EXPRESSION; SURFACE-PROTEINS; DIFFERENTIAL EXPRESSION; CATTLE PATHOGEN; MARGINALE; MEMBRANE; ADHESION; CELLS; HOST	Anaplasma phagocytophilum is an emerging zoonotic pathogen transmitted by Ixodes scapularis that causes human granulocytic anaplasmosis. Here, a high throughput quantitative proteomics approach was used to characterize A. phagocytophilum proteome during rickettsial multiplication and identify proteins involved in infection of the tick vector, I. scapularis. The first step in this research was focused on tick cells infected with A. phagocytophilum and sampled at two time points containing 10-15% and 65-71% infected cells, respectively to identify key bacterial proteins over-represented in high percentage infected cells. The second step was focused on adult female tick guts and salivary glands infected with A. phagocytophilum to compare in vitro results with those occurring during bacterial infection in vivo. The results showed differences in the proteome of A. phagocytophilum in infected ticks with higher impact on protein synthesis and processing than on bacterial replication in tick salivary glands. These results correlated well with the developmental cycle of A. phagocytophilum, in which cells convert from an intracellular reticulated, replicative form to the nondividing infectious dense-core form. The analysis of A. phagocytophilum differentially represented proteins identified stress response (GroEL, HSP70) and surface (MSP4) proteins that were over-represented in high percentage infected tick cells and salivary glands when compared to low percentage infected cells and guts, respectively. The results demonstrated that MSP4, GroEL and HSP70 interact and bind to tick cells, thus playing a role in rickettsia-tick interactions. The most important finding of these studies is the increase in the level of certain bacterial stress response and surface proteins in A. phagocytophilum-infected tick cells and salivary glands with functional implication in tick-pathogen interactions. These results gave a new dimension to the role of these stress response and surface proteins during A. phagocytophilum infection in ticks. Characterization of Anaplasma proteome contributes information on host-pathogen interactions and provides targets for development of novel control strategies for pathogen infection and transmission.	[Villar, Margarita; Ayllon, Nieves; Alberdi, Pilar; Mateos-Hernandez, Lourdes; Cabezas-Cruz, Alejandro; Contreras, Marinela; de la Fuente, Jose] Inst Invest Recursos Cineget IREC CSIC UCLM JCCM, SaBio, Ronda Toledo S-N, Ciudad Real 13005, Spain; [Kocan, Katherine M.; Blouin, Edmour F.; de la Fuente, Jose] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK 74078 USA; [Bonzon-Kulichenko, Elena; Vazquez, Jesus] Ctr Nacl Invest Cardiovasc, Madrid 28029, Spain; [Weisheit, Sabine; Bell-Sakyi, Lesley] Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland; [Weisheit, Sabine; Bell-Sakyi, Lesley] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush EH25 9RG, Midlothian, Scotland; [Weisheit, Sabine; Bell-Sakyi, Lesley] Pirbright Inst, Woking GU24 0NF, Surrey, England; [Cabezas-Cruz, Alejandro] Univ Lille Nord France, Inst Pasteur Lille, CIIL, INSERM,U1019,CNRS,UMR 8204, Lille, France; [Vancova, Marie; Bily, Tomas; Sterba, Jan; Rudenko, Nataliia; Grubhoffer, Libor] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, CZ-37005 Ceske Budejovice, Czech Republic; [Vancova, Marie; Bily, Tomas; Grubhoffer, Libor] Univ South Bohemia, Fac Sci, CZ-37005 Ceske Budejovice, Czech Republic; [Meyer, Damien F.] CIRAD, UMR CMAEE, F-97170 Petit Bourg, Guadeloupe, France; [Meyer, Damien F.] INRA, CMAEE UMR1309, F-34398 Montpellier, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Oklahoma State University System; Oklahoma State University - Stillwater; Centro Nacional de Investigaciones Cardiovasculares (CNIC); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; CIRAD; INRAE	de la Fuente, J (corresponding author), Inst Invest Recursos Cineget IREC CSIC UCLM JCCM, SaBio, Ronda Toledo S-N, Ciudad Real 13005, Spain.	jose_delafuente@yahoo.com	Villar-Rayo, Marga M/J-4155-2012; Rudenko, Natalie/AAD-8980-2021; Bonzon-Kulichenko, Elena/R-4208-2018; Contreras, Marinela/R-4474-2019; Cabezas-Cruz, Alejandro/P-2755-2017; Štěrba, Ján/E-9533-2012; Alberdi, Pilar/K-7788-2014; Hernández, Lourdes Mateos/P-6717-2019; Vazquez, Jesus/B-7697-2015; Vancova, Marie/G-8347-2014; Rudenko, Nataliia/J-8571-2012; Bily, Tomas/AAT-8692-2020; Rojo, Marinela Contreras/AAD-9995-2021; Grubhoffer, Libor/G-9762-2014; Meyer, Damien/G-2607-2013	Villar-Rayo, Marga M/0000-0003-4172-9079; Bonzon-Kulichenko, Elena/0000-0003-0852-7520; Cabezas-Cruz, Alejandro/0000-0002-8660-730X; Štěrba, Ján/0000-0003-1005-1787; Alberdi, Pilar/0000-0002-6999-9735; Hernández, Lourdes Mateos/0000-0001-9566-7710; Vazquez, Jesus/0000-0003-1461-5092; Vancova, Marie/0000-0003-0678-8268; Bily, Tomas/0000-0003-1450-1693; Grubhoffer, Libor/0000-0003-0885-1849; Contreras Rojo, Marinela/0000-0002-1505-5624; Meyer, Damien/0000-0003-2735-176X	MEC, Spain [BFU2011-23896]; European Union [278976]; Postdok BIOGLOBE, Czech Republic [CZ.1.07/2.3.00/30.0032]; European Social Fund; state budget of the Czech Republic; Ministerio de Educacion, Cultura y Deporte, Spain; EU [238511]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001741] Funding Source: researchfish; BBSRC [BBS/E/I/00001741] Funding Source: UKRI	MEC, Spain(Spanish Government); European Union(European Commission); Postdok BIOGLOBE, Czech Republic; European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic; Ministerio de Educacion, Cultura y Deporte, Spain; EU(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by MEC, Spain, grant BFU2011-23896 (JF), European Union FP7 ANTIGONE project number 278976 (JF) and Postdok BIOGLOBE, Czech Republic CZ.1.07/2.3.00/30.0032 co-financed by the European Social Fund and the state budget of the Czech Republic (JS). N. Ayllon was funded by Ministerio de Educacion, Cultura y Deporte, Spain. S. Weisheit was supported by the POSTICK ITN (Post-graduate training network for capacity building to control ticks and tick-borne diseases) within the FP7-PEOPLE-ITN programme (EU Grant No. 238511). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayllon N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005120; Ayllon N, 2013, INFECT IMMUN, V81, P2415, DOI 10.1128/IAI.00194-13; Blouin EF, 2003, VET PARASITOL, V111, P247, DOI 10.1016/S0304-4017(02)00378-3; Brayton KA, 2006, EXPERT REV VACCINES, V5, P95, DOI 10.1586/14760584.5.1.95; de la Fuente J, 2005, CELL MICROBIOL, V7, P549, DOI 10.1111/j.1462-5822.2004.00485.x; de la Fuente J, 2003, VET MICROBIOL, V91, P265, DOI 10.1016/S0378-1135(02)00309-7; de la Fuente J, 2001, INT J PARASITOL, V31, P145, DOI 10.1016/S0020-7519(00)00162-4; de la Fuente J, 2007, GENOMICS, V90, P712, DOI 10.1016/j.ygeno.2007.08.009; de la Fuente J, 2006, PARASITOL RES, V100, P85, DOI 10.1007/s00436-006-0244-6; de la Fuente J, 2010, VET PARASITOL, V167, P175, DOI 10.1016/j.vetpar.2009.09.019; Dumler JS, 2001, INT J SYST EVOL MICR, V51, P2145, DOI 10.1099/00207713-51-6-2145; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Galindo RC, 2012, J PROTEOM BIOINFORM, V5, P108, DOI DOI 10.4172/JPB.1000221; Galindo RC, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-181; Garcia-Garcia JC, 2004, VET MICROBIOL, V98, P261, DOI 10.1016/j.vetmic.2003.10.021; Ge Y, 2007, J BACTERIOL, V189, P7819, DOI 10.1128/JB.00866-07; Ge Y, 2006, CELL MICROBIOL, V8, P1406, DOI 10.1111/j.1462-5822.2006.00720.x; Goulhen F, 1998, INFECT IMMUN, V66, P5307, DOI 10.1128/IAI.66.11.5307-5313.1998; Hajdusek O, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00026; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; Johnson JL, 2012, BBA-MOL CELL RES, V1823, P607, DOI 10.1016/j.bbamcr.2011.09.020; Kocan KM, 2008, FRONT BIOSCI-LANDMRK, V13, P7032, DOI 10.2741/3208; Kocan KM, 2012, TICKS TICK-BORNE DIS, V3, P147, DOI 10.1016/j.ttbdis.2012.01.004; Kocan KM, 2002, EXP APPL ACAROL, V28, P9, DOI 10.1023/A:1025329728269; Lin MQ, 2007, CELL MICROBIOL, V9, P2644, DOI 10.1111/j.1462-5822.2007.00985.x; Lin MQ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00024; Lis K, 2014, TICKS TICK-BORNE DIS, V5, P511, DOI 10.1016/j.ttbdis.2014.03.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Low HH, 2014, NATURE, V508, P550, DOI 10.1038/nature13081; Martinez-Bartolome S, 2008, MOL CELL PROTEOMICS, V7, P1135, DOI 10.1074/mcp.M700239-MCP200; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mastronunzio JE, 2012, J BACTERIOL, V194, P2238, DOI 10.1128/JB.06791-11; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; Meyer DF, 2013, NUCLEIC ACIDS RES, V41, P9218, DOI 10.1093/nar/gkt718; Multhoff G, 2007, METHODS, V43, P229, DOI 10.1016/j.ymeth.2007.06.006; Munderloh UG, 1999, J CLIN MICROBIOL, V37, P2518, DOI 10.1128/JCM.37.8.2518-2524.1999; Naranjo V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065915; Navarro P, 2009, J PROTEOME RES, V8, P1792, DOI 10.1021/pr800362h; Niu H, 2006, CELL MICROBIOL, V8, P523, DOI 10.1111/j.1462-5822.2005.00643.x; Nogueira T, 2000, CURR OPIN MICROBIOL, V3, P154, DOI 10.1016/S1369-5274(00)00068-0; Noh SM, 2008, INFECT IMMUN, V76, P2219, DOI 10.1128/IAI.00008-08; Ramabu SS, 2010, INFECT IMMUN, V78, P3047, DOI 10.1128/IAI.00300-10; Reichard MV, 2009, VECTOR-BORNE ZOONOT, V9, P565, DOI 10.1089/vbz.2008.0106; Rikihisa Y, 2011, CLIN MICROBIOL REV, V24, P469, DOI 10.1128/CMR.00064-10; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; SCORPIO A, 1994, J BACTERIOL, V176, P6449, DOI 10.1128/JB.176.21.6449-6456.1994; Severo MS, 2012, FUTURE MICROBIOL, V7, P719, DOI [10.2217/fmb.12.45, 10.2217/FMB.12.45]; Severo MS, 2014, MOL MED MICROBIOLOGY, P2029; Seydlova G, 2012, J APPL MICROBIOL, V112, P765, DOI 10.1111/j.1365-2672.2012.05238.x; Sinclair SH, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00274; Stuen S, 2007, VET RES COMMUN, V31, P79, DOI 10.1007/s11259-007-0071-y; Stuen S, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00031; Sukumaran B, 2006, J EXP MED, V203, P1507, DOI 10.1084/jem.20060208; Sumner JW, 1997, J CLIN MICROBIOL, V35, P2087, DOI 10.1128/JCM.35.8.2087-2092.1997; Susin MF, 2006, J BACTERIOL, V188, P8044, DOI 10.1128/JB.00824-06; Troese MJ, 2011, INFECT IMMUN, V79, P4696, DOI 10.1128/IAI.05658-11; Villar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089564; Villar Margarita, 2010, Int J Proteomics, V2010, P657261, DOI 10.1155/2010/657261; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Zhi N, 2002, MOL MICROBIOL, V46, P135, DOI 10.1046/j.1365-2958.2002.03143.x; Zhu HY, 2013, MICROBES INFECT, V15, P172, DOI 10.1016/j.micinf.2012.10.001; Zivkovic Z, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/705034	63	24	25	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137237	10.1371/journal.pone.0137237	http://dx.doi.org/10.1371/journal.pone.0137237			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340562	Green Published, Green Submitted, gold			2022-12-26	WOS:000360688200038
J	Bonato, M; Spironelli, C; Lisi, M; Priftis, K; Zorzi, M				Bonato, Mario; Spironelli, Chiara; Lisi, Matteo; Priftis, Konstantinos; Zorzi, Marco			Effects of Multimodal Load on Spatial Monitoring as Revealed by ERPs	PLOS ONE			English	Article							TOP-DOWN MODULATION; ATTENTIONAL LOAD; PERCEPTUAL LOAD; SELECTIVE ATTENTION; POTENTIALS REVEAL; MEMORY LOAD; HUMAN BRAIN; NEGLECT; VISION; RESPONSES	While the role of selective attention in filtering out irrelevant information has been extensively studied, its characteristics and neural underpinnings when multiple environmental stimuli have to be processed in parallel are much less known. Building upon a dual-task paradigm that induced spatial awareness deficits for contralesional hemispace in right hemisphere-damaged patients, we investigated the electrophysiological correlates of multimodal load during spatial monitoring in healthy participants. The position of appearance of briefly presented, lateralized targets had to be reported either in isolation (single task) or together with a concurrent task, visual or auditory, which recruited additional attentional resources (dual-task). This top-down manipulation of attentional load, without any change of the sensory stimulation, modulated the amplitude of the first positive ERP response (P1) and shifted its neural generators, with a suppression of the signal in the early visual areas during both visual and auditory dual tasks. Furthermore, later N2 contralateral components elicited by left targets were particularly influenced by the concurrent visual task and were related to increased activation of the supramarginal gyrus. These results suggest that the right hemisphere is particularly affected by load manipulations, and confirm its crucial role in subtending automatic orienting of spatial attention and in monitoring both hemispaces.	[Bonato, Mario] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium; [Bonato, Mario; Spironelli, Chiara; Lisi, Matteo; Priftis, Konstantinos; Zorzi, Marco] Univ Padua, Dept Gen Psychol, Padua, Italy; [Spironelli, Chiara; Zorzi, Marco] Univ Padua, Ctr Cognit Neurosci, Padua, Italy; [Lisi, Matteo] Univ Paris 05, Lab Psychol Percept, CNRS, UMR 8242, Paris, France; [Zorzi, Marco] IRCSS San Camillo Hosp, Lido Venice, Italy	Ghent University; University of Padua; University of Padua; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Bonato, M (corresponding author), Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium.	mario.bonato@ugent.be; chiara.spironelli@unipd.it; marco.zorzi@unipd.it	Bonato, Mario/B-4977-2013; Lisi, Matteo/O-6824-2017; Zorzi, Marco/B-7863-2008; Priftis, Konstantinos/B-7862-2008; Spironelli, Chiara/AAC-1701-2021; Spironelli, Chiara/D-1548-2014	Bonato, Mario/0000-0002-2004-9341; Lisi, Matteo/0000-0003-3554-385X; Zorzi, Marco/0000-0002-4651-6390; Priftis, Konstantinos/0000-0002-5215-4621; Spironelli, Chiara/0000-0002-8547-2431; Spironelli, Chiara/0000-0002-8547-2431	Compagnia di San Paolo (Neuroscience Program); University of Padova (Strategic Grant NEURAT); FWO-Pegasus; Marie Curie IEF Fellowship within the 7th European Community Framework Program	Compagnia di San Paolo (Neuroscience Program)(Compagnia di San Paolo); University of Padova (Strategic Grant NEURAT); FWO-Pegasus; Marie Curie IEF Fellowship within the 7th European Community Framework Program	This study was supported by grants from Compagnia di San Paolo (Neuroscience Program) and from the University of Padova (Strategic Grant NEURAT) to MZ. MB was supported by a FWO-Pegasus and by a Marie Curie IEF Fellowship within the 7th European Community Framework Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anticevic A, 2010, NEUROIMAGE, V49, P2638, DOI 10.1016/j.neuroimage.2009.11.008; Arrington CM, 2000, J COGNITIVE NEUROSCI, V12, P106, DOI 10.1162/089892900563975; Bahrami B, 2007, CURR BIOL, V17, P509, DOI 10.1016/j.cub.2007.01.070; Barnhardt J, 2008, NEUROPSYCHOLOGIA, V46, P2071, DOI 10.1016/j.neuropsychologia.2008.02.007; Bartolomeo P, 2002, NEUROSCI BIOBEHAV R, V26, P217, DOI 10.1016/S0149-7634(01)00065-3; Bellgrove MA, 2013, NEUROPSYCHOLOGIA, V51, P1085, DOI 10.1016/j.neuropsychologia.2013.01.019; Bonato M, 2013, BEHAV NEUROL, V26, P179, DOI [10.1155/2013/139812, 10.3233/BEN-2012-129005]; Bonato M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00195; Bonato M, 2012, NEUROPSYCHOLOGY, V26, P20, DOI 10.1037/a0025306; Bonato M, 2010, NEUROPSYCHOLOGIA, V48, P3934, DOI 10.1016/j.neuropsychologia.2010.08.022; Bonato M, 2009, J COGNITIVE NEUROSCI, V21, P745, DOI 10.1162/jocn.2009.21054; Buxbaum LJ, 2012, NEUROPSYCHOLOGY, V26, P430, DOI 10.1037/a0028674; Corbetta M, 2005, NAT NEUROSCI, V8, P1603, DOI 10.1038/nn1574; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; Dell'Acqua R, 2006, PSYCHOPHYSIOLOGY, V43, P394, DOI 10.1111/j.1469-8986.2006.00411.x; Ding YL, 2014, HUM BRAIN MAPP, V35, P3008, DOI 10.1002/hbm.22381; Fu SM, 2008, NEUROIMAGE, V39, P1345, DOI 10.1016/j.neuroimage.2007.09.068; Fu SM, 2010, BIOL PSYCHOL, V85, P171, DOI 10.1016/j.biopsycho.2010.06.008; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; Handy TC, 2001, PSYCHOL SCI, V12, P213, DOI 10.1111/1467-9280.00338; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Hopfinger JB, 2006, NEUROIMAGE, V31, P774, DOI 10.1016/j.neuroimage.2005.12.049; Kinsbourne M, 1977, Adv Neurol, V18, P41; Klemen J, 2010, J COGNITIVE NEUROSCI, V22, P437, DOI 10.1162/jocn.2009.21204; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Luck S.J., 2005, INTRO EVENT RELATED; Luck SJ, 2000, TRENDS COGN SCI, V4, P432, DOI 10.1016/S1364-6613(00)01545-X; Malhotra P, 2009, BRAIN, V132, P645, DOI 10.1093/brain/awn350; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; Marois R, 2000, NEURON, V25, P717, DOI 10.1016/S0896-6273(00)81073-9; O'Connell RG, 2011, CEREB CORTEX, V21, P1056, DOI 10.1093/cercor/bhq178; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 1999, BRAIN, V122, P1731, DOI 10.1093/brain/122.9.1731; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Peers PV, 2006, NEUROPSYCHOLOGIA, V44, P1325, DOI 10.1016/j.neuropsychologia.2006.01.033; Ptak R, 2007, BRAIN, V130, P3211, DOI 10.1093/brain/awm234; R Development Core Team, 2012, R LANG ENV STAT COMP; Rauss K, 2012, HUM BRAIN MAPP, V33, P63, DOI 10.1002/hbm.21193; Rauss K, 2011, NEUROSCI BIOBEHAV R, V35, P1237, DOI 10.1016/j.neubiorev.2010.12.011; Rauss KS, 2009, HUM BRAIN MAPP, V30, P1723, DOI 10.1002/hbm.20636; Recarte MA, 2000, J EXP PSYCHOL-APPL, V6, P31, DOI 10.1037/1076-898X.6.1.31; Rorden C, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.004.2008; Russell C, 2004, NEUROREPORT, V15, P2189, DOI 10.1097/00001756-200410050-00009; Russell C, 2013, CORTEX, V49, P1874, DOI 10.1016/j.cortex.2012.10.005; Santangelo V, 2008, CONSCIOUS COGN, V17, P989, DOI 10.1016/j.concog.2008.02.006; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schluter ND, 2001, NEUROPSYCHOLOGIA, V39, P105, DOI 10.1016/S0028-3932(00)00105-6; Schwartz S, 2005, CEREB CORTEX, V15, P770, DOI 10.1093/cercor/bhh178; Shulman GL, 2003, J NEUROPHYSIOL, V90, P3384, DOI 10.1152/jn.00343.2003; Silvanto J, 2009, CEREB CORTEX, V19, P327, DOI 10.1093/cercor/bhn091; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor MJ, 2002, CLIN NEUROPHYSIOL, V113, P1903, DOI 10.1016/S1388-2457(02)00309-7; Todd JJ, 2005, PSYCHOL SCI, V16, P965, DOI 10.1111/j.1467-9280.2005.01645.x; van Kessel ME, 2013, J NEUROPSYCHOL, V7, P72, DOI 10.1111/j.1748-6653.2012.02036.x; Vogel EK, 2000, PSYCHOPHYSIOLOGY, V37, P190, DOI 10.1111/1469-8986.3720190; Vuilleumier P, 2008, CURR BIOL, V18, P1525, DOI 10.1016/j.cub.2008.08.072; WEBSTER RG, 1964, J EXP PSYCHOL, V68, P269, DOI 10.1037/h0043256; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; WILLIAMS LJ, 1985, HUM FACTORS, V27, P221, DOI 10.1177/001872088502700209	66	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136719	10.1371/journal.pone.0136719	http://dx.doi.org/10.1371/journal.pone.0136719			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335779	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000360615400022
J	Lobo, CLD; do Nascimento, EM; Abelha, R; Queiroz, AMM; Connes, P; Cardoso, GP; Ballas, SK				de Castro Lobo, Clarisse Lopes; do Nascimento, Emilia Matos; Abelha, Renato; Mach Queiroz, Ana Maria; Connes, Philippe; Cardoso, Gilberto Perez; Ballas, Samir K.			Risk Factors of Pulmonary Hypertension in Brazilian Patients with Sickle Cell Anemia	PLOS ONE			English	Article							ERYTHROPOIETIC ACTIVITY; DISEASE; HEART; HYDROXYUREA; HEMOGLOBIN; SURVIVAL	This study was a prospective cross-sectional cohort study of 125 patients with sickle cell anemia (SS) between the ages of 16 to 60 years. Enrolled patients were followed-up prospectively for 15 months. Demographic, clinical, hematological and routine biochemical data were obtained on all patients. Six-minute walk test and Doppler Echocardiography were performed on all patients. A tricuspid regurgitant jet velocity (TRJV) <2.5 m/sec was considered normal, 2.5 <= TRJV <= 3.0 was considered mild-moderate and >3.0 m/sec, severe. Patients with abnormal TRJV were significantly older and more anemic, had significantly higher lactate dehydrogenase (LDH) levels, reticulocyte count and incidence of death. The logistic multimodal model implemented for the 125 patients indicated that age was the covariate that influenced the outcome of normal or abnormal TRJV with a cutoff age of thirty-two years. The survival rate for the group of patients with creatinine (Cr) > 1.0 mg/dL was lower than the group with Cr <= 1 and normal TRJV. A coefficient matrix showed that the LDH values were weakly correlated with the reticulocyte count but strongly correlated with hemoglobin suggesting that the TRJV values were not correlated with the hemolytic rate but with anemia. Ten patients died during the follow-up of whom 7 had TRJV > 2.5 m/sec. Acute chest syndrome was the most common cause of death followed by sepsis. In conclusion, this study shows that patients with SS older than thirty-two years with high LDH, elevated TRJV, severe anemia and Cr > 1 have poor prognosis and may be at risk of having pulmonary hypertension and should undergo RHC.	[de Castro Lobo, Clarisse Lopes; do Nascimento, Emilia Matos; Abelha, Renato; Mach Queiroz, Ana Maria; Ballas, Samir K.] Inst Hematol Arthur de Siqueira Cavalcanti HEMORI, Clin Hematol Div, Rio De Janeiro, RJ, Brazil; [do Nascimento, Emilia Matos] UEZO Ctr Univ Estadual Zona Oeste, Rio De Janeiro, RJ, Brazil; [Connes, Philippe] Univ Lyon 1, Lab CRIS, EA 647, Sect Vasc Biol & Red Blood Cell, F-69622 Villeurbanne, France; [Cardoso, Gilberto Perez] Univ Fed Fluminense, Niteroi, RJ, Brazil; [Ballas, Samir K.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Cardeza Fdn, Philadelphia, PA 19107 USA	Centro Universitario Estadual da Zona Oeste; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universidade Federal Fluminense; Jefferson University	Ballas, SK (corresponding author), Inst Hematol Arthur de Siqueira Cavalcanti HEMORI, Clin Hematol Div, Rio De Janeiro, RJ, Brazil.	samir.ballas@jefferson.edu	Connes, Philippe/J-7835-2019	Connes, Philippe/0000-0002-9232-0268	Office of the Secretary of Health for the State of Rio de Janeiro; Brazilian Ministry of Health	Office of the Secretary of Health for the State of Rio de Janeiro; Brazilian Ministry of Health	Grant sponsor: Office of the Secretary of Health for the State of Rio de Janeiro and the Brazilian Ministry of Health.	Appleton CP, 1997, J AM SOC ECHOCARDIOG, V10, P271, DOI 10.1016/S0894-7317(97)70063-4; Ataga KI, 2010, EUR J HAEMATOL, V85, P257, DOI 10.1111/j.1600-0609.2010.01471.x; Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Ballas SK, 2013, BLOOD, V121, P243, DOI 10.1182/blood-2012-10-462135; Ballas SK, 2000, HEMOGLOBIN, V24, P277, DOI 10.3109/03630260008993134; Ballas SK, 1999, BRIT J HAEMATOL, V105, P491, DOI 10.1111/j.1365-2141.1999.01339.x; Ballas SK, 2006, TRANSFUSION, V46, P105, DOI 10.1111/j.1537-2995.2006.00679.x; Barnett CF, 2008, JAMA-J AM MED ASSOC, V299, P324, DOI 10.1001/jama.299.3.324; Brugnara C, 1997, AM J CLIN PATHOL, V108, P133; CANCADO R. D., 2007, REV BRAS HEMATOL HEM, V29, P203, DOI DOI 10.1590/S1516-84842007000300002; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Charache S, 1996, MEDICINE, V75, P300, DOI 10.1097/00005792-199611000-00002; Connes P, 2011, CLIN HEMORHEOL MICRO, V49, P151, DOI 10.3233/CH-2011-1465; COX DR, 1972, J R STAT SOC B, V34, P187; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Fisher MR, 2009, AM J RESP CRIT CARE, V179, P615, DOI 10.1164/rccm.200811-1691OC; Fonseca GHH, 2012, EUR RESPIR J, V39, P112, DOI 10.1183/09031936.00134410; Ghofrani HA, 2009, J AM COLL CARDIOL, V54, pS108, DOI 10.1016/j.jacc.2009.04.014; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; GUYATT GH, 1985, J CHRON DIS, V38, P517, DOI 10.1016/0021-9681(85)90035-9; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Karazincir S, 2008, DIAGN INTERV RADIOL, V14, P72; Kiba T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-462; Machado RF, 2011, BLOOD, V118, P855, DOI 10.1182/blood-2010-09-306167; Parent F, 2011, NEW ENGL J MED, V365, P44, DOI 10.1056/NEJMoa1005565; Patel RP, 2004, FREE RADICAL BIO MED, V36, P399, DOI 10.1016/j.freeradbiomed.2003.11.019; R Core Team, 2021, R LANGUAGE ENV STAT; Sachdev V, 2011, CIRCULATION, V124, P1452, DOI 10.1161/CIRCULATIONAHA.111.032920; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P354; Seong C, 1998, BRIT J HAEMATOL, V101, P189, DOI 10.1046/j.1365-2141.1998.00657.x; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Tassi EM, 2014, ARQ BRAS CARDIOL, V102, P456, DOI 10.5935/abc.20140052; Williams JR, 2008, B WORLD HEALTH ORGAN, V86, P650, DOI 10.2471/BLT.08.050955; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	35	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137539	10.1371/journal.pone.0137539	http://dx.doi.org/10.1371/journal.pone.0137539			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335226	Green Submitted, gold, Green Published			2022-12-26	WOS:000360615400065
J	Hirsch, HJ; Gross, I; Pollak, Y; Eldar-Geva, T; Gross-Tsur, V				Hirsch, Harry J.; Gross, Itai; Pollak, Yehuda; Eldar-Geva, Talia; Gross-Tsur, Varda			Irisin and the Metabolic Phenotype of Adults with Prader-Willi Syndrome	PLOS ONE			English	Article							GROWTH-HORMONE TREATMENT; BROWN ADIPOSE-TISSUE; CIRCULATING IRISIN; INSULIN SENSITIVITY; FAT DISTRIBUTION; OBESE SUBJECTS; EXERCISE; HUMANS; CHILDREN; GLUCOSE	Context Hyperphagia, low resting energy expenditure, and abnormal body composition contribute to severe obesity in Prader Willi syndrome (PWS). Irisin, a circulating myokine, stimulates "browning" of white adipose tissue resulting in increased energy expenditure and improved insulin sensitivity. Irisin has not been previously studied in PWS. Objectives Compare plasma and salivary irisin in PWS adults and normal controls. Examine the relationship of irisin to insulin sensitivity and plasma lipids. Design and Study Participants A fasting blood sample for glucose, lipids, insulin, leptin, adinopectin, and irisin was obtained from 22 PWS adults and 54 healthy BMI-matched volunteers. Saliva was collected for irisin assay in PWS and controls. Results Fasting glucose (77 +/- 9 vs 83 +/- 7mg/dl, p = 0.004), insulin (4.1 +/- 2.0 vs 7.9 +/- 4.7 mu U/ml, p<0.001), and triglycerides (74 +/- 34 vs 109 +/- 71mg/dl, p = 0.007) were lower in PWS than in controls. Insulin resistance (HOMA-IR) was lower (0.79 +/- 0.041 vs 1.63 +/- 1.02, p<0.001) and insulin sensitivity (QUICKI) was higher (0.41 +/- 0.04 vs 0.36 +/- 0.03, p<0.001) in PWS. Plasma irisin was similar in both groups, but salivary irisin (64.5 +/- 52.0 vs 33.0 +/- 12.1ng/ml), plasma leptin (33.5 +/- 24.2 vs 19.7 +/- 19.3ng/ml) and plasma adinopectin (13.0 +/- 10.8 vs 7.6 +/- 4.5 mu g/ml) were significantly greater in PWS (p<0.001). In PWS, plasma irisin showed positive Pearson correlations with total cholesterol (r = 0.58, p = 0.005), LDL-cholesterol (r = 0.59, p = 0.004), and leptin (r = 0.43, p = 0.045). Salivary irisin correlated negatively with HDL-cholesterol (r = -0.50, p = 0.043) and positively with LDL-cholesterol (r = 0.51, p = 0.037) and triglycerides (r = 0.50, p = 0.041). Conclusions Salivary irisin was markedly elevated in PWS although plasma irisin was similar to levels in controls. Significant associations with plasma lipids suggest that irisin may contribute to the metabolic phenotype of PWS.	[Hirsch, Harry J.; Pollak, Yehuda; Gross-Tsur, Varda] Shaare Zedek Med Ctr, Israel Multidisciplinary Prader Willi Syndrome Cl, Neuropediat Unit, Dept Pediat, Jerusalem, Israel; [Gross, Itai] Hadassah Hebrew Univ Hosp, Dept Pediat, Jerusalem, Israel; [Pollak, Yehuda] Hebrew Univ Jerusalem, Sch Educ, Jerusalem, Israel; [Eldar-Geva, Talia; Gross-Tsur, Varda] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel; [Eldar-Geva, Talia] Shaare Zedek Med Ctr, Dept Obstet & Gynecol, Reprod Endocrinol & Genet Unit, Jerusalem, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Shaare Zedek Medical Center	Hirsch, HJ (corresponding author), Shaare Zedek Med Ctr, Israel Multidisciplinary Prader Willi Syndrome Cl, Neuropediat Unit, Dept Pediat, Jerusalem, Israel.	hirschmd@gmail.com		Pollak, Yehuda/0000-0002-1293-499X	Mirsky Foundation, Shaare Zedek Medical Center, Jerusalem, Israel	Mirsky Foundation, Shaare Zedek Medical Center, Jerusalem, Israel	This study was funded by the Mirsky Foundation, Shaare Zedek Medical Center, Jerusalem, Israel.	Al-Daghri NM, 2014, EUR J CLIN INVEST, V44, P119, DOI 10.1111/eci.12196; Albrecht E, 2015, SCI REP-UK, V5, DOI 10.1038/srep08889; Anastasilakis AD, 2014, J CLIN ENDOCR METAB, V99, P3247, DOI 10.1210/jc.2014-1367; Aydin S, 2014, PEPTIDES, V61, P130, DOI 10.1016/j.peptides.2014.09.014; Aydin S, 2013, PEPTIDES, V50, P13, DOI 10.1016/j.peptides.2013.09.011; Aydin S, 2014, PEPTIDES, V56, P141, DOI 10.1016/j.peptides.2014.04.002; Bluher S, 2014, OBESITY, V22, P1701, DOI 10.1002/oby.20739; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Butler MG, 2007, AM J MED GENET A, V143A, P449, DOI 10.1002/ajmg.a.31507; Cassidy SB, 2009, EURO J HUM GENET, V17, P219; Chen H, 2005, DIABETES, V54, P1914, DOI 10.2337/diabetes.54.7.1914; Choi HY, 2014, J CLIN ENDOCR METAB, V99, P2778, DOI 10.1210/jc.2014-1195; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; de la Iglesia R, 2014, CLIN ENDOCRINOL, V81, P306, DOI 10.1111/cen.12383; Goldstone AP, 2001, J CLIN ENDOCR METAB, V86, P4330, DOI 10.1210/jc.86.9.4330; Haqq AM, 2011, J CLIN ENDOCR METAB, V96, pE225, DOI 10.1210/jc.2010-1733; Hart PS, 1998, ANN NY ACAD SCI, V842, P125, DOI 10.1111/j.1749-6632.1998.tb09640.x; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Lindgren AC, 1999, HORM RES, V51, P157, DOI 10.1159/000023350; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; Miller JL, 2011, AM J MED GENET A, V155A, P1040, DOI 10.1002/ajmg.a.33951; Panagiotou G, 2014, METABOLISM, V63, P1265, DOI 10.1016/j.metabol.2014.06.001; Pardo M, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/857270; Park KH, 2013, J CLIN ENDOCR METAB, V98, P4899, DOI 10.1210/jc.2013-2373; Saeves R, 2012, ARCH ORAL BIOL, V57, P1335, DOI 10.1016/j.archoralbio.2012.05.003; Sanchis-Gomar F, 2014, ENDOCRINE, V46, P674, DOI 10.1007/s12020-014-0170-9; Schuster DP, 1996, METABOLISM, V45, P1514, DOI 10.1016/S0026-0495(96)90181-X; Song YQ, 2007, DIABETES CARE, V30, P1747, DOI 10.2337/dc07-0358; Spiegelman BM, 2013, DIABETES, V62, P1774, DOI 10.2337/db12-1665; Talebizadeh Z, 2005, CLIN GENET, V67, P230, DOI 10.1111/j.1399-0004.2004.00392.x; Tanaka Y, 2013, AM J MED GENET A, V161A, P27, DOI 10.1002/ajmg.a.35653; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wang C, 2015, ENDOCRINE, V49, P90, DOI 10.1007/s12020-014-0458-9; Yan B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094235; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106	36	20	21	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136864	10.1371/journal.pone.0136864	http://dx.doi.org/10.1371/journal.pone.0136864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334732	Green Published, gold, Green Submitted			2022-12-26	WOS:000360615400029
J	Iqbal, A; Labib, M; Muharemagic, D; Sattar, S; Dixon, BR; Berezovski, MV				Iqbal, Asma; Labib, Mahmoud; Muharemagic, Darija; Sattar, Syed; Dixon, Brent R.; Berezovski, Maxim V.			Detection of Cryptosporidium parvum Oocysts on Fresh Produce Using DNA Aptamers	PLOS ONE			English	Article							EXPONENTIAL ENRICHMENT; SYSTEMATIC EVOLUTION; CELL-SELEX; GIARDIA; LIGANDS; POLYMERASE; PATHOGENS	There are currently no standard methods for the detection of Cryptosporidium spp., or other protozoan parasites, in foods, and existing methods are often inadequate, with low and variable recovery efficiencies. Food testing is difficult due to the low concentrations of parasites, the difficulty in eluting parasites from some foods, the lack of enrichment methods, and the presence of PCR inhibitors. The main objectives of the present study were to obtain DNA aptamers binding to the oocyst wall of C. parvum, and to use the aptamers to detect the presence of this parasite in foods. DNA aptamers were selected against C. parvum oocysts using SELEX (Systematic Evolution of Ligands by EXponential enrichment). Ten rounds of selection led to the discovery of 14 aptamer clones with high affinities for C. parvum oocysts. For detecting parasite-bound aptamers, a simple electrochemical sensor was employed, which used a gold nanoparticle-modified screen-printed carbon electrode. This aptasensor was fabricated by self-assembling a hybrid of a thiolated ssDNA primer and the anti-C. parvum aptamer. Square wave voltammetry was employed to quantitate C. parvum in the range of 150 to 800 oocysts, with a detection limit of approximately 100 oocysts. The high sensitivity and specificity of the developed aptasensor suggests that this novel method is very promising for the detection and identification of C. parvum oocysts on spiked fresh fruits, as compared to conventional methods such as microscopy and PCR.	[Iqbal, Asma; Dixon, Brent R.] Hlth Canada, Bur Microbial Hazards, Food Directorate, Ottawa, ON K1A 0L2, Canada; [Labib, Mahmoud; Muharemagic, Darija; Berezovski, Maxim V.] Univ Ottawa, Dept Chem & Biomol Sci, Ottawa, ON, Canada; [Sattar, Syed] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	Health Canada; University of Ottawa; University of Ottawa	Dixon, BR (corresponding author), Hlth Canada, Bur Microbial Hazards, Food Directorate, Ottawa, ON K1A 0L2, Canada.	Brent.Dixon@hc-sc.gc.ca; Maxim.Berezovski@uottawa.ca	Berezovski, Maxim V./N-1247-2019; Berezovski, Maxim V./F-8961-2012; Labib, Mahmoud/P-2267-2014; Labib, Mahmoud/ABB-1104-2021	Berezovski, Maxim V./0000-0003-0514-599X; Berezovski, Maxim V./0000-0003-0514-599X; Labib, Mahmoud/0000-0003-4565-2056; Labib, Mahmoud/0000-0003-4565-2056	Mitacs Elevate Fellowship Program; Natural Sciences and Engineering Research Council of Canada Visiting Fellowships in Canadian Government Laboratories Program; Natural Sciences and Engineering Research Council of Canada	Mitacs Elevate Fellowship Program; Natural Sciences and Engineering Research Council of Canada Visiting Fellowships in Canadian Government Laboratories Program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the following sources of funding: Mitacs Elevate Fellowship Program for ML; Natural Sciences and Engineering Research Council of Canada Visiting Fellowships in Canadian Government Laboratories Program for AI; and Natural Sciences and Engineering Research Council of Canada for MVB.	Berezovski MV, 2008, J AM CHEM SOC, V130, P9137, DOI 10.1021/ja801951p; Budu-Amoako E, 2011, J FOOD PROTECT, V74, P1944, DOI 10.4315/0362-028X.JFP-11-107; Chalmers RM, 2013, TRENDS PARASITOL, V29, P237, DOI 10.1016/j.pt.2013.03.001; Chalmers RM, 2012, ANN I SUPER SANITA, V48, P429, DOI 10.4415/ANN_12_04_10; Coklin T, 2011, J VET DIAGN INVEST, V23, P260, DOI 10.1177/104063871102300210; Daniels DA, 2003, P NATL ACAD SCI USA, V100, P15416, DOI 10.1073/pnas.2136683100; Dixon BR, 2011, RAPID DETECTION, CHARACTERIZATION, AND ENUMERATION OF FOODBORNE PATHOGENS, P349; Dixon B.R., 2015, FOODBORNE PARASITES, P317, DOI [10.1016/B978-1-78242-332-4.00013-8, DOI 10.1016/B978-1-78242-332-4.00013-8]; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Labib M, 2014, ADV BIOCHEM ENG BIOT, V140, P155, DOI 10.1007/10_2013_229; Ryan U, 2014, PARASITOLOGY, V141, P1667, DOI 10.1017/S0031182014001085; Savioli L, 2006, TRENDS PARASITOL, V22, P203, DOI 10.1016/j.pt.2006.02.015; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Sefah K, 2010, NAT PROTOC, V5, P1169, DOI 10.1038/nprot.2010.66; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Xiao Y, 2007, NAT PROTOC, V2, P2875, DOI 10.1038/nprot.2007.413	16	35	35	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137455	10.1371/journal.pone.0137455	http://dx.doi.org/10.1371/journal.pone.0137455			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334529	Green Published, gold, Green Submitted			2022-12-26	WOS:000360615400059
J	King, R; Bird, N; Ramirez-Gonzalez, R; Coghill, JA; Patil, A; Hassani-Pak, K; Uauy, C; Phillips, AL				King, Robert; Bird, Nicholas; Ramirez-Gonzalez, Ricardo; Coghill, Jane A.; Patil, Archana; Hassani-Pak, Keywan; Uauy, Cristobal; Phillips, Andrew L.			Mutation Scanning in Wheat by Exon Capture and Next-Generation Sequencing	PLOS ONE			English	Article							GENOME; DISCOVERY; LENGTH; TOOL	Targeted Induced Local Lesions in Genomes (TILLING) is a reverse genetics approach to identify novel sequence variation in genomes, with the aims of investigating gene function and/or developing useful alleles for breeding. Despite recent advances in wheat genomics, most current TILLING methods are low to medium in throughput, being based on PCR amplification of the target genes. We performed a pilot-scale evaluation of TILLING in wheat by next-generation sequencing through exon capture. An oligonucleotide-based enrichment array covering similar to 2Mbp of wheat coding sequence was used to carry out exon capture and sequencing on three mutagenised lines of wheat containing previously-identified mutations in the TaGA20ox1 homoeologous genes. After testing different mapping algorithms and settings, candidate SNPs were identified by mapping to the IWGSC wheat Chromosome Survey Sequences. Where sequence data for all three homoeologues were found in the reference, mutant calls were unambiguous; however, where the reference lacked one or two of the homoeologues, captured reads from these genes were mis-mapped to other homoeologues, resulting either in dilution of the variant allele frequency or assignment of mutations to the wrong homoeologue. Competitive PCR assays were used to validate the putative SNPs and estimate cut-off levels for SNP filtering. At least 464 high-confidence SNPs were detected across the three mutagenized lines, including the three known alleles in TaGA20ox1, indicating a mutation rate of similar to 35 SNPs per Mb, similar to that estimated by PCR-based TILLING. This demonstrates the feasibility of using exon capture for genome re-sequencing as a method of mutation detection in polyploid wheat, but accurate mutation calling will require an improved genomic reference with more comprehensive coverage of homoeologues.	[King, Robert; Hassani-Pak, Keywan] Rothamsted Res, Computat & Syst Biol Dept, Harpenden AL5 2JQ, Herts, England; [Bird, Nicholas; Ramirez-Gonzalez, Ricardo; Uauy, Cristobal] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; [Ramirez-Gonzalez, Ricardo] Genome Anal Ctr, Norwich NR4 7UH, Norfolk, England; [Coghill, Jane A.] Univ Bristol, Sch Biol Sci, Transcript Facil, Bristol BS8 1UG, Avon, England; [Patil, Archana; Phillips, Andrew L.] Rothamsted Res, Plant Biol & Crop Sci Dept, Harpenden AL5 2JQ, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; The Genome Analysis Centre (TGAC); University of Bristol; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Phillips, AL (corresponding author), Rothamsted Res, Plant Biol & Crop Sci Dept, Harpenden AL5 2JQ, Herts, England.	andy.phillips@rothamsted.ac.uk	Hassani-Pak, Keywan/AAY-5854-2020; king, rob/AAT-3739-2020; Ramírez, Ricardo/H-4808-2019; Uauy, Cristobal/T-4382-2019	Ramírez, Ricardo/0000-0001-5745-7085; Uauy, Cristobal/0000-0002-9814-1770; Hassani-Pak, Keywan/0000-0001-9625-0511	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I000712/1, BB/J003557/1, BB/J004588/1, BBS/E/C/00005202]; Norwich Research Park PhD Studentship; Genome Analysis Centre Funding and Maintenance Grant; Biotechnology and Biological Sciences Research Council [BB/I000712/1, BBS/E/C/00005202, BB/J003557/1, BB/J003743/1, BB/J003913/1, BB/I000607/1, BBS/E/J/000C0628] Funding Source: researchfish; BBSRC [BB/J003557/1, BB/J003913/1, BB/I000607/1, BBS/E/C/00005202, BBS/E/J/000C0628, BB/I000712/1, BB/J003743/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Norwich Research Park PhD Studentship; Genome Analysis Centre Funding and Maintenance Grant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants BB/I000712/1, BB/J003557/1, BB/J004588/1 (GRO Institute Strategic Programme Grant to JIC) and BBS/E/C/00005202 (2020 Wheat Institute Strategic Programme Grant to Rothamsted Research) from the UK Biotechnology and Biological Sciences Research Council (BBSRC). RRG is supported by a Norwich Research Park PhD Studentship and by The Genome Analysis Centre Funding and Maintenance Grant.	Appleford NEJ, 2006, PLANTA, V223, P568, DOI 10.1007/s00425-005-0104-0; Avila-Arcos MC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00074; Botticella E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-156; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Chen A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003134; Chen L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031005, 10.1371/journal.pone.0046239, 10.1371/journal.pone.0041570, 10.1371/journal.pone.0035254]; Choulet F, 2014, SCIENCE, V345, DOI 10.1126/science.1249721; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; De Koeyer D, 2010, MOL BREEDING, V25, P67, DOI 10.1007/s11032-009-9309-4; DVORAK J, 1988, GENOME, V30, P680, DOI 10.1139/g88-115; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hazard B, 2012, CROP SCI, V52, P1754, DOI 10.2135/cropsci2012.02.0126; Henry IM, 2014, PLANT CELL, V26, P1382, DOI 10.1105/tpc.113.121590; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Jordan KW, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0606-4; King R, 2015, VARSCAN ALLELE FILTE; King R, 2015, REFERENCE FASTA REDU; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Krasileva KV, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r66; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lochlainn SO, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-43; Mascher M, 2013, PLANT J, V76, P494, DOI 10.1111/tpj.12294; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Mochida K, 2009, PLANT PHYSIOL, V150, P1135, DOI 10.1104/pp.109.138214; Mokry M, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq072; Parry MAJ, 2009, J EXP BOT, V60, P2817, DOI 10.1093/jxb/erp189; Pearce S, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0520-7; Rakszegi M, 2010, EUPHYTICA, V174, P409, DOI 10.1007/s10681-010-0149-4; Ramirez-Gonzalez RH, 2015, POLYMARKER; Ramirez-Gonzalez RH, 2015, PLANT BIOTECHNOL J, V13, P613, DOI 10.1111/pbi.12281; Saintenac C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r88; Sestili F, 2010, MOL BREEDING, V25, P145, DOI 10.1007/s11032-009-9314-7; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Slade AJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-69; Suzuki T, 2008, MOL GENET GENOMICS, V279, P213, DOI 10.1007/s00438-007-0293-2; Taylor NE, 2003, NUCLEIC ACIDS RES, V31, P3808, DOI 10.1093/nar/gkg574; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Tsai H, 2011, PLANT PHYSIOL, V156, P1257, DOI 10.1104/pp.110.169748; Uauy C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-115; Wilkinson PA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-219; Winfield MO, 2012, PLANT BIOTECHNOL J, V10, P733, DOI 10.1111/j.1467-7652.2012.00713.x	46	44	45	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137549	10.1371/journal.pone.0137549	http://dx.doi.org/10.1371/journal.pone.0137549			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335335	Green Published, Green Submitted, gold			2022-12-26	WOS:000360615400066
J	Rother, S; Bartels, M; Schweda, AT; Resch, K; Pallua, N; Nourbakhsh, M				Rother, Sascha; Bartels, Myriam; Schweda, Aike Torben; Resch, Klaus; Pallua, Norbert; Nourbakhsh, Mahtab			NF-kappa B-repressing factor phosphorylation regulates transcription elongation via its interactions with 5 '-> 3 ' exoribonuclease 2 and negative elongation factor	FASEB JOURNAL			English	Article						NKRF; gene regulation; transcription initiation; NELF-E; XRN2	RNA-POLYMERASE-II; MESSENGER-RNA; BASAL REPRESSION; EXPRESSION; NRF; ACTIVATION; PROMOTER; BINDING; INFECTION; DSIF	NF-kappa B-repressing factor (NKRF) inhibits transcription elongation by binding to specific sequences in target promoters. Stimuli such as IL-1 have been shown to overcome this inhibitory action and enable the resumption of transcription elongation machinery by an unknown mechanism. Using mass spectrometry and in vitro phosphorylation analyses, we demonstrate that NKRF is phosphorylated within 3 different domains in unstimulated HeLa cells. Phosphoamino acid mapping and mutation analysis of NKRF further suggest that only Ser phosphorylation within aa 421-429 is regulated by IL-1 stimulation. In copurification studies, aa 421-429 is required for interactions between NKRF, 5 '-> 3 ' exoribonuclease 2 (XRN2) and the negative elongation factor (NELF)-E in HeLa cells. Chromatin immunoprecipitation experiments further show that IL-1 stimulation leads to decrease in NKRF aa 421-429 phosphorylation and dissociation of NELF-E and XRN2 by concomitant resumption of transcription elongation of a synthetic reporter or the endogenous NKRF target gene, IL-8. Together, NKRF phosphorylation modulates promoter-proximal transcription elongation of NF-kappa kB/NKRF-regulated genes via direct interactions with elongation complex in response to specific stimuli.-Rother, S., Bartels, M., Schweda, A. T., Resch, K., Pallua, N., Nourbakhsh, M. NF-kappa B-repressing factor phosphorylation regulates transcription elongation via its interactions with 5 '-> 3 ' exoribonuclease 2 and negative elongation factor. FASEB J. 30, 174-185 (2016). www.fasebj.org	[Rother, Sascha; Bartels, Myriam; Schweda, Aike Torben; Resch, Klaus] Hannover Med Sch, Inst Pharmacol, Hannover, Germany; [Pallua, Norbert; Nourbakhsh, Mahtab] RWTH Aachen Univ Hosp, Hand Surg & Burn Ctr, Dept Plast & Reconstruct Surg, D-52074 Aachen, Germany	Hannover Medical School; RWTH Aachen University; RWTH Aachen University Hospital	Nourbakhsh, M (corresponding author), RWTH Aachen Univ Hosp, Hand Surg & Burn Ctr, Dept Plast & Reconstruct Surg, Pauwelsstr 30, D-52074 Aachen, Germany.	mnourbakhsh@ukaachen.de	Nourbakhsh, Mahtab/U-8818-2019	Nourbakhsh, Mahtab/0000-0003-4102-0748; Nourbakhsh, Mahtab/0000-0003-0918-1736	Deutsche Forschungsgemeinschaft [SFB 566, NO457]; European Research Council (APPI) [PIOFGA-2008-221359]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council (APPI)	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 566 and NO457) and the European Research Council (APPI, PIOFGA-2008-221359).	Bartels M, 2007, J IMMUNOL, V179, P7605, DOI 10.4049/jimmunol.179.11.7605; Bian JC, 2011, ARCH VIROL, V156, P1335, DOI 10.1007/s00705-011-0987-y; Bjorkegren JLM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004201; Brannan K, 2012, MOL CELL, V46, P311, DOI 10.1016/j.molcel.2012.03.006; Cai WJ, 2006, P NATL ACAD SCI USA, V103, P13801, DOI 10.1073/pnas.0600362103; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; Core LJ, 2012, CELL REP, V2, P1025, DOI 10.1016/j.celrep.2012.08.034; Davidson L, 2012, EMBO J, V31, P2566, DOI 10.1038/emboj.2012.101; Diamant G, 2013, BBA-GENE REGUL MECH, V1829, P937, DOI 10.1016/j.bbagrm.2013.04.007; Diamant G, 2012, CELL REP, V2, P722, DOI 10.1016/j.celrep.2012.08.041; Dreikhausen U, 2005, MOL CELL BIOL, V25, P7473, DOI 10.1128/MCB.25.17.7473-7483.2005; Feng XS, 2002, P NATL ACAD SCI USA, V99, P14212, DOI 10.1073/pnas.212306199; Gaertner B, 2014, DEVELOPMENT, V141, P1179, DOI 10.1242/dev.088492; Guo JN, 2013, CHEM REV, V113, P8583, DOI 10.1021/cr400105n; Huang CY, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-24; Huang KH, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0071-5; Huang LS, 2013, IMMUNOLOGY, V140, P314, DOI 10.1111/imm.12139; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Kwak H, 2013, ANNU REV GENET, V47, P483, DOI 10.1146/annurev-genet-110711-155440; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Li YA, 2010, ENVIRON HEALTH PERSP, V118, P936, DOI 10.1289/ehp.0901677; Ling C, 2015, J VIROL, V89, P952, DOI 10.1128/JVI.02581-14; Lu Y, 2010, ONCOGENE, V29, P1041, DOI 10.1038/onc.2009.396; Lu ZX, 2011, EMBO J, V30, P57, DOI 10.1038/emboj.2010.296; Miki TS, 2014, MOL CELL, V53, P351, DOI 10.1016/j.molcel.2014.01.001; Miko E, 2009, EXP LUNG RES, V35, P646, DOI 10.3109/01902140902822312; Ni ZY, 2008, MOL CELL BIOL, V28, P1161, DOI 10.1128/MCB.01859-07; Niedick I, 2004, J CELL SCI, V117, P3447, DOI 10.1242/jcs.01129; Nourbakhsh M, 1999, EMBO J, V18, P6415, DOI 10.1093/emboj/18.22.6415; Nourbakhsh M, 2001, J BIOL CHEM, V276, P4501, DOI 10.1074/jbc.M007532200; Omnus DJ, 2011, J MOL BIOL, V407, P492, DOI 10.1016/j.jmb.2011.01.050; Oumard A, 2000, MOL CELL BIOL, V20, P2755, DOI 10.1128/MCB.20.8.2755-2759.2000; Reboll MR, 2011, J BIOCHEM, V150, P553, DOI 10.1093/jb/mvr099; Reboll MR, 2007, RNA, V13, P1328, DOI 10.1261/rna.545407; Ritter B, 2011, J CLIN IMMUNOL, V31, P60, DOI 10.1007/s10875-010-9467-5; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Shi W, 2011, CANCER RES, V71, P2926, DOI 10.1158/0008-5472.CAN-10-3369; Shi Y, 2002, BIOL CHEM, V383, P1519, DOI 10.1515/BC.2002.173; Yamaguchi Y, 2013, BBA-GENE REGUL MECH, V1829, P98, DOI 10.1016/j.bbagrm.2012.11.007; Yung TMC, 2009, EXP CELL RES, V315, P1693, DOI 10.1016/j.yexcr.2009.02.013; Zhou QQ, 2015, GASTROENTEROLOGY, V148, P158, DOI 10.1053/j.gastro.2014.09.037; Zhu YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035147	43	10	10	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					174	185		10.1096/fj.15-270256	http://dx.doi.org/10.1096/fj.15-270256			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26340924	Green Published			2022-12-26	WOS:000367621000019
J	Boeszoermenyi, A; Nagy, HM; Arthanari, H; Pillip, CJ; Lindermuth, H; Luna, RE; Wagner, G; Zechner, R; Zangger, K; Oberer, M				Boeszoermenyi, Andras; Nagy, Harald Manuel; Arthanari, Haribabu; Pillip, Christoph Jens; Lindermuth, Hanna; Luna, Rafael Eulogio; Wagner, Gerhard; Zechner, Rudolf; Zangger, Klaus; Oberer, Monika			Structure of a CGI-58 Motif Provides the Molecular Basis of Lipid Droplet Anchoring	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; HORMONE-SENSITIVE LIPASE; COMPARATIVE GENE IDENTIFICATION-58; PROTEIN SECONDARY STRUCTURE; CHANARIN-DORFMAN-SYNDROME; CHEMICAL-SHIFT INDEX; CELLULAR FAT STORES; NMR-SPECTROSCOPY; MONOACYLGLYCEROL LIPASE; 3T3-L1 ADIPOCYTES	Triacylglycerols (TGs) stored in lipid droplets (LDs) are hydrolyzed in a highly regulated metabolic process called lipolysis to free fatty acids that serve as energy substrates for beta-oxidation, precursors for membrane lipids and signaling molecules. Comparative gene identification-58 (CGI-58) stimulates the enzymatic activity of adipose triglyceride lipase (ATGL), which catalyzes the hydrolysis of TGs to diacylglycerols and free fatty acids. In adipose tissue, protein-protein interactions between CGI-58 and the LD coating protein perilipin 1 restrain the ability of CGI-58 to activate ATGL under basal conditions. Phosphorylation of perilipin 1 disrupts these interactions and mobilizes CGI-58 for the activation of ATGL. We have previously demonstrated that the removal of a peptide at the N terminus (residues 10-31) of CGI-58 abrogates CGI-58 localization to LDs and CGI-58-mediated activation of ATGL. Here, we show that this tryptophan-rich N-terminal peptide serves as an independent LD anchor, with its three tryptophans serving as focal points of the left (harboring Trp(21) and Trp(25)) and right (harboring Trp(29)) anchor arms. The solution state NMR structure of a peptide comprising the LD anchor bound to dodecylphosphocholine micelles as LD mimic reveals that the left arm forms a concise hydrophobic core comprising tryptophans Trp(21) and Trp(25) and two adjacent leucines. Trp(29) serves as the core of a functionally independent anchor arm. Consequently, simultaneous tryptophan alanine permutations in both arms abolish localization and activity of CGI-58 as opposed to tryptophan substitutions that occur in only one arm.	[Boeszoermenyi, Andras; Nagy, Harald Manuel; Pillip, Christoph Jens; Lindermuth, Hanna; Zechner, Rudolf; Oberer, Monika] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Boeszoermenyi, Andras; Arthanari, Haribabu; Luna, Rafael Eulogio; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Zangger, Klaus] Graz Univ, Inst Chem, A-8010 Graz, Austria; [Lindermuth, Hanna] Med Univ Graz, Inst Biophys, A-8010 Graz, Austria	University of Graz; Harvard University; Harvard Medical School; University of Graz; Medical University of Graz	Oberer, M (corresponding author), Graz Univ, Inst Mol Biosci, Humboldtstr 50-3, A-8010 Graz, Austria.	m.oberer@uni-graz.at	Regan, Clinton/E-6250-2012; Boeszoermenyi, Andras/AAD-9808-2020	Boeszoermenyi, Andras/0000-0001-9810-7241; Zechner, Rudolf/0000-0001-5483-1182; Zangger, Klaus/0000-0003-1682-1594; Arthanari, Haribabu/0000-0002-7281-1289; Oberer, Monika/0000-0003-2525-9513	National Institutes of Health [P41 EB002026]; NAWI Graz; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [F 3002, W 901] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NAWI Graz; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We acknowledge the assistance of Astrid Gruber, Petra Ebner, and Pia Gruber at early stages of the project and we are grateful to Jim Zhen-Yu Sun and Barbara Ogorek for helpful discussions. Also, we thank Luna Scientific Storytelling, LLC for invaluable input and advice during the preparation of this manuscript. The IMB-Graz Microscopy and Imaging Resource, BioTechMed, NAWI Graz is gratefully acknowledged for access to their facilities. Maintenance and operation of NMR instruments was supported in part by the National Institutes of Health Grant P41 EB002026. The authors gratefully acknowledge support from NAWI Graz.	Bertrand T, 2010, J MOL BIOL, V396, P663, DOI 10.1016/j.jmb.2009.11.060; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cerk IK, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.602599; Chung C, 2008, J HEPATOL, V48, P471, DOI 10.1016/j.jhep.2007.10.012; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cornaciu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026349; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P121, DOI 10.1007/s10858-007-9213-3; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P107, DOI 10.1007/s10858-007-9214-2; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doreleijers JF, 2012, J BIOMOL NMR, V54, P267, DOI 10.1007/s10858-012-9669-7; Dunne SJ, 1996, BIOCHEMISTRY-US, V35, P11975, DOI 10.1021/bi960821+; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; Eichmann TO, 2012, J BIOL CHEM, V287, P41446, DOI 10.1074/jbc.M112.400416; Ellong EN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021889; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Franzmann M, 2009, CHEMBIOCHEM, V10, P2339, DOI 10.1002/cbic.200900347; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Gandotra S, 2011, J BIOL CHEM, V286, P34998, DOI 10.1074/jbc.M111.278853; Gobl C, 2010, J PHYS CHEM B, V114, P4717, DOI 10.1021/jp9114089; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2011, J BIOL CHEM, V286, P5126, DOI 10.1074/jbc.M110.180711; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Gruber A, 2010, J BIOL CHEM, V285, P12289, DOI 10.1074/jbc.M109.064469; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Hartono YD, 2013, PROTEINS, V81, P933, DOI 10.1002/prot.24256; Hickenbottom SJ, 2004, STRUCTURE, V12, P1199, DOI 10.1016/j.str.2004.04.021; Hofer P, 2015, J BIOL CHEM, V290, P18438, DOI 10.1074/jbc.M114.628958; Hyberts SG, 2013, J BIOMOL NMR, V55, P167, DOI 10.1007/s10858-012-9698-2; Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; Kwak BY, 2002, J BIOL CHEM, V277, P4343, DOI 10.1074/jbc.M109163200; Labar G, 2010, CHEMBIOCHEM, V11, P218, DOI 10.1002/cbic.200900621; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lee HC, 2015, BIOCHEMISTRY-US, V54, P2539, DOI 10.1021/acs.biochem.5b00207; Lee JY, 2009, J BIOL CHEM, V284, P33535, DOI 10.1074/jbc.M109.053363; Mouchlis VD, 2015, P NATL ACAD SCI USA, V112, pE516, DOI 10.1073/pnas.1424651112; Nagy HM, 2014, BBA-MOL CELL BIOL L, V1841, P588, DOI 10.1016/j.bbalip.2014.01.005; Nasr ML, 2013, PROTEIN SCI, V22, P774, DOI 10.1002/pro.2257; Oberer M, 2011, CURR OPIN LIPIDOL, V22, P149, DOI 10.1097/MOL.0b013e328346230e; Patel S, 2014, P NATL ACAD SCI USA, V111, P9163, DOI 10.1073/pnas.1318791111; Radner FPW, 2014, BBA-MOL CELL BIOL L, V1841, P409, DOI 10.1016/j.bbalip.2013.07.013; Respondek M, 2007, J AM CHEM SOC, V129, P5228, DOI 10.1021/ja069004f; Sahu-Osen A, 2015, J LIPID RES, V56, P109, DOI 10.1194/jlr.M055004; Schalk-Hihi C, 2011, PROTEIN SCI, V20, P670, DOI 10.1002/pro.596; Schrodinger LCC, 2022, PYMOL MOL GRAPHICS S; Schweiger M, 2008, J BIOL CHEM, V283, P17211, DOI 10.1074/jbc.M710566200; Schweiger M, 2012, J LIPID RES, V53, P2307, DOI 10.1194/jlr.M027409; Schweiger M, 2009, AM J PHYSIOL-ENDOC M, V297, pE289, DOI 10.1152/ajpendo.00099.2009; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Simon GM, 2006, J BIOL CHEM, V281, P26465, DOI 10.1074/jbc.M604660200; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Squizzato S, 2015, NUCLEIC ACIDS RES, V43, pW585, DOI 10.1093/nar/gkv316; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; SWINDELLS MB, 1995, NAT STRUCT BIOL, V2, P596, DOI 10.1038/nsb0795-596; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Young SG, 2013, GENE DEV, V27, P459, DOI 10.1101/gad.209296.112; Zierler KA, 2014, CURR OPIN LIPIDOL, V25, P102, DOI 10.1097/MOL.0000000000000058; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	75	35	35	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26361	26372		10.1074/jbc.M115.682203	http://dx.doi.org/10.1074/jbc.M115.682203			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26350461	Green Published, hybrid			2022-12-26	WOS:000364793600002
J	Kabeche, R; Madrid, M; Cansado, J; Moseley, JB				Kabeche, Ruth; Madrid, Marisa; Cansado, Jose; Moseley, James B.			Eisosomes Regulate Phosphatidylinositol 4,5-Bisphosphate (PI(4,5)P-2) Cortical Clusters and Mitogen-activated Protein (MAP) Kinase Signaling upon Osmotic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL INTEGRITY PATHWAY; PLECKSTRIN HOMOLOGY DOMAINS; EXCHANGE FACTOR ROM2; PLASMA-MEMBRANE; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; BUDDING YEAST; ACTIN CYTOSKELETON; RHO1	Eisosomes are multiprotein structures that generate linear invaginations at the plasma membrane of yeast cells. The core component of eisosomes, the BAR domain protein Pil1, generates these invaginations through direct binding to lipids including phosphoinositides. Eisosomes promote hydrolysis of phosphatidylinositol 4,5 bisphosphate (PI(4,5)P-2) by functioning with synaptojanin, but the cellular processes regulated by this pathway have been unknown. Here, we found that PI(4,5)P-2 regulation by eisosomes inhibits the cell integrity pathway, a conserved MAPK signal transduction cascade. This pathway is activated by multiple environmental conditions including osmotic stress in the fission yeast Schizosaccharomyces pombe. Activation of theMAPKPmk1 was impaired by mutations in the phosphatidylinositol (PI) 5-kinase Its3, but this defect was suppressed by removal of eisosomes. Using fluorescent biosensors, we found that osmotic stress induced the formation of PI(4,5)P-2 clusters that were spatially organized by eisosomes in both fission yeast and budding yeast cells. These cortical clusters contained the PI 5-kinase Its3 and did not assemble in the its3-1 mutant. The GTPase Rho2, an upstream activator of Pmk1, also co-localized with PI(4,5)P-2 clusters under osmotic stress, providing a molecular link between these novel clusters and MAPK activation. Our findings have revealed that eisosomes regulate activation of MAPK signal transduction through the organization of cortical lipid-based microdomains.	[Kabeche, Ruth; Moseley, James B.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA; [Madrid, Marisa; Cansado, Jose] Univ Murcia, Fac Biol, Dept Genet & Microbiol, Yeast Physiol Grp, E-30071 Murcia, Spain	Dartmouth College; University of Murcia	Moseley, JB (corresponding author), Geisel Sch Med Dartmouth, Dept Biochem, 412 Remsen Bldg, Hanover, NH 03755 USA.	james.b.moseley@dartmouth.edu	Madrid, Marisa/AAV-2154-2020; Madrid, Marisa/K-7755-2014; Cansado, Jose/ABC-6872-2020; Cansado, Jose/K-5212-2014; Regan, Clinton/E-6250-2012	Madrid, Marisa/0000-0002-7970-2587; Madrid, Marisa/0000-0002-7970-2587; Cansado, Jose/0000-0002-2342-8152; 	National Institutes of Health [GM099774]; Norris Cotton Cancer Center; Pew Scholars Program in the Biomedical Sciences; Robert D. Watkins Fellowship from the American Society for Microbiology; Ministerio de Economia y Competitividad (Spain) [BFU2014-52828-P]; European Regional Development Fund (ERDF); European Union; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norris Cotton Cancer Center; Pew Scholars Program in the Biomedical Sciences; Robert D. Watkins Fellowship from the American Society for Microbiology; Ministerio de Economia y Competitividad (Spain); European Regional Development Fund (ERDF)(European Commission); European Union(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM099774 (to J. B. M.). This work was also supported by The Norris Cotton Cancer Center, The Pew Scholars Program in the Biomedical Sciences, a Robert D. Watkins Fellowship from the American Society for Microbiology (to R. K.), Ministerio de Economia y Competitividad (Spain) Grant BFU2014-52828-P (to J. C.), and European Regional Development Fund (ERDF) co-funding from the European Union. The authors declare that they have no conflicts of interest with the contents of this article.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Barba G, 2008, CELL SIGNAL, V20, P748, DOI 10.1016/j.cellsig.2007.12.017; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bickle M, 1998, EMBO J, V17, P2235, DOI 10.1093/emboj/17.8.2235; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Deng L, 2005, J BIOL CHEM, V280, P27561, DOI 10.1074/jbc.M502660200; Desrivieres S, 1998, J BIOL CHEM, V273, P15787, DOI 10.1074/jbc.273.25.15787; Douglas LM, 2014, ANNU REV MICROBIOL, V68, P377, DOI 10.1146/annurev-micro-091313-103507; Frohlich F, 2014, MOL BIOL CELL, V25, P2797, DOI 10.1091/mbc.E13-11-0639; Garcia P, 2009, MOL BIOL CELL, V20, P721, DOI 10.1091/mbc.E08-07-0673; Goode BL, 2015, GENETICS, V199, P315, DOI 10.1534/genetics.112.145540; Green RA, 2011, CELL, V145, P470, DOI 10.1016/j.cell.2011.03.037; Guiney EL, 2015, MOL BIOL CELL, V26, P769, DOI 10.1091/mbc.E14-05-1019; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Helliwell SB, 1998, GENETICS, V148, P99; Helliwell SB, 1998, CURR BIOL, V8, P1211, DOI 10.1016/S0960-9822(07)00511-8; Homma K, 1998, J BIOL CHEM, V273, P15779, DOI 10.1074/jbc.273.25.15779; Honigmann A, 2013, NAT STRUCT MOL BIOL, V20, P679, DOI 10.1038/nsmb.2570; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Ikeda K, 2008, CELL CYCLE, V7, P358, DOI 10.4161/cc.7.3.5245; Kabeche R, 2014, J CELL SCI, V127, P1318, DOI 10.1242/jcs.143545; Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005; Karotki L, 2011, J CELL BIOL, V195, P889, DOI 10.1083/jcb.201104040; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Kwiatkowska K, 2010, CELL MOL LIFE SCI, V67, P3927, DOI 10.1007/s00018-010-0432-5; Lee J. H., 2015, EUKARYOT CELL; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Ma Y, 2006, MOL BIOL CELL, V17, P5028, DOI 10.1091/mbc.E06-08-0688; Madrid M, 2006, J BIOL CHEM, V281, P2033, DOI 10.1074/jbc.M506467200; Madrid M, 2007, MOL BIOL CELL, V18, P4405, DOI 10.1091/mbc.E07-05-0484; Madrid M, 2015, J CELL SCI, V128, P266, DOI 10.1242/jcs.158295; Mascaraque V, 2013, MOL CELL PROTEOMICS, V12, P557, DOI 10.1074/mcp.M112.020438; Matsuo T, 2003, EMBO J, V22, P3073, DOI 10.1093/emboj/cdg298; Morales-Johansson H, 2004, J BIOL CHEM, V279, P39604, DOI 10.1074/jbc.M405589200; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Olivera-Couto A, 2012, MOL GENET GENOMICS, V287, P607, DOI 10.1007/s00438-012-0706-8; Olivera-Couto A, 2011, MOL BIOL CELL, V22, P2360, DOI 10.1091/mbc.E10-12-1021; Posor Y, 2015, BBA-MOL CELL BIOL L, V1851, P794, DOI 10.1016/j.bbalip.2014.09.014; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schmelzle T, 2002, MOL CELL BIOL, V22, P1329, DOI 10.1128/MCB.22.5.1329-1339.2002; Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0; Spitzer NC, 2004, P NATL ACAD SCI USA, V101, P5311, DOI 10.1073/pnas.0401270101; Stradalova V, 2009, J CELL SCI, V122, P2887, DOI 10.1242/jcs.051227; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Weinberg J, 2012, TRENDS CELL BIOL, V22, P1, DOI 10.1016/j.tcb.2011.09.001; Yan Y, 2011, DEVELOPMENT, V138, P1697, DOI 10.1242/dev.059279; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Zhang D, 2012, CURR BIOL, V22, P2048, DOI 10.1016/j.cub.2012.08.047; Zhang YJ, 2000, J BIOL CHEM, V275, P35600, DOI 10.1074/jbc.M005575200; Ziolkowska NE, 2012, TRENDS CELL BIOL, V22, P151, DOI 10.1016/j.tcb.2011.12.002; Ziolkowska NE, 2011, NAT STRUCT MOL BIOL, V18, P854, DOI 10.1038/nsmb.2080	52	21	21	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25960	+		10.1074/jbc.M115.674192	http://dx.doi.org/10.1074/jbc.M115.674192			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26359496	Green Published, hybrid			2022-12-26	WOS:000363527300018
J	Chekabab, SM; Silverman, RJ; Lafayette, SL; Luo, YS; Rousseau, S; Nguyen, D				Chekabab, Samuel M.; Silverman, Richard J.; Lafayette, Shantelle L.; Luo, Yishan; Rousseau, Simon; Nguyen, Dao			Staphylococcus aureus Inhibits IL-8 Responses Induced by Pseudomonas aeruginosa in Airway Epithelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; CYSTIC-FIBROSIS PATIENTS; INTERLEUKIN-8 PRODUCTION; IN-VITRO; INFLAMMATORY RESPONSES; PULMONARY INFECTION; SIGNALING PATHWAYS; KINASE ACTIVATION; VIRULENCE FACTORS; EXPRESSION	Pseudomonas aeruginosa (PA) and Staphylococcus aureus (SA) are major respiratory pathogens and can concurrently colonize the airways of patients with chronic obstructive diseases, such as cystic fibrosis (CF). Airway epithelial cell signalling is critical to the activation of innate immune responses. In the setting of polymicrobial colonization or infection of the respiratory tract, how epithelial cells integrate different bacterial stimuli remains unknown. Our study examined the inflammatory responses to PA and SA co-stimulations. Immortalised airway epithelial cells (Beas-2B) exposed to bacteria-free filtrates from PA (PAF) induced a robust production of the neutrophil chemoattractant IL-8 while bacteriafree filtrates from SA (SAF) had a minimal effect. Surprisingly, co-stimulation with PAF+SAF demonstrated that SAF strongly inhibited the PAF-driven IL-8 production, showing that SAF has potent anti-inflammatory effects. Similarly SAF decreased IL-8 production induced by the TLR1/TLR2 ligand Pam(3)CysSK(4) but not the TLR4 ligand LPS nor TLR5 ligand flagellin in Beas-2B cells. Moreover, SAF greatly dampened TLR1/TLR2-mediated activation of the NF-kappa B pathway, but not the p38 MAPK pathway. We observed this SAF-dependent antiinflammatory activity in several SA clinical strains, as well as in the CF epithelial cell line CFBE41o-. These findings show a novel direct anti-inflammatory effect of SA on airway epithelial cells, highlighting its potential to modulate inflammatory responses in the setting of polymicrobial infections.	[Chekabab, Samuel M.; Silverman, Richard J.; Lafayette, Shantelle L.; Luo, Yishan; Rousseau, Simon; Nguyen, Dao] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Chekabab, Samuel M.; Lafayette, Shantelle L.; Rousseau, Simon; Nguyen, Dao] McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada; [Nguyen, Dao] McGill Univ, Dept Med, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Nguyen, D (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada.	dao.nguyen@mcgill.ca		Rousseau, Simon/0000-0002-8773-575X; Wu, Min/0000-0003-1205-982X; Chekabab, Samuel M/0000-0002-5636-4095	Burroughs Wellcome Fund; Meakins-Christie Laboratories; Cystic Fibrosis Canada [2148]	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Meakins-Christie Laboratories; Cystic Fibrosis Canada	The authors acknowledge funding support from the Burroughs Wellcome Fund (to DN), Meakins-Christie Laboratories (to SMC) and Cystic Fibrosis Canada grant #2148 (to DN and SR).	Baldan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089614; Beaudoin T, 2013, J INFECT DIS, V207, P1544, DOI 10.1093/infdis/jit059; Beaudoin T, 2012, J BACTERIOL, V194, P3128, DOI 10.1128/JB.06178-11; Becker MN, 2004, AM J RESP CRIT CARE, V169, P645, DOI 10.1164/rccm.200207-765OC; Below S, 2009, AM J PHYSIOL-LUNG C, V296, pL470, DOI 10.1152/ajplung.90498.2008; Berube J, 2010, J BIOL CHEM, V285, P22299, DOI 10.1074/jbc.M109.098566; Berube J, 2009, CELL SIGNAL, V21, P448, DOI 10.1016/j.cellsig.2008.12.001; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Chau TA, 2009, NAT MED, V15, P641, DOI 10.1038/nm.1965; da Silva MCA, 2004, AM J PHYSIOL-LUNG C, V287, pL543, DOI 10.1152/ajplung.00256.2003; Dalton T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027317; DeLeon S, 2014, INFECT IMMUN, V82, P4718, DOI 10.1128/IAI.02198-14; Devalaraja MN, 1999, CANCER RES, V59, P1372; DIMANGO E, 1995, J CLIN INVEST, V96, P2204, DOI 10.1172/JCI118275; Elewaut D, 1999, J IMMUNOL, V163, P1457; Filkins LM, 2015, J BACTERIOL; Fugere A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086705; Gangell C, 2011, CLIN INFECT DIS, V53, P425, DOI 10.1093/cid/cir399; Hawdon NA, 2010, FEMS IMMUNOL MED MIC, V59, P207, DOI 10.1111/j.1574-695X.2010.00693.x; Held K, 2012, J BACTERIOL, V194, P6387, DOI 10.1128/JB.01479-12; Heyer G, 2002, INFECT IMMUN, V70, P127, DOI 10.1128/IAI.70.1.127-133.2002; Hippenstiel S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-97; Hubert D, 2013, J CYST FIBROS, V12, P497, DOI 10.1016/j.jcf.2012.12.003; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Korgaonkar A, 2013, P NATL ACAD SCI USA, V110, P1059, DOI 10.1073/pnas.1214550110; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; MACHAN ZA, 1992, J ANTIMICROB CHEMOTH, V30, P615, DOI 10.1093/jac/30.5.615; Martel G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059116; Mashburn LM, 2005, J BACTERIOL, V187, P554, DOI 10.1128/JB.187.2.554-566.2005; MASSION PP, 1994, J CLIN INVEST, V93, P26, DOI 10.1172/JCI116954; Mayer AK, 2007, J IMMUNOL, V178, P3134, DOI 10.4049/jimmunol.178.5.3134; Michelsen CF, 2014, J BACTERIOL, V196, P3903, DOI 10.1128/JB.02006-14; Moreilhon C, 2005, PHYSIOL GENOMICS, V20, P244, DOI 10.1152/physiolgenomics.00135.2004; Oogai Y, 2011, APPL ENVIRON MICROB, V77, P8097, DOI 10.1128/AEM.05316-11; Ordonez CL, 2001, PEDIATR PULM, V32, P29, DOI 10.1002/ppul.1085; OREILLY M, 1986, MICROB PATHOGENESIS, V1, P125, DOI 10.1016/0882-4010(86)90015-X; Palmer KL, 2005, J BACTERIOL, V187, P5267, DOI 10.1128/JB.187.15.5267-5277.2005; Parker D, 2012, SEMIN IMMUNOPATHOL, V34, P281, DOI 10.1007/s00281-011-0291-7; Parker D, 2011, TRENDS IMMUNOL, V32, P582, DOI 10.1016/j.it.2011.09.003; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Pastar I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056846; PATEL AH, 1987, INFECT IMMUN, V55, P3103, DOI 10.1128/IAI.55.12.3103-3110.1987; Pena J, 2009, INFECT IMMUN, V77, P2857, DOI 10.1128/IAI.01355-08; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rath S, 2013, CELL MICROBIOL, V15, P1253, DOI 10.1111/cmi.12113; Raoust E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007259; Ratner AJ, 2001, J BIOL CHEM, V276, P19267, DOI 10.1074/jbc.M007703200; Roussel L, 2010, J IMMUNOL, V184, P4531, DOI 10.4049/jimmunol.0903162; Rudkjobing VB, 2012, FEMS IMMUNOLOGY MED; Sadowska B, 2013, ARCH IMMUNOL THER EX, V61, P413, DOI 10.1007/s00005-013-0240-3; Shah PL, 1999, EUR RESPIR J, V14, P1340, DOI 10.1183/09031936.99.14613409; Tajima A, 2007, CLIN EXP IMMUNOL, V147, P148, DOI 10.1111/j.1365-2249.2006.03254.x; Tajima A, 2009, INFECT IMMUN, V77, P327, DOI 10.1128/IAI.00748-08; Tiedemann RE, 2009, BLOOD, V113, P4027, DOI 10.1182/blood-2008-09-179796; TODER DS, 1994, INFECT IMMUN, V62, P1320, DOI 10.1128/IAI.62.4.1320-1327.1994; Winder AA, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-96; Wu Q, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-26; Zhang Z, 2005, INFECT IMMUN, V73, P7151, DOI 10.1128/IAI.73.11.7151-7160.2005	58	19	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137753	10.1371/journal.pone.0137753	http://dx.doi.org/10.1371/journal.pone.0137753			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360879	Green Published, Green Submitted, gold			2022-12-26	WOS:000361043100082
J	Cui, GY; Chen, YM; Cao, Y				Cui, Gaoyang; Chen, Yunming; Cao, Yang			Temporal-Spatial Pattern of Carbon Stocks in Forest Ecosystems in Shaanxi, Northwest China	PLOS ONE			English	Article							EUROPEAN FORESTS; BIOMASS; STORAGE; SEQUESTRATION; AMAZON; SINK; SOIL; DEFORESTATION; EMISSIONS; DIOXIDE	The precise and accurate quantitative evaluation of the temporal and spatial pattern of carbon (C) storage in forest ecosystems is critical for understanding the role of forests in the global terrestrial C cycle and is essential for formulating forest management policies to combat climate change. In this study, we examined the C dynamics of forest ecosystems in Shaanxi, northwest China, based on four forest inventories (1989-1993, 1994-1998, 1999-2003, and 2004-2008) and field-sampling measurements (2012). The results indicate that the total C storage of forest ecosystems in Shaanxi increased by approximately 29.3%, from 611.72 Tg in 1993 to 790.75 Tg in 2008, partially as a result of ecological restoration projects. The spatial pattern of C storage in forest ecosystems mainly exhibited a latitude-zonal distribution across the province, increasing from north (high latitude) to south (low latitude) generally, which signifies the effect of environmental conditions, chiefly water and heat related factors, on forest growth and C sequestration. In addition, different data sources and estimation methods had a significant effect on the results obtained, with the C stocks in 2008 being considerably overestimated (864.55 Tg) and slightly underestimated (778.07 Tg) when measured using the mean C density method and integrated method, respectively. Overall, our results demonstrated that the forest ecosystem in Shaanxi acted as a C sink over the last few decades. However, further studies should be carried out with a focus on adaption of plants to environmental factors along with forest management for vegetation restoration to maximize the C sequestration potential and to better cope with climate change.	[Cui, Gaoyang] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China; [Cui, Gaoyang] Minist Water Resources, Yangling, Shaanxi, Peoples R China; [Chen, Yunming; Cao, Yang] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; Northwest A&F University - China	Cao, Y (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China.	yang.cao@nwsuaf.edu.cn			Chinese Academy of Sciences [XDA05050203-05, K318021304]; National Natural Science Foundation of China [41201088, 41371506]; Ministry of Education of China [2014YB056]; Institute of Soil and Water Conservation [A315021380]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Institute of Soil and Water Conservation	Funding: This study was supported by the Chinese Academy of Sciences (XDA05050203-05, http://www.cas.ac.cn/) (to YMC), the Chinese Academy of Sciences (K318021304, http://www.cas.ac.cn/) (to YC), the National Natural Science Foundation of China (41201088, http://www.nsfc.gov.cn/) (to YC), the National Natural Science Foundation of China (41371506, http://www.nsfc.gov.cn/) (to YMC), the Ministry of Education of China (2014YB056, http://www.moe.edu.cn/) (to YC), and the Institute of Soil and Water Conservation (A315021380, http://www.iswc.ac.cn/) (to YC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, SOIL PHYS CHEM ANAL; [Anonymous], 2005, SOURCEBOOK LAND USE; Asner GP, 2010, P NATL ACAD SCI USA, V107, P16738, DOI 10.1073/pnas.1004875107; Cao Y, 2013, J NW A F U, V41, P114; Chen LD, 2007, ECOL RES, V22, P641, DOI 10.1007/s11284-006-0065-1; Ciais P, 2008, NAT GEOSCI, V1, P425, DOI 10.1038/ngeo233; de Castilho CV, 2006, FOREST ECOL MANAG, V234, P85, DOI 10.1016/j.foreco.2006.06.024; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Eggleston H.S., 2006, 2019 REF 2006 IPCC G; Fan S, 1998, SCIENCE, V282, P442, DOI 10.1126/science.282.5388.442; Fang J., 1996, ACTA ECOL SIN, V16, P497; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Fang JY, 2001, ACTA BOT SIN, V43, P967; Fang JY, 1998, ECOL APPL, V8, P1084, DOI 10.2307/2640963; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; Goulden ML, 1996, SCIENCE, V271, P1576, DOI 10.1126/science.271.5255.1576; Houghton RA, 2000, NATURE, V403, P301, DOI 10.1038/35002062; Hu HF, 2008, FOREST ECOL MANAG, V255, P1400, DOI 10.1016/j.foreco.2007.10.064; Kauffman J. B, 2012, PROTOCOLS MEASUREMEN; KAUPPI PE, 1992, SCIENCE, V256, P70, DOI 10.1126/science.256.5053.70; Keith H, 2009, P NATL ACAD SCI USA, V106, P11635, DOI 10.1073/pnas.0901970106; Laurance WF, 1999, FOREST ECOL MANAG, V118, P127, DOI 10.1016/S0378-1127(98)00494-0; LI KR, 2002, LAND USE CHANGE GREE; Liu HX, 2014, J ENVIRON MANAGE, V133, P86, DOI 10.1016/j.jenvman.2013.11.037; Miles L, 2008, SCIENCE, V320, P1454, DOI 10.1126/science.1155358; Nabuurs GJ, 2010, FOREST ECOL MANAG, V260, P239, DOI 10.1016/j.foreco.2009.11.024; Nabuurs GJ, 2003, GLOBAL CHANGE BIOL, V9, P152, DOI 10.1046/j.1365-2486.2003.00570.x; Pan YD, 2004, CLIMATIC CHANGE, V67, P211, DOI 10.1007/s10584-004-2799-5; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Ren H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108163; Ren H, 2013, PLANT SOIL, V363, P123, DOI 10.1007/s11104-012-1302-8; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; SEDJO RA, 1993, WATER AIR SOIL POLL, V70, P295, DOI 10.1007/BF01105003; Wang Xin-chuang, 2011, Yingyong Shengtai Xuebao, V22, P2013; WANG XK, 2001, CHINESE J APPL ECOLO, V12, P13; [吴庆标 WU QingBiao], 2008, [生态学报, Acta Ecologica Sinica], V28, P517; Zhou Y.R., 2000, CHIN J PLANT ECOL, V24, P518	38	7	7	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137452	10.1371/journal.pone.0137452	http://dx.doi.org/10.1371/journal.pone.0137452			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353011	Green Submitted, Green Published, gold			2022-12-26	WOS:000360932800087
J	Ullah, G; Demuro, A; Parker, I; Pearson, JE				Ullah, Ghanim; Demuro, Angelo; Parker, Ian; Pearson, John E.			Analyzing and Modeling the Kinetics of Amyloid Beta Pores Associated with Alzheimer's Disease Pathology	PLOS ONE			English	Article							AGGREGATED MARKOV-MODELS; INTRACELLULAR A-BETA; IMAGING CA2+ FLUX; ION-CHANNEL; ACETYLCHOLINE-RECEPTOR; INOSITOL TRISPHOSPHATE; CALCIUM; OLIGOMERS; PROTEIN; HYPOTHESIS	Amyloid beta (A beta) oligomers associated with Alzheimer's disease (AD) form Ca2+-permeable plasma membrane pores, leading to a disruption of the otherwise well-controlled intracellular calcium (Ca2+) homeostasis. The resultant up-regulation of intracellular Ca2+ concentration has detrimental implications for memory formation and cell survival. The gating kinetics and Ca2+ permeability of A beta pores are not well understood. We have used computational modeling in conjunction with the ability of optical patch-clamping for massively parallel imaging of Ca2+ flux through thousands of pores in the cell membrane of Xenopus oocytes to elucidate the kinetic properties of A beta pores. The fluorescence time-series data from individual pores were idealized and used to develop data-driven Markov chain models for the kinetics of the A beta pore at different stages of its evolution. Our study provides the first demonstration of developing Markov chain models for ion channel gating that are driven by optical-patch clamp data with the advantage of experiments being performed under close to physiological conditions. Towards the end, we demonstrate the upregulation of gating of various Ca2+ release channels due to A beta pores and show that the extent and spatial range of such up-regulation increases as A beta pores with low open probability and Ca2+ permeability transition into those with high open probability and Ca2+ permeability.	[Ullah, Ghanim] Univ S Florida, Dept Phys, Tampa, FL 33620 USA; [Demuro, Angelo; Parker, Ian] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Pearson, John E.] Los Alamos Natl Lab, Theoret Biol & Biophys, Los Alamos, NM 87545 USA	State University System of Florida; University of South Florida; University of California System; University of California Irvine; United States Department of Energy (DOE); Los Alamos National Laboratory	Ullah, G (corresponding author), Univ S Florida, Dept Phys, Tampa, FL 33620 USA.	gullah@usf.edu			College of Arts and Sciences at USF; National Institute of Health (USA) [P50-AG16573, R37-GM48071, R01 GM065830]; Mathematical Biosciences Institute at OSU; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065830, R37GM048071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016573] Funding Source: NIH RePORTER	College of Arts and Sciences at USF; National Institute of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathematical Biosciences Institute at OSU; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by a start up grant from College of Arts and Sciences at USF (GU), National Institute of Health (USA) grants P50-AG16573 (AD), R37-GM48071 (IP), and R01 GM065830 (JEP). Part of the work was conducted at the Ohio State University. GU would like to thank the Mathematical Biosciences Institute at OSU for an earlier career award.	Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; Arispe N, 2007, BBA-BIOMEMBRANES, V1768, P1952, DOI 10.1016/j.bbamem.2007.03.014; BAUER RJ, 1987, BIOPHYS J, V52, P961, DOI 10.1016/S0006-3495(87)83289-7; Berridge MJ, 2011, NEUROCHEM RES, V36, P1149, DOI 10.1007/s11064-010-0371-4; Berridge MJ, 2010, PFLUG ARCH EUR J PHY, V459, P441, DOI 10.1007/s00424-009-0736-1; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Bezprozvanny I, 2009, TRENDS MOL MED, V15, P89, DOI 10.1016/j.molmed.2009.01.001; Bruno WJ, 2013, BIOPHYS J, V105, P68, DOI 10.1016/j.bpj.2013.02.060; Bruno WJ, 2005, P NATL ACAD SCI USA, V102, P6326, DOI 10.1073/pnas.0409110102; Capone R, 2012, BIOCHEMISTRY-US, V51, P776, DOI 10.1021/bi2017427; CRAS P, 1991, P NATL ACAD SCI USA, V88, P7552, DOI 10.1073/pnas.88.17.7552; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Demuro A, 2005, J GEN PHYSIOL, V126, P179, DOI 10.1085/jgp.200509331; Demuro A, 2004, BIOL RES, V37, P675, DOI 10.4067/s0716-97602004000400025; Demuro A, 2004, BIOPHYS J, V86, P3250, DOI 10.1016/S0006-3495(04)74373-8; Demuro A, 2003, CELL CALCIUM, V34, P499, DOI 10.1016/S0143-4160(03)00154-4; Demuro A, 2013, J NEUROSCI, V33, P3824, DOI 10.1523/JNEUROSCI.4367-12.2013; Demuro A, 2011, J CELL BIOL, V195, P515, DOI 10.1083/jcb.201104133; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Diaz JC, 2009, P NATL ACAD SCI USA, V106, P3348, DOI 10.1073/pnas.0813355106; Gillman AL, 2014, J PHYS CHEM B, V118, P7335, DOI 10.1021/jp5040954; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hatip FFB, 2010, CURR ALZHEIMER RES, V7, P602; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hirakura Y, 1999, J NEUROSCI RES, V57, P458, DOI 10.1002/(SICI)1097-4547(19990815)57:4<458::AID-JNR5>3.0.CO;2-4; Kagan BL, 2002, PEPTIDES, V23, P1311, DOI 10.1016/S0196-9781(02)00067-0; KIENKER P, 1989, PROC R SOC SER B-BIO, V236, P269, DOI 10.1098/rspb.1989.0024; Knobloch M, 2007, NEUROBIOL AGING, V28, P1297, DOI 10.1016/j.neurobiolaging.2006.06.019; Lal R, 2007, BBA-BIOMEMBRANES, V1768, P1966, DOI 10.1016/j.bbamem.2007.04.021; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Mason RP, 1999, J BIOL CHEM, V274, P18801, DOI 10.1074/jbc.274.26.18801; McQuarrie A. D, 1998, REGRESSION TIME SERI; Milescu LS, 2000, QUB SOFTWARE; Muller M, 2011, P NATL ACAD SCI USA, V108, P13293, DOI 10.1073/pnas.1109297108; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Prangkio P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047261; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Small DH, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-7; Sokolov Yuri, 2006, J Gen Physiol, V128, P637, DOI 10.1085/jgp.200609533; Ullah G, 2006, BIOPHYS J, V90, P3485, DOI 10.1529/biophysj.105.073460; Ullah G, 2012, J GEN PHYSIOL, V140, P159, DOI 10.1085/jgp.201110753; Ullah G, 2012, CELL CALCIUM, V52, P152, DOI 10.1016/j.ceca.2012.04.018; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Womack MD, 2002, EUR J NEUROSCI, V16, P1214, DOI 10.1046/j.1460-9568.2002.02171.x	50	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137357	10.1371/journal.pone.0137357	http://dx.doi.org/10.1371/journal.pone.0137357			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348728	Green Submitted, gold, Green Published			2022-12-26	WOS:000360897600040
J	Krishnan, NP; Nguyen, NQ; Papp-Wallace, KM; Bonomo, RA; van den Akker, F				Krishnan, Nikhil P.; Nguyen, Nhu Q.; Papp-Wallace, Krisztina M.; Bonomo, Robert A.; van den Akker, Focco			Inhibition of Klebsiella beta-Lactamases (SHV-1 and KPC-2) by Avibactam: A Structural Study	PLOS ONE			English	Article							TRANS-ENAMINE INTERMEDIATE; CRYSTAL-STRUCTURE; CLASS-A; CLAVULANIC ACID; BORONIC ACID; COMPLEX; EPIDEMIOLOGY; PNEUMONIAE; INSIGHTS; NXL104	beta-Lactamase inhibition is an important clinical strategy in overcoming beta-lactamase-mediated resistance to beta-lactam antibiotics in Gram negative bacteria. A new beta-lactamase inhibitor, avibactam, is entering the clinical arena and promising to be a major step forward in our antibiotic armamentarium. Avibactam has remarkable broad-spectrum activity in being able to inhibit classes A, C, and some class D beta-lactamases. We present here structural investigations into class A beta-lactamase inhibition by avibactam as we report the crystal structures of SHV-1, the chromosomal penicillinase of Klebsiella pneumoniae, and KPC-2, an acquired carbapenemase found in the same pathogen, complexed with avibactam. The 1.80 angstrom KPC-2 and 1.42 angstrom resolution SHV-1 beta-lactamase avibactam complex structures reveal avibactam covalently bonded to the catalytic S70 residue. Analysis of the interactions and chair-shaped conformation of avibactam bound to the active sites of KPC-2 and SHV-1 provides structural insights into recently laboratory-generated amino acid substitutions that result in resistance to avibactam in KPC-2 and SHV-1. Furthermore, we observed several important differences in the interactions with amino acid residues, in particular that avibactam forms hydrogen bonds to S130 in KPC-2 but not in SHV-1, that can possibly explain some of the different kinetic constants of inhibition. Our observations provide a possible reason for the ability of KPC-2 beta-lactamase to slowly desulfate avibactam with a potential role for the stereochemistry around the N1 atom of avibactam and/or the presence of an active site water molecule that could aid in avibactam desulfation, an unexpected consequence of novel inhibition chemistry.	[Krishnan, Nikhil P.; Nguyen, Nhu Q.; Bonomo, Robert A.; van den Akker, Focco] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Papp-Wallace, Krisztina M.; Bonomo, Robert A.] Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA	Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	van den Akker, F (corresponding author), Case Western Reserve Univ, Dept Biochem, 10900 Euclid Ave, Cleveland, OH 44106 USA.	focco.vandenakker@case.edu	Papp-Wallace, Krisztina/L-2923-2019	Papp-Wallace, Krisztina/0000-0002-9976-7898	AstraZeneca; Cleveland Department of Veterans Affairs; Veterans Affairs Career Development Award; Department of Veterans Affairs Merit Review Program [1I01BX001974]; Veterans Integrated Service Network 10 Geriatric Research, Education, and Clinical Center (VISN 10 GRECC); National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01 AI100560, R01 AI063517]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063517, R01AI100560, R01AI072219] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001974] Funding Source: NIH RePORTER	AstraZeneca(AstraZeneca); Cleveland Department of Veterans Affairs; Veterans Affairs Career Development Award; Department of Veterans Affairs Merit Review Program(US Department of Veterans Affairs); Veterans Integrated Service Network 10 Geriatric Research, Education, and Clinical Center (VISN 10 GRECC); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a research grant from AstraZeneca (KMP-W, RAB, and FVDA), who also provided the avibactam compound for the study. KMP-W is supported by funds and/or facilities provided by the Cleveland Department of Veterans Affairs and a Veterans Affairs Career Development Award. RAB is supported in part by funds and/or facilities provided by the Cleveland Department of Veterans Affairs, the Department of Veterans Affairs Merit Review Program 1I01BX001974, the Veterans Integrated Service Network 10 Geriatric Research, Education, and Clinical Center (VISN 10 GRECC), and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Numbers R01 AI100560 and R01 AI063517. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bratu S, 2005, ANTIMICROB AGENTS CH, V49, P3018, DOI 10.1128/AAC.49.7.3018-3020.2005; Bush K, 2013, J INFECT CHEMOTHER, V19, P549, DOI 10.1007/s10156-013-0640-7; Bush K, 2013, ANN NY ACAD SCI, V1277, P84, DOI 10.1111/nyas.12023; Castanheira M, 2014, MICROB DRUG RESIST, V20, P436, DOI 10.1089/mdr.2013.0181; Deshpande LM, 2006, DIAGN MICR INFEC DIS, V56, P367, DOI 10.1016/j.diagmicrobio.2006.07.004; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Ehmann DE, 2013, J BIOL CHEM, V288, P27960, DOI 10.1074/jbc.M113.485979; Ehmann DE, 2012, P NATL ACAD SCI USA, V109, P11663, DOI 10.1073/pnas.1205073109; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endimiani A, 2011, ANTIMICROB AGENTS CH, V55, P82, DOI 10.1128/AAC.01198-10; Endimiani A, 2009, ANTIMICROB AGENTS CH, V53, P3599, DOI 10.1128/AAC.00641-09; Ke W, 2007, BIOCHEMISTRY-US, V46, P5732, DOI 10.1021/bi700300u; Ke W, 2012, ANTIMICROB AGENTS CH, V56, P2713, DOI 10.1128/AAC.06099-11; King DT, 2015, ACS INFECT DIS, V1, P175, DOI 10.1021/acsinfecdis.5b00007; Kuzin AP, 2001, BIOCHEMISTRY-US, V40, P1861, DOI 10.1021/bi0022745; Lahiri SD, 2015, ACS CHEM BIOL, V10, P591, DOI 10.1021/cb500703p; Lahiri SD, 2013, ANTIMICROB AGENTS CH, V57, P2496, DOI 10.1128/AAC.02247-12; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Livermore DM, 2012, KOREAN J INTERN MED, V27, P128, DOI 10.3904/kjim.2012.27.2.128; Livermore DM, 2011, ANTIMICROB AGENTS CH, V55, P390, DOI 10.1128/AAC.00756-10; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padayatti PS, 2006, J AM CHEM SOC, V128, P13235, DOI 10.1021/ja063715w; Padayatti PS, 2004, BIOCHEMISTRY-US, V43, P843, DOI 10.1021/bi035985m; Padayatti PS, 2005, J BIOL CHEM, V280, P34900, DOI 10.1074/jbc.M505333200; Papp-Wallace KM, 2015, ANTIMICROB AGENTS CH, V59, P3710, DOI 10.1128/AAC.04406-14; Petrella S, 2008, ANTIMICROB AGENTS CH, V52, P3725, DOI 10.1128/AAC.00163-08; Rodkey EA, 2012, J AM CHEM SOC, V134, P16798, DOI 10.1021/ja3073676; Rydberg P, 2013, ANGEW CHEM INT EDIT, V52, P993, DOI 10.1002/anie.201206207; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sgrignani J, 2014, BIOCHEMISTRY-US, V53, P5174, DOI 10.1021/bi500589x; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Winkler ML, 2015, ANTIMICROB AGENTS CH, V59, P3700, DOI 10.1128/AAC.04405-14; Winkler ML, 2013, J MED CHEM, V56, P1084, DOI 10.1021/jm301490d; Xu H, 2012, BIOCHEMISTRY-US, V51, P4551, DOI 10.1021/bi300508r	36	53	55	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0136813	10.1371/journal.pone.0136813	http://dx.doi.org/10.1371/journal.pone.0136813			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340563	gold, Green Published, Green Submitted			2022-12-26	WOS:000360688200018
J	Schick, MA; Baar, W; Bruno, RR; Wollborn, J; Held, C; Schneider, R; Flemming, S; Schlegel, N; Roewer, N; Neuhaus, W; Wunder, C				Schick, Martin Alexander; Baar, Wolfgang; Bruno, Raphael Romano; Wollborn, Jakob; Held, Christopher; Schneider, Reinhard; Flemming, Sven; Schlegel, Nicolas; Roewer, Norbert; Neuhaus, Winfried; Wunder, Christian			Balanced Hydroxyethylstarch (HES 130/0.4) Impairs Kidney Function In-Vivo without Inflammation	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; SEVERE SEPSIS; FLUID RESUSCITATION; INTENSIVE-CARE; STARCH; THERAPY; CRYSTALLOIDS; COLLOIDS; SAFETY; REPLACEMENT	Volume therapy is a standard procedure in daily perioperative care, and there is an ongoing discussion about the benefits of colloid resuscitation with hydroxyethylstarch (HES). In sepsis HES should be avoided due to a higher risk for acute kidney injury (AKI). Results of the usage of HES in patients without sepsis are controversial. Therefore we conducted an animal study to evaluate the impact of 6% HES 130/0.4 on kidney integrity with sepsis or under healthy conditions Sepsis was induced by standardized Colon Ascendens Stent Peritonitis (sCASP). sCASP-group as well as control group (C) remained untreated for 24 h. After 18 h sCASP+HES group (sCASP+VOL) and control+HES (C+VOL) received 50 ml/KG balanced 6% HES (VOL) 130/0.4 over 6h. After 24h kidney function was measured via Inulin- and PAH-Clearance in re-anesthetized rats, and serum urea, creatinine (crea), cystatin C and Neutrophil gelatinase-associated lipocalin (NGAL) as well as histopathology were analysed. In vitro human proximal tubule cells (PTC) were cultured +/- lipopolysaccharid (LPS) and with 0.1-4.0% VOL. Cell viability was measured with XTT-, cell toxicity with LDH-test. sCASP induced severe septic AKI demonstrated divergent results regarding renal function by clearance or creatinine measure focusing on VOL. Soleley HES (C+VOL) deteriorated renal function without sCASP. Histopathology revealed significantly derangements in all HES groups compared to control. In vitro LPS did not worsen the HES induced reduction of cell viability in PTC cells. For the first time, we demonstrated, that application of 50 ml/KG 6% HES 130/0.4 over 6 hours induced AKI without inflammation in vivo. Severity of sCASP induced septic AKI might be no longer susceptible to the way of volume expansion.	[Schick, Martin Alexander; Baar, Wolfgang; Bruno, Raphael Romano; Wollborn, Jakob; Roewer, Norbert; Neuhaus, Winfried; Wunder, Christian] Univ Hosp Wurzburg, Inst Anaesthesia & Crit Care, Wurzburg, Germany; [Baar, Wolfgang; Wollborn, Jakob] Univ Med Ctr Freiburg, Dept Anesthesiol & Intens Care Med, Freiburg, Germany; [Neuhaus, Winfried] Univ Vienna, Dept Med Chem, Vienna, Austria; [Held, Christopher; Schneider, Reinhard] Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany; [Flemming, Sven; Schlegel, Nicolas] Univ Wurzburg, Dept Gen Visceral Vasc & Paediat Surg, Dept Surg 1, D-97070 Wurzburg, Germany; [Neuhaus, Winfried] Med Univ Vienna, Inst Med Genet, Vienna, Austria	University of Wurzburg; University of Freiburg; University of Vienna; University of Wurzburg; University of Wurzburg; Medical University of Vienna	Schick, MA (corresponding author), Univ Hosp Wurzburg, Inst Anaesthesia & Crit Care, Wurzburg, Germany.	schick_m@ukw.de	Schick, Martin/ABH-6971-2020; Flemming, Sven/AAA-9950-2020	Flemming, Sven/0000-0002-6304-3169; Neuhaus, Winfried/0000-0002-6552-7183; Bruno, Raphael Romano/0000-0003-3776-3530	German Research Foundation (DFG); University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing.	Adamson RH, 2004, J PHYSIOL-LONDON, V557, P889, DOI 10.1113/jphysiol.2003.058255; Annane D, 2013, JAMA-J AM MED ASSOC, V310, P1809, DOI 10.1001/jama.2013.280502; Bayer O, 2012, CRIT CARE MED, V40, P2543, DOI 10.1097/CCM.0b013e318258fee7; Bruno RR, 2014, ANESTH ANALG, V119, P570, DOI 10.1213/ANE.0000000000000325; Chen N, 2006, PEDIATR NEPHROL, V21, P160, DOI 10.1007/s00467-005-2105-4; Corrigan G, 1999, AM J PHYSIOL-RENAL, V277, pF312, DOI 10.1152/ajprenal.1999.277.2.F312; Flemming S, 2014, SHOCK, V41, P537, DOI 10.1097/SHK.0000000000000152; Guidet B, 2012, CRIT CARE, V16, DOI 10.1186/cc11358; Irwin MG, 2014, ANESTH ANALG, V119, P737, DOI 10.1213/ANE.0000000000000221; Li LX, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0815-y; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; Neuhaus W, 2012, ANESTH ANALG, V114, P371, DOI 10.1213/ANE.0b013e3182367a54; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Raghunathan K, 2014, ANESTH ANALG, V119, P731, DOI 10.1213/ANE.0000000000000186; Schick MA BW, 2014, INTENSIVE CARE MED E, V2; Schick MA, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-179; Schick MA, 2012, J PHYSIOL-LONDON, V590, P2693, DOI 10.1113/jphysiol.2012.232116; Schick MA, 2010, INTENS CARE MED, V36, P541, DOI 10.1007/s00134-009-1704-0; Schneider R, 2007, AM J PHYSIOL-RENAL, V292, pF1599, DOI 10.1152/ajprenal.00473.2006; Starling E H, 1896, J Physiol, V19, P312; Stumpner J, 2012, ACTA ANAESTH SCAND, V56, P904, DOI 10.1111/j.1399-6576.2012.02657.x; Van der Linden P, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0830-z; Weiskopf RB, 2014, ANESTH ANALG, V119, P509, DOI 10.1213/ANE.0000000000000323; Witt L, 2014, PEDIATR ANESTH, V24, P974, DOI 10.1111/pan.12445; Woodcock TE, 2012, BRIT J ANAESTH, V108, P384, DOI 10.1093/bja/aer515; Xu C, 2014, KIDNEY INT, V85, P72, DOI 10.1038/ki.2013.286	27	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137247	10.1371/journal.pone.0137247	http://dx.doi.org/10.1371/journal.pone.0137247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340751	Green Submitted, Green Published, gold			2022-12-26	WOS:000360688200040
J	Heishima, K; Mori, T; Sakai, H; Sugito, N; Murakami, M; Yamada, N; Akao, Y; Maruo, K				Heishima, Kazuki; Mori, Takashi; Sakai, Hiroki; Sugito, Nobuhiko; Murakami, Mami; Yamada, Nami; Akao, Yukihiro; Maruo, Kohji			MicroRNA-214 Promotes Apoptosis in Canine Hemangiosarcoma by Targeting the COP1-p53 Axis	PLOS ONE			English	Article							CERVICAL-CANCER CELLS; DOWN-REGULATION; NEGATIVE REGULATOR; GROWTH-FACTOR; P53; ANGIOGENESIS; ANGIOSARCOMA; EXPRESSION; MIR-214; BREAST	MicroRNA-214 regulates both angiogenic function in endothelial cells and apoptosis in various cancers. However, the regulation and function of miR-214 is unclear in canine hemangiosarcoma, which is a spontaneous model of human angiosarcoma. The expression and functional roles of miR-214 in canine hemangiosarcoma were presently explored by performing miRNA TaqMan qRT-PCR and transfecting cells with synthetic microRNA. Here, we report that miR-214 was significantly down-regulated in the cell lines used and in clinical samples of canine hemangiosarcoma. Restoration of miR-214 expression reduced cell growth and induced apoptosis in canine hemangiosarcoma cell lines through transcriptional activation of p53-regulated genes although miR-214 had a slight effect of growth inhibition on normal endothelial cells. We identified COP1, which is a critical negative regulator of p53, as a novel direct target of miR-214. COP1 was overexpressed and the specific COP1 knockdown induced apoptosis through transcriptional activation of p53-regulated genes as well as did miR-214-transfection in HSA cell lines. Furthermore, p53 knockdown abolished the miR-214-COP1-mediated apoptosis; thus, miR-214 and COP1 regulated apoptosis through controlling p53 in HSA. In conclusion, miR-214 functioned as a tumor suppressor in canine hemangiosarcoma by inducing apoptosis through recovering the function of p53. miR-214 down-regulation and COP1 overexpression is likely to contribute to tumorigenesis of HSA. Therefore, targeting miR-214-COP1-p53 axis would possibly be a novel effective strategy for treatment of canine hemangiosarcoma and capable of being applied to the development of novel therapeutics for human angiosarcoma.	[Heishima, Kazuki; Mori, Takashi; Sakai, Hiroki; Maruo, Kohji] Gifu Univ, United Grad Sch Vet Sci, Gifu, Gifu, Japan; [Heishima, Kazuki; Mori, Takashi; Murakami, Mami; Maruo, Kohji] Gifu Univ, Fac Appl Biol Sci, Dept Vet Clin Oncol, Gifu, Gifu, Japan; [Sakai, Hiroki] Gifu Univ, Fac Appl Biol Sci, Dept Vet Pathol, Gifu, Gifu, Japan; [Sugito, Nobuhiko; Yamada, Nami; Akao, Yukihiro] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Gifu, Japan	Gifu University; Gifu University; Gifu University; Gifu University	Mori, T (corresponding author), Gifu Univ, United Grad Sch Vet Sci, Gifu, Gifu, Japan.	tmori@gifu-u.ac.jp	Heishima, Kazuki/J-6233-2019	Heishima, Kazuki/0000-0002-4629-8661; Yamada, Nami/0000-0002-1220-0814				Abraham JA, 2007, ANN SURG ONCOL, V14, P1953, DOI 10.1245/s10434-006-9335-y; Anoun S, 2014, TURK J HEMATOL, V31, P408, DOI 10.4274/tjh.2013.0049; Blanchard DK, 2002, AM J SURG, V184, P356, DOI 10.1016/S0002-9610(02)00943-1; Chan LS, 2009, EUR J PHARM SCI, V38, P370, DOI 10.1016/j.ejps.2009.08.008; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Coindre JM, 2001, CANCER-AM CANCER SOC, V91, P1914, DOI 10.1002/1097-0142(20010515)91:10<1914::AID-CNCR1214>3.0.CO;2-3; Derfoul A, 2011, CARCINOGENESIS, V32, P1607, DOI 10.1093/carcin/bgr184; DONNELL RM, 1981, AM J SURG PATHOL, V5, P629, DOI 10.1097/00000478-198110000-00005; DORN CR, 1968, J NATL CANCER I, V40, P295; Dornan D, 2004, CANCER RES, V64, P7226, DOI 10.1158/0008-5472.CAN-04-2601; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Duan QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031518; Fayette J, 2007, ANN ONCOL, V18, P2030, DOI 10.1093/annonc/mdm381; Gamlem H, 2008, APMIS, V116, P41, DOI 10.1111/j.1600-0463.2008.125m4.x; Goga A, 2007, MOL INTERV, V7, P199, DOI 10.1124/mi.7.4.6; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Huang HJ, 2014, ONCOTARGET, V5, P2161, DOI 10.18632/oncotarget.1855; Italiano A, 2012, CANCER-AM CANCER SOC, V118, P5878, DOI 10.1002/cncr.27614; Khanna C, 2006, NATURE; Lee YH, 2010, CANCER RES, V70, P8264, DOI 10.1158/0008-5472.CAN-10-0749; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li B, 2012, FEBS J, V279, P2393, DOI 10.1111/j.1742-4658.2012.08618.x; Long LM, 2015, ONCOL LETT, V9, P645, DOI 10.3892/ol.2014.2746; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; Millau JF, 2009, MUTAT RES-REV MUTAT, V681, P118, DOI 10.1016/j.mrrev.2008.06.002; Misiewicz-Krzeminska I, 2013, HAEMATOLOGICA, V98, P640, DOI 10.3324/haematol.2012.070011; Murai A, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-128; Ogilvie GK, 1996, J VET INTERN MED, V10, P379, DOI 10.1111/j.1939-1676.1996.tb02085.x; Peng RQ, 2012, J BIOL CHEM, V287, P14301, DOI 10.1074/jbc.M111.337642; Peters IR, 2007, VET IMMUNOL IMMUNOP, V117, P55, DOI 10.1016/j.vetimm.2007.01.011; Ratert N, 2013, J MOL DIAGN, V15, P695, DOI 10.1016/j.jmoldx.2013.05.008; Rouhani P, 2008, CANCER-AM CANCER SOC, V113, P616, DOI 10.1002/cncr.23571; Sharma T, 2015, FUTURE ONCOL, V11, P349, DOI [10.2217/fon.14.193, 10.2217/FON.14.193]; Shen JK, 2008, MOL THER, V16, P1208, DOI 10.1038/mt.2008.104; Shih TC, 2012, J HEPATOL, V57, P584, DOI 10.1016/j.jhep.2012.04.031; Srivastava A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076994; Taniguchi K, 2015, SCI REP-UK, V5, DOI 10.1038/srep08647; Tate G, 2007, CANCER GENET CYTOGEN, V178, P160, DOI 10.1016/j.cancergencyto.2007.07.017; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; van Mil A, 2012, CARDIOVASC RES, V93, P655, DOI 10.1093/cvr/cvs003; vanLeeuwen IS, 1997, CANCER LETT, V111, P173, DOI 10.1016/S0304-3835(96)04529-6; Wang F, 2013, FEBS LETT, V587, P488, DOI 10.1016/j.febslet.2013.01.016; Wang JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118086; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Yamada N, 2014, BBA-GENE REGUL MECH, V1839, P1256, DOI 10.1016/j.bbagrm.2014.09.002; Yang ZZ, 2009, IUBMB LIFE, V61, P1075, DOI 10.1002/iub.252; Yonemaru K, 2007, J VET MED SCI, V69, P271, DOI 10.1292/jvms.69.271; Zhao ZQ, 2012, BMB REP, V45, P641, DOI 10.5483/BMBRep.2012.45.11.097; Zietz C, 1998, AM J PATHOL, V153, P1425, DOI 10.1016/S0002-9440(10)65729-X	51	26	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137361	10.1371/journal.pone.0137361	http://dx.doi.org/10.1371/journal.pone.0137361			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335793	Green Published, gold, Green Submitted			2022-12-26	WOS:000360615400054
J	Lee, YS; Jeng, MJ; Tsao, PC; Soong, WJ; Chou, P				Lee, Yu-Sheng; Jeng, Mei-Jy; Tsao, Pei-Chen; Soong, Wen-Jue; Chou, Pesus			Prognosis and Risk Factors for Congenital Airway Anomalies in Children with Congenital Heart Disease: A Nationwide Population-Based Study in Taiwan	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; CARDIAC-SURGERY; EXTRACARDIAC ABNORMALITIES; TRACHEOBRONCHIAL ANOMALIES; DIAGNOSIS; MALFORMATIONS; COMPRESSION; OBSTRUCTION; VALIDATION; ACCURACY	The mortality risk associated with congenital airway anomalies (CAA) in children with congenital heart disease (CHD) is unclear. This study aimed to investigate the factors associated with CAA, and the associated mortality risk, among children with CHD. Methods This nationwide, population-based study evaluated 39,652 children with CHD aged 0-5 years between 2000 and 2011, using the Taiwan National Health Insurance Research Database (NHIRD). We performed descriptive, logistic regression, Kaplan-Meier, and Cox regression analyses of the data. Results Among the children with CHD, 1,591 (4.0%) had concomitant CAA. Children with CHD had an increased likelihood of CAA if they were boys (odds ratio [OR], 1.48; 95% confidence interval [CI], 1.33-1.64), infants (OR, 5.42; 95% CI, 4.06-7.24), or had a congenital musculoskeletal anomaly (OR, 3.19; 95% CI, 2.67-3.81), and were typically identified 0-3 years after CHD diagnosis (OR, 1.33; 95% CI 1.17-1.51). The mortality risk was increased in children with CHD and CAA (crude hazard ratio [HR], 2.05; 95% CI, 1.77-2.37), even after adjusting for confounders (adjusted HR, 1.76; 95% CI, 1.51-2.04). Mortality risk also changed by age and sex (adjusted HR and 95% CI are quoted): neonates, infants, and toddlers and preschool children, 1.67 (1.40-2.00), 1.93 (1.47-2.55), and 4.77 (1.39-16.44), respectively; and boys and girls, 1.62 (1.32-1.98) and 2.01 (1.61-2.50), respectively. Conclusion The mortality risk is significantly increased among children with CHD and comorbid CAA. Clinicians should actively seek CAA during the follow-up of children with CHD.	[Lee, Yu-Sheng; Jeng, Mei-Jy; Tsao, Pei-Chen; Soong, Wen-Jue] Taipei Vet Gen Hosp, Dept Pediat, Div Gen Pediat, Taipei, Taiwan; [Lee, Yu-Sheng; Jeng, Mei-Jy; Tsao, Pei-Chen; Soong, Wen-Jue] Natl Yang Ming Univ, Sch Med, Dept Pediat, Taipei 112, Taiwan; [Lee, Yu-Sheng; Chou, Pesus] Natl Yang Ming Univ, Sch Med, Inst Publ Hlth, Taipei 112, Taiwan; [Lee, Yu-Sheng; Chou, Pesus] Natl Yang Ming Univ, Sch Med, Community Med Res Ctr, Taipei 112, Taiwan; [Jeng, Mei-Jy] Natl Yang Ming Univ, Sch Med, Inst Emergency & Crit Care Med, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Soong, WJ (corresponding author), Taipei Vet Gen Hosp, Dept Pediat, Div Gen Pediat, Taipei, Taiwan.	wjsoong@vghtpe.gov.tw; pschou@ym.edu.tw			Taipei Veterans General Hospital, Taiwan [V102B-047]	Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital)	This study was supported by a grant from the Taipei Veterans General Hospital (V102B-047), Taiwan, and YSL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alli A, 2013, J CRANIOFAC SURG, V24, P1423, DOI 10.1097/SCS.0b013e3182953b43; Altman KW, 1999, ARCH OTOLARYNGOL, V125, P525, DOI 10.1001/archotol.125.5.525; BACKER CL, 1989, J THORAC CARDIOV SUR, V97, P725; Bernier Pierre-Luc, 2010, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V13, P26, DOI 10.1053/j.pcsu.2010.02.005; Bernstein D, 2011, NELSON TXB PEDIAT, V19th; Bertrand P, 2003, PEDIATR PULM, V36, P137, DOI 10.1002/ppul.10332; Billett J, 2008, HEART, V94, P1194, DOI 10.1136/hrt.2007.122671; Brown JW, 2006, ANN THORAC SURG, V82, P2221, DOI 10.1016/j.athoracsur.2006.07.022; Chen YJ, 2012, ARCH DERMATOL, V148, P103, DOI 10.1001/archdermatol.2011.682; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Connor JA, 2005, PEDIATRICS, V116, P689, DOI 10.1542/peds.2004-2071; Cuneo BF, 2006, CURR OPIN PEDIATR, V18, P490, DOI 10.1097/01.mop.0000245348.52960.11; Gittenberger-de Groot AC, 2013, SEMIN FETAL NEONAT M, V18, P237, DOI 10.1016/j.siny.2013.04.008; Gonzalez JH, 2009, PEDIATR CARDIOL, V30, P269, DOI 10.1007/s00246-008-9331-z; GREENWOOD RD, 1984, CLIN PEDIATR, V23, P145, DOI 10.1177/000992288402300303; GREENWOOD RD, 1975, PEDIATRICS, V55, P485; Guillemaud JP, 2007, ARCH OTOLARYNGOL, V133, P672, DOI 10.1001/archotol.133.7.672; HANNA EJ, 1994, J MED GENET, V31, P858, DOI 10.1136/jmg.31.11.858; Healy F, 2012, PAEDIATR RESPIR REV, V13, P10, DOI 10.1016/j.prrv.2011.01.007; Healy F, 2010, EUR J PEDIATR, V169, P1, DOI 10.1007/s00431-009-1027-8; Jenkins KJ, 2002, J THORAC CARDIOV SUR, V123, P110, DOI 10.1067/mtc.2002.119064; Jiao H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082826; Kazim R, 1998, J CARDIOTHOR VASC AN, V12, P553, DOI 10.1016/S1053-0770(98)90100-8; Khariwala SS, 2005, ARCH OTOLARYNGOL, V131, P336, DOI 10.1001/archotol.131.4.336; Lee SL, 2002, PEDIATR PULM, V34, P304, DOI 10.1002/ppul.10164; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lyons M, 2012, EARLY HUM DEV, V88, P951, DOI 10.1016/j.earlhumdev.2012.09.001; Massin MM, 2007, ACTA PAEDIATR, V96, P753, DOI 10.1111/j.1651-2227.2007.00275.x; Mehta RP, 2005, LARYNGOSCOPE, V115, P1923, DOI 10.1097/01.mlg.0000172037.49945.2f; MITCHELL SC, 1971, CIRCULATION, V43, P323, DOI 10.1161/01.CIR.43.3.323; Noel CV, 2014, CONGENIT HEART DIS, V9, P294, DOI 10.1111/chd.12138; Pereira KD, 1997, CHEST, V111, P1769, DOI 10.1378/chest.111.6.1769; Pfammatter JP, 2006, ANN THORAC SURG, V81, P1008, DOI 10.1016/j.athoracsur.2005.09.015; Rogers DJ, 2013, JAMA OTOLARYNGOL, V139, P586, DOI 10.1001/jamaoto.2013.3214; Roodpeyma S, 2002, CLIN PEDIATR, V41, P653, DOI 10.1177/000992280204100903; Sivanandam S, 2006, AM J PERINAT, V23, P241, DOI 10.1055/s-2006-939535; STOLL C, 1989, EUR J EPIDEMIOL, V5, P382, DOI 10.1007/BF00144842; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Wang CC, 2013, PEDIATR PULM, V48, P587, DOI 10.1002/ppul.22674; Welke KF, 2006, ANN THORAC SURG, V82, P164, DOI 10.1016/j.athoracsur.2006.03.004	41	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137437	10.1371/journal.pone.0137437	http://dx.doi.org/10.1371/journal.pone.0137437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334302	Green Submitted, Green Published, gold			2022-12-26	WOS:000360615400058
J	Petrillo, M; Zannoni, GF; Martinelli, E; Anchora, LP; Ferrandina, G; Tropeano, G; Fagotti, A; Scambia, G				Petrillo, Marco; Zannoni, Gian Franco; Martinelli, Enrica; Anchora, Luigi Pedone; Ferrandina, Gabriella; Tropeano, Giovanna; Fagotti, Anna; Scambia, Giovanni			Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical Cancer	PLOS ONE			English	Article							RADICAL SURGERY; CONCURRENT CHEMOTHERAPY; RADIATION-THERAPY; PELVIC RADIATION; CARCINOMA; CISPLATIN; STAGE; COMPLICATIONS; HYSTERECTOMY; RADIOTHERAPY	Objective we investigate the prognostic role of pre-treatment ratio between Type 1 (M1) and Type 2 (M2) tumor-associated macrophages (TAMs) in locally advanced cervical cancer (LACC) patients treated with chemoradiation (CT/RT). Methods 84 consecutive LACC patients treated with cisplatin-based CT/RT for a total dose of 50.0 Gy, followed by radical surgery were analysed. Double-staining immunohistochemistry of CD163/p-STAT, CD68/pSTAT1, CD163/c-MAF, and CD68/c-MAF was performed on tumor samples taken at the time of diagnosis. TAMs with CD163+pSTAT1+, or CD68+pSTAT1+ were defined M1; CD163+c-MAF+ or CD68+c-MAF+ defined the M2 phenotype. The number of M1 and M2 cells was counted at low magnification by evaluating for each case the same tumour area. The ratio between M1 and M2 (M1/M2) was finally calculated. Results At diagnosis, we observed a direct correlation between the number of circulating monocytes and of TAMs (p-value = 0.001). Patients with high M1/M2 experienced more frequently complete pathologic response (no residual tumor) to CT/RT, compared to cases with low M1/M2 (55.0% Vs 29.5%; p-value = 0.029). At multivariate analysis M1/M2 (OR = 2.067; p-value = 0.037) emerged as independent predictor of pathologic response to CT/RT. Women with high M1/M2 showed a longer 5-yrs Disease-free (67.2% Vs. 44.3%; p-value = 0.019), and 5-yrs Overall (69.3% Vs. 46.9%; p-value = 0.037) survival, compared to cases with low M1/M2. The presence of a high M1/M2 ratio was independently associated with an unfavourable survival outcome in multivariate analysis. Conclusions polarisation of TAMs toward a M2 phenotype, as reflected by a lower M1/M2 ratio, is an independent predictor of poor response to CT/RT, and shorter survival in LACC.	[Petrillo, Marco; Martinelli, Enrica; Anchora, Luigi Pedone; Ferrandina, Gabriella; Tropeano, Giovanna; Scambia, Giovanni] Univ Cattolica Sacro Cuore, Dept Obstet & Gynecol, Gynecol Oncol Unit, Rome, Italy; [Petrillo, Marco] Univ Cattolica Sacro Cuore, Dept Oncol, Gynecol Oncol Unit, Fdn John Paul 2, Campobasso, Italy; [Zannoni, Gian Franco] Univ Cattolica Sacro Cuore, Dept Human Pathol, Div Gynecol Pathol, Rome, Italy; [Fagotti, Anna] Univ Perugia, St Maria Hosp, Div Gynecol Oncol, Terni, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Perugia	Petrillo, M (corresponding author), Univ Cattolica Sacro Cuore, Dept Obstet & Gynecol, Gynecol Oncol Unit, Rome, Italy.	marco.petrillo@gmail.com	Anchora, Luigi Pedone/AAC-1331-2019; Zannoni, Gian Franco/AAC-4754-2020; Ferrandina, Gabriella/AAA-9083-2019; fagotti, anna AF/K-5233-2018	Anchora, Luigi Pedone/0000-0001-8036-9323; Zannoni, Gian Franco/0000-0002-4473-7560; FERRANDINA, Maria Gabriella/0000-0003-4672-4197; Petrillo, Marco/0000-0003-0306-4328				Allavena P, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.24614; Barros MHM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080908; Benedetti-Panici P, 2003, EUR J CANCER, V39, P2470, DOI 10.1016/S0959-8049(03)00425-8; Cellini N, 2008, AM J CLIN ONCOL-CANC, V31, P280, DOI 10.1097/COC.0b013e31815aff03; Dijkgraaf EM, 2013, CANCER RES, V73, P2480, DOI 10.1158/0008-5472.CAN-12-3542; Distefano M, 2005, GYNECOL ONCOL, V99, pS166, DOI 10.1016/j.ygyno.2005.07.074; Ferlay J SH, 2008, GLOBOCAN 2008 V2 0 C; Ferrandina G, 2010, GYNECOL ONCOL, V119, P404, DOI 10.1016/j.ygyno.2010.08.004; Jurado M, 1999, GYNECOL ONCOL, V74, P30, DOI 10.1006/gyno.1999.5424; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Keys HM, 1999, NEW ENGL J MED, V340, P1154, DOI 10.1056/NEJM199904153401503; Lee HW, 2013, BBA-REV CANCER, V1835, P170, DOI 10.1016/j.bbcan.2012.12.007; Lee YY, 2012, GYNECOL ONCOL, V124, P92, DOI 10.1016/j.ygyno.2011.09.034; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mazibrada J, 2008, GYNECOL ONCOL, V108, P112, DOI 10.1016/j.ygyno.2007.08.095; McNeil C, 1999, J NATL CANCER I, V91, P500, DOI 10.1093/jnci/91.6.500a; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Morris M, 1999, NEW ENGL J MED, V340, P1137, DOI 10.1056/NEJM199904153401501; Peters WA, 2000, J CLIN ONCOL, V18, P1606, DOI 10.1200/JCO.2000.18.8.1606; Rigo A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-273; Rose PG, 1999, NEW ENGL J MED, V340, P1144, DOI 10.1056/NEJM199904153401502; Schoppmann SF, 2002, AM J PATHOL, V161, P947, DOI 10.1016/S0002-9440(10)64255-1; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Tewari KS, 2014, NEW ENGL J MED, V370, P734, DOI 10.1056/NEJMoa1309748; van Steenwijk PJD, 2013, INT J CANCER, V133, P2884, DOI 10.1002/ijc.28309; Wang YC, 2010, CANCER RES, V70, P4840, DOI 10.1158/0008-5472.CAN-10-0269; Whitney CW, 1999, J CLIN ONCOL, V17, P1339, DOI 10.1200/JCO.1999.17.5.1339; Zannoni GF, 2008, INT J GYNECOL PATHOL, V27, P274, DOI 10.1097/PGP.0b013e31815b1263	30	50	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136654	10.1371/journal.pone.0136654	http://dx.doi.org/10.1371/journal.pone.0136654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335330	Green Submitted, Green Published, gold			2022-12-26	WOS:000360615400018
J	Silva, CRE; Borges, FFV; Bernardes, A; Perez, CN; Silva, DDE; Chen-Chen, L				Ribeiro e Silva, Carolina; Veloso Borges, Flavio Fernandes; Bernardes, Aline; Perez, Caridad Noda; de Melo e Silva, Daniela; Chen-Chen, Lee			Genotoxic, Cytotoxic, Antigenotoxic, and Anticytotoxic Effects of Sulfonamide Chalcone Using the Ames Test and the Mouse Bone Marrow Micronucleus Test	PLOS ONE			English	Article							CHEMOPREVENTIVE AGENTS; INDUCED MUTAGENICITY; ACYL SULFONAMIDE; ANTIMUTAGENICITY; ANTIOXIDANT; DERIVATIVES; INHIBITORS; ASSAY; MODULATION; ACTIVATION	Chalcones present several biological activities and sulfonamide chalcone derivatives have shown important biological applications, including antitumor activity. In this study, genotoxic, cytotoxic, antigenotoxic, and anticytotoxic activities of the sulfonamide chalcone N-{4[3-(4-nitrophenyl)prop-2-enoyl]phenyl}benzenesulfonamide (CPN) were assessed using the Salmonella typhimurium reverse mutation test (Ames test) and the mouse bone marrow micronucleus test. The results showed that CPN caused a small increase in the number of histidine revertant colonies in S. typhimurium strains TA98 and TA100, but not statistically significant (p > 0.05). The antimutagenicity test showed that CPN significantly decreased the number of His(+) revertants in strain TA98 at all doses tested (p < 0.05), whereas in strain TA100 this occurred only at doses higher than 50 mu g/plate (p < 0.05). The results of the micronucleus test indicated that CPN significantly increased the frequency of micronucleated polychromatic erythrocytes (MNPCE) at 24 h and 48 h, revealing a genotoxic effect of this compound. Also, a significant decrease in polychromatic/normochromatic erythrocyte ratio (PCE/NCE) was observed at the higher doses of CPN at 24 h and 48 h (p < 0.05), indicating its cytotoxic action. CPN co-administered with mitomycin C (MMC) significantly decreased the frequency of MNPCE at almost all doses tested at 24 h (p < 0.05), showing its antigenotoxic activity, and also presented a small decrease in MNPCE at 48 h (p > 0.05). Additionally, CPN co-administered with MMC significantly increased PCE/NCE ratio at all doses tested, demonstrating its anticytotoxic effect. In summary, CPN presented genotoxic, cytotoxic, antigenotoxic, and anticytotoxic properties.	[Ribeiro e Silva, Carolina; Veloso Borges, Flavio Fernandes; de Melo e Silva, Daniela; Chen-Chen, Lee] Univ Fed Goias, Inst Ciencias Biol, Goiania, Go, Brazil; [Bernardes, Aline; Perez, Caridad Noda] Univ Fed Goias, Inst Quim, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias	Silva, CRE (corresponding author), Univ Fed Goias, Inst Ciencias Biol, Goiania, Go, Brazil.	crs_bio@hotmail.com	Perez, Caridad C. Noda Noda/M-6704-2013; Chen-Chen, Lee/Q-9797-2019; Chen, Lee Chen/B-1668-2013; Noda-Perez, Caridad/AAO-1659-2021	Perez, Caridad C. Noda Noda/0000-0003-0586-0774; Chen-Chen, Lee/0000-0002-0386-247X; Chen, Lee Chen/0000-0002-0386-247X; Noda-Perez, Caridad/0000-0003-0586-0774; Silva, Daniela de Melo/0000-0003-0362-0988				Andrighetti-Frohner CR, 2007, ACTA CRYSTALLOGR E, V63, pO3275, DOI 10.1107/S1600536807029303; Boots AW, 2008, EUR J PHARMACOL, V585, P325, DOI 10.1016/j.ejphar.2008.03.008; Cheng JH, 2008, BIOORGAN MED CHEM, V16, P7270, DOI 10.1016/j.bmc.2008.06.031; Claxton LD, 2010, ENVIRON HEALTH PERSP, V118, P1515, DOI 10.1289/ehp.1002336; Damazio RG, 2010, EUR J MED CHEM, V45, P1332, DOI 10.1016/j.ejmech.2009.12.017; Dashwood RH, 2002, MUTAT RES-REV MUTAT, V511, P89, DOI 10.1016/S1383-5742(02)00005-4; Decordier I, 2008, MUTAT RES-GEN TOX EN, V651, P30, DOI 10.1016/j.mrgentox.2007.10.016; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Furtado MA, 2008, MUTAT RES-GEN TOX EN, V657, P150, DOI 10.1016/j.mrgentox.2008.09.003; GUENGERICH FP, 1992, PHARMACOL THERAPEUT, V54, P17; Jawetz E, 1998, MICROBIOLOGIA MED; Kang JE, 2013, MOLECULES, V18, P140, DOI 10.3390/molecules18010140; Kato K, 2011, MUTAT RES-GEN TOX EN, V721, P21, DOI 10.1016/j.mrgentox.2010.11.012; Kim EJ, 2010, BIOORG MED CHEM LETT, V20, P4237, DOI 10.1016/j.bmcl.2010.05.033; KURODA Y, 1992, MUTAT RES, V267, P201, DOI 10.1016/0027-5107(92)90064-9; Lee SA, 2009, HEPATOLOGY, V49, P1316, DOI 10.1002/hep.22777; Luo Y, 2011, BIOORGAN MED CHEM, V19, P6069, DOI 10.1016/j.bmc.2011.08.038; Luo Y, 2011, BIOORGAN MED CHEM, V19, P4730, DOI 10.1016/j.bmc.2011.06.088; MANFREDI JJ, 1984, PHARMACOL THERAPEUT, V25, P83, DOI 10.1016/0163-7258(84)90025-1; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; Mortelmans K, 2000, MUTAT RES-FUND MOL M, V455, P29, DOI 10.1016/S0027-5107(00)00064-6; Narayan BH, 2010, FOOD FUNCT, V1, P174, DOI 10.1039/c0fo00102c; Pelczar MJ, 1996, MICROBIOLOGIA CONCEI; POIRIER LA, 1974, BIOCHEM PHARMACOL, V23, P661, DOI 10.1016/0006-2952(74)90631-5; Ramalho SD, 2013, CHEM BIODIVERS, V10, P1999, DOI 10.1002/cbdv.201200344; Seo WD, 2005, BIOORG MED CHEM LETT, V15, P5514, DOI 10.1016/j.bmcl.2005.08.087; Seo WD, 2010, EUR J MED CHEM, V45, P2010, DOI 10.1016/j.ejmech.2010.01.049; Sghaier MB, 2011, S AFR J BOT, V77, P730, DOI 10.1016/j.sajb.2011.03.014; TORIGOE T, 1983, BIOCHEM BIOPH RES CO, V112, P833, DOI 10.1016/0006-291X(83)91693-5; VONLEDEB.M, 1973, MUTAT RES, V19, P109, DOI 10.1016/0027-5107(73)90118-8; Wang SJ, 2010, EUR J MED CHEM, V45, P1250, DOI 10.1016/j.ejmech.2009.12.031; WATERS MD, 1990, MUTAT RES, V238, P57, DOI 10.1016/0165-1110(90)90039-E	32	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137063	10.1371/journal.pone.0137063	http://dx.doi.org/10.1371/journal.pone.0137063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335560	gold, Green Published, Green Submitted			2022-12-26	WOS:000360615400036
J	Seinstra, M; Grzymek, K; Kalenscher, T				Seinstra, Maayke; Grzymek, Katharina; Kalenscher, Tobias			Gender-Specific Differences in the Relationship between Autobiographical Memory and Intertemporal Choice in Older Adults	PLOS ONE			English	Article							DECISION-MAKING; SEX-DIFFERENCES; TEMPORAL-LOBE; EPISODIC MEMORY; TIME PERSPECTIVE; AGE-DIFFERENCES; DISCOUNT RATES; FUTURE; HIPPOCAMPUS; REWARD	As the population of older adults grows, their economic choices will have increasing impact on society. Research on the effects of aging on intertemporal decisions shows inconsistent, often opposing results, indicating that yet unexplored factors might play an essential role in guiding one's choices. Recent studies suggest that episodic future thinking, which is based on the same neural network involved in episodic memory functions, leads to reductions in discounting of future rewards. As episodic memory functioning declines with normal aging, but to greatly variable degrees, individual differences in delay discounting might be due to individual differences in the vitality of this memory system in older adults. We investigated this hypothesis, using a sample of healthy older adults who completed an intertemporal choice task as well as two episodic memory tasks. We found no clear evidence for a relationship between episodic memory performance and delay discounting in older adults. However, when additionally considering gender differences, we found an interaction effect of gender and autobiographical memory on delay discounting: while men with higher memory scores showed less delay discounting, women with higher memory scores tended to discount the future more. We speculate that this gender effect might stem from the gender-specific use of different modal representation formats (i.e. temporal or visual) during assessment of intertemporal choice options.	[Seinstra, Maayke; Grzymek, Katharina; Kalenscher, Tobias] Univ Dusseldorf, Dept Comparat Psychol, Inst Expt Psychol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Seinstra, M (corresponding author), Univ Dusseldorf, Dept Comparat Psychol, Inst Expt Psychol, Dusseldorf, Germany.	Maayke.Seinstra@hhu.de	Kalenscher, Tobias/U-8438-2019	Kalenscher, Tobias/0000-0002-0358-9020				Agarwal S, 2009, BROOKINGS PAP ECO AC, P51, DOI 10.1353/eca.0.0067; AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; Anderson CL, 2009, DEV ECON, V47, P123, DOI 10.1111/j.1746-1049.2009.00080.x; Backman L, 2006, NEUROSCI BIOBEHAV R, V30, P791, DOI 10.1016/j.neubiorev.2006.06.005; Baller G, 2006, INVENTAR ZUR GEDACHT; Benoit RG, 2011, J NEUROSCI, V31, P6771, DOI 10.1523/JNEUROSCI.6559-10.2011; Boyer P, 2008, TRENDS COGN SCI, V12, P219, DOI 10.1016/j.tics.2008.03.003; Boyle PA, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-48; Brown SBRE, 2009, COGN AFFECT BEHAV NE, V9, P365, DOI 10.3758/CABN.9.4.365; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P197, DOI 10.1162/089892900561832; Cabeza R, 1997, NEURON, V19, P863, DOI 10.1016/S0896-6273(00)80967-8; Chao LW, 2009, JUDGM DECIS MAK, V4, P1; CHUNG SH, 1967, J EXP ANAL BEHAV, V10, P67, DOI 10.1901/jeab.1967.10-67; Davachi L, 2002, J NEUROPHYSIOL, V88, P982, DOI 10.1152/jn.2002.88.2.982; Deakin J, 2004, J INT NEUROPSYCH SOC, V10, P590, DOI 10.1017/S1355617704104104; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Denburg NL, 2006, INT J PSYCHOPHYSIOL, V61, P19, DOI 10.1016/j.ijpsycho.2005.10.021; Ebner NC, 2010, BEHAV RES METHODS, V42, P351, DOI 10.3758/BRM.42.1.351; Eichenbaum H, 2000, CURR BIOL, V10, pR785, DOI 10.1016/S0960-9822(00)00763-6; Eisenhauer JG, 2006, APPL ECON, V38, P1223, DOI 10.1080/00036840500392391; Eppinger B, 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE.0036953; Fink GR, 1996, J NEUROSCI, V16, P4275; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GREEN L, 1994, PSYCHOL SCI, V5, P33, DOI 10.1111/j.1467-9280.1994.tb00610.x; Green L, 1996, PSYCHOL AGING, V11, P79, DOI 10.1037/0882-7974.11.1.79; Harrison GW, 2002, AM ECON REV, V92, P1606, DOI 10.1257/000282802762024674; Haushofer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078597; Henson RNA, 1999, BRAIN, V122, P1367, DOI 10.1093/brain/122.7.1367; Herlitz A, 2008, CURR DIR PSYCHOL SCI, V17, P52, DOI 10.1111/j.1467-8721.2008.00547.x; Irish M, 2012, BRAIN, V135, P2178, DOI 10.1093/brain/aws119; Jacques PLS, 2011, MEMORY, V19, P723, DOI 10.1080/09658211.2010.516266; Jimura K, 2011, BEHAV PROCESS, V87, P253, DOI 10.1016/j.beproc.2011.04.006; Johnson A, 2007, CURR OPIN NEUROBIOL, V17, P692, DOI 10.1016/j.conb.2008.01.003; Kalenscher T, 2008, PROG NEUROBIOL, V84, P284, DOI 10.1016/j.pneurobio.2007.11.004; Kopelman MD, 1997, NEUROPSYCHOLOGIA, V35, P1533, DOI 10.1016/S0028-3932(97)00076-6; Kramer JH, 1997, NEUROPSYCHOLOGY, V11, P577, DOI 10.1037/0894-4105.11.4.577; Kwan D, 2015, HIPPOCAMPUS, V25, P432, DOI 10.1002/hipo.22431; Kwan D, 2013, J EXP PSYCHOL GEN, V142, P1355, DOI 10.1037/a0034001; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Lebreton M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001684; Levine B, 2002, PSYCHOL AGING, V17, P677, DOI 10.1037//0882-7974.17.4.677; Lin H, 2014, BEHAV NEUROSCI, V128, P12, DOI 10.1037/a0035705; Lockenhoff CE, 2011, PSYCHOL AGING, V26, P274, DOI 10.1037/a0023280; LOGUE AW, 1984, J EXP ANAL BEHAV, V41, P53, DOI 10.1901/jeab.1984.41-53; Lundervold AJ, 2014, SCAND J PSYCHOL, V55, P225, DOI 10.1111/sjop.12114; Maguire EA, 2003, J NEUROSCI, V23, P5302; Maguire EA, 1996, P ROY SOC B-BIOL SCI, V263, P1745, DOI 10.1098/rspb.1996.0255; Maguire EA, 2000, HIPPOCAMPUS, V10, P475; Malkova L, 2003, J NEUROSCI, V23, P1956; Marschner A, 2005, BRAIN RES BULL, V67, P382, DOI 10.1016/j.brainresbull.2005.06.010; MAZUR JE, 1984, J EXP PSYCHOL ANIM B, V10, P426, DOI 10.1037/0097-7403.10.4.426; Mell T, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.034.2009; Mohr PNC, 2010, NEUROSCI BIOBEHAV R, V34, P678, DOI 10.1016/j.neubiorev.2009.05.010; Musch J, 2009, 10 MINUTEN TES UNPUB; Nyberg L, 2012, TRENDS COGN SCI, V16, P292, DOI 10.1016/j.tics.2012.04.005; Oberg C, 2002, J INT NEUROPSYCH SOC, V8, P691, DOI 10.1017/S1355617702801424; Ostapczuk M, 2006, THESIS U BONN GERMAN; Ostapczuk M, 2011, Z ARB ORGAN, V55, P1, DOI 10.1026/0932-4089/a000031; Palombo DJ, 2015, HIPPOCAMPUS, V25, P345, DOI 10.1002/hipo.22376; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; Piefke M, 2005, ANAT EMBRYOL, V210, P497, DOI 10.1007/s00429-005-0038-0; Piefke M, 2005, HUM BRAIN MAPP, V24, P313, DOI 10.1002/hbm.20092; Piolino P, 2002, MEMORY, V10, P239, DOI 10.1080/09658210143000353; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Read D, 2004, ORGAN BEHAV HUM DEC, V94, P22, DOI 10.1016/j.obhdp.2004.01.002; Reimers S, 2009, PERS INDIV DIFFER, V47, P973, DOI 10.1016/j.paid.2009.07.026; Renoult L, 2012, TRENDS COGN SCI, V16, P550, DOI 10.1016/j.tics.2012.09.003; Rick S, 2008, PHILOS T R SOC B, V363, P3813, DOI 10.1098/rstb.2008.0150; Ronnlund M, 2005, PSYCHOL AGING, V20, P3, DOI 10.1037/0882-7974.20.1.3; Rybash JM, 1999, J GEN PSYCHOL, V126, P85, DOI 10.1080/00221309909595353; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Samanez-Larkin GR, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00126; Samanez-Larkin GR, 2010, J NEUROSCI, V30, P1426, DOI 10.1523/JNEUROSCI.4902-09.2010; Schacter DL, 2007, BEHAV BRAIN SCI, V30, P331, DOI 10.1017/S0140525X07002178; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; Schacter DL, 2009, PHILOS T R SOC B, V364, P1245, DOI 10.1098/rstb.2008.0308; Schacter DL, 2007, NATURE, V445, P27, DOI 10.1038/445027a; Schroots JJF, 2004, INT J AGING HUM DEV, V58, P69, DOI 10.2190/7A1A-8HCE-0FD9-7CTX; Seidlitz L, 1998, J PERS SOC PSYCHOL, V74, P262, DOI 10.1037/0022-3514.74.1.262; Sozou PD, 2003, P ROY SOC B-BIOL SCI, V270, P1047, DOI 10.1098/rspb.2003.2344; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Suddendorf T, 2007, BEHAV BRAIN SCI, V30, P299, DOI 10.1017/S0140525X07001975; Suzuki M, 2002, NEUROIMAGE, V17, P1790, DOI 10.1006/nimg.2002.1303; Suzuki WA, 2007, ANN NY ACAD SCI, V1097, P1, DOI 10.1196/annals.1379.007; Tsukiura T, 2002, HUM BRAIN MAPP, V17, P203, DOI 10.1002/hbm.10068; Tulving E, 2001, PHILOS T R SOC B, V356, P1505, DOI 10.1098/rstb.2001.0937; Weiler JA, 2008, LEARN MEMORY, V15, P190, DOI 10.1101/lm.890408; Whelan R, 2009, PSYCHOL REC, V59, P247, DOI 10.1007/BF03395661; Wimmer GE, 2012, SCIENCE, V338, P270, DOI 10.1126/science.1223252; Worthy DA, 2011, PSYCHOL SCI, V22, P1375, DOI 10.1177/0956797611420301; Young KD, 2013, HUM BRAIN MAPP, V34, P3320, DOI 10.1002/hbm.22144	93	7	7	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137061	10.1371/journal.pone.0137061	http://dx.doi.org/10.1371/journal.pone.0137061			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ5AJ	26335426	Green Published, gold			2022-12-26	WOS:000360615400035
J	Shin, SH; Huang, M; Kim, SH; Choi, JY				Shin, Seung-Ho; Huang, Mei; Kim, Sung Huhn; Choi, Jae Young			Differential Protein Expression in Congenital and Acquired Cholesteatomas	PLOS ONE			English	Article							DEVELOPING MIDDLE-EAR; TITIN; ORIGIN; CELLS	Congenital cholesteatomas are epithelial lesions that present as an epithelial pearl behind an intact eardrum. Congenital and acquired cholesteatomas progress quite differently from each other and progress patterns can provide clues about the unique origin and pathogenesis of the abnormality. However, the exact pathogenic mechanisms by which cholesteatomas develop remain unknown. In this study, key proteins that directly affect cholesteatoma pathogenesis are investigated with proteomics and immunohistochemistry. Congenital cholesteatoma matrices and retroauricular skin were harvested during surgery in 4 patients diagnosed with a congenital cholesteatoma. Tissue was also harvested from the retraction pocket in an additional 2 patients during middle ear surgery. We performed 2-dimensional (2D) electrophoresis to detect and analyze spots that are expressed only in congenital cholesteatoma and matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF/MS) to separate proteins by molecular weight. Protein expression was confirmed by immunohistochemical staining. The image analysis of 2D electrophoresis showed that 4 congenital cholesteatoma samples had very similar protein expression patterns and that 127 spots were exclusively expressed in congenital cholesteatomas. Of these 127 spots, 10 major spots revealed the presence of titin, forkhead transcription activator homolog (FKH 5-3), plectin 1, keratin 10, and leucine zipper protein 5 by MALDI-TOF/MS analysis. Immunohistochemical staining showed that FKH 5-3 and titin were expressed in congenital cholesteatoma matrices, but not in acquired cholesteatomas. Our study shows that protein expression patterns are completely different in congenital cholesteatomas, acquired cholesteatomas, and skin. Moreover, non-epithelial proteins, including FKH 5-3 and titin, were unexpectedly expressed in congenital cholesteatoma tissue. Our data indicates that congenital cholesteatoma origins may differ from those of acquired cholesteatomas, which originate from retraction pocket epithelia.	[Shin, Seung-Ho] Ewha Womans Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Shin, Seung-Ho] Yonsei Univ, Dept Med, Grad Sch, Seoul 120749, South Korea; [Huang, Mei] Yonsei Univ, Res Ctr Human Nat Def Syst, Coll Med, Seoul 120749, South Korea; [Kim, Sung Huhn; Choi, Jae Young] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea	Ewha Womans University; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, SH (corresponding author), Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea.	fledermaus@yuhs.ac; jychoi@yuhs.ac	; Shin, Seung Ho/C-5403-2014	choi, jae young/0000-0001-9493-3458; Kim, Sung Huhn/0000-0003-4408-3066; Shin, Seung Ho/0000-0001-8093-2673	National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning [2013M3A9D5072551]; National Research Foundation of Korea(NRF) - Ministry of Education, Science and Technology [R11-2007-040-02001-0]	National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning; National Research Foundation of Korea(NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning (2013M3A9D5072551) and Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education, Science and Technology (grant number) R11-2007-040-02001-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIMI K, 1983, LARYNGOSCOPE, V93, P1140; Akimoto R, 2000, ORL J OTO-RHINO-LARY, V62, P257, DOI 10.1159/000027756; Bennett M, 2006, OTOLARYNG CLIN N AM, V39, P1081, DOI 10.1016/j.otc.2006.08.001; Cho SY, 2005, PROTEOMICS, V5, P3386, DOI 10.1002/pmic.200401310; Choi BK, 2003, PROTEOMICS, V3, P1955, DOI 10.1002/pmic.200300558; FRANKEL S, 1993, LARYNGOSCOPE, V103, P1214; FRIEDBERG J, 1994, LARYNGOSCOPE, V104, P1, DOI 10.1288/00005537-199403001-00001; Friedland DR, 2009, OTOL NEUROTOL, V30, P998, DOI 10.1097/MAO.0b013e3181b4e91f; Granzier HL, 2005, ADV PROTEIN CHEM, V71, P89, DOI 10.1016/S0065-3233(04)71003-7; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; HROMAS R, 1993, BLOOD, V81, P2854; Karmody CS, 1998, AM J OTOL, V19, P292; Kotter S, 2014, BIOL CHEM, V395, P1341, DOI 10.1515/hsz-2014-0178; Kojima H, 2001, LARYNGOSCOPE, V111, P867, DOI 10.1097/00005537-200105000-00021; Liu W, 2014, EUR ARCH OTO-RHINO-L, V271, P265, DOI 10.1007/s00405-013-2403-6; Machado C, 2000, J CELL BIOL, V151, P639, DOI 10.1083/jcb.151.3.639; Machado C, 1998, J CELL BIOL, V141, P321, DOI 10.1083/jcb.141.2.321; Macias JD, 2013, LARYNGOSCOPE, V123, pS1, DOI 10.1002/lary.24176; Maniu A, 2014, ROM J MORPHOL EMBRYO, V55, P7; MICHAELS L, 1986, J OTOLARYNGOL, V15, P169; MICHAELS L, 1988, INT J PEDIATR OTORHI, V15, P51, DOI 10.1016/0165-5876(88)90050-X; Mukherjee S, 2014, MOL PHARMACOL, V86, P318, DOI 10.1124/mol.114.093757; Olszewska E, 2013, OTOL NEUROTOL, V34, P266, DOI 10.1097/MAO.0b013e31827c9d8d; Park HR, 2009, ACTA OTO-LARYNGOL, V129, P268, DOI 10.1080/00016480802251591; RUEDI L, 1959, Acta Otolaryngol, V50, P233, DOI 10.3109/00016485909129191; SADE J, 1983, ACTA OTO-LARYNGOL, V96, P119, DOI 10.3109/00016488309132882; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Teed RW, 1936, ARCHIV OTOLARYNGOL, V24, P455; Tuteja G, 2007, CELL, V130, DOI 10.1016/j.cell.2007.09.005; Zastrow MS, 2006, J CELL SCI, V119, P239, DOI 10.1242/jcs.02728	30	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137011	10.1371/journal.pone.0137011	http://dx.doi.org/10.1371/journal.pone.0137011			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335306	Green Published, gold, Green Submitted			2022-12-26	WOS:000360615400034
J	Yang, J; Farmer, LM; Agyekum, AAA; Elbaz-Younes, I; Hirschi, KD				Yang, Jian; Farmer, Lisa M.; Agyekum, Abia A. A.; Elbaz-Younes, Ismail; Hirschi, Kendal D.			Detection of an Abundant Plant-Based Small RNA in Healthy Consumers	PLOS ONE			English	Article							MICRORNAS; MIRNAS; COMMUNICATION; BACTERIA; DELIVERY; PROTEIN; CANCER; CELLS; PCR	The mechanisms of delivery of plant small RNAs to consumers must be investigated in order to harness this technology to positively impact biotechnology. Two groups have used honeysuckle (Lonicera japonica) feeding regimes to detect a plant-based small RNA, termed MIR2911, in sera. Meanwhile, numerous groups have failed to detect dietary plant-based small RNAs in consumers. Here we catalog levels of MIR2911 in different herbs, and suggest that in particular herb MIR2911 levels are elevated. Feeding these different herb-based diets to mice, we found MIR2911 levels in the sera and urine were associated with dietary intake levels. Abundance was not the sole determinate of apparent RNA bioavailability, as gavage-feeding large-doses of synthetic MIR2911 permitted only small transient increases in serum levels. Dietary MIR2911 were not modified in circulation by association with the host's RNA-induced silencing complex, as the RNA did not co-immunoprecipitate with AGO2. The stability of dietary MIR2911 in circulation differed from synthesized small RNAs, as tail vein administration of various synthetic plant-based small RNAs resulted in rapid clearance. However, synthetic MIR2911 appeared to be more stable than the other plant miRNAs tested. Notably, this uptake of dietary MIR2911 was not related to perturbations in the host's microbiome or gut permeability. We suggest dietary uptake of MIR2911 is commonplace in healthy consumers, and reproducible detection of plant-based small RNAs in consumers depends on dietary abundance, RNA stability and digestion from within the food-matrix.	[Yang, Jian; Farmer, Lisa M.; Agyekum, Abia A. A.; Elbaz-Younes, Ismail; Hirschi, Kendal D.] Baylor Coll Med, Childrens Nutr Res Ctr, USDA ARS, Houston, TX 77030 USA; [Hirschi, Kendal D.] Texas A&M Univ, Vegetable & Fruit Improvement Ctr, College Stn, TX USA	Baylor College of Medicine; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station	Hirschi, KD (corresponding author), Baylor Coll Med, Childrens Nutr Res Ctr, USDA ARS, Houston, TX 77030 USA.	kendalh@bcm.edu	hirschi, kendal/GNP-0351-2022	Elbaz Younes, Ismail/0000-0001-8957-194X	NIH [5T32HD071839-02]; USDA/ARIS [6250-51000-051-00D]; Soy Health Research Program; Dry Bean Health Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD071839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA/ARIS; Soy Health Research Program; Dry Bean Health Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	L.M.F. was supported by a grant from the NIH (5T32HD071839-02). This work was supported by USDA/ARIS 6250-51000-051-00D and funds from the Soy Health and Dry Bean Health Research Programs.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Baier SR, 2014, J NUTR, V144, P1495, DOI 10.3945/jn.114.196436; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beatty M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-933; Brandl K, 2009, P NATL ACAD SCI USA, V106, P3300, DOI 10.1073/pnas.0813036106; Bryniarski K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122991; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079652; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dickinson B, 2013, NAT BIOTECHNOL, V31, P965, DOI 10.1038/nbt.2737; FURNER RL, 1975, LAB ANIM SCI, V25, P648; Ghosal A, 2015, MICROBIOLOGYOPEN, V4, P252, DOI 10.1002/mbo3.235; Heneghan HM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2798; HOLTON TA, 1991, NUCLEIC ACIDS RES, V19, P1156, DOI 10.1093/nar/19.5.1156; Ivashuta SI, 2009, FOOD CHEM TOXICOL, V47, P353, DOI 10.1016/j.fct.2008.11.025; Jain K. K., 2008, Current Drug Delivery, V5, P27, DOI 10.2174/156720108783331023; Liang G, 2014, FOOD SCI NUTR, V2, P8; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lukasik A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099963; Marx JO, 2014, J AM ASSOC LAB ANIM, V53, P301; Mlotshwa S, 2015, CELL RES, V25, P521, DOI 10.1038/cr.2015.25; Mu JY, 2014, MOL NUTR FOOD RES, V58, P1561, DOI 10.1002/mnfr.201300729; Nagy-Szakal D, 2011, GUT MICROBES, V2, P178, DOI 10.4161/gmic.2.3.16107; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Snow JW, 2013, RNA BIOL, V10, P1107, DOI 10.4161/rna.24909; Taylor RS, 2014, TRENDS PLANT SCI, V19, P175, DOI 10.1016/j.tplants.2013.11.008; Turchinovich A., 2013, Frontiers in Genetics, V4, P119, DOI 10.3389/fgene.2013.00119; Ulluwishewa D, 2011, J NUTR, V141, P769, DOI 10.3945/jn.110.135657; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051009; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WATTS RH, 1971, J CLIN PATHOL, V24, P667, DOI 10.1136/jcp.24.7.667; Witwer KW, 2014, J NUTR, V144, P1880, DOI 10.3945/jn.114.202523; Witwer KW, 2014, BIOESSAYS, V36, P394, DOI 10.1002/bies.201300150; Witwer KW, 2013, RNA BIOL, V10, P1080, DOI 10.4161/rna.25246; Yamamoto H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/276186; Yang J, 2015, NUTRIENTS, V7, P3184, DOI 10.3390/nu7053184; Yang J, 2015, CELL RES, V25, P517, DOI 10.1038/cr.2015.26; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhang Y, 2013, J CONTROL RELEASE, V172, P962, DOI 10.1016/j.jconrel.2013.09.015; Zhang Y, 2012, MOL THER, V20, P1298, DOI 10.1038/mt.2012.79; Zhou Z, 2015, CELL RES, V25, P39, DOI 10.1038/cr.2014.130	42	59	61	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137516	10.1371/journal.pone.0137516	http://dx.doi.org/10.1371/journal.pone.0137516			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335106	Green Published, gold, Green Submitted			2022-12-26	WOS:000360615400064
J	Langham, GM; Schuetz, JG; Distler, T; Soykan, CU; Wilsey, C				Langham, Gary M.; Schuetz, Justin G.; Distler, Trisha; Soykan, Candan U.; Wilsey, Chad			Conservation Status of North American Birds in the Face of Future Climate Change	PLOS ONE			English	Article							RANGE SHIFTS; MODELS	Human-induced climate change is increasingly recognized as a fundamental driver of biological processes and patterns. Historic climate change is known to have caused shifts in the geographic ranges of many taxa and future climate change is expected to result in even greater redistributions of species. As a result, predicting the impact of climate change on future patterns of biodiversity will greatly aid conservation planning. Using the North American Breeding Bird Survey and Audubon Christmas Bird Count, two of the most comprehensive continental datasets of vertebrates in the world, and correlative distribution modeling, we assessed geographic range shifts for 588 North American bird species during both the breeding and non-breeding seasons under a range of future emission scenarios (SRES A2, A1B, B2) through the end of the century. Here we show that 314 species (53%) are projected to lose more than half of their current geographic range across three scenarios of climate change through the end of the century. For 126 species, loss occurs without concomitant range expansion; whereas for 188 species, loss is coupled with potential to colonize new replacement range. We found no strong associations between projected climate sensitivities and existing conservation prioritizations. Moreover, species responses were not clearly associated with habitat affinities, migration strategies, or climate change scenarios. Our results demonstrate the need to include climate sensitivity into current conservation planning and to develop adaptive management strategies that accommodate shrinking and shifting geographic ranges. The persistence of many North American birds will depend on their ability to colonize climatically suitable areas outside of current ranges and management actions that target climate adaptation.	[Langham, Gary M.] Natl Audubon Soc, Washington, DC 20036 USA; [Schuetz, Justin G.; Distler, Trisha; Soykan, Candan U.; Wilsey, Chad] Natl Audubon Soc, San Francisco, CA USA		Langham, GM (corresponding author), Natl Audubon Soc, Washington, DC 20036 USA.	climatescience@audubon.org		Wilsey, Chad/0000-0002-1448-1445	U.S. Fish and Wildlife Service [F11AP00380/912001-9700]	U.S. Fish and Wildlife Service(US Fish & Wildlife Service)	This work was supported by the U.S. Fish and Wildlife Service (contract #F11AP00380/912001-9700) to GML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Beidleman CA, 2001, COLORADO PARTNERS FL; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Case MJ, 2015, BIOL CONSERV, V187, P127, DOI 10.1016/j.biocon.2015.04.013; Cerovski AM, 2001, WYOMING BIRD CONSERV; Distler T, 2015, J BIOGEOGR, V42, P976, DOI 10.1111/jbi.12479; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dunn EH, 2005, AUK, V122, P338, DOI 10.1642/0004-8038(2005)122[0338:ETSVOT]2.0.CO;2; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Fink D., 2010, ECOL APPL, V20, P2131, DOI 10.1890/09-1340.1.; Fischlin A., 2007, IMPACTS ADAPTATION V, P211; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Garson G. D., 2012, VARIANCE COMPONENTS; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hijmans R.J., DISMO SPECIES DISTRI; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, GEOGRAPHIC ANAL MODE; IPCC Apndice, 2007, AR4 CLIMATE CHANGE 2; IUCN, 2013, IUCN RED LIST THREAT; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Link WA, 2006, CONDOR, V108, P13, DOI 10.1650/0010-5422(2006)108[0013:AHMFRA]2.0.CO;2; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; McDonald KW, 2012, ECOL EVOL, V2, P3052, DOI 10.1002/ece3.410; McKenney DW, 2006, AGR FOREST METEOROL, V138, P69, DOI 10.1016/j.agrformet.2006.03.012; McKenney DW, 2011, B AM METEOROL SOC, V92, P1611, DOI 10.1175/2011BAMS3132.1; McLachlan JS, 2007, CONSERV BIOL, V21, P297, DOI 10.1111/j.1523-1739.2007.00676.x; Nenzen HK, 2011, ECOL MODEL, V222, P3346, DOI 10.1016/j.ecolmodel.2011.07.011; Oksanen J., **DATA OBJECT**; Panjabi A.O., 2012, PARTNERS FLIGHT TECH, V3; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peterson AT, 2009, EPIDEMICS-NETH, V1, P240, DOI 10.1016/j.epidem.2009.11.003; Peterson AT, 2003, GLOBAL CHANGE BIOL, V9, P647, DOI 10.1046/j.1365-2486.2003.00616.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Ridgeway G., 2010, GBM GEN BOOSTED REGR; ROOT T, 1988, ECOLOGY, V69, P330, DOI 10.2307/1940431; Rowland EL, 2011, ENVIRON MANAGE, V47, P322, DOI 10.1007/s00267-010-9608-x; Sauer JR, 2012, N AM BREEDING BIRD S; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schneider SH, 2002, CLIMATE CHANGE OVERV; Schuetz JG, 2015, ECOL APP IN PRESS; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Small-Lorenz SL, 2013, NAT CLIM CHANGE, V3, P91, DOI 10.1038/nclimate1810; Stralberg D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006825; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; U.S. Fish and Wildlife Service, 2008, BIRDS CONS CONC 2008; Warren R, 2013, NAT CLIM CHANGE, V3, P678, DOI [10.1038/nclimate1887, 10.1038/NCLIMATE1887]; Welsh AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052015; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325	53	74	76	1	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135350	10.1371/journal.pone.0135350	http://dx.doi.org/10.1371/journal.pone.0135350			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26333202	Green Published, gold, Green Submitted			2022-12-26	WOS:000360613800029
J	Bali, V; Lazrak, A; Guroji, P; Fu, LW; Matalon, S; Bebok, Z				Bali, Vedrana; Lazrak, Ahmed; Guroji, Purushotham; Fu, Lianwu; Matalon, Sadis; Bebok, Zsuzsanna			A synonymous codon change alters the drug sensitivity of Delta F508 cystic fibrosis transmembrane conductance regulator	FASEB JOURNAL			English	Article							RETICULUM-ASSOCIATED DEGRADATION; NUCLEOTIDE-BINDING DOMAIN; ENDOPLASMIC-RETICULUM; MESSENGER-RNA; THERMAL-INSTABILITY; MUTANT PROTEIN; CELL-SURFACE; IN-VITRO; CFTR; MUTATIONS	Synonymous mutations, such as I507-ATC -> ATT, in deletion of Phe508 in cystic fibrosis transmembrane conductance regulator (Delta F508 CFTR), the most frequent disease-associated mutant of CFTR, may affect protein biogenesis, structure, and function and contribute to an altered disease phenotype. Small-molecule drugs are being developed to correct Delta F508 CFTR. To understand correction mechanisms and the consequences of synonymous mutations, we analyzed the effect of mechanistically distinct correctors, corrector 4a (C4) and lumacaftor (VX-809), on I507-ATT and I507-ATC Delta F508 CFTR biogenesis and function. C4 stabilized I507-ATT Delta F508 CFTR band B, but without considerable biochemical and functional correction. VX-809 biochemically corrected similar to 10% of both of the variants, leading to stable, forskolin+3isobutyl-1-methylxanthine (IBMX)-activated whole-cell currents in the presence of the corrector. Omitting VX-809 during whole-cell recordings led to a spontaneous decline of the currents, suggesting posttranslational stabilization by VX-809. Treatment of cells with the C4+VX-809 combination resulted in enhanced rescue and 2-fold higher forskolin+IBMX-activated currents of both I507-ATT and I507-ATC Delta F508 CFTR, compared with VX-809 treatment alone. The lack of an effect of C4 on I507-ATC Delta F508 CFTR, but its additive effect in combination with VX-809, implies that C4 acted on VX-809-modified I507-ATC Delta F508 CFTR. Our results suggest that binding of C4 and VX-809 to Delta F508 CFTR is conformation specific and provide evidence that synonymous mutations can alter the drug sensitivity of proteins.-Bali, V., Lazrak, A., Guroji, P., Fu, L., Matalon, S., Bebok, Z. A synonymous codon change alters the drug sensitivity of Delta F508 cystic fibrosis transmembrane conductance regulator. FASEB J. 30, 201-213 (2016). www.fasebj.org	[Bali, Vedrana; Guroji, Purushotham; Fu, Lianwu; Matalon, Sadis; Bebok, Zsuzsanna] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Lazrak, Ahmed; Matalon, Sadis] Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Birmingham, AL 35294 USA; [Lazrak, Ahmed; Matalon, Sadis; Bebok, Zsuzsanna] Univ Alabama Birmingham, Lung Injury & Repair Res Ctr, Birmingham, AL 35294 USA; [Fu, Lianwu; Matalon, Sadis; Bebok, Zsuzsanna] Univ Alabama Birmingham, Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Bebok, Z (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 1918 Univ Blvd,MCLM 350A, Birmingham, AL 35294 USA.	bebok@uab.edu		Lazrak, Ahmed/0000-0002-4127-1937; Fu, Karl/0000-0001-5386-9429; Guroji, Purushotham/0000-0001-9331-5711	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [2R01-HL076587, 2R01HL031197-24A1]; Cystic Fibrosis Foundation [CFF14P0]; CounterACT Program, NIH Office of the Director; NIH National Institute of Neurological Disorders and Stroke [5R21 ES024027 02, 1R21ES025423 01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076587, R01HL031197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES026458, R21ES024027, R21ES025423] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); CounterACT Program, NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Drs. E. Sorscher and J. F. Collawn for helpful discussions and Mrs. N. Brissie for excellent technical support. This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant 2R01-HL076587 (to Z.B.) and Grant 2R01HL031197-24A1 (to S.M.); Cystic Fibrosis Foundation Grant CFF14P0 (to Z.B.); the CounterACT Program, NIH Office of the Director (to S.M.); and NIH National Institute of Neurological Disorders and Stroke Grants 5R21 ES024027 02 and 1R21ES025423 01 (to S.M.). The authors declare no conflicts of interest.	Bali V, 2015, INT J BIOCHEM CELL B, V64, P58, DOI 10.1016/j.biocel.2015.03.011; Bartoszewski R, 2008, AM J RESP CELL MOL, V39, P448, DOI 10.1165/rcmb.2008-0065OC; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Bebok Z, 1998, J BIOL CHEM, V273, P29873, DOI 10.1074/jbc.273.45.29873; Carter PJ, 2011, EXP CELL RES, V317, P1261, DOI 10.1016/j.yexcr.2011.02.013; CHENG SH, 1995, AM J PHYSIOL-LUNG C, V268, pL615, DOI 10.1152/ajplung.1995.268.4.L615; Cholon DM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008680; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Eckford PDW, 2014, CHEM BIOL, V21, P666, DOI 10.1016/j.chembiol.2014.02.021; Elena C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00021; Fu LW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123131; Fung KL, 2014, CANCER RES, V74, P598, DOI 10.1158/0008-5472.CAN-13-2064; Grove DE, 2009, MOL BIOL CELL, V20, P4059, DOI 10.1091/mbc.E08-09-0929; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; He LH, 2013, FASEB J, V27, P536, DOI 10.1096/fj.12-216119; Hunt RC, 2014, TRENDS GENET, V30, P308, DOI 10.1016/j.tig.2014.04.006; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Jia HY, 1999, HYPERTENSION, V34, P8, DOI 10.1161/01.HYP.34.1.8; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; JONES OW, 1966, BIOCHIM BIOPHYS ACTA, V119, P400, DOI 10.1016/0005-2787(66)90198-5; Jurkuvenaite A, 2010, AM J RESP CELL MOL, V42, P363, DOI 10.1165/rcmb.2008-0434OC; Kelly SM, 2007, MOL BIOL CELL, V18, P4279, DOI 10.1091/mbc.E07-05-0487; Kim SJ, 2015, SCIENCE, V348, P444, DOI 10.1126/science.aaa3974; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kimchi-Sarfaty C, 2013, TRENDS PHARMACOL SCI, V34, P534, DOI 10.1016/j.tips.2013.08.005; Kirk KL, 2011, J BIOL CHEM, V286, P12813, DOI 10.1074/jbc.R111.219634; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Kopeikin Z, 2014, J CYST FIBROS, V13, P508, DOI 10.1016/j.jcf.2014.04.003; Lazrak A, 2013, FASEB J, V27, P4630, DOI 10.1096/fj.13-227330; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Lee S, 2014, MOL CELL BIOL, V34, P2554, DOI 10.1128/MCB.01042-13; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Li Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059706; Liu XH, 2014, BIOCHEMISTRY-US, V53, P5613, DOI 10.1021/bi501007v; Liu XH, 2012, BIOCHEMISTRY-US, V51, P5113, DOI 10.1021/bi300018e; Londino JD, 2015, FASEB J, V29, P2712, DOI 10.1096/fj.14-268755; Loo TW, 2008, BIOCHEM J, V413, P29, DOI 10.1042/BJ20071690; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; O'Brien EP, 2014, ACCOUNTS CHEM RES, V47, P1536, DOI 10.1021/ar5000117; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pizzo L, 2015, MUTAT RES-FUND MOL M, V775, P19, DOI 10.1016/j.mrfmmm.2015.03.005; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Ren HY, 2013, MOL BIOL CELL, V24, P3016, DOI 10.1091/mbc.E13-05-0240; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rowe SM, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009761; Sato S, 1998, J BIOL CHEM, V273, P7189, DOI 10.1074/jbc.273.13.7189; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Shah K, 2015, J MOL BIOL, V427, P1464, DOI 10.1016/j.jmb.2015.02.003; Sondo E, 2011, AM J PHYSIOL-CELL PH, V301, pC872, DOI 10.1152/ajpcell.00507.2010; Spiess C, 2015, MOL IMMUNOL, V67, P95, DOI 10.1016/j.molimm.2015.01.003; Sroubek J, 2013, FASEB J, V27, P3039, DOI 10.1096/fj.12-227009; Straley KS, 1998, MOL BIOL CELL, V9, P1683, DOI 10.1091/mbc.9.7.1683; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Varga K, 2004, J BIOL CHEM, V279, P22578, DOI 10.1074/jbc.M401522200; Veit G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008889; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; Wang W, 2011, J BIOL CHEM, V286, P41937, DOI 10.1074/jbc.M111.296061; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WEISBLUM B, 1962, P NATL ACAD SCI USA, V48, P1449, DOI 10.1073/pnas.48.8.1449	72	6	6	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					201	213		10.1096/fj.15-273714	http://dx.doi.org/10.1096/fj.15-273714			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26336913	Green Published			2022-12-26	WOS:000367621000021
J	Levy, DE; Adamkiewicz, G; Rigotti, NA; Fang, SC; Winickoff, JP				Levy, Douglas E.; Adamkiewicz, Gary; Rigotti, Nancy A.; Fang, Shona C.; Winickoff, Jonathan P.			Changes in Tobacco Smoke Exposure following the Institution of a Smoke-Free Policy in the Boston Housing Authority	PLOS ONE			English	Article							SECONDHAND SMOKE; NICOTINE; COTININE; US	Introduction To protect residents from tobacco smoke exposure (TSE), the Boston Housing Authority (BHA) prohibited smoking in BHA-owned apartments beginning in 2012. Our goal was to determine if the smoke-free policy reduced TSE for non-smoking BHA residents. Methods We compared TSE before the smoke-free policy (2012) and one year later among BHA residents as well as residents of the neighboring Cambridge Housing Authority (CHA) where no such policy was in place. Participants were a convenience sample of adult non-smoking BHA and CHA residents cohabitating with only non-smokers. Main outcomes were 7-day airborne nicotine in participants' apartments; residents' saliva cotinine; and residents' self-reported TSE. Results We enrolled 287 confirmed non-smokers (192 BHA, 95 CHA). Seventy-nine percent (229) were assessed at follow-up. At baseline, apartment and resident TSE were high in both housing authorities (detectable airborne nicotine: 46% BHA, 48% CHA; detectable saliva cotinine: 49% BHA, 70% CHA). At follow-up there were significant but similar declines in nicotine in both sites (detectable: -33% BHA, -39% CHA, p = 0.40). Detectable cotinine rose among BHA residents while declining among CHA participants (+17% BHA vs. -13% CHA, p = 0.002). Resident self-reported TSE within and outside of the housing environment decreased similarly for both BHA and CHA residents. Conclusions Apartment air nicotine decreased after the introduction of the smoke-free policy, though the decline may not have resulted from the policy. The BHA policy did not result in reduced individual-level TSE. Unmeasured sources of non-residential TSE may have contributed to BHA residents' cotinine levels.	[Levy, Douglas E.; Rigotti, Nancy A.] Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Boston, MA 02114 USA; [Levy, Douglas E.; Rigotti, Nancy A.; Winickoff, Jonathan P.] Massachusetts Gen Hosp, Tobacco Res & Treatment Ctr, Boston, MA 02114 USA; [Levy, Douglas E.; Rigotti, Nancy A.; Winickoff, Jonathan P.] Harvard Univ, Sch Med, Boston, MA USA; [Adamkiewicz, Gary; Fang, Shona C.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Fang, Shona C.] New England Res Inst, Watertown, MA 02172 USA; [Winickoff, Jonathan P.] Massachusetts Gen Hosp Children, Div Gen Pediat, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; HealthCore, Inc	Levy, DE (corresponding author), Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Boston, MA 02114 USA.	dlevy3@mgh.harvard.edu	Levy, Douglas/W-1516-2019	Levy, Douglas/0000-0001-9446-7899	National Institutes of Health/National Heart, Lung, and Blood Institute [R01-HL112212]; Flight Attendants Medical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112212] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Flight Attendants Medical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: Support was provided by the National Institutes of Health/National Heart, Lung, and Blood Institute R01-HL112212 (www.nhlbi.nih.gov) to DEL, GA, NAR, SCF, and JPW; and by the Flight Attendants Medical Research Institute (www.famri.org) to DEL. Neither funder had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society for Heating Refrigerating and Air- Conditioning Engineers, 2013, ASHRAE POS DOC ENV T; Arku RE, 2015, INDOOR AIR, V25, P13, DOI 10.1111/ina.12121; Benowitz NL, 1996, EPIDEMIOL REV, V18, P188, DOI 10.1093/oxfordjournals.epirev.a017925; Eisner MD, 2001, ENVIRON HEALTH PERSP, V109, P809, DOI 10.2307/3454823; Fargen J., 2010, BOSTON HERALD   0131; HAMMOND SK, 1987, ATMOS ENVIRON, V21, P457, DOI 10.1016/0004-6981(87)90027-8; HAMMOND SK, 1987, ENVIRON SCI TECHNOL, V21, P494, DOI 10.1021/es00159a012; HAMMOND SK, 1995, JAMA-J AM MED ASSOC, V274, P956, DOI 10.1001/jama.274.12.956; Hammond SK, 1999, ENVIRON HEALTH PERSP, V107, P329, DOI 10.2307/3434425; Homa DM, 2015, MMWR-MORBID MORTAL W, V64, P103; Jacob P, 2011, J CHROMATOGR B, V879, P267, DOI 10.1016/j.jchromb.2010.12.012; Kaufmann R. B., 2010, Morbidity and Mortality Weekly Report, V59, P1141; Kraev TA, 2009, TOB CONTROL, V18, P438, DOI 10.1136/tc.2009.029728; Levy D, 2010, COMMUNICATION; Levy DE, 2013, AM J PREV MED, V44, P63, DOI 10.1016/j.amepre.2012.09.048; Matt GE, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.037382; Max W, 2009, INT J ENV RES PUB HE, V6, P1633, DOI 10.3390/ijerph6051633; MIESNER EA, 1989, JAPCA J AIR WASTE MA, V39, P1577, DOI 10.1080/08940630.1989.10466652; National Center for Health in Public Housing, DEM FACTS RES LIV PU; [Office on Smoking and Health U. S. Department of Health and Human Services], 2006, HLTH CONS INV EXP TO; Pion M, 2004, TOB CONTROL, V13, P37, DOI 10.1136/tc.2003.005447; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Russo ET, 2015, NICOTINE TOB RES, V17, P316, DOI 10.1093/ntr/ntu146; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; U. S. Environmental Protection Agency, 2010, BLOOD COT LEV 2010; US Department of Housing and Urban Development, 2009, NONSM POL PUBL HOUS; US Department of Housing and Urban Development, HUDS PUBL HOUS PROGR; US Surgeon General, 2014, HLTH CONS SMOK 50 YE; Wilson KM, 2011, PEDIATRICS, V127, P85, DOI 10.1542/peds.2010-2046	29	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137740	10.1371/journal.pone.0137740	http://dx.doi.org/10.1371/journal.pone.0137740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360258	Green Published, Green Submitted, gold			2022-12-26	WOS:000361043100078
J	Marco, EM; Rapino, C; Caprioli, A; Borsini, F; Laviola, G; Maccarrone, M				Marco, Eva M.; Rapino, Cinzia; Caprioli, Antonio; Borsini, Franco; Laviola, Giovanni; Maccarrone, Mauro			Potential Therapeutic Value of a Novel FAAH Inhibitor for the Treatment of Anxiety	PLOS ONE			English	Article							ACID AMIDE HYDROLASE; ELEVATED PLUS-MAZE; ENDOCANNABINOID SYSTEM; REVERSIBLE INHIBITORS; ANIMAL-MODELS; BEHAVIOR; CANNABINOIDS; STRESS; URB597; ANANDAMIDE	Anxiety disorders are among the most prevalent psychiatric diseases with high personal costs and a remarkable socio-economic burden. However, current treatment of anxiety is far from satisfactory. Novel pharmacological targets have emerged in the recent years, and attention has focused on the endocannabinoid (eCB) system, given the increasing evidence that supports its central role in emotion, coping with stress and anxiety. In the management of anxiety disorders, drug development strategies have left apart the direct activation of type-1 cannabinoid receptors to indirectly enhance eCB signalling through the inhibition of eCB deactivation, that is, the inhibition of the fatty acid amide hydrolase (FAAH) enzyme. In the present study, we provide evidence for the anxiolytic-like properties of a novel, potent and selective reversible inhibitor of FAAH, ST4070, orally administered to rodents. ST4070 (3 to 30 mg/kg per os) administered to CD1 male mice induced an increase of time spent in the exploration of the open arms of the elevated-plus maze. A partial reduction of anxiety-related behaviour by ST4070 was also obtained in Wistar male rats, which moderately intensified the time spent in the illuminated compartment of the light-dark box. ST4070 clearly inhibited FAAH activity and augmented the levels of two of its substrates, N-arachidonoylethanolamine (anandamide) and N-palmitoylethanolamine, in anxiety-relevant brain regions. Altogether, ST4070 offers a promising anxiolytic-like profile in preclinical studies, although further studies are warranted to clearly demonstrate its efficacy in the clinic management of anxiety disorders.	[Marco, Eva M.; Laviola, Giovanni] Ist Super Sanita, Sect Behav Neurosci, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Rapino, Cinzia] Univ Teramo, Dept Biomed Sci, Teramo, Italy; [Caprioli, Antonio; Borsini, Franco] Sigma Tau R&D, Pomezia, Italy; [Maccarrone, Mauro] Campus Biomed Univ Rome, Sch Med, Rome, Italy; [Maccarrone, Mauro] Fdn Santa Lucia, IRCCS, CERC, Rome, Italy	Istituto Superiore di Sanita (ISS); University of Teramo; University Campus Bio-Medico - Rome Italy; IRCCS Santa Lucia	Laviola, G (corresponding author), Ist Super Sanita, Sect Behav Neurosci, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	giovanni.laviola@iss.it; m.maccarrone@unicampus.it	Laviola, Giovanni/K-4392-2016; Laviola, Giovanni/AAA-2391-2022; Maccarrone, Mauro/K-5398-2012; Marco, Eva M./ABH-3257-2020; Marco, Eva M./Q-3870-2019; Lodola, Alessio/H-9078-2013	Laviola, Giovanni/0000-0003-0388-0835; Laviola, Giovanni/0000-0003-0388-0835; Maccarrone, Mauro/0000-0002-3990-2963; Marco, Eva M./0000-0002-2457-475X; Lodola, Alessio/0000-0002-8675-1002	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN)	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This investigation was supported by the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN 2010-2011 grant to MM). EMM was a postdoctoral fellow from the Spanish "Ministerio de Ciencia e Innovacion (MCINN)" - ref. 2008-0489. The authors declare a commercial affiliation with the Drug Company ALFASIGMA (actual name for Sigma-Tau). Further, the authors declare that the funding organization did provide some research material and did play a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. Further, at the time the study was performed, the following authors (Dr. Franco Borsini and Dr. Antonio Caprioli) were employed at the Sigma-Tau (IT).	Ahn K, 2009, EXPERT OPIN DRUG DIS, V4, P763, DOI 10.1517/17460440903018857; Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Batista LA, 2014, BEHAV PHARMACOL, V25, P425, DOI 10.1097/FBP.0000000000000073; Bortolato M, 2007, BIOL PSYCHIAT, V62, P1103, DOI 10.1016/j.biopsych.2006.12.001; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Campos AC, 2013, REV BRAS PSIQUIATR, V35, pS101, DOI 10.1590/1516-4446-2013-1139; Canteras NS, 2010, CURR TOP BEHAV NEURO, V2, P77, DOI 10.1007/7854_2009_7; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Crippa JA, 2009, HUM PSYCHOPHARM CLIN, V24, P515, DOI 10.1002/hup.1048; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Francavilla F, 2009, ENDOCRINOLOGY, V150, P4692, DOI 10.1210/en.2009-0057; Gattinoni S, 2010, BIOORG MED CHEM LETT, V20, P4406, DOI 10.1016/j.bmcl.2010.06.050; Gattinoni S, 2010, CHEMMEDCHEM, V5, P357, DOI 10.1002/cmdc.200900472; Haller J, 2014, PSYCHOPHARMACOLOGY, V231, P593, DOI 10.1007/s00213-013-3273-8; Hansen HS, 2010, EXP NEUROL, V224, P48, DOI 10.1016/j.expneurol.2010.03.022; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Keith JM, 2008, BIOORG MED CHEM LETT, V18, P4838, DOI 10.1016/j.bmcl.2008.07.081; KILFOIL T, 1989, NEUROPHARMACOLOGY, V28, P901, DOI 10.1016/0028-3908(89)90188-3; Kinden R, 2015, BEHAV BRAIN RES, V284, P225, DOI 10.1016/j.bbr.2015.02.025; Kinsey SG, 2011, PHARMACOL BIOCHEM BE, V98, P21, DOI 10.1016/j.pbb.2010.12.002; Kwilasz AJ, 2014, BEHAV PHARMACOL, V25, P119, DOI 10.1097/FBP.0000000000000023; Leung D, 2003, NAT BIOTECHNOL, V21, P687, DOI 10.1038/nbt826; Lichtman AH, 2004, J PHARMACOL EXP THER, V311, P441, DOI 10.1124/jpet.104.069401; Maccarrone M, 2014, NAT REV NEUROSCI, V15, P786, DOI 10.1038/nrn3846; Marco EM, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00063; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; Micale V, 2009, NEUROPSYCHOPHARMACOL, V34, P593, DOI 10.1038/npp.2008.98; Milian MJ, 2015, EUR NEUROPSYCHOPHARM, V25, P599, DOI 10.1016/j.euroneuro.2015.01.016; Moise AM, 2008, PSYCHOPHARMACOLOGY, V200, P333, DOI 10.1007/s00213-008-1209-5; Moreira FA, 2008, ADDICT BIOL, V13, P196, DOI 10.1111/j.1369-1600.2008.00104.x; Moreira FA, 2008, NEUROPHARMACOLOGY, V54, P141, DOI 10.1016/j.neuropharm.2007.07.005; Morgane PJ, 2005, PROG NEUROBIOL, V75, P143, DOI 10.1016/j.pneurobio.2005.01.001; Naidu PS, 2007, PSYCHOPHARMACOLOGY, V192, P61, DOI 10.1007/s00213-006-0689-4; Okamoto Y, 2009, VITAM HORM, V81, P1, DOI 10.1016/S0083-6729(09)81001-7; Patel S, 2006, J PHARMACOL EXP THER, V318, P304, DOI 10.1124/jpet.106.101287; Pertwee RG, 2009, BRIT J PHARMACOL, V156, P397, DOI 10.1111/j.1476-5381.2008.00048.x; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Piomelli D, 2006, CNS DRUG REV, V12, P21, DOI 10.1111/j.1527-3458.2006.00021.x; Rivera P, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00098; Rutkowska M, 2006, PHARMACOL REP, V58, P200; Scherma M, 2008, NEUROPHARMACOLOGY, V54, P129, DOI 10.1016/j.neuropharm.2007.08.011; Simon GM, 2010, MOL BIOSYST, V6, P1411, DOI 10.1039/c000237b; Steimer T, 2003, STRESS, V6, P87, DOI 10.1080/1025389031000111320; Steimer Thierry, 2011, Dialogues Clin Neurosci, V13, P495; Viveros Maria-Paz, 2007, Neural Plasticity, V2007, DOI 10.1155/2007/52908; Viveros MP, 2005, PHARMACOL BIOCHEM BE, V81, P331, DOI 10.1016/j.pbb.2005.01.029; YOUNG R, 1991, PHARMACOL BIOCHEM BE, V40, P739, DOI 10.1016/0091-3057(91)90078-G	51	27	27	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137034	10.1371/journal.pone.0137034	http://dx.doi.org/10.1371/journal.pone.0137034			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360704	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000361043100021
J	Bachert, BA; Choi, SJ; Snyder, AK; Rio, RVM; Durney, BC; Holland, LA; Amemiya, K; Welkos, SL; Bozue, JA; Cote, CK; Berisio, R; Lukomski, S				Bachert, Beth A.; Choi, Soo J.; Snyder, Anna K.; Rio, Rita V. M.; Durney, Brandon C.; Holland, Lisa A.; Amemiya, Kei; Welkos, Susan L.; Bozue, Joel A.; Cote, Christopher K.; Berisio, Rita; Lukomski, Slawomir			A Unique Set of the Burkholderia Collagen-Like Proteins Provides Insight into Pathogenesis, Genome Evolution and Niche Adaptation, and Infection Detection	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; III SECRETION SYSTEM; TIME PCR ASSAY; TRIPLE-HELIX; SURFACE PROTEIN; CELLULAR FIBRONECTIN; MOLECULAR-STRUCTURE; CRYSTAL-STRUCTURE; CAUSATIVE AGENT; SIGNAL PEPTIDES	Burkholderia pseudomallei and Burkholderia mallei, classified as category B priority pathogens, are significant human and animal pathogens that are highly infectious and broad-spectrum antibiotic resistant. Currently, the pathogenicity mechanisms utilized by Burkholderia are not fully understood, and correct diagnosis of B. pseudomallei and B. mallei infection remains a challenge due to limited detection methods. Here, we provide a comprehensive analysis of a set of 13 novel Burkholderia collagen-like proteins (Bucl) that were identified among B. pseudomallei and B. mallei select agents. We infer that several Bucl proteins participate in pathogenesis based on their noncollagenous domains that are associated with the components of a type III secretion apparatus and membrane transport systems. Homology modeling of the outer membrane efflux domain of Bucl8 points to a role in multi-drug resistance. We determined that bucl genes are widespread in B. pseudomallei and B. mallei; Fischer's exact test and Cramer's V-2 values indicate that the majority of bucl genes are highly associated with these pathogenic species versus nonpathogenic B. thai-landensis. We designed a bucl-based quantitative PCR assay which was able to detect B. pseudomallei infection in a mouse with a detection limit of 50 CFU. Finally, chromosomal mapping and phylogenetic analysis of bucl loci revealed considerable genomic plasticity and adaptation of Burkholderia spp. to host and environmental niches. In this study, we identified a large set of phylogenetically unrelated bucl genes commonly found in Burkholderia select agents, encoding predicted pathogenicity factors, detection targets, and vaccine candidates.	[Bachert, Beth A.; Choi, Soo J.; Lukomski, Slawomir] W Virginia Univ, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA; [Snyder, Anna K.; Rio, Rita V. M.] W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA; [Durney, Brandon C.; Holland, Lisa A.] W Virginia Univ, Dept Chem, Morgantown, WV 26506 USA; [Amemiya, Kei; Welkos, Susan L.; Bozue, Joel A.; Cote, Christopher K.] United States Army Med Res Inst Infect Dis, Bacteriol Div, Frederick, MD USA; [Berisio, Rita] CNR, Inst Biostruct & Bioimaging, Naples, Italy	West Virginia University; West Virginia University; West Virginia University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR)	Lukomski, S (corresponding author), W Virginia Univ, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA.	slukomski@hsc.wvu.edu	Bozue, Joel/AAE-4363-2022; Bozue, Joel/AAE-4357-2022	Bozue, Joel/0000-0001-6959-8176; Bozue, Joel/0000-0001-6959-8176	National Science Foundation [EPS-1003907, CHE1212537]; NSF-EPSCoR Graduate Fellowship Program [1003907]	National Science Foundation(National Science Foundation (NSF)); NSF-EPSCoR Graduate Fellowship Program	This work was supported by the National Science Foundation Cooperative Agreement EPS-1003907 (to SL). BAB was supported by the NSF-EPSCoR Graduate Fellowship Program (under Cooperative Agreement 1003907). Amplicon size determination using naonogel separation described in this report is based upon work supported by the National Science Foundation under Grant No. CHE1212537. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; Angus AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083779; Anuntagool N, 2000, J MED MICROBIOL, V49, P1075, DOI 10.1099/0022-1317-49-12-1075; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Beres SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003026; Berisio R, 2002, PROTEIN PEPTIDE LETT, V9, P107, DOI 10.2174/0929866023408922; Berisio R, 2009, J PEPT SCI, V15, P131, DOI 10.1002/psc.1082; Bowers Jolene R, 2010, PLoS One, V5, pe15413, DOI 10.1371/journal.pone.0015413; Boydston JA, 2005, J BACTERIOL, V187, P5310, DOI 10.1128/JB.187.15.5310-5317.2005; Bozue J, 2007, INFECT IMMUN, V75, P4498, DOI 10.1128/IAI.00434-07; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Castanha ER, 2006, J MICROBIOL METH, V64, P27, DOI 10.1016/j.mimet.2005.04.032; Caswell CC, 2007, MOL MICROBIOL, V64, P1319, DOI 10.1111/j.1365-2958.2007.05741.x; Caswell CC, 2010, FEMS MICROBIOL LETT, V303, P61, DOI 10.1111/j.1574-6968.2009.01864.x; Caswell CC, 2008, J BIOL CHEM, V283, P36168, DOI 10.1074/jbc.M806865200; Chan VC, 1997, J BIOL CHEM, V272, P31441, DOI 10.1074/jbc.272.50.31441; Chan YY, 2004, ANTIMICROB AGENTS CH, V48, P1128, DOI 10.1128/AAC.48.4.1128-1135.2004; Choh LC, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00005; Currie BJ, 2015, SEMIN RESP CRIT CARE, V36, P111, DOI 10.1055/s-0034-1398389; De Simone A, 2008, BIOCHEM BIOPH RES CO, V372, P121, DOI 10.1016/j.bbrc.2008.04.190; Doxey AC, 2013, VIRULENCE, V4, P453, DOI 10.4161/viru.25180; Durney BC, 2015, ANAL CHIM ACTA, V880, P136, DOI 10.1016/j.aca.2015.03.009; Durney BC, 2013, ANAL CHEM, V85, P6617, DOI 10.1021/ac303745g; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; French CT, 2011, P NATL ACAD SCI USA, V108, P12095, DOI 10.1073/pnas.1107183108; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Godoy D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003; Han RL, 2006, MOL MICROBIOL, V61, P351, DOI 10.1111/j.1365-2958.2006.05237.x; Han RL, 2006, APPL MICROBIOL BIOT, V72, P109, DOI 10.1007/s00253-006-0387-5; Hoffmaster Alex R, 2015, Emerg Infect Dis, V21, DOI 10.3201/eid2102.141045; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Ikeda Masami, 2002, In Silico Biology, V2, P19; Johnson JM, 1999, J MOL BIOL, V287, P695, DOI 10.1006/jmbi.1999.2630; Karlstrom A, 2004, VET MICROBIOL, V104, P179, DOI 10.1016/j.vetmic.2004.09.014; Karlstrom A, 2005, VET MICROBIOL; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Leski TA, 2009, APPL ENVIRON MICROB, V75, P7163, DOI 10.1128/AEM.01069-09; Losada L, 2010, GENOME BIOL EVOL, V2, P102, DOI 10.1093/gbe/evq003; Lukomski S, 2001, INFECT IMMUN, V69, P1729, DOI 10.1128/IAI.69.3.1729-1738.2001; Lukomski S, 2000, INFECT IMMUN, V68, P6542, DOI 10.1128/IAI.68.12.6542-6553.2000; Luo RJ, 2010, ANAL CHEM, V82, P1228, DOI 10.1021/ac902052m; Meumann EM, 2006, J CLIN MICROBIOL, V44, P3028, DOI 10.1128/JCM.00913-06; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Moore RA, 1999, ANTIMICROB AGENTS CH, V43, P465, DOI 10.1128/AAC.43.3.465; Nielsen H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P122; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101; Novak RT, 2006, J CLIN MICROBIOL, V44, P85, DOI 10.1128/JCM.44.1.85-90.2006; Nylander J.A.A, 2004, MRMODELTEST V2; Okuyama K, 2008, CONNECT TISSUE RES, V49, P299, DOI 10.1080/03008200802325110; Oliver-Kozup H, 2013, MOL MICROBIOL, V87, P672, DOI 10.1111/mmi.12125; Pahlman LI, 2007, J BIOL CHEM, V282, P24873, DOI 10.1074/jbc.M610015200; Paterson GK, 2008, FEMS MICROBIOL LETT, V285, P170, DOI 10.1111/j.1574-6968.2008.01217.x; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Phan G, 2010, STRUCTURE, V18, P507, DOI 10.1016/j.str.2010.01.018; Pizarro-Guajardo M, 2014, ANAEROBE, V25, P18, DOI 10.1016/j.anaerobe.2013.11.003; Price EP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037723; Rainbow L, 2002, J MED MICROBIOL, V51, P374, DOI 10.1099/0022-1317-51-5-374; Rasmussen M, 2000, INFECT IMMUN, V68, P6370, DOI 10.1128/IAI.68.11.6370-6377.2000; Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200; Rasmussen M, 2001, MOL MICROBIOL, V40, P1427, DOI 10.1046/j.1365-2958.2001.02493.x; Reuter M, 2010, J BIOL CHEM, V285, P38473, DOI 10.1074/jbc.M110.143727; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruggiero A, 2009, J MOL BIOL, V385, P153, DOI 10.1016/j.jmb.2008.10.042; Schwarz S, 2014, INFECT IMMUN, V82, P1445, DOI 10.1128/IAI.01368-13; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Stevens MP, 2002, MOL MICROBIOL, V46, P649, DOI 10.1046/j.1365-2958.2002.03190.x; Sun JJ, 2014, BIOCHEM BIOPH RES CO, V453, P254, DOI 10.1016/j.bbrc.2014.05.090; Sylvestre P, 2003, J BACTERIOL, V185, P1555, DOI 10.1128/JB.185.5.1555-1563.2003; Sylvestre P, 2002, MOL MICROBIOL, V45, P169, DOI 10.1046/j.1365-2958.2000.03000.x; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thibault FM, 2004, J ANTIMICROB CHEMOTH, V54, P1134, DOI 10.1093/jac/dkh471; Tuntevski K, 2013, APPL ENVIRON MICROB, V79, P7882, DOI 10.1128/AEM.02835-13; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Van Zandt KE, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-131; Vandamme P, 2011, SYST APPL MICROBIOL, V34, P87, DOI 10.1016/j.syapm.2010.10.002; Vandersmissen L, 2010, FEMS MICROBIOL LETT, V306, P168, DOI 10.1111/j.1574-6968.2010.01951.x; Walsh AL, 1995, CLIN INFECT DIS, V21, P1498, DOI 10.1093/clinids/21.6.1498; Warawa J, 2005, FEMS MICROBIOL LETT, V242, P101, DOI 10.1016/j.femsle.2004.10.045; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Welkos SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124667; Whatmore AM, 2001, MICROBIOL-UK, V147, P419, DOI 10.1099/00221287-147-2-419; Wheelis M, 1998, NATURE, V395, P213, DOI 10.1038/26089; White CM, 2007, ELECTROPHORESIS, V28, P3049, DOI 10.1002/elps.200600816; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wongsuvan G, 2009, SE ASIAN J TROP MED, V40, P781; Xu CY, 2010, BIOMACROMOLECULES, V11, P348, DOI 10.1021/bm900894b; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Yu YT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-46; Yu ZX, 2014, J STRUCT BIOL, V186, P451, DOI 10.1016/j.jsb.2014.01.003	103	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137578	10.1371/journal.pone.0137578	http://dx.doi.org/10.1371/journal.pone.0137578			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356298	Green Published, gold			2022-12-26	WOS:000360965800064
J	Carrillo, M; Migliorati, F; Bruls, R; Han, YY; Heinemans, M; Pruis, I; Gazzola, V; Keysers, C				Carrillo, Maria; Migliorati, Filippo; Bruls, Rune; Han, Yingying; Heinemans, Mirjam; Pruis, Ilanah; Gazzola, Valeria; Keysers, Christian			Repeated Witnessing of Conspecifics in Pain: Effects on Emotional Contagion	PLOS ONE			English	Article							CONDITIONED FEAR; EMPATHY; MICE; RATS; CHIMPANZEES; BEHAVIOR; ANXIETY	Witnessing of conspecifics in pain has been shown to elicit socially triggered freezing in rodents. It is unknown how robust this response is to repeated exposure to a cage-mate experiencing painful stimulation. To address this question, shock-experienced Observer rats repeatedly witnessed familiar Demonstrators receive painful footshocks (six sessions). Results confirm that Observers freeze during the first testing session. The occurrence of this behaviour however gradually diminished as the experimental sessions progressed, reaching minimal freezing levels by the end of the experiments. In contrast, the appearance and continuous increase in the frequency of yawning, a behavior that was inhibited by metyrapone (i. e,. a glucocorticoid synthesis blocker), might represent an alternative coping strategy, suggesting that the observer's reduced freezing does not necessarily indicate a disappearance in the affective response to the Demonstrator's distress.	[Carrillo, Maria; Migliorati, Filippo; Bruls, Rune; Han, Yingying; Heinemans, Mirjam; Pruis, Ilanah; Gazzola, Valeria; Keysers, Christian] Netherlands Inst Neurosci, Amsterdam, Netherlands; [Heinemans, Mirjam; Gazzola, Valeria; Keysers, Christian] Univ Amsterdam, Fac Social & Behav Sci, Amsterdam, Netherlands; [Pruis, Ilanah] Vrije Univ Amsterdam, Earth & Life Sci, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Vrije Universiteit Amsterdam	Carrillo, M (corresponding author), Netherlands Inst Neurosci, Amsterdam, Netherlands.	m.carrillo@nin.knaw.nl; v.gazzola@nin.knaw.nl; c.keysers@nin.knaw.nl	Keysers, Christian/H-6251-2013; Han, Yingying/AAD-3628-2020	Keysers, Christian/0000-0002-2845-5467; Han, Yingying/0000-0002-2894-5626; Gazzola, Valeria/0000-0003-0324-0619; Heinemans, Mirjam/0000-0002-9321-9727	European Research Council [ERC-StG 312511]	European Research Council(European Research Council (ERC)European Commission)	The research was funded by a European Research Council starting grant (ERC-StG 312511) to CK (http://erc.europa.eu/starting-grants).	Anderson JR, 2004, P ROY SOC B-BIOL SCI, V271, pS468, DOI 10.1098/rsbl.2004.0224; ARGIOLAS A, 1987, BRAIN RES, V421, P349, DOI 10.1016/0006-8993(87)91305-9; Atsak P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021855; BAENNINGER R, 1987, J COMP PSYCHOL, V101, P349, DOI 10.1037/0735-7036.101.4.349; Baker KC, 1997, BEHAVIOUR, V134, P1031, DOI 10.1163/156853997X00386; Bruchey AK, 2010, BEHAV BRAIN RES, V214, P80, DOI 10.1016/j.bbr.2010.04.047; Castles DL, 1999, ANIM BEHAV, V58, P1207, DOI 10.1006/anbe.1999.1250; Chen QL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004387; EGUfBAR J, 1984, ACTA NEUROBIOL EXP, V44, P179; Gallup AC, 2011, ETHOLOGY, V117, P145, DOI 10.1111/j.1439-0310.2010.01854.x; Gallup AC, 2010, J COMP PSYCHOL, V124, P133, DOI 10.1037/a0018006; Gonzalez-Liencres C, 2014, BEHAV BRAIN RES, V263, P16, DOI 10.1016/j.bbr.2014.01.020; Guzman YF, 2009, BEHAV BRAIN RES, V201, P173, DOI 10.1016/j.bbr.2009.02.024; Hatfield E., 1994, REV PERSONALITY SOCI; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; Kim S, 2012, P NATL ACAD SCI USA, V109, P15497, DOI 10.1073/pnas.1213903109; Kiyokawa Y, 2014, BEHAV BRAIN RES, V267, P189, DOI 10.1016/j.bbr.2014.03.043; Knapska E, 2010, LEARN MEMORY, V17, P824, DOI 10.1101/lm.1670910; Kubota N, 2014, NEUROSCI LETT, V566, P182, DOI 10.1016/j.neulet.2014.02.064; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Leone A, 2014, SCI REP, P4; Liang AC, 2015, PHYSIOL BEHAV, V140, P38, DOI 10.1016/j.physbeh.2014.11.029; Major CA, 2009, LIFE SCI, V85, P753, DOI 10.1016/j.lfs.2009.10.003; Martin LJ, 2015, CURR BIOL, V25, P326, DOI 10.1016/j.cub.2014.11.028; Miller ML, 2010, ANIM BEHAV, V80, P615, DOI 10.1016/j.anbehav.2010.05.018; Panksepp J, 2013, TRENDS NEUROSCI, V36, P489, DOI 10.1016/j.tins.2013.04.009; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Sanders J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074609; Sauer EF, 1967, AUK, P571; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x	30	18	18	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0136979	10.1371/journal.pone.0136979	http://dx.doi.org/10.1371/journal.pone.0136979			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9WL	26356506	gold, Green Submitted, Green Published			2022-12-26	WOS:000360965800021
J	Hsiou, AS; De Franca, MAG; Ferigolo, J				Hsiou, Annie Schmaltz; Gallo De Franca, Marco Aurelio; Ferigolo, Jorge			New Data on the Clevosaurus (Sphenodontia: Clevosauridae) from the Upper Triassic of Southern Brazil	PLOS ONE			English	Article							GRANDE-DO-SUL; DIAPSIDA LEPIDOSAURIA; CATURRITA FORMATION; 1ST RECORD; RHYNCHOCEPHALIA; THERAPSIDA; PHYLOGENY; REPTILIA; CLASSIFICATION; BIOGEOGRAPHY	The sphenodontian fossil record in South America is well known from Mesozoic and Paleogene deposits of Argentinean Patagonia, mainly represented by opisthodontians, or taxa closely related to the modern Sphenodon. In contrast, the Brazilian fossil record is restricted to the Caturrita Formation, Late Triassic of Rio Grande do Sul, represented by several specimens of Clevosauridae, including Clevosaurus brasiliensis Bonaparte and Sues, 2006. Traditionally, Clevosauridae includes several Late Triassic to Early Jurassic taxa, such as Polysphenodon, Brachyrhinodon, and Clevosaurus, the latter well-represented by several species. The detailed description of the specimen MCN-PV 2852 allowed the first systematic revision of most Clevosaurus species. Within Clevosauridae, Polysphenodon is the most basal taxon, and an IterPCR analysis revealed Brachrhynodon as a possible Clevosaurus; C. petilus, C. wangi, and C. mcgilli as possibly distinct taxonomic entities; and the South African Clevosaurus sp. is not closely related to C. brasiliensis. These data indicate the need of a deep phylogenetic review of Clevosauridae, in order to discover synapomorphic characters among the diversity of these Triassic/Jurassic sphenodontians.	[Hsiou, Annie Schmaltz] Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo, Brazil; [Gallo De Franca, Marco Aurelio] Univ Fed Vale Sao Francisco, Colegiado Ciencias Biol, Petr, PE, Brazil; [Ferigolo, Jorge] Fundacao Zoobot Rio Grande Sul, Secao Paleontol, Museu Ciencias Nat, Porto Alegre, RS, Brazil	Universidade de Sao Paulo; Universidade Federal do Vale do Sao Francisco	Hsiou, AS (corresponding author), Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo, Brazil.	anniehsiou@ffclrp.usp.br	Hsiou, Annie Schmaltz/B-9061-2012; Ferigolo, Jorge/AAV-2684-2021; França, Marco A G/F-3018-2014	Hsiou, Annie Schmaltz/0000-0003-2392-6191; Ferigolo, Jorge/0000-0001-7985-6466; França, Marco A G/0000-0002-9671-1485	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/14080-0, 2011/23834-9]; Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco [APQ-0165-204/14]; Projeto Pro-Guaiba, Sub-projeto Preservacao de Sitos Paleontologicos de Vertebrados da Bacia do Guaiba, RS	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Projeto Pro-Guaiba, Sub-projeto Preservacao de Sitos Paleontologicos de Vertebrados da Bacia do Guaiba, RS	This work was funded by the Brazilian agencies Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grant to ASH, FAPESP Process n. 2011/14080-0; and grant to M.A.G.F. Postdoctoral Fellowship FAPESP Process n. 2011/23834-9), Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (grant to M.A.G.F., FACEPE process APQ-0165-204/14), and Projeto Pro-Guaiba, Sub-projeto Preservacao de Sitos Paleontologicos de Vertebrados da Bacia do Guaiba, RS (grant to J.F.).	Abdala F, 2010, PALAEOGEOGR PALAEOCL, V286, P202, DOI 10.1016/j.palaeo.2010.01.011; Albino Adriana, 2007, P87; Andreis R.R., 1980, 31 C BRAS GEOL SBG B, P659; Apesteguia S, 2005, CR PALEVOL, V4, P663, DOI 10.1016/j.crpv.2005.06.003; Apesteguia S, 2012, CRETACEOUS RES, V34, P154, DOI 10.1016/j.cretres.2011.10.014; Apesteguia S, 2003, NATURE, V425, P609, DOI 10.1038/nature01995; Apesteguia S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0811; Apesteguia S, 2014, J VERTEBR PALEONTOL, V34, P303, DOI 10.1080/02724634.2013.803974; Apesteguia S, 2012, ZOOL J LINN SOC-LOND, V166, P342, DOI 10.1111/j.1096-3642.2012.00837.x; Apesteguia S, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3581[1:ALCSMF]2.0.CO;2; Arantes BA, 2011, THESIS U FEDERAL RIO; Arantes BD, 2009, REV BRAS PALEONTOLOG, V12, P43, DOI 10.4072/rbp.2009.1.04; Barboni R, 2013, AMEGHINIANA, V50, P14, DOI 10.5710/AMGH.28.11.2012.444; BENTON MJ, 1985, ZOOL J LINN SOC-LOND, V84, P97, DOI 10.1111/j.1096-3642.1985.tb01796.x; Bittencourt JS, 2012, ALCHERINGA, V36, P269, DOI 10.1080/03115518.2012.634111; Bonaparte JF, 2001, PALAEONTOLOGY, V44, P623, DOI 10.1111/1475-4983.00194; Bonaparte Jose F., 2005, Revista Brasileira de Paleontologia, V8, P25; Bonaparte JF, 2006, PALAEONTOLOGY, V49, P917, DOI 10.1111/j.1475-4983.2006.00568.x; Bonaparte Jose F., 2003, Revista Brasileira de Paleontologia, V5, P5; Bonaparte JF, 2010, REV BRAS PALEONTOLOG, V13, P233, DOI 10.4072/rbp.2010.3.07; Bonaparte Jose F., 1999, National Science Museum Monographs, V15, P89; Cisneros JC, 2003, NEUES JAHRB GEOL P-A, V227, P365; Conrad JL, 2006, HIST BIOL, V18, P405, DOI 10.1080/08912960600679570; Da Silva RC, 2007, GONDWANA RES, V11, P303, DOI 10.1016/j.gr.2006.05.011; Dias-da-Silva S, 2009, GONDWANA RES, V15, P131, DOI 10.1016/j.gr.2008.07.002; Dumeril AMC, 1839, ERPETOLOGIE GEN HIST, Vviii; EVANS SE, 1983, COPEIA, P845, DOI 10.2307/1444363; Evans SE, 2004, ACTA PALAEONTOL POL, V49, P393; EVANS SE, 1980, ZOOL J LINN SOC-LOND, V70, P203, DOI 10.1111/j.1096-3642.1980.tb00852.x; EVANS SE, 1984, ZOOL J LINN SOC-LOND, V82, P87, DOI 10.1111/j.1096-3642.1984.tb00537.x; EVANS SE, 1981, COPEIA, P883, DOI 10.2307/1444191; Evans SE, 2001, ZOOL J LINN SOC-LOND, V133, P309, DOI 10.1006/zjls.2000.0266; Evans Susan E., 2009, Palaeontologia Polonica, P179; Faccini U., 1989, THESIS U FEDERAL RIO; Ferigolo J., 2006, HIST BIOL, V19, P1, DOI DOI 10.1080/08912960600845767; Ferigolo J, PALEONTOLOGIA RIO GR, P236; Ferigolo J, 1999, B INFORM SOC BRASILE, P60; Ferigolo J, 2009, VERTEBRADOS FOSSEIS, P89, DOI [10.1371/journal.pone.0116716, DOI 10.1371/JOURNAL.PONE.0116716]; Ferigolo J, 1999, 7 INT S MES TERR EC, P24; FRASER NC, 1988, PHILOS T ROY SOC B, V321, P125, DOI 10.1098/rstb.1988.0092; FRASER NC, 1989, ZOOL J LINN SOC-LOND, V96, P413, DOI 10.1111/j.1096-3642.1989.tb02521.x; FRASER NC, 1986, PALAEONTOLOGY, V29, P165; Fraser NC, 1993, NEW MEX MUSEUM NAT H, V3, P135; Gauthier J., 1988, P15; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gonzaga, 1980, ACT 2 C ARG PAL BIOE, V2, P159; Gunther A., 1867, PHILOS T ROYAL SOC L, V157, P595, DOI DOI 10.1098/RSTL.1867.0019; Jones Marc E.H., 2006, P55; Jones MEH, 2008, J MORPHOL, V269, P945, DOI 10.1002/jmor.10634; Jones MEH, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-208; Jones Marc E.H., 2006, Bulletin of the New Mexico Museum of Natural History and Science, V37, P548; Kischlat EE, 2003, J VERTEBR PALEONTOL, V23, P464, DOI 10.1671/0272-4634(2003)023[0464:APFTUT]2.0.CO;2; Langer M. C., 2007, NEW MEXICO MUSEUM NA, V41, P201; Langer MC, 2006, J SYST PALAEONTOL, V4, P309, DOI 10.1017/S1477201906001970; Langer MC, 2010, EARTH ENV SCI T R SO, V101, P301, DOI 10.1017/S175569101102007X; Langer MC, 2012, PALEONTOLOGIA DESTAQ, P47; Leal LA, 2004, ZOOTAXA, P1; Martinelli AG, 2005, AMEGHINIANA, V42, P191; Martinez PRRV, 2013, PALEONTOLOGIA DESTAQ, V66, P67; Martinez PRRV, 2014, THESIS U FEDERAL RIO; Martinez RN, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2057; Pol D, 2009, CLADISTICS, V25, P515, DOI 10.1111/j.1096-0031.2009.00258.x; Rauhut OWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046839; Reynoso V-H, 1996, THESIS MCGILL U MCGI, P297; Reynoso VH, 1998, J VERTEBR PALEONTOL, V18, P333, DOI 10.1080/02724634.1998.10011061; Reynoso VH, 1997, J VERTEBR PALEONTOL, V17, P52, DOI 10.1080/02724634.1997.10010953; Reynoso VH, 1996, J VERTEBR PALEONTOL, V16, P210, DOI 10.1080/02724634.1996.10011309; Reynoso VH, 2000, J PALEONTOL, V74, P133, DOI 10.1666/0022-3360(2000)074<0133:AUASRD>2.0.CO;2; RIEPPEL O, 1992, J HERPETOL, V26, P80, DOI 10.2307/1565028; Robinson P.L., 1973, Journal geol Soc Lond, V129, P457, DOI 10.1144/gsjgs.129.5.0457; Martinez PRRD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119307; RUBERT RR, 2004, PESQUISAS GEOCIENCIA, V31, P71; Saila LK, 2005, PALAEONTOLOGY, V48, P817, DOI 10.1111/j.1475-4983.2005.00486.x; SCHERER C.M.S., 2000, GEOLOGIA RIO GRANDE, P335; Simon Maria Edith, 2003, Boletim do Museu Nacional Nova Serie Geologia, V68, P1; Soares MB, 2011, GEODIVERSITAS, V33, P265, DOI 10.5252/g2011n2a4; SUES HD, 1994, J VERTEBR PALEONTOL, V14, P327, DOI 10.1080/02724634.1994.10011563; SUES HD, 1995, J PALEONTOL, V69, P123, DOI 10.1017/S0022336000026974; Swinton WE, 1939, J NATURAL HIST 11, V4, P37; Whiteside DI, 1986, PHILOS T R SOC B, V312, P597, DOI [10.1098/rstb.1986.0014, DOI 10.1098/RSTB.1986.0014]; Wilkinson M, 1996, PHILOS T ROY SOC B, V351, P1, DOI 10.1098/rstb.1996.0001; WILLISTON S. W., 1925, OSTEOLOGY REPTILES; Wu X-C, 1991, THESIS MCGILL U, P229; WU XC, 1994, IN THE SHADOW OF THE DINOSAURS, P38; Zerfass H, 2003, SEDIMENT GEOL, V161, P85, DOI 10.1016/S0037-0738(02)00397-4	86	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137523	10.1371/journal.pone.0137523	http://dx.doi.org/10.1371/journal.pone.0137523			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355294	Green Published, Green Submitted, gold			2022-12-26	WOS:000360965800055
J	Kim, ED; Han, SJ; Byun, YH; Yoon, SC; Choi, KS; Seong, BL; Seo, KY				Kim, Eun-Do; Han, Soo Jung; Byun, Young-Ho; Yoon, Sang Chul; Choi, Kyoung Sub; Seong, Baik Lin; Seo, Kyoung Yul			Inactivated Eyedrop Influenza Vaccine Adjuvanted with Poly( I:C) Is Safe and Effective for Inducing Protective Systemic and Mucosal Immunity	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; CROSS-PROTECTION; VIRUS INFECTION; MICE; RESPONSES; NANOPARTICLES; PROTEINS; ANTIBODY; HUMANS; ROUTE	The eye route has been evaluated as an efficient vaccine delivery routes. However, in order to induce sufficient antibody production with inactivated vaccine, testing of the safety and efficacy of the use of inactivated antigen plus adjuvant is needed. Here, we assessed various types of adjuvants in eyedrop as an anti-influenza serum and mucosal Ab production-enhancer in BALB/c mice. Among the adjuvants, poly (I:C) showed as much enhancement in antigen-specific serum IgG and mucosal IgA antibody production as cholera toxin (CT) after vaccinations with trivalent hemagglutinin-subunits or split H1N1 vaccine antigen in mice. Vaccination with split H1N1 eyedrop vaccine antigen plus poly(I:C) showed a similar or slightly lower efficacy in inducing antibody production than intranasal vaccination; the eyedrop vaccine-induced immunity was enough to protect mice from lethal homologous influenza A/California/04/09 (H1N1) virus challenge. Additionally, ocular inoculation with poly(I:C) plus vaccine antigen generated no signs of inflammation within 24 hours:no increases in the mRNA expression levels of inflammatory cytokines nor in the infiltration of mononuclear cells to administration sites. In contrast, CT administration induced increased expression of IL-6 cytokine mRNA and mononuclear cell infiltration in the conjunctiva within 24 hours of vaccination. Moreover, inoculated visualizing materials by eyedrop did not contaminate the surface of the olfactory bulb in mice; meanwhile, intranasally administered materials defiled the surface of the brain. On the basis of these findings, we propose that the use of eyedrop inactivated influenza vaccine plus poly(I:C) is a safe and effective mucosal vaccine strategy for inducing protective anti-influenza immunity.	[Kim, Eun-Do; Han, Soo Jung; Yoon, Sang Chul; Seo, Kyoung Yul] Yonsei Univ, Coll Med, Dept Ophthalmol, Eye & Ear Hosp,Severance Hosp,Inst Vis Res, Seoul, South Korea; [Kim, Eun-Do] Yonsei Univ, Brain Korea Project Med Sci 21, Seoul 120749, South Korea; [Byun, Young-Ho; Seong, Baik Lin] Yonsei Univ, Coll Med, Dept Biotechnol, Seoul, South Korea; [Choi, Kyoung Sub] Yonsei Univ, Grad Sch, Seoul 120749, South Korea; [Byun, Young-Ho; Seong, Baik Lin] Yonsei Univ, Vaccine Translat Res Ctr, Seoul 120749, South Korea; [Choi, Kyoung Sub] Ilsan Hosp, Natl Hlth Insurance Corp, Dept Ophthalmol, Gyounggi Do, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; NHIS Ilsan Hospital	Seo, KY (corresponding author), Yonsei Univ, Coll Med, Dept Ophthalmol, Eye & Ear Hosp,Severance Hosp,Inst Vis Res, Seoul, South Korea.	seoky@yuhs.ac	Seo, Kyoung Yul/I-5484-2019	Yoon, Sangchul/0000-0003-0454-9597; Seo, Kyoung Yul/0000-0002-9855-1980	TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea) [A103001]; Vaccine Translational Research Center by Ministry of Health & Welfare, Republic of Korea [HI13Co826]	TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea); Vaccine Translational Research Center by Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea) (Grant No.: A103001) and Vaccine Translational Research Center (Grant No: HI13Co826), in part of Korea Healthcare technology R&D Project by Ministry of Health & Welfare, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Baz M, 2012, CLIN VACCINE IMMUNOL, V19, P209, DOI 10.1128/CVI.05441-11; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Brandtzaeg P, 2004, TRENDS IMMUNOL, V25, P570, DOI 10.1016/j.it.2004.09.005; Cai QY, 2007, INVEST RADIOL, V42, P797, DOI 10.1097/RLI.0b013e31811ecdcd; Caskey M, 2011, J EXP MED, V208, P2357, DOI 10.1084/jem.20111171; CDC, INVL VACC LIV ATT VA; Centers for Disease Control and Prevention (CDC), 2012, INFL VACC LIV INTR 2; Cho HJ, 2010, VACCINE, V28, P2598, DOI 10.1016/j.vaccine.2010.01.013; Choi KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100229; Martins RD, 2012, J CONTROL RELEASE, V162, P553, DOI 10.1016/j.jconrel.2012.07.030; Hafner AM, 2013, ADV DRUG DELIVER REV, V65, P1386, DOI 10.1016/j.addr.2013.05.013; Hikono H, 2013, VET IMMUNOL IMMUNOP, V151, P83, DOI 10.1016/j.vetimm.2012.10.005; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Ichinohe T, 2007, J INFECT DIS, V196, P1313, DOI 10.1086/521304; Jang YH, 2014, VACCINE, V32, P535, DOI 10.1016/j.vaccine.2013.12.002; Jansson B, 2004, THESIS FACULTY PHARM, P305; Kaufman DR, 2008, J IMMUNOL, V181, P4188, DOI 10.4049/jimmunol.181.6.4188; KRISTENSSON K, 1971, ACTA NEUROPATHOL, V19, P145, DOI 10.1007/BF00688493; LIEW FY, 1984, EUR J IMMUNOL, V14, P350, DOI 10.1002/eji.1830140414; Malik B, 2014, INT IMMUNOPHARMACOL, V19, P17, DOI 10.1016/j.intimp.2013.12.023; MESTECKY J, 1987, ADV IMMUNOL, V40, P153, DOI 10.1016/S0065-2776(08)60240-0; Miyaki C, 2010, VACCINE, V28, P2505, DOI 10.1016/j.vaccine.2010.01.044; Mo JS, 2001, EUR J IMMUNOL, V31, P3806, DOI 10.1002/1521-4141(200112)31:12<3806::AID-IMMU3806>3.0.CO;2-M; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Nagatake T, 2009, J EXP MED, V206, P2351, DOI 10.1084/jem.20091436; NISBET AD, 1981, EUR J BIOCHEM, V115, P335, DOI 10.1111/j.1432-1033.1981.tb05243.x; Okada H, 2011, J CLIN ONCOL, V29, P330, DOI 10.1200/JCO.2010.30.7744; Okada K, 2011, ADV OTO-RHINO-LARYNG, V72, P31, DOI 10.1159/000324591; Pedersen GK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026973; Quintilio W, 2009, VACCINE, V27, P4219, DOI 10.1016/j.vaccine.2009.04.047; Rosenfeld MR, 2010, NEURO-ONCOLOGY, V12, P1071, DOI 10.1093/neuonc/noq071; Seo KY, 2010, J IMMUNOL, V185, P3610, DOI 10.4049/jimmunol.1000680; Sircar P, 2013, MUCOSAL IMMUNOL, V6, P93, DOI 10.1038/mi.2012.52; Song JH, 2008, P NATL ACAD SCI USA, V105, P1644, DOI 10.1073/pnas.0708684105; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; Steven P, 2008, INVEST OPHTH VIS SCI, V49, P1512, DOI 10.1167/iovs.07-0809; Tamura S, 2010, JPN J INFECT DIS, V63, P8; UNDERDOWN BJ, 1986, ANNU REV IMMUNOL, V4, P389, DOI 10.1146/annurev.iy.04.040186.002133; van Ginkel FW, 2000, J IMMUNOL, V165, P4778, DOI 10.4049/jimmunol.165.9.4778; Veglia F, 2011, INFECT IMMUN, V79, P1300, DOI 10.1128/IAI.01181-10	42	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137608	10.1371/journal.pone.0137608	http://dx.doi.org/10.1371/journal.pone.0137608			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355295	gold, Green Published, Green Submitted			2022-12-26	WOS:000360965800070
J	Naticchioni, M; Karani, R; Smith, MA; Onusko, E; Robbins, N; Jiang, M; Radzyukevich, T; Fulford, L; Gao, X; Apel, R; Heiny, J; Rubinstein, J; Koch, SE				Naticchioni, Mindi; Karani, Rajiv; Smith, Margaret A.; Onusko, Evan; Robbins, Nathan; Jiang, Min; Radzyukevich, Tatiana; Fulford, Logan; Gao, Xu; Apel, Ryan; Heiny, Judith; Rubinstein, Jack; Koch, Sheryl E.			Transient Receptor Potential Vanilloid 2 Regulates Myocardial Response to Exercise	PLOS ONE			English	Article							SKELETAL-MUSCLE; CARDIAC-HYPERTROPHY; TRPV2; MOUSE; MICE; PHOSPHORYLATION; PERFORMANCE; CHANNELS	The myocardial response to exercise is an adaptive mechanism that permits the heart to maintain cardiac output via improved cardiac function and development of hypertrophy. There are many overlapping mechanisms via which this occurs with calcium handling being a crucial component of this process. Our laboratory has previously found that the stretch sensitive TRPV2 channels are active regulators of calcium handling and cardiac function under baseline conditions based on our observations that TRPV2-KO mice have impaired cardiac function at baseline. The focus of this study was to determine the cardiac function of TRPV2-KO mice under exercise conditions. We measured skeletal muscle at baseline in WT and TRPV2-KO mice and subjected them to various exercise protocols and measured the cardiac response using echocardiography and molecular markers. Our results demonstrate that the TRPV2-KO mouse did not tolerate forced exercise although they became increasingly exercise tolerant with voluntary exercise. This occurs as the cardiac function deteriorates further with exercise. Thus, our conclusion is that TRPV2-KO mice have impaired cardiac functional response to exercise.	[Naticchioni, Mindi; Karani, Rajiv; Smith, Margaret A.; Onusko, Evan; Robbins, Nathan; Jiang, Min; Fulford, Logan; Gao, Xu; Apel, Ryan; Rubinstein, Jack; Koch, Sheryl E.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Cardiovasc Hlth & Dis, Cincinnati, OH 45220 USA; [Radzyukevich, Tatiana; Heiny, Judith] Univ Cincinnati, Coll Med, Dept Mol & Cellular Physiol, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Koch, SE (corresponding author), Univ Cincinnati, Coll Med, Dept Internal Med, Div Cardiovasc Hlth & Dis, Cincinnati, OH 45220 USA.	sheryl.koch@uc.edu		Robbins, Nathan/0000-0002-9275-0778; Rubinstein, Jack/0000-0002-8811-1551	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [RO1 AM063710]; American Heart Association [13BGIA17140069]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063710] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number RO1 AM063710 (JH) and the American Heart Association (Beginning Grant in Aid 13BGIA17140069 to JR). The funders have no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allen DL, 2001, J APPL PHYSIOL, V90, P1900, DOI 10.1152/jappl.2001.90.5.1900; Barro-Soria R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049624; Bolte C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022217; BROOKS SV, 1995, J PHYSIOL-LONDON, V488, P459, DOI 10.1113/jphysiol.1995.sp020980; Buitrago M, 2005, NAT MED, V11, P837, DOI 10.1038/nm1272; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Dorn GW, 2007, HYPERTENSION, V49, P962, DOI 10.1161/HYPERTENSIONAHA.106.079426; GROSSMAN W, 1975, J CLIN INVEST, V56, P56, DOI 10.1172/JCI108079; Huke S, 2008, BIOCHEM BIOPH RES CO, V376, P80, DOI 10.1016/j.bbrc.2008.08.084; Iwata Y, 2013, CARDIOVASC RES, V99, P760, DOI 10.1093/cvr/cvt163; Iwata Y, 2009, HUM MOL GENET, V18, P824, DOI 10.1093/hmg/ddn408; Katanosaka Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4932; Koch SE, 2012, J MOL CELL CARDIOL, V53, P134, DOI 10.1016/j.yjmcc.2012.04.011; Lerman I, 2002, J APPL PHYSIOL, V92, P2245, DOI 10.1152/japplphysiol.01045.2001; Maillet M, 2013, NAT REV MOL CELL BIO, V14, P38, DOI 10.1038/nrm3495; Maron BJ, 2006, CIRCULATION, V114, P1633, DOI 10.1161/CIRCULATIONAHA.106.613562; Mattiazzi A, 2005, CARDIOVASC RES, V68, P366, DOI 10.1016/j.cardiores.2005.08.010; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; National Research Council, 2011, GUIDE CARE USE LAB A; Park U, 2011, J NEUROSCI, V31, P11425, DOI 10.1523/JNEUROSCI.1384-09.2011; Radzyukevich TL, 2009, P NATL ACAD SCI USA, V106, P2565, DOI 10.1073/pnas.0804150106; Radzyukevich TL, 2013, J BIOL CHEM, V288, P1226, DOI 10.1074/jbc.M112.424663; Rubinstein J, 2014, AM J PHYSIOL-HEART C, V306, pH574, DOI 10.1152/ajpheart.00854.2013; Seth M, 2009, CIRC RES, V105, P1023, DOI 10.1161/CIRCRESAHA.109.206581; Weiner RB, 2014, EXPERT REV CARDIOVAS, V12, P1243, DOI 10.1586/14779072.2014.970178; Zanou N, 2010, AM J PHYSIOL-CELL PH, V298, pC149, DOI 10.1152/ajpcell.00241.2009; Zanou N, 2009, FEBS LETT, V583, P3600, DOI 10.1016/j.febslet.2009.10.033	28	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0136901	10.1371/journal.pone.0136901	http://dx.doi.org/10.1371/journal.pone.0136901			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356305	gold, Green Published, Green Submitted			2022-12-26	WOS:000360965800019
J	Toyama, T; Furuichi, K; Shimizu, M; Hara, A; Iwata, Y; Sakai, N; Perkovic, V; Kobayashi, M; Mano, T; Kaneko, S; Wada, T				Toyama, Tadashi; Furuichi, Kengo; Shimizu, Miho; Hara, Akinori; Iwata, Yasunori; Sakai, Norihiko; Perkovic, Vlado; Kobayashi, Makoto; Mano, Toshiki; Kaneko, Shuichi; Wada, Takashi			Relationship between Serum Uric Acid Levels and Chronic Kidney Disease in a Japanese Cohort with Normal or Mildly Reduced Kidney Function	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CARDIOVASCULAR MORTALITY; GENERAL-POPULATION; BLOOD-PRESSURE; RENAL-DISEASE; ALLOPURINOL; ASSOCIATION; PROTEINURIA; PROGRESSION; CREATININE	Background Some observational studies have shown the relationships between hyperuricemia and chronic kidney disease (CKD); however, the threshold of serum uric acid (SUA) for deterioration of kidney function and the association between SUA and kidney injury by baseline kidney function remains unclear. This study aimed to clarify the relationships between SUA and reduced kidney function. Methods We analyzed a historical cohort of male Japanese individuals who underwent medical checkup between 1998 and 2007. Participants with baseline data and who were followed up for at least one year were included and stratified according to baseline kidney function. Kidney function was classified as normal [estimated glomerular filtration rate (eGFR) >= 90 ml/min/1.73 m(2)] or mildly reduced (eGFR 60-89 ml/min/1.73 m(2)). The outcome measured was kidney impairment defined as a decrease in eGFR to < 60 ml/min/1.73 m(2). Associations between SUA and risk for outcome and eGFR slopes were assessed. Results A total of 41632 subjects with mean age 45.4 years were included. During a mean follow-up of four years, 3186 (7.6%) subjects developed kidney dysfunction. Subjects with SUA >= 6.0 mg/dL had a significantly increased risk for kidney impairment compared with subjects with SUA of 4-4.9 mg/dL. SUA threshold levels were different according to baseline kidney function; SUA >= 7.0 and >= 6.0 mg/dL for normal and mildly reduced kidney function, respectively. Approximately the same trends were observed for eGFR slopes. Conclusion In the general population, hyperuricemia appears to be a risk factor for kidney impairment in males. For participants with mild kidney dysfunction, even a slight elevation of SUA can be a risk factor.	[Toyama, Tadashi; Furuichi, Kengo; Shimizu, Miho; Hara, Akinori; Iwata, Yasunori; Sakai, Norihiko; Wada, Takashi] Kanazawa Univ Hosp, Div Nephrol, Kanazawa, Ishikawa, Japan; [Toyama, Tadashi; Perkovic, Vlado] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Kobayashi, Makoto; Mano, Toshiki] Tama Grad Sch Management & Informat Sci, Tokyo, Japan; [Kobayashi, Makoto] CRECON Res & Consulting Inc, Tokyo, Japan; [Kaneko, Shuichi] Kanazawa Univ, Dept Dis Control & Homeostasis, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan; [Wada, Takashi] Kanazawa Univ, Dept Lab Med, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan	Kanazawa University; George Institute for Global Health; University of Sydney; Kanazawa University; Kanazawa University	Wada, T (corresponding author), Kanazawa Univ Hosp, Div Nephrol, Kanazawa, Ishikawa, Japan.	twada@m-kanazawa.jp	Perkovic, Vlado/AAY-1933-2021; Hara, Akinori/W-8522-2019		Ministry of Health, Labour and Welfare of Japan; JSPS [26870218]; Grants-in-Aid for Scientific Research [15K09251] Funding Source: KAKEN	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a Grant-in-Aid for Diabetic Nephropathy Research, a Grant-in-Aid for Diabetic Nephropathy and Nephrosclerosis Research, and a Grant-in-Aid for Progressive Renal Diseases Research, from the Ministry of Health, Labour and Welfare of Japan. This work was also supported by JSPS KAKENHI Grant Number 26870218. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrassy KM, 2013, KIDNEY INT, V84, P622, DOI 10.1038/ki.2013.243; Bose B, 2014, NEPHROL DIAL TRANSPL, V29, P406, DOI 10.1093/ndt/gft378; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Fang YF, 2014, KIDNEY INT, V85, P142, DOI 10.1038/ki.2013.271; Ficociello LH, 2010, DIABETES CARE, V33, P1337, DOI 10.2337/dc10-0227; Hunsicker LG, 1997, KIDNEY INT, V51, P1908, DOI 10.1038/ki.1997.260; Imai E, 2008, HYPERTENS RES, V31, P433, DOI 10.1291/hypres.31.433; Irie F, 2006, KIDNEY INT, V69, P1264, DOI 10.1038/sj.ki.5000284; Ishikawa I, 1990, Nihon Jinzo Gakkai Shi, V32, P923; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Kanbay M, 2007, INT UROL NEPHROL, V39, P1227, DOI 10.1007/s11255-007-9253-3; Kanda E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118031; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Kohagura K, 2013, HYPERTENS RES, V36, P43, DOI 10.1038/hr.2012.135; Kokubo Y, 2009, STROKE, V40, P2674, DOI 10.1161/STROKEAHA.109.550707; Levey AS, 1991, ASSESSING PROGRESSIO, P9; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Ministry of Health, 1982, NAT NUTR SURV JAP; Mohandas R, 2015, AM HEART J, V169, P412, DOI 10.1016/j.ahj.2014.12.010; Obermayr RP, 2008, J AM SOC NEPHROL, V19, P2407, DOI 10.1681/ASN.2008010080; Ohta T, 2004, NEPHROL DIAL TRANSPL, V19, P1447, DOI 10.1093/ndt/gfh094; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Siu YP, 2006, AM J KIDNEY DIS, V47, P51, DOI 10.1053/j.ajkd.2005.10.006; Wen CP, 2010, AM J KIDNEY DIS, V56, P273, DOI 10.1053/j.ajkd.2010.01.024	26	20	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137449	10.1371/journal.pone.0137449	http://dx.doi.org/10.1371/journal.pone.0137449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356235	Green Published, Green Submitted, gold			2022-12-26	WOS:000360965800048
J	Johler, SM; Rejman, J; Guan, S; Rosenecker, J				Johler, Sarah M.; Rejman, Joanna; Guan, Shan; Rosenecker, Joseph			Nebulisation of IVT mRNA Complexes for Intrapulmonary Administration	PLOS ONE			English	Article							GENE DELIVERY; AEROSOL DELIVERY; PULMONARY DELIVERY; PHYSICAL STABILITY; CYSTIC-FIBROSIS; PSEUDOURIDINE; EXPRESSION; EFFICIENCY; CAPACITY; THERAPY	During the last years the potential role of in vitro transcribed (IVT) mRNA as a vehicle to deliver genetic information has come into focus. IVT mRNA could be used for anti-cancer therapies, vaccination purposes, generation of pluripotent stem cells and also for genome engineering or protein replacement. However, the administration of IVT mRNA into the target organ is still challenging. The lung with its large surface area is not only of interest for delivery of genetic information for treatment of e.g. for cystic fibrosis or alpha-1-antitrypsin deficiency, but also for vaccination purposes. Administration of IVT mRNA to the lung can be performed by direct intratracheal instillation or by aerosol inhalation/nebulisation. The latter approach shows a non-invasive tool, although it is not known, if IVT mRNA is resistant during the process of nebulisation. Therefore, we investigated the transfection efficiency of non-nebulised and nebulised IVT mRNA polyplexes and lipoplexes in human bronchial epithelial cells (16HBE). A slight reduction in transfection efficiency was observed for lipoplexes (Lipofectamine 2000) in the nebulised part compared to the non-nebulised which can be overcome by increasing the amount of Lipofectamine. However, Lipofectamine was more than three times more efficient in transfecting 16HBE than DMRIE and linear PEI performed almost 10 times better than its branched derivative. By contrast, the nebulisation process did not affect the cationic polymer complexes. Furthermore, aerosolisation of IVT mRNA complexes did neither affect the protein duration nor the toxicity of the cationic complexes. Taken together, these data show that aerosolisation of cationic IVT mRNA complexes constitute a potentially powerful means to transfect cells in the lung with the purpose of protein replacement for genetic diseases such as cystic fibrosis or alpha-1-antitrypsin deficiency or for infectious disease vaccines, while bringing along the advantages of IVT mRNA as compared to pDNA as transfection agent.	[Johler, Sarah M.; Rejman, Joanna; Guan, Shan; Rosenecker, Joseph] Klinikum Univ Munchen, Dr von Haunerschen Kinderspital, Kinderklin & Kinderpoliklin, Munich, Germany	University of Munich	Rejman, J (corresponding author), Klinikum Univ Munchen, Dr von Haunerschen Kinderspital, Kinderklin & Kinderpoliklin, Munich, Germany.	Joanna.Rejman@med.uni-muenchen.de; Joseph.rosenecker@med.uni-muenchen.de	Rosenecker, Joseph/AAA-7330-2020		Bundesministerium fur Bildung und Forschung [01GM1106A]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the Bundesministerium fur Bildung und Forschung, 01GM1106A.	Anderson BR, 2010, NUCLEIC ACIDS RES, V38, P5884, DOI 10.1093/nar/gkq347; Arulmuthu ER, 2007, BIOTECHNOL BIOENG, V98, P939, DOI 10.1002/bit.21493; Birchall J, 2007, EXPERT OPIN DRUG DEL, V4, P575, DOI 10.1517/17425247.4.6.575; Birchall JC, 2000, INT J PHARM, V197, P221, DOI 10.1016/S0378-5173(00)00339-2; Catanese DJ, 2012, GENE THER, V19, P94, DOI 10.1038/gt.2011.77; Davies LA, 2008, MOL THER, V16, P1283, DOI 10.1038/mt.2008.96; Davies LA, 2014, HUM GENE THER CL DEV, V25, P97, DOI 10.1089/humc.2014.019; Holtkamp S, 2006, BLOOD, V108, P4009, DOI 10.1182/blood-2006-04-015024; Huth S, 2006, J GENE MED, V8, P1416, DOI 10.1002/jgm.975; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Kariko K, 2007, CURR OPIN DRUG DISC, V10, P523; Lentz YK, 2006, J PHARM SCI-US, V95, P607, DOI 10.1002/jps.20511; Pardi Norbert, 2013, Methods Mol Biol, V969, P29, DOI 10.1007/978-1-62703-260-5_2; Pastor M, 2014, INT J PHARMACEUT, V477, P485, DOI 10.1016/j.ijpharm.2014.10.048; Rajapaksa AE, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-60; Rejman J, 2010, J CONTROL RELEASE, V147, P385, DOI 10.1016/j.jconrel.2010.07.124; Rudolph C, 2005, MOL THER, V12, P493, DOI 10.1016/j.ymthe.2005.03.002; Rudolph C, 2005, J GENE MED, V7, P59, DOI 10.1002/jgm.646; Rudolph C, 2002, J GENE MED, V4, P66, DOI 10.1002/jgm.225; Sahin U, 2014, NAT REV DRUG DISCOV, V13, P759, DOI 10.1038/nrd4278; Tavernier G, 2011, J CONTROL RELEASE, V150, P238, DOI 10.1016/j.jconrel.2010.10.020; Yamamoto A, 2009, EUR J PHARM BIOPHARM, V71, P484, DOI 10.1016/j.ejpb.2008.09.016	23	26	26	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137504	10.1371/journal.pone.0137504	http://dx.doi.org/10.1371/journal.pone.0137504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352268	Green Published, Green Submitted, gold			2022-12-26	WOS:000360932800091
J	Kreuzinger-Janik, B; Schroeder, F; Majdi, N; Traunspurger, W				Kreuzinger-Janik, Bianca; Schroeder, Fabian; Majdi, Nabil; Traunspurger, Walter			Depth-Related Effects on a Meiofaunal Community Dwelling in the Periphyton of a Mesotrophic Lake	PLOS ONE			English	Article							EPILITHIC PERIPHYTON; BIOMASS; NEMATODES; PATTERNS; RIVER; BIOFILMS; ECOLOGY; LIGHT; HYDRODYNAMICS; ASSEMBLAGES	Periphyton is a complex assemblage of micro- and meiofauna embedded in the organic matrix that coats most submerged substrate in the littoral of lakes. The aim of this study was to better understand the consequences of depth-level fluctuation on a periphytic community. The effects of light and wave disturbance on the development of littoral periphyton were evaluated in Lake Erken (Sweden) using an experimental design that combined in situ shading with periphyton depth transfers. Free-living nematodes were a major contributor to the meiofaunal community. Their species composition was therefore used as a proxy to distinguish the contributions of light-and wave-related effects. The periphyton layer was much thicker at a depth of 30 cm than at 200 cm, as indicated by differences in the amounts of organic and phototrophic biomass and meiofaunal and nematode densities. A reduction of the depth-level of periphyton via a transfer from a deep to a shallow location induced rapid positive responses by its algal, meiofaunal, and nematode communities. The slower and weaker negative responses to the reverse transfer were attributed to the potentially higher resilience of periphytic communities to increases in the water level. In the shallow littoral of the lake, shading magnified the effects of phototrophic biomass erosion by waves, as the increased exposure to wave shear stress was not compensated for by an increase in photosynthesis. This finding suggests that benthic primary production will be strongly impeded in the shallow littoral zones of lakes artificially shaded by construction or embankments. However, regardless of the light constraints, an increased exposure to wave action had a generally positive short-term effect on meiofaunal density, by favoring the predominance of species able to anchor themselves to the substrate, especially the Chromadorid nematode Punctodora ratzeburgensis.	[Kreuzinger-Janik, Bianca; Schroeder, Fabian; Majdi, Nabil; Traunspurger, Walter] Univ Bielefeld, Anim Ecol, D-33615 Bielefeld, Germany	University of Bielefeld	Kreuzinger-Janik, B (corresponding author), Univ Bielefeld, Anim Ecol, Konsequenz 45, D-33615 Bielefeld, Germany.	bianca.kreuzinger@gmx.de	Majdi, Nabil/J-8578-2016	Majdi, Nabil/0000-0001-7052-4297	Deutsche Forschungsgemeinschaft; Open Access Publication Fund of Bielefeld University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of Bielefeld University	Funding: The authors acknowledge support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of Bielefeld University.	Ask J, 2009, ECOLOGY, V90, P1923, DOI 10.1890/07-1855.1; Axler RP, 1996, LIMNOL OCEANOGR, V41, P659, DOI 10.4319/lo.1996.41.4.0659; Azim M. E., 2005, Periphyton: ecology, exploitation and management, P15, DOI 10.1079/9780851990965.0015; BARTON DR, 1982, CAN J ZOOL, V60, P984, DOI 10.1139/z82-137; Beier S, 2003, HYDROBIOLOGIA, V498, P107, DOI 10.1023/A:1026258607551; Bouletreau S, 2006, FRESHWATER BIOL, V51, P901, DOI 10.1111/j.1365-2427.2006.01541.x; Bourassa N, 2000, FRESHWATER BIOL, V44, P629, DOI 10.1046/j.1365-2427.2000.00610.x; CATTANEO A, 1990, HYDROBIOLOGIA, V206, P1, DOI 10.1007/BF00018964; CROLL NA, 1972, J NEMATOL, V4, P256; Eisendle-Flockner U, 2013, ECOL EVOL, V3, P2832, DOI 10.1002/ece3.679; Eriksson PG, 2001, BIOGEOCHEMISTRY, V55, P29, DOI 10.1023/A:1010679306361; Estifanos TK, 2013, NEMATOLOGY, V15, P1, DOI 10.1163/156854112X639900; EVANS WA, 1984, HYDROBIOLOGIA, V108, P105, DOI 10.1007/BF00014869; Gaudes A, 2006, NEMATOLOGY, V8, P909, DOI 10.1163/156854106779799169; Giere O., 1993, MEIOBENTHOLOGY; Graba M, 2014, FRESHWATER BIOL, V59, P1213, DOI 10.1111/fwb.12341; HAGERMAN G M JR, 1981, Marine Ecology, V2, P245, DOI 10.1111/j.1439-0485.1981.tb00099.x; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Harrison SSC, 1998, FRESHWATER BIOL, V39, P477, DOI 10.1046/j.1365-2427.1998.00296.x; Hill Walter, 1996, P121, DOI 10.1016/B978-012668450-6/50034-5; Hillebrand H, 2001, LIMNOL OCEANOGR, V46, P1881, DOI 10.4319/lo.2001.46.8.1881; Hillebrand H, 2005, J ECOL, V93, P758, DOI 10.1111/j.1365-2745.2005.00978.x; Hillebrand H, 2002, ECOLOGY, V83, P2205, DOI 10.1890/0012-9658(2002)083[2205:COMCBG]2.0.CO;2; Hillebrand H, 2002, J N AM BENTHOL SOC, V21, P349, DOI 10.2307/1468475; HOAGLAND KD, 1990, J PHYCOL, V26, P450, DOI 10.1111/j.0022-3646.1990.00450.x; Hoagland KD, 1986, ALGAL BIOFOULING; JENSEN P, 1982, NEMATOLOGICA, V28, P71, DOI 10.1163/187529282X00529; JONSSON GS, 1987, ARCH HYDROBIOL, V108, P531; Kairesalo T., 1983, PERIPHITON FRESHWATE, V17, P153; Kazemi-Dinan A, 2014, LIMNOLOGICA, V44, P49, DOI 10.1016/j.limno.2013.05.011; Larned ST, 2010, J N AM BENTHOL SOC, V29, P182, DOI 10.1899/08-063.1; Liu Y, 2015, HYDROBIOLOGIA, V744, P165, DOI 10.1007/s10750-014-2074-3; Majdi N, 2015, J NEMATOLOGY, V47; Majdi N, 2012, FRESHWATER BIOL, V57, P1180, DOI 10.1111/j.1365-2427.2012.02784.x; Majdi N, 2012, FRESHW SCI, V31, P38, DOI 10.1899/11-073.1; Majdi N, 2012, HYDROBIOLOGIA, V680, P219, DOI 10.1007/s10750-011-0920-0; Majdi N, 2011, HYDROBIOLOGIA, V673, P229, DOI 10.1007/s10750-011-0781-6; Mialet B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075352; Moens T, 1997, J MAR BIOL ASSOC UK, V77, P211, DOI 10.1017/S0025315400033889; Peters L, 2005, NEMATOLOGY, V7, P267, DOI 10.1163/1568541054879520; Peters L, 2007, J N AM BENTHOL SOC, V26, P232, DOI 10.1899/0887-3593(2007)26[232:ECIALL]2.0.CO;2; Peters L, 2012, AQUAT ECOL, V46, P371, DOI 10.1007/s10452-012-9408-x; Peters L, 2012, AQUAT SCI, V74, P229, DOI 10.1007/s00027-011-0214-7; REUTER JE, 1986, LIMNOL OCEANOGR, V31, P149, DOI 10.4319/lo.1986.31.1.0149; Ricci C, 2000, FRESHWATER BIOL, V44, P15, DOI 10.1046/j.1365-2427.2000.00584.x; Schroeder F, 2013, INT REV HYDROBIOL, V98, P322, DOI 10.1002/iroh.201301652; Schroeder F, 2012, FUND APPL LIMNOL, V181, P143, DOI 10.1127/1863-9135/2012/0332; Schroeder F, 2012, J LIMNOL, V71, P216, DOI 10.4081/jlimnol.2012.e23; Seinhorst J. W., 1959, Nematologica, V4, P67; STEINMAN AD, 1987, CAN J FISH AQUAT SCI, V44, P1640, DOI 10.1139/f87-199; STEVENSON RJ, 1981, J PHYCOL, V17, P29, DOI 10.1111/j.0022-3646.1981.00029.x; Stich HB, 2005, ARCH HYDROBIOL, V162, P111, DOI 10.1127/0003-9136/2005/0162-0111; STRAYER D, 1986, ECOLOGY, V67, P303, DOI 10.2307/1938574; Tiekjen J.H., 1977, Belle W. Baruch Library in Marine Science, P21; Traunspurger W, 2000, FRESHWATER BIOL, V44, P29, DOI 10.1046/j.1365-2427.2000.00585.x; Traunspurger W, 1997, VIE MILIEU, V47, P1; Traunspurger Walter, 1992, Spixiana, V15, P233; Vadeboncoeur Y, 2000, J N AM BENTHOL SOC, V19, P68, DOI 10.2307/1468282; Vadeboncoeur Y, 2002, BIOSCIENCE, V52, P44, DOI 10.1641/0006-3568(2002)052[0044:PTLBTR]2.0.CO;2; Vadeboncoeur Y, 2001, ECOLOGY, V82, P1065, DOI 10.1890/0012-9658(2001)082[1065:WLFEOD]2.0.CO;2; Vadeboncoeur Y, 2008, ECOLOGY, V89, P2542, DOI 10.1890/07-1058.1; van Dam AA, 2002, REV FISH BIOL FISHER, V12, P1, DOI 10.1023/A:1022639805031; Young Orson Whitney, 1945, TRANS AMER MICROSC SOC, V64, P1, DOI 10.2307/3223433	63	7	8	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137793	10.1371/journal.pone.0137793	http://dx.doi.org/10.1371/journal.pone.0137793			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353016	Green Published, Green Submitted, gold			2022-12-26	WOS:000360932800114
J	Obakan, P; Barrero, C; Coker-Gurkan, A; Arisan, ED; Merali, S; Palavan-Unsal, N				Obakan, Pinar; Barrero, Carlos; Coker-Gurkan, Ajda; Arisan, Elif Damla; Merali, Salim; Palavan-Unsal, Narcin			SILAC-Based Mass Spectrometry Analysis Reveals That Epibrassinolide Induces Apoptosis via Activating Endoplasmic Reticulum Stress in Prostate Cancer Cells	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; AMINO-ACIDS; CALRETICULIN; EXPRESSION; OVEREXPRESSION; CHAPERONE; ANDROGEN; SURVIVAL; CULTURE; BINDING	Epibrassinolide (EBR) is a polyhydroxylated sterol derivative and biologically active compound of the brassinosteroids. In addition to well-described roles in plant growth, EBR induces apoptosis in the LNCaP prostate cancer cells expressing functional androgen receptor (AR). Therefore, it is suggested that EBR might have an inhibitory potential on androgen receptor signaling pathway. However, the mechanism by which EBR exerts its effects on LNCaP is poorly understood. To address this gap in knowledge, we used an unbiased global proteomics approach, i.e., stable-isotope labeling by amino acids in cell culture (SILAC). In total, 964 unique proteins were identified, 160 of which were differentially expressed after 12 h of EBR treatment. The quantification of the differentially expressed proteins revealed that the expression of the unfolded protein response (UPR) chaperone protein, calreticulin (CALR), was dramatically downregulated. The decrease in CALR expression was also validated by immunoblotting. Because our data revealed the involvement of the UPR in response to EBR exposure, we evaluated the expression of the other UPR proteins. We demonstrated that EBR treatment downregulated calnexin and upregulated BiP and IRE1a expression levels and induced CHOP translocation from the cytoplasm to nucleus. The translocation of CHOP was associated with caspase-9 and caspase-3 activation after a 12 h EBR treatment. Co-treatment of EBR with rapamycin, an upstream mTOR pathway inhibitor, prevented EBR-induced cell viability loss and PARP cleavage in LNCaP prostate cancer cells, suggesting that EBR could induce ER stress in these cells. In addition, we observed similar results in DU145 cells with nonfunctional androgen receptor. When proteasomal degradation of proteins was blocked by MG132 co-treatment, EBR treatment further induced PARP cleavage relative to drug treatment alone. EBR also induced Ca2+ sequestration, which confirmed the alteration of the ER pathway due to drug treatment. Therefore, we suggest that EBR promotes ER stress and induces apoptosis.	[Obakan, Pinar; Coker-Gurkan, Ajda; Arisan, Elif Damla; Palavan-Unsal, Narcin] Istanbul Kultur Univ, Dept Mol Biol & Genet, Istanbul, Turkey; [Barrero, Carlos; Merali, Salim] Temple Univ, Sch Med, Fels Inst, Dept Biochem, Philadelphia, PA 19122 USA	Istanbul Kultur University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Obakan, P (corresponding author), Istanbul Kultur Univ, Dept Mol Biol & Genet, Atakoy Campus, Istanbul, Turkey.	p.obakan@iku.edu.tr	OBAKAN, PINAR/D-2836-2015; Arisan, Elif Damla/W-8682-2019	Arisan, Elif Damla/0000-0002-4844-6381; Barrero, Carlos/0000-0001-5779-6642; Unsal Palavan, Narcin/0000-0002-2945-540X; Gurkan, Ajda/0000-0003-1475-2417	Istanbul Kultur University Scientific Projects Support Center	Istanbul Kultur University Scientific Projects Support Center(Istanbul Kultur University)	This study was supported by the Istanbul Kultur University Scientific Projects Support Center and the Temple University Fels Institute of Cancer and Molecular Biology Department by using their own resources.	Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006; Babcock JT, 2013, J BIOL CHEM, V288, P15687, DOI 10.1074/jbc.M112.431056; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen YN, 2013, TRENDS CELL BIOL, V23, P547, DOI 10.1016/j.tcb.2013.06.005; Chiu SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033742; Duan XB, 2010, PROTEOMICS, V10, P2165, DOI 10.1002/pmic.201000020; Dyrlund TF, 2012, PROTEOMICS, V12, P2792, DOI 10.1002/pmic.201200109; Groenendyk J, 2005, ACTA BIOCHIM POL, V52, P381; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hu YX, 2004, CELL RES, V14, P8, DOI 10.1038/sj.cr.7290197; Ismaili J, 2012, STEROIDS, V77, P91, DOI 10.1016/j.steroids.2011.10.009; Kageyama K, 2002, J BIOL CHEM, V277, P19255, DOI 10.1074/jbc.M112377200; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Liu J, 2014, PLANT BIOLOGY, V16, P440, DOI 10.1111/plb.12052; Malikova J, 2008, PHYTOCHEMISTRY, V69, P418, DOI 10.1016/j.phytochem.2007.07.028; Mery L, 1996, J BIOL CHEM, V271, P9332, DOI 10.1074/jbc.271.16.9332; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Obakan P, 2014, AMINO ACIDS, V46, P553, DOI 10.1007/s00726-013-1574-1; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Quick QA, 2012, EXP THER MED, V3, P487, DOI 10.3892/etm.2011.422; Steigerova J, 2012, FOOD CHEM TOXICOL, V50, P4068, DOI 10.1016/j.fct.2012.08.031; Xu YH, 2009, BIOTECHNOL APPL BIOC, V54, P11, DOI 10.1042/BA20090007; Zhu N, 1999, CANCER RES, V59, P1896; Zhu N, 1998, ENDOCRINOLOGY, V139, P4337, DOI 10.1210/en.139.10.4337	26	13	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135788	10.1371/journal.pone.0135788	http://dx.doi.org/10.1371/journal.pone.0135788			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353013	gold, Green Submitted, Green Published			2022-12-26	WOS:000360932800015
J	Yang, CY; Chen, FA; Chen, CF; Liu, WS; Shih, CJ; Ou, SM; Yang, WC; Lin, CC; Yang, AH				Yang, Chih-Yu; Chen, Fu-An; Chen, Chun-Fan; Liu, Wen-Sheng; Shih, Chia-Jen; Ou, Shuo-Ming; Yang, Wu-Chang; Lin, Chih-Ching; Yang, An-Hang			Diagnostic Accuracy of Urine Protein/Creatinine Ratio Is Influenced by Urine Concentration	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CREATININE EXCRETION; PROTEINURIA; GRAVITY	Background The usage of urine protein/creatinine ratio to estimate daily urine protein excretion is prevalent, but relatively little attention has been paid to the influence of urine concentration and its impact on test accuracy. We took advantage of 24-hour urine collection to examine both urine protein/creatinine ratio (UPCR) and daily urine protein excretion, with the latter as the reference standard. Specific gravity from a concomitant urinalysis of the same urine sample was used to indicate the urine concentration. Methods During 2010 to 2014, there were 540 adequately collected 24h urine samples with protein concentration, creatinine concentration, total volume, and a concomitant urinalysis of the same sample. Variables associated with an accurate UPCR estimation were determined by multivariate linear regression analysis. Receiver operating characteristic (ROC) curves were generated to determine the discriminant cut-off values of urine creatinine concentration for predicting an accurate UPCR estimation in either dilute or concentrated urine samples. Results Our findings indicated that for dilute urine, as indicated by a low urine specific gravity, UPCR is more likely to overestimate the actual daily urine protein excretion. On the contrary, UPCR of concentrated urine is more likely to result in an underestimation. By ROC curve analysis, the best cut-off value of urine creatinine concentration for predicting overestimation by UPCR of dilute urine (specific gravity <= 1.005) was <= 38.8 mg/dL, whereas the best cut-off values of urine creatinine for predicting underestimation by UPCR of thick urine were >= 63.6 mg/dL (specific gravity >= 1.015), >= 62.1 mg/dL (specific gravity >= 1.020), >= 61.5 mg/dL (specific gravity >= 1.025), respectively. We also compared distribution patterns of urine creatinine concentration of 24h urine cohort with a concurrent spot urine cohort and found that the underestimation might be more profound in single voided samples. Conclusions The UPCR in samples with low or high specific gravity is more likely to overestimate or underestimate actual daily urine protein amount, respectively, especially in a dilute urine sample with its creatinine below 38.8 mg/dL or a concentrated sample with its creatinine above 61.5 mg/dL. In particular, UPCR results should be interpreted with caution in cases that involve dilute urine samples because its overestimation may lead to an erroneous diagnosis of proteinuric renal disease or an incorrect staging of chronic kidney disease.	[Yang, Chih-Yu; Ou, Shuo-Ming; Yang, Wu-Chang; Lin, Chih-Ching] Taipei Vet Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan; [Yang, An-Hang] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan; [Yang, Chih-Yu; Yang, An-Hang] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Yang, Chih-Yu; Chen, Fu-An; Chen, Chun-Fan; Liu, Wen-Sheng; Shih, Chia-Jen; Ou, Shuo-Ming; Yang, Wu-Chang; Lin, Chih-Ching; Yang, An-Hang] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chen, Fu-An; Chen, Chun-Fan] Natl Yang Ming Univ Hosp, Div Nephrol, Dept Med, Yilan, Taiwan; [Liu, Wen-Sheng] Taipei City Hosp, Zhongxing Branch, Dept Med, Div Nephrol, Taipei, Taiwan; [Liu, Wen-Sheng] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Shih, Chia-Jen] Taipei Vet Gen Hosp, Yuanshan Branch, Dept Med, Div Nephrol, Taipei, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital; Fu Jen Catholic University; Taipei Veterans General Hospital	Lin, CC (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan.	lincc2@vghtpe.gov.tw; ahyang@vghtpe.gov.tw	Yang, Chih-Yu/AAR-6147-2020; liu, wen/HGE-3071-2022	Yang, Chih-Yu/0000-0001-9899-3159; Chen, Chun-Fan/0000-0003-1932-3590	Taipei Veterans General Hospital, National Yang-Ming University Excellent Physician Scientists Cultivation Program [103-V-B-024]	Taipei Veterans General Hospital, National Yang-Ming University Excellent Physician Scientists Cultivation Program	Funding: This study was supported by the Taipei Veterans General Hospital, National Yang-Ming University Excellent Physician Scientists Cultivation Program, No. 103-V-B-024 to CY.	Clark N, 2003, DIABETES CARE, V26, P3333; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Constantiner M, 2005, AM J KIDNEY DIS, V45, P833, DOI 10.1053/j.ajkd.2005.02.012; Cote AM, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.009; Drawz P, 2009, ANN INTERN MED, V150, pITC2; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Eknoyan G, 2003, AM J KIDNEY DIS, V42, P617, DOI 10.1016/S0272-6386(03)00826-6; FORBES GB, 1976, AM J CLIN NUTR, V29, P1359, DOI 10.1093/ajcn/29.12.1359; GINSBERG JM, 1983, NEW ENGL J MED, V309, P1543, DOI 10.1056/NEJM198312223092503; HEYMSFIELD SB, 1983, AM J CLIN NUTR, V37, P478, DOI 10.1093/ajcn/37.3.478; Kalantari K, 2013, CLIN J AM SOC NEPHRO, V8, P1847, DOI 10.2215/CJN.09770913; Keane WF, 1999, AM J KIDNEY DIS, V33, P1004, DOI 10.1016/S0272-6386(99)70442-7; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Moore RR, 1997, KIDNEY INT, V52, P240, DOI 10.1038/ki.1997.326; Parikh CR, 2002, AM J NEPHROL, V22, P315, DOI 10.1159/000065220; PERRONE RD, 1992, CLIN CHEM, V38, P1933; WALSER M, 1987, JPEN-PARENTER ENTER, V11, pS73, DOI 10.1177/014860718701100510	18	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137460	10.1371/journal.pone.0137460	http://dx.doi.org/10.1371/journal.pone.0137460			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353117	Green Submitted, Green Published, gold			2022-12-26	WOS:000360932800088
J	Muhly, T; Serrouya, R; Neilson, E; Li, HT; Boutin, S				Muhly, Tyler; Serrouya, Robert; Neilson, Eric; Li, Haitao; Boutin, Stan			Influence of In-Situ Oil Sands Development on Caribou (Rangifer tarandus) Movement	PLOS ONE			English	Article							WOODLAND CARIBOU; ANIMAL MOVEMENT; POPULATIONS; DYNAMICS; PREDATION; SELECTION; BEHAVIOR; WOLVES; MOOSE	In-situ oil sands development (ISD) involves a network of facilities, wells, roads and pipelines to extract and transport subsurface bitumen. This technology is rapidly expanding and there is uncertainty whether ISDs restrict animal movement, leading to increased extinction probabilities for some wide-ranging species. Here we test for effects of simulated future (i.e., 50 years from now) and current ISDs on simulated movements of woodland caribou (Rangifer tarandus), a threatened species across North America. In simulations of future scenarios, we varied the spacing and permeability of ISDs and the presence/absence of protected areas. Permeability was measured as the number of times simulated caribou crossed ISDs with different levels of modelled permeability. We estimated the effects of these factors on caribou step length and annual home range size, key metrics of small and large spatiotemporal scales of movement, respectively. Current caribou crossings of above-ground pipeline features of ISDs were measured using camera traps and compared to expected caribou crossing rates based on present-day caribou movement simulations. Current crossing rates were evaluated within the context of predicted future crossing success rates necessary to maintain caribou step lengths and home ranges. With few exceptions, permeability across ISDs was the main factor affecting caribou movement, more so than spacing between developments or the presence of protected areas. However, minimal permeability (crossing rates of c. 15% to 60%, relative to an undisturbed site was needed to maintain existing home range size and step lengths. The effect of permeability on home range size and step length was non-linear, suggesting that small increases in permeability would provide a disproportionately greater benefit to caribou movement. Our predictions demonstrate that maintaining permeability across ISDs is more important than spacing between leases or including protected areas, and thus provides clear direction for mitigation efforts for features that will exist on the landscape for decades to come.	[Muhly, Tyler; Serrouya, Robert; Li, Haitao] Univ Alberta, Alberta Biodivers Monitoring Inst, Dept Biol Sci, Edmonton, AB, Canada; [Muhly, Tyler] Stantec, Environm Serv, Sidney, BC, Canada; [Neilson, Eric; Boutin, Stan] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta; University of Alberta	Serrouya, R (corresponding author), Univ Alberta, Alberta Biodivers Monitoring Inst, Dept Biol Sci, Edmonton, AB, Canada.	Serrouya@ualberta.ca	Boutin, Stan/A-2619-2014	Boutin, Stan/0000-0001-6317-038X	Environmental Monitoring Committee of the Lower Athabasca; Santec	Environmental Monitoring Committee of the Lower Athabasca; Santec	Funding was provided by the Environmental Monitoring Committee of the Lower Athabasca. They helped to set the direction of the research, and approved the scenarios for future in situ developments. They did not influence or comment on the Results or Discussion sections of the Manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Santec provided support in the form of a salary for author TM, (from a contract from ABMI during the submission and review phase to PLOS ONE), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Alberta Go, LOW ATH REG PLAN 201; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Beauchesne D, 2014, BIOL CONSERV, V172, P190, DOI 10.1016/j.biocon.2014.03.002; Beyer H. L, 2012, GEOSPATIAL MODELLING; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Canada E., 2012, RECOVERY STRATEGY WO; CURATOLO JA, 1986, CAN FIELD NAT, V100, P218; Dunne BM, 2009, BIOL CONSERV, V142, P332, DOI 10.1016/j.biocon.2008.10.029; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Hervieux D, 2013, CAN J ZOOL, V91, P872, DOI 10.1139/cjz-2013-0123; JOHNSON AR, 1992, LANDSCAPE ECOL, V7, P63, DOI 10.1007/BF02573958; Latham ADM, 2011, J WILDLIFE MANAGE, V75, P204, DOI 10.1002/jwmg.28; Lawhead BE, 2006, LIT REV SYNTHESIS EF; Ltd. GA, 2004, REV WILDL CROSS STRU; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; Mcloughlin PD, 2007, ECOLOGY, V88, P3192, DOI 10.1890/06-1974.1; McLoughlin PD, 2003, J WILDLIFE MANAGE, V67, P755, DOI 10.2307/3802682; Meek P, 2012, INTRO CAMERA TRAPPIN; Miller C, 2000, ECOL APPL, V10, P85, DOI 10.1890/1051-0761(2000)010[0085:MTEOFM]2.0.CO;2; Morales JM, 2010, PHILOS T R SOC B, V365, P2289, DOI 10.1098/rstb.2010.0082; Nams VO, 2006, J ANIM ECOL, V75, P298, DOI 10.1111/j.1365-2656.2006.01047.x; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Northrup JM, 2013, ECOL LETT, V16, P112, DOI 10.1111/ele.12009; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; Revilla E, 2008, P NATL ACAD SCI USA, V105, P19120, DOI 10.1073/pnas.0801725105; Scheller RM, 2005, GLOBAL CHANGE BIOL, V11, P307, DOI 10.1111/j.1365-2486.2005.00906.x; Schneider RR, 2010, BIOL CONSERV, V143, P1603, DOI 10.1016/j.biocon.2010.04.002; SEIP DR, 1992, CAN J ZOOL, V70, P1494, DOI 10.1139/z92-206; Serrouya R, 2012, MOL ECOL, V21, P2588, DOI 10.1111/j.1365-294X.2012.05570.x; Shifley SR, 2000, COMPUT ELECTRON AGR, V27, P7, DOI 10.1016/S0168-1699(00)00087-9; Sorensen T, 2008, J WILDLIFE MANAGE, V72, P900, DOI 10.2193/2007-079; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Turchin Peter, 1998; Wasser SK, 2011, FRONT ECOL ENVIRON, V9, P546, DOI 10.1890/100071; Wittmer HU, 2005, OECOLOGIA, V144, P257, DOI 10.1007/s00442-005-0055-y	36	14	14	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136933	10.1371/journal.pone.0136933	http://dx.doi.org/10.1371/journal.pone.0136933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26349062	gold, Green Published, Green Submitted			2022-12-26	WOS:000360897600016
J	Milani, L; Ghiselli, F; Pecci, A; Maurizii, MG; Passamonti, M				Milani, Liliana; Ghiselli, Fabrizio; Pecci, Andrea; Maurizii, Maria Gabriella; Passamonti, Marco			The Expression of a Novel Mitochondrially-Encoded Gene in Gonadic Precursors May Drive Paternal Inheritance of Mitochondria	PLOS ONE			English	Article							VASA-LIKE GENE; LARGE RIBOSOMAL-RNA; GERM PLASM; UNIPARENTAL INHERITANCE; SMALL MICROMERES; POLAR GRANULES; BLUE MUSSEL; SEA-URCHIN; I-TASSER; PROTEIN	Mitochondria have an active role in germ line development, and their inheritance dynamics are relevant to this process. Recently, a novel protein (RPHM21) was shown to be encoded in sperm by the male-transmitted mtDNA of Ruditapes philippinarum, a species with Doubly Uniparental Inheritance (DUI) of mitochondria. In silico analyses suggested a viral origin of RPHM21, and we hypothesized that the endogenization of a viral element provided sperm mitochondria of R. philippinarum with the ability to invade male germ line, thus being transmitted to the progeny. In this work we investigated the dynamics of germ line development in relation to mitochondrial transcription and expression patterns using qPCR and specific antibodies targeting the germ line marker VASPH (R. philippinarum VASA homolog), and RPHM21. Based on the experimental results we conclude that both targets are localized in the primordial germ cells (PGCs) of males, but while VASPH is detected in all PGCs, RPHM21 appears to be expressed only in a subpopulation of them. Since it has been predicted that RPHM21 might have a role in cell proliferation and migration, we here suggest that PGCs expressing it might gain advantage over others and undertake spermatogenesis, accounting for RPHM21 presence in all spermatozoa. Understanding how foreign sequence endogenization and co-option can modify the biology of an organism is of particular importance to assess the impact of such events on evolution.	[Milani, Liliana; Ghiselli, Fabrizio; Pecci, Andrea; Maurizii, Maria Gabriella; Passamonti, Marco] Univ Bologna, Dept Biol Geol & Environm Sci, Bologna, Italy	University of Bologna	Milani, L (corresponding author), Univ Bologna, Dept Biol Geol & Environm Sci, Bologna, Italy.	liliana.milani@unibo.it	Milani, Liliana/B-7063-2015; Ghiselli, Fabrizio/D-2260-2010	Milani, Liliana/0000-0001-5052-2075; Ghiselli, Fabrizio/0000-0002-1680-8616	Italian Ministry of Education, Universities and Research "Futuro in Ricerca"; University of Bologna "RFO"; Canziani bequest; Fondazione del Monte	Italian Ministry of Education, Universities and Research "Futuro in Ricerca"; University of Bologna "RFO"; Canziani bequest; Fondazione del Monte	This work was supported by the Italian Ministry of Education, Universities and Research "Futuro in Ricerca 2013" grant to FG, University of Bologna "RFO 2013" funding to MGM, and "Canziani bequest" and "Fondazione del Monte" funding to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amikura R, 2001, MECH DEVELOP, V107, P97, DOI 10.1016/S0925-4773(01)00455-5; Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Citorik RJ, 2014, CURR OPIN MICROBIOL, V19, P59, DOI 10.1016/j.mib.2014.05.022; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Delgado M, 2004, SCI MAR, V71; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Fabioux C, 2004, BIOCHEM BIOPH RES CO, V320, P592, DOI 10.1016/j.bbrc.2004.06.009; Fabioux C, 2004, BIOCHEM BIOPH RES CO, V315, P897, DOI 10.1016/j.bbrc.2004.01.145; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; Ghiselli F, 2013, GENOME BIOL EVOL, V5, P1535, DOI 10.1093/gbe/evt112; Ghiselli F, 2012, MOL BIOL EVOL, V29, P771, DOI 10.1093/molbev/msr248; Ghiselli F, 2011, MOL BIOL EVOL, V28, P949, DOI 10.1093/molbev/msq271; Goic B, 2012, CURR OPIN MICROBIOL, V15, P531, DOI 10.1016/j.mib.2012.06.002; Gosling E, 2003, BIVALVE MOLLUSCS BIO; Gustafson EA, 2010, BIOESSAYS, V32, P626, DOI 10.1002/bies.201000001; HAY B, 1988, DEVELOPMENT, V103, P625; HAY B, 1988, CELL, V55, P577, DOI 10.1016/0092-8674(88)90216-4; Hickford DE, 2011, BIOL REPROD, V85, P733, DOI 10.1095/biolreprod.111.091629; Ina S, 2003, GENE EXPR PATTERNS, V3, P635, DOI 10.1016/S1567-133X(03)00111-X; Jones G.G., 1993, MANILA CLAMS HATCHER; Kloc M, 2004, CURR TOP DEV BIOL, V59, P1, DOI 10.1016/S0070-2153(04)59001-4; Kobayashi S, 1998, CURR BIOL, V8, P1117, DOI 10.1016/S0960-9822(98)70466-X; KOBAYASHI S, 1993, SCIENCE, V260, P1521, DOI 10.1126/science.7684857; Kotaja N, 2007, MOL CELL BIOL, V8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKO PF, 1990, GENE DEV, V4, P905, DOI 10.1101/gad.4.6.905; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorsch JR, 2002, CELL, V109, P797, DOI 10.1016/S0092-8674(02)00804-8; Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590; Marracci S, 2007, DEV GENES EVOL, V217, P395, DOI 10.1007/s00427-007-0143-6; Matova N, 2001, DEV BIOL, V231, P291, DOI 10.1006/dbio.2000.0120; Meneghetti F, 2004, AQUACULTURE, V240, P473, DOI 10.1016/j.aquaculture.2004.04.011; Milani L, 2012, J EXP ZOOL PART B, V318; Milani L, 2014, CURR GENET, V60, P163, DOI 10.1007/s00294-014-0420-7; Milani L, 2014, GENOME BIOL EVOL, V6, P391, DOI 10.1093/gbe/evu021; Milani L, 2013, J EXP ZOOL PART B, V320, P442, DOI 10.1002/jez.b.22520; Milani L, 2013, GENOME BIOL EVOL, V5, P1408, DOI 10.1093/gbe/evt101; Milani L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028194; Mitra K, 2013, BIOESSAYS, V35, P955, DOI 10.1002/bies.201300011; NEWMARK PA, 1994, DEVELOPMENT, V120, P1303; Obata M, 2011, DEV GROWTH DIFFER, V53, P878, DOI 10.1111/j.1440-169X.2011.01294.x; Obata M, 2010, DEV GENES EVOL, V220, P139, DOI 10.1007/s00427-010-0335-3; Ogawa M, 1999, ZOOL SCI, V16, P445, DOI 10.2108/zsj.16.445; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; Parvinen M, 2005, INT J ANDROL, V28, P189, DOI 10.1111/j.1365-2605.2005.00542.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfister D, 2008, DEV BIOL, V319, P146, DOI 10.1016/j.ydbio.2008.02.045; Ponurovsky S. K., 1992, Journal of Shellfish Research, V11, P265; Reunov A, 2000, DEV GROWTH DIFFER, V42, P139; Reunov AA, 2014, ZYGOTE; Reunov A, 2006, ZYGOTE, V14, P231, DOI 10.1017/S0967199406003789; Reunov AA, 2013, ZYGOTE, V21, P95, DOI 10.1017/S0967199411000402; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rozen S, 2000, Methods Mol Biol, V132, P365; SKIBINSKI DOF, 1994, NATURE, V368, P817, DOI 10.1038/368817b0; SKIBINSKI DOF, 1994, GENETICS, V138, P801; Styhler S, 1998, DEVELOPMENT, V125, P1569; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thandapani P, EXPRESSION MOUSE AVE; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Venetis C, 2006, P R SOC B, V273, P2483, DOI 10.1098/rspb.2006.3607; Voronina E, 2008, DEV BIOL, V314, P276, DOI 10.1016/j.ydbio.2007.11.039; White DJ, 2008, MOL ECOL, V17, P4925, DOI 10.1111/j.1365-294X.2008.03982.x; Wilsch-Br Reunova YA, 1997, J CELL BIOL, V139; Yan RH, 2010, J CELL BIOL, V188, P335, DOI 10.1083/jcb.200904040; Yuan YM, 2014, GENE, V545, P15, DOI 10.1016/j.gene.2014.05.017; Yusa Y, 2013, J HERED, V104, P380, DOI 10.1093/jhered/est014; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; ZOUROS E, 1994, P NATL ACAD SCI USA, V91, P7463, DOI 10.1073/pnas.91.16.7463; ZOUROS E, 1994, NATURE, V368, P818, DOI 10.1038/368818a0; Zouros E, 2013, EVOL BIOL, V40, P1, DOI 10.1007/s11692-012-9195-2	77	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137468	10.1371/journal.pone.0137468	http://dx.doi.org/10.1371/journal.pone.0137468			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339998	gold, Green Published, Green Submitted			2022-12-26	WOS:000360688200063
J	Vallejo, MC; Mayinger, P				Vallejo, Milene Carmes; Mayinger, Peter			Delayed Turnover of Unphosphorylated Ssk1 during Carbon Stress Activates the Yeast Hog1 Map Kinase Pathway	PLOS ONE			English	Article							PROTEASOME; PHOSPHORYLATION; DEGRADATION; CASCADE	In Saccharomyces cerevisiae, the Hog1 mitogen-activated protein kinase (MAPK) pathway coordinates the adaptation to osmotic stress and was recently reported to respond to acute changes in glucose levels. Similarly as in osmotic stress, glucose starvation leads to a transient accumulation of Hog1 in the nucleus. However, the kinetics and the mechanism of Hog1 activation are different for these stress conditions. During osmotic shock the activation of Hog1 can be transduced by either the Sho1 or the Sln1/Ypd1/Ssk1 branch. During glucose starvation the phosphorylation of Hog1 is slower and is completely dependent on Ssk1, but independent of Sho1. To characterize the mechanism of activation of Hog1 during carbon stress, we examined the turnover of Ssk1 protein levels upon glucose starvation in the presence of cycloheximide and monitored protein levels by western blotting. Our data demonstrate that unphosphorylated Ssk1 was quickly degraded during exponential growth and after osmotic stress but remained remarkably stable during glucose limitation. We conclude that glucose starvation induces a delay in the turnover of unphosphorylated Ssk1, which is sufficient to activate the Hog1 MAPK pathway. Although unphosphorylated Ssk1 is known to be degraded by the proteasome, its stabilization is apparently not due to changes in cellular localization or decrease in ubiquitination levels during glucose limitation.	[Vallejo, Milene Carmes; Mayinger, Peter] Oregon Hlth & Sci Univ, Div Nephrol & Hypertens, Portland, OR 97239 USA	Oregon Health & Science University	Mayinger, P (corresponding author), Oregon Hlth & Sci Univ, Div Nephrol & Hypertens, Portland, OR 97239 USA.	mayinger@ohsu.edu			National Institutes of Health [RO1GM084088]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health grant RO1GM084088 to PM.	Adams A, 1998, METHODS YEAST GENETI, pxiv; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Blagoveshchenskaya A, 2008, J CELL BIOL, V180, P803, DOI 10.1083/jcb.200708109; de Nadal E, 2002, EMBO REP, V3, P735, DOI 10.1093/embo-reports/kvf158; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; Dihazi H, 2004, J BIOL CHEM, V279, P23961, DOI 10.1074/jbc.M312974200; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Duch A, 2012, FEBS LETT, V586, P2925, DOI 10.1016/j.febslet.2012.07.034; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Hickman MJ, 2011, GENETICS, V188, P325, DOI 10.1534/genetics.111.128322; Laporte D, 2008, J CELL BIOL, V181, P737, DOI 10.1083/jcb.200711154; Liu C, 2007, BIOTECHNIQUES, V42, P156, DOI 10.2144/000112389; Lu JMY, 2003, EUKARYOT CELL, V2, P1304, DOI 10.1128/EC.2.6.1304-1314.2003; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; O'Rourke SM, 2002, TRENDS GENET, V18, P405, DOI 10.1016/S0168-9525(02)02723-3; Panadero J, 2006, J BIOL CHEM, V281, P4638, DOI 10.1074/jbc.M512736200; Peters LZ, 2013, J CELL BIOL, V201, P663, DOI 10.1083/jcb.201211146; Piao HL, 2012, TRAFFIC, V13, P1522, DOI 10.1111/j.1600-0854.2012.01406.x; Proft M, 2004, CELL, V118, P351, DOI 10.1016/j.cell.2004.07.016; Saito H, 2004, J BIOCHEM, V136, P267, DOI 10.1093/jb/mvh135; Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863; Saito H, 2010, CURR OPIN MICROBIOL, V13, P677, DOI 10.1016/j.mib.2010.09.001; Sato N, 2003, MOL CELL BIOL, V23, P6662, DOI 10.1128/MCB.23.18.6662-6671.2003; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Winkler A, 2002, EUKARYOT CELL, V1, P163, DOI 10.1128/EC.1.2.163-173.2002	27	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137199	10.1371/journal.pone.0137199	http://dx.doi.org/10.1371/journal.pone.0137199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340004	Green Published, gold, Green Submitted			2022-12-26	WOS:000360688200033
J	Pan, XD; Pang, M; Ma, AJ; Wang, K; Zhang, Z; Zhong, QW; Yang, SN				Pan, Xudong; Pang, Meng; Ma, Aijun; Wang, Kun; Zhang, Zhang; Zhong, Qianwei; Yang, Shuna			Association of TRAIL and Its Receptors with Large-Artery Atherosclerotic Stroke	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; OSTEOPROTEGERIN; APOPTOSIS; LIGAND; PROLIFERATION; ACTIVATION	Objective To investigate the association of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its receptors, osteoprotegerin (OPG) and death receptor 5 (DR5) with largeartery atherosclerosis (LAA) stroke and its prognosis. Methods We included patients with LAA stroke (n = 132) according to the TOAST classification system and controls (n = 60). To evaluate the extent and severity of cerebral atherosclerosis, the LAA stroke group was subdivided into 3 subgroups by number of cerebral arteries with atherosclerotic stenosis (>= 50%): single, double and multiple (>= 3). Plasma levels of TRAIL, OPG and DR5 were measured by ELISA. Ordinal logistic regression was used to analyze the association between the plasma levels of TRAIL, OPG, DR5 and the severity of cerebral atherosclerosis. Prognosis was determined by the Modified Rankin Scale at 3 months after stroke. Receiver operating characteristic (ROC) curve was used to evaluated TRAIL as a predictor of prognosis. Results Plasma TRAIL level was significantly lower for LAA patients than controls (P < 0.001), while plasma OPG and DR5 levels were higher (both P < 0.001). Logistic regression analysis revealed that risk of severe cerebral atherosclerosis was reduced significantly with increased plasma level of TRAIL (OR 0.438; 95% CI 0.282-0.681; P < 0.001), whereas increased with high plasma levels of OPG and DR5 (OR 2.707; 95% CI 1.702-4.302, P < 0.001; OR 3.593; 95% CI 1.878-6.869, P < 0.001). Plasma TRAIL level was negatively correlated with the prognosis (r = -0.372, P < 0.001). The optimal cut-off value of TRAIL for prognosis was 848.63 pg/mL. The sensitivity and specificity at this cut-off value were 63.1% and 86.2%, respectively. After adding the plasma TRAIL level into the multivariate model of ROC, the area under the ROC curve was increased from 0.639 to 0.785, but the change was not statistical significant (P = 0.146). Conclusions TRAIL and its receptors OPG and DR5 may be involved in LAA stroke and the plasma level of TRAIL may be a biomarker predicting the severity of cerebral atherosclerosis and the prognosis of LAA stroke.	[Pan, Xudong; Pang, Meng; Ma, Aijun; Wang, Kun; Zhang, Zhang; Zhong, Qianwei; Yang, Shuna] Qingdao Univ, Affiliated Hosp, Dept Neurol, Qingdao 266100, Shandong, Peoples R China	Qingdao University	Ma, AJ (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Neurol, Qingdao 266100, Shandong, Peoples R China.	pangmeng6666@163.com			Shandong Province Natural Science Foundation [ZR2011HM087]	Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province)	XDP was fully supported by a grant from Shandong Province Natural Science Foundation (ZR2011HM087).	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Alladina SJ, 2005, J VASC RES, V42, P337, DOI 10.1159/000086599; Corallini F, 2008, FRONT BIOSCI-LANDMRK, V13, P135, DOI 10.2741/2665; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Kaplan MJ, 2000, J IMMUNOL, V164, P2897, DOI 10.4049/jimmunol.164.6.2897; Kavurma MM, 2008, BIOCHEM PHARMACOL, V75, P1441, DOI 10.1016/j.bcp.2007.10.020; Kavurma MM, 2008, J BIOL CHEM, V283, P7754, DOI 10.1074/jbc.M706927200; Kim J, 2013, CLIN BIOCHEM, V46, P1036, DOI 10.1016/j.clinbiochem.2013.05.048; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lieb W, 2010, ARTERIOSCL THROM VAS, V30, P1849, DOI 10.1161/ATVBAHA.109.199661; Martin-Ventura JL, 2007, FRONT BIOSCI-LANDMRK, V12, P3656, DOI 10.2741/2342; Mogelvang R, 2012, AM J CARDIOL, V109, P515, DOI 10.1016/j.amjcard.2011.09.043; Mori K, 2010, THROMB RES, V125, P322, DOI 10.1016/j.thromres.2009.11.024; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Sato K, 2006, J EXP MED, V203, P239, DOI 10.1084/jem.20051062; Secchiero P, 2003, CIRCULATION, V107, P2250, DOI 10.1161/01.CIR.0000062702.60708.C4; Secchiero P, 2006, CIRCULATION, V114, P1522, DOI 10.1161/CIRCULATIONAHA.106.643841; Secchiero P, 2010, ATHEROSCLEROSIS, V210, P274, DOI 10.1016/j.atherosclerosis.2009.11.005; Secchiero P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004442; Volpato S, 2011, ATHEROSCLEROSIS, V215, P452, DOI 10.1016/j.atherosclerosis.2010.11.004; Watt V, 2011, ATHEROSCLEROSIS, V215, P348, DOI 10.1016/j.atherosclerosis.2011.01.010; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8	23	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136414	10.1371/journal.pone.0136414	http://dx.doi.org/10.1371/journal.pone.0136414			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334877	gold, Green Published, Green Submitted			2022-12-26	WOS:000360615400014
J	King, K; Lin, NP; Cheng, YH; Chen, GH; Chein, RJ				King, Klim; Lin, Nai-Pin; Cheng, Yu-Hong; Chen, Gao-Hui; Chein, Rong-Jie			Isolation of Positive Modulator of Glucagon-like Peptide-1 Signaling from Trigonella foenum-graecum (Fenugreek) Seed	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 DIABETES-MELLITUS; PROTEIN-COUPLED-RECEPTORS; INCRETIN-BASED THERAPIES; GASTRIC-INHIBITORY POLYPEPTIDE; INSULIN-SECRETION; GLP-1; GLUCOSE; EXENATIDE; PEPTIDE-1(7-36)AMIDE; TRANSDUCTION	The glucagon-like peptide-1 receptor (GLP-1R) is expressed in many tissues and has been implicated in diverse physiological functions, such as energy homeostasis and cognition. GLP-1 analogs are approved for treatment of type 2 diabetes and are undergoing clinical trials for other disorders, including neurodegenerative diseases. GLP-1 analog therapies maintain chronically high plasma levels of the analog and can lead to loss of spatiotemporal control of GLP-1R activation. To avoid adverse effects associated with current therapies, we characterized positive modulators of GLP-1R signaling. We screened extracts from edible plants using an intracellular cAMP biosensor and GLP-1R endocytosis assays. Ethanol extracts from fenugreek seeds enhanced GLP-1 signaling. These seeds have previously been found to reduce glucose and glycated hemoglobin levels in humans. An active compound (N55) with a new N-linoleoyl-2-amino-gamma-butyrolactone structure was purified from fenugreek seeds. N55 promoted GLP-1-dependent cAMP production and GLP-1R endocytosis in a dose-dependent and saturable manner. N55 specifically enhanced GLP-1 potency more than 40-fold, but not that of exendin 4, to stimulate cAMP production. In contrast to the current allosteric modulators that bind to GLP-1R, N55 binds to GLP-1 peptide and facilitates trypsinmediated GLP-1 inactivation. These findings identify a new class of modulators of GLP-1R signaling and suggest that GLP-1 might be a viable target for drug discovery. Our results also highlight a feasible approach for screening bioactive activity of plant extracts.	[King, Klim; Cheng, Yu-Hong] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan; [Lin, Nai-Pin; Chein, Rong-Jie] Acad Sinica, Inst Chem, Taipei 11529, Taiwan; [Chen, Gao-Hui] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan	King, K (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan.	bmkxk@ibms.sinica.edu.tw; rjchein@chem.sinica.edu.tw	Chein, Rong-Jie/F-1975-2015; Chein, Rong-Jie/F-4743-2015	Chein, Rong-Jie/0000-0002-0119-8288	Academia Sinica, Taiwan	Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This work was supported by Academia Sinica, Taiwan. R.-J. C. and K. K. have filed a patent application covering chemical compositions and applications for developing N55 analogs.	Al-Okbi SY, 2014, TOXICOL IND HEALTH, V30, P738, DOI 10.1177/0748233712462468; Andersen NH, 2002, BIOORGAN MED CHEM, V10, P79, DOI 10.1016/S0968-0896(01)00263-2; Aviles-Olmos I, 2014, J PARKINSON DIS, V4, P337, DOI 10.3233/JPD-140364; Bae MJ, 2012, J ETHNOPHARMACOL, V144, P514, DOI 10.1016/j.jep.2012.09.030; Belaid-Nouira Y, 2013, NUTR NEUROSCI, V16, P218, DOI 10.1179/1476830512Y.0000000048; Butler PC, 2013, DIABETES CARE, V36, P2118, DOI 10.2337/dc12-2713; Calanna S, 2013, DIABETOLOGIA, V56, P965, DOI 10.1007/s00125-013-2841-0; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Cheng YH, 2015, J BIOL CHEM, V290, P14302, DOI 10.1074/jbc.M115.655662; Cordova A, 2002, J AM CHEM SOC, V124, P1842, DOI 10.1021/ja017270h; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Faerch K, 2015, DIABETES, V64, P2513, DOI 10.2337/db14-1751; Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/157339913804143225; GALLWITZ B, 1993, J MOL ENDOCRINOL, V10, P259, DOI 10.1677/jme.0.0100259; GEFEL D, 1990, ENDOCRINOLOGY, V126, P2164, DOI 10.1210/endo-126-4-2164; GOKE R, 1988, Z GASTROENTEROL, V26, P715; Gu GB, 2013, J COMP NEUROL, V521, P2235, DOI 10.1002/cne.23282; Haber SL, 2013, AM J HEALTH-SYST PH, V70, P1196, DOI 10.2146/ajhp120523; Hannan JMA, 2007, BRIT J NUTR, V97, P514, DOI 10.1017/S0007114507657869; Holscher C, 2014, J ENDOCRINOL, V221, pT31, DOI 10.1530/JOE-13-0221; Hudson CC, 2006, METHOD ENZYMOL, V414, P63, DOI 10.1016/S0076-6879(06)14005-7; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Koole C, 2010, MOL PHARMACOL, V78, P456, DOI 10.1124/mol.110.065664; Lonborg J, 2012, CIRC-CARDIOVASC INTE, V5, P288, DOI 10.1161/CIRCINTERVENTIONS.112.968388; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Lu FR, 2008, CHIN J INTEGR MED, V14, P56, DOI 10.1007/s11655-007-9005; MADAR Z, 1988, EUR J CLIN NUTR, V42, P51; Madsen K, 2007, J MED CHEM, V50, P6126, DOI 10.1021/jm070861j; Mathern JR, 2009, PHYTOTHER RES, V23, P1543, DOI 10.1002/ptr.2795; Meier JJ, 2004, DIABETES, V53, P654, DOI 10.2337/diabetes.53.3.654; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Muscogiuri G, 2014, J ENDOCRINOL INVEST, V37, P1143, DOI 10.1007/s40618-014-0137-y; Nauck MA, 2011, DIABETOLOGIA, V54, P10, DOI 10.1007/s00125-010-1896-4; Nauck MA, 2011, AM J MED, V124, pS19, DOI 10.1016/j.amjmed.2010.11.002; Neelakantan N, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-7; Nolte WM, 2014, NAT CHEM BIOL, V10, P629, DOI 10.1038/nchembio.1581; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Runge S, 2007, BIOCHEMISTRY-US, V46, P5830, DOI 10.1021/bi062309m; Sauvaire Y, 1998, DIABETES, V47, P206, DOI 10.2337/diabetes.47.2.206; SHARMA RD, 1986, NUTR RES, V6, P1353, DOI 10.1016/S0271-5317(86)80020-3; Sloop KW, 2010, DIABETES, V59, P3099, DOI 10.2337/db10-0689; Uemura T, 2010, MOL NUTR FOOD RES, V54, P1596, DOI 10.1002/mnfr.200900609; Wang E, 2008, DIABETES EDUCATOR, V34, P645, DOI 10.1177/0145721708320559; Ward BP, 2013, MOL METAB, V2, P468, DOI 10.1016/j.molmet.2013.08.008; WIDMANN C, 1994, MOL PHARMACOL, V45, P1029; Zhang L, 2012, CURR MED CHEM, V19, P1602; Zhou J, 2012, CURR MED CHEM, V19, P3523, DOI 10.2174/092986712801323171	49	18	18	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26235	+		10.1074/jbc.M115.672097	http://dx.doi.org/10.1074/jbc.M115.672097			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26336108	hybrid, Green Published			2022-12-26	WOS:000363527300040
J	Simon, JM; Parker, JS; Liu, F; Rothbart, SB; Ait-Si-Ali, S; Strahl, BD; Jin, J; Davis, IJ; Mosley, AL; Pattenden, SG				Simon, Jeremy M.; Parker, Joel S.; Liu, Feng; Rothbart, Scott B.; Ait-Si-Ali, Slimane; Strahl, Brian D.; Jin, Jian; Davis, Ian J.; Mosley, Amber L.; Pattenden, Samantha G.			A Role for Widely Interspaced Zinc Finger (WIZ) in Retention of the G9a Methyltransferase on Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITION-EFFECT VARIEGATION; DROSOPHILA HETEROCHROMATIN PROTEIN; TRANSCRIPTION FACTOR-IIIA; MASS SPECTROMETRY DATA; DNA-BINDING PROTEIN; HISTONE H3; LYSINE-9 METHYLATION; SEQUENCE RECOGNITION; CHROMOSOMAL-PROTEIN; PROTEOMIC ANALYSIS	G9a and GLP lysine methyltransferases form a heterodimeric complex that is responsible for the majority of histone H3 lysine 9 mono-and di-methylation (H3K9me1/me2). Widely interspaced zinc finger (WIZ) associates with the G9a-GLP protein complex, but its role in mediating lysine methylation is poorly defined. Here, we show that WIZ regulates global H3K9me2 levels by facilitating the interaction of G9a with chromatin. Disrupting the association of G9a-GLP with chromatin by depleting WIZ resulted in altered gene expression and protein-protein interactions that were distinguishable from that of small molecule-based inhibition of G9a/GLP, supporting discrete functions of the G9a-GLP-WIZ chromatin complex in addition to H3K9me2 methylation.	[Simon, Jeremy M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Carolina Inst Dev Disabil, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Simon, Jeremy M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, Curriculum Bioinformat & Computat Biol, Chapel Hill, NC 27599 USA; [Parker, Joel S.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Parker, Joel S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Liu, Feng; Pattenden, Samantha G.] Univ N Carolina, Eshelman Sch Pharm, Ctr Integrat Chem Biol & Drug Discovery, Chapel Hill, NC 27599 USA; [Rothbart, Scott B.] Van Andel Res Inst, Ctr Epigenet, Grand Rapids, MI 49503 USA; [Ait-Si-Ali, Slimane] Univ Paris Diderot, Sorbonne Paris Cite, Lab Epigenet & Destin Cellulaire, CNRS,UMR7216, F-75013 Paris, France; [Strahl, Brian D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Strahl, Brian D.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Jin, Jian] Icahn Sch Med Mt Sinai, Dept Struct & Chem Biol, Dept Oncol Sci, New York, NY 10029 USA; [Jin, Jian] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Davis, Ian J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pediat, Dept Genet, Chapel Hill, NC 27599 USA; [Davis, Ian J.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Mosley, Amber L.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Mosley, Amber L.] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Van Andel Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Pattenden, SG (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Ctr Integrat Chem Biol & Drug Discovery, Marsico Hall,125 Mason Farm, Chapel Hill, NC 27599 USA.	pattenden@unc.edu	Parker, Joel/AAG-1108-2019; Regan, Clinton/E-6250-2012; Strahl, Brian D/C-7601-2012	Strahl, Brian D/0000-0002-4947-6259; Davis, Ian/0000-0002-1552-0960	National Institutes of Health [CA181343, R01GM110058, R01CA166447, R01GM103893]; W. M. Keck Foundation; National Institutes of Health from NIGMS [R01GM100919]; Carolina Partnership; University Cancer Research Fund, University of North Carolina at Chapel Hill; NATIONAL CANCER INSTITUTE [R00CA181343, R01CA166447, K99CA181343] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108, UL1TR002529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103893, R01GM110058, R01GM100919] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Carolina Partnership; University Cancer Research Fund, University of North Carolina at Chapel Hill; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA181343 (to S. B. R.), R01GM110058 (to B. D. S.), R01CA166447 (to I. J. D), and R01GM103893 (to J. J.). This work was also supported by the W. M. Keck Foundation (to B. D. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Institutes of Health Grant R01GM100919 from NIGMS (awarded to Dr. Stephen Frye) and by the Carolina Partnership and the University Cancer Research Fund, University of North Carolina at Chapel Hill.	Alexandre E, 1996, MECH DEVELOP, V59, P191, DOI 10.1016/0925-4773(96)00594-1; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Baust C, 2002, MAMM GENOME, V13, P423, DOI 10.1007/s00335-002-2178-3; Bian CJ, 2015, ELIFE, V4, DOI 10.7554/eLife.05606; Biggar KK, 2015, NAT REV MOL CELL BIO, V16, P5, DOI 10.1038/nrm3915; Bittencourt D, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-27; Bittencourt D, 2012, P NATL ACAD SCI USA, V109, P19673, DOI 10.1073/pnas.1211803109; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Bunnage ME, 2013, NAT CHEM BIOL, V9, P195, DOI 10.1038/nchembio.1197; Caron C, 2003, EMBO REP, V4, P877, DOI 10.1038/sj.embor.embor917; Caubit X, 2000, MECH DEVELOP, V91, P445, DOI 10.1016/S0925-4773(99)00318-4; Chaturvedi CP, 2009, P NATL ACAD SCI USA, V106, P18303, DOI 10.1073/pnas.0906769106; Chin HG, 2007, NUCLEIC ACIDS RES, V35, P7313, DOI 10.1093/nar/gkm726; Choi H., 2012, CURR PROTOC BIOINFOR, V39; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; CLEARD F, 1995, NUCLEIC ACIDS RES, V23, P796, DOI 10.1093/nar/23.5.796; Cleard F, 1997, EMBO J, V16, P5280, DOI 10.1093/emboj/16.17.5280; Cole PA, 2008, NAT CHEM BIOL, V4, P590, DOI 10.1038/nchembio.111; Collins R, 2010, NUCLEIC ACIDS RES, V38, P3503, DOI 10.1093/nar/gkq081; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Del Rizzo PA, 2014, BBA-GENE REGUL MECH, V1839, P1404, DOI 10.1016/j.bbagrm.2014.06.008; Ding ZH, 2003, MOL CELL BIOL, V23, P250, DOI 10.1128/MCB.23.1.250-258.2003; Dong KB, 2008, EMBO J, V27, P2691, DOI 10.1038/emboj.2008.193; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Florens Laurence, 2006, V328, P159; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Herz HM, 2013, TRENDS BIOCHEM SCI, V38, P621, DOI 10.1016/j.tibs.2013.09.004; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; Konze KD, 2014, CHEMMEDCHEM, V9, P549, DOI 10.1002/cmdc.201300450; Konze KD, 2013, ACS CHEM BIOL, V8, P1324, DOI [10.1021/cb400133J, 10.1021/cb400133j]; Lahn BT, 2002, P NATL ACAD SCI USA, V99, P8707, DOI 10.1073/pnas.082248899; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lassmann T, 2009, BIOINFORMATICS, V25, P2839, DOI 10.1093/bioinformatics/btp527; Lee DY, 2006, J BIOL CHEM, V281, P8476, DOI 10.1074/jbc.M511093200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maier VK, 2015, MOL CELL PROTEOMICS, V14, P1435, DOI 10.1074/mcp.M114.044586; Manfroid I, 2004, DEVELOPMENT, V131, P1065, DOI 10.1242/dev.00977; Matsumoto K, 1998, MOL BRAIN RES, V61, P179, DOI 10.1016/S0169-328X(98)00216-2; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Mosley AL, 2013, MOL CELL PROTEOMICS, V12, P1530, DOI 10.1074/mcp.M112.024034; Mozzetta C, 2015, NAT REV MOL CELL BIO, V16, P499, DOI 10.1038/nrm4029; Mozzetta C, 2014, MOL CELL, V53, P277, DOI 10.1016/j.molcel.2013.12.005; Mulligan P, 2008, MOL CELL, V32, P718, DOI 10.1016/j.molcel.2008.10.025; Oh ST, 2014, FEBS LETT, V588, P685, DOI 10.1016/j.febslet.2014.01.039; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Purcell DJ, 2011, J BIOL CHEM, V286, P41963, DOI 10.1074/jbc.M111.298463; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; REUTER G, 1990, NATURE, V344, P219, DOI 10.1038/344219a0; ROSENBERG UB, 1986, NATURE, V319, P336, DOI 10.1038/319336a0; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; SAUNDERS WS, 1993, J CELL SCI, V104, P573; Shankar SR, 2013, EPIGENETICS-US, V8, P16, DOI 10.4161/epi.23331; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; SINGH PB, 1991, NUCLEIC ACIDS RES, V19, P789, DOI 10.1093/nar/19.4.789; Smith-Kinnaman WR, 2014, MOL BIOSYST, V10, P1730, DOI 10.1039/c4mb00109e; Snowden AW, 2002, CURR BIOL, V12, P2159, DOI 10.1016/S0960-9822(02)01391-X; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; TAKATSUJI H, 1992, EMBO J, V11, P241, DOI 10.1002/j.1460-2075.1992.tb05047.x; TAKATSUJI H, 1994, PLANT CELL, V6, P947, DOI 10.1105/tpc.6.7.947; Takatsuji H, 1996, J BIOL CHEM, V271, P23368, DOI 10.1074/jbc.271.38.23368; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Trojer P, 2009, J BIOL CHEM, V284, P8395, DOI 10.1074/jbc.M807818200; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ueda J, 2006, J BIOL CHEM, V281, P20120, DOI 10.1074/jbc.M603087200; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; Waltzer L, 2001, EMBO J, V20, P137, DOI 10.1093/emboj/20.1.137; Weiss T, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-7; Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Wu H, 2011, CELL RES, V21, P365, DOI 10.1038/cr.2010.157; Yu YX, 2012, MOL CELL, V46, P7, DOI 10.1016/j.molcel.2012.01.019; Yuan XJ, 2007, MOL CELL, V27, P585, DOI 10.1016/j.molcel.2007.06.021	85	20	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26088	26102		10.1074/jbc.M115.654459	http://dx.doi.org/10.1074/jbc.M115.654459			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26338712	Green Published, hybrid			2022-12-26	WOS:000363527300029
J	Alves, LGA; Mendes, RS; Lenzi, EK; Ribeiro, HV				Alves, Luiz G. A.; Mendes, Renio S.; Lenzi, Ervin K.; Ribeiro, Haroldo V.			Scale-Adjusted Metrics for Predicting the Evolution of Urban Indicators and Quantifying the Performance of Cities	PLOS ONE			English	Article							GROWTH; LAWS	More than a half of world population is now living in cities and this number is expected to be two-thirds by 2050. Fostered by the relevancy of a scientific characterization of cities and for the availability of an unprecedented amount of data, academics have recently immersed in this topic and one of the most striking and universal finding was the discovery of robust allometric scaling laws between several urban indicators and the population size. Despite that, most governmental reports and several academic works still ignore these nonlinearities by often analyzing the raw or the per capita value of urban indicators, a practice that actually makes the urban metrics biased towards small or large cities depending on whether we have super or sublinear allometries. By following the ideas of Bettencourt et al. [PLoS ONE 5 (2010) e13541], we account for this bias by evaluating the difference between the actual value of an urban indicator and the value expected by the allometry with the population size. We show that this scale-adjusted metric provides a more appropriate/informative summary of the evolution of urban indicators and reveals patterns that do not appear in the evolution of per capita values of indicators obtained from Brazilian cities. We also show that these scale-adjusted metrics are strongly correlated with their past values by a linear correspondence and that they also display crosscorrelations among themselves. Simple linear models account for 31%-97% of the observed variance in data and correctly reproduce the average of the scale-adjusted metric when grouping the cities in above and below the allometric laws. We further employ these models to forecast future values of urban indicators and, by visualizing the predicted changes, we verify the emergence of spatial clusters characterized by regions of the Brazilian territory where we expect an increase or a decrease in the values of urban indicators.	[Alves, Luiz G. A.; Mendes, Renio S.; Lenzi, Ervin K.; Ribeiro, Haroldo V.] Univ Estadual Maringa, Dept Fis, BR-87020900 Maringa, Parana, Brazil; [Alves, Luiz G. A.; Mendes, Renio S.; Lenzi, Ervin K.] CNPq, Natl Inst Sci & Technol Complex Syst, BR-22290180 Rio De Janeiro, RJ, Brazil; [Lenzi, Ervin K.] Univ Estadual Ponta Grossa, Dept Fis, BR-84030900 Ponta Grossa, PR, Brazil; [Ribeiro, Haroldo V.] Univ Tecnol Fed Parana, Dept Fis, BR-86812460 Apucarana, PR, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Ponta Grossa; Universidade Tecnologica Federal do Parana	Ribeiro, HV (corresponding author), Univ Estadual Maringa, Dept Fis, BR-87020900 Maringa, Parana, Brazil.	hvr@dfi.uem.br	Mendes, Renio/F-9261-2017; Alves, Luiz G A/H-3389-2013; Lenzi, Ervin Kaminski/N-1767-2019; Ribeiro, Haroldo Valentin/C-8614-2012	Alves, Luiz G A/0000-0001-6204-5552; Lenzi, Ervin Kaminski/0000-0003-3853-1790; Ribeiro, Haroldo Valentin/0000-0002-9532-5195	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacaoo de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Araucaria (FA); CNPq [440650/2014-3]; RSM [263/2014]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacaoo de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Araucaria (FA)(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); RSM	This work has been supported by the agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacaoo de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao Araucaria (FA). HVR thanks the financial support of CNPq (grant 440650/2014-3) and RSM thanks FA (grant 263/2014) for partial financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves LGA, 2014, PHYSICA A, V409, P175, DOI 10.1016/j.physa.2014.04.046; Alves LGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069580; Alves LGA, 2013, PHYSICA A, V392, P2672, DOI 10.1016/j.physa.2013.02.002; Angel S., 2005, DYNAMICS GLOBAL URBA; Arbesman S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016115; Arcaute E, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0745; Bettencourt LMA, 2015, HYPOTHESIS URBAN SCA; Bettencourt L, 2010, NATURE, V467, P912, DOI 10.1038/467912a; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Gomez-Lievano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040393; Gordon MB, 2010, EUR J APPL MATH, V21, P283, DOI 10.1017/S0956792510000069; Hanley QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109004; Hesketh T, 2006, P NATL ACAD SCI USA, V103, P13271, DOI 10.1073/pnas.0602203103; Ignazzi C.A., 2014, ESPACE GEOGRAPHIQUE, V43, P324, DOI [DOI 10.3917/EG.434.0324, 10.3917/eg.434.0324]; Jones E., 2001, SCIPY OPEN SOURCE SC; Lobo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058407; Louf R, 2014, ENVIRON PLANN B, V41, P767, DOI 10.1068/b4105c; Louf R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102007; Louf R, 2014, SCI REP-UK, V4, DOI 10.1038/srep05561; Mantovani MC, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.024802; Mantovani MC, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/48001; Melo HPM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06239; Oliveira EA, 2014, SCI REP-UK, V4, DOI 10.1038/srep04235; Ortman SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087902; Pan W, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2961; Podobnik B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00678; Pumain D, 2004, SCALING LAWS URBAN S; Pumain D, 2006, CYBERGEO, DOI 10.4000/cybergeo.2519; Rybski D, 2014, CITIES NUCL SUSTAINA; Samaniego H., 2008, J TRANSP LAND USE, V1, P21, DOI [DOI 10.5198/JTLU.V1I1.29, 10.5198/jtlu.v1i1.29]; Schlapfer M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0789; United Nations, 2014, WORLD FERT REP 2013, P1	34	42	44	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0134862	10.1371/journal.pone.0134862	http://dx.doi.org/10.1371/journal.pone.0134862			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356081	Green Published, gold, Green Submitted			2022-12-26	WOS:000360965800002
J	Matziridi, M; Brenner, E; Smeets, JBJ				Matziridi, Maria; Brenner, Eli; Smeets, Jeroen B. J.			The Role of Temporal Information in Perisaccadic Mislocalization	PLOS ONE			English	Article							SACCADIC EYE-MOVEMENTS; VISUAL-PERCEPTION; PSYCHOPHYSICS TOOLBOX; APPARENT POSITION; LOCALIZATION; STIMULI; COMPRESSION; SPACE; TIME; REPRESENTATION	In dynamic environments, it is crucial to accurately consider the timing of information. For instance, during saccades the eyes rotate so fast that even small temporal errors in relating retinal stimulation by flashed stimuli to extra-retinal information about the eyes' orientations will give rise to substantial errors in where the stimuli are judged to be. If spatial localization involves judging the eyes' orientations at the estimated time of the flash, we should be able to manipulate the pattern of mislocalization by altering the estimated time of the flash. We reasoned that if we presented a relevant flash within a short rapid sequence of irrelevant flashes, participants' estimates of when the relevant flash was presented might be shifted towards the centre of the sequence. In a first experiment, we presented five bars at different positions around the time of a saccade. Four of the bars were black. Either the second or the fourth bar in the sequence was red. The task was to localize the red bar. We found that when the red bar was presented second in the sequence, it was judged to be further in the direction of the saccade than when it was presented fourth in the sequence. Could this be because the red bar was processed faster when more black bars preceded it? In a second experiment, a red bar was either presented alone or followed by two black bars. When two black bars followed it, it was judged to be further in the direction of the saccade. We conclude that the spatial localization of flashed stimuli involves judging the eye orientation at the estimated time of the flash.	[Matziridi, Maria; Brenner, Eli; Smeets, Jeroen B. J.] Vrije Univ Amsterdam, Res Inst MOVE, Dept Human Movement Sci, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Matziridi, M (corresponding author), Vrije Univ Amsterdam, Res Inst MOVE, Dept Human Movement Sci, Amsterdam, Netherlands.	mmatziridi@yahoo.gr	Smeets, Jeroen/B-4198-2008	Smeets, Jeroen/0000-0002-3794-0579; Brenner, Eli/0000-0002-3611-2843	Greek State Scholarships Foundation [10079]; Netherlands Organization for Scientific Research, NWO Vici [453-08-004]	Greek State Scholarships Foundation(Greek Ministry of Development-GSRT); Netherlands Organization for Scientific Research, NWO Vici(Netherlands Organization for Scientific Research (NWO))	The research leading to these results has received funding from the Greek State Scholarships Foundation (www.iky.gr) under grant agreement number 10079 and the Netherlands Organization for Scientific Research (www.nwo.nl), NWO Vici grant 453-08-004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Awater H, 2006, J NEUROSCI, V26, P12, DOI 10.1523/JNEUROSCI.2407-05.2006; Awater H, 2001, PERCEPTION, V30, P24; Awater H, 2004, J NEUROPHYSIOL, V91, P2457, DOI 10.1152/jn.00821.2003; Battellil L, 2008, CURR OPIN NEUROBIOL, V18, P120, DOI 10.1016/j.conb.2008.08.004; Binda P, 2007, J NEUROSCI, V27, P8525, DOI 10.1523/JNEUROSCI.0737-07.2007; Binda P, 2010, J VISION, V10, DOI 10.1167/10.2.7; BISCHOF N, 1968, PSYCHOL FORSCH, V32, P185, DOI 10.1007/BF00418660; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brenner E, 2005, VISION RES, V45, P1587, DOI 10.1016/j.visres.2004.11.020; Brenner E, 2000, VISION RES, V40, P1645, DOI 10.1016/S0042-6989(00)00067-5; Brenner E, 2006, J EXP PSYCHOL HUMAN, V32, P811, DOI 10.1037/0096-1523.32.4.811; Brenner E, 2010, VISION RES, V50, P1101, DOI 10.1016/j.visres.2010.03.004; Brenner E, 2008, J VISION, V8, DOI 10.1167/8.2.7; Cicchini GM, 2013, J NEUROPHYSIOL, V109, P1117, DOI 10.1152/jn.00478.2012; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; DASSONVILLE P, 1992, VISUAL NEUROSCI, V9, P261, DOI 10.1017/S0952523800010671; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; HONDA H, 1989, PERCEPT PSYCHOPHYS, V45, P162, DOI 10.3758/BF03208051; HONDA H, 1991, VISION RES, V31, P1915, DOI 10.1016/0042-6989(91)90186-9; HONDA H, 1993, VISION RES, V33, P709, DOI 10.1016/0042-6989(93)90190-8; HONDA H, 1990, PERCEPT PSYCHOPHYS, V48, P509, DOI 10.3758/BF03211595; Kusunoki M, 2003, J NEUROPHYSIOL, V89, P1519, DOI 10.1152/jn.00519.2002; Lappe M, 2000, NATURE, V403, P892, DOI 10.1038/35002588; Lappe M, 2006, J VISION, V6, P1282, DOI 10.1167/6.11.11; Linares D, 2009, J VISION, V9, DOI 10.1167/9.13.9; Maij F, 2011, J NEUROSCI, V31, P3708, DOI 10.1523/JNEUROSCI.5097-10.2011; Maij F, 2011, VISION RES, V51, P154, DOI 10.1016/j.visres.2010.10.024; Maij F, 2010, J VISION, V10, DOI 10.1167/10.4.7; Maij F, 2009, J NEUROPHYSIOL, V102, P490, DOI 10.1152/jn.91253.2008; MATEEFF S, 1978, PERCEPT PSYCHOPHYS, V24, P215, DOI 10.3758/BF03206092; MATIN L, 1965, SCIENCE, V148, P1485, DOI 10.1126/science.148.3676.1485; MATIN L, 1970, PERCEPT PSYCHOPHYS, V8, P9, DOI 10.3758/BF03208921; Matziridi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062436; Morrone MC, 1997, J NEUROSCI, V17, P7941; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Nava E, 2008, EXP BRAIN RES, V190, P179, DOI 10.1007/s00221-008-1459-9; O'Regan JK, 2001, BEHAV BRAIN SCI, V24, P939, DOI 10.1017/S0140525X01000115; Ostendorf F, 2007, J NEUROSCI, V27, P7559, DOI 10.1523/JNEUROSCI.2074-07.2007; Pola J, 2004, VISION RES, V44, P2799, DOI 10.1016/j.visres.2004.06.008; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Schlag J, 2002, NAT REV NEUROSCI, V3, P191, DOI 10.1038/nrn750; van Mierlo CM, 2009, J VISION, V9, DOI 10.1167/9.3.25	45	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0134081	10.1371/journal.pone.0134081	http://dx.doi.org/10.1371/journal.pone.0134081			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352603	Green Published, Green Submitted, gold			2022-12-26	WOS:000360932800003
J	Tamaki, N; Kurosaki, M; Higuchi, M; Takada, H; Nakakuki, N; Yasui, Y; Suzuki, S; Tsuchiya, K; Nakanishi, H; Itakura, J; Takahashi, Y; Ogawa, S; Tanaka, Y; Asahina, Y; Izumi, N				Tamaki, Nobuharu; Kurosaki, Masayuki; Higuchi, Mayu; Takada, Hitomi; Nakakuki, Natsuko; Yasui, Yutaka; Suzuki, Shoko; Tsuchiya, Kaoru; Nakanishi, Hiroyuki; Itakura, Jun; Takahashi, Yuka; Ogawa, Shintaro; Tanaka, Yasuhito; Asahina, Yasuhiro; Izumi, Namiki			Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New Regimens	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; FATTY LIVER-DISEASE; GENOME-WIDE ASSOCIATION; INTERFERON THERAPY; AMINOTRANSFERASE LEVELS; STEATOSIS; VIRUS; CLEARANCE; INFECTION; IMPACT	The assessment of individual risk of fibrosis progression in patients with chronic hepatitis C is an unmet clinical need. Recent genome-wide association studies have highlighted several genetic alterations as predictive risk factors of rapid fibrosis progression in chronic hepatitis C. However, most of these results require verification, and whether the combined use of these genetic predictors can assess the risk of fibrosis progression remains unclear. Therefore, genetic risk factors associated with fibrosis progression were analyzed in 176 chronic hepatitis C patients who did not achieve sustained virological response by interferon-based therapy and linked to the fibrosis progression rate (FPR). FPR was determined in all patients by paired liver biopsy performed before and after therapy (mean interval: 6.2 years). Mean FPR in patients with IL28B (rs8099917) TG/GG and PNPLA3 (rs738409) CG/GG were significantly higher than in those with IL28B TT (FPR: 0.144 vs. 0.034, P < 0.001) and PNPLA3 CC (FPR: 0.10 vs. 0.018, P = 0.005), respectively. IL28B TG/GG [hazard ratio (HR): 3.9, P = 0.001] and PNPLA3 CG/GG (HR: 3.1, P = 0.04) remained independent predictors of rapid fibrosis progression upon multivariate analysis together with average alanine aminotransferase after interferon therapy >= 40 IU/l (HR: 4.2, P = 0.002). Based on these data, we developed a new clinical score predicting the risk of fibrosis progression (FPR-score). The FPR-score identified subgroups of patients with a low (FPR: 0.005), intermediate (FPR: 0.103, P < 0.001), and high (FPR: 0.197, P < 0.001) risk of fibrosis progression. In conclusion, IL28B and PNPLA3 genotypes are associated with rapid fibrosis progression, and the FPR-score identifies patients who has a high risk of fibrosis progression and require urgent antiviral treatment.	[Tamaki, Nobuharu; Kurosaki, Masayuki; Higuchi, Mayu; Takada, Hitomi; Nakakuki, Natsuko; Yasui, Yutaka; Suzuki, Shoko; Tsuchiya, Kaoru; Nakanishi, Hiroyuki; Itakura, Jun; Takahashi, Yuka; Izumi, Namiki] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Ogawa, Shintaro; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan; [Ogawa, Shintaro; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi, Japan; [Asahina, Yasuhiro] Tokyo Med & Dent Univ, Dept Hepatitis Control, Tokyo, Japan	Nagoya City University; Nagoya City University; Tokyo Medical & Dental University (TMDU)	Izumi, N (corresponding author), Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan.	izumi012@musashino.jrc.or.jp	Nakanishi, Hiroyuki/AAD-9324-2020	Nakanishi, Hiroyuki/0000-0003-3982-3314; Yasui, Yutaka/0000-0002-6117-4990; Tanaka, Yasuhito/0000-0002-2473-6966; Tamaki, Nobuharu/0000-0003-4634-6616	Japan Agency for Medical Research and Development [15fk0210007h0002]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	The authors' financial disclosure is as follows: NI received a grant-in-aid from the Japan Agency for Medical Research and Development (grant number: 15fk0210007h0002, URL: http://www.amed.go.jp). The funder had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Asahina Y, 2013, J GASTROENTEROL, V17, P17; Asahina Y, 2013, HEPATOLOGY, V58, P1253, DOI 10.1002/hep.26442; Bochud PY, 2012, HEPATOLOGY, V55, P384, DOI 10.1002/hep.24678; Carrion JA, 2007, GASTROENTEROLOGY, V132, P1746, DOI 10.1053/j.gastro.2007.03.041; Di Bisceglie AM, 2008, NEW ENGL J MED, V359, P2429, DOI 10.1056/NEJMoa0707615; Fartoux L, 2005, HEPATOLOGY, V41, P82, DOI 10.1002/hep.20519; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2003, GASTROENTEROLOGY, V124, P97, DOI 10.1053/gast.2003.50018; Huang CF, 2015, J HEPATOL, V62, P512, DOI 10.1016/j.jhep.2014.10.011; Kawaguchi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038322; Kitamoto T, 2014, J HUM GENET, V13, P17; Kitamoto T, 2013, HUM GENET, V132, P783, DOI 10.1007/s00439-013-1294-3; KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409; Kurosaki M, 2008, J HEPATOL, V48, P736, DOI 10.1016/j.jhep.2007.12.025; Kurosaki M, 2011, J HEPATOL, V54, P439, DOI 10.1016/j.jhep.2010.07.037; Kyrlagkitsis L, 2003, AM J GASTROENTEROL, V98, P1588, DOI [10.1016/S0002-9270(03)00368-X, 10.1111/j.1572-0241.2003.07539.x]; Leandro G, 2006, GASTROENTEROLOGY, V130, P1636, DOI 10.1053/j.gastro.2006.03.014; LEFKOWITCH JH, 1993, GASTROENTEROLOGY, V104, P595, DOI 10.1016/0016-5085(93)90432-C; Marabita F, 2011, HEPATOLOGY, V54, P1127, DOI 10.1002/hep.24503; Noureddin M, 2013, HEPATOLOGY, V58, P1548, DOI 10.1002/hep.26506; Ohno T, 1997, J CLIN MICROBIOL, V35, P201, DOI 10.1128/JCM.35.1.201-207.1997; Patin E, 2012, GASTROENTEROLOGY, V143, P1244, DOI 10.1053/j.gastro.2012.07.097; Poynard T, 2000, HEPATOLOGY, V32, P1131, DOI 10.1053/jhep.2000.19347; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Puoti C, 2002, J HEPATOL, V37, P117, DOI 10.1016/S0168-8278(02)00101-0; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Rotman Y, 2010, HEPATOLOGY, V52, P894, DOI 10.1002/hep.23759; Shiratori Y, 2000, ANN INTERN MED, V132, P517, DOI 10.7326/0003-4819-132-7-200004040-00002; Stickel F, 2011, HEPATOLOGY, V53, P86, DOI 10.1002/hep.24017; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Trepo E, 2011, HEPATOLOGY, V54, P60, DOI 10.1002/hep.24350; Valenti L, 2011, HEPATOLOGY, V53, P791, DOI 10.1002/hep.24123; Valenti L, 2010, HEPATOLOGY, V51, P1209, DOI 10.1002/hep.23622	37	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137351	10.1371/journal.pone.0137351	http://dx.doi.org/10.1371/journal.pone.0137351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352693	Green Published, Green Submitted, gold			2022-12-26	WOS:000360932800076
J	Yang, J; Zhou, S; Gu, JJ; Guo, MF; Xia, HH; Liu, YZ				Yang, Jing; Zhou, Sheng; Gu, Jianjun; Guo, Minfei; Xia, Honghui; Liu, Yizhi			UPR Activation and the Down-Regulation of alpha-Crystallin in Human High Myopia-Related Cataract Lens Epithelium	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; ER STRESS; TRANSCRIPTION FACTOR; RISK-FACTORS; ATF6; CHAPERONE; RESISTANCE; CLEAVAGE; DISEASES	Purpose To investigate the expression of alpha A- and alpha B-crystallin and the unfolded protein response in the lens epithelium of patients with high myopia-related cataracts. Methods and Materials The central portion of the human anterior lens capsule together with the adhering epithelial cells, approximately 5 mm in diameter, were harvested and processed within two hours after cataract surgery from high myopia-related (spherical equivalent >=-10.00 diopters) and age-related cataract patients or from high myopia but non-cataractous patients (tissue were collected from ocular trauma patients with high myopia and lens trauma). Anterior lens samples from fresh cadaver normal human eyes were used as normal control (collected within 6 hours from death). Real-time PCR was performed to detect the mRNA levels of alpha-crystallins as well as unfolded protein response (UPR)-related GRP78, spliced-XBP1, ATF4 and ATF6. Western blot analysis was used to determine the protein level of alpha-crystallin, GRP78, p-IRE1 alpha, p-eIF2 alpha and ATF6. Results In the lens epithelium of the high myopia-related cataract group and the age related cataract group, the mRNA and soluble protein expression of alpha A- and alpha B-crystallin were both decreased; additionally, the protein levels of ATF6, p-eIF2 alpha and p-IRE1 alpha and the gene expression levels of spliced XBP1, GRP78, ATF6 and ATF4 were greatly increased relative to the normal control. Conclusion These results suggest the significant loss of soluble alpha-crystallin and the activation of the UPR in the lens epithelium of patients with high myopia-related cataract, which may be associated with the cataractogenesis of high myopia-related cataract.	[Yang, Jing; Zhou, Sheng; Gu, Jianjun; Liu, Yizhi] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Sheng] First Peoples Hosp Foshan, Dept Ophthalmol, Foshan, Guangdong, Peoples R China; [Guo, Minfei] Huichang Cty Peoples Hosp, Dept Ophthalmol, Ganzhou, Jiangxi, Peoples R China; [Xia, Honghui] Zhaoqing Gaoyao Peoples Hosp, Dept Ophthalmol, Zhaoqing, Guangdong, Peoples R China	Sun Yat Sen University	Liu, YZ (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	yizhi_liu@aliyun.com	liu, yi/GXE-9662-2022		Chinese State Key Laboratory of Ophthalmology grant [303060202400402001]	Chinese State Key Laboratory of Ophthalmology grant	Funding: This study was supported by the Chinese State Key Laboratory of Ophthalmology grant (No. 303060202400402001) received by Dr. Jing Yang.	Akal A, 2014, INT J OPHTHALMOL-CHI, V7, P828, DOI 10.3980/j.issn.2222-3959.2014.05.16; Alemayehu H, 2014, PEDIATR SURG INT, V30, P649, DOI 10.1007/s00383-014-3513-y; Ali MMU, 2011, EMBO J, V30, P894, DOI 10.1038/emboj.2011.18; Andley UP, 2008, INT J BIOCHEM CELL B, V40, P317, DOI 10.1016/j.biocel.2007.10.034; Boelens WC, 2014, PROG BIOPHYS MOL BIO, V115, P3, DOI 10.1016/j.pbiomolbio.2014.02.005; Fernandez-Buenaga R, 2013, EYE, V27, P795, DOI 10.1038/eye.2013.95; Foufelle F, 2007, M S-MED SCI, V23, P291, DOI 10.1051/medsci/2007233291; Halliday M, 2014, NEUROPHARMACOLOGY, V76, P169, DOI 10.1016/j.neuropharm.2013.08.034; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hegde SM, 2014, INVEST OPHTH VIS SCI, V55, P6398, DOI 10.1167/iovs.14-14623; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Kaufman BJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P1178, DOI 10.1001/archopht.1996.01100140378001; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Lazar C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00433; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; Luo K, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/328791; Ma K, 2002, J BIOL CHEM, V277, P18728, DOI 10.1074/jbc.M200903200; Moreau KL, 2012, TRENDS MOL MED, V18, P273, DOI 10.1016/j.molmed.2012.03.005; Park SW, 2013, SEMIN IMMUNOPATHOL, V35, P351, DOI 10.1007/s00281-013-0370-z; PERKINS ES, 1984, BRIT J OPHTHALMOL, V68, P293, DOI 10.1136/bjo.68.5.293; Praveen MR, 2010, EYE, V24, P686, DOI 10.1038/eye.2009.137; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rzymski T, 2009, CELL CYCLE, V8, P3838, DOI 10.4161/cc.8.23.10086; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; WEALE R, 1980, BRIT J OPHTHALMOL, V64, P311, DOI 10.1136/bjo.64.5.311; Yadav Raj Kumar, 2014, J Cancer Prev, V19, P75, DOI 10.15430/JCP.2014.19.2.75; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Younan C, 2002, INVEST OPHTH VIS SCI, V43, P3625; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhu GY, 2015, J CELL PHYSIOL, V230, P1413, DOI 10.1002/jcp.24923; Zhu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081900	39	10	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137582	10.1371/journal.pone.0137582	http://dx.doi.org/10.1371/journal.pone.0137582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26351848	gold, Green Submitted, Green Published			2022-12-26	WOS:000360932800098
J	Vadyvaloo, V; Hinz, AK				Vadyvaloo, Viveka; Hinz, Angela K.			A LysR-Type Transcriptional Regulator, RovM, Senses Nutritional Cues Suggesting that It Is Involved in Metabolic Adaptation of Yersinia pestis to the Flea Gut	PLOS ONE			English	Article							BORNE TRANSMISSION; BIOFILM FORMATION; VIRULENCE; EVOLUTION; MOTILITY; GENES; PSEUDOTUBERCULOSIS; EXPRESSION; INFECTION; VECTOR	Yersinia pestis has evolved as a clonal variant of Yersinia pseudotuberculosis to cause flea-borne biofilm-mediated transmission of the bubonic plague. The LysR-type transcriptional regulator, RovM, is highly induced only during Y. pestis infection of the flea host. RovM homologs in other pathogens regulate biofilm formation, nutrient sensing, and virulence; including in Y. pseudotuberculosis, where RovM represses the major virulence factor, RovA. Here the role that RovM plays during flea infection was investigated using a Y. pestis KIM6+ strain deleted of rovM, Delta rovM. The Delta rovM mutant strain was not affected in characteristic biofilm gut blockage, growth, or survival during single infection of fleas. Nonetheless, during a co-infection of fleas, the Delta rovM mutant exhibited a significant competitive fitness defect relative to the wild type strain. This competitive fitness defect was restored as a fitness advantage relative to the wild type in a Delta rovM mutant complemented in trans to over-express rovM. Consistent with this, Y. pestis strains, producing elevated transcriptional levels of rovM, displayed higher growth rates, and differential ability to form biofilm in response to specific nutrients in comparison to the wild type. In addition, we demonstrated that rovA was not repressed by RovM in fleas, but that elevated transcriptional levels of rovM in vitro correlated with repression of rovA under specific nutritional conditions. Collectively, these findings suggest that RovM likely senses specific nutrient cues in the flea gut environment, and accordingly directs metabolic adaptation to enhance flea gut colonization by Y. pestis.	[Vadyvaloo, Viveka; Hinz, Angela K.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA	Washington State University	Vadyvaloo, V (corresponding author), Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.	viveka@vetmed.wsu.edu						Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Blumer C, 2005, MICROBIOL-SGM, V151, P3287, DOI 10.1099/mic.0.28098-0; Cathelyn JS, 2007, MOL MICROBIOL, V66, P189, DOI 10.1111/j.1365-2958.2007.05907.x; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chouikha I, 2012, CURR OPIN MICROBIOL, V15, P239, DOI 10.1016/j.mib.2012.02.003; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; Erickson DL, 2007, CELL MICROBIOL, V9, P2658, DOI 10.1111/j.1462-5822.2007.00986.x; Erickson DL, 2006, J BACTERIOL, V188, P1113, DOI 10.1128/JB.188.3.1113-1119.2006; Harris SJ, 1998, MOL MICROBIOL, V28, P705, DOI 10.1046/j.1365-2958.1998.00825.x; Heroven AK, 2008, MOL MICROBIOL, V68, P1179, DOI 10.1111/j.1365-2958.2008.06218.x; Heroven AK, 2007, ADV EXP MED BIOL, V603, P156; Heroven AK, 2006, MOL MICROBIOL, V62, P1469, DOI 10.1111/j.1365-2958.2006.05458.x; Hinnebusch BJ, 2012, YERSINIA: SYSTEMS BIOLOGY AND CONTROL, P1; Hinnebusch BJ, 1998, J INFECT DIS, V178, P1406, DOI 10.1086/314456; Hinnebusch BJ, 1996, SCIENCE, V273, P367, DOI 10.1126/science.273.5273.367; Jarrett CO, 2004, J INFECT DIS, V190, P783, DOI 10.1086/422695; Jones RT, 2013, ISME J, V7, P224, DOI 10.1038/ismej.2012.95; Jones RT, 2012, J MED ENTOMOL, V49, P492, DOI 10.1603/ME11244; Joyce SA, 2003, MOL MICROBIOL, V47, P1445, DOI 10.1046/j.1365-2958.2003.03389.x; Lawrenz MB, 2007, J BACTERIOL, V189, P5963, DOI 10.1128/JB.00528-07; Lehnen D, 2002, MOL MICROBIOL, V45, P521, DOI 10.1046/j.1365-2958.2002.03032.x; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Osborne SE, 2009, P NATL ACAD SCI USA, V106, P3982, DOI 10.1073/pnas.0811669106; Perez JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000428; Perez JC, 2009, P NATL ACAD SCI USA, V106, P4319, DOI 10.1073/pnas.0810343106; Perry RD, 2004, J BACTERIOL, V186, P1638, DOI 10.1128/JB.186.6.1638-1647.2004; Quade N, 2011, ACTA CRYSTALLOGR D, V67, P81, DOI 10.1107/S0907444910049681; Rempe KA, 2012, J BACTERIOL, V194, P2036, DOI 10.1128/JB.06568-11; Richards GR, 2008, J BACTERIOL, V190, P4870, DOI 10.1128/JB.00358-08; Richards GR, 2009, CELL MICROBIOL, V11, P1025, DOI 10.1111/j.1462-5822.2009.01322.x; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Sebbane F, 2004, INFECT IMMUN, V72, P7334, DOI 10.1128/IAI.72.12.7334-7337.2004; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P11766, DOI 10.1073/pnas.0601182103; SELZER G, 1983, CELL, V32, P119, DOI 10.1016/0092-8674(83)90502-0; Spinner JL, 2013, INFECT IMMUN, V81, P4041, DOI 10.1128/IAI.00648-13; STRALEY SC, 1986, INFECT IMMUN, V51, P445, DOI 10.1128/IAI.51.2.445-454.1986; Surgey N, 1996, J BACTERIOL, V178, P1593, DOI 10.1128/jb.178.6.1593-1599.1996; Tanikawa T, 2006, MICROBIOL IMMUNOL, V50, P587, DOI 10.1111/j.1348-0421.2006.tb03833.x; Vadyvaloo V, 2015, MICROBIOL-SGM, V161, P1198, DOI 10.1099/mic.0.000082; Vadyvaloo V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000783	41	17	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137508	10.1371/journal.pone.0137508	http://dx.doi.org/10.1371/journal.pone.0137508			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348850	gold, Green Published, Green Submitted			2022-12-26	WOS:000360897600050
J	Lelieveld, IM; Bottcher, A; Hennermann, JB; Beck, M; Fellgiebel, A				Lelieveld, Irene M.; Boettcher, Anna; Hennermann, Julia B.; Beck, Michael; Fellgiebel, Andreas			Eight-Year Follow-Up of Neuropsychiatric Symptoms and Brain Structural Changes in Fabry Disease	PLOS ONE			English	Article							WHITE-MATTER LESIONS; ALPHA-GALACTOSIDASE; DEPRESSION; MUTATIONS; GENE; HIPPOCAMPUS	Brain structural alterations and neuropsychiatric symptoms have been described repeatedly in Fabry disease, yet cognitive deficits have been shown to be only mild. Here, we aimed to investigate neuropsychiatric symptoms and brain structure longitudinally. We expected no clinically relevant increase of neuropsychiatric symptoms in parallel to increased brain structural alterations. We assessed 14 Fabry patients (46.1 +/- 10.8 years) who had participated in our investigation eight years ago. Patients engaged in neuropsychiatric testing, as well as structural magnetic resonance imaging and angiography to determine white matter lesions, hippocampal volume, and the diameter of the larger intracranial arteries. While Fabry patients did not differ on cognitive performance, they showed progressive and significant hippocampal volume loss over the 8-year observation period. White matter lesions were associated with older age and higher white matter lesion load at baseline, but did not reach statistical significance when comparing baseline to follow-up. Likewise, intracranial artery diameters did not increase significantly. None of the imaging parameters were associated with the neuropsychiatric parameters. Depression frequency reduced from 50% at baseline to 21% at follow-up, but it did not reach significance. This investigation demonstrates clinical stability in cognitive function, while pronounced hippocampal atrophy is apparent throughout the 8 years. Our middle-aged Fabry patients appeared to compensate successfully for progressive hippocampal volume loss. The hippocampal volume decline indicates brain regional neuronal involvement in Fabry disease.	[Lelieveld, Irene M.; Boettcher, Anna; Fellgiebel, Andreas] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychiat & Psychotherapy, D-55122 Mainz, Germany; [Hennermann, Julia B.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Pediat & Adolescent Med, Villa Metab, D-55122 Mainz, Germany; [Beck, Michael] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Human Genet, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Lelieveld, IM (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychiat & Psychotherapy, D-55122 Mainz, Germany.	irene.lelieveld@unimedizin-mainz.de			Shire; Genzyme; Actelion	Shire; Genzyme(Sanofi-AventisGenzyme Corporation); Actelion	The authors of this manuscript have the following competing interests: Michael Beck and Julia Hennermann received unrestricted grants, honoraria and travel support from Shire, Genzyme and Actelion. Andreas Fellgiebel received unrestricted grants, honoraria, and travel support from Shire and Genzyme. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Ashton-Prolla P, 2000, J INVEST MED, V48, P227; Barnes J, 2009, NEUROBIOL AGING, V30, P1711, DOI 10.1016/j.neurobiolaging.2008.01.010; Bolsover FE, 2014, J INHERIT METAB DIS, V37, P177, DOI 10.1007/s10545-013-9643-x; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Davies JP, 1996, EUR J HUM GENET, V4, P219; Desnick RJ, 2003, ANN INTERN MED, V138, P338, DOI 10.7326/0003-4819-138-4-200302180-00014; ENG CM, 1994, HUM MOL GENET, V3, P1795, DOI 10.1093/hmg/3.10.1795; ENG CM, 1993, AM J HUM GENET, V53, P1186; Fellgiebel A, 2012, J INHERIT METAB DIS, V35, P363, DOI 10.1007/s10545-011-9390-9; Fellgiebel A, 2011, CEREBROVASC DIS, V31, P294, DOI 10.1159/000322558; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fotuhi M, 2012, NAT REV NEUROL, V8, P189, DOI 10.1038/nrneurol.2012.27; Germain DP, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-30; Godin O, 2009, CEREBROVASC DIS, V28, P177, DOI 10.1159/000226117; Grady C, 2012, NAT REV NEUROSCI, V13, P491, DOI 10.1038/nrn3256; Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224; Hamilton M, 1986, ASSESSMENT DEPRESSIO, P143, DOI [10.1007/9783642704864_14, 10.1007/978-3-642-70486-4_14, DOI 10.1007/978-3-642-70486-4_14]; Hurting C., 2000, WMS R WECHSLER GEDAC; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; KAYE EM, 1988, ANN NEUROL, V23, P505, DOI 10.1002/ana.410230513; Maletic V, 2007, INT J CLIN PRACT, V61, P2030, DOI 10.1111/j.1742-1241.2007.01602.x; MEANEY C, 1994, HUM MOL GENET, V3, P1019, DOI 10.1093/hmg/3.6.1019; Okeda R, 2008, NEUROPATHOLOGY, V28, P532, DOI 10.1111/j.1440-1789.2008.00883.x; Pfefferbaum A, 2013, NEUROIMAGE, V65, P176, DOI 10.1016/j.neuroimage.2012.10.008; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Radbruch L, 1999, J PAIN SYMPTOM MANAG, V18, P180, DOI 10.1016/S0885-3924(99)00064-0; Reitan R.M., 1979, TRAIL MAKING TEST MA; Rey A, 1964, LEXAMEN CLINIQUE PSY; Salat DH, 2014, NEUROSCIENCE, V276, P174, DOI 10.1016/j.neuroscience.2013.11.041; Schafer Ellen, 2005, Hum Mutat, V25, P412; Schermuly I, 2011, EUR J NEUROL, V18, P347, DOI 10.1111/j.1468-1331.2010.03155.x; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Tuttolomondo A, 2013, CURR PHARM DESIGN, V19, P6014, DOI 10.2174/13816128113199990387; Uceyler N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087054; Villablanca JP, 2006, INVEST RADIOL, V41, P799, DOI 10.1097/01.rli.0000242835.00032.f5; Wang L, 2014, J PSYCHIATR RES, V56, P56, DOI 10.1016/j.jpsychires.2014.05.005; Whybra C, 2004, CLIN GENET, V65, P299, DOI 10.1111/j.1399-0004.2004.00219.x; Yalcin I, 2014, CURR OPIN ANESTHESIO, V27, P520, DOI 10.1097/ACO.0000000000000116; Zimmerman M, 2013, J AFFECT DISORDERS, V150, P384, DOI 10.1016/j.jad.2013.04.028	39	22	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137603	10.1371/journal.pone.0137603	http://dx.doi.org/10.1371/journal.pone.0137603			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340726	Green Published, Green Submitted, gold			2022-12-26	WOS:000360688200070
J	Ben Messaoud, N; Katzarova, I; Lopez, JM				Ben Messaoud, Nabil; Katzarova, Ilina; Lopez, Jose M.			Basic Properties of the p38 Signaling Pathway in Response to Hyperosmotic Shock	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; GENE-EXPRESSION; TRANSDUCTION PATHWAY; EPITHELIAL-CELLS; MAP-KINASES; STRESS; APOPTOSIS; CASCADE; YEAST; PHOSPHORYLATION	Some properties of signaling systems, like ultrasensitivity, hysteresis (a form of biochemical memory), and all-or-none responses at a single cell level, are important to understand the regulation of irreversible processes. Xenopus oocytes are a suitable cell model to study these properties. The p38 MAPK (mitogen-activated protein kinase) pathway is activated by different stress stimuli, including osmostress, and regulates multiple biological processes, from immune response to cell cycle. Recently, we have reported that activation of p38 and JNK regulate osmostress-induced apoptosis in Xenopus oocytes and that sustained activation of p38 accelerates cytochrome c release and caspase-3 activation. However, the signaling properties of p38 in response to hyperosmotic shock have not been studied. Here we show, using Xenopus oocytes as a cell model, that hyperosmotic shock activates the p38 signaling pathway with an ultrasensitive and bimodal response in a time-dependent manner, and with low hysteresis. At a single cell level, p38 activation is not well correlated with cytochrome c release 2 h after hyperosmotic shock, but a good correlation is observed at 4 h after treatment. Interestingly, cytochrome c microinjection induces p38 phosphorylation through caspase-3 activation, and caspase inhibition reduces p38 activation induced by osmostress, indicating that a positive feedback loop is engaged by hyperosmotic shock. To know the properties of the stress protein kinases activated by hyperosmotic shock will facilitate the design of computational models to predict cellular responses in human diseases caused by perturbations in fluid osmolarity.	[Ben Messaoud, Nabil; Katzarova, Ilina; Lopez, Jose M.] Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Unitat Bioquim,Inst Neurociencies, E-08193 Barcelona, Spain	Autonomous University of Barcelona; University of Barcelona	Lopez, JM (corresponding author), Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Unitat Bioquim,Inst Neurociencies, E-08193 Barcelona, Spain.	josemanuel.lopez@uab.cat	Lopez, Jose M/D-1654-2011; Lopez, Jose/AAF-3798-2020	Lopez, Jose M/0000-0002-4104-6262; Lopez, Jose/0000-0002-4104-6262	Spanish Ministerio de Economia y Competitividad [BFU2009-10765, BFU2010-15978]	Spanish Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by the Spanish Ministerio de Economia y Competitividad (grant numbers BFU2009-10765 and BFU2010-15978). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagowski CP, 2001, CURR BIOL, V11, P1176, DOI 10.1016/S0960-9822(01)00330-X; Bagowski CP, 2001, J BIOL CHEM, V276, P1459, DOI 10.1074/jbc.M008050200; Bellou S, 2009, AM J PHYSIOL-CELL PH, V297, pC1477, DOI 10.1152/ajpcell.00058.2009; Ben Messaoud N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124482; Bhuyan AK, 2001, CELL DEATH DIFFER, V8, P63, DOI 10.1038/sj.cdd.4400773; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Clotet J, 2007, METHOD ENZYMOL, V428, P63, DOI 10.1016/S0076-6879(07)28004-8; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Cuenda A, 1996, EMBO J, V15, P4156, DOI 10.1002/j.1460-2075.1996.tb00790.x; Cuenda A, 1998, BIOCHEM J, V333, P11, DOI 10.1042/bj3330011; Cuenda A, 1997, EMBO J, V16, P295, DOI 10.1093/emboj/16.2.295; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; Deak JC, 1998, P NATL ACAD SCI USA, V95, P5595, DOI 10.1073/pnas.95.10.5595; Ferreiro I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-144; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Ito T, 2005, AM J PHYSIOL-REG I, V289, pR432, DOI 10.1152/ajpregu.00027.2004; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lopez Jose M, 2010, Commun Integr Biol, V3, P146; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; Martianez T, 2009, J BIOL CHEM, V284, P23902, DOI 10.1074/jbc.M109.026054; Mitono H, 2005, J APPL PHYSIOL, V99, P902, DOI 10.1152/japplphysiol.00156.2005; Nicke B, 2005, MOL CELL, V20, P673, DOI 10.1016/j.molcel.2005.10.038; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Pelet S, 2011, SCIENCE, V332, P732, DOI 10.1126/science.1198851; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Tomlinson DR, 1999, DIABETOLOGIA, V42, P1271, DOI 10.1007/s001250051439; Wang KKW, 1998, ARCH BIOCHEM BIOPHYS, V356, P187, DOI 10.1006/abbi.1998.0748; Wang L, 2011, J BIOL CHEM, V286, P1951, DOI 10.1074/jbc.M110.166009; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Widmann C, 1998, MOL CELL BIOL, V18, P2416, DOI 10.1128/MCB.18.4.2416	38	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0135249	10.1371/journal.pone.0135249	http://dx.doi.org/10.1371/journal.pone.0135249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335493	Green Submitted, Green Published, gold			2022-12-26	WOS:000360615400003
J	Halder, B; Singh, S; Thakur, SS				Halder, Babli; Singh, Shruti; Thakur, Suman S.			Withania somnifera Root Extract Has Potent Cytotoxic Effect against Human Malignant Melanoma Cells	PLOS ONE			English	Article							CANCER; MICE; SKIN; CARCINOMA; LEAVES; LINES	In Ayurveda, Withania somnifera is commonly known as Ashwagandha, its roots are specifically used in medicinal and clinical applications. It possesses numerous therapeutic actions which include anti-inflammatory, sedative, hypnotic and narcotic. Extracts from this plant have been reported for its anticancer properties. In this study we evaluated for the first time, the cytotoxic effect of Withania root extract on human malignant melanoma A375 cells. The crude extract of Withania was tested for cytotoxicity against A375 cells by MTT assay. Cell morphology of treated A375 cells was visualized through phase contrast as well as fluorescence microscopy. Agarose gel electrophoresis was used to check DNA fragmentation of the crude extract treated cells. Crude extract of Withania root has the potency to reduce viable cell count in dose as well as time dependent manner. Morphological change of the A375 cells was also observed in treated groups in comparison to untreated or vehicle treated control. Apoptotic body and nuclear blebbing were observed in DAPI stained treated cells under fluorescence microscope. A ladder of fragmented DNA was noticed in treated cells. Thus it might be said that the crude water extract of Withania somnifera has potent cytotoxic effect on human malignant melanoma A375 cells.	[Halder, Babli; Singh, Shruti; Thakur, Suman S.] CCMB, CSIR, Telengana 500007, India	Council of Scientific & Industrial Research (CSIR) - India	Thakur, SS (corresponding author), CCMB, CSIR, Uppal Rd, Telengana 500007, India.	sst@ccmb.res.in		Thakur, Suman/0000-0001-5928-8836	Department of Biotechnology, India; Council of Scientific and Industrial Research, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	The authors are thankful to the Department of Biotechnology, India and Council of Scientific and Industrial Research, India for funding.	Aggarwal BB, 2006, EXPERT OPIN THER TAR, V10, P87, DOI 10.1517/14728222.10.1.87; Ahmad M, 2005, HUM EXP TOXICOL, V24, P137, DOI 10.1191/0906327105ht209oa; Bhattacharya A, 2001, J ETHNOPHARMACOL, V74, P1, DOI 10.1016/S0378-8741(00)00309-3; Bhattacharya S K, 1997, Indian J Exp Biol, V35, P236; Bone K, 1996, MONOGRAPHS W HERBAL; BREKHMAN II, 1969, ANNU REV PHARMACOLOG, V9, P419, DOI 10.1146/annurev.pa.09.040169.002223; Chatterjee A, 1995, NEW DELHI PUBLICATIO, V4, P208; Chatterjee A., 1995, TREATISE INDIAN MED, V4, P208; Davis L, 2002, J EXP CLIN CANC RES, V21, P585; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Jayaprakasam B, 2003, LIFE SCI, V74, P125, DOI 10.1016/j.lfs.2003.07.007; Jerant AF, 2000, AM FAM PHYSICIAN, V62, P357; Kaur K, 2004, FOOD CHEM TOXICOL, V42, P2015, DOI 10.1016/j.fct.2004.07.015; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; Mathur S, 2004, PHYTOMEDICINE, V11, P452, DOI 10.1016/j.phymed.2003.05.004; Muralikrishnan G, 2010, IMMUNOL INVEST, V39, P688, DOI 10.3109/08820139.2010.487083; Nagashayana N, 2000, J NEUROL SCI, V176, P124, DOI 10.1016/S0022-510X(00)00329-4; Prakash J, 2002, NUTR CANCER, V42, P91, DOI 10.1207/S15327914NC421_12; Singh B, 2001, PHYTOTHER RES, V15, P311, DOI 10.1002/ptr.858; SINGH N, 1982, International Journal of Crude Drug Research, V20, P29; SINGH N, 1986, International Journal of Crude Drug Research, V24, P90; Singh N, 1986, ANN NAT ACAD IND MED, V2, P14; Singh N, 1976, P IND PHARM SOC, V17; Singh SP, 1979, P 11 ANN C IND PHARM, V11, P65; Yadav B, 2010, INDIAN J PHARM SCI, V72, P659, DOI 10.4103/0250-474X.78543; Yang ES, 2011, CHEM-BIOL INTERACT, V190, P9, DOI 10.1016/j.cbi.2011.01.015; Yu YK, 2010, BIOCHEM PHARMACOL, V79, P542, DOI 10.1016/j.bcp.2009.09.017	27	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137498	10.1371/journal.pone.0137498	http://dx.doi.org/10.1371/journal.pone.0137498			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334881	gold, Green Published, Green Submitted			2022-12-26	WOS:000360615400062
J	Thurman, JM; Wong, M; Renner, B; Frazer-Abel, A; Giclas, PC; Joy, MS; Jalal, D; Radeva, MK; Gassman, J; Gipson, DS; Kaskel, F; Friedman, A; Trachtman, H				Thurman, Joshua M.; Wong, Maria; Renner, Brandon; Frazer-Abel, Ashley; Giclas, Patricia C.; Joy, Melanie S.; Jalal, Diana; Radeva, Milena K.; Gassman, Jennifer; Gipson, Debbie S.; Kaskel, Frederick; Friedman, Aaron; Trachtman, Howard			Complement Activation in Patients with Focal Segmental Glomerulosclerosis	PLOS ONE			English	Article							ALTERNATIVE PATHWAY; CONTRIBUTES; PRODUCTS; CHILDREN; DISEASE; SAMPLES; PLASMA	Background Recent pre-clinical studies have shown that complement activation contributes to glomerular and tubular injury in experimental FSGS. Although complement proteins are detected in the glomeruli of some patients with FSGS, it is not known whether this is due to complement activation or whether the proteins are simply trapped in sclerotic glomeruli. We measured complement activation fragments in the plasma and urine of patients with primary FSGS to determine whether complement activation is part of the disease process. Study Design Plasma and urine samples from patients with biopsy-proven FSGS who participated in the FSGS Clinical Trial were analyzed. Setting and Participants We identified 19 patients for whom samples were available from weeks 0, 26, 52 and 78. The results for these FSGS patients were compared to results in samples from 10 healthy controls, 10 patients with chronic kidney disease (CKD), 20 patients with vasculitis, and 23 patients with lupus nephritis. Outcomes Longitudinal control of proteinuria and estimated glomerular filtration rate (eGFR). Measurements Levels of the complement fragments Ba, Bb, C4a, and sC5b-9 in plasma and urine. Results Plasma and urine Ba, C4a, sC5b-9 were significantly higher in FSGS patients at the time of diagnosis than in the control groups. Plasma Ba levels inversely correlated with the eGFR at the time of diagnosis and at the end of the study. Plasma and urine Ba levels at the end of the study positively correlated with the level of proteinuria, the primary outcome of the study. Limitations Limited number of patients with samples from all time-points. Conclusions The complement system is activated in patients with primary FSGS, and elevated levels of plasma Ba correlate with more severe disease. Measurement of complement fragments may identify a subset of patients in whom the complement system is activated. Further investigations are needed to confirm our findings and to determine the prognostic significance of complement activation in patients with FSGS.	[Thurman, Joshua M.; Wong, Maria; Renner, Brandon; Joy, Melanie S.; Jalal, Diana] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA; [Frazer-Abel, Ashley; Giclas, Patricia C.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Radeva, Milena K.; Gassman, Jennifer] Cleveland Clin Fdn, Cleveland, OH 44195 USA; [Gipson, Debbie S.] Univ Michigan, CS Mott Childrens Hosp, Dept Pediat, Ann Arbor, MI 48109 USA; [Kaskel, Frederick] Childrens Hosp Montefiore, Albert Einstein Coll Med, Dept Pediat, Bronx, NY USA; [Friedman, Aaron] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; [Trachtman, Howard] NYU Langone Med Ctr, NYU Sch Med, Dept Pediat, New York, NY 10016 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health; Cleveland Clinic Foundation; University of Michigan System; University of Michigan; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; University of Minnesota System; University of Minnesota Twin Cities; New York University; NYU Langone Medical Center	Trachtman, H (corresponding author), NYU Langone Med Ctr, NYU Sch Med, Dept Pediat, New York, NY 10016 USA.	howard.trachtman@nyumc.org	Trachtman, Howard/GSE-2340-2022	Thurman, Joshua Michael/0000-0002-3476-9956; Trachtman, Howard/0000-0001-7447-9489; Jalal, Diana/0000-0002-1975-8650; Gipson, Debbie/0000-0003-4473-9045	NIH-NIDDK [RO1-DK076690, U01-DK063385, DK063490, DK063455, DK063549]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK063490, U01DK063549, U01DK063455, U01DK063385, R01DK076690] Funding Source: NIH RePORTER	NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH-NIDDK RO1-DK076690 (JT), NIH-NIDDK U01-DK063385, NIH-NIDDK DK063490, NIH-NIDDK DK063455, and NIH-NIDDK DK063549 (HT, MR, JG, DG, FK, AF).	Chua JS, 2015, J AM SOC NEPHROL; Chun MJ, 2004, J AM SOC NEPHROL, V15, P2169, DOI 10.1097/01.ASN.0000135051.62500.97; Cosio FG, 1996, CLIN NEPHROL, V45, P146; D'Agati VD, 2004, AM J KIDNEY DIS, V43, P368, DOI 10.1053/j.ajkd.2003.10.024; DAHA MR, 1976, J IMMUNOL, V117, P630; Daina E, 2012, NEW ENGL J MED, V366, P1161, DOI 10.1056/NEJMc1112273; Fernandez-Fresnedo G, 2009, CLIN J AM SOC NEPHRO, V4, P1317, DOI 10.2215/CJN.00570109; GEPHARDT GN, 1986, ARCH PATHOL LAB MED, V110, P902; Gipson DS, 2011, KIDNEY INT, V80, P868, DOI 10.1038/ki.2011.195; Gipson DS, 2011, KIDNEY INT, V79, P678, DOI 10.1038/ki.2010.485; Gou SJ, 2013, KIDNEY INT, V83, P129, DOI 10.1038/ki.2012.313; HABIB R, 1988, PEDIATR NEPHROL, V2, P402, DOI 10.1007/BF00853431; HEBERT LA, 1991, KIDNEY INT, V39, P811, DOI 10.1038/ki.1991.102; Kiffel J, 2011, ADV CHRONIC KIDNEY D, V18, P332, DOI 10.1053/j.ackd.2011.03.005; Korbet SM, 2012, J AM SOC NEPHROL, V23, P1769, DOI 10.1681/ASN.2012040389; Lenderink AM, 2007, AM J PHYSIOL-RENAL, V293, pF555, DOI 10.1152/ajprenal.00403.2006; McCarthy ET, 2010, CLIN J AM SOC NEPHRO, V5, P2115, DOI 10.2215/CJN.03800609; MOLLNES TE, 1988, CLIN EXP IMMUNOL, V73, P484; Morita Y, 2000, J AM SOC NEPHROL, V11, P700, DOI 10.1681/ASN.V114700; Nangaku M, 1999, J AM SOC NEPHROL, V10, P2323; NEWMAN WJ, 1976, MEDICINE, V55, P67, DOI 10.1097/00005792-197601000-00004; PERRIN LH, 1975, J CLIN INVEST, V56, P165, DOI 10.1172/JCI108065; Pfeifer PH, 1999, CLIN CHEM, V45, P1190; Pickering MC, 2013, KIDNEY INT, V84, P1079, DOI 10.1038/ki.2013.377; Renner B, 2013, J AM SOC NEPHROL, V24, P1849, DOI 10.1681/ASN.2012111064; Sadowski CE, 2015, J AM SOC NEPHROL, V26, P1279, DOI 10.1681/ASN.2014050489; Salinas-Carmona MC, 2009, AUTOIMMUNITY, V42, P537, DOI 10.1080/08916930903019119; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Sethna C, 2011, J TRANSPLANT, V2011, DOI 10.1155/2011/389542; Strassheim D, 2013, J AM SOC NEPHROL, V24, P393, DOI 10.1681/ASN.2012020187; Sun QQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036654; Thurman JM, 2009, CLIN J AM SOC NEPHRO, V4, P1920, DOI 10.2215/CJN.02730409; Turnberg D, 2006, J IMMUNOL, V177, P4094, DOI 10.4049/jimmunol.177.6.4094; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wei CL, 2012, J AM SOC NEPHROL, V23, P2051, DOI 10.1681/ASN.2012030302; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411	36	37	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136558	10.1371/journal.pone.0136558	http://dx.doi.org/10.1371/journal.pone.0136558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335102	gold, Green Published, Green Submitted			2022-12-26	WOS:000360615400016
J	Morishita, Y; Tsutsumi, K; Ohta, Y				Morishita, Yuji; Tsutsumi, Koji; Ohta, Yasutaka			Phosphorylation of Serine 402 Regulates RacGAP Protein Activity of FilGAP Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; RHO GTPASES; FILAMIN-A; ADHESION; KINASE; CROSSTALK; GAPS; GEFS	FilGAP is a Rho GTPase-activating protein (GAP) that specifically regulates Rac. FilGAP is phosphorylated by ROCK, and this phosphorylation stimulates its RacGAP activity. However, it is unclear how phosphorylation regulates cellular functions and localization of FilGAP. We found that non-phosphorylatable FilGAP (ST/A) mutant is predominantly localized to the cytoskeleton along actin filaments and partially co-localized with vinculin around cell periphery, whereas phosphomimetic FilGAP (ST/D) mutant is diffusely cytoplasmic. Moreover, phosphorylated FilGAP detected by Phos-tag is also mainly localized in the cytoplasm. Of the six potential phosphorylation sites in FilGAP tested, only mutation of serine 402 to alanine (S402A) resulted in decreased cell spreading on fibronectin. FilGAP phosphorylated at Ser-402 is localized to the cytoplasm but not at the cytoskeleton. Although Ser-402 is highly phosphorylated in serum-starved quiescent cells, dephosphorylation of Ser-402 is accompanied with the cell spreading on fibronectin. Treatment of the cells expressing wild-type FilGAP with calyculin A, a Ser/Thr phosphatase inhibitor, suppressed cell spreading on fibronectin, whereas cells transfected with FilGAP S402A mutant were not affected by calyculin A. Expression of constitutively activate Arf6 Q67L mutant stimulated membrane blebbing activity of both non-phosphorylatable (ST/A) and phosphomimetic (ST/D) FilGAP mutants. Conversely, depletion of endogenous Arf6 suppressed membrane blebbing induced by FilGAP (ST/A) and (ST/D) mutants. Our study suggests that Arf6 and phosphorylation of FilGAP may regulate FilGAP, and phosphorylation of Ser-402 may play a role in the regulation of cell spreading on fibronectin.	[Morishita, Yuji; Tsutsumi, Koji; Ohta, Yasutaka] Kitasato Univ, Sch Sci, Dept Biosci, Div Cell Biol,Minami Ku, Sagamihara, Kanagawa 2520373, Japan	Kitasato University	Ohta, Y (corresponding author), Kitasato Univ, Sch Sci, Dept Biosci, Div Cell Biol,Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.	yohta@kitasato-u.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grant for All Kitasato Project Study; Kitasato University Research Grant for Young Researchers	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grant for All Kitasato Project Study; Kitasato University Research Grant for Young Researchers	This work was supported by grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology of Japan, a Grant for All Kitasato Project Study, and a Kitasato University Research Grant for Young Researchers. The authors declare that they have no conflicts of interest with the contents of this article.	Bianchi M, 2005, BIOCHEM J, V391, P359, DOI 10.1042/BJ20050282; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cook DR, 2014, ONCOGENE, V33, P4021, DOI 10.1038/onc.2013.362; Ehrlicher AJ, 2011, NATURE, V478, P260, DOI 10.1038/nature10430; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Hall EH, 2009, J BIOL CHEM, V284, P34713, DOI 10.1074/jbc.M109.059592; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kawaguchi K, 2014, J BIOL CHEM, V289, P9675, DOI 10.1074/jbc.M113.546051; Kiely PA, 2006, MOL CELL BIOL, V26, P4041, DOI 10.1128/MCB.01868-05; Kinoshita E, 2011, PROTEOMICS, V11, P319, DOI 10.1002/pmic.201000472; Kinoshita-Kikuta E, 2007, MOL CELL PROTEOMICS, V6, P356, DOI 10.1074/mcp.T600044-MCP200; Kong M, 2007, J BIOL CHEM, V282, P29712, DOI 10.1074/jbc.M703159200; Lawson Campbell D, 2014, Small GTPases, V5, pe27958, DOI 10.4161/sgtp.27958; McCormack J, 2013, J CELL SCI, V126, P379, DOI 10.1242/jcs.097923; Miller NLG, 2014, CURR MOL MED, V14, P221, DOI 10.2174/1566524014666140128110339; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2013, BIOCHEM J, V453, P17, DOI 10.1042/BJ20130290; Nakamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004928; Nieves B, 2010, J CELL SCI, V123, P1216, DOI 10.1242/jcs.056549; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Petrie RJ, 2012, J CELL SCI, V125, P5917, DOI 10.1242/jcs.093732; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sadok Amine, 2014, Small GTPases, V5, pe29710, DOI 10.4161/sgtp.29710; Saito K, 2012, MOL BIOL CELL, V23, P4739, DOI 10.1091/mbc.E12-04-0310; Shifrin Y, 2009, MOL BIOL CELL, V20, P1269, DOI 10.1091/mbc.E08-08-0872; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; van Buul JD, 2014, CELL ADHES MIGR, V8, P108, DOI 10.4161/cam.27599; Winograd-Katz SE, 2014, NAT REV MOL CELL BIO, V15, P273, DOI 10.1038/nrm3769; Wolfenson H, 2013, DEV CELL, V24, P447, DOI 10.1016/j.devcel.2013.02.012	36	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26328	26338		10.1074/jbc.M115.666875	http://dx.doi.org/10.1074/jbc.M115.666875			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26359494	hybrid, Green Published			2022-12-26	WOS:000363527300048
J	Cabrera, M; Gomez, N; Lenicov, FR; Echeverria, E; Shayo, C; Moglioni, A; Fernandez, N; Davio, C				Cabrera, Maia; Gomez, Natalia; Remes Lenicov, Federico; Echeverria, Emiliana; Shayo, Carina; Moglioni, Albertina; Fernandez, Natalia; Davio, Carlos			G2/M Cell Cycle Arrest and Tumor Selective Apoptosis of Acute Leukemia Cells by a Promising Benzophenone Thiosemicarbazone Compound	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; TAXOL-INDUCED APOPTOSIS; CATHEPSIN-L INHIBITORS; IRON CHELATORS; IN-VITRO; ANTITUMOR-ACTIVITY; MITOTIC ARREST; FUNCTIONALIZED BENZOPHENONE; RIBONUCLEOTIDE REDUCTASE; SPINDLE CHECKPOINT	Anti-mitotic therapies have been considered a hallmark in strategies against abnormally proliferating cells. Focusing on the extensively studied family of thiosemicarbazone (TSC) compounds, we have previously identified 4,4'-dimethoxybenzophenone thiosemicarbazone (T44Bf) as a promising pharmacological compound in a panel of human leukemia cell lines (HL60, U937, KG1a and Jurkat). Present findings indicate that T44Bf-mediated antiproliferative effects are associated with a reversible chronic mitotic arrest caused by defects in chromosome alignment, followed by induced programmed cell death. Furthermore, T44Bf selectively induces apoptosis in leukemia cell lines when compared to normal peripheral bloodmononuclear cells. The underlying mechanism of action involves the activation of the mitochondria signaling pathway, with loss of mitochondrial membrane potential and sustained phosphorylation of anti-apoptotic protein Bcl-xL as well as increased Bcl-2 (enhanced phosphorylated fraction) and pro-apoptotic protein Bad levels. In addition, ERK signaling pathway activation was found to be a requisite for T44Bf apoptotic activity. Our findings further describe a novel activity for a benzophenone thiosemicarbazone and propose T44Bf as a promising anti-mitotic prototype to develop chemotherapeutic agents to treat acute leukemia malignancies.	[Cabrera, Maia; Gomez, Natalia; Echeverria, Emiliana; Fernandez, Natalia; Davio, Carlos] UBA, CONICET, ININFA, Inst Invest Farmacol,Fac Farm & Bioquim, Buenos Aires, DF, Argentina; [Remes Lenicov, Federico] UBA, CONICET, INBIRS, Inst Invest Biomed Retrovirus,Fac Med, Buenos Aires, DF, Argentina; [Remes Lenicov, Federico] UBA, CONICET, INBIRS, SIDA,Fac Med, Buenos Aires, DF, Argentina; [Shayo, Carina] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, IBYME, RA-1033 Buenos Aires, DF, Argentina; [Moglioni, Albertina] UBA, CONICET, IQUIMEFA, Inst Quim & Metab Farm,Fac Farm & Bioquim, Buenos Aires, DF, Argentina; [Gomez, Natalia; Moglioni, Albertina; Fernandez, Natalia; Davio, Carlos] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Quim Med, RA-1113 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Cabrera, M (corresponding author), UBA, CONICET, ININFA, Inst Invest Farmacol,Fac Farm & Bioquim, Buenos Aires, DF, Argentina.	cabrera.maia@gmail.com			Universidad de Buenos Aires UBACyT [20020100100601]; Agencia Nacional de Promocion Cientifica y Tecnologica [Prestamo BID-PICT-2013-2050]	Universidad de Buenos Aires UBACyT(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by grants from the Universidad de Buenos Aires UBACyT 20020100100601 CD; Agencia Nacional de Promocion Cientifica y Tecnologica: Prestamo BID-PICT-2013-2050 CD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham R, 1996, DRUG SAFETY, V15, P406, DOI 10.2165/00002018-199615060-00005; Aguirre G, 2004, BIOORGAN MED CHEM, V12, P4885, DOI 10.1016/j.bmc.2004.07.003; Alho MA, 2000, ARKIVOC, Viv, P627; Bacus SS, 2001, ONCOGENE, V20, P147, DOI 10.1038/sj.onc.1204062; BAUER DJ, 1969, AM J EPIDEMIOL, V90, P130, DOI 10.1093/oxfordjournals.aje.a121057; Belaud-Rotureau MA, 2000, LEUKEMIA, V14, P1266, DOI 10.1038/sj.leu.2401803; Beraldo H, 2004, MINI-REV MED CHEM, V4, P31, DOI 10.2174/1389557043487484; Berndtsson M, 2005, FEBS LETT, V579, P3090, DOI 10.1016/j.febslet.2005.04.067; Bharti N, 2004, BIOORGAN MED CHEM, V12, P4679, DOI 10.1016/j.bmc.2004.06.036; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Buschini A, 2009, J INORG BIOCHEM, V103, P666, DOI 10.1016/j.jinorgbio.2008.12.016; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Chan KS, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.148; Chao J, 2012, CANCER CHEMOTH PHARM, V69, P835, DOI 10.1007/s00280-011-1779-5; Chavarria GE, 2012, EUR J MED CHEM, V58, P568, DOI 10.1016/j.ejmech.2012.10.039; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cleveland DW, CANC CELL, V8, P7; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Elloumi-Mseddi J, 2014, J RECEPT SIG TRANSD, P1; Finkielsztein LM, 2008, EUR J MED CHEM, V43, P1767, DOI 10.1016/j.ejmech.2007.10.023; Fung TK, 2005, SEMIN CELL DEV BIOL, V16, P335, DOI 10.1016/j.semcdb.2005.02.014; Fung TK, 2007, MOL BIOL CELL, V18, P1861, DOI 10.1091/mbc.E06-12-1092; Furukawa Y, 2000, J BIOL CHEM, V275, P21661, DOI 10.1074/jbc.M906893199; Gan CF, 2014, STEROIDS, V87, P99, DOI 10.1016/j.steroids.2014.05.026; HAIM N, 1994, CANCER, V73, P2515, DOI 10.1002/1097-0142(19940515)73:10<2515::AID-CNCR2820731011>3.0.CO;2-G; HAIM N, 1991, ACTA ONCOL, V30, P707, DOI 10.3109/02841869109092444; Han CR, 2012, BIOORG MED CHEM LETT, V22, P945, DOI 10.1016/j.bmcl.2011.12.023; HEINER GG, 1971, AM J EPIDEMIOL, V94, P435, DOI 10.1093/oxfordjournals.aje.a121340; Hortobagyi GN, 1997, DRUGS, V54, P1, DOI 10.2165/00003495-199700544-00003; Huang H, 2010, J MED CHEM, V53, P3048, DOI 10.1021/jm9014394; Hughes JP, 2011, BRIT J PHARMACOL, V162, P1239, DOI 10.1111/j.1476-5381.2010.01127.x; Ibrado AM, 1998, LEUKEMIA, V12, P1930, DOI 10.1038/sj.leu.2401218; Kalinowski DS, 2007, J MED CHEM, V50, P3716, DOI 10.1021/jm070445z; Kalinowski DS, 2009, FUTURE MED CHEM, V1, P1143, DOI [10.4155/fmc.09.80, 10.4155/FMC.09.80]; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kikuchi R, 2014, J BIOL CHEM, V289, P3457, DOI 10.1074/jbc.M113.514430; Kizilcikli I, 2007, FOLIA MICROBIOL, V52, P15, DOI 10.1007/BF02932132; Kumar GDK, 2010, BIOORG MED CHEM LETT, V20, P6610, DOI 10.1016/j.bmcl.2010.09.026; Kumar GDK, 2010, BIOORG MED CHEM LETT, V20, P1415, DOI 10.1016/j.bmcl.2009.12.090; Kunos CA, 2013, GYNECOL ONCOL, V130, P75, DOI 10.1016/j.ygyno.2013.04.019; Kunos CA, 2010, CLIN CANCER RES, V16, P1298, DOI 10.1158/1078-0432.CCR-09-2469; Ling YH, 1998, J BIOL CHEM, P273; Liu MY, 2014, ACTA PHARMACOL SIN, V35, P1302, DOI 10.1038/aps.2014.71; Matson DR, 2011, MOL INTERV, V11, P141, DOI 10.1124/mi.11.2.12; MCCULLOCH EA, 1983, BLOOD, V62, P1; Mendes IC, 2008, EUR J MED CHEM, V43, P1454, DOI 10.1016/j.ejmech.2007.09.016; Michel L, 2004, P NATL ACAD SCI USA, V101, P4459, DOI 10.1073/pnas.0306069101; Mondesire WH, 2004, CLIN CANCER RES, V10, P7031, DOI 10.1158/1078-0432.CCR-04-0361; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Mortazavi A, 2013, INVEST NEW DRUG, V31, P685, DOI 10.1007/s10637-012-9863-1; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Nguyen TTT, 2004, CARCINOGENESIS, V25, P647, DOI 10.1093/carcin/bgh052; Otero L, 2006, J MED CHEM, V49, P3322, DOI 10.1021/jm0512241; Pathan N, 2001, NEOPLASIA, V3, P550, DOI 10.1038/sj.neo.7900213; Pelosi G, 2010, OPEN CRYSTALLOGRAPHY; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Rao VA, 2013, ANTIOXID REDOX SIGN, V18, P930, DOI 10.1089/ars.2012.4877; Richardson DR, 2009, J MED CHEM, V52, P1459, DOI 10.1021/jm801585u; Schimmer AD, 2001, BLOOD, V98, P3541, DOI 10.1182/blood.V98.13.3541; Shao JM, 2006, MOL CANCER THER, V5, P586, DOI 10.1158/1535-7163.MCT-05-0384; Shapiro GI, 1999, J CLIN INVEST, V104, P1645, DOI 10.1172/JCI9054; Stahnke K, 2003, LEUKEMIA, V17, P2130, DOI 10.1038/sj.leu.2403144; Su TT, 2001, CURR BIOL, V11, pR467, DOI 10.1016/S0960-9822(01)00283-4; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Terrano DT, 2010, MOL CELL BIOL, V30, P640, DOI 10.1128/MCB.00882-09; Thomadaki H, 2009, ANN NY ACAD SCI, V1171, P276, DOI 10.1111/j.1749-6632.2009.04912.x; Topham CH, 2013, CURR OPIN CELL BIOL, V25, P780, DOI 10.1016/j.ceb.2013.07.003; Tsai SC, 2012, INT J ONCOL, V41, P2065, DOI 10.3892/ijo.2012.1640; Tyagi C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S8-S10; Vogel C, 2005, J BIOL CHEM, V280, P4025, DOI 10.1074/jbc.C400545200; Wang TH, 2000, CANCER, V88, P2619, DOI 10.1002/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yu Y, 2009, J MED CHEM, V52, P5271, DOI 10.1021/jm900552r; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868; Zeglis BM, 2011, J MED CHEM, V54, P2391, DOI 10.1021/jm101532u	77	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0136878	10.1371/journal.pone.0136878	http://dx.doi.org/10.1371/journal.pone.0136878			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360247	Green Submitted, Green Published, gold			2022-12-26	WOS:000361043100018
J	Espino, M; Font-Llitjos, M; Vilches, C; Salido, E; Prat, E; de Heredia, ML; Palacin, M; Nunes, V				Espino, Meritxell; Font-Llitjos, Mariona; Vilches, Clara; Salido, Eduardo; Prat, Esther; Lopez de Heredia, Miguel; Palacin, Manuel; Nunes, Virginia			Digenic Inheritance in Cystinuria Mouse Model	PLOS ONE			English	Article							MUTATIONS; SLC7A9; SLC3A1; REABSORPTION; MICE	Cystinuria is an aminoaciduria caused by mutations in the genes that encode the two subunits of the amino acid transport system b(0,+), responsible for the renal reabsorption of cystine and dibasic amino acids. The clinical symptoms of cystinuria relate to nephrolithiasis, due to the precipitation of cystine in urine. Mutations in SLC3A1, which codes for the heavy subunit rBAT, cause cystinuria type A, whereas mutations in SLC7A9, which encodes the light subunit b(0,+) AT, cause cystinuria type B. By crossing Slc3a(1-/-) with Slc7a9(-/-) mice we generated a type AB cystinuria mouse model to test digenic inheritance of cystinuria. The 9 genotypes obtained have been analyzed at early (2- and 5-months) and late stage (8-months) of the disease. Monitoring the lithiasic phenotype by X-ray, urine amino acid content analysis and protein expression studies have shown that double heterozygous mice (Slc7a9(+/-)Slc3a1(+/-)) present lower expression of system b(0,+) and higher hyperexcretion of cystine than single heterozygotes (Slc7a9(+/-)Slc3a1(+/+) and Slc7a9(+/+) Slc3a1(+/-)) and give rise to lithiasis in 4% of the mice, demonstrating that cystinuria has a digenic inheritance in this mouse model. Moreover in this study it has been demonstrated a genotype/phenotype correlation in type AB cystinuria mouse model providing new insights for further molecular and genetic studies of cystinuria patients.	[Espino, Meritxell; Font-Llitjos, Mariona; Vilches, Clara; Prat, Esther; Lopez de Heredia, Miguel; Nunes, Virginia] Bellvitge Biomed Res Inst IDIBELL, Mol Genet Lab, Barcelona, Spain; [Font-Llitjos, Mariona; Lopez de Heredia, Miguel; Nunes, Virginia] Ctr Biomed Network Res Rare Dis CIBERER, U730, Barcelona, Spain; [Salido, Eduardo] Canarias Univ Hosp La Laguna, Dept Pathol, Tenerife, Spain; [Salido, Eduardo] Ctr Biomed Network Res Rare Dis CIBERER, U740, Tenerife, Spain; [Palacin, Manuel] IRB, Barcelona, Spain; [Palacin, Manuel] Ctr Biomed Network Res Rare Dis CIBERER, U731, Barcelona, Spain; [Palacin, Manuel] Univ Barcelona, Biochem & Mol Biol Dept, Barcelona, Spain; [Nunes, Virginia] Univ Barcelona, Genet Sect, Physiol Sci Dept 2, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; University of Barcelona	Nunes, V (corresponding author), Bellvitge Biomed Res Inst IDIBELL, Mol Genet Lab, Barcelona, Spain.	vnunes@idibell.cat	Nunes, Virginia/AAD-1014-2019; Guarch, Meritxell Espino/AAR-4026-2020; López de Heredia, Miguel/A-7727-2008; Palacín, Manuel/G-9786-2015; Salido, Eduardo/I-2232-2015	Nunes, Virginia/0000-0002-5747-9310; Guarch, Meritxell Espino/0000-0002-7211-3229; López de Heredia, Miguel/0000-0003-2826-9565; Salido, Eduardo/0000-0001-9599-9854; Palacin, Manuel/0000-0002-8670-293X; Vilches, Clara/0000-0002-2695-2128	Instituto de Salud Carlos III, organism adscrito al Ministerio de Economia y Competitividad; Fondo Europeo de Desarrollo Regional (FEDER) [PI13/00121]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [SGR2009-1490, SGR2009-1355]; Ministerio de Economia y Competitividad [SAF2012-40080];  [SAF2011-23933]	Instituto de Salud Carlos III, organism adscrito al Ministerio de Economia y Competitividad; Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Ministerio de Economia y Competitividad(Spanish Government); 	"Funding was provided by Instituto de Salud Carlos III, organism adscrito al Ministerio de Economia y Competitividad" and "Fondo Europeo de Desarrollo Regional (FEDER)" reference: PI13/00121 to Virginia Nunes, http://gesdoc.isciii.es/?action=download?&id=14/11/2013-7e20e3561c; Agencia de Gestio d'Ajuts Universitaris i de Recerca SGR2009-1490 to Virginia Nunes and SGR2009-1355 to Manuel Palacin, http://www10.gencat.cat/agaur_web/genera?dos/catala/home/recurs/doc/resolucio_3ju? l09_def.pdf; Ministerio de Economia y Competitividad SAF2012-40080 to Manuel Palacin, http://www.idi.mineco.gob.es/stfls/eSede?/Ficheros/2013/resolucion_concesion_pred?oc_2013completoFIRMADO.pdf; SAF2011-23933 to Eduardo Salido, https://sede.micinn.gob.es/stfls/eSede/F?icheros/2012/2012_resolucion%20concesion?_fpi_firmada.pdf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biber J, 2007, NAT PROTOC, V2, P1356, DOI 10.1038/nprot.2007.156; CALONGE MJ, 1995, P NATL ACAD SCI USA, V92, P9667, DOI 10.1073/pnas.92.21.9667; Chillaron J, 1996, J BIOL CHEM, V271, P17761, DOI 10.1074/jbc.271.30.17761; Chillaron J, 2010, NAT REV NEPHROL, V6, P424, DOI 10.1038/nrneph.2010.69; Dello Strologo L, 2002, J AM SOC NEPHROL, V13, P2547, DOI 10.1097/01.ASN.0000029586.17680.E5; Di Giacopo A, 2013, AM J PHYSIOL-RENAL, V305, pF1645, DOI 10.1152/ajprenal.00221.2013; Feliubadalo L, 1999, NAT GENET, V23, P52, DOI 10.1038/12652; Feliubadalo L, 2003, HUM MOL GENET, V12, P2097, DOI 10.1093/hmg/ddg228; Fernandez E, 2002, AM J PHYSIOL-RENAL, V283, pF540, DOI 10.1152/ajprenal.00071.2002; Font-Llitjos M, 2005, J MED GENET, V42, P58, DOI 10.1136/jmg.2004.022244; Gucev Z, 2011, J GENET, V90, P157, DOI 10.1007/s12041-011-0045-2; Kummer S, 2014, PEDIATR NEPHROL, V29, P155, DOI 10.1007/s00467-013-2617-2; Livrozet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102700; MCNAMARA PD, 1992, BIOCHIM BIOPHYS ACTA, V1103, P101, DOI 10.1016/0005-2736(92)90062-Q; Palacin M, 2001, CURR OPIN GENET DEV, V11, P328, DOI 10.1016/S0959-437X(00)00198-2; Peters T, 2003, HUM MOL GENET, V12, P2109, DOI 10.1093/hmg/ddg189; Pfeiffer R, 1999, MOL BIOL CELL, V10, P4135, DOI 10.1091/mbc.10.12.4135; ROSENBERG LE, 1965, NEW ENGL J MED, V273, P1239, DOI 10.1056/NEJM196512022732303; Scriver C.R., 2001, METABOLIC MOL BASES; THIER S, 1964, SCIENCE, V143, P482, DOI 10.1126/science.143.3605.482	20	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137277	10.1371/journal.pone.0137277	http://dx.doi.org/10.1371/journal.pone.0137277			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359869	gold, Green Submitted, Green Published			2022-12-26	WOS:000361043100028
J	Watanabe, S; Takanashi, F; Ishida, K; Kobayashi, S; Kitamura, Y; Hamasaki, Y; Saito, M				Watanabe, Satoshi; Takanashi, Fumihito; Ishida, Kohei; Kobayashi, Suguru; Kitamura, Yoshiichiro; Hamasaki, Yuuta; Saito, Minoru			Nitric Oxide-Mediated Modulation of Central Network Dynamics during Olfactory Perception	PLOS ONE			English	Article							LONG-TERM-MEMORY; TERRESTRIAL SLUG; IN-VITRO; ODOR; OSCILLATIONS; SYNTHASE; INTERNEURONS; NEURONS; DISCRIMINATION; IMPAIRMENT	Nitric oxide (NO) modulates the dynamics of central olfactory networks and has been implicated in olfactory processing including learning. Land mollusks have a specialized olfactory lobe in the brain called the procerebral (PC) lobe. The PC lobe produces ongoing local field potential (LFP) oscillation, which is modulated by olfactory stimulation. We hypothesized that NO should be released in the PC lobe in response to olfactory stimulation, and to prove this, we applied an NO electrode to the PC lobe of the land slug Limax in an isolated tentacle-brain preparation. Olfactory stimulation applied to the olfactory epithelium transiently increased the NO concentration in the PC lobe, and this was blocked by the NO synthase inhibitor L-NAME at 3.7 mM. L-NAME at this concentration did not block the ongoing LFP oscillation, but did block the frequency increase during olfactory stimulation. Olfactory stimulation also enhanced spatial synchronicity of activity, and this response was also blocked by L-NAME. Single electrical stimulation of the superior tentacle nerve (STN) mimicked the effects of olfactory stimulation on LFP frequency and synchronicity, and both of these effects were blocked by L-NAME. L-NAME did not block synaptic transmission from the STN to the nonbursting (NB)-type PC lobe neurons, which presumably produce NO in an activity-dependent manner. Previous behavioral experiments have revealed impairment of olfactory discrimination after L-NAME injection. The recording conditions in the present work likely reproduce the in vivo brain state in those behavioral experiments. We speculate that the dynamical effects of NO released during olfactory perception underlie precise odor representation and memory formation in the brain, presumably through regulation of NB neuron activity.	[Watanabe, Satoshi] Tohoku Univ, Grad Sch Engn, Dept Bioengn & Robot, Sendai, Miyagi 980, Japan; [Watanabe, Satoshi; Takanashi, Fumihito] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Ishida, Kohei; Hamasaki, Yuuta; Saito, Minoru] Nihon Univ, Grad Sch Integrated Basic Sci, Dept Correlat Study Phys & Chem, Tokyo, Japan; [Kobayashi, Suguru] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Sanuki, Japan; [Kitamura, Yoshiichiro] Kanto Gakuin Univ, Coll Sci & Engn, Yokohama, Kanagawa, Japan	Tohoku University; University of Tokyo; Nihon University; Tokushima Bunri University; Kanto Gakuin University	Watanabe, S (corresponding author), Tohoku Univ, Grad Sch Engn, Dept Bioengn & Robot, Sendai, Miyagi 980, Japan.	swatanabe@biomems.mech.tohoku.ac.jp	Kobayashi, Suguru/AAN-9001-2021		JSPS KAKENHI [17790032]; Nihon University Academic Research grant [14-002, 15-002]; Grants-in-Aid for Scientific Research [26440183] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Nihon University Academic Research grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a JSPS KAKENHI (https://www.jsps.go.jp/english/e-grants/) Grant Number 17790032 to S.W. and Nihon University Academic Research grant (Total Research 14-002 and 15-002) to M.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime P, 2007, BEHAV BRAIN RES, V179, P258, DOI 10.1016/j.bbr.2007.02.012; Aonuma H, 2008, NEUROSCIENCE, V157, P749, DOI 10.1016/j.neuroscience.2008.09.032; Barnes DC, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00134; Bicker G, 2001, CELL TISSUE RES, V303, P137, DOI 10.1007/s004410000321; Bohnen NI, 2010, BRAIN, V133, P1747, DOI 10.1093/brain/awq079; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; DELANEY KR, 1994, P NATL ACAD SCI USA, V91, P669, DOI 10.1073/pnas.91.2.669; Feldman DE, 2012, NEURON, V75, P556, DOI 10.1016/j.neuron.2012.08.001; Fletcher ML, 2010, LEARN MEMORY, V17, P561, DOI 10.1101/lm.941510; Fujie S, 2005, J NEUROBIOL, V62, P14, DOI 10.1002/neu.20046; Fujie S, 2002, ZOOL SCI, V19, P15, DOI 10.2108/zsj.19.15; Gage SL, 2013, J EXP BIOL, V216, P3294, DOI 10.1242/jeb.086694; Gelperin A, 2000, J NEUROPHYSIOL, V83, P116, DOI 10.1152/jn.2000.83.1.116; Gelperin A, 2006, J NEUROSCI, V26, P1663, DOI 10.1523/JNEUROSCI.3737-05b.2006; GELPERIN A, 1994, NATURE, V369, P61, DOI 10.1038/369061a0; GELPERIN A, 1990, NATURE, V345, P437, DOI 10.1038/345437a0; Higgins M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042556; Hosler JS, 2000, BEHAV NEUROSCI, V114, P514, DOI 10.1037/0735-7044.114.3.514; Inamura K, 1998, AM J PHYSIOL, P1201; Inoue T, 2000, J NEUROPHYSIOL, V84, P1112, DOI 10.1152/jn.2000.84.2.1112; Inoue T, 2004, J NEUROPHYSIOL, V91, P372, DOI 10.1152/jn.00247.2003; Inoue T, 2001, J NEUROPHYSIOL, V85, P2634, DOI 10.1152/jn.2001.85.6.2634; Inoue T, 2006, J NEUROPHYSIOL, V95, P3898, DOI 10.1152/jn.00853.2005; Ito E, 2013, NEUROSCI LETT, V541, P1, DOI 10.1016/j.neulet.2013.02.021; Katzoff A, 2002, J NEUROSCI, V22, P9581; Kemenes I, 2002, J NEUROSCI, V22, P1414, DOI 10.1523/JNEUROSCI.22-04-01414.2002; Kimura T, 1998, LEARN MEMORY, V4, P365, DOI 10.1101/lm.4.5.365; Kitamura Y, 2001, NEUROSCI RES, V41, P129, DOI 10.1016/S0168-0102(01)00271-1; Kobayashi S, 2000, NEUROSCI RES, V38, P27, DOI 10.1016/S0168-0102(00)00136-X; Lowe G, 2008, NEUROSCIENCE, V153, P842, DOI 10.1016/j.neuroscience.2008.03.003; MALINSKI T, 1993, BIOCHEM BIOPH RES CO, V193, P1076, DOI 10.1006/bbrc.1993.1735; Marine N, 2014, NEUROSCI BIOBEHAV R, V45, P262, DOI 10.1016/j.neubiorev.2014.06.016; Matsumoto Y, 2006, LEARN MEMORY, V13, P35, DOI 10.1101/lm.130506; Matsuo R, 2008, GENE, V415, P74, DOI 10.1016/j.gene.2008.02.021; Matsuo R, 2009, BIOCHEM BIOPH RES CO, V386, P724, DOI 10.1016/j.bbrc.2009.06.112; Mochizuki S, 2005, HEART VESSELS, V20, P175, DOI 10.1007/s00380-005-0827-7; Muller U, 2002, J NEUROSCI, V22, P8739; Murakami M, 2004, J NEUROBIOL, V58, P369, DOI 10.1002/neu.10295; Ott SR, 2007, EUR J NEUROSCI, V25, P181, DOI 10.1111/j.1460-9568.2006.05271.x; Pavesi E, 2013, LEARN MEMORY, V20, P482, DOI 10.1101/lm.031450.113; Pietrobon M, 2011, J NEUROSCI, V31, P8395, DOI 10.1523/JNEUROSCI.6722-10.2011; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; Sakura M, 2004, NEUROSCI LETT, V370, P257, DOI 10.1016/j.neulet.2004.08.025; Samama B, 1999, NEUROBIOL LEARN MEM, V71, P219, DOI 10.1006/nlme.1998.3869; Sanchez-Andrade G, 2009, BEHAV BRAIN RES, V200, P323, DOI 10.1016/j.bbr.2008.12.021; Teyke T, 1999, NEUROREPORT, V10, P1061, DOI 10.1097/00001756-199904060-00030; Watanabe S, 1999, J COMP PHYSIOL A, V184, P553, DOI 10.1007/s003590050355; Watanabe S, 2003, J NEUROSCI, V23, P2932; Watanabe S, 1998, J EXP BIOL, V201, P925; Watanabe S, 2008, LEARN MEMORY, V15, P633, DOI 10.1101/lm920908; Wilson CH, 2007, J COMP PHYSIOL A, V193, P715, DOI 10.1007/s00359-007-0227-9; Yabumoto T, 2008, LEARN MEMORY, V15, P229, DOI 10.1101/lm.936508	52	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0136846	10.1371/journal.pone.0136846	http://dx.doi.org/10.1371/journal.pone.0136846			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360020	Green Published, gold, Green Submitted			2022-12-26	WOS:000361043100017
J	Watzlawick, R; Kenngott, EE; Liu, FDM; Schwab, JM; Hamann, A				Watzlawick, Ralf; Kenngott, Elisabeth E.; Liu, Francesca Diane M.; Schwab, Jan M.; Hamann, Alf			Anti-Inflammatory Effects of IL-27 in Zymosan-Induced Peritonitis: Inhibition of Neutrophil Recruitment Partially Explained by Impaired Mobilization from Bone Marrow and Reduced Chemokine Levels	PLOS ONE			English	Article							CD4(+) T-CELLS; INFLAMMATION; INTERLEUKIN-27; MACROPHAGES; ACTIVATION; SUPPRESSION; MECHANISM; IMMUNITY; SYSTEM; P-28	Rapid activation of the innate immune system is critical for an efficient host response to invading pathogens. However, the inflammatory reaction has to be strictly controlled to minimize harmful immunopathology. A number of mediators including the cytokine interleukin-27 (IL-27) appear to be responsible for limitation and resolution of inflammation. Despite increasing knowledge of its suppressive effects on T cells, the influence on neutrophils and macrophages is poorly understood. To determine the role of IL-27 in innate immune responses we analysed the effect of IL-27 in a T cell independent model of zymosan-induced peritonitis. Early administration of recombinant IL-27 strongly reduced the number of neutrophils recruited to the peritoneal cavity after zymosan application as well as the neutrophil frequency in the blood. Simultaneously, IL-27 reduced the release of neutrophils from the bone marrow upon inflammation. Although cytokine levels were not affected by IL-27 treatment, the levels of the chemokines KC, MCP-1 and MIP-1 alpha in the peritoneal fluid were strongly decreased. These findings demonstrate that IL-27 is able to control mobilisation and recruitment of neutrophils into the peritoneal cavity and identify a novel mechanism to limit inflammation caused by innate immune cells.	[Watzlawick, Ralf; Schwab, Jan M.] Charite, Clin & Expt Spinal Cord Injury Res Lab Neuroparap, Dept Neurol & Expt Neurol, D-13353 Berlin, Germany; [Kenngott, Elisabeth E.; Liu, Francesca Diane M.; Hamann, Alf] Deutsch Rheuma Forschungszentrum, Dept Expt Rheumatol, Berlin, Germany; [Kenngott, Elisabeth E.; Hamann, Alf] Charite, Dept Rheumatol & Clin Immunol, D-13353 Berlin, Germany; [Schwab, Jan M.] Ohio State Univ, Dept Neurol, Wexner Med Ctr, Spinal Cord Injury Div,Inst Neurosci, Columbus, OH 43210 USA; [Schwab, Jan M.] Ohio State Univ, Wexner Med Ctr, Neurosci Inst, Dept Neurosci, Columbus, OH 43210 USA; [Schwab, Jan M.] Ohio State Univ, Wexner Med Ctr, Neurosci Inst, Ctr Brain & Spinal Cord Repair,Dept Phys Med & Re, Columbus, OH 43210 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Hamann, A (corresponding author), Deutsch Rheuma Forschungszentrum, Dept Expt Rheumatol, Berlin, Germany.	hamann@drfz.de		Schwab, Jan/0000-0001-6784-4919	Studienstiftung des deutschen Volkes [186392]; DAAD; Else-Kroehner-Fresenius Foundation; Wings-for-Life Spinal Cord Research Foundation [60-2012]; W.E. Hunt & C.M. Curtis Endowment; Deutsche Forschungsgemeinschaft [SFB633, SFB650]	Studienstiftung des deutschen Volkes; DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Else-Kroehner-Fresenius Foundation; Wings-for-Life Spinal Cord Research Foundation; W.E. Hunt & C.M. Curtis Endowment; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	RWs work was supported by the Studienstiftung des deutschen Volkes (grant 186392, http://www.studienstiftung.de/) and FDL by the DAAD (http://www.daad.de/en/). JMS received funding from the Else-Kroehner-Fresenius Foundation (http://www.ekfs.de/de/start.html), the Wings-for-Life Spinal Cord Research Foundation (grant 60-2012, http://www.wingsforlife.com/en/) and by the W.E. Hunt & C.M. Curtis Endowment. AH received funding from the Deutsche Forschungsgemeinschaft (SFB633, SFB650, http://www.dfg.de/en/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bosmann M, 2012, J IMMUNOL, V188, P5086, DOI 10.4049/jimmunol.1102914; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; Cash JL, 2009, METHOD ENZYMOL, V461, P379, DOI 10.1016/S0076-6879(09)05417-2; Fitzgerald DC, 2007, J IMMUNOL, V179, P3268, DOI 10.4049/jimmunol.179.5.3268; Gompertz S, 2000, Semin Respir Infect, V15, P14; Hause L, 2007, ANTIVIR RES, V76, P159, DOI 10.1016/j.antiviral.2007.06.013; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Hunter CA, 2012, IMMUNITY, V37, P960, DOI 10.1016/j.immuni.2012.11.003; Jaillon S, 2013, SEMIN IMMUNOPATHOL, V35, P377, DOI 10.1007/s00281-013-0374-8; Kalliolias GD, 2010, J IMMUNOL, V185, P7047, DOI 10.4049/jimmunol.1001290; Karakhanova S, 2011, J LEUKOCYTE BIOL, V89, P837, DOI 10.1189/jlb.1209788; Li JP, 2010, SCAND J IMMUNOL, V72, P284, DOI 10.1111/j.1365-3083.2010.02422.x; Liu FDM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004110; Navarro-Xavier RA, 2010, J IMMUNOL, V184, P1516, DOI 10.4049/jimmunol.0902866; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Rankin SM, 2010, J LEUKOCYTE BIOL, V88, P241, DOI 10.1189/jlb.0210112; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Wengner AM, 2008, BLOOD, V111, P42, DOI 10.1182/blood-2007-07-099648; Wirtz S, 2005, J IMMUNOL, V174, P2814, DOI 10.4049/jimmunol.174.5.2814; Yoshimura T, 2006, J IMMUNOL, V177, P5377, DOI 10.4049/jimmunol.177.8.5377	24	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137651	10.1371/journal.pone.0137651	http://dx.doi.org/10.1371/journal.pone.0137651			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360023	Green Published, Green Submitted, gold			2022-12-26	WOS:000361043100065
J	Asadzadeh, J; Neligan, N; Canabal-Alvear, JJ; Daly, AC; Kramer, SG; Labrador, JP				Asadzadeh, Jamshid; Neligan, Niamh; Canabal-Alvear, Judith J.; Daly, Amanda C.; Kramer, Sunita Gupta; Labrador, Juan-Pablo			The Unc-5 Receptor Is Directly Regulated by Tinman in the Developing Drosophila Dorsal Vessel	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; NETRIN-RECEPTOR; HEART-DISEASE; GENES; SLIT; CELLS; EXPRESSION; REPULSION; MESODERM; GUIDANCE	During early heart morphogenesis cardiac cells migrate in two bilateral opposing rows, meet at the dorsal midline and fuse to form a hollow tube known as the primary heart field in vertebrates or dorsal vessel (DV) in Drosophila. Guidance receptors are thought to mediate this evolutionarily conserved process. A core of transcription factors from the NK2, GATA and T-box families are also believed to orchestrate this process in both vertebrates and invertebrates. Nevertheless, whether they accomplish their function, at least in part, through direct or indirect transcriptional regulation of guidance receptors is currently unknown. In our work, we demonstrate how Tinman (Tin), the Drosophila homolog of the Nkx-2.5 transcription factor, regulates the Unc-5 receptor during DV tube morphogenesis. We use genetics, expression analysis with single cell mRNA resolution and enhancer-reporter assays in vitro or in vivo to demonstrate that Tin is required for Unc-5 receptor expression specifically in cardioblasts. We show that Tin can bind to evolutionary conserved sites within an Unc-5 DV enhancer and that these sites are required for Tin-dependent transactivation both in vitro and in vivo.	[Asadzadeh, Jamshid; Neligan, Niamh; Daly, Amanda C.; Labrador, Juan-Pablo] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [Asadzadeh, Jamshid; Daly, Amanda C.; Labrador, Juan-Pablo] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland; [Canabal-Alvear, Judith J.; Kramer, Sunita Gupta] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Piscataway, NJ 08854 USA	Trinity College Dublin; Trinity College Dublin; Rutgers State University New Brunswick; Rutgers State University Medical Center	Labrador, JP (corresponding author), Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland.	labradoj@tcd.ie	Labrador, Juan Pablo/C-3018-2014	Labrador, Juan Pablo/0000-0003-3671-848X; Kramer, Sunita/0000-0001-8372-5928	Science Foundation Ireland [07/IN.1/B913, 08/RFP/NSC1617]; Irish Research Council New Foundations Award; Trinity Research Award from Trinity College Dublin; National Science Foundation [IOS-1123963]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055145] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council New Foundations Award(Irish Research Council for Science, Engineering and Technology); Trinity Research Award from Trinity College Dublin; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by Science Foundation Ireland awards 07/IN.1/B913 and 08/RFP/NSC1617 (http://www.sfi.ie); Irish Research Council New Foundations Award 2012 (http://research.ie); Trinity Research Award 2009 from Trinity College Dublin (http://www.tcd.ie); and National Science Foundation, grant number IOS-1123963 (http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht S, 2011, DEV BIOL, V350, P89, DOI 10.1016/j.ydbio.2010.11.016; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; BODMER R, 1990, DEVELOPMENT, V110, P661; BODMER R, 1993, DEVELOPMENT, V118, P719; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Engelkamp D, 2002, MECH DEVELOP, V118, P191, DOI 10.1016/S0925-4773(02)00248-4; Fish JE, 2011, DEVELOPMENT, V138, P1409, DOI 10.1242/dev.060046; Fish MP, 2007, NAT PROTOC, V2, P2325, DOI 10.1038/nprot.2007.328; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Gajewski K, 2000, GENESIS, V28, P36, DOI 10.1002/1526-968X(200009)28:1<36::AID-GENE50>3.0.CO;2-4; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; Harvey RP, 2002, COLD SPRING HARB SYM, V67, P107, DOI 10.1101/sqb.2002.67.107; Jin H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003195; Junion G, 2012, CELL, V148, P473, DOI 10.1016/j.cell.2012.01.030; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Kodo K, 2009, P NATL ACAD SCI USA, V106, P13933, DOI 10.1073/pnas.0904744106; Labrador JP, 2005, CURR BIOL, V15, P1413, DOI 10.1016/j.cub.2005.06.058; LAI ZC, 1993, P NATL ACAD SCI USA, V90, P4122, DOI 10.1073/pnas.90.9.4122; Lo PCH, 2001, MECH DEVELOP, V104, P49, DOI 10.1016/S0925-4773(01)00361-6; Macabenta FD, 2013, DEV BIOL, V380, P233, DOI 10.1016/j.ydbio.2013.05.007; MacMullin A, 2006, DEV BIOL, V293, P154, DOI 10.1016/j.ydbio.2006.01.027; Medioni C, 2010, DEV DYNAM, V239, P3303, DOI 10.1002/dvdy.22449; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Mommersteeg MTM, 2013, CIRC RES, V112, P465, DOI 10.1161/CIRCRESAHA.112.277426; Neely GG, 2010, CELL, V141, P142, DOI 10.1016/j.cell.2010.02.023; Oka T, 2007, SEMIN CELL DEV BIOL, V18, P117, DOI 10.1016/j.semcdb.2006.11.012; Qian L, 2005, CURR BIOL, V15, P2271, DOI 10.1016/j.cub.2005.10.037; Rosenthal N., 2010, HEART DEV REGENERATI, P47, DOI DOI 10.1016/B978-0-12-381332-9.00002-5; Santiago-Martinez E, 2008, J CELL BIOL, V182, P241, DOI 10.1083/jcb.200804120; Santiago-Martinez E, 2006, P NATL ACAD SCI USA, V103, P12441, DOI 10.1073/pnas.0605284103; Su MT, 1999, DEVELOPMENT, V126, P3241; Toyofuku T, 2008, DEV BIOL, V321, P251, DOI 10.1016/j.ydbio.2008.06.028; von Hilchen CM, 2010, DEVELOPMENT, V137, P1251, DOI 10.1242/dev.042853; Ward EJ, 2000, MECH DEVELOP, V96, P233, DOI 10.1016/S0925-4773(00)00389-0; Ward EJ, 2000, DEVELOPMENT, V127, P4959; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103; Xu X, 1998, GENE DEV, V12, P2354, DOI 10.1101/gad.12.15.2354; Zaffran S, 2006, DEVELOPMENT, V133, P4073, DOI 10.1242/dev.02586; Zarin AA, 2014, NEURON, V81, P1297, DOI 10.1016/j.neuron.2014.01.038; Zarin AA, 2014, CELL MOL LIFE SCI, V71, P419, DOI 10.1007/s00018-013-1434-x; Zarin AA, 2012, DEVELOPMENT, V139, P1798, DOI 10.1242/dev.070656	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137688	10.1371/journal.pone.0137688	http://dx.doi.org/10.1371/journal.pone.0137688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356221	Green Published, gold, Green Submitted			2022-12-26	WOS:000360965800078
J	Troester, N; Palfner, M; Schmidberger, E; Olschewski, H; Avian, A				Troester, Natascha; Palfner, Michael; Schmidberger, Erich; Olschewski, Horst; Avian, Alexander			Sleep Related Breathing Disorders and Inflammation - The Missing Link? A Cohort Study Evaluating the Interaction of Inflammation and Sleep Related Breathing Disorders and Effects of Treatment	PLOS ONE			English	Article							C-REACTIVE PROTEIN; POSITIVE AIRWAY PRESSURE; CARDIOVASCULAR RISK; APNEA SYNDROME; ASSOCIATION; MARKERS; OBESITY; INTERLEUKIN-6; HYPOPNEA; DISEASE	Introduction Sleep related breathing disorders (SRBD) are associated with both obesity and systemic inflammation. While the relationship between obesity and SRBD is established, the causality between inflammation and SRBD remains unclear. In this study we investigated the relation between SRBD and C-reactive protein (CRP) as a parameter of inflammation and the influence of SRBD treatment on CRP with additional regard to changes in metabolic and cardiovascular parameters. Methods Polysomnography (PSG) and laboratory data of patients diagnosed with SRBD over a period of 5 years were prospectively collected in a database and retrospectively analysed regarding the association of SRBD (according to apnoea-hypopnoea-index (AHI), duration of events and extent of desaturation) to CRP, blood pressure, cholesterol, fasting plasma glucose, HbA1c, quality of life measured via a visual analogue scale (VAS 0-100%), and the effects of SRBD therapy on these parameters. Results 716 patients were included in the study, 171 withmild SRBD (AHI >= 5 to < 15/h), 209 with moderate SRBD (AHI 15 to < 30/h), 336 with severe SRBD (AHI >= 30/h). Results according to severity of SRBD. Severe SRBD was significantly associated with elevated levels of CRP (3.7 [1.8-7.0] mg/l, vs. moderate (p = 0.001), and mild SRBD (p< 0.001), and higher prevalence of hypertension as compared to moderate and mild SRBD (p< 0.001, respectively). Results in highly successful treatment. If SRBD treatment was highly successful (AHI <5/h), CRP and quality of life improved significantly (p = 0.001 and p = 0.002), as did blood pressure (p<0.001 for systolic and diastolic values), although BMI increased (p<0.001). Results in partially successful treatment. If success was defined as reduction of AHI of >= 50%, CRP also decreased (p<0.001), as did blood pressure (p<0.001). Again, BMI increased (p<0.001). Conclusion This is the first study to show an association of SRBD and CRP independently of BMI in a large cohort. The SRBD therapy-induced CRP decrease was not associated with BMI changes or metabolic changes but rather with the magnitude of AHI improvement.	[Troester, Natascha; Palfner, Michael; Olschewski, Horst] Med Univ, Div Pulmonol, Dept Internal Med, Graz, Austria; [Schmidberger, Erich; Avian, Alexander] Med Univ, Inst Med Informat Stat & Documentat, Graz, Austria; [Olschewski, Horst; Avian, Alexander] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria	Medical University of Graz; Medical University of Graz; Ludwig Boltzmann Institute	Troester, N (corresponding author), Med Univ, Div Pulmonol, Dept Internal Med, Graz, Austria.	natascha.troester@klinikum-graz.at	Olschewski, Horst/L-3547-2019	Olschewski, Horst/0000-0002-2834-7466; Avian, Alexander/0000-0003-1084-5763				[Anonymous], 2014, INT CLASSIFICATION S; Arnardottir ES, 2012, SLEEP, V35, P921, DOI 10.5665/sleep.1952; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Boudjeltia KZ, 2006, RESPIRATION, V73, P243, DOI 10.1159/000090201; Bradley TD, 2009, LANCET, V373, P82, DOI 10.1016/S0140-6736(08)61622-0; Can M, 2006, CHEST, V129, P233, DOI 10.1378/chest.129.2.233; Friedman M, 2012, OTOLARYNG HEAD NECK, V147, P423, DOI 10.1177/0194599812451840; Guilleminault C, 2004, SLEEP, V27, P1507, DOI 10.1093/sleep/27.8.1507; Guven SF, 2012, SLEEP BREATH, V16, P217, DOI 10.1007/s11325-011-0492-2; Hatipoglu U, 2003, RESPIRATION, V70, P665, DOI 10.1159/000075218; Hayashi M, 2006, RESPIROLOGY, V11, P24, DOI 10.1111/j.1440-1843.2006.00780.x; Iber C., 2007, AASM MANUAL SCORING; Ishida K, 2009, CHEST, V136, P125, DOI 10.1378/chest.08-1431; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kohler M, 2009, THORAX, V64, P67, DOI 10.1136/thx.2008.097931; Kokturk O, 2005, INT HEART J, V46, P801, DOI 10.1536/ihj.46.801; Lagrand WK, 1999, CIRCULATION, V100, P96, DOI 10.1161/01.CIR.100.1.96; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lui MMS, 2009, CHEST, V135, P950, DOI 10.1378/chest.08-1798; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; McNicholas WT, 2009, PROG CARDIOVASC DIS, V51, P392, DOI 10.1016/j.pcad.2008.10.005; Nural S, 2013, INFLAMMATION, V36, P66, DOI 10.1007/s10753-012-9520-z; Panoutsopoulos A, 2012, MED SCI MONITOR, V18, pCR747, DOI 10.12659/MSM.883603; Pasceri V, 2000, CIRCULATION, V102, P2165; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Punjabi NM, 2007, SLEEP, V30, P29, DOI 10.1093/sleep/30.1.29; Quercioli A, 2010, SLEEP BREATH, V14, P261, DOI 10.1007/s11325-010-0338-3; Ryan S, 2007, THORAX, V62, P509, DOI 10.1136/thx.2006.066720; Sahlman J, 2010, J SLEEP RES, V19, P341, DOI 10.1111/j.1365-2869.2009.00787.x; Saletu M, 2006, J NEUROL, V253, P746, DOI 10.1007/s00415-006-0110-6; Schiza SE, 2010, EUR J CLIN INVEST, V40, P968, DOI 10.1111/j.1365-2362.2010.02348.x; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Shamsuzzaman ASM, 2002, CIRCULATION, V105, P2462, DOI 10.1161/01.CIR.0000018948.95175.03; Su MC, 2013, EUR ARCH OTO-RHINO-L, V270, P749, DOI 10.1007/s00405-012-2191-4; Taheri S, 2007, SLEEP, V30, P991, DOI 10.1093/sleep/30.8.991; Torzewski M, 2000, ARTERIOSCL THROM VAS, V20, P2094, DOI 10.1161/01.ATV.20.9.2094; Yao M, 2006, SLEEP, V29, P661; Yokoe T, 2003, CIRCULATION, V107, P1129, DOI 10.1161/01.CIR.0000052627.99976.18; Young Terry, 2009, WMJ, V108, P246; Zwaka TP, 2001, CIRCULATION, V103, P1194	42	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137594	10.1371/journal.pone.0137594	http://dx.doi.org/10.1371/journal.pone.0137594			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356577	Green Published, Green Submitted, gold			2022-12-26	WOS:000360965800067
J	Boeddeker, N; Mertes, M; Dittmar, L; Egelhaaf, M				Boeddeker, Norbert; Mertes, Marcel; Dittmar, Laura; Egelhaaf, Martin			Bumblebee Homing: The Fine Structure of Head Turning Movements	PLOS ONE			English	Article							COLOR DISCRIMINATION; BLOWFLY FLIGHT; BEES; HONEYBEES; MOTION; INSECTS; DIRECTIONS; DISTANCE; VISION; ACUITY	Changes in flight direction in flying insects are largely due to roll, yaw and pitch rotations of their body. Head orientation is stabilized for most of the time by counter rotation. Here, we use high-speed video to analyse head-and body-movements of the bumblebee Bombus terrestris while approaching and departing from a food source located between three landmarks in an indoor flight-arena. The flight paths consist of almost straight flight segments that are interspersed with rapid turns. These short and fast yaw turns ("saccades") are usually accompanied by even faster head yaw turns that change gaze direction. Since a large part of image rotation is thereby reduced to brief instants of time, this behavioural pattern facilitates depth perception from visual motion parallax during the intersaccadic intervals. The detailed analysis of the fine structure of the bees' head turning movements shows that the time course of single head saccades is very stereotypical. We find a consistent relationship between the duration, peak velocity and amplitude of saccadic head movements, which in its main characteristics resembles the so-called "saccadic main sequence" in humans. The fact that bumblebee head saccades are highly stereotyped as in humans, may hint at a common principle, where fast and precise motor control is used to reliably reduce the time during which the retinal images moves.	[Boeddeker, Norbert; Mertes, Marcel; Dittmar, Laura; Egelhaaf, Martin] Univ Bielefeld, Dept Neurobiol, D-33615 Bielefeld, Germany; [Boeddeker, Norbert; Mertes, Marcel; Dittmar, Laura; Egelhaaf, Martin] Univ Bielefeld, CITEC, D-33615 Bielefeld, Germany; [Boeddeker, Norbert] Univ Bielefeld, Dept Cognit Neurosci, D-33615 Bielefeld, Germany	University of Bielefeld; University of Bielefeld; University of Bielefeld	Boeddeker, N (corresponding author), Univ Bielefeld, Dept Neurobiol, D-33615 Bielefeld, Germany.	norbert.boeddeker@uni-bielefeld.de	Egelhaaf, Martin/A-9824-2010	Egelhaaf, Martin/0000-0002-9336-4270	Deutsche Forschungsgemeinschaft [EXC 277]; Studienstiftung des deutschen Volkes	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Studienstiftung des deutschen Volkes	The study was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de, EXC 277). L.D. was funded by the Studienstiftung des deutschen Volkes.	BAHILL A T, 1975, Mathematical Biosciences, V24, P191, DOI 10.1016/0025-5564(75)90075-9; BOEDDEKER N, 2009, P ROY SOC LOND B BIO, V1685, P1209; Boeddeker N, 2010, P ROY SOC B-BIOL SCI, V277, P1899, DOI 10.1098/rspb.2009.2326; Bouguet J.-Y., 1999, THESIS CALTECH; Braun E, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00001; CARTWRIGHT BA, 1979, J EXP BIOL, V82, P367; CARTWRIGHT BA, 1983, J COMP PHYSIOL, V151, P521, DOI 10.1007/BF00605469; CHENG K, 1986, J COMP PHYSIOL A, V159, P69, DOI 10.1007/BF00612497; Collett TS, 2013, J EXP BIOL, V216, P1105, DOI 10.1242/jeb.081463; Collett TS, 1996, CURR DIR PSYCHOL SCI, V5, P149, DOI 10.1111/1467-8721.ep11512352; Collett TS, 2002, NAT REV NEUROSCI, V3, P542, DOI 10.1038/nrn872; COLLETT TS, 1975, J COMP PHYSIOL, V100, P59, DOI 10.1007/BF00623930; COLLETT TS, 1978, J EXP BIOL, V76, P237; de Ibarra NH, 2009, J EXP BIOL, V212, P3193, DOI 10.1242/jeb.029751; Dittmar L, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00020; Dittmar L, 2010, J EXP BIOL, V213, P2913, DOI 10.1242/jeb.043737; Dyer AG, 2008, J COMP PHYSIOL A, V194, P617, DOI 10.1007/s00359-008-0335-1; Dyer AG, 2004, J COMP PHYSIOL A, V190, P759, DOI 10.1007/s00359-004-0547-y; Dyer AG, 2004, NATURWISSENSCHAFTEN, V91, P224, DOI 10.1007/s00114-004-0508-x; Egelhaaf M, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00108; Ellington CP, 1999, J EXP BIOL, V202, P3439; Fry SN, 2005, J EXP BIOL, V208, P3945, DOI 10.1242/jeb.01833; Gibson JJ, 1950, PERCEPTION VISUAL WO; Graham P, 2009, CURR BIOL, V19, pR935, DOI 10.1016/j.cub.2009.08.015; Harris CM, 2009, BIOL CYBERN, V95, P21; Hengstenberg Roland, 1993, Reviews of Oculomotor Research, V5, P285; Huston SJ, 2011, CURR OPIN NEUROBIOL, V21, P527, DOI 10.1016/j.conb.2011.05.030; Kapustjansky A, 2010, NATURWISSENSCHAFTEN, V97, P229, DOI 10.1007/s00114-009-0627-5; Kern R, 2006, J EXP BIOL, V209, P1251, DOI 10.1242/jeb.02127; KOENDERINK JJ, 1987, BIOL CYBERN, V56, P247, DOI 10.1007/BF00365219; Lappe M, 2000, NEURONAL PROCESSING, V44; LEHRER M, 1993, J COMP PHYSIOL A, V172, P549, DOI 10.1007/BF00213678; LEHRER M, 1994, J COMP PHYSIOL A, V175, P171, DOI 10.1007/BF00215113; LEHRER M, 1991, NATURWISSENSCHAFTEN, V78, P274, DOI 10.1007/BF01134357; Lihoreau M, 2012, BIOL LETTERS, V8, P13, DOI 10.1098/rsbl.2011.0661; Macuda T, 2001, J EXP BIOL, V204, P559; Mertes M, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00335; Morawetz L, 2012, J EXP BIOL, V215, P2515, DOI 10.1242/jeb.066399; Paulk AC, 2008, J NEUROSCI, V28, P6319, DOI 10.1523/JNEUROSCI.1196-08.2008; Paulk AC, 2009, J NEUROSCI, V29, P9987, DOI 10.1523/JNEUROSCI.1325-09.2009; Paulk AC, 2009, J COMP NEUROL, V513, P441, DOI 10.1002/cne.21993; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Pfeiffer K, 2011, J COMP NEUROL, V229, P212; Philippides A, 2013, J EXP BIOL, V216, P1093, DOI 10.1242/jeb.081455; Riabinina O, 2014, J EXP BIOL, V217, P2633, DOI 10.1242/jeb.102897; Riveros Andre J., 2009, Communicative & Integrative Biology, V2, P437; SANDEMAN DC, 1980, J EXP BIOL, V85, P43; Schilstra C, 1998, NATURE, V395, P654, DOI 10.1038/27114; Schilstra C, 1999, J EXP BIOL, V202, P1481; Sherman A, 2004, J EXP BIOL, V207, P133, DOI 10.1242/jeb.00731; Sherman A, 2003, J EXP BIOL, V206, P295, DOI 10.1242/jeb.00075; Spaethe J, 2003, J EXP BIOL, V206, P3447, DOI 10.1242/jeb.00570; SRINIVASAN MV, 1988, J COMP PHYSIOL A, V162, P159, DOI 10.1007/BF00606081; van Beers RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002070; Van Hateren JH, 1999, J EXP BIOL, V202, P1491; Warzecha AK, 2000, VISION RES, V40, P2973, DOI 10.1016/S0042-6989(00)00147-4; Webb B, 2004, TRENDS NEUROSCI, V27, P278, DOI 10.1016/j.tins.2004.03.004; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Zeil J, 2007, COLD SPRING HARB MON, V49, P381; Zeil J, 2008, CURR BIOL, V18, pR320, DOI 10.1016/j.cub.2008.02.017; Zeil J, 2012, CURR OPIN NEUROBIOL, V22, P285, DOI 10.1016/j.conb.2011.12.008; Zeil J, 2009, FLYING INSECTS AND ROBOTS, P87, DOI 10.1007/978-3-540-89393-6_7	62	16	16	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135020	10.1371/journal.pone.0135020	http://dx.doi.org/10.1371/journal.pone.0135020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352836	Green Published, Green Submitted, gold			2022-12-26	WOS:000360932800005
J	Pedro, S; Xavier, JC; Tavares, S; Trathan, PN; Ratcliffe, N; Paiva, VH; Medeiros, R; Pereira, E; Pardal, MA				Pedro, Sara; Xavier, Jose C.; Tavares, Silvia; Trathan, Phil N.; Ratcliffe, Norman; Paiva, Vitor H.; Medeiros, Renata; Pereira, Eduarda; Pardal, Miguel A.			Feathers as a Tool to Assess Mercury Contamination in Gentoo Penguins: Variations at the Individual Level	PLOS ONE			English	Article							BIRD FEATHERS; BODY FEATHERS; EXTERNAL CONTAMINATION; ORGANIC POLLUTANTS; MARINE-ENVIRONMENT; BIOMONITORING TOOL; PYGOSCELIS-PAPUA; STABLE-ISOTOPES; HEAVY-METALS; MOLT	Feathers have been widely used to assess mercury contamination in birds as they reflect metal concentrations accumulated between successive moult periods: they are also easy to sample and have minimum impact on the study birds. Moult is considered the major pathway for mercury excretion in seabirds. Penguins are widely believed to undergo a complete, annual moult during which they do not feed. As penguins lose all their feathers, they are expected to have a low individual-variability in feather mercury concentration as all feathers are formed simultaneously from the same somatic reserves. This assumption is central to penguin studies that use feathers to examine the annual or among-individual variation in mercury concentrations in penguins. To test this assumption, we measured the mercury concentrations in 3-5 body feathers of 52 gentoo penguins (Pygoscelis papua) breeding at Bird Island, South Georgia (54 degrees S 38 degrees W). Twenty-five percent of the penguins studied showed substantial within-individual variation in the amount of mercury in their feathers (Coefficient of Variation: 34.7-96.7%). This variation may be caused by differences in moult patterns among individuals within the population leading to different interpretations in the overall population. Further investigation is now needed to fully understand individual variation in penguins' moult.	[Pedro, Sara; Tavares, Silvia; Pardal, Miguel A.] Univ Coimbra, Dept Life Sci, Ctr Funct Ecol, Coimbra, Portugal; [Xavier, Jose C.; Paiva, Vitor H.] Univ Coimbra, Dept Life Sci, MARE Marine & Environm Sci Ctr, Coimbra, Portugal; [Xavier, Jose C.; Trathan, Phil N.; Ratcliffe, Norman] British Antarctic Survey, Cambridge CB3 0ET, England; [Medeiros, Renata] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Pereira, Eduarda] Univ Aveiro, Dept Chem, Ctr Environm & Marine Studies, P-3800 Aveiro, Portugal	Universidade de Coimbra; Universidade de Coimbra; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Cardiff University; Universidade de Aveiro	Pedro, S (corresponding author), Univ Coimbra, Dept Life Sci, Ctr Funct Ecol, Coimbra, Portugal.	sara.pedro@student.uc.pt	Paiva, Vitor H./J-1092-2019; Paiva, Vitor Hugo/GRX-9179-2022; Pardal, Miguel Ângelo/C-3984-2009; Medeiros, Renata/M-8616-2015	Paiva, Vitor H./0000-0001-6368-9579; Pardal, Miguel Ângelo/0000-0001-6048-7007; Medeiros, Renata/0000-0002-5833-309X; /0000-0002-9621-6660; Pereira, Eduarda/0000-0002-6046-5243	Ministry of Science and Higher Education, Portugal (Fundacao para a Ciencia e a Tecnologia); Tinker Foundation; British Antarctic Survey under CEPH; British Antarctic Survey under SCAR AnT-ERA; British Antarctic Survey under PROPOLAR; British Antarctic Survey under ICED; NERC [bas0100035] Funding Source: UKRI; Natural Environment Research Council [bas0100035] Funding Source: researchfish	Ministry of Science and Higher Education, Portugal (Fundacao para a Ciencia e a Tecnologia); Tinker Foundation; British Antarctic Survey under CEPH; British Antarctic Survey under SCAR AnT-ERA; British Antarctic Survey under PROPOLAR; British Antarctic Survey under ICED; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding: This research was supported by the Ministry of Science and Higher Education, Portugal (Fundacao para a Ciencia e a Tecnologia, http://www.fct.pt/), the Tinker Foundation (http://www.tinker.org/) and the British Antarctic Survey (http://www.antarctica.ac.uk/), under the research programs CEPH, SCAR AnT-ERA, PROPOLAR and ICED. British Antarctic Survey plays an important role in data collection protocols.	Ancel A, 2013, CR BIOL, V336, P1, DOI 10.1016/j.crvi.2013.02.002; Anderson ORJ, 2009, MAR ECOL PROG SER, V375, P277, DOI 10.3354/meps07784; Bargagli R, 2008, SCI TOTAL ENVIRON, V400, P212, DOI 10.1016/j.scitotenv.2008.06.062; Bond AL, 2008, ENVIRON TOXICOL CHEM, V27, P2375, DOI 10.1897/08-163.1; Bond AL, 2010, ENVIRON POLLUT, V158, P1182, DOI 10.1016/j.envpol.2010.01.004; Brasso RL, 2013, ENVIRON TOXICOL CHEM, V32, P2331, DOI 10.1002/etc.2303; Bridge Eli S., 2006, Marine Ornithology, V34, P7; Burger J.., 2004, ECOHEALTH, V1, P263, DOI [10.1007/s10393-004-0096-4, DOI 10.1007/S10393-004-0096-4]; Burger J, 2013, ENVIRON RES, V122, P11, DOI 10.1016/j.envres.2013.01.003; Carravieri A, 2014, MAR BIOL, V161, P963, DOI 10.1007/s00227-014-2394-x; CHEREL Y, 1994, AM J PHYSIOL, V266, pR1182, DOI 10.1152/ajpregu.1994.266.4.R1182; Cristol DA, 2012, ECOL INDIC, V18, P20, DOI 10.1016/j.ecolind.2011.10.007; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; Dauwe T, 2003, ENVIRON POLLUT, V124, P429, DOI 10.1016/S0269-7491(03)00044-7; DAVIS RW, 1989, J ANIM ECOL, V58, P59, DOI 10.2307/4986; Ek KH, 2004, ARCH ENVIRON CON TOX, V47, P259, DOI 10.1007/s00244-004-3138-6; FURNESS RW, 1986, MAR POLLUT BULL, V17, P27, DOI 10.1016/0025-326X(86)90801-5; GOEDE AA, 1986, ENVIRON MONIT ASSESS, V7, P249, DOI 10.1007/BF00418017; Hallinger KK, 2011, ECOTOXICOLOGY, V20, P39, DOI 10.1007/s10646-010-0554-4; Head JA, 2011, ECOTOXICOLOGY, V20, P1636, DOI 10.1007/s10646-011-0738-6; Jaeger A, 2009, MAR BIOL, V156, P1233, DOI 10.1007/s00227-009-1165-6; Jaspers VLB, 2007, ENVIRON INT, V33, P766, DOI 10.1016/j.envint.2007.02.013; Jaspers VLB, 2007, ENVIRON INT, V33, P328, DOI 10.1016/j.envint.2006.11.011; Jaspers VLB, 2011, ENVIRON INT, V37, P1349, DOI 10.1016/j.envint.2011.06.004; Jerez S, 2011, ENVIRON POLLUT, V159, P2412, DOI 10.1016/j.envpol.2011.06.036; Langston NE, 1996, OIKOS, V76, P498, DOI 10.2307/3546343; Martinez A, 2012, SCI TOTAL ENVIRON, V425, P254, DOI 10.1016/j.scitotenv.2012.03.017; MONTEIRO LR, 1995, WATER AIR SOIL POLL, V80, P851, DOI 10.1007/BF01189736; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Pedro S, 2015, POLAR BIOL, V38, P1335, DOI 10.1007/s00300-015-1697-9; Tavares S, 2013, ENVIRON POLLUT, V181, P315, DOI 10.1016/j.envpol.2013.06.032; THOMPSON DR, 1993, POLAR BIOL, V13, P239	32	10	10	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137622	10.1371/journal.pone.0137622	http://dx.doi.org/10.1371/journal.pone.0137622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352664	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000360932800103
J	Shitara, H; Shimoyama, D; Sasaki, T; Hamano, N; Ichinose, T; Yamamoto, A; Kobayashi, T; Osawa, T; Iizuka, H; Hanakawa, T; Tsushima, Y; Takagishi, K				Shitara, Hitoshi; Shimoyama, Daisuke; Sasaki, Tsuyoshi; Hamano, Noritaka; Ichinose, Tsuyoshi; Yamamoto, Atsushi; Kobayashi, Tsutomu; Osawa, Toshihisa; Iizuka, Haku; Hanakawa, Takashi; Tsushima, Yoshito; Takagishi, Kenji			The Neural Correlates of Shoulder Apprehension: A Functional MRI Study	PLOS ONE			English	Article							HUMAN AMYGDALA; EXTINCTION; HUMANS; FEAR; HIPPOCAMPUS; INSTABILITY; KNOWLEDGE; MONKEYS	Although shoulder apprehension is an established clinical finding and is important for the prevention of shoulder dislocation, how this subjective perception is evoked remains unclear. We elucidated the functional neuroplasticity associated with apprehension in patients with recurrent anterior shoulder instability (RSI) using functional magnetic resonance imaging (fMRI). Twelve healthy volunteers and 14 patients with right-sided RSI performed a motor imagery task and a passive shoulder motion task. Brain activity was compared between healthy participants and those with RSI and was correlated with the apprehension intensity reported by participants after each task. Compared to healthy volunteers, participants with RSI exhibited decreased brain activity in the motor network, but increased activity in the hippocampus and amygdala. During the passive motion task, participants with RSI exhibited decreased activity in the left premotor and primary motor/somatosensory areas. Furthermore, brain activity was correlated with apprehension intensity in the left amygdala and left thalamus during the motor imagery task (memory-induced), while a correlation between apprehension intensity and brain activity was found in the left prefrontal cortex during the passive motion task (instability-induced). Our findings provide insight into the pathophysiology of RSI by identifying its associated neural alterations. We elucidated that shoulder apprehension was induced by two different factors, namely instability and memory.	[Shitara, Hitoshi; Shimoyama, Daisuke; Sasaki, Tsuyoshi; Hamano, Noritaka; Ichinose, Tsuyoshi; Yamamoto, Atsushi; Iizuka, Haku; Takagishi, Kenji] Gunma Univ, Grad Sch Med, Dept Orthopaed Surg, Maebashi, Gunma, Japan; [Kobayashi, Tsutomu] Takasaki Univ Hlth & Welf, Dept Phys Therapy, Takasaki, Gunma, Japan; [Osawa, Toshihisa] Natl Hosp Org, Takasaki Gen Med Ctr, Dept Orthopaed Surg, Takasaki, Gunma, Japan; [Hanakawa, Takashi] Natl Ctr Neurol & Psychiat, Integrat Brain Imaging Ctr, Dept Adv Neuroimaging, Kodaira, Tokyo, Japan; [Tsushima, Yoshito] Gunma Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Maebashi, Gunma 371, Japan	Gunma University; National Center for Neurology & Psychiatry - Japan; Gunma University	Shitara, H (corresponding author), Gunma Univ, Grad Sch Med, Dept Orthopaed Surg, Maebashi, Gunma, Japan.	hshitara@gunma-u.ac.jp	一ノ瀬, 剛/HDM-5592-2022; Shitara, Hitoshi/AAS-7991-2020; Hanakawa, Takashi/AEU-7951-2022	Shitara, Hitoshi/0000-0003-3547-0718; 	Nakatomi foundation Grand for medical and pharmacological research	Nakatomi foundation Grand for medical and pharmacological research	This work was supported by Nakatomi foundation Grand for medical and pharmacological research (https://www.nakatomi.or.jp/en/index.html), Award number: None; Recipient: Hitoshi Shitara. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPHS R, 1995, J NEUROSCI, V15, P5879; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Carel C, 2000, J CEREBR BLOOD F MET, V20, P478, DOI 10.1097/00004647-200003000-00006; Dodson CC, 2008, ORTHOP CLIN N AM, V39, P507, DOI 10.1016/j.ocl.2008.06.001; Gottfried JA, 2004, NAT NEUROSCI, V7, P1145, DOI 10.1038/nn1314; HALGREN E, 1978, BRAIN, V101, P83, DOI 10.1093/brain/101.1.83; Haller S, 2014, AM J NEURORADIOL, V35, P691, DOI 10.3174/ajnr.A3738; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; Hirnstein M, 2011, NEUROPSYCHOLOGIA, V49, P29, DOI 10.1016/j.neuropsychologia.2010.10.028; Isenberg N, 1999, P NATL ACAD SCI USA, V96, P10456, DOI 10.1073/pnas.96.18.10456; Jobe F W, 1989, Orthop Rev, V18, P963; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Kalisch R, 2006, J NEUROSCI, V26, P9503, DOI 10.1523/JNEUROSCI.2021-06.2006; Ketter TA, 1996, ARCH GEN PSYCHIAT, V53, P59; Kluver H, 1997, J NEUROPSYCH CLIN N, V9, P606; Lorey B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020368; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Owens BD, 2014, AM J SPORT MED, V42, P2591, DOI 10.1177/0363546514551149; Owens BD, 2011, ORTHOPEDICS, V34, P460, DOI 10.3928/01477447-20110427-21; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; ROWE C R, 1961, Clin Orthop, V20, P40; ROWE CR, 1981, J BONE JOINT SURG AM, V63, P863, DOI 10.2106/00004623-198163060-00001; Scott SK, 1997, NATURE, V385, P254, DOI 10.1038/385254a0; Walch G, 1996, J BONE JOINT SURG BR, V78B, P670, DOI 10.1302/0301-620X.78B4.0780670; WEISKRANTZ L, 1956, J COMP PHYSIOL PSYCH, V49, P381, DOI 10.1037/h0088009; Whalen PJ, 1998, J NEUROSCI, V18, P411	28	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137387	10.1371/journal.pone.0137387	http://dx.doi.org/10.1371/journal.pone.0137387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26351854	Green Submitted, Green Published, gold			2022-12-26	WOS:000360932800080
J	Yao, H; Gao, M; Ma, JH; Zhang, MY; Li, SW; Wu, BS; Nie, XH; Jiao, J; Zhao, H; Wang, SS; Yang, YY; Zhang, YS; Sun, YL; Wicha, MS; Chang, AE; Gao, SR; Li, Q; Xu, RX				Yao, Hui; Gao, Mou; Ma, Jianhua; Zhang, Maoying; Li, Shaowu; Wu, Bingshan; Nie, Xiaohu; Jiao, Jiao; Zhao, Hao; Wang, Shanshan; Yang, Yuanyuan; Zhang, Yesen; Sun, Yilin; Wicha, Max S.; Chang, Alfred E.; Gao, Shaorong; Li, Qiao; Xu, Ruxiang			Transdifferentiation-Induced Neural Stem Cells Promote Recovery of Middle Cerebral Artery Stroke Rats	PLOS ONE			English	Article							DIRECT CONVERSION; MOUSE FIBROBLASTS; PROGENITOR CELLS; MODEL; TRANSPLANTATION; SPECTROSCOPY; GENERATION; IPSCS	Induced neural stem cells (iNSCs) can be directly transdifferentiated from somatic cells. One potential clinical application of the iNSCs is for nerve regeneration. However, it is unknown whether iNSCs function in disease models. We produced transdifferentiated iNSCs by conditional overexpressing Oct4, Sox2, Klf4, c-Mycin mouse embryonic fibroblasts. They expanded readily in vitro and expressed NSC mRNA profile and protein markers. These iNSCs differentiated into mature astrocytes, neurons and oligodendrocytes in vitro. Importantly, they reduced lesion size, promoted the recovery of motor and sensory function as well as metabolism status in middle cerebral artery stroke rats. These iNSCs secreted nerve growth factors, which was associated with observed protection of neurons from apoptosis. Furthermore, iNSCs migrated to and passed through the lesion in the cerebral cortex, where Tuj1+ neurons were detected. These findings have revealed the function of transdifferentiated iNSCs in vivo, and thus provide experimental evidence to support the development of personalized regenerative therapy for CNS diseases by using genetically engineered autologous somatic cells.	[Yao, Hui; Gao, Mou; Ma, Jianhua; Zhang, Maoying; Nie, Xiaohu; Zhao, Hao; Wang, Shanshan; Zhang, Yesen; Xu, Ruxiang] PLA, Gen Hosp Beijing Mil Reg, Affiliated Bayi Brain Hosp, Beijing 100700, Peoples R China; [Yao, Hui; Zhao, Hao; Wang, Shanshan; Xu, Ruxiang] Neurosurg Inst Beijing Mil Reg, Beijing 100700, Peoples R China; [Gao, Mou] Third Mil Med Univ, Chongqing 400038, Peoples R China; [Ma, Jianhua; Wu, Bingshan; Zhang, Yesen] Anhui Med Univ, Hefei 230032, Peoples R China; [Zhang, Maoying; Nie, Xiaohu] So Med Univ, Guangzhou 510515, Guangdong, Peoples R China; [Li, Shaowu; Sun, Yilin] Beijing Tiantan Hosp, Beijing 100050, Peoples R China; [Jiao, Jiao; Yang, Yuanyuan; Gao, Shaorong] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Wicha, Max S.; Chang, Alfred E.; Li, Qiao] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	Seventh Medical Center of Chinese PLA General Hospital; Army Medical University; Anhui Medical University; Southern Medical University - China; Capital Medical University; National Institute of Biological Sciences, Beijing; University of Michigan System; University of Michigan	Xu, RX (corresponding author), PLA, Gen Hosp Beijing Mil Reg, Affiliated Bayi Brain Hosp, Beijing 100700, Peoples R China.	gaoshaorong@tongji.edu.cn; qiaoli@umich.edu; bjjzxuruxiang@163.com	Wicha, Max/AAE-7268-2019		China Postdoctoral Science Foundation [2013M532138]; Military Twelfth Five-Year Key Sci-Tech Research Projects [BWS11J002, BWS12J010]; Gillson Longenbaugh Foundation	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Military Twelfth Five-Year Key Sci-Tech Research Projects; Gillson Longenbaugh Foundation	This work was supported by the China Postdoctoral Science Foundation (2013M532138) and Military Twelfth Five-Year Key Sci-Tech Research Projects (Grant Nos. BWS11J002 and BWS12J010). This work was also supported in part by the Gillson Longenbaugh Foundation.	ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Bacigaluppi M, 2009, BRAIN, V132, P2239, DOI 10.1093/brain/awp174; Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Bertholdo D, 2013, NEUROIMAG CLIN N AM, V23, P359, DOI 10.1016/j.nic.2012.10.002; Briggs JA, 2013, STEM CELLS, V31, P467, DOI 10.1002/stem.1297; Di Tullio A, 2012, CELL CYCLE, V11, P2739, DOI 10.4161/cc.21119; Emborg ME, 2013, CELL REP, V3, P646, DOI 10.1016/j.celrep.2013.02.016; Fayed N, 2006, ACAD RADIOL, V13, P728, DOI 10.1016/j.acra.2006.01.047; Filippi CG, 2002, AM J NEURORADIOL, V23, P882; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Hsu Yuan-Yu, 2004, Chang Gung Med J, V27, P399; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; Jiao J, 2013, HUM MOL GENET, V22, P4241, DOI 10.1093/hmg/ddt275; Kawai H, 2010, J CEREBR BLOOD F MET, V30, P1487, DOI 10.1038/jcbfm.2010.32; Kendall GS, 2014, RADIOLOGY, V271, P230, DOI 10.1148/radiol.13122679; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kubas B, 2007, Neuroradiol J, V19, P699; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; Masip M, 2010, MOL HUM REPROD, V16, P856, DOI 10.1093/molehr/gaq059; Matsui T, 2012, STEM CELLS, V30, P1109, DOI 10.1002/stem.1091; McBride JL, 2004, J COMP NEUROL, V475, P211, DOI 10.1002/cne.20176; Mueller SG, 2011, J NEUROL, V258, P603, DOI 10.1007/s00415-010-5799-6; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; Redmond DE, 2007, P NATL ACAD SCI USA, V104, P12175, DOI 10.1073/pnas.0704091104; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Schultz SS, 2005, CURR DRUG TARGETS, V6, P63, DOI 10.2174/1389450053345046; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Sheng C, 2012, CELL RES, V22, P208, DOI 10.1038/cr.2011.175; Shetty AK, 2012, NEURAL STEM CELL THE; Smith EJ, 2012, STEM CELLS, V30, P785, DOI 10.1002/stem.1024; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Tornero D, 2013, BRAIN, V136, P3561, DOI 10.1093/brain/awt278; Wang LH, 2013, NAT METHODS, V10, P84, DOI [10.1038/NMETH.2283, 10.1038/nmeth.2283]; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Xu LY, 2006, TRANSPLANTATION, V82, P865, DOI 10.1097/01.tp.0000235532.00920.7a; Yang N, 2013, NAT MED, V19, P1580, DOI 10.1038/nm.3425	48	17	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137211	10.1371/journal.pone.0137211	http://dx.doi.org/10.1371/journal.pone.0137211			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352672	Green Published, Green Submitted, gold			2022-12-26	WOS:000360932800067
J	Arminjon, M; Chamseddine, A; Kopta, V; Paunovic, A; Mohr, C				Arminjon, Mathieu; Chamseddine, Amer; Kopta, Vladimir; Paunovic, Aleksandar; Mohr, Christine			Are We Modular Lying Cues Detectors? The Answer Is "Yes, Sometimes"	PLOS ONE			English	Article							FACIAL FEATURES; EVOLUTION; ACCURACY; TRUSTWORTHINESS; INTERNET; FACES	We quickly form first impressions about newly encountered people guiding our subsequent behaviour (approach, avoidance). Such instant judgments might be innate and automatic, being performed unconsciously and independently to other cognitive processes. Lying detection might be subject to such a modular process. Unfortunately, numerous studies highlighted problems with lying detection paradigms such as high error rates and learning effects. Additionally, humans should be motivated doing both detecting others' lies and disguising own lies. Disguising own lies might even be more challenging than detecting other people's lies. Thus, when trying to disguise cheating behaviour, liars might display a mixture of disguising (fake) trust cues and uncontrolled lying cues making the interpretation of the expression difficult (perceivers are guessing). In two consecutive online studies, we tested whether seeing an increasing amount (range 0-4) of lying cues (LC) and non-lying cues (NLC) on a standard face results in enhanced guessing behaviour (studies 1 and 2) and that enhanced guessing is accompanied by slower responding (study 2). Results showed that pronounced guessing and slowest responding occurred for faces with an intermediate number and not with the highest number of LC and NLC. In particular, LC were more important than NLC to uncertain lying decisions. Thus, only a few LC may interfere with automatic processing of lying detection (irrespective of NLC), probably because too little lying cue information is yet available.	[Arminjon, Mathieu] Univ Geneva, Dept Psychiat, Agalma Fdn, Geneva, Switzerland; [Chamseddine, Amer] Ecole Polytech Fed Lausanne, Dependable Syst Lab, CH-1015 Lausanne, Switzerland; [Kopta, Vladimir] Ecole Polytech Fed Lausanne, Lab Elect & Elect Engn, CH-1015 Lausanne, Switzerland; [Paunovic, Aleksandar] Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci I&C, CH-1015 Lausanne, Switzerland; [Mohr, Christine] Fac Social & Polit Sci, Inst Psychol, CH-1015 Lausanne, Switzerland	University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Arminjon, M (corresponding author), Univ Geneva, Dept Psychiat, Agalma Fdn, Geneva, Switzerland.	Mathieu.Arminjon@unige.ch	Arminjon, Mathieu/GQQ-9159-2022	/0000-0003-2254-8555; Mohr, Christine/0000-0002-3720-7115				Ambady N, 2000, ADV EXP SOC PSYCHOL, V32, P201, DOI 10.1016/S0065-2601(00)80006-4; Antonakis J, 2009, SCIENCE, V323, P1183, DOI 10.1126/science.1167748; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Bond CF, 2006, PERS SOC PSYCHOL REV, V10, P214, DOI 10.1207/s15327957pspr1003_2; Bonnefon JF, 2013, J EXP PSYCHOL GEN, V142, P143, DOI 10.1037/a0028930; Buller DB, 1996, COMMUN THEOR, V6, P203, DOI 10.1111/j.1468-2885.1996.tb00127.x; Cabin RJ., 2000, B ECOL SOC AM, V81, P246, DOI [DOI 10.2307/20168454, 10.2307/20168454]; CHENG PW, 1989, COGNITION, V33, P285, DOI 10.1016/0010-0277(89)90031-0; Chiappe D., 2004, EVOLUTIONARY PSYCHOL, V2, P108, DOI DOI 10.1177/147470490400200117; Cosmides L., 1992, ADAPTED MIND EVOLUTI, P163; Cosmides L., 2005, HDB EVOLUTIONARY PSY, P584; De Neys W, 2013, BIOL LETT, V9, P143; De Neys W, 2015, J ECON PSYCHOL, V47, P17, DOI 10.1016/j.joep.2015.01.002; DePaulo BM, 2003, PSYCHOL BULL, V129, P74, DOI 10.1037//0033-2909.129.1.74; EKMAN P, 1991, J NONVERBAL BEHAV, V15, P125, DOI 10.1007/BF00998267; Ekman P, 1999, PSYCHOL SCI, V10, P263, DOI 10.1111/1467-9280.00147; Fodor J, 1983, MODULARITY MIND; FRANK RH, 1993, ETHOL SOCIOBIOL, V14, P247, DOI 10.1016/0162-3095(93)90020-I; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Kovacs-Balint Z, 2013, BRIT J PSYCHOL, V104, P563, DOI 10.1111/bjop.12007; Lewis I, 2009, AUST J PSYCHOL, V61, P107, DOI 10.1080/00049530802105865; Little AC, 2013, PERS INDIV DIFFER, V54, P507, DOI 10.1016/j.paid.2012.10.018; MANDERSCHEID LV, 1965, J FARM ECON, V47, P1381, DOI 10.2307/1236396; Manson JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082531; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; NORMAN DA, 1975, COGNITIVE PSYCHOL, V7, P44, DOI 10.1016/0010-0285(75)90004-3; Okubo M, 2012, J NONVERBAL BEHAV, V36, P217, DOI 10.1007/s10919-012-0134-9; Paas F, 2003, EDUC PSYCHOL-US, V38, P63, DOI 10.1207/S15326985EP3801_8; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Schaller M., 2008, 1 IMPRESSIONS, P15; Schupp HT, 2004, EMOTION, V4, P189, DOI 10.1037/1528-3542.4.2.189; Sell A, 2003, ENCY COGNITIVE SCI, P47; Skitka LJ, 2006, ANNU REV PSYCHOL, V57, P529, DOI 10.1146/annurev.psych.57.102904.190048; Todorov A, 2009, SOC COGNITION, V27, P813, DOI 10.1521/soco.2009.27.6.813; Tognetti A, 2013, EVOL HUM BEHAV, V34, P427, DOI 10.1016/j.evolhumbehav.2013.08.002; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Van Lier J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053827; Vanneste S, 2007, EVOL HUM BEHAV, V28, P272, DOI 10.1016/j.evolhumbehav.2007.02.005; Verplaetse J, 2007, EVOL HUM BEHAV, V28, P260, DOI 10.1016/j.evolhumbehav.2007.04.006; von Hippel W, 2011, BEHAV BRAIN SCI, V34, DOI 10.1017/S0140525X10001354	40	1	1	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136418	10.1371/journal.pone.0136418	http://dx.doi.org/10.1371/journal.pone.0136418			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ8YQ	26349057	Green Published, gold			2022-12-26	WOS:000360897600007
J	Utsunomiya, YT; Ribeiro, ES; Quintal, APN; Sangalli, JR; Gazola, VR; Paula, HB; Trinconi, CM; Lima, VMF; Perri, SHV; Taylor, JF; Schnabel, RD; Sonstegard, TS; Garcia, JF; Nunes, CM				Utsunomiya, Yuri T.; Ribeiro, Erica S.; Quintal, Amanda P. N.; Sangalli, Juliano R.; Gazola, Valquiria R.; Paula, Henrique B.; Trinconi, Cristiana M.; Lima, Valeria M. F.; Perri, Silvia H. V.; Taylor, Jeremy F.; Schnabel, Robert D.; Sonstegard, Tad S.; Garcia, Jose F.; Nunes, Caris M.			Genome-Wide Scan for Visceral Leishmaniasis in Mixed-Breed Dogs Identifies Candidate Genes Involved in T Helper Cells and Macrophage Signaling	PLOS ONE			English	Article							CANINE LEISHMANIASIS; INTERFERON; GAMMA; AREA	We conducted a genome-wide scan for visceral leishmaniasis in mixed-breed dogs from a highly endemic area in Brazil using 149,648 single nucleotide polymorphism (SNP) markers genotyped in 20 cases and 28 controls. Using a mixed model approach, we found two candidate loci on canine autosomes 1 and 2. The positional association on chromosome 2 mapped to a predicted DNAse sensitive site in CD14+ monocytes that serve as a cis-regulatory element for the expression of interleukin alpha receptors 2 (IL2RA) and 15 (IL15RA). Both interleukins were previously found to lead to protective T helper 1 cell (Th1) response against Leishmania spp. in humans and mice. The associated marker on chromosome 1 was located between two predicted transcription factor binding sites regulating the expression of the transducin-like enhancer of split 1 gene (TLE1), an important player in Notch signaling. This pathway is critical for macrophage activity and CD4+ T cell differentiation into Th1 and T helper 2. Together, these findings suggest that the human and mouse model for protective response against Leishmania spp., which involves Th1 and macrophage modulation by interleukins 2, 15, gamma interferon and Notch signaling, may also hold for the canine model.	[Utsunomiya, Yuri T.; Garcia, Jose F.] UNESP Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Med Vet Prevent & Reprod Anim, Sao Paulo, Brazil; [Ribeiro, Erica S.; Quintal, Amanda P. N.; Sangalli, Juliano R.; Gazola, Valquiria R.; Paula, Henrique B.; Trinconi, Cristiana M.; Lima, Valeria M. F.; Perri, Silvia H. V.; Garcia, Jose F.; Nunes, Caris M.] UNESP Univ Estadual Paulista, Fac Med Vet Aracatuba, Dept Apoio Saude & Prod Anim, Sao Paulo, Brazil; [Taylor, Jeremy F.; Schnabel, Robert D.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Sonstegard, Tad S.] USDA ARS, Anim Genom & Improvement Lab, Beltsville, MD USA	Universidade Estadual Paulista; Universidade Estadual Paulista; University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA)	Nunes, CM (corresponding author), UNESP Univ Estadual Paulista, Fac Med Vet Aracatuba, Dept Apoio Saude & Prod Anim, Sao Paulo, Brazil.	caris@fmva.unesp.br	Sangalli, Juliano Rodrigues/C-1834-2013; Nunes, Caris M/R-9337-2016; de Melo Trinconi Tronco, Cristiana/N-5208-2015; de Lima, Valéria M.F./B-7867-2013; Utsunomiya, Yuri Tani T/K-5214-2013	Nunes, Caris M/0000-0002-5463-3845; de Melo Trinconi Tronco, Cristiana/0000-0003-3493-7339; de Lima, Valéria M.F./0000-0002-0954-5045; Utsunomiya, Yuri Tani T/0000-0002-6526-8337	Sao Paulo Research Foundation (FAPESP) [2014/01095-8]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	YTU is supported by a scholarship from the Sao Paulo Research Foundation (FAPESP-http://www.fapesp.br/) (process 2014/01095-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRANCHES P, 1991, J PARASITOL, V77, P557, DOI 10.2307/3283159; Altet L, 2002, INFECT IMMUN, V70, P2763, DOI 10.1128/IAI.70.6.2763-2771.2002; Auderset F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002560; CARVALHO EM, 1985, J CLIN INVEST, V76, P2066, DOI 10.1172/JCI112209; D'Agostino P, 2004, SCAND J IMMUNOL, V60, P609, DOI 10.1111/j.0300-9475.2004.01522.x; de Lima VMF, 2005, PESQUISA VET BRASIL, V25, P215, DOI 10.1590/S0100-736X2005000400005; Fakiola M, 2013, NAT GENET, V45, P208, DOI 10.1038/ng.2518; Franca-Silva JC, 2003, VET PARASITOL, V111, P161, DOI 10.1016/S0304-4017(02)00351-5; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Larabee JL, 2013, J BIOL CHEM, V288, P21526, DOI 10.1074/jbc.M113.465120; Milano S, 2002, CLIN EXP IMMUNOL, V127, P360, DOI 10.1046/j.1365-2249.2002.01749.x; Nunes CM, 2008, VET PARASITOL, V153, P19, DOI 10.1016/j.vetpar.2008.01.005; Quilez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035349; Quinnell RJ, 2003, IMMUNOGENETICS, V55, P23, DOI 10.1007/s00251-003-0545-1; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; RODGERS MR, 1990, EXP PARASITOL, V71, P267, DOI 10.1016/0014-4894(90)90031-7; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez-Robert E, 2005, J HERED, V96, P755, DOI 10.1093/jhered/esi111; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; World Health Organization, 2010, CONTR LEISHM REP M W	20	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136749	10.1371/journal.pone.0136749	http://dx.doi.org/10.1371/journal.pone.0136749			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348501	Green Submitted, Green Published, gold			2022-12-26	WOS:000360897600011
J	Verma, V; Mallik, L; Hariadi, RF; Sivaramakrishnan, S; Skiniotis, G; Joglekar, AP				Verma, Vikash; Mallik, Leena; Hariadi, Rizal F.; Sivaramakrishnan, Sivaraj; Skiniotis, Georgios; Joglekar, Ajit P.			Using Protein Dimers to Maximize the Protein Hybridization Efficiency with Multisite DNA Origami Scaffolds	PLOS ONE			English	Article							KINETOCHORE-MICROTUBULE ATTACHMENT; NANOSCALE SHAPES; FOLDING DNA; NANOSTRUCTURES; ARCHITECTURE; PURIFICATION; COMPLEX	DNA origami provides a versatile platform for conducting 'architecture-function' analysis to determine how the nanoscale organization of multiple copies of a protein component within a multi-protein machine affects its overall function. Such analysis requires that the copy number of protein molecules bound to the origami scaffold exactly matches the desired number, and that it is uniform over an entire scaffold population. This requirement is challenging to satisfy for origami scaffolds with many protein hybridization sites, because it requires the successful completion of multiple, independent hybridization reactions. Here, we show that a cleavable dimerization domain on the hybridizing protein can be used to multiplex hybridization reactions on an origami scaffold. This strategy yields nearly 100% hybridization efficiency on a 6-site scaffold even when using low protein concentration and short incubation time. It can also be developed further to enable reliable patterning of a large number of molecules on DNA origami for architecture-function analysis.	[Verma, Vikash; Hariadi, Rizal F.; Sivaramakrishnan, Sivaraj; Joglekar, Ajit P.] Univ Michigan, Sch Med, Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Mallik, Leena; Skiniotis, Georgios] Univ Michigan, Sch Med, Inst Life Sci, Ann Arbor, MI USA; [Mallik, Leena; Skiniotis, Georgios] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Joglekar, AP (corresponding author), Univ Michigan, Sch Med, Cell & Dev Biol, Ann Arbor, MI 48109 USA.	ajitj@umich.edu	Verma, Vikash/AAU-6550-2020; Mallik, Leena/AAM-4619-2020	Verma, Vikash/0000-0003-2371-4164; Joglekar, Ajit/0000-0002-0607-5332; Hariadi, Rizal/0000-0001-7840-859X; Skiniotis, Georgios/0000-0003-0238-7846	National Institute of General Medical Sciences [R01-GM105948]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105948] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences grant R01-GM105948 to APJ.	Aravamudhan P, 2015, NAT CELL BIOL, V17, P868, DOI 10.1038/ncb3179; Aravamudhan P, 2014, CURR BIOL, V24, P1437, DOI 10.1016/j.cub.2014.05.014; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Derr ND, 2012, SCIENCE, V338, P662, DOI 10.1126/science.1226734; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Hariadi RF, 2014, P NATL ACAD SCI USA, V111, P4091, DOI 10.1073/pnas.1315923111; Joglekar AP, 2006, NAT CELL BIOL, V8, P581, DOI 10.1038/ncb1414; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Lin CX, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1070; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maure JF, 2011, CURR BIOL, V21, P207, DOI 10.1016/j.cub.2010.12.050; Meyer R, 2015, SMALL, V11, P2669, DOI 10.1002/smll.201403544; Mutch SA, 2007, BIOPHYS J, V92, P2926, DOI 10.1529/biophysj.106.101428; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Shaw A, 2015, ACS NANO, V9, P4968, DOI 10.1021/nn507035g; Wang HW, 2008, J MOL BIOL, V383, P894, DOI 10.1016/j.jmb.2008.08.077; Woo S, 2011, NAT CHEM, V3, P620, DOI [10.1038/NCHEM.1070, 10.1038/nchem.1070]	18	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137125	10.1371/journal.pone.0137125	http://dx.doi.org/10.1371/journal.pone.0137125			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348722	Green Submitted, Green Published, gold			2022-12-26	WOS:000360897600022
J	Fereshtehnejad, SM; Shafieesabet, M; Farhadi, F; Hadizadeh, H; Rahmani, A; Naderi, N; Khaefpanah, D; Shahidi, GA; Delbari, A; Lokk, J				Fereshtehnejad, Seyed-Mohammad; Shafieesabet, Mahdiyeh; Farhadi, Farzaneh; Hadizadeh, Hasti; Rahmani, Arash; Naderi, Nader; Khaefpanah, Dena; Shahidi, Gholam Ali; Delbari, Ahmad; Lokk, Johan			Heterogeneous Determinants of Quality of Life in Different Phenotypes of Parkinson's Disease	PLOS ONE			English	Article							NUTRITIONAL-STATUS; SYMPTOMS; DEPRESSION; NONMOTOR	Objectives Health-related quality of life (HRQoL) is considered a very important outcome indicator in patients with Parkinson's disease (PD). A broad list of motor and non-motor features have been shown to affect HRQoL in PD, however, there is a dearth of information about the complexity of interrelationships between determinants of HRQoL in different PD phenotypes. We aimed to find independent determinates and the best structural model for HRQoL, also to investigate the heterogeneity in HRQoL between PD patients with different phenotypes regarding onset-age, progression rate and dominant symptom. Methods A broad spectrum of demographic, motor and non-motor characteristics were collected in 157 idiopathic PD patients, namely comorbidity profile, nutritional status, UPDRS (total items), psychiatric symptoms (depression, anxiety), fatigue and psychosocial functioning through physical examination, validated questionnaires and scales. Structural equation model (SEM) and multivariate regressions were applied to find determinants of Parkinson's disease summary index (PDSI) and different domains of HRQoL (PDQ-39). Results Female sex, anxiety, depression and UPDRS-part II scores were the significant independent determinants of PDSI. A structural model consisting of global motor, global non-motor and co-morbidity indicator as three main components was able to predict 89% of the variance in HRQoL. In older-onset and slow-progression phenotypes, the motor domain showed smaller contribution on HRQoL and the majority of its effects were mediated through non-motor features. Comorbidity component was a significant determinant of HRQoL only among older-onset and non-tremor-dominant PD patients. Fatigue was not a significant indicator of non-motor component to affect HRQoL in rapid-progression PD. Conclusions Our findings showed outstanding heterogeneities in the pattern and determinants of HRQoL among PD phenotypes. These factors should be considered during the assessments and developing personalized interventions to improve HRQOL in PD patients with different phenotypes or prominent feature.	[Fereshtehnejad, Seyed-Mohammad; Delbari, Ahmad; Lokk, Johan] Karolinska Inst, Div Clin Geriatr, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden; [Fereshtehnejad, Seyed-Mohammad; Khaefpanah, Dena] Iran Univ Med Sci, FCRDC, Firoozgar Hosp, Tehran, Iran; [Shafieesabet, Mahdiyeh; Farhadi, Farzaneh; Hadizadeh, Hasti; Rahmani, Arash; Naderi, Nader] Iran Univ Med Sci, MSRC, Fac Med, Tehran, Iran; [Rahmani, Arash] Iran Univ Med Sci, Mental Hlth Res Ctr, Tehran Inst Psychiat, Sch Behav Sci & Mental Hlth, Tehran, Iran; [Shahidi, Gholam Ali] Iran Univ Med Sci, Fac Med, Dept Neurol, Movement Disorders Clin, Tehran, Iran; [Delbari, Ahmad] Univ Social Welf & Rehabil, Iranian Res Ctr Aging, Tehran, Iran; [Lokk, Johan] Karolinska Univ Hosp, Dept Geriatr Med, Stockholm, Sweden	Karolinska Institutet; Iran University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences; Karolinska Institutet; Karolinska University Hospital	Fereshtehnejad, SM (corresponding author), Karolinska Inst, Div Clin Geriatr, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden.	sm.fereshtehnejad@ki.se	rahmani, arash/AAL-5457-2020; Fereshtehnejad, Seyed-Mohammad/ABF-6020-2020; Hadizadeh, Hasti/H-9613-2018; Delbari, Ahmad/D-8560-2017	rahmani, arash/0000-0002-2948-3478; Fereshtehnejad, Seyed-Mohammad/0000-0001-9255-9351; Hadizadeh, Hasti/0000-0002-2099-6859; Shahidi, Gholam Ali/0000-0002-3889-4973				Akbar U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124541; Berganzo K, 2014, NEUROLOGIA; Fereshtehnejad SM, 2014, NEUROL RES INT, V2014, DOI 10.1155/2014/260684; Fereshtehnejad SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091153; Fereshtehnejad SM, 2013, PARKINSONS DIS-US, V2013, DOI 10.1155/2013/935429; Gasparoli E, 2002, NEUROL SCI, V23, pS77, DOI 10.1007/s100720200078; Ghazi L, 2015, ECOL FOOD NUTR, V54, P342, DOI 10.1080/03670244.2014.994743; Hancock G.R., 2003, J MOD APPL STAT METH, V2, P293, DOI [DOI 10.22237/JMASM/1067644980, DOI 10.22237/jmasm/1067644980]; Hinnell C, 2012, MOVEMENT DISORD, V27, P236, DOI 10.1002/mds.23961; Hooper D., 2008, EJBRM, V6, P53, DOI [DOI 10.1037/1082[HYPHEN]989X.12.1.58, 10.21427/D79B73]; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jones JD, 2015, J NEUROPSYCH CLIN N, V27, P213, DOI 10.1176/appi.neuropsych.13120380; Kasten M, 2012, MOVEMENT DISORD, V27, P754, DOI 10.1002/mds.24999; 홍석경, 2002, [Journal of the Korean Neurological Association, 대한신경과학회지], V20, P227; Langston JW, 2006, ANN NEUROL, V59, P591, DOI 10.1002/ana.20834; Lee J, 2015, WESTERN J NURS RES, V37, P1062, DOI 10.1177/0193945914528588; Li HJ, 2010, MOVEMENT DISORD, V25, P2740, DOI 10.1002/mds.23368; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462; Montazeri Ali, 2003, Health Qual Life Outcomes, V1, P14, DOI 10.1186/1477-7525-1-14; Nojomi M, 2010, J RES MED SCI, V15, P63; Qin ZH, 2009, PARKINSONISM RELAT D, V15, P767, DOI 10.1016/j.parkreldis.2009.05.011; Quelhas R, 2009, J NEUROPSYCH CLIN N, V21, P413, DOI 10.1176/appi.neuropsych.21.4.413; Rahman S, 2008, MOVEMENT DISORD, V23, P1428, DOI 10.1002/mds.21667; Rodriguez-Violante M, 2013, ARCH MED RES, V44, P110, DOI 10.1016/j.arcmed.2013.01.005; Sheard JM, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0212-1; Shearer J, 2012, J NEUROL, V259, P462, DOI 10.1007/s00415-011-6202-y; Sieber BA, 2014, ANN NEUROL, V76, P469, DOI 10.1002/ana.24261; Soh SE, 2013, QUAL LIFE RES, V22, P1543, DOI 10.1007/s11136-012-0289-1; Soh SE, 2011, PARKINSONISM RELAT D, V17, P1, DOI 10.1016/j.parkreldis.2010.08.012; Visser M, 2008, J NEUROL, V255, P1580, DOI 10.1007/s00415-008-0994-4; Winter Y, 2010, J NEUROL, V257, P638, DOI 10.1007/s00415-009-5389-7; Wu Y, 2014, J NEUROL SCI, V340, P144, DOI 10.1016/j.jns.2014.03.014; Zhao YJ, 2008, EUR J NEUROL, V15, P737, DOI 10.1111/j.1468-1331.2008.02178.x	33	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137081	10.1371/journal.pone.0137081	http://dx.doi.org/10.1371/journal.pone.0137081			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335773	Green Published, Green Submitted, gold			2022-12-26	WOS:000360615400038
J	Gan, P; Xie, Y; Duan, WJ; Deng, Q; Yu, XL				Gan, Pei; Xie, Yan; Duan, Wenjie; Deng, Qing; Yu, Xiuli			Rumination and Loneliness Independently Predict Six-Month Later Depression Symptoms among Chinese Elderly in Nursing Homes	PLOS ONE			English	Article							PRIMARY-CARE; RISK-FACTORS; PREVALENCE; COMMUNITY; DISORDERS; RESIDENTS; QUALITY; ROLES; SCALE; MOOD	Background Previous studies conducted in Western countries independently demonstrated that loneliness and rumination are remarkable risk factors of depression among the elderly in both community and nursing homes. However, knowledge on the relationship between these three constructs among the elderly in Eastern countries is scarce. The current study aims to determine the relationship between loneliness, rumination, and depression among Chinese elderly in nursing homes. Methods A total of 71 elderly participants with an average age of 82.49 years completed this six-month longitudinal study. Physical reports indicated that none of the participants were clinically depressed before the study. At Time 1, their loneliness and rumination were measured using UCLA-8 Loneliness Scale and Ruminative Responses Scale. Six months later, the participants completed the Center for Epidemiologic Studies Depression Scale to assess depressive symptoms (Time 2). Results Multiple regression analysis revealed that both loneliness and rumination at Time 1 were the predictors of depression symptoms at Time 2 among the Chinese elderly in nursing homes. However, in the mediation analysis using PROCESS, the indirect effect between loneliness at Time 1 and depression symptoms at Time 2 was insignificant. Conclusions Results suggest that previous loneliness and rumination thinking are predictors of future depression symptoms among the Chinese elderly in nursing homes. However, the insignificant mediation further suggests that the differences between loneliness and rumination should be explored in future studies. Findings have important implications for mental health professionals in nursing homes in China.	[Gan, Pei; Xie, Yan; Deng, Qing; Yu, Xiuli] Chongqing Med Univ, Affiliated Hosp 1, Qinggang Senior Care Ctr, Chongqing, Peoples R China; [Duan, Wenjie] City Univ Hong Kong, Dept Appl Social Sci, Hong Kong, Hong Kong, Peoples R China	Chongqing Medical University; City University of Hong Kong	Xie, Y (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Qinggang Senior Care Ctr, Chongqing, Peoples R China.	zhourushui123@163.com; duan.w@outlook.com	Duan, Wenjie/C-8722-2016	Duan, Wenjie/0000-0002-1251-3685	National Key Clinical Specialties Construction Program of China (Nursing) [MOF-MOHRSS[2010]305]	National Key Clinical Specialties Construction Program of China (Nursing)	This study was supported by National Key Clinical Specialties Construction Program of China (Nursing, MOF-MOHRSS[2010]305).	Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2; Asnani MR, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-40; Aylaz R, 2012, ARCH GERONTOL GERIAT, V55, P548, DOI 10.1016/j.archger.2012.03.006; Azam WMYWM, 2013, ASIA-PAC PSYCHIAT, V5, P134, DOI 10.1111/appy.12061; Barcelos-Ferreira R, 2013, J AFFECT DISORDERS, V150, P616, DOI 10.1016/j.jad.2013.02.024; Boorsma M, 2012, AM J GERIAT PSYCHIAT, V20, P932, DOI 10.1097/JGP.0b013e31825d08ac; Cacioppo JT, 2006, PSYCHOL AGING, V21, P140, DOI 10.1037/0882-7974.21.1.140; Casey DA, 2012, ASIA-PAC PSYCHIAT, V4, P160, DOI 10.1111/j.1758-5872.2012.00191.x; Cole MG, 1999, AM J PSYCHIAT, V156, P1182; Cole MG, 2003, AM J PSYCHIAT, V160, P1147, DOI 10.1176/appi.ajp.160.6.1147; DiTommaso E, 2004, EDUC PSYCHOL MEAS, V64, P99, DOI 10.1177/0013164403258450; Duan WJ, 2012, RES SOCIAL WORK PRAC, V22, P680, DOI 10.1177/1049731512450074; GUPTA R, 2001, J MENTAL HLTH AGING, V7, P257; Hansen NB, 2013, J HEALTH PSYCHOL, V18, P198, DOI 10.1177/1359105312440299; Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; HAYS RD, 1987, J PERS ASSESS, V51, P69, DOI 10.1207/s15327752jpa5101_6; Ingersoll-Dayton B, 2010, AGING MENT HEALTH, V14, P439, DOI 10.1080/13607860903483136; JONES WH, 1985, J PERS SOC PSYCHOL, V48, P1503, DOI 10.1037/0022-3514.48.6.1503; Jongenelis K, 2004, J AFFECT DISORDERS, V83, P135, DOI 10.1016/j.jad.2004.06.001; Liu LJ, 2016, J HEALTH PSYCHOL, V21, P750, DOI 10.1177/1359105314536941; McCusker J, 2005, J AM GERIATR SOC, V53, P1344, DOI 10.1111/j.1532-5415.2005.53404.x; Mechakra-Tahiri S, 2009, INT J GERIATR PSYCH, V24, P1226, DOI 10.1002/gps.2250; Mehta M, 2008, INT J GERIATR PSYCH, V23, P238, DOI 10.1002/gps.1868; NOLENHOEKSEMA S, 1991, J PERS SOC PSYCHOL, V61, P115, DOI 10.1037/0022-3514.61.1.115; Olivera J, 2008, INT J GERIATR PSYCH, V23, P915, DOI 10.1002/gps.2004; Ostbye T, 2004, CHRONIC DIS CANADA, V26, P93; Park J, 2013, J HEALTH PSYCHOL, V18, P226, DOI 10.1177/1359105312439731; Rabins PV, 1996, J GERONTOL A-BIOL, V51, pM319, DOI 10.1093/gerona/51A.6.M319; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RUSSELL D, 1978, J PERS ASSESS, V42, P290, DOI 10.1207/s15327752jpa4203_11; Smith JM, 2009, CLIN PSYCHOL REV, V29, P116, DOI 10.1016/j.cpr.2008.10.003; Sutcliffe C, 2007, AM J GERIAT PSYCHIAT, V15, P708, DOI 10.1097/JGP.0b013e3180381537; Treynor W, 2003, COGNITIVE THER RES, V27, P247, DOI 10.1023/A:1023910315561; Tsai FJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-567; Tucker RP, 2013, PERS INDIV DIFFER, V55, P606, DOI 10.1016/j.paid.2013.05.013; Underwood M, 2013, LANCET, V382, P41, DOI 10.1016/S0140-6736(13)60649-2; Vanhalst J, 2012, J PSYCHOL, V146, P259, DOI 10.1080/00223980.2011.555433; von Hippel W, 2008, COGNITIVE THER RES, V32, P474, DOI 10.1007/s10608-006-9034-9; Wang GY, 2011, INT J GERIATR PSYCH, V26, P1162, DOI 10.1002/gps.2656; WILSON D, 1992, J PERS ASSESS, V59, P72, DOI 10.1207/s15327752jpa5901_7; Yuen ANY, 2014, PSYCHO-ONCOLOGY, V23, P412, DOI 10.1002/pon.3433; YUM JO, 1988, COMMUN MONOGR, V55, P374, DOI 10.1080/03637758809376178; Zawadzki MJ, 2013, HEALTH PSYCHOL, V32, P212, DOI 10.1037/a0029007	44	33	35	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137176	10.1371/journal.pone.0137176	http://dx.doi.org/10.1371/journal.pone.0137176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ5AJ	26334298	Green Published, Green Submitted, gold			2022-12-26	WOS:000360615400042
J	Mori, S; Kodaira, M; Ito, A; Okazaki, M; Kawaguchi, N; Hamada, Y; Takada, Y; Matsuura, N				Mori, Seiji; Kodaira, Moe; Ito, Ayano; Okazaki, Mika; Kawaguchi, Naomasa; Hamada, Yoshinosuke; Takada, Yoshikazu; Matsuura, Nariaki			Enhanced Expression of Integrin alpha v beta 3 Induced by TGF-beta Is Required for the Enhancing Effect of Fibroblast Growth Factor 1 (FGF1) in TGF-beta-Induced Epithelia-lMesenchymal Transition (EMT) in Mammary Epithelial Cells	PLOS ONE			English	Article							TERNARY COMPLEX-FORMATION; FIBROBLAST GROWTH-FACTORS; HUMAN LUNG FIBROBLASTS; MESENCHYMAL TRANSITION; RECEPTOR IGF1R; DIRECT BINDING; CANCER; INDUCTION; TGF-BETA-1; COOPERATION	Epithelial-to-mesenchymal transition (EMT) plays a critical role in cancer metastasis, and is regulated by growth factors such as transforming growth factor beta (TGF-beta) and fibroblast growth factors (FGF) secreted from the stromal and tumor cells. However, the role of growth factors in EMT has not been fully established. Several integrins are upregulated by TGF-beta 1 during EMT. Integrins are involved in growth factor signaling through integrin-growth factor receptor crosstalk. We previously reported that FGF1 directly binds to integrin alpha v beta 3 and the interaction was required for FGF1 functions such as cell proliferation and migration. We studied the role of alpha v beta 3 induced by TGF-beta on TGF-beta-induced EMT. Here, we describe that FGF1 augmented EMT induced by TGF-beta 1 in MCF10A and MCF12A mammary epithelial cells. TGF-beta 1 markedly amplified integrin alpha v beta 3 and FGFR1 (but not FGFR2). We studied if the enhancing effect of FGF1 on TGF-beta 1-induced EMT requires enhanced levels of both integrin alpha v beta 3 expression and FGFR1. Knockdown of beta 3 suppressed the enhancement by FGF1 of TGF-beta 1-induced EMT in MCF10A cells. Antagonists to FGFR suppressed the enhancing effect of FGF1 on EMT. Integrin-binding defective FGF1 mutant did not augment TGF-beta 1-induced EMT in MCF10A cells. These findings suggest that enhanced integrin alpha v beta 3 expression in addition to enhanced FGFR1 expression is critical for FGF1 to augment TGF-beta 1-induced EMT in mammary epithelial cells.	[Mori, Seiji; Kodaira, Moe; Ito, Ayano; Okazaki, Mika; Kawaguchi, Naomasa; Hamada, Yoshinosuke; Matsuura, Nariaki] Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Mol Pathol, Suita, Osaka 5650871, Japan; [Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; [Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Biochem, Sacramento, CA 95817 USA; [Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Mol Med, Sacramento, CA 95817 USA; [Takada, Yoshikazu] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Translat Med, Taipei 11031, Taiwan	Osaka University; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Taipei Medical University	Takada, Y (corresponding author), Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu; matsuura@sahs.med.osaka-u.ac.jp		takada, yoshikazu/0000-0001-5481-9589	Japan Society for the Promotion of Science [26460471]; NIH [CA13015, DOD W81XWH-10-1-0312]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Grant-in-Aid for Scientific Research (Grant No. 26460471) from the Japan Society for the Promotion of Science (to SM and NM) and NIH CA13015 and DOD W81XWH-10-1-0312 (to YT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Billottet C, 2004, MOL BIOL CELL, V15, P4725, DOI 10.1091/mbc.E04-04-0336; Billottet C, 2008, J CELL BIOCHEM, V104, P826, DOI 10.1002/jcb.21667; Blatchford DR, 1999, J CELL PHYSIOL, V181, P304, DOI 10.1002/(SICI)1097-4652(199911)181:2<304::AID-JCP12>3.0.CO;2-5; Brown KA, 2004, BREAST CANCER RES, V6, pR215, DOI 10.1186/bcr778; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Feng X, 2013, 2013 IEEE 7TH INTERNATIONAL CONFERENCE ON SOFTWARE SECURITY AND RELIABILITY - COMPANION (SERE-C), P1, DOI 10.1109/SERE-C.2013.24; Finlay GA, 2000, J BIOL CHEM, V275, P27650; Fischer ANM, 2007, ONCOGENE, V26, P3395, DOI 10.1038/sj.onc.1210121; Fujita M, 2013, J BIOL CHEM, V288, P19593, DOI 10.1074/jbc.M113.470872; Fujita M, 2013, J BIOL CHEM, V288, P3059, DOI 10.1074/jbc.M112.412536; Fujita M, 2012, J BIOL CHEM, V287, P12491, DOI 10.1074/jbc.M111.304170; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Gotzmann J, 2006, ONCOGENE, V25, P3170, DOI 10.1038/sj.onc.1209083; Gotzmann J, 2004, MUTAT RES-REV MUTAT, V566, P9, DOI 10.1016/S1383-5742(03)00033-4; Guillemot F, 2011, NEURON, V71, P574, DOI 10.1016/j.neuron.2011.08.002; Hollestelle A, 2013, BREAST CANCER RES TR, V138, P47, DOI 10.1007/s10549-013-2415-3; Hong JP, 2013, INT J MOL MED, V31, P1436, DOI 10.3892/ijmm.2013.1337; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ivaska J, 2010, CELL TISSUE RES, V339, P111, DOI 10.1007/s00441-009-0857-z; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Mamuya FA, 2012, J CELL MOL MED, V16, P445, DOI 10.1111/j.1582-4934.2011.01419.x; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; Mori S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057927; Moustakas A, 2012, SEMIN CANCER BIOL, V22, P446, DOI 10.1016/j.semcancer.2012.04.002; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Pechkovsky DV, 2008, J BIOL CHEM, V283, P12898, DOI 10.1074/jbc.M708226200; Ramos C, 2006, AM J PHYSIOL-LUNG C, V291, pL871, DOI 10.1152/ajplung.00019.2006; Ramos C, 2010, AM J PHYSIOL-LUNG C, V299, pL222, DOI 10.1152/ajplung.00070.2010; Saegusa J, 2009, J BIOL CHEM, V284, P24106, DOI 10.1074/jbc.M109.013201; Scaffidi AK, 2004, J BIOL CHEM, V279, P37726, DOI 10.1074/jbc.M403010200; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Shirakihara T, 2011, EMBO J, V30, P783, DOI 10.1038/emboj.2010.351; Shukla MN, 2009, AM J RESP CELL MOL, V40, P643, DOI 10.1165/rcmb.2008-0217OC; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tran DD, 2011, MOL CANCER RES, V9, P1644, DOI 10.1158/1541-7786.MCR-11-0371; Turner C, 2010, J THEOR BIOL, V265, P329, DOI 10.1016/j.jtbi.2010.05.024; Uttamsingh S, 2008, ONCOGENE, V27, P2626, DOI 10.1038/sj.onc.1210915; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yamaji S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010273	50	42	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137486	10.1371/journal.pone.0137486	http://dx.doi.org/10.1371/journal.pone.0137486			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334633	Green Published, gold, Green Submitted			2022-12-26	WOS:000360615400060
J	Su, Z; Mao, YP; OuYang, PY; Tang, J; Xie, FY				Su, Zhen; Mao, Yan-Ping; OuYang, Pu-Yun; Tang, Jie; Xie, Fang-Yun			Initial Hyperleukocytosis and Neutrophilia in Nasopharyngeal Carcinoma: Incidence and Prognostic Impact	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; INTENSITY-MODULATED RADIOTHERAPY; TUMOR-RELATED LEUKOCYTOSIS; PREOPERATIVE LEUKOCYTOSIS; ENDOMETRIAL CARCINOMA; PRETREATMENT LEUKOCYTOSIS; LEUKEMOID REACTION; CERVICAL-CANCER; BLADDER-CANCER; POOR-PROGNOSIS	Background This study aimed to evaluate initial hyperleukocytosis and neutrophilia as prognostic indicators in patients with nasopharyngeal carcinoma. Methods A retrospective analysis of 5,854 patients identified from a cohort of 6,035 patients diagnosed with nasopharyngeal carcinoma was performed with initial hyperleukocytosis and neutrophilia analyzed as prognostic factors. Multivariate Cox proportional hazards analyses were applied. Results Hyperleukocytosis was observed in 508 patients (8.7%). Multivariate analysis showed that initial hyperleukocytosis was an independent predictor of death (HR 1.40, 95% CI 1.15-1.70, p = 0.001), progression (HR 1.25, 95% CI 1.06-1.47, p = 0.007) and, marginally, distant metastasis (HR 1.21, 95% CI 0.97-1.52, p = 0.088). Neutrophilia was also an independent predictor of death (HR 1.46, 95% CI 1.18-1.81, p = 0.001), progression (HR 1.31, 95% CI 1.10-1.56, p = 0.003), and distant metastasis (HR 1.29, 95% CI 1.02-1.65, p = 0.036), after adjusting for prognostic factors and excluding hyperleukocytosis. Conclusion Initial hyperleukocytosis and neutrophilia were independent, poor prognostic factors and may be convenient and useful biological markers for survival of patients with nasopharyngeal carcinoma.	[Su, Zhen; Mao, Yan-Ping; OuYang, Pu-Yun; Tang, Jie; Xie, Fang-Yun] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Radiat Oncol,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University	Xie, FY (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Radiat Oncol,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China.	xiefy@sysucc.org.cn						Adham M, 2012, CHIN J CANCER, V31, P185, DOI 10.5732/cjc.011.10328; Banerjee R, 2013, DIS COLON RECTUM, V56, P1036, DOI 10.1097/DCR.0b013e31829ab0d4; Brandau S, 2013, SEMIN CANCER BIOL, V23, P139, DOI 10.1016/j.semcancer.2013.02.008; Brandau S, 2013, SEMIN CANCER BIOL, V23, P171, DOI 10.1016/j.semcancer.2013.02.007; Cerny J, 2012, HEMATOL ONCOL CLIN N, V26, P303, DOI 10.1016/j.hoc.2012.01.001; Cetin B, 2012, ASIAN PAC J CANCER P, V13, P1059, DOI 10.7314/APJCP.2012.13.3.1059; Chakraborty A, 2006, UROLOGY, V68, P208, DOI 10.1016/j.urology.2006.01.046; Chen L, 2012, RADIOTHER ONCOL, V104, P331, DOI 10.1016/j.radonc.2011.10.009; Chen YW, 2014, BRIT J ORAL MAX SURG, V52, P425, DOI 10.1016/j.bjoms.2014.02.014; Coppin CML, 1996, J CLIN ONCOL, V14, P2901, DOI 10.1200/JCO.1996.14.11.2901; CVITKOVIC E, 1993, J CLIN ONCOL, V11, P2434, DOI 10.1200/JCO.1993.11.12.2434; Donskov F, 2013, SEMIN CANCER BIOL, V23, P200, DOI 10.1016/j.semcancer.2013.02.001; Dumitru CA, 2011, INT J CANCER, V129, P859, DOI 10.1002/ijc.25991; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Granger JM, 2009, CANCER-AM CANCER SOC, V115, P3919, DOI 10.1002/cncr.24480; Gutschalk CM, 2006, CANCER RES, V66, P8026, DOI 10.1158/0008-5472.CAN-06-0158; He JR, 2012, HEAD NECK-J SCI SPEC, V34, P1769, DOI 10.1002/hed.22008; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Hirai K, 2001, J DERMATOL SCI, V25, P179, DOI 10.1016/S0923-1811(00)00131-6; [黄腾波 Huang Tengbo], 2002, [中华医学遗传学杂志, Chinese Journal of Medical Genetics], V19, P134; Imai Y, 2005, J GASTROEN HEPATOL, V20, P287, DOI 10.1111/j.1440-1746.2004.03575.x; Kasuga I, 2001, CANCER-AM CANCER SOC, V92, P2399, DOI 10.1002/1097-0142(20011101)92:9<2399::AID-CNCR1588>3.0.CO;2-W; Kohne CH, 2002, ANN ONCOL, V13, P308, DOI 10.1093/annonc/mdf034; Kus AB, 2014, INT J PEDIATR OTORHI, V78, P885, DOI 10.1016/j.ijporl.2014.02.016; Leung TW, 2005, HEAD NECK-J SCI SPEC, V27, P555, DOI 10.1002/hed.20189; Luomaranta A, 2013, GYNECOL ONCOL, V129, P28, DOI 10.1016/j.ygyno.2013.01.008; Ma J, 2007, CLIN CANCER RES, V13, P1445, DOI 10.1158/1078-0432.CCR-06-2059; Mabuchi S, 2012, INT J GYNECOL CANCER, V22, P1545, DOI 10.1097/IGC.0b013e31826ea0eb; Mabuchi S, 2011, GYNECOL ONCOL, V122, P25, DOI 10.1016/j.ygyno.2011.03.037; Maione P, 2009, LUNG CANCER, V66, P8, DOI 10.1016/j.lungcan.2009.02.022; Negrier S, 2002, ANN ONCOL, V13, P1460, DOI 10.1093/annonc/mdf257; OuYang PY, 2013, ANN ONCOL, V24, P2136, DOI 10.1093/annonc/mdt146; Peng G, 2012, RADIOTHER ONCOL, V104, P286, DOI 10.1016/j.radonc.2012.08.013; Pfister DG, 2014, J NATL COMPR CANC NE, V12, P1454, DOI 10.6004/jnccn.2014.0142; Qiu MZ, 2010, TUMOR BIOL, V31, P633, DOI 10.1007/s13277-010-0079-8; Queen MM, 2005, CANCER RES, V65, P8896, DOI 10.1158/0008-5472.CAN-05-1734; Rutkowski P, 2007, J CANCER RES CLIN, V133, P589, DOI 10.1007/s00432-007-0202-4; Shamamian P, 2001, J CELL PHYSIOL, V189, P197, DOI 10.1002/jcp.10014; Shin JH, 2014, CARDIOVASC DRUG THER, V28, P211, DOI 10.1007/s10557-014-6519-8; So KA, 2014, GYNECOL ONCOL, V132, P551, DOI 10.1016/j.ygyno.2014.01.010; Strell C, 2010, EXP CELL RES, V316, P138, DOI 10.1016/j.yexcr.2009.09.003; Teramukai S, 2009, EUR J CANCER, V45, P1950, DOI 10.1016/j.ejca.2009.01.023; Worley MJ, 2013, INT J GYNECOL CANCER, V23, P312, DOI 10.1097/IGC.0b013e31827da21b; Worley MJ, 2012, GYNECOL ONCOL, V125, P561, DOI 10.1016/j.ygyno.2012.03.043; Wu F, 2014, RADIOTHER ONCOL, V112, P106, DOI 10.1016/j.radonc.2014.05.005; Yang XD, 2014, WORLD J GASTROENTERO, V20, P1074, DOI 10.3748/wjg.v20.i4.1074	46	13	13	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136752	10.1371/journal.pone.0136752	http://dx.doi.org/10.1371/journal.pone.0136752			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26336064	Green Submitted, Green Published, gold			2022-12-26	WOS:000360615400024
J	Zhang, JT; Ren, W; An, PL; Pan, ZH; Wang, LW; Dong, ZQ; He, D; Yang, J; Pan, SF; Tian, HQ				Zhang, Jingting; Ren, Wei; An, Pingli; Pan, Zhihua; Wang, Liwei; Dong, Zhiqiang; He, Di; Yang, Jia; Pan, Shufen; Tian, Hanqin			Responses of Crop Water Use Efficiency to Climate Change and Agronomic Measures in the Semiarid Area of Northern China	PLOS ONE			English	Article							NITROGEN-FERTILIZATION; WINTER-WHEAT; YIELD; SOIL; PHOTOSYNTHESIS; RESILIENCE; VARIETIES; CULTIVAR; IMPACTS; WEATHER	It has long been concerned how crop water use efficiency (WUE) responds to climate change. Most of existing researches have emphasized the impact of single climate factor but have paid less attention to the effect of developed agronomic measures on crop WUE. Based on the long-term field observations/experiments data, we investigated the changing responses of crop WUE to climate variables (temperature and precipitation) and agronomic practices (fertilization and cropping patterns) in the semi-arid area of northern China (SAC) during two periods, 1983-1999 and 2000-2010 (drier and warmer). Our results suggest that crop WUE was an intrinsical system sensitive to climate change and agronomic measures. Crops tend to reach the maximum WUE (WUEmax) in warm-dry environment while reach the stable minimum WUE (WUEmin) in warm-wet environment, with a difference between WUEmax and WUEmin ranging from 29.0%-55.5%. Changes in temperature and precipitation in the past three decades jointly enhanced crop WUE by 8.1%-30.6%. Elevated fertilizer and rotation cropping would increase crop WUE by 5.6-11.0% and 19.5-92.9%, respectively. These results indicate crop has the resilience by adjusting WUE, which is not only able to respond to subsequent periods of favorable water balance but also to tolerate the drought stress, and reasonable agronomic practices could enhance this resilience. However, this capacity would break down under impact of climate changes and unconscionable agronomic practices (e.g. excessive N/P/K fertilizer or traditional continuous cropping). Based on the findings in this study, a conceptual crop WUE model is constructed to indicate the threshold of crop resilience, which could help the farmer develop appropriate strategies in adapting the adverse impacts of climate warming.	[Zhang, Jingting; An, Pingli; Pan, Zhihua; Wang, Liwei; Dong, Zhiqiang; He, Di] China Agr Univ, Coll Resources & Environm Sci, Beijing 100193, Peoples R China; [Zhang, Jingting; An, Pingli; Pan, Zhihua; Wang, Liwei; Dong, Zhiqiang] Minist Agr Field Sci Observat Hohhot, Key Ecol & Environm Expt Stn, Wuchuan 011705, Hohhot, Peoples R China; [Ren, Wei] Univ Kentucky, Dept Plant & Soil Sci, Coll Agr Food & Environm, Lexington, KY 40506 USA; [Ren, Wei; Yang, Jia; Pan, Shufen; Tian, Hanqin] Auburn Univ, Int Ctr Climate & Global Change Res, Auburn, AL 36849 USA	China Agricultural University; University of Kentucky; Auburn University System; Auburn University	An, PL (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing 100193, Peoples R China.	anpl@cau.edu.cn	Yang, Jia/A-6483-2012; Ren, Wei/I-4048-2014; Ren, Wei/G-8317-2016; Tian, Hanqin/A-6484-2012	Yang, Jia/0000-0003-2019-9603; Ren, Wei/0000-0002-4840-4835; Tian, Hanqin/0000-0002-1806-4091; pan, shufen/0000-0001-7920-1427	National Natural Science Foundation of China [41271110, 41371232]; National Basic Research Program of China [2012CB956204]; National Non-profit Research Foundation for Meteorology [GYHY201506016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Non-profit Research Foundation for Meteorology	The National Natural Science Foundation of China (41271110, 41371232), the National Basic Research Program of China (2012CB956204) and the National Non-profit Research Foundation for Meteorology (GYHY201506016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley RB, 2003, SCIENCE, V299, P2005, DOI 10.1126/science.1081056; An CB, 2006, QUATERNARY SCI REV, V25, P351, DOI 10.1016/j.quascirev.2005.03.013; [Anonymous], 1965, RES PAP; Campos GEP, 2013, NATURE, V494, P349, DOI 10.1038/nature11836; Chen C, 2010, AGRON J, V102, P1037, DOI 10.2134/agronj2009.0505; Chen C, 2010, AGR WATER MANAGE, V97, P1175, DOI 10.1016/j.agwat.2008.11.012; [陈拓 Chen Tuo], 2003, [冰川冻土, Journal of Glaciology and Geocryology], V25, P83; Du X, 2010, AGR SCI CHINA, V9, P1183, DOI 10.1016/S1671-2927(09)60206-6; Fan JL, 2007, CLIN CHANGE MIDDLE F, V3, P91; Fu BJ, 2003, CATENA, V54, P197, DOI 10.1016/S0341-8162(03)00065-1; Fu CB, 2001, CHINESE SCI BULL, V46, P1199, DOI 10.1007/BF02900602; Gaiser T, 2004, PLANT SOIL, V263, P165, DOI 10.1023/B:PLSO.0000047733.98854.9f; Gao JuLin, 2007, Acta Agronomica Sinica, V33, P455; Gong DY, 2004, J ARID ENVIRON, V59, P771, DOI 10.1016/j.jaridenv.2004.02.006; Gouveia AC, 2009, TREES-STRUCT FUNCT, V23, P267, DOI 10.1007/s00468-008-0274-z; Habtegebrial K, 2007, SOIL TILL RES, V94, P55, DOI 10.1016/j.still.2006.07.002; Halitligil MB, 2000, BIOL FERT SOILS, V31, P175, DOI 10.1007/s003740050642; He D, 2013, FRONT EARTH SCI-PRC, V7, P417, DOI 10.1007/s11707-013-0381-z; Ji Lanzhu, 2005, Ying Yong Sheng Tai Xue Bao, V16, P408; Jiang GM, 2000, ACTA BOT SIN, V42, P855; [李春梅 Li Chunmei], 2002, [水土保持学报, Journal of soil and water conservation], V16, P68; Liu YA, 2010, GLOBAL CHANGE BIOL, V16, P2287, DOI 10.1111/j.1365-2486.2009.02077.x; Loader NJ, 1995, HOLOCENE, V5, P457, DOI 10.1177/095968369500500408; Lobell DB, 2010, AGR FOREST METEOROL, V150, P1443, DOI 10.1016/j.agrformet.2010.07.008; Ma ZG, 2006, CHINESE SCI BULL, V51, P2913, DOI 10.1007/s11434-006-2159-0; Maltais-Landry G, 2012, AGRON J, V104, P301, DOI 10.2134/agronj2011.0220; Mei XR, 2013, J INTEGR AGR, V12, P1243, DOI 10.1016/S2095-3119(13)60437-2; Monson RK, 2010, OECOLOGIA, V162, P491, DOI 10.1007/s00442-009-1465-z; Moosavi S. G., 2014, Annual Research & Review in Biology, V4, P2318, DOI 10.9734/ARRB/2014/9261; Ogaya R, 2003, ENVIRON EXP BOT, V50, P137, DOI 10.1016/S0098-8472(03)00019-4; Pan Zhihua, 2003, J CHINA AGR RESOURCE, V24, P37; Picotte JJ, 2007, OECOLOGIA, V153, P821, DOI 10.1007/s00442-007-0794-z; Ponton S, 2006, GLOBAL CHANGE BIOL, V12, P294, DOI 10.1111/j.1365-2486.2005.01103.x; Ren GY, 2012, ADV ATMOS SCI, V29, P958, DOI 10.1007/s00376-012-1200-2; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; SCHLESER GH, 1990, J EXP BOT, V41, P565, DOI 10.1093/jxb/41.5.565; Seneviratne SI, 2010, EARTH-SCI REV, V99, P125, DOI 10.1016/j.earscirev.2010.02.004; Slafer GA, GENETIC IMPROVEMENT, P1; Stepowski J, 1996, EFFECT DIFFERENT FER; Tao FL, 2014, AGR FOREST METEOROL, V189, P91, DOI 10.1016/j.agrformet.2014.01.013; Tao FL, 2012, EUR J AGRON, V43, P201, DOI 10.1016/j.eja.2012.07.005; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Walker B, 2004, ECOL SOC, V9; Wang J, 2012, CLIMATIC CHANGE, V113, P825, DOI 10.1007/s10584-011-0385-1; Wells N, 2004, J CLIMATE, V17, P2335, DOI 10.1175/1520-0442(2004)017&lt;2335:ASPDSI&gt;2.0.CO;2; Wildy DT, 2004, PLANT SOIL, V262, P111, DOI 10.1023/B:PLSO.0000037030.61945.0d; Xiao DP, CONTRIBUTIONS CULTIV; Xiao GJ, 2013, AGR ECOSYST ENVIRON, V181, P108, DOI 10.1016/j.agee.2013.09.019; [杨利民 Yang Limin], 2007, [生态学报, Acta Ecologica Sinica], V27, P16; Zhang LiFeng, 2002, Agricultural Sciences in China, V1, P76; Zhang XY, 2013, EUR J AGRON, V50, P52, DOI 10.1016/j.eja.2013.05.005; Zhang YC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044465, 10.1155/2012/583417]; [赵风华 ZHAO FengHua], 2008, [地理科学进展, Progress in Geography], V27, P32; Zheng TC, 2011, FIELD CROP RES, V122, P225, DOI 10.1016/j.fcr.2011.03.015; Zou T, 2010, ECOL RES, V25, P185, DOI 10.1007/s11284-009-0642-1	55	17	18	5	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137409	10.1371/journal.pone.0137409	http://dx.doi.org/10.1371/journal.pone.0137409			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26336098	gold, Green Published, Green Submitted			2022-12-26	WOS:000360615400057
J	Kuster, A; Nola, S; Dingli, F; Vacca, B; Gauchy, C; Beaujouan, JC; Nunez, M; Moncion, T; Loew, D; Formstecher, E; Galli, T; Proux-Gillardeaux, V				Kuster, Aurelia; Nola, Sebastien; Dingli, Florent; Vacca, Barbara; Gauchy, Christian; Beaujouan, Jean-Claude; Nunez, Marcela; Moncion, Thomas; Loew, Damarys; Formstecher, Etienne; Galli, Thierry; Proux-Gillardeaux, Veronique			The Q-soluble N-Ethylmaleimide-sensitive Factor Attachment Protein Receptor (Q-SNARE) SNAP-47 Regulates Trafficking of Selected Vesicle-associated Membrane Proteins (VAMPs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; ENDOPLASMIC-RETICULUM; TI-VAMP; SUBCELLULAR-LOCALIZATION; RECYCLING ENDOSOMES; VESICULAR TRANSPORT; PLASMA-MEMBRANE; ALPHA-SYNUCLEIN; CELL-MIGRATION; SYNTAXIN 5	SNAREs constitute the core machinery of intracellular membrane fusion, but vesicular SNAREs localize to specific compartments via largely unknown mechanisms. Here, we identified an interaction between VAMP7 and SNAP-47 using a proteomics approach. We found that SNAP-47 mainly localized to cytoplasm, the endoplasmic reticulum (ER), and ERGIC and could also shuttle between the cytoplasm and the nucleus. SNAP-47 preferentially interacted with the trans-Golgi network VAMP4 and post-Golgi VAMP7 and -8. SNAP-47 also interacted with ER and Golgi syntaxin 5 and with syntaxin 1 in the absence of Munc18a, when syntaxin 1 is retained in the ER. A C-terminally truncated SNAP-47 was impaired in interaction with VAMPs and affected their subcellular distribution. SNAP-47 silencing further shifted the subcellular localization of VAMP4 from the Golgi apparatus to the ER. WT and mutant SNAP-47 overexpression impaired VAMP7 exocytic activity. We conclude that SNAP-47 plays a role in the proper localization and function of a subset of VAMPs likely via regulation of their transport through the early secretory pathway.	[Kuster, Aurelia; Nola, Sebastien; Vacca, Barbara; Gauchy, Christian; Beaujouan, Jean-Claude; Galli, Thierry; Proux-Gillardeaux, Veronique] Univ Paris Diderot, Sorbonne Paris Cite, Inst Jacques Monod, CNRS,UMR 7592,INSERM U950,Membrane Traff Hlth & D, F-75013 Paris, France; [Dingli, Florent; Loew, Damarys] Inst Curie, Prot Mass Spectrometry Lab, F-75005 Paris, France; [Nunez, Marcela; Moncion, Thomas; Formstecher, Etienne] Hybrigenics, F-75014 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Galli, T (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Inst Jacques Monod, CNRS,UMR 7592,INSERM U950,Membrane Traff Hlth & D, F-75013 Paris, France.	thierry.galli@inserm.fr; veronique.proux@ijm.fr	Galli, Thierry/Q-2249-2019; Galli, Thierry/G-8842-2011; Nola, Sebastien/D-6518-2017	Galli, Thierry/0000-0001-8514-7455; Galli, Thierry/0000-0001-8514-7455; Nola, Sebastien/0000-0002-6485-9856; Vacca, Barbara/0000-0001-9064-0228; FORMSTECHER, Etienne/0000-0002-6410-4365; Damarys, Loew/0000-0002-9111-8842	French National Research Agency [ANR-10-INSB-04]	French National Research Agency(French National Research Agency (ANR))	We are grateful to N. Sakamoto for help with experiments; T. Binz for SNAP-29 and H. Ben-Tekaya for GFP-ER-GIC53 plasmids; and C. Jackson, S. Robby, L. Pintard for discussions. We acknowledge the ImagoSeine Facility, member of the France Bio-Imaging infrastructure supported by the French National Research Agency Grant ANR-10-INSB-04, "Investments of the Future."	Advani RJ, 1999, J CELL BIOL, V146, P765, DOI 10.1083/jcb.146.4.765; Advani RJ, 1998, J BIOL CHEM, V273, P10317, DOI 10.1074/jbc.273.17.10317; Annaert WG, 1997, J CELL BIOL, V139, P1397, DOI 10.1083/jcb.139.6.1397; Antonin W, 2000, MOL BIOL CELL, V11, P3289, DOI 10.1091/mbc.11.10.3289; Arendt KL, 2015, NEURON, V86, P442, DOI 10.1016/j.neuron.2015.03.009; Bartel P. L., 1993, CELLULAR INTERACTION, P153; BROWN A, 1995, NAT GENET, V10, P301, DOI 10.1038/ng0795-301; Burgo A, 2012, DEV CELL, V23, P166, DOI 10.1016/j.devcel.2012.04.019; Burgo A, 2009, EMBO REP, V10, P1117, DOI 10.1038/embor.2009.186; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Chaineau M, 2009, FEBS LETT, V583, P3817, DOI 10.1016/j.febslet.2009.10.026; Chaineau M, 2008, J BIOL CHEM, V283, P34365, DOI 10.1074/jbc.M804587200; Chia J, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.59; Coco S, 1999, J NEUROSCI, V19, P9803; Das V, 2004, IMMUNITY, V20, P577, DOI 10.1016/S1074-7613(04)00106-2; DASCHER C, 1994, J BIOL CHEM, V269, P29363; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Galli T, 1998, MOL BIOL CELL, V9, P1437, DOI 10.1091/mbc.9.6.1437; Guo B, 2014, NAT CELL BIOL, V16, P1215, DOI 10.1038/ncb3066; Holt M, 2006, J BIOL CHEM, V281, P17076, DOI 10.1074/jbc.M513838200; Ishizaki R, 2008, MOL BIOL CELL, V19, P2650, DOI 10.1091/mbc.E07-10-1067; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Jurado S, 2013, NEURON, V77, P542, DOI 10.1016/j.neuron.2012.11.029; Kakinuma T, 2004, EXP CELL RES, V298, P388, DOI 10.1016/j.yexcr.2004.04.047; Kent HM, 2012, DEV CELL, V22, P979, DOI 10.1016/j.devcel.2012.01.018; Kondo A, 2000, MOL BIOL CELL, V11, P1315, DOI 10.1091/mbc.11.4.1315; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Leung CL, 1999, J CELL BIOL, V147, P1275, DOI 10.1083/jcb.147.6.1275; Liu YT, 2002, MOL BIOL CELL, V13, P3314, DOI 10.1091/mbc.E02-04-0204; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Martinez-Arca S, 2000, J CELL BIOL, V149, P889, DOI 10.1083/jcb.149.4.889; Martinez-Arca S, 2003, J CELL SCI, V116, P2805, DOI 10.1242/jcs.00467; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; Miyazaki K, 2012, J CELL SCI, V125, P5658, DOI 10.1242/jcs.105304; Morelli E, 2014, AUTOPHAGY, V10, P2251, DOI 10.4161/15548627.2014.981913; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Peden AA, 2001, J BIOL CHEM, V276, P49183, DOI 10.1074/jbc.M106646200; Poullet P, 2007, PROTEOMICS, V7, P2553, DOI 10.1002/pmic.200600784; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Prekeris R, 1998, J CELL BIOL, V143, P957, DOI 10.1083/jcb.143.4.957; Proux-Gillardeaux V, 2007, BIOL CELL, V99, P261, DOI 10.1042/BC20060097; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Rao SK, 2004, J BIOL CHEM, V279, P20471, DOI 10.1074/jbc.M400798200; Rossi V, 2004, BIOL CELL, V96, P251, DOI 10.1016/j.biolcel.2003.12.009; Shimojo M, 2015, CELL REP, V11, P1054, DOI 10.1016/j.celrep.2015.04.032; Siddiqi SA, 2006, J BIOL CHEM, V281, P20974, DOI 10.1074/jbc.M601401200; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Stauber T, 2006, CURR BIOL, V16, P2245, DOI 10.1016/j.cub.2006.09.060; Stynen B, 2012, MICROBIOL MOL BIOL R, V76, P331, DOI 10.1128/MMBR.05021-11; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Suga K, 2005, FEBS LETT, V579, P4226, DOI 10.1016/j.febslet.2005.06.053; Takats S, 2013, AUTOPHAGY, V9, P1251, DOI 10.4161/auto.25470; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Tran THT, 2007, J CELL SCI, V120, P1028, DOI 10.1242/jcs.03387; Toonen RFG, 2005, J NEUROCHEM, V93, P1393, DOI 10.1111/j.1471-4159.2005.03128.x; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Xu DL, 2000, J BIOL CHEM, V275, P39631, DOI 10.1074/jbc.M007684200	60	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28056	+		10.1074/jbc.M115.666362	http://dx.doi.org/10.1074/jbc.M115.666362			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26359495	hybrid, Green Published			2022-12-26	WOS:000365761900003
J	Heier, C; Radner, FPW; Moustafa, T; Schreiber, R; Grond, S; Eichmann, TO; Schweiger, M; Schmidt, A; Cerk, IK; Oberer, M; Theussl, HC; Wojciechowski, J; Penninger, JM; Zimmermann, R; Zechner, R				Heier, Christoph; Radner, Franz P. W.; Moustafa, Tarek; Schreiber, Renate; Grond, Susanne; Eichmann, Thomas O.; Schweiger, Martina; Schmidt, Albrecht; Cerk, Ines K.; Oberer, Monika; Theussl, H. -Christian; Wojciechowski, Jacek; Penninger, Josef M.; Zimmermann, Robert; Zechner, Rudolf			G(0)/G(1) Switch Gene 2 Regulates Cardiac Lipolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID STORAGE DISEASE; ADIPOSE LIPOLYSIS; ENERGY-METABOLISM; TRIGLYCERIDE; MICE; HEART; OVEREXPRESSION; PROLIFERATION; CATABOLISM; STEATOSIS	The anabolism and catabolism of myocardial triacylglycerol (TAG) stores are important processes for normal cardiac function. TAG synthesis detoxifies and stockpiles fatty acids to prevent lipotoxicity, whereas TAG hydrolysis (lipolysis) remobilizes fatty acids from endogenous storage pools as energy substrates, signaling molecules, or precursors for complex lipids. This study focused on the role of G(0)/G(1) switch 2 (G0S2) protein, which was previously shown to inhibit the principal TAG hydrolase adipose triglyceride lipase (ATGL), in the regulation of cardiac lipolysis. Using wild-type and mutant mice, we show the following: (i) G0S2 is expressed in the heart and regulated by the nutritional status with highest expression levels after re-feeding. (ii) Cardiac-specific overexpression of G0S2 inhibits cardiac lipolysis by direct protein-protein interaction with ATGL. This leads to severe cardiac steatosis. The steatotic hearts caused by G0S2 overexpression are less prone to fibrotic remodeling or cardiac dysfunction than hearts with a lipolytic defect due to ATGL deficiency. (iii) Conversely to the phenotype of transgenic mice, G0S2 deficiency results in a de-repression of cardiac lipolysis and decreased cardiac TAG content. We conclude that G0S2 acts as a potent ATGL inhibitor in the heart modulating cardiac substrate utilization by regulating cardiac lipolysis.	[Eichmann, Thomas O.; Schweiger, Martina; Cerk, Ines K.; Oberer, Monika] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Moustafa, Tarek] Med Univ Graz, Lab Expt & Mol Hepatol, Div Gastroenterol & Hepatol, Dept Internal Med, A-8036 Graz, Austria; [Schmidt, Albrecht] Med Univ Graz, Div Cardiol, Dept Internal Med, A-8036 Graz, Austria; [Theussl, H. -Christian; Wojciechowski, Jacek; Penninger, Josef M.] Res Inst Mol Pathol IMP, Transgen Serv, A-1030 Vienna, Austria; [Theussl, H. -Christian; Wojciechowski, Jacek; Penninger, Josef M.] Austrian Acad Sci, IMBA Inst Mol Biotechnol, A-1030 Vienna, Austria	University of Graz; Medical University of Graz; Medical University of Graz; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Zechner, R (corresponding author), Graz Univ, Inst Mol Biosci, Heinrichstr 31-2, A-8010 Graz, Austria.	rudolf.zechner@uni-graz.at	Moustafa, Tarek/P-9509-2016; Penninger, Josef M/I-6860-2013	Moustafa, Tarek/0000-0002-6755-4687; Penninger, Josef M/0000-0002-8194-3777; Schweiger, Martina/0000-0002-3419-1007; Schreiber, Renate/0000-0002-3475-157X; Zechner, Rudolf/0000-0001-5483-1182; Zimmermann, Robert/0000-0002-7354-870X; Heier, Christoph/0000-0001-6858-408X; Grond, Susanne/0000-0002-7121-9013; Eichmann, Thomas O./0000-0002-8521-2795; Radner, Franz/0000-0003-3466-0181; Oberer, Monika/0000-0003-2525-9513; Schmidt, Albrecht/0000-0003-4783-4603	SFB LIPOTOX [F3002]; Wittgenstein Award [Z136]; DK Molecular Enzymology - Austrian Science Fund (FWF) [W901]; Fondation Leducq [12CVD04]; European Research Council (ERC) [340896]; European Research Council under the European Union;  [P22170]; Austrian Science Fund (FWF) [F 3002, W 901] Funding Source: researchfish	SFB LIPOTOX(German Research Foundation (DFG)); Wittgenstein Award(Austrian Science Fund (FWF)); DK Molecular Enzymology - Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Fondation Leducq(Leducq Foundation); European Research Council (ERC)(European Research Council (ERC)); European Research Council under the European Union(European Research Council (ERC)); ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the SFB LIPOTOX F3002, Wittgenstein Award Z136, Grant P22170, and DK Molecular Enzymology W901, which are funded by the Austrian Science Fund (FWF), Grant 12CVD04 from the Fondation Leducq and European Research Council (ERC) Grant Agreement 340896 (LipoCheX) - European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013). The authors declare that they have no conflicts of interest with the contents of this article.	Banke NH, 2010, CIRC RES, V107, P233, DOI 10.1161/CIRCRESAHA.110.221713; Borradaile NA, 2005, CURR HYPERTENS REP, V7, P412, DOI 10.1007/s11906-005-0035-y; Bosma M, 2014, BBA-MOL CELL BIOL L, V1841, P1648, DOI 10.1016/j.bbalip.2014.09.012; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; FOLCH J, 1957, J BIOL CHEM, V226, P497; Goldberg IJ, 2012, CELL METAB, V15, P805, DOI 10.1016/j.cmet.2012.04.006; Gruber A, 2010, J BIOL CHEM, V285, P12289, DOI 10.1074/jbc.M109.064469; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Heckmann BL, 2014, J BIOL CHEM, V289, P1905, DOI 10.1074/jbc.M113.522011; Hirano K, 2008, NEW ENGL J MED, V359, P2396, DOI 10.1056/NEJMc0805305; Kaneko K, 2014, NEUROMUSCULAR DISORD, V24, P634, DOI 10.1016/j.nmd.2014.04.001; Kienesberger PC, 2013, CARDIOVASC RES, V99, P442, DOI 10.1093/cvr/cvt124; Kienesberger PC, 2013, J MOL CELL CARDIOL, V55, P101, DOI 10.1016/j.yjmcc.2012.06.018; Kienesberger PC, 2012, MOL CELL BIOL, V32, P740, DOI 10.1128/MCB.06470-11; Kioka H, 2014, P NATL ACAD SCI USA, V111, P273, DOI 10.1073/pnas.1318547111; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lewin TM, 2003, BBA-MOL CELL BIOL L, V1634, P63, DOI 10.1016/j.bbalip.2003.09.006; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Mayer N, 2013, NAT CHEM BIOL, V9, P785, DOI [10.1038/NCHEMBIO.1359, 10.1038/nchembio.1359]; McGavock JM, 2006, ANN INTERN MED, V144, P517, DOI 10.7326/0003-4819-144-7-200604040-00011; McGavock JM, 2007, CIRCULATION, V116, P1170, DOI 10.1161/CIRCULATIONAHA.106.645614; Moustafa T, 2012, GASTROENTEROLOGY, V142, P140, DOI 10.1053/j.gastro.2011.09.051; NEELY JR, 1974, ANNU REV PHYSIOL, V36, P413, DOI 10.1146/annurev.ph.36.030174.002213; Radner FPW, 2010, J BIOL CHEM, V285, P7300, DOI 10.1074/jbc.M109.081877; RUSSELL L, 1991, DNA CELL BIOL, V10, P581, DOI 10.1089/dna.1991.10.581; SADDIK M, 1991, J BIOL CHEM, V266, P8162; Schweiger M, 2012, J LIPID RES, V53, P2307, DOI 10.1194/jlr.M027409; Schweiger M, 2009, AM J PHYSIOL-ENDOC M, V297, pE289, DOI 10.1152/ajpendo.00099.2009; Welch C, 2009, CANCER RES, V69, P6782, DOI 10.1158/0008-5472.CAN-09-0128; Yamada T, 2014, LEUKEMIA RES, V38, P210, DOI 10.1016/j.leukres.2013.10.006; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zandbergen F, 2005, BIOCHEM J, V392, P313, DOI 10.1042/BJ20050636; Zhang XD, 2014, DIABETES, V63, P934, DOI 10.2337/db13-1422; Zierler KA, 2013, J BIOL CHEM, V288, P9892, DOI 10.1074/jbc.M112.420620; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	38	25	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26141	26150		10.1074/jbc.M115.671842	http://dx.doi.org/10.1074/jbc.M115.671842			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26350455	hybrid, Green Published			2022-12-26	WOS:000363527300033
J	Higa-Nakamine, S; Maeda, N; Toku, S; Yamamoto, H				Higa-Nakamine, Sayomi; Maeda, Noriko; Toku, Seikichi; Yamamoto, Hideyuki			Involvement of Protein Kinase D1 in Signal Transduction from the Protein Kinase C Pathway to the Tyrosine Kinase Pathway in Response to Gonadotropin-releasing Hormone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; CULTURED HYPOTHALAMIC NEURONS; COUPLED RECEPTOR; AUTOCRINE REGULATION; MAP KINASE; ACTIVATION; PHOSPHORYLATION; SCHIZOPHRENIA; MECHANISMS; TRANSACTIVATION	The receptor for gonadotropin-releasing hormone (GnRH) belongs to the G protein-coupled receptors (GPCRs), and its stimulation activates extracellular signal-regulated protein kinase (ERK). We found that the transactivation of ErbB4 was involved in GnRH-induced ERK activation in immortalized GnRH neurons (GT1-7 cells). We found also that GnRH induced the cleavage of ErbB4. In the present study, we examined signal transduction for the activation of ERK and the cleavage of ErbB4 after GnRH treatment. Both ERK activation and ErbB4 cleavage were completely inhibited by YM-254890, an inhibitor ofGq/11 proteins. Down-regulation of protein kinase C (PKC) markedly decreased both ERK activation and ErbB4 cleavage. Experiments with two types of PKC inhibitors, Go 6976 and bisindolylmaleimide I, indicated that novel PKC isoforms but not conventional PKC isoforms were involved in ERK activation and ErbB4 cleavage. Our experiments indicated that the novel PKC isoforms activated protein kinase D (PKD) after GnRH treatment. Knockdown and inhibitor experiments suggested that PKD1 stimulated the phosphorylation of Pyk2 by constitutively activated Src and Fyn for ERK activation. Taken together, it is highly possible that PKD1 plays a critical role in signal transduction from the PKC pathway to the tyrosine kinase pathway. Activation of the tyrosine kinase pathway may be involved in the progression of cancer.	[Higa-Nakamine, Sayomi; Maeda, Noriko; Toku, Seikichi; Yamamoto, Hideyuki] Univ Ryukyus, Grad Sch Med, Dept Biochem, Nishihara, Okinawa 9030215, Japan	University of the Ryukyus	Higa-Nakamine, S (corresponding author), Univ Ryukyus, Grad Sch Med, 207 Uehara, Nishihara, Okinawa 9030215, Japan.	higasa@med.u-ryukyu.ac.jp			Japan Society for the Promotion of Science KAKENHI Grants [23500451, 24700381]	Japan Society for the Promotion of Science KAKENHI Grants(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 23500451 and 24700381. The authors declare that they have no conflicts of interest with the contents of this article.	Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Caunt CJ, 2006, J BIOL CHEM, V281, P2701, DOI 10.1074/jbc.M507242200; Denning MF, 1996, J BIOL CHEM, V271, P5325, DOI 10.1074/jbc.271.10.5325; Dobkin-Bekman M, 2010, ENDOCRINOLOGY, V151, P4894, DOI 10.1210/en.2010-0114; Fu Y, 2011, EMBO REP, V12, P785, DOI 10.1038/embor.2011.139; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; Higa-Nakamine S, 2012, J CELL PHYSIOL, V227, P2492, DOI 10.1002/jcp.22988; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kennett SB, 2004, J BIOL CHEM, V279, P3300, DOI 10.1074/jbc.M305734200; Koyama H., 2012, J CLIN TOXICOL S, VS3, P002; Krsmanovic LZ, 1999, ENDOCRINOLOGY, V140, P1423, DOI 10.1210/en.140.3.1423; KRSMANOVIC LZ, 1993, P NATL ACAD SCI USA, V90, P3908, DOI 10.1073/pnas.90.9.3908; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li DW, 2006, HUM MOL GENET, V15, P1995, DOI 10.1093/hmg/ddl122; LI WQ, 1994, J BIOL CHEM, V269, P2349; Linggi B, 2006, TRENDS CELL BIOL, V16, P649, DOI 10.1016/j.tcb.2006.10.008; Maeda N, 2009, J NEUROCHEM, V109, P393, DOI 10.1111/j.1471-4159.2009.05971.x; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Naor Z, 2009, FRONT NEUROENDOCRIN, V30, P10, DOI 10.1016/j.yfrne.2008.07.001; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Norton N, 2006, AM J MED GENET B, V141B, P96, DOI 10.1002/ajmg.b.30236; Reiss N, 1997, ENDOCRINOLOGY, V138, P1673, DOI 10.1210/en.138.4.1673; Rey O, 2004, J BIOL CHEM, V279, P34361, DOI 10.1074/jbc.M403265200; Roelle S, 2003, J BIOL CHEM, V278, P47307, DOI 10.1074/jbc.M304377200; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Ryvkin V, 2015, J BIOL CHEM, V290, P11199, DOI 10.1074/jbc.M115.643742; Shah BH, 2004, TRENDS NEUROSCI, V27, P48, DOI 10.1016/j.tins.2003.11.003; Shah BH, 2003, J BIOL CHEM, V278, P2866, DOI 10.1074/jbc.m208783200; Srivastava J, 2002, BIOCHEM J, V368, P349, DOI 10.1042/BJ20020737; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Yamanaka A, 2007, ARCH BIOCHEM BIOPHYS, V466, P234, DOI 10.1016/j.abb.2007.06.009	37	11	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25974	25985		10.1074/jbc.M115.681700	http://dx.doi.org/10.1074/jbc.M115.681700			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26338704	hybrid, Green Published			2022-12-26	WOS:000363527300019
J	Desai, SS; Kharade, SS; Parekh, VI; Iyer, S; Agarwal, SK				Desai, Shruti S.; Kharade, Sampada S.; Parekh, Vaishali I.; Iyer, Sucharitha; Agarwal, Sunita K.			Pro-oncogenic Roles of HLXB9 Protein in Insulinoma Cells through Interaction with Nono Protein and Down-regulation of the c-Met Inhibitor Cblb (Casitas B-lineage Lymphoma b)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE ENDOCRINE NEOPLASIA; PANCREATIC NEUROENDOCRINE TUMORS; MEN1 GENE; MICE DEVELOP; TYPE-1 MEN1; MOUSE MODEL; YANG 1; EXPRESSION; MUTATIONS; P54(NRB)	Pancreatic islet beta-cells that lack the MEN1-encoded protein menin develop into tumors. Such tumors express the phosphorylated isoform of the beta-cell differentiation transcription factor HLXB9. It is not known how phospho-HLXB9 acts as an oncogenic factor in insulin-secreting beta-cell tumors (insulinomas). In this study we investigated the binding partners and target genes of phospho-HLXB9 in mouse insulinoma MIN6 beta-cells. Co-immunoprecipitation coupled with mass spectrometry showed a significant association of phospho-HLXB9 with the survival factor p54nrb/Nono (54-kDa nuclear RNA-binding protein, non-POU-domain-containing octamer). Endogenous phospho-HLXB9 co-localized with endogenous Nono in the nucleus. Overexpression of HLXB9 decreased the level of overexpressed Nono but not endogenousNono. Anti-phospho-HLXB9 chromatin immunoprecipitation followed by deep sequencing (ChIP-Seq) identified the c-Met inhibitor, Cblb, as a direct phospho-HLXB9 target gene. Phospho-HLXB9 occupied the promoter of Cblb and reduced the expression of Cblb mRNA. Cblb overexpression or HLXB9 knockdown decreased c-Met protein and reduced cell migration. Also, increased phospho-HLXB9 coincided with reduced Cblb and increased c-Met in insulinomas of two mouse models of menin loss. These data provide mechanistic insights into the role of phospho-HLXB9 as a pro-oncogenic factor by interacting with a survival factor and by promoting the oncogenic c-Met pathway. These mechanisms have therapeutic implications for reducing beta-cell proliferation in insulinomas by inhibiting phospho-HLXB9 or its interaction with Nono and modulating the expression of its direct (Cblb) or indirect(c-Met) targets. Our data also implicate the use of pro-oncogenic activities of phospho-HLXB9 in beta-cell expansion strategies to alleviate beta-cell loss in diabetes.	[Desai, Shruti S.; Kharade, Sampada S.; Parekh, Vaishali I.; Iyer, Sucharitha; Agarwal, Sunita K.] NIDDK, Metab Dis Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Agarwal, SK (corresponding author), NIH, Bldg 10,Rm 8C-101, Bethesda, MD 20814 USA.	sunitaa@mail.nih.gov	Agarwal, Sunita K/D-1428-2016; Regan, Clinton/E-6250-2012	Agarwal, Sunita K/0000-0002-7557-3191; Desai, Shruti/0000-0002-5234-5890	National Institutes of Health [1ZIADK075035-03]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075085, ZIADK075035] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 1ZIADK075035-03 (NIDDK; Intramural Research Program; to S. K. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal SK, 2014, INT J ENDOCR ONCOL, V1, P153, DOI 10.2217/IJE.14.16; Alvarez-Perez JC, 2014, DIABETES, V63, P216, DOI 10.2337/db13-0333; Amelio AL, 2007, P NATL ACAD SCI USA, V104, P20314, DOI 10.1073/pnas.0707999105; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Bertolino P, 2003, MOL ENDOCRINOL, V17, P1880, DOI 10.1210/me.2003-0154; Bertolino P, 2003, CANCER RES, V63, P4836; Biondi CA, 2004, MOL CELL BIOL, V24, P3125, DOI 10.1128/MCB.24.8.3125-3131.2004; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Cao YN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3810; Conrad E, 2014, TRENDS ENDOCRIN MET, V25, P407, DOI 10.1016/j.tem.2014.03.013; Crabtree JS, 2003, MOL CELL BIOL, V23, P6075, DOI 10.1128/MCB.23.17.6075-6085.2003; Crabtree JS, 2001, P NATL ACAD SCI USA, V98, P1118, DOI 10.1073/pnas.98.3.1118; Cromer MK, 2015, P NATL ACAD SCI USA, V112, P4062, DOI 10.1073/pnas.1503696112; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Desai SS, 2014, J BIOL CHEM, V289, P5386, DOI 10.1074/jbc.M113.533612; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; GIORDANO S, 1989, ONCOGENE, V4, P1383; Guru SC, 1998, P NATL ACAD SCI USA, V95, P1630, DOI 10.1073/pnas.95.4.1630; Hansel DE, 2004, CLIN CANCER RES, V10, P6152, DOI 10.1158/1078-0432.CCR-04-0285; Harding B, 2009, ENDOCR-RELAT CANCER, V16, P1313, DOI 10.1677/ERC-09-0082; Harrison KA, 1999, NAT GENET, V23, P71, DOI 10.1038/12674; Hendy GN, 2009, ADV EXP MED BIOL, V668, P37; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Li H, 1999, NAT GENET, V23, P67; Li SY, 2009, NUCLEIC ACIDS RES, V37, P6746, DOI 10.1093/nar/gkp741; Lichtenauer UD, 2015, J CLIN ENDOCR METAB, V100, pE776, DOI 10.1210/jc.2015-1100; Loffler KA, 2007, INT J CANCER, V120, P259, DOI 10.1002/ijc.22288; Mellado-Gil J, 2011, DIABETES, V60, P525, DOI 10.2337/db09-1305; Miguel-Aliaga I, 2008, PLOS BIOL, V6, P538, DOI 10.1371/journal.pbio.0060058; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Modali SD, 2015, MOL ENDOCRINOL, V29, P224, DOI 10.1210/me.2014-1304; Mohapatra B, 2013, BBA-MOL CELL RES, V1833, P122, DOI 10.1016/j.bbamcr.2012.10.010; Peschard P, 2004, J BIOL CHEM, V279, P29565, DOI 10.1074/jbc.M403954200; Roccisana J, 2005, DIABETES, V54, P2090, DOI 10.2337/diabetes.54.7.2090; Schiffnery S, 2011, CARCINOGENESIS, V32, P1176, DOI 10.1093/carcin/bgr103; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Shen HCJ, 2009, CANCER RES, V69, P1858, DOI 10.1158/0008-5472.CAN-08-3662; Shi K, 2013, ENDOCR-RELAT CANCER, V20, P111, DOI 10.1530/ERC-12-0077; Shin JJ, 2010, FUTURE ONCOL, V6, P229, DOI [10.2217/fon.09.165, 10.2217/FON.09.165]; Sukhodolets KE, 2003, MOL CELL BIOL, V23, P493, DOI 10.1128/MCB.23.2.493-509.2003; Thakker RV, 2010, BEST PRACT RES CL EN, V24, P355, DOI 10.1016/j.beem.2010.07.003; Yadav SP, 2014, HUM MOL GENET, V23, P2132, DOI 10.1093/hmg/ddt609; Zanfardino M, 2013, INT J ONCOL, V43, P1763, DOI 10.3892/ijo.2013.2126	44	8	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25595	25608		10.1074/jbc.M115.661413	http://dx.doi.org/10.1074/jbc.M115.661413			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26342078	hybrid, Green Published			2022-12-26	WOS:000362962800033
J	Liu, SH; Yang, RS; Yen, YP; Chiu, CY; Tsai, KS; Lan, KC				Liu, Shing Hwa; Yang, Rong-Sen; Yen, Yuan-Peng; Chiu, Chen-Yuan; Tsai, Keh-Sung; Lan, Kuo-Cheng			Low-Concentration Arsenic Trioxide Inhibits Skeletal Myoblast Cell Proliferation via a Reactive Oxygen Species-Independent Pathway	PLOS ONE			English	Article							CYCLE ARREST; MITOCHONDRIAL DYSFUNCTION; TRANSCRIPTION FACTOR; MUSCLE REGENERATION; DEPENDENT PATHWAY; C2C12 MYOBLASTS; CARCINOMA-CELLS; GROWTH-FACTORS; CANCER; DIFFERENTIATION	Myoblast proliferation and differentiation are essential for skeletal muscle regeneration. Myoblast proliferation is a critical step in the growth and maintenance of skeletal muscle. The precise action of inorganic arsenic on myoblast growth has not been investigated. Here, we investigated the in vitro effect of inorganic arsenic trioxide (As2O3) on the growth of C2C12 myoblasts. As2O3 decreased myoblast growth at submicromolar concentrations (0.25-1 mu M) after 72 h of treatment. Submicromolar concentrations of As2O3 did not induce the myoblast apoptosis. Low-concentration As2O3 (0.5 and 1 mu M) significantly suppressed the myoblast cell proliferative activity, which was accompanied by a small proportion of bromodeoxyuridine (BrdU) incorporation and decreased proliferating cell nuclear antigen (PCNA) protein expression. As2O3 (0.5 and 1 mu M) increased the intracellular arsenic content but did not affect the reactive oxygen species (ROS) levels in the myoblasts. Cell cycle analysis indicated that low-concentrations of As2O3 inhibited cell proliferation via cell cycle arrest in the G1 and G2/M phases. As2O3 also decreased the protein expressions of cyclin D1, cyclin E, cyclin B1, cyclin-dependent kinase (CDK) 2, and CDK4, but did not affect the protein expressions of p21 and p27. Furthermore, As2O3 inhibited the phosphorylation of Akt. Insulin-like growth factor-1 significantly reversed the inhibitory effect of As2O3 on Akt phosphorylation and cell proliferation in the myoblasts. These results suggest that submicromolar concentrations of As2O3 alter cell cycle progression and reduce myoblast proliferation, at least in part, through a ROS-independent Akt inhibition pathway.	[Liu, Shing Hwa; Yen, Yuan-Peng; Chiu, Chen-Yuan] Natl Taiwan Univ, Inst Toxicol, Coll Med, Taipei 10764, Taiwan; [Liu, Shing Hwa] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Yang, Rong-Sen] Natl Taiwan Univ, Dept Orthopaed, Coll Med & Hosp, Taipei 10764, Taiwan; [Tsai, Keh-Sung] Natl Taiwan Univ, Dept Lab Med, Coll Med & Hosp, Taipei 10764, Taiwan; [Lan, Kuo-Cheng] Triserv Gen Hosp, Dept Emergency Med, Natl Def Med Ctr, Taipei, Taiwan	National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Taiwan University; National Taiwan University; National Defense Medical Center; Tri-Service General Hospital	Lan, KC (corresponding author), Triserv Gen Hosp, Dept Emergency Med, Natl Def Med Ctr, Taipei, Taiwan.	d92447005@ntu.edu.tw		Chiu, Chen-Yuan/0000-0003-4378-993X; LIU, SHING-HWA/0000-0002-9976-1197; Yang, Rong-Sen/0000-0002-0553-4779; TSAI, KEH-SUNG/0000-0001-8528-1566	National Science Council of Taiwan [NSC100-2314-B-002-104]; Tri-Service General Hospital [TSGH-C104-060]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital	Funding was provided by National Science Council of Taiwan (NSC100-2314-B-002-104) (SHL); Tri-Service General Hospital (TSGH-C104-060) (KCL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai ZL, 2007, BIOCHEM BIOPH RES CO, V360, P684, DOI 10.1016/j.bbrc.2007.06.123; ALLEN DL, 1995, J APPL PHYSIOL, V78, P1969, DOI 10.1152/jappl.1995.78.5.1969; Bobe P, 2006, BLOOD, V108, P3967, DOI 10.1182/blood-2006-04-020610; Brameld JM, 2000, J ENDOCRINOL, V167, P429, DOI 10.1677/joe.0.1670429; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen F, 2002, P NATL ACAD SCI USA, V99, P1990, DOI 10.1073/pnas.032428899; Chen GQ, 1997, BLOOD, V89, P3345; Chen YC, 1998, J CELL PHYSIOL, V177, P324, DOI 10.1002/(SICI)1097-4652(199811)177:2<324::AID-JCP14>3.0.CO;2-9; Conejo R, 2001, J CELL PHYSIOL, V187, P96, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1058>3.0.CO;2-V; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dilda PJ, 2007, CANCER TREAT REV, V33, P542, DOI 10.1016/j.ctrv.2007.05.001; Efferth T, 2007, TRENDS MOL MED, V13, P353, DOI 10.1016/j.molmed.2007.07.001; Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291; Fahey AJ, 2005, J ANIM SCI, V83, P2564; Grabiec K, 2014, J ENDOCRINOL INVEST, V37, P233, DOI 10.1007/s40618-013-0007-z; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Heron-Milhavet L, 2006, MOL CELL BIOL, V26, P8267, DOI 10.1128/MCB.00201-06; Ji M, 2008, CELL SIGNAL, V20, P1452, DOI 10.1016/j.cellsig.2008.03.013; Joulia D, 2003, EXP CELL RES, V286, P263, DOI 10.1016/S0014-4827(03)00074-0; Kaliman P, 1996, J BIOL CHEM, V271, P19146, DOI 10.1074/jbc.271.32.19146; Kligerman AD, 2007, TOXICOL APPL PHARM, V222, P281, DOI 10.1016/j.taap.2006.10.006; Kumagai Y, 2007, ANNU REV PHARMACOL, V47, P243, DOI 10.1146/annurev.pharmtox.47.120505.105144; Li XQ, 2004, CANCER INVEST, V22, P389, DOI 10.1081/CNV-200029068; Lin HJ, 2013, J HAZARD MATER, V262, P1132, DOI 10.1016/j.jhazmat.2012.12.049; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Miller WH, 2002, CANCER RES, V62, P3893; Mitchell PO, 2001, AM J PHYSIOL-CELL PH, V281, pC1706, DOI 10.1152/ajpcell.2001.281.5.C1706; Park WH, 2003, BIOCHEM BIOPH RES CO, V300, P230, DOI 10.1016/S0006-291X(02)02831-0; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Raghu KG, 2009, J TRACE ELEM MED BIO, V23, P61, DOI 10.1016/j.jtemb.2008.10.001; Schabort EJ, 2009, EXP CELL RES, V315, P373, DOI 10.1016/j.yexcr.2008.10.037; Seol JG, 1999, BIOCHEM BIOPH RES CO, V265, P400, DOI 10.1006/bbrc.1999.1697; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Smith AH, 2006, ENVIRON HEALTH PERSP, V114, P1293, DOI 10.1289/ehp.8832; Stark GR, 2006, MOL BIOTECHNOL, V32, P227, DOI 10.1385/MB:32:3:227; Steffens AA, 2011, TOXICOL APPL PHARM, V250, P154, DOI 10.1016/j.taap.2010.10.006; Tapio S, 2006, MUTAT RES-REV MUTAT, V612, P215, DOI 10.1016/j.mrrev.2006.02.001; TSAI LH, 1991, NATURE, V353, P174, DOI 10.1038/353174a0; Vineetha VP, 2013, CARDIOVASC TOXICOL, V13, P123, DOI 10.1007/s12012-012-9191-x; Vineetha VP, 2015, EUR J PHARMACOL, V754, P174, DOI 10.1016/j.ejphar.2015.02.036; Vineetha VP, 2014, FOOD FUNCT, V5, P502, DOI 10.1039/c3fo60470e; Waalkes MP, 2007, TOXICOL APPL PHARM, V222, P271, DOI 10.1016/j.taap.2006.12.034; Watcharasit P, 2012, ENVIRON TOXICOL PHAR, V33, P53, DOI 10.1016/j.etap.2011.10.005; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Woo SH, 2005, J CELL BIOCHEM, V95, P120, DOI 10.1002/jcb.20329; Worster DT, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001986; Wu CT, 2014, ENVIRON HEALTH PERSP, V122, P559, DOI 10.1289/ehp.1307832; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yang W, 2007, J BIOL CHEM, V282, P3799, DOI 10.1074/jbc.M610185200; Yen YP, 2012, ARCH TOXICOL, V86, P923, DOI 10.1007/s00204-012-0864-9; Yen YP, 2010, ENVIRON HEALTH PERSP, V118, P949, DOI 10.1289/ehp.0901525; Yih LH, 2000, CANCER RES, V60, P6346; Zhang W, 1998, LEUKEMIA, V12, P1383, DOI 10.1038/sj.leu.2401112	55	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137907	10.1371/journal.pone.0137907	http://dx.doi.org/10.1371/journal.pone.0137907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359868	gold, Green Published, Green Submitted			2022-12-26	WOS:000361043100100
J	Schunk, M; Mekonnen, SK; Wondafrash, B; Mengele, C; Fleischmann, E; Herbinger, KH; Verweij, JJ; Geldmacher, C; Bretzel, G; Loscher, T; Zeynudin, A				Schunk, Mirjam; Mekonnen, Seleshi Kebede; Wondafrash, Beyene; Mengele, Carolin; Fleischmann, Erna; Herbinger, Karl-Heinz; Verweij, Jaco J.; Geldmacher, Christof; Bretzel, Gisela; Loscher, Thomas; Zeynudin, Ahmed			Use of Occult Blood Detection Cards for Real-Time PCR-Based Diagnosis of Schistosoma Mansoni Infection	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MALARIA PARASITES; REACTION ASSAY; URINE SAMPLES; FILTER-PAPER; DNA; HAEMATOBIUM; PREVALENCE; JAPONICUM; STORAGE	Background In Schistosoma mansoni infection, diagnosis and control after treatment mainly rely on parasitological stool investigations which are laborious and have limited sensitivity. PCR methods have shown equal or superior sensitivity but preservation and storage methods limit their use in the field. Therefore, the use of occult blood detection cards (fecal cards) for easy sampling and storage of fecal samples for further PCR testing was evaluated in a pilot study. Methodology Stool specimens were collected in a highly endemic area for S. mansoni in Ethiopia and submitted in an investigator-blinded fashion to microscopic examination by Kato-Katz thick smear as well as to real-time PCR using either fresh frozen stool samples or stool smears on fecal cards which have been stored at ambient temperature for up to ten months. Principal Findings Out of 55 stool samples, 35 were positive by microscopy, 33 and 32 were positive by PCR of frozen samples and of fecal card samples, respectively. When microscopy was used as diagnostic "gold standard", the sensitivity of PCR on fresh stool was 94.3%(95%-CI: 86.6; 100) and on fecal cards 91.4%(95%-CI: 82.2; 100). Conclusions The use of fecal cards proved to be a simple and useful method for stool collection and prolonged storage prior to PCR based diagnosis of S. mansoni infection. This technique may be a valuable approach for large scale surveillance and post treatment assessments	[Schunk, Mirjam; Mengele, Carolin; Fleischmann, Erna; Herbinger, Karl-Heinz; Geldmacher, Christof; Bretzel, Gisela; Loscher, Thomas] Univ Munich, Dept Infect Dis & Trop Med DITM, Munich, Germany; [Mekonnen, Seleshi Kebede; Wondafrash, Beyene; Zeynudin, Ahmed] Jimma Univ, Dept Med Lab Sci & Pathol, Jimma, Ethiopia; [Fleischmann, Erna] Bundeswehr Inst Microbiol, Munich, Germany; [Verweij, Jaco J.] St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilsburg, Netherlands	University of Munich; Jimma University; Bundeswehr Institute of Microbiology (IMB)	Schunk, M (corresponding author), Univ Munich, Dept Infect Dis & Trop Med DITM, Munich, Germany.	schunk@lrz.uni-muenchen.de	Löscher, Thomas/AAA-8399-2020; wonddafrash, beyene/J-6830-2016	Kasim, Ahmed Zeynudin/0000-0002-0552-1783; wonddafrash, beyene/0000-0001-9161-1509; Verweij, Jaco J./0000-0001-8553-931X	Department of Infectious Diseases and Tropical Medicine, Ludwig-Maximilians-University, Munich, Germany	Department of Infectious Diseases and Tropical Medicine, Ludwig-Maximilians-University, Munich, Germany	Funding: This work received financial support from the Department of Infectious Diseases and Tropical Medicine, Ludwig-Maximilians-University, Munich, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam AF, 2009, TROP MED INT HEALTH, V14, P316, DOI 10.1111/j.1365-3156.2009.02225.x; Basuni M, 2011, AM J TROP MED HYG, V84, P338, DOI 10.4269/ajtmh.2011.10-0499; Carnevale S, 2000, CLIN DIAGN LAB IMMUN, V7, P504, DOI 10.1128/CDLI.7.3.504-506.2000; Cesari IM, 2005, CLIN DIAGN LAB IMMUN, V12, P280, DOI 10.1128/CDLI.12.2.280-286.2005; Chaorattanakawee S, 2003, AM J TROP MED HYG, V69, P42, DOI 10.4269/ajtmh.2003.69.42; Cheesbrough M., 2001, MED LAB MANUAL TRO 1, P216; Colley DG, 2013, AM J TROP MED HYG, V88, P426, DOI 10.4269/ajtmh.12-0639; Coulibaly JT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002109; Coulibaly JT, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-29; Gomes ALD, 2006, MEM I OSWALDO CRUZ, V101, P133, DOI 10.1590/S0074-02762006000900021; Engels D, 1996, AM J TROP MED HYG, V54, P319, DOI 10.4269/ajtmh.1996.54.319; Erko B, 2013, TROP MED INT HEALTH, V18, P1029, DOI 10.1111/tmi.12117; Farnert A, 1999, T ROY SOC TROP MED H, V93, P50, DOI 10.1016/S0035-9203(99)90177-3; Grimes KA, 2008, J CLIN MICROBIOL, V46, P2227, DOI 10.1128/JCM.00073-08; Gryseels B, 1996, PARASITOL TODAY, V12, P115, DOI 10.1016/0169-4758(96)80671-5; Hamburger J, 1998, AM J TROP MED HYG, V59, P872, DOI 10.4269/ajtmh.1998.59.872; HAMBURGER J, 1991, MOL BIOCHEM PARASIT, V44, P73, DOI 10.1016/0166-6851(91)90222-R; Hwang J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-339; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Lier T, 2009, AM J TROP MED HYG, V81, P428, DOI 10.4269/ajtmh.2009.81.428; Lin DD, 2008, PARASITOL INT, V57, P281, DOI 10.1016/j.parint.2008.04.005; Obeng BB, 2008, ANN TROP MED PARASIT, V102, P625, DOI 10.1179/136485908X337490; Pontes LA, 2002, AM J TROP MED HYG, V66, P157, DOI 10.4269/ajtmh.2002.66.157; Sandoval N, 2006, PARASITOLOGY, V133, P581, DOI 10.1017/S0031182006000898; Sousa-Figueiredo JC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002008; Subrungruang I, 2004, J CLIN MICROBIOL, V42, P3490, DOI 10.1128/JCM.42.8.3490-3494.2004; Tansuphasiri Unchalee, 2001, Journal of the Medical Association of Thailand, V84, P1183; Tchuente LAT, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001758; ten Hove RJ, 2008, T ROY SOC TROP MED H, V102, P179, DOI 10.1016/j.trstmh.2007.10.011; Utzinger J, 2011, ACTA TROP, V120, pS121, DOI 10.1016/j.actatropica.2010.08.020; Verweij JJ, 2007, AM J TROP MED HYG, V77, P685, DOI 10.4269/ajtmh.2007.77.685; Wang W, 2012, PARASITOL RES, V111, P1871, DOI 10.1007/s00436-012-3151-z; Wichmann D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000422; Yu J, 1998, AM J TROP MED HYG, V59, P370, DOI 10.4269/ajtmh.1998.59.370	35	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137730	10.1371/journal.pone.0137730	http://dx.doi.org/10.1371/journal.pone.0137730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360049	Green Submitted, Green Published, gold			2022-12-26	WOS:000361043100077
J	Angelakis, E; Armougom, F; Carriere, F; Bachar, D; Laugier, R; Lagier, JC; Robert, C; Michelle, C; Henrissat, B; Raoult, D				Angelakis, Emmanouil; Armougom, Fabrice; Carriere, Frederic; Bachar, Dipankar; Laugier, Rene; Lagier, Jean-Christophe; Robert, Catherine; Michelle, Caroline; Henrissat, Bernard; Raoult, Didier			A Metagenomic Investigation of the Duodenal Microbiota Reveals Links with Obesity	PLOS ONE			English	Article							HUMAN GUT MICROBIOTA; BACTERIAL COMMUNITY; PHOSPHOLIPASE-A; COLONIZATION; DIVERSITY; DIGESTION; TRACT; GENE; COLI; PLDA	Background Few studies have tested the small intestine microbiota in humans, where most nutrient digestion and absorption occur. Here, our objective was to examine the duodenal microbiota between obese and normal volunteers using metagenomic techniques. Methodology/Principal Findings We tested duodenal samples from five obese and five normal volunteers using 16S rDNA V6 pyrosequencing and Illumina MiSeq deep sequencing. The predominant phyla of the duodenal microbiota were Firmicutes and Actinobacteria, whereas Bacteroidetes were absent. Obese individuals had a significant increase in anaerobic genera (p < 0.001) and a higher abundance of genes encoding Acyl-CoA dehydrogenase (p = 0.0018) compared to the control group. Obese individuals also had a reduced abundance of genes encoding sucrose phosphorylase (p = 0.015) and 1,4-alpha-glucan branching enzyme (p = 0.05). Normal weight people had significantly increased FabK (p = 0.027), and the glycerophospholipid metabolism pathway revealed the presence of phospholipase A1 only in the control group (p = 0.05). Conclusions/Significance The duodenal microbiota of obese individuals exhibit alterations in the fatty acid and sucrose breakdown pathways, probably induced by diet imbalance.	[Angelakis, Emmanouil; Armougom, Fabrice; Bachar, Dipankar; Lagier, Jean-Christophe; Robert, Catherine; Michelle, Caroline; Raoult, Didier] Aix Marseille Univ, Fac Med, UMR 6236, URMITE CNRS IRD 198, F-13385 Marseille, France; [Carriere, Frederic] Aix Marseille Univ, CNRS, Enzymol Interfaces & Physiol Lipolysis, UMR7282, F-13009 Marseille, France; [Laugier, Rene] Hop La Timone, Hepatogastroenterol Dept, Marseille, France; [Henrissat, Bernard] Aix Marseille Univ, CNRS, Architecture & Fonct Macromol Biolog, F-13288 Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah 21413, Saudi Arabia	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; King Abdulaziz University	Raoult, D (corresponding author), Aix Marseille Univ, Fac Med, UMR 6236, URMITE CNRS IRD 198, 27 Bd Jean Moulin, F-13385 Marseille, France.	didier.raoult@gmail.com	RAOULT, Didier/A-8434-2008; Lagier, Jean-Christophe/AAY-3837-2021; Henrissat, Bernard/J-2475-2012; Carriere, Frederic/E-8408-2010; Angelakis, Emmanouil/D-8039-2013	RAOULT, Didier/0000-0002-0633-5974; Lagier, Jean-Christophe/0000-0003-0771-8245; Henrissat, Bernard/0000-0002-3434-8588; Carriere, Frederic/0000-0003-4848-9418; Michelle, Caroline/0000-0002-9235-074X; Angelakis, Emmanouil/0000-0001-7327-5441				Angelakis E, 2013, LANCET INFECT DIS, V13, P889, DOI 10.1016/S1473-3099(13)70179-8; Angelakis E, 2012, FUTURE MICROBIOL, V7, P91, DOI [10.2217/FMB.11.142, 10.2217/fmb.11.142]; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Aron-Wisnewsky J, 2012, NAT REV GASTRO HEPAT, V9, P590, DOI 10.1038/nrgastro.2012.161; AUDET A, 1974, BIOCHIM BIOPHYS ACTA, V348, P334, DOI 10.1016/0005-2760(74)90213-6; Barrett E, 2013, MICROBIOLOGYOPEN, V2, P215, DOI 10.1002/mbo3.64; Moreira APB, 2012, BRIT J NUTR, V108, P801, DOI 10.1017/S0007114512001213; Breen DM, 2013, DIABETES, V62, P3005, DOI 10.2337/db13-0523; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carriere F, 2001, AM J PHYSIOL-GASTR L, V281, pG16, DOI 10.1152/ajpgi.2001.281.1.G16; Carroll IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046953; Cotter PD, 2011, CURR OPIN GASTROEN, V27, P99, DOI 10.1097/MOG.0b013e328341dc67; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Derrien M, 2010, GUT MICROBES, V1, P254, DOI 10.4161/gmic.1.4.12778; Dorrell N, 1999, GASTROENTEROLOGY, V117, P1098, DOI 10.1016/S0016-5085(99)70394-X; Dubourg G, 2013, EUR J CLIN MICROBIOL, V32, P637, DOI 10.1007/s10096-012-1787-3; Dubourg G, 2013, INT J ANTIMICROB AG, V41, P149, DOI 10.1016/j.ijantimicag.2012.10.012; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Grant KA, 1997, INFECT IMMUN, V65, P1172, DOI 10.1128/IAI.65.4.1172-1180.1997; Hattori M, 2009, DNA RES, V16, P1, DOI 10.1093/dnares/dsn033; Herieka M, 2014, MOL NUTR FOOD RES, V58, P136, DOI 10.1002/mnfr.201300104; Hildebrand P, 1998, GASTROENTEROLOGY, V114, P123, DOI 10.1016/S0016-5085(98)70640-7; Hugon P, 2013, J CLIN MICROBIOL, V51, P3286, DOI 10.1128/JCM.00473-13; Krajmalnik-Brown R, 2012, NUTR CLIN PRACT, V27, P201, DOI 10.1177/0884533611436116; Lagier JC, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00136; Lam TKT, 2010, NAT MED, V16, P392, DOI 10.1038/nm0410-392; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Laugerette F, 2014, MOL NUTR FOOD RES, V58, P1513, DOI 10.1002/mnfr.201400044; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Murri M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-46; N'Goma JCB, 2012, THER DELIV, V3, P105, DOI 10.4155/TDE.11.138; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Roesch Luiz F W, 2009, Open Microbiol J, V3, P40, DOI 10.2174/1874285800903010040; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yasir M, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2015.3; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212	42	70	74	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137784	10.1371/journal.pone.0137784	http://dx.doi.org/10.1371/journal.pone.0137784			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356733	gold, Green Published			2022-12-26	WOS:000360965800083
J	Kamphee, H; Chaiprasert, A; Prammananan, T; Wiriyachaiporn, N; Kanchanatavee, A; Dharakul, T				Kamphee, Hatairat; Chaiprasert, Angkana; Prammananan, Therdsak; Wiriyachaiporn, Natpapas; Kanchanatavee, Airin; Dharakul, Tararaj			Rapid Molecular Detection of Multidrug-Resistant Tuberculosis by PCR-Nucleic Acid Lateral Flow Immunoassay	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; ISONIAZID RESISTANCE; RIFAMPIN-RESISTANT; DRUG-RESISTANCE; RPOB MUTATIONS; MONORESISTANT TUBERCULOSIS; GENOTYPIC DETECTION; KATG GENE; STRAINS; DIAGNOSIS	Several existing molecular tests for multidrug-resistant tuberculosis (MDR-TB) are limited by complexity and cost, hindering their widespread application. The objective of this proof of concept study was to develop a simple Nucleic Acid Lateral Flow (NALF) immunoassay as a potential diagnostic alternative, to complement conventional PCR, for the rapid molecular detection of MDR-TB. The NALF device was designed using antibodies for the indirect detection of labeled PCR amplification products. Multiplex PCR was optimized to permit the simultaneous detection of the drug resistant determining mutations in the 81-bp hot spot region of the rpoB gene (rifampicin resistance), while semi-nested PCR was optimized for the S315T mutation detection in the katG gene (isoniazid resistance). The amplification process additionally targeted a conserved region of the genes as Mycobacterium tuberculosis (Mtb) DNA control. The optimized conditions were validated with the H37Rv wild-type (WT) Mtb isolate and Mtb isolates with known mutations (MT) within the rpoB and katG genes. Results indicate the correct identification of WT (drug susceptible) and MT (drug resistant) Mtb isolates, with the least limit of detection (LOD) being 10(4) genomic copies per PCR reaction. NALF is a simple, rapid and low-cost device suitable for low resource settings where conventional PCR is already employed on a regular basis. Moreover, the use of antibody-based NALF to target primer-labels, without the requirement for DNA hybridization, renders the device generic, which could easily be adapted for the molecular diagnosis of other infectious and non-infectious diseases requiring nucleic acid detection.	[Kamphee, Hatairat; Kanchanatavee, Airin; Dharakul, Tararaj] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Immunol, Bangkok 10700, Thailand; [Chaiprasert, Angkana] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand; [Prammananan, Therdsak] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand; [Dharakul, Tararaj] Natl Sci & Technol Dev Agcy, Natl Nanotechnol Ctr, Pathum Thani, Thailand	Mahidol University; Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); National Science & Technology Development Agency - Thailand; National Nanotechnology Center (NANOTEC)	Dharakul, T (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Immunol, Bangkok 10700, Thailand.	tararaj.dha@mahidol.ac.th			Cluster Program Management Office, National Science and Technology Development Agency, Thailand [P-12-01393]; Faculty of Graduate Studies, Mahidol University, Thailand	Cluster Program Management Office, National Science and Technology Development Agency, Thailand; Faculty of Graduate Studies, Mahidol University, Thailand	This study was supported by Cluster Program Management Office, National Science and Technology Development Agency, Thailand Grant number: P-12-01393 URL: (www.nstda.or.th/cpmo) to recipients: AC TD TP NW. HK was supported by a scholarship grant from the Faculty of Graduate Studies, Mahidol University, Thailand. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelaal A, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-4; Ahmad S, 2004, INT J ANTIMICROB AG, V23, P473, DOI 10.1016/j.ijantimicag.2003.10.004; Ando H, 2010, ANTIMICROB AGENTS CH, V54, P1793, DOI 10.1128/AAC.01691-09; [Anonymous], 2011, STAND MAN LAB TECHN; [Anonymous], 2010, RV1908C CATALASE PER; [Anonymous], 2010, RV0667 DNA DIRECTED; [Anonymous], TUBERCULOSIS MULTIDR; Avalos E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120470; Bang D, 2010, J INFECTION, V60, P452, DOI 10.1016/j.jinf.2010.03.017; Bostanabad SZ, 2008, INDIAN J MED MICROBI, V26, P143, DOI 10.4103/0255-0857.40528; Bostanabad SZ, 2007, TUBERK TORAK, V55, P231; Bostanabad SZ, 2007, TUBERK TORAK, V55, P370; Cade CE, 2010, PROTEIN SCI, V19, P458, DOI 10.1002/pro.324; Cattamanchi A, 2009, CLIN INFECT DIS, V48, P179, DOI 10.1086/595689; Cavusoglu C, 2002, J CLIN MICROBIOL, V40, P4435, DOI 10.1128/JCM.40.12.4435-4438.2002; Caws M, 2006, J CLIN MICROBIOL, V44, P2333, DOI 10.1128/JCM.00330-06; Coovadia YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077712; Cordray MS, 2012, AM J TROP MED HYG, V87, P223, DOI 10.4269/ajtmh.2012.11-0685; Denkinger CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084197; Fasih N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050551; Fox L, 2011, EUR J CLIN MICROBIOL, V30, P863, DOI 10.1007/s10096-011-1167-4; Goldstein BP, 2014, J ANTIBIOT, V67, P625, DOI 10.1038/ja.2014.107; Guo HL, 2006, J MED MICROBIOL, V55, P1527, DOI 10.1099/jmm.0.46718-0; Gupta A, 2013, J CLIN LAB ANAL, V27, P31, DOI 10.1002/jcla.21558; Hofling CC, 2005, INT J TUBERC LUNG D, V9, P87; Hoopes AJ, 2008, ARCH INTERN MED, V168, P1984, DOI 10.1001/archinte.168.18.1984; Hu SY, 2014, J CLIN MICROBIOL, V52, P1644, DOI 10.1128/JCM.03395-13; Jenkins HE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022927; Kersting S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-99; Lacoma A, 2008, J CLIN MICROBIOL, V46, P3660, DOI 10.1128/JCM.00618-08; Lawn SD, 2011, FUTURE MICROBIOL, V6, P1067, DOI [10.2217/FMB.11.84, 10.2217/fmb.11.84]; Makadia JS, 2012, INDIAN J CLIN BIOCHE, V27, P370, DOI 10.1007/s12291-012-0228-5; Makinen J, 2006, J CLIN MICROBIOL, V44, P350, DOI 10.1128/JCM.44.2.350-352.2006; Marrakchi H, 2000, MICROBIOL-UK, V146, P289, DOI 10.1099/00221287-146-2-289; Mboowa G, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-481; Mens PF, 2008, DIAGN MICR INFEC DIS, V61, P421, DOI 10.1016/j.diagmicrobio.2008.03.009; Mukinda FK, 2012, INT J TUBERC LUNG D, V16, P196, DOI 10.5588/ijtld.11.0116; Negi SS, 2009, INDIAN J MED MICROBI, V27, P226, DOI 10.4103/0255-0857.45364; Padmapriyadarsini C, 2011, INDIAN J MED RES, V134, P850, DOI 10.4103/0971-5916.92630; Pitaksajjakul Pannamthip, 2005, Southeast Asian J Trop Med Public Health, V36 Suppl 4, P228; Prammananan T, 2008, CLIN MICROBIOL INFEC, V14, P446, DOI 10.1111/j.1469-0691.2008.01951.x; Ramachandran R, 2009, INT J TUBERC LUNG D, V13, P1154; Ramaswamy SV, 2003, ANTIMICROB AGENTS CH, V47, P1241, DOI 10.1128/AAC.47.4.1241-1250.2003; Rohrman BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045611; Sajid M, 2015, J SAUDI CHEM SOC, V19, P689, DOI 10.1016/j.jscs.2014.09.001; Sam IC, 2006, EMERG INFECT DIS, V12, P752, DOI 10.3201/eid1205.041339; Sanders M, 2006, INT J TUBERC LUNG D, V10, P178; Seifert M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119628; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Shi XD, 2013, GENE, V530, P95, DOI 10.1016/j.gene.2013.07.060; Singh OP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-154; Stadhouders R, 2010, J MOL DIAGN, V12, P109, DOI 10.2353/jmoldx.2010.090035; Tracevska T, 2002, J CLIN MICROBIOL, V40, P3789, DOI 10.1128/JCM.40.10.3789-3792.2002; Traore H, 2000, INT J TUBERC LUNG D, V4, P481; Varahram Mohammad, 2013, Open Microbiol J, V8, P1, DOI 10.2174/1874285801408010001; Venturini E, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-S1-S5; Wang S, 2013, J TUBERC RES, V01, P1, DOI [10.4236/jtr.2013.11001, DOI 10.4236/JTR.2013.11001]; Wang TY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086316; Weyer K, 2013, EUR RESPIR J, V42, P252, DOI 10.1183/09031936.00157212; World Health Organization, 2013, WHO REC TUB DIAGN XP; World Health Organization, 2014, SUPPL GLOB TUB REP D; World Health Organization, 2008, EXP GROUP REP MOL LI; Yaku H, 2008, ELECTROPHORESIS, V29, P4130, DOI 10.1002/elps.200800097; Yue J, 2003, J CLIN MICROBIOL, V41, P2209, DOI 10.1128/JCM.41.5.2209-2212.2003; Zaczek A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-10; Zakerbostanabad S, 2008, INFECT GENET EVOL, V8, P15, DOI 10.1016/j.meegid.2007.09.002	66	28	32	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137791	10.1371/journal.pone.0137791	http://dx.doi.org/10.1371/journal.pone.0137791			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355296	gold, Green Published, Green Submitted			2022-12-26	WOS:000360965800085
J	Kato, H; Duarte, S; Liu, D; Busuttil, RW; Coito, AJ				Kato, Hiroyuki; Duarte, Sergio; Liu, Daniel; Busuttil, Ronald W.; Coito, Ana J.			Matrix Metalloproteinase-2 (MMP-2) Gene Deletion Enhances MMP-9 Activity, Impairs PARP-1 Degradation, and Exacerbates Hepatic Ischemia and Reperfusion Injury in Mice	PLOS ONE			English	Article							IN-VITRO; MYOCARDIAL INFLAMMATION; LIVER-TRANSPLANTATION; ENDOTHELIAL-CELLS; TUMOR PROGRESSION; POLYMERASE PARP; INHIBITION; EXPRESSION; FIBROSIS; PJ34	Hepatic ischemia and reperfusion injury (IRI) is an inflammatory condition and a significant cause of morbidity and mortality after surgery. Matrix metalloproteinases (MMPs) have been widely implicated in the pathogenesis of inflammatory diseases. Among the different MMPs, gelatinases (MMP-2 and MMP-9) are within the most prominent MMPs detected during liver IRI. While the role of MMP-9 in liver damage has been fairly documented, direct evidence of the role for MMP-2 activity in hepatic IRI remains to be established. Due to the lack of suitable inhibitors to target individual MMPs in vivo, gene manipulation is as an essential tool to assess MMP direct contribution to liver injury. Hence, we used MMP-2(-/-) deficient mice and MMP-2(+/+) wild-type littermates to examine the function of MMP-2 activity in hepatic IRI. MMP-2 expression was detected along the sinusoids of wild-type livers before and after surgery and in a small population of leukocytes post-IRI. Compared to MMP-2(+/+) mice, MMP-2 null (MMP-2(-/-)) mice showed exacerbated liver damage at 6, 24, and 48 hours post-reperfusion, which was fatal in some cases. MMP-2 deficiency resulted in upregulation of MMP-9 activity, spontaneous leukocyte infiltration in naive livers, and amplified MMP-9-dependent transmigration of leukocytes in vitro and after hepatic IRI. Moreover, complete loss of MMP-2 activity impaired the degradation of poly (ADP-ribose) polymerase (PARP-1) in extensively damaged livers post-reperfusion. However, the administration of a PARP-1 inhibitor to MMP-2 null mice restored liver preservation to almost comparable levels of MMP-2(+/+) mice post-IRI. Deficient PARP-1 degradation in MMP-2-null sinusoidal endothelial cells correlated with their increased cytotoxicity, evaluated by the measurement of LDH efflux in the medium. In conclusion, our results show for the first time that MMP-2 gene deletion exacerbates liver IRI. Moreover, they offer new insights into the MMP-2 modulation of inflammatory responses, which could be relevant for the design of new pharmacological MMP-targeted agents to treat hepatic IRI.	[Kato, Hiroyuki; Duarte, Sergio; Liu, Daniel; Busuttil, Ronald W.; Coito, Ana J.] Univ Calif Los Angeles, David Geffen Sch Med, Dumont UCLA Transplant Ctr, Div Liver & Pancreas Transplantat,Dept Surg, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Coito, AJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dumont UCLA Transplant Ctr, Div Liver & Pancreas Transplantat,Dept Surg, Los Angeles, CA 90095 USA.	acoito@mednet.ucla.edu	Duarte, Sergio/AAH-2142-2021	Coito, Ana/0000-0003-1315-5661	National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) [R01AI057832]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057832] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) R01AI057832 grant.	Abdelkarim GE, 2001, INT J MOL MED, V7, P255; Arthur MJP, 2000, AM J PHYSIOL-GASTR L, V279, pG245; Bauvois B, 2012, BBA-REV CANCER, V1825, P29, DOI 10.1016/j.bbcan.2011.10.001; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Braet F, 1996, J MICROSC-OXFORD, V181, P10, DOI 10.1046/j.1365-2818.1996.72348.x; Coito AJ, 2011, CURR OPIN ORGAN TRAN, V16, P34, DOI 10.1097/MOT.0b013e328342542e; Duarte S, 2015, MATRIX BIOL, V44-46, P147, DOI 10.1016/j.matbio.2015.01.004; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Esparza J, 2004, FASEB J, V18, P1682, DOI 10.1096/fj.04-2445com; Fiorillo C, 2006, CELL MOL LIFE SCI, V63, P3061, DOI 10.1007/s00018-006-6345-7; Garg P, 2006, J IMMUNOL, V177, P4103, DOI 10.4049/jimmunol.177.6.4103; Fares RCG, 2013, INFECT IMMUN, V81, P3600, DOI 10.1128/IAI.00153-13; Hamada T, 2008, HEPATOLOGY, V47, P186, DOI 10.1002/hep.21922; HO MK, 1982, J IMMUNOL, V128, P2281; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Itoh T, 2002, J IMMUNOL, V169, P2643, DOI 10.4049/jimmunol.169.5.2643; Jaeschke H, 2011, J GASTROEN HEPATOL, V26, P173, DOI 10.1111/j.1440-1746.2010.06592.x; Junior AM, 2008, BONE MARROW TRANSPL, V41, P95, DOI 10.1038/sj.bmt.1705883; Kato H, 2014, J HEPATOL; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kuyvenhoven JP, 2004, TRANSPLANTATION, V77, P1646, DOI 10.1097/01.TP.0000131170.67671.75; Kuzuya M, 2006, ARTERIOSCL THROM VAS, V26, P1120, DOI 10.1161/01.ATV.0000218496.60097.e0; Kwan JA, 2004, FASEB J, V18, P690, DOI 10.1096/fj.02-1202fje; Le NTV, 2007, FRONT BIOSCI, V12, P1475, DOI 10.2741/2161; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; Matsumura S, 2005, J CLIN INVEST, V115, P599, DOI 10.1172/JCI200522304; Matsusaka H, 2005, AM J PHYSIOL-HEART C, V289, pH1858, DOI 10.1152/ajpheart.00216.2005; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2002, BLOOD, V100, P1160, DOI 10.1182/blood.V100.4.1160.h81602001160_1160_1167; Moore C, 2007, AM J PATHOL, V170, P567, DOI 10.2353/ajpath.2007.060456; Mukhopadhyay P, 2014, HEPATOLOGY, V59, P1998, DOI 10.1002/hep.26763; OPDENAKKER G, 1991, LYMPHOKINE CYTOK RES, V10, P317; Overall CM, 2006, BRIT J CANCER, V94, P941, DOI 10.1038/sj.bjc.6603043; Padrissa-Altes S, 2010, AM J TRANSPLANT, V10, P1167, DOI 10.1111/j.1600-6143.2010.03092.x; Panek AN, 2006, HYPERTENSION, V47, P640, DOI 10.1161/01.HYP.0000208603.97395.44; Pardridge William M, 2005, NeuroRx, V2, P3; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Schofield ZV, 2013, SHOCK, V40, P463, DOI 10.1097/SHK.0000000000000044; Sinha SK, 2014, AM J TRANSL RES, V6, P155; Szabo G, 2002, CIRC RES, V90, P100, DOI 10.1161/hh0102.102657; Tao X, 2015, NEUROSCIENCE, V291, P26, DOI 10.1016/j.neuroscience.2015.01.070; Westermann D, 2011, CIRCULATION, V124, P2082, DOI 10.1161/CIRCULATIONAHA.111.035964; Yadav SS, 1999, HEPATOLOGY, V30, P1223, DOI 10.1002/hep.510300513; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zimmerman MA, 2013, P NATL ACAD SCI USA, V110, P12012, DOI 10.1073/pnas.1221733110	45	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137642	10.1371/journal.pone.0137642	http://dx.doi.org/10.1371/journal.pone.0137642			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355684	gold, Green Published, Green Submitted			2022-12-26	WOS:000360965800073
J	Korithoski, B; Kolaczkowski, O; Mukherjee, K; Kola, R; Earl, C; Kolaczkowski, B				Korithoski, Bryan; Kolaczkowski, Oralia; Mukherjee, Krishanu; Kola, Reema; Earl, Chandra; Kolaczkowski, Bryan			Evolution of a Novel Antiviral Immune-Signaling Interaction by Partial-Gene Duplication	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; MULTIPLE SEQUENCE ALIGNMENT; BRANCH-SITE TEST; RIG-I; PHYLOGENETIC ANALYSIS; PROTEIN FAMILIES; STRUCTURAL BASIS; INNATE IMMUNITY; PREDICTION; PERFORMANCE	The RIG-like receptors (RLRs) are related proteins that identify viral RNA in the cytoplasm and activate cellular immune responses, primarily through direct protein-protein interactions with the signal transducer, IPS1. Although it has been well established that the RLRs, RIG-I and MDA5, activate IPS1 through binding between the twin caspase activation and recruitment domains (CARDs) on the RLR and a homologous CARD on IPS1, it is less clear which specific RLR CARD(s) are required for this interaction, and almost nothing is known about how the RLR-IPS1 interaction evolved. In contrast to what has been observed in the presence of immune-modulating K63-linked polyubiquitin, here we show that-in the absence of ubiquitin-it is the first CARD domain of human RIG-I and MDA5 (CARD1) that binds directly to IPS1 CARD, and not the second (CARD2). Although the RLRs originated in the earliest animals, both the IPS1 gene and the twin-CARD domain architecture of RIG-I and MDA5 arose much later in the deuterostome lineage, probably through a series of tandem partial-gene duplication events facilitated by tight clustering of RLRs and IPS1 in the ancestral deuterostome genome. Functional differentiation of RIG-I CARD1 and CARD2 appears to have occurred early during this proliferation of RLR and related CARDs, potentially driven by adaptive coevolution between RIG-I CARD domains and IPS1 CARD. However, functional differentiation of MDA5 CARD1 and CARD2 occurred later. These results fit a general model in which duplications of protein-protein interaction domains into novel gene contexts could facilitate the expansion of signaling networks and suggest a potentially important role for functionally-linked gene clusters in generating novel immune-signaling pathways.	[Korithoski, Bryan; Kolaczkowski, Oralia; Kola, Reema; Kolaczkowski, Bryan] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Mukherjee, Krishanu] Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL USA; [Kola, Reema] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA; [Earl, Chandra] Univ Florida, Dept Biol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Kolaczkowski, B (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	bryank@ufl.edu		Earl, Chandra/0000-0001-9850-882X	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R21AI101571]; USDA National Institute of Food and Agriculture [FLA-MCS-005262]; University of Florida; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101571] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); University of Florida(University of Florida); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number R21AI101571, grant number FLA-MCS-005262 from the USDA National Institute of Food and Agriculture, and by the University of Florida. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bruns AM, 2014, MOL CELL, V55, P771, DOI 10.1016/j.molcel.2014.07.003; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Falkhausen M, 1995, P EUR, P1487; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gao X, 2009, P NATL ACAD SCI USA, V106, P20818, DOI 10.1073/pnas.0911093106; Gharib WH, 2013, MOL BIOL EVOL, V30, P1675, DOI 10.1093/molbev/mst062; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hanson-Smith V, 2010, MOL BIOL EVOL, V27, P1988, DOI 10.1093/molbev/msq081; Howe K, 2002, BIOINFORMATICS, V18, P1546, DOI 10.1093/bioinformatics/18.11.1546; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lensink MF, 2013, PROTEINS, V81, P2082, DOI 10.1002/prot.24428; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Lu A, 2014, MOL BIOL EVOL, V31, P484, DOI 10.1093/molbev/mst198; Mansai SP, 2010, GENETICS, V184, P517, DOI 10.1534/genetics.109.111161; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Mukherjee K, 2014, MOL BIOL EVOL, V31, P140, DOI 10.1093/molbev/mst184; Nozawa M, 2009, P NATL ACAD SCI USA, V106, P6700, DOI 10.1073/pnas.0901855106; Peisley A, 2014, NATURE, V509, P110, DOI 10.1038/nature13140; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Potter JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-11; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Roberts VA, 2013, J COMPUT CHEM, V34, P1743, DOI 10.1002/jcc.23304; Rose PW, 2013, NUCLEIC ACIDS RES, V41, pD475, DOI 10.1093/nar/gks1200; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Sarkar D, 2008, P NATL ACAD SCI USA, V105, P17040, DOI 10.1073/pnas.0804956105; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Schuster-Bockler B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-7; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Susko E, 2013, SYST BIOL, V62, P330, DOI 10.1093/sysbio/sys075; Suzuki Y, 2008, GENES GENET SYST, V83, P331, DOI 10.1266/ggs.83.331; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Vernot B, 2008, J COMPUT BIOL, V15, P981, DOI 10.1089/cmb.2008.0092; Wu B, 2014, MOL CELL, V55, P511, DOI 10.1016/j.molcel.2014.06.010; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; YANG ZH, 1995, GENETICS, V141, P1641; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yang ZH, 2011, MOL BIOL EVOL, V28, P1217, DOI 10.1093/molbev/msq303; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171; Zou J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-85	71	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137276	10.1371/journal.pone.0137276	http://dx.doi.org/10.1371/journal.pone.0137276			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356745	gold, Green Submitted, Green Published			2022-12-26	WOS:000360965800038
J	Popova, B; Schubert, S; Bulla, I; Buchwald, D; Kramer, W				Popova, Blagovesta; Schubert, Steffen; Bulla, Ingo; Buchwald, Daniela; Kramer, Wilfried			A Robust and Versatile Method of Combinatorial Chemical Synthesis of Gene Libraries via Hierarchical Assembly of Partially Randomized Modules	PLOS ONE			English	Article							DESIGNING REPEAT PROTEINS; TRINUCLEOTIDE PHOSPHORAMIDITES; MIXED OLIGONUCLEOTIDES; CONVENIENT APPROACH; DIRECTED EVOLUTION; RANDOM MUTAGENESIS; GENERATION; ANTIBODIES; DIVERSITY; ENZYME	A major challenge in gene library generation is to guarantee a large functional size and diversity that significantly increases the chances of selecting different functional protein variants. The use of trinucleotides mixtures for controlled randomization results in superior library diversity and offers the ability to specify the type and distribution of the amino acids at each position. Here we describe the generation of a high diversity gene library using tHisF of the hyperthermophile Thermotoga maritima as a scaffold. Combining various rational criteria with contingency, we targeted 26 selected codons of the thisF gene sequence for randomization at a controlled level. We have developed a novel method of creating full-length gene libraries by combinatorial assembly of smaller sub-libraries. Full-length libraries of high diversity can easily be assembled on demand from smaller and much less diverse sublibraries, which circumvent the notoriously troublesome long-term archivation and repeated proliferation of high diversity ensembles of phages or plasmids. We developed a generally applicable software tool for sequence analysis of mutated gene sequences that provides efficient assistance for analysis of library diversity. Finally, practical utility of the library was demonstrated in principle by assessment of the conformational stability of library members and isolating protein variants with HisF activity from it. Our approach integrates a number of features of nucleic acids synthetic chemistry, biochemistry and molecular genetics to a coherent, flexible and robust method of combinatorial gene synthesis.	[Popova, Blagovesta] Univ Gottingen, Inst Microbiol & Genet, Dept Mol Microbiol & Genet, D-37073 Gottingen, Germany; [Popova, Blagovesta; Schubert, Steffen; Kramer, Wilfried] Univ Gottingen, Inst Microbiol & Genet, Dept Mol Genet & Preparat Mol Biol, D-37073 Gottingen, Germany; [Schubert, Steffen] Univ Med Ctr, Dept Dermatol Venereol & Allergol, Gottingen, Germany; [Schubert, Steffen] Dept Dermatol IVDK, Informat Network, Gottingen, Germany; [Bulla, Ingo] Los Alamos Natl Lab, Theoret Biol & Biophys, Grp T 6, Los Alamos, NM USA; [Bulla, Ingo] Ernst Moritz Arndt Univ Greifswald, Inst Math & Informat, Greifswald, Germany; [Bulla, Ingo; Buchwald, Daniela] Univ Gottingen, Inst Microbiol & Genet, Dept Bioinformat, D-37073 Gottingen, Germany; [Buchwald, Daniela] German Primate Ctr GmbH, Neurobiol Lab, Gottingen, Germany; [Kramer, Wilfried] Univ Gottingen, Inst Microbiol & Genet, Dept Mol Genet, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen; United States Department of Energy (DOE); Los Alamos National Laboratory; Ernst Moritz Arndt Universitat Greifswald; University of Gottingen; Deutsches Primatenzentrum (DPZ); University of Gottingen	Popova, B (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Dept Mol Microbiol & Genet, D-37073 Gottingen, Germany.	bpopova@gwdg.de	Buchwald, Daniela/X-1035-2019	Buchwald, Daniela/0000-0002-7840-641X; Popova, Blagovesta/0000-0001-6323-374X	German Research Foundation; Gottingen University; Cluster of Excellence; DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain	German Research Foundation(German Research Foundation (DFG)); Gottingen University; Cluster of Excellence; DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain(German Research Foundation (DFG))	The authors acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University. BP was supported by the Cluster of Excellence and DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain.	Arndt KM, 2000, J MOL BIOL, V295, P627, DOI 10.1006/jmbi.1999.3352; Arunachalam TS, 2012, ORG BIOMOL CHEM, V10, P4641, DOI 10.1039/c2ob25328c; Ashraf M, 2013, BIOCHEM SOC T, V41, P1189, DOI 10.1042/BST20130123; Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7; Beismann-Driemeyer S, 2001, J BIOL CHEM, V276, P20387, DOI 10.1074/jbc.M102012200; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; Chothia C, 1998, J MOL BIOL, V278, P457, DOI 10.1006/jmbi.1998.1653; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Fukuchi S, 2001, J MOL BIOL, V309, P835, DOI 10.1006/jmbi.2001.4718; Gaytan P, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp602; He M, 2007, BIOCHEM SOC T, V35, P962, DOI 10.1042/BST0350962; Hoet RM, 2005, NAT BIOTECHNOL, V23, P344, DOI 10.1038/nbt1067; Hughes MD, 2003, J MOL BIOL, V331, P973, DOI 10.1016/S0022-2836(03)00833-7; Isalan M, 2006, NAT PROTOC, V1, P468, DOI 10.1038/nprot.2006.68; Janczyk M, 2012, ORG BIOMOL CHEM, V10, P1510, DOI 10.1039/c2ob06934b; Kayushin A, 2000, NUCLEOS NUCLEOT NUCL, V19, P1967, DOI 10.1080/15257770008045471; Kayushin AL, 1996, NUCLEIC ACIDS RES, V24, P3748, DOI 10.1093/nar/24.19.3748; Kille S, 2013, ACS SYNTH BIOL, V2, P83, DOI 10.1021/sb300037w; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Kohl A, 2003, P NATL ACAD SCI USA, V100, P1700, DOI 10.1073/pnas.0337680100; Krumpe LR, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-65; Lang D, 2000, SCIENCE, V289, P1546, DOI 10.1126/science.289.5484.1546; Levy M, 2008, CHEM BIOL, V15, P979, DOI 10.1016/j.chembiol.2008.07.017; Ochoa-Leyva A, 2011, J MOL BIOL, V411, P143, DOI 10.1016/j.jmb.2011.05.027; Pingoud A, 2005, CELL MOL LIFE SCI, V62, P685, DOI 10.1007/s00018-004-4513-1; Rauchenberger R, 2003, J BIOL CHEM, V278, P38194, DOI 10.1074/jbc.M303164200; Richter A, 2014, FEBS LETT, V588, P213, DOI 10.1016/j.febslet.2013.11.006; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Ruff AJ, 2013, FEBS J, V280, P2961, DOI 10.1111/febs.12325; Shivange AV, 2009, CURR OPIN CHEM BIOL, V13, P19, DOI 10.1016/j.cbpa.2009.01.019; Sterner R, 2005, CHEM REV, V105, P4038, DOI 10.1021/cr030191z; Sterner R, 2001, CRIT REV BIOCHEM MOL, V36, P39, DOI 10.1080/20014091074174; Stumpp MT, 2003, J MOL BIOL, V332, P471, DOI 10.1016/S0022-2836(03)00897-0; Tang LX, 2012, BIOTECHNIQUES, V52, P149, DOI 10.2144/000113820; Tee KL, 2013, BIOTECHNOL ADV, V31, P1707, DOI 10.1016/j.biotechadv.2013.08.021; VIRNEKAS B, 1994, NUCLEIC ACIDS RES, V22, P5600, DOI 10.1093/nar/22.25.5600; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wong TS, 2007, ENVIRON MICROBIOL, V9, P2645, DOI 10.1111/j.1462-2920.2007.01411.x; Yanez J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh156; Zehl A, 1996, CHEM COMMUN, P2677, DOI 10.1039/cc9960002677	43	5	5	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0136778	10.1371/journal.pone.0136778	http://dx.doi.org/10.1371/journal.pone.0136778			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355961	Green Published, Green Submitted, gold			2022-12-26	WOS:000360965800016
J	Ortega-Cisneros, K; Scharler, UM				Ortega-Cisneros, Kelly; Scharler, Ursula M.			Nutrient Dynamics of Estuarine Invertebrates Are Shaped by Feeding Guild Rather than Seasonal River Flow	PLOS ONE			English	Article							TEMPORARILY OPEN/CLOSED ESTUARIES; STABLE CARBON-ISOTOPE; SOUTH-AFRICAN ESTUARY; ECOLOGICAL STOICHIOMETRY; ELEMENTAL COMPOSITION; FOOD-WEB; PHOSPHORUS-CONTENT; NETWORK ANALYSIS; C-N; ZOOPLANKTON	This study aimed to determine the variability of carbon and nitrogen elemental content, stoichiometry and diet proportions of invertebrates in two sub-tropical estuaries in South Africa experiencing seasonal changes in rainfall and river inflow. The elemental ratios and stable isotopes of abiotic sources, zooplankton and macrozoobenthos taxa were analyzed over a dry/wet seasonal cycle. Nutrient content (C, N) and stoichiometry of suspended particulate matter exhibited significant spatio-temporal variations in both estuaries, which were explained by the variability in river inflow. Sediment particulate matter (%C, %N and C: N) was also influenced by the variability in river flow but to a lesser extent. The nutrient content and ratios of the analyzed invertebrates did not significantly vary among seasons with the exception of the copepod Pseudodiaptomus spp. (C:N) and the tanaid Apseudes digitalis (%N, C:N). These changes did not track the seasonal variations of the suspended or sediment particulate matter. Our results suggest that invertebrates managed to maintain their stoichiometry independent of the seasonality in river flow. A significant variability in nitrogen content among estuarine invertebrates was recorded, with highest %N recorded from predators and lowest %N from detritivores. Due to the otherwise general lack of seasonal differences in elemental content and stoichiometry, feeding guild was a major factor shaping the nutrient dynamics of the estuarine invertebrates. The nutrient richer suspended particulate matter was the preferred food source over sediment particulate matter for most invertebrate consumers in many, but not all seasons. The most distinct preference for suspended POM as a food source was apparent from the temporarily open/closed system after the estuary had breached, highlighting the importance of river flow as a driver of invertebrate nutrient dynamics under extreme events conditions. Moreover, our data showed that estuarine invertebrates concentrated C and N between 10-100 fold from trophic level I (POM) to trophic level II (detritivores/deposit feeders) and thus highlighted their importance not only as links to higher trophic level organisms in the food web, but also as providers of a stoichiometrically homeostatic food source for such consumers. As climate change scenarios for the east coast of South Africa predict increased rainfall as a higher number of rainy days and days with higher rainfall, our results suggest that future changes in rainfall and river inflow will have measurable effects on the nutrient content and stoichiometry of food sources and possibly also in estuarine consumers.	[Ortega-Cisneros, Kelly; Scharler, Ursula M.] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa	University of Kwazulu Natal	Ortega-Cisneros, K (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Westville Campus, Durban, South Africa.	flypper5@hotmail.com	Ortega, Kelly/I-4520-2019	Ortega-Cisneros, Kelly/0000-0003-2511-5448; Scharler, Ursula/0000-0003-0493-2684	Kleinemonde SEAChange Project; South African Institute for Aquatic Biodiversity - National Research Foundation; Rufford Small Grant for Nature Conservation (KOC) National Research Foundation Incentive funding	Kleinemonde SEAChange Project; South African Institute for Aquatic Biodiversity - National Research Foundation; Rufford Small Grant for Nature Conservation (KOC) National Research Foundation Incentive funding	This work was supported by Kleinemonde SEAChange Project, South African Institute for Aquatic Biodiversity - National Research Foundation (KOC), Rufford Small Grant for Nature Conservation (KOC) National Research Foundation Incentive funding (UMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Janine, 1999, P91, DOI 10.1017/CBO9780511525490.005; Albuquerque ALS, 1997, WETLANDS, V17, P1, DOI 10.1007/BF03160713; ANDERSEN T, 1991, LIMNOL OCEANOGR, V36, P807, DOI 10.4319/lo.1991.36.4.0807; BEERS JR, 1966, LIMNOL OCEANOGR, V11, P520; Bowman MF, 2005, FRESHWATER BIOL, V50, P1836, DOI 10.1111/j.1365-2427.2005.01454.x; Carmichael RH, 2005, LIMNOL OCEANOGR, V50, P97, DOI 10.4319/lo.2005.50.1.0097; CAUWET G, 1993, MAR CHEM, V43, P235, DOI 10.1016/0304-4203(93)90229-H; Christian RR, 2005, AQUATIC FOOD WEBS: AN ECOSYSTEM APPROACH, P25; Chrystal RA, 2014, ECOL INDIC, V38, P130, DOI 10.1016/j.ecolind.2013.10.025; Chrzanowski TH, 2008, LIMNOL OCEANOGR, V53, P1242, DOI 10.4319/lo.2008.53.4.1242; Clarke A, 2008, MAR ECOL PROG SER, V369, P25, DOI 10.3354/meps07670; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Cross WF, 2003, ECOL LETT, V6, P721, DOI 10.1046/j.1461-0248.2003.00481.x; DAVIES B. R., 1998, VANISHING WATERS; DeMott WR, 2003, HYDROBIOLOGIA, V491, P177, DOI 10.1023/A:1024408430472; EKZNW, 2012, EST MAN PLAN MPENJ E; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Elser JJ, 1999, ECOLOGY, V80, P735, DOI 10.2307/177013; ELSER JJ, 1988, LIMNOL OCEANOGR, V33, P1, DOI 10.4319/lo.1988.33.1.0001; Evans-White MA, 2005, FRESHWATER BIOL, V50, P1786, DOI 10.1111/j.1365-2427.2005.01455.x; Fagan WF, 2002, AM NAT, V160, P784, DOI 10.1086/343879; Fauchald K., 1979, Oceanography and Marine Biology an Annual Review, V17, P193; Froneman PW, 2002, ESTUAR COAST SHELF S, V55, P535, DOI 10.1006/ecss.2001.0921; Frost PC, 2003, J N AM BENTHOL SOC, V22, P51, DOI 10.2307/1467977; Frost PC, 2002, ECOL LETT, V5, P232, DOI 10.1046/j.1461-0248.2002.00307.x; GAEDKE U, 1994, ECOL MODEL, V75, P435, DOI 10.1016/0304-3800(94)90038-8; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Gismervik I, 1997, J PLANKTON RES, V19, P279, DOI 10.1093/plankt/19.2.279; Golz AL, 2015, J PLANKTON RES, V37, P293, DOI 10.1093/plankt/fbu109; Hessen DO, 1997, FRESHWATER BIOL, V38, P447, DOI 10.1046/j.1365-2427.1997.00224.x; Jacob U, 2005, MAR ECOL PROG SER, V287, P251, DOI 10.3354/meps287251; Kibirige I, 2002, J PLANKTON RES, V24, P1089, DOI 10.1093/plankt/24.10.1089; Liess A, 2005, J N AM BENTHOL SOC, V24, P256, DOI 10.1899/04-015.1; Martinson HM, 2008, ECOL RES, V23, P487, DOI 10.1007/s11284-008-0471-7; MATSON EA, 1990, LIMNOL OCEANOGR, V35, P1290, DOI 10.4319/lo.1990.35.6.1290; Montagna PA, 2002, ESTUARIES, V25, P1243, DOI 10.1007/BF02692221; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Mulder K, 2007, ECOL MODEL, V202, P427, DOI 10.1016/j.ecolmodel.2006.11.007; Ortega-Cisneros K, 2014, ESTUAR COAST SHELF S, V136, P139, DOI 10.1016/j.ecss.2013.11.021; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Paterson AW, 1997, ESTUAR COAST SHELF S, V45, P705, DOI 10.1006/ecss.1997.0243; Perissinotto R, 2003, ACTA OECOL, V24, pS307, DOI 10.1016/S1146-609X(03)00028-6; Persson J, 2010, OIKOS, V119, P741, DOI 10.1111/j.1600-0706.2009.18545.x; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Richoux NB, 2007, ESTUAR COAST SHELF S, V71, P545, DOI 10.1016/j.ecss.2006.09.007; Scharler UM, 2012, ESTUAR COAST SHELF S, V108, P119, DOI 10.1016/j.ecss.2011.08.003; STERNER RW, 1994, ANNU REV ECOL SYST, V25, P1, DOI 10.1146/annurev.es.25.110194.000245; STERNER RW, 2002, ECOLOGICAL STOICHIOM, P584; Trimmer M, 1998, MAR ECOL PROG SER, V163, P109, DOI 10.3354/meps163109; Turpie J. K, 2012, CSIRNREECOSER2011004, V3; Ventura M, 2005, LIMNOL OCEANOGR, V50, P2043, DOI 10.4319/lo.2005.50.6.2043; Walve J, 1999, J PLANKTON RES, V21, P2309, DOI 10.1093/plankt/21.12.2309; Wang H, 2012, ECOL MODEL, V243, P81, DOI 10.1016/j.ecolmodel.2012.06.003; Whitfield A.K., 2013, 7 SANCOR; Yu FL, 2010, ESTUAR COAST SHELF S, V87, P618, DOI 10.1016/j.ecss.2010.02.018; Zhang ZH, 2013, J SOIL SEDIMENT, V13, P140, DOI [10.1007/s11368-012-0571-4, 10.1007/s11368-013-0693-3]	57	7	7	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137417	10.1371/journal.pone.0137417	http://dx.doi.org/10.1371/journal.pone.0137417			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352433	Green Published, Green Submitted, gold			2022-12-26	WOS:000360932800083
J	Thangavel, T; Tegg, RS; Wilson, CR				Thangavel, Tamilarasan; Tegg, Robert S.; Wilson, Calum R.			Monitoring Spongospora subterranea Development in Potato Roots Reveals Distinct Infection Patterns and Enables Efficient Assessment of Disease Control Methods	PLOS ONE			English	Article							F-SP SUBTERRANEA; POWDERY SCAB DISEASE; COMMON SCAB; SEED-TUBER; SUSCEPTIBILITY; PCR; QUANTIFICATION; RESISTANCE; INOCULUM; TIME	Spongospora subterranea is responsible for significant potato root and tuber disease globally. Study of this obligate (non-culturable) pathogen that infects below-ground plant parts is technically difficult. The capacity to measure the dynamics and patterns of root infections can greatly assist in determining the efficacy of control treatments on disease progression. This study used qPCR and histological analysis in time-course experiments to measure temporal patterns of pathogen multiplication and disease development in potato (and tomato) roots and tubers. Effects of delayed initiation of infection and fungicidal seed tuber and soil treatments were assessed. This study found roots at all plant developmental ages were susceptible to infection but that delaying infection significantly reduced pathogen content and resultant disease at final harvest. The pathogen was first detected in roots 15-20 days after inoculation (DAI) and the presence of zoosporangia noted 15-45 DAI. Following initial infection pathogen content in roots increased at a similar rate regardless of plant age at inoculation. All fungicide treatments (except soil-applied mancozeb which had a variable response) suppressed pathogen multiplication and root and tuber disease. In contrast to delayed inoculation, the fungicide treatments slowed disease progress (rate) rather than delaying onset of infection. Trials under suboptimal temperatures for disease expression provided valuable data on root infection rate, demonstrating the robustness of monitoring root infection. These results provide an early measure of the efficacy of control treatments and indicate two possible patterns of disease suppression by either delayed initiation of infection which then proceeds at a similar rate or diminished epidemic rate.	[Thangavel, Tamilarasan; Tegg, Robert S.; Wilson, Calum R.] Univ Tasmania, Tasmanian Inst Agr, Sch Land & Food, New Town Res Labs, Newtown, Tas 7008, Australia	University of Tasmania	Wilson, CR (corresponding author), Univ Tasmania, Tasmanian Inst Agr, Sch Land & Food, New Town Res Labs, 13 St Johns Ave, Newtown, Tas 7008, Australia.	Calum.Wilson@utas.edu.au	Thangavel, Tamilarasan/P-8050-2019	Thangavel, Tamilarasan/0000-0002-8800-0990; Wilson, Calum/0000-0001-5434-3816	Simplot Australia Pty. Ltd.; McCain Foods Australia Pty. Ltd.; Federal Government through Horticulture Innovation Australia Limited [PT14002]	Simplot Australia Pty. Ltd.; McCain Foods Australia Pty. Ltd.; Federal Government through Horticulture Innovation Australia Limited	Funding: This study was supported by Simplot Australia Pty. Ltd. and McCain Foods Australia Pty. Ltd., with matched funds from the Federal Government through Horticulture Innovation Australia Limited: project number PT14002 (http://www.horticulture.com.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MJ, 1975, ANN APPL BIOL, V79, P275, DOI 10.1111/j.1744-7348.1975.tb01583.x; ADAMS MJ, 1978, ANN APPL BIOL, V90, P335, DOI 10.1111/j.1744-7348.1978.tb02641.x; Bell KS, 1999, EUR J PLANT PATHOL, V105, P905, DOI 10.1023/A:1008782309333; BRAITHWAITE M, 1994, NEW ZEAL J CROP HORT, V22, P121, DOI 10.1080/01140671.1994.9513815; Falloon RE, 1996, NEW ZEAL J CROP HORT, V24, P341, DOI 10.1080/01140671.1996.9513971; Falloon RE, 2003, AUSTRALAS PLANT PATH, V32, P377, DOI 10.1071/AP03040; Falloon RE, 2004, P S 88 ANN M POT ASS, P253; Falloon RE, 2008, AM J POTATO RES, V85, P253, DOI 10.1007/s12230-008-9022-6; Harrison JG, 1997, PLANT PATHOL, V46, P1, DOI 10.1046/j.1365-3059.1997.d01-214.x; HUGHES IK, 1980, AUST J EXP AGR, V20, P625, DOI 10.1071/EA9800625; Khatri BB, 2011, PLANT PATHOL, V60, P776, DOI 10.1111/j.1365-3059.2011.02435.x; Khatri BB, 2010, J PHYTOPATHOL, V158, P453, DOI 10.1111/j.1439-0434.2009.01637.x; Maldonado M. L. H., 2013, Plant Pathology, V62, P1089, DOI 10.1111/ppa.12015; Merz U, 2009, POTATO RES, V52, P17, DOI 10.1007/s11540-008-9105-2; Merz U, 1989, EPPO B, V19, P585, DOI DOI 10.1111/J.1365-2338.1989.TB00436.X; Merz U, 2008, AM J POTATO RES, V85, P241, DOI 10.1007/s12230-008-9019-1; Nitzan N, 2008, PLANT DIS, V92, P1643, DOI 10.1094/PDIS-92-12-1643; Ophel-Keller K, 2008, AUSTRALAS PLANT PATH, V37, P243, DOI 10.1071/AP08029; Qu XS, 2006, AM J POTATO RES, V83, P21, DOI 10.1007/BF02869606; Ramsay A, 2014, POT IND C 7 BIENN C; Shah FA, 2012, AUSTRALAS PLANT PATH, V41, P219, DOI 10.1007/s13313-011-0110-6; TAYLOR PA, 1986, AUST J EXP AGR, V26, P745, DOI 10.1071/EA9860745; Tegg RS, 2013, PLANT PATHOL, V62, P922, DOI 10.1111/j.1365-3059.2012.02698.x; Tegg RS, 2015, PLANT DIS, V99, P50, DOI 10.1094/PDIS-04-14-0337-RE; Tegg RS, 2014, EUR J PLANT PATHOL, V139, P353, DOI 10.1007/s10658-014-0392-y; van de Graaf P, 2007, PLANT PATHOL, V56, P1005, DOI 10.1111/j.1365-3059.2007.01686.x; van de Graaf P, 2005, PLANT PATHOL, V54, P22, DOI 10.1111/j.1365-3059.2005.01111.x; Weller SA, 2000, APPL ENVIRON MICROB, V66, P2853, DOI 10.1128/AEM.66.7.2853-2858.2000; Wilson CR, 1999, J PHYTOPATHOL, V147, P13, DOI 10.1111/j.1439-0434.1999.tb03801.x	29	19	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137647	10.1371/journal.pone.0137647	http://dx.doi.org/10.1371/journal.pone.0137647			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352757	gold, Green Submitted, Green Published			2022-12-26	WOS:000360932800104
J	Kostylev, M; Otwell, AE; Richardson, RE; Suzuki, Y				Kostylev, Maxim; Otwell, Anne E.; Richardson, Ruth E.; Suzuki, Yo			Cloning Should Be Simple: Escherichia coli DH5 alpha-Mediated Assembly of Multiple DNA Fragments with Short End Homologies	PLOS ONE			English	Article							PCR PRODUCTS; IN-VIVO; SACCHAROMYCES-CEREVISIAE; DIRECT TRANSFORMATION; CAS SYSTEMS; RECOMBINATION; YEAST; EXPRESSION; EXTENSION; PATHWAYS	Numerous DNA assembly technologies exist for generating plasmids for biological studies. Many procedures require complex in vitro or in vivo assembly reactions followed by plasmid propagation in recombination-impaired Escherichia coli strains such as DH5 alpha, which are optimal for stable amplification of the DNA materials. Here we show that despite its utility as a cloning strain, DH5 alpha retains sufficient recombinase activity to assemble up to six double-stranded DNA fragments ranging in size from 150 bp to at least 7 kb into plasmids in vivo. This process also requires surprisingly small amounts of DNA, potentially obviating the need for upstream assembly processes associated with most common applications of DNA assembly. We demonstrate the application of this process in cloning of various DNA fragments including synthetic genes, preparation of knockout constructs, and incorporation of guide RNA sequences in constructs for clustered regularly interspaced short palindromic repeats (CRISPR) genome editing. This consolidated process for assembly and amplification in a widely available strain of E. coli may enable productivity gain across disciplines involving recombinant DNA work.	[Kostylev, Maxim; Suzuki, Yo] J Craig Venter Inst, Dept Synthet Biol & Bioenergy, La Jolla, CA 92037 USA; [Otwell, Anne E.] Cornell Univ, Dept Microbiol, Ithaca, NY USA; [Richardson, Ruth E.] Cornell Univ, Sch Civil & Environm Engn, Ithaca, NY 14853 USA	J. Craig Venter Institute; Cornell University; Cornell University	Kostylev, M (corresponding author), J Craig Venter Inst, Dept Synthet Biol & Bioenergy, La Jolla, CA 92037 USA.	mkostyle@jcvi.org; ysuzuki@jcvi.org	Ibrahim, Essam Hassan/G-1960-2018; Richardson, Ruth E/B-8265-2017	Ibrahim, Essam Hassan/0000-0003-0130-2257; 	US Department of Energy [DE-EE0006109, DE-SC0006644]	US Department of Energy(United States Department of Energy (DOE))	This work was supported by the US Department of Energy DE-EE0006109 to YS (http://energy.gov/eere/office-energy-efficiency-renewableenergy); US Department of Energy DE-SC0006644 to RER (http://genomicscience.energy.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUBECK P, 1993, NUCLEIC ACIDS RES, V21, P3601, DOI 10.1093/nar/21.15.3601; Cao PG, 2014, PLASMID, V76, P40, DOI 10.1016/j.plasmid.2014.09.002; Chayot R, 2010, P NATL ACAD SCI USA, V107, P2141, DOI 10.1073/pnas.0906355107; Colloms SD, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1101; Degryse E, 1996, GENE, V170, P45, DOI 10.1016/0378-1119(95)00858-6; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Dutra BE, 2007, P NATL ACAD SCI USA, V104, P216, DOI 10.1073/pnas.0608293104; Fu J, 2012, NAT BIOTECHNOL, V30, P440, DOI 10.1038/nbt.2183; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jacobus AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119221; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Koskela EV, 2015, MOL BIOTECHNOL, V57, P233, DOI 10.1007/s12033-014-9817-2; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Labunskyy VM, 2014, G3-GENES GENOM GENET, V4, P1183, DOI 10.1534/g3.114.010868; Lanza AM, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-33; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Lovett ST, 2002, GENETICS, V160, P851; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; Maniatis T., 1982, MOL CLONING; Mitchell LA, 2015, NUCLEIC ACIDS RES, V43, P6620, DOI 10.1093/nar/gkv466; Noskov V, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e8; OLINER JD, 1993, NUCLEIC ACIDS RES, V21, P5192, DOI 10.1093/nar/21.22.5192; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Smith C, 1993, PCR Methods Appl, V2, P328, DOI 10.1101/gr.2.4.328; Suzuki Y, 2011, NAT METHODS, V8, P159, DOI 10.1038/NMETH.1550; Swingle B, 2010, MOL MICROBIOL, V75, P138, DOI 10.1111/j.1365-2958.2009.06976.x; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Thomason Lynn C, 2014, Curr Protoc Mol Biol, V106, DOI 10.1002/0471142727.mb0116s106; Wang RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057943; Wright MS, 2014, ANTIMICROB AGENTS CH, V58, P4961, DOI 10.1128/AAC.00125-14; You C, 2012, APPL ENVIRON MICROB, V78, P1593, DOI 10.1128/AEM.07105-11; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288	40	66	69	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137466	10.1371/journal.pone.0137466	http://dx.doi.org/10.1371/journal.pone.0137466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348330	Green Published, Green Submitted, gold			2022-12-26	WOS:000360897600046
J	Levin, II; Zonana, DM; Burt, JM; Safran, RJ				Levin, Iris I.; Zonana, David M.; Burt, John M.; Safran, Rebecca J.			Performance of Encounternet Tags: Field Tests of Miniaturized Proximity Loggers for Use on Small Birds	PLOS ONE			English	Article							SOCIAL NETWORK ANALYSIS; TEMPORAL DYNAMICS; BEHAVIOR; ATTACHMENT; QUALITY	Proximity logging is a new tool for understanding social behavior as it allows for accurate quantification of social networks. We report results from field calibration and deployment tests of miniaturized proximity tags (Encounternet), digital transceivers that log encounters between tagged individuals. We examined radio signal behavior in relation to tag attachment (tag, tag on bird, tag on saline-filled balloon) to understand how radio signal strength is affected by the tag mounting technique used for calibration tests. We investigated inter-tag and inter-receiver station variability, and in each calibration test we accounted for the effects of antennae orientation. Additionally, we used data from a live deployment on breeding barn swallows (Hirundo rustica erythrogaster) to analyze the quality of the logs, including reciprocal agreement in dyadic logs. We evaluated the impact (in terms of mass changes) of tag attachment on the birds. We were able to statistically distinguish between RSSI values associated with different close-proximity (<5m) tag-tag distances regardless of antennae orientation. Inter-tag variability was low, but we did find significant inter-receiver station variability. Reciprocal agreement of dyadic logs was high and social networks were constructed from proximity tag logs based on two different RSSI thresholds. There was no evidence of significant mass loss in the time birds were wearing tags. We conclude that proximity loggers are accurate and effective for quantifying social behavior. However, because RSSI and distance cannot be perfectly resolved, data from proximity loggers are most appropriate for comparing networks based on specific RSSI thresholds. The Encounternet system is flexible and customizable, and tags are now light enough for use on small animals (<50g).	[Levin, Iris I.; Zonana, David M.; Safran, Rebecca J.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Burt, John M.] Encounternet LLC, Portland, OR USA; [Burt, John M.] Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA	University of Colorado System; University of Colorado Boulder; University of Washington; University of Washington Seattle	Levin, II (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	Iris.Levin@colorado.edu		Zonana, David/0000-0002-1599-8913	University of Colorado; National Science Foundation [1306059]	University of Colorado; National Science Foundation(National Science Foundation (NSF))	Funding for this research was provided by a University of Colorado Innovative Seed Grant award. I. Levin was supported by a National Science Foundation Postdoctoral Research Fellowship No. 1306059. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082316; Barron DG, 2010, METHODS ECOL EVOL, V1, P180, DOI 10.1111/j.2041-210X.2010.00013.x; Blonder B, 2012, METHODS ECOL EVOL, V3, P958, DOI 10.1111/j.2041-210X.2012.00236.x; Boyland NK, 2013, BEHAV ECOL SOCIOBIOL, V67, P1877, DOI 10.1007/s00265-013-1622-6; Bridge ES, 2013, J FIELD ORNITHOL, V84, P121, DOI 10.1111/jofo.12011; Castles M, 2014, ANIM BEHAV, V96, P59, DOI 10.1016/j.anbehav.2014.07.023; Cross PC, 2013, ECOLOGY, V94, P2076, DOI 10.1890/12-2086.1; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Drewe JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039068; Fair J., 2010, ORNITHOLOGICAL COUNC; Farine DR, 2015, ANIM BEHAV, V104, pE1, DOI 10.1016/j.anbehav.2014.11.019; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Hamede RK, 2009, ECOL LETT, V12, P1147, DOI 10.1111/j.1461-0248.2009.01370.x; Hobson EA, 2013, ANIM BEHAV, V85, P83, DOI 10.1016/j.anbehav.2012.10.010; Krause J, 2013, TRENDS ECOL EVOL, V28, P541, DOI 10.1016/j.tree.2013.06.002; Krause J, 2011, TRENDS ECOL EVOL, V26, P5, DOI 10.1016/j.tree.2010.10.004; Kuznetsova A, 2014, LMER TEST TESTS RAND; Meise K, 2013, AQUAT BIOL, V18, P81, DOI 10.3354/ab00492; Mennill DJ, 2012, METHODS ECOL EVOL, V3, P663, DOI 10.1111/j.2041-210X.2012.00206.x; Naef-Daenzer B, 2005, J EXP BIOL, V208, P4063, DOI 10.1242/jeb.01870; Naef-Daenzer B, 2007, J AVIAN BIOL, V38, P404, DOI 10.1111/j.2007.0908-8857.03863.x; Patison KP, 2010, APPL ANIM BEHAV SCI, V128, P10, DOI 10.1016/j.applanim.2010.10.001; Prange S, 2006, WILDLIFE SOC B, V34, P1333, DOI 10.2193/0091-7648(2006)34[1333:NRFTDO]2.0.CO;2; Ralls K, 2013, J MAMMAL, V94, P1185, DOI 10.1644/13-MAMM-A-057.1; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Rutz C, 2015, METHODS ECOL EVOL, V6, P656, DOI 10.1111/2041-210X.12370; Rutz C, 2012, CURR BIOL, V22, pR669, DOI 10.1016/j.cub.2012.06.037; Ryder TB, 2012, BIOL LETTERS, V8, P917, DOI 10.1098/rsbl.2012.0536; Safran RJ, 2008, CURR BIOL, V18, pR461, DOI 10.1016/j.cub.2008.03.031; Safran RJ, 2005, SCIENCE, V309, P2210, DOI 10.1126/science.1115090; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Sih A, 2009, BEHAV ECOL SOCIOBIOL, V63, P975, DOI 10.1007/s00265-009-0725-6; Snijders L, 2014, ANIM BEHAV, V98, P95, DOI 10.1016/j.anbehav.2014.09.029; Vitousek MN, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0539; Walrath R, 2011, WILDLIFE SOC B, V35, P452, DOI 10.1002/wsb.76; Watson-Haigh NS, 2012, IEEE SENS J, V12, P1611, DOI 10.1109/JSEN.2011.2175215; Weber N, 2013, CURR BIOL, V23, pR915, DOI 10.1016/j.cub.2013.09.011; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020	38	22	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137242	10.1371/journal.pone.0137242	http://dx.doi.org/10.1371/journal.pone.0137242			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348329	gold, Green Published, Green Submitted			2022-12-26	WOS:000360897600028
J	Shao, YZ; Wei, R; Zhang, XC; Xiang, QP				Shao, Yizhen; Wei, Ran; Zhang, Xianchun; Xiang, Qiaoping			Molecular Phylogeny of the Cliff Ferns (Woodsiaceae: Polypodiales) with a Proposed Infrageneric Classification	PLOS ONE			English	Article							EUPOLYPOD II FERNS; RBCL NUCLEOTIDE-SEQUENCES; F REGION SEQUENCES; GENE-SEQUENCES; ATHYRIACEAE; INFERENCE; INSIGHTS; MRBAYES	The cliff fern family Woodsiaceae has experienced frequent taxonomic changes at the familial and generic ranks since its establishment. The bulk of its species were placed in Woodsia, while Cheilanthopsis, Hymenocystis, Physematium, and Protowoodsia are segregates recognized by some authors. Phylogenetic relationships among the genera of Woodsiaceae remain unclear because of the extreme morphological diversity and inadequate taxon sampling in phylogenetic studies to date. In this study, we carry out comprehensive phylogenetic analyses of Woodsiaceae using molecular evidence from four chloroplast DNA markers (atpA, matK, rbcL and trnL-F) and covering over half the currently recognized species. Our results show three main clades in Woodsiaceae corresponding to Physematium (clade I), Cheilanthopsis-Protowoodsia (clade II) and Woodsia s.s. (clade III). In the interest of preserving monophyly and taxonomic stability, a broadly defined Woodsia including the other segregates is proposed, which is characterized by the distinctive indument and inferior indusia. Therefore, we present a new subgeneric classification of the redefined Woodsia based on phylogenetic and ancestral state reconstructions to better reflect the morphological variation, geographic distribution pattern, and evolutionary history of the genus. Our analyses of the cytological character evolution support multiple aneuploidy events that have resulted in the reduction of chromosome base number from 41 to 33, 37, 38, 39 and 40 during the evolutionary history of the cliff ferns.	[Shao, Yizhen; Wei, Ran; Zhang, Xianchun; Xiang, Qiaoping] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China; [Shao, Yizhen] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xiang, QP (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China.	qpxiang@ibcas.ac.cn	WEI, RAN/M-1994-2018	WEI, RAN/0000-0001-7393-9965; Xiang, Qiao-Ping/0000-0003-3028-7244	National Natural Science Foundation of China [31370260, 31170199]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant Nos. 31370260, 31170199).	ALSTON A. H. G., 1956, TAXON, V5, P23, DOI 10.2307/1216940; Brown DFM, 1964, NOVA HEDWIGIA S, V16, P1; Brown R., 1810, PRODROMUS FLORAE NOV; CHING R. C., 1954, ACTA PHYTOTAXONOMICA, V3, P93; CHING RC, 1978, ACTA PHYTOTAX SINICA, V16, P1; Ching RC., 1940, SUNYATSENIA, V5, P1; Christenhusz MJM, 2011, PHYTOTAXA, V19, P7, DOI 10.11646/phytotaxa.19.1.2; Christensen C., 1938, MANUAL PTERIDOLOGY, P522, DOI [10.1007/978-94-017-6111-6_20, DOI 10.1007/978-94-017-6111-6_20]; Copeland EB, 1947, GENERA FILICUM; Fiz-Palacios O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-341; Flora of North America Editorial Committee, 1993, FLORA N AM N MEXICO, V2, P270; Hall T.A., 1999, BIOEDIT USER FRIENDL; HASEBE M, 1994, P NATL ACAD SCI USA, V91, P5730, DOI 10.1073/pnas.91.12.5730; Hasebe M, 1995, AM FERN J, V85, P134, DOI 10.2307/1547807; Hieronymus G., 1920, NOTIZBLATT BOT GARTE, V7, P406, DOI [10.2307/3994377, DOI 10.2307/3994377]; HOLTTUM RE, 1949, BIOL REV, V24, P267, DOI 10.1111/j.1469-185X.1949.tb00577.x; Hooker W. J., 1846, SPECIES FILICUM, V1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Kaulfuss GF, 1829, FLORA, V12, P341; KRAMER KU, 1990, PTERIDOPHYTES GYMNOS, P130; Kuo LY, 2011, MOL PHYLOGENET EVOL, V59, P556, DOI 10.1016/j.ympev.2011.03.010; Kurita S., 1965, J JAP BOT, V40, P358; Larsson A., 2014, THESIS; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Lovis JD, 1977, ADV BOT RES, V4, P229, DOI DOI 10.1016/S0065-2296(08)60371-7; Ma YL, 1983, THESIS CAS BEIJING; Maddison WP, 2011, MESQUITE MODULAR SYS; Manton I., 1950, PROBLEMS CYTOLOGY EV; MasonGamer RJ, 1996, SYST BIOL, V45, P524, DOI 10.1093/sysbio/45.4.524; Mickel J, 2004, PTERIDOPHYTES MEXI 1, P686; Murakami N, 1999, AM FERN J, V89, P232, DOI 10.2307/1547233; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2009, TRACER V1 5; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rothfels CJ, 2012, TAXON, V61, P515, DOI 10.1002/tax.613003; Rothfels CJ, 2012, SYST BIOL, V61, P490, DOI 10.1093/sysbio/sys001; Sano R, 2000, MOL PHYLOGENET EVOL, V15, P403, DOI 10.1006/mpev.1999.0708; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; Schuettpelz E, 2007, TAXON, V56, P1037, DOI 10.2307/25065903; Shmakov AI, 2003, PTERIDOLOGY IN THE NEW MILLENNIUM, P49; Smith AR, 2006, TAXON, V55, P705, DOI 10.2307/25065646; Smith AR, 2008, BIOLOGY AND EVOLUTION OF FERNS AND LYCOPHYTES, P417, DOI 10.1017/CBO9780511541827.017; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stolze RG, 1994, FLORA ECUADOR, V49, P101; Sundue MA, 2014, ANN BOT-LONDON, V113, P35, DOI 10.1093/aob/mct247; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tagawa M, 1972, COLOURED ILLUSTRATIO; Tagawa M, 1937, ACTA PHYTOTAXONOMICA, V6, P251; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tryon R. M., 1982, FERNS ALLIED PLANTS; Wang L, 2010, MOL PHYLOGENET EVOL, V54, P211, DOI 10.1016/j.ympev.2009.08.032; Wang Ma-Li, 2008, Bulletin of Botanical Research, V28, P175; Wang ML, 2002, ACTA PHYTOTAXON SIN, V41, P416; WEI R, 2010, ACTA BOT YUNNAN, V17, P46; Wei R, 2013, TAXON, V62, P441, DOI 10.12705/623.8; Whitfield JB, 2007, TRENDS ECOL EVOL, V22, P258, DOI 10.1016/j.tree.2007.01.012; Wu SH, 1999, FLORA REIPUBLICAE PO, V4, P166; WU SK, 1991, FERN FAMILIES GENERA; Zhang GM, 2013, FLORA CHINA, V2-3, P397	61	7	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136318	10.1371/journal.pone.0136318	http://dx.doi.org/10.1371/journal.pone.0136318			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348852	Green Published, gold, Green Submitted			2022-12-26	WOS:000360897600005
J	Strube-Bloss, MF; Brown, A; Spaethe, J; Schmitt, T; Rossler, W				Strube-Bloss, Martin F.; Brown, Austin; Spaethe, Johannes; Schmitt, Thomas; Roessler, Wolfgang			Extracting the Behaviorally Relevant Stimulus: Unique Neural Representation of Farnesol, a Component of the Recruitment Pheromone of Bombus terrestris	PLOS ONE			English	Article							OLFACTORY OUTPUT NEURONS; ANTENNAL LOBE; MORPHOLOGICAL CHARACTERIZATION; ACQUISITION MEMORY; FLORAL SCENTS; HONEY-BEE; DROSOPHILA; ODOR; RESPONSES; ORGANIZATION	To trigger innate behavior, sensory neural networks are pre-tuned to extract biologically relevant stimuli. Many male-female or insect-plant interactions depend on this phenomenon. Especially communication among individuals within social groups depends on innate behaviors. One example is the efficient recruitment of nest mates by successful bumblebee foragers. Returning foragers release a recruitment pheromone in the nest while they perform a 'dance' behavior to activate unemployed nest mates. A major component of this pheromone is the sesquiterpenoid farnesol. How farnesol is processed and perceived by the olfactory system, has not yet been identified. It is much likely that processing farnesol involves an innate mechanism for the extraction of relevant information to trigger a fast and reliable behavioral response. To test this hypothesis, we used population response analyses of 100 antennal lobe (AL) neurons recorded in alive bumblebee workers under repeated stimulation with four behaviorally different, but chemically related odorants (geraniol, citronellol, citronellal and farnesol). The analysis identified a unique neural representation of the recruitment pheromone component compared to the other odorants that are predominantly emitted by flowers. The farnesol induced population activity in the AL allowed a reliable separation of farnesol from all other chemically related odor stimuli we tested. We conclude that the farnesol induced population activity may reflect a predetermined representation within the AL-neural network allowing efficient and fast extraction of a behaviorally relevant stimulus. Furthermore, the results show that population response analyses of multiple single AL-units may provide a powerful tool to identify distinct representations of behaviorally relevant odors.	[Strube-Bloss, Martin F.; Spaethe, Johannes; Schmitt, Thomas; Roessler, Wolfgang] Univ Wurzburg, Dept Behav Physiol & Sociobiol, Theodor Boveri Inst Biosci, Bioctr, D-97074 Wurzburg, Germany; [Brown, Austin] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	University of Wurzburg; University of Arizona	Strube-Bloss, MF (corresponding author), Univ Wurzburg, Dept Behav Physiol & Sociobiol, Theodor Boveri Inst Biosci, Bioctr, Hubland, D-97074 Wurzburg, Germany.	martin.strube-bloss@uni-wuerzburg.de	Spaethe, Johannes/B-8826-2014; Rössler, Wolfgang/E-9526-2019	Rössler, Wolfgang/0000-0002-5195-8214; Strube-Bloss, Martin Fritz/0000-0001-8264-7534; Spaethe, Johannes/0000-0002-0734-2869	University of Arizona [HHMI 52001427]; DFG [SPP 1392, RO 1177/5-2]; German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg; German Research Foundation; University of Wurzburg	University of Arizona; DFG(German Research Foundation (DFG)); German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg; German Research Foundation(German Research Foundation (DFG)); University of Wurzburg	Austin Brown was funded by the HHMI 52001427 through the BRAVO! program of the University of Arizona. Further support was provided by the DFG Priority Program SPP 1392 "Integrative Analysis of Olfaction" (RO 1177/5-2 to WR). Martin Strube-Bloss was supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg. This publication was funded by the German Research Foundation and the University of Wurzburg in the funding program Open Access Publishing.	Abel R, 2001, J COMP NEUROL, V437, P363, DOI 10.1002/cne.1289; Acebes A, 2001, J NEUROSCI, V21, P6264, DOI 10.1523/JNEUROSCI.21-16-06264.2001; Ayasse M, 2014, ANNU REV ENTOMOL, V59, P299, DOI 10.1146/annurev-ento-011613-161949; Bergman P, 1997, J CHEM ECOL, V23, P1235, DOI 10.1023/B:JOEC.0000006461.69512.33; Beyaert I, 2010, ANIM BEHAV, V79, P1077, DOI 10.1016/j.anbehav.2010.02.001; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Brill MF, 2014, JOVE-J VIS EXP, DOI 10.3791/51750; Carcaud J, 2015, J NEUROSCI, V35, P4157, DOI 10.1523/JNEUROSCI.0734-14.2015; Chaffiol A, 2014, CHEM SENSES, V39, P451, DOI 10.1093/chemse/bju017; CHRISTENSEN TA, 1987, J COMP PHYSIOL A, V160, P553, DOI 10.1007/BF00611929; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Dani FR, 2005, CHEM SENSES, V30, P477, DOI 10.1093/chemse/bji040; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Deisig N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033159; Dornhaus A, 2003, J COMP PHYSIOL A, V189, P47, DOI 10.1007/s00359-002-0374-y; Dornhaus A, 2001, BEHAV ECOL SOCIOBIOL, V50, P570, DOI 10.1007/s002650100395; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; FONTA C, 1984, J CHEM ECOL, V10, P1157, DOI 10.1007/BF00988546; FREE JB, 1981, PHYSIOL ENTOMOL, V6, P263, DOI 10.1111/j.1365-3032.1981.tb00270.x; Friedrich RW, 2004, J NEUROPHYSIOL, V91, P2658, DOI 10.1152/jn.01143.2003; Galizia CG, 2010, ANNU REV ENTOMOL, V55, P399, DOI 10.1146/annurev-ento-112408-085442; Galizia CG, 2004, J COMP PHYSIOL A, V190, P21, DOI 10.1007/s00359-003-0469-0; Grabe V, 2015, J COMP NEUROL, V523, P530, DOI 10.1002/cne.23697; Granero AM, 2005, NATURWISSENSCHAFTEN, V92, P371, DOI 10.1007/s00114-005-0002-0; HANSSON BS, 1991, J COMP NEUROL, V312, P264, DOI 10.1002/cne.903120209; Heinbockel T, 2013, J COMP PHYSIOL A, V199, P929, DOI 10.1007/s00359-013-0842-6; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hong EJ, 2015, NEURON, V85, P573, DOI 10.1016/j.neuron.2014.12.040; Hussaini SA, 2009, LEARN MEMORY, V16, P698, DOI 10.1101/lm.1578409; Ito K, 2014, NEURON, V81, P755, DOI 10.1016/j.neuron.2013.12.017; Junker RR, 2010, PLANT SIGNAL BEHAV, V5, P1014, DOI 10.4161/psb.5.8.12289; Junker RR, 2010, ANN BOT-LONDON, V105, P777, DOI 10.1093/aob/mcq045; Kirschner S, 2006, J COMP NEUROL, V499, P933, DOI 10.1002/cne.21158; Kleineidam CJ, 2005, CHEM SENSES, V30, P383, DOI 10.1093/chemse/bji033; Knaden M, 2012, CELL REPORTS, V1, P392, DOI 10.1016/j.celrep.2012.03.002; KNUDSEN JT, 1993, PHYTOCHEMISTRY, V33, P253, DOI 10.1016/0031-9422(93)85502-I; Krofczik S, 2009, FRONT COMPUT NEUROSC, V2, DOI 10.3389/neuro.10.009.2008; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Laissue PP, 1999, J COMP NEUROL, V405, P543; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; McCormick AC, 2014, PLANT CELL ENVIRON, V37, P1909, DOI 10.1111/pce.12287; Meier R, 2008, NEURAL NETWORKS, V21, P1085, DOI 10.1016/j.neunet.2008.06.019; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; Muller D, 2002, J COMP PHYSIOL A, V188, P359, DOI 10.1007/s00359-002-0310-1; Namiki S, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.001.2008; Nawrot M, 1999, J NEUROSCI METH, V94, P81, DOI 10.1016/S0165-0270(99)00127-2; Okada R, 2007, J NEUROSCI, V27, P11736, DOI 10.1523/JNEUROSCI.2216-07.2007; Pamir E, 2011, LEARN MEMORY, V18, P733, DOI 10.1101/lm.2232711; Pregitzer P, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00042; Rossler W, 2011, ARTHROPOD STRUCT DEV, V40, P349, DOI 10.1016/j.asd.2010.12.001; Ronderos DS, 2014, J NEUROSCI, V34, P3959, DOI 10.1523/JNEUROSCI.4582-13.2014; ROSPARS JP, 1992, CELL TISSUE RES, V270, P205, DOI 10.1007/BF00328007; Roussel E, 2014, CURR BIOL, V24, P561, DOI 10.1016/j.cub.2014.01.063; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Schiestl FP, 2010, ECOL LETT, V13, P643, DOI 10.1111/j.1461-0248.2010.01451.x; Schiestl FP, 2000, BEHAV ECOL SOCIOBIOL, V48, P303, DOI 10.1007/s002650000241; Seki Y, 2010, J NEUROPHYSIOL, V104, P1007, DOI 10.1152/jn.00249.2010; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; Silbering AF, 2008, J NEUROSCI, V28, P13075, DOI 10.1523/JNEUROSCI.2973-08.2008; Sommerlandt FMJ, 2014, APIDOLOGIE, V45, P106, DOI 10.1007/s13592-013-0227-4; Stollhoff N, 2005, J NEUROSCI, V25, P4485, DOI 10.1523/JNEUROSCI.0117-05.2005; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Strube-Bloss MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050322; Strube-Bloss MF, 2011, J NEUROSCI, V31, P3129, DOI 10.1523/JNEUROSCI.2583-10.2011; Tabor R, 2004, J NEUROSCI, V24, P6611, DOI 10.1523/JNEUROSCI.1834-04.2004; Thai L, 1999, P NATL ACAD SCI USA, V96, P13080, DOI 10.1073/pnas.96.23.13080; Tinbergen, 1951, STUDY INSTINCT; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wyatt TD, 2014, PHEROMONES AND ANIMAL BEHAVIOR: CHEMICAL SIGNALS AND SIGNATURES, 2ND EDITION, P1; Zube C, 2008, J COMP NEUROL, V506, P425, DOI 10.1002/cne.21548	77	9	9	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137413	10.1371/journal.pone.0137413	http://dx.doi.org/10.1371/journal.pone.0137413			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340263	Green Published, gold, Green Submitted			2022-12-26	WOS:000360688200055
J	Yang, L; Ma, YM; Han, WX; Li, WW; Cui, L; Zhao, XH; Tian, YT; Zhou, ZX; Wang, WG; Wang, HY				Yang, Lan; Ma, Yiming; Han, Wenxiao; Li, Weiwei; Cui, Liang; Zhao, Xinhua; Tian, Yantao; Zhou, Zhixiang; Wang, Wengong; Wang, Hongying			Proteinase-activated Receptor 2 Promotes Cancer Cell Migration through RNA Methylation-mediated Repression of miR-125b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CANCER; BREAST-CANCER; MESSENGER-RNA; EXPRESSION; PROLIFERATION; METASTASIS; INVASION; TRYPSIN; TUMOR; PROTEASE-ACTIVATED-RECEPTOR-1	Proteinase activated-receptor 2 (PAR(2)) participates in cancer metastasis promoted by serine proteinases. The current study aimed to test the molecular mechanism by which PAR(2) promotes cancer cell migration. In different cancer cells, activation of PAR(2) by activating peptide (PAR(2)-AP) dramatically increased cell migration, whereas knock down of PAR(2) inhibited cellular motility. The PAR(2) activation also repressed miR-125b expression while miR-125b mimic successfully blocked PAR(2)-induced cell migration. Moreover, Grb associated-binding protein 2 (Gab2) was identified as a novel target gene of miR-125b and it mediated PAR(2)-induced cell migration. The correlation of PAR(2) with miR-125b and Gab2 was further supported by the findings obtained from human colorectal carcinoma specimens. Remarkably, knock down of NOP2/Sun domain family, member 2 (NSun2), a RNA methyltransferase, blocked the reduction in miR-125b induced by PAR(2). Furthermore, PAR(2) activation increased the level of N-6-methyladenosine (m(6)A)-containing pre-miR-125b in NSun2-dependent manner. Taken together, our results demonstrated that miR-125b mediates PAR(2)-induced cancer cell migration by targeting Gab2 and that NSun2-dependent RNA methylation contributes to the down-regulation of miR-125b by PAR(2) signaling. These findings suggest a novel epigenetic mechanism by which microenvironment regulates cancer cell migration by altering miRNA expression.	[Yang, Lan; Ma, Yiming; Han, Wenxiao; Li, Weiwei; Zhao, Xinhua; Wang, Hongying] Chinese Acad Med Sci, State Key Lab Mol Oncol, Inst Canc, Canc Hosp,Peking Union Med Coll, Beijing 100021, Peoples R China; [Cui, Liang; Tian, Yantao] Chinese Acad Med Sci, Dept Abdominal Surg Oncol, Inst Canc, Canc Hosp,Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhou, Zhixiang] Chinese Acad Med Sci, Dept Gastrointestinal Surg Oncol, Inst Canc, Canc Hosp,Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Wengong] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Peking University	Wang, HY (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Oncol, Inst Canc, Canc Hosp,Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China.	hongyingwang@cicams.ac.cn		Li, Weiwei/0000-0002-8298-2719; Wang, Hongying/0000-0001-8443-3839	973 National Key Fundamental Research Program of China [2012CB967003]; National Nature Science Foundation of China [81172034, 91129717]	973 National Key Fundamental Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funding from the 973 National Key Fundamental Research Program of China (2012CB967003) and the National Nature Science Foundation of China (81172034 and 91129717). The authors declare that they have no conflicts of interest with the contents of this article.	Amir S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061064; Bera A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106343; Black PC, 2007, PROSTATE, V67, P743, DOI 10.1002/pros.20503; Blanco S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002403; Caruso R, 2006, AM J PATHOL, V169, P268, DOI 10.2353/ajpath.2006.050841; Darmoul D, 2004, J BIOL CHEM, V279, P20927, DOI 10.1074/jbc.M401430200; Dorn J, 2011, ANN ONCOL, V22, P877, DOI 10.1093/annonc/mdq462; Frye M, 2006, CURR BIOL, V16, P971, DOI 10.1016/j.cub.2006.04.027; Gieseler F, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-86; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Guan Y, 2011, INT J CANCER, V128, P2274, DOI 10.1002/ijc.25575; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hu LC, 2013, TUMOR BIOL, V34, P2573, DOI 10.1007/s13277-013-0803-2; Huang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033762; Ji LJ, 2012, CELL RES, V22, P624, DOI 10.1038/cr.2012.36; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Li YY, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-33; Liang LH, 2010, HEPATOLOGY, V52, P1731, DOI 10.1002/hep.23904; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072383; Massi D, 2005, HUM PATHOL, V36, P676, DOI 10.1016/j.humpath.2005.04.008; Matsumura T, 2014, ANN SURG ONCOL, V21, pS743, DOI 10.1245/s10434-014-3889-x; Melillo RM, 2010, ONCOGENE, V29, P6203, DOI 10.1038/onc.2010.348; Nishibori M, 2005, J PHARMACOL SCI, V97, P25, DOI 10.1254/jphs.FMJ04005X5; Nishida N, 2011, INT J ONCOL, V38, P1437, DOI 10.3892/ijo.2011.969; Ohta T, 2003, INT J ONCOL, V23, P61; Saetrom P, 2009, CANCER RES, V69, P7459, DOI 10.1158/0008-5472.CAN-09-1201; Sanchez-Hernandez PE, 2008, GYNECOL ONCOL, V108, P19, DOI 10.1016/j.ygyno.2007.08.083; Schaffner F, 2012, THROMB RES, V129, pS127, DOI 10.1016/S0049-3848(12)70032-4; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Soreide K, 2006, J PATHOL, V209, P147, DOI 10.1002/path.1999; Su S, 2009, ONCOGENE, V28, P3047, DOI 10.1038/onc.2009.163; Tsai KW, 2009, EPIGENETICS-US, V4, P587, DOI 10.4161/epi.4.8.10230; Uusitalo-Jarvinen H, 2007, ARTERIOSCL THROM VAS, V27, P1456, DOI 10.1161/ATVBAHA.107.142539; Versteeg HH, 2008, CANCER RES, V68, P7219, DOI 10.1158/0008-5472.CAN-08-0419; Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048; Wang H, 2008, J BIOL CHEM, V283, P809, DOI 10.1074/jbc.M703021200; Wilson SR, 2004, PROSTATE, V60, P168, DOI 10.1002/pros.20047; Wohrle FU, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-22; Yada K, 2005, J SURG ONCOL, V89, P79, DOI 10.1002/jso.20197; Yang RX, 2011, BREAST CANCER RES TR, V127, P549, DOI 10.1007/s10549-010-1244-x; Yang S, 2013, ONCOGENE, V32, P4294, DOI 10.1038/onc.2012.432; Yuan S, 2014, MOL CELL BIOL, V34, P3630, DOI 10.1128/MCB.00243-14; Zhang XT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1692; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007	46	44	47	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26627	26637		10.1074/jbc.M115.667717	http://dx.doi.org/10.1074/jbc.M115.667717			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26354435	hybrid, Green Published			2022-12-26	WOS:000364793600028
J	Rifatbegovic, F; Abbasi, MR; Taschner-Mandl, S; Kauer, M; Weinhausel, A; Handgretinger, R; Ambros, PF				Rifatbegovic, Fikret; Abbasi, M. Reza; Taschner-Mandl, Sabine; Kauer, Maximilian; Weinhaeusel, Andreas; Handgretinger, Rupert; Ambros, Peter F.			Enriched Bone Marrow Derived Disseminated Neuroblastoma Cells Can Be a Reliable Source for Gene Expression Studies-A Validation Study	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; RISK STRATIFICATION; MESSENGER-RNA; TUMOR-CELLS; IMPACT; TISSUE; CLASSIFICATION; SIGNATURE; BLOOD; BIOBANKING	Background Metastases in the bone marrow (BM) in form of disseminated tumor cells (DTCs) are frequent events at diagnosis and also at relapse in high-risk neuroblastoma patients. The frequently highly diluted occurrence of DTCs requires adequate enrichment strategies to enable their detailed characterization. However, to avoid methodical artifacts we tested whether pre-analytical processing steps-including transport duration, temperature and, importantly, tumor cell enrichment techniques-are confounding factors for gene expression analysis in DTCs. Methods LAN-1 neuroblastoma cells were spiked into tumor free BM and/or peripheral blood and: i) kept at room temperature or at 4 degrees C for 24, 48 and 72 hours; ii) frozen down at -80 degrees C and thawed; iii) enriched via magnetic beads. The effect on the gene expression signature of LAN-1 cells was analyzed by qPCR arrays and gene expression microarrays. Results Neither storage at -80 degrees C in DMSO and subsequent thawing nor enrichment of spiked-in neuroblastoma cells changed the expression of the analyzed genes significantly. Whereas storage at 4 degrees C altered the expression of analyzed genes (14.3%) only at the 72h-timepoint in comparison to the 0h-timepoint, storage at room temperature had a much more profound effect on gene expression by affecting 20% at 24h, 26% at 48h and 43% at 72h of the analyzed genes. Conclusion Using neuroblastoma as a model, we show that tumor cell enrichment by magnetic bead separation has virtually no effect on gene expression in DTCs. However, transport time and temperature can influence the expression profile remarkably. Thus, the expression profile of routinely collected BM samples can be analyzed without concern as long as the transport conditions are monitored.	[Rifatbegovic, Fikret; Abbasi, M. Reza; Taschner-Mandl, Sabine; Kauer, Maximilian; Ambros, Peter F.] St Anna Kinderkrebsforsch, Childrens Canc Res Inst, Vienna, Austria; [Weinhaeusel, Andreas] AIT Austrian Inst Technol GmbH, Mol Diagnost Hlth & Environm Dept, Vienna, Austria; [Handgretinger, Rupert] Univ Tubingen, Childrens Univ Hosp, Tubingen, Germany; [Ambros, Peter F.] Med Univ Vienna, Dept Pediat, Vienna, Austria	Saint Anna Children's Hospital; Austrian Institute of Technology (AIT); Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; Medical University of Vienna	Rifatbegovic, F (corresponding author), St Anna Kinderkrebsforsch, Childrens Canc Res Inst, Vienna, Austria.	fikret.rifatbegovic@ccri.at; peter.ambros@ccri.at	Weinhaeusel, Andreas/A-7644-2018; Ambros, Peter/AAA-1266-2021	Ambros, Peter/0000-0002-5507-7211; Taschner-Mandl, Sabine/0000-0002-1439-5301; Weinhaeusel, Andreas/0000-0002-9318-1204	St. Anna Kinderkrebsforschung (Vienna, Austria); European Union's Seventh Framework Program (FP7) under the project ENCCA [HEALTH-F2-2011-261474]	St. Anna Kinderkrebsforschung (Vienna, Austria); European Union's Seventh Framework Program (FP7) under the project ENCCA	The research leading to these results has received funding from: St. Anna Kinderkrebsforschung (Vienna, Austria) and the European Union's Seventh Framework Program (FP7/2007-2013) under the project ENCCA, grant agreement HEALTH-F2-2011-261474.	Abbasi RM, 2014, MOL ONCOLOGY, DOI [http://dx.doi.org/10.1016/j.molonc.2014.10.010, DOI 10.1016/J.M0L0NC.2014.10.010]; Ambros IM, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00202; Ambros PF, 2003, CANCER LETT, V197, P29, DOI 10.1016/S0304-3835(03)00078-8; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Asgharzadeh S, 2006, JNCI-J NATL CANCER I, V98, P1193, DOI 10.1093/jnci/djj330; Asgharzadeh S, 2012, J CLIN ONCOL, V30, P3525, DOI 10.1200/JCO.2011.40.9169; Bao WG, 2013, ANN SURG ONCOL, V20, P1737, DOI 10.1245/s10434-012-2440-1; Barnes RO, 2008, CANCER EPIDEM BIOMAR, V17, P3344, DOI 10.1158/1055-9965.EPI-08-0622; Becker J, 2010, CLIN CANCER RES, V16, P1431, DOI 10.1158/1078-0432.CCR-09-1936; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benoy IH, 2006, CLIN CHEM LAB MED, V44, P1082, DOI 10.1515/CCLM.2006.210; Bray SE, 2010, HISTOPATHOLOGY, V56, P240, DOI 10.1111/j.1365-2559.2009.03470.x; Breit S, 2004, BRIT J HAEMATOL, V126, P231, DOI 10.1111/j.1365-2141.2004.05017.x; Brodeur GM, 2014, NAT REV CLIN ONCOL, V11, P704, DOI 10.1038/nrclinonc.2014.168; Cueille N, 2007, J PROTEOME RES, V6, P2640, DOI 10.1021/pr070081z; De Cecco L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-409; De Preter K, 2011, CLIN CANCER RES, V17, P7684, DOI 10.1158/1078-0432.CCR-11-0610; Eggert A, 2000, CLIN CANCER RES, V6, P1900; Fardin P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-185; Fischer M, 2006, CLIN CANCER RES, V12, P5118, DOI 10.1158/1078-0432.CCR-06-0985; Garcia I, 2012, CLIN CANCER RES, V18, P2012, DOI 10.1158/1078-0432.CCR-11-2483; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glas AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-278; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Halsall A, 2008, INT J EPIDEMIOL, V37, P7, DOI 10.1093/ije/dym278; Hong Sang Hyun, 2010, J Korean Soc Coloproctol, V26, P316, DOI 10.3393/jksc.2010.26.5.316; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Lee SY, 2008, FEBS LETT, V582, P2826, DOI 10.1016/j.febslet.2008.07.021; Letzkus M, 2014, CLIN TRANSL MED, V3, DOI 10.1186/s40169-014-0036-z; Li MC, 2011, J ALLERGY CLIN IMMUN, V128, P626, DOI 10.1016/j.jaci.2011.04.032; Luchetti F, 2003, HISTOL HISTOPATHOL, V18, P1041, DOI 10.14670/HH-18.1041; Lyons PA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-64; Ma Y, 2012, ANAL BIOCHEM, V423, P229, DOI 10.1016/j.ab.2012.02.003; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Micke P, 2006, LAB INVEST, V86, P202, DOI 10.1038/labinvest.3700372; Moos PJ, 2002, CLIN CANCER RES, V8, P3118; Morandi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029922; Mosse YP, 2007, GENE CHROMOSOME CANC, V46, P936, DOI 10.1002/gcc.20477; Musella V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053406; Oberthuer A, 2010, J CLIN ONCOL, V28, P3506, DOI 10.1200/JCO.2009.27.3367; Pantel Klaus, 2014, Bonekey Rep, V3, P584, DOI 10.1038/bonekey.2014.79; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Sampaio-Silva F, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056507, 10.1371/annotation/cb8b37ac-cbe2-45e3-b9fe-d62e7ced4b25]; Schlomm T, 2008, EUR UROL, V53, P333, DOI 10.1016/j.eururo.2007.03.075; Seeger RC, 2000, J CLIN ONCOL, V18, P4067, DOI 10.1200/JCO.2000.18.24.4067; Segerstrom L, 2006, PEDIATR RES, V60, P576, DOI 10.1203/01.pdr.0000242494.94000.52; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Spruessel A, 2004, BIOTECHNIQUES, V36, P1030, DOI 10.2144/04366RR04; Steinberg KK, 1997, EPIDEMIOL REV, V19, P156, DOI 10.1093/oxfordjournals.epirev.a017938; TUCKER RP, 1989, NEURON, V2, P1245, DOI 10.1016/0896-6273(89)90309-7; Valentijn LJ, 2012, P NATL ACAD SCI USA, V109, P19190, DOI 10.1073/pnas.1208215109; van Maldegem F, 2008, DIAGN MOL PATHOL, V17, P51, DOI 10.1097/PDM.0b013e31814b8866; Vermeulen J, 2009, LANCET ONCOL, V10, P663, DOI 10.1016/S1470-2045(09)70154-8; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zeng Y, 2005, MOL IMMUNOL, V42, P1311, DOI 10.1016/j.molimm.2004.12.018	56	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137995	10.1371/journal.pone.0137995	http://dx.doi.org/10.1371/journal.pone.0137995			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360775	Green Submitted, gold, Green Published			2022-12-26	WOS:000361043100105
J	Song, YJ; Li, GL; He, JH; Guo, Y; Yang, L				Song, Yi-Jiang; Li, Guiling; He, Jian-Hua; Guo, Yao; Yang, Li			Bioinformatics-Based Identification of MicroRNA-Regulated and Rheumatoid Arthritis-Associated Genes	PLOS ONE			English	Article							FIBROBLAST ACTIVATION PROTEIN; BLOOD MONONUCLEAR-CELLS; SYNOVIAL FIBROBLASTS; EXPRESSION ANALYSIS; DNA METHYLATION; ALTERED EXPRESSION; ROR2 EXPRESSION; UP-REGULATION; INFLAMMATION; PATHWAY	MicroRNAs (miRNAs) act as epigenetic markers and regulate the expression of their target genes, including those characterized as regulators in autoimmune diseases. Rheumatoid arthritis (RA) is one of the most common autoimmune diseases. The potential roles of miRNA-regulated genes in RA pathogenesis have greatly aroused the interest of clinicians and researchers in recent years. In the current study, RA-related miRNAs records were obtained from PubMed through conditional literature retrieval. After analyzing the selected records, miRNA targeted genes were predicted. We identified 14 RA-associated miRNAs, and their sub-analysis in 5 microarray or RNA sequencing (RNA-seq) datasets was performed. The microarray and RNA-seq data of RA were also downloaded from NCBI Gene Expression Omnibus (GEO) and Sequence Read Archive (SRA), analyzed, and annotated. Using a bioinformatics approach, we identified a series of differentially expressed genes (DEGs) by comparing studies on RA and the controls. The RA-related gene expression profile was thus obtained and the expression of miRNA-regulated genes was analyzed. After functional annotation analysis, we found GO molecular function (MF) terms significantly enriched in calcium ion binding (GO: 0005509). Moreover, some novel dysregulated target genes were identified in RA through integrated analysis of miRNA/mRNA expression. The result revealed that the expression of a number of genes, including ROR2, ABI3BP, SMOC2, etc., was not only affected by dysregulated miRNAs, but also altered in RA. Our findings indicate that there is a close association between negatively correlated mRNA/miRNA pairs and RA. These findings may be applied to identify genetic markers for RA diagnosis and treatment in the future.	[Song, Yi-Jiang; He, Jian-Hua; Guo, Yao; Yang, Li] Chongqing Univ, Key Lab Biorheol Sci & Technol, Minist Educ, Bioengn Coll, Chongqing 630044, Peoples R China; [Li, Guiling] Wenzhou Med Univ, Inst Genom Med, Wenzhou, Zhejiang, Peoples R China	Chongqing University; Wenzhou Medical University	Yang, L (corresponding author), Chongqing Univ, Key Lab Biorheol Sci & Technol, Minist Educ, Bioengn Coll, Chongqing 630044, Peoples R China.	yanglibme@cqu.edu.cn			National Innovation and Attracting Talents Project ("111" Project) [B06023]; National Natural Science Foundation of China [11032012, 10902130, 30870608, 31200976]	National Innovation and Attracting Talents Project ("111" Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Innovation and Attracting Talents Project ("111" Project) (B06023), National Natural Science Foundation of China (grant no. 11032012, 10902130, 30870608, 31200976).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ballestar E, 2011, NAT REV RHEUMATOL, V7, P264, DOI 10.1038/nrrheum.2011.16; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bauer S, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2080; Birlea SA, 2010, J INVEST DERMATOL, V130, P798, DOI 10.1038/jid.2009.347; Bolzoni M, 2013, LEUKEMIA, V27, P451, DOI 10.1038/leu.2012.190; Bottini N, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0372-9; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Burska AN, 2014, PHARMACOGENOMICS J, V14, P93, DOI 10.1038/tpj.2013.48; Ceribelli A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3377; Chatzikyriakidou A, 2012, AUTOIMMUN REV, V11, P636, DOI 10.1016/j.autrev.2011.11.004; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; CORVETTA A, 1991, J CHROMATOGR-BIOMED, V566, P481, DOI 10.1016/0378-4347(91)80265-E; de la Rica L, 2013, J AUTOIMMUN, V41, P6, DOI 10.1016/j.jaut.2012.12.005; Del Rey MJ, 2012, ANN RHEUM DIS, V71, P275, DOI 10.1136/annrheumdis-2011-200281; Del Rey MJ, 2010, ARTHRITIS RHEUM-US, V62, P3584, DOI 10.1002/art.27750; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Glant TT, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-35; Guo L, 2010, COMPUT BIOL CHEM, V34, P165, DOI 10.1016/j.compbiolchem.2010.06.001; Heruth DP, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-43; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Karouzakis E, 2009, ARTHRITIS RHEUM-US, V60, P3613, DOI 10.1002/art.25018; Karouzakis E, 2009, NAT REV RHEUMATOL, V5, P266, DOI 10.1038/nrrheum.2009.55; Katoh Y, 2005, INT J ONCOL, V27, P275; Kaur P, 2012, TUMOR BIOL, V33, P325, DOI 10.1007/s13277-012-0331-5; Khurana R, 2008, J RHEUMATOL, V35, P1704; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kimoto O, 2011, J RHEUMATOL, V38, P310, DOI 10.3899/jrheum.100486; Lai DM, 2012, INT J ONCOL, V41, P541, DOI 10.3892/ijo.2012.1475; Latini FRM, 2008, ENDOCR-RELAT CANCER, V15, P787, DOI 10.1677/ERC-08-0079; Lefevre S, 2009, NAT MED, V15, P1414, DOI 10.1038/nm.2050; Levy L, 2008, CLIN EXP RHEUMATOL, V26, P673; Levy MT, 1999, HEPATOLOGY, V29, P1768, DOI 10.1002/hep.510290631; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3006; Li XC, 2013, INT J MOL SCI, V14, P23910, DOI 10.3390/ijms141223910; Li YT, 2012, ARTHRITIS RHEUM-US, V64, P3240, DOI 10.1002/art.34550; Lin JP, 2014, ARTHRITIS RHEUMATOL, V66, P49, DOI 10.1002/art.38142; Long L, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/296139; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miao CG, 2013, CELL SIGNAL, V25, P2069, DOI 10.1016/j.cellsig.2013.04.002; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murata K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069118; Nakamachi Y, 2009, ARTHRITIS RHEUM-US, V60, P1294, DOI 10.1002/art.24475; Nakano K, 2013, ANN RHEUM DIS, V72, P110, DOI 10.1136/annrheumdis-2012-201526; Nakasa T, 2008, ARTHRITIS RHEUM-US, V58, P1284, DOI 10.1002/art.23429; Niederer F, 2012, ARTHRITIS RHEUM-US, V64, P1771, DOI 10.1002/art.34334; Ospelt C, 2010, ARTHRITIS RHEUM-US, V62, P1224, DOI 10.1002/art.27395; Pandis I, 2012, ANN RHEUM DIS, V71, P1716, DOI 10.1136/annrheumdis-2011-200803; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; PETTY RE, 1986, J RHEUMATOL, V13, P246; Philippe L, 2012, J IMMUNOL, V188, P454, DOI 10.4049/jimmunol.1102348; Pohlers D, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2217; Rasmussen NR, 2013, J BIOL CHEM, V288, P26301, DOI 10.1074/jbc.M113.466086; RICHARDSON B, 1990, ARTHRITIS RHEUM, V33, P1665, DOI 10.1002/art.1780331109; Rocnik EF, 2006, J BIOL CHEM, V281, P22855, DOI 10.1074/jbc.M513463200; Saito Y, 2014, CLIN REV ALLERG IMMU, V47, P128, DOI 10.1007/s12016-013-8401-z; Sanayama Y, 2014, ARTHRITIS RHEUMATOL, V66, P1421, DOI 10.1002/art.38400; Schena M, 1998, TRENDS BIOTECHNOL, V16, P301, DOI 10.1016/S0167-7799(98)01219-0; Schmidt TA, 2007, ARTHRITIS RHEUM-US, V56, P882, DOI 10.1002/art.22446; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Seki T, 1998, ARTHRITIS RHEUM-US, V41, P1356, DOI 10.1002/1529-0131(199808)41:8<1356::AID-ART4>3.0.CO;2-X; Semaan N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019827; Shibuya H, 2013, MOD RHEUMATOL, V23, P674, DOI 10.1007/s10165-012-0710-1; Singh RP, 2013, AUTOIMMUN REV, V12, P1160, DOI 10.1016/j.autrev.2013.07.003; Sonomoto K, 2012, ARTHRITIS RHEUM-US, V64, P3355, DOI 10.1002/art.34555; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Stanczyk J, 2011, ARTHRITIS RHEUM-US, V63, P373, DOI 10.1002/art.30115; Taylor PC, 2002, ARTHRITIS RES THER, V4, pS99, DOI 10.1186/ar582; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trenkmann M, 2013, ARTHRITIS RHEUM-US, V65, P916, DOI 10.1002/art.37834; Trenkmann M, 2011, ANN RHEUM DIS, V70, P1482, DOI 10.1136/ard.2010.143040; Turesson C, 2013, CURR OPIN RHEUMATOL, V25, P360, DOI 10.1097/BOR.0b013e32835f693f; Ungethuem U, 2010, PHYSIOL GENOMICS, V42A, P267, DOI 10.1152/physiolgenomics.00004.2010; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wang YH, 2010, INFLAMM RES, V59, P1009, DOI 10.1007/s00011-010-0217-1; Worthington J, 2005, J AUTOIMMUN, V25, P16, DOI 10.1016/j.jaut.2005.09.011; Wright H. L., 2014, RHEUMATOLOGY; Xu K, 2013, INFLAMM RES, V62, P229, DOI 10.1007/s00011-012-0572-1; You S, 2014, P NATL ACAD SCI USA, V111, P550, DOI 10.1073/pnas.1311239111; Young A, 2007, BEST PRACT RES CL RH, V21, P907, DOI 10.1016/j.berh.2007.05.007; Yuan DT, 2013, J SURG ONCOL, V108, P157, DOI 10.1002/jso.23368; Yuan FL, 2014, CELL BIOCHEM BIOPHYS, V70, P77, DOI 10.1007/s12013-014-9913-8; Zhang F, 2014, HUM GENET, V133, P793, DOI 10.1007/s00439-014-1418-4; Zhu S, 2012, NAT MED, V18, P1077, DOI 10.1038/nm.2815	91	22	23	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137551	10.1371/journal.pone.0137551	http://dx.doi.org/10.1371/journal.pone.0137551			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359667	Green Submitted, Green Published, gold			2022-12-26	WOS:000361043100051
J	Bach, CC; Henriksen, TB; Bossi, R; Bech, BH; Fuglsang, J; Olsen, J; Nohr, EA				Bach, Cathrine Carlsen; Henriksen, Tine Brink; Bossi, Rossana; Bech, Bodil Hammer; Fuglsang, Jens; Olsen, Jorn; Nohr, Ellen Aagaard			Perfluoroalkyl Acid Concentrations in Blood Samples Subjected to Transportation and Processing Delay	PLOS ONE			English	Article							NATIONAL BIRTH COHORT; PERFLUORINATED CHEMICALS; PERFLUOROOCTANOATE PFOA; PRENATAL EXPOSURES; FETAL-GROWTH; HUMAN SERUM; DURATION	Background In studies of perfluoroalkyl acids, the validity and comparability of measured concentrations may be affected by differences in the handling of biospecimens. We aimed to investigate whether measured plasma levels of perfluoroalkyl acids differed between blood samples subjected to delay and transportation prior to processing and samples with immediate processing and freezing. Methods Pregnant women recruited at Aarhus University Hospital, Denmark, (n = 88) provided paired blood samples. For each pair of samples, one was immediately processed and plasma was frozen, and the other was delayed and transported as whole blood before processing and freezing of plasma (similar to the Danish National Birth Cohort). We measured 12 perfluoroalkyl acids and present results for compounds with more than 50% of samples above the lower limit of quantification. Results For samples taken in the winter, relative differences between the paired samples ranged between -77 and +38% for individual perfluoroalkyl acids. In most cases concentrations were lower in the delayed and transported samples, e.g. the relative difference was -29% (95% confidence interval -30; -27) for perfluorooctane sulfonate. For perfluorooctanoate there was no difference between the two setups [corresponding estimate 1% (0, 3)]. Differences were negligible in the summer for all compounds. Conclusions Transport of blood samples and processing delay, similar to conditions applied in some large, population-based studies, may affect measured perfluoroalkyl acid concentrations, mainly when outdoor temperatures are low. Attention to processing conditions is needed in studies of perfluoroalkyl acid exposure in humans.	[Bach, Cathrine Carlsen; Henriksen, Tine Brink] Aarhus Univ Hosp, Perinatal Epidemiol Res Unit, DK-8000 Aarhus, Denmark; [Henriksen, Tine Brink] Aarhus Univ Hosp, Dept Pediat, DK-8000 Aarhus, Denmark; [Bossi, Rossana] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark; [Bech, Bodil Hammer; Olsen, Jorn] Aarhus Univ, Epidemiol Sect, Dept Publ Hlth, Aarhus, Denmark; [Fuglsang, Jens] Aarhus Univ Hosp, Dept Obstet & Gynecol, DK-8000 Aarhus, Denmark; [Olsen, Jorn] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Nohr, Ellen Aagaard] Univ Southern Denmark, Inst Clin Res, Res Unit Obstet & Gynecol, Odense, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; University of California System; University of California Los Angeles; University of Southern Denmark	Bach, CC (corresponding author), Aarhus Univ Hosp, Perinatal Epidemiol Res Unit, DK-8000 Aarhus, Denmark.	ccbach@clin.au.dk	Bech, Bodil Hammer/B-9646-2016; Fuglsang, Jens/AAJ-4724-2020	Bech, Bodil Hammer/0000-0002-0287-3687; Fuglsang, Jens/0000-0002-0181-1986; Henriksen, Tine Brink/0000-0001-6933-8294	Danish Council for Strategic Research [10-092818]	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	The work was supported by The Danish Council for Strategic Research (http://ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-strategic-research), grant number 10-092818, and is part of the Fetotox project (fetotox.au.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CS, 2013, AM J EPIDEMIOL, V178, P921, DOI 10.1093/aje/kwt057; Andersen CS, 2010, AM J EPIDEMIOL, V172, P1230, DOI 10.1093/aje/kwq289; Apelberg BJ, 2007, ENVIRON HEALTH PERSP, V115, P1670, DOI 10.1289/ehp.10334; Bach CC, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0040-9; Berger U, 2011, ANAL BIOANAL CHEM, V400, P1625, DOI 10.1007/s00216-011-4823-8; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Buck Robert C., 2011, Integrated Environmental Assessment and Management, V7, P513, DOI 10.1002/ieam.258; Butenhoff JL, 2006, ENVIRON HEALTH PERSP, V114, P1776, DOI 10.1289/ehp.9060; Ehresman DJ, 2007, ENVIRON RES, V103, P176, DOI 10.1016/j.envres.2006.06.008; Environment Canada, ENV PERF AGR AGR RES; European Parliament, 2006, OFFICIAL J EU   1227, V27; Fei CY, 2008, AM J EPIDEMIOL, V168, P66, DOI 10.1093/aje/kwn095; Fei CY, 2007, ENVIRON HEALTH PERSP, V115, P1677, DOI 10.1289/ehp.10506; Fei CY, 2010, SCAND J WORK ENV HEA, V36, P413, DOI 10.5271/sjweh.2908; Fei CY, 2009, HUM REPROD, V24, P1200, DOI 10.1093/humrep/den490; Flaherty JM, 2005, J CHROMATOGR B, V819, P329, DOI 10.1016/j.jchromb.2005.03.002; HELSEL DR, 1990, ENVIRON SCI TECHNOL, V24, P1766, DOI 10.1021/es00082a001; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Kantiani L, 2010, ANAL BIOANAL CHEM, V398, P2413, DOI 10.1007/s00216-010-3944-9; Kato K, 2013, CHEMOSPHERE, V91, P115, DOI 10.1016/j.chemosphere.2012.11.013; Keller JM, 2010, ANAL BIOANAL CHEM, V397, P439, DOI 10.1007/s00216-009-3222-x; Nilsson H, 2013, ENVIRON INT, V51, P8, DOI 10.1016/j.envint.2012.09.001; Olsen GW, 2007, ENVIRON HEALTH PERSP, V115, P1298, DOI 10.1289/ehp.10009; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Shoeib M, 2011, ENVIRON SCI TECHNOL, V45, P7999, DOI 10.1021/es103562v; Thomas L., 1998, CLIN LAB DIAGNOSTICS, V1; U.S. Environmental Protection Agency, 2010 2015 PFOA STEW; US EPA, EPA 3M ANN PHAS OUT; Wu KS, 2012, ENVIRON INT, V48, P1, DOI 10.1016/j.envint.2012.06.018	29	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137768	10.1371/journal.pone.0137768	http://dx.doi.org/10.1371/journal.pone.0137768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356420	Green Submitted, Green Published, gold			2022-12-26	WOS:000360965800080
J	Georgianos, PI; Agarwal, R				Georgianos, Panagiotis I.; Agarwal, Rajiv			Relative Importance of Aortic Stiffness and Volume as Predictors of Treatment-Induced Improvement in Left Ventricular Mass Index in Dialysis	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; STAGE RENAL-DISEASE; HEMODIALYSIS-PATIENTS; ARTERIAL STIFFNESS; HYPERTROPHY; HYPERTENSION; REDUCTION; IMPACT; REGRESSION; ATENOLOL	This study aimed to explore the relative contribution of aortic stiffness and volume in treatment- induced change of left ventricular mass in dialysis. Hypertension in Hemodialysis Patients Treated with Atenolol or Lisinopril trial compared the effect of lisinopril versus atenolol in reducing left ventricular mass index; 179 patients with echo measurements of aortic pulse wave velocity and left ventricular mass at baseline were included. In unadjusted analysis, overall reductions of 26.24 g/m(2) (95% CI: -49.20, -3.29) and 35.67 g/m(2) (95% CI: -63.70, -7.64) in left ventricular mass index were noted from baseline to 6 and 12 months respectively. Volume control emerged as an important determinant of regression of left ventricular mass index due to the following reasons: (i) additional control for change in ambulatory systolic blood pressure mitigated the reduction in left ventricular mass index in the statistical model above [6-month visit: -18.6 g/m(2) (95% CI: -43.7, 6.5); 12-month visit: -22.1 g/m(2) (95% CI: -52.2, 8.0)] (ii) regression of left ventricular hypertrophy was primarily due to reduction in left ventricular chamber and not wall thickness and (iii) adjustment for inferior vena cava diameter (as a proxy for volume) removed the effect of time on left ventricular mass index reduction [6-month visit: -6.6 g/m(2) (95% CI: (-41.6, 28.4); 12-month visit: 0.6 g/m(2) (95% CI: -39.5, 40.7)]. In contrast, aortic pulse wave velocity was neither a determinant of baseline left ventricular mass index nor predictor of its reduction. Among dialysis patients, ambulatory systolic pressure, a proxy for volume expansion, but not aortic stiffness is more important predictor of reduction in left ventricular mass index. Improving blood pressure control via adequate volume management appears as an effective strategy to improve left ventricular hypertrophy in dialysis.	[Agarwal, Rajiv] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; Richard L Roudebush Vet Adm Med Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Agarwal, R (corresponding author), Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA.	ragarwal@iu.edu	Georgianos, Panagiotis/H-7498-2019; Agarwal, Rajiv/H-3454-2019	Agarwal, Rajiv/0000-0001-8355-7100; Georgianos, Panagiotis/0000-0001-7065-2096	NIH [2R01-DK062030-10]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062030] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH 2R01-DK062030-10. The sponsors or funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2014, NEPHROL DIAL TRANSPL, V29, P672, DOI 10.1093/ndt/gft515; Agarwal R, 2011, AM J NEPHROL, V33, P373, DOI 10.1159/000326235; Agarwal R, 2011, CLIN J AM SOC NEPHRO, V6, P1066, DOI 10.2215/CJN.09321010; Agarwal Rajiv, J AM SOC NEPHROL; Bossola M, 2008, SEMIN DIALYSIS, V21, P422, DOI 10.1111/j.1525-139X.2008.00471.x; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; Devereux RB, 2004, CIRCULATION, V110, P1456, DOI 10.1161/01.CIR.0000141573.44737.5A; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Drighil A, 2008, EUR J ECHOCARDIOGR, V9, P530, DOI 10.1093/ejechocard/jen125; Hashimoto J, 2008, J HYPERTENS, V26, P1017, DOI 10.1097/HJH.0b013e3282f62a9b; Hur E, 2013, AM J KIDNEY DIS, V61, P957, DOI 10.1053/j.ajkd.2012.12.017; Kayikcioglu M, 2009, NEPHROL DIAL TRANSPL, V24, P956, DOI 10.1093/ndt/gfn599; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lehmann ED, 1997, LANCET S1, V350, pSI14; Levin A, 1999, AM J KIDNEY DIS, V34, P125, DOI 10.1016/S0272-6386(99)70118-6; LEVY D, 1991, J CARDIOVASC PHARM, V17, pS1, DOI 10.1097/00005344-199117002-00002; LIEBSON PR, 1995, CIRCULATION, V91, P698, DOI 10.1161/01.CIR.91.3.698; London G, 2011, KIDNEY INT SUPPL, V1, P10, DOI 10.1038/kisup.2011.5; London GM, 1996, KIDNEY INT, V50, P600, DOI 10.1038/ki.1996.355; Nitta K, 2004, HYPERTENS RES, V27, P47, DOI 10.1291/hypres.27.47; Palmieri V, 2008, AM J HYPERTENS, V21, P701, DOI 10.1038/ajh.2008.162; Parati G, 2014, J HYPERTENS, V32, P1359, DOI 10.1097/HJH.0000000000000221; Sinha AD, 2009, AM J KIDNEY DIS, V54, P788, DOI 10.1053/j.ajkd.2009.07.004; Zoccali C, 2004, KIDNEY INT, V65, P1492, DOI 10.1111/j.1523-1755.2004.00530.x; Zoccali C, 2001, J AM SOC NEPHROL, V12, P2768, DOI 10.1681/ASN.V12122768; Zoccali C, 2011, AM J NEPHROL, V33, P370, DOI 10.1159/000326239	26	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0135457	10.1371/journal.pone.0135457	http://dx.doi.org/10.1371/journal.pone.0135457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356419	Green Published, gold, Green Submitted			2022-12-26	WOS:000360965800005
J	Mueller, NH; Fogueri, U; Pedler, MG; Montana, K; Petrash, JM; Ammar, DA				Mueller, Niklaus H.; Fogueri, Uma; Pedler, Michelle G.; Montana, Kameron; Petrash, J. Mark; Ammar, David A.			Impact of Subunit Composition on the Uptake of alpha-Crystallin by Lens and Retina	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; B-CRYSTALLIN; A-CRYSTALLIN; INDUCED APOPTOSIS; CHAPERONE; CELLS; ACTIVATION; CASPASE-3; EXCHANGE; TRANSLOCATION	Misfolded protein aggregation, including cataract, cause a significant amount of blindness worldwide. alpha-Crystallin is reported to bind misfolded proteins and prevent their aggregation. We hypothesize that supplementing retina and lens with alpha-crystallin may help to delay disease onset. The purpose of this study was to determine if alpha B-crystallin subunits containing a cell penetration peptide (gC-tagged alpha B-crystallin) facilitate the uptake of wild type alpha Acrystallin (WT-alpha A) in lens and retina. Recombinant human alpha B-crystallin was modified by the addition of a novel cell penetration peptide derived from the gC gene product of herpes simplex virus (gC-alpha B). Recombinant gC-alpha B and wild-type alpha A-crystallin (WT-alpha A) were purified from E. coli over-expression cultures. After Alexa-labeling of WT-alpha A, these proteins were mixed at ratios of 1:2, 1:5 and 1:10, respectively, and incubated at 37 degrees C for 4 hours to allow for subunit exchange. Mixed oligomers were subsequently incubated with tissue culture cells or mouse organ cultures. Similarly, crystallin mixtures were injected into the vitreous of rat eyes. At various times after exposure, tissues were harvested and analyzed for protein uptake by confocal microscopy or flow cytometry. Chaperone-like activity assays were performed on alpha-crystallins ratios showing optimal uptake using chemically-induced or heat induced substrate aggregation assays. As determined by flow cytometry, a ratio of 1:5 for gC-alpha B to WT-alpha A was found to be optimal for uptake into retinal pigmented epithelial cells (ARPE-19). Chaperone-like activity assays demonstrated that hetero-oligomeric complex of gC-alpha B to WT-alpha A (in 1:5 ratio) retained protein aggregation protection. We observed a significant increase in protein uptake when optimized (gC-alpha B to WT-alpha A (1:5 ratio)) hetero-oligomers were used in mouse lens and retinal organ cultures. Increased levels of alpha-crystallin were found in lens and retina following intravitreal injection of homo-and hetero-oligomers in rats.	[Mueller, Niklaus H.; Pedler, Michelle G.; Montana, Kameron; Petrash, J. Mark; Ammar, David A.] Univ Colorado, Dept Ophthalmol, Sch Med, Aurora, CO 80045 USA; [Fogueri, Uma; Petrash, J. Mark] Univ Colorado, Skaggs Sch Pharm, Dept Pharmaceut Sci, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Mueller, NH (corresponding author), Univ Colorado, Dept Ophthalmol, Sch Med, Aurora, CO 80045 USA.	Niklaus.Mueller@ucdenver.edu		Ammar, David A./0000-0002-7848-7192; Mueller, Niklaus/0000-0002-3201-7742	National Eye Institute [RC1 EY020361]; National Center Research Resources [UL1 RR025780];  [P30CA046934];  [P30AR057212]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [RC1EY020361] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Center Research Resources; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	JMP received grant RC1 EY020361 from the National Eye Institute. Institutional core grant for the Advance Light Microscopy facility was award by National Center Research Resources to the University of Colorado Grant number UL1 RR025780. Flow Cytometry core funding was awarded to the University of Colorado Canter Center Grant P30CA046934 and Skin Diseases Research Core Grant P30AR057212 (http://www.nih.gov/).	Andley UP, 1996, J BIOL CHEM, V271, P31973, DOI 10.1074/jbc.271.50.31973; Aquilina JA, 2013, J BIOL CHEM, V288, P13602, DOI 10.1074/jbc.M112.443812; Bloemendal H, 1981, LENS PROTEINS MOL CE, P1; Bova MP, 2000, J BIOL CHEM, V275, P1035, DOI 10.1074/jbc.275.2.1035; Bova MP, 1997, J BIOL CHEM, V272, P29511, DOI 10.1074/jbc.272.47.29511; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; Brzezinski JAt, 2011, DEVELOPMENT, V138, P3519, DOI [10.1242/dev.064006, DOI 10.1242/DEV.064006]; CAMMARATA PR, 1986, TISSUE CELL, V18, P83, DOI 10.1016/0040-8166(86)90009-1; Christopher KL, 2014, BBA-MOL CELL RES, V1843, P309, DOI 10.1016/j.bbamcr.2013.11.010; Cobb BA, 2000, J BIOL CHEM, V275, P6664, DOI 10.1074/jbc.275.9.6664; Danysh BP, 2010, MATRIX BIOL, V29, P228, DOI 10.1016/j.matbio.2009.12.004; Datiles MB, 2008, ARCH OPHTHALMOL-CHIC, V126, P1687, DOI 10.1001/archophthalmol.2008.507; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; GOPALAKRISHNAN S, 1992, INVEST OPHTH VIS SCI, V33, P2936; HORWITZ J, 1992, CURR EYE RES, V11, P817, DOI 10.3109/02713689209000754; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P2360, DOI 10.1073/pnas.79.7.2360; Johnson LN, 2010, VISION RES, V50, P686, DOI 10.1016/j.visres.2009.08.028; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; Kamradt MC, 2005, J BIOL CHEM, V280, P11059, DOI 10.1074/jbc.M413382200; Kamradt MC, 2002, J BIOL CHEM, V277, P38731, DOI 10.1074/jbc.M201770200; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Kastner C, 2013, CURR EYE RES, V38, P1057, DOI 10.3109/02713683.2013.803288; KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652; Lin JH, 2010, ADV EXP MED BIOL, V664, P115, DOI 10.1007/978-1-4419-1399-9_14; Liu BF, 2008, EXP EYE RES, V87, P515, DOI 10.1016/j.exer.2008.08.021; Malecki J, 2004, MOL BIOL CELL, V15, P801, DOI 10.1091/mbc.E03-08-0589; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; Mueller NH, 2013, INVEST OPHTH VIS SCI, V54, P2, DOI 10.1167/iovs.12-10947; NAASH MI, 1993, P NATL ACAD SCI USA, V90, P5499, DOI 10.1073/pnas.90.12.5499; Nagaraj RH, 2012, BBA-MOL BASIS DIS, V1822, P120, DOI 10.1016/j.bbadis.2011.11.011; Nahomi RB, 2013, J BIOL CHEM, V288, P13022, DOI 10.1074/jbc.M112.440214; Nahomi RB, 2013, BBA-MOL BASIS DIS, V1832, P195, DOI 10.1016/j.bbadis.2012.08.015; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; Noorwez SM, 2008, INVEST OPHTH VIS SCI, V49, P3224, DOI 10.1167/iovs.07-1539; Puppala M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031399; Sharma KK, 2000, J BIOL CHEM, V275, P3767, DOI 10.1074/jbc.275.6.3767	39	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137659	10.1371/journal.pone.0137659	http://dx.doi.org/10.1371/journal.pone.0137659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355842	gold, Green Published, Green Submitted			2022-12-26	WOS:000360965800075
J	McCarthy, K; Cai, LB; Xu, FR; Wang, PG; Xue, HL; Ye, YL; Xiong, SZ; Liu, ZM; He, QQ				McCarthy, Kayne; Cai, Long-biao; Xu, Fang-rong; Wang, Pei-gang; Xue, Hong-liang; Ye, Yong-ling; Xiong, Shang-zhi; Liu, Zhao-min; He, Qi-qiang			Urban-Rural Differences in Cardiovascular Disease Risk Factors: A Cross-Sectional Study of Schoolchildren in Wuhan, China	PLOS ONE			English	Article							BODY-MASS INDEX; NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; METABOLIC SYNDROME; WAIST CIRCUMFERENCE; PHYSICAL-ACTIVITY; CHILDREN; PREVALENCE; ADOLESCENTS; OBESITY	Background China's rapid population growth and urban migration has developed healthcare inequity across the urban-rural divide. Past studies comparing cardiovascular disease (CVD) risk factor prevalence amongst urban-rural Chinese children are sparse and conflicting. We examined the association between urban-rural residence and risk of offspring CVD in Chinese children. Methods A cross-sectional study was conducted in Wuhan, China, during May and June 2010. CVD risk factors include; waist circumference (WC), systolic blood pressure (SBP), diastolic blood pressure (DBP), fasting blood glucose (FBG), triglycerides (TG), high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, body mass index (BMI), cardiorespiratory fitness (CRF), metabolic syndrome (MetS), and metabolic risk score (MRS). Analysis of covariance and multivariable logistic regression were used to estimate associations between urban-rural residence and offspring CVD risks. Findings A total of 579 Chinese children (338 boys and 241 girls) aged 9.6 (0.7) years participated in this study. Rural boys had significantly lower CRF and higher FBG, TG, and MRS, while urban boys had significantly higher LDL and DBP. Rural girls had significantly higher BMI, FBG, and TG, as well as lower CRF. Rural children were at increased risks for decreased CRF, elevated MRS, and TG, (OR: 2.04, 95% CI: 1.29-3.25), (OR: 2.33, 95% CI: 1.50-3.62), and (OR: 2.40, 95% CI: 1.62-3.57), respectively. Rural girls and mothers were at increased risks for overweight(OR: 7.19, 95% CI: 1.64-31.6)/obesity (OR: 1.683, 95% CI: 1.01-2.82). However, rural boys and fathers were less likely to have overweight(OR: 0.62, 95% CI: 0.34-1.12)/obesity (OR:0.68, 95% CI:0.48-0.97). Conclusions Rural residence was significantly associated with increased CVD risks amongst Chinese children. It is important to provide interventions aiming at China's urban-rural healthcare inequity and community-based approaches that reduce familial CVD risk.	[McCarthy, Kayne; Cai, Long-biao; Xu, Fang-rong; Wang, Pei-gang; Xue, Hong-liang; Ye, Yong-ling; Xiong, Shang-zhi; He, Qi-qiang] Wuhan Univ, Sch Publ Hlth, Wuhan 430072, Peoples R China; [McCarthy, Kayne] Univ Hawaii, Off Publ Hlth Studies, Honolulu, HI 96822 USA; [Liu, Zhao-min] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [He, Qi-qiang] Wuhan Univ, Global Hlth Inst, Wuhan 430072, Peoples R China	Wuhan University; University of Hawaii System; Chinese University of Hong Kong; Wuhan University	He, QQ (corresponding author), Wuhan Univ, Sch Publ Hlth, Wuhan 430072, Peoples R China.	heqiqiang@gmail.com	Liu, Zhaomin/L-8685-2019; He, Qiqiang/A-7990-2012; LIU, Zhao-min/ABA-4413-2021					Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; [Anonymous], 2011, NATL BUREAU STAT CHI; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Chen F, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031645, 10.1371/journal.pone.0039197]; Chen YY, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-34; Chillon P, 2011, J SCI MED SPORT, V14, P417, DOI 10.1016/j.jsams.2011.04.004; China Salt Substitute Study Collaborative Group, 2007, CHINA SALT SUBSTITUT, V25, P2011; Davis AM, 2011, J PEDIATR PSYCHOL, V36, P669, DOI 10.1093/jpepsy/jsq117; de Ferranti SD, 2004, CIRCULATION, V110, P2494, DOI 10.1161/01.CIR.0000145117.40114.C7; Eisenmann JC, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-17; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; He FJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003388; Hejazi N, 2009, Pak J Biol Sci, V12, P730, DOI 10.3923/pjbs.2009.730.733; Hodgkin E, 2010, RURAL REMOTE HEALTH, V10; Hofhuis W, 2003, ARCH DIS CHILD, V88, P1086, DOI 10.1136/adc.88.12.1086; Hu Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-686; Ji CY, 2010, BIOMED ENVIRON SCI, V23, P12, DOI 10.1016/S0895-3988(10)60026-8; Jones-Smith JC, 2012, INT J OBESITY, V36, P866, DOI 10.1038/ijo.2011.134; Kim ES, 2004, DIABETIC MED, V21, P1141, DOI 10.1111/j.1464-5491.2004.01398.x; Kriemler S, 2008, DIABETOLOGIA, V51, P1408, DOI 10.1007/s00125-008-1067-z; Kuczmarski MF, 2001, J AM DIET ASSOC, V101, P28, DOI 10.1016/S0002-8223(01)00008-6; Kwiterovich PO, 2008, J CLIN ENDOCR METAB, V93, P4200, DOI 10.1210/jc.2008-1270; Mahoney C, 1992, Br J Sports Med, V26, P45; McCarthy K, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.140384; On JY, 2004, DIABETES CARE, V27, P2027, DOI 10.2337/diacare.27.8.2027; Qian JC, 2010, B WORLD HEALTH ORGAN, V88, P769, DOI 10.2471/BLT.09.064709; Ramsbottom R, 1988, Br J Sports Med, V22, P141; Sung RYT, 2007, INT J OBESITY, V31, P550, DOI 10.1038/sj.ijo.0803452; Tanner JM, 1962, GROWTH ADOLESCENCE G; Wang L., 2005, COMPREHENSIVE REPORT, P21; Wang PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027896; Wang SQ, 2015, ASIA-PAC J PUBLIC HE, V27, pNP674, DOI 10.1177/1010539513496137; Weng X, 2007, PUBLIC HEALTH NUTR, V10, P131, DOI 10.1017/S1368980007226023; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Xu S, 2014, BMC PUBLIC HEALTH, V14, P1; Yan WL, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-195; Yu ZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051949; Zhan YQ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-921; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	40	9	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137615	10.1371/journal.pone.0137615	http://dx.doi.org/10.1371/journal.pone.0137615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9KG	26352586	Green Submitted, Green Published, gold			2022-12-26	WOS:000360932800102
J	Schwartzbaum, J; Seweryn, M; Holloman, C; Harris, R; Handelman, SK; Rempala, GA; Huang, RP; Burkholder, B; Brandemihl, A; Kallberg, H; Johannesen, TB; Ahlbom, A; Feychting, M; Grimsrud, TK				Schwartzbaum, Judith; Seweryn, Michal; Holloman, Christopher; Harris, Randall; Handelman, Samuel K.; Rempala, Grzegorz A.; Huang, Ruo-Pan; Burkholder, Brett; Brandemihl, Adam; Kallberg, Henrik; Johannesen, Tom Borge; Ahlbom, Anders; Feychting, Maria; Grimsrud, Tom K.			Association between Prediagnostic Allergy-Related Serum Cytokines and Glioma	PLOS ONE			English	Article							IL-4 RECEPTOR-ALPHA; CELLS; GLIOBLASTOMA; BRAIN; PATHOGENESIS; EXPRESSION; MEMBRANE; PATHWAYS; ASTHMA; CANCER	Allergy is inversely related to glioma risk. To determine whether prediagnostic allergy-related serum proteins are associated with glioma, we conducted a nested case-control study of seven cytokines (IL4, IL13, IL5, IL6, IL10, IFNG, TGFB2), two soluble cytokine receptors (sIL4RA, sIL13RA2) and three allergy-related transcription factors (FOXP3, STAT3, STAT6) using serum specimens from the Janus Serum Bank Cohort in Oslo, Norway. Blood donors subsequently diagnosed with glioma (n = 487) were matched to controls (n = 487) on age and date of blood draw and sex. We first estimated individual effects of the 12 serum proteins and then interactions between IL4 and IL13 and their receptors using conditional logistic regression. We next tested equality of case-control inter-correlations among the 12 serum proteins. We found that TGFB2 is inversely related to glioblastoma (Odds Ratio (OR) = 0.87, 95% Confidence Interval (CI)) = 0.76, 0.98). In addition, <= 5 years before diagnosis, we observed associations between IL4 (OR = 0.82, 95% CI = 0.66, 1.01), sIL4RA (OR = 0.80, 95% CI = 0.65, 1.00), their interaction (OR = 1.06, 95% CI = 1.01, 1.12) and glioblastoma. This interaction was apparent > 20 years before diagnosis (IL4-sIL4RA OR = 1.20, 95% CI = 1.05, 1.37). Findings for glioma were similar. Case correlations were different from control correlations stratified on time before diagnosis. Five years or less before diagnosis, correlations among case serum proteins were weaker than were those among controls. Our findings suggest that IL4 and sIL4RA reduce glioma risk long before diagnosis and early gliomagenesis affects circulating immune function proteins.	[Schwartzbaum, Judith; Harris, Randall] Ohio State Univ, Div Epidemiol, Coll Publ Hlth, Columbus, OH 43210 USA; [Schwartzbaum, Judith; Harris, Randall] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Seweryn, Michal; Rempala, Grzegorz A.] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA; [Seweryn, Michal; Rempala, Grzegorz A.] Math Biosci Inst, Columbus, OH USA; [Seweryn, Michal] Univ Lodz, Dept Math, PL-90131 Lodz, Poland; [Holloman, Christopher] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA; [Handelman, Samuel K.] Ohio State Univ, Wexner Med Ctr, Ctr Pharmacogenet, Columbus, OH 43210 USA; [Huang, Ruo-Pan; Burkholder, Brett] RayBiotech Inc, Norcross, GA USA; [Huang, Ruo-Pan] RayBiotech Inc, Guangzhou, Guangdong, Peoples R China; [Brandemihl, Adam] Buckeye Psychiat, Columbus, OH USA; [Kallberg, Henrik; Ahlbom, Anders; Feychting, Maria] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Johannesen, Tom Borge] Canc Registry Norway, Dept Registrat, Oslo, Norway; [Grimsrud, Tom K.] Canc Registry Norway, Dept Res, Oslo, Norway	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Lodz; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Karolinska Institutet; University of Oslo; University of Oslo	Schwartzbaum, J (corresponding author), Ohio State Univ, Div Epidemiol, Coll Publ Hlth, Columbus, OH 43210 USA.	ja.schwartzbaum@gmail.com	Schwartzbaum, Judith/A-9022-2016; Grimsrud, Tom K/M-6345-2015; Rempala, Grzegorz/C-3576-2013	Schwartzbaum, Judith/0000-0002-1523-9941; Grimsrud, Tom K/0000-0003-0425-043X; Handelman, Samuel/0000-0001-6970-2172; Seweryn, Michal/0000-0002-9090-3435	National Cancer Institute, National Institutes of Health [R01CA122163]; RayBiotech, Inc; Buckeye Psychiatry; NATIONAL CANCER INSTITUTE [R01CA122163] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); RayBiotech, Inc; Buckeye Psychiatry; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: National Cancer Institute, National Institutes of Health (grant number R01CA122163) to JS. RayBiotech, Inc and Buckeye Psychiatry provided support in the form of salaries for authors (RayBiotech, Inc.: Ruo-Pan Huang, Brett Burkholder; Buckeye Psychiatry: Adam Brandemihl), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andrews AL, 2006, J IMMUNOL, V176, P7456, DOI 10.4049/jimmunol.176.12.7456; Bartee E, 2013, CYTOKINE, V63, P237, DOI 10.1016/j.cyto.2013.04.036; Bartee E, 2009, CYTOKINE, V47, P199, DOI 10.1016/j.cyto.2009.06.006; Bellinghausen I, 2003, IMMUNOLOGY, V108, P167, DOI 10.1046/j.1365-2567.2003.01576.x; Besedovsky HO, 2011, NEUROCHEM RES, V36, P1, DOI 10.1007/s11064-010-0252-x; *CBTRUS, 2011, CBTRUS STAT REP PRIM; Chatila TA, 2004, TRENDS MOL MED, V10, P493, DOI 10.1016/j.molmed.2004.08.004; Chaung WW, 2012, INT J MOL MED, V30, P199, DOI 10.3892/ijmm.2012.959; Chen WG, 2009, J IMMUNOL, V183, P7870, DOI 10.4049/jimmunol.0901028; de la Iglesia N, 2009, CURR MOL MED, V9, P580; Fenn AM, 2012, BRAIN BEHAV IMMUN, V26, P766, DOI 10.1016/j.bbi.2011.10.003; Hau P, 2011, CURR PHARM BIOTECHNO, V12, P2150, DOI 10.2174/138920111798808347; Helgesson G, 2007, NAT BIOTECHNOL, V25, P973, DOI 10.1038/nbt0907-973b; Holtzman MJ, 2003, AM J RESP CELL MOL, V29, P163, DOI 10.1165/rcmb.F276; JELLUM E, 1995, ENVIRON HEALTH PERSP, V103, P85, DOI 10.2307/3432566; JELLUM E, 1993, SCI TOTAL ENVIRON, V140, P527, DOI 10.1016/0048-9697(93)90049-C; Koshy M, 2012, J NEURO-ONCOL, V107, P207, DOI 10.1007/s11060-011-0738-7; Kruse S, 1999, INT IMMUNOL, V11, P1965, DOI 10.1093/intimm/11.12.1965; Ksendzovsky A, 2010, OPEN IMMUNOLOGY J, V3, P30; Langseth H, 2009, JANUS SERUM BANK FRO; Lippitz BE, 2013, LANCET ONCOL, V14, pE218, DOI 10.1016/S1470-2045(12)70582-X; McFarland BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078728; Nestor CE, 2014, ALLERGY, V69, P1564, DOI 10.1111/all.12505; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Principe DR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt369; Quan N, 2007, BRAIN BEHAV IMMUN, V21, P727, DOI 10.1016/j.bbi.2007.05.005; Sangiuliano B, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/821043; Schwartzbaum J, 2012, J NATL CANCER I, V104, P1251, DOI 10.1093/jnci/djs315; Schwartzbaum JA, 2010, NEURO-ONCOLOGY, V12, P320, DOI 10.1093/neuonc/nop035; Simeone-Penney MC, 2007, J IMMUNOL, V178, P6191, DOI 10.4049/jimmunol.178.10.6191; Strombeck A, 2014, CLIN EXP ALLERGY, V44, P940, DOI 10.1111/cea.12290; Turrin NP, 2000, BRAIN RES BULL, V51, P3, DOI 10.1016/S0361-9230(99)00203-8; Verma S, 2006, BRAIN BEHAV IMMUN, V20, P449, DOI 10.1016/j.bbi.2005.10.005; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wei J, 2010, CLIN CANCER RES, V16, P461, DOI 10.1158/1078-0432.CCR-09-1983; Wei J, 2010, MOL CANCER THER, V9, P67, DOI 10.1158/1535-7163.MCT-09-0734; Williams CMM, 2012, TOXICOL PATHOL, V40, P205, DOI 10.1177/0192623311430694; Wu Y, 2012, INTEGR BIOL-UK, V4, P1478, DOI 10.1039/c2ib20044a; Zhao HY, 2014, TUMOR BIOL, V35, P3875, DOI 10.1007/s13277-013-1514-4; Zhu VF, 2012, CANCER LETT, V316, P139, DOI 10.1016/j.canlet.2011.11.001; Zisakis A, 2007, CYTOKINE	41	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137503	10.1371/journal.pone.0137503	http://dx.doi.org/10.1371/journal.pone.0137503			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352148	Green Published, gold, Green Submitted			2022-12-26	WOS:000360932800090
J	Stupica, D; Lusa, L; Maraspin, V; Bogovic, P; Vidmar, D; O'Rourke, M; Traweger, A; Livey, I; Strle, F				Stupica, Dasa; Lusa, Lara; Maraspin, Vera; Bogovic, Petra; Vidmar, Darja; O'Rourke, Maria; Traweger, Andreas; Livey, Ian; Strle, Franc			Correlation of Culture Positivity, PCR Positivity, and Burden of Borrelia burgdorferi Sensu Lato in Skin Samples of Erythema Migrans Patients with Clinical Findings	PLOS ONE			English	Article							EARLY LYME-DISEASE; DOUBLE-BLIND; DOXYCYCLINE; MANIFESTATIONS; AZITHROMYCIN; AMOXICILLIN; PENICILLIN; SYMPTOMS	Background Limited data are available regarding the relationship of Borrelia burden in skin of patients with erythema migrans (EM) and the disease course and post-treatment outcome. Methods We studied 121 adult patients with EM in whom skin biopsy specimens were cultured and analyzed by quantitative PCR for the presence of Borreliae. Evaluation of clinical and microbiological findings were conducted at the baseline visit, and 14 days, 2, 6, and 12 months after treatment with either amoxicillin or cefuroxime axetil. Results In 94/121 (77.7%) patients Borrelia was detected in skin samples by PCR testing and 65/118 (55.1%) patients had positive skin culture result (96.8% B. afzelii, 3.2% B. garinii). Borrelia culture and PCR results correlated significantly with the presence of central clearing and EM size, while Borrelia burden correlated significantly with central clearing, EM size, and presence of newly developed or worsened symptoms since EM onset, with no other known medical explanation (new or increased symptoms, NOIS). In addition, the logistic regression model for repeated measurements adjusted for time from inclusion, indicated higher Borrelia burden was a risk factor for incomplete response (defined as NOIS and/or persistence of EM beyond 14 days and/or occurrence of new objective signs of Lyme borreliosis). The estimated association between PCR positivity and unfavorable outcome was large but not statistically significant, while no corresponding relationship was observed for culture positivity. Conclusions Higher Borrelia burden in EM skin samples was associated with more frequent central clearing and larger EM lesions at presentation, and with a higher chance of incomplete response.	[Stupica, Dasa; Maraspin, Vera; Bogovic, Petra; Vidmar, Darja; Strle, Franc] Univ Med Ctr Ljubljana, Dept Infect Dis, Ljubljana, Slovenia; [Lusa, Lara] Inst Biostat & Med Informat, Fac Med, Ljubljana, Slovenia; [O'Rourke, Maria; Traweger, Andreas; Livey, Ian] Vaccine R&D Baxter Innovat, A-2304 Orth, Austria	University Medical Centre Ljubljana; Baxter International Inc; Baxter Innovations GmbH	Stupica, D (corresponding author), Univ Med Ctr Ljubljana, Dept Infect Dis, Ljubljana, Slovenia.	dasa.stupica@kclj.si	Traweger, Andreas/M-1460-2015; Lusa, Lara/C-6692-2015	Traweger, Andreas/0000-0002-0220-4766; Lusa, Lara/0000-0002-8981-2421	Baxter; Slovenian Research Agency [P3-0296]	Baxter; Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The microbiological analyses were funded by Baxter. The clinical part of the study was supported by the Slovenian Research Agency (grant number P3-0296). Baxter provided support in the form of salaries for authors MOR, AT and IL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Cerar D, 2010, AM J MED, V123, P79, DOI 10.1016/j.amjmed.2009.05.011; DATTWYLER RJ, 1990, LANCET, V336, P1404, DOI 10.1016/0140-6736(90)93103-V; Li X, 2011, ARTHRITIS RHEUM-US, V63, P2238, DOI 10.1002/art.30384; Liveris D, 2002, J CLIN MICROBIOL, V40, P1249, DOI 10.1128/JCM.40.4.1249-1253.2002; Livey I, 2011, CLIN INFECT DIS, V52, pS266, DOI 10.1093/cid/ciq118; Luft BJ, 1996, ANN INTERN MED, V124, P785, DOI 10.7326/0003-4819-124-9-199605010-00002; LUGER SW, 1995, ANTIMICROB AGENTS CH, V39, P661, DOI 10.1128/AAC.39.3.661; MASSAROTTI EM, 1992, AM J MED, V92, P396, DOI 10.1016/0002-9343(92)90270-L; Nowakowski J, 2003, AM J MED, V115, P91, DOI 10.1016/S0002-9343(03)00308-5; O'Rourke M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063968; R Core Team, 2020, R LANG ENV STAT COMP; Ruzic-Sabljic E, 2001, J MED MICROBIOL, V50, P896, DOI 10.1099/0022-1317-50-10-896; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P69, DOI 10.1111/j.1469-0691.2010.03175.x; Stanek G, 2003, LANCET, V362, P1639, DOI 10.1016/S0140-6736(03)14798-8; STEERE AC, 1983, ANN INTERN MED, V99, P76, DOI 10.7326/0003-4819-99-1-76; STEERE AC, 1983, ANN INTERN MED, V99, P22, DOI 10.7326/0003-4819-99-1-22; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Strle K, 2014, CLIN INFECT DIS, V58, P372, DOI 10.1093/cid/cit735; Stupica D, 2012, CLIN INFECT DIS, V55, P343, DOI 10.1093/cid/cis402; Stupica D, 2011, VECTOR-BORNE ZOONOT, V11, P883, DOI 10.1089/vbz.2010.0018; WEBER K, 1986, ZBL BAKT-INT J MED M, V263, P209; WEBER K, 1993, INFECTION, V21, P367, DOI 10.1007/BF01728915; WEBER K, 1990, INFECTION, V18, P91, DOI 10.1007/BF01641422; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wormser GP, 2003, ANN INTERN MED, V138, P697, DOI 10.7326/0003-4819-138-9-200305060-00005	25	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136600	10.1371/journal.pone.0136600	http://dx.doi.org/10.1371/journal.pone.0136600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352832	Green Published, gold, Green Submitted			2022-12-26	WOS:000360932800041
J	Ramaprasad, ASE; Singh, S; Gajendra, PSR; Venkatesan, S				Ramaprasad, Azhagiya Singam Ettayapuram; Singh, Sandeep; Gajendra, Raghava P. S.; Venkatesan, Subramanian			AntiAngioPred: A Server for Prediction of Anti-Angiogenic Peptides	PLOS ONE			English	Article							CANCER; DATABASE; THROMBOSPONDIN-1; IDENTIFICATION; COLLAGEN; FAMILY; LOGO	The process of angiogenesis is a vital step towards the formation of malignant tumors. Antiangiogenic peptides are therefore promising candidates in the treatment of cancer. In this study, we have collected anti-angiogenic peptides from the literature and analyzed the residue preference in these peptides. Residues like Cys, Pro, Ser, Arg, Trp, Thr and Gly are preferred while Ala, Asp, Ile, Leu, Val and Phe are not preferred in these peptides. There is a positional preference of Ser, Pro, Trp and Cys in the N terminal region and Cys, Gly and Arg in the C terminal region of anti-angiogenic peptides. Motif analysis suggests the motifs "CG-G", "TC", "SC", "SP-S", etc., which are highly prominent in anti-angiogenic peptides. Based on the primary analysis, we developed prediction models using different machine learning based methods. The maximum accuracy and MCC for amino acid composition based model is 80.9% and 0.62 respectively. The performance of the models on independent dataset is also reasonable. Based on the above study, we have developed a user-friendly web server named "AntiAngioPred" for the prediction of anti-angiogenic peptides.	[Ramaprasad, Azhagiya Singam Ettayapuram; Venkatesan, Subramanian] CSIR, Cent Leather Res Inst, Chem Lab, Madras, Tamil Nadu, India; [Singh, Sandeep; Gajendra, Raghava P. S.] Inst Microbial Technol, CSIR, Bioinformat Ctr, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Leather Research Institute (CLRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Venkatesan, S (corresponding author), CSIR, Cent Leather Res Inst, Chem Lab, Madras, Tamil Nadu, India.	subbu@clri.res.in	singam, Ettayapuram Ramapras Azhagiya/D-3824-2011; Raghava, Gajendra/B-1717-2009; Raghava, Gajendra P.S./AAA-2413-2022; Ramaprasad, Azhagiya Singam Ettayapuram/L-7343-2019	singam, Ettayapuram Ramapras Azhagiya/0000-0003-4978-286X; Raghava, Gajendra P.S./0000-0002-8902-2876; Ramaprasad, Azhagiya Singam Ettayapuram/0000-0003-4978-286X; Singh, Sandeep/0000-0001-5361-4303	DBT; CSIR	DBT(Department of Biotechnology (DBT) India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by DBT (http://www.dbtindia.nic.in/) and CSIR (http://www.csir.res.in/).	AHA DW, 1991, MACH LEARN, V6, P37, DOI 10.1007/BF00153759; [Anonymous], 2001, RANDOM FORESTS MACHI; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; BREM S, 1972, J NATL CANCER I, V48, P347; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; FOLKMAN J, 1972, ANN SURG, V175, P409, DOI 10.1097/00000658-197203000-00014; Gautam A, 2014, NUCLEIC ACIDS RES, V42, pD444, DOI 10.1093/nar/gkt1008; Gautam A, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas015; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; John G. H., 1995, Uncertainty in Artificial Intelligence. Proceedings of the Eleventh Conference (1995), P338; Kapoor P, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035187, DOI 10.1371/J0URNAL.P0NE.0035187]; Karagiannis ED, 2008, P NATL ACAD SCI USA, V105, P13775, DOI 10.1073/pnas.0803241105; Kohn E C, 1998, Angiogenesis, V2, P25, DOI 10.1023/A:1009046208807; Koskimaki JE, 2009, NEOPLASIA, V11, P1285, DOI 10.1593/neo.09620; Kumar R, 2015, NUCLEIC ACIDS RES, V43, pD956, DOI 10.1093/nar/gku1141; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; Maeshima Y, 2000, J BIOL CHEM, V275, P23745, DOI 10.1074/jbc.C000186200; Maeshima Y, 2001, J BIOL CHEM, V276, P15240, DOI 10.1074/jbc.M007764200; Mark Hall EF, 2009, SIGKDD EXPLORATIONS, P11; Mehta Divya, 2014, Database (Oxford), V2014, DOI 10.1093/database/bau051; Nyberg P, 2008, EXP CELL RES, V314, P3292, DOI 10.1016/j.yexcr.2008.08.011; Oka Y, 2008, CURR MED CHEM, V15, P3052, DOI 10.2174/092986708786848631; Osborne S, New peptide analogues acting as NK-2 receptor antagonists| are useful as analgesics, anti-angiogenic agents for treating e. g. rheumatoid arthritis or tumours, for appetite suppression or treating psychosis patent, Patent No. [US5554644-A, 5554644]; Pilla L, 2009, EXPERT OPIN BIOL TH, V9, P1043, DOI 10.1517/14712590903085109; Quinlan R., 1993, PROGRAMS MACHINE LEA; Rosca EV, 2011, CURR PHARM BIOTECHNO, V12, P1101; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Scholkopf B BC, 1999, MAKING LARGE SCALE S; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Sulochana KN, 2007, CURR PHARM DESIGN, V13, P2074; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thundimadathil Jyothi, 2012, J Amino Acids, V2012, P967347, DOI 10.1155/2012/967347; TOLSMA SS, 1993, J CELL BIOL, V122, P497, DOI 10.1083/jcb.122.2.497; Tyagi A, 2015, NUCLEIC ACIDS RES, V43, pD837, DOI 10.1093/nar/gku892; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Van Dorpe S, 2012, BRAIN STRUCT FUNCT, V217, P687, DOI 10.1007/s00429-011-0375-0; Waghu FH, 2014, NUCLEIC ACIDS RES, V42, pD1154, DOI 10.1093/nar/gkt1157; Wu CH, 2003, COMPUT BIOL CHEM, V27, P37, DOI 10.1016/S1476-9271(02)00098-1; Wynendaele E, 2013, NUCLEIC ACIDS RES, V41, pD655, DOI 10.1093/nar/gks1137; Xu Y, 2012, J INT MED RES, V40, P1217, DOI 10.1177/147323001204000401	40	38	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136990	10.1371/journal.pone.0136990	http://dx.doi.org/10.1371/journal.pone.0136990			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335203	Green Published, gold, Green Submitted			2022-12-26	WOS:000360615400033
J	Mori, Y; Akita, K; Yashiro, M; Sawada, T; Hirakawa, K; Murata, T; Nakada, H				Mori, Yugo; Akita, Kaoru; Yashiro, Masakazu; Sawada, Tetsuji; Hirakawa, Kosei; Murata, Takeomi; Nakada, Hiroshi			Binding of Galectin-3, a beta-Galactoside-binding Lectin, to MUC1 Protein Enhances Phosphorylation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) and Akt, Promoting Tumor Cell Malignancy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; INTERCELLULAR-ADHESION MOLECULE-1; LUNG-CANCER CELLS; KAPPA-B P65; CIRCULATING GALECTIN-3; BREAST-CANCER; ANTIGEN; METASTASIS; EXPRESSION; PATHWAYS	Both mucin 1 (MUC1) and galectin-3 are known to be over-expressed in various malignant tumors and associated with a poor prognosis. It has been extensively reported that MUC1 is involved in potentiation of growth factor-dependent signal transduction. Because some carbohydrate moieties carried on MUC1 change to preferable ones for binding of galectin-3 in cancer cells, we speculated that MUC1-mediated signaling may occur through direct binding of galectin-3. Immunochemical studies showed that the distribution of galectin-3 coincided with that of MUC1 in various human tumor tissues but not in human nonmalignant tissues, and the level of galectin-3 retained on the surface of various cancer cells paralleled that of MUC1. Treatment of MUC1-expressing cells with galectin-3 induced phosphorylation of ERK1/2 and Akt following enhanced phosphorylation of MUC1 C-terminal domain, consistently promoting tumor cell malignancy. It is also noted that this enhanced phosphorylation occurred independently of EGF receptor-mediated signaling in both EGF receptor-and MUC1-expressing cells, and multivalency of galectin-3 was important for initiation of MUC1-mediated signaling. Expectedly, both silencing of endogenous galectin-3 and treatment with galectin-3 antagonists down-regulated cell proliferation of MUC1-expressing cells. These results suggest that the binding of galectin-3 to MUC1 plays a key role in MUC1-mediated signaling. Thus, constitutive activation of MUC1-mediated signaling in an autocrine/paracrine manner caused by ligation of galectin-3 promotes uncontrolled tumor cell malignancy. This signaling may be another MUC1-mediated pathway and function in parallel with a growth factor-dependent MUC1-mediated signaling pathway.	[Mori, Yugo; Akita, Kaoru; Nakada, Hiroshi] Kyoto Sangyo Univ, Dept Mol Biosci, Fac Life Sci, Kyoto 6038555, Japan; [Akita, Kaoru; Yashiro, Masakazu; Sawada, Tetsuji] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 5458585, Japan; [Yashiro, Masakazu] Osaka City Univ, Grad Sch Med, Oncol Inst Geriatr & Med Sci, Osaka 5458585, Japan; [Murata, Takeomi] Shizuoka Univ, Fac Agr, Dept Appl Biol Chem, Shizuoka 4228529, Japan	Kyoto Sangyo University; Osaka Metropolitan University; Osaka Metropolitan University; Shizuoka University	Nakada, H (corresponding author), Kyoto Sangyo Univ, Dept Mol Biosci, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan.	hnakada@cc.kyoto-su.ac.jp			Fugaku Trust for Medical Research; Private University Strategic Research Foundation Support Program	Fugaku Trust for Medical Research; Private University Strategic Research Foundation Support Program	This work was supported by a grants-in-aid of the Fugaku Trust for Medical Research and the Private University Strategic Research Foundation Support Program. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; BECKER JW, 1989, P NATL ACAD SCI USA, V86, P1088, DOI 10.1073/pnas.86.3.1088; Bian CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025007; BRAMWELL ME, 1986, J CELL SCI, V86, P249; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Cascio S, 2011, J BIOL CHEM, V286, P42248, DOI 10.1074/jbc.M111.297630; Chauhan D, 2005, CANCER RES, V65, P8350, DOI 10.1158/0008-5472.CAN-05-0163; DAGHER SF, 1995, P NATL ACAD SCI USA, V92, P1213, DOI 10.1073/pnas.92.4.1213; Dam TK, 2005, BIOCHEMISTRY-US, V44, P12564, DOI 10.1021/bi051144z; Davidson PJ, 2002, GLYCOBIOLOGY, V12, P329, DOI 10.1093/glycob/12.5.329; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Gao XG, 2014, ONCOTARGET, V5, P2077, DOI 10.18632/oncotarget.1786; GENDLER S, 1988, J BIOL CHEM, V263, P12820; Glinskii OV, 2012, NEOPLASIA, V14, P65, DOI 10.1593/neo.111544; HERRMANN J, 1993, J BIOL CHEM, V268, P26704; Hidari KIPJ, 2008, GLYCOBIOLOGY, V18, P779, DOI 10.1093/glycob/cwn067; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Honjo Y, 2001, CLIN CANCER RES, V7, P661; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Iurisci I, 2000, CLIN CANCER RES, V6, P1389; John CM, 2003, CLIN CANCER RES, V9, P2374; Kato K, 2007, AM J PHYSIOL-LUNG C, V293, pL686, DOI 10.1152/ajplung.00423.2006; Kharbanda A, 2014, CLIN CANCER RES, V20, P5423, DOI 10.1158/1078-0432.CCR-13-3168; Kinlough CL, 2004, J BIOL CHEM, V279, P53071, DOI 10.1074/jbc.M409360200; KUFE D, 1984, HYBRIDOMA, V3, P223, DOI 10.1089/hyb.1984.3.223; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; LIGTENBERG MJL, 1992, J BIOL CHEM, V267, P6171; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Lloyd KO, 1996, J BIOL CHEM, V271, P33325, DOI 10.1074/jbc.271.52.33325; Mahanta S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002054; Merlin J, 2011, ONCOGENE, V30, P2514, DOI 10.1038/onc.2010.631; Mori Y, 2014, J BIOL CHEM, V289, P35193, DOI 10.1074/jbc.M114.586461; Morris S, 2004, GLYCOBIOLOGY, V14, P293, DOI 10.1093/glycob/cwh029; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Ochieng J, 1998, BIOCHEM BIOPH RES CO, V246, P788, DOI 10.1006/bbrc.1998.8708; PANDEY P, 1995, CANCER RES, V55, P4000; Parry S, 2001, BIOCHEM BIOPH RES CO, V283, P715, DOI 10.1006/bbrc.2001.4775; Rahn JJ, 2004, J BIOL CHEM, V279, P29386, DOI 10.1074/jbc.C400010200; Raina D, 2012, INT J ONCOL, V40, P1644, DOI 10.3892/ijo.2011.1308; Raina D, 2011, MOL CANCER THER, V10, P806, DOI 10.1158/1535-7163.MCT-10-1050; Ramasamy S, 2007, MOL CELL, V27, P992, DOI 10.1016/j.molcel.2007.07.031; Ren J, 2006, MOL CANCER RES, V4, P873, DOI 10.1158/1541-7786.MCR-06-0204; SATO S, 1994, J BIOL CHEM, V269, P4424; Saussez S, 2008, ORAL ONCOL, V44, P86, DOI 10.1016/j.oraloncology.2006.12.014; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Senapati S, 2010, TRENDS BIOCHEM SCI, V35, P236, DOI 10.1016/j.tibs.2009.10.003; Shen Q, 2008, MOL CANCER RES, V6, P555, DOI 10.1158/1541-7786.MCR-07-2033; SIDDIQUI J, 1988, P NATL ACAD SCI USA, V85, P2320, DOI 10.1073/pnas.85.7.2320; SPARROW CP, 1987, J BIOL CHEM, V262, P7383; Streetly MJ, 2010, BLOOD, V115, P3939, DOI 10.1182/blood-2009-10-251660; Tanida S, 2014, BBA-GEN SUBJECTS, V1840, P1790, DOI 10.1016/j.bbagen.2014.02.008; Tanida S, 2013, J BIOL CHEM, V288, P31842, DOI 10.1074/jbc.M113.471318; van den Brule F, 2002, GLYCOCONJUGATE J, V19, P537, DOI 10.1023/B:GLYC.0000014083.48508.6a; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Yang RY, 1998, BIOCHEMISTRY-US, V37, P4086, DOI 10.1021/bi971409c; Yu F, 2002, J BIOL CHEM, V277, P15819, DOI 10.1074/jbc.M200154200; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200; Zhao QC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-154; Zhao QC, 2009, CANCER RES, V69, P6799, DOI 10.1158/0008-5472.CAN-09-1096	62	34	36	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26125	26140		10.1074/jbc.M115.651489	http://dx.doi.org/10.1074/jbc.M115.651489			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26342075	Green Published, hybrid			2022-12-26	WOS:000363527300032
J	Joshi, L; Ponnana, M; Sivangala, R; Chelluri, LK; Nallari, P; Penmetsa, S; Valluri, V; Gaddam, S				Joshi, Lavanya; Ponnana, Meenakshi; Sivangala, Ramya; Chelluri, Lakshmi Kiran; Nallari, Prathiba; Penmetsa, Sitaramaraju; Valluri, Vijayalakshmi; Gaddam, Sumanlatha			Evaluation of TNF-alpha, IL-10 and IL-6 Cytokine Production and Their Correlation with Genotype Variants amongst Tuberculosis Patients and Their Household Contacts	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; DIAGNOSIS; RESPONSES; ANTIGENS; PATTERNS; GAMMA	Background Household contacts of diagnostically established tuberculosis (TB) patients are highly susceptible to disease development. It is surmised that cytokines perhaps play a synergistic and a prognostic role in the activation of the otherwise latent infection in these house hold contacts. Evaluation of the cytokines and any of their inherent polymorphisms might provide a useful diagnostic tool in evaluating the immune regulation and the progression of the disease. The cytokines thus released in a paracrine manner in serum may also provide an indirect measure of the cytokine function. Objective The present study was aimed to evaluate the levels of TNF-alpha, IL-10 & IL-6 cytokines and their correlation with genotype variants amongst tuberculosis patients and their household contacts. Methods The cytokine levels were estimated in serum by enzyme-linked immunosorbent assay (ELISA) and their polymorphisms were studied by amplification refractory mutation system polymerase chain reaction (ARMs PCR) in active pulmonary tuberculosis patients (APTB = 150), household contacts (HHC = 190), and healthy controls (HC = 150). Results The median values of TNF-a cytokine were significantly high among APTB and HHC compared to HCs (P<0.0001 and 0.0001). IL-6 levels also were elevated among APTB compared to HHC and HC, and a significant difference was observed between APTB and HHC at P<0.0001; APTB & HC at P<0.04; HHC & HC at P<0.01. The IL-10 levels were low in APTB compared to HHC and HCs and no significant difference was observed. TNF-alpha/IL-10 ratio was significant and indicated Th1 predominance in APTB and HHC. IL-6/IL-10 showed pronounced Th1 expression in APTB and Th2 in HHC and HC. The ROC analysis indicated that both IL-10 and IL-6 can be used to decide the risk of exposed individual to a disease. The results of multivariate analysis indicate that IL-10 (-1082) GA genotype was significantly associated with p<0.028 in APTB. No significant association was observed between genotypes, other serum cytokine levels and clinical characteristics between APTB, HHC and HCs. Conclusion Large sample size with follow-up at different time points may further illuminate the role of IL-10 and IL-6 cytokines as a prognostic marker in house hold contacts.	[Joshi, Lavanya; Ponnana, Meenakshi; Sivangala, Ramya; Penmetsa, Sitaramaraju; Gaddam, Sumanlatha] Bhagwan Mahavir Med Res Ctr, Hyderabad, Andhra Pradesh, India; [Chelluri, Lakshmi Kiran] Global Hosp, Dept Transplant Biol & Stem Cell, Hyderabad, Andhra Pradesh, India; [Nallari, Prathiba; Gaddam, Sumanlatha] Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India; [Valluri, Vijayalakshmi] Blue Peter Publ Hlth & Res Ctr, LEPRA India, Hyderabad, Andhra Pradesh, India	Osmania University	Gaddam, S (corresponding author), Bhagwan Mahavir Med Res Ctr, Hyderabad, Andhra Pradesh, India.	sumanlathag@yahoo.com	Valluri, Vijaya Lakshmi/S-9219-2019		DBT-RGYI [102/IFD/PR/2029/2007-2008]; Department of Biotechnology (DBT) [BT/01/COE/07/02]	DBT-RGYI; Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India)	Financial support was provided by DBT-RGYI (rapid grants for young investigator) (Sanction no: 102/IFD/PR/2029/2007-2008 dated 18/01/2008); Department of Biotechnology (DBT), Sanction order no: BT/01/COE/07/02, dated 30/12/08, (COE-Center of excellence).	Abhimanyu, 2011, INFECT GENET EVOL, V11, P1015, DOI 10.1016/j.meegid.2011.03.017; Franceschi DSA, 2009, INT J INFECT DIS, V13, P493, DOI 10.1016/j.ijid.2008.08.019; Amanda M, 2009, INFLAMM ALLERGY DRUG, V8, P53; Ameglio F, 2005, INT J TUBERC LUNG D, V9, P98; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Biketov S, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-146; Catriona HT, 2009, ANN NY ACAD SCI, V1182, P69, DOI [10.1111/j.1749-6632.2009.05069.x, DOI 10.1111/J.1749-6632.2009.05069.X]; Deveci F, 2005, MEDIAT INFLAMM, P256, DOI 10.1155/MI.2005.256; Dhabhar FS, 2009, J PSYCHIATR RES, V43, P962, DOI 10.1016/j.jpsychires.2009.05.010; Djoba Siawaya JF, 2009, CLIN EXP IMMUNOL, V156, P69, DOI 10.1111/j.1365-2249.2009.03875.x; Ellertsen LK, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-100; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Hoffmann SC, 2002, AM J TRANSPLANT, V2, P560, DOI 10.1034/j.1600-6143.2002.20611.x; Hussain R, 2007, CLIN VACCINE IMMUNOL, V14, P1578, DOI 10.1128/CVI.00289-07; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Jepson A, 2001, INFECT IMMUN, V69, P3989, DOI 10.1128/IAI.69.6.3989-3994.2001; Kart L, 2003, MEDIAT INFLAMM, V12, P9, DOI 10.1080/0962935031000096926; Karyadi E, 2007, ASIA PAC J CLIN NUTR, V16, P218; Kawaguchi H, 1996, Kekkaku, V71, P259; Mattos AMM, 2010, INT IMMUNOL, V22, P775, DOI 10.1093/intimm/dxq429; Nakaya M, 1995, Kekkaku, V70, P461; Nemeth J, 2011, CLIN IMMUNOL, V138, P50, DOI 10.1016/j.clim.2010.09.005; Cavalcanti YVN, 2012, PULM MED, V2012, DOI 10.1155/2012/745483; Olobo JO, 2001, SCAND J IMMUNOL, V53, P85, DOI 10.1046/j.1365-3083.2001.00844.x; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Salmaggi A, 1996, J NEUROL, V243, P13; Saunders BM, 2000, INFECT IMMUN, V68, P3322, DOI 10.1128/IAI.68.6.3322-3326.2000; Shu CC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-45; Tang S, 2013, PLOS ONE, V8; Tang Shenjie, 2002, Zhonghua Jiehe He Huxi Zazhi, V25, P325; Turner J, 2002, J IMMUNOL, V169, P6343, DOI 10.4049/jimmunol.169.11.6343; WHO, GLOB TUB CONTR 2011	32	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137727	10.1371/journal.pone.0137727	http://dx.doi.org/10.1371/journal.pone.0137727			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359865	gold, Green Published, Green Submitted			2022-12-26	WOS:000361043100076
J	Tomita, M; Kikuchi, E; Maeda, T; Kabeya, Y; Katsuki, T; Oikawa, Y; Kato, K; Ohashi, M; Nakamura, S; Oya, M; Shimada, A				Tomita, Masuomi; Kikuchi, Eiji; Maeda, Takahiro; Kabeya, Yusuke; Katsuki, Takeshi; Oikawa, Yoichi; Kato, Kiyoe; Ohashi, Masakazu; Nakamura, So; Oya, Mototsugu; Shimada, Akira			Clinical Background of Patients with Sperm in Their Urinary Sediment	PLOS ONE			English	Article							BENIGN PROSTATIC HYPERPLASIA; RETROGRADE EJACULATION; SEXUAL DYSFUNCTION; SEMINAL EMISSION; DOUBLE-BLIND; MEN; ANEJACULATION; SILODOSIN	Introduction The detection rate and associated factors of at least one sperm in urinary sediment is not well-known in real clinical practice. Aims The aim of the present study was to evaluate the clinical features associated with the presence of sperm in urinary sediment in a large number of samples. Methods We conducted a cross-sectional study at Tokyo Saiseikai Central Hospital. We identified 5,005 males who were aged >= 20 years in whom urinary sedimentation had been performed at least twice between May 2011 and June 2012. The sperm group included patients in whom at least one urinary sediment test performed under a microscope had detected at least one sperm. We evaluated the associations between the presence of at least one sperm in urinary sediment and clinical parameters such as various diseases and the use of particular oral medicines. Main Outcomes In total, 1.6% (339/20,937) of urinary sediment samples contained at least one sperm. The sperm group consisted of 282 subjects (5.6%), and the no-sperm group included 4,723 subjects (94.3%). Results Multivariate analysis demonstrated that younger age (< 65) (odds ratio [OR]: 1.71, 95% confidence interval [CI]: 1.32-2.21), the total number of examinations (>= 4) (OR: 1.46, 95% CI: 1.11-1.92), diabetes (OR: 1.72, 95% CI: 1.31-2.25), a history of pelvic surgery for colon cancer (OR: 4.89, 95% CI: 2.38-10.02), alpha-1 blocker use (OR: 1.55, 95% CI: 1.16-2.08), a history of trans-urethral resection of the prostate (OR: 2.77, 95% CI: 1.46-5.13), and selective serotonin reuptake inhibitor use (OR: 2.12, 95% CI: 1.07-4.19) were independent predictors of the presence of at least one sperm in urinary sediment. Conclusion There is considerable overlap between the factors associated with the presence of at least one sperm in urinary sediment and those that are strongly associated with ejaculatory disorders.	[Tomita, Masuomi; Kabeya, Yusuke; Katsuki, Takeshi; Oikawa, Yoichi; Kato, Kiyoe; Shimada, Akira] Tokyo Saiseikai Cent Hosp, Dept Internal Med, Tokyo, Japan; [Kikuchi, Eiji; Oya, Mototsugu] Keio Univ, Sch Med, Dept Urol, Tokyo, Japan; [Maeda, Takahiro; Nakamura, So] Tokyo Saiseikai Cent Hosp, Dept Urol, Tokyo, Japan; [Ohashi, Masakazu] Ogikubo Hosp, Dept Urol, Tokyo, Japan	Tokyo Saiseikai Central Hospital; Keio University; Tokyo Saiseikai Central Hospital	Kikuchi, E (corresponding author), 35 Shinano Machi,Shinjuku Ku, Tokyo, Japan.	eiji-k@kb3.so-net.ne.jp		Kikuchi, Eiji/0000-0002-1624-6676				Ariagno JI, 2005, ARCH ANDROLOGY, V51, P431, DOI 10.1080/014850190953294; Chapple CR, 2011, EUR UROL, V59, P342, DOI 10.1016/j.eururo.2010.10.046; Colpi G, 2004, EUR UROL, V46, P555, DOI 10.1016/j.eururo.2004.07.020; Ebiko M, 2006, JAPANESE J IMPOTENCE, P221; Examinaton of Urinary Sediment, 2010, GP1P4 JCCLS JAP ASS; Fedder J, 2013, ANDROLOGY-US, V1, P602, DOI 10.1111/j.2047-2927.2013.00083.x; Fode M, 2012, ASIAN J ANDROL, V14, P61, DOI 10.1038/aja.2011.70; Grimes DA, 2015, HUM REPROD, V30, P1749, DOI 10.1093/humrep/dev151; Hisasue S, 2006, INT J UROL, V13, P1311, DOI 10.1111/j.1442-2042.2006.01535.x; Jefferys A, 2012, FERTIL STERIL, V97, P306, DOI 10.1016/j.fertnstert.2011.11.019; Kawabe K, 2006, BJU INT, V98, P1019, DOI 10.1111/j.1464-410X.2006.06448.x; Kobayashi K, 2008, J SEX MED, V5, P2185, DOI 10.1111/j.1743-6109.2008.00779.x; Isidro ML, 2012, POSTGRAD MED J, V88, P152, DOI 10.1136/postgradmedj-2011-130069; Madersbacher S, 1999, BJU INT, V83, P227; Marks LS, 2009, J UROLOGY, V181, P2634, DOI 10.1016/j.juro.2009.02.034; Ohl DA, 2008, UROL CLIN N AM, V35, P211, DOI 10.1016/j.ucl.2008.01.014; Rosen RC, 2007, UROLOGY, V69, P805, DOI 10.1016/j.urology.2007.02.036; Schmidt HM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003546.pub3; Schulman CC, 2003, UROLOGY, V62, P24, DOI 10.1016/S0090-4295(03)00471-0; Sivananthan T, 2012, ASIAN J ANDROL, V14, P476, DOI 10.1038/aja.2012.2; Vinik AI, 2003, SEMIN NEUROL, V23, P365; Yee CLS, 2012, UROL INT, V88, P165, DOI 10.1159/000333046	22	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0136844	10.1371/journal.pone.0136844	http://dx.doi.org/10.1371/journal.pone.0136844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359862	gold, Green Submitted, Green Published			2022-12-26	WOS:000361043100016
J	Dreissig, S; Fuchs, J; Capal, P; Kettles, N; Byrne, E; Houben, A				Dreissig, Steven; Fuchs, Joerg; Capal, Petr; Kettles, Nicola; Byrne, Ed; Houben, Andreas			Measuring Meiotic Crossovers via Multi-Locus Genotyping of Single Pollen Grains in Barley	PLOS ONE			English	Article							RECOMBINATION LANDSCAPE	The detection of meiotic crossovers in crop plants currently relies on scoring DNA markers in a segregating population or cytological visualization. We investigated the feasibility of using flow-sorted haploid nuclei, Phi29 DNA polymerase-based whole-genome-amplification (WGA) and multi-locus KASP-genotyping to measure meiotic crossovers in individual barley pollen grains. To demonstrate the proof of concept, we used 24 gene-based physically mapped single nucleotide polymorphisms to genotype the WGA products of 50 single pollen nuclei. The number of crossovers per chromosome, recombination frequencies along chromosome 3H and segregation distortion were analysed and compared to a doubled haploid (DH) population of the same genotype. The number of crossovers and chromosome wide recombination frequencies show that this approach is able to produce results that resemble those obtained from other methods in a biologically meaningful way. Only the segregation distortion was found to be lower in the pollen population than in DH plants.	[Dreissig, Steven; Fuchs, Joerg; Houben, Andreas] Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, D-06466 Stadt Seeland, Germany; [Capal, Petr] Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot, CZ-78371 Olomouc, Czech Republic; [Kettles, Nicola; Byrne, Ed] KWS UK Ltd, Thriplow SG8 7RE, Herts, England	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Houben, A (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, Corrensstr 3, D-06466 Stadt Seeland, Germany.	houben@ipk-gatersleben.de	Houben, Andreas/I-1517-2015	Dreissig, Steven/0000-0002-4766-9698; Fuchs, Joerg/0000-0003-4171-5371; Houben, Andreas/0000-0003-3419-239X	IPK; Ministry of Education, Youth and Sports of the Czech Republic [LO1204]	IPK; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the IPK, P. Capal was supported by the Ministry of Education, Youth and Sports of the Czech Republic (grant LO1204 from the National Program of Sustainability I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz AN, 2008, MOL BREEDING, V21, P227, DOI 10.1007/s11032-007-9123-9; Baker K, 2014, PLANT J, V79, P981, DOI 10.1111/tpj.12600; Chen PH, 2008, J INTEGR PLANT BIOL, V50, P375, DOI 10.1111/j.1744-7909.2007.00624.x; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Copenhaver GP, 2000, PLANT PHYSIOL, V124, P7, DOI 10.1104/pp.124.1.7; Crismani W, 2012, SCIENCE, V336, P1588, DOI 10.1126/science.1220381; de Bourcy CFA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105585; De Storme N, 2011, PLANT PHYSIOL, V155, P1403, DOI 10.1104/pp.110.170415; GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049; Gole J, 2013, NAT BIOTECHNOL, V31, P1126, DOI 10.1038/nbt.2720; Higgins JD, 2012, PLANT CELL, V24, P4096, DOI 10.1105/tpc.112.102483; Kunzel G, 2000, GENETICS, V154, P397; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Milne I, 2010, BIOINFORMATICS, V26, P3133, DOI 10.1093/bioinformatics/btq580; Mirouze M, 2012, P NATL ACAD SCI USA, V109, P5880, DOI 10.1073/pnas.1120841109; Petersen G, 1996, PLANT MOL BIOL, V31, P189, DOI 10.1007/BF00020620; Phillips D, 2013, J EXP BOT, V64, P2139, DOI 10.1093/jxb/ert079; Salome PA, 2012, HEREDITY, V108, P447, DOI 10.1038/hdy.2011.95; Sayed H, 2002, EUPHYTICA, V125, P265, DOI 10.1023/A:1015861610226; SYBENGA J, 1966, GENETICA, V37, P199, DOI 10.1007/BF01547131; Tondelli A, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.03.0007; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030	22	20	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137677	10.1371/journal.pone.0137677	http://dx.doi.org/10.1371/journal.pone.0137677			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356084	gold, Green Published, Green Submitted			2022-12-26	WOS:000360965800077
J	King, TL; Thornton, LE; Bentley, RJ; Kavanagh, AM				King, Tania L.; Thornton, Lukar E.; Bentley, Rebecca J.; Kavanagh, Anne M.			The Use of Kernel Density Estimation to Examine Associations between Neighborhood Destination Intensity and Walking and Physical Activity	PLOS ONE			English	Article							BODY-MASS INDEX; BUILT ENVIRONMENT; FOOD; BEHAVIOR; ACCESS; GIS; MULTILEVEL; MELBOURNE; PROXIMITY; TRANSPORT	Background Local destinations have previously been shown to be associated with higher levels of both physical activity and walking, but little is known about how the distribution of destinations is related to activity. Kernel density estimation is a spatial analysis technique that accounts for the location of features relative to each other. Using kernel density estimation, this study sought to investigate whether individuals who live near destinations (shops and service facilities) that are more intensely distributed rather than dispersed: 1) have higher odds of being sufficiently active; 2) engage in more frequent walking for transport and recreation. Methods The sample consisted of 2349 residents of 50 urban areas in metropolitan Melbourne, Australia. Destinations within these areas were geocoded and kernel density estimates of destination intensity were created using kernels of 400m (meters), 800m and 1200m. Using multilevel logistic regression, the association between destination intensity (classified in quintiles Q1(least)-Q5(most)) and likelihood of: 1) being sufficiently active (compared to insufficiently active); 2) walking >= 4/week (at least 4 times per week, compared to walking less), was estimated in models that were adjusted for potential confounders. Results For all kernel distances, there was a significantly greater likelihood of walking >= 4/week, among respondents living in areas of greatest destinations intensity compared to areas with least destination intensity: 400m (Q4 OR 1.41 95% CI 1.02-1.96; Q5 OR 1.49 95% CI 1.06-2.09), 800m (Q4 OR 1.55, 95% CI 1.09-2.21; Q5, OR 1.71, 95% CI 1.18-2.48) and 1200m (Q4, OR 1.7, 95% CI 1.18-2.45; Q5, OR 1.86 95% CI 1.28-2.71). There was also evidence of associations between destination intensity and sufficient physical activity, however these associations were markedly attenuated when walking was included in the models. Conclusions This study, conducted within urban Melbourne, found that those who lived in areas of greater destination intensity walked more frequently, and showed higher odds of being sufficiently physically active-an effect that was largely explained by levels of walking. The results suggest that increasing the intensity of destinations in areas where they are more dispersed; and or planning neighborhoods with greater destination intensity, may increase residents' likelihood of being sufficiently active for health.	[King, Tania L.; Bentley, Rebecca J.; Kavanagh, Anne M.] Univ Melbourne, Melbourne Sch Populat Hlth, Ctr Hlth Equ, Gender & Womens Hlth, Melbourne, Vic, Australia; [Thornton, Lukar E.] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr Res, Burwood, Vic, Australia	University of Melbourne; Deakin University	King, TL (corresponding author), Univ Melbourne, Melbourne Sch Populat Hlth, Ctr Hlth Equ, Gender & Womens Hlth, Melbourne, Vic, Australia.	tking@unimelb.edu.au	Kavenagh, Mellissa/S-7899-2018; Kavanagh, Anne/U-4826-2019; Thornton, Lukar E/C-9554-2014	King, Tania/0000-0002-1201-2485; Thornton, Lukar/0000-0001-8759-8671; Bentley, Rebecca/0000-0003-3334-7353; Kavanagh, Anne/0000-0002-1573-3464	Victorian Health Promotion Foundation PhD scholarship	Victorian Health Promotion Foundation PhD scholarship	TLK was supported by a Victorian Health Promotion Foundation PhD scholarship. The VicLANES project was funded by the Victorian Health Promotion Foundation.	Armstrong T, 2000, RESULTS 1999 NATL PH; Australian Bureau of Statistics, 2011, NAT HLTH SURV SUMM R; Australian Bureau of Statistics, 2014, AUSTR SOC TRENDS JUL; Australian Bureau of Statistics, 2013, AUSTR HLTH SURV PHYS; Australian Electoral Commission, 2005, MEAS ACC EL ROLLS TE; Australian Institute of Health and Welfare (AIHW), 2003, ACT AUSTR SURV GUID; Bader MDM, 2010, ECON GEOGR, V86, P409, DOI 10.1111/j.1944-8287.2010.01084.x; Bauman A F, 2001, TRENDS POPULATION LE; Buck C, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-65; Centers for Disease Control and Prevention, 1996, PHYS ACT HLTH REP SU; Chaix B, 2009, SOC SCI MED, V69, P1306, DOI 10.1016/j.socscimed.2009.07.018; Charreire H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-59; Department of Health, 2004, LEAST 5 WEEK EV IMP; Dillman D. A., 2000, MAIL INTERNET SURVEY, V2; Environmental Systems Research Institute (ESRI), 2012, ARCGIS 10 1; Frank L., 2003, HLTH COMMUNITY DESIG; Giles-Corti B, 2002, PREV MED, V35, P601, DOI 10.1006/pmed.2002.1115; Guagliardo Mark F, 2004, Int J Health Geogr, V3, P3; Halldin M, 2007, NUTR METAB CARDIOVAS, V17, P349, DOI 10.1016/j.numecd.2006.01.002; Handy S, 2006, J AM PLANN ASSOC, V72, P55, DOI 10.1080/01944360608976724; Hoehner CM, 2005, AM J PREV MED, P28; Jones-Smith JC, 2013, DIABETES CARE, V36, P2697, DOI 10.2337/dc12-2190; Kavanagh AM, 2005, J EPIDEMIOL COMMUN H, V59, P934, DOI 10.1136/jech.2005.035931; Kavanagh AM, 2011, ADDICTION, V106, P1772, DOI 10.1111/j.1360-0443.2011.03510.x; King T, 2006, INT J OBESITY, V30, P281, DOI 10.1038/sj.ijo.0803176; Kloog I, 2009, COMPUT ENVIRON URBAN, V33, P55, DOI 10.1016/j.compenvurbsys.2008.09.006; Krizek KJ, 2006, J AM PLANN ASSOC, V72, P33, DOI 10.1080/01944360608976722; Lee C, 2006, TRANSPORT RES D-TR E, V11, P204, DOI 10.1016/j.trd.2006.02.003; Maroko AR, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-34; Mbalilaki JA, 2007, NUTR METAB CARDIOVAS, V17, P344, DOI 10.1016/j.numecd.2006.03.003; McConville ME, 2011, AM J PREV MED, V40, P25, DOI 10.1016/j.amepre.2010.09.023; McCormack GR, 2008, PREV MED, V46, P33, DOI 10.1016/j.ypmed.2007.01.013; McCormack GR, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-125; Millward H, 2013, J TRANSP GEOGR, V28, P101, DOI 10.1016/j.jtrangeo.2012.11.012; Moore K, 2013, J EPIDEMIOL COMMUN H, V67, P846, DOI 10.1136/jech-2013-202682; Moore LV, 2008, J URBAN HEALTH, V85, P206, DOI 10.1007/s11524-008-9259-x; Nathan A, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-133; Owen N, 2007, AM J PREV MED, V33, P387, DOI 10.1016/j.amepre.2007.07.025; Owen N, 2010, J URBAN HEALTH, V87, P189, DOI 10.1007/s11524-009-9424-x; Roberts C. K., 2013, COMPREHENSIVE PHYSL; Roux AVD, 2007, AM J PUBLIC HEALTH, V97, P493, DOI 10.2105/AJPH.2006.087734; Rundle A, 2009, ENVIRON HEALTH PERSP, V117, P442, DOI 10.1289/ehp.11590; Saelens BE, 2008, MED SCI SPORT EXER, V40, pS550, DOI 10.1249/MSS.0b013e31817c67a4; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Simpson ME, 2003, AM J PREV MED, V25, P95, DOI 10.1016/S0749-3797(03)00112-0; Smiley MJ, 2010, HEALTH PLACE, V16, P885, DOI 10.1016/j.healthplace.2010.04.014; Sugiyama T, 2012, ASIA PACIFIC J PUBLI; Sugiyama T, 2012, MED SCI SPORT EXER, V44, P1275, DOI 10.1249/MSS.0b013e318247d286; Sugiyama T, 2009, HEALTH PLACE, V15, P1058, DOI 10.1016/j.healthplace.2009.05.001; Suminski RR, 2005, AM J PREV MED, V28, P149, DOI 10.1016/j.amepre.2004.09.009; Thornton LE, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-29; Thornton LE, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-71; Thornton LE, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-28; Witten K, 2012, ENVIRON HEALTH PERSP, V120, P971, DOI 10.1289/ehp.1104584; Witten K, 2011, ENVIRON PLANN A, V43, P205, DOI 10.1068/a43219	55	12	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137402	10.1371/journal.pone.0137402	http://dx.doi.org/10.1371/journal.pone.0137402			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9WL	26355848	Green Published, Green Submitted, gold			2022-12-26	WOS:000360965800045
J	Mori, S; Usami, N; Fukumoto, K; Mizuno, T; Kuroda, H; Sakakura, N; Yokoi, K; Sakao, Y				Mori, Shunsuke; Usami, Noriyasu; Fukumoto, Koichi; Mizuno, Tetsuya; Kuroda, Hiroaki; Sakakura, Noriaki; Yokoi, Kohei; Sakao, Yukinori			The Significance of the Prognostic Nutritional Index in Patients with Completely Resected Non-Small Cell Lung Cancer	PLOS ONE			English	Article							LYMPHOCYTE; PREDICTORS; SURVIVAL; CARCINOMA; SMOKING; COUNTS	Objectives Immunological parameters and nutritional status influence the outcome of patients with malignant tumors. A prognostic nutritional index, calculated using serum albumin levels and peripheral lymphocyte count, has been used to assess prognosis for various cancers. This study aimed to investigate whether this prognostic nutritional index affects overall survival and the incidence of postoperative complications in patients with completely resected nonsmall cell lung cancer. Methods We retrospectively reviewed the medical records of 409 patients with non-small cell lung cancer who underwent complete resection between 2005 and 2007 at the Aichi Cancer Center. Results The 5-year survival rates of patients with high (>= 50) and low (< 50) prognostic nutritional indices were 84.4% and 70.7%, respectively (p = 0.0011). Univariate analysis showed that gender, histology, pathological stage, smoking history, serum carcinoembryonic antigen levels, and prognostic nutritional index were significant prognostic factors. Multivariate analysis identified pathological stage and the prognostic nutritional index as independent prognostic factors. The frequency of postoperative complications tended to be higher in patients with a low prognostic nutritional index. Conclusions The prognostic nutritional index is an independent prognostic factor for survival of patients with completely resected non-small cell lung cancer.	[Mori, Shunsuke; Usami, Noriyasu; Mizuno, Tetsuya; Kuroda, Hiroaki; Sakakura, Noriaki; Sakao, Yukinori] Aichi Canc Ctr Hosp, Dept Thorac Surg, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Mori, Shunsuke; Usami, Noriyasu; Fukumoto, Koichi; Yokoi, Kohei] Nagoya Univ, Grad Sch Med, Dept Thorac Surg, Showa Ku, Nagoya, Aichi 4668550, Japan	Aichi Cancer Center; Nagoya University	Sakao, Y (corresponding author), Aichi Canc Ctr Hosp, Dept Thorac Surg, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	ysakao@aichi-cc.jp	Sakakura, Noriaki/HCI-9070-2022; Fukumoto, Koichi/M-4842-2014; Yokoi, Kohei/I-7261-2014	Sakao, Yukinori/0000-0002-6826-2280; Sakakura, Noriaki/0000-0002-9598-9629				Alvares-da-Silva MR, 2005, NUTRITION, V21, P113, DOI 10.1016/j.nut.2004.02.002; BUZBY GP, 1980, AM J SURG, V139, P160, DOI 10.1016/0002-9610(80)90246-9; Cerfolio RJ, 2009, ANN THORAC SURG, V88, P405, DOI 10.1016/j.athoracsur.2009.04.015; Fogar P, 2006, PANCREAS, V32, P22, DOI 10.1097/01.mpa.0000188305.90290.50; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Gupta D, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-69; Hespanhol V, 1995, LUNG CANCER, V13, P253, DOI 10.1016/0169-5002(95)00497-1; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kanda M, 2011, BRIT J SURG, V98, P268, DOI 10.1002/bjs.7305; Kobayashi N, 2012, LUNG CANCER, V75, P223, DOI 10.1016/j.lungcan.2011.06.009; Marugame T, 2005, CANCER SCI, V96, P120, DOI 10.1111/j.1349-7006.2005.00013.x; Muers MF, 1996, THORAX, V51, P894, DOI 10.1136/thx.51.9.894; Nozoe T, 2002, EUR J SURG ONCOL, V28, P396, DOI 10.1053/ejso.2002.1257; Nozoe T, 2010, SURG TODAY, V40, P440, DOI 10.1007/s00595-009-4065-y; Okada M, 2004, ANN THORAC SURG, V78, P216, DOI 10.1016/j.athoracsur.2004.02.009; Onodera T, 1984, Nihon Geka Gakkai Zasshi, V85, P1001; OWNBY HE, 1983, CANCER, V52, P126, DOI 10.1002/1097-0142(19830701)52:1<126::AID-CNCR2820520123>3.0.CO;2-Y; PAESMANS M, 1995, J CLIN ONCOL, V13, P1221, DOI 10.1200/JCO.1995.13.5.1221; Pinato DJ, 2012, BRIT J CANCER, V106, P1439, DOI 10.1038/bjc.2012.92; Sawabata N, 2011, J THORAC ONCOL, V6, P1229, DOI 10.1097/JTO.0b013e318219aae2; Suzuki K, 1999, CANCER-AM CANCER SOC, V86, P1976, DOI 10.1002/(SICI)1097-0142(19991115)86:10<1976::AID-CNCR14>3.0.CO;2-I; Teramukai S, 2009, EUR J CANCER, V45, P1950, DOI 10.1016/j.ejca.2009.01.023; Wakai K, 2006, JPN J CLIN ONCOL, V36, P309, DOI 10.1093/jjco/hyl025	23	69	70	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0136897	10.1371/journal.pone.0136897	http://dx.doi.org/10.1371/journal.pone.0136897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356222	Green Submitted, gold, Green Published			2022-12-26	WOS:000360965800018
J	Riedelsberger, J; Dreyer, I; Gonzalez, W				Riedelsberger, Janin; Dreyer, Ingo; Gonzalez, Wendy			Outward Rectification of Voltage-Gated K+ Channels Evolved at Least Twice in Life History	PLOS ONE			English	Article							POTASSIUM CHANNEL; INWARD RECTIFICATION; S4-S5 LINKER; SENSOR; EXPRESSION; ACTIVATION; MECHANISM; TRANSPORT; REQUIRES; MODELS	Voltage-gated potassium (K+) channels are present in all living systems. Despite high structural similarities in the transmembrane domains (TMD), this K+ channel type segregates into at least two main functional categories-hyperpolarization-activated, inward-rectifying (Kin) and depolarization-activated, outward-rectifying (Kout) channels. Voltage-gated K+ channels sense the membrane voltage via a voltage-sensing domain that is connected to the conduction pathway of the channel. It has been shown that the voltage-sensing mechanism is the same in Kin and Kout channels, but its performance results in opposite pore conformations. It is not known how the different coupling of voltage-sensor and pore is implemented. Here, we studied sequence and structural data of voltage-gated K+ channels from animals and plants with emphasis on the property of opposite rectification. We identified structural hotspots that alone allow already the distinction between Kin and Kout channels. Among them is a loop between TMD S5 and the pore that is very short in animal Kout, longer in plant and animal Kin and the longest in plant Kout channels. In combination with further structural and phylogenetic analyses this finding suggests that outward-rectification evolved twice and independently in the animal and plant kingdom.	[Riedelsberger, Janin; Dreyer, Ingo; Gonzalez, Wendy] Univ Talca, CBSM, Talca, Chile; [Dreyer, Ingo] Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, Madrid, Spain; [Dreyer, Ingo] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany	Universidad de Talca; Universidad Politecnica de Madrid; University of Potsdam	Riedelsberger, J (corresponding author), Univ Talca, CBSM, Talca, Chile.	jriedelsberger@utalca.cl; idreyer@utalca.cl	Dreyer, Ingo/N-4747-2014	Dreyer, Ingo/0000-0002-2781-0359; Riedelsberger, Janin/0000-0002-4687-7495; Gonzalez, Wendy/0000-0002-7535-6883	Chilean Fondo Nacional de Desarrollo Cientifico y Tecnologico [3150173, 1140624]; Chilean Comision Nacional de Investigacion Cientifica y Tecnologica [Anillo ACT-1104]; Deutsche Forschungsgemeinschaft [DR430/8-1]; Marie Curie Career Integration Grant of the European Union [303674-Regopoc]	Chilean Fondo Nacional de Desarrollo Cientifico y Tecnologico; Chilean Comision Nacional de Investigacion Cientifica y Tecnologica; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Marie Curie Career Integration Grant of the European Union	This work was supported by grants from the Chilean Fondo Nacional de Desarrollo Cientifico y Tecnologico (http://www.conicyt.cl/fondecyt) to JR (No. 3150173) and WG (No. 1140624), and by the Chilean Comision Nacional de Investigacion Cientifica y Tecnologica (http://www.conicyt.cl) to JR and WG (Anillo ACT-1104). ID was supported by grants of the Deutsche Forschungsgemeinschaft (DR430/8-1) (http://www.dfg.de/) and Marie Curie Career Integration Grant of the European Union (FP7-PEOPLE-2011-CIG No. 303674-Regopoc) (http://ec.europa.eu/research/mariecurieactions/about-mca/actions/cig/index_en.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JA, 1992, P NATL ACAD SCI USA, V89, P3736, DOI 10.1073/pnas.89.9.3736; Anselmi C, 2007, PROTEINS, V66, P136, DOI 10.1002/prot.21187; Bright J N, 2004, IEE Proc Nanobiotechnol, V151, P17, DOI 10.1049/ip-nbt:20040101; Caprini M, 2005, J BIOL CHEM, V280, P18253, DOI 10.1074/jbc.M413389200; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; DIFRANCESCO D, 1981, J PHYSIOL-LONDON, V314, P377, DOI 10.1113/jphysiol.1981.sp013714; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dreyer I, 2001, FEBS LETT, V505, P233, DOI 10.1016/S0014-5793(01)02832-0; Dreyer I, 2009, TRENDS PLANT SCI, V14, P383, DOI 10.1016/j.tplants.2009.04.001; DURELL SR, 1992, BIOPHYS J, V62, P238, DOI 10.1016/S0006-3495(92)81809-X; Gajdanowicz P, 2009, NEW PHYTOL, V182, P380, DOI 10.1111/j.1469-8137.2008.02749.x; Gonzalez C, 2012, COMPR PHYSIOL, V2, P2087, DOI 10.1002/cphy.c110047; Hori K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4978; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Jensen MO, 2010, P NATL ACAD SCI USA, V107, P5833, DOI 10.1073/pnas.0911691107; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Johansson I, 2006, PLANT J, V46, P269, DOI [10.1111/j.1365-313X.2006.02690.x, 10.1111/j.1365-313X.2006.02690.X]; Kwan DCH, 2012, J GEN PHYSIOL, V140, P279, DOI 10.1085/jgp.201210838; Labro AJ, 2003, J BIOL CHEM, V278, P50724, DOI 10.1074/jbc.M306097200; Labro AJ, 2008, J GEN PHYSIOL, V132, P667, DOI 10.1085/jgp.200810048; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Latorre R, 2003, J GEN PHYSIOL, V122, P459, DOI 10.1085/jgp.200308818; Lee SY, 2009, PLOS BIOL, V7, P676, DOI 10.1371/journal.pbio.1000047; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Gomez-Porras JL, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00167; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; Michard E, 2005, J GEN PHYSIOL, V126, P605, DOI 10.1085/jgp.200509413; Michard E, 2005, PLANT J, V44, P783, DOI 10.1111/j.1365-313X.2005.02566.x; Nieves-Cordones M, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/15592316.2014.972892; Poree F, 2005, BIOCHEM BIOPH RES CO, V332, P465, DOI 10.1016/j.bbrc.2005.04.150; Riedelsberger J, 2010, MOL PLANT, V3, P236, DOI 10.1093/mp/ssp096; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; SENTENAC H, 1992, SCIENCE, V256, P663, DOI 10.1126/science.1585180; Sesti F, 2003, NAT NEUROSCI, V6, P353, DOI 10.1038/nn1028; Sharma T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00224; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; Very AA, 2014, J PLANT PHYSIOL, V171, P748, DOI 10.1016/j.jplph.2014.01.011; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103	47	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137600	10.1371/journal.pone.0137600	http://dx.doi.org/10.1371/journal.pone.0137600			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356684	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000360965800068
J	Roper, AC; Orabi, J; Lutken, H; Christensen, B; Skou, AMT; Muller, R				Roper, Anna-Catharina; Orabi, Jihad; Lutken, Henrik; Christensen, Brian; Skou, Anne-Marie Thonning; Muller, Renate			Phenotypic and Genotypic Analysis of Newly Obtained Interspecific Hybrids in the Campanula Genus	PLOS ONE			English	Article							HYBRIDIZATION; POLYMORPHISMS; CONSTRUCTION; INHERITANCE; PHYLOGENY; MARKERS; AFLP	Interspecific hybridisation creates new phenotypes within several ornamental plant species including the Campanula genus. We have employed phenotypic and genotypic methods to analyse and evaluate interspecific hybridisation among cultivars of four Campanula species, i.e. C. cochleariifolia, C. isophylla, C. medium and C. formanekiana. Hybrids were analysed using amplified fragment length polymorphism (AFLP), flow cytometry and biometrical measurements. Results of correlation matrices demonstrated heterogeneous phenotypes for the parental species, which confirmed our basic premise for new phenotypes of interspecific hybrids. AFLP assays confirmed the hybridity and identified self-pollinated plants. Limitation of flow cytometry analysis detection was observed while detecting the hybridity status of two closely related parents, e.g. C. cochleariiafolia x C. isophylla. Phenotypic characteristics such as shoot habitus and flower colour were strongly influenced by one of the parental species in most crosses. Rooting analysis revealed that inferior rooting quality occurred more often in interspecific hybrids than in the parental species. Only interspecific hybrid lines of C. formanekiana 'White' x C. medium 'Pink' showed a high rooting level. Phenotype analyses demonstrated a separation from the interspecific hybrid lines of C. formanekiana 'White' x C. medium 'Pink' to the other clustered hybrids of C. formanekiana and C. medium. In our study we demonstrated that the use of correlation matrices is a suitable tool for identifying suitable cross material. This study presents a comprehensive overview for analysing newly obtained interspecific hybrids. The chosen methods can be used as guidance for analyses for further interspecific hybrids in Campanula, as well as in other ornamental species.	[Roper, Anna-Catharina; Lutken, Henrik; Muller, Renate] Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, DK-2630 Taastrup, Denmark; [Orabi, Jihad] Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, DK-1871 Frederiksberg, Denmark; [Christensen, Brian; Skou, Anne-Marie Thonning] AgroTech AS, Inst Agri Technol & Food Innovat, DK-2630 Taastrup, Denmark	University of Copenhagen; University of Copenhagen	Roper, AC (corresponding author), Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, Hojbakkegaard Alle 9-13, DK-2630 Taastrup, Denmark.	ac.roeper@gmail.com	Orabi, Jihad/ABB-1020-2020; Müller, Renate/F-8932-2014; Lutken, Henrik/F-9449-2014	Müller, Renate/0000-0003-4029-240X; Orabi, Jihad/0000-0001-9641-6657; Lutken, Henrik/0000-0003-3719-8324	Danish Agency for Science, Technology and Innovation; Copenhagen University; Nordic Seed A/S; AgroTech A/S	Danish Agency for Science, Technology and Innovation; Copenhagen University; Nordic Seed A/S; AgroTech A/S	Funding: This project has partly been funded by the Danish Agency for Science, Technology and Innovation and supported by Copenhagen University by co-funding of the PhD project of A-CR (http://ufm.dk/en/the-minister-and-the-ministry/organisation/the-danish-agency-for-science-technology-and-innovation). Nordic Seed A/S and AgroTech A/S provided support in the form of salaries for authors JO, BC and AMTS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alarcon M, 2013, MOL PHYLOGENET EVOL, V69, P828, DOI 10.1016/j.ympev.2013.06.021; Aleza P, 2010, PLANT CELL REP, V29, P1023, DOI 10.1007/s00299-010-0888-7; Banjanac T, 2014, TURK J BOT, V38, P68, DOI 10.3906/bot-1211-58; Bogdanova VS, 2007, THEOR APPL GENET, V114, P333, DOI 10.1007/s00122-006-0436-6; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Butlin R, 2012, TRENDS ECOL EVOL, V27, P27, DOI 10.1016/j.tree.2011.09.002; Carl P., 2013, ECONOMETRIC TOOLS PE; Evgenidis G, 2011, HINDAWI PUBLISHING C, V2011, P1; Fedorov AA, 1957, CAMPANULACEAE, V24, P92; Floradania Marketing A/S, 2014, TOP 10 PROD PLANTS D; Fourar-Belaifa R, 2011, J STORED PROD RES, V47, P48, DOI 10.1016/j.jspr.2010.09.002; GESLOT A, 1980, PLANT SYST EVOL, V134, P193, DOI 10.1007/BF00986799; Haarman BCM, 2014, J BIOMEDICA IN PRESS; HOFINGER BJ, 2000, BIOTECHNOLOGICAL APP, P215; Husson F, 2014, MULTIVARIATE EXPLORA, P16; Ikeda Y, 2007, PLANT CELL PHYSIOL, V48, P205, DOI 10.1093/pcp/pcl061; Ishizaka H, 2008, PLANT BIOTECHNOL-NAR, V25, P511, DOI 10.5511/plantbiotechnology.25.511; Jorgensen MH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-346; Kinoshita T, 2007, GENES GENET SYST, V82, P177, DOI 10.1266/ggs.82.177; Kovacic Sanja, 2004, Acta Botanica Croatica, V63, P171; Kradolfer D, 2013, DEV CELL, V26, P525, DOI 10.1016/j.devcel.2013.08.006; Kumari M, 2009, CRIT REV PLANT SCI, V28, P393, DOI 10.1080/07352680903133252; Lammers GL, 2007, WORLD CHECK LIST BIB, P144; Lammers Thomas G., 1996, SIDA Contributions to Botany, V17, P519; Martienssen RA, 2010, NEW PHYTOL, V186, P46, DOI 10.1111/j.1469-8137.2010.03193.x; Meiners J, 2012, PLANT BIOLOGY, V14, P576, DOI 10.1111/j.1438-8677.2011.00542.x; Miyashita T, 2010, SCI HORTIC-AMSTERDAM, V125, P692, DOI 10.1016/j.scienta.2010.05.032; Munoz-Amatriain M, 2009, FUNCT INTEGR GENOMIC, V9, P311, DOI 10.1007/s10142-009-0113-3; Nicchols G, 2006, DWARF CAMPANULAS ASS; NYMAN Y, 1991, PLANT SYST EVOL, V177, P185, DOI 10.1007/BF00937956; Park JM, 2006, SYST BOT, V31, P862, DOI 10.1600/036364406779695924; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Ronikier M, 2008, MOL ECOL, V17, P1763, DOI 10.1111/j.1365-294X.2008.03664.x; Roper A-C, EUPHYTICA IN PRESS; Roquet C, 2008, SYST BOT, V33, P203, DOI 10.1600/036364408783887465; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Schulte K, 2010, MOL PHYLOGENET EVOL, V57, P1105, DOI 10.1016/j.ympev.2010.09.001; Singh RJ., 2003, PLANT CYTOGENETICS; Strid A, 1985, CHROMOSOME NUMBERS G; Sujatha M, 2003, GENET RESOUR CROP EV, V50, P75, DOI 10.1023/A:1022961028064; Tornadore N, 1974, NUMERI CHROMOSMICI F; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Walia H, 2009, CURR BIOL, V19, P1128, DOI 10.1016/j.cub.2009.05.068; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; Ziems LA, 2014, THEOR APPL GENET, V127, P1199, DOI 10.1007/s00122-014-2291-1	46	4	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137537	10.1371/journal.pone.0137537	http://dx.doi.org/10.1371/journal.pone.0137537			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352688	Green Published, gold, Green Submitted			2022-12-26	WOS:000360932800094
J	Bruchmann, M; Thaler, K; Vorberg, D				Bruchmann, Maximilian; Thaler, Kathrin; Vorberg, Dirk			Visible Persistence of Single-Transient Random Dot Patterns: Spatial Parameters Affect the Duration of Fading Percepts	PLOS ONE			English	Article							VISUAL PERSISTENCE; CORTICAL DYNAMICS; STIMULUS-DURATION; NEURAL DYNAMICS; GANGLION-CELLS; LUMINANCE; ONSET; SEGREGATION; INFORMATION; COMPLETION	Visible persistence refers to the continuation of visual perception after the physical termination of a stimulus. We studied an extreme case of visible persistence by presenting two matrices of randomly distributed black and white pixels in succession. On the transition from one matrix to the second, the luminance polarity of all pixels within a disk- or annulus-shaped area reversed, physically creating a single second-order transient signal. This transient signal produces the percept of a disk or an annulus with an abrupt onset and a gradual offset. To study the nature of this fading percept we varied spatial parameters, such as the inner and the outer diameter of annuli (Experiment I) and the radius and eccentricity of disks (Experiment III), and measured the duration of visible persistence by having subjects adjust the synchrony of the onset of a reference stimulus with the onset or the offset of the fading percept. We validated this method by comparing two modalities of the reference stimuli (Experiment I) and by comparing the judgments of fading percepts with the judgments of stimuli that actually fade in luminance contrast (Experiment II). The results show that (i) irrespective of the reference modality, participants are able to precisely judge the on- and the offsets of the fading percepts, (ii) auditory reference stimuli lead to higher visible persistence durations than visual ones, (iii) visible persistence duration increases with the thickness of annuli and the diameter of disks, but decreases with the diameter of annuli, irrespective of stimulus eccentricity. These effects cannot be explained by stimulus energy, which suggests that more complex processing mechanisms are involved. Seemingly contradictory effects of disk and annulus diameter can be unified by assuming an abstract filling-in mechanism that speeds up with the strength of the edge signal and takes more time the larger the stimulus area is.	[Bruchmann, Maximilian] Univ Munster, Inst Med Psychol & Syst Neurosci, D-48149 Munster, Germany; [Thaler, Kathrin] Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany; [Vorberg, Dirk] Univ Munster, Dept Psychol, D-48149 Munster, Germany	University of Munster; University of Munster; University of Munster	Bruchmann, M (corresponding author), Univ Munster, Inst Med Psychol & Syst Neurosci, D-48149 Munster, Germany.	Maximilian.Bruchmann@uni-muenster.de			German Research Foundation [BR3832/1-2]	German Research Foundation(German Research Foundation (DFG))	MB received funding from the the German Research Foundation (www.dfg.de), grant number: BR3832/1-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRINGTON KF, 1994, VISION RES, V34, P3371, DOI 10.1016/0042-6989(94)90071-X; BOWEN RW, 1974, VISION RES, V14, P295, DOI 10.1016/0042-6989(74)90079-0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CAVANAGH P, 1989, Spatial Vision, V4, P103, DOI 10.1163/156856889X00077; COLTHEART M, 1980, PERCEPT PSYCHOPHYS, V27, P183, DOI 10.3758/BF03204258; CRONER LJ, 1995, VISION RES, V35, P7, DOI 10.1016/0042-6989(94)E0066-T; DILOLLO V, 1995, PSYCHOL BULL, V118, P223, DOI 10.1037/0033-2909.118.2.223; DILOLLO V, 1977, NATURE, V267, P241, DOI 10.1038/267241a0; EFRON R, 1970, NEUROPSYCHOLOGIA, V8, P37, DOI 10.1016/0028-3932(70)90024-2; EFRON R, 1970, NEUROPSYCHOLOGIA, V8, P57, DOI 10.1016/0028-3932(70)90025-4; EFRON R, 1970, PERCEPT PSYCHOPHYS, V8, P231, DOI 10.3758/BF03210211; Ferber S, 2005, NEUROPSYCHOLOGIA, V43, P41, DOI 10.1016/j.neuropsychologia.2004.06.020; Ferber S, 2003, CEREB CORTEX, V13, P716, DOI 10.1093/cercor/13.7.716; Francis G, 1996, PERCEPTION, V25, P543, DOI 10.1068/p250543; Francis G, 1999, SPATIAL VISION, V12, P31, DOI 10.1163/156856899X00021; FRANCIS G, 1994, VISION RES, V34, P1089, DOI 10.1016/0042-6989(94)90012-4; Francis G, 1996, PERCEPT PSYCHOPHYS, V58, P1103, DOI 10.3758/BF03206836; GRONER M T, 1988, Spatial Vision, V3, P293, DOI 10.1163/156856888X00177; Grossberg S, 1999, VISION RES, V39, P3796, DOI 10.1016/S0042-6989(99)00095-4; GROSSBERG S, 1985, PSYCHOL REV, V92, P173, DOI 10.1037/0033-295X.92.2.173; IKEDA H, 1972, J PHYSIOL-LONDON, V227, P769, DOI 10.1113/jphysiol.1972.sp010058; IRWIN DE, 1986, J EXP PSYCHOL HUMAN, V12, P343, DOI 10.1037/0096-1523.12.3.343; Kleiner M, 2007, PERCEPTION, V36, P14; KLING SC, 1983, B PSYCHONOMIC SOC, V21, P435, DOI 10.3758/BF03330001; LOFTUS GR, 1992, J EXP PSYCHOL HUMAN, V18, P530, DOI 10.1037/0096-1523.18.2.530; Loftus GR, 1998, COGNITIVE PSYCHOL, V35, P135, DOI 10.1006/cogp.1998.0678; LONG GM, 1985, PERCEPT PSYCHOPHYS, V38, P381, DOI 10.3758/BF03207167; LONG GM, 1981, VISION RES, V21, P1387, DOI 10.1016/0042-6989(81)90244-3; LOVEGROVE WJ, 1984, VISION RES, V24, P255, DOI 10.1016/0042-6989(84)90128-7; MEYER GE, 1988, CAN J PSYCHOL, V42, P479, DOI 10.1037/h0084201; PARADISO MA, 1991, VISION RES, V31, P1221, DOI 10.1016/0042-6989(91)90047-9; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pessoa L, 1998, BEHAV BRAIN SCI, V21, P723; REGAN D, 1986, Spatial Vision, V1, P305, DOI 10.1163/156856886X00106; REGAN D, 1984, J OPT SOC AM A, V1, P433, DOI 10.1364/JOSAA.1.000433; Sackur J, 2011, J VISION, V11, DOI 10.1167/11.4.10; SHIOIRI S, 1992, VISION RES, V32, P943, DOI 10.1016/0042-6989(92)90037-J; SPERLING G, 1967, ACTA PSYCHOL, V27, P285, DOI 10.1016/0001-6918(67)90070-4; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; WILSON JTL, 1981, PERCEPT PSYCHOPHYS, V30, P353, DOI 10.3758/BF03206150; WILSON JTL, 1983, VISION RES, V23, P1699, DOI 10.1016/0042-6989(83)90186-4; Wong YJ, 2009, J NEUROPHYSIOL, V102, P3461, DOI 10.1152/jn.00243.2009; YEOMANS JM, 1985, PERCEPT PSYCHOPHYS, V37, P163, DOI 10.3758/BF03202852	43	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137091	10.1371/journal.pone.0137091	http://dx.doi.org/10.1371/journal.pone.0137091			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348616	gold, Green Published, Green Submitted			2022-12-26	WOS:000360897600021
J	Mejean, C; Morzel, M; Neyraud, E; Issanchou, S; Martin, C; Bozonnet, S; Urbano, C; Schlich, P; Hercberg, S; Peneau, S; Feron, G				Mejean, Caroline; Morzel, Martine; Neyraud, Eric; Issanchou, Sylvie; Martin, Christophe; Bozonnet, Sophie; Urbano, Christine; Schlich, Pascal; Hercberg, Serge; Peneau, Sandrine; Feron, Gilles			Salivary Composition Is Associated with Liking and Usual Nutrient Intake	PLOS ONE			English	Article							PROTEIN PROFILES; SODIUM-CHLORIDE; LIFE-STYLE; TASTE PREFERENCES; FAT PERCEPTION; DIETARY-SODIUM; BITTER TASTE; URIC-ACID; FOOD; CONSUMPTION	Salivary flow and composition have an impact on flavor perception. However, very few studies have explored the relationship between saliva, individual liking and usual dietary intake. The aim of our study was to evaluate the association of salivary flow and composition with both a liking for fat, saltiness and sweetness and the usual nutrient intake in an adult French population. Liking for fat, saltiness, and sweetness were inferred from liking scores obtained during hedonic tests on 32 food products among 282 French adults participating in the Nutrinet-Sante Study. Before assessing liking, resting saliva was collected. Standard biochemical analyses were performed to assess specific component concentrations and enzymatic activities. Dietary data were collected using three web-based 24h records. Relationships between salivary flow and composition, sensory liking and nutrient intake were assessed using linear regression. Total antioxidant capacity was positively associated with simple carbohydrate intake (beta = 31.3, 95% CI = 1.58; 60.99) and inversely related to complex carbohydrate consumption (beta = -52.4, 95% CI = -87.51; -19.71). Amylolysis was positively associated with both total (beta = 0.20, 95% CI = 0.01; 0.38) and simple carbohydrate intake (beta = 0.21, 95% CI = 0.01; 0.39). Salivary flow was positively associated with liking for fat (beta = 0.14, 95% CI = 0.03; 0.25). Proteolysis was positively associated with liking for saltiness and for fat (beta = 0.31, 95% CI = 0.02; 0.59; beta = 0.28, 95% CI = 0.01; 0.56, respectively). Amylolysis was inversely associated with liking for sweetness (beta = -10.13, 95% CI = -19.51; -0.75). Carbonic anhydrase 6 was inversely associated with liking for saltiness (beta = -46.77, 95% CI = -86.24; -7.30). Saliva does not substantially vary according to a usual diet, except for carbohydrate intake, whereas the specific association between salivary flow/composition and sensory liking suggests the influence of saliva characteristics in food acceptance.	[Mejean, Caroline; Hercberg, Serge; Peneau, Sandrine] Univ Paris 07, Univ Paris 05,COMUE, Univ Paris 13,U1125,Cnam,EREN,Sorbonne Paris Cite, Ctr Epidemiol & Stat Paris Nord,Inserm,U1153,Inra, F-93017 Bobigny, France; [Morzel, Martine; Neyraud, Eric; Issanchou, Sylvie; Martin, Christophe; Urbano, Christine; Schlich, Pascal; Feron, Gilles] CNRS, Ctr Sci Gout & Alimentat, UMR6265, F-21000 Dijon, France; [Morzel, Martine; Neyraud, Eric; Issanchou, Sylvie; Martin, Christophe; Urbano, Christine; Schlich, Pascal; Feron, Gilles] INRA, Ctr Sci Gout & Alimentat, UMR1324, F-21000 Dijon, France; [Morzel, Martine; Neyraud, Eric; Issanchou, Sylvie; Martin, Christophe; Urbano, Christine; Schlich, Pascal; Feron, Gilles] Univ Bourgogne, Ctr Sci Gout & Alimentat, UMR, F-21000 Dijon, France; [Bozonnet, Sophie] Univ Toulouse, INSA, UPS, INP,LISBP, F-31077 Toulouse, France; [Bozonnet, Sophie] INRA, UMR792, Ingn Syst Biol & Proc, F-31400 Toulouse, France; [Bozonnet, Sophie] CNRS, UMR5504, F-31400 Toulouse, France; [Hercberg, Serge] Hop Avicenne, Dept Publ Hlth, F-93300 Bobigny, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13	Mejean, C (corresponding author), Univ Paris 07, Univ Paris 05,COMUE, Univ Paris 13,U1125,Cnam,EREN,Sorbonne Paris Cite, Ctr Epidemiol & Stat Paris Nord,Inserm,U1153,Inra, F-93017 Bobigny, France.	c.mejean@uren.smbh.univ-paris13.fr	Serge, Hercberg/F-3038-2017; HERCBERG, Serge/B-4429-2008; Peneau, Sandrine/F-2701-2017; Neyraud, Eric/L-2296-2017; Schlich, Pascal/AAM-1384-2020; Schlich, Pascal/O-6869-2015; FERON, Gilles/AAW-8714-2020; Schlich, Pascal/AES-0066-2022	Serge, Hercberg/0000-0002-3168-1350; HERCBERG, Serge/0000-0002-3168-1350; Peneau, Sandrine/0000-0002-3463-0989; Neyraud, Eric/0000-0001-7060-1336; Schlich, Pascal/0000-0001-7919-5135; Morzel, Martine/0000-0002-3589-3641; Bozonnet, Sophie/0000-0001-5091-2209; Feron, Gilles/0000-0002-9522-9654	French National Research Agency (Agence Nationale de la Recherche) in the context of the Programme de Recherche "Alimentation et Industries Alimentaires" (Epipref project) [ANR-08-ALIA-006]; INRA' Metaprogramme Did'It (Diet Impact and Determinants Interactions and Transitions); Regional Council of Burgundy France (PARI Agral 1); FEDER (European Funding for Regional Economical Development); Ministere de la Sante (DGS); Institut de Veille Sanitaire (InVS); Institut National de la Prevention et de l'Education pour la Sante (INPES); Fondation pour la Recherche Medicale (FRM); Institut de Recherche en Sante Publique (IRESP); Institut National de la Sante et de la Recherche Medicale (INSERM); Institut National de la Recherche Agronomique (INRA); Conservatoire National des Arts et Metiers (CNAM); Universite Paris 13	French National Research Agency (Agence Nationale de la Recherche) in the context of the Programme de Recherche "Alimentation et Industries Alimentaires" (Epipref project)(French National Research Agency (ANR)); INRA' Metaprogramme Did'It (Diet Impact and Determinants Interactions and Transitions); Regional Council of Burgundy France (PARI Agral 1)(Region Bourgogne-Franche-Comte); FEDER (European Funding for Regional Economical Development); Ministere de la Sante (DGS); Institut de Veille Sanitaire (InVS); Institut National de la Prevention et de l'Education pour la Sante (INPES); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut de Recherche en Sante Publique (IRESP); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National de la Recherche Agronomique (INRA); Conservatoire National des Arts et Metiers (CNAM); Universite Paris 13	This work was supported by the French National Research Agency (Agence Nationale de la Recherche) in the context of the 2008 Programme de Recherche "Alimentation et Industries Alimentaires" (Epipref project, ANR-08-ALIA-006), by the INRA' Metaprogramme Did'It (Diet Impact and Determinants Interactions and Transitions), and by the Regional Council of Burgundy France (PARI Agral 1) and the FEDER (European Funding for Regional Economical Development). The Nutrinet-Sante study is supported by the following institutions: Ministere de la Sante (DGS), Institut de Veille Sanitaire (InVS), Institut National de la Prevention et de l'Education pour la Sante (INPES), Fondation pour la Recherche Medicale (FRM), Institut de Recherche en Sante Publique (IRESP), Institut National de la Sante et de la Recherche Medicale (INSERM), Institut National de la Recherche Agronomique (INRA), Conservatoire National des Arts et Metiers (CNAM) and Universite Paris 13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actis AB, 2005, ARCH ORAL BIOL, V50, P1, DOI 10.1016/j.archoralbio.2004.08.001; [Anonymous], 2003, DIET NUTR PREV CHRON; Anwesha Sarkar, 2012, Food oral processing: fundamentals of eating and sensory perception, P111; Arnault N., 2013, TABLE COMPOSITION AL; Battino M, 2002, J CLIN PERIODONTOL, V29, P189, DOI 10.1034/j.1600-051X.2002.290301x.x; BERTINO M, 1982, AM J CLIN NUTR, V36, P1134, DOI 10.1093/ajcn/36.6.1134; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Brussaard JH, 2002, EUR J CLIN NUTR, V56, pS89, DOI 10.1038/sj.ejcn.1601432; Castetbon K, 2009, BRIT J NUTR, V102, P733, DOI 10.1017/S0007114509274745; CHRISTENSEN CM, 1986, ARCH ORAL BIOL, V31, P825, DOI 10.1016/0003-9969(86)90136-6; Cox CL, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-68; da Costa G, 2008, J CHEM ECOL, V34, P376, DOI 10.1007/s10886-007-9413-z; DINICOLANTONIO R, 1984, CLIN EXP PHARMACOL P, V11, P335, DOI 10.1111/j.1440-1681.1984.tb00273.x; Drewnowski A, 1997, ANNU REV NUTR, V17, P237, DOI 10.1146/annurev.nutr.17.1.237; Dsamou M, 2012, CHEM SENSES, V37, P87, DOI 10.1093/chemse/bjr070; Feeney EL, 2014, PHYSIOL BEHAV, V128, P148, DOI 10.1016/j.physbeh.2014.02.013; Feron G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093113; Ferry ALS, 2006, J AGR FOOD CHEM, V54, P8869, DOI 10.1021/jf061607n; Gorelik S, 2007, ARCH BIOCHEM BIOPHYS, V458, P236, DOI 10.1016/j.abb.2006.12.006; Harthoorn LF, 2008, EUR J APPL PHYSIOL, V102, P601, DOI 10.1007/s00421-007-0622-5; Harthoorn LF, 2009, INT J FOOD SCI NUTR, V60, P637, DOI 10.3109/09637480802039814; Henkin RI, 1999, AM J MED SCI, V318, P380, DOI 10.1097/00000441-199912000-00005; Henkin RI, 1999, AM J MED SCI, V318, P392, DOI 10.1097/00000441-199912000-00006; Hercberg S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-242; JOHANSSON G, 1994, ARCH ORAL BIOL, V39, P283, DOI 10.1016/0003-9969(94)90118-X; Karjalainen S, 2011, J DENT RES, V90, P868, DOI 10.1177/0022034511405328; Khan NA, 2009, BBA-MOL CELL BIOL L, V1791, P149, DOI 10.1016/j.bbalip.2009.01.001; Lampure A, 2015, J NUTR, V145, P587, DOI 10.3945/jn.114.201269; Lampure A, 2014, BRIT J NUTR, V112, P1353, DOI 10.1017/S0007114514002050; Lesschaeve I, 2005, AM J CLIN NUTR, V81, p330S, DOI 10.1093/ajcn/81.1.330S; Liem DG, 2004, CHEM SENSES, V29, P713, DOI 10.1093/chemse/bjh077; Mandel AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013352; Marsh P D, 1994, Adv Dent Res, V8, P263; Matsuo R, 2000, CRIT REV ORAL BIOL M, V11, P216, DOI 10.1177/10454411000110020501; Mejean C, 2011, BRIT J NUTR, V105, P776, DOI 10.1017/S0007114510004174; Mela DJ, 2001, OBES RES, V9, p249S, DOI 10.1038/oby.2001.127; MINAH GE, 1985, ARCH ORAL BIOL, V30, P397, DOI 10.1016/0003-9969(85)90066-4; Mitchell M, 2013, FOOD QUAL PREFER, V28, P356, DOI 10.1016/j.foodqual.2012.11.002; Mobini S, 2007, APPETITE, V48, P20, DOI 10.1016/j.appet.2006.05.017; Morzel M, 2014, EUR J PEDIATR, V173, P575, DOI 10.1007/s00431-013-2216-z; Morzel M, 2011, ARCH ORAL BIOL, V56, P634, DOI 10.1016/j.archoralbio.2010.12.015; Morzel M, 2012, J PROTEOMICS, V75, P3665, DOI 10.1016/j.jprot.2012.04.028; Moullec N. le, 1996, Cahiers de Nutrition et de Dietetique, V31, P158; Mounayar R, 2013, CHEMOSENS PERCEPT, V6, P118, DOI 10.1007/s12078-013-9152-1; Nachtsheim R, 2014, FOOD QUAL PREFER, V32, P173, DOI 10.1016/j.foodqual.2013.10.009; Nachtsheim R, 2013, FOOD QUAL PREFER, V29, P137, DOI 10.1016/j.foodqual.2013.03.011; Nagler RM, 2002, FREE RADICAL BIO MED, V32, P268, DOI 10.1016/S0891-5849(01)00806-1; Neyraud E, 2006, J PROTEOME RES, V5, P2474, DOI 10.1021/pr060189z; Neyraud E, 2012, ARCH ORAL BIOL, V57, P556, DOI 10.1016/j.archoralbio.2011.09.016; PANGBORN RM, 1982, AM J CLIN NUTR, V35, P510, DOI 10.1093/ajcn/35.3.510; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Piombino P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085611; Poette J, 2014, FLAVOUR FRAG J, V29, P39, DOI 10.1002/ffj.3177; Quintana M, 2009, CHEMOSENS PERCEPT, V2, P133, DOI 10.1007/s12078-009-9048-2; REISER S, 1989, AM J CLIN NUTR, V49, P832, DOI 10.1093/ajcn/49.5.832; Schipper RG, 2007, ARCH ORAL BIOL, V52, P1114, DOI 10.1016/j.archoralbio.2007.06.009; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Silletti E, 2007, J COLLOID INTERF SCI, V313, P485, DOI 10.1016/j.jcis.2007.05.030; Silletti E, 2010, ARCH ORAL BIOL, V55, P268, DOI 10.1016/j.archoralbio.2010.02.004; SKINNER A, 1984, ARCH ORAL BIOL, V29, P323, DOI 10.1016/0003-9969(84)90106-7; SPIELMAN AI, 1990, J DENT RES, V69, P838, DOI 10.1177/00220345900690030101; SQUIRES BT, 1953, J PHYSIOL-LONDON, V119, P153, DOI 10.1113/jphysiol.1953.sp004835; TEOW BH, 1985, CLIN EXP HYPERTENS A, V7, P1681, DOI 10.3109/10641968509073618; Touger-Decker R, 2003, AM J CLIN NUTR, V78, p881S, DOI 10.1093/ajcn/78.4.881S; Touvier M, 2011, BRIT J NUTR, V105, P1055, DOI 10.1017/S0007114510004617; Westman EC, 2002, AM J MED, V113, P30, DOI 10.1016/S0002-9343(02)01129-4; World Health Organization, 1995, PHYS STAT US INT ANT	67	45	47	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137473	10.1371/journal.pone.0137473	http://dx.doi.org/10.1371/journal.pone.0137473			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340090	Green Published, Green Submitted, gold			2022-12-26	WOS:000360688200064
J	Franzolin, E; Salata, C; Bianchi, V; Rampazzo, C				Franzolin, Elisa; Salata, Cristiano; Bianchi, Vera; Rampazzo, Chiara			The Deoxynucleoside Triphosphate Triphosphohydrolase Activity of SAMHD1 Protein Contributes to the Mitochondrial DNA Depletion Associated with Genetic Deficiency of Deoxyguanosine Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AICARDI-GOUTIERES SYNDROME; RESTRICTION FACTOR SAMHD1; HIV-1 RESTRICTION; THYMIDINE KINASE; ALLOSTERIC ACTIVATION; DEOXYCYTIDINE KINASE; REPLICATION FIDELITY; STRUCTURAL BASIS; HUMAN-CELLS; POOLS	The dNTP triphosphohydrolase SAMHD1 is a nuclear antiviral host restriction factor limiting HIV-1 infection in macrophages and a major regulator of dNTP concentrations in human cells. In normal human fibroblasts its expression increases during quiescence, contributing to the small dNTP pool sizes of these cells. Down-regulation of SAMHD1 by siRNA expands all four dNTP pools, with dGTP undergoing the largest relative increase. The deoxyguanosine released by SAMHD1 from dGTP can be phosphorylated inside mitochondria by deoxyguanosine kinase (dGK) or degraded in the cytosol by purine nucleoside phosphorylase. Genetic mutations of dGK cause mitochondrial (mt) DNA depletion in noncycling cells and hepato-cerebral mtDNA depletion syndrome in humans. We studied if SAMHD1 and dGK interact in the regulation of the dGTP pool during quiescence employing dGK-mutated skin fibroblasts derived from three unrelated patients. In the presence of SAMHD1 quiescent mutant fibroblasts manifested mt dNTP pool imbalance and mtDNA depletion. When SAMHD1 was silenced by siRNA transfection the composition of the mt dNTP pool approached that of the controls, and mtDNA copy number increased, compensating the depletion to various degrees in the different mutant fibroblasts. Chemical inhibition of purine nucleoside phosphorylase did not improve deoxyguanosine recycling by dGK in WT cells. We conclude that the activity of SAMHD1 contributes to the pathological phenotype of dGK deficiency. Our results prove the importance of SAMHD1 in the regulation of all dNTP pools and suggest that dGK inside mitochondria has the function of recycling the deoxyguanosine derived from endogenous dGTP degraded by SAMHD1 in the nucleus.	[Franzolin, Elisa; Bianchi, Vera; Rampazzo, Chiara] Univ Padua, Dept Biol, I-35131 Padua, Italy; [Salata, Cristiano] Univ Padua, Dept Mol Med, I-35121 Padua, Italy	University of Padua; University of Padua	Bianchi, V (corresponding author), Dipartimento Biol, Via Ugo Bassi 58B, I-35131 Padua, Italy.	vbianchi@bio.unipd.it; chiara.rampazzo.1@unipd.it	Salata, Cristiano/T-6601-2019	Salata, Cristiano/0000-0002-5136-7406	Fondazione Telethon Grant [GGP14005]; Associazione Italiana per la Ricerca sul Cancro Grant [IG 2014 15818]	Fondazione Telethon Grant(Fondazione Telethon); Associazione Italiana per la Ricerca sul Cancro Grant(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Fondazione Telethon Grant GGP14005 (to V. B.) and Associazione Italiana per la Ricerca sul Cancro Grant IG 2014 15818 (to V. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006; ARNER ESJ, 1992, BIOCHEM BIOPH RES CO, V188, P712, DOI 10.1016/0006-291X(92)91114-6; Behrendt R, 2013, CELL REP, V4, P689, DOI 10.1016/j.celrep.2013.07.037; Beloglazova N, 2013, J BIOL CHEM, V288, P8101, DOI 10.1074/jbc.M112.431148; Bianchi V, 2003, J BIOL CHEM, V278, P46195, DOI 10.1074/jbc.R300032200; Camara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; DARE E, 1995, J MOL BIOL, V252, P514, DOI 10.1006/jmbi.1995.0516; Del Toro M, 2005, J INHERIT METAB DIS, V28, P135; DeLucia M, 2013, J BIOL CHEM, V288, P19116, DOI 10.1074/jbc.M113.469007; Di Noia MA, 2014, J BIOL CHEM, V289, P33137, DOI 10.1074/jbc.M114.610808; Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x; Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Frangini M, 2013, J BIOL CHEM, V288, P5624, DOI 10.1074/jbc.M112.441147; Frangini M, 2009, FEBS J, V276, P1104, DOI 10.1111/j.1742-4658.2008.06853.x; Franzolin E, 2006, BIOCHEM BIOPH RES CO, V344, P30, DOI 10.1016/j.bbrc.2006.03.147; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Franzolin E, 2012, EXP CELL RES, V318, P2226, DOI 10.1016/j.yexcr.2012.05.028; Gazziola C, 2001, J BIOL CHEM, V276, P6185, DOI 10.1074/jbc.M007623200; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Govindarajan R, 2009, AM J PHYSIOL-GASTR L, V296, pG910, DOI 10.1152/ajpgi.90672.2008; Ji XY, 2014, P NATL ACAD SCI USA, V111, pE4305, DOI 10.1073/pnas.1412289111; Ji XY, 2013, NAT STRUCT MOL BIOL, V20, P1304, DOI 10.1038/nsmb.2692; Kicska GA, 2001, P NATL ACAD SCI USA, V98, P4593, DOI 10.1073/pnas.071050798; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Koharudin LMI, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.591958; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lai YR, 2004, J BIOL CHEM, V279, P4490, DOI 10.1074/jbc.M307938200; Leanza L, 2008, J BIOL CHEM, V283, P16437, DOI 10.1074/jbc.M801572200; Li N, 2000, IMMUNOL LETT, V74, P221, DOI 10.1016/S0165-2478(00)00276-5; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; MARKERT M L, 1991, Immunodeficiency Reviews, V3, P45; Miazzi C, 2014, J BIOL CHEM, V289, P18339, DOI 10.1074/jbc.M114.571091; Nakabeppu Y, 2010, MUTAT RES-GEN TOX EN, V703, P51, DOI 10.1016/j.mrgentox.2010.06.006; Pauls E, 2014, J IMMUNOL, V193, P1988, DOI 10.4049/jimmunol.1400873; Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100; Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Pursell ZF, 2008, NUCLEIC ACIDS RES, V36, P2174, DOI 10.1093/nar/gkn062; Rampazzo C, 2004, J BIOL CHEM, V279, P17019, DOI 10.1074/jbc.M313957200; Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002; Rehwinkel J, 2013, EMBO J, V32, P2454, DOI 10.1038/emboj.2013.163; Resta R, 1997, IMMUNOL TODAY, V18, P371, DOI 10.1016/S0167-5699(97)01047-5; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Ryoo J, 2014, NAT MED, V20, P936, DOI 10.1038/nm.3626; Saada A, 2003, BIOCHEM BIOPH RES CO, V310, P963, DOI 10.1016/j.bbrc.2003.09.104; Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5; Saada A, 2008, MOL GENET METAB, V95, P169, DOI 10.1016/j.ymgme.2008.07.007; Schmidt S, 2015, J LEUKOCYTE BIOL, V98, P5, DOI 10.1189/jlb.4HI0714-338RR; Shepherd D., 1969, METHODS ENZYMOL, V13, P11, DOI [10.1016/0076-6879(69)13006-2, DOI 10.1016/0076-6879(69)13006-2]; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102; SPASOKOUKOTSKAJA T, 1995, EUR J CANCER, V31A, P202, DOI 10.1016/0959-8049(94)00435-8; Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z; Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192; Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005; Yan JP, 2015, J BIOL CHEM, V290, P13279, DOI 10.1074/jbc.M115.646588; Zhu CF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3722	61	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25986	25996		10.1074/jbc.M115.675082	http://dx.doi.org/10.1074/jbc.M115.675082			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26342080	Green Published, hybrid			2022-12-26	WOS:000363527300020
J	Kajabadi, NS; Ghoochani, A; Peymani, M; Ghaedi, K; Kiani-Esfahani, A; Hashemi, MS; Nasr-Esfahani, MH; Baharvand, H				Kajabadi, Nasim-Sadat; Ghoochani, Ali; Peymani, Maryam; Ghaedi, Kamran; Kiani-Esfahani, Abbas; Hashemi, Motahareh-Sadat; Nasr-Esfahani, Mohammad Hossein; Baharvand, Hossein			The Synergistic Enhancement of Cloning Efficiency in Individualized Human Pluripotent Stem Cells by Peroxisome Proliferative-activated Receptor-gamma (PPAR gamma) Activation and Rho-associated Kinase (ROCK) Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-RENEWAL; BETA-CATENIN; MOUSE PPAR-GAMMA-1; E-CADHERIN; LOCALIZATION; SURVIVAL; PATHWAY; PHOSPHORYLATION; DIFFERENTIATION; APOPTOSIS	Although human pluripotent stem cells (hPSCs) provide valuable sources for regenerative medicine, their applicability is dependent on obtaining both suitable up-scaled and cost effective cultures. The Rho-associated kinase (ROCK) inhibitor Y-27632 permits hPSC survival upon dissociation; however, cloning efficiency is often still low. Here we have shown that pioglitazone, a selective peroxisome proliferative-activated receptor-gamma agonist, along with Y-27632 synergistically diminished dissociation-induced apoptosis and increased cloning efficiency (2-3-fold versus Y-27632) without affecting pluripotency of hPSCs. Pioglitazone exerted its positive effect by inhibition of glycogen synthase kinase (GSK3) activity and enhancement of membranous beta-catenin and E-cadherin proteins. These effects were reversed by GW-9662, an irreversible peroxisome proliferative-activated receptor-gamma antagonist. This novel setting provided a step toward hPSC manipulation and its biomedical applications.	[Kajabadi, Nasim-Sadat; Ghaedi, Kamran] Univ Isfahan, Fac Sci, Dept Biol, Esfahan 8174673441, Iran; [Ghoochani, Ali; Peymani, Maryam; Ghaedi, Kamran; Kiani-Esfahani, Abbas; Hashemi, Motahareh-Sadat; Nasr-Esfahani, Mohammad Hossein] ACECR, Royan Inst Biotechnol, Dept Cellular Biotechnol, Cell Sci Res Ctr, Esfahan 8165131378, Iran; [Baharvand, Hossein] ACECR, Royan Inst Stem Cell Biol & Technol, Dept Stem Cells & Dev Biol, Cell Sci Res Ctr, Tehran 1665659911, Iran; Univ Sci & Culture, ACECR, Dept Dev Biol, Tehran, Iran	University of Isfahan; Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR)	Ghaedi, K (corresponding author), ACECR, Royan Inst Biotechnol, Dept Cellular Biotechnol, Cell Sci Res Ctr, POB 816513-1378, Esfahan 8165131378, Iran.	kamranghaedi@royaninstitute.org; mh_nasr@royaninstitute.org; Baharvand@royaninstitute.org	Nasr-Esfahani, Mohammad Hossein/AAN-2577-2020; Ghaedi, Kamran/X-9824-2018; , Nasr-Esfahani/AAR-2434-2021; Peymani, Maryam/AAN-2134-2021	Nasr-Esfahani, Mohammad Hossein/0000-0003-1983-3435; Ghaedi, Kamran/0000-0002-9790-5644; Peymani, Maryam/0000-0001-5075-5661	Royan Institute	Royan Institute	This work was supported by a grant from the Royan Institute. The authors declare that they have no conflicts of interest with the contents of this article.	Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Atkins KB, 2009, AM J PHYSIOL-CELL PH, V296, pC1151, DOI 10.1152/ajpcell.00343.2008; Baharvand H, 2006, DEV GROWTH DIFFER, V48, P117, DOI 10.1111/j.1440-169x.2006.00851.x; Chen GK, 2010, CELL STEM CELL, V7, P240, DOI 10.1016/j.stem.2010.06.017; Dietrich C, 2002, BIOCHEM BIOPH RES CO, V292, P195, DOI 10.1006/bbrc.2002.6625; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Faunes F, 2013, DEVELOPMENT, V140, P1171, DOI 10.1242/dev.085654; Fujisawa T, 2008, J PHARMACOL SCI, V106, P627, DOI 10.1254/jphs.FP0071766; Ghasemi S, 2010, YAKHTEH, V12, P97; Gien J, 2014, AM J PHYSIOL-LUNG C, V306, pL299, DOI 10.1152/ajplung.00271.2013; Hiroki Oda, 2012, Subcell Biochem, V60, P9, DOI 10.1007/978-94-007-4186-7_2; Kilter H, 2009, DIABETES OBES METAB, V11, P1060, DOI 10.1111/j.1463-1326.2009.01097.x; Lachinani Liana, 2012, Avicenna Journal of Medical Biotechnology, V4, P160; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li L, 2012, CELL ADHES MIGR, V6, P59, DOI 10.4161/cam.19583; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Mao YS, 2007, PFLUG ARCH EUR J PHY, V455, P5, DOI 10.1007/s00424-007-0286-3; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Orsulic S, 1999, J CELL SCI, V112, P1237; Pakzad M, 2010, STEM CELL REV REP, V6, P96, DOI 10.1007/s12015-009-9103-z; Peymani M, 2013, EUR J CELL BIOL, V92, P160, DOI 10.1016/j.ejcb.2013.03.003; Prunier C, 2004, GROWTH FACTORS, V22, P141, DOI 10.1080/08977190410001720860; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shin SJ, 2006, STEM CELLS, V24, P125, DOI 10.1634/stemcells.2004-0150; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takao Y, 2007, BIOCHEM BIOPH RES CO, V353, P699, DOI 10.1016/j.bbrc.2006.12.072; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Totonchi M, 2010, INT J DEV BIOL, V54, P877, DOI 10.1387/ijdb.092903mt; Wakino S, 2004, CIRC RES, V95, pE45, DOI 10.1161/01.RES.0000142313.68389.92; Wang XF, 2009, J BIOL CHEM, V284, P34054, DOI 10.1074/jbc.M109.052290; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Webster MT, 2000, GENE CHROMOSOME CANC, V28, P443	33	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26303	26313		10.1074/jbc.M114.624841	http://dx.doi.org/10.1074/jbc.M114.624841			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26336103	hybrid, Green Published			2022-12-26	WOS:000363527300046
J	Kang, J; Lee, HJ; Jun, SY; Park, ES; Maeng, LS				Kang, Jun; Lee, Hee Jin; Jun, Sun-Young; Park, Eun Su; Maeng, Lee-so			Cancer-Testis Antigen Expression in Serous Endometrial Cancer with Loss of X Chromosome Inactivation	PLOS ONE			English	Article							GENOMIC CHARACTERIZATION; BREAST-CANCER; TUMOR-ANTIGEN; GENE; IMMUNOTHERAPY; MELANOMA; ABNORMALITIES; LYMPHOCYTES; ACTIVATION; RNA	Background Cancertestis antigens (CTAs) are potential targets for cancer immunotherapy. Many CTAs are located on the X chromosome and are epigenetically regulated. Loss of X chromosome inactivation (XCI) is observed in breast and ovarian cancers and is thought to be related to the overexpression of CTAs. We investigated the relation between expression of CTAs and loss of XCI in endometrial cancer. Materials and Methods We used data generated by The Cancer Genome Atlas Genome Data Analysis Centers and data for Xist knockout mice available at the Gene Expression Omnibus. Results The status of XCI was estimated by methylation status, and deletion or gain of the X chromosome. The endometrial cancers were classified into the following three groups: preserved inactivated X chromosome (Xi) (n = 281), partial reactivation of Xi (n = 52), and two copies of active X group (n = 38). Loss of XCI was more common in serous adenocarcinoma. Expression of CTAs increased in endometrial cancer with loss of XCI, which was accompanied by global hypomethylation. Expression of CTAs did not increase in Xist knockout mice. Conclusions Loss of XCI is common in serous adenocarcinoma. Global hypomethylation, and not loss of XCI, is the main mechanism of overexpression of CTAs.	[Kang, Jun; Jun, Sun-Young; Park, Eun Su; Maeng, Lee-so] Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Dept Hosp Pathol, Inchon, South Korea; [Lee, Hee Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea	Catholic University of Korea; University of Ulsan; Asan Medical Center	Kang, J (corresponding author), Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Dept Hosp Pathol, Inchon, South Korea.	jkang.alien@gmail.com		Jun, Sun-Young/0000-0002-3007-2094				Ahn J., 2008, NAT ED, V1, P24; [Anonymous], 2012, NATURE, V489, P519, DOI [DOI 10.1038/NATURE11404, 10.1038/nature11404]; BOEL P, 1995, IMMUNITY, V2, P167, DOI 10.1016/S1074-7613(95)80053-0; Chen ME, 1998, J BIOL CHEM, V273, P17618, DOI 10.1074/jbc.273.28.17618; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; De Backer O, 1999, CANCER RES, V59, P3157; DEPLAEN E, 1994, IMMUNOGENETICS, V40, P360, DOI 10.1007/BF01246677; Ganesan S, 2005, COLD SH Q B, V70, P93, DOI 10.1101/sqb.2005.70.045; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Jacobsen A, 2013, CGDSR R BASED API AC; Kang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118927; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lax S F, 1997, Verh Dtsch Ges Pathol, V81, P228; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Loriot A, 2006, J BIOL CHEM, V281, P10118, DOI 10.1074/jbc.M510469200; Melero I, 2014, NAT REV CLIN ONCOL, V11, P509, DOI 10.1038/nrclinonc.2014.111; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Pageau GJ, 2007, NAT REV CANCER, V7, P628, DOI 10.1038/nrc2172; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Tureci O, 1996, CANCER RES, V56, P4766; Ulloa-Montoya F, 2013, J CLIN ONCOL, V31, P2388, DOI 10.1200/JCO.2012.44.3762; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Vansteenkiste J, 2013, J CLIN ONCOL, V31, P2396, DOI 10.1200/JCO.2012.43.7103; WEBER J, 1994, CANCER RES, V54, P1766; Whitehurst AW, 2014, ANNU REV PHARMACOL, V54, P251, DOI 10.1146/annurev-pharmtox-011112-140326; Yildirim E, 2013, CELL, V152, P727, DOI 10.1016/j.cell.2013.01.034	27	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137476	10.1371/journal.pone.0137476	http://dx.doi.org/10.1371/journal.pone.0137476			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360551	gold, Green Published, Green Submitted			2022-12-26	WOS:000361043100044
J	Liu, Y; Dun, BQ; Shi, PJ; Ma, R; Luo, HY; Bai, YG; Xie, XM; Yao, B				Liu, Yun; Dun, Baoqing; Shi, Pengjun; Ma, Rui; Luo, Huiying; Bai, Yingguo; Xie, Xiangming; Yao, Bin			A Novel GH7 Endo-beta-1,4-Glucanase from Neosartorya fischeri P1 with Good Thermostability, Broad Substrate Specificity and Potential Application in the Brewing Industry	PLOS ONE			English	Article							CLONING; ENDOGLUCANASES; PURIFICATION; DEGRADATION; CELLULOSE	An endo-beta-1,4-glucanase gene, cel7A, was cloned from the thermophilic cellulase-producing fungus Neosartorya fischeri P1 and expressed in Pichia pastoris. The 1,410-bp fulllength gene encodes a polypeptide of 469 amino acids consisting of a putative signal peptide at residues 1-20, a catalytic domain of glycoside hydrolase family 7 (GH7), a short Thr/Ser-rich linker and a family 1 carbohydrate-binding module (CBM 1). The purified recombinant Cel7A had pH and temperature optima of pH 5.0 and 60 degrees C, respectively, and showed broad pH adaptability (pH 3.0-6.0) and excellent stability at pH3.0-8.0 and 60 degrees C. Belonging to the group of nonspecific endoglucanases, Cel7A exhibited the highest activity on barley beta-glucan (2020 +/- 9 Umg(-1)), moderate on lichenan and CMC-Na, and weak on laminarin, locust bean galactomannan, Avicel, and filter paper. Under simulated mashing conditions, addition of Cel7A (99 mu g) reduced the mash viscosity by 9.1% and filtration time by 24.6%. These favorable enzymatic properties make Cel7A as a good candidate for applications in the brewing industry.	[Liu, Yun; Xie, Xiangming] Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Beijing 100083, Peoples R China; [Liu, Yun; Shi, Pengjun; Ma, Rui; Luo, Huiying; Bai, Yingguo; Yao, Bin] Chinese Acad Agr Sci, Feed Res Inst, Key Lab Feed Biotechnol, Minist Agr, Beijing 100081, Peoples R China; [Dun, Baoqing] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China	Beijing Forestry University; Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Xie, XM (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Beijing 100083, Peoples R China.	xxm1005@126.com; binyao@caas.cn			National High Technology Research and Development Program of China [2012AA022208]; National Science Foundation for Distinguished Young Scholars of China [31225026]; National Natural Science Foundation of China [31101346, J1103516]; China Modern Agriculture Research System [CARS-42]; Fundamental Research Funds for the Central University of China [TD2012-03]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Modern Agriculture Research System; Fundamental Research Funds for the Central University of China	This research was supported by the National High Technology Research and Development Program of China (2012AA022208), the National Science Foundation for Distinguished Young Scholars of China (31225026), the National Natural Science Foundation of China (31101346, J1103516), the China Modern Agriculture Research System (CARS-42) and the Fundamental Research Funds for the Central University of China (TD2012-03).	Bai YG, 2010, APPL MICROBIOL BIOT, V87, P251, DOI 10.1007/s00253-010-2452-3; Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x; BECKER DM, 1991, METHOD ENZYMOL, V194, P182; Bhat MK, 2000, BIOTECHNOL ADV, V18, P355, DOI 10.1016/S0734-9750(00)00041-0; Boyce A, 2007, APPL MICROBIOL BIOT, V76, P835, DOI 10.1007/s00253-007-1058-x; Brummell DA, 1997, P NATL ACAD SCI USA, V94, P4794, DOI 10.1073/pnas.94.9.4794; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Conde R, 2004, J BIOL CHEM, V279, P43789, DOI 10.1074/jbc.M406678200; Dashtban M, 2009, INT J BIOL SCI, V5, P578, DOI 10.7150/ijbs.5.578; Dimarogona M, 2012, BIORESOURCE TECHNOL, V110, P480, DOI 10.1016/j.biortech.2012.01.116; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Karlsson J, 2002, BIOPOLYMERS, V63, P32, DOI 10.1002/bip.1060; Karnaouri AC, 2014, APPL MICROBIOL BIOT, V98, P231, DOI 10.1007/s00253-013-4895-9; Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lu HQ, 2014, APPL MICROBIOL BIOT, V98, P2155, DOI 10.1007/s00253-013-5112-6; Luo HY, 2010, APPL MICROBIOL BIOT, V85, P1015, DOI 10.1007/s00253-009-2119-0; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Silveira Celestino Klecius R., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-23; Tomme P, 1995, Adv Microb Physiol, V37, P1, DOI 10.1016/S0065-2911(08)60143-5; Vlasenko E, 2010, BIORESOURCE TECHNOL, V101, P2405, DOI 10.1016/j.biortech.2009.11.057; Wang HM, 2014, BIORESOURCE TECHNOL, V153, P361, DOI 10.1016/j.biortech.2013.11.078; Wang K, 2014, PROCESS BIOCHEM, V49, P1448, DOI 10.1016/j.procbio.2014.06.003; Wei XM, 2010, J MICROBIOL BIOTECHN, V20, P265, DOI 10.4014/jmb.0904.04047; Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007; Yang XZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106785; Zhao JQ, 2012, J BIOSCI BIOENG, V114, P379, DOI 10.1016/j.jbiosc.2012.04.021	28	14	15	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137485	10.1371/journal.pone.0137485	http://dx.doi.org/10.1371/journal.pone.0137485			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360701	Green Published, Green Submitted, gold			2022-12-26	WOS:000361043100045
J	Ghisleni, C; Bollmann, S; Biason-Lauber, A; Poil, SS; Brandeis, D; Martin, E; Michels, L; Hersberger, M; Suckling, J; Klaver, P; O'Gorman, RL				Ghisleni, Carmen; Bollmann, Steffen; Biason-Lauber, Anna; Poil, Simon-Shlomo; Brandeis, Daniel; Martin, Ernst; Michels, Lars; Hersberger, Martin; Suckling, John; Klaver, Peter; O'Gorman, Ruth L.			Effects of Steroid Hormones on Sex Differences in Cerebral Perfusion	PLOS ONE			English	Article							DEHYDROEPIANDROSTERONE-SULFATE LEVELS; BLOOD-FLOW; GENDER-DIFFERENCES; ENDOTHELIAL FUNCTION; REPLACEMENT THERAPY; BRAIN PERFUSION; POSTMENOPAUSAL WOMEN; MRI; ESTROGEN; AGE	Sex differences in the brain appear to play an important role in the prevalence and progression of various neuropsychiatric disorders, but to date little is known about the cerebral mechanisms underlying these differences. One widely reported finding is that women demonstrate higher cerebral perfusion than men, but the underlying cause of this difference in perfusion is not known. This study investigated the putative role of steroid hormones such as oestradiol, testosterone, and dehydroepiandrosterone sulphate (DHEAS) as underlying factors influencing cerebral perfusion. We acquired arterial spin labelling perfusion images of 36 healthy adult subjects (16 men, 20 women). Analyses on average whole brain perfusion levels included a multiple regression analysis to test for the relative impact of each hormone on the global perfusion. Additionally, voxel-based analyses were performed to investigate the sex difference in regional perfusion as well as the correlations between local perfusion and serum oestradiol, testosterone, and DHEAS concentrations. Our results replicated the known sex difference in perfusion, with women showing significantly higher global and regional perfusion. For the global perfusion, DHEAS was the only significant predictor amongst the steroid hormones, showing a strong negative correlation with cerebral perfusion. The voxel-based analyses revealed modest sex-dependent correlations between local perfusion and testosterone, in addition to a strong modulatory effect of DHEAS in cortical, subcortical, and cerebellar regions. We conclude that DHEAS in particular may play an important role as an underlying factor driving the difference in cerebral perfusion between men and women.	[Ghisleni, Carmen; Bollmann, Steffen; Poil, Simon-Shlomo; Martin, Ernst; Michels, Lars; Klaver, Peter; O'Gorman, Ruth L.] Univ Childrens Hosp Zurich, Ctr MR Res, Zurich, Switzerland; [Ghisleni, Carmen; Bollmann, Steffen; Poil, Simon-Shlomo; Brandeis, Daniel; Martin, Ernst; Klaver, Peter; O'Gorman, Ruth L.] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Ghisleni, Carmen; Bollmann, Steffen; Brandeis, Daniel; Martin, Ernst; Klaver, Peter] Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland; [Ghisleni, Carmen; Bollmann, Steffen; Brandeis, Daniel; Martin, Ernst; Klaver, Peter] Swiss Fed Inst Technol, Zurich, Switzerland; [Biason-Lauber, Anna] Univ Fribourg, Dept Med, Endocrinol, CH-1700 Fribourg, Switzerland; [Brandeis, Daniel] Univ Zurich, Dept Child & Adolescent Psychiat, Zurich, Switzerland; [Brandeis, Daniel] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat & Psychotherapy, Mannheim, Germany; [Michels, Lars] Univ Zurich Hosp, Klin Neuroradiol, CH-8091 Zurich, Switzerland; [Hersberger, Martin] Univ Childrens Hosp Zurich, Div Clin Chem & Biochem, Zurich, Switzerland; [Suckling, John] Univ Cambridge, Dept Psychiat, Cambridge, England; [Klaver, Peter] Univ Zurich, Dept Psychol, Zurich, Switzerland	University Children's Hospital Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Fribourg; University of Zurich; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Zurich; University Zurich Hospital; University Children's Hospital Zurich; University of Cambridge; University of Zurich	O'Gorman, RL (corresponding author), Univ Childrens Hosp Zurich, Ctr MR Res, Zurich, Switzerland.	Ruth.OGorman@kispi.uzh.ch	Michels, Lars/X-6939-2018; Bollmann, Steffen/N-3413-2014; Klaver, Peter/G-7988-2011; Klaver, Peter/M-9506-2019; Suckling, John/ABD-7246-2021	Bollmann, Steffen/0000-0002-2909-0906; Klaver, Peter/0000-0002-6541-9975; Klaver, Peter/0000-0002-6541-9975; Suckling, John/0000-0002-5098-1527; Hersberger, Martin/0000-0002-4472-329X; Michels, Lars/0000-0003-3750-1100; O'Gorman, Ruth/0000-0001-5932-7786	University Research Priority Program	University Research Priority Program	This work was supported by University Research Priority Program "Integrative Human Physiology": www.zihp.uzh.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akishita M, 2008, HYPERTENS RES, V31, P69, DOI 10.1291/hypres.31.69; Alsop DC, 1996, J CEREBR BLOOD F MET, V16, P1236, DOI 10.1097/00004647-199611000-00019; American Psychiatric Association, 1994, DIAGNOSTIC AND STATI; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Azad N, 2003, J CLIN ENDOCR METAB, V88, P3064, DOI 10.1210/jc.2002-020632; BAXTER LR, 1987, PSYCHIAT RES, V21, P237, DOI 10.1016/0165-1781(87)90028-X; Behringer V, 2012, J ENDOCRINOL, V214, P55, DOI 10.1530/JOE-12-0103; Carlson LE, 1999, HORM BEHAV, V35, P254, DOI 10.1006/hbeh.1999.1518; Chamberlain SR, 2009, BIOL PSYCHIAT, V65, P550, DOI 10.1016/j.biopsych.2008.10.014; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; Deegan BM, 2010, J APPL PHYSIOL, V109, P1424, DOI 10.1152/japplphysiol.01262.2009; Grasa MD, 2013, NEUROPSYCHOBIOLOGY, V67, P230, DOI 10.1159/000350473; DEPERETTI E, 1978, J CLIN ENDOCR METAB, V47, P572, DOI 10.1210/jcem-47-3-572; Detre JA, 2012, J MAGN RESON IMAGING, V35, P1026, DOI 10.1002/jmri.23581; DEVOUS MD, 1986, J CEREBR BLOOD F MET, V6, P95, DOI 10.1038/jcbfm.1986.12; Dong Y, 2012, J NEUROENDOCRINOL, V24, P215, DOI 10.1111/j.1365-2826.2011.02256.x; Elmlinger MW, 2002, CLIN CHEM LAB MED, V40, P1151, DOI 10.1515/CCLM.2002.202; Esposito G, 1996, J NUCL MED, V37, P559; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; GUR RE, 1990, SCHIZOPHRENIA BULL, V16, P247, DOI 10.1093/schbul/16.2.247; HAFNER H, 1991, EUR ARCH PSY CLIN N, V241, P65, DOI 10.1007/BF02193758; Hofer A, 2006, NEUROIMAGE, V32, P854, DOI 10.1016/j.neuroimage.2006.03.053; Ilg R, 2008, J NEUROSCI, V28, P4210, DOI 10.1523/JNEUROSCI.5722-07.2008; Jarnum H, 2010, NEURORADIOLOGY, V52, P307, DOI 10.1007/s00234-009-0616-6; Jimenez MC, 2013, STROKE, V44, P1785, DOI 10.1161/STROKEAHA.111.000485; Kaya E, 2008, MATURITAS, V59, P72, DOI 10.1016/j.maturitas.2007.10.004; Krause DN, 2006, J APPL PHYSIOL, V101, P1252, DOI 10.1152/japplphysiol.01095.2005; Labrie F, 1997, J CLIN ENDOCR METAB, V82, P2396, DOI 10.1210/jc.82.8.2396; Labrie F, 1998, STEROIDS, V63, P322, DOI 10.1016/S0039-128X(98)00007-5; Liu YN, 2012, MAGN RESON MED, V68, P912, DOI 10.1002/mrm.23286; Lu HZ, 2011, CEREB CORTEX, V21, P1426, DOI 10.1093/cercor/bhq224; Lu HZ, 2004, MAGN RESON MED, V52, P679, DOI 10.1002/mrm.20178; Maki PM, 2000, NEUROBIOL AGING, V21, P373, DOI 10.1016/S0197-4580(00)00123-8; Maninger N, 2009, FRONT NEUROENDOCRIN, V30, P65, DOI 10.1016/j.yfrne.2008.11.002; Mazat L, 2001, P NATL ACAD SCI USA, V98, P8145, DOI 10.1073/pnas.121177998; Murialdo G, 2000, NEUROPSYCHOBIOLOGY, V42, P51, DOI 10.1159/000026672; Naruo T, 2001, BMC PSYCHIATRY, V1, DOI 10.1186/1471-244X-1-2; Nevo O, 2007, AM J PHYSIOL-HEART C, V293, pH3265, DOI 10.1152/ajpheart.00633.2007; ORENTREICH N, 1984, J CLIN ENDOCR METAB, V59, P551, DOI 10.1210/jcem-59-3-551; PARDRIDGE WM, 1979, J CLIN INVEST, V64, P145, DOI 10.1172/JCI109433; Parkes LM, 2004, MAGN RESON MED, V51, P736, DOI 10.1002/mrm.20023; Penotti M, 2001, FERTIL STERIL, V76, P235, DOI 10.1016/S0015-0282(01)01923-9; PODREKA I, 1989, STROKE, V20, P183, DOI 10.1161/01.STR.20.2.183; Savineau JP, 2013, BIOCHEM PHARMACOL, V85, P718, DOI 10.1016/j.bcp.2012.12.004; Silvestri A, 2005, MATURITAS, V50, P305, DOI 10.1016/j.maturitas.2004.07.012; Simpson ER, 2003, J STEROID BIOCHEM, V86, P225, DOI 10.1016/S0960-0760(03)00360-1; Suckling J, 2004, HUM BRAIN MAPP, V22, P193, DOI 10.1002/hbm.20027; Sulcova J, 1997, J ENDOCRINOL, V154, P57, DOI 10.1677/joe.0.1540057; Taki Y, 2011, NEUROIMAGE, V58, P709, DOI 10.1016/j.neuroimage.2011.07.020; Tannenbaum C, 2004, EUR J ENDOCRINOL, V151, P717, DOI 10.1530/eje.0.1510717; Tchernof A, 2004, EUR J ENDOCRINOL, V151, P1, DOI 10.1530/eje.0.1510001; Toda N, 2009, PHARMACOL REV, V61, P62, DOI 10.1124/pr.108.000547; Traish AM, 2011, J SEX MED, V8, P2960, DOI 10.1111/j.1743-6109.2011.02523.x; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wang JJ, 2005, RADIOLOGY, V235, P218, DOI 10.1148/radiol.2351031663; Williams MRI, 2004, J CLIN ENDOCR METAB, V89, P4708, DOI 10.1210/jc.2003-031560	59	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0135827	10.1371/journal.pone.0135827	http://dx.doi.org/10.1371/journal.pone.0135827			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356576	gold, Green Published, Green Accepted			2022-12-26	WOS:000360965800007
J	Kingston, ACN; Wardill, TJ; Hanlon, RT; Cronin, TW				Kingston, Alexandra C. N.; Wardill, Trevor J.; Hanlon, Roger T.; Cronin, Thomas W.			An Unexpected Diversity of Photoreceptor Classes in the Longfin Squid, Doryteuthis pealeii	PLOS ONE			English	Article							SEPIA-OFFICINALIS; CEPHALOPODS; CUTTLEFISH; RETINOCHROME; CAMOUFLAGE; LIGHT; SKIN; COLORATION; MORPHOLOGY; RHODOPSIN	Cephalopods are famous for their ability to change color and pattern rapidly for signaling and camouflage. They have keen eyes and remarkable vision, made possible by photoreceptors in their retinas. External to the eyes, photoreceptors also exist in parolfactory vesicles and some light organs, where they function using a rhodopsin protein that is identical to that expressed in the retina. Furthermore, dermal chromatophore organs contain rhodopsin and other components of phototransduction (including retinochrome, a photoisomerase first found in the retina), suggesting that they are photoreceptive. In this study, we used a modified whole-mount immunohistochemical technique to explore rhodopsin and retinochrome expression in a number of tissues and organs in the longfin squid, Doryteuthis pealeii. We found that fin central muscles, hair cells (epithelial primary sensory neurons), arm axial ganglia, and sucker peduncle nerves all express rhodopsin and retinochrome proteins. Our findings indicate that these animals possess an unexpected diversity of extraocular photoreceptors and suggest that extraocular photoreception using visual opsins and visual phototransduction machinery is far more widespread throughout cephalopod tissues than previously recognized.	[Kingston, Alexandra C. N.; Cronin, Thomas W.] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA; [Wardill, Trevor J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Hanlon, Roger T.] Marine Biol Lab, Woods Hole, MA 02543 USA	University System of Maryland; University of Maryland Baltimore County; University of Cambridge; Marine Biological Laboratory - Woods Hole	Kingston, ACN (corresponding author), Univ Maryland Baltimore Cty, Dept Biol Sci, 1000 Hilltop Circle, Baltimore, MD 21250 USA.	anahm1@umbc.edu	Hanlon, Roger T/Q-8687-2016	Hanlon, Roger T/0000-0003-0004-5674; Wardill, Trevor/0000-0002-2049-113X	Office of Naval Research Basic Research Challenge [N00014-10-0989]; Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Fellowship [BB/L024667/1]; Air Force Office of Scientific Research [FA9550-09-0346, FA9550-12-1-0321]; Biotechnology and Biological Sciences Research Council [BB/L024667/1] Funding Source: researchfish; BBSRC [BB/L024667/1] Funding Source: UKRI	Office of Naval Research Basic Research Challenge; Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by the Office of Naval Research Basic Research Challenge grant number N00014-10-0989 to TWC and RTH and a Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Fellowship BB/L024667/1 to TJW. The authors gratefully acknowledge support from the Air Force Office of Scientific Research via grants numbered FA9550-09-0346 to RTH. and FA9550-12-1-0321 to TWC.	Allen JJ, 2009, J COMP PHYSIOL A, V195, P547, DOI 10.1007/s00359-009-0430-y; BUDELMANN BU, 1988, J COMP PHYSIOL A, V164, P1, DOI 10.1007/BF00612711; Chiao CC, 2010, J EXP BIOL, V213, P187, DOI 10.1242/jeb.030247; CLONEY RA, 1983, AM ZOOL, V23, P581, DOI 10.1093/icb/23.3.581; Cobb CS, 1998, J MOLLUS STUD, V64, P111, DOI 10.1093/mollus/64.1.111; Gartner W, 2000, HDB BIOL PHYS; Gonzalez-Bellido P. T., 2012, COLD SPRING HARB PRO, DOI DOI 10.1101/PDB.PR0T069625; HANLON RT, 1988, PHILOS T ROY SOC B, V320, P437, DOI 10.1098/rstb.1988.0087; HARA T, 1976, J GEN PHYSIOL, V67, P791, DOI 10.1085/jgp.67.6.791; HARA T, 1980, J GEN PHYSIOL, V75, P1, DOI 10.1085/jgp.75.1.1; Jones BW, 2004, MAR BIOL, V144, P1151, DOI 10.1007/s00227-003-1285-3; KIER WM, 1989, J ZOOL, V217, P23, DOI 10.1111/j.1469-7998.1989.tb02472.x; Kingston ACN, 2015, J EXPT BIOL; Mackie GO, 2008, TISSUE CELL, V40, P21, DOI 10.1016/j.tice.2007.08.005; Mathger LM, 2007, J EXP BIOL, V210, P2657, DOI 10.1242/jeb.004382; Mathger LM, 2009, J EXP BIOL, V212, P2133, DOI 10.1242/jeb.020800; MESSENGER JB, 1974, J ZOOL, V174, P387; ROWELL CHF, 1966, J EXP BIOL, V44, P589; SAIBIL H, 1987, J CELL BIOL, V105, P19, DOI 10.1083/jcb.105.1.19; SANTI PA, 1975, TISSUE CELL, V7, P689, DOI 10.1016/0040-8166(75)90037-3; Shigeno S, 2002, J MORPHOL, V254, P65, DOI 10.1002/jmor.10020; SPERLING L, 1975, J GEN PHYSIOL, V65, P235, DOI 10.1085/jgp.65.2.235; Sperling L, 1973, BIOL BULL, V145, P456; Sumbre G, 2001, SCIENCE, V293, P1845, DOI 10.1126/science.1060976; Tong D, 2009, P NATL ACAD SCI USA, V106, P9836, DOI 10.1073/pnas.0904571106; Wardill TJ, 2012, P ROY SOC B-BIOL SCI, V279, P4243, DOI 10.1098/rspb.2012.1374; YOUNG RE, 1973, PAC SCI, V27, P1; Zylinski S, 2011, CURR BIOL, V21, P1937, DOI 10.1016/j.cub.2011.10.014	28	16	16	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135381	10.1371/journal.pone.0135381	http://dx.doi.org/10.1371/journal.pone.0135381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26351853	Green Submitted, Green Published, gold			2022-12-26	WOS:000360932800008
J	Motawi, TK; Shaker, OG; El-Maraghy, SA; Senousy, MA				Motawi, Tarek K.; Shaker, Olfat G.; El-Maraghy, Shohda A.; Senousy, Mahmoud A.			Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients	PLOS ONE			English	Article							CIRCULATING MICRORNAS; LIVER-DISEASE; RISK-FACTORS; EXPRESSION; CELLS; PROGRESSION; HEPATOCARCINOGENESIS; OVEREXPRESSION; IDENTIFICATION; TUMORIGENESIS	Circulating microRNAs are deregulated in liver fibrosis and hepatocellular carcinoma (HCC) and are candidate biomarkers. This study investigated the potential of serum microRNAs; miR-19a, miR-296, miR-130a, miR-195, miR-192, miR-34a, and miR-146a as early diagnostic biomarkers for hepatitis C virus (HCV)-related HCC. As how these microRNAs change during liver fibrosis progression is not clear, we explored their serum levels during fibrosis progression in HCV-associated chronic liver disease (CLD) and if they could serve as non-invasive biomarkers for fibrosis progression to HCC. 112 Egyptian HCV-HCC patients, 125 nonmalignant HCV-CLD patients, and 42 healthy controls were included. CLD patients were subdivided according to Metavir fibrosis-scoring. Serum microRNAs were measured by qRT-PCR customarray. Serum microRNAs were deregulated in HCC versus controls, and except miR-130a, they were differentially expressed between HCC and CLD or late fibrosis (F3-F4) subgroup. Serum microRNAs were not significantly different between individual fibrosis-stages or between F1-F2 (early/moderate fibrosis) and F3-F4. Only miR-19a was significantly downregulated from liver fibrosis (F1-F3) to cirrhosis (F4) to HCC. Individual microRNAs discriminated HCC from controls, and except miR-130a, they distinguished HCC from CLD or F3-F4 patients by receiver-operating-characteristic analysis. Multivariate logistic analysis revealed a panel of four microRNAs (miR-19a, miR-195, miR-192, and miR-146a) with high diagnostic accuracy for HCC (AUC = 0.946). The microRNA panel also discriminated HCC from controls (AUC = 0.949), CLD (AUC = 0.945), and F3-F4 (AUC = 0.955). Studied microRNAs were positively correlated in HCC group. miR-19a and miR-34a were correlated with portal vein thrombosis and HCC staging scores, respectively. In conclusion, studied microRNAs, but not miR-130a, could serve as potential early biomarkers for HCC in high-risk groups, with miR-19a as a biomarker for liver fibrosis progression to cirrhosis to HCC. We identified a panel of four serum microRNAs with high accuracy in HCC diagnosis. Additional studies are required to confirm this panel and test its prognostic significance.	[Motawi, Tarek K.; El-Maraghy, Shohda A.; Senousy, Mahmoud A.] Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt; [Shaker, Olfat G.] Cairo Univ, Fac Med, Med Biochem & Mol Biol Dept, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Senousy, MA (corresponding author), Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt.	mohmoud.ali@pharma.cu.edu.eg	Issa, Randa @M.T/E-7144-2019; Senousy, Mahmoud Ahmed/AAB-6410-2022; Shaker, Olfat G/S-2010-2017; O, Shaker/Y-6125-2019	Issa, Randa @M.T/0000-0003-0619-1234; O, Shaker/0000-0002-3031-3599; Motawi, Tarek/0000-0001-8925-9702	Research Service of the Faculty of Pharmacy, Cairo University	Research Service of the Faculty of Pharmacy, Cairo University	Funding: This research was supported by the Research Service of the Faculty of Pharmacy, Cairo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-El-Fattah AA, 2013, CELL BIOCHEM BIOPHYS, V67, P875, DOI 10.1007/s12013-013-9575-y; Attallah AM, 2013, BRIT J CANCER, V109, P1657, DOI 10.1038/bjc.2013.481; Borel F, 2012, J HEPATOL, V56, P1371, DOI 10.1016/j.jhep.2011.11.026; Braconi C, 2010, CLIN CANCER RES, V16, P957, DOI 10.1158/1078-0432.CCR-09-2123; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; El-Garem H, 2014, WORLD J HEPATOL, V6, P818, DOI 10.4254/wjh.v6.i11.818; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; ElHefnawi Mahmoud, 2013, Genomics Proteomics & Bioinformatics, V11, P354, DOI 10.1016/j.gpb.2013.05.007; Freedman LS, 2006, CANC INCIDENCE 4 MEM; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Gui JH, 2011, CLIN SCI, V120, P183, DOI 10.1042/CS20100297; Guo CJ, 2009, FEBS J, V276, P5163, DOI 10.1111/j.1742-4658.2009.07213.x; Han ZB, 2012, MOL ONCOL, V6, P445, DOI 10.1016/j.molonc.2012.04.001; Hatzakis A, 2013, J VIRAL HEPATITIS, V20, P1, DOI 10.1111/jvh.12120; Henrici A, 2013, MOL CARCINOG; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Huang S, 2011, BRIT J CANCER, V104, P235, DOI 10.1038/sj.bjc.6606010; Huang XH, 2009, HEPATOL RES, V39, P786, DOI 10.1111/j.1872-034X.2009.00502.x; Jeong SW, 2012, CLIN MOL HEPATOL, V18, P347, DOI 10.3350/cmh.2012.18.4.347; Karakatsanis A, 2013, MOL CARCINOGEN, V52, P297, DOI 10.1002/mc.21864; Katayama Y, 2012, ONCOL LETT, V4, P817, DOI 10.3892/ol.2012.810; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Liu AM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000825; Liu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109347; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lok AS, 2009, GASTROENTEROLOGY, V136, P138, DOI 10.1053/j.gastro.2008.09.014; Marrero JA, 2009, GASTROENTEROLOGY, V137, P110, DOI 10.1053/j.gastro.2009.04.005; Matsumura H, 2013, WORLD J GASTROENTERO, V19, P4887, DOI 10.3748/wjg.v19.i30.4887; Mizuguchi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015304; Motawi TK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120794; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Pok S, 2013, J GASTROEN HEPATOL, V28, P1545, DOI 10.1111/jgh.12216; Povero D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113651; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Qi J, 2013, NEOPLASMA, V60, P135, DOI 10.4149/neo_2013_018; Qi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028486; Qu KZ, 2011, J CLIN GASTROENTEROL, V45, P355, DOI 10.1097/MCG.0b013e3181f18ac2; Rong MH, 2014, UPSALA J MED SCI, V119, P19, DOI 10.3109/03009734.2013.856970; Shrivastava S, 2013, HEPATOLOGY, V58, P863, DOI 10.1002/hep.26296; Sun XX, 2015, CELL CYCLE, V14, P243, DOI 10.4161/15384101.2014.977112; Tan YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107986; Tomimaru Y, 2012, J HEPATOL, V56, P167, DOI 10.1016/j.jhep.2011.04.026; Trebicka J, 2013, J HEPATOL, V58, P234, DOI 10.1016/j.jhep.2012.10.015; Tryndyak VP, 2009, MOL CARCINOGEN, V48, P479, DOI 10.1002/mc.20484; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Vaira V, 2012, ONCOGENE, V31, P27, DOI 10.1038/onc.2011.209; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Xu J, 2012, LIVER INT, V32, P752, DOI 10.1111/j.1478-3231.2011.02750.x; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Yoon A, 2011, NUCLEIC ACIDS RES, V39, P8078, DOI 10.1093/nar/gkr492; Zhang Z, 2015, MOL CANCER, V14, DOI 10.1186/1476-4598-14-5; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697	60	53	58	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137706	10.1371/journal.pone.0137706	http://dx.doi.org/10.1371/journal.pone.0137706			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352740	Green Published, Green Submitted, gold			2022-12-26	WOS:000360932800112
J	Russell, BJ; Dierssen, HM				Russell, Brandon J.; Dierssen, Heidi M.			Use of Hyperspectral Imagery to Assess Cryptic Color Matching in Sargassum Associated Crabs	PLOS ONE			English	Article							GULF-OF-MEXICO; IN-SITU SPECTROMETRY; FIDDLER-CRAB; PELAGIC SARGASSUM; CALLINECTES-SAPIDUS; VISUAL PIGMENTS; MATE CHOICE; BLUE-CRAB; CAMOUFLAGE; ECOLOGY	Mats of the pelagic macroalgae Sargassum represent a complex environment for the study of marine camouflage at the air-sea interface. Endemic organisms have convergently evolved similar colors and patterns, but quantitative assessments of camouflage strategies are lacking. Here, spectral camouflage of two crab species (Portunus sayi and Planes minutus) was assessed using hyperspectral imagery (HSI). Crabs matched Sargassum reflectance across blue and green wavelengths (400-550 nm) and diverged at longer wavelengths. Maximum discrepancy was observed in the far-red (i.e., 675 nm) where Chlorophyll a absorption occurred in Sargassum and not the crabs. In a quantum catch color model, both crabs showed effective color matching against blue/green sensitive dichromat fish, but were still discernible to tetrachromat bird predators that have visual sensitivity to far red wavelengths. The two species showed opposing trends in background matching with relation to body size. Variation in model parameters revealed that discrimination of crab and background was impacted by distance from the predator, and the ratio of cone cell types for bird predators. This is one of the first studies to detail background color matching in this unique, challenging ecosystem at the air-sea interface.	[Russell, Brandon J.; Dierssen, Heidi M.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Dierssen, Heidi M.] Univ Connecticut, Dept Geog, Storrs, CT 06268 USA	University of Connecticut; University of Connecticut	Russell, BJ (corresponding author), Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA.	Brandon.Russell@uconn.edu			Office of Naval Research, Multi-University Research Initiative [N000140911054]	Office of Naval Research, Multi-University Research Initiative	This work was funded by the Office of Naval Research (http://www.onr.navy.mil/) Multi-University Research Initiative (N000140911054). Ship time was donated by the Bermuda Alliance for the Sargasso Sea, and the Bermuda Aquarium, Museum, and Zoo.	Akkaynak D, 2013, J COMP PHYSIOL A, V199, P211, DOI 10.1007/s00359-012-0785-3; Baldwin J, 2012, J EXP BIOL, V215, P1184, DOI 10.1242/jeb.067512; Barbosa P., 2005, ECOLOGY PREDATOR PRE; Barnard ME, 2012, INVERTEBR BIOL, V131, P52, DOI 10.1111/j.1744-7410.2011.00256.x; Brady PC, 2013, P NATL ACAD SCI USA, V110, P9764, DOI 10.1073/pnas.1222125110; Brooks W. Randy, 2007, Gulf of Mexico Science, V25, P144; Brown FA, 1939, AM NAT, V73, P564, DOI 10.1086/280866; BURSEY CR, 1984, CRUSTACEANA, V47, P278, DOI 10.1163/156854084X00531; Chang GC, 2004, J GEOPHYS RES, V109, P10; Cheney KL, 2009, P R SOC B, V276, P1565, DOI 10.1098/rspb.2008.1819; Chiao CC, 2011, P NATL ACAD SCI USA, V108, P9148, DOI 10.1073/pnas.1019090108; Chronin TW, 2014, VISUAL ECOLOGY, DOI [10.1186/1472-6785-14-14, DOI 10.1186/1472-6785-14-14]; Coston-Clements L., 1991, NMFSSEFSC296 NOAA; Cott H.B., 1940, ADAPTIVE COLORATION; Crozier WJ, 1918, AM NAT, V52, P262, DOI 10.1086/279666; Cummings ME, 2008, ANIM BEHAV, V75, P175, DOI 10.1016/j.anbehav.2007.04.016; Darnell MZ, 2012, J EXP MAR BIOL ECOL, V426, P39, DOI 10.1016/j.jembe.2012.05.014; Defrize J, 2010, J EXP BIOL, V213, P1425, DOI 10.1242/jeb.039743; Detto T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001629; Detto T, 2007, P ROY SOC B-BIOL SCI, V274, P2785, DOI 10.1098/rspb.2007.1059; Dierssen HM, 2015, REMOTE SENS ENVIRON, V167, P247, DOI 10.1016/j.rse.2015.01.027; DOOLEY JK, 1972, CONTRIB MAR SCI, V16, P1; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; FINE ML, 1970, MAR BIOL, V7, P112, DOI 10.1007/BF00354914; Fritsches KA, 2000, PHILOS T ROY SOC B, V355, P1253, DOI 10.1098/rstb.2000.0678; Gilerson AA, 2013, APPL OPTICS, V52, P8685, DOI 10.1364/AO.52.008685; Gower J, 2006, IEEE T GEOSCI REMOTE, V44, P3619, DOI 10.1109/TGRS.2006.882258; Green JP, 1963, THESIS U MINNESOTA M; HACKER SD, 1991, MAR ECOL PROG SER, V70, P143, DOI 10.3354/meps070143; Hanlon RT, 2009, PHILOS T R SOC B, V364, P429, DOI 10.1098/rstb.2008.0270; Hanlon RT, 2013, BIOL J LINN SOC, V109, P535, DOI 10.1111/bij.12071; Hart NS, 2007, AM NAT, V169, pS7, DOI 10.1086/510141; Hart NS, 2004, J EXP BIOL, V207, P1229, DOI 10.1242/jeb.00857; Hart NS, 2001, J COMP PHYSIOL A, V187, P685, DOI 10.1007/s00359-001-0240-3; Hemmi JM, 2006, J EXP BIOL, V209, P4140, DOI 10.1242/jeb.02483; HITCHCOCK HAROLD B., 1941, BIOL BULL, V80, P26, DOI 10.2307/1537704; Hultgren KM, 2012, ANIMAL CAMOUFLAGE ME; Hultgren KM, 2008, OECOLOGIA, V155, P519, DOI 10.1007/s00442-007-0926-5; Hurtado-Gonzales JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101497; HUTCHINSON KA, 2004, THESIS FLORIDA ATLAN; Hyatt GW, 1975, PHYSL ECOLOGY ESTUAR; Iampietro P., 1999, THESIS CALIFORNIA ST; Jobe CF, 2009, SYMBIOSIS, V49, P77, DOI 10.1007/s13199-009-0017-y; Johnsen S, 2006, J EXP BIOL, V209, P789, DOI 10.1242/jeb.02053; Josef N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037579; Langmore NE, 2011, P ROY SOC B-BIOL SCI, V278, P2455, DOI 10.1098/rspb.2010.2391; Manolakis D., 2003, Lincoln Laboratory Journal, V14, P79; McPherson ML, 2011, ESTUAR COAST, V34, P1150, DOI 10.1007/s12237-011-9411-9; Mobley C.D.., 1994, LIGHT WATER RAD TRAN; MONAHAN E, 1986, OCEANIC WHITECAPS TH; Morris BF, 1973, IDENTIFICATION MANUA; Moser ML, 2012, WILSON J ORNITHOL, V124, P66, DOI 10.1676/11-067.1; MUNZ FW, 1975, VISION RES, V15, P1045, DOI 10.1016/0042-6989(75)90001-2; Palko B. J., 1982, FAO FISHERIES SYNOPS, V130; PARR ALBERT EIDE, 1939, BULL BINGHAM OCEANOGR COLL PEABODY MUS NAT HIST, V6, P1; Peres JM, 1982, MARINE ECOLOGY 1, V5, P314; Pinto F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073234; Randolph K, 2014, J GEOPHYS RES-OCEANS, V119, P757, DOI 10.1002/2013JC009227; Rooker JR, 2006, MAR ECOL PROG SER, V313, P249, DOI 10.3354/meps313249; Russell BJ, 2012, OC OPT C 21 OCT 8 12; Siddiqi A, 2004, J EXP BIOL, V207, P2471, DOI 10.1242/jeb.01047; Silbiger N, 2008, J EXP MAR BIOL ECOL, V355, P41, DOI 10.1016/j.jembe.2007.11.014; SMITH K L JR, 1973, Journal of Experimental Marine Biology and Ecology, V12, P219, DOI 10.1016/0022-0981(73)90055-5; Stevens M., 2011, ANIMAL CAMOUFLAGE ME; Stevens M, 2007, P ROY SOC B-BIOL SCI, V274, P1457, DOI 10.1098/rspb.2007.0220; Stevens M, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00014; Stevens M, 2013, BIOL J LINN SOC, V109, P257, DOI 10.1111/bij.12039; Thery M, 2002, NATURE, V415, P133, DOI 10.1038/415133a; Troscianko J, 2015, METHODS ECOL EVOL; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; WEIS JS, 1968, AM MIDL NAT, V80, P554, DOI 10.2307/2423550; Wells RJD, 2009, J FISH BIOL, V75, P1719, DOI 10.1111/j.1095-8649.2009.02424.x; West L. E., 2012, THESIS FLORIDA ATLAN	74	18	18	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136260	10.1371/journal.pone.0136260	http://dx.doi.org/10.1371/journal.pone.0136260			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352667	gold, Green Published, Green Submitted			2022-12-26	WOS:000360932800031
J	Takeuchi, M; Sato, T; Tanaka, A; Muraoka, T; Taguchi, M; Sakurai, Y; Karasawa, Y; Ito, M				Takeuchi, Masaru; Sato, Tomohito; Tanaka, Atsushi; Muraoka, Tadashi; Taguchi, Manzo; Sakurai, Yutaka; Karasawa, Yoko; Ito, Masataka			Elevated Levels of Cytokines Associated with Th2 and Th17 Cells in Vitreous Fluid of Proliferative Diabetic Retinopathy Patients	PLOS ONE			English	Article							T-CELLS; ANGIOGENIC FACTORS; EXPRESSION; IL-31; IL-17; VEGF; INTERLEUKIN-31	Macrophages are involved in low-grade inflammation in diabetes, and play pathogenic roles in proliferative diabetic retinopathy (PDR) by producing proinflammatory cytokines. T cells as well as other cells are also activated by proinflammatory cytokines, and infiltration into the vitreous of patients with PDR has been shown. In this study, we measured helper T (Th) cell-related cytokines in the vitreous of PDR patients to define the characteristics of Th-mediated immune responses associated with PDR. The study group consisted of 25 type 2 diabetic patients (25 eyes) with PDR. The control group consisted of 27 patients with epiretinal membrane (ERM), 26 patients with idiopathic macular hole (MH), and 26 patients with uveitis associated with sarcoidosis. Vitreous fluid was obtained at the beginning of vitrectomy, and centrifuging for cellular removals was not performed. Serum was also collected from PDR patients. IL-1 beta, IL-4, IL-6, IL-10, IL-17A, IL-17F, IL-21, IL-22, IL-23, IL-25, IL-31, IL-33, IFN-gamma, soluble sCD40L, and TNF alpha in the vitreous and serum samples were measured. Both percent detectable and levels of IL-4, IL-6, IL-17A, IL-21, IL-22, and TNF alpha in the vitreous were significantly higher than those in the serum in PDR patients. Vitreous levels of these cytokines and IL-31 were significantly higher in PDR than in ERM or MH patients. Vitreous levels of IL-4, IL-17A, IL-22, IL-31, and TNF alpha in PDR patients were also significantly higher than those of sarcoidosis patients. In PDR patients, vitreous IL-17A level correlated significantly with vitreous levels of IL-22 and IL-31, and especially with IL-4 and TNF alpha. Although it is unclear whether these cytokines play facilitative roles or inhibitory roles for the progression of PDR, the present study indicated that Th2- and Th17-related immune responses are involved in the pathogenesis of PDR.	[Takeuchi, Masaru; Sato, Tomohito; Tanaka, Atsushi; Muraoka, Tadashi; Taguchi, Manzo; Sakurai, Yutaka; Karasawa, Yoko] Natl Def Med Coll, Dept Ophthalmol, Saitama, Japan; [Ito, Masataka] Natl Def Med Coll, Dept Dev Anat & Regenerat Biol, Saitama, Japan	National Defense Medical College - Japan; National Defense Medical College - Japan	Takeuchi, M (corresponding author), Natl Def Med Coll, Dept Ophthalmol, Saitama, Japan.	masatake@ndmc.ac.jp						Adamiec-Mroczek J, 2010, CYTOKINE, V49, P269, DOI 10.1016/j.cyto.2009.11.004; Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Arimura N, 2009, OPHTHALMOLOGY, V116, P921, DOI 10.1016/j.ophtha.2008.12.024; Bromberg-White JL, 2013, INVEST OPHTH VIS SCI, V54, P6472, DOI 10.1167/iovs.13-12518; Canataroglu H, 2005, OCUL IMMUNOL INFLAMM, V13, P375, DOI 10.1080/09273940490518900; Canton A, 2004, ARCH OPHTHALMOL-CHIC, V122, P743, DOI 10.1001/archopht.122.5.743; Dambacher J, 2007, GUT, V56, P1257, DOI 10.1136/gut.2006.118679; Demircan N, 2006, EYE, V20, P1366, DOI 10.1038/sj.eye.6702138; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Gologorsky D, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/629452; Kakehashi A, 2008, DIABETES RES CLIN PR, V79, P438, DOI 10.1016/j.diabres.2007.10.018; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; Lei Z, 2008, ALLERGY, V63, P327, DOI 10.1111/j.1398-9995.2007.01566.x; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Murugeswari P, 2008, RETINA-J RET VIT DIS, V28, P817, DOI 10.1097/IAE.0b013e31816576d5; Nawaz MI, 2013, EXP EYE RES, V109, P67, DOI 10.1016/j.exer.2013.01.008; Neis MM, 2006, J ALLERGY CLIN IMMUN, V118, P930, DOI 10.1016/j.jaci.2006.07.015; Qu N, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/968549; Schoenberger SD, 2012, INVEST OPHTH VIS SCI, V53, P5906, DOI 10.1167/iovs.12-10410; Schuerwegh AJ, 2003, CYTOM PART B-CLIN CY, V55B, P52, DOI 10.1002/cyto.b.10041; Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886; Stott B, 2013, J ALLERGY CLIN IMMUN, V132, P446, DOI 10.1016/j.jaci.2013.03.050; Suzuki Y, 2011, JPN J OPHTHALMOL, V55, P256, DOI 10.1007/s10384-011-0004-8; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Urbancic M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/251528; Zhou JZ, 2012, CURR EYE RES, V37, P416, DOI 10.3109/02713683.2012.661114; Zuniga LA, 2010, J IMMUNOL, V185, P6947, DOI 10.4049/jimmunol.1001269	29	61	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137358	10.1371/journal.pone.0137358	http://dx.doi.org/10.1371/journal.pone.0137358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352837	gold, Green Published, Green Submitted			2022-12-26	WOS:000360932800077
J	Ranjbar, M; Rotondi, MA; Ardern, CI; Kuk, JL				Ranjbar, Mahsa; Rotondi, Michael A.; Ardern, Chris I.; Kuk, Jennifer L.			Urinary Biomarkers of Polycyclic Aromatic Hydrocarbons Are Associated with Cardiometabolic Health Risk	PLOS ONE			English	Article							METABOLIC SYNDROME; UNITED-STATES; HEART-DISEASE; LUNG-CANCER; EXPOSURE; WORKERS; POPULATION; DIAGNOSIS; PAHS	Background Polycyclic aromatic hydrocarbons (PAH) are both man-made and naturally occurring environmental pollutants that may be related to cardiometabolic health risk. Objective To determine whether PAH is associated with obesity in the adult population and to examine whether urinary concentrations of PAH metabolites are associated with differences in how obesity relates to 3 or more risk factors for the metabolic syndrome (3RFMetS), type 2 diabetes (T2D), hypertension, and dyslipidemia. Methods A total of 4765 adult participants from the 2001-2008 National Health and Nutrition Examination Survey were examined. The association between 8 urinary hydroxylated PAH metabolites, obesity, and health were examined using weighted logistic regressions adjusting for age, sex, ethnicity, PIR, smoking status, and urinary creatinine. Results There was a positive dose-dependent association between obesity and 2-phenanthrene quintiles (P trend < 0.0001). Contrarily, higher quintiles of 1-naphthalene were associated with lower risk of obesity (P trend = 0.0004). For a given BMI, those in the highest quintile of 2-naphthalene, 2-fluorene, 3-fluorene and 2-phenanthrene had a 66-80% greater likelihood of 3RFMetS (P <= 0.05) compared to low levels. Higher quintiles of 1-naphthalene, 2-naphthalene, 2-phenanthrene and 1-pyrene were associated with a 78-124% greater likelihood of T2D (P <= 0.05) compared to low levels while high 1-naphthalene, 2-naphthalene, 2-fluorene, 3-fluorene and 2-phenanthrene were associated with a 38-68% greater likelihood of dyslipidemia (P <= 0.05) compared to lower levels. Finally, 2-naphthalene and 2-phenanthrene were positively associated with hypertension (P trend = 0.008 and P trend = 0.02 respectively). Conclusions PAH is related to obesity and the expression of a number of obesity-related cardiometabolic health risk factors. Future research is needed to bring to light the mechanistic pathways related to these findings.	[Ranjbar, Mahsa; Rotondi, Michael A.; Ardern, Chris I.; Kuk, Jennifer L.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada	York University - Canada	Kuk, JL (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	jennkuk@yorku.ca			Canadian Institute for Health Research Grant [131594]	Canadian Institute for Health Research Grant(Canadian Institutes of Health Research (CIHR))	This study was supported by a Canadian Institute for Health Research Grant 131594 (http://www.cihr-irsc.gc.ca/e/37788.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Toxic Substances and Disease Registry, 1995, TOX PROF POL AR HYDR; Alshaarawy O, 2014, OCCUP ENVIRON MED, V71, P437, DOI 10.1136/oemed-2013-101987; Alshaarawy O, 2013, ENVIRON RES, V126, P98, DOI 10.1016/j.envres.2013.07.006; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055; [Anonymous], 2004, NIH PUBLICATION; Armstrong B, 2004, ENVIRON HEALTH PERSP, V112, P970, DOI 10.1289/ehp.6895; Beltran-Sanchez H, 2013, J AM COLL CARDIOL, V62, P697, DOI 10.1016/j.jacc.2013.05.064; BONASSI S, 1989, INT J CANCER, V44, P648, DOI 10.1002/ijc.2910440415; Bosetti C, 2007, ANN ONCOL, V18, P431, DOI 10.1093/annonc/mdl172; Buratti M, 2007, BIOMARKERS, V12, P221, DOI 10.1080/13547500601100110; Burstyn I, 2005, EPIDEMIOLOGY, V16, P744, DOI 10.1097/01.ede.0000181310.65043.2f; CDC, 2009, 4 CDCP; CDC, 2012, LAB PROC MAN MON POL; COSTANTINO JP, 1995, J OCCUP ENVIRON MED, V37, P597, DOI 10.1097/00043764-199505000-00009; Curfs DMJ., 2005, FASEB J; Everett CJ, 2010, ENVIRON RES, V110, P79, DOI 10.1016/j.envres.2009.09.010; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hecht SS, 2002, CARCINOGENESIS, V23, P907, DOI 10.1093/carcin/23.6.907; Li Z, 2010, J ENVIRON MONITOR, V12, P1110, DOI 10.1039/c000689k; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; MCLAUGHLIN JK, 1992, BRIT J IND MED, V49, P167; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; OBANA H, 1981, B ENVIRON CONTAM TOX, V27, P23, DOI 10.1007/BF01610981; Patel CJ, 2012, INT J EPIDEMIOL, V41, P828, DOI 10.1093/ije/dys003; Raaschou-Nielsen O, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-67; Rundle A, 2012, AM J EPIDEMIOL, V175, P1163, DOI 10.1093/aje/kwr455; Scinicariello F, 2013, ENV HLTH PERSPECT; St Helen G, 2012, CHEM RES TOXICOL, V25, P952, DOI 10.1021/tx300043k; The NIDDK National Diabetes Information, 2011, NAT DIAB STAT 2011; Vaananen V, 2003, J ENVIRON MONITOR, V5, P739, DOI 10.1039/b304096h; Xu XH, 2013, SCI TOTAL ENVIRON, V461, P341, DOI 10.1016/j.scitotenv.2013.04.089; Xu XH, 2010, SCI TOTAL ENVIRON, V408, P4943, DOI 10.1016/j.scitotenv.2010.07.034; Yang LL, 2014, ENVIRON POLLUT, V195, P24, DOI 10.1016/j.envpol.2014.08.012	33	48	49	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137536	10.1371/journal.pone.0137536	http://dx.doi.org/10.1371/journal.pone.0137536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340343	gold, Green Published, Green Submitted			2022-12-26	WOS:000360688200066
J	Schmidt, D; Germano, AMC; Milani, TL				Schmidt, Daniel; Germano, Andresa M. C.; Milani, Thomas L.			Aspects of Dynamic Balance Responses: Inter- and Intra-Day Reliability	PLOS ONE			English	Article							DIRECTIONAL SENSITIVITY; POSTURAL CONTROL; TEST-RETEST; PLATFORM; AGE; PROPRIOCEPTION; PERFORMANCE; STRENGTH; VALIDITY; REFLEXES	The Posturomed device is used as a scientific tool to quantify human dynamic balance ability due to unexpected perturbations, and as a training device. Consequently, the question arises whether such measurements are compromised by learning effects. Therefore, this study aimed to analyze inter- and intra-day reliability of dynamic balance responses using the Posturomed. Thirty healthy young subjects participated (24.3 +/- 3.2 years). The Posturomed was equipped with a triggering mechanism to enable unexpected, horizontal platform perturbations. A force platform was used to quantify Center of Pressure (COP) excursions for two time intervals: interval 1 (0-70 ms post perturbation) and interval 2 (71-260 ms post perturbation). Dynamic balance tests were performed in single leg stances in medio-lateral and anterior-posterior perturbation directions. Inter- and intra-day reliability were assessed descriptively using Bland-Altman plots and inferentially using tests for systematic error and intra-class-correlations. With regard to the mean COP excursions for every subject and all intervals, some cases revealed significant differences between measurement sessions, however, none were considered relevant. Furthermore, intra class correlation coefficients reflected high magnitudes, which leads to the assumption of good relative reliability. However, analyzing inter- and intra-day reliability using Bland-Altman plots revealed one exception: intra-day comparisons for the anterior-posterior direction in interval 2, which points towards possible learning effects. In summary, results reflected good overall reliability with the exception of certain intra-day comparisons in the anterior-posterior perturbation direction, which could indicate learning effects in those particular conditions.	[Schmidt, Daniel; Germano, Andresa M. C.; Milani, Thomas L.] Tech Univ Chemnitz, Dept Human Locomot, Inst Human Movement Sci & Hlth, Chemnitz, Saxony, Germany	Technische Universitat Chemnitz	Schmidt, D (corresponding author), Tech Univ Chemnitz, Dept Human Locomot, Inst Human Movement Sci & Hlth, Chemnitz, Saxony, Germany.	daniel.schmidt@hsw.tu-chemnitz.de		Schmidt, Daniel/0000-0001-6730-4621				Allum JHJ, 2002, J PHYSIOL-LONDON, V542, P643, DOI 10.1113/jphysiol.2001.015644; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Bedard M, 2000, EXP AGING RES, V26, P353, DOI 10.1080/036107300750015741; Benvenuti F, 1999, ARCH PHYS MED REHAB, V80, P278, DOI 10.1016/S0003-9993(99)90138-7; Bloem BR, 2000, EXP BRAIN RES, V130, P375, DOI 10.1007/s002219900259; Boeer J, 2010, SPORTVERLETZ SPORTSC, V24, P40, DOI 10.1055/s-0029-1245184; Bower KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115282; Bruhn S, 2004, INT J SPORTS MED, V25, P56; Bruton A, 2000, PHYSIOTHERAPY, V86, P94, DOI [10.1016/S0031-9406(05)61211-4, DOI 10.1016/S0031-9406(05)61211-4, 10.1016/s0031-9406(05)61211-4]; Carpenter MG, 1999, EXP BRAIN RES, V129, P93, DOI 10.1007/s002210050940; Condron JE, 2002, J AM GERIATR SOC, V50, P157, DOI 10.1046/j.1532-5415.2002.50022.x; Corriveau H, 2001, ARCH PHYS MED REHAB, V82, P80, DOI 10.1053/apmr.2001.18678; Crisan AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120573; Granacher U, 2009, INT J SPORTS MED, V30, P652, DOI 10.1055/s-0029-1224178; Hilberg T, 2001, HAEMOPHILIA, V7, P582, DOI 10.1046/j.1365-2516.2001.00563.x; Hirschmuller A, 2011, INJURY, V42, P1135, DOI 10.1016/j.injury.2010.09.040; Hulsdunker T, 2015, NEUROSCI LETT, V592, P1, DOI 10.1016/j.neulet.2015.02.049; Kiss RM, 2011, MED ENG PHYS, V33, P1160, DOI 10.1016/j.medengphy.2011.04.017; Kiss RM, 2010, J ELECTROMYOGR KINES, V20, P1052, DOI 10.1016/j.jelekin.2010.06.005; Kramer A, 2014, ARCH PHYS MED REHAB, V95, P1803, DOI 10.1016/j.apmr.2014.04.020; Latash M.L., 2008, NEUROPHYSIOLOGICAL B, V3rd ed.; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; Mergner T, 1998, BRAIN RES REV, V28, P118, DOI 10.1016/S0165-0173(98)00032-0; MOORE SP, 1988, EXP BRAIN RES, V73, P648, DOI 10.1007/BF00406624; Muller MLTM, 2004, J BIOMECH, V37, P1573, DOI 10.1016/j.jbiomech.2004.01.004; Muller O, 2004, BIOMED TECH, V49, P56, DOI 10.1515/BMT.2004.011; MULLER R, 1994, STAT MED, V13, P2465, DOI 10.1002/sim.4780132310; Nevill AM, 1997, BRIT J SPORT MED, V31, P314, DOI 10.1136/bjsm.31.4.314; Patel P, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12247; Perry SD, 2000, BRAIN RES, V877, P401, DOI 10.1016/S0006-8993(00)02712-8; Pfusterschmied J, 2013, EUR J SPORT SCI, V13, P49, DOI 10.1080/17461391.2011.583991; SAMSON M, 1996, GAIT POSTURE, V4, P252; Santos MJ, 2010, J ELECTROMYOGR KINES, V20, P388, DOI 10.1016/j.jelekin.2009.06.006; Schlee G, 2009, CLIN NEUROPHYSIOL, V120, P1548, DOI 10.1016/j.clinph.2009.06.010; Schwab MJ, 2008, J CHIROPR MED, V7, P146, DOI 10.1016/j.jcm.2008.06.001; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; ShumwayCook A, 1997, J GERONTOL A-BIOL, V52, pM232, DOI 10.1093/gerona/52A.4.M232; Smith GV., 2000, J STROKE CEREBROVASC, V9, P238, DOI DOI 10.1053/JSCD.2000.16607; STELMACH GE, 1989, J GERONTOL, V44, pB100, DOI 10.1093/geronj/44.4.B100; Taube W, 2007, ACTA PHYSIOL, V189, P347, DOI 10.1111/j.1748-1716.2007.01665.x; Taube W, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00972; Traub R.E., 1991, EDUC MEAS-ISSUES PRA, V10, P37, DOI [10.1111/j.1745-3992.1991.tb00183.x, DOI 10.1111/J.1745-3992.1991.TB00183.X]; Vaz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073990; Vincent J., 1994, STAT KINESIOLOGY; Vrieling AH, 2008, GAIT POSTURE, V28, P222, DOI 10.1016/j.gaitpost.2007.12.002; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4	47	13	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0136551	10.1371/journal.pone.0136551	http://dx.doi.org/10.1371/journal.pone.0136551			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340753	Green Published, gold, Green Submitted			2022-12-26	WOS:000360688200010
J	Tanaka, T; Kitajima, Y; Miyake, S; Yanagihara, K; Hara, H; Nishijima-Matsunobu, A; Baba, K; Shida, M; Wakiyama, K; Nakamura, J; Noshiro, H				Tanaka, Tomokazu; Kitajima, Yoshihiko; Miyake, Shuusuke; Yanagihara, Kazuyoshi; Hara, Hiromitsu; Nishijima-Matsunobu, Aki; Baba, Koichi; Shida, Masaaki; Wakiyama, Kota; Nakamura, Jun; Noshiro, Hirokazu			The Apoptotic Effect of HIF-1 alpha Inhibition Combined with Glucose plus Insulin Treatment on Gastric Cancer under Hypoxic Conditions	PLOS ONE			English	Article							LUNG EPITHELIAL-CELLS; INDUCIBLE FACTOR-1; PLASMA-MEMBRANE; EXPRESSION; HIF-1; GROWTH; GENE; INDUCTION; TRANSLOCATION; DEHYDROGENASE	Gastric cancer grows under a hypoxic environment. HIF-1 alpha is known to play an important role in controlling the production of reactive oxygen species (ROS) in the mitochondria under hypoxic conditions. We previously established HIF-1 alpha knockdown (KD) cells and control (SC) cells in the 58As9 gastric cancer cell line. In this study, we revealed that KD cells, but not SC cells, induced apoptosis under conditions of hypoxia (1% O-2) due to excessive production of ROS. A quantitative RT-PCR analysis demonstrated that the expressions of ten genes, which are involved in the control mechanisms of ROS (including the Warburg effect, mitophagy, electron transport chain [ETC] modification and ROS scavenging), were regulated by HIF-1 alpha. Moreover, the promotion of glucose uptake by glucose plus insulin (GI) treatment enhanced the apoptotic effect, which was accompanied by further ROS production in hypoxic KD cells. A Western blot analysis showed that the membranous expression of GLUT1 in KD cells was elevated by glucose and/or insulin treatments, indicating that the GI-induced glucose uptake is mediated by the increased translocation of GLUT1 on the cell membrane. Finally, the anti-tumor effect of HIF-1 alpha knockdown (KD) plus GI was evaluated using a tumor xenograft model, where a hypoxic environment naturally exists. As a result, the GI treatment strongly inhibited the growth of the KD tumors whereby cell apoptosis was highly induced in comparison to the control treatment. In contrast, the growth of the SC tumors expressing HIF-1 alpha was not affected by the GI treatment. Taken together, the results suggest that HIF-1 alpha inhibition plus GI may be an ideal therapy, because the apoptosis due to the destruction of ROS homeostasis is specifically induced in gastric cancer that grows under a hypoxic environment, but not in the normal tissue under the aerobic conditions.	[Tanaka, Tomokazu; Kitajima, Yoshihiko; Miyake, Shuusuke; Baba, Koichi; Shida, Masaaki; Wakiyama, Kota; Nakamura, Jun; Noshiro, Hirokazu] Saga Univ, Fac Med, Dept Surg, Saga 840, Japan; [Kitajima, Yoshihiko] NHO Higashisaga Hosp, Dept Surg, Miyaki Town, Saga, Japan; [Yanagihara, Kazuyoshi] Natl Canc Ctr Hosp East, Div Pathol, Res Ctr Innovat Oncol, Kashiwa, Chiba, Japan; [Hara, Hiromitsu] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Immunol, Kagoshima 890, Japan; [Nishijima-Matsunobu, Aki] Akita Univ, Grad Sch Med, Dept Mol & Tumor Pathol, Hondo, Akita, Japan	Saga University; National Cancer Center - Japan; Kagoshima University; Akita University	Kitajima, Y (corresponding author), Saga Univ, Fac Med, Dept Surg, Saga 840, Japan.	kitajiy@hosp.go.jp	Nakamura, Jun/AAT-3274-2021	MIYAKE, SHUUSUKE/0000-0002-3148-2087; Nakamura, Jun/0000-0002-3167-3908				Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Burroughs SK, 2013, FUTURE MED CHEM, V5, P553, DOI [10.4155/fmc.13.17, 10.4155/FMC.13.17]; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Comerford KM, 2002, CANCER RES, V62, P3387; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Hara S, 2006, ORAL ONCOL, V42, P593, DOI 10.1016/j.oraloncology.2005.10.016; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; HAUSDORFF SF, 1995, J BIOL CHEM, V270, P12965, DOI 10.1074/jbc.270.22.12965; Hayashi M, 2004, J ENDOCRINOL, V183, P145, DOI 10.1677/joe.1.05599; Ide T, 2006, INT J CANCER, V119, P2750, DOI 10.1002/ijc.22178; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jean JC, 2006, AM J PHYSIOL-LUNG C, V291, pL950, DOI 10.1152/ajplung.00087.2006; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kitajima Yoshihiko, 2013, Cancers (Basel), V5, P15, DOI 10.3390/cancers5010015; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Micucci C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105550; Miyake S, 2013, INT J ONCOL, V43, P1431, DOI 10.3892/ijo.2013.2068; Nagle DG, 2006, CURR DRUG TARGETS, V7, P355, DOI 10.2174/138945006776054979; Nakamura J, 2010, INT J CANCER, V127, P1158, DOI 10.1002/ijc.25129; Ohman T, 1999, AM J RESP CELL MOL, V21, P119, DOI 10.1165/ajrcmb.21.1.3521; Onnis B, 2009, J CELL MOL MED, V13, P2780, DOI 10.1111/j.1582-4934.2009.00876.x; Poellinger L, 2004, CURR OPIN GENET DEV, V14, P81, DOI 10.1016/j.gde.2003.12.006; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Rohwer N, 2010, CANCER BIOL THER, V10, P383, DOI 10.4161/cbt.10.4.12850; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2011, BBA-MOL CELL RES, V1813, P1263, DOI 10.1016/j.bbamcr.2010.08.006; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Stoeltzing O, 2004, JNCI-J NATL CANCER I, V96, P946, DOI 10.1093/jnci/djh168; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Vander Heiden MG, 2009, J ENDOCRINOL, V324, P1029, DOI [10.1126/science.1160809, DOI 10.1126/SCIENCE.1160809]; Vaupel P, 2004, METHOD ENZYMOL, V381, P335; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yanagihara K, 2005, CANCER SCI, V96, P323, DOI 10.1111/j.1349-7006.2005.00054.x; Yang CM, 2001, J CLIN INVEST, V107, P1311, DOI 10.1172/JCI12274; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zou P, 2015, ONCOTARGET, V6, P5860, DOI 10.18632/oncotarget.3333	41	13	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137257	10.1371/journal.pone.0137257	http://dx.doi.org/10.1371/journal.pone.0137257			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339797	gold, Green Submitted, Green Published			2022-12-26	WOS:000360688200041
J	Tardy, C; Goffinet, M; Boubekeur, N; Cholez, G; Ackermann, R; Sy, G; Keyserling, C; Lalwani, N; Paolini, JF; Dasseux, JL; Barbaras, R; Baron, R				Tardy, Claudine; Goffinet, Marine; Boubekeur, Nadia; Cholez, Guy; Ackermann, Rose; Sy, Gavin; Keyserling, Constance; Lalwani, Narendra; Paolini, John F.; Dasseux, Jean-Louis; Barbaras, Ronald; Baron, Rudi			HDL and CER-001 Inverse-Dose Dependent Inhibition of Atherosclerotic Plaque Formation in apoE(-/-) Mice: Evidence of ABCA1 Down-Regulation	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; CASSETTE TRANSPORTER 1; TRANSINTESTINAL CHOLESTEROL EXCRETION; PRE-BETA; TANGIER-DISEASE; CAROTID-ARTERY; APOA-I; EFFLUX; RABBITS	Objective CER-001 is a novel engineered HDL-mimetic comprised of recombinant human apoA-I and charged phospholipids that was designed to mimic the beneficial properties of nascent pre-beta HDL. In this study, we have evaluated the dose-dependent regulation of ABCA1 expression in vitro and in vivo in the presence of CER-001 and native HDL (HDL3). Methods and Results CER-001 induced cholesterol efflux from J774 macrophages in a dose-dependent manner similar to natural HDL. A strong down-regulation of the ATP-binding cassette A1 (ABCA1) transporter mRNA (-50%) as well as the ABCA1 membrane protein expression (-50%) was observed at higher doses of CER-001 and HDL3 compared to non-lipidated apoA-I. In vivo, in an apoE(-/-) mouse "flow cessation model," in which the left carotid artery was ligatured to induce local inflammation, the inhibition of atherosclerotic plaque burden progression in response to a dose-range of every-other-day CER-001 or HDL in the presence of a high-fat diet for two weeks was assessed. We observed a U-shaped dose-response curve: inhibition of the plaque total cholesterol content increased with increasing doses of CER-001 or HDL3 up to a maximum inhibition (-51%) at 5 mg/kg; however, as the dose was increased above this threshold, a progressively less pronounced inhibition of progression was observed, reaching a complete absence of inhibition of progression at doses of 20 mg/kg and over. ABCA1 protein expression in the same atherosclerotic plaque was decreased by-45% and-68% at 50 mg/kg for CER-001 and HDL respectively. Conversely, a-12% and 0% decrease in ABCA1 protein expression was observed at the 5 mg/kg dose for CER-001 and HDL respectively. Conclusions These data demonstrate that high doses of HDL and CER-001 are less effective at slowing progression of atherosclerotic plaque in apoE(-/-) mice compared to lower doses, following a U-shaped dose-response curve. A potential mechanism for this phenomenon is supported by the observation that high doses of HDL and CER-001 induce a rapid and strong down-regulation of ABCA1 both in vitro and in vivo. In conclusion, maximally efficient HDL- or CER-001-mediated cholesterol removal from atherosclerotic plaque is achieved by maximizing macrophage-mediated efflux from the plaque while minimizing dose-dependent down-regulation of ABCA1 expression. These observations may help define the optimal dose of HDL mimetics for testing in clinical trials of atherosclerotic burden regression.	[Tardy, Claudine; Goffinet, Marine; Boubekeur, Nadia; Cholez, Guy; Keyserling, Constance; Paolini, John F.; Dasseux, Jean-Louis; Barbaras, Ronald; Baron, Rudi] Cerenis Therapeut SA, Labege, France; [Ackermann, Rose; Sy, Gavin; Lalwani, Narendra] Cerenis Therapeut Inc, Ann Arbor, MI USA		Barbaras, R (corresponding author), Cerenis Therapeut SA, Labege, France.	barbaras@cerenis.com	Tardy, Claudine/AAE-5026-2019; Tardy, Claudine/G-2737-2017	Tardy, Claudine/0000-0002-5292-0672; 	Cerenis Therapeutics	Cerenis Therapeutics	Cerenis Therapeutics provided support in the form of salaries for authors (All), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AMELI S, 1994, CIRCULATION, V90, P1935, DOI 10.1161/01.CIR.90.4.1935; Attie AD, 2001, J LIPID RES, V42, P1717; BADIMON JJ, 1989, LAB INVEST, V60, P455; BADIMON JJ, 1990, J CLIN INVEST, V85, P1234, DOI 10.1172/JCI114558; BARBARAS R, 1986, BIOCHIM BIOPHYS ACTA, V888, P143, DOI 10.1016/0167-4889(86)90015-7; Bleck G. T., 2006, BIOPROCESS J, V5, P36; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; BOTHAM KM, 1995, PROG LIPID RES, V34, P71, DOI 10.1016/0163-7827(94)00007-9; BRAVO E, 1994, BBA-LIPID LIPID MET, V1215, P93, DOI 10.1016/0005-2760(94)90096-5; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brown WV, 2010, J CLIN LIPIDOL, V4, P5, DOI 10.1016/j.jacl.2009.12.005; CASTRO GR, 1988, BIOCHEMISTRY-US, V27, P25, DOI 10.1021/bi00401a005; Clee SM, 2000, J CLIN INVEST, V106, P1263, DOI 10.1172/JCI10727; Duverger N, 1996, CIRCULATION, V94, P713, DOI 10.1161/01.CIR.94.4.713; Frikke-Schmidt R, 2004, J CLIN INVEST, V114, P1343, DOI 10.1172/JCI200420361; Godin D, 2000, CIRCULATION, V102, P2861; ISHIDA BY, 1987, J LIPID RES, V28, P778; Ivan E, 2002, CIRCULATION, V105, P2686, DOI 10.1161/01.CIR.0000016825.17448.11; Jaspard B, 1996, BIOCHEMISTRY-US, V35, P1352, DOI 10.1021/bi950938i; Joyce C, 2003, ARTERIOSCL THROM VAS, V23, P965, DOI 10.1161/01.ATV.0000055194.85073.FF; Kootte RS, 2014, EFFECT OF INFUSION O; Kruit JK, 2006, WORLD J GASTROENTERO, V12, P6429, DOI 10.3748/wjg.v12.i40.6429; Kuo MS, 2008, J LIPID RES, V49, P1353, DOI 10.1194/jlr.D700037-JLR200; Langmann T, 1999, BIOCHEM BIOPH RES CO, V257, P29, DOI 10.1006/bbrc.1999.0406; Le May C, 2013, ARTERIOSCL THROM VAS, V33, P1484, DOI 10.1161/ATVBAHA.112.300263; Lee JMS, 2010, EXPERT REV CARDIOVAS, V8, P1325, DOI 10.1586/ERC.10.108; Lessner SM, 2004, ARTERIOSCL THROM VAS, V24, P2123, DOI 10.1161/01.ATV.0000141840.27300.fd; Marcil M, 1999, LANCET, V354, P1341, DOI 10.1016/S0140-6736(99)07026-9; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; O'Connor PM, 1998, J LIPID RES, V39, P670; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Sakr SW, 1999, BBA-MOL CELL BIOL L, V1438, P85, DOI 10.1016/S1388-1981(99)00041-4; Schaefer EJ, 2014, CURR OPIN LIPIDOL, V25, P194, DOI 10.1097/MOL.0000000000000074; SCHWARTZ CC, 1978, SCIENCE, V200, P62, DOI 10.1126/science.204996; Singaraja RR, 2003, ARTERIOSCL THROM VAS, V23, P1322, DOI 10.1161/01.ATV.0000078520.89539.77; Soderlund S, 2005, J LIPID RES, V46, P1643, DOI 10.1194/jlr.M400480-JLR200; SOMA MR, 1995, CIRC RES, V76, P405, DOI 10.1161/01.RES.76.3.405; Tardif JC, 2014, EUR HEART J, V35, P3277, DOI 10.1093/eurheartj/ehu171; Tarling EJ, 2013, CURR OPIN LIPIDOL, V24, P138, DOI 10.1097/MOL.0b013e32835da122; Tietge UJF, 2013, ARTERIOSCL THROM VAS, V33, P1452, DOI 10.1161/ATVBAHA.113.301562; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; Wang SP, 2013, J LIPID RES, V54, P2858, DOI 10.1194/jlr.M041541; Watanabe H, 2006, ARTERIOSCL THROM VAS, V26, P897, DOI 10.1161/01.ATV.0000209577.04246.c0	44	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137584	10.1371/journal.pone.0137584	http://dx.doi.org/10.1371/journal.pone.0137584			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335690	gold, Green Published, Green Submitted			2022-12-26	WOS:000360615400069
J	Yu, ZC; Tang, BL; Zhao, DL; Pang, XH; Qin, QL; Zhou, BC; Zhang, XY; Chen, XL; Zhang, YZ				Yu, Zi-Chao; Tang, Bai-Lu; Zhao, Dian-Li; Pang, Xiuhua; Qin, Qi-Long; Zhou, Bai-Cheng; Zhang, Xi-Ying; Chen, Xiu-Lan; Zhang, Yu-Zhong			Development of a Cold-Adapted Pseudoalteromonas Expression System for the Pseudoalteromonas Proteins Intractable for the Escherichia coli System	PLOS ONE			English	Article							SP SM9913; HALOPLANKTIS TAC-125; EFFICIENT PRODUCTION; ECOLOGICAL ROLES; GENETIC SYSTEM; STRATEGIES; VECTOR; STRAIN; EXOPOLYSACCHARIDE; CHAPERONINS	Although the Escherichia coli expression system is the most commonly used expression system, some proteins are still difficult to be expressed by this system, such as proteins with high thermolability and enzymes that cannot mature by autoprocessing. Therefore, it is necessary to develop alternative expression systems. In this study, a cold-adapted Pseudoalteromonas expression system was developed. A shuttle vector was constructed, and a conjugational transfer system between E. coli and psychrophilic strain Pseudoalteromonas sp. SM20429 was established. Based on the shuttle vector, three reporter vectors were constructed to compare the strength of the cloned promoters at low temperature. The promoter of xylanase gene from Pseudoalteromonas sp. BSi20429 was chosen due to its high activity at 10-15 degrees C. An expression vector pEV containing the chosen promoter, multiple cloning sites and a His tag was constructed for protein expression and purification. With pEV as expression vector and SM20429 as the host, a cold-adapted protease, pseudoalterin, which cannot be maturely expressed in E. coli, was successfully expressed as an active extracellular enzyme when induced by 2% oat spelt xylan at 15 degrees C for 48 h. Recombinant pseudoalterin purified from the culture by Ni affinity chromatography had identical N-terminal sequence, similar molecular mass and substrate specificity as the native pseudoalterin. In addition, another two cold-adapted enzymes were also successfully expressed by this system. Our results indicate that this cold-adapted Pseudoalteromonas expression system will provide an alternative choice for protein expression, especially for the Pseudoalteromonas proteins intractable for the E. coli system.	[Yu, Zi-Chao; Tang, Bai-Lu; Zhao, Dian-Li; Pang, Xiuhua; Qin, Qi-Long; Zhang, Xi-Ying; Chen, Xiu-Lan; Zhang, Yu-Zhong] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Yu, Zi-Chao; Tang, Bai-Lu; Zhao, Dian-Li; Qin, Qi-Long; Zhou, Bai-Cheng; Zhang, Xi-Ying; Chen, Xiu-Lan; Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, Jinan 250100, Peoples R China	Shandong University; Shandong University	Chen, XL (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	cxl0423@sdu.edu.cn			National Natural Science Foundation of China [31290230, 31290231, 91228210, 41176130, 41106161]; Hi-Tech Research and Development Program of China [2012AA092105, 2012AA092103]; China Ocean Mineral Resources R & D Association (COMRA) Special Foundation [DY125-15- T-05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); China Ocean Mineral Resources R & D Association (COMRA) Special Foundation	The work was supported by the National Natural Science Foundation of China (grants 31290230, 31290231, 91228210, 41176130 and 41106161), the Hi-Tech Research and Development Program of China (2012AA092105, 2012AA092103), the China Ocean Mineral Resources R & D Association (COMRA) Special Foundation (DY125-15- T-05). Independent Innovation Foundation of Shandong University (2012GN019, 2012ZD028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowman JP, 2007, MAR DRUGS, V5, P220, DOI 10.3390/md20070017; Chen XL, 2003, MAR BIOL, V143, P989, DOI 10.1007/s00227-003-1128-2; Cui ZS, 2008, ENVIRON MICROBIOL, V10, P2138, DOI 10.1111/j.1462-2920.2008.01637.x; Cusano AM, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-40; Dlugolecka A, 2008, PROTEIN EXPRES PURIF, V62, P179, DOI 10.1016/j.pep.2008.07.006; Ferrer M, 2004, MOL MICROBIOL, V53, P167, DOI 10.1111/j.1365-2958.2004.04077.x; Ferrer M, 2004, APPL ENVIRON MICROB, V70, P4499, DOI 10.1128/AEM.70.8.4499-4504.2004; Ferrer M, 2003, NAT BIOTECHNOL, V21, P1266, DOI 10.1038/nbt1103-1266; GELLISSEN G, 2005, PRODUCTION RECOMBINA; Georgiou G, 1996, CURR OPIN BIOTECH, V7, P190, DOI 10.1016/S0958-1669(96)80012-7; Gouka RJ, 1997, APPL MICROBIOL BIOT, V47, P1, DOI 10.1007/s002530050880; Hennig M, 1995, STRUCTURE, V3, P1295, DOI 10.1016/S0969-2126(01)00267-2; Holmstrom C, 1999, FEMS MICROBIOL ECOL, V30, P285, DOI 10.1111/j.1574-6941.1999.tb00656.x; Hoyoux A, 2001, APPL ENVIRON MICROB, V67, P1529, DOI 10.1128/AEM.67.4.1529-1535.2001; Jana S, 2005, APPL MICROBIOL BIOT, V67, P289, DOI 10.1007/s00253-004-1814-0; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; KAWAMURA T, 1979, J BIOL CHEM, V254, P8457; Khow Orawan, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P159, DOI 10.1016/S2221-1691(11)60213-X; KOPETZKI E, 1989, MOL GEN GENET, V216, P149, DOI 10.1007/BF00332244; Kruger Nicholas J., 1996, P15, DOI 10.1007/978-1-60327-259-9_4; Liu SB, 2013, APPL ENVIRON MICROB, V79, P224, DOI 10.1128/AEM.01801-12; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; Madonna S, 2006, EXTREMOPHILES, V10, P41, DOI 10.1007/s00792-005-0470-3; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Paget MSB, 1999, J BACTERIOL, V181, P204, DOI 10.1128/JB.181.1.204-211.1999; Papa R, 2007, J BIOTECHNOL, V127, P199, DOI 10.1016/j.jbiotec.2006.07.003; Qin GK, 2007, MICROBIOL-SGM, V153, P1566, DOI 10.1099/mic.0.2006/003327-0; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SMITH GE, 1983, MOL CELL BIOL, V3, P2156, DOI 10.1128/MCB.3.12.2156; Tanner ME, 2002, ACCOUNTS CHEM RES, V35, P237, DOI 10.1021/ar000056y; Wood T.M., 1988, METHOD ENZYMOL, P160; Wu JW, 2011, APPL MICROBIOL BIOT, V92, P253, DOI 10.1007/s00253-011-3532-8; Yu ZC, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-13; Zhao DL, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-30; Zhao HL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405076; Zhou MY, 2009, MICROB ECOL, V58, P582, DOI 10.1007/s00248-009-9506-z	36	8	8	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137384	10.1371/journal.pone.0137384	http://dx.doi.org/10.1371/journal.pone.0137384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26333173	gold, Green Submitted, Green Published			2022-12-26	WOS:000360613800129
J	Nikel, PI; Chavarria, M; Fuhrer, T; Sauer, U; de Lorenzo, V				Nikel, Pablo I.; Chavarria, Max; Fuhrer, Tobias; Sauer, Uwe; de Lorenzo, Victor			Pseudomonas putida KT2440 Strain Metabolizes Glucose through a Cycle Formed by Enzymes of the Entner-Doudoroff, Embden-Meyerhof-Parnas, and Pentose Phosphate Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL CARBON METABOLISM; ESCHERICHIA-COLI; FLUX ANALYSIS; MICROBIAL-METABOLISM; GLYCOLYTIC STRATEGY; OXIDATIVE STRESS; CATABOLISM; MUTANTS; AERUGINOSA; BACTERIA	The soil bacterium Pseudomonas putida KT2440 lacks a functional Embden-Meyerhof-Parnas (EMP) pathway, and glycolysis is known to proceed almost exclusively through the Entner-Doudoroff (ED) route. To investigate the raison d'etre of this metabolic arrangement, the distribution of periplasmic and cytoplasmic carbon fluxes was studied in glucose cultures of this bacterium by using C-13-labeled substrates, combined with quantitative physiology experiments, metabolite quantification, and in vitro enzymatic assays under both saturating and non-saturating, quasi in vivo conditions. Metabolic flux analysis demonstrated that 90% of the consumed sugar was converted into gluconate, entering central carbon metabolism as 6-phosphogluconate and further channeled into the ED pathway. Remarkably, about 10% of the triose phosphates were found to be recycled back to form hexose phosphates. This set of reactions merges activities belonging to the ED, the EMP (operating in a gluconeogenic fashion), and the pentose phosphate pathways to form an unforeseen metabolic architecture (EDEMP cycle). Determination of the NADPH balance revealed that the default metabolic state of P. putida KT2440 is characterized by a slight catabolic overproduction of reducing power. Cells growing on glucose thus run a biochemical cycle that favors NADPH formation. Because NADPH is required not only for anabolic functions but also for counteracting different types of environmental stress, such a cyclic operation may contribute to the physiological heftiness of this bacterium in its natural habitats.	[Nikel, Pablo I.; de Lorenzo, Victor] CSIC, Ctr Nacl Biotecnol, Syst & Synthet Biol Program, E-28049 Madrid, Spain; [Chavarria, Max] Univ Costa Rica, Escuela Quim, San Jose, Costa Rica; [Fuhrer, Tobias; Sauer, Uwe] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Universidad Costa Rica; Swiss Federal Institutes of Technology Domain; ETH Zurich	de Lorenzo, V (corresponding author), CSIC, Ctr Nacl Biotecnol, Syst & Synthet Biol Program, Plaza Murillo 2, E-28049 Madrid, Spain.	vdlorenzo@cnb.csic.es	Fuhrer, Tobias/B-5667-2013; Nikel, Pablo Ivan/L-4146-2014; Chavarria, Max/J-3940-2019; Sauer, Uwe/Y-3556-2019	Fuhrer, Tobias/0000-0001-5006-6874; Nikel, Pablo Ivan/0000-0002-9313-7481; Chavarria, Max/0000-0001-5901-3576; de Lorenzo, Victor/0000-0002-6041-2731	CAMBIOS Project of the Spanish Ministry of Economy and Competitiveness; ST-FLOW Contract of the European Union; EVOPROG Contract of the European Union; ARI-SYS Contract of the European Union; EmpowerPutida Contract of the European Union; PROMT Project of the Autonomous Community of Madrid; Marie Sklodowska-Curie Actions Program Grant from the European Union ALLE-GRO [UE-FP7-PEOPLE-2011-IIF-300508]; University of Costa Rica	CAMBIOS Project of the Spanish Ministry of Economy and Competitiveness(Spanish Government); ST-FLOW Contract of the European Union; EVOPROG Contract of the European Union; ARI-SYS Contract of the European Union; EmpowerPutida Contract of the European Union; PROMT Project of the Autonomous Community of Madrid; Marie Sklodowska-Curie Actions Program Grant from the European Union ALLE-GRO; University of Costa Rica	This work was supported in part by the CAMBIOS Project of the Spanish Ministry of Economy and Competitiveness, the ST-FLOW, EVOPROG, ARI-SYS, and EmpowerPutida Contracts of the European Union, the PROMT Project of the Autonomous Community of Madrid (to V.D.L.), and Marie Sklodowska-Curie Actions Program Grant from the European Union ALLE-GRO, UE-FP7-PEOPLE-2011-IIF-300508 (to P. I. N.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a fellowship from the University of Costa Rica.	Ahmed H, 2004, BIOCHEM SOC T, V32, P303, DOI 10.1042/BST0320303; ANDERSON A, 1969, FEBS LETT, V4, P19, DOI 10.1016/0014-5793(69)80184-5; Molina-Henares MA, 2010, ENVIRON MICROBIOL, V12, P1468, DOI 10.1111/j.1462-2920.2010.02166.x; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BAGDASARIAN M, 1981, GENE, V16, P237, DOI 10.1016/0378-1119(81)90080-9; BANERJEE PC, 1987, J GEN MICROBIOL, V133, P1099; BANERJEE PC, 1989, FOLIA MICROBIOL, V34, P81, DOI 10.1007/BF02823683; Bar-Even A, 2012, NAT CHEM BIOL, V8, P509, DOI [10.1038/NCHEMBIO.971, 10.1038/nchembio.971]; BAUMANN P, 1975, ARCH MICROBIOL, V105, P225, DOI 10.1007/BF00447141; Behrends V, 2013, J BIOL CHEM, V288, P15098, DOI 10.1074/jbc.M112.442814; Berger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088368; Bidart GN, 2012, APPL ENVIRON MICROB, V78, P8784, DOI 10.1128/AEM.02558-12; Blank LM, 2008, FEBS J, V275, P5173, DOI 10.1111/j.1742-4658.2008.06648.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buescher JM, 2010, ANAL CHEM, V82, P4403, DOI 10.1021/ac100101d; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Chavarria M, 2013, ENVIRON MICROBIOL, V15, P1772, DOI 10.1111/1462-2920.12069; Chavarria M, 2012, MBIO, V3, DOI 10.1128/mBio.00028-12; Chen RR, 2013, APPL BIOCHEM BIOTECH, V170, P805, DOI 10.1007/s12010-013-0239-6; Chubukov V, 2014, NAT REV MICROBIOL, V12, P327, DOI 10.1038/nrmicro3238; CONWAY T, 1992, FEMS MICROBIOL LETT, V103, P1; del Castillo T, 2008, J BACTERIOL, V190, P2331, DOI 10.1128/JB.01726-07; del Castillo T, 2007, J BACTERIOL, V189, P5142, DOI 10.1128/JB.00203-07; dos Santos VAPM, 2004, ENVIRON MICROBIOL, V6, P1264, DOI 10.1111/j.1462-2920.2004.00734.x; Duque E., 2007, PSEUDOMONAS MODEL SY, P227, DOI DOI 10.1007/978-1-4020-6097-7_8; Ebert BE, 2011, APPL ENVIRON MICROB, V77, P6597, DOI 10.1128/AEM.05588-11; ENTNER N, 1952, J BIOL CHEM, V196, P853; Felux AK, 2015, P NATL ACAD SCI USA, V112, pE4298, DOI 10.1073/pnas.1507049112; Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x; Fischer E, 2004, ANAL BIOCHEM, V325, P308, DOI 10.1016/j.ab.2003.10.036; Flamholz A, 2013, P NATL ACAD SCI USA, V110, P10039, DOI 10.1073/pnas.1215283110; Fuhrer T, 2005, J BACTERIOL, V187, P1581, DOI 10.1128/JB.187.5.1581-1590.2005; Fuhrer T, 2009, J BACTERIOL, V191, P2112, DOI 10.1128/JB.01523-08; Green MR, 2012, MOL CLONING LAB MANU, V1; Hanke T, 2013, APPL ENVIRON MICROB, V79, P2336, DOI 10.1128/AEM.03414-12; HEATH HE, 1978, J BACTERIOL, V136, P638, DOI 10.1128/JB.136.2.638-646.1978; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Kim J, 2014, APPL MICROBIOL BIOT, V98, P6933, DOI 10.1007/s00253-014-5883-4; Klingner A, 2015, APPL ENVIRON MICROB, V81, P2408, DOI 10.1128/AEM.03157-14; Klinke S, 2000, APPL ENVIRON MICROB, V66, P909, DOI 10.1128/AEM.66.3.909-913.2000; LESSIE TG, 1984, ANNU REV MICROBIOL, V38, P359, DOI 10.1146/annurev.mi.38.100184.002043; Maleki S, 2015, APPL ENVIRON MICROB, V81, P3349, DOI 10.1128/AEM.03653-14; Nanchen Annik, 2007, V358, P177, DOI 10.1007/978-1-59745-244-1_11; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Nikel P. I., 2015, HYDROCARBON LIPID MI; Nikel PI, 2015, MBIO, V6, DOI 10.1128/mBio.00340-15; Nikel PI, 2014, NAT REV MICROBIOL, V12, P368, DOI 10.1038/nrmicro3253; Nikel PI, 2014, ENVIRON MICROBIOL, V16, P239, DOI 10.1111/1462-2920.12224; Nikel PI, 2013, MICROB CELL FACT, V12, DOI [10.1186/s12934-014-0159-3, 10.1186/1475-2859-12-50]; Nikel PI, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0377; Nikel PI, 2013, METAB ENG, V15, P98, DOI 10.1016/j.ymben.2012.09.006; Nikel PI, 2010, APPL ENVIRON MICROB, V76, P7400, DOI 10.1128/AEM.02067-10; Nikel PI, 2009, J BACTERIOL, V191, P5538, DOI 10.1128/JB.00174-09; Nikel PI, 2014, ENVIRON MICROBIOL, V16, P628, DOI 10.1111/1462-2920.12360; Nogales J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-79; Noor E, 2010, MOL CELL, V39, P809, DOI 10.1016/j.molcel.2010.08.031; Patra T, 2012, J BACTERIOL, V194, P3377, DOI 10.1128/JB.06379-11; Peekhaus N, 1998, J BACTERIOL, V180, P3495, DOI 10.1128/JB.180.14.3495-3502.1998; Puchalka J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000210; Reher M, 2010, J BACTERIOL, V192, P964, DOI 10.1128/JB.01281-09; Romano AH, 1996, RES MICROBIOL, V147, P448, DOI 10.1016/0923-2508(96)83998-2; Ruhl M, 2012, BIOTECHNOL BIOENG, V109, P763, DOI 10.1002/bit.24344; Schatschneider S, 2014, MOL BIOSYST, V10, P2663, DOI 10.1039/c4mb00198b; Schleissner C, 1997, MICROBIOL-SGM, V143, P1595, DOI 10.1099/00221287-143-5-1595; Sohn SB, 2010, BIOTECHNOL J, V5, P739, DOI 10.1002/biot.201000124; STEINBUCHEL A, 1986, J BACTERIOL, V166, P319, DOI 10.1128/jb.166.1.319-327.1986; Stettner AI, 2013, P NATL ACAD SCI USA, V110, P9629, DOI 10.1073/pnas.1307485110; Sudarsan S, 2014, APPL ENVIRON MICROB, V80, P5292, DOI 10.1128/AEM.01643-14; Tlemcani LL, 2008, ARCH MICROBIOL, V190, P141, DOI 10.1007/s00203-008-0380-8; van der Werf MJ, 2008, MOL BIOSYST, V4, P315, DOI 10.1039/b717340g; VICENTE M, 1973, ARCH MIKROBIOL, V93, P53, DOI 10.1007/BF00666080; VICENTE M, 1973, J BACTERIOL, V116, P908, DOI 10.1128/JB.116.2.908-914.1973; Waligora EA, 2014, INFECT IMMUN, V82, P2746, DOI 10.1128/IAI.01575-13; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Zamboni N, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-209	77	184	186	6	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25920	25932		10.1074/jbc.M115.687749	http://dx.doi.org/10.1074/jbc.M115.687749			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26350459	hybrid, Green Published			2022-12-26	WOS:000363527300015
J	Alkahyyat, F; Ni, M; Kim, SC; Yu, JH				Alkahyyat, Fahad; Ni, Min; Kim, Sun Chang; Yu, Jae-Hyuk			The WOPR Domain Protein OsaA Orchestrates Development in Aspergillus nidulans	PLOS ONE			English	Article							SEXUAL DEVELOPMENT; TRANSCRIPTION FACTOR; ASEXUAL SPORULATION; GENE ENCODES; MULTISPECIES CURATION; MASTER REGULATOR; EXPRESSION; FLUG; STERIGMATOCYSTIN; IDENTIFICATION	Orchestration of cellular growth and development occurs during the life cycle of Aspergillus nidulans. A multi-copy genetic screen intended to unveil novel regulators of development identified the AN6578 locus predicted to encode a protein with the WOPR domain, which is a broadly present fungi-specific DNA-binding motif. Multi-copy of AN6578 disrupted the normal life cycle of the fungus leading to enhanced proliferation of vegetative cells, whereas the deletion resulted in hyper-active sexual fruiting with reduced asexual development (conidiation), thus named as osaA (Orchestrator of Sex and Asex). Further genetic studies indicate that OsaA balances development mainly by repressing sexual development downstream of the velvet regulator VeA. The absence of osaA is sufficient to suppress the veA1 allele leading to the sporulation levels comparable to veA(+) wild type (WT). Genome-wide transcriptomic analyses of WT, veA1, and Delta osaA veA1 strains by RNA-Seq further corroborate that OsaA functions in repressing sexual development downstream of VeA. However, OsaA also plays additional roles in controlling development, as the Delta osaA veA1 mutant exhibits precocious and enhanced formation of Hulle cells compared to WT. The OsaA orthologue of Aspergillus flavus is able to complement the osaA null phenotype in A. nidulans, suggesting a conserved role of this group of WOPR domain proteins. In summary, OsaA is an upstream orchestrator of morphological and chemical development in Aspergillus that functions downstream of VeA.	[Alkahyyat, Fahad; Ni, Min; Yu, Jae-Hyuk] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Alkahyyat, Fahad] Univ Wisconsin, Dept Food Sci, Madison, WI 53706 USA; [Kim, Sun Chang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Dae Jon, South Korea	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Korea Advanced Institute of Science & Technology (KAIST)	Yu, JH (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	jyu1@wisc.edu	Kim, Sun Chang/C-2026-2011; Yu, Jae-Hyuk/A-2343-2008; Kim, Sun/GSN-4867-2022	Yu, Jae-Hyuk/0000-0002-6530-8407	Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Education, Science and Technology [2011-0031955]; Kuwait University Graduated Fellowship from the Ministry of Higher Education, kuniv.edu	Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Education, Science and Technology; Kuwait University Graduated Fellowship from the Ministry of Higher Education, kuniv.edu	This work was supported by the Intelligent Synthetic Biology Center of Global Frontier Project funded by the Ministry of Education, Science and Technology, 2011-0031955, SCK and JHY; and Kuwait University Graduated Fellowship from the Ministry of Higher Education, kuniv.edu, FA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; Ahmed YL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001750; ANDRIANOPOULOS A, 1994, MOL CELL BIOL, V14, P2503, DOI 10.1128/MCB.14.4.2503; Arnaud MB, 2012, NUCLEIC ACIDS RES, V40, pD653, DOI 10.1093/nar/gkr875; AXELROD DE, 1972, J GEN MICROBIOL, V73, P181, DOI 10.1099/00221287-73-1-181; Barron G, 2013, EMERICELLA NIDULANS; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Rodriguez-Urra AB, 2012, ACS CHEM BIOL, V7, P599, DOI 10.1021/cb200455u; Beyhan S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001614; Blumenstein A, 2005, CURR BIOL, V15, P1833, DOI 10.1016/j.cub.2005.08.061; Bok JW, 2009, NAT CHEM BIOL, V5, P462, DOI 10.1038/nchembio.177; Brown SH, 2008, APPL ENVIRON MICROB, V74, P5674, DOI 10.1128/AEM.00565-08; Cain CW, 2012, GENETICS, V190, P511, DOI 10.1534/genetics.111.134080; Cerqueira GC, 2014, NUCLEIC ACIDS RES, V42, pD705, DOI 10.1093/nar/gkt1029; Champe S, 1981, FUNGAL SPORE MORPHOG, P255; CHANG YC, 1993, GENETICS, V133, P29; CLUTTERBUCK AJ, 1990, J GEN MICROBIOL, V136, P1731, DOI 10.1099/00221287-136-9-1731; Dyer PS, 2012, FEMS MICROBIOL REV, V36, P165, DOI 10.1111/j.1574-6976.2011.00308.x; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Geiser DM, 1996, MOL BIOL EVOL, V13, P809, DOI 10.1093/oxfordjournals.molbev.a025641; Gerke J, 2012, APPL ENVIRON MICROB, V78, P8234, DOI 10.1128/AEM.01808-12; Gohari AM, 2014, MOL PLANT PATHOL, V15, P394, DOI 10.1111/mpp.12102; Han KH, 2004, MOL MICROBIOL, V51, P1333, DOI 10.1111/j.1365-2958.2003.03940.x; Han KH, 2001, MOL MICROBIOL, V41, P299, DOI 10.1046/j.1365-2958.2001.02472.x; Han KH, 2004, MOL MICROBIOL, V53, P529, DOI 10.1111/j.1365-2958.2004.04163.x; Hoffmann B, 2000, MOL MICROBIOL, V37, P28, DOI 10.1046/j.1365-2958.2000.01954.x; Huang GH, 2006, P NATL ACAD SCI USA, V103, P12813, DOI 10.1073/pnas.0605270103; Jonkers W, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002724; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; KAFER E, 1965, GENETICS, V52, P217; Kato N, 2003, EUKARYOT CELL, V2, P1178, DOI 10.1128/EC.2.6.1178-1186.2003; Kim HS, 2002, FUNGAL GENET BIOL, V37, P72, DOI 10.1016/S1087-1845(02)00029-4; Krijgsheld P, 2013, STUD MYCOL, P1, DOI 10.3114/sim0006; KUNITOMO H, 1995, CURR GENET, V28, P32, DOI 10.1007/BF00311879; Kwon NJ, 2010, MOL MICROBIOL, V77, P1203, DOI 10.1111/j.1365-2958.2010.07282.x; LEE BN, 1994, GENE DEV, V8, P641, DOI 10.1101/gad.8.6.641; Lee MK, 2014, GENETICS, V197, P159, DOI 10.1534/genetics.114.161430; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Lohse MB, 2014, P NATL ACAD SCI USA, V111, P10404, DOI 10.1073/pnas.1410110111; MAYORGA ME, 1992, MOL GEN GENET, V235, P205, DOI 10.1007/BF00279362; Michielse CB, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r4; Nguyen VQ, 2008, P NATL ACAD SCI USA, V105, P4880, DOI 10.1073/pnas.0710448105; Ni M, 2005, EUKARYOT CELL, V4, P1465, DOI 10.1128/EC.4.8.1465-1476.2005; Ni M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000970; Osherov N, 2000, FUNGAL GENET BIOL, V31, P181, DOI 10.1006/fgbi.2000.1236; Park HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032847, 10.1371/journal.pone.0039921]; Park HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089883; Park HS, 2012, CURR OPIN MICROBIOL, V15, P669, DOI 10.1016/j.mib.2012.09.006; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seo JA, 2006, GENETICS, V172, P1535, DOI 10.1534/genetics.105.052258; Seo JA, 2003, GENETICS, V165, P1083; Sohn K. T., 2002, Mycobiology, V30, P117; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsitsigiannis DI, 2005, MICROBIOL-SGM, V151, P1809, DOI 10.1099/mic.0.27880-0; Ugalde U, 2014, APPL MICROBIOL BIOT, V98, P8809, DOI 10.1007/s00253-014-6019-6; Vienken K, 2005, GENETICS, V169, P619, DOI 10.1534/genetics.104.030767; Vienken K, 2006, MOL MICROBIOL, V61, P544, DOI 10.1111/j.1365-2958.2006.05257.x; Yager L N, 1992, Biotechnology, V23, P19; Yu Jae-Hyuk, 2010, Mycobiology, V38, P229, DOI 10.4489/MYCO.2010.38.4.229; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	69	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137554	10.1371/journal.pone.0137554	http://dx.doi.org/10.1371/journal.pone.0137554			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359867	gold, Green Published, Green Submitted			2022-12-26	WOS:000361043100052
J	Rodriguez, CE; Reidel, SI; Joffe, EDBD; Jasnis, MA; Fiszman, GL				Rodriguez, Cristina E.; Reidel, Sara I.; Bal de Kier Joffe, Elisa D.; Jasnis, Maria A.; Fiszman, Gabriel L.			Autophagy Protects from Trastuzumab-Induced Cytotoxicity in HER2 Overexpressing Breast Tumor Spheroids	PLOS ONE			English	Article							CANCER; RESISTANCE; APOPTOSIS; MICROENVIRONMENT; ASSOCIATION; PROGRESSION; INHIBITION; EFFICACY; THERAPY; HYPOXIA	Multicellular tumor spheroids represent a 3D in vitro model that mimics solid tumor essential properties including assembly and development of extracellular matrix and nutrient, oxygen and proliferation gradients. In the present study, we analyze the impact of 3D spatial organization of HER2-overexpressing breast cancer cells on the response to Trastuzumab. We cultured human mammary adenocarcinoma cell lines as spheroids with the hanging drop method and we observed a gradient of proliferating, quiescent, hypoxic, apoptotic and autophagic cells towards the inner core. This 3D organization decreased Trastuzumab sensitivity of HER2 over-expressing cells compared to monolayer cell cultures. We did not observe apoptosis induced by Trastuzumab but found cell arrest in G0/G1 phase. Moreover, the treatment downregulated the basal apoptosis only found in tumor spheroids, by eliciting protective autophagy. We were able to increase sensitivity to Trastuzumab by autophagy inhibition, thus exposing the interaction between apoptosis and autophagy. We confirmed this result by developing a resistant cell line that was more sensitive to autophagy inhibition than the parental BT474 cells. In summary, the development of Trastuzumab resistance relies on the balance between death and survival mechanisms, characteristic of 3D cell organization. We propose the use of spheroids to further improve the understanding of Trastuzumab antitumor activity and overcome resistance.	[Rodriguez, Cristina E.; Bal de Kier Joffe, Elisa D.; Jasnis, Maria A.; Fiszman, Gabriel L.] Univ Buenos Aires, Inst Oncol Angel H Roffo, Res Area, Buenos Aires, DF, Argentina; [Reidel, Sara I.; Fiszman, Gabriel L.] Natl Inst Ind Technol, Ind Biotechnol Res & Dev Ctr, Buenos Aires, DF, Argentina	University of Buenos Aires; Instituto Nacional de Tecnologia Industrial (INTI)	Fiszman, GL (corresponding author), Univ Buenos Aires, Inst Oncol Angel H Roffo, Res Area, Buenos Aires, DF, Argentina.	gfiszman@gmail.com		Reidel, Sara/0000-0003-1887-9538	University of Buenos Aires (UBACYT) [01/2366, 20020130100728BA]; Agencia Nacional de Promocion Cientifica y Tecnologica (Prestamo BID-PICT) [2010-01296]	University of Buenos Aires (UBACYT)(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica (Prestamo BID-PICT)	This work was supported by University of Buenos Aires (UBACYT 01/2366) http://secinves.com.ar/guias/ubacyt (GF) and University of Buenos Aires (UBACYT 20020130100728BA). Agencia Nacional de Promocion Cientifica y Tecnologica (Prestamo BID-PICT: 2010-01296) http://www.agencia.mincyt.gob.ar/ (EB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey Tameka A, 2011, J Carcinog, V10, P28, DOI 10.4103/1477-3163.90442; Berardi DE, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/595092; Choi CH, 2010, MOL PHARMACOL, V78, P114, DOI 10.1124/mol.110.063495; Correia AL, 2012, DRUG RESIST UPDATE, V15, P39, DOI 10.1016/j.drup.2012.01.006; Del Duca D, 2004, J NEURO-ONCOL, V67, P295, DOI 10.1023/B:NEON.0000024220.07063.70; Esteve Juan M, 2011, World J Biol Chem, V2, P232, DOI 10.4331/wjbc.v2.i10.232; Feitelson MA, 2015, SEMIN CANCER BIOL, V35, pS25, DOI 10.1016/j.semcancer.2015.02.006; Fiszman GL, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/352182; Ghosh R, 2011, CANCER RES, V71, P1871, DOI 10.1158/0008-5472.CAN-10-1872; Ginestier C, 2007, ONCOGENE, V26, P7163, DOI 10.1038/sj.onc.1210528; Han J, 2013, J BIOL CHEM, V288, P20315, DOI 10.1074/jbc.M113.461350; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hockel M, 1996, CANCER RES, V56, P4509; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kute T, 2004, CYTOM PART A, V57A, P86, DOI 10.1002/cyto.a.10095; Lee S, 2002, CANCER RES, V62, P5703; Liu QJ, 2014, MOL MED REP, V10, P625, DOI 10.3892/mmr.2014.2296; Maes H, 2013, TRENDS MOL MED, V19, P428, DOI 10.1016/j.molmed.2013.04.005; Martin HL, 2014, BREAST CANCER-TARGET, V6, P1, DOI 10.2147/BCTT.S37638; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Moulder SL, 2001, CANCER RES, V61, P8887; Munoz L, 2010, TISSUE CELL, V42, P334, DOI 10.1016/j.tice.2010.07.006; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; Nahta R, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1612; Negri T, 2010, GENE CHROMOSOME CANC, V49, P901, DOI 10.1002/gcc.20798; Pickl M, 2009, ONCOGENE, V28, P461, DOI 10.1038/onc.2008.394; Press MF, 1997, J CLIN ONCOL, V15, P2894, DOI 10.1200/JCO.1997.15.8.2894; Vu T, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00062; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Vazquez Martin A, 2011, GENE CHROMOSOME CANC, V290, P284, DOI [10.1002/gcc, DOI 10.1002/GCC]; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Weigelt B, 2010, BREAST CANCER RES TR, V122, P35, DOI 10.1007/s10549-009-0502-2; Xia WL, 2005, ONCOGENE, V24, P6213, DOI 10.1038/sj.onc.1208774; Yakes FM, 2002, CANCER RES, V62, P4132; Zhu XM, 2013, J CELL BIOCHEM, V114, P2643, DOI 10.1002/jcb.24611	39	32	33	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137920	10.1371/journal.pone.0137920	http://dx.doi.org/10.1371/journal.pone.0137920			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360292	Green Published, gold, Green Submitted			2022-12-26	WOS:000361043100102
J	Shin, B; Park, W				Shin, Bora; Park, Woojun			Synergistic Effect of Oleanolic Acid on Aminoglycoside Antibiotics against Acinetobacter baumannii	PLOS ONE			English	Article							URSOLIC ACID; PROTEOMIC ANALYSIS; TRITERPENOIDS; COMBINATION; EXPRESSION; RESISTANCE; PROTEINS; EFFLUX	Difficulties involved in treating drug-resistant pathogens have created a need for new therapies. In this study, we investigated the possibility of using oleanolic acid (OA), a natural pen-tacyclic triterpenoid, as a natural adjuvant for antibiotics against Acinetobacter baumannii. High concentrations of OA can kill cells, partly because it generates reactive oxygen species. Measurement of the fractional inhibitory concentration (FIC) for OA and time-kill experiments demonstrated that it only synergizes with aminoglycoside antibiotics (e.g., gentamicin, kanamycin). Other classes of antibiotics (e.g., ampicillin, rifampicin, norfloxacin, chloramphenicol, and tetracycline) have no interactions with OA. Microarray and quantitative reverse transcription-PCR analysis indicated that genes involved in ATP synthesis and cell membrane permeability, the gene encoding glycosyltransferase, peptidoglycan-related genes, phage-related genes, and DNA repair genes were upregulated under OA. OA highly induces the expression of adk, which encodes an adenylate kinase, and des6, which encodes a linoleoyl-CoA desaturase, and deletion of these genes increased FICs; these observations indicate that adk and des6 are involved in the synergism of OA with aminoglycosides. Data obtained using 8-anilino-1-naphthalenesulfonic acid, fluorescenceconjugated gentamicin, and membrane fatty acid analysis indicates that adk and des6 are involved in changes in membrane permeability. Proton-motive force and ATP synthesis tests show that those genes are also involved in energy metabolism. Taken together, our data show that OA boosts aminoglycoside uptake by changing membrane permeability and energy metabolism in A. baumannii.	[Shin, Bora; Park, Woojun] Korea Univ, Dept Environm Sci & Ecol Engn, Lab Mol Environm Microbiol, Seoul, South Korea	Korea University	Park, W (corresponding author), Korea Univ, Dept Environm Sci & Ecol Engn, Lab Mol Environm Microbiol, Seoul, South Korea.	wpark@korea.ac.kr			Mid-career Researcher Program through an NRF - Ministry of Science, ICT, and Future Planning (MSIP) [2014R1A2A2A05007010]	Mid-career Researcher Program through an NRF - Ministry of Science, ICT, and Future Planning (MSIP)	This work was supported by the Mid-career Researcher Program through an NRF grant (2014R1A2A2A05007010) funded by the Ministry of Science, ICT, and Future Planning (MSIP).	Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; BALANEHRU S, 1991, BIOCHEM INT, V24, P981; Bassetti M, 2008, FUTURE MICROBIOL, V3, P649, DOI 10.2217/17460913.3.6.649; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; Black PA, 2014, ANTIMICROB AGENTS CH, V58, P2491, DOI 10.1128/AAC.02293-13; Cabral MP, 2011, J PROTEOME RES, V10, P3399, DOI 10.1021/pr101299j; Castellano JM, 2013, DIABETES, V62, P1791, DOI 10.2337/db12-1215; Clemmer KM, 2011, MICROBIOL-SGM, V157, P2534, DOI 10.1099/mic.0.049791-0; Cussiol JRR, 2010, J BIOL CHEM, V285, P21943, DOI 10.1074/jbc.M110.117283; Dawis MA, 2003, J ANTIMICROB CHEMOTH, V51, P1203, DOI 10.1093/jac/dkg238; de Melo CL, 2010, CHEM-BIOL INTERACT, V185, P59, DOI 10.1016/j.cbi.2010.02.028; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Dzeja P, 2009, INT J MOL SCI, V10, P1729, DOI 10.3390/ijms10041729; Elkins CA, 2004, APPL ENVIRON MICROB, V70, P7200, DOI 10.1128/AEM.70.12.7200-7209.2004; Giamarellou H, 2001, MED CLIN N AM, V85, P19, DOI 10.1016/S0025-7125(05)70303-5; Gopal R, 2014, ANTIMICROB AGENTS CH, V58, P1622, DOI 10.1128/AAC.02473-13; Grudniak AM, 2011, CURR MICROBIOL, V62, P1331, DOI 10.1007/s00284-010-9866-0; He ZD, 2001, CHEM PHARM BULL, V49, P780, DOI 10.1248/cpb.49.780; Hermann T, 2007, CELL MOL LIFE SCI, V64, P1841, DOI 10.1007/s00018-007-7034-x; Hong H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107716; Hong YY, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/761403; Hwang YY, 2013, ANTIMICROB AGENTS CH, V57, P3568, DOI 10.1128/AAC.02109-12; Jimenez-Arellanes A, 2007, J ETHNOPHARMACOL, V111, P202, DOI 10.1016/j.jep.2006.11.033; Jung J, 2013, APPL MICROBIOL BIOT, V97, P4511, DOI 10.1007/s00253-012-4669-9; Kalghatgi S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006055; Karasawa T, 2008, J CELL SCI, V121, P2871, DOI 10.1242/jcs.023705; Kim J, 2013, FEMS MICROBIOL LETT, V343, P89, DOI 10.1111/1574-6968.12135; Kim M, 2014, BIOMOL THER, V22, P254, DOI 10.4062/biomolther.2014.008; Kurek A, 2010, ANTON LEEUW INT J G, V97, P61, DOI 10.1007/s10482-009-9388-6; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lamers RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060666; Lee KW, 2012, J MICROBIOL BIOTECHN, V22, P1432, DOI 10.4014/jmb.1203.03066; Lee SG, 2012, J MICROBIOL BIOTECHN, V22, P516, DOI 10.4014/jmb.1109.09012; Liu C., 2013, ABSTR APPL ANAL, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0084849; Magnet S, 2001, ANTIMICROB AGENTS CH, V45, P3375, DOI 10.1128/AAC.45.12.3375-3380.2001; Murray BE, 2000, NEW ENGL J MED, V342, P710, DOI 10.1056/NEJM200003093421007; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Ovesna Z, 2006, MUTAT RES-FUND MOL M, V600, P131, DOI 10.1016/j.mrfmmm.2006.03.008; Park J, 2011, CURR MICROBIOL, V62, P249, DOI 10.1007/s00284-010-9698-y; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; RAND KH, 1993, ANTIMICROB AGENTS CH, V37, P613, DOI 10.1128/AAC.37.3.613; REDDY AS, 1993, PLANT MOL BIOL, V22, P293, DOI 10.1007/BF00014936; Renato J, 2003, J BIOL CHEM, V278, P11570, DOI 10.1074/jbc.M300252200; Sarkar C, 2014, FOOD CHEM TOXICOL, V66, P224, DOI 10.1016/j.fct.2014.01.020; Shakil S, 2008, J BIOMED SCI, V15, P5, DOI 10.1007/s11373-007-9194-y; Somova LO, 2003, PHYTOMEDICINE, V10, P115, DOI 10.1078/094471103321659807; Tamburro A, 2004, FEMS MICROBIOL LETT, V241, P151, DOI 10.1016/j.femsle.2004.10.013; Toba FA, 2011, MICROBIOL-SGM, V157, P1640, DOI 10.1099/mic.0.045161-0; Wachter GA, 2001, J NAT PROD, V64, P37, DOI 10.1021/np000267b; Yeom J, 2012, RES MICROBIOL, V163, P258, DOI 10.1016/j.resmic.2012.01.008; Yin MC, 2007, J AGR FOOD CHEM, V55, P7177, DOI 10.1021/jf071242m; Yu F, 2013, J MED CHEM, V56, P4300, DOI 10.1021/jm301910a; Zhang ZS, 2001, J NUTR BIOCHEM, V12, P144, DOI 10.1016/S0955-2863(00)00137-6; Zhou L, 2013, ORAL DIS, V19, P494, DOI 10.1111/odi.12031	54	23	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137751	10.1371/journal.pone.0137751	http://dx.doi.org/10.1371/journal.pone.0137751			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360766	Green Submitted, Green Published, gold			2022-12-26	WOS:000361043100081
J	Thrane, JE; Kyle, M; Striebel, M; Haande, S; Grung, M; Rohrlack, T; Andersen, T				Thrane, Jan-Erik; Kyle, Marcia; Striebel, Maren; Haande, Sigrid; Grung, Merete; Rohrlack, Thomas; Andersen, Tom			Spectrophotometric Analysis of Pigments: A Critical Assessment of a High-Throughput Method for Analysis of Algal Pigment Mixtures by Spectral Deconvolution	PLOS ONE			English	Article							NUTRIENT LIMITATION; CHLOROPHYLL-A; CAROTENOIDS; HPLC; PHYTOPLANKTON; LIGHT; QUANTIFICATION; ACCLIMATION; ABSORPTION; EQUATIONS	The Gauss-peak spectra (GPS) method represents individual pigment spectra as weighted sums of Gaussian functions, and uses these to model absorbance spectra of phytoplankton pigment mixtures. We here present several improvements for this type of methodology, including adaptation to plate reader technology and efficient model fitting by open source software. We use a one-step modeling of both pigment absorption and background attenuation with non-negative least squares, following a one-time instrument-specific calibration. The fitted background is shown to be higher than a solvent blank, with features reflecting contributions from both scatter and non-pigment absorption. We assessed pigment aliasing due to absorption spectra similarity by Monte Carlo simulation, and used this information to select a robust set of identifiable pigments that are also expected to be common in natural samples. To test the method's performance, we analyzed absorbance spectra of pigment extracts from sediment cores, 75 natural lake samples, and four phytoplankton cultures, and compared the estimated pigment concentrations with concentrations obtained using high performance liquid chromatography (HPLC). The deviance between observed and fitted spectra was generally very low, indicating that measured spectra could successfully be reconstructed as weighted sums of pigment and background components. Concentrations of total chlorophylls and total carotenoids could accurately be estimated for both sediment and lake samples, but individual pigment concentrations (especially carotenoids) proved difficult to resolve due to similarity between their absorbance spectra. In general, our modified-GPS method provides an improvement of the GPS method that is a fast, inexpensive, and high-throughput alternative for screening of pigment composition in samples of phytoplankton material.	[Thrane, Jan-Erik] Univ Oslo, CEES, Dept Biosci, Oslo, Norway; [Kyle, Marcia; Rohrlack, Thomas] Norwegian Univ Life Sci NMBU, Dept Environm Sci, As, Norway; [Striebel, Maren] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, D-26111 Oldenburg, Germany; [Haande, Sigrid; Grung, Merete] Norwegian Inst Water Res NIVA, Oslo, Norway; [Thrane, Jan-Erik; Grung, Merete; Andersen, Tom] Univ Oslo, Sect Aquat Biol & Toxicol AQUA, Dept Biosci, Oslo, Norway	University of Oslo; Norwegian University of Life Sciences; Carl von Ossietzky Universitat Oldenburg; Norwegian Institute for Water Research (NIVA); University of Oslo	Thrane, JE (corresponding author), Univ Oslo, CEES, Dept Biosci, Oslo, Norway.	j.e.thrane@ibv.uio.no	Striebel, Maren/AAF-9996-2019	Striebel, Maren/0000-0003-2061-2154	Norwegian Institute for Water Research; University of Oslo; Norwegian University of Life Sciences	Norwegian Institute for Water Research; University of Oslo; Norwegian University of Life Sciences	This project was funded in part by internal grants from Norwegian Institute for Water Research for SH, MG, MK, and TR, and by internal grants from University of Oslo and Norwegian University of Life Sciences for JET, MK, and TR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACEMOGLU M, 1988, HELV CHIM ACTA, V71, P931, DOI 10.1002/hlca.19880710502; Antoine D, 1996, GLOBAL BIOGEOCHEM CY, V10, P57, DOI 10.1029/95GB02832; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; BAUMELER A, 1994, HELV CHIM ACTA, V77, P909, DOI 10.1002/hlca.19940770405; DAVIES AJ, 1984, J CHEM SOC PERK T 1, P2147, DOI 10.1039/p19840002147; Dogan M, 2009, B ENVIRON CONTAM TOX, V83, P249, DOI 10.1007/s00128-009-9733-5; Elser JJ, 2009, SCIENCE, V326, P835, DOI 10.1126/science.1176199; ENGLERT G, 1991, HELV CHIM ACTA, V74, P969, DOI 10.1002/hlca.19910740507; GANGULY J, 1956, ARCH BIOCHEM BIOPHYS, V60, P345, DOI 10.1016/0003-9861(56)90436-2; HAGER A, 1966, PLANTA, V69, P198, DOI 10.1007/BF00384873; HAUGAN JA, 1989, PHYTOCHEMISTRY, V28, P2797; HEATH MR, 1990, J PLANKTON RES, V12, P381, DOI 10.1093/plankt/12.2.381; HERTZBERG S, 1969, PHYTOCHEMISTRY, V8, P1259, DOI 10.1016/S0031-9422(00)85566-1; Hobaek A, 2012, FRESHWATER BIOL, V57, P1998, DOI 10.1111/j.1365-2427.2012.02832.x; HYNNINEN PH, 1983, SYNTHESIS-STUTTGART, P705; ISLER O, 1956, HELV CHIM ACTA, V39, P249, DOI 10.1002/hlca.19560390128; Jeffrey S.W., 2011, MICROALGAL CLASSES T, DOI [10.1017/CBO9780511732263.004, DOI 10.1017/CBO9780511732263.004]; Jeffrey S.W, 1997, MONOGRAPHS OCEANOGRA, P10; JEFFREY SW, 1972, BIOCHIM BIOPHYS ACTA, V279, P15, DOI 10.1016/0304-4165(72)90238-3; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; JOHANSEN JE, 1974, PHYTOCHEMISTRY, V13, P2261, DOI 10.1016/0031-9422(74)85038-7; KOBAYASHI M, 1993, APPL ENVIRON MICROB, V59, P867, DOI 10.1128/AEM.59.3.867-873.1993; Kupper H, 2000, ANAL BIOCHEM, V286, P247, DOI 10.1006/abio.2000.4794; Kupper H, 2002, J PHYCOL, V38, P429, DOI 10.1046/j.1529-8817.2002.01148.x; Kupper H, 2007, ANAL CHEM, V79, P7611, DOI 10.1021/ac070236m; Latasa M, 1996, MAR CHEM, V51, P315, DOI 10.1016/0304-4203(95)00056-9; Lawson CL, 1974, SOLVING LEAST SQUARE; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Maberly SC, 2002, FRESHWATER BIOL, V47, P2136, DOI 10.1046/j.1365-2427.2002.00962.x; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; MANTOURA RFC, 1983, ANAL CHIM ACTA, V151, P297, DOI 10.1016/S0003-2670(00)80092-6; Marschall M, 2004, ANN BOT-LONDON, V94, P593, DOI 10.1093/aob/mch178; Naqvi KR, 2004, SPECTROCHIM ACTA A, V60, P2783, DOI 10.1016/j.saa.2004.01.017; Picazo A, 2013, LIMNETICA, V32, P139; Porra RJ, 2006, CHLOROPHYLLS BACTERI, DOI DOI 10.1007/1-4020-4516-6; R Core Team, 2012, R LANG ENV STAT COMP; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; Roy S., 2011, PHYTOPLANKTON PIGMEN; Sairam RK, 2002, PLANT SCI, V163, P1037, DOI 10.1016/S0168-9452(02)00278-9; Schagerl M, 2007, BIOLOGIA, V62, P270, DOI 10.2478/s11756-007-0048-x; Schagerl M, 2006, J PLANT PHYSIOL, V163, P709, DOI 10.1016/j.jplph.2005.09.015; Schneider SC, 2015, AQUAT BOT, V120, P121, DOI 10.1016/j.aquabot.2014.05.002; STRAIN HH, 1976, ACTA CHEM SCAND B, V30, P109, DOI 10.3891/acta.chem.scand.30b-0109; Strain HH, 1938, CARNEGIE I WASHINGTO, V490, P147; SURMATIS JD, 1970, HELV CHIM ACTA, V53, P974, DOI 10.1002/hlca.19700530513; Tamminen T, 2007, MAR ECOL PROG SER, V340, P121, DOI 10.3354/meps340121; Thrane JE, 2014, ECOSYSTEMS, V17, P1040, DOI 10.1007/s10021-014-9776-2; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; WRIGHT SW, 1991, MAR ECOL PROG SER, V77, P183, DOI 10.3354/meps077183; Zscheile FP, 1942, PLANT PHYSIOL, V17, P331, DOI 10.1104/pp.17.3.331	50	57	57	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137645	10.1371/journal.pone.0137645	http://dx.doi.org/10.1371/journal.pone.0137645			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359659	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000361043100063
J	Chong, EW; Wang, YY; Robman, LD; Aung, KZ; Makeyeva, GA; Giles, GG; Graves, S; Cicuttini, FM; Guymer, RH				Chong, Elaine W.; Wang, Yuanyuan; Robman, Liubov D.; Aung, Khin Zaw; Makeyeva, Galina A.; Giles, Graham G.; Graves, Stephen; Cicuttini, Flavia M.; Guymer, Robyn H.			Age Related Macular Degeneration and Total Hip Replacement Due to Osteoarthritis or Fracture: Melbourne Collaborative Cohort Study	PLOS ONE			English	Article							BLUE MOUNTAINS EYE; VISUAL IMPAIRMENT; SYMPTOMATIC HIP; SYNOVIAL-FLUID; INFLAMMATION; OLDER; EPIDEMIOLOGY; AUSTRALIA; PEOPLE; DRUSEN	Osteoarthritis is the leading cause of total hip replacement, accounting for more than 80% of all total hip replacements. Emerging evidence suggests that osteoarthritis has a chronic inflammatory component to its pathogenesis similar to age-related macular degeneration. We evaluated the association between age-related macular degeneration and total hip replacement as proxy for severe osteoarthritis or fractured neck of femur in the Melbourne Collaborative Cohort Study. 20,744 participants had complete data on both age-related macular degeneration assessed from colour fundus photographs taken during 2003-2007 and total hip replacement. Total hip replacements due to hip osteoarthritis and fractured neck of femur during 2001-2011 were identified by linking the cohort records to the Australian Orthopedic Association National Joint Replacement Registry. Logistic regression was used to examine the association between age-related macular degeneration and risk of total hip replacement due to osteoarthritis and fracture separately, adjusted for confounders. There were 791 cases of total hip replacement for osteoarthritis and 102 cases of total hip replacement due to fractured neck of femur. After adjustment for age, sex, body mass index, smoking, and grouped country of birth, intermediate age-related macular degeneration was directly associated with total hip replacement for osteoarthritis (odds ratio 1.22, 95% CI 1.00-1.49). Late age-related macular degeneration was directly associated with total hip replacement due to fractured neck of femur (odds ratio 5.21, 95% CI2.25-12.02). The association between intermediate age-related macular degeneration and an increased 10-year incidence of total hip replacement due to osteoarthritis suggests the possibility of similar inflammatory processes underlying both chronic diseases. The association of late age-related macular degeneration with an increased 10-year incidence of total hip replacement due to fractured neck of femur may be due to an increased prevalence of fractures in those with poor central vision associated with the late complications of age-related macular degeneration.	[Chong, Elaine W.; Robman, Liubov D.; Aung, Khin Zaw; Makeyeva, Galina A.; Guymer, Robyn H.] Univ Melbourne, Ctr Eye Res Australia CERA, Royal Victorian Eye & Ear Hosp, Melbourne, Vic, Australia; [Chong, Elaine W.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Wang, Yuanyuan; Robman, Liubov D.; Cicuttini, Flavia M.] Monash Univ, Alfred Hosp, Dept Epidemiol & Prevent Med, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3181, Australia; [Giles, Graham G.] Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Giles, Graham G.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Graves, Stephen] Repatriat Gen Hosp, Dept Orthopaed, Adelaide, SA, Australia; [Graves, Stephen] Univ Adelaide, Australian Orthopaed Assoc Natl Joint Replacement, Discipline Publ Hlth, Sch Populat Hlth & Clin Practice, Adelaide, SA, Australia	Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; National University of Singapore; Singapore National Eye Center; Florey Institute of Neuroscience & Mental Health; Monash University; University of Melbourne; Cancer Council Victoria; Flinders University South Australia; University of Adelaide	Chong, EW (corresponding author), Univ Melbourne, Ctr Eye Res Australia CERA, Royal Victorian Eye & Ear Hosp, Melbourne, Vic, Australia.	elainechongwt@alumni.unimelb.edu.au	Graves, Stephen E/A-9463-2016; Wang, Yuanyuan/AAC-1109-2019; Cicuttini, Flavia/H-4978-2014	Graves, Stephen E/0000-0002-1629-319X; Wang, Yuanyuan/0000-0002-7629-4178; Guymer, Robyn/0000-0002-9441-4356; Cicuttini, Flavia/0000-0002-8200-1618; Giles, Graham/0000-0003-4946-9099	Victoria Health, The Cancer Council Victoria; National Health & Medical Research Council of Australia (NHMRC) [209057, 251533, 396414]; Ophthalmic Research Institute of Australia; American Health Assistance Foundation [M2008-082]; NHMRC Centre for Clinical Research Excellence Grant [529923]; Commonwealth Department of Health	Victoria Health, The Cancer Council Victoria; National Health & Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Ophthalmic Research Institute of Australia; American Health Assistance Foundation; NHMRC Centre for Clinical Research Excellence Grant(National Health and Medical Research Council (NHMRC) of Australia); Commonwealth Department of Health	Victoria Health, The Cancer Council Victoria and National Health & Medical Research Council of Australia (NHMRC) [Program Grant 209057, Capacity Building Grant 251533 and Enabling Grant 396414] funded the MCCS study. Ophthalmic component was funded by the Ophthalmic Research Institute of Australia and American Health Assistance Foundation # M2008-082. CERA is a recipient of the NHMRC Centre for Clinical Research Excellence Grant [529923] and Operational Infrastructure Support from the Victorian Government. The AOA NJRR is funded by the Commonwealth Department of Health. People support was provided through the NHMRC public health medical scholarship (EC), Novartis Medical Retinal Fellowship (EC), NHMRC Career Development Fellowship (YW, # 1065464), Wagstaff Fellowship (LR), NHMRC Career Development (RG, # 300052) and Practitioner (RG, # 529905) Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasopoulos E, 2006, AM J OPHTHALMOL, V142, P1081, DOI 10.1016/j.ajo.2006.06.058; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Aung KZ, 2009, OPHTHAL EPIDEMIOL, V16, P254, DOI [10.3109/09286580902864419, 10.1080/09286580902864419]; Benito MJ, 2005, ANN RHEUM DIS, V64, P1263, DOI 10.1136/ard.2004.025270; Bondeson J, 2010, ARTHRITIS RHEUM-US, V62, P647, DOI 10.1002/art.27290; DEAN G, 1993, BRIT J RHEUMATOL, V32, P671; Deloitte Access Economics, 2011, EYES FUT CLEAR OUTL; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; Giles G G, 2002, IARC Sci Publ, V156, P69; Goldring MB, 2011, CURR OPIN RHEUMATOL, V23, P471, DOI 10.1097/BOR.0b013e328349c2b1; Graves SE, 2004, MED J AUSTRALIA, V180, pS31; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Hong T, 2014, INVEST OPHTH VIS SCI, V55, P7589, DOI 10.1167/iovs.14-14262; Legood R, 2002, INJ PREV, V8, P155, DOI 10.1136/ip.8.2.155; MAROTTOLI RA, 1992, J AM GERIATR SOC, V40, P861, DOI 10.1111/j.1532-5415.1992.tb01980.x; Masud T, 2001, AGE AGEING, V30, P3, DOI 10.1093/ageing/30.suppl_4.3; Murphy LB, 2010, OSTEOARTHR CARTILAGE, V18, P1372, DOI 10.1016/j.joca.2010.08.005; Panula J, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-105; Rahman N, 2007, IMP DIS ASS ARTHR OS; Registry AOANJR, 2013, ANN REPORT; Salaffi F, 2005, AGING CLIN EXP RES, V17, P255; Sanders KM, 1999, MED J AUSTRALIA, V170, P467, DOI 10.5694/j.1326-5377.1999.tb127845.x; Scanzello CR, 2008, CURR OPIN RHEUMATOL, V20, P565, DOI 10.1097/BOR.0b013e32830aba34; Skrzeczynska-Moncznik J, 2009, ACTA BIOCHIM POL, V56, P355; Sohn DH, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3555; Sokolove J, 2013, THER ADV MUSCULOSKEL, V5, P77, DOI 10.1177/1759720X12467868; Spector TD, 1997, ARTHRITIS RHEUM, V40, P723, DOI 10.1002/art.1780400419; Stevens Judy A., 2000, Morbidity and Mortality Weekly Report, V49, P3; Telander DG, 2011, SEMIN OPHTHALMOL, V26, P192, DOI 10.3109/08820538.2011.570849; Valdes AM, 2010, CURR OPIN RHEUMATOL, V22, P139, DOI 10.1097/BOR.0b013e3283367a6e; VanNewkirk MR, 2001, OPHTHALMOLOGY, V108, P960, DOI 10.1016/S0161-6420(01)00554-1; Wang JJ, 2007, OPHTHALMOLOGY, V114, P92, DOI 10.1016/j.ophtha.2006.07.017; Wysong A, 2009, ARCH OPHTHALMOL-CHIC, V127, P320, DOI 10.1001/archophthalmol.2008.613	35	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137322	10.1371/journal.pone.0137322	http://dx.doi.org/10.1371/journal.pone.0137322			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355683	Green Published, Green Submitted, gold			2022-12-26	WOS:000360965800043
J	Lal, S; Ndyomugenyi, R; Alexander, ND; Lagarde, M; Paintain, L; Magnussen, P; Chandramohan, D; Clarke, SE				Lal, Sham; Ndyomugenyi, Richard; Alexander, Neal D.; Lagarde, Mylene; Paintain, Lucy; Magnussen, Pascal; Chandramohan, Daniel; Clarke, Sian E.			Health Facility Utilisation Changes during the Introduction of Community Case Management of Malaria in South Western Uganda: An Interrupted Time Series Approach	PLOS ONE			English	Article							HOME-BASED MANAGEMENT; QUALITY; CARE; IMPLEMENTATION; MORBIDITY; ILLNESS; IMPACT; POLICY; DRUGS	Background Malaria endemic countries have scaled-up community health worker (CHW) interventions, to diagnose and treat malaria in communities with limited access to public health systems. The evaluations of these programmes have centred on CHW's compliance to guidelines, but the broader changes at public health centres including utilisation and diagnoses made, has received limited attention. Methods This analysis was conducted during a CHW-intervention for malaria in Rukungiri District, Western Uganda. Outpatient department (OPD) visit data were collected for children under-5 attending three health centres one year before the CHW-intervention started (pre-intervention period) and for 20 months during the intervention (intervention-period). An interrupted time series analysis with segmented regression models was used to compare the trends in malaria, non-malaria and overall OPD visits during the pre-intervention and intervention-period. Results The introduction of a CHW-intervention suggested the frequency of diagnoses of diarrhoeal diseases, pneumonia and helminths increased, whilst the frequency of malaria diagnoses declined at health centres. In May 2010 when the intervention began, overall health centre utilisation decreased by 63% compared to the pre-intervention period and the health centres saw 32 fewer overall visits per month compared to the pre-intervention period (p<0.001). Malaria visits also declined shortly after the intervention began and there were 27 fewer visits per month during the intervention-period compared with the pre-intervention period (p<0.05). The declines in overall and malaria visits were sustained for the entire intervention-period. In contrast, there were no observable changes in trends of non-malarial visits between the pre-intervention and intervention-period. Conclusions This analysis suggests introducing a CHW-intervention can reduce the number of child malaria visits and change the profile of cases presenting at health centres. The reduction in workload of health workers may allow them to spend more time with patients or undertake additional curative or preventative roles.	[Lal, Sham; Paintain, Lucy; Chandramohan, Daniel; Clarke, Sian E.] London Sch Hyg & Trop Med, Fac Infect Trop Dis, Dept Dis Control, London WC1, England; [Ndyomugenyi, Richard] Minist Hlth, Vector Control Div, Kampala, Uganda; [Alexander, Neal D.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, MRC Trop Epidemiol Grp, Dept Infect Dis Epidemiol, London WC1, England; [Lagarde, Mylene] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Magnussen, Pascal] Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Fac Hlth & Med Sci, DK-1168 Copenhagen, Denmark; [Magnussen, Pascal] Univ Copenhagen, Inst Vet Dis Biol, Fac Hlth & Med Sci, DK-1168 Copenhagen, Denmark	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Copenhagen; University of Copenhagen	Lal, S (corresponding author), London Sch Hyg & Trop Med, Fac Infect Trop Dis, Dept Dis Control, London WC1, England.	sham.lal@lshtm.ac.uk	Clarke, Sian/AAF-5805-2019; Lagarde, Mylene/GVS-9289-2022	Magnussen, Pascal/0000-0001-7372-0250; Lal, Sham/0000-0002-3650-1398	ACT Consortium through Bill & Melinda Gates Foundation; United Kingdom Medical Research Council (MRC); Department for International Development (DFID) [MR/K012126/1]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	ACT Consortium through Bill & Melinda Gates Foundation; United Kingdom Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department for International Development (DFID); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was funded by the ACT Consortium through a grant from the Bill & Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine (www.actconsortium.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NDA receives support from the United Kingdom Medical Research Council (MRC) and Department for International Development (DFID) (MR/K012126/1).	Agresti A, 2007, INTRO CATEGORICAL DA; Ajayi IO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-6; [Anonymous], 2006, WORK TOG HLTH; [Anonymous], 2003, AFR MAL REP 2003; Dubois CA, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-87; HABERMAN SJ, 1973, BIOMETRICS, V29, P205, DOI 10.2307/2529686; Hay SI, 1998, T ROY SOC TROP MED H, V92, P12, DOI 10.1016/S0035-9203(98)90936-1; Kallander Karin, 2006, BMC Int Health Hum Rights, V6, P2, DOI 10.1186/1472-698X-6-2; Kalyango JN, 2012, AM J TROP MED HYG, V87, P36, DOI 10.4269/ajtmh.2012.11-0733; Kidane G, 2000, LANCET, V356, P550, DOI 10.1016/S0140-6736(00)02580-0; Lagarde M, 2012, HEALTH POLICY PLANN, V27, P76, DOI 10.1093/heapol/czr004; Lemma H, 2010, TROP MED INT HEALTH, V15, P241, DOI 10.1111/j.1365-3156.2009.02447.x; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Martens P, 1999, GLOBAL ENVIRON CHANG, V9, pS89, DOI 10.1016/S0959-3780(99)00020-5; McCleary R., 1980, APPL TIME SERIES ANA; Ministry of Health, 2014, HLTH SECT STRAT PLAN; Needleman J, 2002, NEW ENGL J MED, V346, P1715, DOI 10.1056/NEJMsa012247; Nsungwa-Sabiiti J, 2007, T ROY SOC TROP MED H, V101, P1199, DOI 10.1016/j.trstmh.2007.08.005; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Okwundu CI, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009527.pub2; Penfold RB, 2013, ACAD PEDIATR, V13, pS38, DOI 10.1016/j.acap.2013.08.002; Ramsay CR, 2003, INT J TECHNOL ASSESS, V19, P613, DOI 10.1017/S0266462303000576; Rasanathan K, 2014, J GLOB HEALTH, V4, P48, DOI 10.7189/jogh.04.020401; Rukungiri District Local Government, 2009, HIGH LOC GOV STAT AB; Sievers AC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-167; Sirima SB, 2003, TROP MED INT HEALTH, V8, P133, DOI 10.1046/j.1365-3156.2003.00997.x; Sserwanga A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016316; Steinhardt LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089050; Thomson A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-94; Tiono AB, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-201; Uganda Ministry of Health, 2010, MIN HLTH STAT ABSTR; Uganda Ministry of Health, 2011, UG MAL PROGR REV REP; Uganda Ministry of Health, 2011, HLTH SYST 20 20; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wazny K, 2014, J GLOB HEALTH, V4, P193, DOI 10.7189/jogh.04.020413; WHO, 2006, AFR MAL REP 2006; Zurovac D, 2004, INT J EPIDEMIOL, V33, P1080, DOI 10.1093/ije/dyh253	37	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137448	10.1371/journal.pone.0137448	http://dx.doi.org/10.1371/journal.pone.0137448			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356099	Green Published, Green Submitted, gold			2022-12-26	WOS:000360965800047
J	Markova, DN; Mason-Gamer, RJ				Markova, Dragomira N.; Mason-Gamer, Roberta J.			The Role of Vertical and Horizontal Transfer in the Evolutionary Dynamics of PIF-Like Transposable Elements in Triticeae	PLOS ONE			English	Article							NORTH-AMERICAN ELYMUS; SANT DOMAIN; DNA; GENOME; DROSOPHILA; MARINER; GENE; DIVERSITY; SELECTION; POACEAE	PIF-like transposable elements are members of the PIF/Harbinger superfamily of DNA transposons found in the genomes of many plants, animals, and fungi. The evolution of the gene that encodes the transposase responsible for mobilizing PIF-like elements has been studied in both plants and animals, but the elements' history in flowering plants remains poorly known. In this work, we describe the phylogenetic distribution and evolution of PIF-like elements in the genomes of 21 diploid species from the wheat tribe, Triticeae, and we present the first convincing evidence of horizontal transfer of PIF elements in plant genomes. A phylogenetic analysis of 240 PIF sequences based on the conserved region of the transposase domain revealed at least four main transposase lineages. Their complex evolutionary history can be best explained by a combination of vertical transmission with differential evolutionary success among lineages, and occasional horizontal transfer between phylogenetically distant Triticeae genera. In addition, we identified 127 potentially functional transposase sequences indicating possible recent activity of PIF.	[Markova, Dragomira N.; Mason-Gamer, Roberta J.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Markova, DN (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	markova@ucdavis.edu			National Science Foundation [DEB-0426194]; University of Illinois at Chicago Graduate College; Department of Biological Sciences	National Science Foundation(National Science Foundation (NSF)); University of Illinois at Chicago Graduate College; Department of Biological Sciences	This study was supported by a National Science Foundation grant (grant number DEB-0426194) to RJMG; Provost's Research Award from the University of Illinois at Chicago Graduate College and an Elmer Hadley award from the Department of Biological Sciences to DNM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabidopsis Genome Initiative A, 2000, 00280836 AR GEN IN; Arca B, 2000, GENETICA, V108, P263, DOI 10.1023/A:1004185024017; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Capy P, 1998, MOL B INT U, P1; Casola C, 2007, MOL BIOL EVOL, V24, P1872, DOI 10.1093/molbev/msm116; Charles M, 2008, GENETICS, V180, P1071, DOI 10.1534/genetics.108.092304; Clark JB, 1997, P NATL ACAD SCI USA, V94, P11428, DOI 10.1073/pnas.94.21.11428; Cm Gilbert, 2010, NATURE, V464, P1347, DOI [10.1038/ nature08939, DOI 10.1038/NATURE08939]; DANIELS SB, 1990, GENETICS, V124, P339; Dewey D, 1985, GENE MANIPULATION PL, P209; DEWEY DR, 1983, BRITTONIA, V35, P30, DOI 10.2307/2806044; DEWEY DR, 1983, CROP SCI, V23, P637, DOI 10.2135/cropsci1983.0011183X002300040009x; Ding ZH, 2004, J BIOL CHEM, V279, P28009, DOI 10.1074/jbc.M403793200; Doyle J. J., 1987, PHYTOCHEM B, P11; El Baidouri M, 2014, GENOME RES, V24, P831, DOI 10.1101/gr.164400.113; Escobar JS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-181; FARRIS JS, 1972, AM NAT, V106, P645, DOI 10.1086/282802; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feschotte C, 2002, P NATL ACAD SCI USA, V99, P280, DOI 10.1073/pnas.022626699; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; Grzebelus D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-409; Helfgott DM, 2004, SYST BOT, V29, P850, DOI 10.1600/0363644042451017; Jiang N, 2003, NATURE, V421, P163, DOI 10.1038/nature01214; Kapitonov VV, 2003, P NATL ACAD SCI USA, V100, P6569, DOI 10.1073/pnas.0732024100; Kellogg EA, 1996, SYST BOT, V21, P321, DOI 10.2307/2419662; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; Lampe DJ, 2003, MOL BIOL EVOL, V20, P554, DOI 10.1093/molbev/msg069; Li WL, 2004, PLANT J, V40, P500, DOI 10.1111/j.1365-313X.2004.02228.x; Loreto ELD, 2001, J HERED, V92, P375, DOI 10.1093/jhered/92.5.375; Love A., 1984, Feddes Repertorium, V95, P425; Maddison DR, 2005, ANAL PHYLOGENY CHARA; MARUYAMA K, 1991, J MOL EVOL, V33, P514, DOI 10.1007/BF02102804; Mason-Gamer RJ, 2002, GENOME, V45, P991, DOI [10.1139/g02-065, 10.1139/G02-065]; Mason-Gamer RJ, 2001, SYST BOT, V26, P757; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Meyers BC, 2001, GENOME RES, V11, P1660, DOI 10.1101/gr.188201; Middleton CP, 2013, PLANT J, V73, P347, DOI 10.1111/tpj.12048; Mo XM, 2005, GENE DEV, V19, P2447, DOI 10.1101/gad.355405; NEI M, 1986, MOL BIOL EVOL, V3, P418; Paux E, 2006, PLANT J, V48, P463, DOI 10.1111/j.1365-313X.2006.02891.x; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; REZSOHAZY R, 1993, MOL MICROBIOL, V9, P1283, DOI 10.1111/j.1365-2958.1993.tb01258.x; Robertson H.M., 1993, Insect Molecular Biology, V2, P125, DOI 10.1111/j.1365-2583.1993.tb00132.x; ROBERTSON HM, 1995, MOL BIOL EVOL, V12, P850; Shen ZC, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.24; Silva JC, 2004, CURR ISSUES MOL BIOL, V6, P57; Sterner DE, 2002, J BIOL CHEM, V277, P8178, DOI 10.1074/jbc.M108601200; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomita M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-269; Wagner A, 1994, SYSTEMATIC BIOL, V43; Walker EL, 1997, GENETICS, V146, P681; Wicker T, 2009, PLANT J, V59, P712, DOI 10.1111/j.1365-313X.2009.03911.x; Witherspoon DJ, 1999, MOL BIOL EVOL, V16, P472, DOI 10.1093/oxfordjournals.molbev.a026129; Yu CM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-214; Yuan YW, 2011, P NATL ACAD SCI USA, V108, P7884, DOI 10.1073/pnas.1104208108; Zhang XY, 2004, GENETICS, V166, P971, DOI 10.1534/genetics.166.2.971; Zhong H, 2010, BIOCHEM SYST ECOL, V38, P750, DOI 10.1016/j.bse.2010.06.010; Zhou MB, 2010, PLANT SCI, V179, P257, DOI 10.1016/j.plantsci.2010.05.012; Zwickl DJ., 2006, THESIS	67	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137648	10.1371/journal.pone.0137648	http://dx.doi.org/10.1371/journal.pone.0137648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355747	Green Published, gold, Green Submitted			2022-12-26	WOS:000360965800074
J	Ratovoson, R; Rasetarinera, OR; Andrianantenaina, I; Rogier, C; Piola, P; Pacaud, P				Ratovoson, Rila; Rasetarinera, Ony Rabarisoa; Andrianantenaina, Ionimalala; Rogier, Christophe; Piola, Patrice; Pacaud, Pierre			Hypertension, a Neglected Disease in Rural and Urban Areas in Moramanga, Madagascar	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; BLOOD-PRESSURE; RISK-FACTORS; MARITAL-STATUS; GLOBAL BURDEN; PREVALENCE; AWARENESS; SEX; EPIDEMIOLOGY; TRANSITION	Background Hypertension is one of the main risk factors of cardiovascular diseases. In Madagascar, studies on hypertension in urban and rural communities are scarce. Objectives The aim of this study was to determine the prevalence of hypertension and identify associated risk factors in adults living in a health and demographic system in Moramanga, Madagascar. Methods The study included people aged 15 years old and above living in a health and demographic system in Moramanga. A household census was performed in 2012 to enumerate the population in 3 communities in Moramanga. In addition to the questionnaire used in the initial census, a standardized questionnaire and blood pressure were taken twice after 5 and 10 minutes of rest. In urban areas, heights and weights were also measured to calculate the body mass index. Results There were 3621 and 4010 participants respectively in rural and urban areas. Prevalence of hypertension in rural population was 27.0%(IC95%[25.6-28.5]) and 29.7% (IC95% [28.3-31.1]) in urban population. Among hypertensive subjects, 1.7% (17/979) and 5.3% (64/1191) were on antihypertensive treatment for at least 1 month before the survey in rural and urban population, respectively. In rural areas, increasing age (65 years and older vs 18-25 years OR = 11.81, IC95% [7.79-18.07]), giving more than 3 positive responses to the usual risks factors of hypertension (OR = 1.67, IC95% [1.14-2.42]) and singles in comparison with married people (OR = 1.61, IC95% [1.20-2.17]) were associated to hypertension in a logistic regression model. In urban areas, increasing age (65 years and older vs 18-25 years OR = 37.54, IC95% [24.81-57.92]), more than 3 positive responses to the usual risks of hypertension (OR = 3.47, IC95% [2.58-4.67]) and obesity (OR = 2.45, IC95% [1.56-3.87]) were found as risk factors. Conclusion Hypertension is highly prevalent in rural areas although it is significantly less treated. As a result, a major epidemic of cardiovascular diseases is at risk in Madagascar's progressively aging society.	[Ratovoson, Rila; Andrianantenaina, Ionimalala; Rogier, Christophe; Piola, Patrice] Inst Pasteur Madagascar, Antananarivo, Madagascar; [Rasetarinera, Ony Rabarisoa] Antananarivo Univ, Fac Med, Antananarivo, Madagascar; [Rogier, Christophe] URMITE, UMR 6236, F-13385 Marseille 05, France; [Rogier, Christophe] French Armed Forces IRBA, Inst Biomed Res, F-91223 Bretigny Sur Orge, France; [Pacaud, Pierre] Univ Nantes, INSERM, UMR S1087, CHU Nantes,Inst Thorax, F-44000 Nantes, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; University Antananarivo; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Ratovoson, R (corresponding author), Inst Pasteur Madagascar, POB 1274 Ambatofotsikely, Antananarivo, Madagascar.	rila@pasteur.mg	Pacaud, Pierre/D-6392-2015	Ratovoson, Rila/0000-0002-3867-6343	University of Nantes; Institut Pasteur de Madagascar	University of Nantes; Institut Pasteur de Madagascar	This study was supported by University of Nantes: This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; Institut Pasteur de Madagascar: This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Saad K, 2014, AM J HYPERTENS, V27, P1511, DOI 10.1093/ajh/hpu081; Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Agyemang C, 2006, J HUM HYPERTENS, V20, P67, DOI 10.1038/sj.jhh.1001923; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Balla Siham Ahmed, 2014, Glob J Health Sci, V6, P206, DOI 10.5539/gjhs.v6n3p206; Barros AJD, 2005, REV SAUDE PUBL, V39, P523, DOI 10.1590/S0034-89102005000400002; Bovet P, 2003, J HYPERTENS, V21, P509, DOI 10.1097/00004872-200303000-00016; Bovet P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-407; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choukem SP, 2007, DIABETES RES CLIN PR, V77, P293, DOI 10.1016/j.diabres.2006.11.007; Damasceno A, 2009, HYPERTENSION, V54, P77, DOI 10.1161/HYPERTENSIONAHA.109.132423; Danaei G, 2013, CIRCULATION, V127, P1493, DOI 10.1161/CIRCULATIONAHA.113.001470; Dzudie A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001217; Fourcade L, 2007, Med Trop (Mars), V67, P559; Institut National de la Statistique (INSTAT) ICF Macro, 2010, ENQ DEM SANT MAD 200; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kotwani P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1151; Kuller LH, 2007, HYPERTENSION, V50, P1004, DOI 10.1161/HYPERTENSIONAHA.107.095620; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Malaza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047761; Maselko J, 2009, J AM GERIATR SOC, V57, P2293, DOI 10.1111/j.1532-5415.2009.02555.x; Masquelier B, 2014, GLOBAL HEALTH ACTION, V7, P110, DOI 10.3402/gha.v7.23237; Mengistu MD, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-33; Mensah GA, 2008, HEART, V94, P697, DOI 10.1136/hrt.2007.127753; Musinguzi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062236; Opie LH, 2005, CIRCULATION, V112, P3562, DOI 10.1161/CIRCULATIONAHA.105.539569; Organisation Mondiale de la Sante, STAT SAN MOND 2013; Peck RN, 2013, J HYPERTENS, V31, P1806, DOI 10.1097/HJH.0b013e328362bad7; Pereira M, 2009, J HYPERTENS, V27, P963, DOI 10.1097/HJH.0b013e3283282f65; Psaltopoulou T, 2004, INT J EPIDEMIOL, V33, P1345, DOI 10.1093/ije/dyh249; R Core Team, 2021, R LANGUAGE ENV STAT; Rabarijaona L, 2009, REV ANESTHESIE REANI, V1, P24; Rakotoarimanana S, 2005, MED AFR NOIRE, V52, P135; Tibazarwa KB, 2014, CAN J CARDIOL, V30, P527, DOI 10.1016/j.cjca.2014.02.020; Twagirumukiza M, 2011, J HYPERTENS, V29, P1243, DOI 10.1097/HJH.0b013e328346995d; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Walker R, 2010, LANCET NEUROL, V9, P786, DOI 10.1016/S1474-4422(10)70144-7	37	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137408	10.1371/journal.pone.0137408	http://dx.doi.org/10.1371/journal.pone.0137408			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9WL	26355997	Green Submitted, Green Published, gold			2022-12-26	WOS:000360965800046
J	Green, JP; Foster, R; Wilkins, L; Osorio, D; Hartley, SE				Green, Jonathan P.; Foster, Rosie; Wilkins, Lucas; Osorio, Daniel; Hartley, Susan E.			Leaf Colour as a Signal of Chemical Defence to Insect Herbivores in Wild Cabbage (Brassica oleracea)	PLOS ONE			English	Article							AUTUMN TREE COLORS; PIERIS-RAPAE; GLUCOSINOLATE POLYMORPHISM; SPECIALIST HERBIVORE; HOST-PLANT; RESPONSES; APHID; PREFERENCE; POPULATIONS; RED	Leaf colour has been proposed to signal levels of host defence to insect herbivores, but we lack data on herbivory, leaf colour and levels of defence for wild host populations necessary to test this hypothesis. Such a test requires measurements of leaf spectra as they would be sensed by herbivore visual systems, as well as simultaneous measurements of chemical defences and herbivore responses to leaf colour in natural host-herbivore populations. In a large-scale field survey of wild cabbage (Brassica oleracea) populations, we show that variation in leaf colour and brightness, measured according to herbivore spectral sensitivities, predicts both levels of chemical defences (glucosinolates) and abundance of specialist lepidopteran (Pieris rapae) and hemipteran (Brevicoryne brassicae) herbivores. In subsequent experiments, P. rapae larvae achieved faster growth and greater pupal mass when feeding on plants with bluer leaves, which contained lower levels of aliphatic glucosinolates. Glucosinolate-mediated effects on larval performance may thus contribute to the association between P. rapae herbivory and leaf colour observed in the field. However, preference tests found no evidence that adult butterflies selected host plants based on leaf coloration. In the field, B. brassicae abundance varied with leaf brightness but greenhouse experiments were unable to identify any effects of brightness on aphid preference or performance. Our findings suggest that although leaf colour reflects both levels of host defences and herbivore abundance in the field, the ability of herbivores to respond to colour signals may be limited, even in species where performance is correlated with leaf colour.	[Green, Jonathan P.; Hartley, Susan E.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Foster, Rosie; Wilkins, Lucas; Osorio, Daniel] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of York - UK; University of Sussex	Hartley, SE (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	sue.hartley@york.ac.uk		Osorio, Daniel/0000-0002-5856-527X; Hartley, Sue/0000-0002-5117-687X	Biotechnology and Biological Sciences PhD studentship; University of York; University of Sussex	Biotechnology and Biological Sciences PhD studentship; University of York(European Commission); University of Sussex	The work was funded by a Biotechnology and Biological Sciences PhD studentship and by the University of York and the University of Sussex. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2003, J CHEM ECOL, V29, P1403, DOI 10.1023/A:1024265420375; [Anonymous], 2014, R LANG ENV STAT COMP; Archetti M, 2005, OIKOS, V110, P339, DOI 10.1111/j.0030-1299.2005.13656.x; Archetti M, 2009, TRENDS ECOL EVOL, V24, P166, DOI 10.1016/j.tree.2008.10.006; Arikawa K., 2014, INSECT PHOTOPIGMENTS, P137; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benrey B, 1997, ECOLOGY, V78, P987, DOI 10.2307/2265852; Berdegue M, 1998, ENTOMOL EXP APPL, V89, P57, DOI 10.1023/A:1003464102518; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Clark KE, 2011, ECOL ENTOMOL, V36, P117, DOI 10.1111/j.1365-2311.2010.01248.x; Courtney S.P., 1990, P161; Doring TF, 2007, ENTOMOL GEN, V30, P233; Doring TF, 2014, ANN APPL BIOL, V165, P3, DOI 10.1111/aab.12142; Doring TF, 2009, P ROY SOC B-BIOL SCI, V276, P121, DOI 10.1098/rspb.2008.0858; Doring TF, 2007, ARTHROPOD-PLANT INTE, V1, P3, DOI 10.1007/s11829-006-9000-1; Ewald NC, 2011, ECOL ENTOMOL, V36, P596, DOI 10.1111/j.1365-2311.2011.01304.x; Frentiu FD, 2008, BIOESSAYS, V30, P1151, DOI 10.1002/bies.20828; Gols R, 2008, ECOLOGY, V89, P1616, DOI 10.1890/07-0873.1; Gripenberg S, 2010, ECOL LETT, V13, P383, DOI 10.1111/j.1461-0248.2009.01433.x; Hamilton WD, 2001, P ROY SOC B-BIOL SCI, V268, P1489, DOI 10.1098/rspb.2001.1672; Hare JD, 2012, SCIENCE, V338, P50, DOI 10.1126/science.1228893; Hemm MR, 2003, PLANT CELL, V15, P179, DOI 10.1105/tpc.006544; Hoagland DR, 1950, CIRC; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623; Hopper KR, 1999, ANNU REV ENTOMOL, V44, P535, DOI 10.1146/annurev.ento.44.1.535; HUANG XP, 1994, J CHEM ECOL, V20, P1025, DOI 10.1007/BF02059739; Kazana E, 2007, P ROY SOC B-BIOL SCI, V274, P2271, DOI 10.1098/rspb.2007.0237; Kelber A, 2001, ENTOMOL EXP APPL, V99, P231, DOI 10.1023/A:1019244619503; Kelber A, 1999, J EXP BIOL, V202, P2619; Kirchner SM, 2005, J INSECT PHYSIOL, V51, P1255, DOI 10.1016/j.jinsphys.2005.07.002; Kos M, 2012, PHYTOCHEMISTRY, V77, P162, DOI 10.1016/j.phytochem.2012.01.005; Koshitaka H, 2008, P ROY SOC B-BIOL SCI, V275, P947, DOI 10.1098/rspb.2007.1614; LEATHER SR, 1988, OIKOS, V51, P386, DOI 10.2307/3565323; Li YH, 2014, OECOLOGIA, V174, P853, DOI 10.1007/s00442-013-2805-6; LOADER C, 1991, ECOLOGY, V72, P1586, DOI 10.2307/1940958; MacDonald JH, 2014, HDB BIOL STAT, DOI DOI 10.1016/j.aquatox.2007.10.001; Mewis I, 2005, PLANT PHYSIOL, V138, P1149, DOI 10.1104/pp.104.053389; Miles CI, 2005, J COMP PHYSIOL A, V191, P147, DOI 10.1007/s00359-004-0580-x; MITCHELL ND, 1979, J ECOL, V67, P1087, DOI 10.2307/2259229; MITHEN R, 1995, HEREDITY, V75, P472, DOI 10.1038/hdy.1995.164; Moyes CL, 2000, J CHEM ECOL, V26, P2625, DOI 10.1023/A:1005549115751; Mumm R, 2008, J CHEM ECOL, V34, P1311, DOI 10.1007/s10886-008-9534-z; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Newton E, 2010, OECOLOGIA, V164, P689, DOI 10.1007/s00442-010-1702-5; Newton EL, 2009, OECOLOGIA, V160, P63, DOI 10.1007/s00442-009-1281-5; NOTTINGHAM SF, 1991, J CHEM ECOL, V17, P1231, DOI 10.1007/BF01402946; Pirih P, 2010, J COMP PHYSIOL A, V196, P501, DOI 10.1007/s00359-010-0538-0; Poelman EH, 2008, MOL ECOL, V17, P3352, DOI 10.1111/j.1365-294X.2008.03838.x; Poelman EH, 2009, ECOLOGY, V90, P1863, DOI 10.1890/08-0977.1; PROKOPY RJ, 1983, SCIENCE, V221, P190, DOI 10.1126/science.221.4606.190; Qiu XD, 2003, J EXP BIOL, V206, P2787, DOI 10.1242/jeb.00493; Ramirez CC, 2008, J EVOLUTION BIOL, V21, P49, DOI 10.1111/j.1420-9101.2007.01469.x; Reeves JL, 2011, ENVIRON ENTOMOL, V40, P855, DOI 10.1603/EN10212; Rolshausen G, 2007, PLANT ECOL, V191, P77, DOI 10.1007/s11258-006-9215-3; Santolamazza-Carbone S, 2014, OECOLOGIA, V174, P893, DOI 10.1007/s00442-013-2817-2; Schaefer HM, 2006, BIOESSAYS, V28, P65, DOI 10.1002/bies.20340; Schaefer HM, 2011, PLANT-ANIMAL COMMUNICATION, P1, DOI 10.1093/acprof:osobl/9780199563609.001.0001; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schwarzkopf A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075298; Sinkkonen A, 2012, NEW PHYTOL, V195, P461, DOI 10.1111/j.1469-8137.2012.04156.x; Snell-Rood EC, 2009, AM NAT, V173, P615, DOI 10.1086/597609; Stavenga DG, 2011, J COMP PHYSIOL A, V197, P373, DOI 10.1007/s00359-010-0622-5; Strauss SY, 2004, J ECOL, V92, P132, DOI 10.1111/j.1365-2745.2004.00843.x; TRAYNIER RMM, 1979, PHYSIOL ENTOMOL, V4, P87, DOI 10.1111/j.1365-3032.1979.tb00181.x; TRAYNIER RMM, 1986, ENTOMOL EXP APPL, V40, P25, DOI 10.1007/BF00187019; van Dam NM, 2004, NEW PHYTOL, V161, P801, DOI 10.1111/j.1469-8137.2004.00984.x; Wittstock U, 2004, P NATL ACAD SCI USA, V101, P4859, DOI 10.1073/pnas.0308007101; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	70	13	13	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136884	10.1371/journal.pone.0136884	http://dx.doi.org/10.1371/journal.pone.0136884			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353086	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000360932800052
J	Kolb, P; Wallich, R; Nassal, M				Kolb, Philipp; Wallich, Reinhard; Nassal, Michael			Whole-Chain Tick Saliva Proteins Presented on Hepatitis B Virus Capsid-Like Particles Induce High-Titered Antibodies with Neutralizing Potential	PLOS ONE			English	Article							BORRELIA-BURGDORFERI; SURFACE PROTEIN; CORE PROTEIN; CRYSTAL-STRUCTURE; DISPLAY; SALP15; ANTIGEN; IDENTIFICATION; COMPLEMENT; EXPRESSION	Ticks are vectors for various, including pathogenic, microbes. Tick saliva contains multiple anti-host defense factors that enable ticks their bloodmeals yet also facilitate microbe transmission. Lyme disease-causing borreliae profit specifically from the broadly conserved tick histamine release factor (tHRF), and from cysteine-rich glycoproteins represented by Salp15 from Ixodes scapularis and Iric-1 from Ixodes ricinus ticks which they recruit to their outer surface protein C (OspC). Hence these tick proteins are attractive targets for anti-tick vaccines that simultaneously impair borrelia transmission. Main obstacles are the tick proteins immunosuppressive activities, and for Salp15 orthologs, the lack of efficient recombinant expression systems. Here, we exploited the immune-enhancing properties of hepatitis B virus core protein (HBc) derived capsid-like particles (CLPs) to generate, in E. coli, nanoparticulate vaccines presenting tHRF and, as surrogates for the barely soluble wild-type proteins, cysteine-free Salp15 and Iric-1 variants. The latter CLPs were exclusively accessible in the less sterically constrained SplitCore system. Mice immunized with tHRF CLPs mounted a strong anti-tHRF antibody response. CLPs presenting cysteine-free Salp15 and Iric-1 induced antibodies to wild-type, including glycosylated, Salp15 and Iric-1. The broadly distributed epitopes included the OspC interaction sites. In vitro, the anti-Salp15 antibodies interfered with OspC binding and enhanced human complement-mediated killing of Salp15 decorated borreliae. A mixture of all three CLPs induced high titered antibodies against all three targets, suggesting the feasibility of combination vaccines. These data warrant in vivo validation of the new candidate vaccines' protective potential against tick infestation and Borrelia transmission.	[Kolb, Philipp; Nassal, Michael] Univ Hosp Freiburg, Internal Med Mol Biol 2, D-79106 Freiburg, Germany; [Kolb, Philipp] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Wallich, Reinhard] Univ Heidelberg Hosp, Inst Immunol, D-69120 Heidelberg, Germany	University of Freiburg; University of Freiburg; Ruprecht Karls University Heidelberg	Nassal, M (corresponding author), Univ Hosp Freiburg, Internal Med Mol Biol 2, Hugstetter Str 55, D-79106 Freiburg, Germany.	nassal2@ukl.uni-freiburg.de	Kolb, Philipp/AAE-4007-2021; Nassal, Michael/U-4529-2019	Kolb, Philipp/0000-0001-7935-217X; Nassal, Michael/0000-0003-2204-9158	Deutsche Forschungsgemeinschaft; German Research Foundation (DFG); Albert Ludwigs University Freiburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	This study was supported by Deutsche Forschungsgemeinschaft (URL: http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing.	Acunzo J, 2014, CANCER TREAT REV, V40, P760, DOI 10.1016/j.ctrv.2014.02.007; Anguita J, 2002, IMMUNITY, V16, P849, DOI 10.1016/S1074-7613(02)00325-4; BIRNBAUM F, 1990, J VIROL, V64, P3319, DOI 10.1128/JVI.64.7.3319-3330.1990; BreitnerRuddock S, 1997, MED MICROBIOL IMMUN, V185, P253, DOI 10.1007/s004300050038; Calderon-Perez B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085514; Dai JF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001205; Dai JF, 2009, CELL HOST MICROBE, V6, P482, DOI 10.1016/j.chom.2009.10.006; Daub H, 2002, J VIROL, V76, P8124, DOI 10.1128/JVI.76.16.8124-8137.2002; Demain AL, 2009, BIOTECHNOL ADV, V27, P297, DOI 10.1016/j.biotechadv.2009.01.008; Desel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053531; Embers ME, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00006; Estrada-Pena A, 2014, ANTIVIR RES, V108, P104, DOI 10.1016/j.antiviral.2014.05.016; Fehr T, 1998, P NATL ACAD SCI USA, V95, P9477, DOI 10.1073/pnas.95.16.9477; Grosskinsky S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004858; Hovius JW, 2008, J INFECT DIS, V198, P1189, DOI 10.1086/591917; Hovius JWR, 2007, VECTOR-BORNE ZOONOT, V7, P296, DOI 10.1089/vbz.2006.0624; Ibanez LI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059081; Juncadella IJ, 2007, FEMS IMMUNOL MED MIC, V49, P433, DOI 10.1111/j.1574-695X.2007.00223.x; Koniger C, 2014, P NATL ACAD SCI USA, V111, pE4244, DOI 10.1073/pnas.1409986111; Kolb P., 2015, VIRAL NANOTECHNOLOGY, P187; Kolb P, 2015, FEBS OPEN BIO, V5, P42, DOI 10.1016/j.fob.2014.12.002; Konig S, 1998, J VIROL, V72, P4997; Kratz PA, 1999, P NATL ACAD SCI USA, V96, P1915, DOI 10.1073/pnas.96.5.1915; Kung F, 2013, FUTURE MICROBIOL, V8, P41, DOI [10.2217/FMB.12.121, 10.2217/fmb.12.121]; Lee BO, 2009, J IMMUNOL, V182, P6670, DOI 10.4049/jimmunol.0803683; Li H, 1997, P NATL ACAD SCI USA, V94, P3584, DOI 10.1073/pnas.94.8.3584; Mason LMK, 2014, TRENDS PARASITOL, V30, P95, DOI 10.1016/j.pt.2013.12.003; Merino O, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00030; Mulenga A, 2005, EXP APPL ACAROL, V37, P215, DOI 10.1007/s10493-005-3261-8; Nassal M, 2005, EUR J IMMUNOL, V35, P655, DOI 10.1002/eji.200425449; NASSAL M, 1988, GENE, V66, P279, DOI 10.1016/0378-1119(88)90364-2; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; Nassal M, 2008, INT J MED MICROBIOL, V298, P135, DOI 10.1016/j.ijmm.2007.08.002; Nguyen VD, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-1; Porterfield JZ, 2010, J VIROL, V84, P7174, DOI 10.1128/JVI.00586-10; Pumpens P, 2001, INTERVIROLOGY, V44, P98, DOI 10.1159/000050037; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Ramamoorthi N, 2005, NATURE, V436, P573, DOI 10.1038/nature03812; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Riedl P, 2002, J IMMUNOL, V168, P4951, DOI 10.4049/jimmunol.168.10.4951; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Schuijt TJ, 2011, TRENDS PARASITOL, V27, P40, DOI 10.1016/j.pt.2010.06.006; Schuijt TJ, 2008, INFECT IMMUN, V76, P2888, DOI 10.1128/IAI.00232-08; Skamel C, 2006, J BIOL CHEM, V281, P17474, DOI 10.1074/jbc.M513571200; Skrastina D, 2008, VACCINE, V26, P1972, DOI 10.1016/j.vaccine.2008.02.030; Sominskaya I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075938; Steven AC, 2005, ADV VIRUS RES, V64, P125, DOI 10.1016/S0065-3527(05)64005-5; Ulrich R, 1998, ADV VIRUS RES, V50, P141, DOI 10.1016/S0065-3527(08)60808-8; Vogel M, 2005, PROTEINS, V58, P478, DOI 10.1002/prot.20312; Walker A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00005; Walker A, 2008, J BIOL CHEM, V283, P33508, DOI 10.1074/jbc.M805211200; Wang JW, 2013, EXPERT REV VACCINES, V12, P129, DOI [10.1586/erv.12.151, 10.1586/ERV.12.151]; Whitacre DC, 2009, EXPERT REV VACCINES, V8, P1565, DOI 10.1586/ERV.09.121; Wikel S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00337; Wynne SA, 1999, MOL CELL, V3, P771, DOI 10.1016/S1097-2765(01)80009-5; Zhao QJ, 2013, TRENDS BIOTECHNOL, V31, P654, DOI 10.1016/j.tibtech.2013.09.002; Zlotnick A, 1997, P NATL ACAD SCI USA, V94, P9556, DOI 10.1073/pnas.94.18.9556; Zuckert WR, 2004, INFECT IMMUN, V72, P1463, DOI 10.1128/IAI.72.3.1463-1469.2004	58	9	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136180	10.1371/journal.pone.0136180	http://dx.doi.org/10.1371/journal.pone.0136180			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352137	gold, Green Submitted, Green Published			2022-12-26	WOS:000360932800027
J	Netzahuatl-Munoz, AR; Cristiani-Urbina, MD; Cristiani-Urbina, E				Rosa Netzahuatl-Munoz, Alma; del Carmen Cristiani-Urbina, Maria; Cristiani-Urbina, Eliseo			Chromium Biosorption from Cr(VI) Aqueous Solutions by Cupressus lusitanica Bark: Kinetics, Equilibrium and Thermodynamic Studies	PLOS ONE			English	Article							HEXAVALENT CHROMIUM; WASTE-WATER; HEAVY-METALS; NICKEL(II) BIOSORPTION; ACTIVATED CARBONS; REMOVAL MECHANISM; FUNGAL BIOMASS; ADSORPTION; SORPTION; BIOSORBENT	The present study investigated the kinetics, equilibrium and thermodynamics of chromium (Cr) ion biosorption from Cr(VI) aqueous solutions by Cupressus lusitanica bark (CLB). CLB total Cr biosorption capacity strongly depended on operating variables such as initial Cr(VI) concentration and contact time: as these variables rose, total Cr biosorption capacity increased significantly. Total Cr biosorption rate also increased with rising solution temperature. The pseudo-second-order model described the total Cr biosorption kinetic data best. Langmuir ' s model fitted the experimental equilibrium biosorption data of total Cr best and predicted a maximum total Cr biosorption capacity of 305.4 mg g(-1). Total Cr biosorption by CLB is an endothermic and non-spontaneous process as indicated by the thermodynamic parameters. Results from the present kinetic, equilibrium and thermodynamic studies suggest that CLB biosorbs Cr ions from Cr(VI) aqueous solutions pre-dominantly by a chemical sorption phenomenon. Low cost, availability, renewable nature, and effective total Cr biosorption make CLB a highly attractive and efficient method to remediate Cr(VI)-contaminated water and wastewater.	[Rosa Netzahuatl-Munoz, Alma; Cristiani-Urbina, Eliseo] Inst Politecn Nacl, Dept Ingn Bioquim, Escuela Nacl Ciencias Biol, Mexico City, DF, Mexico; [Rosa Netzahuatl-Munoz, Alma] Univ Politecn Tlaxcala, Tepeyanco, Tlaxcala, Mexico; [del Carmen Cristiani-Urbina, Maria] Univ Autonoma Chiapas, Tuxtla Gutierrez, Chiapas, Mexico	Instituto Politecnico Nacional - Mexico; Universidad Autonoma de Chiapas	Cristiani-Urbina, E (corresponding author), Inst Politecn Nacl, Dept Ingn Bioquim, Escuela Nacl Ciencias Biol, Mexico City, DF, Mexico.	ecristia@encb.ipn.mx	Muñoz, Alma Rosa Netzahuatl/ABC-9252-2020	Muñoz, Alma Rosa Netzahuatl/0000-0003-1963-8357; Cristiani-Urbina, Eliseo/0000-0002-8470-0711				Aksu Z, 2002, PROCESS BIOCHEM, V38, P89, DOI 10.1016/S0032-9592(02)00051-1; Altundogan HS, 2005, PROCESS BIOCHEM, V40, P1443, DOI 10.1016/j.procbio.2004.06.027; Aranda-Garcia E, 2014, ENVIRON MONIT ASSESS, V186, P6207, DOI 10.1007/s10661-014-3849-8; Aravindhan R, 2012, CLEAN TECHNOL ENVIR, V14, P727, DOI 10.1007/s10098-011-0440-7; Arica MY, 2005, PROCESS BIOCHEM, V40, P2351, DOI 10.1016/j.procbio.2004.09.008; Bayramoglu G, 2008, CHEM ENG J, V139, P20, DOI 10.1016/j.cej.2007.07.068; Benavente M, 2011, J TAIWAN INST CHEM E, V42, P976, DOI 10.1016/j.jtice.2011.05.003; Cabatingan LK, 2001, IND ENG CHEM RES, V40, P2302, DOI 10.1021/ie0008575; Chojnacka K, 2005, CHEMOSPHERE, V59, P75, DOI 10.1016/j.chemosphere.2004.10.005; Cimino G, 2000, WATER RES, V34, P2955, DOI 10.1016/S0043-1354(00)00048-8; Company Hach, 2008, HACH WAT AN HDB; Deng SB, 2005, ENVIRON SCI TECHNOL, V39, P8490, DOI 10.1021/es050697u; Dogan M, 2009, J HAZARD MATER, V164, P172, DOI 10.1016/j.jhazmat.2008.07.155; Dupont L, 2003, ENVIRON SCI TECHNOL, V37, P4235, DOI 10.1021/es0342345; Eisler R, 1986, US FISH WILDLIFE SER, V85; Elangovan R, 2008, J HAZARD MATER, V152, P100, DOI 10.1016/j.jhazmat.2007.06.067; Fathy NA, 2015, J ENVIRON CHEM ENG, V3, P1137, DOI 10.1016/j.jece.2015.04.011; Febrianto J, 2009, J HAZARD MATER, V162, P616, DOI 10.1016/j.jhazmat.2008.06.042; Fiol N, 2003, ENVIRON CHEM LETT, V1, P135, DOI 10.1007/s10311-003-0027-6; Gaggelli E, 2002, ENVIRON HEALTH PERSP, V110, P733, DOI 10.1289/ehp.02110s5733; Gardea-Torresday JL, 2000, J HAZARD MATER, V80, P175, DOI 10.1016/S0304-3894(00)00301-0; Ghodbane I, 2008, J HAZARD MATER, V160, P301, DOI 10.1016/j.jhazmat.2008.02.116; GILES CH, 1974, J COLLOID INTERF SCI, V47, P755, DOI 10.1016/0021-9797(74)90252-5; Bermudez YG, 2012, CHEM ENG J, V183, P68, DOI 10.1016/j.cej.2011.12.022; Flores-Garnica JG, 2013, BIORESOURCE TECHNOL, V136, P635, DOI 10.1016/j.biortech.2013.02.059; Guerrero-Coronilla I, 2015, J ENVIRON MANAGE, V152, P99, DOI 10.1016/j.jenvman.2015.01.026; Gupta VK, 2009, J HAZARD MATER, V163, P396, DOI 10.1016/j.jhazmat.2008.06.104; Hanif MA, 2007, J HAZARD MATER, V139, P345, DOI 10.1016/j.jhazmat.2006.06.040; Hasan SH, 2008, J HAZARD MATER, V152, P356, DOI 10.1016/j.jhazmat.2007.07.006; Hernandez-Estevez A, 2014, ENVIRON MONIT ASSESS, V186, P7987, DOI 10.1007/s10661-014-3981-5; Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5; Ho YS, 2002, ADSORPT SCI TECHNOL, V20, P797, DOI 10.1260/026361702321104282; Puentes-Cardenas IJ, 2012, ENVIRON ENG MANAG J, V11, P1741; Kalyani G., 2009, ARPN J ENG APPL SCI, V4, P39; Khambhaty Y, 2009, CHEM ENG J, V145, P489, DOI 10.1016/j.cej.2008.05.002; Khezami L, 2005, J HAZARD MATER, V123, P223, DOI 10.1016/j.jhazmat.2005.04.012; Kim EJ, 2011, BIORESOURCE TECHNOL, V102, P11155, DOI 10.1016/j.biortech.2011.09.107; Kumar NS, 2012, COLLOID SURFACE B, V94, P125, DOI 10.1016/j.colsurfb.2012.01.048; Kumar R, 2008, CHEM ENG J, V135, P202, DOI 10.1016/j.cej.2007.03.004; Leon-Torres A, 2012, J COLLOID INTERF SCI, V386, P325, DOI 10.1016/j.jcis.2012.07.038; Liang FB, 2013, J ENVIRON CHEM ENG, V1, P1301, DOI 10.1016/j.jece.2013.09.025; Limousin G, 2007, APPL GEOCHEM, V22, P249, DOI 10.1016/j.apgeochem.2006.09.010; Lin CJ, 2002, WATER AIR SOIL POLL, V139, P137, DOI 10.1023/A:1015870907389; Deng LP, 2007, J HAZARD MATER, V143, P220, DOI 10.1016/j.jhazmat.2006.09.009; Liu CC, 2006, IND ENG CHEM RES, V45, P8891, DOI 10.1021/ie060978q; Liu SX, 2007, J HAZARD MATER, V141, P315, DOI 10.1016/j.jhazmat.2006.07.006; Ma W, 2015, BIORESOURCE TECHNOL, V186, P356, DOI 10.1016/j.biortech.2015.03.133; Malkoc E, 2007, CHEM ENG PROCESS, V46, P1020, DOI 10.1016/j.cep.2007.05.007; Masaki Y, 2015, EXTREMOPHILES, V19, P495, DOI 10.1007/s00792-015-0733-6; Matouq M, 2015, J ENVIRON CHEM ENG, V3, P775, DOI 10.1016/j.jece.2015.03.027; Mauguet MC, 2005, J MATER SCI, V40, P747, DOI 10.1007/s10853-005-6316-7; Miretzky P, 2006, CHEMOSPHERE, V62, P247, DOI 10.1016/j.chemosphere.2005.05.010; Mohan D, 2006, J HAZARD MATER, V137, P762, DOI 10.1016/j.jhazmat.2006.06.060; Morales-Barrera L, 2008, BIOCHEM ENG J, V40, P284, DOI 10.1016/j.bej.2007.12.014; Murphy V, 2008, CHEMOSPHERE, V70, P1128, DOI 10.1016/j.chemosphere.2007.08.015; Nakajima A, 2004, WATER RES, V38, P2859, DOI 10.1016/j.watres.2004.04.005; Niu HC, 2006, HYDROMETALLURGY, V84, P28, DOI 10.1016/j.hydromet.2006.03.057; Oliveira EA, 2005, PROCESS BIOCHEM, V40, P3485, DOI 10.1016/j.procbio.2005.02.026; Padmavathy V, 2008, BIORESOURCE TECHNOL, V99, P3100, DOI 10.1016/j.biortech.2007.05.070; Pagnanelli F, 2011, MICROBIAL BIOSORPTIO, P59; Pandey PK, 2010, INT J ENVIRON SCI TE, V7, P395, DOI 10.1007/BF03326149; Park D, 2007, CHEMOSPHERE, V70, P298, DOI 10.1016/j.chemosphere.2007.06.007; Plazinski W, 2009, ADV COLLOID INTERFAC, V152, P2, DOI 10.1016/j.cis.2009.07.009; Rakhunde R, 2012, CRIT REV ENV SCI TEC, V42, P776, DOI 10.1080/10643389.2010.534029; Netzahuatl-Munoz AR, 2012, FRESEN ENVIRON BULL, V21, P1793; Netzahuatl-Munoz AR, 2012, WATER AIR SOIL POLL, V223, P625, DOI 10.1007/s11270-011-0888-4; Netzahuatl-Munoz AR, 2010, FRESEN ENVIRON BULL, V19, P2911; Saha B, 2010, COORDIN CHEM REV, V254, P2959, DOI 10.1016/j.ccr.2010.06.005; Samuel MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116884; Samuel MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118999; Sari A, 2008, J HAZARD MATER, V160, P349, DOI 10.1016/j.jhazmat.2008.03.005; Stasinakis AS, 2003, CHEMOSPHERE, V52, P1059, DOI 10.1016/S0045-6535(03)00309-6; Suazo-Madrid A, 2011, J IND MICROBIOL BIOT, V38, P51, DOI 10.1007/s10295-010-0828-0; Uysal M, 2007, J HAZARD MATER, V149, P482, DOI 10.1016/j.jhazmat.2007.04.019; Vaghetti JCP, 2008, BIOCHEM ENG J, V42, P67, DOI 10.1016/j.bej.2008.05.021; Viamajala S, 2004, BIOTECHNOL PROGR, V20, P87, DOI 10.1021/bp034131q; Lopez-Nunez PV, 2014, ENVIRON ENG MANAG J, V13, P1927; Vijayaraghavan K, 2006, PROCESS BIOCHEM, V41, P853, DOI 10.1016/j.procbio.2005.10.028; Vinod VTP, 2010, J HAZARD MATER, V178, P851, DOI 10.1016/j.jhazmat.2010.02.016; VOLESKY B, 2003, SORPTION BIOSORPTION, P233; Weng CH, 2008, J HAZARD MATER, V155, P65, DOI 10.1016/j.jhazmat.2007.11.029; Xu LH, 2015, MINER PETROL, V109, P309, DOI 10.1007/s00710-014-0332-8; Yang L, 2008, BIORESOURCE TECHNOL, V99, P297, DOI 10.1016/j.biortech.2006.12.021; Zhao JQ, 2015, J MATER CHEM A, V3, P14703, DOI 10.1039/c5ta03089g; Zhitkovich A, 2005, CHEM RES TOXICOL, V18, P3, DOI 10.1021/tx049774+	85	47	48	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137086	10.1371/journal.pone.0137086	http://dx.doi.org/10.1371/journal.pone.0137086			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352933	gold, Green Submitted, Green Published			2022-12-26	WOS:000360932800060
J	Song, JH; Zhu, CX; Zhang, X; Wen, X; Liu, LL; Peng, JY; Guo, HW; Yi, CQ				Song, Jinghui; Zhu, Chenxu; Zhang, Xing; Wen, Xing; Liu, Lulu; Peng, Jinying; Guo, Hongwei; Yi, Chengqi			Biochemical and Structural Insights into the Mechanism of DNA Recognition by Arabidopsis ETHYLENE INSENSITIVE3	PLOS ONE			English	Article							RECEPTOR GENE FAMILY; SIGNALING PATHWAY; RESPONSE PATHWAY; EIN3; TRANSCRIPTION; BINDING; ETHYLENE-INSENSITIVE3; EXPRESSION; REGULATOR; JASMONATE	Gaseous hormone ethylene regulates numerous stress responses and developmental adaptations in plants by controlling gene expression via transcription factors ETHYLENE INSENSITIVE3 (EIN3) and EIN3-Like1 (EIL1). However, our knowledge regarding to the accurate definition of DNA-binding domains (DBDs) within EIN3 and also the mechanism of specific DNA recognition by EIN3 is limited. Here, we identify EIN3 82-352 and 174-306 as the optimal and core DBDs, respectively. Results from systematic biochemical analyses reveal that both the number of EIN3-binding sites (EBSs) and the spacing length between two EBSs affect the binding affinity of EIN3; accordingly, a new DNA probe which has higher affinity with EIN3 than ERF1 is also designed. Furthermore, we show that palindromic repeat sequences in ERF1 promoter are not necessary for EIN3 binding. Finally, we provide, to our knowledge, the first crystal structure of EIN3 core DBD, which contains amino acid residues essential for DNA binding and signaling. Collectively, these data suggest the detailed mechanism of DNA recognition by EIN3 and provide an in-depth view at molecular level for the transcriptional regulation mediated by EIN3.	[Song, Jinghui; Zhu, Chenxu; Zhang, Xing; Wen, Xing; Liu, Lulu; Peng, Jinying; Guo, Hongwei; Yi, Chengqi] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Song, Jinghui; Zhu, Chenxu; Zhang, Xing; Wen, Xing; Liu, Lulu; Peng, Jinying; Guo, Hongwei; Yi, Chengqi] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Yi, Chengqi] Peking Univ, Dept Biol Chem, Beijing 100871, Peoples R China; [Yi, Chengqi] Peking Univ, Synthet & Funct Biomol Ctr, Coll Chem & Mol Engn, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University	Guo, HW (corresponding author), Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	hongweig@pku.edu.cn; chengqi.yi@pku.edu.cn	Zhu, Chenxu/ABC-4679-2021; Wen, Xing/ABI-5408-2020	Zhu, Chenxu/0000-0003-4216-6562; Wen, Xing/0000-0002-9322-2272; Yi, Chengqi/0000-0003-2540-9729	National Basic Research Foundation of China [2014CB964900]; National Natural Science Foundation of China [31270838, 21472009]	National Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Foundation of China (http://www.most.gov.cn/; 2014CB964900 to C.Y.), and the National Natural Science Foundation of China (http://www.nsfc.gov.cn/; 31270838 to C.Y., 21472009 to C.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; An FY, 2010, PLANT CELL, V22, P2384, DOI 10.1105/tpc.110.076588; Bisson MMA, 2009, BIOCHEM J, V424, P1, DOI 10.1042/BJ20091102; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Boutrot F, 2010, P NATL ACAD SCI USA, V107, P14502, DOI 10.1073/pnas.1003347107; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chang KN, 2013, ELIFE, V2, DOI 10.7554/eLife.00675; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chen HM, 2009, PLANT CELL, V21, P2527, DOI 10.1105/tpc.108.065193; Chen YF, 2005, ANN BOT-LONDON, V95, P901, DOI 10.1093/aob/mci100; Desjardins G, 2014, P NATL ACAD SCI USA, V111, P11019, DOI 10.1073/pnas.1401891111; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gagne JM, 2004, P NATL ACAD SCI USA, V101, P6803, DOI 10.1073/pnas.0401698101; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hua J, 1998, PLANT CELL, V10, P1321, DOI 10.1105/tpc.10.8.1321; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; HUA J, 1995, SCIENCE, V269, P1712, DOI 10.1126/science.7569898; Ji YS, 2013, MOL PLANT, V6, P11, DOI 10.1093/mp/sss150; Johnson PR, 1998, ANNU REV GENET, V32, P227, DOI 10.1146/annurev.genet.32.1.227; Ju CL, 2012, P NATL ACAD SCI USA, V109, P19486, DOI 10.1073/pnas.1214848109; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Konishi M, 2008, PLANT J, V55, P821, DOI 10.1111/j.1365-313X.2008.03551.x; Kosugi S, 2000, NUCLEIC ACIDS RES, V28, P960, DOI 10.1093/nar/28.4.960; Li ZH, 2013, PLANT CELL, V25, P3311, DOI 10.1105/tpc.113.113340; Maruyama-Nakashita A, 2006, PLANT CELL, V18, P3235, DOI 10.1105/tpc.106.046458; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potuschak T, 2003, CELL, V115, P679, DOI 10.1016/S0092-8674(03)00968-1; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Sakai H, 1998, P NATL ACAD SCI USA, V95, P5812, DOI 10.1073/pnas.95.10.5812; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Song SS, 2014, PLANT CELL, V26, P263, DOI 10.1105/tpc.113.120394; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Stepanova AN, 2007, PLANT CELL, V19, P2169, DOI 10.1105/tpc.107.052068; Stepanova AN, 2009, CURR OPIN PLANT BIOL, V12, P548, DOI 10.1016/j.pbi.2009.07.009; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wuriyanghan H, 2009, PLANT CELL, V21, P1473, DOI 10.1105/tpc.108.065391; Yamasaki K, 2005, J MOL BIOL, V348, P253, DOI 10.1016/j.jmb.2005.02.065; Yin CC, 2015, PLANT CELL; Yoo SD, 2008, NATURE, V451, P789, DOI 10.1038/nature06543; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang LX, 2011, PLANT PHYSIOL, V157, P854, DOI 10.1104/pp.111.179028; Zhang X, 2014, PLANT CELL, V26, P1105, DOI 10.1105/tpc.113.122002; Zhao Q, 2011, MOL PLANT, V4, P626, DOI 10.1093/mp/ssr042; Zhong SW, 2010, PLANT SIGNAL BEHAV, V5, P739, DOI 10.4161/psb.5.6.11698; Zhong SW, 2009, P NATL ACAD SCI USA, V106, P21431, DOI 10.1073/pnas.0907670106; Zhu ZQ, 2011, P NATL ACAD SCI USA, V108, P12539, DOI 10.1073/pnas.1103959108	55	18	19	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137439	10.1371/journal.pone.0137439	http://dx.doi.org/10.1371/journal.pone.0137439			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352699	Green Published, gold, Green Submitted			2022-12-26	WOS:000360932800085
J	You, D; Kim, Y; Jang, MJ; Lee, C; Jeong, IG; Cho, YM; Hwang, JJ; Hong, JH; Ahn, H; Kim, CS				You, Dalsan; Kim, Yunlim; Jang, Myoung Jin; Lee, Chunwoo; Jeong, In Gab; Cho, Yong Mee; Hwang, Jung Jin; Hong, Jun Hyuk; Ahn, Hanjong; Kim, Choung-Soo			KML001 Induces Apoptosis and Autophagic Cell Death in Prostate Cancer Cells via Oxidative Stress Pathway	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ARSENIC TRIOXIDE AS2O3; DOWN-REGULATION; UP-REGULATION; STEM-CELLS; LINES; INDUCTION; TELOMERE; MITOXANTRONE; PREDNISONE	We investigated the effects of KML001 (NaAsO2, sodium metaarsenite, Kominox), an orally bioavailable arsenic compound, on the growth and death of human prostate cancer cells and its mechanism of action. Growth inhibition was assessed by cytotoxicity assays in the presence or absence of inhibitor of apoptosis, inhibitor of autophagy or antioxidant N-Acetyl-(L)-cysteine to study mechanism of cell death induced by KML001 in PC3, DU145 and LNCaP prostate cancer cell lines. Electron microscopy, flow cytometry and Western blotting were used to study apoptotic and autophagic mechanisms. The DU145 xenograft model was used to determine the efficacy of KML001 in vivo. KML001 decreased the viability of cells and increased the percentage of annexin V-positive cells dose-dependently in prostate cancer cells, and LNCaP cells were more sensitive to KML001 than PC3 or DU145 cells. Electron microscopy revealed typical apoptotic characters and autophagic vacuoles in cells treated with KML001. Exposure to KML001 in prostate cancer cells induced apoptosis and autophagy in a time-and dose-dependent manner. KML001 induced dose-dependent accumulation of reactive oxygen species, and scavenging the reactive oxygen species with N-Acetyl-(L)-cysteine reduced LC3 and cleaved poly (ADP-ribose) polymerase. KML001 significantly inhibited tumor growth in the DU145 xenograft model. In addition, significant decrease of proliferation and significant increases of apoptosis and autophagy were observed in KML001-treated tumors than in vehicle-treated tumors. Exposure of human prostate cancer cells to KML001 induced both apoptosis and autophagic cell death via oxidative stress pathway. And KML001 had an antiproliferative effect on DU145 cells in xenograft mice.	[You, Dalsan; Kim, Yunlim; Lee, Chunwoo; Jeong, In Gab; Hong, Jun Hyuk; Ahn, Hanjong; Kim, Choung-Soo] Univ Ulsan, Coll Med, Dept Urol, Asan Med Ctr, Seoul, South Korea; [Jang, Myoung Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Cho, Yong Mee] Univ Ulsan, Coll Med, Dept Pathol, Asan Med Ctr, Seoul, South Korea; [Hwang, Jung Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Inst Innovat Canc Res, Seoul, South Korea	University of Ulsan; University of Ulsan; Asan Medical Center; University of Ulsan; University of Ulsan; Asan Medical Center	Kim, CS (corresponding author), Univ Ulsan, Coll Med, Dept Urol, Asan Med Ctr, Seoul, South Korea.	cskim@amc.seoul.kr	Hwang, Jung Jin/F-3424-2014		Korea Health Technology RD Project; Ministry of Health Welfare [A062254, A102059]	Korea Health Technology RD Project; Ministry of Health Welfare	Funding: This study was supported by grants of the Korea Health Technology R&D Project and Ministry of Health & Welfare (A062254 and A102059).	Alemany M, 2000, LEUKEMIA LYMPHOMA, V38, P153, DOI 10.3109/10428190009060329; Aronson S M, 1994, R I Med, V77, P233; Dilda PJ, 2007, CANCER TREAT REV, V33, P542, DOI 10.1016/j.ctrv.2007.05.001; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Glienke W, 2006, LEUKEMIA LYMPHOMA, V47, P1629, DOI 10.1080/10428190600625398; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kanzawa T, 2003, CANCER RES, V63, P2103; Kim Y, 2013, AUTOPHAGY, V9, P2126, DOI 10.4161/auto.26308; Kim Y, 2014, ANTI-CANCER DRUG, V25, P53, DOI 10.1097/CAD.0000000000000013; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Miller WH, 2002, CANCER RES, V62, P3893; Murgo AJ, 2001, ONCOLOGIST, V6, P22, DOI 10.1634/theoncologist.6-suppl_2-22; Niu C, 1999, BLOOD, V94, P3315, DOI 10.1182/blood.V94.10.3315.422k16_3315_3324; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Phatak P, 2008, CLIN CANCER RES, V14, P4593, DOI 10.1158/1078-0432.CCR-07-4572; Poonepalli A, 2005, CANCER RES, V65, P10977, DOI 10.1158/0008-5472.CAN-05-2336; Qian WB, 2007, LEUKEMIA RES, V31, P329, DOI 10.1016/j.leukres.2006.06.021; Rosenblatt AE, 2009, MOL ENDOCRINOL, V23, P412, DOI 10.1210/me.2008-0235; Sauer H, 2005, ANTIOXID REDOX SIGN, V7, P1423, DOI 10.1089/ars.2005.7.1423; Shen SS, 2012, AUTOPHAGY, V8, P1, DOI 10.4161/auto.8.1.16618; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; So A, 2005, WORLD J UROL, V23, P1, DOI 10.1007/s00345-004-0473-1; Soignet SL, 2001, J CLIN ONCOL, V19, P3852, DOI 10.1200/JCO.2001.19.18.3852; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Wei YM, 2001, ACTA PHARMACOL SIN, V22, P725; You D, 2013, UROLOGY, V81, P104, DOI 10.1016/j.urology.2012.08.046; Zhang B, 2012, MOL PHARMACOL, V82, P310, DOI 10.1124/mol.111.076752; Zhang Y, 2005, EUR J PHARMACOL, V516, P1, DOI 10.1016/j.ejphar.2005.04.022	31	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137589	10.1371/journal.pone.0137589	http://dx.doi.org/10.1371/journal.pone.0137589			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352139	Green Submitted, Green Published, gold			2022-12-26	WOS:000360932800099
J	Liu, LK; Lee, WJ; Chen, LY; Hwang, AC; Lin, MH; Peng, LN; Chen, LK				Liu, Li-Kuo; Lee, Wei-Ju; Chen, Liang-Yu; Hwang, An-Chun; Lin, Ming-Hsien; Peng, Li-Ning; Chen, Liang-Kung			Association between Frailty, Osteoporosis, Falls and Hip Fractures among Community-Dwelling People Aged 50 Years and Older in Taiwan: Results from I-Lan Longitudinal Aging Study	PLOS ONE			English	Article							DENSITY-MEASUREMENT; PREVALENCE; MORTALITY; ADULTS; MEN; POPULATION; DISABILITY; OBESITY; DEFINITION; SARCOPENIA	Background Association of frailty with adverse clinical outcomes has been reported in Western countries, but data from the Asian population are scarce. This study aimed to evaluate the epidemiology of frailty among community-dwelling middle-aged and elderly population and to explore its association with musculoskeletal health in Taiwan. Methods I-Lan Longitudinal Aging Study (ILAS) data were retrieved for this study. Frailty was defined by the Fried's criteria; a comparison of demographic characteristics, physical performance, and body composition, including skeletal muscle mass and bone mineral density (BMD), as well as recent falls, history of hip fractures and the functional status of subjects with different frailty statuses were accomplished. Results Overall, the data of 1,839 participants (mean age: 63.9 +/- 9.3 years, male 47.5%) were obtained for analysis. The prevalence of pre-frailty was 42.3% in men and 38.8% in women, whereas the prevalence of frailty was 6.9% and 6.7% in men and women, respectively. Frailty was significantly associated with older age, the male gender, larger waist circumference, lower skeletal muscle index, lower hip BMD, poorer physical function, poorer nutritional status, and poorer cognitive function. Also, frailty was significantly associated with osteoporosis (OR: 7.73, 95% CI: 5.01-11.90, p<0.001), history of hip fractures (OR: 8.66, 95% CI: 2.47-30.40, p = 0.001), and recent falls (O.R: 2.53, 95% CI: 1.35-4.76, p = 0.004). Conclusions Frailty and pre-frailty, in Taiwan, was closely associated with recent falls, history of hip fractures and osteoporosis among community-dwelling people 50 years of age and older. Furthermore, frailty intervention programs should take an integrated approach towards strengthening both and muscle mass, as well as prevention of falls.	[Liu, Li-Kuo; Lee, Wei-Ju; Chen, Liang-Yu; Hwang, An-Chun; Lin, Ming-Hsien; Peng, Li-Ning; Chen, Liang-Kung] Natl Yang Ming Univ, Aging & Hlth Res Ctr, Taipei 112, Taiwan; [Lee, Wei-Ju; Chen, Liang-Yu; Hwang, An-Chun; Peng, Li-Ning] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Liu, Li-Kuo; Chen, Liang-Yu; Hwang, An-Chun; Lin, Ming-Hsien; Peng, Li-Ning; Chen, Liang-Kung] Taipei Vet Gen Hosp, Ctr Geriatr & Gerontol, Taipei, I Lan County, Taiwan; [Lee, Wei-Ju] Taipei Vet Gen Hosp, Yuanshan Branch, Dept Family Med, Taipei, I Lan County, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Chen, LK (corresponding author), Natl Yang Ming Univ, Aging & Hlth Res Ctr, Taipei 112, Taiwan.	lkchen2@vghtpe.gov.tw	Lee, Wei-Ju/AAK-1549-2021	Lee, Wei-Ju/0000-0003-4326-333X; Chen, Liang-Kung/0000-0002-2387-8508	Ministry of Science and Technology of Taiwan [MOST 103-2633-B-400-002]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology of Taiwan (MOST 103-2633-B-400-002).	Abbatecola AM, 2004, J AM GERIATR SOC, V52, P399, DOI 10.1111/j.1532-5415.2004.52112.x; Ahmed N, 2007, AM J MED, V120, P748, DOI 10.1016/j.amjmed.2006.10.018; Blain H, 2014, JOINT BONE SPINE, V81, P403, DOI 10.1016/j.jbspin.2014.01.020; Cawthon PM, 2007, J AM GERIATR SOC, V55, P1216, DOI 10.1111/j.1532-5415.2007.01259.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen CY, 2010, ARCH GERONTOL GERIAT, V50, pS43, DOI 10.1016/S0167-4943(10)70012-1; Chen LK, 2012, J CLIN GERONTOL GERI, V3, P3, DOI 10.1016/j.jcgg.2011.12.003; Chen LK, 2013, J CLIN GERONTOL GERI, V4, P97, DOI 10.1016/j.jcgg.2013.05.001; Cheung EYN, 2012, OSTEOPOROSIS INT, V23, P871, DOI 10.1007/s00198-011-1647-5; Cooper C, 2012, OSTEOPOROSIS INT, V23, P1839, DOI 10.1007/s00198-012-1913-1; Crepaldi G, 2005, J Endocrinol Invest, V28, P66; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Delgado C, 2013, J RENAL NUTR, V23, P356, DOI 10.1053/j.jrn.2013.02.010; Fang X, 2012, J NUTR HEALTH AGING, V16, P903, DOI 10.1007/s12603-012-0368-6; Folstein MF, 1075, J PSYCHIATR RES, V12, P189; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Frisoli A, 2011, BONE, V48, P952, DOI 10.1016/j.bone.2010.12.025; Gobbens RJ, 2010, NURS OUTLOOK, V58, P76, DOI 10.1016/j.outlook.2009.09.005; Goulet EDB, 2009, EXP GERONTOL, V44, P740, DOI 10.1016/j.exger.2009.08.008; Guigoz Y, 2006, J NUTR HEALTH AGING, V10, P466; Han D, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-95, 10.1186/1471-2164-15-477]; HEBERT R, 1988, AGE AGEING, V17, P293, DOI 10.1093/ageing/17.5.293; Hirani V, 2013, J GERONTOL A-BIOL, V68, P1112, DOI 10.1093/gerona/glt059; Hubbard RE, 2010, J GERONTOL A-BIOL, V65, P377, DOI 10.1093/gerona/glp186; Jurschik P, 2012, ARCH GERONTOL GERIAT, V55, P625, DOI 10.1016/j.archger.2012.07.002; Jung HW, 2014, J AM GERIATR SOC, V62, P2110, DOI 10.1111/jgs.13107; Jung HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087958; Lin CC, 2013, J AM GERIATR SOC, V61, P292, DOI 10.1111/jgs.12103; Liou Yiing Mei, 2008, J Nurs Res, V16, P252; Liu LK, 2014, GERIATR GERONTOL INT, V14, P36, DOI 10.1111/ggi.12208; Liu LK, 2013, GERIATR GERONTOL INT, V13, P964, DOI 10.1111/ggi.12040; Makary MA, 2010, J AM COLL SURGEONS, V210, P901, DOI 10.1016/j.jamcollsurg.2010.01.028; Moreira VG, 2013, CLINICS, V68, P979, DOI 10.6061/clinics/2013(07)15; Morley JE, 2004, J GERONTOL A-BIOL, V59, P924; Morley JE, 2006, MED CLIN N AM, V90, P837, DOI 10.1016/j.mcna.2006.05.019; Newton JL, 2003, AGE AGEING, V32, P497, DOI 10.1093/ageing/afg062; Qu Ning-ning, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P265; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rolland Y, 2008, J NUTR HEALTH AGING, V12, P335; Shah K, 2012, J AM GERIATR SOC, V60, P545, DOI 10.1111/j.1532-5415.2011.03819.x; Shamliyan T, 2013, AGEING RES REV, V12, P719, DOI 10.1016/j.arr.2012.03.001; Shimada H, 2013, J AM MED DIR ASSOC, V14, P518, DOI 10.1016/j.jamda.2013.03.010; Sternberg SA, 2014, OSTEOPOROSIS INT, V25, P763, DOI 10.1007/s00198-013-2471-x; Strandberg TE, 2013, AM J EPIDEMIOL, V178, P1452, DOI 10.1093/aje/kwt157; Tom SE, 2013, J AM GERIATR SOC, V61, P327, DOI 10.1111/jgs.12146; van Iersel MB, 2006, J AM GERIATR SOC, V54, P728, DOI 10.1111/j.1532-5415.2006.00668_14.x; Womack JA, 2013, CLIN INFECT DIS, V56, P1498, DOI 10.1093/cid/cit056; Wong YYE, 2013, J CLIN ENDOCR METAB, V98, P3821, DOI 10.1210/jc.2013-1702; Yamada M, 2011, J CLIN GERONTOL GERI, V2, P42, DOI 10.1016/j.jcgg.2011.02.004	51	63	69	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136968	10.1371/journal.pone.0136968	http://dx.doi.org/10.1371/journal.pone.0136968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ8YQ	26348034	Green Published, Green Submitted, gold			2022-12-26	WOS:000360897600017
J	Willeke, P; Schluter, B; Sauerland, C; Becker, H; Reuter, S; Jacobi, A; Schotte, H				Willeke, P.; Schlueter, B.; Sauerland, C.; Becker, H.; Reuter, S.; Jacobi, A.; Schotte, H.			Farm Exposure as a Differential Risk Factor in ANCA-Associated Vasculitis	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; NEUTROPHIL EXTRACELLULAR TRAPS; RHEUMATOLOGY 1990 CRITERIA; WEGENERS-GRANULOMATOSIS; ENVIRONMENTAL EXPOSURES; AUTOIMMUNE-DISEASES; NASAL COLONIZATION; CLASSIFICATION; EPIDEMIOLOGY; MRSA	Objective To investigate the association of farm exposure and the development of ANCA-associated vasculitis (AAV). Methods One hundred eighty-nine well defined patients with AAV (n = 119 with granulomatosis with polyangiitis [GPA], n = 48 with microscopic polyangiitis [MPA], n = 22 patients with eosinophilic granulomatosis with polyangiitis [EGPA]) and 190 controls (n = 119 patients with rheumatoid arthritis, n = 71 with large vessel vasculitis) were interrogated using a structured questionnaire. Factors investigated were occupation, farm exposure, contact to different livestock, participation in harvesting, residence next to a farm, MRSA status, and contact to domestic pets at disease onset or ever before. The odds ratio (OR) and 95% confidence interval [95% CI] were calculated for each item. Results Univariate analysis revealed a strong association of AAV with regular farm exposure; OR 3.44 [95% CI 1.43-8.27]. AAV was also associated with regular contact to cattle 4.30 (1.43-8.27), pigs 2.75 (1.12-6.75) and MRSA carriage 3.38 (1.11-10.3). This association was stronger in the subgroup of GPA patients. OR in this group for farm exposure was 4.97; [2.02-12.2], for cattle 6.71 [95% CI 2.19-20.7], for pigs 4.34 [1.75-10.9], and MRSA carriage 5.06 [1.62-15.8]). There was no significant association of MPA or EGPA with these parameters. Conclusion A significant association between farm exposure or farm animal exposure and AAV especially in the subgroup of patients with GPA has been identified. This suggests that these entities are distinct and have different triggers for the immune process.	[Willeke, P.; Becker, H.; Reuter, S.; Schotte, H.] Univ Hosp Munster, Sect Rheumatol & Clin Immunol, Dept Med D, Munster, Germany; [Schlueter, B.] Univ Hosp Munster, Ctr Lab Med, Munster, Germany; [Sauerland, C.] Univ Munster, Inst Biostat & Clin Res, D-48149 Munster, Germany; [Jacobi, A.] Brandenburg Med Sch, Div Rheumatol & Clin Immunol, Neuruppin, Germany	University of Munster; University of Munster; University of Munster	Willeke, P (corresponding author), Univ Hosp Munster, Sect Rheumatol & Clin Immunol, Dept Med D, Munster, Germany.	willeke.peter@uni-muenster.de	Sauerland, Maria Cristina/A-4154-2014					ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Beaudreuil S, 2005, KIDNEY INT, V67, P1961, DOI 10.1111/j.1523-1755.2005.00295.x; Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Carruthers DM, 1996, BRIT J RHEUMATOL, V35, P142; Chen M, 2010, AUTOIMMUN REV, V9, pA293, DOI 10.1016/j.autrev.2009.10.008; Cooper GS, 2002, INT IMMUNOPHARMACOL, V2, P303, DOI 10.1016/S1567-5769(01)00181-3; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; Dimola S, 1999, ANTICANCER RES, V19, P3889; Duna GE, 1998, CLIN EXP RHEUMATOL, V16, P669; Hogan SL, 2007, CLIN J AM SOC NEPHRO, V2, P290, DOI 10.2215/CJN.03501006; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Kallenberg CGM, 2013, AM J KIDNEY DIS, V62, P1176, DOI 10.1053/j.ajkd.2013.05.009; Knight A, 2010, ANN RHEUM DIS, V69, P737, DOI 10.1136/ard.2009.107953; Kock R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055040; Kock R, 2012, APPL ENVIRON MICROB, V78, P4046, DOI 10.1128/AEM.00212-12; Kock R, 2011, DTSCH ARZTEBL INT, V108, P761, DOI 10.3238/arztebl.2011.0761; Konstantinov KN, 2015, AUTOIMMUN REV, V14, P201, DOI 10.1016/j.autrev.2014.10.020; Lane SE, 2003, ARTHRITIS RHEUM-US, V48, P814, DOI 10.1002/art.10830; Laudien M, 2010, CLIN EXP RHEUMATOL, V28, pS51; LEAVITT RY, 1990, ARTHRITIS RHEUM, V33, P1101, DOI 10.1002/art.1780330807; Lee JHM, 2007, ANN RHEUM DIS, V66, P278, DOI 10.1136/ard.2006.056226; Lidar M, 2009, ANN NY ACAD SCI, V1173, P649, DOI 10.1111/j.1749-6632.2009.04641.x; Logters T, 2009, MED MICROBIOL IMMUN, V198, P211, DOI 10.1007/s00430-009-0121-x; Lutalo PMK, 2014, J AUTOIMMUN, V48-49, P94, DOI 10.1016/j.jaut.2014.01.028; Lyons PA, 2012, NEW ENGL J MED, V367, P214, DOI 10.1056/NEJMoa1108735; Mahr AD, 2006, CLIN EXP RHEUMATOL, V24, pS82; MASI AT, 1990, ARTHRITIS RHEUM, V33, P1094, DOI 10.1002/art.1780330806; Miller FW, 2012, J AUTOIMMUN, V39, P259, DOI 10.1016/j.jaut.2012.05.002; Millet A, 2013, ANN RHEUM DIS, V72, P1273, DOI 10.1136/annrheumdis-2013-203255; Mukhtyar C, 2009, ANN RHEUM DIS, V68, P1827, DOI 10.1136/ard.2008.101279; Mutneja R, 2013, CHEST J, V144, p354A; Ntatsaki E, 2010, RHEUM DIS CLIN N AM, V36, P447, DOI 10.1016/j.rdc.2010.04.002; Ohlsson SM, 2014, CLIN EXP IMMUNOL, DOI [10.1111/cei.12555, DOI 10.1111/CEI.12555]; Oporto B, 2007, J APPL MICROBIOL, V103, P977, DOI 10.1111/j.1365-2672.2007.03328.x; Pilsczek FH, 2010, J IMMUNOL, V185, P7413, DOI 10.4049/jimmunol.1000675; Rondina MT, 2013, CIRC RES, V112, P1506, DOI 10.1161/CIRCRESAHA.113.300512; Salvarani C, 2008, LANCET, V372, P234, DOI 10.1016/S0140-6736(08)61077-6; Watts R, 2007, ANN RHEUM DIS, V66, P222, DOI 10.1136/ard.2006.054593	38	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137196	10.1371/journal.pone.0137196	http://dx.doi.org/10.1371/journal.pone.0137196			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339905	Green Published, Green Submitted, gold			2022-12-26	WOS:000360688200032
J	Yang, G; Cheng, QL; Liu, S; Zhao, JH				Yang, Guang; Cheng, Qingli; Liu, Sheng; Zhao, Jiahui			The Role of Bone Marrow Cells in the Phenotypic Changes Associated with Diabetic Nephropathy	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; STROMAL CELLS	The aim of our study was to investigate the role of bone marrow cells in the phenotypic changes that occur in diabetic nephropathy. Bone marrow cells were obtained from either streptozotocin-induced diabetic or untreated control C3H/He mice and transplanted into control C3H/He mice. Eight weeks after bone marrow cell transplantation, renal morphologic changes and clinical parameters of diabetic nephropathy, including the urine albumin/creatinine ratio and glucose tolerance, were measured in vivo. Expression levels of the genes encoding alpha 1 type IV collagen and transforming growth factor-beta 1 in the kidney were assayed. Our results demonstrated that glucose tolerance was normal in the recipients of bone marrow transplants from both diabetic and control donors. However, compared with recipients of the control bone marrow transplant, the urinary albumin/creatinine ratio, glomerular size, and the mesangial/glomerular area ratio increased 3.3-fold (p < 0.01), 1.23-fold (p < 0.01), and 2.13-fold (p < 0.001), respectively, in the recipients of the diabetic bone marrow transplant. Expression levels of the genes encoding glomerular a1 type IV collagen and transforming growth factor-beta 1 were also significantly increased (p < 0.01) in the recipients of the diabetic bone marrow transplant. Our data suggest that bone marrow cells from the STZ-induced diabetic mice can confer a diabetic phenotype to recipient control mice without the presence of hyperglycemia.	[Yang, Guang; Cheng, Qingli; Liu, Sheng; Zhao, Jiahui] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Nephrol, State Key Lab Kidney Dis, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Cheng, QL (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Nephrol, State Key Lab Kidney Dis, Beijing, Peoples R China.	qlcheng64@163.com		Yang, Guang/0000-0001-5075-401X	National Natural Science Foundation of China [81170312, 30772296]; National Natural Science Foundation of Beijing [7122163]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This work was supported by the National Natural Science Foundation of China (81170312, 30772296) (http://www.nsfc.gov.cn), and the National Natural Science Foundation of Beijing (7122163) (http://www.bjkw.gov.cn/n8785584/index.html) granted to QC. The funders had participated in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abdi R, 2008, DIABETES, V57, P1759, DOI 10.2337/db08-0180; Ben Nasr M, 2015, ACTA DIABETOL; Bernardi S, 2012, EXP DIABETES RES, DOI 10.1155/2012/872504; Cornacchia F, 2001, J CLIN INVEST, V108, P1649; Cramer C, 2010, STEM CELLS DEV, V19, P1875, DOI 10.1089/scd.2010.0009; Doria A, 2012, SEMIN NEPHROL, V32, P437, DOI 10.1016/j.semnephrol.2012.07.006; Ezquer F, 2009, BIOL BLOOD MARROW TR, V15, P1354, DOI 10.1016/j.bbmt.2009.07.022; Ezquer FE, 2008, BIOL BLOOD MARROW TR, V14, P631, DOI 10.1016/j.bbmt.2008.01.006; Fiorina P, 2014, J AM SOC NEPHROL, V25, P1415, DOI 10.1681/ASN.2013050518; Guang Y, 2015, ZHONGHUA LINCHUANG Y, V15, P246; Hasan M J, 2015, Mymensingh Med J, V24, P18; KAKU K, 1988, DIABETES, V37, P707, DOI 10.2337/diabetes.37.6.707; Kume S, 2005, J BONE MINER RES, V20, P1647, DOI 10.1359/JBMR.050514; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Loeffler I, 2012, AM J PHYSIOL-RENAL, V303, pF733, DOI 10.1152/ajprenal.00212.2012; MACKAY K, 1988, KIDNEY INT, V33, P677, DOI 10.1038/ki.1988.53; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Schena FP, 2005, J AM SOC NEPHROL, V16, pS30, DOI 10.1681/ASN.2004110970; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stolzing A, 2012, STEM CELLS DEV, V21, P2718, DOI 10.1089/scd.2011.0406; Stolzing A, 2010, CELLS TISSUES ORGANS, V191, P453, DOI 10.1159/000281826; Thum T, 2007, DIABETES, V56, P666, DOI 10.2337/db06-0699; Volarevic V, 2011, STEM CELLS, V29, P5, DOI 10.1002/stem.556; Volarevic V, 2010, AUTOIMMUNITY, V43, P255, DOI 10.3109/08916930903305641; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zheng F, 2004, DIABETES, V53, P2420, DOI 10.2337/diabetes.53.9.2420	26	3	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137245	10.1371/journal.pone.0137245	http://dx.doi.org/10.1371/journal.pone.0137245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340671	Green Submitted, Green Published, gold			2022-12-26	WOS:000360688200039
J	Malone, CD; Olson, ES; Mattrey, RF; Jiang, T; Tsien, RY; Nguyen, QT				Malone, Christopher D.; Olson, Emilia S.; Mattrey, Robert F.; Jiang, Tao; Tsien, Roger Y.; Nguyen, Quyen T.			Tumor Detection at 3 Tesla with an Activatable Cell Penetrating Peptide Dendrimer (ACPPD-Gd), alpha T1 Magnetic Resonance (MR) Molecular Imaging Agent	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-2 ACTIVITY; ACTIVITY IN-VIVO; BREAST-CANCER; NONINVASIVE DETECTION; CONTRAST AGENT; MOUSE MODEL; FLUORESCENCE; PROGRESSION; METASTASIS; SWITCH	Purpose The ability to detect small malignant lesions with magnetic resonance imaging (MRI) is limited by inadequate accumulations of Gd with standard chelate agents. To date, no T1-targeted agents have proven superiority to Gd chelates in their ability to detect small tumors at clinically relevant field strengths. Activatable cell-penetrating peptides and their Gd-loaded dendrimeric form (ACPPD-Gd) have been shown to selectively accumulate in tumors. In this study we compared the performance of ACPPD-Gd vs. untargeted Gd chelates to detect small tumors in rodent models using a clinical 3T-MR system. Materials and Methods This study was approved by the Institutional-Animal Care-and-Use Committee. 2 of 4 inguinal breast fat pads of 16 albino-C57BL/6mice were inoculated with tumor Py8119 cells and the other 2 with saline at random. MRI at 3T was performed at 4, 9, and 14 days after inoculation on 8 mice 24-hours after injection of 0.036mmol Gd/kg (ACPPD-Gd), and before and 2- 3 minutes after 0.1 mmol/kg gadobutrol on the other 8 mice. T1-weighted (T1w) tumor signal normalized to muscle, was compared among the non-contrast, gadobutrol, and ACPPD-Gd groups using ANOVA. Experienced and trainee readers blinded to experimental conditions assessed for the presence of tumor in each of the 4 breast regions. Receiver operator characteristic (ROC) curves and area-under-curve (AUC) values were constructed and analyzed. Results Tumors >= 1mm(3) were iso-intense to muscle without contrast on T1w sequences. They enhanced diffusely and homogeneously by 57 +/- 20% (p<0.001) 24 hours after ACPPD-Gd and by 25 +/- 13% (p<0.001) immediately after gadobutrol. The nearly 2-fold difference was similar for small tumors (1-5mm(3)) (45 +/- 19% vs. 19 +/- 18%, p = 0.03). ACPPD-Gd tended to improve tumor detection by an experienced reader (AUC 0.98 vs 0.91) and significantly more for a trainee (0.93 vs. 0.82, p = 0.02) compared to gadobutrol. This improvement was more pronounced when obvious tumors (>5mm(3)) were removed from the ROC analysis for both the experienced observer (0.96 vs. 0.86) and more so for the trainee (0.86 vs. 0.69, p = 0.04). Conclusion ACPPD-Gd enhances MMP-expressing tumors of any size at 3T 24 hours after administration, improving their detection by blinded observers when compared to non-contrast and contrast groups given commercial Gd-chelates and imaged during the equilibrium phase.	[Malone, Christopher D.; Olson, Emilia S.; Mattrey, Robert F.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Jiang, Tao; Tsien, Roger Y.] Univ Calif San Diego, Howard Hughes Med Inst, San Diego, CA 92103 USA; [Tsien, Roger Y.] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92103 USA; [Tsien, Roger Y.] Univ Calif San Diego, Dept Chem & Biochem, San Diego, CA 92103 USA; [Nguyen, Quyen T.] Univ Calif San Diego, Dept Otolaryngol Head & Neck Surg, San Diego, CA 92103 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Malone, CD (corresponding author), Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA.	cmalone@ucsd.edu			National Institutes of Health (NIH)/National Cancer Institute [5R01CA158448]; NIH in vivo cellular and molecular imaging centers (ICMIC) [P50-CA128346]; NIH [5T32EB005970-07]; Radiological Society of North America (RSNA) [RR1361]; Howard Hughes Medical Institute; Burroughs Wellcome Fund - CAMS; NATIONAL CANCER INSTITUTE [P50CA128346, R01CA158448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB005970] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH in vivo cellular and molecular imaging centers (ICMIC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Radiological Society of North America (RSNA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Fund - CAMS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported in part by National Institutes of Health (NIH)/National Cancer Institute grant 5R01CA158448, www.cancer.gov, (RYT); NIH in vivo cellular and molecular imaging centers (ICMIC) P50-CA128346, http://imaging.cancer.gov/programsandresources/specializedinitiatives/icmicp50 (RFM, RYT); NIH 5T32EB005970-07 (ESO, RFM, CDM); Radiological Society of North America (RSNA) RR1361, http://www.rsna.org/research_resident_grant.aspx (CDM); Howard Hughes Medical Institute, http://www.hhmi.org (TJ, RYT); Burroughs Wellcome Fund - CAMS, http://www.bwfund.org/grant-programs/biomedicalsciences/career-awards-medical-scientists, (QTN).	Aguilera TA, 2009, INTEGR BIOL, V1, P371, DOI 10.1039/b904878b; Artacho-Cordon F, 2012, SURG ONCOL, V21, pE143, DOI 10.1016/j.suronc.2012.06.001; Biswas T, 2014, CANCER LETT, V346, P129, DOI 10.1016/j.canlet.2013.12.018; Bremer C, 2001, RADIOLOGY, V221, P523, DOI 10.1148/radiol.2212010368; Burden-Gulley SM, 2013, TRANSL ONCOL, V6, P329, DOI 10.1593/tlo.12490; Chatterji M, 2010, MAGN RESON IMAGING C, V18, P207, DOI 10.1016/j.mric.2010.02.011; Chen S, STROKE UNPUB; Coumans FAW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-283; Crisp JL, 2014, MOL CANCER THER, V13, P1514, DOI 10.1158/1535-7163.MCT-13-1067; Eng J, 2015, ROC ANAL WEB BASED C; Fang JM, 2000, P NATL ACAD SCI USA, V97, P3884, DOI 10.1073/pnas.97.8.3884; Hanaoka K, 2008, MAGN RESON IMAGING, V26, P608, DOI 10.1016/j.mri.2007.11.002; Hua H, 2011, CELL MOL LIFE SCI, V68, P3853, DOI 10.1007/s00018-011-0763-x; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; Kircher MF, 2012, RADIOLOGY, V263, P633, DOI 10.1148/radiol.12102394; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lebel R, 2008, MAGN RESON MED, V60, P1056, DOI 10.1002/mrm.21741; Lepage M, 2007, MOL IMAGING, V6, P393, DOI 10.2310/7290.2007.00035; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Mehner C, 2014, ONCOTARGET, V5, P2736, DOI 10.18632/oncotarget.1932; Nguyen QT, 2010, P NATL ACAD SCI USA, V107, P4317, DOI 10.1073/pnas.0910261107; Obuchowski NA, 2005, AM J ROENTGENOL, V184, P364, DOI 10.2214/ajr.184.2.01840364; Olson ES, 2010, P NATL ACAD SCI USA, V107, P4311, DOI 10.1073/pnas.0910283107; Olson ES, 2009, INTEGR BIOL-UK, V1, P382, DOI 10.1039/b904890a; Pais A, 2011, CANCER RES, V71, P7387, DOI 10.1158/0008-5472.CAN-11-1226; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Savariar EN, 2013, CANCER RES, V73, P855, DOI 10.1158/0008-5472.CAN-12-2969; Shazeeb MS, 2011, CANCER RES, V71, P2230, DOI 10.1158/0008-5472.CAN-10-1139; Tester AM, 2001, CLIN EXP METASTAS, V18, P553, DOI 10.1023/A:1011953118186; Turnbull LW, 2009, NMR BIOMED, V22, P28, DOI 10.1002/nbm.1273; Turpeenniemi-Hujanen T, 2005, BIOCHIMIE, V87, P287, DOI 10.1016/j.biochi.2005.01.014	31	12	12	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137104	10.1371/journal.pone.0137104	http://dx.doi.org/10.1371/journal.pone.0137104			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26336058	Green Published, gold			2022-12-26	WOS:000360615400040
J	Nishiyama, K; Nakashima, H; Ikarashi, M; Kinoshita, M; Nakashima, M; Aosasa, S; Seki, S; Yamamoto, J				Nishiyama, Kiyoshi; Nakashima, Hiroyuki; Ikarashi, Masami; Kinoshita, Manabu; Nakashima, Masahiro; Aosasa, Suefumi; Seki, Shuhji; Yamamoto, Junji			Mouse CD11b(+)Kupffer Cells Recruited from Bone Marrow Accelerate Liver Regeneration after Partial Hepatectomy	PLOS ONE			English	Article							NECROSIS-FACTOR RECEPTOR; KILLER T-CELLS; KUPFFER CELLS; ALPHA-GALACTOSYLCERAMIDE; MONOCYTE CHEMOATTRACTANT; HEPATOCYTE PROLIFERATION; GADOLINIUM CHLORIDE; HEPATIC-FIBROSIS; INNATE IMMUNITY; EARLY PHASE	TNF and Fas/FasL are vital components, not only in hepatocyte injury, but are also required for hepatocyte regeneration. Liver F4/80(+)Kupffer cells are classified into two subsets; resident radio-resistant CD68(+)cells with phagocytic and bactericidal activity, and recruited radio-sensitive CD11b(+)cells with cytokine-producing capacity. The aim of this study was to investigate the role of these Kupffer cells in the liver regeneration after partial hepatectomy (PHx) in mice. The proportion of Kupffer cell subsets in the remnant liver was examined in C57BL/6 mice by flow cytometry after PHx. To examine the role of CD11b(+)Kupffer cells/Mf, mice were depleted of these cells before PHx by non-lethal 5 Gy irradiation with or without bone marrow transplantation (BMT) or the injection of a CCR2 (MCP-1 receptor) antagonist, and liver regeneration was evaluated. Although the proportion of CD68(+)Kupffer cells did not significantly change after PHx, the proportion of CD11b(+)Kupffer cells/Mf and their FasL expression was greatly increased at three days after PHx, when the hepatocytes vigorously proliferate. Serum TNF and MCP-1 levels peaked one day after PHx. Irradiation eliminated the CD11b(+)Kupffer cells/Mf for approximately two weeks in the liver, while CD68(+)Kupffer cells, NK cells and NKT cells remained, and hepatocyte regeneration was retarded. However, BMT partially restored CD11b(+)Kupffer cells/Mf and recovered the liver regeneration. Furthermore, CCR2 antagonist treatment decreased the CD11b(+)Kupffer cells/Mf and significantly inhibited liver regeneration. The CD11b(+)Kupffer cells/Mf recruited from bone marrow by the MCP-1 produced by CD68(+)Kupffer cells play a pivotal role in liver regeneration via the TNF/FasL/Fas pathway after PHx.	[Nishiyama, Kiyoshi; Aosasa, Suefumi; Yamamoto, Junji] Natl Def Med Coll, Dept Surg, Tokorozawa, Saitama 3598513, Japan; [Nakashima, Hiroyuki; Ikarashi, Masami; Kinoshita, Manabu; Nakashima, Masahiro; Seki, Shuhji] Natl Def Med Coll, Dept Immunol & Microbiol, Tokorozawa, Saitama 3598513, Japan	National Defense Medical College - Japan; National Defense Medical College - Japan	Seki, S (corresponding author), Natl Def Med Coll, Dept Immunol & Microbiol, Namiki 3-2, Tokorozawa, Saitama 3598513, Japan.	btraums@ndmc.ac.jp			National Defense Medical College; JSPS KAKENHI Grant [25460508]; Takeda Science Foundation	National Defense Medical College; JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by grant-in-aid for Special Research Program from the National Defense Medical College, JSPS KAKENHI Grant Number 25460508, and Takeda Science Foundation to NH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERMAN P, 1992, AM J PHYSIOL, V263, pG579, DOI 10.1152/ajpgi.1992.263.4.G579; Biswas SK, 2002, J INTERF CYTOK RES, V22, P527, DOI 10.1089/10799900252982007; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Boulton RA, 1998, J HEPATOL, V29, P271, DOI 10.1016/S0168-8278(98)80013-5; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Cherney RJ, 2008, J MED CHEM, V51, P721, DOI 10.1021/jm701488f; Desbarats J, 2000, NAT MED, V6, P920, DOI 10.1038/78688; DIEHL AM, 1994, AM J PHYSIOL-GASTR L, V267, pG552, DOI 10.1152/ajpgi.1994.267.4.G552; Diehl AM, 1996, J GASTROEN HEPATOL, V11, P466, DOI 10.1111/j.1440-1746.1996.tb00292.x; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Doherty DG, 2000, IMMUNOL REV, V174, P5, DOI 10.1034/j.1600-0528.2002.017416.x; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Fernandez MA, 2006, SCIENCE, V313, P1628, DOI 10.1126/science.1130773; GALLIGANI L, 1979, TOXICOL APPL PHARM, V48, P131, DOI 10.1016/S0041-008X(79)80015-0; Higgins GM, 1931, ARCH PATHOL, V12, P186; Ikarashi M, 2013, J LEUKOCYTE BIOL, V94, P1325, DOI 10.1189/jlb.0313144; Inui T, 2005, J HEPATOL, V43, P670, DOI 10.1016/j.jhep.2005.02.027; Inui T, 2002, J IMMUNOL, V169, P6127, DOI 10.4049/jimmunol.169.11.6127; ITOH H, 1988, J IMMUNOL, V141, P315; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kawabata T, 2008, HEPATOLOGY, V48, P1586, DOI 10.1002/hep.22489; Kinoshita M, 2005, SHOCK, V23, P65, DOI 10.1097/01.shk.0000144423.40270.96; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Kobayashi E, 1995, ONCOL RES, V7, P529; Liu C, 2010, LAB INVEST, V90, P1805, DOI 10.1038/labinvest.2010.123; Louis H, 1998, HEPATOLOGY, V28, P1607, DOI 10.1002/hep.510280621; Mei Y, 2011, HEPATOLOGY, V54, P1777, DOI 10.1002/hep.24560; Meijer C, 2000, LIVER, V20, P66, DOI 10.1034/j.1600-0676.2000.020001066.x; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Minagawa M, 2000, HEPATOLOGY, V31, P907, DOI 10.1053/he.2000.5850; MORITA M, 1995, J MED CHEM, V38, P2176, DOI 10.1021/jm00012a018; Nakagawa R, 2001, J IMMUNOL, V166, P6578, DOI 10.4049/jimmunol.166.11.6578; Nakashima H, 2006, GASTROENTEROLOGY, V131, P1573, DOI 10.1053/j.gastro.2006.08.028; Nakashima H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049339; Nakashima H, 2008, HEPATOLOGY, V48, P1979, DOI 10.1002/hep.22561; Nakashima M, 2012, J LEUKOCYTE BIOL, V91, P537, DOI 10.1189/jlb.0411214; Newberry EP, 2008, HEPATOLOGY, V48, P1097, DOI 10.1002/hep.22473; Ogasawara K, 1998, J IMMUNOL, V160, P3522; Rai RM, 1996, AM J PHYSIOL-GASTR L, V270, pG909, DOI 10.1152/ajpgi.1996.270.6.G909; Sato A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092515; Seki S, 2000, IMMUNOL REV, V174, P35, DOI 10.1034/j.1600-0528.2002.017404.x; Seki S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/868345; Takehara T, 1998, HEPATOLOGY, V27, P1643, DOI 10.1002/hep.510270625; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Webber EM, 1998, HEPATOLOGY, V28, P1226, DOI 10.1002/hep.510280509; Yamada Y, 1998, HEPATOLOGY, V28, P959, DOI 10.1002/hep.510280410; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Yang YP, 2003, J HEPATOL, V39, P200, DOI 10.1016/S0168-8278(03)00229-0; Zimmermann HW, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00056; Zimmers TA, 2003, HEPATOLOGY, V38, P326, DOI 10.1053/jhep.2003.50318	51	40	43	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136774	10.1371/journal.pone.0136774	http://dx.doi.org/10.1371/journal.pone.0136774			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26333171	Green Submitted, Green Published, gold			2022-12-26	WOS:000360613800069
J	Guzman, RE; Miranda-Laferte, E; Franzen, A; Fahlke, C				Guzman, Raul E.; Miranda-Laferte, Erick; Franzen, Arne; Fahlke, Christoph			Neuronal ClC-3 Splice Variants Differ in Subcellular Localizations, but Mediate Identical Transport Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE CHANNEL; PLASMA-MEMBRANE; TRANSMEMBRANE PROTEINS; CHARGE MOVEMENT; EXPRESSION; EXCHANGER; VOLUME; LEADS; OSTEOPETROSIS; TRANSMISSION	ClC-3 is a member of the CLC family of anion channels and transporters, for which multiple functional properties and subcellular localizations have been reported. Since alternative splicing often results in proteins with diverse properties, we investigated to what extent alternative splicing might influence subcellular targeting and function of ClC-3. Weidentified three alternatively spliced ClC-3 isoforms, ClC-3a, ClC-3b, and ClC-3c, in mouse brain, with ClC-3c being the predominant splice variant. Whereas ClC-3a and ClC-3b are present in late endosomes/lysosomes, ClC-3c is targeted to recycling endosomes via a novel N-terminal isoleucine-proline (IP) motif. Surface membrane insertion of a fraction of ClC-3c transporters permitted electrophysiological characterization of this splice variant through whole-cell patch clamping on transfected mammalian cells. In contrast, neutralization of the N-terminal dileucine-like motifs was required for functional analysis of ClC-3a and ClC-3b. Heterologous expression of ClC-3a or ClC-3b carrying mutations in N-terminal dileucine motifs as well as WTClC-3c in HEK293T cells resulted in outwardly rectifying Cl- currents with significant capacitive current components. We conclude that alternative splicing of Clcn3 results in proteins with different subcellular localizations, but leaves the transport function of the proteins unaffected.	[Guzman, Raul E.; Miranda-Laferte, Erick; Franzen, Arne; Fahlke, Christoph] Forschungszentrum Julich, Inst Complex Syst, Zellulare Biophys ICS 4, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich	Guzman, RE (corresponding author), Forschungszentrum Julich, Inst Complex Syst, Zellulare Biophys ICS 4, D-52425 Julich, Germany.	r.guzman@fz-juelich.de; c.fahlke@fz-juelich.de	Fahlke, Christoph/G-3635-2013	Fahlke, Christoph/0000-0001-8602-9952; Franzen, Arne/0000-0002-8731-674X				Alekov AK, 2009, J GEN PHYSIOL, V133, P485, DOI 10.1085/jgp.200810155; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Cheng CL, 2002, J NEUROSCI, V22, P10643; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; Dickerson LW, 2002, BRAIN RES, V958, P227, DOI 10.1016/S0006-8993(02)03519-9; Duan D, 1997, NATURE, V390, P417, DOI 10.1038/37151; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Fahlke C, 2001, J BIOL CHEM, V276, P1759, DOI 10.1074/jbc.M007649200; Farmer LM, 2013, J PHYSIOL-LONDON, V591, P1001, DOI 10.1113/jphysiol.2012.243485; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; Gentzsch M, 2003, J BIOL CHEM, V278, P6440, DOI 10.1074/jbc.M211050200; Gough NR, 1999, J CELL SCI, V112, P4257; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Grieschat M, 2014, BIOPHYS J, V107, pL13, DOI 10.1016/j.bpj.2014.07.063; Grieschat M, 2012, J BIOL CHEM, V287, P8101, DOI 10.1074/jbc.M111.298265; Guzman RE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00143; Guzman RE, 2013, ACS CHEM NEUROSCI, V4, P994, DOI 10.1021/cn400032z; Hidalgo P, 2006, J BIOL CHEM, V281, P24104, DOI 10.1074/jbc.M605930200; Huang P, 2001, J BIOL CHEM, V276, P20093, DOI 10.1074/jbc.M009376200; KAWASAKI M, 1995, NEURON, V14, P1285, DOI 10.1016/0896-6273(95)90275-9; KAWASAKI M, 1994, NEURON, V12, P597, DOI 10.1016/0896-6273(94)90215-1; Khvotchev MV, 2003, J NEUROSCI, V23, P10531; Kobayashi Hotaka, 2013, Commun Integr Biol, V6, pe25036, DOI 10.4161/cib.25036; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Leisle L, 2011, EMBO J, V30, P2140, DOI 10.1038/emboj.2011.137; Li XH, 2002, AM J PHYSIOL-CELL PH, V282, pC1483, DOI 10.1152/ajpcell.00504.2001; Mao JW, 2009, BIOCHEM PHARMACOL, V77, P159, DOI 10.1016/j.bcp.2008.10.009; Maritzen T, 2008, J NEUROSCI, V28, P10587, DOI 10.1523/JNEUROSCI.3750-08.2008; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Miranda-Laferte E, 2014, J BIOL CHEM, V289, P10387, DOI 10.1074/jbc.M113.507244; Neagoe I, 2010, J BIOL CHEM, V285, P21689, DOI 10.1074/jbc.M110.125971; Ogura T, 2002, FASEB J, V16, P863, DOI 10.1096/fj.01-0845fje; Okada T, 2014, CELL PHYSIOL BIOCHEM, V33, P539, DOI 10.1159/000358633; Orhan G, 2011, BIOPHYS J, V100, P1233, DOI 10.1016/j.bpj.2011.01.045; Pavlos NJ, 2010, J NEUROSCI, V30, P13441, DOI 10.1523/JNEUROSCI.0907-10.2010; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Riazanski V, 2011, NAT NEUROSCI, V14, P487, DOI 10.1038/nn.2775; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwake M, 2001, J BIOL CHEM, V276, P12049, DOI 10.1074/jbc.M010642200; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Smith AJ, 2010, FASEB J, V24, P3696, DOI 10.1096/fj.09-150649; Stauber T, 2010, J BIOL CHEM, V285, P34537, DOI 10.1074/jbc.M110.162545; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; STOCKER M, 1990, P NATL ACAD SCI USA, V87, P8903, DOI 10.1073/pnas.87.22.8903; Suzuki T, 2006, J CELL PHYSIOL, V206, P792, DOI 10.1002/jcp.20516; Suzuki T, 2014, J BIOL CHEM, V289, P7438, DOI 10.1074/jbc.M113.542324; TIMPE LC, 1988, NEURON, V1, P659, DOI 10.1016/0896-6273(88)90165-1; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wang XQ, 2006, NEURON, V52, P321, DOI 10.1016/j.neuron.2006.08.035; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072; Yamazaki J, 1998, J PHYSIOL-LONDON, V507, P729, DOI 10.1111/j.1469-7793.1998.729bs.x; Yoshikawa M, 2002, GENES CELLS, V7, P597, DOI 10.1046/j.1365-2443.2002.00539.x; Zhang HF, 2014, INT J BIOCHEM CELL B, V57, P96, DOI 10.1016/j.biocel.2014.10.014; Zhao ZF, 2007, J BIOL CHEM, V282, P29022, DOI 10.1074/jbc.M703506200; Zifarelli G, 2012, BIOPHYS J, V102, P2060, DOI 10.1016/j.bpj.2012.03.067	60	33	33	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25851	25862		10.1074/jbc.M115.668186	http://dx.doi.org/10.1074/jbc.M115.668186			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26342074	Green Published, hybrid			2022-12-26	WOS:000363527300010
J	Narayana, SK; Helbig, KJ; McCartney, EM; Eyre, NS; Bull, RA; Eltahla, A; Lloyd, AR; Beard, MR				Narayana, Sumudu K.; Helbig, Karla J.; McCartney, Erin M.; Eyre, Nicholas S.; Bull, Rowena A.; Eltahla, Auda; Lloyd, Andrew R.; Beard, Michael R.			The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WEST NILE VIRUS; S-PALMITOYLATION; DENGUE VIRUS; ANTIVIRAL EFFECTOR; MEMBRANE-PROTEINS; FAMILY PROTEINS; REPLICATION; INFECTION; EXPRESSION; RESISTANCE	The interferon-induced transmembrane (IFITM) family of proteins have recently been identified as important host effector molecules of the type I interferon response against viruses. IFITM1 has been identified as a potent antiviral effector against hepatitis C virus (HCV), whereas the related family members IFITM2 and IFITM3 have been described to have antiviral effects against a broad range of RNA viruses. Here, we demonstrate that IFITM2 and IFITM3 play an integral role in the interferon response against HCV and act at the level of late entry stages of HCV infection. We have established that in hepatocytes, IFITM2 and IFITM3 localize to the late and early endosomes, respectively, as well as the lysosome. Furthermore, we have demonstrated that S-palmitoylation of all three IFITM proteins is essential for anti-HCV activity, whereas the conserved tyrosine residue in the N-terminal domain of IFITM2 and IFITM3 plays a significant role in protein localization. However, this tyrosine was found to be dispensable for anti-HCV activity, with mutation of the tyrosine resulting in an IFITM1-like phenotype with the retention of anti-HCV activity and colocalization of IFITM2 and IFITM3 with CD81. In conclusion, we propose that the IFITM proteins act in a coordinated manner to restrict HCV infection by targeting the endocytosed HCV virion for lysosomal degradation and demonstrate that the actions of the IFITM proteins are indeed virus and cell-type specific.	[Narayana, Sumudu K.; Helbig, Karla J.; McCartney, Erin M.; Eyre, Nicholas S.; Beard, Michael R.] Univ Adelaide, Sch Biol Sci, Adelaide, SA 5005, Australia; [Narayana, Sumudu K.; Helbig, Karla J.; McCartney, Erin M.; Eyre, Nicholas S.; Beard, Michael R.] Univ Adelaide, Res Ctr Infect Dis, Adelaide, SA 5005, Australia; [Narayana, Sumudu K.; Helbig, Karla J.; McCartney, Erin M.; Eyre, Nicholas S.; Beard, Michael R.] SA Pathol, Ctr Canc Biol, Adelaide, SA 5000, Australia; [Bull, Rowena A.; Eltahla, Auda; Lloyd, Andrew R.] Univ New S Wales, Sch Med Sci, Inflammat & Infect Res Ctr, Sydney, NSW 2052, Australia	University of Adelaide; University of Adelaide; Centre for Cancer Biology; SA Pathology; University of New South Wales Sydney	Beard, MR (corresponding author), Univ Adelaide, Sch Biol Sci, Dept Mol & Cellular Biol, Adelaide, SA 5005, Australia.	michael.beard@adelaide.edu.au	Helbig, Karla/AAC-5515-2019; Lloyd, Andrew/AFJ-8960-2022; Lloyd, Andrew/AAF-6071-2022; Lloyd, Andrew/E-7334-2017; Beard, Michael/AAS-3477-2020	Helbig, Karla/0000-0001-6306-2821; Lloyd, Andrew/0000-0001-6277-8887; Lloyd, Andrew/0000-0001-6277-8887; Beard, Michael/0000-0002-4106-1016; Eyre, Nicholas/0000-0002-5424-7573; Bull, Rowena/0000-0002-9844-3744; Eltahla, Auda/0000-0002-2995-8832	National Health & Medical Research Council of Australia [1053206]	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by National Health & Medical Research Council of Australia Grant 1053206. The authors declare that they have no conflicts of interest with the contents of this article.	Aloia AL, 2012, ANTIVIR THER, V17, P1147, DOI 10.3851/IMP2426; Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Bailey CC, 2014, ANNU REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Blaskovic S, 2013, FEBS J, V280, P2766, DOI 10.1111/febs.12263; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Chan YK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034508; Chesarino NM, 2014, J BIOL CHEM, V289, P11986, DOI 10.1074/jbc.M114.557694; Chowdhury JB, 2012, J VIROL, V86, P10221, DOI 10.1128/JVI.00882-12; Chutiwitoonchai N, 2013, MICROBES INFECT, V15, P280, DOI 10.1016/j.micinf.2012.12.003; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Dubuisson J, 2014, J HEPATOL, V61, pS3, DOI 10.1016/j.jhep.2014.06.031; Eyre NS, 2014, J VIROL, V88, P3636, DOI 10.1128/JVI.02490-13; Eyre NS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001130; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Helbig KJ, 2011, HEPATOLOGY, V54, P1506, DOI 10.1002/hep.24542; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Helbig KJ, 2004, HEPATOLOGY, V39, P1220, DOI 10.1002/hep.20167; Hickford D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-155; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Ikeda M, 2002, J VIROL, V76, P2997, DOI 10.1128/JVI.76.6.2997-3006.2002; Jia R, 2014, CELL MICROBIOL, V16, P1080, DOI 10.1111/cmi.12262; Jia R, 2012, J VIROL, V86, P13697, DOI 10.1128/JVI.01828-12; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13; LEWIN AR, 1991, EUR J BIOCHEM, V199, P417, DOI 10.1111/j.1432-1033.1991.tb16139.x; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Li QS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004163; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Manna D, 2010, VIROLOGY, V398, P21, DOI 10.1016/j.virol.2009.11.034; McCartney EM, 2013, HEPATOLOGY, V58, P1558, DOI 10.1002/hep.26496; Moffatt P, 2008, J BONE MINER RES, V23, P1497, DOI 10.1359/JBMR.080412; Raychoudhuri A, 2011, J VIROL, V85, P12881, DOI 10.1128/JVI.05633-11; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schulze H, 2009, BBA-MOL CELL RES, V1793, P674, DOI 10.1016/j.bbamcr.2008.09.020; Siegrist F., 2011, J INTERFERON CYTOKIN, V1, P183; Thomas DL, 2013, NAT MED, V19, P850, DOI 10.1038/nm.3184; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang SS, 2012, J GEN VIROL, V93, P83, DOI 10.1099/vir.0.033860-0; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Wilkins C, 2013, HEPATOLOGY, V57, P461, DOI 10.1002/hep.26066; Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]; Zhao H, 2012, J HEPATOL, V56, P326, DOI 10.1016/j.jhep.2011.07.026; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	46	89	93	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25946	25959		10.1074/jbc.M115.657346	http://dx.doi.org/10.1074/jbc.M115.657346			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26354436	Green Published, hybrid			2022-12-26	WOS:000363527300017
J	Ebert, SM; Dyle, MC; Bullard, SA; Dierdorff, JM; Murry, DJ; Fox, DK; Bongers, KS; Lira, VA; Meyerholz, DK; Talley, JJ; Adams, CM				Ebert, Scott M.; Dyle, Michael C.; Bullard, Steven A.; Dierdorff, Jason M.; Murry, Daryl J.; Fox, Daniel K.; Bongers, Kale S.; Lira, Vitor A.; Meyerholz, David K.; Talley, John J.; Adams, Christopher M.			Identification and Small Molecule Inhibition of an Activating Transcription Factor 4 (ATF4)-dependent Pathway to Age-related Skeletal Muscle Weakness and Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA EXPRESSION SIGNATURES; PROTEIN-SYNTHESIS; URSOLIC ACID; MASS; REVEALS; DISRUPTION; SARCOPENIA; AUTOPHAGY; PROFILES; MYOPATHY	Aging reduces skeletal muscle mass and strength, but the underlying molecular mechanisms remain elusive. Here, we used mouse models to investigate molecular mechanisms of age-related skeletal muscle weakness and atrophy as well as new potential interventions for these conditions. We identified two small molecules that significantly reduce age-related deficits in skeletal muscle strength, quality, and mass: ursolic acid (a pentacyclic triterpenoid found in apples) and tomatidine (a steroidal alkaloid derived from green tomatoes). Because small molecule inhibitors can sometimes provide mechanistic insight into disease processes, we used ursolic acid and tomatidine to investigate the pathogenesis of age-related muscle weakness and atrophy. We found that ursolic acid and tomatidine generate hundreds of small positive and negative changes in mRNA levels in aged skeletal muscle, and the mRNA expression signatures of the two compounds are remarkably similar. Interestingly, a subset of the mRNAs repressed by ursolic acid and tomatidine in aged muscle are positively regulated by activating transcription factor 4 (ATF4). Based on this finding, we investigated ATF4 as a potential mediator of age-related muscle weakness and atrophy. We found that a targeted reduction in skeletal muscle ATF4 expression reduces age-related deficits in skeletal muscle strength, quality, and mass, similar to ursolic acid and tomatidine. These results elucidate ATF4 as a critical mediator of age-related muscle weakness and atrophy. In addition, these results identify ursolic acid and tomatidine as potential agents and/or lead compounds for reducing ATF4 activity, weakness, and atrophy in aged skeletal muscle.	[Ebert, Scott M.; Dyle, Michael C.; Bullard, Steven A.; Dierdorff, Jason M.; Murry, Daryl J.; Fox, Daniel K.; Bongers, Kale S.; Adams, Christopher M.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Dyle, Michael C.; Fox, Daniel K.; Bongers, Kale S.; Adams, Christopher M.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Lira, Vitor A.] Univ Iowa, Dept Hlth & Human Physiol, Iowa City, IA 52242 USA; [Meyerholz, David K.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Ebert, Scott M.; Dyle, Michael C.; Bullard, Steven A.; Dierdorff, Jason M.; Fox, Daniel K.; Bongers, Kale S.; Lira, Vitor A.; Adams, Christopher M.] Univ Iowa, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA; [Murry, Daryl J.] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA; [Ebert, Scott M.; Dyle, Michael C.; Bullard, Steven A.; Dierdorff, Jason M.; Fox, Daniel K.; Bongers, Kale S.; Adams, Christopher M.] Iowa City Vet Affairs Med Ctr, Iowa City, IA 52246 USA; [Ebert, Scott M.; Talley, John J.; Adams, Christopher M.] Emmyon Inc, Coralville, IA 52241 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Adams, CM (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA.	christopher-adams@uiowa.edu	Lira, Vitor/AAN-3403-2021; Meyerholz, David/J-8131-2019	Lira, Vitor/0000-0002-3162-3804; Meyerholz, David/0000-0003-1552-3253; Bongers, Kale/0000-0002-9297-9185; Adams, Christopher/0000-0002-5795-7212	National Institutes of Health Grants [1R43AG044898, 1R01AR059115, 1F31AG04603801]; Department of Veterans Affairs Biomedical Laboratory Research and Development Service Grant [IBX000976A]; Department of Veterans Affairs Rehabilitation and Research Development Service Grant [1I01RX001477]; Fraternal Order of Eagles Diabetes Research Center at University of Iowa; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R43AG044898, F30AG044964] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000976, I01RX001477] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Biomedical Laboratory Research and Development Service Grant(US Department of Veterans Affairs); Department of Veterans Affairs Rehabilitation and Research Development Service Grant(US Department of Veterans Affairs); Fraternal Order of Eagles Diabetes Research Center at University of Iowa; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants 1R43AG044898, 1R01AR059115, and 1F31AG04603801. This work was also supported by Department of Veterans Affairs Biomedical Laboratory Research and Development Service Grant IBX000976A, Department of Veterans Affairs Rehabilitation and Research Development Service Grant 1I01RX001477, and the Fraternal Order of Eagles Diabetes Research Center at the University of Iowa. C. M. A., S. M. E., and M. C. D. are inventors on patent applications related to ursolic acid and tomatidine that have been filed by the University of Iowa Research Foundation and licensed to Emmyon, Inc. C. M. A. is a co-founder and officer of Emmyon, Inc. S. M. E. is an employee of Emmyon, Inc. C. M. A., J. J. T., and S. M. E. hold equity in Emmyon, Inc.	Adams CM, 2015, CURR OPIN CLIN NUTR, V18, P263, DOI 10.1097/MCO.0000000000000159; Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bongers KS, 2013, AM J PHYSIOL-ENDOC M, V305, pE907, DOI 10.1152/ajpendo.00380.2013; Bujak AL, 2015, CELL METAB, V21, P883, DOI 10.1016/j.cmet.2015.05.016; Castets P, 2013, CELL METAB, V17, P731, DOI 10.1016/j.cmet.2013.03.015; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; Demontis F, 2013, DIS MODEL MECH, V6, P1339, DOI 10.1242/dmm.012559; Dubowitz V., 2007, MUSCLE BIOPSY PRACTI; Dyle MC, 2014, J BIOL CHEM, V289, P14913, DOI 10.1074/jbc.M114.556241; Ebert SM, 2012, J BIOL CHEM, V287, P27290, DOI 10.1074/jbc.M112.374777; Ebert SM, 2010, MOL ENDOCRINOL, V24, P790, DOI 10.1210/me.2009-0345; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Federal Interagency Forum on Aging-Related Statistics, 2013, OLD AM KEY IND WELL; Figueiredo VC, 2012, CELL BIOCHEM FUNCT, V30, P432, DOI 10.1002/cbf.2821; Fox DK, 2014, AM J PHYSIOL-ENDOC M, V307, pE245, DOI 10.1152/ajpendo.00010.2014; Frighetto RTS, 2008, FOOD CHEM, V106, P767, DOI 10.1016/j.foodchem.2007.06.003; Goodman CA, 2013, EXERC SPORT SCI REV, V41, P107, DOI 10.1097/JES.0b013e3182798a95; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; Gordon BS, 2013, INT J BIOCHEM CELL B, V45, P2147, DOI 10.1016/j.biocel.2013.05.039; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hwee DT, 2014, AGING CELL, V13, P92, DOI 10.1111/acel.12150; Ibebunjo C, 2013, MOL CELL BIOL, V33, P194, DOI 10.1128/MCB.01036-12; Kunkel SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039332; Kunkel SD, 2011, CELL METAB, V13, P627, DOI 10.1016/j.cmet.2011.03.020; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Maden-Wilkinson TM, 2014, AGE, V36, P383, DOI 10.1007/s11357-013-9571-6; Neff F, 2013, J CLIN INVEST, V123, P3272, DOI 10.1172/JCI67674; Sandri M, 2013, BIOGERONTOLOGY, V14, P303, DOI 10.1007/s10522-013-9432-9; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Welle S, 2004, EXP GERONTOL, V39, P369, DOI 10.1016/j.exger.2003.11.011; Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106	34	68	72	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25497	25511		10.1074/jbc.M115.681445	http://dx.doi.org/10.1074/jbc.M115.681445			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26338703	hybrid, Green Published			2022-12-26	WOS:000362962800025
J	Jawin, V; Ang, HL; Omar, A; Thong, MK				Jawin, Vida; Ang, Hak-Lee; Omar, Asma; Thong, Meow-Keong			Beyond Critical Congenital Heart Disease: Newborn Screening Using Pulse Oximetry for Neonatal Sepsis and Respiratory Diseases in a Middle-Income Country	PLOS ONE			English	Article							DEFECTS; INFECTION; ACCURACY; INFANCY	Background Studies on pulse oximetry screening for neonatal sepsis and respiratory disease in a middle-income country are lacking. Newborn screening for critical congenital heart disease (CCHD) using pulse oximetry is an effective and life-saving strategy in developed countries. While most studies have reported false-positive results during CCHD screening, they have not elaborated on the detected disease types. We studied the effectiveness and outcomes of pulse oximetry newborn screening for non-cardiac hypoxemic diseases such as neonatal sepsis, respiratory diseases, and CCHD in a middle-income country. Methods and Findings In a pilot study performed at the University Malaya Medical Centre (UMMC), Malaysia, all apparently healthy term newborns, delivered at UMMC were screened pre-discharge using pulse oximetry. Echocardiography was performed for newborns that had positive screening results on two separate occasions, 1-h apart. Newborns with normal echocardiograms were evaluated and treated for other non-cardiac diseases. Fifteen of 5247 term newborns had positive screening results. The median age at screening was 20 h. Thirteen newborns (0.24%) had significant non-cardiac diseases: sepsis (n = 2) and respiratory diseases (n = 11) that required hospitalization and treatment. The remaining two newborns with normal antenatal ultrasonograms had positive screening test and confirmed to have CCHD. Another 18 newborns with negative screening test were later admitted for treatment of sepsis (n = 16) and penumonia (n = 2). All newborns were treated and alive at the end of the study. The sensitivity and specificity of pulse oximetry screening for non-cardiac diseases were 42% and 99.9% respectively, and 100% and 99.7% for CCHD, respectively. Conclusions Routine pulse oximetry screening test was effective in identifying newborns with CCHD and other hypoxemia illnesses, which may led to potential life-threatening condition. This study showed that the expanded use of pulse oximetry has immediate implications for low- and middle-income countries contemplating strategies to reduce neonatal mortality and morbidity.	[Jawin, Vida; Ang, Hak-Lee; Omar, Asma; Thong, Meow-Keong] Univ Malaya, Fac Med, Dept Paediat, Kuala Lumpur, Malaysia	Universiti Malaya	Thong, MK (corresponding author), Univ Malaya, Fac Med, Dept Paediat, Kuala Lumpur, Malaysia.	thongmk@um.edu.my	Thong, Meow-Keong/B-9960-2010; Ang, Hak Lee/G-4150-2015	Thong, Meow-Keong/0000-0002-7288-7910; Ang, Hak Lee/0000-0001-5492-9091	University of Malaya [RG435/12HTM]; Malaysian Rare Disorders Society	University of Malaya(Universiti Malaya); Malaysian Rare Disorders Society	H-LA received funding for clinical research from the University of Malaya. This research was funded by the University of Malaya Research Grant (RG435/12HTM), URL: umresearch.um.edu.my. VJ received a fund from The Malaysian Rare Disorders Society. This is a personal private fund. URL: www.mrds.org.my. The funders have played a role in the data collection and analysis by providing the material needed for the study.	Ainsworth SB, 1999, ARCH DIS CHILD-FETAL, V80, pF43, DOI 10.1136/fn.80.1.F43; Al-Taiar A, 2013, ARCH DIS CHILD-FETAL, V98, pF249, DOI 10.1136/archdischild-2012-301767; Andrews JP, 2014, CLIN PEDIATR, V53, P173, DOI 10.1177/0009922813502850; [Anonymous], 2010, LEVEL TRENDS CHILD M; de-Wahl Granelli Anne, 2009, BMJ, V338, pa3037, DOI 10.1136/bmj.a3037; Ewer AK, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16020; Ewer AK, 2014, LANCET, V384, P725, DOI 10.1016/S0140-6736(14)60575-4; Fink M, 1997, Acta Anaesthesiol Scand Suppl, V110, P87; Hunter S, 2000, HEART, V84, P294, DOI 10.1136/heart.84.3.294; King E. M., 2014, British Journal of Medicine and Medical Research, V4, P1115; Klein SK, 1999, PRENATAL DIAG, V19, P318, DOI 10.1002/(SICI)1097-0223(199904)19:4<318::AID-PD538>3.0.CO;2-X; Knowles R, 2005, HEALTH TECHNOL ASSES, V9, P1; Koh IHJ, 2010, SHOCK, V34, P27, DOI 10.1097/SHK.0b013e3181e7e80c; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Mahle WT, 2009, CIRCULATION, V120, P447, DOI 10.1161/CIRCULATIONAHA.109.192576; Mik EG, 1985, J APPL PHYSL, P2015; PAYNE RM, 1995, CIRCULATION, V91, P494, DOI 10.1161/01.CIR.91.2.494; Randall P, 2005, BJOG-INT J OBSTET GY, V112, P24, DOI 10.1111/j.1471-0528.2004.00295.x; Riede FT, 2010, EUR J PEDIATR, V169, P975, DOI 10.1007/s00431-010-1160-4; Ruangritmachai C, 2007, PEDIAT CARDIOL, V9, P10; Schultz AH, 2008, PEDIATRICS, V121, P751, DOI 10.1542/peds.2007-0421; Seale AC, 2013, PEDIATR RES, V74, P73, DOI 10.1038/pr.2013.207; Seale AC, 2012, EARLY HUM DEV, V88, P957, DOI 10.1016/j.earlhumdev.2012.09.005; Sebelius K, 2011, HHS SECRETARY ADOPTS; Singh A, 2014, ARCH DIS CHILD-FETAL, V99, pF297, DOI [10.1136/archdischild-2013-303968, 10.1136/archdischild-2013-305657]; Talner NS, 1998, PEDIATRICS, V102, P258; Thangaratinam S, 2012, LANCET, V379, P2459, DOI 10.1016/S0140-6736(12)60107-X; Thaver D, 2009, PEDIATR INFECT DIS J, V28, pS3, DOI 10.1097/INF.0b013e3181958755; Wren C, 1999, ARCH DIS CHILD-FETAL, V80, pF49, DOI 10.1136/fn.80.1.F49; Wright J, 2014, PEDIATRICS, V133, pE561, DOI 10.1542/peds.2013-3284; Zhao QM, 2014, LANCET, V384, P747, DOI 10.1016/S0140-6736(14)60198-7	31	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137580	10.1371/journal.pone.0137580	http://dx.doi.org/10.1371/journal.pone.0137580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360420	gold, Green Published, Green Submitted			2022-12-26	WOS:000361043100055
J	Terry, CM; Zhuplatov, I; He, YX; Wun, TC; Kim, SE; Cheung, AK				Terry, Christi M.; Zhuplatov, Ilya; He, Yuxia; Wun, Tze-Chein; Kim, Seong-Eun; Cheung, Alfred K.			Assessment of Novel Anti-thrombotic Fusion Proteins for Inhibition of Stenosis in a Porcine Model of Arteriovenous Graft	PLOS ONE			English	Article							COMPRISING ANNEXIN-V; NEOINTIMAL HYPERPLASIA; INTIMAL HYPERPLASIA; ATTENUATES STENOSIS; ARTERIAL INJURY; PLUS ASPIRIN; HEMODIALYSIS; PATENCY; THROMBIN; FAILURE	Background Hemodialysis arteriovenous synthetic grafts (AVG) provide high volumetric blood flow rates shortly after surgical placement. However, stenosis often develops at the vein-graft anastomosis contributing to thrombosis and early graft failure. Two novel fusion proteins, ANV-6L15 and TAP-ANV, inhibit the tissue factor/factor VIIa coagulation complex and the factor Xa/factor Va complex, respectively. Each inhibitor domain is fused to an annexin V domain that targets the inhibitor activity to sites of vascular injury to locally inhibit thrombosis. This study's objective was to determine if these antithrombotic proteins are safe and effective in inhibiting AVG stenosis. Methods A bolus of either TAP-ANV or ANV-6L15 fusion protein was administered intravenously immediately prior to surgical placement of a synthetic graft between the external jugular vein and common carotid artery in a porcine model. At surgery, the vein and artery were irrigated with the anti-thrombotic fusion protein. Control animals received intravenous heparin. At 4 weeks, MRI was performed to evaluate graft patency, the pigs were then euthanized and grafts and attached vessels were explanted for histomorphometric assessment of neointimal hyperplasia at the vein-graft anastomosis. Blood was collected at surgery, immediately after surgery and at euthanasia for serum metabolic panels and coagulation chemistries. Results No acute thrombosis occurred in the control group or in either experimental group. No abnormal serum chemistries, activated clotting times or PT, PTT values were observed after treatment in experimental or control animals. However, at the vein-graft anastomosis, there was no difference between the control and experimental groups in cross-sectional lumen areas, as measured on MRI, and no difference in hyperplasia areas as determined by histomorphometry. These results suggest that local irrigation of TAP-ANV or ANV-6L15 intra-operatively was as effective in inhibiting acute graft thrombosis as intravenous administration of heparin, but failed to inhibit hyperplasia development and stenosis in AVG.	[Terry, Christi M.; Zhuplatov, Ilya; He, Yuxia; Cheung, Alfred K.] Univ Utah, Div Nephrol & Hypertens, Salt Lake City, UT 84132 USA; [Wun, Tze-Chein] EVAS Therapeut LLC, Ballwin, MO USA; [Kim, Seong-Eun] Univ Utah, Dept Radiol, Utah Ctr Adv Imaging Res, Salt Lake City, UT 84132 USA; [Cheung, Alfred K.] Vet Affairs Salt Lake City Healthcare Syst, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs	Terry, CM (corresponding author), Univ Utah, Div Nephrol & Hypertens, Salt Lake City, UT 84132 USA.	christi.terry@hsc.utah.edu			SBIR [R44HL093848]; National Heart Lung Blood Institute at the National Institutes of Health; University of Utah Study Design and Biostatistics Center; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [5UL1TR001067-02]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000105, UL1TR001067] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025764] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL093848] Funding Source: NIH RePORTER	SBIR; National Heart Lung Blood Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Utah Study Design and Biostatistics Center; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by an SBIR (R44HL093848), awarded by the National Heart Lung Blood Institute at the National Institutes of Health to TCW, and by the University of Utah Study Design and Biostatistics Center, with funding in part from the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant 5UL1TR001067-02 (formerly 8UL1TR000105 and UL1RR025764). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abendschein DR, 1996, J AM COLL CARDIOL, V28, P1849, DOI 10.1016/S0735-1097(96)00362-2; Al-Jaishi AA, 2014, AM J KIDNEY DIS, V63, P464, DOI 10.1053/j.ajkd.2013.08.023; Allemang MT, 2014, ANN VASC SURG, V28, P28, DOI 10.1016/j.avsg.2013.08.001; Brown DM, 1996, ARCH SURG-CHICAGO, V131, P1086; Chen HH, 2005, BLOOD, V105, P3902, DOI 10.1182/blood-2004-11-4435; Coleman CI, 2010, INT J CLIN PRACT, V64, P1239, DOI 10.1111/j.1742-1241.2009.02329.x; Crowther MA, 2002, J AM SOC NEPHROL, V13, P2331, DOI 10.1097/01.ASN.0000027356.16598.99; Dember LM, 2008, JAMA-J AM MED ASSOC, V299, P2164, DOI 10.1001/jama.299.18.2164; Dixon BS, 2011, J AM SOC NEPHROL, V22, P773, DOI 10.1681/ASN.2010060582; Dixon BS, 2009, NEW ENGL J MED, V360, P2191, DOI 10.1056/NEJMoa0805840; FAGER G, 1995, CIRC RES, V77, P645, DOI 10.1161/01.RES.77.4.645; Guomundsdottir IJ, 2008, J AM COLL CARDIOL, V51, P1749, DOI 10.1016/j.jacc.2007.12.047; He Y, 2013, J BIOMECH, V46, P165, DOI 10.1016/j.jbiomech.2012.09.005; Hung YN, 2010, CLIN J AM SOC NEPHRO, V5, P1029, DOI 10.2215/CJN.08181109; Huynh TTT, 2001, J VASC SURG, V33, P400, DOI 10.1067/mva.2001.111989; Kaufman JS, 2003, J AM SOC NEPHROL, V14, P2313, DOI 10.1097/01.ASN.0000081661.10246.33; Kim SE, 2004, MAGNET RESON MED, V52, P1379, DOI 10.1002/mrm.20296; KOSTERING H, 1983, LAB ANIM, V17, P346, DOI 10.1258/002367783781062262; Li L, 2007, NEPHROL DIAL TRANSPL, V22, P3139, DOI 10.1093/ndt/gfm415; Liao MH, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/675701; Lindholt JS, 2011, EUR J VASC ENDOVASC, V41, P668, DOI 10.1016/j.ejvs.2011.01.021; Lok CE, 2013, CLIN J AM SOC NEPHRO, V8, P810, DOI 10.2215/CJN.00730112; Lok CE, 2012, JAMA-J AM MED ASSOC, V307, P1809, DOI 10.1001/jama.2012.3473; Masaki T, 2004, KIDNEY INT, V66, P2061, DOI 10.1111/j.1523-1755.2004.00985.x; Mehta RI, 2011, CARDIOVASC PATHOL, V20, P213, DOI 10.1016/j.carpath.2010.06.005; NEUENSCHWANDER PF, 1995, BIOCHEMISTRY-US, V34, P13988, DOI 10.1021/bi00043a004; Oltrona L, 1997, CIRCULATION, V96, P646; Osborn G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002786.pub2; Palmer SC, 2013, AM J KIDNEY DIS, V61, P112, DOI 10.1053/j.ajkd.2012.08.031; Roque M, 2000, J AM COLL CARDIOL, V36, P2303, DOI 10.1016/S0735-1097(00)01018-4; Roy-Chaudhury P, 2001, KIDNEY INT, V59, P2325, DOI 10.1046/j.1523-1755.2001.00750.x; Roy-Chaudhury P, 2006, J AM SOC NEPHROL, V17, P1112, DOI 10.1681/ASN.2005050615; Sanders WG, 2012, AM J PHYSIOL-CELL PH, V303, pC278, DOI 10.1152/ajpcell.00386.2011; SAREMBOCK IJ, 1991, CIRCULATION, V84, P232, DOI 10.1161/01.CIR.84.1.232; Schwartz RS, 1996, CIRCULATION, V93, P1542, DOI 10.1161/01.CIR.93.8.1542; Stouffer GA, 1998, SEMIN THROMB HEMOST, V24, P145, DOI 10.1055/s-2007-995833; Terry CM, 2006, NEPHROL DIAL TRANSPL, V21, P3172, DOI 10.1093/ndt/gfl366; Terry CM, 2012, J CONTROL RELEASE, V160, P459, DOI 10.1016/j.jconrel.2012.03.011; Terry CM, 2009, ACAD RADIOL, V16, P96, DOI 10.1016/j.acra.2008.05.019; Thome LM, 1998, CIRCULATION, V98, P2301, DOI 10.1161/01.CIR.98.21.2301; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Wong G, 2008, J VASC SURG, V47, P608, DOI 10.1016/j.jvs.2007.11.025; Yeh CH, 2013, J THROMB HAEMOST, V11, P1454, DOI 10.1111/jth.12314; Yin XH, 2002, CARDIOVASC RES, V56, P454, DOI 10.1016/S0008-6363(02)00595-3; Zhou J, 2010, ULTRASOUND MED BIOL, V36, P1876, DOI 10.1016/j.ultrasmedbio.2010.08.013	45	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137381	10.1371/journal.pone.0137381	http://dx.doi.org/10.1371/journal.pone.0137381			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360605	Green Published, gold, Green Submitted			2022-12-26	WOS:000361043100032
J	Wollebo, HS; Bellizzi, A; Kaminski, R; Hu, WH; White, MK; Khalili, K				Wollebo, Hassen S.; Bellizzi, Anna; Kaminski, Rafal; Hu, Wenhui; White, Martyn K.; Khalili, Kamel			CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; HEPATITIS-B-VIRUS; INACTIVATING LENTIVIRUS VECTOR; RNA-GUIDED ENDONUCLEASE; EPSTEIN-BARR-VIRUS; FETAL GLIAL-CELLS; IN-VIVO; PRIMATE POLYOMAVIRUSES; HIV-1 INFECTION; GENE-EXPRESSION	Progressive multifocal leukoencephalopathy (PML) is a fatal demyelinating disease of the central nervous system (CNS) caused by reactivation of the human polyomavirus JCV gene expression and its replication in oligodendrocytes, the myelin producing cells in the brain. Once a rare disease seen in patients with lymphotproliferative and myeloproliferative disorders, PML has been seen more frequently in HIV-1 positive/AIDS patients as well as patients undergoing immunomodulatory therapy due for autoimmune disorders including multiple sclerosis, rheumatoid arthritis, and others. As of now there is no cure for PML and in most cases disease progression leads to death within two years. Similar to other polyomaviruses, the JCV genome is small circular double stranded DNA that includes coding sequences for the viral early protein, T-antigen, which is critical for directing viral reactivation and lytic infection. Here, we employ a newly developed gene editing strategy, CRISPR/Cas9, to introduce mutations in the viral genome and, by inactivating the gene encoding T-antigen, inhibit viral replication. We first used bioinformatics screening and identified several potential targets within the JCV T-antigen gene that can serve as sites for the creation of guide RNAs (gRNAs) for positioning the Cas9 nuclease on the designated area of the viral genome for editing. Results from a series of integrated genetic and functional studies showed that transient or conditional expression of Cas9 and gRNAs specifically targets the DNA sequences corresponding to the N-terminal region of T-antigen, and by introducing mutation, interferes with expression and function of of the viral protein, hence suppressing viral replication in permissive cells. Results from SURVEYOR assay revealed no off-target effects of the JCV-specific CRISPR/Cas9 editing apparatus. These observations provide the first evidence for the employment of a gene editing strategy as a promising tool for the elimination of the JCV genome and a potential cure for PML.	[Wollebo, Hassen S.; Bellizzi, Anna; Kaminski, Rafal; Hu, Wenhui; White, Martyn K.; Khalili, Kamel] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Khalili, K (corresponding author), Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA.	kamel.khalili@temple.edu	Kaminski, Rafal/V-3516-2018	Kaminski, Rafal/0000-0001-8827-6658; Wollebo, Hassen/0000-0003-2285-3496	National Institutes of Health [R01NS087971, R01MH086358, P30 MH092177, R01AI077460]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093271, R01MH086358, P30MH092177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS087971] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Grants awarded by the National Institutes of Health to: KK (R01NS087971, R01MH086358 and P30 MH092177- please note that this grant did not directly support this research; however, the services provided by this center grant were utilized in the experiments presented in the manuscript) MKW (R01AI077460). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrei G, 1997, ANTIMICROB AGENTS CH, V41, P587, DOI 10.1128/AAC.41.3.587; ASTROM KE, 1958, BRAIN, V81, P93, DOI 10.1093/brain/81.1.93; Berger Joseph R, 2011, Cleve Clin J Med, V78 Suppl 2, pS8, DOI 10.3949/ccjm.78.s2.03; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Campos SK, 2007, CURR GENE THER, V7, P189, DOI 10.2174/156652307780859062; Chalkley JJ, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0408-6; Chang CF, 1996, J VIROL, V70, P4150, DOI 10.1128/JVI.70.6.4150-4156.1996; Chapagain ML, 2008, J NEUROVIROL, V14, P448, DOI 10.1080/13550280802235916; Clifford DB, 2011, ARCH NEUROL-CHICAGO, V68, P1156, DOI 10.1001/archneurol.2011.103; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daya S, 2008, CLIN MICROBIOL REV, V21, P583, DOI 10.1128/CMR.00008-08; DeCaprio J. A., 2013, FIELDS VIROLOGY, P1633; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Elphick GF, 2004, SCIENCE, V306, P1380, DOI 10.1126/science.1103492; FRISQUE RJ, 1984, J VIROL, V51, P458, DOI 10.1128/JVI.51.2.458-469.1984; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hamid NA, 2009, CELL MOL LIFE SCI, V66, P1700, DOI 10.1007/s00018-009-8631-7; Hou J, 1998, J NEUROVIROL, V4, P451, DOI 10.3109/13550289809114545; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Hu Z, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/612823; Kennedy EM, 2015, VIROLOGY, V476, P196, DOI 10.1016/j.virol.2014.12.001; Kennedy EM, 2014, J VIROL, V88, P11965, DOI 10.1128/JVI.01879-14; Khalili K, 2005, J CELL PHYSIOL, V204, P1, DOI 10.1002/jcp.20266; Khalili K, 2015, J NEUROVIRO IN PRESS; Krynska B, 2000, VIROLOGY, V274, P65, DOI 10.1006/viro.2000.0450; LASHGARI MS, 1989, VIROLOGY, V170, P292, DOI 10.1016/0042-6822(89)90381-4; Liao HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7413; Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Nagayama S, 2013, CLIN NEUROL NEUROSUR, V115, P1482, DOI 10.1016/j.clineuro.2012.11.016; Pagano JS, 1999, P ASSOC AM PHYSICIAN, V111, P573, DOI 10.1046/j.1525-1381.1999.t01-1-99220.x; Radhakrishnan S, 2004, J VIROL, V78, P7264, DOI 10.1128/JVI.78.13.7264-7269.2004; Radhakrishnan S, 2003, J VIROL, V77, P10638, DOI 10.1128/JVI.77.19.10638-10644.2003; RAJ GV, 1995, INT J ONCOL, V7, P801; ROBINSON WS, 1974, J VIROL, V14, P384, DOI 10.1128/JVI.14.2.384-391.1974; Schwab N, 2012, NEUROLOGY, V78, P458, DOI 10.1212/WNL.0b013e3182478d4b; Seeger C, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.68; Tavazzi E, 2012, REV MED VIROL, V22, P18, DOI 10.1002/rmv.710; Wang JB, 2014, P NATL ACAD SCI USA, V111, P13157, DOI 10.1073/pnas.1410785111; White MK, 2006, ONCOGENE, V25, P5286, DOI 10.1038/sj.onc.1209618; White MK, 2014, CLIN MICROBIOL REV, V27, P463, DOI 10.1128/CMR.00124-13; White MK, 2011, J INFECT DIS, V203, P578, DOI 10.1093/infdis/jiq097; White MK, 2004, VIROLOGY, V324, P1, DOI 10.1016/j.virol.2004.03.025; Wollebo HS, 2013, METHODS MOL BIOL, V1078, P141, DOI 10.1007/978-1-62703-640-5_12; Wollebo HS, 2012, VIROLOGY, V432, P146, DOI 10.1016/j.virol.2012.06.010; Wollebo HS, 2011, J NEUROIMMUNOL, V233, P46, DOI 10.1016/j.jneuroim.2010.11.013; Yuen KS, 2015, J GEN VIROL, V96, P626, DOI 10.1099/jgv.0.000012; Zhen S, 2015, GENE THER IN PRESS; Zhen S, 2014, BIOCHEM BIOPH RES CO, V450, P1422, DOI 10.1016/j.bbrc.2014.07.014; Zhu WJ, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0150-z; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	56	60	65	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0136046	10.1371/journal.pone.0136046	http://dx.doi.org/10.1371/journal.pone.0136046			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360417	gold, Green Published, Green Submitted			2022-12-26	WOS:000361043100007
J	Kim, HK; Konishi, M; Takahashi, M; Tabata, H; Endo, N; Numao, S; Lee, SK; Kim, YH; Suzuki, K; Sakamoto, S				Kim, Hyeon-Ki; Konishi, Masayuki; Takahashi, Masaki; Tabata, Hiroki; Endo, Naoya; Numao, Shigeharu; Lee, Sun-Kyoung; Kim, Young-Hak; Suzuki, Katsuhiko; Sakamoto, Shizuo			Effects of Acute Endurance Exercise Performed in the Morning and Evening on Inflammatory Cytokine and Metabolic Hormone Responses	PLOS ONE			English	Article							CIRCADIAN-RHYTHM; SKELETAL-MUSCLE; INTERLEUKIN-6; IL-6; CORTISOL; LIPOPOLYSACCHARIDE; DETERMINES; EXPRESSION; INTENSITY; PLASMA	Purpose To compare the effects of endurance exercise performed in the morning and evening on inflammatory cytokine responses in young men. Methods Fourteen healthy male participants aged 24.3 +/- 0.8 years (mean +/- standard error) performed endurance exercise in the morning (0900-1000 h) on one day and then in the evening (1700-1800 h) on another day with an interval of at least 1 week between each trial. In both the morning and evening trials, the participants walked for 60 minutes at approximately 60% of the maximal oxygen uptake ((V) over dotO(2max)) on a treadmill. Blood samples were collected to determine hormones and inflammatory cytokines at pre-exercise, immediately post exercise, and 2 h post exercise. Results Plasma interleukin (IL)-6 and adrenaline concentrations were significantly higher immediately after exercise in the evening trial than in the morning trial (P < 0.01, both). Serum free fatty acids concentrations were significantly higher in the evening trial than in the morning trial at 2 h after exercise (P < 0.05). Furthermore, a significant correlation was observed between the levels of IL-6 immediately post-exercise and free fatty acids 2 h post-exercise in the evening (r = 0.68, P < 0.01). Conclusions These findings suggest that the effect of acute endurance exercise in the evening enhances the plasma IL-6 and adrenaline concentrations compared to that in the morning. In addition, IL-6 was involved in increasing free fatty acids, suggesting that the evening is more effective for exercise-induced lipolysis compared with the morning.	[Kim, Hyeon-Ki; Tabata, Hiroki] Waseda Univ, Grad Sch Sport Sci, Saitama, Japan; [Kim, Hyeon-Ki] Japan Soc Promot Sci, Tokyo, Japan; [Konishi, Masayuki; Suzuki, Katsuhiko; Sakamoto, Shizuo] Waseda Univ, Fac Sport Sci, Saitama, Japan; [Takahashi, Masaki] Waseda Univ, Fac Sci & Engn, Tokyo, Japan; [Endo, Naoya] Japan Inst Sports Sci, Tokyo, Japan; [Numao, Shigeharu] Kyoto Pharmaceut Univ, Dept Hlth & Sports Sci, Kyoto 607, Japan; [Numao, Shigeharu] Waseda Univ, Waseda Inst Sport Sci, Tokyo, Japan; [Lee, Sun-Kyoung] Myongji Univ, Dept Sports & Phys Arts, Seoul, South Korea; [Kim, Young-Hak] Yongin Univ, Dept Oriental Martial Arts, Yongin, South Korea	Waseda University; Japan Society for the Promotion of Science; Waseda University; Waseda University; Kyoto Pharmaceutical University; Waseda University; Myongji University; Yongin University	Kim, HK (corresponding author), Waseda Univ, Grad Sch Sport Sci, Saitama, Japan.	gusrl82@ruri.waseda.jp	Endo, Naoya/GOJ-7466-2022; Suzuki, Katsuhiko/AAI-2197-2019	Suzuki, Katsuhiko/0000-0002-6572-5809; Takahashi, Masaki/0000-0002-4038-8164; Tabata, Hiroki/0000-0001-9396-5247; Konishi, Masayuki/0000-0003-1512-3014	Ministry of Education, Culture, Sports Science, and Technology of Japan;  [24300238]	Ministry of Education, Culture, Sports Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	Funding: This study was supported by grants from the Ministry of Education, Culture, Sports Science, and Technology of Japan; and a Grant-in-Aid for the Global COE Program "Sport Science for the Promotion of Active Life" (2011-2012) and Scientific Research (B) 24300238.	Born J, 1997, J IMMUNOL, V158, P4454; BRANDENBERGER G, 1982, J CLIN ENDOCR METAB, V54, P592, DOI 10.1210/jcem-54-3-592; DAVIES CTM, 1973, J APPL PHYSIOL, V35, P887, DOI 10.1152/jappl.1973.35.6.887; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; Dimitriou L, 2002, BRIT J SPORT MED, V36, P260, DOI 10.1136/bjsm.36.4.260; Fischer CP, 2006, EXERC IMMUNOL REV, V12, P6; Gagnon DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110774; Giraldo E, 2009, NEUROIMMUNOMODULAT, V16, P237, DOI 10.1159/000212384; Gleeson M, 2007, J APPL PHYSIOL, V103, P693, DOI 10.1152/japplphysiol.00008.2007; Helge JW, 2003, J PHYSIOL-LONDON, V546, P299, DOI 10.1113/jphysiol.2002.030437; Hermann C, 2006, EUR J IMMUNOL, V36, P371, DOI 10.1002/eji.200535470; Keller C, 2006, CYTOKINE, V36, P141, DOI 10.1016/j.cyto.2006.10.014; Keller P, 2004, J APPL PHYSIOL, V97, P1309, DOI 10.1152/japplphysiol.00284.2004; Kim HK, 2014, JAPANESE SOC CLIN SP, V22, P497; Martin-Cordero L, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-42; Midgley AW, 2007, SPORTS MED, V37, P1019, DOI 10.2165/00007256-200737120-00002; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; Papanicolaou DA, 1996, AM J PHYSIOL-ENDOC M, V271, pE601; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pedersen BK, 2003, PFLUG ARCH EUR J PHY, V446, P9, DOI 10.1007/s00424-002-0981-z; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Petersen EW, 2005, AM J PHYSIOL-ENDOC M, V288, pE155, DOI 10.1152/ajpendo.00257.2004; Ploeger HE, 2009, EXERC IMMUNOL REV, V15, P6; Rahman SA, 2015, BRAIN BEHAV IMMUN, V47, P4, DOI 10.1016/j.bbi.2014.11.003; Scheer FAJL, 2010, P NATL ACAD SCI USA, V107, P20541, DOI 10.1073/pnas.1006749107; Shephard RJ, 1997, CAN J APPL PHYSIOL, V22, P95, DOI 10.1139/h97-009; Stallknecht B, 1995, AM J PHYSIOL-ENDOC M, V269, pE1059, DOI 10.1152/ajpendo.1995.269.6.E1059; Steensberg A, 2001, AM J PHYSIOL-CELL PH, V281, pC1001; Takagi S, 2014, J SPORT SCI, V32, P175, DOI 10.1080/02640414.2013.815360; TRINE MR, 1995, SPORTS MED, V20, P328, DOI 10.2165/00007256-199520050-00004; van Hall G, 2003, J CLIN ENDOCR METAB, V88, P3005, DOI 10.1210/jc.2002-021687; Wolsk E, 2010, AM J PHYSIOL-ENDOC M, V299, pE832, DOI 10.1152/ajpendo.00328.2010; Zelazowska EB, 1997, MED SCI SPORT EXER, V29, P467, DOI 10.1097/00005768-199704000-00007	33	24	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137567	10.1371/journal.pone.0137567	http://dx.doi.org/10.1371/journal.pone.0137567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352938	Green Submitted, Green Published, gold			2022-12-26	WOS:000360932800096
J	Luo, YG; Liu, P; Shi, L; Luo, YS; Yi, L; Li, A; Qin, J; Heng, PA; Wang, DF				Luo, Yun-gang; Liu, Ping; Shi, Lin; Luo, Yishan; Yi, Lei; Li, Ang; Qin, Jing; Heng, Pheng-Ann; Wang, Defeng			Accelerating Neuroimage Registration through Parallel Computation of Similarity Metric	PLOS ONE			English	Article							IMAGE REGISTRATION; OPTIMIZATION; ROBUST	Neuroimage registration is crucial for brain morphometric analysis and treatment efficacy evaluation. However, existing advanced registration algorithms such as FLIRT and ANTs are not efficient enough for clinical use. In this paper, a GPU implementation of FLIRT with the correlation ratio (CR) as the similarity metric and a GPU accelerated correlation coefficient (CC) calculation for the symmetric diffeomorphic registration of ANTs have been developed. The comparison with their corresponding original tools shows that our accelerated algorithms can greatly outperform the original algorithm in terms of computational efficiency. This paper demonstrates the great potential of applying these registration tools in clinical applications.	[Luo, Yun-gang] Jilin Univ, Dept Stomatol, Hosp 2, Changchun 130041, Jilin, Peoples R China; [Liu, Ping; Qin, Jing; Heng, Pheng-Ann] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Shi, Lin] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Shi, Lin] Chinese Univ Hong Kong, Chow Yuk Ho Technol Ctr Innovat Med, Hong Kong, Hong Kong, Peoples R China; [Luo, Yishan; Li, Ang; Wang, Defeng] Chinese Univ Hong Kong, Res Ctr Med Image Comp, Dept Imaging & Intervent Radiol, Hong Kong, Hong Kong, Peoples R China; [Yi, Lei] Second Peoples Hosp Shenzhen, Dept Radiol, Shenzhen, Peoples R China; [Heng, Pheng-Ann] Chinese Univ Hong Kong, Dept Comp Sci & Engn, Hong Kong, Hong Kong, Peoples R China; [Wang, Defeng] CUHK Shenzhen Res Inst, Shenzhen, Peoples R China; [Wang, Defeng] Chinese Univ Hong Kong, Dept Biomed Engn, Hong Kong, Hong Kong, Peoples R China; [Wang, Defeng] Chinese Univ Hong Kong, Shun Hing Inst Adv Engn, Hong Kong, Hong Kong, Peoples R China	Jilin University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Second People's Hospital of Shenzhen; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Luo, YG (corresponding author), Jilin Univ, Dept Stomatol, Hosp 2, Changchun 130041, Jilin, Peoples R China.	luoyungang@sohu.com; shilin@cuhk.edu.hk	Shi, Lin/K-5241-2014	Shi, Lin/0000-0003-2318-4669; Heng, Pheng Ann/0000-0003-3055-5034	Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK 475711, CUHK 416712, CUHK 473012, CUHK 14113214]; Ministry of Science and Technology of the People's Republic of China [2013DFG12900]; National Natural Science Foundation of China [61233012, 81201157]; Science, Technology and Innovation Commission of Shenzhen Municipality [CXZZ20140606164105361, JCYJZ20130401112102666]; Shenzhen Basic Research Project [CYJ20130402113127511]; Natural Science Foundation of Guangdong [S2013010014973]; Shun Hing Institute of Advanced Engineering, The Chinese University of Hong Kong [BME-p2-13/BME-CUHK]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science, Technology and Innovation Commission of Shenzhen Municipality; Shenzhen Basic Research Project; Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Shun Hing Institute of Advanced Engineering, The Chinese University of Hong Kong(Chinese University of Hong Kong)	The work described in this paper was supported by grants from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No.: CUHK 475711, CUHK 416712, CUHK 473012, CUHK 14113214), a grant from Ministry of Science and Technology of the People's Republic of China (Project No.: 2013DFG12900), and grants from the National Natural Science Foundation of China (Project No. 61233012, and 81201157), and grants from The Science, Technology and Innovation Commission of Shenzhen Municipality (No. CXZZ20140606164105361, JCYJZ20130401112102666), a grant of Shenzhen Basic Research Project (No. CYJ20130402113127511), a grant from Natural Science Foundation of Guangdong (No. S2013010014973) and by project BME-p2-13/BME-CUHK of the Shun Hing Institute of Advanced Engineering, The Chinese University of Hong Kong.	Ang L, DIG SYST DES DSD 201, P82; Avants B, 2009, INSIGHT J; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Chen SF, 2009, 2009 INTERNATIONAL CONFERENCE ON FUTURE BIOMEDICAL INFORMATION ENGINEERING (FBIE 2009), P544, DOI 10.1109/FBIE.2009.5405778; Chen SF, 2009, LECT NOTES COMPUT SC, V5574, P281, DOI 10.1007/978-3-642-03095-6_28; Chou CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050540; Eklund A, 2013, MED IMAGE ANAL, V17, P1073, DOI 10.1016/j.media.2013.05.008; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Muyan-Ozcelik P, 2008, INTERNATIONAL CONFERENCE ON COMPUTATIONAL SCIENCES AND ITS APPLICATIONS, PROCEEDINGS, P223, DOI 10.1109/ICCSA.2008.22; Podlozhnyuk V., 2007, TECHNICAL REPORT; Roche A, 1998, LECT NOTES COMPUT SC, V1496, P1115, DOI 10.1007/BFb0056301; Satish N, 2009, INT PARALL DISTRIB P, P257; Shackleford J., 2013, HIGH PERFORMANCE DEF; Shams R., 2007, P INT C SIGN PROC CO, P418; Shams R, 2010, COMPUT METH PROG BIO, V99, P133, DOI 10.1016/j.cmpb.2009.11.004; Shams R, 2010, IEEE SIGNAL PROC MAG, V27, P50, DOI 10.1109/MSP.2009.935387; Vetter C, 2011, I S BIOMED IMAGING, P1227, DOI 10.1109/ISBI.2011.5872623	20	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136718	10.1371/journal.pone.0136718	http://dx.doi.org/10.1371/journal.pone.0136718			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352412	Green Submitted, gold, Green Published			2022-12-26	WOS:000360932800047
J	Tornero-Esteban, P; Peralta-Sastre, A; Herranz, E; Rodriguez-Rodriguez, L; Mucientes, A; Abasolo, L; Marco, F; Fernandez-Gutierrez, B; Lamas, JR				Tornero-Esteban, Pilar; Peralta-Sastre, Ascension; Herranz, Eva; Rodriguez-Rodriguez, Luis; Mucientes, Arkaitz; Abasolo, Lydia; Marco, Fernando; Fernandez-Gutierrez, Benjamin; Ramon Lamas, Jose			Altered Expression of Wnt Signaling Pathway Components in Osteogenesis of Mesenchymal Stem Cells in Osteoarthritis Patients	PLOS ONE			English	Article							HIGH BONE MASS; BETA-CATENIN; STROMAL CELLS; DKK1-MEDIATED INHIBITION; SUBCHONDRAL BONE; LRP5 GENE; OSTEOBLASTS; MUTATIONS; PROTEIN; DENSITY	Introduction Osteoarthritis (OA) is characterized by altered homeostasis of joint cartilage and bone, whose functional properties rely on chondrocytes and osteoblasts, belonging to mesenchymal stem cells (MSCs). WNT signaling acts as a hub integrating and crosstalking with other signaling pathways leading to the regulation of MSC functions. The aim of this study was to evaluate the existence of a differential signaling between Healthy and OA-MSCs during osteogenesis. Methods MSCs of seven OA patients and six healthy controls were isolated, characterised and expanded. During in vitro osteogenesis, cells were recovered at days 1, 10 and 21. RNA and protein content was obtained. Expression of WNT pathway genes was evaluated using RT-qPCR. Functional studies were also performed to study the MSC osteogenic commitment and functional and post-traslational status of beta-catenin and several receptor tyrosine kinases. Results Several genes were downregulated in OA-MSCs during osteogenesis in vitro. These included soluble Wnts, inhibitors, receptors, co-receptors, several kinases and transcription factors. Basal levels of beta-catenin were higher in OA-MSCs, but calcium deposition and expression of osteogenic genes was similar between Healthy and OA-MSCs. Interestingly an increased phosphorylation of p44/42 MAPK (ERK1/2) signaling node was present in OA-MSCs. Conclusion Our results point to the existence in OA-MSCs of alterations in expression of Wnt pathway components during in vitro osteogenesis that are partially compensated by post-translational mechanisms modulating the function of other pathways. We also point the relevance of other signaling pathways in OA pathophysiology suggesting their role in the maintenance of joint homeostasis through modulation of MSC osteogenic potential.	[Tornero-Esteban, Pilar; Peralta-Sastre, Ascension; Herranz, Eva; Rodriguez-Rodriguez, Luis; Mucientes, Arkaitz; Abasolo, Lydia; Fernandez-Gutierrez, Benjamin; Ramon Lamas, Jose] Hosp Clin San Carlos, UGC Reumatol, Inst Invest Sanitaria, Madrid 28040, Spain; [Marco, Fernando] Hosp Clin San Carlos, UGC Traumatol, Inst Invest Sanitaria, Madrid 28040, Spain	Hospital Clinico San Carlos; Hospital Clinico San Carlos	Lamas, JR (corresponding author), Hosp Clin San Carlos, UGC Reumatol, Inst Invest Sanitaria, 4a Planta,C Prof Martin Lagos S-N, Madrid 28040, Spain.	jrlamas@gmail.com	Rodriguez-Rodriguez, Luis/H-5880-2013; Mucientes, Arkaitz/AAJ-4567-2021; Mucientes, Arkaitz/AAE-4162-2022; Lamas, José Ramón/C-8318-2012; Fernandez-Gutierrez, Benjamin/AAM-9063-2020	Rodriguez-Rodriguez, Luis/0000-0002-2869-7861; Mucientes, Arkaitz/0000-0002-7431-7225; Mucientes, Arkaitz/0000-0002-7431-7225; Lamas, José Ramón/0000-0003-1913-7261; TORNERO, PILAR/0000-0003-3565-2722	ISCIII-Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER); RETICS Program (RIER) from Instituto de Salud Carlos III (ISCIII) [RD08/0075];  [CP10/00346]	ISCIII-Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); RETICS Program (RIER) from Instituto de Salud Carlos III (ISCIII); 	This work was supported by project CP10/00346 included in the Plan Nacional de I+D+I (AES 2010) and co-financed by ISCIII-Subdireccion General de Evaluacion and Fondo Europeo de Desarrollo Regional (FEDER). PT is supported by RETICS Program, RD08/0075 (RIER) from Instituto de Salud Carlos III (ISCIII).	Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Artigas N, 2014, J BIOL CHEM, V289, P27105, DOI 10.1074/jbc.M114.576793; Balemans W, 2007, J BONE MINER RES, V22, P708, DOI 10.1359/JBMR.070211; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Bernatik O, 2011, J BIOL CHEM, V286, P10396, DOI 10.1074/jbc.M110.169870; Bhat BM, 2007, GENE, V391, P103, DOI 10.1016/j.gene.2006.12.014; Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Buechling T, 2011, CURR TOP DEV BIOL, V97, P21, DOI 10.1016/B978-0-12-385975-4.00008-5; Chapman K, 2012, BONE, V51, P258, DOI 10.1016/j.bone.2011.11.026; Corr M, 2008, NAT CLIN PRACT RHEUM, V4, P550, DOI 10.1038/ncprheum0904; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; Dequeker J, 2003, AGING CLIN EXP RES, V15, P426, DOI 10.1007/BF03327364; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Gao Y, 2006, J BIOL CHEM, V281, P18394, DOI 10.1074/jbc.M601112200; Golan T, 2004, J BIOL CHEM, V279, P14879, DOI 10.1074/jbc.M306421200; Greenblatt MB, 2013, ANNU REV CELL DEV BI, V29, P63, DOI 10.1146/annurev-cellbio-101512-122347; Guilak F, 2011, BEST PRACT RES CL RH, V25, P815, DOI 10.1016/j.berh.2011.11.013; Gupta PK, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt116; Hardcastle SA, 2013, RHEUMATOLOGY, V52, P1042, DOI 10.1093/rheumatology/kes411; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Kawaguchi H, 2009, J BONE MINER RES, V24, P8, DOI 10.1359/JBMR.081115; Kim JA, 2009, STEM CELLS, V27, P1318, DOI 10.1002/stem.52; Korvala J, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-26; Lajeunesse D, 2003, CURR OPIN RHEUMATOL, V15, P628, DOI 10.1097/00002281-200309000-00018; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; Lories RJ, 2013, NAT REV RHEUMATOL, V9, P328, DOI 10.1038/nrrheum.2013.25; Lories RJ, 2011, NAT REV RHEUMATOL, V7, P43, DOI 10.1038/nrrheum.2010.197; Lories RJU, 2008, BEST PRACT RES CL RH, V22, P209, DOI 10.1016/j.berh.2007.12.001; Lories RJU, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2642; MacFarlane RJ, 2013, EXPERT OPIN THER TAR, V17, P243, DOI 10.1517/14728222.2013.746954; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Mak KK, 2008, DEV CELL, V14, P674, DOI 10.1016/j.devcel.2008.02.003; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mills CN, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00047; Pangrazio A, 2011, BONE, V49, P568, DOI 10.1016/j.bone.2011.05.006; Person AD, 2010, DEV DYNAM, V239, P327, DOI 10.1002/dvdy.22156; Prasadam I, 2012, J RHEUMATOL, V39, P621, DOI 10.3899/jrheum.110777; Shui CX, 2003, J BONE MINER RES, V18, P213, DOI 10.1359/jbmr.2003.18.2.213; Stagg J, 2013, CURR MOL MED, V13, P856, DOI 10.2174/1566524011313050016; Suda T, 2008, CELL, V132, P729, DOI 10.1016/j.cell.2008.02.017; Tat SK, 2010, BEST PRACT RES CL RH, V24, P51, DOI 10.1016/j.berh.2009.08.004; Uitterlinden AG, 2004, AM J HUM GENET, V75, P1032, DOI 10.1086/426458; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Yavropoulou Maria P, 2007, Hormones (Athens), V6, P279; Yuan YA, 2011, INT J MOL MED, V27, P63, DOI 10.3892/ijmm.2010.560; Zhang J, 2011, J BONE MINER RES, V26, P1953, DOI 10.1002/jbmr.377	48	28	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137170	10.1371/journal.pone.0137170	http://dx.doi.org/10.1371/journal.pone.0137170			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352263	gold, Green Submitted, Green Published			2022-12-26	WOS:000360932800064
J	Urrutia-Jalabert, R; Malhi, Y; Lara, A				Urrutia-Jalabert, Rocio; Malhi, Yadvinder; Lara, Antonio			The Oldest, Slowest Rainforests in the World? Massive Biomass and Slow Carbon Dynamics of Fitzroya cupressoides Temperate Forests in Southern Chile	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; NEW-ZEALAND; STORAGE; PRODUCTIVITY; CORDILLERA; ALLOCATION; BALANCE; PIUCHUE; RANGE; PINE	Old-growth temperate rainforests are, per unit area, the largest and most long-lived stores of carbon in the terrestrial biosphere, but their carbon dynamics have rarely been described. The endangered Fitzroya cupressoides forests of southern South America include stands that are probably the oldest dense forest stands in the world, with long-lived trees and high standing biomass. We assess and compare aboveground biomass, and provide the first estimates of net primary productivity (NPP), carbon allocation and mean wood residence time in medium-age stands in the Alerce Costero National Park (AC) in the Coastal Range and in old-growth forests in the Alerce Andino National Park (AA) in the Andean Cordillera. Aboveground live biomass was 113-114 Mg C ha(-1) and 448-517 Mg C ha(-1) in AC and AA, respectively. Aboveground productivity was 3.35-3.36 Mg C ha(-1) year(-1) in AC and 2.22-2.54 Mg C ha(-1) year(-1) in AA, values generally lower than others reported for temperate wet forests worldwide, mainly due to the low woody growth of Fitzroya. NPP was 4.21-4.24 and 3.78-4.10 Mg C ha(-1) year(-1) in AC and AA, respectively. Estimated mean wood residence time was a minimum of 539-640 years for the whole forest in the Andes and 1368-1393 years for only Fitzroya in this site. Our biomass estimates for the Andes place these ecosystems among the most massive forests in the world. Differences in biomass production between sites seem mostly apparent as differences in allocation rather than productivity. Residence time estimates for Fitzroya are the highest reported for any species and carbon dynamics in these forests are the slowest reported for wet forests worldwide. Although primary productivity is low in Fitzroya forests, they probably act as ongoing biomass carbon sinks on long-term timescales due to their low mortality rates and exceptionally long residence times that allow biomass to be accumulated for millennia.	[Urrutia-Jalabert, Rocio; Malhi, Yadvinder] Univ Oxford, Environm Change Inst, Sch Geog & Environm, Oxford OX1 3QY, England; [Urrutia-Jalabert, Rocio; Lara, Antonio] Univ Austral Chile, Lab Dendrocronol & Cambio Global, Inst Conservac Biodiversidad & Terr, Fac Ciencias Forestales & Recursos Nat, Valdivia, Chile; [Lara, Antonio] Univ Chile, Fac Ciencias Fis & Matemat, Ctr Climate & Resilience Res CR2, Santiago, Chile; [Lara, Antonio] Fdn Ctr Ios Bosques Nativos FORECOS, Valdivia, Chile	University of Oxford; Universidad Austral de Chile; Universidad de Chile	Urrutia-Jalabert, R (corresponding author), Univ Oxford, Environm Change Inst, Sch Geog & Environm, S Parks Rd, Oxford OX1 3QY, England.	rocio.urrutia@ouce.ox.ac.uk		Lara, Antonio/0000-0003-4998-4584	FONDECYT [1130410]; CRNII2047 project of the Inter-American Institute for Global Change Research by NSF [GEO-0452325]; Gordon and Betty Moore Foundation; Center for Climate and Resilience Research (CR)2 - CONICYT/FONDAP [15110009]; Rufford Small Grants for Nature Conservation [11371-1]; Royal Geographical Society under Monica Cole Research Grant; Jackson Foundation; European Research Council	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CRNII2047 project of the Inter-American Institute for Global Change Research by NSF; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Center for Climate and Resilience Research (CR)2 - CONICYT/FONDAP(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Rufford Small Grants for Nature Conservation; Royal Geographical Society under Monica Cole Research Grant; Jackson Foundation; European Research Council(European Research Council (ERC)European Commission)	Funding: This work was supported by the FONDECYT Project No. 1130410 (RU-J, www.conicyt.cl/fondecyt), the CRNII2047 project of the Inter-American Institute for Global Change Research supported by NSF (Grant GEO-0452325, RU-J, http://www.iai.int/), the Gordon and Betty Moore Foundation grant (YM, http://www.moore.org/), the Center for Climate and Resilience Research (CR)2 funded by CONICYT/FONDAP/15110009 (AL, http://www.cr2.cl/), the Rufford Small Grants for Nature Conservation (Project 11371-1, RU-J, http://www.rufford.org/) and the Royal Geographical Society under the Monica Cole Research Grant (RU-J, http://www.rgs.org/HomePage.htm). YM is supported by the Jackson Foundation and an European Research Council Advanced Investigator Award, GEM-TRAITS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker SA, 2002, TREE PHYSIOL, V22, P213, DOI 10.1093/treephys/22.2-3.213; [Anonymous], [No title captured]; Barichivich J, 2005, THESIS U AUSTRAL CHI; Battles JJ, 2002, PLANT ECOL, V158, P5, DOI 10.1023/A:1014741821292; Binkley D, 2003, FOREST ECOL MANAG, V172, P271, DOI 10.1016/S0378-1127(01)00794-0; Busing RT, 2005, PLANT ECOL, V177, P177, DOI 10.1007/s11258-005-2322-8; Clark DA, 2001, ECOL APPL, V11, P356, DOI 10.1890/1051-0761(2001)011[0356:MNPPIF]2.0.CO;2; Clement Joel P., 2001, Selbyana, V22, P76; Clinton PW, 2002, CAN J FOREST RES, V32, P344, DOI 10.1139/X01-188; CONAF, 1985, 1 CONAF; CONAF, 2011, CAT REC VEG NAT CHIL; DGA, 2011, EST PREC MENS EST VE; Donoso C., 1990, Bosque, V11, P21; DONOSO C, 1993, J VEG SCI, V4, P303, DOI 10.2307/3235588; DONOSO C, 1993, REV CHIL HIST NAT, V66, P53; Donoso C., 2006, ESPECIES ARB REAS BO, P68; Donoso C, 1984, MEDIO AMBIENTE, V7, P9; Eggleston S., 2006, 2006 IPCC GUIDELINES, V5; Enright N., 1995, ECOLOGY SO CONIFERS, P271; Fenn K, 2015, ECOSYSTEMS, V18, P1, DOI 10.1007/s10021-014-9793-1; Ferrando J, 2001, REV FACULTAD AGRONOM, V103, P139; Fujimori T., 1976, Journal of the Japanese Forestry Society, V58, P360; Galbraith D, 2013, PLANT ECOL DIVERS, V6, P139, DOI 10.1080/17550874.2013.770578; GAYOSO A JORGE, 2005, Bosque (Valdivia), V26, P33; Gayoso J, 2002, D98I1076 FONDEF U AU; Gerding V, 2013, COMMUNICATION; GHOLZ HL, 1982, ECOLOGY, V63, P469, DOI 10.2307/1938964; Godoy R., 1989, Bosque, V10, P89; GODOY R, 1994, REV CHIL HIST NAT, V67, P209; Gower S. T., 1994, ECOL BULL, P115; Gower ST, 1997, J GEOPHYS RES-ATMOS, V102, P29029, DOI [10.1029/97JD02317, 10.1029/97JD01440]; GOWER ST, 1995, RESOURCE PHYSL CONIF, P217; Gutiurrez E., 1991, OECOLOGIA AQUATICA, V10, P351; Harmon ME, 2004, ECOSYSTEMS, V7, P498, DOI 10.1007/s10021-004-0140-9; Hessl A.E., 2004, ECOPHYSIOLOGICAL PAR; Huston MA, 2009, ECOL MONOGR, V79, P343, DOI 10.1890/08-0588.1; IUCN, 2013, IUCN RED LIST THREAT; Johnson CM, 1999, THESIS U PENNSYLVANI; Joshi AB, 2006, SOIL SCI SOC AM J, V70, P153, DOI 10.2136/sssaj2004.0173; Keeling HC, 2007, GLOBAL ECOL BIOGEOGR, V16, P618, DOI 10.1111/j.1466-8238.2007.00314.x; Keith H, 2009, P NATL ACAD SCI USA, V106, P11635, DOI 10.1073/pnas.0901970106; Laclau P, 2003, FOREST ECOL MANAG, V180, P317, DOI 10.1016/S0378-1127(02)00580-7; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3; LARA A, 1993, SCIENCE, V260, P1104, DOI 10.1126/science.260.5111.1104; Lara A, 1999, ECOSCIENCE, V6, P100, DOI 10.1080/11956860.1999.11952199; Lara A., 1991, THESIS U COLORADO BO; Lara A, 2002, ENZYKLOPADIE HOLZGEW, P1; Litton CM, 2007, GLOBAL CHANGE BIOL, V13, P2089, DOI 10.1111/j.1365-2486.2007.01420.x; Lusk CH, 2000, J BIOGEOGR, V27, P1011, DOI 10.1046/j.1365-2699.2000.00449.x; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2509, DOI 10.1111/j.1365-2486.2007.01439.x; Malhi Y, 2014, PLANT ECOL DIVERS, V7, P85, DOI 10.1080/17550874.2013.820805; Malhi Y, 2011, PHILOS T R SOC B, V366, P3225, DOI 10.1098/rstb.2011.0062; Malhi Y, 2009, GLOBAL CHANGE BIOL, V15, P1255, DOI 10.1111/j.1365-2486.2008.01780.x; Marthews T., 2012, MEASURING TROPICAL F; Pan Y, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200004; Peralta M., 1982, CIENCIAS FORESTALES, V2, P39; Perez CA, 2003, AUSTRAL ECOL, V28, P591, DOI 10.1046/j.1442-9993.2003.01315.x; Pregitzer KS, 2004, GLOBAL CHANGE BIOL, V10, P2052, DOI 10.1111/j.1365-2486.2004.00866.x; Prodan M., 1997, MENSURA FORESTAL; RUNYON J, 1994, ECOL APPL, V4, P226, DOI 10.2307/1941929; Schlegel BC, 2008, FOREST ECOL MANAG, V255, P1906, DOI 10.1016/j.foreco.2007.12.013; SCHULMAN E, 1954, SCIENCE, V119, P396, DOI 10.1126/science.119.3091.396; Silvester WB, 1999, NEW ZEAL J BOT, V37, P553, DOI 10.1080/0028825X.1999.9512653; Smithwick EAH, 2002, ECOL APPL, V12, P1303, DOI 10.1890/1051-0761(2002)012[1303:PUBOCS]2.0.CO;2; Teobaldelli M, 2009, FOREST ECOL MANAG, V257, P1004, DOI 10.1016/j.foreco.2008.11.002; Urrutia-Jalabert R, ECOSPHERE UNPUB; Van Tuyl S, 2005, FOREST ECOL MANAG, V209, P273, DOI 10.1016/j.foreco.2005.02.002; Vann DR, 2002, BIOGEOCHEMISTRY, V60, P25, DOI 10.1023/A:1016550027991; Vann DR, 1998, FOREST ECOL MANAG, V106, P55, DOI 10.1016/S0378-1127(97)00215-6; Vann DR, 2013, COMMUNICATION; VEBLEN T T, 1976, Environmental Conservation, V3, P291; Veblen T.T., 2005, ECOSYSTEMS WORLD CON, P701; VEBLEN TT, 1982, BIOL CONSERV, V23, P141, DOI 10.1016/0006-3207(82)90036-2; Vicca S, 2012, ECOL LETT, V15, P520, DOI 10.1111/j.1461-0248.2012.01775.x; VOGT KA, 1986, ADV ECOL RES, V15, P303, DOI 10.1016/S0065-2504(08)60122-1; Waring RH, 1998, TREE PHYSIOL, V18, P129; WESTMAN WE, 1975, J ECOL, V63, P493, DOI 10.2307/2258732; Wolodarsky-Franke Alexia, 2005, Dendrochronologia, V22, P235, DOI 10.1016/j.dendro.2005.05.008	78	19	20	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137569	10.1371/journal.pone.0137569	http://dx.doi.org/10.1371/journal.pone.0137569			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353111	Green Submitted, Green Published, gold			2022-12-26	WOS:000360932800097
J	Wang, XF; Liu, YG				Wang, Xiaofeng; Liu, Yiguang			Accurate and Fast Convergent Initial-Value Belief Propagation for Stereo Matching	PLOS ONE			English	Article							ADAPTIVE SUPPORT-WEIGHT	The belief propagation (BP) algorithm has some limitations, including ambiguous edges and textureless regions, and slow convergence speed. To address these problems, we present a novel algorithm that intrinsically improves both the accuracy and the convergence speed of BP. First, traditional BP generally consumes time due to numerous iterations. To reduce the number of iterations, inspired by the crucial importance of the initial value in nonlinear problems, a novel initial-value belief propagation (IVBP) algorithm is presented, which can greatly improve both convergence speed and accuracy. Second,. the majority of the existing research on BP concentrates on the smoothness term or other energy terms, neglecting the significance of the data term. In this study, a self-adapting dissimilarity data term (SDDT) is presented to improve the accuracy of the data term, which incorporates an additional gradient-based measure into the traditional data term, with the weight determined by the robust measure-based control function. Finally, this study explores the effective combination of local methods and global methods. The experimental results have demonstrated that our method performs well compared with the state-of-the-art BP and simultaneously holds better edge-preserving smoothing effects with fast convergence speed in the Middlebury and new 2014 Middlebury datasets.	[Wang, Xiaofeng; Liu, Yiguang] Sichuan Univ, Coll Comp Sci, Vis & Image Proc Lab, Chengdu 610064, Peoples R China; [Wang, Xiaofeng] Chongqing Univ Sci & Technol, Coll Math & Phys Sci, Chongqing, Peoples R China	Sichuan University; Chongqing University of Science & Technology	Liu, YG (corresponding author), Sichuan Univ, Coll Comp Sci, Vis & Image Proc Lab, Chengdu 610064, Peoples R China.	liuyg@scu.edu.cn	Liu, Yiguang/C-6404-2011		National Natural Science Foundation of China [61571313, 61173182, 61411130133]; Sichuan Province [2014HH0048, 2014HH0025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Province	This work was supported in part by the National Natural Science Foundation of China under Grant 61571313, Grant 61173182, and Grant 61411130133 and in part by the Sichuan Province under Grant 2014HH0048 and Grant 2014HH0025.	Barzigar N, 2012, J VISUAL COMMUNICATI, V24, P137; Brown MZ, 2003, IEEE T PATTERN ANAL, V25, P993, DOI 10.1109/TPAMI.2003.1217603; Felzenszwalb PF, 2006, INT J COMPUT VISION, V70, P41, DOI 10.1007/s11263-006-7899-4; Gu Z, 2008, PATTERN RECOGN LETT, V29, P1230, DOI 10.1016/j.patrec.2008.01.032; He KM, 2010, LECT NOTES COMPUT SC, V6311, P1; Hong L, 2004, PROC CVPR IEEE, P74; Hosni A, 2009, IEEE IMAGE PROC, P2093, DOI 10.1109/ICIP.2009.5414478; Jung HY, 2011, IEEE I CONF COMP VIS, P1211, DOI 10.1109/ICCV.2011.6126371; Klaus A, 2006, INT C PATT RECOG, P15; Kowalczuk J, 2013, IEEE T CIRC SYST VID, V23, P94, DOI 10.1109/TCSVT.2012.2203200; Larsen ES, 2007, IEEE I CONF COMP VIS, P1440; Li G., 2006, IEEE COMP SOC C, P2355; Liang Wang, 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P3033, DOI 10.1109/CVPR.2011.5995480; Mei TC, 2015, APPL OPTICS, V54, P3372, DOI 10.1364/AO.54.003372; Mei X, 2011, PROC CVPR IEEE, P1257; Min DB, 2013, IEEE T PATTERN ANAL, V35, P2539, DOI 10.1109/TPAMI.2013.15; Montserrat T, 2009, IEEE IMAGE PROC, P2353, DOI 10.1109/ICIP.2009.5413610; Mozerov MG, 2015, IEEE T IMAGE PROCESS, V24, P1153, DOI 10.1109/TIP.2015.2395820; Neilson D, 2011, IEEE T PATTERN ANAL, V33, P2147, DOI 10.1109/TPAMI.2011.67; Pugeault N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010663; Rhemann C, 2011, PROC CVPR IEEE, DOI 10.1109/CVPR.2011.5995372; Sato H, 2015, SWARM EVOL COMPUT, V23, P1, DOI 10.1016/j.swevo.2015.02.002; Scharstein D, 2002, INT J COMPUT VISION, V47, P7, DOI 10.1023/A:1014573219977; Su QL, 2015, IEEE T SIGNAL PROCES, V63, P1144, DOI 10.1109/TSP.2015.2389755; Sun J, 2005, PROC CVPR IEEE, P399; Sun J, 2003, IEEE T PATTERN ANAL, V25, P787, DOI 10.1109/TPAMI.2003.1206509; Tappen MF, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P900; Woodford O, 2008, IEEE COMP SOC C COMP, P900; Wu PF, 2015, IEEE T MED IMAGING, V34, P1321, DOI 10.1109/TMI.2015.2388699; Yang Q, 2008, BMVC, V1, P924; Yang Q., 2006, PROC BR MACH VIS C, P989, DOI [10.5244/c.20.101, DOI 10.5244/C.20.101]; Yang QX, 2010, PROC CVPR IEEE, P1458, DOI 10.1109/CVPR.2010.5539797; Yang QX, 2009, PROC CVPR IEEE, P557, DOI 10.1109/CVPRW.2009.5206542; Yang QX, 2009, IEEE T PATTERN ANAL, V31, P492, DOI 10.1109/TPAMI.2008.99; Yoon KJ, 2006, IEEE T PATTERN ANAL, V28, P650, DOI 10.1109/TPAMI.2006.70; Zabih R., 1994, P 3 EUR C COMP VIS, P150; Zitnick CL, 2007, INT J COMPUT VISION, V75, P49, DOI 10.1007/s11263-006-0018-8	37	0	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137530	10.1371/journal.pone.0137530	http://dx.doi.org/10.1371/journal.pone.0137530			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26349063	gold, Green Submitted, Green Published			2022-12-26	WOS:000360897600052
J	Vanithamani, S; Shanmughapriya, S; Narayanan, R; Raja, V; Kanagavel, M; Sivasankari, K; Natarajaseenivasan, K				Vanithamani, Shanmugam; Shanmughapriya, Santhanam; Narayanan, Ramasamy; Raja, Veerapandian; Kanagavel, Murugesan; Sivasankari, Karikalacholan; Natarajaseenivasan, Kalimuthusamy			Lipopolysaccharide Specific Immunochromatography Based Lateral Flow Assay for Serogroup Specific Diagnosis of Leptospirosis in India	PLOS ONE			English	Article							SERODIAGNOSIS; IMMUNOGLOBULIN; ANTIBODY; ANTIGEN	Background Leptospirosis is a re-emerging infectious disease that is under-recognized due to low-sensitivity and cumbersome serological tests. MAT is the gold standard test and it is the only serogroup specific test used till date. Rapid reliable alternative serogroup specific tests are needed for surveillance studies to identify locally circulating serogroups in the study area. Methods/Principal Findings In the present investigation the serological specificity of leptospiral lipopolysaccharides (LPS) was evaluated by enzyme linked immunosorbent assay (ELISA), dot blot assay and rapid immunochromatography based lateral flow assay (ICG-LFA). Sera samples from 120 MAT positive cases, 174 cases with febrile illness other than leptospirosis, and 121 seronegative healthy controls were evaluated for the diagnostic sensitivity and specificity of the developed assays. LPS was extracted from five locally predominant circulating serogroups including: Australis (27.5%), Autumnalis (11.7%), Ballum (25.8%), Grippotyphosa (12.5%), Pomona (10%) and were used as antigens in the diagnostics to detect IgM antibodies in patients' sera. The sensitivity observed by IgM ELISA and dot blot assay using various leptospiral LPS was >90% for homologous sera. Except for Ballum LPS, no other LPS showed cross-reactivity to heterologous sera. An attempt was made to develop LPS based ICG-LFA for rapid and sensitive serogroup specific diagnostics of leptospirosis. The developed ICG-LFA showed sensitivity in the range between 93 and 100% for homologous sera. The Wilcoxon analysis showed LPS based ICG-LFA did not differ significantly from the gold standard MAT (P>0.05). Conclusion The application of single array of LPS for serogroup specific diagnosis is first of its kind. The developed assay could potentially be evaluated and employed for as MAT alternative.	[Vanithamani, Shanmugam; Shanmughapriya, Santhanam; Narayanan, Ramasamy; Raja, Veerapandian; Kanagavel, Murugesan; Sivasankari, Karikalacholan; Natarajaseenivasan, Kalimuthusamy] Bharathidasan Univ, Dept Microbiol, Ctr Excellence Life Sci, Med Microbiol Lab, Tiruchirappalli 620024, India	Bharathidasan University	Natarajaseenivasan, K (corresponding author), Bharathidasan Univ, Dept Microbiol, Ctr Excellence Life Sci, Med Microbiol Lab, Tiruchirappalli 620024, India.	natarajaseenivasan@rediffmail.com	Veerapandian, Raja/AAJ-1425-2020; Murugesan, Kanagavel/K-2006-2019	Veerapandian, Raja/0000-0003-1118-0038; Murugesan, Kanagavel/0000-0003-3334-5358	Indian Council of Medical Research (ICMR) and Department of Biotechnology, Ministry of Science and Technology, New Delhi [5/3/3/3/2007-ECD-I, BT/PR6872/MED/14/892/2005]; Indian Council of Medical Research (ICMR)	Indian Council of Medical Research (ICMR) and Department of Biotechnology, Ministry of Science and Technology, New Delhi; Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR))	The research was funded by Indian Council of Medical Research (ICMR) and Department of Biotechnology, Ministry of Science and Technology, New Delhi (ICMR Grant No: 5/3/3/3/2007-ECD-I; DBT Grant No. BT/PR6872/MED/14/892/2005). The funders had no role in study design, data collection and analysis, decision to publish or preparation of manuscript.	Bajani MD, 2003, J CLIN MICROBIOL, V41, P803, DOI 10.1128/JCM.41.2.803-809.2003; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Goris MGA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018279; Gouveia EL, 2008, EMERG INFECT DIS, V14, P757; Hull-Jackson C, 2006, J CLIN MICROBIOL, V44, P1853, DOI 10.1128/JCM.44.5.1853-1855.2006; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; Merien F, 2005, FEMS MICROBIOL LETT, V249, P139, DOI 10.1016/j.femsle.2005.06.011; Nally JE, 2004, AM J PATHOL, V164, P1115, DOI 10.1016/S0002-9440(10)63198-7; Natarajaseenivasan K., 2012, WORLD J VACCINE, P85; Prabhakaran SG, 2014, J PUBLIC HEALTH-HEID, V22, P323, DOI 10.1007/s10389-014-0611-1; Priya CG, 2003, J MED MICROBIOL, V52, P667, DOI 10.1099/jmm.0.05120-0; Raja V, 2015, CRIT REV MICROBIOL, V41, P1, DOI 10.3109/1040841X.2013.787387; Ramadass P, 1999, VET MICROBIOL, V70, P137, DOI 10.1016/S0378-1135(99)00133-9; Sehgal S C, 2003, Southeast Asian J Trop Med Public Health, V34 Suppl 2, P170; Sehgal SC, 1999, T ROY SOC TROP MED H, V93, P161, DOI 10.1016/S0035-9203(99)90293-6; Sehgal SC, 1997, INDIAN J MED RES, V106, P504; Shim WB, 2006, J AGR FOOD CHEM, V54, P9728, DOI 10.1021/jf0620057; TERPSTRA WJ, 1985, J GEN MICROBIOL, V131, P377; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Toyokawa T, 2011, EXPERT REV ANTI-INFE, V9, P111, DOI [10.1586/eri.10.151, 10.1586/ERI.10.151]; Trueba G A, 1990, J Vet Diagn Invest, V2, P323; Vijayachari P, 2001, INDIAN J MED RES, V114, P99; Vijayachari P, 2002, EPIDEMIOL INFECT, V129, P617, DOI 10.1017/S0950268802007537; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; Widiyanti D, 2013, CLIN VACCINE IMMUNOL, V20, P683, DOI 10.1128/CVI.00756-12; Winslow WE, 1997, J CLIN MICROBIOL, V35, P1938, DOI 10.1128/JCM.35.8.1938-1942.1997	28	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137130	10.1371/journal.pone.0137130	http://dx.doi.org/10.1371/journal.pone.0137130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340095	Green Submitted, Green Published, gold			2022-12-26	WOS:000360688200024
J	Clemens, KK; Shariff, S; Liu, KA; Hramiak, I; Mahon, JL; McArthur, E; Garg, AX				Clemens, Kristin K.; Shariff, Salimah; Liu, Kuan; Hramiak, Irene; Mahon, Jeffrey L.; McArthur, Eric; Garg, Amit X.			Trends in Antihyperglycemic Medication Prescriptions and Hypoglycemia in Older Adults: 2002-2013	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; ROSIGLITAZONE; MONOTHERAPY; THERAPY; COMPLICATIONS; HYPERGLYCEMIA; PIOGLITAZONE; METFORMIN; ONTARIO; EVENTS	Background Over the last decade, several new antihyperglycemic medications have been introduced including those associated with a lower hypoglycemia risk. We aimed to investigate how these medications are being prescribed to older adults in our region. Methods We conducted population-based cross-sectional analyses of older adults (mean age 75 years) with treated diabetes in Ontario, Canada from 2002 until 2013, to examine the percentage prescribed insulin, sulphonylureas, alpha-glucosidase inhibitors, metformin, thiazolidinediones, meglitinides, and dipeptidyl peptidase-4 inhibitors. Over the study period, we also examined their hospital encounters for hypoglycemia (emergency room or inpatient encounter). Results The mean age of treated patients increased slightly over the study quarters and the proportion that were women declined. With the exception of chronic kidney disease, cancer, dementia, and neuropathy, the percentage with a comorbidity appeared to decline. The percentage of treated patients prescribed metformin, gliclazide and dipeptidyl peptidase-4 inhibitors increased as did combination therapy. Glyburide and thiazolidinedione prescriptions declined, and insulin use remained stable. In those with newly treated diabetes, the majority were prescribed metformin, with smaller percentages prescribed insulin and other oral agents. Although the absolute number of treated patients with a hypoglycemia encounter increased until mid-2006 and then decreased, the overall percentage with an encounter declined over the study period (0.8% with an event in the first quarter, 0.4% with an event in the last quarter). Conclusions Antihyperglycemic medications with safer profiles are being increasingly prescribed to older adults. In this setting there has been a decrease in the percentage of treated patients with a hospital encounter for hypoglycemia.	[Clemens, Kristin K.; Garg, Amit X.] Univ Western Ontario, Dept Med, London, ON, Canada; [Shariff, Salimah; Liu, Kuan; McArthur, Eric; Garg, Amit X.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Hramiak, Irene; Mahon, Jeffrey L.] Univ Western Ontario, Dept Med, Div Endocrinol, London, ON, Canada; [Mahon, Jeffrey L.; Garg, Amit X.] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada	Western University (University of Western Ontario); University of Toronto; Western University (University of Western Ontario); Western University (University of Western Ontario)	Clemens, KK (corresponding author), Univ Western Ontario, Dept Med, London, ON, Canada.	kclemens2008@meds.uwo.ca	Clemens, Kristin K/K-8898-2016; Garg, Amit X/G-3295-2011; Hramiak, Irene/G-3305-2011; Mahon, Jeff/G-3324-2011	Shariff, Salimah/0000-0002-1219-6763	Ontario Ministry of Health; Long-term Care (MOHLTC); Academic Medical Organization of Southwestern Ontario (AMOSO); Schulich School of Medicine and Dentistry (SSMD), Western University; Lawson Health Research Institute (LHRI); Adam Linton Chair in Kidney Health Analytics	Ontario Ministry of Health(Ministry of Health and Long-Term Care, Ontario); Long-term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Academic Medical Organization of Southwestern Ontario (AMOSO); Schulich School of Medicine and Dentistry (SSMD), Western University; Lawson Health Research Institute (LHRI); Adam Linton Chair in Kidney Health Analytics	This project was conducted at the Institute for Clinical Evaluative Sciences (ICES) Western Site. ICES is funded by an annual grant from the Ontario Ministry of Health and Long-term Care (MOHLTC). Core funding for ICES Western is provided by the Academic Medical Organization of Southwestern Ontario (AMOSO), the Schulich School of Medicine and Dentistry (SSMD), Western University, and the Lawson Health Research Institute (LHRI). Dr. Amit Garg was supported by the Adam Linton Chair in Kidney Health Analytics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions, results, and conclusions are those of the authors, and no endorsement by ICES, AMOSO, SSMD, LHRI or the MOHLTC is intended or should be inferred. Parts of this material are based upon data and information compiled and provided by the Canadian Institute for Health Information (CIHI). However the analysis, conclusions, opinions and statements expressed herein are those of the authors and not necessarily CIHI.	Baviera M, 2011, DIABETES RES CLIN PR, V93, P123, DOI 10.1016/j.diabres.2011.05.004; Booth GL, 2005, DIABETES CARE, V28, P1045, DOI 10.2337/diacare.28.5.1045; Bronskill S, 2010, AGING ONTARIO ICES C; Cohen A, 2010, DIABETES CARE, V33, P823, DOI 10.2337/dc09-1834; Desai NR, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.07.033; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Doucet J, 2011, CURR MED RES OPIN, V27, P863, DOI 10.1185/03007995.2011.554532; Filion KB, 2009, PHARMACOEPIDEM DR S, V18, P973, DOI 10.1002/pds.1802; Foster PD, 2013, DIABETIC MED, V30, P1209, DOI 10.1111/dme.12214; Garber AJ, 2002, DIABETES OBES METAB, V4, P201, DOI 10.1046/j.1463-1326.2002.00211.x; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Hampp C, 2014, DIABETES CARE, V37, P1367, DOI 10.2337/dc13-2289; Harper W, 2013, CANADIAN DIABETES AS; Hashim S, 2013, J POPUL THER CLIN PH, V20, pE238; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Huang ES, 2013, JAMA INTERN MED, P251; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Kahn SE, 2008, DIABETES CARE, V31, P845, DOI 10.2337/dc07-2270; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Lipscombe LL, 2007, JAMA-J AM MED ASSOC, V298, P2634, DOI 10.1001/jama.298.22.2634; Lipska KJ, 2014, JAMA INTERN MED, V174, P1116, DOI 10.1001/jamainternmed.2014.1824; Meinelly G, 2013, CANADIAN DIABETES AS; Nissen SE, 2010, ARCH INTERN MED, V170, P1191, DOI 10.1001/archinternmed.2010.207; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Rathmann W, 2007, DIABETES CARE, V30, P848, DOI 10.2337/dc06-2000; Rosenstock J, 2006, DIABETES OBES METAB, V8, P650, DOI 10.1111/j.1463-1326.2006.00659.x; Rosenstock J, 2013, DIABETES OBES METAB, V15, P906, DOI 10.1111/dom.12102; Rosenstock J, 2006, DIABETES OBES METAB, V8, P49, DOI 10.1111/j.1463-1326.2005.00541.x; Statistics Canada website, 2014, STAT CAN POP SEX AG; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; vanStaa T, 1997, J CLIN EPIDEMIOL, V50, P735, DOI 10.1016/S0895-4356(97)00024-3; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Zaharan NL, 2014, IRISH J MED SCI, V183, P311, DOI 10.1007/s11845-013-1011-1	34	33	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137596	10.1371/journal.pone.0137596	http://dx.doi.org/10.1371/journal.pone.0137596			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335938	Green Submitted, Green Published, gold			2022-12-26	WOS:000360615400071
J	Conchuir, SO; Barlow, KA; Pache, RA; Ollikainen, N; Kundert, K; O'Meara, MJ; Smith, CA; Kortemme, T				Conchuir, Shane O.; Barlow, Kyle A.; Pache, Roland A.; Ollikainen, Noah; Kundert, Kale; O'Meara, Matthew J.; Smith, Colin A.; Kortemme, Tanja			A Web Resource for Standardized Benchmark Datasets, Metrics, and Rosetta Protocols for Macromolecular Modeling and Design	PLOS ONE			English	Article							PROTEIN-PROTEIN DOCKING; STRUCTURE PREDICTION; BINDING-ENERGY; HOT-SPOTS; SIMULATION; INFORMATION; STABILITY; EVOLUTION; DATABASE; DENSITY	The development and validation of computational macromolecular modeling and design methods depend on suitable benchmark datasets and informative metrics for comparing protocols. In addition, if a method is intended to be adopted broadly in diverse biological applications, there needs to be information on appropriate parameters for each protocol, as well as metrics describing the expected accuracy compared to experimental data. In certain disciplines, there exist established benchmarks and public resources where experts in a particular methodology are encouraged to supply their most efficient implementation of each particular benchmark. We aim to provide such a resource for protocols inmacromolecularmodeling and design. We present a freely accessible web resource (https://kortemmelab.ucsf.edu/benchmarks) to guide the development of protocols for protein modeling and design. The site provides benchmark datasets and metrics to compare the performance of a variety of modeling protocols using different computational samplingmethods and energy functions, providing a "best practice" set of parameters for each method. Each benchmark has an associated downloadable benchmark capture archive containing the input files, analysis scripts, and tutorials for running the benchmark. The capturesmay be run with any suitable modeling method; we supply command lines for running the benchmarks using the Rosetta software suite. We have compiled initial benchmarks for the resource spanning three key areas: prediction of energetic effects of mutations, protein design, and protein structure prediction, each with associated state-of-the-art modeling protocols. With the help of the wider macromolecular modeling community, we hope to expand the variety of benchmarks included on the website and continue to evaluate new iterations of currentmethods as they become available.	[Conchuir, Shane O.; Pache, Roland A.; Smith, Colin A.; Kortemme, Tanja] Univ Calif San Francisco, Calif Inst Quantitat Biosci QB3, San Francisco, CA 94143 USA; [Conchuir, Shane O.; Pache, Roland A.; Smith, Colin A.; Kortemme, Tanja] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Barlow, Kyle A.; Ollikainen, Noah; Smith, Colin A.; Kortemme, Tanja] Univ Calif San Francisco, Grad Program Bioinformat, San Francisco, CA 94143 USA; [Kundert, Kale; Kortemme, Tanja] Univ Calif San Francisco, Grad Program Biophys, San Francisco, CA 94143 USA; [O'Meara, Matthew J.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Barlow, KA (corresponding author), Univ Calif San Francisco, Grad Program Bioinformat, San Francisco, CA 94143 USA.	kb@kylebarlow.com; kortemme@cgl.ucsf.edu	Smith, Colin A/E-5713-2012; Kortemme, Tanja/AAN-3180-2021	Smith, Colin A/0000-0002-4651-167X; Barlow, Kyle/0000-0002-9787-0066; Kortemme, Tanja/0000-0002-8494-680X; Pache, Roland/0000-0002-4723-6729; O'Meara, Matthew/0000-0002-3128-5331	National Science Foundation (NSF) [DBI-1262182]; National Institutes of Health (NIH) [R01GM098101]; Achievement Awards for College Scientists (ARCS) Scholarship; Direct For Biological Sciences [1262182] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098101, R01GM110089, T32GM067547, T32GM008284] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Achievement Awards for College Scientists (ARCS) Scholarship; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants from the National Science Foundation (NSF) to TK (NSF DBI-1262182), the National Institutes of Health (NIH) (NIH R01GM098101), and an Achievement Awards for College Scientists (ARCS) Scholarship to KAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley D, 2004, COMPUTER LANGUAGE BE; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benedix A, 2009, NAT METHODS, V6, P3, DOI 10.1038/nmeth0109-3; Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Calpini A, 2003, GREAT WIN32 COMPUTER; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Coutsias EA, 2004, J COMPUT CHEM, V25, P510, DOI 10.1002/jcc.10416; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darnell SJ, 2008, NUCLEIC ACIDS RES, V36, pW265, DOI 10.1093/nar/gkn346; Dickson RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011082; Dokholyan NV, 2001, J MOL BIOL, V312, P289, DOI 10.1006/jmbi.2001.4949; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Ernst A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000416; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hwang H, 2010, PROTEINS, V78, P3111, DOI 10.1002/prot.22830; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Janin J, 2007, STRUCTURE, V15, P755, DOI 10.1016/j.str.2007.06.007; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kumar MDS, 2006, NUCLEIC ACIDS RES, V34, pD204, DOI 10.1093/nar/gkj103; Leaver-Fay A, 2013, METHOD ENZYMOL, V523, P109, DOI [10.1016/B978-0-12:394292-0.00006-0, 10.1016/B978-0-12-394292-0.00006-0]; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Mintseris J, 2005, PROTEINS, V60, P214, DOI 10.1002/prot.20560; Moult J, 2014, PROTEINS, V82, P1, DOI 10.1002/prot.24452; O'Meara MJ, 2015, J CHEM THEORY COMPUT, V11, P609, DOI 10.1021/ct500864r; Ollikainen N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003313; Ollikainen N, 2013, METHOD ENZYMOL, V523, P61, DOI 10.1016/B978-0-12-394292-0.00004-7; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; Rohl CA, 2004, PROTEINS, V55, P656, DOI 10.1002/prot.10629; Sellers BD, 2008, PROTEINS, V72, P959, DOI 10.1002/prot.21990; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; Smith CA, 2008, J MOL BIOL, V380, P742, DOI 10.1016/j.jmb.2008.05.023; Smith CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020451; Smith CA, 2010, J MOL BIOL, V402, P460, DOI 10.1016/j.jmb.2010.07.032; Stein A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063090; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Yona G, 2002, J MOL BIOL, V315, P1257, DOI 10.1006/jmbi.2001.5293; Zhao SW, 2011, PROTEINS, V79, P2920, DOI 10.1002/prot.23129; Zhu K, 2006, PROTEINS, V65, P438, DOI 10.1002/prot.21040; Zhu XL, 2011, PROTEINS, V79, P2671, DOI 10.1002/prot.23094	52	44	44	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0130433	10.1371/journal.pone.0130433	http://dx.doi.org/10.1371/journal.pone.0130433			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335248	Green Published, gold, Green Submitted			2022-12-26	WOS:000360615400001
J	Muldoon, KM; Goodman, SM				Muldoon, Kathleen M.; Goodman, Steven M.			Primates as Predictors of Mammal Community Diversity in the Forest Ecosystems of Madagascar	PLOS ONE			English	Article							NATURELLE-INTEGRALE-DANDOHAHELA; CROSS-TAXON CONGRUENCE; SPECIES RICHNESS; INDICATOR GROUPS; CONSERVATION PRIORITIES; BIODIVERSITY HOTSPOTS; SUBFOSSIL OCCURRENCE; HUMID FORESTS; RESERVE; BIOGEOGRAPHY	The geographic distribution of species is the typical metric for identifying priority areas for conservation. Since most biodiversity remains poorly studied, a subset of charismatic species, such as primates, often stand as surrogates for total biodiversity. A central question is therefore, how effectively do primates predict the pooled species richness of other mammalian taxa? We used lemurs as indicator species to predict total non-primate mammal community richness in the forest ecosystems of Madagascar. We combine environmental and species occurrence data to ascertain the extent to which primate diversity can predict (1) non-primate mammal alpha-diversity (species richness), (2) non-primate complementarity, and (3) non-primate beta-diversity (species turnover). Our results indicate that primates are effective predictors of non-primate mammal community diversity in the forest ecosystems of Madagascar after controlling for habitat. When individual orders of mammals are considered, lemurs effectively predict the species richness of carnivorans and rodents (but not afrosoricids), complementarity of rodents (but not carnivorans or afrosoricids), and all individual components of beta-diversity. We conclude that lemurs effectively predict total non-primate community richness. However, surrogate species alone cannot achieve complete representation of biodiversity.	[Muldoon, Kathleen M.] Midwestern Univ, Arizona Coll Osteopath Med, Dept Anat, Glendale, AZ 85308 USA; [Goodman, Steven M.] Field Museum Nat Hist, Chicago, IL 60605 USA; [Goodman, Steven M.] Assoc Vahatra, Antananarivo, Madagascar	Midwestern University; Field Museum of Natural History (Chicago)	Muldoon, KM (corresponding author), Midwestern Univ, Arizona Coll Osteopath Med, Dept Anat, Glendale, AZ 85308 USA.	kmuldo@midwestern.edu			Conservation International; John D. and Catherine T. MacArthur Foundation; National Science Foundation [DEB 05-16313]; Volkswagen Foundation; World Wide Fund for Nature	Conservation International; John D. and Catherine T. MacArthur Foundation; National Science Foundation(National Science Foundation (NSF)); Volkswagen Foundation(Volkswagen); World Wide Fund for Nature	This work was supported by Conservation International, John D. and Catherine T. MacArthur Foundation, National Science Foundation (DEB 05-16313), Volkswagen Foundation, and World Wide Fund for Nature.	Allnutt TF, 2008, CONSERV LETT, V1, P173, DOI 10.1111/j.1755-263X.2008.00027.x; Andriamialisoa F., 2003, P1; Andrianjakarivelo V, 2005, ACTA THERIOL, V50, P537, DOI 10.1007/BF03192647; Avenant NL, 2000, S AFR J WILDL RES, V30, P26; Balmford A, 1995, CONSERV BIOL, V9, P1539, DOI 10.1046/j.1523-1739.1995.09061539.x; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; BROWN JH, 1971, ECOLOGY, V52, P305, DOI 10.2307/1934589; Burgess N.D., 2004, TERRESTRIAL ECOREGIO; Burney DA, 2004, J HUM EVOL, V47, P25, DOI 10.1016/j.jhevol.2004.05.005; Carleton Michael D., 2000, Fieldiana Zoology, V97, P231; Cohen J., 1983, APPL MULTIPLE REGRES; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; Crowley BE, 2011, AM J PRIMATOL, V73, P25, DOI 10.1002/ajp.20817; Dewar RE, 2013, P NATL ACAD SCI USA, V110, P12583, DOI 10.1073/pnas.1306100110; Dollar L, 2007, DEV PRIMATOL-PROG PR, P63, DOI 10.1007/978-0-387-34810-0_3; EMMONS LH, 1999, PRIMATE COMMUNITIES, P171, DOI DOI 10.1017/CBO9780511542381.011; Faith DP, 2003, ENVIRON SCI POLICY, V6, P311, DOI 10.1016/S1462-9011(03)00044-3; Feistner ATC, 1999, FIELD ZOOL, P269; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Fleishman E, 2005, CONSERV BIOL, V19, P1125, DOI 10.1111/j.1523-1739.2005.00168.x; Fox BJ, 2000, GLOBAL ECOL BIOGEOGR, V9, P19, DOI 10.1046/j.1365-2699.2000.00184.x; Ganzhorn J.U., 1994, P51; Ganzhorn JU, 1998, FOLIA PRIMATOL, V69, P332; Ganzhorn JU, 1997, J ZOOL, V241, P533, DOI 10.1111/j.1469-7998.1997.tb04845.x; Ganzhorn JU, 1999, BIODIVERSITY ECOSYST; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Godfrey Laurie G., 2004, Lemur News, V9, P9; Godfrey LR, 1999, NEW DIRECTIONS IN LEMUR STUDIES, P19; Godfrey LR, AM J PHYS A IN PRESS; GODFREY LR, 1997, NATURAL CHANGE HUMAN, P218; Goodman SM, 2004, INT J PRIMATOL, V25, P331, DOI 10.1023/B:IJOP.0000019155.33815.bf; Goodman SM, 1999, FIELD ZOOL, P187; Goodman SM, 2004, J BIOGEOGR, V31, P47, DOI 10.1111/j.1365-2699.2004.00953.x; Goodman SM, 1999, FIELD ZOOL, P217; Goodman SM, 2001, J NAT HIST, V35, P285, DOI 10.1080/00222930150215387; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; Goodman SM, 1996, COLLOQ SEMI, P283; Goodman SM, 1998, FIELDIANA ZOOLOGY, V90, P1; Goodman SM, 2002, BOISSIERA, P359; Goodman SM, 2008, PAYSAGES NATURELS BI, P435; Goodman SM, 1996, FIELDIANA ZOOLOGY, V85, P1; Goodman SM, 2002, AKONNY ALA, V28, P136; Goodman Steven M., 2000, Fieldiana Zoology, V97, P1; Goodman SM, 2006, CR PALEVOL, V5, P953, DOI 10.1016/j.crpv.2006.09.008; Goodman Steven M., 2000, Fieldiana Zoology, V97, P201; Goodman Steven M., 1998, Fieldiana Zoology, V90, P139; Goodman Steven M., 2007, P25; Goodman Steven M., 1996, Fieldiana Zoology, V85, P218; Goodman Steven M., 1998, Fieldiana Zoology, V90, P201; Grelle CEV, 2002, BIOL CONSERV, V108, P101, DOI 10.1016/S0006-3207(02)00094-0; Groves C, 2001, EVOL ANTHROPOL, V10, P192, DOI 10.1002/evan.10005; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Hawkins AFA, 1999, FIELD ZOOL, P175; Hortal J, 2008, J BIOGEOGR, V35, P1202, DOI 10.1111/j.1365-2699.2007.01850.x; Howard PC, 1998, NATURE, V394, P472, DOI 10.1038/28843; IBM Corporation, 2014, IBM SPSS STAT WIND V; Irwin MT, 2009, ANIM CONSERV, V12, P220, DOI 10.1111/j.1469-1795.2009.00243.x; Kelley Elizabeth A., 2007, Primate Conservation, V22, P71, DOI 10.1896/052.022.0105; Kerr JT, 1997, NATURE, V385, P252, DOI 10.1038/385252a0; Kistler L, 2015, J HUM EVOL, V79, P45, DOI 10.1016/j.jhevol.2014.06.016; KOTLER BP, 1988, ANNU REV ECOL SYST, V19, P281, DOI 10.1146/annurev.es.19.110188.001433; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Kremen C, 1999, CONSERV BIOL, V13, P1055, DOI 10.1046/j.1523-1739.1999.98374.x; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Lawler JJ, 2008, ANIM CONSERV, V11, P270, DOI 10.1111/j.1469-1795.2008.00176.x; Lehman SM, 2006, AM J PHYS ANTHROPOL, V129, P232, DOI 10.1002/ajpa.20241; Lomolino MV, 2010, BIOGEOGRAPHY; Loyola RD, 2007, DIVERS DISTRIB, V13, P389, DOI 10.1111/j.1472-4642.2007.00345.x; Lund MP, 2002, ANIM CONSERV, V5, P163, DOI 10.1017/S1367943002002226; Magurren AE, 2004, MEASURING BIOL DIVER; Manne LL, 2003, ANIM CONSERV, V6, P291, DOI 10.1017/S1367943003003354; MANTEL N, 1967, CANCER RES, V27, P209; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Markolf M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-216; Mittermeier R.A., 2010, LEMURS MADAGASCAR; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; MITTERMEIER RA, 2006, LEMURS MADAGASCAR; Mittermeier RA., 2005, HOTSPOTS REVISITED E, DOI DOI 10.1111/j.1471-8286.2007.01678.x; Mittermeier RA, 1994, LEMURS MADAGASCAR; Moat J., 2007, ATLAS VEGETATION MAD; Moore JL, 2003, CONSERV BIOL, V17, P207, DOI 10.1046/j.1523-1739.2003.01126.x; Muldoon KM, 2007, AM J PHYS ANTHROPOL, V134, P152, DOI 10.1002/ajpa.20651; Muldoon KM, 2010, J HUM EVOL, V58, P338, DOI 10.1016/j.jhevol.2010.01.005; Muldoon KM, 2010, J BIOGEOGR, V37, P1144, DOI 10.1111/j.1365-2699.2010.02276.x; Muldoon KM, 2009, J MAMMAL, V90, P1111, DOI 10.1644/08-MAMM-A-242.1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Negi HR, 2002, BIOL CONSERV, V105, P143, DOI 10.1016/S0006-3207(01)00158-6; Nicoll ME, 2003, NATURAL HIST MADAGAS, P1432; Pearson RG, 2009, EVOLUTION, V63, P959, DOI 10.1111/j.1558-5646.2008.00596.x; Perez VR, 2005, J HUM EVOL, V49, P722, DOI 10.1016/j.jhevol.2005.08.004; Prendergast JR, 1997, ECOGRAPHY, V20, P210, DOI 10.1111/j.1600-0587.1997.tb00363.x; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Randrianandianina B.N., 2003, P1423; Revell LJ, 2006, MULTIMANTEL PROGRAM; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Rodriguez J, 2006, J BIOGEOGR, V33, P291, DOI 10.1111/j.1365-2699.2005.01397.x; Ryan TM, 2008, P NATL ACAD SCI USA, V105, P10699, DOI 10.1073/pnas.0805195105; Sarkar S, 2006, ACTA BIOTHEOR, V54, P133, DOI 10.1007/s10441-006-8259-z; Schmid Jutta, 1998, Fieldiana Zoology, V90, P227; SCHROPFER R, 1991, ACTA THERIOL, V36, P109, DOI 10.4098/AT.arch.91-7; Sebastiao H, 2009, ECOL INDIC, V9, P160, DOI 10.1016/j.ecolind.2008.03.002; Smith Andrew P., 1997, P415; Smith RJ, 2009, AM J PHYS ANTHROPOL, V140, P476, DOI 10.1002/ajpa.21090; SMITH RJ, 1980, J THEOR BIOL, V87, P97, DOI 10.1016/0022-5193(80)90222-2; Soarimalala V, 2008, MAMM BIOL, V73, P468, DOI 10.1016/j.mambio.2007.09.002; Sokal R. R., 1981, BIOMETRY; Sterling Eleanor, 2000, Fieldiana Zoology, V97, P265; Su JC, 2004, CONSERV BIOL, V18, P167, DOI 10.1111/j.1523-1739.2004.00337.x; Sussman Robert W., 2003, Primate Conservation, V19, P32; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; van Weerd M, 2010, BIODIVERS CONSERV, V19, P3393, DOI 10.1007/s10531-010-9902-1; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Williams P, 2006, BIOL CONSERV, V128, P253, DOI 10.1016/j.biocon.2005.09.047; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Wright P. C., 2003, NATURAL HIST MADAGAS, P1485	117	10	13	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136787	10.1371/journal.pone.0136787	http://dx.doi.org/10.1371/journal.pone.0136787			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334525	Green Submitted, gold, Green Published			2022-12-26	WOS:000360615400027
J	Schumacher, N; Meyer, D; Mauermann, A; von der Heyde, J; Wolf, J; Schwarz, J; Knittler, K; Murphy, G; Michalek, M; Garbers, C; Bartsch, JW; Guo, SB; Schacher, B; Eickholz, P; Chalaris, A; Rose-John, S; Rabe, B				Schumacher, Neele; Meyer, Doerte; Mauermann, Andre; von der Heyde, Jan; Wolf, Janina; Schwarz, Jeanette; Knittler, Katharina; Murphy, Gillian; Michalek, Matthias; Garbers, Christoph; Bartsch, Joerg W.; Guo, Songbo; Schacher, Beate; Eickholz, Peter; Chalaris, Athena; Rose-John, Stefan; Rabe, Bjoern			Shedding of Endogenous Interleukin-6 Receptor (IL-6R) Is Governed by A Disintegrin and Metalloproteinase (ADAM) Proteases while a Full-length IL-6R Isoform Localizes to Circulating Microvesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXOSOME-LIKE VESICLES; T-CELL; DISINTEGRIN/METALLOPROTEINASE ADAM10; BIOLOGICAL FUNCTION; SERINE PROTEASES; MESSENGER-RNA; HUMAN PLASMA; INFLAMMATION; GENERATION; ECTODOMAIN	Generation of the soluble interleukin-6 receptor (sIL-6R) is a prerequisite for pathogenic IL-6 trans-signaling, which constitutes a distinct signaling pathway of the pleiotropic cytokine interleukin-6 (IL-6). Although in vitro experiments using ectopically overexpressed IL-6R and candidate proteases revealed major roles for the metalloproteinases ADAM10 and ADAM17 in IL-6R shedding, the identity of the protease(s) cleaving IL-6R in more physiological settings, or even in vivo, remains unknown. By taking advantage of specific pharmacological inhibitors and primary cells from ADAM-deficient mice we established that endogenous IL-6R of both human and murine origin is shed by ADAM17 in an induced manner, whereas constitutive release of endogenous IL-6R is largely mediated by ADAM10. Although circulating IL-6R levels are altered in various diseases, the origin of blood-borne IL-6R is still poorly understood. It has been shown previously that ADAM17 hypomorphic mice exhibit unaltered levels of serum sIL-6R. Here, by quantification of serum sIL-6R in protease-deficient mice as well as human patients we also excluded ADAM10, ADAM8, neutrophil elastase, cathepsin G, and proteinase 3 from contributing to circulating sIL-6R. Furthermore, we ruled out alternative splicing of the IL-6R mRNA as a potential source of circulating sIL-6R in the mouse. Instead, we found full-length IL-6R on circulating microvesicles, establishing microvesicle release as a novel mechanism for sIL-6R generation.	[Schumacher, Neele; Meyer, Doerte; Mauermann, Andre; von der Heyde, Jan; Wolf, Janina; Schwarz, Jeanette; Knittler, Katharina; Michalek, Matthias; Garbers, Christoph; Chalaris, Athena; Rose-John, Stefan; Rabe, Bjoern] Univ Kiel, Fac Med, Inst Biochem, D-24118 Kiel, Germany; [Murphy, Gillian] Univ Cambridge, Canc Res UK Cambridge Inst, Dept Oncol, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Bartsch, Joerg W.; Guo, Songbo] Univ Marburg, Dept Neurosurg Lab, D-35033 Marburg, Germany; [Schacher, Beate; Eickholz, Peter] Goethe Univ Frankfurt, Ctr Dent & Oral Med Carolinum, Dept Periodontol, D-60596 Frankfurt, Germany	University of Kiel; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Philipps University Marburg; Goethe University Frankfurt	Rabe, B (corresponding author), Univ Kiel, Fac Med, Inst Biochem, Rudolf Hober Str 1, D-24118 Kiel, Germany.	brabe@biochem.uni-kiel.de	Garbers, Christoph/D-9932-2015; Bartsch, Joerg Walter/AAB-2951-2020; Rose-John, Stefan/A-7998-2010	Garbers, Christoph/0000-0003-4939-6950; Rose-John, Stefan/0000-0002-7519-3279; Bartsch, Prof. Joerg Walter/0000-0002-2773-3357	Deutsche Forschungsgemeinschaft, Bonn, Germany [RA 2404/1-1, SFB 877]; Cluster of Excellence "Inflammation at Interfaces"; Cancer Research UK	Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"; Cancer Research UK(Cancer Research UK)	This work was supported in part by Deutsche Forschungsgemeinschaft, Bonn, Germany, Project Grant RA 2404/1-1 (to B. R.), SFB 877, project A1 (to A. C. and S. R.-J.), and project A10 (to C. G.), the Cluster of Excellence "Inflammation at Interfaces" (to S. R.-J., B. R., and A. C.), and Cancer Research UK (to G. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Bank U, 1999, J INTERF CYTOK RES, V19, P1277, DOI 10.1089/107999099312957; Calabrese LH, 2014, NAT REV RHEUMATOL, V10, P720, DOI 10.1038/nrrheum.2014.127; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Chalaris A, 2011, EUR J CELL BIOL, V90, P484, DOI 10.1016/j.ejcb.2010.10.007; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Dimitrov S, 2006, FASEB J, V20, P2174, DOI 10.1096/fj.06-5754fje; Dusterhoft S, 2014, J BIOL CHEM, V289, P16336, DOI 10.1074/jbc.M114.557322; Effenberger T, 2014, FASEB J, V28, P4847, DOI 10.1096/fj.14-254565; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Ferreira RC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003444; Garbers C, 2014, BBA-MOL BASIS DIS, V1842, P1485, DOI 10.1016/j.bbadis.2014.05.018; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hawari FI, 2004, P NATL ACAD SCI USA, V101, P1297, DOI 10.1073/pnas.0307981100; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Higginbotham JN, 2011, CURR BIOL, V21, P779, DOI 10.1016/j.cub.2011.03.043; HONDA M, 1992, J IMMUNOL, V148, P2175; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; HORIUCHI S, 1994, EUR J IMMUNOL, V24, P1945, DOI 10.1002/eji.1830240837; Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kelly K, 2005, DEV DYNAM, V232, P221, DOI 10.1002/dvdy.20221; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Levine SJ, 2008, J BIOL CHEM, V283, P14177, DOI 10.1074/jbc.R700052200; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; LUST JA, 1992, CYTOKINE, V4, P96, DOI 10.1016/1043-4666(92)90043-Q; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; McFarland-Mancini MM, 2010, J IMMUNOL, V184, P7219, DOI 10.4049/jimmunol.0901929; Moller-Hackbarth K, 2013, J BIOL CHEM, V288, P34529, DOI 10.1074/jbc.M113.488478; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; MULLBERG J, 1993, EUR J IMMUNOL, V23, P473, DOI 10.1002/eji.1830230226; MullerNewen G, 1996, EUR J BIOCHEM, V236, P837, DOI 10.1111/j.1432-1033.1996.00837.x; Oberg HH, 2006, INT IMMUNOL, V18, P555, DOI 10.1093/intimm/dxh396; Oh JW, 1996, CYTOKINE, V8, P401, DOI 10.1006/cyto.1996.0055; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Rabe B, 2008, BLOOD, V111, P1021, DOI 10.1182/blood-2007-07-102137; Reich D, 2007, AM J HUM GENET, V80, P716, DOI 10.1086/513206; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Sanderson MP, 2008, J CELL BIOCHEM, V103, P1783, DOI 10.1002/jcb.21569; Scheller J, 2014, SEMIN IMMUNOL, V26, P2, DOI 10.1016/j.smim.2013.11.002; Scheller J, 2012, LANCET, V380, P338, DOI 10.1016/S0140-6736(12)61246-X; Schlomann U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7175; Segura E, 2005, BLOOD, V106, P216, DOI 10.1182/blood-2005-01-0220; Stoeck A, 2006, BIOCHEM J, V393, P609, DOI 10.1042/BJ20051013; Tape CJ, 2011, P NATL ACAD SCI USA, V108, P5578, DOI 10.1073/pnas.1017067108; Toomes C, 1999, NAT GENET, V23, P421, DOI 10.1038/70525; Weber S, 2011, DEVELOPMENT, V138, P495, DOI 10.1242/dev.055210; WOGNUM AW, 1993, BLOOD, V81, P2036; Zhang J, 2008, BIOCHEM BIOPH RES CO, V366, P579, DOI 10.1016/j.bbrc.2007.12.011	54	91	92	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26059	26071		10.1074/jbc.M115.649509	http://dx.doi.org/10.1074/jbc.M115.649509			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26359498	Green Published, hybrid			2022-12-26	WOS:000363527300027
J	Choo, J; Lee, Y; Yan, XJ; Noh, TH; Kim, SJ; Son, S; Pothoulakis, C; Moon, HR; Jung, JH; Im, E				Choo, Jieun; Lee, Yunna; Yan, Xin-jia; Noh, Tae Hwan; Kim, Seong Jin; Son, Sujin; Pothoulakis, Charalabos; Moon, Hyung Ryong; Jung, Jee H.; Im, Eunok			A Novel Peroxisome Proliferator-activated Receptor (PPAR) gamma Agonist 2-Hydroxyethyl 5-chloro-4,5-didehydrojasmonate Exerts Anti-Inflammatory Effects in Colitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; EPITHELIAL-CELLS; MOLECULAR-MECHANISMS; PROTEIN-KINASE; PATHWAYS; CYTOKINES; MUCOSA; IL-6; MACROPHAGES	Inflammatory bowel disease (IBD) is a chronic inflammatory disease with increasing incidence and prevalence worldwide. Here we investigated the newly synthesized jasmonate analogue 2-hydroxyethyl 5-chloro-4,5-didehydrojasmonate (J11-Cl) for its anti-inflammatory effects on intestinal inflammation. First, to test whether J11-Cl can activate peroxisome proliferator-activated receptors (PPARs), we performed docking simulations because J11-Cl has a structural similarity with anti-inflammatory 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)), one of the endogenous ligands of PPAR gamma. J11-Cl bound to the ligand binding domain of PPAR gamma in the same manner as 15d-PGJ(2) and rosiglitazone, and significantly increased transcriptional activity of PPAR gamma. In animal experiments, colitis was significantly reduced in mice with J11-Cl treatment, determined by analyses of survival rate, body weight changes, clinical symptoms, and histological evaluation. Moreover, J11-Cl decreased production of pro-inflammatory cytokines including IL-6, IL-8, and G-CSF as well as chemokines including chemokine (C-C motif) ligand (CCL) 20, chemokine (C-X-C motif) ligand (CXCL) 2, CXCL3, and chemokine (C-X3-C motif) ligand 1 (CX3CL1) in colon tissues, and LPS or TNF-alpha-stimulated macrophages and epithelial cells. In contrast, production of anti-inflammatory cytokines including IL-2 and IL-4 as well as the proliferative factor, GM-CSF, was increased by J11-Cl. Furthermore, inhibition of MAPKs and NF-kappa B activation by J11-Cl was also observed. J11-Cl reduced intestinal inflammation by increasing the transcriptional activity of PPAR gamma and modulating inflammatory signaling pathways. Therefore, our study suggests that J11-Cl may serve as a novel therapeutic agent against IBD.	[Choo, Jieun; Lee, Yunna; Noh, Tae Hwan; Kim, Seong Jin; Son, Sujin; Moon, Hyung Ryong; Jung, Jee H.; Im, Eunok] Pusan Natl Univ, Coll Pharm, Busan 609735, South Korea; [Yan, Xin-jia] Harbin Univ Commerce, Coll Pharm, Harbin 150076, Heilongjiang, Peoples R China; [Pothoulakis, Charalabos] Univ Calif Los Angeles, David Geffen Sch Med, Sect Inflammatory Bowel Dis, Ctr Inflammatory Bowel Dis, Los Angeles, CA 90095 USA; [Pothoulakis, Charalabos] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Ctr Inflammatory Bowel Dis, Los Angeles, CA 90095 USA	Pusan National University; Harbin University of Commerce; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Im, E (corresponding author), Pusan Natl Univ, Coll Pharm, Busan 609735, South Korea.	eoim@pusan.ac.kr			National Research Foundation of Korea (NRF) [2009-0083538, 2014R1A1A2057432]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Research Foundation of Korea (NRF) Grant 2009-0083538 and 2014R1A1A2057432. The authors declare that they have no conflicts of interest with the contents of this article.	Ananthakrishnan AN, 2013, GASTROENTEROL HEPATO, V9, P367; Assi K, 2006, IMMUNOLOGY, V118, P112, DOI 10.1111/j.1365-2567.2006.02349.x; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Baker MS, 2003, J SURG RES, V110, P295, DOI 10.1016/S0022-4804(03)00027-1; Banchereau J, 2012, NAT IMMUNOL, V13, P925, DOI 10.1038/ni.2406; Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Broom OJ, 2009, CLIN EXP IMMUNOL, V158, P272, DOI 10.1111/j.1365-2249.2009.04033.x; Carothers AM, 2010, CANCER RES, V70, P4433, DOI 10.1158/0008-5472.CAN-09-4289; Caruso R, 2007, GASTROENTEROLOGY, V132, P166, DOI 10.1053/j.gastro.2006.09.053; Cesari Italo Mario, 2014, Int J Cell Biol, V2014, P572097, DOI 10.1155/2014/572097; Daig R, 1996, GUT, V38, P216, DOI 10.1136/gut.38.2.216; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; Dang HT, 2008, BIOORGAN MED CHEM, V16, P10228, DOI 10.1016/j.bmc.2008.10.050; Dubuquoy L, 2006, GUT, V55, P1341, DOI 10.1136/gut.2006.093484; Egea L, 2013, J IMMUNOL, V190, P1702, DOI 10.4049/jimmunol.1202368; Fujiie S, 2001, INT IMMUNOL, V13, P1255, DOI 10.1093/intimm/13.10.1255; Garat C, 2003, CYTOKINE, V23, P31, DOI 10.1016/S1043-4666(03)00182-0; Hollenbach E, 2004, FASEB J, V18, P1550, DOI 10.1096/fj.04-1642fje; Dang HT, 2012, BIOORGAN MED CHEM, V20, P4109, DOI 10.1016/j.bmc.2012.04.052; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kim JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004561; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kolonics A, 2001, CELL SIGNAL, V13, P743, DOI 10.1016/S0898-6568(01)00201-7; Kota BP, 2005, PHARMACOL RES, V51, P85, DOI 10.1016/j.phrs.2004.07.012; Kwon KH, 2007, LIFE SCI, V81, P362, DOI 10.1016/j.lfs.2007.05.022; Leonard M, 1999, KIDNEY INT, V56, P1366, DOI 10.1046/j.1523-1755.1999.00664.x; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Mitsuyama K, 2006, INT J MOL MED, V17, P449; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Mudter J, 2007, INFLAMM BOWEL DIS, V13, P1016, DOI 10.1002/ibd.20148; Muzes G, 2012, WORLD J GASTROENTERO, V18, P5848, DOI 10.3748/wjg.v18.i41.5848; Puleston J, 2005, ALIMENT PHARM THER, V21, P109, DOI 10.1111/j.1365-2036.2004.02262.x; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; Rotondo D, 2002, IMMUNOLOGY, V105, P20, DOI 10.1046/j.0019-2805.2001.01361.x; Sainathan SK, 2008, INFLAMM BOWEL DIS, V14, P88, DOI 10.1002/ibd.20279; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shih David Q, 2009, Curr Gastroenterol Rep, V11, P473; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Suttles J, 1999, J BIOL CHEM, V274, P5835, DOI 10.1074/jbc.274.9.5835; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Waetzig GH, 2002, J IMMUNOL, V168, P5342, DOI 10.4049/jimmunol.168.10.5342; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	43	41	42	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25609	25619		10.1074/jbc.M115.673046	http://dx.doi.org/10.1074/jbc.M115.673046			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26342083	Green Published, hybrid			2022-12-26	WOS:000362962800034
J	Doijad, SP; Barbuddhe, SB; Garg, S; Poharkar, KV; Kalorey, DR; Kurkure, NV; Rawool, DB; Chakraborty, T				Doijad, Swapnil P.; Barbuddhe, Sukhadeo B.; Garg, Sandeep; Poharkar, Krupali V.; Kalorey, Dewanand R.; Kurkure, Nitin V.; Rawool, Deepak B.; Chakraborty, Trinad			Biofilm-Forming Abilities of Listeria monocytogenes Serotypes Isolated from Different Sources	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; BENZALKONIUM CHLORIDE; GROWTH; STRAINS; EPIDEMIOLOGY; TEMPERATURE; RESISTANCE; HYDROPHOBICITY; DIVERSITY; VIRULENCE	A total of 98 previously characterized and serotyped L. monocytogenes strains, comprising 32 of 1/2a; 20 of 1/2b and 46 of 4b serotype, from clinical and food sources were studied for their capability to form a biofilm. The microtiter plate assay revealed 62 (63.26%) strains as weak, 27 (27.55%) strains as moderate, and 9 (9.18%) strains as strong biofilm formers. Among the strong biofilm formers, 6 strains were of serotype 1/2a and 3 strains were of serotype 1/2b. None of the strain from 4b serotype exhibited strong biofilm formation. No firm correlation (p = 0.015) was noticed between any serotype and respective biofilm formation ability. Electron microscopic studies showed that strong biofilm forming isolates could synthesize a biofilm within 24 h on surfaces important in food industries such as stainless steel, ceramic tiles, high-density polyethylene plastics, polyvinyl chloride pipes, and glass. Cell enumeration of strong, moderate, and weak biofilm was performed to determine if the number of cells correlated with the biofilm-forming capabilities of the isolates. Strong, moderate, and weak biofilm showed 570 +/- 127x 10(3) cells/cm(2), 33 +/- 26x 10(3) cells/cm2, 5 +/- 3x 10(3) cells/cm2, respectively, indicating that the number of cells was directly proportional to the strength of the biofilm. The hydrophobicity index (HI) analysis revealed higher hydrophobicity with an increased biofilm formation. Fatty acid methyl esterase analysis revealed the amount of certain fatty acids such as iso-C15:0, anteiso-C15:0, and anteiso-C17:0 fatty acids correlated with the biofilm-forming capability of L. monocytogenes. This study showed that different strains of L. monocytogenes form biofilm of different intensities which did not completely correlate with their serotype; however, it correlated with the number of cells, hydrophobicity, and amount of certain fatty acids.	[Doijad, Swapnil P.; Barbuddhe, Sukhadeo B.; Poharkar, Krupali V.] ICAR Res Complex Goa, Old Goa 403402, India; [Garg, Sandeep] Goa Univ, Dept Microbiol, Taleigaon Plateau 403206, Goa, India; [Kalorey, Dewanand R.; Kurkure, Nitin V.] Maharashtra Anim & Fishery Sci Univ, Nagpur Vet Coll, Dept Microbiol & Anim Biotechnol, Nagpur 440006, Maharashtra, India; [Rawool, Deepak B.] Indian Vet Res Inst, Div Vet Publ Hlth, Izatnagar 243122, Uttar Pradesh, India; [Chakraborty, Trinad] Univ Giessen, Inst Med Microbiol, D-35392 Giessen, Germany; [Barbuddhe, Sukhadeo B.] Natl Inst Biot Stress Management, Raipur 492012, Chhattisgarh, India	Indian Council of Agricultural Research (ICAR); ICAR - Central Coastal Agricultural Research Institute; Goa University; Maharashtra Animal & Fishery Sciences University; Nagpur Veterinary College; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Justus Liebig University Giessen; Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Biotic Stresses Management	Barbuddhe, SB (corresponding author), ICAR Res Complex Goa, Old Goa 403402, India.	barbuddhesb@gmail.com; Trinad.Chakraborty@mikrobio.med.uni-giessen.de	Rawool, Deepak/AAS-9197-2020; Doijad, Swapnil/C-4848-2013; Garg, Sandeep/E-9780-2019; Barbuddhe, Sukhadeo/AAI-8477-2020	Rawool, Deepak/0000-0002-6173-4708; Doijad, Swapnil/0000-0002-0932-8542; 	Department of Biotechnology, Government of India [BT/IN/FRG/01/SBB/2008, BT/01/CEIB/11/VI/13]; German Ministry of Education and Research (BMBF) under Indo-German Collaborative programme	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); German Ministry of Education and Research (BMBF) under Indo-German Collaborative programme	The research work is supported by grants from Department of Biotechnology, Government of India (BT/IN/FRG/01/SBB/2008; BT/01/CEIB/11/VI/13) and the German Ministry of Education and Research (BMBF) under Indo-German Collaborative programme to SBB and TC.	Adzitey F., 2010, African Journal of Microbiology Research, V4, P2848; Alonso AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113696; Annous BA, 1997, APPL ENVIRON MICROB, V63, P3887, DOI 10.1128/AEM.63.10.3887-3894.1997; Barbuddhe SB, 2012, INT J FOOD MICROBIOL, V154, P113, DOI 10.1016/j.ijfoodmicro.2011.08.030; Barbuddhe SB, 2009, CURR TOP MICROBIOL, V337, P173, DOI 10.1007/978-3-642-01846-6_6; Bertsch D, 2013, PLASMID, V70, P284, DOI 10.1016/j.plasmid.2013.06.001; Borucki MK, 2003, APPL ENVIRON MICROB, V69, P7336, DOI 10.1128/AEM.69.12.7336-7342.2003; Bujdakova H, 2013, CENT EUR J BIOL, V8, P259, DOI 10.2478/s11535-013-0136-y; Carpentier B, 2011, INT J FOOD MICROBIOL, V145, P1, DOI 10.1016/j.ijfoodmicro.2011.01.005; Chao J, 2010, CAN J MICROBIOL, V56, P1028, DOI 10.1139/W10-093; Chavant P, 2004, FEMS MICROBIOL LETT, V236, P241, DOI 10.1111/j.1574-6968.2004.tb09653.x; Chen Yi, 2008, P203, DOI 10.1201/9781420051414.ch7; Chihib NE, 2003, FEMS MICROBIOL LETT, V218, P155, DOI 10.1111/j.1574-6968.2003.tb11512.x; da Silva EP, 2013, APPL MICROBIOL BIOT, V97, P957, DOI 10.1007/s00253-012-4611-1; Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08; Di Bonaventura G, 2008, J APPL MICROBIOL, V104, P1552, DOI 10.1111/j.1365-2672.2007.03688.x; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Gianotti A, 2008, INT J FOOD MICROBIOL, V123, P9, DOI 10.1016/j.ijfoodmicro.2007.11.039; Guo K, 2013, ENVIRON SCI TECHNOL, V47, P7563, DOI 10.1021/es400901u; Harvey J, 2007, FOOD MICROBIOL, V24, P380, DOI 10.1016/j.fm.2006.06.006; Jensen AK, 2010, EUROSURVEILLANCE, V15, P12; Jeyasekaran G, 2011, IND J FISH, P211; Kadam SR, 2013, INT J FOOD MICROBIOL, V165, P259, DOI 10.1016/j.ijfoodmicro.2013.05.025; Kalmokoff ML, 2001, J APPL MICROBIOL, V91, P725, DOI 10.1046/j.1365-2672.2001.01419.x; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; Kathariou S, 2003, FOOD BORNE OUTBREAKS; Lemon KP, 2007, J BACTERIOL, V189, P4418, DOI 10.1128/JB.01967-06; Lemon KP, 2010, J BACTERIOL, V192, P3969, DOI 10.1128/JB.00179-10; Li J, 2011, INFLUENCE ENV CONDIT; Marsh EJ, 2003, FEMS MICROBIOL LETT, V228, P203, DOI 10.1016/S0378-1097(03)00752-3; Martin B, 2014, FOOD MICROBIOL, V44, P119, DOI 10.1016/j.fm.2014.05.014; Mirani ZA, 2013, PAK J PHARM SCI, V26, P383; Moretro T., 2004, Biofilms, V1, P107, DOI 10.1017/S1479050504001322; Mullapudi S, 2008, APPL ENVIRON MICROB, V74, P1464, DOI 10.1128/AEM.02426-07; Norwood DE, 2001, LETT APPL MICROBIOL, V33, P320, DOI 10.1046/j.1472-765X.2001.01004.x; Perez LJ, 2012, J MED CHEM, V55, P9669, DOI 10.1021/jm300908t; PUTTMANN M, 1993, RES MICROBIOL, V144, P279, DOI 10.1016/0923-2508(93)90012-Q; Ramaswamy Vidhya, 2007, Journal of Microbiology Immunology and Infection, V40, P4; Ratti RP, 2010, CIENCIA TECNOL ALIME, V30, P1011, DOI 10.1590/S0101-20612010000400027; Renier S, 2011, ENVIRON MICROBIOL, V13, P835, DOI 10.1111/j.1462-2920.2010.02378.x; Ruckerl I, 2014, INT J FOOD MICROBIOL, V189, P98, DOI 10.1016/j.ijfoodmicro.2014.08.001; Saa Ibusquiza P, 2011, BIOFILM FORMATION LI; Skovager A, 2013, INT J FOOD MICROBIOL, V165, P35, DOI 10.1016/j.ijfoodmicro.2013.04.014; Somers EB, 2004, J FOOD PROTECT, V67, P2218, DOI 10.4315/0362-028X-67.10.2218; Stepanovic S, 2004, LETT APPL MICROBIOL, V38, P428, DOI 10.1111/j.1472-765X.2004.01513.x; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; van der Veen S, 2011, INT J FOOD MICROBIOL, V144, P421, DOI 10.1016/j.ijfoodmicro.2010.10.029; van der Veen S, 2010, APPL ENVIRON MICROB, V76, P7854, DOI 10.1128/AEM.01519-10; van Loosdrecht M C, 1990, J Biomater Appl, V5, P91, DOI 10.1177/088532829000500202; Weiler C, 2013, INT J FOOD MICROBIOL, V161, P61, DOI 10.1016/j.ijfoodmicro.2012.11.027; Wen J, 2009, APPL ENVIRON MICROB, V75, P1581, DOI 10.1128/AEM.01942-08; Whittaker P, 2003, J MICROBIOL METH, V55, P709, DOI 10.1016/j.mimet.2003.07.005	52	93	93	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137046	10.1371/journal.pone.0137046	http://dx.doi.org/10.1371/journal.pone.0137046			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360831	gold, Green Published, Green Submitted			2022-12-26	WOS:000361043100022
J	Guyot, V; Castagneyrol, B; Vialatte, A; Deconchat, M; Selvi, F; Bussotti, F; Jactel, H				Guyot, Virginie; Castagneyrol, Bastien; Vialatte, Aude; Deconchat, Marc; Selvi, Federico; Bussotti, Filippo; Jactel, Herve			Tree Diversity Limits the Impact of an Invasive Forest Pest	PLOS ONE			English	Article							CHESTNUT GALL WASP; DRYOCOSMUS-KURIPHILUS; VEGETATIONAL DIVERSITY; ASSOCIATIONAL SUSCEPTIBILITY; PHYLOGENETIC DIVERSITY; BIOLOGICAL-CONTROL; TORYMUS-SINENSIS; PLANT INVASIONS; VOLATILES; RELEASE	The impact of invasive herbivore species may be lower in more diverse plant communities due to mechanisms of associational resistance. According to the "resource concentration hypothesis" the amount and accessibility of host plants is reduced in diverse plant communities, thus limiting the exploitation of resources by consumers. In addition, the "natural enemy hypothesis" suggests that richer plant assemblages provide natural enemies with more complementary resources and habitats, thus promoting top down regulation of herbivores. We tested these two hypotheses by comparing crown damage by the invasive Asian chestnut gall wasp (Dryocosmus kuriphilus) on chestnut trees (Castanea sativa) in pure and mixed stands in Italy. We estimated the defoliation on 70 chestnut trees in 15 mature stands sampled in the same region along a gradient of tree species richness ranging from one species (chestnut monocultures) to four species (mixtures of chestnut and three broadleaved species). Chestnut defoliation was significantly lower in stands with higher tree diversity. Damage on individual chestnut trees decreased with increasing height of neighboring, heterospecific trees. These results suggest that conservation biological control method based on tree species mixtures might help to reduce the impact of the Asian chestnut gall.	[Guyot, Virginie; Vialatte, Aude; Deconchat, Marc] INRA, DYNAFOR, UMR 1201, F-31326 Castanet Tolosan, France; [Vialatte, Aude] Univ Toulouse, INPT ENSAT, DYNAFOR, UMR 1201, F-31326 Castanet Tolosan, France; [Castagneyrol, Bastien; Jactel, Herve] Univ Bordeaux, BIOGECO, UMR 1202, F-33405 Talence, France; [Guyot, Virginie; Castagneyrol, Bastien; Jactel, Herve] INRA, BIOGECO, UMR 1202, F-33610 Cestas, France; [Selvi, Federico; Bussotti, Filippo] Univ Florence, DISPAA, Lab Bot, I-50144 Florence, Italy	INRAE; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; UDICE-French Research Universities; Universite de Bordeaux; INRAE; University of Florence	Guyot, V (corresponding author), INRA, DYNAFOR, UMR 1201, F-31326 Castanet Tolosan, France.	virginie.guyot@ensat.fr	Deconchat, Marc/N-7383-2013	Deconchat, Marc/0000-0002-4638-3858; Castagneyrol, Bastien/0000-0001-8795-7806	European Union Seventh Framework Programme (FP7) [265171]; EFPA department of INRA; Aquitaine French region	European Union Seventh Framework Programme (FP7); EFPA department of INRA; Aquitaine French region	The study design and data collection leading to these results received funding from the European Union Seventh Framework Programme (FP7/2007-2013), grant agreement no265171: HJ. EFPA department of INRA and Aquitaine French region: VG PhD.	Acs Z, 2007, SYST ENTOMOL, V32, P70, DOI 10.1111/j.1365-3113.2006.00351.x; Aebi A., 2007, Bulletin OEPP, V37, P166, DOI 10.1111/j.1365-2338.2007.01099.x; Aebi A, 2006, GALLING ARTHROPODS AND THEIR ASSOCIATES: ECOLOGY AND EVOLUTION, P103, DOI 10.1007/4-431-32185-3_9; ALUJA M, 1993, J CHEM ECOL, V19, P2671, DOI 10.1007/BF00980700; ANDOW DA, 1991, ANNU REV ENTOMOL, V36, P561, DOI 10.1146/annurev.en.36.010191.003021; [Anonymous], 2005, Bulletin OEPP/EPPO Bulletin, V35, P422; [Anonymous], 2014, R LANG ENV STAT COMP; Asner GP, 2008, P NATL ACAD SCI USA, V105, P4519, DOI 10.1073/pnas.0710811105; Baeten L, 2013, PERSPECT PLANT ECOL, V15, P281, DOI 10.1016/j.ppees.2013.07.002; Barbosa P, 2009, ANNU REV ECOL EVOL S, V40, P1, DOI 10.1146/annurev.ecolsys.110308.120242; Battisti A, 2014, AGR FOREST ENTOMOL, V16, P75, DOI 10.1111/afe.12036; Borden JH, 1997, J CHEM ECOL, V23, P2479, DOI 10.1023/B:JOEC.0000006661.99953.26; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Byers JA, 1998, NATURWISSENSCHAFTEN, V85, P557, DOI 10.1007/s001140050551; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Castagneyrol B, 2014, J APPL ECOL, V51, P134, DOI 10.1111/1365-2664.12175; Castagneyrol B, 2013, J ECOL, V101, P418, DOI 10.1111/1365-2745.12055; Castagneyrol B, 2012, ECOLOGY, V93, P2115, DOI 10.1890/11-1300.1; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Cooper WR, 2007, ANN ENTOMOL SOC AM, V100, P236, DOI 10.1603/0013-8746(2007)100[236:CAOAEG]2.0.CO;2; Cooper WR, 2011, BIOCONTROL, V56, P725, DOI 10.1007/s10526-011-9350-1; Davies KF, 2005, ECOLOGY, V86, P1602, DOI 10.1890/04-1196; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; DeWalt SJ, 2004, ECOLOGY, V85, P471, DOI 10.1890/02-0728; Dulaurent AM, 2012, AGR FOREST ENTOMOL, V14, P19, DOI 10.1111/j.1461-9563.2011.00549.x; Eichhorn J, 2010, MANUAL ON METHODS AN; Elton C S., 1958, THE ECOLOGY OF INVAS; Endara MJ, 2011, FUNCT ECOL, V25, P389, DOI 10.1111/j.1365-2435.2010.01803.x; ESRI, 2012, US ARCGIS DESKT VERS; European and Mediterranean Plant Protection Organization, 2013, FIRST REPORT OF DRYO; FEENY P, 1970, ECOLOGY, V51, P565, DOI 10.2307/1934037; Floater GJ, 2000, J APPL ECOL, V37, P87, DOI 10.1046/j.1365-2664.2000.00468.x; Forster B, 2011, NEW DIS REPORTS, V23, P2044; Fridley JD, 2007, ECOLOGY, V88, P3, DOI 10.1890/0012-9658(2007)88[3:TIPRPA]2.0.CO;2; Gibbs M, 2011, BIOCONTROL, V56, P527, DOI 10.1007/s10526-011-9364-8; Giraudoux P., 2014, PGIRMESS DATA ANAL E; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Hamback PA, 2014, ECOLOGY, V95, P1370, DOI 10.1890/13-0793.1; Huber DPW, 2001, J CHEM ECOL, V27, P217, DOI 10.1023/A:1005668019434; Iverson AL, 2014, J APPL ECOL, V51, P1593, DOI 10.1111/1365-2664.12334; Jactel H, 2006, CAN J FOREST RES, V36, P314, DOI 10.1139/x05-251; Jactel H, 2005, ECOL STUD-ANAL SYNTH, V176, P235; Jactel H, 2011, OECOLOGIA, V166, P703, DOI 10.1007/s00442-011-1918-z; Jactel H, 2007, ECOL LETT, V10, P835, DOI 10.1111/j.1461-0248.2007.01073.x; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Liebhold AM, 2013, DIVERS DISTRIB, V19, P1208, DOI 10.1111/ddi.12112; Maltoni A, 2012, IFOREST, V5, P50, DOI 10.3832/ifor0598-008; Maron JL, 2001, OIKOS, V95, P361, DOI 10.1034/j.1600-0706.2001.950301.x; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Moriya S, 2003, PROCEEDINGS OF THE F, P14; Oksanen J., 2013, R PACKAGE VERSION 23, V2; Panzavolta T, 2013, B INSECTOL, V66, P195; Pearse IS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1841; Quacchia A, 2008, BIOCONTROL, V53, P829, DOI 10.1007/s10526-007-9139-4; Quacchia A, 2013, INSECT CONSERV DIVER, V6, P114, DOI 10.1111/j.1752-4598.2012.00192.x; Ray-Mukherjee J, 2014, METHODS ECOL EVOL, V5, P320, DOI 10.1111/2041-210X.12166; Richardson DM, 2007, DIVERS DISTRIB, V13, P126, DOI 10.1111/j.1366-9516.2006.00314.x; Rigot T, 2014, ECOGRAPHY, V37, P648, DOI 10.1111/j.1600-0587.2013.00447.x; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; RUSSELL EP, 1989, ENVIRON ENTOMOL, V18, P590, DOI 10.1093/ee/18.4.590; Santi F, 2011, B INSECTOL, V64, P275; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Schuldt A, 2014, NEW PHYTOL, V202, P864, DOI 10.1111/nph.12695; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; TAHVANAINEN JO, 1972, OECOLOGIA, V10, P321, DOI 10.1007/BF00345736; Tasin M, 2006, NATURWISSENSCHAFTEN, V93, P141, DOI 10.1007/s00114-005-0077-7; Thompson JN, 1999, SCIENCE, V284, P2116, DOI 10.1126/science.284.5423.2116; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Underwood N, 2014, Q REV BIOL, V89, P1, DOI 10.1086/674991; Vehvilainen H, 2007, OECOLOGIA, V152, P287, DOI 10.1007/s00442-007-0673-7; White JA, 2000, ECOLOGY, V81, P1795, DOI 10.1890/0012-9658(2000)081[1795:ASOCTA]2.0.CO;2; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Wilsey BJ, 2002, ECOL LETT, V5, P676, DOI 10.1046/j.1461-0248.2002.00372.x; WOOD DL, 1982, ANNU REV ENTOMOL, V27, P411, DOI 10.1146/annurev.en.27.010182.002211; Zhang AJ, 1999, J CHEM ECOL, V25, P1221, DOI 10.1023/A:1020910305873; Zhang QH, 2004, AGR FOREST ENTOMOL, V6, P1, DOI 10.1111/j.1461-9555.2004.00202.x; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	81	35	39	1	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0136469	10.1371/journal.pone.0136469	http://dx.doi.org/10.1371/journal.pone.0136469			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360881	Green Published, Green Submitted, gold			2022-12-26	WOS:000361043100010
J	Kiddee, W; Montriwet, M				Kiddee, Weerawat; Montriwet, Mayuree			Intraocular Pressure Changes in Non-Glaucomatous Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Agents	PLOS ONE			English	Article							RANIBIZUMAB LUCENTIS; MACULAR DEGENERATION; SUSTAINED ELEVATION; BEVACIZUMAB; INJECTION	Purpose To study the prevalence of sustained intraocular pressure (IOP) elevation associated with intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) agents. Methods Prospective comparative study. Non-glaucomatous patients scheduled to receive intravitreal injection of anti-VEGF therapy were recruited from an outpatient eye clinic, Songklanagarind Hospital between April 2013 and March 2014. The IOP was measured by Goldmann applanation tonometer before and at 1 hour, 1 week, 1 month, 3 months, and 6 months after injection. The IOP was compared using the repeated measures analysis. Sustained IOP elevation was defined as either an IOP > 21 mmHg or an increase from baseline >= 5mmHg on two consecutive visits. Results Seventy eyes of 54 patients met the inclusion criteria. The most common diagnosis was diabetic macular edema (48%). The mean IOP +/- standard deviation (SD) before treatment was 13.7 +/- 2.8 mmHg. The means +/- SDs after treatment at 1 hour, 1 week, 1 month, 3 months, and 6 months were 11.3 +/- 2.6, 13.7 +/- 3.6, 14.1 +/- 3.3, 14.0 +/- 2.3, and 13.7 +/- 2.4 mmHg, respectively. A mean of IOP difference at 1 hour postinjection and at baseline was -2.36 +/- 2.5 mmHg (P < 0.001). Four of 70 treated eyes (5.7%) developed sustained IOP elevation (IOP >= 5 mmHg from baseline on two consecutive visits). The IOP returned to baseline levels after 1 month, in three eyes. One eye had sustained IOP elevation at 3 and 6 months follow-up. Thereafter, IOP returned to baseline level. There was no need of anti-glaucoma medication. Conclusions After receiving intravitreal injection of anti-VEGF agent, a small proportion of non-glaucomatous eyes developed a sustained IOP elevation without requiring IOP-lowering treatment. At 1 hour postinjection, there was a significant reduction of the mean IOP compared with the baseline level.	[Kiddee, Weerawat; Montriwet, Mayuree] Prince Songkla Univ, Dept Ophthalmol, Fac Med, Hat Yai, Songkhla Provin, Thailand	Prince of Songkla University	Kiddee, W (corresponding author), Prince Songkla Univ, Dept Ophthalmol, Fac Med, Hat Yai, Songkhla Provin, Thailand.	kweerawat@hotmail.com	Kiddee, Weerawat/ABH-3241-2020	Kiddee, Weerawat/0000-0002-0055-8210	Faculty of Medicine, Prince of Songkla University [EC-56-168-02-4-2]	Faculty of Medicine, Prince of Songkla University	WK; the Faculty of Medicine, Prince of Songkla University funded this study (EC-56-168-02-4-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman RA, 2010, J OCUL PHARMACOL TH, V26, P105, DOI 10.1089/jop.2009.0076; Aref AA, 2012, CURR OPIN OPHTHALMOL, V23, P105, DOI 10.1097/ICU.0b013e32834ff41d; Axer-Siegel R, 2012, RETINA-J RET VIT DIS, V32, P1811, DOI 10.1097/IAE.0b013e31825db771; Bakri SJ, 2008, GRAEF ARCH CLIN EXP, V246, P955, DOI 10.1007/s00417-008-0819-2; Choi DY, 2011, RETINA-J RET VIT DIS, V31, P1028, DOI 10.1097/IAE.0b013e318217ffde; Falkenstein IA, 2007, RETINA-J RET VIT DIS, V27, P1044, DOI 10.1097/IAE.0b013e3180592ba6; Gismondi M, 2009, J GLAUCOMA, V18, P658, DOI 10.1097/IJG.0b013e31819c4893; Good TJ, 2011, BRIT J OPHTHALMOL, V95, P1111, DOI 10.1136/bjo.2010.180729; Hoang QV, 2013, RETINA-J RET VIT DIS, V33, P179, DOI 10.1097/IAE.0b013e318261a6f7; Hoang QV, 2012, OPHTHALMOLOGY, V119, P321, DOI 10.1016/j.ophtha.2011.08.011; Hollands H, 2007, CAN J OPHTHALMOL, V42, P807, DOI 10.3129/i07-172; Kahook MY, 2009, OPHTHAL SURG LAS IM, V40, P293, DOI 10.3928/15428877-20090430-12; Kernt M, 2007, OPHTHALMOLOGE, V104, P965, DOI 10.1007/s00347-007-1569-y; Kim JE, 2008, AM J OPHTHALMOL, V146, P930, DOI 10.1016/j.ajo.2008.07.007; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Mathalone N, 2012, GRAEF ARCH CLIN EXP, V250, P1435, DOI 10.1007/s00417-012-1981-0; Schmucker C, 2010, CURR OPIN OPHTHALMOL, V21, P218, DOI 10.1097/ICU.0b013e3283386783; Sniegowski M, 2010, OPEN OPHTHALMOL J, V4, P28, DOI 10.2174/1874364101004010028; Tolentino M, 2011, SURV OPHTHALMOL, V56, P95, DOI 10.1016/j.survophthal.2010.08.006; Tseng JJ, 2012, J GLAUCOMA, V21, P241, DOI 10.1097/IJG.0b013e31820d7d19; Van der Reis MI, 2011, RETINA-J RET VIT DIS, V31, P1449, DOI 10.1097/IAE.0b013e3182278ab4; Wehrli SJ, 2012, RETINA-J RET VIT DIS, V32, P1295, DOI 10.1097/IAE.0b013e31823f0c95	22	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137833	10.1371/journal.pone.0137833	http://dx.doi.org/10.1371/journal.pone.0137833			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360382	Green Published, Green Submitted, gold			2022-12-26	WOS:000361043100091
J	Murakami, M; Ono, K; Tsubokura, M; Nomura, S; Oikawa, T; Oka, T; Kami, M; Oki, T				Murakami, Michio; Ono, Kyoko; Tsubokura, Masaharu; Nomura, Shuhei; Oikawa, Tomoyoshi; Oka, Tosihiro; Kami, Masahiro; Oki, Taikan			Was the Risk from Nursing-Home Evacuation after the Fukushima Accident Higher than the Radiation Risk?	PLOS ONE			English	Article							ATOMIC-BOMB SURVIVORS; CANCER INCIDENCE; JAPAN; RESIDENTS; MORTALITY; RATES	After the 2011 accident at the Fukushima Daiichi nuclear power plant, nursing-home residents and staff were evacuated voluntarily from damaged areas to avoid radiation exposure. Unfortunately, the evacuation resulted in increased mortalities among nursing home residents. We assessed the risk trade-off between evacuation and radiation for 191 residents and 184 staff at three nursing homes by using the same detriment indicator, namely loss of life expectancy (LLE), under four scenarios, i.e. "rapid evacuation (in accordance with the actual situation; i.e. evacuation on 22 March)," "deliberate evacuation (i.e. evacuation on 20 June)," " 20-mSv exposure," and "100-mSv exposure." The LLE from evacuation-related mortality among nursing home residents was assessed with survival probability data from nursing homes in the city of Minamisoma and the city of Soma. The LLE from radiation mortality was calculated from the estimated age-specific mortality rates from leukemia and all solid cancers based on the additional effective doses and the survival probabilities. The total LLE of residents due to evacuation-related risks in rapid evacuation was 11,000 persons-d-much higher than the total LLEs of residents and staff due to radiation in the other scenarios (27, 1100, and 5800 persons-d for deliberate evacuation, 20 mSv-exposure, and 100 mSv-exposure, respectively). The latitude for reducing evacuation risks among nursing home residents is surprisingly large. Evacuation regulation and planning should therefore be well balanced with the trade-offs against radiation risks. This is the first quantitative assessment of the risk trade-off between radiation exposure and evacuation after a nuclear power plant accident.	[Murakami, Michio; Oki, Taikan] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Ono, Kyoko] Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil, Tsukuba, Ibaraki 3058569, Japan; [Tsubokura, Masaharu; Kami, Masahiro] Univ Tokyo, Inst Med Sci, Div Social Commun Syst Adv Clin Res, Minato Ku, Tokyo 1088639, Japan; [Nomura, Shuhei] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London W2 1PG, England; [Oikawa, Tomoyoshi] Minamisoma Municipal Gen Hosp, Dept Radiat Protect, Fukushima 9750033, Japan; [Oka, Tosihiro] Fukui Prefectural Univ, Fac Econ, Fukui 9101195, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; Imperial College London; Fukui Prefectural University	Murakami, M (corresponding author), Fukushima Med Univ, Dept Hlth Risk Commun, Sch Med, 1 Hikarigaoka, Fukushima 9601295, Japan.	michio@fmu.ac.jp	Tsubokura, Masaharu/AAV-4364-2021; Oki, Taikan/E-5778-2010; Nomura, Shuhei/HCH-5356-2022; Tsubokura, Masaharu/D-7300-2017; Ono, Kyoko/J-4346-2018	Tsubokura, Masaharu/0000-0001-8027-202X; Oki, Taikan/0000-0003-4067-4678; Tsubokura, Masaharu/0000-0001-8027-202X; Ono, Kyoko/0000-0001-8100-3905; Nomura, Shuhei/0000-0002-2963-7297	"Core Research for Evolutionary Science and Technology (CREST)" grant from the Japan Science and Technology Agency	"Core Research for Evolutionary Science and Technology (CREST)" grant from the Japan Science and Technology Agency	This study was supported by a "Core Research for Evolutionary Science and Technology (CREST)" grant from the Japan Science and Technology Agency, http://www.jst.go.jp/kisoken/crest/en/index.html. MM and TOki receive the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahane K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01670; [Anonymous], 2007, Ann ICRP, V37, P1, DOI 10.1016/j.icrp.2008.08.001; [Anonymous], 2006, CHERNOBYL FORUM 2003; Gamo M, 2003, CHEMOSPHERE, V53, P277, DOI 10.1016/S0045-6535(03)00053-5; Harada KH, 2014, P NATL ACAD SCI USA, V111, pE914, DOI 10.1073/pnas.1315684111; ICRP, 1991, ANN ICRP; Journy N, 2014, RADIAT ENVIRON BIOPH, V53, P39, DOI 10.1007/s00411-013-0491-8; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kodama Y, 2014, DISASTER MED PUBLIC, V8, P471, DOI 10.1017/dmp.2014.112; LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473; Matsuda A, 2013, JPN J CLIN ONCOL, V43, P328, DOI 10.1093/jjco/hys233; Ministry of Health and Welfare, 2012, 21 LIF TABL; Murakami M, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0112791, 10.1]; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; [National Cancer Center Japan Center for Cancer Control and Information Services], 2013, CANC INC 1975 2008; Nomura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060192; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; R Development Core Team, 2011, R 2 1 3 0 R LANG ENV; Reconstruction Agency, 2014, EARTHQ REL DEATH GRE; Royal Society, 1983, RISK ASS REP ROYAL S; Statistics Bureau of Japan, 2011, GEN MORT 2010; Tsubokura M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-267; United Nations Scientific Committee on the Effects of Atomic Radiation, 2006, REP UN SCI COMM EFF; United Nations Scientific Committee on the Effects of Atomic Radiation, 2014, UNSCEAR 2013 REP GEN; United Nations Scientific Committee on the Effects of Atomic Radiation, 2008, ANN A EP STUD RAD CA, V1; World Health Organization, 2012, PREL DOS EST NUCL AC; World Health Organization, 2013, HLTH RISK ASS NUCL A; Yasumura S, 2013, PUBLIC HEALTH, V127, P186, DOI 10.1016/j.puhe.2012.10.019	29	47	47	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137906	10.1371/journal.pone.0137906	http://dx.doi.org/10.1371/journal.pone.0137906			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359666	Green Published, Green Submitted, gold			2022-12-26	WOS:000361043100099
J	Nogueira-Paiva, NC; Vieira, PMD; Oliveri, LMR; Fonseca, KD; Pound-Lana, G; de Oliveira, MT; de Lana, M; Veloso, VM; Reis, AB; Tafuri, WL; Carneiro, CM				Nogueira-Paiva, Nivia Carolina; de Abreu Vieira, Paula Melo; Rezende Oliveri, Larissa Maris; Fonseca, Katia da Silva; Pound-Lana, Gwenaelle; de Oliveira, Maykon Tavares; de Lana, Marta; Veloso, Vanja Maria; Reis, Alexandre Barbosa; Tafuri, Washington Luiz; Carneiro, Claudia Martins			Host-Parasite Interactions in Chagas Disease: Genetically Unidentical Isolates of a Single Trypanosoma cruzi Strain Identified In Vitro via LSSP-PCR	PLOS ONE			English	Article							DIFFERENTIAL TISSUE DISTRIBUTION; LONG-TERM INFECTION; PATHOGENESIS; VARIABILITY; DIVERSITY; ISOENZYME; PATTERNS; BE-78; DOGS; DNA	The present study aims at establishing whether the diversity in pathogenesis within a genetically diverse host population infected with a single polyclonal strain of Trypanosoma cruzi is due to selection of specific subpopulations within the strain. For this purpose we infected Swiss mice, a genetically diverse population, with the polyclonal strain of Trypanosoma cruzi Berenice-78 and characterized via LSSP-PCR the kinetoplast DNA of subpopulations isolated from blood samples collected from the animals at various times after inoculation (3, 6 and 12 months after inoculation). We examined the biological behavior of the isolates in acellular medium and in vitro profiles of infectivity in Vero cell medium. We compared the characteristics of the isolates with the inoculating strain and with another strain, Berenice 62, isolated from the same patient 16 years earlier. We found that one of the isolates had intermediate behavior in comparison with Berenice-78 and Berenice-62 and a significantly different genetic profile by LSSP-PCR in comparison with the inoculating strain. We hereby demonstrate that genetically distinct Trypanosoma cruzi isolates may be obtained upon experimental murine infection with a single polyclonal Trypanosoma cruzi strain.	[Nogueira-Paiva, Nivia Carolina; de Abreu Vieira, Paula Melo; Rezende Oliveri, Larissa Maris; Fonseca, Katia da Silva; Pound-Lana, Gwenaelle; Reis, Alexandre Barbosa; Tafuri, Washington Luiz; Carneiro, Claudia Martins] Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol, Inst Ciencias Exatas & Biol, Lab Imunopatol, Ouro Preto, MG, Brazil; [de Oliveira, Maykon Tavares; de Lana, Marta] Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol, Inst Ciencias Exatas & Biol, Lab Doenca Chagas, Ouro Preto, MG, Brazil; [de Abreu Vieira, Paula Melo] Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol, Inst Ciencias Exatas & Biol, Dept Ciencias Biol, Ouro Preto, MG, Brazil; [Veloso, Vanja Maria] Univ Fed Ouro Preto, Dept Farm, Escola Farm, Ouro Preto, MG, Brazil; [Reis, Alexandre Barbosa; Carneiro, Claudia Martins] Univ Fed Ouro Preto, Dept Anal Clin, Escola Farm, Ouro Preto, MG, Brazil	Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto	Carneiro, CM (corresponding author), Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol, Inst Ciencias Exatas & Biol, Lab Imunopatol, Ouro Preto, MG, Brazil.	claudiamartinscarneiro@gmail.com	Pound-Lana, Gwenaelle E N/C-5835-2015; Reis, Alexandre Barbosa/I-9945-2014; carneiro, Claudia Martins/AAP-4455-2020; carneiro, claudia m/B-6205-2013; Tavares, Maykon/Q-4801-2019	Pound-Lana, Gwenaelle E N/0000-0003-0569-0242; Reis, Alexandre Barbosa/0000-0001-8123-4164; carneiro, Claudia Martins/0000-0002-6002-857X; Lana, Marta/0000-0002-1565-4707; Tavares de Oliveira, Maykon/0000-0002-7652-3225; Nogueira-Paiva, Nivia Carolina/0000-0002-2048-9400	Universidade Federal de Ouro Preto (UFOP); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CNPq	Universidade Federal de Ouro Preto (UFOP); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding was provided by the Universidade Federal de Ouro Preto (UFOP), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and research fellowships from CNPq (Carneiro CM, Reis AB, Lana M, Oliveri LMR), CAPES (Fonseca KS, Nogueira-Paiva NC) and FAPEMIG (Pound-Lana G, Oliveira MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade LO, 1999, MOL BIOCHEM PARASIT, V100, P163, DOI 10.1016/S0166-6851(99)90035-X; Andrade LO, 2002, EXP PARASITOL, V100, P269, DOI 10.1016/S0014-4894(02)00024-3; Andrade LO, 2010, MEM I OSWALDO CRUZ, V105, P834, DOI 10.1590/S0074-02762010000600018; Andrade Sonia G., 1997, Revista da Sociedade Brasileira de Medicina Tropical, V30, P27, DOI 10.1590/S0037-86821997000100006; BRENER Z., 1962, REV INST MED TROP SAO PAULO, V4, P389; BRENER Z, 1965, ANN TROP MED PARASIT, V59, P19, DOI 10.1080/00034983.1965.11686277; Brito CMM, 2008, PARASITOL RES, V103, P1111, DOI 10.1007/s00436-008-1102-5; Carneiro CM, 2007, ACTA TROP, V101, P120, DOI 10.1016/j.actatropica.2006.12.009; CARNEIRO M, 1990, ACTA TROP, V47, P35, DOI 10.1016/0001-706X(90)90005-K; Chagas C, 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008; Cruz RE, 2006, ACTA TROP, V97, P239, DOI 10.1016/j.actatropica.2005.03.011; D'Avila DA, 2009, J CLIN MICROBIOL, V47, P1718, DOI 10.1128/JCM.01658-08; Vieira PMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032912; Vieira PMD, 2009, EXP PARASITOL, V121, P76, DOI 10.1016/j.exppara.2008.09.023; Gomes ML, 1998, EXP PARASITOL, V88, P28, DOI 10.1006/expr.1998.4191; Guedes PMM, 2007, MEM I OSWALDO CRUZ, V102, P141, DOI 10.1590/S0074-02762007005000003; LANA M, 1986, Memorias do Instituto Oswaldo Cruz, V81, P247, DOI 10.1590/S0074-02761986000300001; Lana M, 1981, THESIS U FEDERAL MIN; Macedo AM, 2004, MEM I OSWALDO CRUZ, V99, P1, DOI 10.1590/S0074-02762004000100001; Macedo AM, 1998, PARASITOL TODAY, V14, P119, DOI 10.1016/S0169-4758(97)01179-4; Macedo Andra M, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004118; Nogueira-Paiva NC, 2014, MEM I OSWALDO CRUZ, V109, P51, DOI 10.1590/0074-0276130216; Oliveira LT, 2011, J PHARMACEUT BIOMED, V56, P70, DOI 10.1016/j.jpba.2011.04.016; PENA SDJ, 1994, P NATL ACAD SCI USA, V91, P1946, DOI 10.1073/pnas.91.5.1946; Rimoldi A, 2012, PARASITOLOGY, V139, P37, DOI 10.1017/S0031182011001697; Rodrigues CM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000846; ROMANHA AJ, 1979, COMP BIOCHEM PHYS B, V62, P139, DOI 10.1016/0305-0491(79)90299-2; SALGADO JOAO AMILCAR, 1962, REV INST MED TROP SSB PAULO, V4, P330; Valadares HMS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001722; Vago AR, 1996, LANCET, V348, P891, DOI 10.1016/S0140-6736(05)64761-7; Vago AR, 2000, AM J PATHOL, V156, P1805, DOI 10.1016/S0002-9440(10)65052-3; Veloso VM, 2012, INFECT GENET EVOL, V12, P1128, DOI 10.1016/j.meegid.2012.03.019; Veloso VM, 2005, PARASITOL RES, V96, P382, DOI 10.1007/s00436-005-1373-z; Villarreal D, 2004, EXP PARASITOL, V108, P24, DOI 10.1016/j.exppara.2004.07.001; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021	35	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137788	10.1371/journal.pone.0137788	http://dx.doi.org/10.1371/journal.pone.0137788			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359864	Green Published, gold, Green Submitted			2022-12-26	WOS:000361043100088
J	Lin, YK; Yang, SH; Chen, CC; Kao, HC; Fang, JY				Lin, Yin-Ku; Yang, Sien-Hung; Chen, Chin-Chuan; Kao, Hsiao-Ching; Fang, Jia-You			Using Imiquimod-Induced Psoriasis-Like Skin as a Model to Measure the Skin Penetration of Anti-Psoriatic Drugs	PLOS ONE			English	Article							5-AMINOLEVULINIC ACID DELIVERY; NANOSTRUCTURED LIPID CARRIERS; PROTOPORPHYRIN-IX; BETA-CATENIN; INDIGO NATURALIS; STRATUM-CORNEUM; ABSORPTION; PERMEATION; EXPRESSION; BARRIER	Objective Psoriasis is a chronic inflammatory skin disease and topical therapy remains a key role for treatment. The aim of this study is to evaluate the influence of psoriasis-like lesions on the cutaneous permeation of anti-psoriatic drugs. Methods We first set up imiquimod-induced dermatitis in mice that closely resembles human psoriasis lesions. The development of the lesions is based on the IL-23/IL17A axis for phenotypical and histological characteristics. Four drugs, 5-aminolevulinic acid (ALA), tacrolimus, calcipotriol, and retinoic acid, were used to evaluate percutaneous absorption. Results The most hydrophilic molecule, ALA, revealed the greatest enhancement on skin absorption after imiquimod treatment. Imiquimod increased the skin deposition and flux of ALA by 5.6 to 14.4-fold, respectively, compared to normal skin. The follicular accumulation of ALA was also increased 3.8-fold. The extremely lipophilic drug retinoic acid showed a 1.7-and 3.8-fold increase in skin deposition and flux, respectively. Tacrolimus flux was enhanced from 2 to 21 mu g/cm(2)/h by imiquimod intervention. However, imiquimod did not promote skin deposition of this macrolide. The lipophilicity, but not the molecular size, dominated drug permeation enhancement by psoriatic lesions. The in vivo percutaneous absorption of ALA and rhodamine B examined by confocal microscopy confirmed the deficient resistance of epidermal barrier for facilitating cutaneous delivery of drugs via psoriasis-like skin. Conclusion We established the topical delivery profiles of anti-psoriatic drugs via imiquimod-treated psoriasis-like skin.	[Lin, Yin-Ku; Yang, Sien-Hung] Chang Gung Univ, Sch Tradit Chinese Med, Taoyuan, Taiwan; [Lin, Yin-Ku] Chang Gung Mem Hosp Keelung, Dept Tradit Chinese Med, Keelung, Taiwan; [Yang, Sien-Hung] Chang Gung Mem Hosp Linkou, Dept Tradit Chinese Med, Taoyuan, Taiwan; [Chen, Chin-Chuan] Chang Gung Univ, Grad Inst Nat Prod, Mol Genet Lab, Taoyuan, Taiwan; [Kao, Hsiao-Ching; Fang, Jia-You] Chang Gung Univ, Grad Inst Nat Prod, Pharmaceut Lab, Taoyuan, Taiwan; [Fang, Jia-You] Chang Gung Univ, Hlth Aging Res Ctr, Chinese Herbal Med Res Team, Taoyuan, Taiwan; [Fang, Jia-You] Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University of Science & Technology	Fang, JY (corresponding author), Chang Gung Univ, Grad Inst Nat Prod, Pharmaceut Lab, Taoyuan, Taiwan.	fajy@mail.cgu.edu.tw	Chen, Chin-Chuan/G-3094-2013	Chen, Chin-Chuan/0000-0002-8938-3209	Chang Gung Memorial Hospital [CMRPG3D1191]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	Jia-You Fang received the financial support from Chang Gung Memorial Hospital (grant number: CMRPG3D1191).	Akazawa Y, 2013, SKIN PHARMACOL PHYS, V26, P15, DOI 10.1159/000343173; Andrews SN, 2013, PHARM RES-DORDR, V30, P1099, DOI 10.1007/s11095-012-0946-7; Antoniou C, 2010, AM J CLIN DERMATOL, V11, P95, DOI 10.2165/11530210-000000000-00000; Ben-Shabat S, 2005, PHARM RES-DORDR, V22, P50, DOI 10.1007/s11095-004-9008-0; Boehncke WH, 2013, AM J CLIN DERMATOL, V14, P377, DOI 10.1007/s40257-013-0032-x; Brune A, 2007, PEDIATR DERMATOL, V24, P76, DOI 10.1111/j.1525-1470.2007.00341.x; Chang HN, 2010, MOLECULES, V15, P6423, DOI 10.3390/molecules15096423; Chen WY, 2013, LASER MED SCI, V28, P1363, DOI 10.1007/s10103-012-1257-2; Chiang A, 2012, J APPL TOXICOL, V32, P537, DOI 10.1002/jat.1773; de Bruijn HS, 2008, J PHOTOCH PHOTOBIO B, V92, P91, DOI 10.1016/j.jphotobiol.2008.05.005; Donnelly RF, 2008, J CONTROL RELEASE, V129, P154, DOI 10.1016/j.jconrel.2008.05.002; El Malki K, 2013, J INVEST DERMATOL, V133, P441, DOI 10.1038/jid.2012.318; Fang JY, 2008, EUR J PHARM BIOPHARM, V70, P633, DOI 10.1016/j.ejpb.2008.05.008; Fang JY, 2004, BRIT J DERMATOL, V151, P132, DOI 10.1111/j.1365-2133.2004.06051.x; Frum Y, 2007, EUR J PHARM SCI, V30, P280, DOI 10.1016/j.ejps.2006.11.014; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Gaber MAE, 2015, INDIAN DERMATOL ONLI, V6, P13, DOI [10.4103/2229-5178.148923, DOI 10.4103/2229-5178.148923]; Gattu S, 2010, SKIN PHARMACOL PHYS, V23, P171, DOI 10.1159/000288163; Hanel KH, 2013, INT J MOL SCI, V14, P6720, DOI 10.3390/ijms14046720; Hampton PJ, 2007, BRIT J DERMATOL, V157, P1168, DOI 10.1111/j.1365-2133.2007.08195.x; Hung CF, 2012, J DERMATOL SCI, V68, P135, DOI 10.1016/j.jdermsci.2012.09.005; Jiang WW, 2013, J INVEST DERMATOL, V133, P1777, DOI 10.1038/jid.2013.57; Kasting GB, 2013, SKIN PHARMACOL PHYS, V26, P295, DOI 10.1159/000351956; Kawasaki H, 2012, J ALLERGY CLIN IMMUN, V129, P1538, DOI 10.1016/j.jaci.2012.01.068; Kim BE, 2011, J INVEST DERMATOL, V131, P1272, DOI 10.1038/jid.2011.24; Kirkham BW, 2014, IMMUNOLOGY, V141, P133, DOI 10.1111/imm.12142; Kono F, 2014, BRIT J DERMATOL, V170, P1048, DOI 10.1111/bjd.12812; Krieg RC, 2002, PHOTOCHEM PHOTOBIOL, V76, P518, DOI 10.1562/0031-8655(2002)076<0518:MCOTCS>2.0.CO;2; Levin AA, 2014, J AM ACAD DERMATOL, V70, P555, DOI 10.1016/j.jaad.2013.10.043; Li M, 2007, CANCER LETT, V248, P58, DOI 10.1016/j.canlet.2006.05.019; Li ZX, 2008, INT J DERMATOL, V47, P207, DOI 10.1111/j.1365-4632.2007.03318.x; Lin YK, 2010, INT J NANOMED, V5, P117; Lin YK, 2009, J DERMATOL SCI, V54, P168, DOI 10.1016/j.jdermsci.2009.02.007; Liu X, 2011, BRIT J CLIN PHARMACO, V72, P768, DOI 10.1111/j.1365-2125.2011.04022.x; McCarron PA, 2008, PHARM RES, V25, P812, DOI 10.1007/s11095-007-9352-y; McCormack PL, 2011, DRUGS, V71, P709, DOI 10.2165/11207300-000000000-00000; McGeachy MJ, 2011, NAT IMMUNOL, V12, P521, DOI 10.1038/ni.2044; Monteleone G, 2011, CLIN SCI, V120, P1, DOI 10.1042/CS20100163; Nair RP, 2008, J INVEST DERMATOL, V128, P1653, DOI 10.1038/sj.jid.5701255; Nickoloff BJ, 2004, J CLIN INVEST, V113, P1664, DOI 10.1172/JCI200422147; Nickoloff BJ, 2007, CLIN DERMATOL, V25, P568, DOI 10.1016/j.clindermatol.2007.08.011; Nielsen JB, 2005, ARCH DERMATOL RES, V296, P560, DOI 10.1007/s00403-005-0555-y; O'goshi K, 2000, ARCH DERMATOL RES, V292, P605, DOI 10.1007/s004030000185; Otberg N, 2004, J INVEST DERMATOL, V122, P14, DOI 10.1046/j.0022-202X.2003.22110.x; Ray S, 2013, J CELL BIOL, V202, P45, DOI 10.1083/jcb.201212140; Raychaudhuri SK, 2014, AUTOIMMUN REV, V13, P490, DOI 10.1016/j.autrev.2014.01.008; Shah PP, 2012, BIOMATERIALS, V33, P1607, DOI 10.1016/j.biomaterials.2011.11.011; Simon GA, 2000, SKIN PHARMACOL APPL, V13, P229, DOI 10.1159/000029928; Smits T, 2005, J INVEST DERMATOL, V125, P833, DOI 10.1111/j.0022-202X.2005.23843.x; Swindell WR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018266; Teichmann A, 2005, J INVEST DERMATOL, V125, P264, DOI 10.1111/j.0022-202X.2005.23779.x; Tonel G, 2010, J IMMUNOL, V185, P5688, DOI 10.4049/jimmunol.1001538; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Zhang LW, 2011, DERMATOL SIN, V29, P1, DOI 10.1016/j.dsi.2011.02.002; Zhang LW, 2011, INT J NANOMED, V6, DOI 10.2147/IJN.S17524	55	124	124	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137890	10.1371/journal.pone.0137890	http://dx.doi.org/10.1371/journal.pone.0137890			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355594	Green Published, gold, Green Submitted			2022-12-26	WOS:000360965800087
J	Palao, T; Sward, K; Jongejan, A; Moerland, PD; de Vos, J; van Weert, A; Arribas, SM; Groma, G; vanBavel, E; Bakker, ENTP				Palao, Teresa; Sward, Karl; Jongejan, Aldo; Moerland, Perry D.; de Vos, Judith; van Weert, Angela; Arribas, Silvia M.; Groma, Gergely; vanBavel, Ed; Bakker, Erik N. T. P.			Gene Expression and MicroRNA Expression Analysis in Small Arteries of Spontaneously Hypertensive Rats. Evidence for ER Stress	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; WISTAR-KYOTO RATS; RESISTANCE ARTERIES; PROTEIN; THROMBOSPONDIN-4; CONTRACTILITY; HETEROGENEITY; PRESSURE; TORSINA; GROWTH	Small arteries are known to develop functional and structural alterations in hypertension. However, the mechanisms of this remodeling are not fully understood. We hypothesized that altered gene expression is associated with the development of hypertension in mesenteric arteries of spontaneously hypertensive rats (SHR). Three sublines of SHR and normotensive Wistar Kyoto rats (WKY) were studied at 6 weeks and 5 months of age. MiRNA and mRNA microarray experiments were performed and analyzed with bioinformatical tools, including Ingenuity Pathway Analysis (IPA). Principal component analysis showed a clear separation in both miRNA and mRNA expression levels between both ages studied, demonstrating strong age-related changes in expression. At the miRNA level, IPA identified differences between SHR and WKY related to metabolic diseases, cellular growth, and proliferation. The mRNAs differentially expressed between SHR and WKY were related to metabolism, cellular movement and proliferation. The most strongly upregulated gene (9.2-fold) was thrombospondin 4 (Thbs4), a protein involved in the endoplasmic reticulum (ER) stress response that activates transcription factor 6 alpha (ATF6 alpha). ATF6 alpha downstream targets were also differentially expressed in SHR vs. WKY. Differential expression of THBS4, the cleaved form of ATF6a, and two of its targets were further confirmed at the protein level by western blot. In summary, these data revealed a number of genes (n = 202) and miRNAs (n = 3) in mesenteric arteries of SHR that had not been related to hypertension previously. The most prominent of these, Thbs4, is related to vascular ER stress that is associated with hypertension.	[Palao, Teresa; de Vos, Judith; van Weert, Angela; Groma, Gergely; vanBavel, Ed; Bakker, Erik N. T. P.] Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, NL-1105 AZ Amsterdam, Netherlands; [Sward, Karl] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Jongejan, Aldo; Moerland, Perry D.] Univ Amsterdam, Acad Med Ctr, Bioinformat Lab, NL-1105 AZ Amsterdam, Netherlands; [Arribas, Silvia M.] Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain	University of Amsterdam; Academic Medical Center Amsterdam; Lund University; University of Amsterdam; Academic Medical Center Amsterdam; Autonomous University of Madrid	Bakker, ENTP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	n.t.bakker@amc.uva.nl	Moerland, Perry/AAG-1425-2020	Moerland, Perry/0000-0002-2357-3659; Groma, Gergely/0000-0001-8487-0465; van Bavel, Ed/0000-0001-8654-986X; de Vos, Judith/0000-0003-0736-7449; Bakker, Erik/0000-0003-2819-5818; Sward, Karl/0000-0002-7255-5510; Palao, Teresa/0000-0002-1291-7153; Arribas, Silvia M/0000-0001-7103-6105	European Union, Marie Curie ITN [606998, 235711]	European Union, Marie Curie ITN	This work was supported by the European Union, Marie Curie ITN number 606998 and 235711. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abonnenc M, 2013, CIRC RES, V113, P1138, DOI 10.1161/CIRCRESAHA.113.302400; Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Ashenagar MS, 2010, MOL MED REP, V3, P213, DOI 10.3892/mmr_00000242; Bakker ENTP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107998; Balta S, 2014, ANGIOLOGY, V65, P773, DOI 10.1177/0003319713513492; Boon RA, 2011, CIRC RES, V109, P1115, DOI 10.1161/CIRCRESAHA.111.255737; Chen P, 2010, HUM MOL GENET, V19, P3502, DOI 10.1093/hmg/ddq266; Christensen KL, 2001, J VASC RES, V38, P1, DOI 10.1159/000051024; Cingolani OH, 2011, CIRC RES, V109, P1410, DOI 10.1161/CIRCRESAHA.111.256743; Feng BA, 2011, DIABETES, V60, P2975, DOI 10.2337/db11-0478; Frolova EG, 2012, FASEB J, V26, P2363, DOI 10.1096/fj.11-190728; Grayson TH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-404; Hadoke PWF, 2000, GEN PHARMACOL-VASC S, V35, P119, DOI 10.1016/S0306-3623(01)00085-4; Hewett J, 2003, J NEUROSCI RES, V72, P158, DOI 10.1002/jnr.10567; Hu WY, 2002, J HYPERTENS, V20, P1323, DOI 10.1097/00004872-200207000-00019; Janssen R, 2013, ENDOCRINOLOGY, V154, P1973, DOI 10.1210/en.2012-2017; Jin W, 2012, J BIOL CHEM, V287, P15672, DOI 10.1074/jbc.M111.322669; KURTZ TW, 1989, HYPERTENSION, V13, P188, DOI 10.1161/01.HYP.13.2.188; KURTZ TW, 1987, HYPERTENSION, V10, P127, DOI 10.1161/01.HYP.10.1.127; Liang B, 2013, ARTERIOSCL THROM VAS, V33, P595, DOI 10.1161/ATVBAHA.112.300606; Liu XJ, 2011, J BIOL CHEM, V286, P42371, DOI 10.1074/jbc.M111.261065; Lopez-Romero P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-64; Lynch JM, 2012, CELL, V149, P1257, DOI 10.1016/j.cell.2012.03.050; O'Farrell C, 2004, MOL BRAIN RES, V127, P1, DOI 10.1016/j.molbrainres.2004.05.005; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; Okuda T, 2002, HYPERTENS RES, V25, P249, DOI 10.1291/hypres.25.249; Okuda T, 2002, BIOCHEM BIOPH RES CO, V296, P537, DOI 10.1016/S0006-291X(02)00902-6; Raitoharju E, 2011, ATHEROSCLEROSIS, V219, P211, DOI 10.1016/j.atherosclerosis.2011.07.020; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rose AE, 2014, J BIOL CHEM, V289, P552, DOI 10.1074/jbc.M113.515791; Schiffrin EL, 2004, AM J HYPERTENS, V17, P1192, DOI 10.1016/j.amjhyper.2004.05.023; Spitler KM, 2014, HYPERTENSION, V63, pE40, DOI 10.1161/HYPERTENSIONAHA.113.02558; Spitler KM, 2013, AM J PHYSIOL-HEART C, V305, pH344, DOI 10.1152/ajpheart.00952.2012; Sun SG, 2011, EMBO REP, V12, P56, DOI 10.1038/embor.2010.172; Turczynska KM, 2015, ARTERIOSCL THROM VAS, V35, P1489, DOI 10.1161/ATVBAHA.114.305065; Unthank JL, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.5; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401; Zwaveling J, 1997, FUNDAM CLIN PHARM, V11, P41, DOI 10.1111/j.1472-8206.1997.tb00167.x	38	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137027	10.1371/journal.pone.0137027	http://dx.doi.org/10.1371/journal.pone.0137027			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356734	Green Submitted, Green Published, gold			2022-12-26	WOS:000360965800023
J	Talukdar, P; Douglas, A; Price, AH; Norton, GJ				Talukdar, Partha; Douglas, Alex; Price, Adam H.; Norton, Gareth J.			Biallelic and Genome Wide Association Mapping of Germanium Tolerant Loci in Rice (Oryza sativa L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ARSENIC ACCUMULATION; SILICON UPTAKE; GENETIC DISSECTION; ROOT MORPHOLOGY; TRANSPORTER; METABOLISM; GRAIN; QTLS; DIVERSITY	Rice plants accumulate high concentrations of silicon. Silicon has been shown to be involved in plant growth, high yield, and mitigating biotic and abiotic stresses. However, it has been demonstrated that inorganic arsenic is taken up by rice through silicon transporters under anaerobic conditions, thus the ability to efficiently take up silicon may be considered either a positive or a negative trait in rice. Germanium is an analogue of silicon that produces brown lesions in shoots and leaves, and germanium toxicity has been used to identify mutants in silicon and arsenic transport. In this study, two different genetic mapping methods were performed to determine the loci involved in germanium sensitivity in rice. Genetic mapping in the biparental cross of Bala x Azucena (an F-6 population) and a genome wide association (GWA) study with 350 accessions from the Rice Diversity Panel 1 were conducted using 15 mu M of germanic acid. This identified a number of germanium sensitive loci: some co-localised with previously identified quantitative trait loci (QTL) for tissue silicon or arsenic concentration, none co-localised with Lsi1 or Lsi6, while one single nucleotide polymorphism (SNP) was detected within 200 kb of Lsi2 (these are genes known to transport silicon, whose identity was discovered using germanium toxicity). However, examining candidate genes that are within the genomic region of the loci detected above reveals genes homologous to both Lsi1 and Lsi2, as well as a number of other candidate genes, which are discussed.	[Talukdar, Partha; Douglas, Alex; Price, Adam H.; Norton, Gareth J.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen AB24 3UU, Scotland	University of Aberdeen	Norton, GJ (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen AB24 3UU, Scotland.	g.norton@abdn.ac.uk	Talukdar, Partha/AAI-4040-2020	Talukdar, Partha/0000-0001-8825-589X; Douglas, Alex/0000-0001-6606-1058; Price, Adam/0000-0003-3094-0485; Norton, Gareth/0000-0003-4560-170X	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J003336/1]; Biotechnology and Biological Sciences Research Council [BB/J003336/1] Funding Source: researchfish; BBSRC [BB/J003336/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was partially funded by a Biotechnology and Biological Sciences Research Council (BBSRC) grant (BB/J003336/1) awarded to AHP. The work was also supported by a self-funded studentship (PT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin MJ, 2002, ENVIRON SCI TECHNOL, V36, P962, DOI 10.1021/es0101678; Basten JC, 2001, QTL CARTOGRAPHER VER; Bryant R, 2011, GENETICA, V139, P1383, DOI 10.1007/s10709-012-9637-x; Dai WM, 2008, EUPHYTICA, V160, P317, DOI 10.1007/s10681-007-9501-8; Dai WM, 2005, CROP SCI, V45, P1345, DOI 10.2135/cropsci2004.0505; Detmann KC, 2012, NEW PHYTOL, V196, P752, DOI 10.1111/j.1469-8137.2012.04299.x; Eizenga GC, 2014, J PLANT REGIST, V8, P109, DOI 10.3198/jpr2013.03.0013crmp; Hayes JE, 2013, FUNCT PLANT BIOL, V40, P618, DOI 10.1071/FP12329; Jia Y, 2012, ENVIRON SCI TECHNOL, V46, P8090, DOI 10.1021/es300499a; Li RY, 2009, PLANT PHYSIOL, V150, P2071, DOI 10.1104/pp.109.140350; Lomax C, 2012, NEW PHYTOL, V193, P665, DOI 10.1111/j.1469-8137.2011.03956.x; Ma JF, 2006, NATURE, V440, P688, DOI 10.1038/nature04590; Ma JF, 2008, P NATL ACAD SCI USA, V105, P9931, DOI 10.1073/pnas.0802361105; Ma JF, 2007, NATURE, V448, P209, DOI 10.1038/nature05964; Mitani N, 2005, J EXP BOT, V56, P1255, DOI 10.1093/jxb/eri121; Norton GJ, 2012, ANN APPL BIOL, V161, P46, DOI 10.1111/j.1744-7348.2012.00549.x; Norton GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089685; Norton GJ, 2009, EUPHYTICA, V166, P229, DOI 10.1007/s10681-008-9833-z; Price AH, 2006, TRENDS PLANT SCI, V11, P213, DOI 10.1016/j.tplants.2006.03.006; Price AH, 2000, THEOR APPL GENET, V100, P49, DOI 10.1007/s001220050007; Price AH, 2002, FIELD CROP RES, V76, P25, DOI 10.1016/S0378-4290(02)00010-2; Rains DW, 2006, PLANT SOIL, V280, P223, DOI 10.1007/s11104-005-3082-x; Sakurai G, 2015, PLANT CELL PHYSIOL, V56, P631, DOI 10.1093/pcp/pcv017; Song WY, 2014, P NATL ACAD SCI USA, V111, P15699, DOI 10.1073/pnas.1414968111; Sparks JP, 2011, BIOGEOCHEMISTRY, V104, P237, DOI 10.1007/s10533-010-9498-2; Sun GX, 2009, ENVIRON INT, V35, P473, DOI 10.1016/j.envint.2008.07.020; Takahashi E., 1976, Journal of the Science of Soil and Manure, Japan, V47, P191; Takahashi E., 1976, Journal of the Science of Soil and Manure, Japan, V47, P183; Wang D.L., 1999, USER MANUAL QTLMAPPE; Wang DL, 1999, THEOR APPL GENET, V99, P1255, DOI 10.1007/s001220051331; Wu QS, 2006, PLANT SCI, V171, P441, DOI 10.1016/j.plantsci.2006.05.001; Yamaji N, 2008, PLANT CELL, V20, P1381, DOI 10.1105/tpc.108.059311; Yoshida S., 1981, FUNDAMENTAL RICE CRO; Yoshida S., 1976, LAB MANUAL PHYSL STU; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao FJ, 2009, NEW PHYTOL, V181, P777, DOI 10.1111/j.1469-8137.2008.02716.x; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780	45	6	8	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137577	10.1371/journal.pone.0137577	http://dx.doi.org/10.1371/journal.pone.0137577			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356220	Green Published, Green Submitted, gold			2022-12-26	WOS:000360965800063
J	Tong, DY; Jin, Y; Xue, TY; Ma, XY; Zhang, JX; Ou, XL; Cheng, JD; Sun, HY				Tong, Dayue; Jin, Yi; Xue, Tianyu; Ma, Xiaoyan; Zhang, Jinxiang; Ou, Xueling; Cheng, Jianding; Sun, Hongyu			Investigation of the Application of miR10b and miR135b in the Identification of Semen Stains	PLOS ONE			English	Article							BODY-FLUID IDENTIFICATION; MICRORNA BIOGENESIS; MARKERS; PCR	To evaluate the identification method using the microRNA markers miR10b and miR135b to distinguish semen stains from menstrual blood, peripheral blood, vaginal fluid and so on body fluid stains. The expression levels of miR10b and miR35b in semen stains and menstrual blood and so on were detected utilizing a real-time quantitative PCR technique with a specific fluorescence-labeled TaqMan probe. RNU6b was used as the internal reference gene; the difference in their expression was analyzed, and the specificity, sensitivity, and detection capability of the techniques were evaluated. The expression of miR10b and miR135b in semen stains was significantly higher than that of other body fluid stains, with a mean value of Delta C-T from-6 to-7. However, it ranged from-2 to-4 for other body fluid stains. The initial criteria for judging which semen stains can be identified were determined by analyzing the research results. When the threshold value was set to 0.04, the C-T value could be detected in the target genes miR10b, miR135b and in the internal reference gene RNU6b, and C-T values are< 40, Delta C-T[10b-U6]<-5.5, and Delta C-T[135b-U6]<-6, respectively, and the semen stain could be identified. The expression levels of miR10b and miR135b are higher in semen with strong tissue specificity; thus, they can be used to differentiate semen stains from other body fluid stains in forensic science.	[Tong, Dayue; Xue, Tianyu; Ma, Xiaoyan; Zhang, Jinxiang; Ou, Xueling; Cheng, Jianding; Sun, Hongyu] Sun Yat Sen Univ, Zhongshan Schoool Med, Forens Biol Sect, Guangzhou 510080, Guangdong, Peoples R China; [Jin, Yi] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Pathol, Guangzhou 510630, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Sun, HY (corresponding author), Sun Yat Sen Univ, Zhongshan Schoool Med, Forens Biol Sect, Guangzhou 510080, Guangdong, Peoples R China.	sunhongyu125678@21cn.com	Ou, Xueling/W-9964-2019; MA, XIAO/HHN-5611-2022; Sun, 宏钰/H-7885-2018	Ou, Xueling/0000-0003-2345-4980; Sun, 宏钰/0000-0002-5926-4495	National Natural Science Foundation [30400519]; Scientific Research Foundation of Ministry of Education [2008-890]; Ministry of Public Security [2007YYCXGDST079]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of Ministry of Education; Ministry of Public Security	This research is supported by the National Natural Science Foundation (30400519), the Scientific Research Foundation of Ministry of Education (2008-890), and the application innovation program of the Ministry of Public Security (2007YYCXGDST079).	An JH, 2012, BMB REP, V45, P545, DOI 10.5483/BMBRep.2012.45.10.206; Beuvink I, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1118; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Finnegan EF, 2013, CRIT REV BIOCHEM MOL, V48, P51, DOI 10.3109/10409238.2012.738643; Gao Lin-Lin, 2011, Fa Yi Xue Za Zhi, V27, P455; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hanson Erin K, 2013, Methods Mol Biol, V1024, P221, DOI 10.1007/978-1-62703-453-1_18; Hanson EK, 2009, ANAL BIOCHEM, V387, P303, DOI 10.1016/j.ab.2009.01.037; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Uchimoto ML, 2013, FORENSIC SCI INT-GEN, V7, P418, DOI 10.1016/j.fsigen.2013.04.006; Virkler K, 2009, FORENSIC SCI INT, V188, P1, DOI 10.1016/j.forsciint.2009.02.013; Wang Z, 2013, FORENSIC SCI INT-GEN, V7, P116, DOI 10.1016/j.fsigen.2012.07.006; Zhu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069856; Zubakov D, 2010, INT J LEGAL MED, V124, P217, DOI 10.1007/s00414-009-0402-3	14	8	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137067	10.1371/journal.pone.0137067	http://dx.doi.org/10.1371/journal.pone.0137067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355456	Green Published, Green Submitted, gold			2022-12-26	WOS:000360965800026
J	Tully, T; Potapov, M				Tully, Thomas; Potapov, Mikhail			Intraspecific Phenotypic Variation and Morphological Divergence of Strains of Folsomia candida (Willem) (Collembola: Isotomidae), the "Standard" Test Springtaill	PLOS ONE			English	Article							BRISTLE PATTERNS; EVOLUTION; VARIABILITY; CHAETOTAXY	We describe and compare the external morphology of eleven clonal strains and one sexual lineage of the globally distributed Folsomia candida, known as "standard" test Collembola. Of the 18 morphological characters studied, we measured 14 to have significant between-strains genetic variations, 9 of these had high heritabilities (> 78%). The quantified morphological polymorphism was used to analyse the within-species relationships between strains by using both a parsimony analysis and a distance tree. These two detailed morphological phylogenies have revealed that the parthenogenetic strains grouped themselves into two major clades. However the exact position of the sexual strain remains unclear and further analysis is needed to confirm its exact relationship with the parthenogenetic ones. The two morphologically based clades were found to be the same as the ones previously described using molecular analysis. This shows that despite large within-strain variations, morphological characters can be used to differentiate some strains that have diverged within a single morphospecies. We discuss the potential evolutionary interpretations and consequences of these different levels of phenotypic variability.	[Tully, Thomas] Sorbonne Univ, Univ Paris 06, CNRS, iEES Paris,UMR 7618, Paris, France; [Tully, Thomas] Univ Paris 04, ESPE Paris, Paris, France; [Potapov, Mikhail] Moscow State Pedag Univ, Dept Zool & Ecol, Moscow 119435, Russia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Institut de Recherche pour le Developpement (IRD); Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Sorbonne Universite; Moscow State University of Education	Tully, T (corresponding author), Sorbonne Univ, Univ Paris 06, CNRS, iEES Paris,UMR 7618, Paris, France.	thomas.tully@upmc.fr		Tully, Thomas/0000-0003-1847-7504; Potapov, Mikhail/0000-0002-6111-3354	Ministry of Education and Science of the Russian Federation [6.632.2014/K]; Angence Nationale de la Recherche [ANR-09-PEXT-011]; UPMC; CNRS (France)	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Angence Nationale de la Recherche; UPMC(University of Pittsburgh); CNRS (France)(Centre National de la Recherche Scientifique (CNRS))	This study received financial support of the Ministry of Education and Science of the Russian Federation (Project No 6.632.2014/K) and of the Angence Nationale de la Recherche ANR-09-PEXT-011 and from UPMC and CNRS (France).	Barateiro Diogo J, 2007, J SOIL SEDIMENT, V7, P388, DOI 10.1065/jss2007.09.252; Birky CW, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P201, DOI 10.1007/978-90-481-2770-2_10; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bruce Walsh., 1998, GENETICS ANAL QUANTI; Bur T, 2012, SCI TOTAL ENVIRON, V414, P187, DOI 10.1016/j.scitotenv.2011.10.029; Chenon P, 2000, APPL SOIL ECOL, V14, P103, DOI 10.1016/S0929-1393(00)00047-0; Chernova NM., 2010, ENTOMOL REV, V90, P23, DOI DOI 10.1134/S0013873810010033; CHRISTIANSEN K, 1968, EVOLUTION, V22, P237, DOI 10.1111/j.1558-5646.1968.tb05891.x; Cicconardi F, 2010, MOL ECOL, V19, P386, DOI 10.1111/j.1365-294X.2009.04457.x; Cicconardi F, 2013, MOL ECOL, V22, P5382, DOI 10.1111/mec.12472; Crouau Y, 1999, APPL SOIL ECOL, V12, P103, DOI 10.1016/S0929-1393(99)00002-5; Crouau Y, 2003, APPL SOIL ECOL, V22, P175, DOI 10.1016/S0929-1393(02)00128-2; de Boer TE, 2011, MOL ECOL, V20, P1144, DOI 10.1111/j.1365-294X.2010.04985.x; Deharveng L, 2004, PEDOBIOLOGIA, V48, P415, DOI 10.1016/j.pedobi.2004.08.001; Environnement Canada, 2007, METH ESS BIOL ESS ME; Faddeeva A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130600; Flatt T, 2005, Q REV BIOL, V80, P287, DOI 10.1086/432265; Fountain MT, 2005, ANNU REV ENTOMOL, V50, P201, DOI 10.1146/annurev.ento.50.071803.130331; Gibert JM, 2005, DEV BIOL, V288, P194, DOI 10.1016/j.ydbio.2005.09.032; Gomez-Skarmeta J, 2003, NAT REV NEUROSCI, V4, P587, DOI 10.1038/nrn1142; Goto H. E., 1961, Entomologist London, V94, P105; Gough HJ, 1973, ENTOMOLOGISTS MONTHL, V108, P205; Grens A, 1995, DEVELOPMENT, V121, P4027; GROW A, 1976, REV ECOL BIOL SOL, V13, P611; GROW AB, 1974, REV ECOL BIOL SOL, V11, P377; Hopkin S.P., 1997, BIOL SPRINGTAILS INS; Hopkin Steve P., 1998, Antenna, V22, P117; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; ISO (International Organization for Standardization), 2014, 11267 ISO; Krogh P.H., 2009, TOXICITY TESTING COL; LAWRENCE PN, 1978, REV ECOL BIOL SOL, V15, P265; Lawrence PN, 1961, ENTOMOLOGIST, V94, P151; Le Bourlot V, 2014, AM NAT, V184, P609, DOI 10.1086/678083; Marcellini S, 2006, PLOS BIOL, V4, P2252, DOI 10.1371/journal.pbio.0040386; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Mendonca M.C., 1992, B MUSEU NACL NOVA Z, V351, P1; MUTT JAM, 1984, INT J ENTOMOL, V26, P369; Paradis E., 2012, ANAL PHYLOGENETICS E; PETERSEN H, 1978, 1ST INT SEM APT SIEN, P19; Pfeffer SP, 2010, PEDOBIOLOGIA, V54, P19, DOI 10.1016/j.pedobi.2010.08.003; PITKIN BR, 1980, SYST ENTOMOL, V5, P405, DOI 10.1111/j.1365-3113.1980.tb00425.x; Porco D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046056; Potapov M, 2001, ISOTOMIDAE SYNOPSES, V3; Potapov M.B., 1984, P26; Potapov MB, 2000, PEDOBIOLOGIA, V44, P234, DOI 10.1078/S0031-4056(04)70043-8; Potapov M, 2012, ANN SOC ENTOMOL FR, V48, P51, DOI 10.1080/00379271.2012.10697750; PRABHOO NR, 1976, ENTOMON, V1, P67; RAPOPORT E. H., 1962, ANN AND MAG NAT HIST, V5, P205; Rougerie R, 2009, PESQUI AGROPECU BRAS, V44, P789, DOI 10.1590/S0100-204X2009000800002; RUSEK JOSEF, 1964, VESTNIK CESK SPOLECNOSTI ZOOL, V28, P44; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Schneider C, 2013, INVERTEBR SYST, V27, P317, DOI 10.1071/IS13002; Schneider Clement, 2011, Soil Organisms, V83, P383; Schon I, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P1; Simpson P, 1999, DEVELOPMENT, V126, P1349; Simpson P, 2007, TRENDS GENET, V23, P350, DOI 10.1016/j.tig.2007.04.006; Stach J., 1947, APTERYGOTAN FAUNA PO; Stam EM, 1996, OECOLOGIA, V107, P283, DOI 10.1007/BF00328444; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Torricelli G, 2010, GENE, V449, P30, DOI 10.1016/j.gene.2009.09.006; Tully T, 2006, PEDOBIOLOGIA, V50, P95, DOI 10.1016/j.pedobi.2005.11.003; Tully T, 2011, EVOLUTION, V65, P3013, DOI 10.1111/j.1558-5646.2011.01347.x; Tully T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003207; Waagner D, 2010, COMP BIOCHEM PHYS A, V157, P177, DOI 10.1016/j.cbpa.2010.06.171; WETTON MN, 1987, SYST ENTOMOL, V12, P257, DOI 10.1111/j.1365-3113.1987.tb00201.x; WHALLEY P, 1981, NATURE, V291, P317, DOI 10.1038/291317a0; Willem V., 1902, Annales de la Societe Entomologique de Belgique, Vxlvi, P275; Yoshii R., 1994, ANN SPEL I JAPAN, V12, P1; Zhang F, 2014, ZOOL SCR, V43, P393, DOI 10.1111/zsc.12056	70	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0136047	10.1371/journal.pone.0136047	http://dx.doi.org/10.1371/journal.pone.0136047			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355293	Green Published, gold, Green Submitted			2022-12-26	WOS:000360965800010
J	Dhawan, D; Paoloni, M; Shukradas, S; Choudhury, DR; Craig, BA; Ramos-Vara, JA; Hahn, N; Bonney, PL; Khanna, C; Knapp, DW				Dhawan, Deepika; Paoloni, Melissa; Shukradas, Shweta; Choudhury, Dipanwita Roy; Craig, Bruce A.; Ramos-Vara, Jose A.; Hahn, Noah; Bonney, Patty L.; Khanna, Chand; Knapp, Deborah W.			Comparative Gene Expression Analyses Identify Luminal and Basal Subtypes of Canine Invasive Urothelial Carcinoma That Mimic Patterns in Human Invasive Bladder Cancer	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; HUMAN BREAST-TUMORS; URINARY-BLADDER; MOLECULAR PORTRAITS; TARGETED THERAPY; LUNG-CANCER; PHASE-III; LAPATINIB; ERLOTINIB; PATHWAYS	More than 160,000 people are expected to die from invasive urothelial carcinoma (iUC) this year worldwide. Research in relevant animal models is essential to improving iUC management. Naturally-occurring canine iUC closely resembles human iUC in histopathology, metastatic behavior, and treatment response, and could provide a relevant model for human iUC. The molecular characterization of canine iUC, however, has been limited. Work was conducted to compare gene expression array results between tissue samples from iUC and normal bladder in dogs, with comparison to similar expression array data from human iUC and normal bladder in the literature. Considerable similarities between enrichment patterns of genes in canine and human iUC were observed. These included patterns mirroring basal and luminal subtypes initially observed in human breast cancer and more recently noted in human iUC. Canine iUC samples also exhibited enrichment for genes involved in P53 pathways, as has been reported in human iUC. This is particularly relevant as drugs targeting these genes/pathways in other cancers could be repurposed to treat iUC, with dogs providing a model to optimize therapy. As part of the validation of the results and proof of principal for evaluating individualized targeted therapy, the overexpression of EGFR in canine bladder iUC was confirmed. The similarities in gene expression patterns between dogs and humans add considerably to the value of naturally-occurring canine iUC as a relevant and much needed animal model for human iUC. Furthermore, the finding of expression patterns that cross different pathologically-defined cancers could allow studies of dogs with iUC to help optimize cancer management across multiple cancer types. The work is also expected to lead to a better understanding of the biological importance of the gene expression patterns, and the potential application of the cross-species comparisons approach to other cancer types as well.	[Dhawan, Deepika; Bonney, Patty L.; Knapp, Deborah W.] Purdue Univ, Dept Vet Clin Sci, Coll Vet Med, W Lafayette, IN 47907 USA; [Dhawan, Deepika; Ramos-Vara, Jose A.; Knapp, Deborah W.] Purdue Univ, Purdue Oncol Sci Ctr, W Lafayette, IN 47907 USA; [Paoloni, Melissa; Khanna, Chand] NCI, CCR Comparat Oncol Program, Ctr Canc Res, Bethesda, MD 20892 USA; [Shukradas, Shweta; Choudhury, Dipanwita Roy] Strand Genom Inc, Dept Bioinformat, San Francisco, CA USA; [Craig, Bruce A.] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; [Ramos-Vara, Jose A.] Purdue Univ, Dept Comparat Pathobiol, Coll Vet Med, W Lafayette, IN 47907 USA; [Hahn, Noah] Johns Hopkins Univ, Sch Med, Dept Oncol & Urol, Baltimore, MD USA; [Knapp, Deborah W.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Johns Hopkins University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Knapp, DW (corresponding author), Purdue Univ, Dept Vet Clin Sci, Coll Vet Med, W Lafayette, IN 47907 USA.	knappd@purdue.edu	Craig, Bruce A/D-5797-2017	Craig, Bruce A/0000-0001-9346-467X	Comparative Oncology Program within the Intramural NCI; Strand Genomics Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108, UL1TR002529] Funding Source: NIH RePORTER	Comparative Oncology Program within the Intramural NCI; Strand Genomics Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by private donations for bladder cancer research made to the Purdue Comparative Oncology Program. At the time the work was done, MP and CK worked in the National Cancer Institute's Comparative Oncology Program. Additional funding for a portion of this work was provided by the Comparative Oncology Program within the Intramural NCI. Strand Genomics Inc. provided support in the form of salaries for authors SS and DRC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	American Cancer Society, 2015, CANC FIG FACTS; Castillo-Martin M, 2010, UROL ONCOL-SEMIN ORI, V28, P401, DOI 10.1016/j.urolonc.2009.04.019; Choi W, 2014, NAT REV UROL, V11, P400, DOI 10.1038/nrurol.2014.129; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Claperon A, 2014, J HEPATOL, V61, P325, DOI 10.1016/j.jhep.2014.03.033; Damrauer JS, 2014, P NATL ACAD SCI USA, V111, P3110, DOI 10.1073/pnas.1318376111; Decker B, 2015, MOL CANCER RES MCR; Dhawan D, 2013, UROL ONCOL-SEMIN ORI, V31, P1761, DOI 10.1016/j.urolonc.2012.03.015; Dhawan D, 2013, CANCER RES, V73, P875, DOI 10.1158/0008-5472.CAN-12-2101; Dhawan D, 2010, MOL CANCER THER, V9, P1371, DOI 10.1158/1535-7163.MCT-10-0049; Dyrskjot L, 2003, NAT GENET, V33, P90, DOI 10.1038/ng1061; Fang ZQ, 2013, GENET MOL RES, V12, P1479, DOI 10.4238/2013.May.6.1; Gala K, 2014, CLIN CANCER RES, V20, P1410, DOI 10.1158/1078-0432.CCR-13-1549; Gatzemeier U, 2007, J CLIN ONCOL, V25, P1545, DOI 10.1200/JCO.2005.05.1474; Gross-Goupil M, 2012, EXPERT OPIN INV DRUG, V21, P1727, DOI 10.1517/13543784.2012.713935; Guan Z, 2013, J CLIN ONCOL; Hahn NM, 2012, J UROLOGY, V187, P302, DOI 10.1016/j.juro.2011.09.010; Hanazono K, 2014, J VET MED SCI JPN SO; Havaleshko DM, 2009, NEOPLASIA, V11, P1185, DOI 10.1593/neo.09898; Iyer G, 2013, J CLIN ONCOL, V31, P3133, DOI 10.1200/JCO.2012.46.5740; Kawaguchi T, 2014, J CLIN ONCOL, V32, P1902, DOI 10.1200/JCO.2013.52.4694; Kim WJ, 2011, MOL MED, V17, P478, DOI 10.2119/molmed.2010.00274; Knapp Deborah W, 2015, Am Soc Clin Oncol Educ Book, pe667, DOI 10.14694/EdBook_AM.2015.35.e667; Knapp DW, 2014, ILAR J, V55, P100, DOI 10.1093/ilar/ilu018; KNAPP DW, 1994, J VET INTERN MED, V8, P273, DOI 10.1111/j.1939-1676.1994.tb03232.x; Knapp DW, 2013, ROW MACEWENS SMALL A; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kurtoglu M, 2015, CLIN GENITOURIN CANC; Lee SM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju151; Li ML, 2014, NAT GENET, V46, P872, DOI 10.1038/ng.3030; Liedberg F, 2008, UROL ONCOL-SEMIN ORI, V26, P17, DOI 10.1016/j.urolonc.2006.08.021; Mason RA, 2009, CARCINOGENESIS, V30, P1155, DOI 10.1093/carcin/bgp077; McHugh LA, 2007, UROLOGY, V69, P390, DOI 10.1016/j.urology.2006.12.003; Metro G, 2006, REV RECENT CLIN TRIA, V1, P1, DOI 10.2174/157488706775246157; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Plimack ER, 2014, PROSPECTS TARGETING; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Renouf DJ, 2014, EUR J CANCER, V50, P1909, DOI 10.1016/j.ejca.2014.04.008; Siegel RL, 2016, CA CANC J CLIN, V2015; Sjodahl G, 2012, CLIN CANCER RES, V18, P3377, DOI 10.1158/1078-0432.CCR-12-0077-T; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Teply Benjamin A, 2014, J Solid Tumors, V4, P25; Tomao F, 2014, ONCOTARGETS THER, V7, DOI 10.2147/OTT.S68286; Villares GJ, 2007, WORLD J UROL, V25, P573, DOI 10.1007/s00345-007-0202-7; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Wulfing C, 2009, CANCER-AM CANCER SOC, V115, P2881, DOI 10.1002/cncr.24337; Yan XL, 2012, BREAST CANCER RES TR, V132, P153, DOI 10.1007/s10549-011-1577-0; Zhang ZF, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-58; Zhu ZW, 2012, ANTI-CANCER AGENT ME, V12, P1081, DOI 10.2174/187152012803529673	49	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136688	10.1371/journal.pone.0136688	http://dx.doi.org/10.1371/journal.pone.0136688			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352142	Green Submitted, gold, Green Published			2022-12-26	WOS:000360932800045
J	Dorneles, EMS; Lima, GK; Teixeira-Carvalho, A; Araujo, MSS; Martins, OA; Sriranganathan, N; Al Qublan, H; Heinemann, MB; Lage, AP				Dorneles, Elaine M. S.; Lima, Graciela K.; Teixeira-Carvalho, Andrea; Araujo, Marcio S. S.; Martins-Filho, Olindo A.; Sriranganathan, Nammalwar; Al Qublan, Hamzeh; Heinemann, Marcos B.; Lage, Andrey P.			Immune Response of Calves Vaccinated with Brucella abortus S19 or RB51 and Revaccinated with RB51	PLOS ONE			English	Article							STRAIN RB51; BALB/C MICE; PROTECTIVE IMMUNITY; NEOSPORA-CANINUM; T-CELLS; INTRACELLULAR BACTERIA; CYTOTOXIC LYMPHOCYTES; ERADICATION PROGRAMS; BOVINE BRUCELLOSIS; C57BL/6 MICE	Brucella abortus S19 and RB51 strains have been successfully used to control bovine brucellosis worldwide; however, currently, most of our understanding of the protective immune response induced by vaccination comes from studies in mice. The aim of this study was to characterize and compare the immune responses induced in cattle prime-immunized with B. abortus S19 or RB51 and revaccinated with RB51. Female calves, aged 4 to 8 months, were vaccinated with either vaccine S19 (0.6-1.2 x 10(11) CFU) or RB51 (1.3 x 10(10) CFU) on day 0, and revaccinated with RB51 (1.3 x 10(10) CFU) on day 365 of the experiment. Characterization of the immune response was performed using serum and peripheral blood mononuclear cells. Blood samples were collected on days 0, 28, 210, 365, 393 and 575 post-immunization. Results showed that S19 and RB51 vaccination induced an immune response characterized by proliferation of CD4(+) and CD8(+) T-cells; IFN-gamma and IL-17A production by CD4(+) T-cells; cytotoxic CD8(+) T-cells; IL-6 secretion; CD4(+) and CD8(+) memory cells; antibodies of IgG1 class; and expression of the phenotypes of activation in T-cells. However, the immune response stimulated by S19 compared to RB51 showed higher persistency of IFN-. and CD4(+) memory cells, induction of CD21(+) memory cells and higher secretion of IL-6. After RB51 revaccination, the immune response was chiefly characterized by increase in IFN-. expression, proliferation of antigen-specific CD4(+) and CD8(+) T-cells, cytotoxic CD8(+) T-cells and decrease of IL-6 production in both groups. Nevertheless, a different polarization of the immune response, CD4(+)or CD8(+)-dominant, was observed after the booster with RB51 for S19 and RB51 prime-vaccinated animals, respectively. Our results indicate that after prime vaccination both vaccine strains induce a strong and complex Th1 immune response, although after RB51 revaccination the differences between immune profiles induced by prime-vaccination become accentuated.	[Dorneles, Elaine M. S.; Lima, Graciela K.; Lage, Andrey P.] Univ Fed Minas Gerais, Lab Bacteriol Aplicada, Dept Med Vet Prevent, Escola Vet, Belo Horizonte, MG, Brazil; [Teixeira-Carvalho, Andrea; Araujo, Marcio S. S.; Martins-Filho, Olindo A.] Fundacao Oswaldo Cruz, Lab Biomarcadores Diagnost & Monitoracao, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Sriranganathan, Nammalwar; Al Qublan, Hamzeh] Virginia Polytech Inst & State Univ, Ctr Mol Med & Infect Dis, Dept Biomed Sci & Pathobiol, Virginia Maryland Coll,Vet Med, Blacksburg, VA 24061 USA; [Heinemann, Marcos B.] Univ Sao Paulo, Dept Med Vet Prevent & Saude Anim, Fac Med Vet & Zootecnia, Sao Paulo, SP, Brazil	Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Virginia Polytechnic Institute & State University; Universidade de Sao Paulo	Lage, AP (corresponding author), Univ Fed Minas Gerais, Lab Bacteriol Aplicada, Dept Med Vet Prevent, Escola Vet, Belo Horizonte, MG, Brazil.	alage@vet.ufmg.br	Dorneles, Elaine/J-1115-2016; Martins-Filho, Olindo Assis/ABE-6278-2021; Araujo, Marcio Sobreira Silva/ABE-7105-2021; Dorneles, Elaine/V-2816-2019; Heinemann, Marcos B/G-2780-2015; Heinemann, Marcos Bryan/AAI-9390-2020	Martins-Filho, Olindo Assis/0000-0002-5494-4889; Araujo, Marcio Sobreira Silva/0000-0002-7532-3360; Dorneles, Elaine/0000-0002-2753-1296; Heinemann, Marcos B/0000-0001-6444-9788; Heinemann, Marcos Bryan/0000-0001-6444-9788	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Fapemig); FEP - MVZ Coordenacao Preventiva; CNPq; Capes (Ciencia Sem Fronteiras) [8808-13]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Fapemig)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FEP - MVZ Coordenacao Preventiva; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Capes (Ciencia Sem Fronteiras)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Fapemig) and FEP - MVZ Coordenacao Preventiva. ATC, OAMF, MBH and APL thank CNPq for their fellowships. EMSD thanks CNPq and Capes (Ciencia Sem Fronteiras 8808-13) for her fellowship as well.	Andrews E, 2006, MICROBIOL IMMUNOL, V50, P389, DOI 10.1111/j.1348-0421.2006.tb03805.x; ARAYA LN, 1990, INFECT IMMUN, V58, P254, DOI 10.1128/IAI.58.1.254-256.1990; ARAYA LN, 1989, J IMMUNOL, V143, P3330; Banks HT, 2011, B MATH BIOL, V73, P116, DOI 10.1007/s11538-010-9524-5; Bernues A, 1997, PREV VET MED, V30, P137, DOI 10.1016/S0167-5877(96)01103-8; Brandao APMS, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/589494; Brasil, 2007, EST COND VAC FEM BOV, P6; Brasil, 2004, REG TECN PROGR NAC C, P6; Brasil, 2006, MAN TECN PROGR NAC C; CHEVILLE NF, 1993, AM J VET RES, V54, P1591; Cheville NF, 1996, AM J VET RES, V57, P1153; Chongsuvivatwong V, 2012, EPICALC EPIDEMIOLOGI; Clapp B, 2011, INFECT IMMUN, V79, P4165, DOI 10.1128/IAI.05080-11; Colby LA, 2002, J WILDLIFE DIS, V38, P752, DOI 10.7589/0090-3558-38.4.752; CONFER AW, 1985, VET MICROBIOL, V10, P561, DOI 10.1016/0378-1135(85)90065-3; Corbel M.J., 2006, BRUCELLOSIS HUMANS A; DIAZ R, 1968, J BACTERIOL, V96, P893, DOI 10.1128/JB.96.4.893-901.1968; Dorneles EMS, 2015, GENET MOL RES, V14, P940, DOI 10.4238/2015.February.3.1; Dorneles EMS, 2015, VACCINE, V33, P3659, DOI 10.1016/j.vaccine.2015.05.057; Dorneles EMS, 2014, VACCINE, V32, P6034, DOI 10.1016/j.vaccine.2014.08.060; Dorneles EMS, 2015, VET RES IN PRESS; Estes DM, 2002, VET IMMUNOL IMMUNOP, V90, P1, DOI 10.1016/S0165-2427(02)00201-5; He YQ, 2001, INFECT IMMUN, V69, P5502, DOI 10.1128/IAI.69.9.5502-5508.2001; Hersperger AR, 2008, CYTOM PART A, V73A, P1050, DOI 10.1002/cyto.a.20596; Hirota K, 2010, SEMIN IMMUNOPATHOL, V32, P3, DOI 10.1007/s00281-009-0187-y; Hoek A, 2009, VET RES, V40, DOI 10.1051/vetres:2008044; Hu XD, 2009, DNA CELL BIOL, V28, P191, DOI 10.1089/dna.2008.0790; Kwong LS, 2002, VET IMMUNOL IMMUNOP, V85, P213, DOI 10.1016/S0165-2427(02)00007-7; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; LASALLE JM, 1991, J IMMUNOL, V147, P774; Luo D, 2006, INFECT IMMUN, V74, P2734, DOI 10.1128/IAI.74.5.2734-2741.2006; Manthei CA, 1959, SUMMARY CONTROLLED R, V19, P91; McDiarmid A., 1960, Veterinary Record, V72, P917; MCDIARMID A., 1957, Veterinary Record, V69, P877; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Miranda KL, 2015, VACCINE, V33, P507, DOI 10.1016/j.vaccine.2014.11.056; Murphy EA, 2001, FEMS IMMUNOL MED MIC, V32, P85, DOI 10.1111/j.1574-695X.2001.tb00536.x; MYERS DM, 1972, APPL MICROBIOL, V23, P894, DOI 10.1128/AEM.23.5.894-902.1972; OIE, 2009, MANUAL DIAGNOSTIC TE; OLIVEIRA SC, 1995, EUR J IMMUNOL, V25, P2551, DOI 10.1002/eji.1830250922; Olsen S C, 2000, Vet Ther, V1, P183; Olsen SC, 2005, EXPERT REV VACCINES, V4, P915, DOI 10.1586/14760584.4.6.915; Palmer MV, 1997, AM J VET RES, V58, P472; Pasquali P, 2001, INFECT IMMUN, V69, P6541, DOI 10.1128/IAI.69.10.6541-6544.2001; Pasquevich KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016203; Poester FP, 2006, VACCINE, V24, P5327, DOI 10.1016/j.vaccine.2006.04.020; Polci A, 2006, Vet Ital, V42, P147; R RCT, 2013, LANG ENV STAT COMP; Ramamoorthy S, 2007, INT J PARASITOL, V37, P1531, DOI 10.1016/j.ijpara.2007.04.021; Ramamoorthy S, 2007, INT J PARASITOL, V37, P1521, DOI 10.1016/j.ijpara.2007.04.020; REDMAN DR, 1967, J AM VET MED ASSOC, V150, P403; Rosinha GMS, 2002, J MED MICROBIOL, V51, P661, DOI 10.1099/0022-1317-51-8-661; Garcia JVSY, 2008, MICROBES INFECT, V10, P635, DOI 10.1016/j.micinf.2008.02.010; Garcia JVSY, 2010, MICROBES INFECT, V12, P1236, DOI 10.1016/j.micinf.2010.09.009; Sampaio IBM, 2002, ESTATISTICA APLICADA; Sanakkayala N, 2005, CLIN DIAGN LAB IMMUN, V12, P1429, DOI 10.1128/CDLI.12.12.1429-1436.2005; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; SCHURIG GG, 1991, VET MICROBIOL, V28, P171, DOI 10.1016/0378-1135(91)90091-S; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Siegrist C-A, 2013, VACCINES, P14, DOI DOI 10.1016/B978-1-4557-0090-5.00004-5; Singh R, 2012, INDIAN J EXP BIOL, V50, P239; SMITH R, 1990, VET IMMUNOL IMMUNOP, V25, P83, DOI 10.1016/0165-2427(90)90112-6; Splitter G, 1996, VET IMMUNOL IMMUNOP, V54, P309, DOI 10.1016/S0165-2427(96)05703-0; Srisuradetchai P, 2013, SKILLINGS MACK SKILL; STEVENS MG, 1994, INFECT IMMUN, V62, P3206, DOI 10.1128/IAI.62.8.3206-3212.1994; STEVENS MG, 1995, VET IMMUNOL IMMUNOP, V44, P223, DOI 10.1016/0165-2427(94)05311-F; STEVENS MG, 1994, INFECT IMMUN, V62, P4646, DOI 10.1128/IAI.62.10.4646-4649.1994; TOBIAS L, 1992, RES VET SCI, V53, P179, DOI 10.1016/0034-5288(92)90107-D; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Vemulapalli R, 2002, VET MICROBIOL, V90, P521, DOI 10.1016/S0378-1135(02)00232-8; Vemulapalli R, 2000, CLIN DIAGN LAB IMMUN, V7, P114, DOI 10.1128/CDLI.7.1.114-118.2000; Vemulapalli R, 2007, VET PARASITOL, V148, P219, DOI 10.1016/j.vetpar.2007.06.029; Vemullpalli R, 2000, INFECT IMMUN, V68, P3290, DOI 10.1128/IAI.68.6.3290-3296.2000; Verger JM, 1988, TECHNIQUES BRUCELLOS; WYCKOFF JH, 1993, VET IMMUNOL IMMUNOP, V36, P45, DOI 10.1016/0165-2427(93)90005-O; Xavier MN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003454; Xu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048140, 10.1371/journal.pone.0029552]; Yu DH, 2007, VACCINE, V25, P6744, DOI 10.1016/j.vaccine.2007.06.061; Yu DH, 2007, DNA CELL BIOL, V26, P435, DOI 10.1089/dna.2006.0552; ZHAN YF, 1993, INFECT IMMUN, V61, P2841, DOI 10.1128/IAI.61.7.2841-2847.1993; ZHAN YF, 1995, INFECT IMMUN, V63, P720, DOI 10.1128/IAI.63.2.720-723.1995	82	39	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136696	10.1371/journal.pone.0136696	http://dx.doi.org/10.1371/journal.pone.0136696			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352261	Green Submitted, gold, Green Published			2022-12-26	WOS:000360932800046
J	Kauhl, B; Heil, J; Hoebe, CJPA; Schweikart, J; Krafft, T; Dukers-Muijrers, NHTM				Kauhl, Boris; Heil, Jeanne; Hoebe, Christian J. P. A.; Schweikart, Juergen; Krafft, Thomas; Dukers-Muijrers, Nicole H. T. M.			The Spatial Distribution of Hepatitis C Virus Infections and Associated Determinants-An Application of a Geographically Weighted Poisson Regression for Evidence-Based Screening Interventions in Hotspots	PLOS ONE			English	Article							GENERAL-POPULATION; COST-EFFECTIVENESS; HCV INFECTION; UNITED-STATES; RISK-FACTORS; PREVALENCE; DISEASE; SEROPREVALENCE; IDENTIFICATION; EPIDEMIOLOGY	Background Hepatitis C Virus (HCV) infections are a major cause for liver diseases. A large proportion of these infections remain hidden to care due to its mostly asymptomatic nature. Population-based screening and screening targeted on behavioural risk groups had not proven to be effective in revealing these hidden infections. Therefore, more practically applicable approaches to target screenings are necessary. Geographic Information Systems (GIS) and spatial epidemiological methods may provide a more feasible basis for screening interventions through the identification of hotspots as well as demographic and socio-economic determinants. Methods Analysed data included all HCV tests (n = 23,800) performed in the southern area of the Netherlands between 2002-2008. HCV positivity was defined as a positive immunoblot or polymerase chain reaction test. Population data were matched to the geocoded HCV test data. The spatial scan statistic was applied to detect areas with elevated HCV risk. We applied global regression models to determine associations between population-based determinants and HCV risk. Geographically weighted Poisson regression models were then constructed to determine local differences of the association between HCV risk and population-based determinants. Results HCV prevalence varied geographically and clustered in urban areas. The main population at risk were middle-aged males, non-western immigrants and divorced persons. Socio-economic determinants consisted of one-person households, persons with low income and mean property value. However, the association between HCV risk and demographic as well as socio-economic determinants displayed strong regional and intra-urban differences. Discussion The detection of local hotspots in our study may serve as a basis for prioritization of areas for future targeted interventions. Demographic and socio-economic determinants associated with HCV risk show regional differences underlining that a one-size-fits-all approach even within small geographic areas may not be appropriate. Future screening interventions need to consider the spatially varying association between HCV risk and associated demographic and socio-economic determinants.	[Kauhl, Boris; Krafft, Thomas] Maastricht Univ, Fac Hlth Med & Life Sci, Sch Publ Hlth & Primary Care CAPHRI, Dept Hlth Eth & Soc, Maastricht, Netherlands; [Heil, Jeanne; Hoebe, Christian J. P. A.; Dukers-Muijrers, Nicole H. T. M.] South Limburg Publ Hlth Serv GGD Zuid Limburg, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands; [Hoebe, Christian J. P. A.; Dukers-Muijrers, Nicole H. T. M.] Maastricht Univ Med Ctr, Sch Publ Hlth & Primary Care CAPHRI, Dept Med Microbiol, Maastricht, Netherlands; [Schweikart, Juergen] Beuth Univ Appl Sci, Dept Civil Engn & Geoinformat 3, Berlin, Germany	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Kauhl, B (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Sch Publ Hlth & Primary Care CAPHRI, Dept Hlth Eth & Soc, Maastricht, Netherlands.	boris.kauhl@maastrichtuniversity.nl	Dukers-Muijrers, Nicole/M-7178-2014	Heil, Jeanne/0000-0002-0057-9599; Dukers-Muijrers, Nicole/0000-0003-4896-758X; Krafft, Thomas/0000-0002-6164-7815; Hoebe, Christian/0000-0003-1815-0974				Alencar CH, 2012, TROP MED INT HEALTH, V17, P518, DOI 10.1111/j.1365-3156.2011.02945.x; Alter M. J., 1998, MMWR MORB MORTAL WKL, V47; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; Anselin L, 2005, EXPLORING SPATIAL DA; Bao YP, 2012, JAIDS-J ACQ IMM DEF, V60, P438, DOI 10.1097/QAI.0b013e31825694f2; Berke O, 2003, J VET MED B, V50, P322, DOI 10.1046/j.1439-0450.2003.00689.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Bush KR, 2008, SEX TRANSM DIS, V35, P291, DOI 10.1097/OLQ.0b013e31815c1edb; Cavlek TV, 2009, J MED VIROL, V81, P1348, DOI 10.1002/jmv.21530; Chen J, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-57; Coleman M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-68; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; Culver DH, 2000, TRANSFUSION, V40, P1176, DOI 10.1046/j.1537-2995.2000.40101176.x; Desenclos J-C, 2003, Euro Surveill, V8, P99; Dijkstra A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072730; Dore GJ, 2011, CURR OPIN HIV AIDS, V6, P508, DOI 10.1097/COH.0b013e32834b87f8; Du P, 2010, CANCER CAUSE CONTROL, V21, P1669, DOI 10.1007/s10552-010-9596-4; ESRI, 2013, EXPL REGR WORKS; Fotheringham A. S., 2003, GEOGRAPHICALLY WEIGH; FOTHERINGHAM AS, 1991, ENVIRON PLANN A, V23, P1025, DOI 10.1068/a231025; Garfein RS, 1996, AM J PUBLIC HEALTH, V86, P655, DOI 10.2105/AJPH.86.5.655; Gebo KA, 2002, HOPKINS HIV REP S, V14, pi; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Hahne SJM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-181; Haque U, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-63; Hu MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038978; Jennings JM, 2005, AM J EPIDEMIOL, V161, P73, DOI 10.1093/aje/kwi012; Jones RC, 2006, PUBLIC HEALTH REP, V121, P133, DOI 10.1177/003335490612100206; Kauhl B, 2015, HEALTH PLACE, V31, P111, DOI 10.1016/j.healthplace.2014.11.002; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M, 2013, SATSCANTM USER GUIDE; Lawson AB, 2000, STAT MED, V19, P2217; Lin CH, 2011, INT J ENV RES PUB HE, V8, P2798, DOI 10.3390/ijerph8072798; LOVETT A, 1989, PROF GEOGR, V41, P190, DOI 10.1111/j.0033-0124.1989.00190.x; LOVETT AA, 1986, SOC SCI MED, V23, P935, DOI 10.1016/0277-9536(86)90251-0; Meffre C, 2010, J MED VIROL, V82, P546, DOI 10.1002/jmv.21734; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Mujeeb SA, 2000, PUBLIC HEALTH, V114, P413, DOI 10.1016/S0033-3506(00)00375-9; Nakaya T, 2005, STAT MED, V24, P2695, DOI 10.1002/sim.2129; Nakaya T., 2012, GWR4 USER MANUAL; OECD, 2013, DEM CHANG NETH STRAT; Paez A, 2011, ENVIRON PLANN A, V43, P2992, DOI 10.1068/a44111; Perz JF, 2004, ESTIMATED GLOBAL PRE; POOLE MA, 1971, T I BRIT GEOGR, P145, DOI 10.2307/621706; Rodrigues Neto Joao, 2012, Rev Bras Epidemiol, V15, P627; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shoff C, 2012, DEMOGR RES, V27, P377; Singer ME, 2001, AM J MED, V111, P614, DOI 10.1016/S0002-9343(01)00951-2; Slavenburg S, 2008, NETH J MED, V66, P13; Smith BD, 2014, AM J PREV MED, V47, P233, DOI 10.1016/j.amepre.2014.05.011; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Statistics Netherlands, 2015, STATL; Tanser F, 2009, INT J EPIDEMIOL, V38, P1008, DOI 10.1093/ije/dyp148; Tsai PJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-191; Tsai Pui-Jen, 2013, Glob J Health Sci, V5, P101, DOI 10.5539/gjhs.v5n3p101; van de Laar TJW, 2007, J INFECT DIS, V196, P230, DOI 10.1086/518796; Veldhuijzen Irene K, 2009, Int J Infect Dis, V13, pe9, DOI 10.1016/j.ijid.2008.05.1224; Vermeiren APA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051194; Vriend HJ, 2013, EPIDEMIOL INFECT, V141, P1310, DOI 10.1017/S0950268812001884; Vriend HJ, 2012, EUR J PUBLIC HEALTH, V22, P819, DOI 10.1093/eurpub/cks013; Waller L.A., 2004, APPL SPATIAL STAT PU; Wang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110861; Weisent J, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-45; WHO, 2014, GUID SCREEN CAR TREA; Zheng S, 2014, EPIDEMIOL INFECT, V142, P1751, DOI 10.1017/S0950268813002586; Zuure FR, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-66	67	36	36	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135656	10.1371/journal.pone.0135656	http://dx.doi.org/10.1371/journal.pone.0135656			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9KG	26352611	Green Submitted, Green Published, gold			2022-12-26	WOS:000360932800012
J	Johanson, Z; Boisvert, C; Maksimenko, A; Currie, P; Trinajstic, K				Johanson, Zerina; Boisvert, Catherine; Maksimenko, Anton; Currie, Peter; Trinajstic, Kate			Development of the Synarcual in the Elephant Sharks (Holocephali; Chondrichthyes): Implications for Vertebral Formation and Fusion	PLOS ONE			English	Article							SALMON SALMO-SALAR; FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; EUROPEAN FISH LARVAE; SKELETAL ANOMALIES; AXIAL SKELETON; CLASSIFICATION; SEGMENTATION; EVOLUTIONARY; COLUMN; INSIGHTS	The synarcual is a structure incorporating multiple elements of two or more anterior vertebrae of the axial skeleton, forming immediately posterior to the cranium. It has been convergently acquired in the fossil group 'Placodermi', in Chondrichthyes (Holocephali, Batoidea), within the teleost group Syngnathiformes, and to varying degrees in a range of mammalian taxa. In addition, cervical vertebral fusion presents as an abnormal pathology in a variety of human disorders. Vertebrae develop from axially arranged somites, so that fusion could result from a failure of somite segmentation early in development, or from later heterotopic development of intervertebral bone or cartilage. Examination of early developmental stages indicates that in the Batoidea and the 'Placodermi', individual vertebrae developed normally and only later become incorporated into the synarcual, implying regular somite segmentation and vertebral development. Here we show that in the holocephalan Callorhinchus milii, uniform and regular vertebral segmentation also occurs, with anterior individual vertebra developing separately with subsequent fusion into a synarcual. Vertebral elements forming directly behind the synarcual continue to be incorporated into the synarcual through growth. This appears to be a common pattern through the Vertebrata. Research into human disorders, presenting as cervical fusion at birth, focuses on gene misexpression studies in humans and other mammals such as the mouse. However, in chondrichthyans, vertebral fusion represents the normal morphology, moreover, taxa such Leucoraja (Batoidea) and Callorhinchus (Holocephali) are increasingly used as laboratory animals, and the Callorhinchus genome has been sequenced and is available for study. Our observations on synarcual development in three major groups of early jawed vertebrates indicate that fusion involves heterotopic cartilage and perichondral bone/mineralised cartilage developing outside the regular skeleton. We suggest that chondrichthyans have potential as ideal extant models for identifying the genes involved in these processes, for application to human skeletal heterotopic disorders.	[Johanson, Zerina] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Boisvert, Catherine; Currie, Peter] Monash Univ, ARMI, Clayton, Vic 3800, Australia; [Maksimenko, Anton] Australian Synchrotron, Clayton, Vic 3168, Australia; [Trinajstic, Kate] Curtin Univ, Dept Environm & Agr, Bentley, WA 6845, Australia; [Trinajstic, Kate] Western Australian Museum, Dept Earth & Planetary Sci, Welshpool, WA 6106, Australia	Natural History Museum London; Australian Regenerative Medicine Institute; Monash University; Curtin University; Western Australian Museum	Johanson, Z (corresponding author), Nat Hist Museum, Dept Earth Sci, Cromwell Rd, London SW7 5BD, England.	z.johanson@nhm.ac.uk	Boisvert, Catherine A/A-9782-2019	Boisvert, Catherine A/0000-0002-0618-7270; Johanson, Zerina/0000-0002-8444-6776; Trinajstic, Kate/0000-0002-6519-6396; Currie, Peter/0000-0001-8874-8862	Australian Research Council [DP110101127]; National Health and Medical Research Council [APP1041885]; Australian Synchrotron [23435]; State Government of Victoria; Australian Federal Government; ARC; Victorian State; Australian Government	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Synchrotron; State Government of Victoria; Australian Federal Government(Australian Government); ARC(Australian Research Council); Victorian State; Australian Government(Australian GovernmentCGIAR)	This work was funded through an Australian Research Council grant to KT, CB and ZJ (QE II to KT and Discovery project number DP110101127), and the National Health and Medical Research Council grant to PDC (Australia, Principal Research Fellowship APP1041885). The specimen of Campbellodus was scanned at the Australian Synchrotron under user grant #23435. The Australian Regenerative Medicine Institute is supported by funds from the State Government of Victoria and the Australian Federal Government. The elephant shark facility was funded via ARC grants and the help of the Australian Regenerative Medicine Institute, supported by grants from the Victorian State and Australian Government. Filtration equipment was provided at cost from Advanced Aquarium Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson RC, 2009, TRENDS GENET, V25, P74, DOI 10.1016/j.tig.2008.11.006; Argot C, 2003, J MORPHOL, V255, P279, DOI 10.1002/jmor.10062; Arratia G, 2001, J MORPHOL, V250, P101, DOI 10.1002/jmor.1062; Aulehla A, 2004, GENE DEV, V18, P2060, DOI 10.1101/gad.1217404; Aulehla A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000869; Bensimon-Brito A, 2012, EVOL DEV, V14, P116, DOI 10.1111/j.1525-142X.2011.00526.x; Bertin L, 1958, TRAITE ZOOL, V13, P2204; BLOT J, 1980, B MUS NATL HIST NAT, V2, P339; Boglione C, 2013, REV AQUACULT, V5, pS99, DOI 10.1111/raq.12015; Boglione C, 2013, REV AQUACULT, V5, pS121, DOI 10.1111/raq.12016; Boisvert CA, 2015, ZOO BIOL, V34, P94, DOI 10.1002/zoo.21183; Buckley D, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-17; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; Christ B, 1998, ANAT EMBRYOL, V197, P1; Claeson KM, 2011, J MORPHOL, V272, P1444, DOI 10.1002/jmor.10996; Cole NJ, 2007, DEV DYNAM, V236, P2421, DOI 10.1002/dvdy.21268; Culbert AL, 2014, STEM CELLS, V32, P1289, DOI 10.1002/stem.1633; Didier DA, 1998, J MORPHOL, V236, P25; Didier DA, 1995, AM MUS NOVIT, V3119, P1; Dittmann K, 2014, ARTHRITIS RHEUMATOL, V66, P831, DOI 10.1002/art.38325; Eckalbar WL, 2012, WIRES DEV BIOL, V1, P401, DOI 10.1002/wdev.34; Fisher S, 2003, DEV BIOL, V264, P64, DOI 10.1016/S0012-1606(03)00399-3; FOREY PL, 1986, ZOOL J LINN SOC-LOND, V86, P43, DOI 10.1111/j.1096-3642.1986.tb01807.x; Gadow H., 1933, THE EVOLUTION OF THE; Galliari FC, 2010, MAMM BIOL, V75, P326, DOI 10.1016/j.mambio.2009.03.014; Goodrich ES, 1958, STUDIES ON THE STRUC; Graham A, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-24; Hatt RT, 1931, B AM MUS NAT HIST, V63, P599; Hughes DST, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-30; James HF, 2009, AUK, V126, P862, DOI 10.1525/auk.2009.08194; Johanson Z, 2013, ZOOMORPHOLOGY, V132, P95, DOI 10.1007/s00435-012-0169-9; Johanson Z, 2010, INT J DEV BIOL, V54, P71, DOI 10.1387/ijdb.072508zj; Khonsari RH, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-27; Lelievre H, 2009, J VERTEBR PALEONTOL, V29, P584, DOI 10.1671/039.029.0233; LIM TM, 1987, DEVELOPMENT, V100, P525; Long JA, 2015, NATURE, V517, P196, DOI 10.1038/nature13825; Mara A, 2007, TRENDS CELL BIOL, V17, P593, DOI 10.1016/j.tcb.2007.09.005; Maroto M, 2012, DEVELOPMENT, V139, P2453, DOI 10.1242/dev.069310; Maxwell EE, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-265; Miao JL, 2012, GENES GENET SYST, V87, P213, DOI 10.1266/ggs.87.213; Miles R. S, 1977, Linnean Soc Symp Ser, VNo. 4, P123; Miyake T., 1988, THESIS, VI; Monsoro-Burq AH, 2005, INT J DEV BIOL, V49, P301, DOI 10.1387/ijdb.041953am; MONSOROBURQ AH, 1994, P NATL ACAD SCI USA, V91, P10435, DOI 10.1073/pnas.91.22.10435; Moran MM, 2015, J MAMM EVOL, V22, P93, DOI 10.1007/s10914-014-9256-7; Morin-Kensicki EM, 2002, DEVELOPMENT, V129, P3851; Neyt C, 2000, NATURE, V408, P82, DOI 10.1038/35040549; Offiah A, 2010, AM J MED GENET A, V152A, P1357, DOI 10.1002/ajmg.a.33361; Pedersen ME, 2011, FISH PHYSIOL BIOCHEM, V37, P821, DOI 10.1007/s10695-011-9480-5; Piekarski N, 2014, J MORPHOL, V275, P141, DOI 10.1002/jmor.20204; Pinheiro FL, 2011, ACTA PALAEONTOL POL, V56, P567, DOI 10.4202/app.2010.0057; Rashid DJ, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-25; Rios AC, 2011, NATURE, V473, P532, DOI 10.1038/nature09970; Scaal Martin, 2006, Anat Embryol (Berl), V211 Suppl 1, P9, DOI 10.1007/s00429-006-0127-8; Schaffer AA, 2005, SPINE, V30, P1379, DOI 10.1097/01.brs.0000166619.22832.2c; Schartl M, 2014, DIS MODEL MECH, V7, P181, DOI 10.1242/dmm.012245; Stensi/ E.A., 1969, TRAITE PALEONTOL, V4, P71; TAYLOR W R, 1985, Cybium, V9, P107; Varela-Lasheras I, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-11; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Wake MH, 1979, HYMANS COMPARATIVE V; Watanabe Y, 1998, DEVELOPMENT, V125, P2631; Witten PE, 2006, AQUACULTURE, V258, P164, DOI 10.1016/j.aquaculture.2006.05.005; Witten PE, 2009, AQUACULTURE, V295, P6, DOI 10.1016/j.aquaculture.2009.06.037; Witten PE, 2005, DIS AQUAT ORGAN, V64, P237, DOI 10.3354/dao064237; Wyffels Jennifer, 2014, F1000Res, V3, P191, DOI 10.12688/f1000research.4996.1; Ytteborg Elisabeth, 2010, BMC Physiology, V10, P12, DOI 10.1186/1472-6793-10-12; Ytteborg Elisabeth, 2010, BMC Physiology, V10, P13, DOI 10.1186/1472-6793-10-13	68	13	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0135138	10.1371/journal.pone.0135138	http://dx.doi.org/10.1371/journal.pone.0135138			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339918	Green Published, gold, Green Submitted			2022-12-26	WOS:000360688200002
J	Liu, Z; Ding, S; Kropachev, K; Lei, J; Amin, S; Broyde, S; Geacintov, NE				Liu, Zhi; Ding, Shuang; Kropachev, Konstantin; Lei, Jia; Amin, Shantu; Broyde, Suse; Geacintov, Nicholas E.			Resistance to Nucleotide Excision Repair of Bulky Guanine Adducts Opposite Abasic Sites in DNA Duplexes and Relationships between Structure and Function	PLOS ONE			English	Article							NMR SOLUTION STRUCTURES; SOLUTION CONFORMATION; DIOL EPOXIDE; MODIFIED DEOXYGUANOSINE; DAMAGE RECOGNITION; BASE DISPLACEMENT; QUALITY-CONTROL; DELETION SITE; LESION; INTERCALATION	The nucleotide excision repair of certain bulky DNA lesions is abrogated in some specific non-canonical DNA base sequence contexts, while the removal of the same lesions by the nucleotide excision repair mechanism is efficient in duplexes in which all base pairs are complementary. Here we show that the nucleotide excision repair activity in human cell extracts is moderate-to-high in the case of two stereoisomeric DNA lesions derived from the pro-carcinogen benzo[a]pyrene (cis- and trans-B[a]P-N-2-dG adducts) in a normal DNA duplex. By contrast, the nucleotide excision repair activity is completely abrogated when the canonical cytosine base opposite the B[a]P-dG adducts is replaced by an abasic site in duplex DNA. However, base excision repair of the abasic site persists. In order to understand the structural origins of these striking phenomena, we used NMR and molecular spectroscopy techniques to evaluate the conformational features of 11mer DNA duplexes containing these B[a]P-dG lesions opposite abasic sites. Our results show that in these duplexes containing the clustered lesions, both B[a]P-dG adducts adopt base-displaced intercalated conformations, with the B[a]P aromatic rings intercalated into the DNA helix. To explain the persistence of base excision repair in the face of the opposed bulky B[a]P ring system, molecular modeling results suggest how the APE1 base excision repair endonuclease, that excises abasic lesions, can bind productively even with the trans-B[a]P-dG positioned opposite the abasic site. We hypothesize that the nucleotide excision repair resistance is fostered by local B[a] P residue-DNA base stacking interactions at the abasic sites, that are facilitated by the absence of the cytosine partner base in the complementary strand. More broadly, this study sets the stage for elucidating the interplay between base excision and nucleotide excision repair in processing different types of clustered DNA lesions that are substrates of nucleotide excision repair or base excision repair mechanisms.	[Liu, Zhi; Kropachev, Konstantin; Geacintov, Nicholas E.] NYU, Dept Chem, New York, NY 10010 USA; [Ding, Shuang; Lei, Jia; Broyde, Suse] NYU, Dept Biol, New York, NY 10003 USA; [Amin, Shantu] Penn State Univ, Dept Pharmacol, Hershey, PA USA	New York University; New York University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Geacintov, NE (corresponding author), NYU, Dept Chem, New York, NY 10010 USA.	ng1@nyu.edu			NIH - NIEHS [5R01ES024050]; NIH [CA-28038]; National Science Foundation [MCB060037]; National Center for Research Resources, NIH [C06 RR-16572]; NSF [MRI 0116222]; NYSTAR;  [CA-75449]; NATIONAL CANCER INSTITUTE [R01CA075449, R01CA028038] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024050] Funding Source: NIH RePORTER	NIH - NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NSF(National Science Foundation (NSF)); NYSTAR; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH - NIEHS grant 5R01ES024050 to NEG and NIH CA-28038 to SB. Computational infrastructure and systems management were partially supported by CA-75449 to SB. Funding for open access charge: NIH - NIEHS grant 5R01ES024050 to NEG. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. Computations were carried out on our own cluster of Dell workstations, the Multipurpose High Performance Computing Resources of New York University (NYU-ITS), and the Extreme Science and Engineering Discovery Environment (XSEDE) computational resources, which is supported by National Science Foundation Grant MCB060037. Components of this work were conducted in the Shared Instrumentation Facility at NYU that was constructed with support from Research Facilities Improvement Grant C06 RR-16572 from the National Center for Research Resources, NIH. The acquisition of the 500MHz spectrometer was supported by NSF Grant MRI 0116222. The data collected at the New York Structural Biology Center NYSBC was made possible by a grant from NYSTAR.	Alekseev S, 2015, CELL MOL LIFE SCI, V72, P2177, DOI 10.1007/s00018-015-1859-5; [Anonymous], PYMOL MOL GRAPHICS S; Arunan E, 2011, PURE APPL CHEM, V83, P1637, DOI 10.1351/PAC-REC-10-01-02; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Buterin T, 2005, CHEM BIOL, V12, P913, DOI 10.1016/j.chembiol.2005.06.011; Cai YQ, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/174252; Case D, 2006, AMBER 9; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; Chen J, 2008, NUCLEIC ACIDS RES, V36, P253, DOI 10.1093/nar/gkm622; Chen JY, 2007, BIOCHEMISTRY-US, V46, P3096, DOI 10.1021/bi6024269; Chen XJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6849; CHENG SC, 1989, CHEM RES TOXICOL, V2, P334, DOI 10.1021/tx00011a011; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; CONNEY AH, 1982, CANCER RES, V42, P4875; COSMAN M, 1994, BIOCHEMISTRY-US, V33, P11507, DOI 10.1021/bi00204a013; COSMAN M, 1993, BIOCHEMISTRY-US, V32, P4145, DOI 10.1021/bi00067a001; COSMAN M, 1992, P NATL ACAD SCI USA, V89, P1914, DOI 10.1073/pnas.89.5.1914; COSMAN M, 1994, BIOCHEMISTRY-US, V33, P11518, DOI 10.1021/bi00204a014; COSMAN M, 1990, CARCINOGENESIS, V11, P1667, DOI 10.1093/carcin/11.9.1667; DELOSSANTOS C, 1992, BIOCHEMISTRY-US, V31, P5245, DOI 10.1021/bi00138a002; Geacintov NE, 1997, CHEM RES TOXICOL, V10, P111, DOI 10.1021/tx9601418; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Goddard T. D., 2006, SPARKY 3; Gunz D, 1996, J BIOL CHEM, V271, P25089, DOI 10.1074/jbc.271.41.25089; Hazel RD, 2010, BIOCHEMISTRY-US, V49, P8978, DOI 10.1021/bi101021e; Hess MT, 1997, MOL CELL BIOL, V17, P7069, DOI 10.1128/MCB.17.12.7069; Hinz JM, 2014, MUTAT RES-FUND MOL M, V766, P19, DOI 10.1016/j.mrfmmm.2014.05.008; Huang WD, 2002, CHEM RES TOXICOL, V15, P118, DOI 10.1021/tx010135y; Huang XW, 2002, CHEM RES TOXICOL, V15, P438, DOI 10.1021/tx015588h; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Kropachev K, 2009, J MOL BIOL, V386, P1193, DOI 10.1016/j.jmb.2008.12.082; Krzeminski J, 2011, CHEM RES TOXICOL, V24, P65, DOI 10.1021/tx100284h; Lin Z, 1998, NUCLEIC ACIDS RES, V26, P2385, DOI 10.1093/nar/26.10.2385; Liu Y, 2011, DNA REPAIR, V10, P684, DOI 10.1016/j.dnarep.2011.04.020; Luijsterburg MS, 2010, J CELL BIOL, V189, P445, DOI 10.1083/jcb.200909175; Mathieu N, 2013, CURR BIOL, V23, P204, DOI 10.1016/j.cub.2012.12.032; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Mocquet V, 2007, EMBO J, V26, P2923, DOI 10.1038/sj.emboj.7601730; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Mu H, 2013, BIOCHEMISTRY-US, V52, P5517, DOI 10.1021/bi4009177; PATEL DJ, 1987, Q REV BIOPHYS, V20, P35, DOI 10.1017/S0033583500004224; Reeves DA, 2011, NUCLEIC ACIDS RES, V39, P8752, DOI 10.1093/nar/gkr537; Scharer OD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012609; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; Shivji MKK, 1999, METH MOL B, V113, P373; Skosareva LV, 2012, DNA REPAIR, V11, P367, DOI 10.1016/j.dnarep.2012.01.002; Smirnov S, 2002, NUCLEIC ACIDS RES, V30, P5561, DOI 10.1093/nar/gkf688; Starostenko LV, 2014, DNA REPAIR, V24, P1, DOI 10.1016/j.dnarep.2014.10.005; Tsutakawa SE, 2014, DNA REPAIR, V19, P95, DOI 10.1016/j.dnarep.2014.03.022; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wood RD, 1999, BIOCHIMIE, V81, P39, DOI 10.1016/S0300-9084(99)80036-4; Zamble DB, 1996, BIOCHEMISTRY-US, V35, P10004, DOI 10.1021/bi960453+	52	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137124	10.1371/journal.pone.0137124	http://dx.doi.org/10.1371/journal.pone.0137124			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340000	gold, Green Submitted, Green Published			2022-12-26	WOS:000360688200023
J	McIlroy, SJ; Awata, T; Nierychlo, M; Albertsen, M; Kindaichi, T; Nielsen, PH				McIlroy, Simon Jon; Awata, Takanori; Nierychlo, Marta; Albertsen, Mads; Kindaichi, Tomonori; Nielsen, Per Halkjaer			Characterization of the In Situ Ecophysiology of Novel Phylotypes in Nutrient Removal Activated Sludge Treatment Plants	PLOS ONE			English	Article							BIOLOGICAL PHOSPHORUS REMOVAL; RNA GENE DATABASE; 16S RIBOSOMAL-RNA; OLIGONUCLEOTIDE PROBES; POPULATION-DYNAMICS; HYBRIDIZATION; MICROAUTORADIOGRAPHY; IDENTIFICATION; DIVERSITY; SEQUENCES	An in depth understanding of the ecology of activated sludge nutrient removal wastewater treatment systems requires detailed knowledge of the community composition and metabolic activities of individual members. Recent 16S rRNA gene amplicon surveys of activated sludge wastewater treatment plants with nutrient removal indicate the presence of a core set of bacterial genera. These organisms are likely responsible for the bulk of nutrient transformations underpinning the functions of these plants. While the basic activities of some of these genera in situ are known, there is little to no information for the majority. This study applied microautoradiography coupled with fluorescence in situ hybridization (MAR-FISH) for the in situ characterization of selected genus-level-phylotypes for which limited physiological information is available. These included Sulfuritalea and A21b, both within the class Betaproteobacteria, as well as Kaga01, within sub-group 10 of the phylum Acidobacteria. While the Sulfuritalea spp. were observed to be metabolically versatile, the A21b and Kaga01 phylotypes appeared to be highly specialized.	[McIlroy, Simon Jon; Awata, Takanori; Nierychlo, Marta; Albertsen, Mads; Nielsen, Per Halkjaer] Aalborg Univ, Dept Chem & Biosci, Ctr Microbial Communities, Aalborg, Denmark; [Awata, Takanori] Nagoya Univ, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Awata, Takanori; Kindaichi, Tomonori] Hiroshima Univ, Grad Sch Engn, Dept Civil & Environm Engn, Higashihiroshima 7398527, Japan	Aalborg University; Nagoya University; Hiroshima University	Nielsen, PH (corresponding author), Aalborg Univ, Dept Chem & Biosci, Ctr Microbial Communities, Aalborg, Denmark.	phn@bio.aau.dk	McIlroy, Simon/P-4785-2017; Kindaichi, Tomonori/I-8551-2015; Nielsen, Per Halkjær/T-6796-2018; Albertsen, Mads/T-7358-2018	McIlroy, Simon/0000-0003-3749-8730; Kindaichi, Tomonori/0000-0003-1500-3397; Nielsen, Per Halkjær/0000-0002-6402-1877; Nierychlo, Marta/0000-0003-1756-3726; Albertsen, Mads/0000-0002-6151-190X	Innovation Fund Denmark [09-067230]; Japan Society for the Promotion of Science [12J00080]	Innovation Fund Denmark; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was partially supported by Innovation Fund Denmark (Grant No.: 09-067230) (http://innovationsfonden.dk/en)(PHN) and a Grant-inAid for JSPS Fellows from the Japan Society for the Promotion of Science (Grant No.: 12J00080)(http://www.jsps.go.jp/english/)(TA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132783; Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Albertsen M, 2012, ISME J, V6, P1094, DOI 10.1038/ismej.2011.176; Barns SM, 2007, APPL ENVIRON MICROB, V73, P3113, DOI 10.1128/AEM.02012-06; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Daims H, 2005, MOL MICROBIAL ECOLOG, P213; Daims H, 2010, MICROBIAL ECOLOGY OF ACTIVATED SLUDGE, P259; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Fuchs BM, 2000, APPL ENVIRON MICROB, V66, P3603, DOI 10.1128/AEM.66.8.3603-3607.2000; Kindaichi T, 2013, ENVIRON MICROBIOL, V15, P1821, DOI 10.1111/1462-2920.12074; Lee N, 1999, APPL ENVIRON MICROB, V65, P1289; Ludwig W, 1997, FEMS MICROBIOL LETT, V153, P181, DOI 10.1016/S0378-1097(97)00256-5; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; McIlroy SJ, 2014, ISME J, V8, P613, DOI 10.1038/ismej.2013.162; McIlroy SJ, 2011, ENVIRON MICROBIOL, V13, P33, DOI 10.1111/j.1462-2920.2010.02306.x; McIlroy SJ, 2016, ENVIRON MICROBIOL, V18, P50, DOI 10.1111/1462-2920.12614; McIlroy SJ, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav062; Meisinger DB, 2007, ENVIRON MICROBIOL, V9, P1523, DOI 10.1111/j.1462-2920.2007.01271.x; Mielczarek AT, 2013, WATER SCI TECHNOL, V67, P2519, DOI 10.2166/wst.2013.151; Mielczarek AT, 2013, WATER RES, V47, P1529, DOI 10.1016/j.watres.2012.12.003; Nielsen JL, 2005, METHOD ENZYMOL, V397, P237, DOI 10.1016/S0076-6879(05)97014-6; Nielsen PH, 2010, WATER RES, V44, P5070, DOI 10.1016/j.watres.2010.07.036; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Rasmussen H, 1996, WATER RES, V30, P551, DOI 10.1016/0043-1354(95)00203-0; Seviour R, 2010, MICROBIAL ECOLOGY OF ACTIVATED SLUDGE, P1; Stoecker K, 2010, APPL ENVIRON MICROB, V76, P922, DOI 10.1128/AEM.02456-09; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; Weelink SAB, 2009, FEMS MICROBIOL ECOL, V70, P575, DOI 10.1111/j.1574-6941.2009.00778.x; Yilmaz LS, 2011, APPL ENVIRON MICROB, V77, P1118, DOI 10.1128/AEM.01733-10; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188	31	5	5	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0136424	10.1371/journal.pone.0136424	http://dx.doi.org/10.1371/journal.pone.0136424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340564	Green Published, Green Submitted, gold			2022-12-26	WOS:000360688200008
J	Zhou, Y; Yin, XC; Duan, RJ; Hao, GP; Guo, JC; Jiang, XY				Zhou, Yang; Yin, Xiaochang; Duan, Ruijun; Hao, Gangping; Guo, Jianchun; Jiang, Xingyu			SpAHA1 and SpSOS1 Coordinate in Transgenic Yeast to Improve Salt Tolerance	PLOS ONE			English	Article							PLASMA-MEMBRANE; ARABIDOPSIS-THALIANA; NA+/H+ ANTIPORTER; OVEREXPRESSION; SOS1; AVP1; HOMEOSTASIS; EXPRESSION; SALINITY; DROUGHT	In plant cells, the plasma membrane Na+/H+ antiporter SOS1 (salt overly sensitive 1) mediates Na+ extrusion using the proton gradient generated by plasma membrane H+-ATPases, and these two proteins are key plant halotolerance factors. In the present study, two genes from Sesuvium portulacastrum, encoding plasma membrane Na+/H+ antiporter (SpSOS1) and H+-ATPase (SpAHA1), were cloned. Localization of each protein was studied in tobacco cells, and their functions were analyzed in yeast cells. Both SpSOS1 and SpAHA1 are plasma membrane-bound proteins. Real-time polymerase chain reaction (PCR) analyses showed that SpSOS1 and SpAHA1 were induced by salinity, and their expression patterns in roots under salinity were similar. Compared with untransformed yeast cells, SpSOS1 increased the salt tolerance of transgenic yeast by decreasing the Na+ content. The Na+/H+ exchange activity at plasma membrane vesicles was higher in SpSOS1-transgenic yeast than in the untransformed strain. No change was observed in the salt tolerance of yeast cells expressing SpAHA1 alone; however, in yeast transformed with both SpSOS1 and SpAHA1, SpAHA1 generated an increased proton gradient that stimulated the Na+/H+ exchange activity of SpSOS1. In this scenario, more Na+ ions were transported out of cells, and the yeast cells co-expressing SpSOS1 and SpAHA1 grew better than the cells transformed with only SpSOS1 or SpAHA1. These findings demonstrate that the plasma membrane Na+/H+ antiporter SpSOS1 and H+-ATPase SpAHA1 can function in coordination. These results provide a reference for developing more salt-tolerant crops via co-transformation with the plasma membrane Na+/H+ antiporter and H+-ATPase.	[Zhou, Yang; Duan, Ruijun; Guo, Jianchun] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Haikou, Peoples R China; [Zhou, Yang; Guo, Jianchun] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Zhou, Yang; Yin, Xiaochang; Jiang, Xingyu] Hainan Univ, Coll Agr, Hainan Key Lab Sustainable Utilizat Trop Bioresou, Haikou, Peoples R China; [Hao, Gangping] Taishan Med Univ, Dept Biochem, Tai An, Shandong, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Huazhong Agricultural University; Hainan University; Shandong First Medical University & Shandong Academy of Medical Sciences	Guo, JC (corresponding author), Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Haikou, Peoples R China.	jianchunguoh@163.com; jiangxingyu2002@yahoo.com	duan, rui/AAK-8037-2020		Natural Science Foundation of China [31260218, 31160185]; Scientific and Technological Foundation of Hainan Province [ZDZX2013023]; Central Level, Non-profit, Scientific Research Institutes for Basic R&D Operations Special Fund Program [ITBB130302]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Foundation of Hainan Province; Central Level, Non-profit, Scientific Research Institutes for Basic R&D Operations Special Fund Program	This work was supported by the Natural Science Foundation of China (No. 31260218, 31160185), the Scientific and Technological Foundation of Hainan Province (No. ZDZX2013023) and the Central Level, Non-profit, Scientific Research Institutes for Basic R&D Operations Special Fund Program (No. ITBB130302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; D'Angelo C, 2006, PLANT J, V48, P857, DOI 10.1111/j.1365-313X.2006.02921.x; Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; Gaxiola RA, 1999, P NATL ACAD SCI USA, V96, P1480, DOI 10.1073/pnas.96.4.1480; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; Gouiaa S, 2012, PLANT MOL BIOL, V79, P137, DOI 10.1007/s11103-012-9901-6; Hong S, 2013, ARCH BIOCHEM BIOPHYS, V537, P125, DOI 10.1016/j.abb.2013.07.005; Kerkeb L, 2001, PHYSIOL PLANTARUM, V113, P217, DOI 10.1034/j.1399-3054.2001.1130209.x; Kim BG, 2007, PLANT J, V52, P473, DOI 10.1111/j.1365-313X.2007.03249.x; Liu SP, 2010, J PLANT BIOL, V53, P444, DOI 10.1007/s12374-010-9135-6; Martinez-Atienza J, 2007, PLANT PHYSIOL, V143, P1001, DOI 10.1104/pp.106.092635; MENENDEZ A, 1995, ANAL BIOCHEM, V230, P308, DOI 10.1006/abio.1995.1479; Oh DH, 2009, PLANT PHYSIOL, V151, P210, DOI 10.1104/pp.109.137802; Pardo JM, 2006, J EXP BOT, V57, P1181, DOI 10.1093/jxb/erj114; Rodriguez-Rosales M, 2009, PLANT SIGNAL BEHAV, V4, P265, DOI 10.4161/psb.4.4.7919; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Quintero FJ, 2002, P NATL ACAD SCI USA, V99, P9061, DOI 10.1073/pnas.132092099; Quintero FJ, 2011, P NATL ACAD SCI USA, V108, P2611, DOI 10.1073/pnas.1018921108; Tang RJ, 2010, PLANT MOL BIOL, V74, P367, DOI 10.1007/s11103-010-9680-x; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; Xu HX, 2008, ARCH BIOCHEM BIOPHYS, V473, P8, DOI 10.1016/j.abb.2008.02.018; Xu YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078098; [杨成龙 Yang Chenglong], 2010, [生态学报, Acta Ecologica Sinica], V30, P4617; Yang Q, 2009, MOL PLANT, V2, P22, DOI 10.1093/mp/ssn058; Yi XP, 2014, J PROTEOMICS, V99, P84, DOI 10.1016/j.jprot.2014.01.017; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhao FY, 2006, MOL BREEDING, V17, P341, DOI 10.1007/s11032-006-9005-6	28	25	32	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137447	10.1371/journal.pone.0137447	http://dx.doi.org/10.1371/journal.pone.0137447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340746	Green Published, gold, Green Submitted			2022-12-26	WOS:000360688200060
J	Dusaban, SS; Kunkel, MT; Smrcka, AV; Brown, JH				Dusaban, Stephanie S.; Kunkel, Maya T.; Smrcka, Alan V.; Brown, Joan Heller			Thrombin Promotes Sustained Signaling and Inflammatory Gene Expression through the CDC25 and Ras-associating Domains of Phospholipase C epsilon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLC-EPSILON; DEPENDENT ACTIVATION; RECEPTOR ACTIVATION; CRUCIAL ROLE; RHO; ENHANCEMENT; REPORTER; DISTINCT; PATHWAY; G(12)	Phospholipase C-epsilon (PLC epsilon) plays a critical role in G-protein-coupled receptor-mediated inflammation. In addition to its ability to generate the second messengers inositol 1,4,5-trisphosphate and diacylglycerol, PLC epsilon, unlike the other phospholipase C family members, is activated in a sustained manner. We hypothesized that the ability of PLC epsilon to function as a guanine nucleotide exchange factor (GEF) for Rap1 supports sustained downstream signaling via feedback of Rap1 to the enzyme Ras-associating (RA2) domain. Using gene deletion and adenoviral rescue, we demonstrate that both the GEF (CDC25 homology domain) and RA2 domains of PLC epsilon are required for long term protein kinase D (PKD) activation and subsequent induction of inflammatory genes. PLC epsilon localization is largely intracellular and its compartmentalization could contribute to its sustained activation. Here we show that localization of PLC epsilon to the Golgi is required for activation of PKD in this compartment as well as for subsequent induction of inflammatory genes. These data provide a molecular mechanism by which PLC epsilon mediates sustained signaling and by which astrocytes mediate pathophysiological inflammatory responses.	[Dusaban, Stephanie S.; Kunkel, Maya T.; Brown, Joan Heller] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Dusaban, Stephanie S.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Smrcka, Alan V.] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Rochester	Brown, JH (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, 9500 Gilman Dr,Biomed Sci Bldg,Rm 3024, La Jolla, CA 92093 USA.	jhbrown@ucsd.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01GM36927, R01GM53536, R03CA178524]; NIH [T32GM007752]; NATIONAL CANCER INSTITUTE [R03CA178524] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL028143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053536, T32GM007752, R01GM036927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01GM36927 (to J. H. B.), R01GM53536 (to A. V. S.), R03CA178524 (to M. T. K.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by NIH Grant T32GM007752.	ARAGAY AM, 1995, J BIOL CHEM, V270, P20073, DOI 10.1074/jbc.270.34.20073; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; Citro S, 2007, P NATL ACAD SCI USA, V104, P15543, DOI 10.1073/pnas.0702943104; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Del Re DP, 2007, J BIOL CHEM, V282, P8069, DOI 10.1074/jbc.M604298200; Dusaban Stephanie S, 2015, Adv Biol Regul, V57, P17, DOI 10.1016/j.jbior.2014.09.014; Dusaban SS, 2013, P NATL ACAD SCI USA, V110, P3609, DOI 10.1073/pnas.1217355110; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Hains MD, 2006, MOL PHARMACOL, V69, P2068, DOI 10.1124/mol.105.017921; Harada Y, 2011, BIOCHEM BIOPH RES CO, V414, P106, DOI 10.1016/j.bbrc.2011.09.032; Ikuta S, 2008, CANCER RES, V68, P64, DOI 10.1158/0008-5472.CAN-07-3245; Jin TG, 2001, J BIOL CHEM, V276, P30301, DOI 10.1074/jbc.M103530200; Kelley GG, 2006, J BIOL CHEM, V281, P2639, DOI 10.1074/jbc.M507681200; Kelley GG, 2004, BIOCHEM J, V378, P129, DOI 10.1042/BJ20031370; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Kunkel MT, 2007, J BIOL CHEM, V282, P6733, DOI 10.1074/jbc.M608086200; Kunkel MT, 2010, J BIOL CHEM, V285, P22746, DOI 10.1074/jbc.C110.123133; Li MZ, 2009, CARCINOGENESIS, V30, P1424, DOI 10.1093/carcin/bgp125; Martin CB, 2001, ONCOGENE, V20, P1953, DOI 10.1038/sj.onc.1204281; Martins M, 2014, P NATL ACAD SCI USA, V111, P4239, DOI 10.1073/pnas.1311500111; Nicole O, 2005, J NEUROSCI, V25, P4319, DOI 10.1523/JNEUROSCI.5200-04.2005; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; Oestreich EA, 2009, J BIOL CHEM, V284, P1514, DOI 10.1074/jbc.M806994200; Oka M, 2010, CARCINOGENESIS, V31, P1897, DOI 10.1093/carcin/bgq164; Sah VP, 2000, ANNU REV PHARMACOL, V40, P459, DOI 10.1146/annurev.pharmtox.40.1.459; Satoh T, 2006, METHOD ENZYMOL, V407, P281, DOI 10.1016/S0076-6879(05)07024-2; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seifert JP, 2008, J BIOL CHEM, V283, P29690, DOI 10.1074/jbc.M805038200; Seifert JP, 2004, J BIOL CHEM, V279, P47992, DOI 10.1074/jbc.M407111200; Shibatohge M, 1998, J BIOL CHEM, V273, P6218, DOI 10.1074/jbc.273.11.6218; Siehler S, 2009, BRIT J PHARMACOL, V158, P41, DOI 10.1111/j.1476-5381.2009.00121.x; Smrcka AV, 2012, CELL SIGNAL, V24, P1333, DOI 10.1016/j.cellsig.2012.01.009; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Song CH, 2002, ONCOGENE, V21, P8105, DOI 10.1038/sj.onc.1206003; Sorensen SD, 2003, MOL PHARMACOL, V64, P1199, DOI 10.1124/mol.64.5.1199; Sternweis PC, 2007, ADV PROTEIN CHEM, V74, P189, DOI 10.1016/S0065-3233(07)74006-8; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Wang H, 2005, CIRC RES, V97, P1305, DOI 10.1161/01.RES.0000196578.15385.bb; Wing MR, 2003, J BIOL CHEM, V278, P41253, DOI 10.1074/jbc.M306904200; Xiang SY, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004405; Xiang SY, 2013, BBA-MOL CELL BIOL L, V1831, P213, DOI 10.1016/j.bbalip.2012.09.004; Zhang LH, 2013, CELL, V153, P216, DOI 10.1016/j.cell.2013.02.047; Zhang LH, 2011, J BIOL CHEM, V286, P23012, DOI 10.1074/jbc.M111.231993	44	11	11	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26776	26783		10.1074/jbc.M115.676098	http://dx.doi.org/10.1074/jbc.M115.676098			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26350460	Green Published, hybrid			2022-12-26	WOS:000364793600039
J	Hagen, S; Drepper, F; Fischer, S; Fodor, K; Passon, D; Platta, HW; Zenn, M; Schliebs, W; Girzalsky, W; Wilmanns, M; Warscheid, B; Erdmann, R				Hagen, Stefanie; Drepper, Friedel; Fischer, Sven; Fodor, Krisztian; Passon, Daniel; Platta, Harald W.; Zenn, Michael; Schliebs, Wolfgang; Girzalsky, Wolfgang; Wilmanns, Matthias; Warscheid, Bettina; Erdmann, Ralf			Structural Insights into Cargo Recognition by the Yeast PTS1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEROXISOMAL TARGETING SIGNAL-1; STEROL CARRIER PROTEIN-2; PHOTO-CROSS-LINKING; N-TERMINAL HALF; CYCLING RECEPTOR; POLYACRYLAMIDE GELS; GENETIC-CODE; AMINO-ACID; IMPORT; BINDING	The peroxisomal matrix protein import is facilitated by cycling import receptors that shuttle between the cytosol and the peroxisomal membrane. The import receptor Pex5p mediates the import of proteins harboring a peroxisomal targeting signal of type I (PTS1). Purified recombinant Pex5p forms a dimeric complex with the PTS1-protein Pcs60p in vitro with a K-D of 0.19 mu M. To analyze the structural basis for receptor-cargo recognition, the PTS1 and adjacent amino acids of Pcs60p were systematically scanned for Pex5p binding by an in vitro site-directed photo-cross-linking approach. The cross-linked binding regions of the receptor were subsequently identified by high resolution mass spectrometry. Most cross-links were found with TPR6, TPR7, as well as the 7C-loop of Pex5p. Surface plasmon resonance analysis revealed a bivalent interaction mode for Pex5p and Pcs60p. Interestingly, Pcs60p lacking its C-terminal tripeptide sequence was efficiently cross-linked to the same regions of Pex5p. The KD value of the interaction of truncated Pcs60p and Pex5p was in the range of 7.7 mu M. Isothermal titration calorimetry and surface plasmon resonance measurements revealed a monovalent binding mode for the interaction of Pex5p and Pcs60p lacking the PTS1. Our data indicate that Pcs60p contains a second contact site for its receptor Pex5p, beyond the C-terminal tripeptide. The physiological relevance of the ancillary binding region was supported by in vivo import studies. The bivalent binding mode might be explained by a two-step concept as follows: first, cargo recognition and initial tethering by the PTS1-receptor Pex5p; second, lock-in of receptor and cargo.	[Hagen, Stefanie; Schliebs, Wolfgang; Girzalsky, Wolfgang; Erdmann, Ralf] Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Fac Med, Syst Biochem, D-44780 Bochum, Germany; [Drepper, Friedel; Fischer, Sven; Warscheid, Bettina] Univ Freiburg, Dept Biochem & Funct Prote, Fac Biol, D-79104 Freiburg, Germany; [Drepper, Friedel; Fischer, Sven; Warscheid, Bettina] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79104 Freiburg, Germany; [Passon, Daniel; Wilmanns, Matthias] European Mol Biol Lab Hamburg, D-22607 Hamburg, Germany; [Fodor, Krisztian] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Platta, Harald W.] Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Fac Med, Biochem Intracellular Transport Mech, D-44781 Bochum, Germany; [Zenn, Michael] Biaffin GmbH & Co KG, D-34132 Kassel, Germany	Ruhr University Bochum; University of Freiburg; University of Freiburg; European Molecular Biology Laboratory (EMBL); Eotvos Lorand University; Ruhr University Bochum	Erdmann, R (corresponding author), Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Univ Str 150, D-44780 Bochum, Germany.	ralf.erdmann@rub.de	Platta, Harald Wolfgang/G-7423-2014	Platta, Harald Wolfgang/0000-0001-8968-7280; Passon, Daniel M/0000-0001-7306-250X; Warscheid, Bettina/0000-0001-5096-1975; Drepper, Friedel/0000-0002-2043-5795; Wilmanns, Matthias/0000-0002-4643-5435; Schliebs, Wolfgang/0000-0003-2762-3403	Deutsche Forschungsgemeinschaft [FOR1905]; Excellence Initiative of the German Federal Government [EXC 294 BIOSS]; Excellence Initiative of the German State Government [EXC 294 BIOSS]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government	This work was supported by Deutsche Forschungsgemeinschaft Grant FOR1905 (to B. W., H. P., M. W., and R. E.) and Excellence Initiative of the German Federal and State Governments Grant EXC 294 BIOSS (to B. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Blobel F, 1996, EUR J BIOCHEM, V240, P468, DOI 10.1111/j.1432-1033.1996.0468h.x; Boteva R, 2003, EUR J BIOCHEM, V270, P4332, DOI 10.1046/j.1432-1033.2003.03827.x; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; Carvalho AF, 2006, J MOL BIOL, V356, P864, DOI 10.1016/j.jmb.2005.12.002; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chin JW, 2002, CHEMBIOCHEM, V3, P1135, DOI 10.1002/1439-7633(20021104)3:11<1135::AID-CBIC1135>3.0.CO;2-M; Costa-Rodrigues J, 2005, J BIOL CHEM, V280, P24404, DOI 10.1074/jbc.M501985200; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cramer Jana, 2015, Cold Spring Harb Protoc, V2015, DOI 10.1101/pdb.top074500; Cristodero M, 2013, MOL MICROBIOL, V90, P744, DOI 10.1111/mmi.12397; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; ELGERSMA Y, 1995, EMBO J, V14, P3472, DOI 10.1002/j.1460-2075.1995.tb07353.x; Elgersma Y, 1996, J BIOL CHEM, V271, P26375, DOI 10.1074/jbc.271.42.26375; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENTIAN KD, 1988, FEBS LETT, V236, P195, DOI 10.1016/0014-5793(88)80313-2; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; Erdmann R, 2005, NAT REV MOL CELL BIO, V6, P738, DOI 10.1038/nrm1710; Fodor K, 2015, TRAFFIC, V16, P85, DOI 10.1111/tra.12238; Fodor K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001309; Foster J, 2014, FEBS LETT, V588, P160, DOI 10.1016/j.febslet.2013.11.026; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Ghosh D, 2010, J AM CHEM SOC, V132, P3973, DOI 10.1021/ja9109049; Gietz R.D., 1994, MOL GENETICS YEAST P, P121; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Gouveia AM, 2003, ADV EXP MED BIOL, V544, P219; Harper CC, 2003, J BIOL CHEM, V278, P7897, DOI 10.1074/jbc.M206651200; Hasan S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00261; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kerssen D, 2006, J BIOL CHEM, V281, P27003, DOI 10.1074/jbc.M509257200; KIONKA C, 1985, J BACTERIOL, V161, P153, DOI 10.1128/JB.161.1.153-157.1985; Kionka C., 1986, THESIS; Klein ATJ, 2001, J BIOL CHEM, V276, P15034, DOI 10.1074/jbc.M010776200; Kragler F, 1998, P NATL ACAD SCI USA, V95, P13336, DOI 10.1073/pnas.95.22.13336; Kumar A, 2001, J MOL BIOL, V307, P271, DOI 10.1006/jmbi.2000.4465; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lametschwandtner G, 1998, J BIOL CHEM, V273, P33635, DOI 10.1074/jbc.273.50.33635; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Ma CL, 2013, J BIOL CHEM, V288, P27220, DOI 10.1074/jbc.M113.492694; Ma CL, 2011, J CELL BIOL, V193, P7, DOI 10.1083/jcb.201010022; Madrid KP, 2004, MOL CELL BIOL, V24, P7331, DOI 10.1128/MCB.24.17.7331-7344.2004; Maynard EL, 2007, J MOL BIOL, V368, P1259, DOI 10.1016/j.jmb.2007.03.005; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Neuberger G, 2003, J MOL BIOL, V328, P567, DOI 10.1016/S0022-2836(03)00318-8; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; NEUHOFF V, 1985, ELECTROPHORESIS, V6, P427, DOI 10.1002/elps.1150060905; Sampathkumar P, 2008, J MOL BIOL, V381, P867, DOI 10.1016/j.jmb.2008.05.089; Schafer A, 2004, MOL CELL BIOL, V24, P8895, DOI 10.1128/MCB.24.20.8895-8906.2004; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; Shimozawa N, 1999, J MED GENET, V36, P779, DOI 10.1136/jmg.36.10.779; SIKORSKI RS, 1989, GENETICS, V122, P19; Song JG, 2015, STRUCTURE, V23, P558, DOI 10.1016/j.str.2015.01.011; Stanley WA, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-24; Stanley WA, 2007, FEBS LETT, V581, P4795, DOI 10.1016/j.febslet.2007.09.001; Stanley WA, 2007, ARCH BIOCHEM BIOPHYS, V461, P50, DOI 10.1016/j.abb.2007.02.026; Stanley WA, 2006, MOL CELL, V24, P653, DOI 10.1016/j.molcel.2006.10.024; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Theodoulou FL, 2013, BIOCHEM J, V451, P345, DOI 10.1042/BJ20130078; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; WALTON PA, 1995, MOL BIOL CELL, V6, P675, DOI 10.1091/mbc.6.6.675; Wang DY, 2003, J BIOL CHEM, V278, P43340, DOI 10.1074/jbc.M307789200; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Willard FS, 2006, ANAL BIOCHEM, V353, P147, DOI 10.1016/j.ab.2006.02.004; Williams CP, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-12; Wittelsberger A, 2006, FEBS LETT, V580, P1872, DOI 10.1016/j.febslet.2006.02.050	66	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26610	26626		10.1074/jbc.M115.657973	http://dx.doi.org/10.1074/jbc.M115.657973			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26359497	Green Published, hybrid			2022-12-26	WOS:000364793600027
J	Oyola-Cintron, J; Caballero-Rivera, D; Ballester, L; Baez-Pagan, CA; Martinez, HL; Velez-Arroyo, KP; Quesada, O; Lasalde-Dominicci, JA				Oyola-Cintron, Jessica; Caballero-Rivera, Daniel; Ballester, Leomar; Baez-Pagan, Carlos A.; Martinez, Hernan L.; Velez-Arroyo, Karla P.; Quesada, Orestes; Lasalde-Dominicci, Jose A.			Lateral Diffusion, Function, and Expression of the Slow Channel Congenital Myasthenia Syndrome alpha C418W Nicotinic Receptor Mutation with Changes in Lipid Raft Components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYL-BETA-CYCLODEXTRIN; ACETYLCHOLINE-RECEPTOR; PLASMA-MEMBRANE; NEUROMUSCULAR-JUNCTION; CELLULAR CHOLESTEROL; POTASSIUM CHANNELS; STRUCTURAL BASIS; MAMMALIAN-CELLS; MUSCLE-FIBERS; GAMMA-SUBUNIT	Lipid rafts, specialized membrane microdomains in the plasma membrane rich in cholesterol and sphingolipids, are hot spots for a number of important cellular processes. The novel nicotinic acetylcholine receptor (nAChR) mutation alpha C418W, the first lipid-exposed mutation identified in a patient that causes slow channel congenital myasthenia syndrome was shown to be cholesterol-sensitive and to accumulate in microdomains rich in the membrane raft marker protein caveolin-1. The objective of this study is to gain insight into the mechanism by which lateral segregation into specialized raft membrane microdomains regulates the activable pool of nAChRs. We performed fluorescent recovery after photobleaching (FRAP), quantitative RT-PCR, and whole cell patch clamp recordings of GFP-encoding Mus musculus nAChRs transfected into HEK 293 cells to assess the role of cholesterol and caveolin-1 (CAV-1) in the diffusion, expression, and functionality of the nAChR (WT and alpha C418W). Our findings support the hypothesis that a cholesterol-sensitive nAChR might reside in specialized membrane microdomains that upon cholesterol depletion become disrupted and release the cholesterol-sensitive nAChRs to the pool of activable receptors. In addition, our results in HEK 293 cells show an interdependence between CAV-1 and alpha C418W that could confer end plates rich in alpha C418W nAChRs to a susceptibility to changes in cholesterol levels that could cause adverse drug reactions to cholesterol-lowering drugs such as statins. The current work suggests that the interplay between cholesterol and CAV-1 provides the molecular basis for modulating the function and dynamics of the cholesterol-sensitive alpha C418W nAChR.	[Oyola-Cintron, Jessica; Caballero-Rivera, Daniel; Velez-Arroyo, Karla P.; Lasalde-Dominicci, Jose A.] Univ Puerto Rico, Dept Chem, Rio Piedras, PR 00931 USA; [Caballero-Rivera, Daniel; Ballester, Leomar; Baez-Pagan, Carlos A.; Lasalde-Dominicci, Jose A.] Univ Puerto Rico, Dept Biol, Rio Piedras, PR 00931 USA; [Quesada, Orestes] Univ Puerto Rico, Dept Phys Sci, Rio Piedras, PR 00931 USA; [Martinez, Hernan L.] Calif State Univ Dominguez Hills, Carson, CA 90747 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; University of Puerto Rico; University of Puerto Rico Rio Piedras; California State University System; California State University Dominguez Hills	Lasalde-Dominicci, JA (corresponding author), Univ Puerto Rico, Dept Biol, Rio Piedras Campus,POB 23360, Rio Piedras, PR 00931 USA.	jlasalde@gmail.com	Regan, Clinton/E-6250-2012		National Institutes of Health [1R01GM098343, 1P20GM103642, 2 R25 GM061151]; Research Initiative for Scientific Enhancement (RISE) Program; Puerto Rico Industrial Development Company (PRIDCO); UPR Golf Tournament Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098343, R25GM061151, P20GM103642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Initiative for Scientific Enhancement (RISE) Program; Puerto Rico Industrial Development Company (PRIDCO); UPR Golf Tournament Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01GM098343 (to J. A. L. D.) and 1P20GM103642 (to J. R. and J. A. L. D.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Research Initiative for Scientific Enhancement (RISE) Program, National Institutes of Health Grant 2 R25 GM061151, and the Puerto Rico Industrial Development Company (PRIDCO).; Supported by the Research Initiative for Scientific Enhancement (RISE) Program, National Institutes of Health Grant 2 R25 GM061151, the Puerto Rico Industrial Development Company (PRIDCO), and the UPR Golf Tournament Fellowship.	Anderson TG, 2004, BIOCHEMISTRY-US, V43, P2251, DOI 10.1021/bi0358869; Antollini SS, 1998, BIOCHEMISTRY-US, V37, P16653, DOI 10.1021/bi9808215; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; AXELROD D, 1976, P NATL ACAD SCI USA, V73, P4594, DOI 10.1073/pnas.73.12.4594; Baenziger JE, 2000, J BIOL CHEM, V275, P777, DOI 10.1074/jbc.275.2.777; Baez-Pagan CA, 2008, CHANNELS, V2, P180, DOI 10.4161/chan.2.3.6155; Baier CJ, 2010, EUR BIOPHYS J BIOPHY, V39, P213, DOI 10.1007/s00249-009-0521-2; Barrantes FJ, 2004, BRAIN RES REV, V47, P71, DOI 10.1016/j.brainresrev.2004.06.008; Barrantes Francisco J, 2014, Front Synaptic Neurosci, V6, P25, DOI 10.3389/fnsyn.2014.00025; Bian JS, 2004, AM J PHYSIOL-HEART C, V287, pH2154, DOI 10.1152/ajpheart.00120.2004; Bian JS, 2001, CIRC RES, V89, P1168, DOI 10.1161/hh2401.101375; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borroni V, 2007, MOL MEMBR BIOL, V24, P1, DOI 10.1080/09687860600903387; Brannigan G, 2008, P NATL ACAD SCI USA, V105, P14418, DOI 10.1073/pnas.0803029105; Bruses JL, 2001, J NEUROSCI, V21, P504, DOI 10.1523/JNEUROSCI.21-02-00504.2001; Campagna JA, 2006, NEUROSCIENCE, V138, P123, DOI 10.1016/j.neuroscience.2005.11.019; Carman CV, 1999, J BIOL CHEM, V274, P8858, DOI 10.1074/jbc.274.13.8858; Christian AE, 1997, J LIPID RES, V38, P2264; Corbin J, 1998, BBA-BIOMEMBRANES, V1414, P65, DOI 10.1016/S0005-2736(98)00153-9; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Engel AG, 2002, MOL NEUROBIOL, V26, P347, DOI 10.1385/MN:26:2-3:347; Fernandes CC, 2010, J NEUROSCI, V30, P8841, DOI 10.1523/JNEUROSCI.6236-09.2010; FERNANDEZBALLESTER G, 1994, BIOCHEM SOC T, V22, P776, DOI 10.1042/bst0220776; FONG TM, 1986, BIOCHEMISTRY-US, V25, P830, DOI 10.1021/bi00352a015; Gensler S, 2001, EUR J BIOCHEM, V268, P2209, DOI 10.1046/j.1432-1327.2001.02093.x; Grajales-Reyes GE, 2013, PHARMACOGENOMICS J, V13, P362, DOI 10.1038/tpj.2012.21; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P4327, DOI 10.1021/bi052281z; He F, 2004, J BIOL CHEM, V279, P8986, DOI 10.1074/jbc.M311488200; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Huang CL, 2007, AM J PHYSIOL-RENAL, V293, pF1761, DOI 10.1152/ajprenal.00400.2007; Hucho F, 1996, EUR J BIOCHEM, V239, P539, DOI 10.1111/j.1432-1033.1996.0539u.x; JONES OT, 1988, BIOCHEMISTRY-US, V27, P2364, DOI 10.1021/bi00407a018; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Klonis N, 2002, EUR BIOPHYS J BIOPHY, V31, P36, DOI 10.1007/s00249-001-0202-2; Lindstrom J, 1997, MOL NEUROBIOL, V15, P193, DOI 10.1007/BF02740634; Ma HP, 2002, J BIOL CHEM, V277, P7641, DOI 10.1074/jbc.C100737200; Marty S, 2009, LANGMUIR, V25, P8780, DOI 10.1021/la900255u; NARAYANASWAMI V, 1993, BIOCHEMISTRY-US, V32, P12420, DOI 10.1021/bi00097a021; Nishimura SY, 2006, BIOPHYS J, V90, P927, DOI 10.1529/biophysj.105.070524; Niu SL, 2002, J BIOL CHEM, V277, P20139, DOI 10.1074/jbc.M200594200; O'Connell KMS, 2005, J CELL SCI, V118, P2155, DOI 10.1242/jcs.02348; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Pochynyuk O, 2005, J BIOL CHEM, V280, P37565, DOI 10.1074/jbc.M509071200; Rohacs T, 2007, PFLUG ARCH EUR J PHY, V453, P753, DOI 10.1007/s00424-006-0153-7; Shen XM, 2006, ANN NEUROL, V60, P128, DOI 10.1002/ana.20861; Shvartsman DE, 2006, TRAFFIC, V7, P917, DOI 10.1111/j.1600-0854.2006.00437.x; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; St John PA, 2009, ACTA PHARMACOL SIN, V30, P656, DOI 10.1038/aps.2009.76; Stetzkowski-Marden F, 2006, J MOL NEUROSCI, V30, P37, DOI 10.1385/JMN:30:1:37; Stetzkowski-Marden F, 2006, J LIPID RES, V47, P2121, DOI 10.1194/jlr.M600182-JLR200; STYA M, 1984, J NEUROSCI, V4, P70; STYA M, 1983, J CELL BIOL, V97, P48, DOI 10.1083/jcb.97.1.48; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Sun M, 2007, J CELL SCI, V120, P2223, DOI 10.1242/jcs.001370; SUNSHINE C, 1994, BBA-BIOMEMBRANES, V1191, P59, DOI 10.1016/0005-2736(94)90233-X; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; Vrljic M, 2005, BIOPHYS J, V88, P334, DOI 10.1529/biophsj.104.045989; Willmann R, 2006, EMBO J, V25, P4050, DOI 10.1038/sj.emboj.7601288; Womack KB, 2000, J NEUROSCI, V20, P2792; YGUERABIDE J, 1982, BIOPHYS J, V40, P69, DOI 10.1016/S0006-3495(82)84459-7; Zolotukhin S, 1996, J VIROL, V70, P4646, DOI 10.1128/JVI.70.7.4646-4654.1996	68	6	6	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26790	26800		10.1074/jbc.M115.678573	http://dx.doi.org/10.1074/jbc.M115.678573			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26354438	hybrid, Green Published			2022-12-26	WOS:000364793600041
J	Cilli, P; Minoprio, A; Bossa, C; Bignami, M; Mazzei, F				Cilli, Piera; Minoprio, Anna; Bossa, Cecilia; Bignami, Margherita; Mazzei, Filomena			Formation and Repair of Mismatches Containing Ribonucleotides and Oxidized Bases at Repeated DNA Sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-BETA; EXCISION-REPAIR; OXIDATIVE DAMAGE; INSERTION; REMOVAL; MUTYH; 8-OXO-DEOXYGUANOSINE; ACCUMULATION; 8-OXOGUANINE; COMPLEX	The cellular pool of ribonucleotide triphosphates (rNTPs) is higher than that of deoxyribonucleotide triphosphates. To ensure genome stability, DNA polymerases must discriminate against rNTPs and incorporated ribonucleotides must be removed by ribo-nucleotide excision repair (RER). We investigated DNA polymerase beta (POL beta) capacity to incorporate ribonucleotides into trinucleotide repeated DNA sequences and the efficiency of base excision repair (BER) and RER enzymes (OGG1, MUTYH, and RNase H2) when presented with an incorrect sugar and an oxidized base. POL beta incorporated rAMP and rCMP opposite 7,8-dihydro-8- oxoguanine (8-oxodG) and extended both mispairs. In addition, POL beta was able to insert and elongate an oxidized rGMP when paired with dA. We show that RNase H2 always preserves the capacity to remove a single ribonucleotide when paired to an oxidized base or to incise an oxidized ribonucleotide in a DNA duplex. In contrast, BER activity is affected by the presence of a ribonucleotide opposite an 8-oxodG. In particular, MUTYH activity on 8-oxodG:rA mispairs is fully inhibited, although its binding capacity is retained. This results in the reduction of RNase H2 incision capability of this substrate. Thus complex mispairs formed by an oxidized base and a ribonucleotide can compromise BER and RER in repeated sequences.	[Cilli, Piera; Minoprio, Anna; Bossa, Cecilia; Bignami, Margherita; Mazzei, Filomena] Ist Super Sanita, Dept Environm & Primary Prevent, I-00161 Rome, Italy; [Cilli, Piera] Univ Roma Tre, Dept Sci, I-00154 Rome, Italy	Istituto Superiore di Sanita (ISS); Italfarmaco; Roma Tre University	Bignami, M (corresponding author), Ist Super Sanita, Viale Regina Elena 299, I-00161 Rome, Italy.	margherita.bignami@gmail.com	Bossa, Cecilia/K-4454-2016	Bossa, Cecilia/0000-0003-2084-2902	Associazione Italiana Ricerca sul Cancro Investigator Grant [11755]; Ministry of Health Project "Malattie Rare"	Associazione Italiana Ricerca sul Cancro Investigator Grant(Fondazione AIRC per la ricerca sul cancro); Ministry of Health Project "Malattie Rare"	This work was supported in part by Associazione Italiana Ricerca sul Cancro Investigator Grant 11755 (to M. B. and F. M.) and Ministry of Health Project "Malattie Rare" (to M. B. and F. M.). The authors declare that there are no competing financial interests in relationship to the work described.	Batra VK, 2012, P NATL ACAD SCI USA, V109, P113, DOI 10.1073/pnas.1112235108; Batra VK, 2010, NAT STRUCT MOL BIOL, V17, P889, DOI 10.1038/nsmb.1852; Beard WA, 2010, MUTAT RES-GEN TOX EN, V703, P18, DOI 10.1016/j.mrgentox.2010.07.013; Bebenek K, 2005, J BIOL CHEM, V280, P20051, DOI 10.1074/jbc.M501981200; Bergoglio V, 2003, J MOL BIOL, V331, P1017, DOI 10.1016/S0022-2836(03)00837-4; Bjoras M, 1997, EMBO J, V16, P6314, DOI 10.1093/emboj/16.20.6314; Brown JA, 2011, BIOCHEMISTRY-US, V50, P1135, DOI 10.1021/bi101915z; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Cavanaugh NA, 2010, J BIOL CHEM, V285, P24457, DOI 10.1074/jbc.M110.132407; Clausen AR, 2013, DNA REPAIR, V12, P121, DOI 10.1016/j.dnarep.2012.11.006; D'Agostino VG, 2010, DNA REPAIR, V9, P700, DOI 10.1016/j.dnarep.2010.03.008; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Fromme JC, 2004, NATURE, V427, P652, DOI 10.1038/nature02306; FURUICHI M, 1994, GENOMICS, V24, P485, DOI 10.1006/geno.1994.1657; Gosavi RA, 2012, NUCLEIC ACIDS RES, V40, P7518, DOI 10.1093/nar/gks413; Goula AV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000749; Helbock HJ, 1998, P NATL ACAD SCI USA, V95, P288, DOI 10.1073/pnas.95.1.288; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Liu Y, 2009, J BIOL CHEM, V284, P28352, DOI 10.1074/jbc.M109.050286; Mazzei F, 2013, MUTAT RES-FUND MOL M, V743, P33, DOI 10.1016/j.mrfmmm.2013.03.003; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; Miller H, 2000, BIOCHEMISTRY-US, V39, P1029, DOI 10.1021/bi991789x; Nick McElhinny S.A., 2003, MOL CELL BIOL, V23, P2309, DOI [DOI 10.1128/MCB.23.7.2309-2315.2003, 10.1128/MCB.23.7.2309-2315.2003]; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Ruggieri V, 2013, ONCOGENE, V32, P4500, DOI 10.1038/onc.2012.479; Rychlik MP, 2010, MOL CELL, V40, P658, DOI 10.1016/j.molcel.2010.11.001; Sastre-Moreno G, 2014, NUCLEIC ACIDS RES, V42, P9821, DOI 10.1093/nar/gku711; SCHARER OD, 1995, J AM CHEM SOC, V117, P10781, DOI 10.1021/ja00148a036; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Turco E, 2013, NUCLEIC ACIDS RES, V41, P4093, DOI 10.1093/nar/gkt130; Vaisman A, 2015, DNA REPAIR, V29, P74, DOI 10.1016/j.dnarep.2015.02.008; van Loon B, 2010, DNA REPAIR, V9, P604, DOI 10.1016/j.dnarep.2010.03.004	39	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26259	26269		10.1074/jbc.M115.679209	http://dx.doi.org/10.1074/jbc.M115.679209			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26338705	hybrid, Green Published			2022-12-26	WOS:000363527300042
J	Kuszak, AJ; Jacobs, D; Gurnev, PA; Shiota, T; Louis, JM; Lithgow, T; Bezrukov, SM; Rostovtseva, TK; Buchanan, SK				Kuszak, Adam J.; Jacobs, Daniel; Gurnev, Philip A.; Shiota, Takuya; Louis, John M.; Lithgow, Trevor; Bezrukov, Sergey M.; Rostovtseva, Tatiana K.; Buchanan, Susan K.			Evidence of Distinct Channel Conformations and Substrate Binding Affinities for the Mitochondrial Outer Membrane Protein Translocase Pore Tom40	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; GENERAL IMPORT PORE; PREPROTEIN TRANSLOCASE; SACCHAROMYCES-CEREVISIAE; PRECURSOR PROTEINS; RECEPTOR COMPLEX; CONDUCTING PORE; PRESEQUENCE; BIOGENESIS; MACHINERY	Nearly all mitochondrial proteins are coded by the nuclear genome and must be transported into mitochondria by the translocase of the outer membrane complex. Tom40 is the central subunit of the translocase complex and forms a pore in the mitochondrial outer membrane. To date, the mechanism it utilizes for protein transport remains unclear. Tom40 is predicted to comprise a membrane-spanning beta-barrel domain with conserved beta-helical domains at both the N and C termini. To investigate Tom40 function, including the role of the N- and C-terminal domains, recombinant forms of the Tom40 protein from the yeast Candida glabrata, and truncated constructs lacking the N- and/or C-terminal domains, were functionally characterized in planar lipid membranes. Our results demonstrate that each of these Tom40 constructs exhibits at least four distinct conductive levels and that full-length and truncated Tom40 constructs specifically interact with a presequence peptide in a concentration- and voltage-dependent manner. Therefore, neither the first 51 amino acids of the N terminus nor the last 13 amino acids of the C terminus are required for Tom40 channel formation or for the interaction with a presequence peptide. Unexpectedly, substrate binding affinity was dependent upon the Tom40 state corresponding to a particular conductive level. A model where two Tom40 pores act in concert as a dimeric protein complex best accounts for the observed biochemical and electrophysiological data. These results provide the first evidence for structurally distinct Tom40 conformations playing a role in substrate recognition and therefore in transport function.	[Kuszak, Adam J.; Jacobs, Daniel; Buchanan, Susan K.] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Louis, John M.] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; [Jacobs, Daniel; Gurnev, Philip A.; Bezrukov, Sergey M.; Rostovtseva, Tatiana K.] NICHD, Program Phys Biol, NIH, Bethesda, MD 20892 USA; [Gurnev, Philip A.] Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA; [Shiota, Takuya; Lithgow, Trevor] Monash Univ, Dept Microbiol, Melbourne, Vic 3800, Australia	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Massachusetts System; University of Massachusetts Amherst; Monash University	Rostovtseva, TK (corresponding author), Eunice Kennedy Shriver NICHD, Program Phys Biol, NIH, Bldg 9,Rm 1E-106,9 Mem Dr, Bethesda, MD 20892 USA.	rostovtt@mail.nih.gov; skbuchan@helix.nih.gov	Lithgow, Trevor J/H-5925-2017	Lithgow, Trevor J/0000-0002-0102-7884; Kuszak, Adam/0000-0001-8719-145X; Louis, John M/0000-0002-0052-1899; Jacobs, Daniel/0000-0001-5280-1254	National Institutes of Health grants from Intramural Research Program of NIDDK; Intramural Research Program of Eunice Kennedy Shriver NICHD; National Science Foundation EAGER Award [1249199]; Gluckstern fund of the University of Massachusetts; Australian Research Council Discovery Project Grant; Australian Research Council Linkage International Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036139] Funding Source: NIH RePORTER	National Institutes of Health grants from Intramural Research Program of NIDDK; Intramural Research Program of Eunice Kennedy Shriver NICHD; National Science Foundation EAGER Award; Gluckstern fund of the University of Massachusetts; Australian Research Council Discovery Project Grant(Australian Research Council); Australian Research Council Linkage International Grant(Australian Research Council); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health grants from Intramural Research Program of NIDDK (to A. J. K., D. J., and S. K. B.) and Intramural Research Program of Eunice Kennedy Shriver NICHD (to T. K. R. and S. M. B.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Science Foundation EAGER Award 1249199 and the Gluckstern fund of the University of Massachusetts.; Australian Research Council Laureate Fellow and acknowledges support from an Australian Research Council Discovery Project Grant and Australian Research Council Linkage International Grant.	Ahting U, 1999, J CELL BIOL, V147, P959, DOI 10.1083/jcb.147.5.959; Ahting U, 2001, J CELL BIOL, V153, P1151, DOI 10.1083/jcb.153.6.1151; Aiyar A, 2000, Methods Mol Biol, V132, P221; Alcock F, 2010, SCIENCE, V327, P649, DOI 10.1126/science.1182129; Alconada A, 1995, METHOD ENZYMOL, V260, P263, DOI 10.1016/0076-6879(95)60144-9; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Becker L, 2005, J MOL BIOL, V353, P1011, DOI 10.1016/j.jmb.2005.09.019; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Buchanan SK, 1999, BIOCHEM SOC T, V27, P903, DOI 10.1042/bst0270903; Chan NC, 2008, MOL BIOL CELL, V19, P126, DOI 10.1091/mbc.E07-08-0796; DAUM G, 1982, J BIOL CHEM, V257, P3075; Dekker PJT, 1998, MOL CELL BIOL, V18, P6515, DOI 10.1128/MCB.18.11.6515; Dietmeier K, 1997, NATURE, V388, P195, DOI 10.1038/40663; Dimmer KS, 2012, BBA-BIOMEMBRANES, V1818, P1085, DOI 10.1016/j.bbamem.2011.08.027; Dukanovic J, 2011, BBA-BIOMEMBRANES, V1808, P971, DOI 10.1016/j.bbamem.2010.06.021; Endo T, 2011, BBA-BIOMEMBRANES, V1808, P955, DOI 10.1016/j.bbamem.2010.07.018; Gessmann D, 2011, BBA-BIOENERGETICS, V1807, P1647, DOI 10.1016/j.bbabio.2011.08.006; Gessmann D, 2011, J MOL BIOL, V413, P150, DOI 10.1016/j.jmb.2011.07.054; Gordon DM, 2001, BIOCHEM J, V356, P207, DOI 10.1042/0264-6021:3560207; Grigoriev SM, 2004, INT REV CYTOL, V238, P227, DOI 10.1016/S0074-7696(04)38005-8; HACHIYA N, 1995, NATURE, V376, P705, DOI 10.1038/376705a0; Harbauer AB, 2014, SCIENCE, V346, P1109, DOI 10.1126/science.1261253; Hewitt VL, 2012, P NATL ACAD SCI USA, V109, pE3358, DOI 10.1073/pnas.1206345109; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; KIEBLER M, 1990, NATURE, V348, P610, DOI 10.1038/348610a0; Kunkele KP, 1998, J BIOL CHEM, V273, P31032, DOI 10.1074/jbc.273.47.31032; Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4; Lueder F, 2009, FEBS LETT, V583, P1475, DOI 10.1016/j.febslet.2009.03.064; Mager F, 2011, J MEMBRANE BIOL, V242, P11, DOI 10.1007/s00232-011-9372-8; Mahendran KR, 2012, BIOPHYS J, V102, P39, DOI 10.1016/j.bpj.2011.11.4003; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Melin J, 2014, MOL CELL BIOL, V34, P3473, DOI 10.1128/MCB.00433-14; Model K, 2002, J MOL BIOL, V316, P657, DOI 10.1006/jmbi.2001.5365; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Model K, 2008, J MOL BIOL, V383, P1049, DOI 10.1016/j.jmb.2008.07.087; O'Malley MA, 2010, STUD HIST PHI PART C, V41, P212, DOI 10.1016/j.shpsc.2010.07.010; Omura T, 1998, J BIOCHEM-TOKYO, V123, P1010; Perry AJ, 2008, PLANT PHYSIOL BIOCH, V46, P265, DOI 10.1016/j.plaphy.2007.12.012; Poynor M, 2008, BIOPHYS J, V95, P1511, DOI 10.1529/biophysj.108.131003; Qiu J, 2013, CELL, V154, P596, DOI 10.1016/j.cell.2013.06.033; Rao S, 2011, CELL CYCLE, V10, P2083, DOI 10.4161/cc.10.13.16054; Rapaport D, 1998, MOL CELL BIOL, V18, P5256, DOI 10.1128/MCB.18.9.5256; Rapaport D, 1998, J BIOL CHEM, V273, P8806, DOI 10.1074/jbc.273.15.8806; Rapaport D, 1997, J BIOL CHEM, V272, P18725, DOI 10.1074/jbc.272.30.18725; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Roetzer A, 2011, FEMS MICROBIOL LETT, V314, P1, DOI 10.1111/j.1574-6968.2010.02102.x; ROISE D, 1988, EMBO J, V7, P649, DOI 10.1002/j.1460-2075.1988.tb02859.x; Rostovtseva TK, 2006, J BIOL CHEM, V281, P37496, DOI 10.1074/jbc.M602548200; Schleiff E, 2005, EMBO REP, V6, P1023, DOI 10.1038/sj.embor.7400563; Shiota T, 2011, P NATL ACAD SCI USA, V108, P15179, DOI 10.1073/pnas.1105921108; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; SOLLNER T, 1992, NATURE, V355, P84, DOI 10.1038/355084a0; Suzuki H, 2004, J BIOL CHEM, V279, P50619, DOI 10.1074/jbc.M408604200; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Zeth K, 2010, BBA-BIOENERGETICS, V1797, P1292, DOI 10.1016/j.bbabio.2010.04.019	60	22	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26204	26217		10.1074/jbc.M115.642173	http://dx.doi.org/10.1074/jbc.M115.642173			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26336107	Green Published, hybrid			2022-12-26	WOS:000363527300038
J	Brennan, MD; Rexius-Hall, ML; Eddington, DT				Brennan, Martin D.; Rexius-Hall, Megan L.; Eddington, David T.			A 3D-Printed Oxygen Control Insert for a 24-Well Plate	PLOS ONE			English	Article							MICROFLUIDIC DEVICES; CHEMICAL-SYNTHESIS; HYPOXIA; REACTIONWARE; POLY(DIMETHYLSILOXANE); NETWORKS; PLATFORM; LAB	3D printing has emerged as a method for directly printing complete microfluidic devices, although printing materials have been limited to oxygen-impermeable materials. We demonstrate the addition of gas permeable PDMS (Polydimethylsiloxane) membranes to 3D-printed microfluidic devices as a means to enable oxygen control cell culture studies. The incorporation of a 3D-printed device and gas-permeable membranes was demonstrated on a 24-well oxygen control device for standard multiwell plates. The direct printing allows integrated distribution channels and device geometries not possible with traditional planar lithography. With this device, four different oxygen conditions were able to be controlled, and six wells were maintained under each oxygen condition. We demonstrate enhanced transcription of the gene VEGFA (vascular endothelial growth factor A) with decreasing oxygen levels in human lung adenocarcinoma cells. This is the first 3D-printed device incorporating gas permeable membranes to facilitate oxygen control in cell culture.	[Brennan, Martin D.; Rexius-Hall, Megan L.; Eddington, David T.] Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Eddington, DT (corresponding author), Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.	dte@uic.edu	, Martin/R-3672-2018	, Martin/0000-0002-1118-0911	National Science Foundation [1253060]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation 1253060, DTE (http://www.nsf.gov/awardsearch/showAward?AWD_ID=1253060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au AK, 2015, LAB CHIP, V15, P1934, DOI 10.1039/c5lc00126a; Au AK, 2014, LAB CHIP, V14, P1294, DOI 10.1039/c3lc51360b; Bhargava KC, 2014, P NATL ACAD SCI USA, V111, P15013, DOI 10.1073/pnas.1414764111; Bley CR, 2011, LUNG CANCER, V73, P294, DOI 10.1016/j.lungcan.2011.01.010; Brennan MD, 2014, LAB CHIP, V14, P4305, DOI 10.1039/c4lc00853g; Busch W, 2012, NAT METHODS, V9, P1101, DOI [10.1038/NMETH.2185, 10.1038/nmeth.2185]; CARRAWAY ER, 1991, ANAL CHEM, V63, P337, DOI 10.1021/ac00004a007; Causier A, 2015, LAB CHIP, V15, P2049, DOI 10.1039/c5lc00193e; Chen CP, 2014, ANALYST, V139, P3219, DOI 10.1039/c3an02357e; Chi A, 2014, DRUG DELIV TRANSL RE, V4, P320, DOI 10.1007/s13346-014-0198-7; Chisholm G, 2014, ENERG ENVIRON SCI, V7, P3026, DOI 10.1039/c4ee01426j; Comina G, 2014, LAB CHIP, V14, P2978, DOI 10.1039/c4lc00394b; Comina G, 2014, LAB CHIP, V14, P424, DOI 10.1039/c3lc50956g; Erkal JL, 2014, LAB CHIP, V14, P2023, DOI 10.1039/c4lc00171k; Femmer T, 2014, LAB CHIP, V14, P2610, DOI 10.1039/c4lc00320a; Gelber MK, 2015, LAB CHIP, V15, P1736, DOI 10.1039/c4lc01392a; Gilkes DM, 2014, NAT REV CANCER, V14, P430, DOI 10.1038/nrc3726; Gregory C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082307; Gross BC, 2014, ANAL CHEM, V86, P3240, DOI 10.1021/ac403397r; Kamei K, 2015, BIOMED MICRODEVICES, V17, DOI 10.1007/s10544-015-9928-y; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; King PH, 2014, LAB CHIP, V14, P722, DOI 10.1039/c3lc51072g; Kitson PJ, 2013, CHEM SCI, V4, P3099, DOI 10.1039/c3sc51253c; Kitson PJ, 2012, LAB CHIP, V12, P3267, DOI 10.1039/c2lc40761b; Kitson PJ, 2014, ANGEW CHEM INT EDIT, P1; Kumar V, 2014, IMMUNOLOGY, V143, P512, DOI 10.1111/imm.12380; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Lee KG, 2014, RSC ADV, V4, P32876, DOI 10.1039/c4ra05072j; Lee W, 2015, SCI REP-UK, V5, DOI 10.1038/srep07717; Lee W, 2014, ANAL CHEM, V86, P6683, DOI 10.1021/ac501436d; Li QF, 2006, CELL RES, V16, P548, DOI 10.1038/sj.cr.7310072; McDonald JC, 2002, ANAL CHEM, V74, P1537, DOI 10.1021/ac010938q; Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]; Oppegard SC, 2010, LAB CHIP, V10, P2366, DOI 10.1039/c004856a; Oppegard SC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006891; Rexius-Hall ML, 2014, LAB CHIP, V14, P4688, DOI 10.1039/c4lc01168f; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Shallan AI, 2014, ANAL CHEM, V86, P3124, DOI 10.1021/ac4041857; Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584; Sinkala E, 2010, LAB CHIP, V10, P3291, DOI 10.1039/c0lc00244e; Symes MD, 2012, NAT CHEM, V4, P349, DOI [10.1038/NCHEM.1313, 10.1038/nchem.1313]; Tek P, 2008, J NEUROSCI METH, V172, P263, DOI 10.1016/j.jneumeth.2008.03.011; Therriault D, 2003, NAT MATER, V2, P265, DOI 10.1038/nmat863; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Waldbaur A, 2011, ANAL METHODS-UK, V3, P2681, DOI 10.1039/c1ay05253e; Wang XD, 2014, CHEM SOC REV, V43, P3666, DOI 10.1039/c4cs00039k; Yuen PK, 2008, LAB CHIP, V8, P1374, DOI 10.1039/b805086d	49	28	29	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137631	10.1371/journal.pone.0137631	http://dx.doi.org/10.1371/journal.pone.0137631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360882	Green Published, gold, Green Submitted			2022-12-26	WOS:000361043100058
J	Song, W; Jiang, KJ; Zhang, FY; Lin, Y; Ma, LB				Song, Wei; Jiang, Keji; Zhang, Fengying; Lin, Yu; Ma, Lingbo			Transcriptome Sequencing, De Novo Assembly and Differential Gene Expression Analysis of the Early Development of Acipenser baeri	PLOS ONE			English	Article							SIBERIAN STURGEON; EARLY ONTOGENY; IDENTIFICATION; ANNOTATION; FULVESCENS; GENERATION; ZEBRAFISH; DISCOVERY; RIBOSOME; GONADS	The molecular mechanisms that drive the development of the endangered fossil fish species Acipenser baeri are difficult to study due to the lack of genomic data. Recent advances in sequencing technologies and the reducing cost of sequencing offer exclusive opportunities for exploring important molecular mechanisms underlying specific biological processes. This manuscript describes the large scale sequencing and analyses of mRNA from Acipenser baeri collected at five development time points using the Illumina Hiseq2000 platform. The sequencing reads were de novo assembled and clustered into 278167 unigenes, of which 57346 (20.62%) had 45837 known homologues proteins in Uniprot protein databases while 11509 proteins matched with at least one sequence of assembled unigenes. The remaining 79.38% of unigenes could stand for non-coding unigenes or unigenes specific to A. baeri. A number of 43062 unigenes were annotated into functional categories via Gene Ontology (GO) annotation whereas 29526 unigenes were associated with 329 pathways by mapping to KEGG database. Subsequently, 3479 differentially expressed genes were scanned within developmental stages and clustered into 50 gene expression profiles. Genes preferentially expressed at each stage were also identified. Through GO and KEGG pathway enrichment analysis, relevant physiological variations during the early development of A. baeri could be better cognized. Accordingly, the present study gives insights into the transcriptome profile of the early development of A. baeri, and the information contained in this large scale transcriptome will provide substantial references for A. baeri developmental biology and promote its aquaculture research.	[Song, Wei; Jiang, Keji; Zhang, Fengying; Lin, Yu; Ma, Lingbo] Minist Agr, Key Lab East China Sea & Ocean Fishery Resources, Shanghai, Peoples R China; [Song, Wei; Jiang, Keji; Zhang, Fengying; Lin, Yu; Ma, Lingbo] Chinese Acad Fishery Sci, East China Sea Fisheries Res Inst, Shanghai, Peoples R China	Ministry of Agriculture & Rural Affairs; Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS	Ma, LB (corresponding author), Minist Agr, Key Lab East China Sea & Ocean Fishery Resources, Shanghai, Peoples R China.	malingbo@vip.sina.com	Fernandes, Jorge/AAC-4632-2022; Fernandes, Jorge MO/A-3526-2013; Jiang, keji/F-1519-2010	Fernandes, Jorge/0000-0002-2550-1640; Fernandes, Jorge MO/0000-0002-2550-1640; 	National Natural Science Foundation of China [31302161]; National Infrastructure of Fishery Germplasm Resources	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Infrastructure of Fishery Germplasm Resources	This work was supported by the National Natural Science Foundation of China (No. 31302161) and the National Infrastructure of Fishery Germplasm Resources.	Anders S., 2012, DIFFERENTIAL EXPRESS, DOI DOI 1016/j.jtbi.2009.04.013PMID:19406131; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BROWN DD, 1962, DEV BIOL, V5, P412, DOI 10.1016/0012-1606(62)90022-2; Byrne ME, 2009, TRENDS PLANT SCI, V14, P512, DOI 10.1016/j.tplants.2009.06.009; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Docan Angelica, 2011, AACL Bioflux, V4, P180; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; Gisbert E, 1998, AQUACULTURE, V167, P195, DOI 10.1016/S0044-8486(98)00312-3; Gisbert E, 1999, J FISH BIOL, V54, P852, DOI 10.1111/j.1095-8649.1999.tb02037.x; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hagihara S, 2014, J APPL ICHTHYOL, V30, P1557, DOI 10.1111/jai.12588; Hale MC, 2010, GENETICA, V138, P745, DOI 10.1007/s10709-010-9455-y; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Jonz MG, 2005, J EXP BIOL, V208, P1537, DOI 10.1242/jeb.01564; King TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102784; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2; Rajkov J, 2014, J HERED, V105, P521, DOI 10.1093/jhered/esu027; Raymakers C, 2006, J APPL ICHTHYOL, V22, P53, DOI 10.1111/j.1439-0426.2007.00929.x; Rodriguez A, 2002, J APPL ICHTHYOL, V18, P280, DOI 10.1046/j.1439-0426.2002.00406.x; Vesterlund L, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-30; Vidotto M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-407; Yuan LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115251; Zhu L, 2014, DEV COMP IMMUNOL, V42, P138, DOI 10.1016/j.dci.2013.08.020	26	10	12	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137450	10.1371/journal.pone.0137450	http://dx.doi.org/10.1371/journal.pone.0137450			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359664	Green Published, gold, Green Submitted			2022-12-26	WOS:000361043100039
J	Altwasser, R; Baldin, C; Weber, J; Guthke, R; Kniemeyer, O; Brakhage, AA; Linde, J; Valiante, V				Altwasser, Robert; Baldin, Clara; Weber, Jakob; Guthke, Reinhard; Kniemeyer, Olaf; Brakhage, Axel A.; Linde, Joerg; Valiante, Vito			Network Modeling Reveals Cross Talk of MAP Kinases during Adaptation to Caspofungin Stress in Aspergillus fumigatus	PLOS ONE			English	Article							CELL-WALL STRESS; TRANSCRIPTION FACTOR; PATHWAYS; IDENTIFICATION; RESISTANCE; SURVIVAL; SYSTEM; DRUGS; GENE; TOOL	Mitogen activated protein kinases (MAPKs) are highly conserved in eukaryotic organisms. In pathogenic fungi, their activities were assigned to different physiological functions including drug adaptation and resistance. Aspergillus fumigatus is a human pathogenic fungus, which causes life-threatening invasive infections. Therapeutic options against invasive mycoses are still limited. One of the clinically used drugs is caspofungin, which specifically targets the fungal cell wall biosynthesis. A systems biology approach, based on comprehensive transcriptome data sets and mathematical modeling, was employed to infer a regulatory network and identify key interactions during adaptation to caspofungin stress in A. fumigatus. Mathematical modeling and experimental validations confirmed an intimate cross talk occurring between the cell wall-integrity and the high osmolarity-glycerol signaling pathways. Specifically, increased concentrations of caspofungin promoted activation of these signalings. Moreover, caspofungin affected the intracellular transport, which caused an additional osmotic stress that is independent of glucan inhibition. High concentrations of caspofungin reduced this osmotic stress, and thus decreased its toxic activity. Our results demonstrated that MAPK signaling pathways play a key role during caspofungin adaptation and are contributing to the paradoxical effect exerted by this drug.	[Altwasser, Robert; Guthke, Reinhard; Linde, Joerg] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Syst Biol Bioinformat, D-07745 Jena, Germany; [Baldin, Clara; Weber, Jakob; Kniemeyer, Olaf; Brakhage, Axel A.] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Mol & Appl Microbiol, D-07745 Jena, Germany; [Baldin, Clara; Weber, Jakob; Kniemeyer, Olaf; Brakhage, Axel A.] Univ Jena, Inst Microbiol, Dept Microbiol & Mol Biol, D-07745 Jena, Germany; [Kniemeyer, Olaf] Jena Univ Hosp, CSCC, Integrated Res & Treatment Ctr, D-07747 Jena, Germany; [Valiante, Vito] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Leibniz Jr Res Grp Biobricks Microbial Nat Prod S, D-07745 Jena, Germany	Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Hans Knoll Institute (HKI)	Linde, J (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Syst Biol Bioinformat, Adolf Reichwein Str 23, D-07745 Jena, Germany.	joerg.linde@leibniz-hki.de; vito.valiante@leibniz-hki.de	Baldin, Clara/L-7703-2019; Kniemeyer, Olaf/K-1253-2013; Valiante, Vito/E-5640-2016	Kniemeyer, Olaf/0000-0002-9493-6402; Valiante, Vito/0000-0002-4405-169X	ERA-NET PathoGenoMics programme ANTIFUN [BFU2008-04709-E/BMC]; German Federal Ministry of Education and Research [BMBF FKZ 0315439]; DFG; "ARIADNE" Marie Curie Training Network	ERA-NET PathoGenoMics programme ANTIFUN; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); "ARIADNE" Marie Curie Training Network	This work was supported by the ERA-NET PathoGenoMics programme ANTIFUN (The cell wall as a target to improve antifungal therapy against Aspergillosis), BFU2008-04709-E/BMC, (German Federal Ministry of Education and Research: BMBF FKZ 0315439). R.A. was supported by the DFG-founded excellence graduate school Jena School for Microbial Communication (JSMC). J.L. was supported by the DFG-founded CRC/Transregio 124 "FungiNet". C.B. was supported by the "ARIADNE" Marie Curie Training Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beauvais A, 2001, J BACTERIOL, V183, P2273, DOI 10.1128/JB.183.7.2273-2279.2001; Bermejo C, 2008, MOL BIOL CELL, V19, P1113, DOI 10.1091/mbc.E07-08-0742; Bowman JC, 2002, ANTIMICROB AGENTS CH, V46, P3001, DOI 10.1128/AAC.46.9.3001-3012.2002; Brakhage AA, 2010, CURR OPIN MICROBIOL, V13, P409, DOI 10.1016/j.mib.2010.04.009; Butte A J, 2000, Pac Symp Biocomput, P418; Cappelletty D, 2007, PHARMACOTHERAPY, V27, P369, DOI 10.1592/phco.27.3.369; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chen SCA, 2011, DRUGS, V71, P11, DOI 10.2165/11585270-000000000-00000; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Deresinski SC, 2003, CLIN INFECT DIS, V36, P1445, DOI 10.1086/375080; Dichtl K, 2015, MOL MICROBIOL, V95, P458, DOI 10.1111/mmi.12877; Dichtl K, 2012, MOL MICROBIOL, V83, P506, DOI 10.1111/j.1365-2958.2011.07946.x; Du C, 2006, MED MYCOL, V44, P211, DOI 10.1080/13693780500338886; Ferreira MED, 2006, EUKARYOT CELL, V5, P207, DOI 10.1128/EC.5.1.207-211.2006; Forster S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033253; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Fuchs BB, 2009, EUKARYOT CELL, V8, P1616, DOI 10.1128/EC.00193-09; Garcia R, 2009, J BIOL CHEM, V284, P10901, DOI 10.1074/jbc.M808693200; Gilsenan JM, 2012, NUCLEIC ACIDS RES, V40, pD660, DOI 10.1093/nar/gkr971; Guthke R, 2005, BIOINFORMATICS, V21, P1626, DOI 10.1093/bioinformatics/bti226; Hamel LP, 2012, PLANT CELL, V24, P1327, DOI 10.1105/tpc.112.096156; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Juvvadi PR, 2015, ANTIMICROB AGENTS CH, V8; Karthaus M, 2011, EUR J MED RES, V16, P145, DOI 10.1186/2047-783X-16-4-145; Konig CC, 2013, CHEMBIOCHEM, V14, P938, DOI 10.1002/cbic.201300070; Kovacs Z, 2013, FUNGAL GENET BIOL, V54, P1, DOI 10.1016/j.fgb.2013.02.004; Lamoth F, 2014, ANTIMICROB AGENTS CH, V58, P1889, DOI 10.1128/AAC.02286-13; Linde J, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-6; Linde J, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-148; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; Rodriguez-Pena JM, 2010, YEAST, V27, P495, DOI 10.1002/yea.1792; May GS, 2005, MED MYCOL, V43, pS83, DOI 10.1080/13693780400024784; Meyer V, 2007, J BIOL CHEM, V282, P32935, DOI 10.1074/jbc.M705856200; Muller Sebastian, 2012, BMC Genomics, V13, P519, DOI 10.1186/1471-2164-13-519; Priebe S, 2011, FUNGAL GENET BIOL, V48, P353, DOI 10.1016/j.fgb.2010.11.001; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reyes G, 2006, EUKARYOT CELL, V5, P1934, DOI 10.1128/EC.00178-06; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Rocha EMF, 2007, ANTIMICROB AGENTS CH, V51, P4174, DOI 10.1128/AAC.00917-07; Samantaray S, 2013, EUKARYOT CELL, V12, P288, DOI 10.1128/EC.00246-12; Tiemey L, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00085; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Valiante V, 2015, ANTIMICROB AGENTS CH, V8; Valiante V, 2015, FRONT MICROBIOL, V6; Valiante V, 2009, FUNGAL GENET BIOL, V46, P909, DOI 10.1016/j.fgb.2009.08.005; Vlaic S, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-147; Vodisch M, 2011, J PROTEOME RES, V10, P2508, DOI 10.1021/pr1012812; Weber M, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-1; Winkelstroter LK, 2015, G3-GENES GENOM GENET, V5, P1525, DOI 10.1534/g3.115.016766; Zadra I, 2000, APPL ENVIRON MICROB, V66, P4810, DOI 10.1128/AEM.66.11.4810-4816.2000	51	49	50	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0136932	10.1371/journal.pone.0136932	http://dx.doi.org/10.1371/journal.pone.0136932			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356475	Green Published, gold, Green Submitted			2022-12-26	WOS:000360965800020
J	Sun, HZ; Peng, T; Zhao, YF; Du, YX; Zhang, J; Li, JZ; Xin, ZY; Zhao, QZ				Sun, Hongzheng; Peng, Ting; Zhao, Yafan; Du, Yanxiu; Zhang, Jing; Li, Junzhou; Xin, Zeyu; Zhao, Quanzhi			Dynamic Analysis of Gene Expression in Rice Superior and Inferior Grains by RNA-Seq	PLOS ONE			English	Article							ORYZA-SATIVA L.; DIFFERENT POSITIONS; SUCROSE SYNTHASE; ABSCISIC-ACID; HYBRID RICE; MAJOR QTL; STARCH; YIELD; SPIKELETS; SIZE	Poor grain filling of inferior grains located on lower secondary panicle branch causes great drop in rice yield and quality. Dynamic gene expression patterns between superior and inferior grains were examined from the view of the whole transcriptome by using RNA-Seq method. In total, 19,442 genes were detected during rice grain development. Genes involved in starch synthesis, grain storage and grain development were interrogated in particular in superior and inferior grains. Of the genes involved in sucrose to starch transformation process, most were expressed at lower level in inferior grains at early filling stage compared to that of superior grains. But at late filling stage, the expression of those genes was higher in inferior grains and lower in superior grains. The same trends were observed in the expression of grain storage protein genes. While, evidence that genes involved in cell cycle showed higher expression in inferior grains during whole period of grain filling indicated that cell proliferation was active till the late filling stage. In conclusion, delayed expression of most starch synthesis genes in inferior grains and low capacity of sink organ might be two important factors causing low filling rate of inferior grain at early filling stage, and shortage of carbohydrate supply was a limiting factor at late filling stage.	[Sun, Hongzheng; Peng, Ting; Zhao, Yafan; Du, Yanxiu; Zhang, Jing; Li, Junzhou; Xin, Zeyu; Zhao, Quanzhi] Henan Agr Univ, Collaberat Innovat Ctr Henan Grain Crops, Zhengzhou, Peoples R China; [Sun, Hongzheng; Peng, Ting; Zhao, Yafan; Du, Yanxiu; Zhang, Jing; Li, Junzhou; Xin, Zeyu; Zhao, Quanzhi] Henan Agr Univ, Rice Engn Ctr, Zhengzhou, Peoples R China; [Sun, Hongzheng; Peng, Ting; Zhao, Yafan; Du, Yanxiu; Zhang, Jing; Li, Junzhou; Xin, Zeyu; Zhao, Quanzhi] Henan Agr Univ, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China	Henan Agricultural University; Henan Agricultural University; Henan Agricultural University	Xin, ZY (corresponding author), Henan Agr Univ, Collaberat Innovat Ctr Henan Grain Crops, Zhengzhou, Peoples R China.	mrxxtz@163.com; qzzhaoh@126.com			National Natural Science Foundation of China [31200973, 30471018]; Program for New Century Excellent Talents in University [NCET-08-0663]; University of Henan Province [2010IRTSTHN005]; Innovation Scientists and Technicians Troop Construction Projects of Henan Province [94200510003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); University of Henan Province; Innovation Scientists and Technicians Troop Construction Projects of Henan Province	This work was supported by the National Natural Science Foundation of China (grant No. 31200973to H.Z.S.), National Natural Science Foundation of China (grant No. 30471018 to Q.-Z.Z.), Program for New Century Excellent Talents in University (grant No. NCET-08-0663 to Q.-Z.Z.), Supported Program for Innovative Research Team (in Science and Technology) in University of Henan Province (grant No 2010IRTSTHN005 to Q.-Z.Z.) and Innovation Scientists and Technicians Troop Construction Projects of Henan Province (grant No. 94200510003 to Q.-Z.Z.).	Abu-Zaitoon YM, 2012, PHYSIOL PLANTARUM, V146, P487, DOI 10.1111/j.1399-3054.2012.01649.x; Bahaji A, 2013, BIOTECHNOL ADV; Baroja-Fernandez E, 2003, PLANT CELL PHYSIOL, V44, P500, DOI 10.1093/pcp/pcg062; Cho JI, 2005, PLANT CELL REP, V24, P225, DOI 10.1007/s00299-004-0910-z; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Dong MH, 2014, J PROTEOMICS, V109, P382, DOI 10.1016/j.jprot.2014.07.001; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Ezquer I, 2010, PLANT CELL PHYSIOL, V51, P1674, DOI 10.1093/pcp/pcq126; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Flugge UI, 2011, J EXP BOT, V62, P2381, DOI 10.1093/jxb/erq361; Geiger D, 2011, MOL PLANT, V4, P395, DOI 10.1093/mp/ssr029; Ishimaru K, 2013, NAT GENET, V45, P707, DOI 10.1038/ng.2612; Ishimaru T, 2005, PLANT CELL PHYSIOL, V46, P620, DOI 10.1093/pcp/pci066; Ishimaru T, 2003, FUNCT PLANT BIOL, V30, P1139, DOI 10.1071/FP03122; Jain M, 2012, BRIEF FUNCT GENOMICS, V11, P63, DOI 10.1093/bfgp/elr038; Jeon JS, 2010, PLANT PHYSIOL BIOCH, V48, P383, DOI 10.1016/j.plaphy.2010.03.006; Kawakatsu T, 2008, J EXP BOT, V59, P4233, DOI 10.1093/jxb/ern265; Kofler H, 2000, MOL GEN GENET, V263, P978, DOI 10.1007/PL00008698; Kyndt T, 2012, J EXP BOT, V63, P2141, DOI 10.1093/jxb/err435; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Peng T, 2015, J INTEGR AGR, V14, P847, DOI 10.1016/S2095-3119(14)60858-3; Peng T, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0196-4; Peng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054148; Peng T, 2011, J EXP BOT, V62, P4943, DOI 10.1093/jxb/err205; Qi P, 2012, CELL RES, V22, P1666, DOI 10.1038/cr.2012.151; Sato Y, 2013, NUCLEIC ACIDS RES, V41, pD1206, DOI 10.1093/nar/gks1125; Shannon JC, 1998, PLANT PHYSIOL, V117, P1235, DOI 10.1104/pp.117.4.1235; She KC, 2010, PLANT CELL, V22, P3280, DOI 10.1105/tpc.109.070821; SINGH R, 1977, PLANT PHYSIOL, V59, P417, DOI 10.1104/pp.59.3.417; Tang T, 2009, J EXP BOT, V60, P2641, DOI 10.1093/jxb/erp114; Toyota K, 2006, PLANTA, V223, P248, DOI 10.1007/s00425-005-0128-5; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Xu F, 2015, PLANT CELL ENVIRON, V38, P800, DOI 10.1111/pce.12452; Yamakawa H, 2007, PLANT PHYSIOL, V144, P258, DOI 10.1104/pp.107.098665; Yang JC, 2006, J EXP BOT, V57, P149, DOI 10.1093/jxb/erj018; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; Zhai H, 2002, SCI CHINA SER C, V45, P637, DOI 10.1007/BF02879752; Zhang ZX, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100416, 10.1371/journal.pone.0089140, 10.1371/journal.pone.0099511]; Zhu GH, 2011, J EXP BOT, V62, P3907, DOI 10.1093/jxb/err088; Zhu T, 2003, PLANT BIOTECHNOL J, V1, P59, DOI 10.1046/j.1467-7652.2003.00006.x	44	21	22	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137168	10.1371/journal.pone.0137168	http://dx.doi.org/10.1371/journal.pone.0137168			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355995	Green Submitted, Green Published, gold			2022-12-26	WOS:000360965800031
J	Chhibber, AV; Hill, PC; Jafali, J; Jasseh, M; Hossain, MI; Ndiaye, M; Pathirana, JC; Greenwood, B; Mackenzie, GA				Chhibber, Aakash Varun; Hill, Philip C.; Jafali, James; Jasseh, Momodou; Hossain, Mohammad Ilias; Ndiaye, Malick; Pathirana, Jayani C.; Greenwood, Brian; Mackenzie, Grant A.			Child Mortality after Discharge from a Health Facility following Suspected Pneumonia, Meningitis or Septicaemia in Rural Gambia: A Cohort Study	PLOS ONE			English	Article							MANAGEMENT; INFECTION	Objective To measure mortality and its risk factors among children discharged from a health centre in rural Gambia. Methods We conducted a cohort study between 12 May 2008 and 11 May 2012. Children aged 2-59 months, admitted with suspected pneumonia, sepsis, or meningitis after presenting to primary and secondary care facilities, were followed for 180 days after discharge. We developed models associating post-discharge mortality with clinical syndrome on admission and clinical risk factors. Findings One hundred and five of 3755 (2.8%) children died, 80% within 3 months of discharge. Among children aged 2-11 and 12-59 months, there were 30 and 29 deaths per 1000 children per 180 days respectively, compared to 11 and 5 respectively in the resident population. Children with suspected pneumonia unaccompanied by clinically severe malnutrition (CSM) had the lowest risk of post-discharge mortality. Mortality increased in children with suspected meningitis or septicaemia without CSM (hazard ratio [HR] 2.6 and 2.2 respectively). The risk of mortality greatly increased with CSM on admission: CSM with suspected pneumonia (HR 8.1; 95% confidence interval (CI) 4.4 to 15), suspected sepsis (HR 18.4; 95% CI 11.3 to 30), or suspected meningitis (HR 13.7; 95% CI 4.2 to 45). Independent associations with mortality were: mid-upper arm circumference (MUAC) of 11.5-13.0 cm compared to > 13.0 cm (HR 7.2; 95% CI 3.0 to 17.0), MUAC 10.5-11.4 cm (HR 24; 95% CI 9.4 to 62), and MUAC <10.5 cm (HR 44; 95% CI 18 to 108), neck stiffness (HR 10.4; 95% CI 3.1 to 34.8), non-medical discharge (HR 4.7; 95% CI 2.0 to 10.9), dry season discharge (HR 2.0; 95% CI 1.2 to 3.3), while greater haemoglobin (HR 0.82; 0.73 to 0.91), axillary temperature (HR 0.71; 95% CI 0.58 to 0.87), and oxygen saturation (HR 0.96; 95% CI 0.93 to 0.99) were associated with reduced mortality. Conclusion Gambian children experience increased mortality after discharge from primary and secondary care. Interventions should target both moderately and severely malnourished children.	[Chhibber, Aakash Varun; Hill, Philip C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand; [Jafali, James; Jasseh, Momodou; Hossain, Mohammad Ilias; Ndiaye, Malick; Pathirana, Jayani C.; Mackenzie, Grant A.] Med Res Council UK, Gambia Unit, Fajara, Gambia; [Greenwood, Brian; Mackenzie, Grant A.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Mackenzie, Grant A.] Murdoch Childrens Res Inst, Infect & Immun Theme, Melbourne, Vic, Australia	University of Otago; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Murdoch Children's Research Institute	Mackenzie, GA (corresponding author), Med Res Council UK, Gambia Unit, Fajara, Gambia.	gmackenzie@mrc.gm	Jasseh, Momodou/AAB-6071-2022	Mackenzie, Grant/0000-0002-4994-2627; Hossain, Ilias/0000-0002-0571-4702	Global Alliance for Vaccines and Immunisation's PneumoADIP; Bill & Melinda Gates Foundation; MRC (UK); University of Otago; Medical Research Council [MC_UP_1003/1] Funding Source: researchfish; MRC [MC_UP_1003/1] Funding Source: UKRI	Global Alliance for Vaccines and Immunisation's PneumoADIP; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Otago; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Global Alliance for Vaccines and Immunisation's PneumoADIP (http://www.gavi.org/), Bill & Melinda Gates Foundation (http://www.gatesfoundation.org/, MRC (UK) (http://www.mrc.ac.uk/), and the University of Otago (http://www.otago.ac.nz/) funded the work. The funding bodies did not influence the design or implementation of the study or the decision to publish, and the authors alone are responsible for the content of this paper.	Briend A, 2012, MATERN CHILD NUTR, V8, P130, DOI 10.1111/j.1740-8709.2011.00340.x; Burkart KA, 2014, T ROY SOC TROP MED H, V108, P393, DOI 10.1093/trstmh/tru055; Chang RKR, 2006, AM HEART J, V152, P386, DOI 10.1016/j.ahj.2005.12.016; Chisti MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107663; Cooper S, 2004, INTENS CARE MED, V30, P113, DOI 10.1007/s00134-003-2074-7; Garenne M, 2013, PUBLIC HEALTH NUTR, V16, P1533, DOI 10.1017/S136898001200448X; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; HANLON P, 1987, ANN TROP PAEDIATR, V7, P238, DOI 10.1080/02724936.1987.11748515; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Mackenzie GA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001161; Moisi JC, 2011, B WORLD HEALTH ORGAN, V89, P725, DOI 10.2471/BLT.11.089235; National AIDS Control Programme, 2012, HIV SENT SURV REP 20; ODEMPSEY TJD, 1994, PEDIATR INFECT DIS J, V13, P122, DOI 10.1097/00006454-199402000-00009; Phiri KS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002903; ROY SK, 1983, BRIT MED J, V287, P1097, DOI 10.1136/bmj.287.6399.1097; Simoes EAF, 2003, B WORLD HEALTH ORGAN, V81, P522; Snow RW, 2000, TROP MED INT HEALTH, V5, P377, DOI 10.1046/j.1365-3156.2000.00568.x; Stark AR, 2008, PEDIATRICS, V121, P627, DOI 10.1542/peds.2007-3282; UNICEF, 2012, ACC PROGR CHILD SURV; United Nations Children's Fund (UNICEF), COMM CHILD SURV PROM; Veirum JE, 2007, ACTA PAEDIATR, V96, P1832, DOI 10.1111/j.1651-2227.2007.00562.x; Villamor E, 2005, INT J EPIDEMIOL, V34, P61, DOI 10.1093/ije/dyh378; West TE, 1999, B WORLD HEALTH ORGAN, V77, P144; Wiens MO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066698	25	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137095	10.1371/journal.pone.0137095	http://dx.doi.org/10.1371/journal.pone.0137095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26353110	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000360932800061
J	Mei, QM; Dvornyk, V				Mei, Qiming; Dvornyk, Volodymyr			Evolutionary History of the Photolyase/Cryptochrome Superfamily in Eukaryotes	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; BLUE-LIGHT PHOTORECEPTORS; AMINO-ACID SITES; CIRCADIAN CLOCK; DNA PHOTOLYASE; FUNCTIONAL DIVERGENCE; ARABIDOPSIS-THALIANA; MOLECULAR EVOLUTION; GENOME DUPLICATION; CRYSTAL-STRUCTURE	Background Photolyases and cryptochromes are evolutionarily related flavoproteins, which however perform distinct physiological functions. Photolyases (PHR) are evolutionarily ancient enzymes. They are activated by light and repair DNA damage caused by UV radiation. Although cryptochromes share structural similarity with DNA photolyases, they lack DNA repair activity. Cryptochrome (CRY) is one of the key elements of the circadian system in animals. In plants, CRY acts as a blue light receptor to entrain circadian rhythms, and mediates a variety of light responses, such as the regulation of flowering and seedling growth. Results We performed a comprehensive evolutionary analysis of the CRY/PHR superfamily. The superfamily consists of 7 major subfamilies: CPD class I and CPD class II photolyases, (6-4) photolyases, CRY-DASH, plant PHR2, plant CRY and animal CRY. Although the whole superfamily evolved primarily under strong purifying selection (average omega = 0.0168), some subfamilies did experience strong episodic positive selection during their evolution. Photolyases were lost in higher animals that suggests natural selection apparently became weaker in the late stage of evolutionary history. The evolutionary time estimates suggested that plant and animal CRYs evolved in the Neoproterozoic Era (similar to 1000-541 Mya), which might be a result of adaptation to the major climate and global light regime changes occurred in that period of the Earth's geological history.	[Mei, Qiming] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Dvornyk, Volodymyr] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Dvornyk, Volodymyr] Alfaisal Univ, Coll Sci & Gen Studies, Dept Life Sci, Riyadh, Saudi Arabia	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Hong Kong; Alfaisal University	Dvornyk, V (corresponding author), Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	dvornyk@hku.hk	Dvornyk, Volodymyr/X-6072-2019; Dvornyk, Volodymyr/C-6031-2008	Dvornyk, Volodymyr/0000-0002-2535-103X; 	University of Hong Kong PhD Fellowship	University of Hong Kong PhD Fellowship(University of Hong Kong)	This study was supported by The University of Hong Kong PhD Fellowship to Mr. Qiming Mei. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Akaike H, 1981, ENG TECHNOLOGY APPL, V19, P716; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baca I, 2010, J MOL EVOL, V70, P453, DOI 10.1007/s00239-010-9344-0; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; BellPedersen D, 1996, J GENET, V75, P387, DOI 10.1007/BF02966317; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Brudler R, 2003, MOL CELL, V11, P59, DOI 10.1016/S1097-2765(03)00008-X; Cadar D, 2013, MOL PHYLOGENET EVOL, V66, P243, DOI 10.1016/j.ympev.2012.09.030; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Castrillo M, 2013, APPL ENVIRON MICROB, V79, P2777, DOI 10.1128/AEM.03110-12; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Chaves I, 2006, MOL CELL BIOL, V26, P1743, DOI 10.1128/MCB.26.5.1743-1753.2006; Chaves I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023447; Chen JJ, 1996, PLANT PHYSIOL, V111, P19, DOI 10.1104/pp.111.1.19; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; de Oliveira AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038634; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Devlin PF, 2000, PLANT CELL, V12, P2499, DOI 10.1105/tpc.12.12.2499; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dvornyk Volodymyr, 2009, P241, DOI 10.1007/978-3-540-88431-6_14; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Essen LO, 2006, CELL MOL LIFE SCI, V63, P1266, DOI 10.1007/s00018-005-5447-y; Garcia-Pichel F, 1998, ORIGINS LIFE EVOL B, V28, P321, DOI 10.1023/A:1006545303412; Gehring W, 2003, J MOL EVOL, V57, pS286, DOI 10.1007/s00239-003-0038-8; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Huang YH, 2006, P NATL ACAD SCI USA, V103, P17701, DOI 10.1073/pnas.0608554103; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kanai S, 1997, J MOL EVOL, V45, P535, DOI 10.1007/PL00006258; Kobayashi Y, 2000, GENES CELLS, V5, P725, DOI 10.1046/j.1365-2443.2000.00364.x; Kondo T, 2000, BIOESSAYS, V22, P10, DOI 10.1002/(SICI)1521-1878(200001)22:1<10::AID-BIES4>3.0.CO;2-A; Langmesser S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-41; Lau SKP, 2012, J VIROL, V86, P11906, DOI 10.1128/JVI.01305-12; Layeghifard M, 2008, GENE, V426, P65, DOI 10.1016/j.gene.2008.08.014; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; Liu C, 2015, SCI REP-UK, V5, DOI 10.1038/srep08113; Lu A, 2014, MOL BIOL EVOL, V31, P484, DOI 10.1093/molbev/mst198; Lucas-Lledo JI, 2009, MOL BIOL EVOL, V26, P1143, DOI 10.1093/molbev/msp029; Lucking R, 2009, MYCOLOGIA, V101, P810, DOI 10.3852/09-016; MALHOTRA K, 1995, BIOCHEMISTRY-US, V34, P6892, DOI 10.1021/bi00020a037; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Mei QM, 2014, CHROMOSOMA, V123, P385, DOI 10.1007/s00412-014-0457-x; Niedzwiedzki G, 2010, NATURE, V463, P43, DOI 10.1038/nature08623; Nielsen R, 1998, GENETICS, V148, P929; Nybakken J W, 2001, MARINE BIOL ECOLOGIC; Oliveri P, 2014, MAR GENOM, V14, P23, DOI 10.1016/j.margen.2014.02.001; Paranjpe Dhanashree A, 2005, J Circadian Rhythms, V3, P7, DOI 10.1186/1740-3391-3-7; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; Petersen JL, 1999, PLANT MOL BIOL, V40, P1063, DOI 10.1023/A:1006279720960; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Pokorny R, 2008, P NATL ACAD SCI USA, V105, P21023, DOI 10.1073/pnas.0805830106; Pond SLK, 2011, MOL BIOL EVOL, V28, P3033, DOI 10.1093/molbev/msr125; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rosbash M, 2009, PLOS BIOL, V7, P421, DOI 10.1371/journal.pbio.1000062; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Sancar A, 2000, ANNU REV BIOCHEM, V69, P31, DOI 10.1146/annurev.biochem.69.1.31; Sanderson MJ, 2004, AM J BOT, V91, P1656, DOI 10.3732/ajb.91.10.1656; SCHMIDT PW, 1995, EARTH PLANET SC LETT, V134, P107, DOI 10.1016/0012-821X(95)00106-M; Schmitz O, 2000, SCIENCE, V289, P765, DOI 10.1126/science.289.5480.765; Schopf JW, 1983, EVOLUTION OF THE EAR; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; Shirai H, 2006, BIOCHEM BIOPH RES CO, V351, P387, DOI 10.1016/j.bbrc.2006.10.031; SIDOW A, 1994, CURR BIOL, V4, P596, DOI 10.1016/S0960-9822(00)00131-7; SMITH KC, 1990, J COMP PHYSIOL A, V166, P597; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Sonett CP, 1996, SCIENCE, V273, P100, DOI 10.1126/science.273.5271.100; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Takahashi M, 2011, PLANT J, V66, P433, DOI 10.1111/j.1365-313X.2011.04500.x; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Thompson CL, 2002, ONCOGENE, V21, P9043, DOI 10.1038/sj.onc.1205958; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Todo T, 1999, MUTAT RES-DNA REPAIR, V434, P89, DOI 10.1016/S0921-8777(99)00013-0; vanVickle-Chavez SJ, 2007, J BIOL CHEM, V282, P10561, DOI 10.1074/jbc.M609314200; Wade HK, 2001, PLANT J, V25, P675, DOI 10.1046/j.1365-313x.2001.01001.x; Wenderoth N, 1999, BIOL CYBERN, V80, P285, DOI 10.1007/s004220050525; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; Yang ZH, 2000, J MOL EVOL, V51, P423, DOI 10.1007/s002390010105; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; ZAHNLE K, 1987, PRECAMBRIAN RES, V37, P95, DOI 10.1016/0301-9268(87)90073-8; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030	107	45	49	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135940	10.1371/journal.pone.0135940	http://dx.doi.org/10.1371/journal.pone.0135940			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352435	Green Published, Green Submitted, gold			2022-12-26	WOS:000360932800020
J	Terlaak, B; Bouwsema, H; van der Sluis, CK; Bongers, RM				Terlaak, Bernhard; Bouwsema, Hanneke; van der Sluis, Corry K.; Bongers, Raoul M.			Virtual Training of the Myosignal	PLOS ONE			English	Article							MYOELECTRIC CONTROL; EFFECT SIZE; PROSTHESIS; PERFORMANCE; STATISTICS; SIMULATOR; GAME	Objective To investigate which of three virtual training methods produces the largest learning effects on discrete and continuous myocontrol. The secondary objective was to examine the relation between myocontrol and manual motor control tests. Design A cohort analytic study. Setting University laboratory. Participants 3 groups of 12 able-bodied participants (N = 36). Interventions Participants trained the control over their myosignals on 3 consecutive days. Training was done with either myosignal feedback on a computer screen, a virtual myoelectric prosthetic hand or a computer game. Participants performed 2 myocontrol tests and 2 manual motor control tests before the first and after the last training session. They were asked to open and close a virtual prosthetic hand on 3 different velocities as a discrete myocontrol test and followed a line with their myosignals for 30 seconds as a continuous myocontrol test. The motor control tests were a pegboard and grip-force test. Main Outcome Measures Discrete myocontrol test: mean velocities. Continuous myocontrol test: error and error SD. Pegboard test: time to complete. Grip-force test: produced forces. Results No differences in learning effects on myocontrol were found for the different virtual training methods. Discrete myocontrol ability did not significantly improve as a result of training. Continuous myocontrol ability improved significantly as a result of training, both on average control and variability. All correlations between the motor control and myocontrol test outcome measures were below .50. Conclusions Three different virtual training methods showed comparable results when learning myocontrol. Continuous myocontrol was improved by training while discrete myocontrol was not. Myocontrol ability could not be predicted by the manual motor control tests.	[Terlaak, Bernhard; Bouwsema, Hanneke; Bongers, Raoul M.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Bouwsema, Hanneke] Adelante Rehabil Ctr, Ctr Expertise Rehabil & Audiol, Hoensbroek, Netherlands; [Bouwsema, Hanneke] Maastricht Univ, Dept Rehabil Med, Res Sch CAPHRI, Maastricht, Netherlands; [van der Sluis, Corry K.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands	University of Groningen; Maastricht University; University of Groningen	Bongers, RM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	r.m.bongers@umcg.nl	Bongers, Raoul/C-1094-2012	Bongers, Raoul/0000-0002-3518-7464	Otto Bock Healthcare GmbH, Vienna, Austria	Otto Bock Healthcare GmbH, Vienna, Austria	This research was performed while Hanneke Bouwsema was financially supported by Otto Bock Healthcare GmbH, Vienna, Austria. By legal contract, Otto Bock had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antuvan CW, 2014, IEEE T NEUR SYS REH, V22, P820, DOI 10.1109/TNSRE.2014.2302212; Armiger RS, 2008, 2008 IEEE BIOMEDICAL CIRCUITS AND SYSTEMS CONFERENCE - INTELLIGENT BIOMEDICAL SYSTEMS (BIOCAS), P121, DOI 10.1109/BIOCAS.2008.4696889; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Behrend C, 2011, J HAND SURG-AM, V36A, P1711, DOI 10.1016/j.jhsa.2011.07.024; Betker AL, 2006, ARCH PHYS MED REHAB, V87, P1141, DOI 10.1016/j.apmr.2006.04.010; Beylefeld AA, 2007, MED TEACH, V29, P933, DOI 10.1080/01421590701601550; Bouwsema H, 2010, ARCH PHYS MED REHAB, V91, P1442, DOI 10.1016/j.apmr.2010.06.025; BURGER H, 1994, PROSTHET ORTHOT INT, V18, P25; Campbell JID, 2012, BEHAV RES METHODS, V44, P1255, DOI 10.3758/s13428-012-0186-0; Cipriani C, 2011, IEEE ENG MED BIO, P1620, DOI 10.1109/IEMBS.2011.6090468; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dalley SA, 2009, IEEE-ASME T MECH, V14, P699, DOI 10.1109/TMECH.2009.2033113; Dawson MR, 2011, EXPERT REV MED DEVIC, V8, P581, DOI [10.1586/erd.11.23, 10.1586/ERD.11.23]; Di Pino G, 2009, PROG NEUROBIOL, V88, P114, DOI 10.1016/j.pneurobio.2009.03.001; Dudkiewicz I, 2004, DISABIL REHABIL, V26, P60, DOI 10.1080/09638280410001645094; Englehart K, 2003, IEEE T BIO-MED ENG, V50, P848, DOI 10.1109/TBME.2003.813539; Fimbel EJ, 2006, HUM MOVEMENT SCI, V25, P165, DOI 10.1016/j.humov.2005.12.001; Fimbel EJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001219; Kuiken TA, 2009, JAMA-J AM MED ASSOC, V301, P619, DOI 10.1001/jama.2009.116; Malone J M, 1984, J Rehabil Res Dev, V21, P33; Nazarpour K, 2012, J NEUROSCI, V32, P12349, DOI 10.1523/JNEUROSCI.5481-11.2012; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Oppenheim H, 2010, IEEE INT SYMP CIRC S, P957, DOI 10.1109/ISCAS.2010.5537390; Perez-Maldonado C, 2010, IEEE T NEUR SYS REH, V18, P203, DOI 10.1109/TNSRE.2009.2039394; Pistohl T, 2013, ANN BIOMED ENG, V41, P2687, DOI 10.1007/s10439-013-0876-5; Radhakrishnan SM, 2008, J NEUROPHYSIOL, V100, P2397, DOI 10.1152/jn.90614.2008; Resnik L, 2011, J REHABIL RES DEV, V48, P707, DOI 10.1682/JRRD.2010.07.0127; Romkema S, 2013, PHYS THER, V93, P22, DOI 10.2522/ptj.20120058; Schabowsky CN, 2008, EXP BRAIN RES, V188, P589, DOI 10.1007/s00221-008-1394-9; Soares A, 2003, J INTELL INF SYST, V21, P127, DOI 10.1023/A:1024758415877; Stansfield S, 2005, ST HEAL T, V111, P515; Takeuchi T, 2007, 2007 IEEE/ICME INTERNATIONAL CONFERENCE ON COMPLEX MEDICAL ENGINEERING, VOLS 1-4, P1351, DOI 10.1109/ICCME.2007.4381964; Weeks DL, 2003, ARCH PHYS MED REHAB, V84, P437, DOI 10.1053/apmr.2003.50014; Weir R, 2007, P ANN INT IEEE EMBS, P4359, DOI 10.1109/IEMBS.2007.4353302	34	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137161	10.1371/journal.pone.0137161	http://dx.doi.org/10.1371/journal.pone.0137161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9KG	26351838	Green Published, Green Submitted, gold			2022-12-26	WOS:000360932800062
J	Hall, MK; Weidner, DA; Edwards, MAJ; Schwalbe, RA				Hall, M. Kristen; Weidner, Douglas A.; Edwards, Michael A. J.; Schwalbe, Ruth A.			Complex N-Glycans Influence the Spatial Arrangement of Voltage Gated Potassium Channels in Membranes of Neuronal-Derived Cells	PLOS ONE			English	Article							ION CHANNELS; GLYCOSYLATION AFFECTS; K+ CHANNELS; LOCALIZATION; SUBUNIT; DIVERSITY; BRAIN	The intrinsic electrical properties of a neuron depend on expression of voltage gated potassium (Kv) channel isoforms, as well as their distribution and density in the plasma membrane. Recently, we showed that N-glycosylation site occupancy of Kv3.1b modulated its placement in the cell body and neurites of a neuronal-derived cell line, B35 neuroblastoma cells. To extrapolate this mechanism to other N-glycosylated Kv channels, we evaluated the impact of N-glycosylation occupancy of Kv3.1a and Kv1.1 channels. Western blots revealed that wild type Kv3.1a and Kv1.1 alpha-subunits had complex and oligomannose N-glycans, respectively, and that abolishment of the N-glycosylation site(s) generated Kv proteins without N-glycans. Total internal reflection fluorescence microscopy images revealed that Nglycans of Kv3.1a contributed to its placement in the cell membrane while N-glycans had no effect on the distribution of Kv1.1. Based on particle analysis of EGFP-Kv proteins in the adhered membrane, glycosylated forms of Kv3.1a, Kv1.1, and Kv3.1b had differences in the number, size or density of Kv protein clusters in the cell membrane of neurites and cell body of B35 cells. Differences were also observed between the unglycosylated forms of the Kv proteins. Cell dissociation assays revealed that cell-cell adhesion was increased by the presence of complex N-glycans of Kv3.1a, like Kv3.1b, whereas cell adhesion was similar in the oligomannose and unglycosylated Kv1.1 subunit containing B35 cells. Our findings provide direct evidence that N-glycans of Kv3.1 splice variants contribute to the placement of these glycoproteins in the plasma membrane of neuronal-derived cells while those of Kv1.1 were absent. Further when the cell membrane distribution of the Kv channel was modified by N-glycans then the cell-cell adhesion properties were altered. Our study demonstrates that N-glycosylation of Kv3.1a, like Kv3.1b, provides a mechanism for the distribution of these proteins to the cell body and outgrowths and thereby can generate different voltage-dependent conductances in these membranes.	[Hall, M. Kristen; Edwards, Michael A. J.; Schwalbe, Ruth A.] E Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27834 USA; [Weidner, Douglas A.] E Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27834 USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	Schwalbe, RA (corresponding author), E Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27834 USA.	schwalber@ecu.edu		Weidner, Douglas/0000-0003-1397-1757	department of Biochemistry and Molecular Biology at ECU	department of Biochemistry and Molecular Biology at ECU	The department of Biochemistry and Molecular Biology at ECU provided the funds for this work.	Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Brooks NL, 2006, FEBS J, V273, P3287, DOI 10.1111/j.1742-4658.2006.05339.x; Cartwright TA, 2007, BBA-GEN SUBJECTS, V1770, P666, DOI 10.1016/j.bbagen.2006.11.013; Cartwright TA, 2009, BIOSCIENCE REP, V29, P301, DOI 10.1042/BSR20080149; DEAL KK, 1994, J NEUROSCI, V14, P1666, DOI 10.1523/JNEUROSCI.14-03-01666.1994; Ednie AR, 2012, COMPR PHYSIOL, V2, P1269, DOI 10.1002/cphy.c110044; Hakomori S, 2004, GLYCOCONJUGATE J, V21, P125, DOI 10.1023/B:GLYC.0000044844.95878.cf; Hall MK, 2014, BBA-GEN SUBJECTS, V1840, P595, DOI 10.1016/j.bbagen.2013.10.025; Hall MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019317; Hall MK, 2014, FEBS OPEN BIO, V4, P892, DOI 10.1016/j.fob.2014.10.006; Hall MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075013; Hall MK, 2011, FEBS LETT, V585, P3322, DOI 10.1016/j.febslet.2011.09.021; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Jones J, 2005, BBA-GEN SUBJECTS, V1726, P121, DOI 10.1016/j.bbagen.2005.07.003; Kaczmarek LK, 2006, NAT REV NEUROSCI, V7, P761, DOI 10.1038/nrn1988; LUNEAU CJ, 1991, P NATL ACAD SCI USA, V88, P3932, DOI 10.1073/pnas.88.9.3932; Otey CA, 2003, METHOD CELL BIOL, V71, P287, DOI 10.1016/S0091-679X(03)01013-6; Ozaita A, 2002, J NEUROPHYSIOL, V88, P394, DOI 10.1152/jn.2002.88.1.394; SAMBROOK J, 1992, MOL CLONING LAB MANU; Shi G, 1999, J MEMBRANE BIOL, V168, P265, DOI 10.1007/s002329900515; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Watanabe I, 2004, J BIOL CHEM, V279, P8879, DOI 10.1074/jbc.M309802200; Watanabe I, 2003, J PHYSIOL-LONDON, V550, P51, DOI 10.1113/jphysiol.2003.040337	26	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137138	10.1371/journal.pone.0137138	http://dx.doi.org/10.1371/journal.pone.0137138			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348848	Green Submitted, gold, Green Published			2022-12-26	WOS:000360897600023
J	Cho, YJ; Silverstein, R; Geisinger, MT; Martinkovich, S; Corkill, H; Cunnick, JM; Planey, SL; Arnott, JA				Cho, Youngjin; Silverstein, Rachel; Geisinger, Max T.; Martinkovich, Stephen; Corkill, Holly; Cunnick, Jess M.; Planey, Sonia L.; Arnott, John A.			AFAP1 Is a Novel Downstream Mediator of TGF-beta 1 for CCN2 Induction in Osteoblasts	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; CHONDROCYTE-SPECIFIC GENE; ACTIN-FILAMENT INTEGRITY; HUMAN LUNG FIBROBLASTS; SMOOTH-MUSCLE-CELLS; FETAL-RAT CALVARIAE; SRC FAMILY KINASES; TGF-BETA; C-SRC; TRANSFORMING GROWTH-FACTOR-BETA-1	Background CCN2 acts as an anabolic growth factor to regulate osteoblast differentiation and function. CCN2 is induced by TGF-beta 1 and acts as a mediator of TGF-beta 1 induced matrix production in osteoblasts and Src is required for CCN2 induction by TGF-beta 1; however, the molecular mechanisms that control CCN2 induction in osteoblasts are poorly understood. AFAP1 binds activated forms of Src and can direct the activation of Src in certain cell types, however a role for AFAP1 downstream of TGF-beta 1 or in osteoblats is undefined. In this study, we investigated the role of AFAP1 for CCN2 induction by TGF-beta 1 in primary osteoblasts. Results We demonstrated that AFAP1 expression in osteoblasts occurs in a biphasic pattern with maximal expression levels occurring during osteoblast proliferation (similar to day 3), reduced expression during matrix production/maturation (similar to day 14-21), an a further increase in expression during mineralization (similar to day 21). AFAP1 expression is induced by TGF-beta 1 treatment in osteoblasts during days 7, 14 and 21. In osteoblasts, AFAP1 binds to Src and is required for Src activation by TGF-beta 1 and CCN2 promoter activity and protein induction by TGF-beta 1 treatment was impaired using AFAP1 siRNA, indicating the requirement of AFAP1 for CCN2 induction by TGF-beta 1. We also demonstrated that TGF-beta 1 induction of extracellular matrix protein collagen XIIa occurs in an AFAP1 dependent fashion. Conclusions This study demonstrates that AFAP1 is an essential downstream signaling component of TGF-beta 1 for Src activation, CCN2 induction and collagen XIIa in osteoblasts.	[Cho, Youngjin; Silverstein, Rachel; Geisinger, Max T.; Martinkovich, Stephen; Corkill, Holly; Cunnick, Jess M.; Planey, Sonia L.; Arnott, John A.] Commonwealth Med Coll, Scranton, PA 18509 USA	Geisinger Commonwealth School of Medicine	Arnott, JA (corresponding author), Commonwealth Med Coll, Scranton, PA 18509 USA.	jarnott@tcmedc.org	Cunnick, Jess/F-1715-2018; Lobo, Sonia/H-6889-2018	Lobo, Sonia/0000-0002-7406-6956	Commonwealth Medical College	Commonwealth Medical College	Support for this project was provided by The Commonwealth Medical College.	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Aleshin A, 2010, NEOPLASIA, V12, P599, DOI 10.1593/neo.10328; Arnott JA, 2008, BONE, V42, P871, DOI 10.1016/j.bone.2008.01.006; Arnott JA, 2007, J CELL PHYSIOL, V210, P843, DOI 10.1002/jcp.20917; Arnott JA, 2008, BONE; Baisden JM, 2001, ONCOGENE, V20, P6435, DOI 10.1038/sj.onc.1204784; Blom IE, 2001, NEPHROL DIAL TRANSPL, V16, P1139, DOI 10.1093/ndt/16.6.1139; Blom IE, 2002, MATRIX BIOL, V21, P473, DOI 10.1016/S0945-053X(02)00055-0; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Boguslawski G, 2000, J BIOL CHEM, V275, P999, DOI 10.1074/jbc.275.2.999; BONEWALD LF, 1994, J CELL BIOCHEM, V55, P350, DOI 10.1002/jcb.240550312; CENTRELLA M, 1987, J BONE MINER RES, V2, P29; CENTRELLA M, 1992, ENDOCRINOLOGY, V131, P2863, DOI 10.1210/en.131.6.2863; Chen YJ, 2002, KIDNEY INT, V62, P1149, DOI 10.1111/j.1523-1755.2002.kid567.x; Cunnick JM, 2015, ONCOGENE, V34, P2640, DOI 10.1038/onc.2014.205; Cunnick JM, 2014, ONCOGENE O, DOI [10.1038/onc.2014.205, DOI 10.1038/ONC.2014.205]; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dorfleutner A, 2008, J CELL SCI, V121, P2394, DOI 10.1242/jcs.026187; Dorfleutner A, 2007, J CELL PHYSIOL, V213, P740, DOI 10.1002/jcp.21143; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Fan WH, 2000, BIOCHEM BIOPH RES CO, V275, P312, DOI 10.1006/bbrc.2000.3314; FLYNN DC, 1993, MOL CELL BIOL, V13, P7892, DOI 10.1128/MCB.13.12.7892; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Gatesman A, 2004, MOL CELL BIOL, V24, P7578, DOI 10.1128/MCB.24.17.7578-7597.2004; Gore-Hyer E, 2002, AM J PHYSIOL-RENAL, V283, pF707, DOI 10.1152/ajprenal.00007.2002; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Guappone AC, 1998, MOL CARCINOGEN, V22, P110, DOI 10.1002/(SICI)1098-2744(199806)22:2<110::AID-MC6>3.0.CO;2-Q; Guappone AC, 1997, MOL CELL BIOCHEM, V175, P243, DOI 10.1023/A:1006840104666; HOCK JM, 1990, ENDOCRINOLOGY, V126, P421, DOI 10.1210/endo-126-1-421; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Kim HP, 2005, BBA-MOL CELL RES, V1743, P151, DOI 10.1016/j.bbamcr.2004.09.014; Kim HP, 2004, BIOCHEM J, V379, P141, DOI 10.1042/BJ20031408; Kim JT, 2002, J BIOL CHEM, V277, P31938, DOI 10.1074/jbc.M201178200; Kucich U, 2001, ARCH BIOCHEM BIOPHYS, V395, P103, DOI 10.1006/abbi.2001.2571; Leask A, 2003, J BIOL CHEM, V278, P13008, DOI 10.1074/jbc.M210366200; Leask A, 2003, BIOCHEM CELL BIOL, V81, P355, DOI 10.1139/O03-069; Lee SJ, 2013, BIOCHEM J, V456, P109, DOI 10.1042/BJ20130744; Leivonen SK, 2005, J INVEST DERMATOL, V124, P1162, DOI 10.1111/j.0022-202X.2005.23750.x; Lener T, 2006, EUR J CELL BIOL, V85, P183, DOI 10.1016/j.ejcb.2005.08.001; Li Xiaotong, 2002, Zhonghua Kou Qiang Yi Xue Za Zhi, V37, P135; Linder S, 2005, J CELL SCI, V118, P2079, DOI 10.1242/jcs.02390; Massague J, 2000, GENE DEV, V14, P627; Mishra R, 2007, AM J PHYSIOL-CELL PH, V292, pC1361, DOI 10.1152/ajpcell.00370.2006; Nakanishi T, 2000, ENDOCRINOLOGY, V141, P264, DOI 10.1210/endo.141.1.7267; Nakanishi T, 1997, BIOCHEM BIOPH RES CO, V234, P206, DOI 10.1006/bbrc.1997.6528; Nishida T, 2002, J CELL PHYSIOL, V192, P55, DOI 10.1002/jcp.10113; Nishida T, 2000, J CELL PHYSIOL, V184, P197, DOI 10.1002/1097-4652(200008)184:2<197::AID-JCP7>3.0.CO;2-R; PARISI MS, 2005, BONE; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P57, DOI 10.1136/mp.54.2.57; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Qian Y, 2004, J CELL BIOCHEM, V91, P602, DOI 10.1002/jcb.10725; Qian Y, 2000, EXP CELL RES, V255, P102, DOI 10.1006/excr.1999.4795; Qian Y, 2002, MOL BIOL CELL, V13, P2311, DOI 10.1091/mbc.E01-12-0148; Safadi FF, 2003, J CELL PHYSIOL, V196, P51, DOI 10.1002/jcp.10319; Sato M, 2005, ARTERIOSCL THROM VAS, V25, P341, DOI 10.1161/01.ATV.0000152608.29351.8f; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shi-Wen X, 2006, J BIOL CHEM, V281, P10715, DOI 10.1074/jbc.M511343200; Skingley Ann, 2007, Br J Community Nurs, V12, P28; Snyder BN, 2011, EUR J CELL BIOL, V90, P376, DOI 10.1016/j.ejcb.2010.11.016; Suzuki K, 2006, UROLOGY, V67, P647, DOI 10.1016/j.urology.2005.10.013; Takigawa M, 2003, J CELL PHYSIOL, V194, P256, DOI 10.1002/jcp.10206; Tanaka Y, 2004, J BIOL CHEM, V279, P8567, DOI 10.1074/jbc.M309131200; Tang CH, 2007, J CELL PHYSIOL, V211, P45, DOI 10.1002/jcp.20896; Ungefroren H, 2011, CURR CANCER DRUG TAR, V11, P524, DOI 10.2174/156800911795538075; Utsugi M, 2003, AM J RESP CELL MOL, V28, P754, DOI 10.1165/rcmb.4892; Varon C, 2006, MOL CELL BIOL, V26, P3582, DOI 10.1128/MCB.26.9.3582-3594.2006; Walker VG, 2007, AM J PHYSIOL-CELL PH, V293, pC119, DOI 10.1152/ajpcell.00525.2006; Way KJ, 2002, DIABETES, V51, P2709, DOI 10.2337/diabetes.51.9.2709; Weston BS, 2003, J AM SOC NEPHROL, V14, P601, DOI 10.1097/01.ASN.0000051600.53134.B9; WRANA JL, 1988, J CELL BIOL, V106, P915, DOI 10.1083/jcb.106.3.915; Xie SP, 2005, AM J PHYSIOL-LUNG C, V288, pL68, DOI 10.1152/ajplung.00156.2004; Xu J, 2000, J CELL BIOCHEM, V77, P103, DOI 10.1002/(SICI)1097-4644(20000401)77:1<103::AID-JCB11>3.0.CO;2-G; Zhang J, 2007, J CLIN INVEST, V117, P2962, DOI 10.1172/JCI30710; Zhang X, 2010, J CELL PHYSIOL, V224, P691, DOI 10.1002/jcp.22173	76	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0136712	10.1371/journal.pone.0136712	http://dx.doi.org/10.1371/journal.pone.0136712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340021	gold, Green Submitted, Green Published			2022-12-26	WOS:000360688200013
J	Min, XS; Ungureanu, D; Maxwell, S; Hammaren, H; Thibault, S; Hillert, EK; Ayres, M; Greenfield, B; Eksterowicz, J; Gabel, C; Walker, N; Silvennoinen, O; Wang, ZL				Min, Xiaoshan; Ungureanu, Daniela; Maxwell, Sarah; Hammaren, Henrik; Thibault, Steve; Hillert, Ellin-Kristina; Ayres, Merrill; Greenfield, Brad; Eksterowicz, John; Gabel, Chris; Walker, Nigel; Silvennoinen, Olli; Wang, Zhulun			Structural and Functional Characterization of the JH2 Pseudokinase Domain of JAK Family Tyrosine Kinase 2 (TYK2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON-ALPHA/BETA; SIGNAL-TRANSDUCTION; PROTEIN-KINASE; JANUS KINASES; RECEPTOR; MUTATION; ACTIVATION; BINDING; AUTOINHIBITION; SPECIFICITY	Background: JAK JH2s (pseudokinase domains) mediate important regulatory functions; it is unclear whether TYK2 JH2 binds ATP and possesses enzymatic activity. Results: TYK2 JH2 binds ATP, but is catalytically inactive; ATP stabilizes JH2 and modulates TYK2 activity. Conclusion: ATP binding to JH2 is functionally important; the rigid activation loop probably hinders substrate phosphorylation. Significance: The TYK2 JH2 domain can be targeted with ATP-competitive compounds for therapeutics. JAK (Janus family of cytoplasmic tyrosine kinases) family tyrosine kinase 2 (TYK2) participates in signaling through cytokine receptors involved in immune responses and inflammation. JAKs are characterized by dual kinase domain: a tyrosine kinase domain (JH1) that is preceded by a pseudokinase domain (JH2). The majority of disease-associated mutations in JAKs map to JH2, demonstrating its central regulatory function. JH2s were considered catalytically inactive, but JAK2 JH2 was found to have low autoregulatory catalytic activity. Whether the other JAK JH2s share ATP binding and enzymatic activity has been unclear. Here we report the crystal structure of TYK2 JH2 in complex with adenosine 5'-O-(thiotriphosphate) (ATP-gamma S) and characterize its nucleotide binding by biochemical and biophysical methods. TYK2 JH2 did not show phosphotransfer activity, but it binds ATP and the nucleotide binding stabilizes the protein without inducing major conformational changes. Mutation of the JH2 ATP-binding pocket increased basal TYK2 phosphorylation and downstream signaling. The overall structural characteristics of TYK2 JH2 resemble JAK2 JH2, but distinct stabilizing molecular interactions around helix alpha AL in the activation loop provide a structural basis for differences in substrate access and catalytic activities among JAK family JH2s. The structural and biochemical data suggest that ATP binding is functionally important for both TYK2 and JAK2 JH2s, whereas the regulatory phosphorylation appears to be a unique property of JAK2. Finally, the co-crystal structure of TYK2 JH2 complexed with a small molecule inhibitor demonstrates that JH2 is accessible to ATP-competitive compounds, which offers novel approaches for targeting cytokine signaling as well as potential therapeutic applications.	[Min, Xiaoshan; Thibault, Steve; Ayres, Merrill; Eksterowicz, John; Walker, Nigel; Wang, Zhulun] Amgen Inc, Dept Therapeut Discovery, San Francisco, CA 94080 USA; [Maxwell, Sarah; Greenfield, Brad; Gabel, Chris] Amgen Inc, Dept Inflammat, San Francisco, CA 94080 USA; [Ungureanu, Daniela; Hillert, Ellin-Kristina] Univ Tampere, Inst Biomed Technol, Tampere 33014, Finland; [Hammaren, Henrik; Silvennoinen, Olli] Univ Tampere, Sch Med, Tampere 33014, Finland; [Silvennoinen, Olli] Tampere Univ Hosp, Dept Clin Hematol, Tampere 33520, Finland	Amgen; Amgen; Tampere University; Tampere University; Tampere University; Tampere University Hospital	Silvennoinen, O (corresponding author), Univ Tampere, Sch Med, Tampere 33014, Finland.	olli.silvennoinen@uta.fi; zwang@amgen.com	Hammarén, Henrik/AAB-5120-2022	Hammarén, Henrik/0000-0002-8534-2530; Ungureanu, Daniela/0000-0002-9314-4972; Hillert Triola, Ellin-Kristina/0000-0001-5619-6450	U. S. Department of Energy at the Lawrence Berkeley National Laboratory [DE-AC03-76SF00098]; Novo Nordisk Fonden [NNF13SA0008469] Funding Source: researchfish; Cancer Foundation Finland sr [140164, 100141] Funding Source: researchfish	U. S. Department of Energy at the Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Novo Nordisk Fonden(Novo Nordisk Foundation); Cancer Foundation Finland sr	We thank Tuija Pekkala, Juha Saarikettu, Yashavanthi Niranjan, Clifford Young, and Ole N. Jensen for experimental contribution and Paula Kosonen, Merja Lehtinen, and Elina Koskenalho for technical assistance. We also thank Michal Hammel and Gregory Hura at the SIBYLS beamline at ALS for data collection and analysis of the SAXS experiments. The ALS is supported by the U. S. Department of Energy under Contract DE-AC03-76SF00098 at the Lawrence Berkeley National Laboratory.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bandaranayake RM, 2012, NAT STRUCT MOL BIOL, V19, P754, DOI 10.1038/nsmb.2348; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Bream JH, 2004, J BIOL CHEM, V279, P41249, DOI 10.1074/jbc.M401168200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forster S, 2010, J APPL CRYSTALLOGR, V43, P639, DOI 10.1107/S0021889810008289; Gakovic M, 2008, J BIOL CHEM, V283, P18522, DOI 10.1074/jbc.M801427200; Gauzzi MC, 1996, J BIOL CHEM, V271, P20494, DOI 10.1074/jbc.271.34.20494; Goldsmith MA, 1998, P NATL ACAD SCI USA, V95, P7006, DOI 10.1073/pnas.95.12.7006; Guinier A., 1955, SMALL ANGLE SCATTERI; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lai SY, 1996, P NATL ACAD SCI USA, V93, P231, DOI 10.1073/pnas.93.1.231; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Levine RL, 2005, BLOOD, V106, P3377, DOI 10.1182/blood-2005-05-1898; Li Z, 2013, J IMMUNOL, V190, P2335, DOI 10.4049/jimmunol.1203118; Liu KD, 1997, CURR BIOL, V7, P817, DOI 10.1016/S0960-9822(06)00369-1; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murphy JM, 2014, BIOCHEM J, V457, P323, DOI 10.1042/BJ20131174; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PELLEGRINI S, 1989, MOL CELL BIOL, V9, P4605, DOI 10.1128/MCB.9.11.4605; Ragimbeau J, 2001, J BIOL CHEM, V276, P30812, DOI 10.1074/jbc.M103559200; Richter MF, 1998, J BIOL CHEM, V273, P24723, DOI 10.1074/jbc.273.38.24723; Saharinen P, 2000, MOL CELL BIOL, V20, P3387, DOI 10.1128/MCB.20.10.3387-3395.2000; Saharinen P, 2003, MOL BIOL CELL, V14, P1448, DOI 10.1091/mbc.E02-06-0342; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Sanda T, 2013, CANCER DISCOV, V3, P564, DOI 10.1158/2159-8290.CD-12-0504; Shan YB, 2014, NAT STRUCT MOL BIOL, V21, P579, DOI 10.1038/nsmb.2849; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Shimoda K, 2000, IMMUNITY, V13, P561, DOI 10.1016/S1074-7613(00)00055-8; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; Strobl B, 2011, FRONT BIOSCI-LANDMRK, V16, P3224, DOI 10.2741/3908; Ten Eyck LF, 2008, BBA-PROTEINS PROTEOM, V1784, P238, DOI 10.1016/j.bbapap.2007.11.002; Tokarski JS, 2015, J BIOL CHEM, V290, P11061, DOI 10.1074/jbc.M114.619502; Tomasson MH, 2008, BLOOD, V111, P4797, DOI 10.1182/blood-2007-09-113027; Ungureanu D, 2011, NAT STRUCT MOL BIOL, V18, P971, DOI 10.1038/nsmb.2099; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; VELAZQUEZ L, 1995, J BIOL CHEM, V270, P3327, DOI 10.1074/jbc.270.7.3327; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253; Yeh TC, 2000, P NATL ACAD SCI USA, V97, P8991, DOI 10.1073/pnas.160130297; Zeqiraj E, 2010, CURR OPIN STRUC BIOL, V20, P772, DOI 10.1016/j.sbi.2010.10.001; Zeqiraj E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000126	44	45	49	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27261	27270		10.1074/jbc.M115.672048	http://dx.doi.org/10.1074/jbc.M115.672048			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26359499	hybrid, Green Published			2022-12-26	WOS:000364794000034
J	Teteloshvili, N; Kluiver, J; van der Geest, KSM; van der Lei, RJ; Jellema, P; Pawelec, G; Brouwer, E; Kroesen, BJ; Boots, AMH; van den Berg, A				Teteloshvili, Nato; Kluiver, Joost; van der Geest, Kornelis S. M.; van der Lei, Roelof Jan; Jellema, Pytrick; Pawelec, Graham; Brouwer, Elisabeth; Kroesen, Bart-Jan; Boots, Annemieke M. H.; van den Berg, Anke			Age-Associated Differences in MiRNA Signatures Are Restricted to CD45RO Negative T Cells and Are Associated with Changes in the Cellular Composition, Activation and Cellular Ageing	PLOS ONE			English	Article							LIFE-SPAN; 2 SUBSETS; SENESCENCE; NAIVE; MICRORNA-21; EXPRESSION; DIFFERENTIATION; LYMPHOCYTES; REPERTOIRE; INCREASES	MicroRNAs (miRNAs) have emerged as important players in the regulation of T-cell functionality. However, comprehensive insight into the extent of age-related miRNA changes in T cells is lacking. We established miRNA expression patterns of CD45RO- naive and CD45RO+ memory T-cell subsets isolated from peripheral blood cells from young and elderly individuals. Unsupervised clustering of the miRNA expression data revealed an age-related clustering in the CD45RO- T cells, while CD45RO+ T cells clustered based on expression of CD4 and CD8. Seventeen miRNAs showed an at least 2-fold up-or downregulation in CD45RO- T cells obtained from young as compared to old donors. Validation on the same and independent samples revealed a statistically significant age-related upregulation of miR-21, miR-223 and miR-15a. In a T-cell subset analysis focusing on known age-related phenotypic changes, we showed significantly higher miR-21 and miR-223 levels in CD8+CD45RO-CCR7- T-EMRA compared to CD45RO-CCR7+ T-NAIVE-cells. Moreover, miR21 but not miR-223 levels were significantly increased in CD45RO-CD31-post-thymic T-NAIVE cells as compared to thymic CD45RO-CD31+ T-NAIVE cells. Upon activation of CD45RO-T-NAIVE cells we observed a significant induction of miR-21 especially in CD4+ T cells, while miR-223 levels significantly decreased only in CD4+ T cells. Besides composition and activation-induced changes, we showed a borderline significant increase in miR-21 levels upon an increasing number of population doublings in CD4+ T-cell clones. Together, our results show that ageing related changes in miRNA expression are dominant in the CD45RO- T-cell compartment. The differential expression patterns can be explained by age related changes in T-cell composition, i.e. accumulation of CD8+ T-EMRA and CD4+ post-thymic expanded CD31-T cells and by cellular ageing, as demonstrated in a longitudinal clonal culture model.	[Teteloshvili, Nato; Kluiver, Joost; van der Lei, Roelof Jan; Jellema, Pytrick; van den Berg, Anke] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [van der Geest, Kornelis S. M.; Brouwer, Elisabeth; Boots, Annemieke M. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands; [Kroesen, Bart-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Teteloshvili, Nato; van der Geest, Kornelis S. M.; Brouwer, Elisabeth; Kroesen, Bart-Jan; Boots, Annemieke M. H.; van den Berg, Anke] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Initiat Hlth Ageing & Immune Longev, Groningen, Netherlands; [Pawelec, Graham] Univ Tubingen, Med Res Ctr, Dept Internal Med 2, Tubingen, Germany; [Pawelec, Graham] Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England	University of Groningen; University of Groningen; University of Groningen; University of Groningen; Eberhard Karls University of Tubingen; Nottingham Trent University	van den Berg, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	a.van.den.berg01@umcg.nl	Kluiver, Joost/G-6406-2014; Brouwer, Elisabeth/A-3198-2015; Pawelec, Graham/H-2713-2019; Brouwer, Elisabeth/AAL-9029-2020; Teteloshvili, Nato/G-5288-2019; van den Berg, Anke/H-1718-2011	Kluiver, Joost/0000-0001-7650-2937; Brouwer, Elisabeth/0000-0002-5652-4423; Pawelec, Graham/0000-0002-3600-0163; Brouwer, Elisabeth/0000-0002-5652-4423; van den Berg, Anke/0000-0002-8894-2638; van der Geest, Kornelis/0000-0003-2798-6765	Abbot; Jan Kornelis de Cock Foundation; Graduate School of Medical Sciences	Abbot; Jan Kornelis de Cock Foundation; Graduate School of Medical Sciences	This study was supported by unrestricted funds from Abbot, Jan Kornelis de Cock Foundation and the Graduate School of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brunner S, 2012, AGING CELL, V11, P579, DOI 10.1111/j.1474-9726.2012.00819.x; Buscaglia Lindsey E Becker, 2011, Chin J Cancer, V30, P371; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Dellago H, 2013, AGING CELL, V12, P446, DOI 10.1111/acel.12069; Effros RB, 2003, CURR HIV RES, V1, P153, DOI 10.2174/1570162033485348; Effros Rita B, 2005, Discov Med, V5, P293; Fagnoni FF, 1996, IMMUNOLOGY, V88, P501, DOI 10.1046/j.1365-2567.1996.d01-689.x; Fornasa G, 2010, J IMMUNOL, V184, P5485, DOI 10.4049/jimmunol.0902219; Fulci V, 2010, HUM IMMUNOL, V71, P206, DOI 10.1016/j.humimm.2009.11.008; Goronzy JJ, 2003, ARTHRITIS RES THER, V5, P225, DOI 10.1186/ar974; Hackl M, 2010, AGING CELL, V9, P291, DOI 10.1111/j.1474-9726.2010.00549.x; Henson SM, 2012, CURR OPIN IMMUNOL, V24, P476, DOI 10.1016/j.coi.2012.04.001; Jazbutyte V, 2013, AGE, V35, P747, DOI 10.1007/s11357-012-9407-9; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Kluiver Joost, 2013, Methods Mol Biol, V971, P265, DOI 10.1007/978-1-62703-269-8_15; Koch S, 2008, IMMUN AGEING, V5, DOI [10.1186/1742-4933-5-6, 10.1186/1742-4933-5-11]; Kohler S, 2005, EUR J IMMUNOL, V35, P1987, DOI 10.1002/eji.200526181; Kohler S, 2009, BLOOD, V113, P769, DOI 10.1182/blood-2008-02-139154; Li GJ, 2012, NAT MED, V18, P1518, DOI 10.1038/nm.2963; LIGTHART GJ, 1984, MECH AGEING DEV, V28, P47, DOI 10.1016/0047-6374(84)90152-0; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Mercken EM, 2013, AGING-US, V5, P692, DOI 10.18632/aging.100598; MICHIE CA, 1992, NATURE, V360, P264, DOI 10.1038/360264a0; Ohyashiki M, 2011, IMMUN AGEING, V8, DOI 10.1186/1742-4933-8-11; Olivieri F, 2012, MECH AGEING DEV, V133, P675, DOI 10.1016/j.mad.2012.09.004; Park S, 2013, IMMUNOL INVEST, V42, P179, DOI 10.3109/08820139.2012.717328; Pawelec G, 2002, EXP GERONTOL, V37, P265, DOI 10.1016/S0531-5565(01)00192-9; Pawelec G, 1997, IMMUNOL REV, V160, P31, DOI 10.1111/j.1600-065X.1997.tb01025.x; Qin OY, 2004, EXP GERONTOL, V39, P607, DOI 10.1016/j.exger.2003.11.016; Ruan Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.47; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Smigielska-Czepiel K, 2014, GENES IMMUN, V15, P115, DOI 10.1038/gene.2013.69; Smigielska-Czepiel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076217; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; van der Geest KSM, 2015, RHEUMATOLOGY, V54, P950, DOI 10.1093/rheumatology/keu407; Wang L, 2014, MOL IMMUNOL, V59, P163, DOI 10.1016/j.molimm.2014.02.004; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Zhu SK, 2013, CIRC RES, V112, P152, DOI 10.1161/CIRCRESAHA.112.280016	39	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137556	10.1371/journal.pone.0137556	http://dx.doi.org/10.1371/journal.pone.0137556			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360056	Green Published, Green Submitted, gold			2022-12-26	WOS:000361043100053
J	Hocking, DR; Reeve, J; Porter, MA				Hocking, Darren R.; Reeve, Jessica; Porter, Melanie A.			Characterising the Profile of Everyday Executive Functioning and Relation to IQ in Adults with Williams Syndrome: Is the BRIEF Adult Version a Valid Rating Scale?	PLOS ONE			English	Article							YOUNG-CHILDREN; IMPAIRMENTS; INHIBITION; INVENTORY; INTERVENTION; INTELLIGENCE; DISABILITIES; INDIVIDUALS; EXPLORATION; DYSFUNCTION	Although there is evidence of a distinct profile of executive dysfunction in Williams syndrome (WS), a rare genetically based neurodevelopmental disorder, the utility of informant reports of everyday executive function (EF) impairments and their relation to intelligence is not yet clear. Here we aimed to evaluate the functional impact of executive dysfunction in adults with WS and to establish the validity of child and adult versions of the most commonly used rating scale for EF assessment, the Behaviour Rating Inventory of Executive Function (BRIEF). We were also interested in whether distinct components of everyday EF relate to intelligence in WS. Parent report child (BRIEF-C) and adult (BRIEF-A) ratings were collected on 20 adults with WS (aged 18.5 to 53 years), with a mean IQ of 60.95 (SD = 17.67). Neuropsychological measures of EF included: The Shape School Test (Espy, 2007); select subdomains of EF from the Woodcock-Johnson III Tests of Cognitive Abilities, Australian Adaptation (WJ III COG); and select subdomains from the Vineland Adaptive Behaviour Scales, Second Edition-Parent Survey (Vineland-II). Results showed that the BRIEF-A, but not the BRIEF-C, was the most highly correlated with neuropsychological measures of EF, suggesting that it was a valid measure of the profile of EF impairments in adults with WS. The profile of everyday EF dysfunction revealed relative impairments in monitoring, working memory, planning and organisation in WS. In addition, both neuropsychological and rating scale measures showed an association between the shifting component of EF and intelligence. These findings indicate that the BRIEF-A is a valid measure of the multidimensional nature of real-world impairments in EF, and highlight its utility as a less labor intensive and low-cost screening tool for measuring specific EF impairments that could become the focus of targeted intervention in adults with WS.	[Hocking, Darren R.] La Trobe Univ, Sch Psychol & Publ Hlth, Olga Tennison Autism Res Ctr, Melbourne, Vic, Australia; [Reeve, Jessica; Porter, Melanie A.] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia; [Porter, Melanie A.] Macquarie Univ, ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW 2109, Australia	La Trobe University; Macquarie University; Macquarie University	Hocking, DR (corresponding author), La Trobe Univ, Sch Psychol & Publ Hlth, Olga Tennison Autism Res Ctr, Melbourne, Vic, Australia.	D.Hocking@latrobe.edu.au		Porter, Melanie/0000-0003-3281-1732; Hocking, Darren/0000-0003-1143-8190	Apex Foundation for Research Into Intellectual Disability	Apex Foundation for Research Into Intellectual Disability	Apex Foundation for Research Into Intellectual Disability awarded to DH and MP, (http://www.afrid.com.au). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anderson V, 2001, Pediatr Rehabil, V4, P119, DOI 10.1080/13638490110091347; Ardila A, 1998, NEUROPSYCHOL REV, V8, P171, DOI 10.1023/A:1021618218943; Atkinson J, 2003, DEV NEUROPSYCHOL, V23, P139, DOI 10.1207/S15326942DN231&2_7; Baddeley A. D, 1986, WORKING MEMORY; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bari A, 2013, PROG NEUROBIOL, V108, P44, DOI 10.1016/j.pneurobio.2013.06.005; Bellugi U, 2001, CLIN NEUROSCI RES, V1, P217, DOI 10.1016/S1566-2772(01)00008-1; Blijd-Hoogewys EMA, 2014, J AUTISM DEV DISORD, V44, P3089, DOI 10.1007/s10803-014-2176-9; Carney DPJ, 2013, RES DEV DISABIL, V34, P46, DOI 10.1016/j.ridd.2012.07.013; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costanzo F, 2013, RES DEV DISABIL, V34, P1770, DOI 10.1016/j.ridd.2013.01.024; Daunhauer LA, 2014, AJIDD-AM J INTELLECT, V119, P303, DOI 10.1352/1944-7558-119.4.303; Diamond A, 2000, CHILD DEV, V71, P44, DOI 10.1111/1467-8624.00117; Diamond A, 2009, DEV PSYCHOL, V45, P130, DOI 10.1037/a0014025; Donnai D, 2000, AM J MED GENET, V97, P164, DOI 10.1002/1096-8628(200022)97:2<164::AID-AJMG8>3.0.CO;2-F; Duncan, 2000, Am J Ophthalmol, V130, P687, DOI 10.1016/S0002-9394(00)00752-2; EINFELD SL, 1995, J AUTISM DEV DISORD, V25, P81, DOI 10.1007/BF02178498; Emslie H., 2003, BEHAV ASSESSMENT DYS; Espy KA, 2006, PSYCHOL ASSESSMENT, V18, P373, DOI 10.1037/1040-3590.18.4.373; Friedman NP, 2006, PSYCHOL SCI, V17, P172, DOI 10.1111/j.1467-9280.2006.01681.x; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Gioia GA, 2000, BEHAV RATING INVENTO; Grattan LM, 1989, NEUROPSYCHOLOGY, V3, P175, DOI 10.1037//0894-4105.3.3.175; Greer J, 2013, RES DEV DISABIL, V34, P4170, DOI 10.1016/j.ridd.2013.08.041; Hocking DR, 2008, NEUROSCI BIOBEHAV R, V32, P497, DOI 10.1016/j.neubiorev.2007.09.003; Hocking DR, 2014, RES DEV DISABIL, V35, P203, DOI 10.1016/j.ridd.2013.10.005; Hocking DR, 2013, DEVELOPMENTAL SCI, V16, P428, DOI 10.1111/desc.12042; Hongwanishkul D, 2005, DEV NEUROPSYCHOL, V28, P617, DOI 10.1207/s15326942dn2802_4; Isquith PK, 2013, APPL NEUROPSYCH-CHIL, V2, P125, DOI 10.1080/21622965.2013.748389; Kenworthy L, 2014, J CHILD PSYCHOL PSYC, V55, P374, DOI 10.1111/jcpp.12161; Kenworthy LE, 2005, DEV NEUROPSYCHOL, V28, P809, DOI 10.1207/s15326942dn2803_4; Lawson RA, 2015, NEUROPSYCHOLOGY, V29, P445, DOI 10.1037/neu0000145; Lee NR, 2011, AJIDD-AM J INTELLECT, V116, P290, DOI 10.1352/1944-7558-116.4.290; Leyfer OT, 2006, AM J MED GENET B, V141B, P615, DOI 10.1002/ajmg.b.30344; Maehler C, 2009, J INTELL DISABIL RES, V53, P3, DOI 10.1111/j.1365-2788.2008.01105.x; Martens MA, 2008, J CHILD PSYCHOL PSYC, V49, P576, DOI 10.1111/j.1469-7610.2008.01887.x; Mather N., 2001, EXAMINERS MANUAL WOO; McAuley T, 2010, J INT NEUROPSYCH SOC, V16, P495, DOI 10.1017/S1355617710000093; Menghini D, 2010, J INTELL DISABIL RES, V54, P418, DOI 10.1111/j.1365-2788.2010.01287.x; Mervis CB, 2010, AM J MED GENET C, V154C, P229, DOI 10.1002/ajmg.c.30263; Mervis CB, 2000, BRAIN COGNITION, V44, P604, DOI 10.1006/brcg.2000.1232; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Osorio A, 2012, RES DEV DISABIL, V33, P1169, DOI 10.1016/j.ridd.2012.02.003; Ozonoff S, 1999, J AUTISM DEV DISORD, V29, P171, DOI 10.1023/A:1023052913110; Porter MA, 2005, DEV NEUROPSYCHOL, V27, P275, DOI 10.1207/s15326942dn2702_5; Porter MA, 2007, NEUROPSYCHOLOGIA, V45, P2839, DOI 10.1016/j.neuropsychologia.2007.05.006; Porter MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047457; Porter MA, 2009, CHILD NEUROPSYCHOL, V15, P359, DOI 10.1080/09297040802577881; Rhodes SM, 2011, BRAIN COGNITION, V77, P208, DOI 10.1016/j.bandc.2011.08.009; Rhodes SM, 2011, J CLIN EXP NEUROPSYC, V33, P147, DOI 10.1080/13803395.2010.495057; Rhodes SM, 2010, NEUROPSYCHOLOGIA, V48, P1216, DOI 10.1016/j.neuropsychologia.2009.12.021; Rosenthal M, 2013, NEUROPSYCHOLOGY, V27, P13, DOI 10.1037/a0031299; Roth RM., 2005, BRIEF A BEHAV RATING; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Russell J, 1999, Cogn Neuropsychiatry, V4, P303; Sparrow S. S., 2005, VINELAND ADAPTIVE BE, Vsecond; Stromme P, 2002, J CHILD NEUROL, V17, P269, DOI 10.1177/088307380201700406; Vicari S, 2006, DEV MED CHILD NEUROL, V48, P126, DOI 10.1017/S0012162206000272; Waid-Ebbs JK, 2012, BRAIN INJURY, V26, P1646, DOI 10.3109/02699052.2012.700087; Willner P, 2010, J INTELL DISABIL RES, V54, P366, DOI 10.1111/j.1365-2788.2010.01249.x; Woodcock R.W., 2001, WOODCOCK JOHNSON 3 T	65	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137628	10.1371/journal.pone.0137628	http://dx.doi.org/10.1371/journal.pone.0137628			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9WL	26355600	gold, Green Published, Green Submitted			2022-12-26	WOS:000360965800072
J	Liu, YB; Li, XR; Chen, GX; Li, MM; Liu, ML; Liu, D				Liu, Yubing; Li, Xinrong; Chen, Guoxiong; Li, Mengmeng; Liu, Meiling; Liu, Dan			Epidermal Micromorphology and Mesophyll Structure of Populus euphratica Heteromorphic Leaves at Different Development Stages	PLOS ONE			English	Article							WATER-USE EFFICIENCY; CALCIUM-OXALATE; LOWER REACHES; LEAF HAIRS; PLANTS; PHOTOSYNTHESIS; RESPONSES; CRYSTALS; GENE; FOG	Leaf epidermal micromorphology and mesophyll structure during the development of Populus euphratica heteromorphic leaves, including linear, lanceolate, ovate, dentate ovate, dentate rhombic, dentate broad-ovate and dentate fan-shaped leaves, were studied by using electron and light microscopy. During development of heteromorphic leaves, epidermal appendages (wax crystals and trichomes) and special cells (mucilage cells and crystal idioblasts) increased in all leaf types while chloroplast ultrastructure and stomatal characters show maximum photosynthetic activity in dentate ovate and rhombic leaves. Also, functional analysis by subordinate function values shows that the maximum adaptability to adverse stress was exhibited in the broad type of mature leaves. The 12 heteromorphic leaf types are classified into three major groups by hierarchical cluster analysis: young, developing and mature leaves. Mature leaves can effectively obtain the highest stress resistance by combining the protection of xerophytic anatomy from drought stress, regulation of water uptake in micro-environment by mucilage and crystal idioblasts, and assistant defense of transpiration reduction through leaf epidermal appendages, which improves photosynthetic activity under arid desert conditions. Our data confirms that the main leaf function is differentiated during the developing process of heteromorphic leaves.	[Liu, Yubing; Li, Xinrong; Chen, Guoxiong; Li, Mengmeng; Liu, Meiling; Liu, Dan] Chinese Acad Sci, Key Lab Stress Physiol & Ecol Cold & Arid Reg Gan, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou 730000, Peoples R China; [Liu, Yubing; Li, Xinrong; Chen, Guoxiong; Li, Mengmeng; Liu, Meiling; Liu, Dan] Chinese Acad Sci, Shapotou Desert Res & Expt Stn, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou 730000, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Liu, YB (corresponding author), Chinese Acad Sci, Key Lab Stress Physiol & Ecol Cold & Arid Reg Gan, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou 730000, Peoples R China.	ybliu13@163.com	Liu, Yubing/AFR-0289-2022	Liu, Yubing/0000-0002-2338-097X	State Key Development Program for Basic Research of China (973 Program) [2013CB429904]; National Natural Science Foundation of China [91125029]	State Key Development Program for Basic Research of China (973 Program)(National Basic Research Program of ChinaState Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the State Key Development Program for Basic Research of China (973 Program, Grant No. 2013CB429904) and the National Natural Science Foundation of China (Grant No. 91125029).	Allen JF, 2011, TRENDS PLANT SCI, V16, P645, DOI 10.1016/j.tplants.2011.10.004; BAMBER RK, 1978, AUST J BOT, V26, P177, DOI 10.1071/BT9780177; Barthlott W, 1998, BOT J LINN SOC, V126, P237, DOI 10.1111/j.1095-8339.1998.tb02529.x; Bernard A, 2013, PROG LIPID RES, V52, P110, DOI 10.1016/j.plipres.2012.10.002; [王金山 Jinshan Wang], 2008, [植物学通报, Chinese Bulletin of Botany], V25, P728; Brown HT, 1900, PHILOS T R SOC LON B, V193, P223, DOI 10.1098/rstb.1900.0014; Brown SL, 2013, PLANT PHYSIOL BIOCH, V73, P219, DOI 10.1016/j.plaphy.2013.10.006; Burgess SSO, 2004, PLANT CELL ENVIRON, V27, P1023, DOI 10.1111/j.1365-3040.2004.01207.x; Cao SK, 2011, ENVIRON EARTH SCI, V62, P1597, DOI 10.1007/s12665-010-0643-y; Chen JH, 2011, GENE, V483, P36, DOI 10.1016/j.gene.2011.05.010; Chen JH, 2009, BIOCHEM BIOPH RES CO, V378, P483, DOI 10.1016/j.bbrc.2008.11.071; Chen YP, 2011, ENVIRON EARTH SCI, V62, P119, DOI 10.1007/s12665-010-0502-x; Chen YN, 2004, ACTA BOT SIN, V46, P1393; Cutler DF, 2008, PLANT ANATOMY APPL A; Dawson TE, 1998, OECOLOGIA, V117, P476, DOI 10.1007/s004420050683; DRIESSCHE TV, 1966, EXP CELL RES, V42, P18, DOI 10.1016/0014-4827(66)90315-6; EHLERINGER J, 1976, SCIENCE, V192, P376, DOI 10.1126/science.192.4237.376; EHLERINGER JR, 1978, OECOLOGIA, V37, P183, DOI 10.1007/BF00344990; Fahmy GM, 1997, J ARID ENVIRON, V36, P499, DOI 10.1006/jare.1996.0217; Fahn A, 1992, ENCY PLANT ANATOMY 3; Feng Q, 2001, ENVIRON GEOL, V41, P229, DOI 10.1007/s002540100387; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; Fu AH, 2011, PHOTOSYNTHETICA, V49, P295, DOI 10.1007/s11099-011-0036-9; Hao JianQing, 2011, Forestry Studies in China, V13, P52, DOI 10.1007/s11632-011-0102-1; He HH, 2012, ANN BOT-LONDON, V109, P887, DOI 10.1093/aob/mcs004; Klich MG, 2000, ENVIRON EXP BOT, V44, P171, DOI 10.1016/S0098-8472(00)00056-3; Knight CA, 2003, NEW PHYTOL, V160, P337, DOI 10.1046/j.1469-8137.2003.00880.x; Li ZhaoXia, 2005, Forestry Studies in China, V7, P11, DOI 10.1007/s11632-005-0050-8; Liu YB, 2007, J ARID ENVIRON, V70, P183, DOI 10.1016/j.jaridenv.2006.12.020; Ma T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3797; Ogle K, 2004, OECOLOGIA, V141, P282, DOI 10.1007/s00442-004-1507-5; Ottow EA, 2005, PLANT MOL BIOL, V58, P75, DOI 10.1007/s11103-005-4525-8; Reynolds CS, 2007, HYDROBIOLOGIA, V578, P37, DOI 10.1007/s10750-006-0431-6; Roth-Nebelsick A, 2007, ANN BOT-LONDON, V100, P23, DOI 10.1093/aob/mcm075; Sayer JD, 1926, OHIO J SCI, V26, P233; Shepherd T, 2006, NEW PHYTOL, V171, P469, DOI 10.1111/j.1469-8137.2006.01826.x; Si JH, 2014, ENVIRON MONIT ASSESS, V186, P5469, DOI 10.1007/s10661-014-3796-4; [苏培玺 Su pei xi], 2003, [植物生态学报, Acta Phytoecologica Sinica], V27, P34; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; van Maarseveen C, 2009, PHYTOCHEMISTRY, V70, P899, DOI 10.1016/j.phytochem.2009.04.011; Wang XZ, 2004, ENVIRON EXP BOT, V51, P21, DOI 10.1016/S0098-8472(03)00057-1; WOOLLEY JOSEPH T., 1964, AGRON J, V56, P569; WUENSCHER JE, 1970, NEW PHYTOL, V69, P65, DOI 10.1111/j.1469-8137.1970.tb04050.x; [严巧娣 YAN QiaoDi], 2006, [植物生理学通讯, Plant Physiology Communications], V42, P761; Yue Ning, 2010, Agricultural Science & Technology - Hunan, V11, P41; Zheng C., 2007, FRONTIERS FORESTRY C, V2, P87; Zhuang L, 2011, J ARID LAND, V3, P261, DOI 10.3724/SP.J.1227.2011.00261; Zimmermann D, 2007, PROTOPLASMA, V232, P10, DOI 10.1007/s00709-007-0279-2; Zimmermann U, 2004, NEW PHYTOL, V162, P575, DOI 10.1111/j.1469-8137.2004.01083.x	50	23	33	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137701	10.1371/journal.pone.0137701	http://dx.doi.org/10.1371/journal.pone.0137701			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356300	Green Published, gold, Green Submitted			2022-12-26	WOS:000360965800079
J	Maekawa, T; Kaneko, H				Maekawa, Toru; Kaneko, Hirohiko			Does Changing Vertical Disparity Induce Horizontal Head Movement?	PLOS ONE			English	Article							PERCEPTION; DIRECTION; MOTION	Theoretically, one can estimate the direction of an object that is relative to the head using vertical disparity if the distance from the head to the object is known. However, several reports describe vertical disparity as having little or no effect on the perception of visual direction. It has been suggested, however, that the visual processes involved in action are different from those involved in perception, and the effect of visual disparity on action has not been investigated in previous studies. This study investigated the influence of vertical disparity on the stability of head direction as a motor response to visual information. We presented a stimulus consisting of horizontal lines with vertical size-disparity oscillation, and examined whether the stimulus affected the subject's head movement. The results showed that the head movement in the condition of vertical size-disparity oscillation was not significantly different from that in the condition of no disparity oscillation. Our results suggest that, despite theoretical validity, vertical disparity is not used for controlling head movement.	[Maekawa, Toru] Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks, Suita, Osaka, Japan; [Maekawa, Toru; Kaneko, Hirohiko] Tokyo Inst Technol, Dept Informat Proc, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa 227, Japan	National Institute of Information & Communications Technology (NICT) - Japan; Tokyo Institute of Technology	Maekawa, T (corresponding author), Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks, Suita, Osaka, Japan.	torumaekawa@nict.go.jp			Japan Society for the Promotion of Science [24500236]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research (no. 24500236) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backus BT, 1999, VISION RES, V39, P1143, DOI 10.1016/S0042-6989(98)00139-4; Banks MS, 2002, VISION RES, V42, P801, DOI 10.1016/S0042-6989(01)00283-8; Berends EM, 2002, PERCEPTION, V31, P1323, DOI 10.1068/p3440; ERKELENS CJ, 1985, VISION RES, V25, P583, DOI 10.1016/0042-6989(85)90164-6; GILLAM B, 1983, PERCEPT PSYCHOPHYS, V34, P121, DOI 10.3758/BF03211336; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Hering E., 1942, SPATIAL SENSE MOVEME; Ishii M, 2009, VISION RES, V49, P1563, DOI 10.1016/j.visres.2009.03.012; LESTIENNE F, 1977, EXP BRAIN RES, V28, P363; Maekawa T, 2014, VISION, V26, P109; MAYHEW JEW, 1982, NATURE, V297, P376, DOI 10.1038/297376a0; NAKAMIZO S, 1994, PERCEPTION, V23, P1037, DOI 10.1068/p231037; Oie KS, 2002, COGNITIVE BRAIN RES, V14, P164, DOI 10.1016/S0926-6410(02)00071-X; ONO H, 1995, PERCEPTION, V24, P237, DOI 10.1068/p240237; ROGERS BJ, 1993, NATURE, V361, P253, DOI 10.1038/361253a0; Uwa N, 1998, PERCEPTION, V27, P49; Uwa N, 1999, J I IMAGE INFORM TEL, V53, P1300; Wade N., 2003, ESSAY SINGLE VISION, P71	18	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137483	10.1371/journal.pone.0137483	http://dx.doi.org/10.1371/journal.pone.0137483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26356478	Green Submitted, Green Published, gold			2022-12-26	WOS:000360965800050
J	Li, JS; Chen, X; Peng, L; Wei, SY; Zhao, SL; Diao, TT; He, YX; Liu, F; Wei, QJ; Zhang, QF; Li, B				Li, Jian-Si; Chen, Xiao; Peng, Lei; Wei, Shi-Yao; Zhao, Shi-Lei; Diao, Tian-Tian; He, Yi-Xin; Liu, Fang; Wei, Qiu-Ju; Zhang, Qing-Fang; Li, Bing			Angiopoietin-Like-4, a Potential Target of Tacrolimus, Predicts Earlier Podocyte Injury in Minimal Change Disease	PLOS ONE			English	Article							RESISTANT NEPHROTIC SYNDROME; ACTIN CYTOSKELETON; KIDNEY REPAIR; CYCLOSPORINE; NEPHROPATHY; INHIBITOR; CELLS; GENE; PROTEINURIA; EXPRESSION	Podocyte injury plays central roles in proteinuria and kidney dysfunction, therefore, identifying specific biomarker to evaluate earlier podocyte injury is highly desirable. Podocytesecreted angiopoietin-like-4 (Angptl4) mediates proteinuria in different types of podocytopathy. In the present study, we established an experimental minimal change disease (MCD) rat model, induced by adriamycin (ADR) and resulted in definite podocyte injury, to identify the dynamic changes in Angptl4 expression. We also investigated the direct effects of tacrolimus on Angptl4 and podocyte repair. We determined that the glomerular Angptl4 expression was rapidly upregulated and reached a peak earlier than desmin, an injured podocyte marker, in the ADR rats. Furthermore, this upregulation occurred prior to heavy proteinuria and was accompanied by increased urinary Angptl4. We observed that the Angptl4 upregulation occurred only when podocyte was mainly damaged since we didn't observe little Angptl4 upregulation in MsPGN patients. In addition, we observed the glomerular Angptl4 mainly located in injured podocytes rather than normal podocytes. Moreover, we found that tacrolimus treatment significantly promoted podocyte repair and reduced glomerular and urinary Angptl4 expression at an earlier stage with a significant serum Angptl4 upregulation. And similar results were confirmed in MCD patients. In conclusion, this study represents the first investigation to demonstrate that Angptl4 can predict podocyte injury at earlier stages in MCD and the identification of earlier podocyte injury biomarkers could facilitate the prompt diagnosis and treatment of patients with podocytopathy, as well as determination of the prognosis and treatment efficacy in these diseases.	[Li, Jian-Si; Chen, Xiao; Peng, Lei; Wei, Shi-Yao; Zhao, Shi-Lei; Diao, Tian-Tian; He, Yi-Xin; Liu, Fang; Wei, Qiu-Ju; Zhang, Qing-Fang; Li, Bing] Harbin Med Univ, Dept Nephrol, Affiliated Hosp 2, Harbin, Peoples R China; [Peng, Lei] Sichuan Acad Med Sci, Chengdu, Peoples R China; [Peng, Lei] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China	Harbin Medical University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Li, B (corresponding author), Harbin Med Univ, Dept Nephrol, Affiliated Hosp 2, Harbin, Peoples R China.	zqfhlj@aliyun.com; icecreamlee@hotmail.com		Zhao, Shilei/0000-0002-8168-8112	National Basic Research Program of China 973 Program [2012CB517602]; National Natural Science Foundation of China [81370812]; research fund for the Doctoral Program of Ministry of Education of China [20122307110018]; Special Grade of China Postdoctoral Science Foundation [201003463]; Heilongjiang Postdoctoral Science Research Foundation [LBHQ10028]	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); research fund for the Doctoral Program of Ministry of Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Special Grade of China Postdoctoral Science Foundation; Heilongjiang Postdoctoral Science Research Foundation	This study was supported by research grants from the National Basic Research Program of China 973 Program (No. 2012CB517602), the National Natural Science Foundation of China (81370812), research fund for the Doctoral Program of Ministry of Education of China (20122307110018), the Special Grade of China Postdoctoral Science Foundation (No. 201003463), and the Heilongjiang Postdoctoral Science Research Foundation (No. LBHQ10028).	Belanger AJ, 2002, J MOL CELL CARDIOL, V34, P765, DOI 10.1006/jmcc.2002.2021; BERTANI T, 1982, LAB INVEST, V46, P16; Brenner BM, 2008, BRENNER RECTORS KIDN; Canaud G, 2013, NAT MED, V19, P1288, DOI 10.1038/nm.3313; Clement LC, 2014, NAT MED, V20, P37, DOI 10.1038/nm.3396; Clement LC, 2011, NAT MED, V17, P117, DOI 10.1038/nm.2261; Fan L, 2013, INT UROL NEPHROL, V45, P459, DOI 10.1007/s11255-012-0205-1; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Ge HF, 2004, J LIPID RES, V45, P2071, DOI 10.1194/jlr.M400138-JLR200; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; Gulati A, 2012, KIDNEY INT, V82, P1130, DOI 10.1038/ki.2012.238; Habashy D, 2003, PEDIATR NEPHROL, V18, P906, DOI 10.1007/s00467-003-1207-0; Hoorn EJ, 2011, NAT MED, V17, P1304, DOI 10.1038/nm.2497; Hoshi S, 2002, LAB INVEST, V82, P25, DOI 10.1038/labinvest.3780392; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kitahara K, 2007, CURR OPIN RHEUMATOL, V19, P238, DOI 10.1097/BOR.0b013e328099af80; Li B, 2006, KIDNEY INT, V69, P323, DOI 10.1038/sj.ki.5000083; Li B, 2010, CIRCULATION, V121, P2211, DOI 10.1161/CIRCULATIONAHA.109.928796; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Li XY, 2009, AM J KIDNEY DIS, V54, P51, DOI 10.1053/j.ajkd.2009.02.018; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; Ma J, 2015, ENDOCRINE, V49, P373, DOI 10.1007/s12020-014-0486-5; Massella L, 2010, PEDIATR NEPHROL, V25, P1269, DOI 10.1007/s00467-010-1484-3; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; OKUDA S, 1986, KIDNEY INT, V29, P502, DOI 10.1038/ki.1986.28; Orth SR, 1998, NEW ENGL J MED, V338, P1202, DOI 10.1056/NEJM199804233381707; Ozbay LA, 2012, BRIT J CLIN PHARMACO, V73, P536, DOI 10.1111/j.1365-2125.2011.04118.x; Peng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106164; Penninga L, 2010, EUR J CLIN PHARMACOL, V66, P1177, DOI 10.1007/s00228-010-0902-6; Presser D, 2009, KIDNEY INT, V76, P557, DOI 10.1038/ki.2009.198; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Waldman M, 2007, CLIN J AM SOC NEPHRO, V2, P445, DOI 10.2215/CJN.03531006; YAOITA E, 1990, AM J PATHOL, V136, P899; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200; Zhang QX, 2012, AM J NEPHROL, V35, P312, DOI 10.1159/000337175	37	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137049	10.1371/journal.pone.0137049	http://dx.doi.org/10.1371/journal.pone.0137049			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352670	Green Published, gold, Green Submitted			2022-12-26	WOS:000360932800058
J	Li, Y; Zhang, W; Wang, RG; Wang, PL; Su, XO				Li, Yang; Zhang, Wei; Wang, Rui-Guo; Wang, Pei-Long; Su, Xiao-Ou			Development of a Efficient and Sensitive Dispersive Liquid-Liquid Microextraction Technique for Extraction and Preconcentration of 10 beta(2)-Agonists in Animal Urine	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; BETA-ADRENERGIC AGONISTS; PHASE MICROEXTRACTION; WATER SAMPLES; CAPILLARY-ELECTROPHORESIS; GAS-CHROMATOGRAPHY; PERFORMANCE; LIVER; CLENBUTEROL; BOVINE	Dispersive liquid-liquid microextraction (DLLME) coupled with ultra-performance liquid chromatography with tandem mass spectrometry (UPLC-MS/MS) was developed for the extraction and determination of 10 beta(2)-agonists in animal urine. Some experimental parameters, such as the type and volume of the extraction solvent, the concentration of the dispersant, the salt concentration, the pH value of the sample solution, the extraction time and the speed of centrifugation, were investigated and optimized. Under the optimized conditions, a good enrichment factors (4.8 to 32.3) were obtained for the extraction. The enrichment factor show that the concentration rate of DLLME is significantly higher than other pretreatment methods, and the detection sensitivity has been greatly improved. The calibration curves were linear, the correlation coefficient ranged from 0.9928 to 0.9999 for the concentration range of 0.05 to 50 ngmL(-1) and 0.1 to 50 ngmL(-1), and the relative standard deviations (RSDs, n = 15, intra and inter-day precision) at a concentration of 5 ngmL(-1) were in the range of 1.8 to 14.6%. The limits of detection (LODs) for the 10 beta(2)-agonists, based on a signal-to-noise ratio (S/N) of 3, were in the range of 0.01 to 0.03 ngmL(-1). The proposed method was used to identify beta(2)-agonists in three types of animal urine (swine, cattle, sheep), and the relative recoveries from each matrix were in the range of 89.2 to 106.8%, 90.0 to 109.8% and 89.2 to 107.2%, respectively.	[Li, Yang; Zhang, Wei; Wang, Rui-Guo; Wang, Pei-Long; Su, Xiao-Ou] Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Quality Standards & Testing Technology for Agro-Products, CAAS	Su, XO (corresponding author), Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Beijing 100193, Peoples R China.	suxiaoou@caas.cn	Wang, Peilong/R-4412-2016; Li, Xiaomin/ABI-2638-2020	Wang, Peilong/0000-0003-1585-2727; 	Special Fund for Agro-scientific Research in the Public Interest of China [201203088-01]	Special Fund for Agro-scientific Research in the Public Interest of China	The authors received financial support from the Special Fund for Agro-scientific Research in the Public Interest of China (No. 201203088-01).	Amendola L, 2002, J CHROMATOGR B, V773, P7, DOI 10.1016/S1570-0232(02)00141-1; Antignac JP, 2003, ANAL CHIM ACTA, V483, P325, DOI 10.1016/S0003-2670(02)01379-X; Assadi Y, 2010, CHROMATOGRAPHIA, V71, P1137, DOI 10.1365/s10337-010-1616-8; Bidari A, 2011, FOOD CHEM, V126, P1840, DOI 10.1016/j.foodchem.2010.11.142; Bocca B, 2003, J AOAC INT, V86, P8; Caban M, 2011, J CHROMATOGR A, V1218, P8110, DOI 10.1016/j.chroma.2011.08.093; Caldas SS, 2010, ANAL CHIM ACTA, V665, P55, DOI 10.1016/j.aca.2010.03.004; Campone L, 2011, J CHROMATOGR A, V1218, P7648, DOI 10.1016/j.chroma.2011.05.028; Chan TYK, 1999, J TOXICOL-CLIN TOXIC, V37, P517, DOI 10.1081/CLT-100102525; Chang LY, 2005, J FOOD DRUG ANAL, V13, P163; Chen H, 2010, J CHROMATOGR A, V1217, P1244, DOI 10.1016/j.chroma.2009.12.062; Chen HX, 2009, ANAL CHIM ACTA, V632, P80, DOI 10.1016/j.aca.2008.10.068; Crescenzi C, 2001, ANAL CHEM, V73, P2171, DOI 10.1021/ac0014360; Ebrahimzadeh H, 2008, J CHROMATOGR B, V863, P229, DOI 10.1016/j.jchromb.2008.01.005; Fu LY, 2009, ANAL CHIM ACTA, V632, P289, DOI 10.1016/j.aca.2008.11.020; Gonzalez-Penas E, 2004, J CHROMATOGR A, V1025, P163, DOI 10.1016/j.chroma.2003.10.113; Haasnoot W, 2002, ANALYST, V127, P87, DOI 10.1039/b108885h; He LJ, 2009, ANAL CHIM ACTA, V655, P52, DOI 10.1016/j.aca.2009.09.044; Herrera-Herrera AV, 2010, TRAC-TREND ANAL CHEM, V29, P728, DOI 10.1016/j.trac.2010.03.016; Kootstra PR, 2005, ANAL CHIM ACTA, V529, P75, DOI 10.1016/j.aca.2004.09.053; Lehner AF, 2004, CHROMATOGRAPHIA, V59, pS79, DOI 10.1365/s10337-004-0249-1; Li JQ, 2013, J CONTROL SCI ENG, V2013, DOI 10.1155/2013/657182; Liu Y, 2009, J CHROMATOGR A, V1216, P885, DOI 10.1016/j.chroma.2008.11.076; Lv LL, 2010, J CHROMATOGR A, V1217, P2365, DOI 10.1016/j.chroma.2010.01.081; Mazzanti G, 2003, TOXICOLOGY, V187, P91, DOI 10.1016/S0300-483X(03)00059-3; Mirzaei M, 2011, J HAZARD MATER, V186, P1739, DOI 10.1016/j.jhazmat.2010.12.080; Mitchell GA, 1998, J ANIM SCI, V76, P208; Moema D, 2012, ANAL CHIM ACTA, V730, P80, DOI 10.1016/j.aca.2011.11.036; Moragues F, 2009, ANAL CHIM ACTA, V637, P193, DOI 10.1016/j.aca.2008.10.065; Nicoli R, 2013, J CHROMATOGR A, V1292, P142, DOI 10.1016/j.chroma.2012.12.008; Nielen MWF, 2008, ANAL BIOANAL CHEM, V391, P199, DOI 10.1007/s00216-007-1760-7; Nuhu AA, 2011, J CHROMATOGR B, V879, P1180, DOI 10.1016/j.jchromb.2011.02.009; Ravelo-Perez LM, 2009, J CHROMATOGR A, V1216, P7336, DOI 10.1016/j.chroma.2009.08.012; Rezaee M, 2009, J CHROMATOGR A, V1216, P1511, DOI 10.1016/j.chroma.2008.12.091; Rezaee M, 2006, J CHROMATOGR A, V1116, P1, DOI 10.1016/j.chroma.2006.03.007; Shao B, 2009, FOOD CHEM, V114, P1115, DOI 10.1016/j.foodchem.2008.10.063; Shelver WL, 2002, J AGR FOOD CHEM, V50, P2742, DOI 10.1021/jf011372+; Sheu SY, 2009, ANAL CHIM ACTA, V654, P148, DOI 10.1016/j.aca.2009.09.026; Pena MT, 2009, J CHROMATOGR A, V1216, P6356, DOI 10.1016/j.chroma.2009.07.032; Traynor IM, 2003, ANAL CHIM ACTA, V483, P187, DOI 10.1016/S0003-2670(03)00256-3; Us MF, 2013, ELECTROPHORESIS, V34, P854, DOI 10.1002/elps.201200348; Waldeck B, 2002, EUR J PHARMACOL, V445, P1, DOI 10.1016/S0014-2999(02)01728-4; Wang L, 2010, CHROMATOGRAPHIA, V71, P737, DOI 10.1365/s10337-010-1495-z; Wang WY, 2010, MEAT SCI, V85, P302, DOI 10.1016/j.meatsci.2010.01.018; Wang Y, 2010, J CHROMATOGR A, V1217, P4241, DOI 10.1016/j.chroma.2010.03.031; Williams LD, 2004, J CHROMATOGR B, V813, P35, DOI 10.1016/j.jchromb.2004.09.005; Yamini Y, 2006, J CHROMATOGR A, V1124, P57, DOI 10.1016/j.chroma.2006.05.001; Zhang JH, 2011, J CHROMATOGR A, V1218, P6621, DOI 10.1016/j.chroma.2011.07.102; Zhang ZH, 2008, ANAL CHIM ACTA, V621, P185, DOI 10.1016/j.aca.2008.05.016	49	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137194	10.1371/journal.pone.0137194	http://dx.doi.org/10.1371/journal.pone.0137194			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348922	Green Published, gold, Green Submitted			2022-12-26	WOS:000360897600024
J	Aribi, M; Meziane, W; Habi, S; Boulatika, Y; Marchandin, H; Aymeric, JL				Aribi, Mourad; Meziane, Warda; Habi, Salim; Boulatika, Yasser; Marchandin, Helene; Aymeric, Jean-Luc			Macrophage Bactericidal Activities against Staphylococcus aureus Are Enhanced In Vivo by Selenium Supplementation in a Dose-Dependent Manner	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; CHEMOTAXIS INHIBITORY PROTEIN; MOUSE PERITONEAL-MACROPHAGES; REACTIVE OXYGEN; DOWN-REGULATION; CUTTING EDGE; L-ARGININE; ACTIVATION; EXPRESSION	Background Dietary selenium is of fundamental importance to maintain optimal immune function and enhance immunity during infection. To this end, we examined the effect of selenium on macrophage bactericidal activities against Staphylococcus aureus. Methods Assays were performed in golden Syrian hamsters and peritoneal macrophages cultured with S. aureus and different concentrations of selenium. Results Infected and selenium-supplemented animals have significantly decreased levels of serum nitric oxide (NO) production when compared with infected but non-selenium-supplemented animals at day 7 post-infection (p < 0.05). A low dose of 5 ng/mL selenium induced a significant decrease in macrophage NO production, but significant increase in hydrogen peroxide (H2O2) levels (respectively, p = 0.009, p < 0.001). The NO production and H2O2 levels were significantly increased with increasing concentrations of selenium; the optimal macrophage activity levels were reached at 20 ng/mL. The concentration of 5 ng/mL of selenium induced a significant decrease in the bacterial arginase activity but a significant increase in the macrophage arginase activity. The dose of 20 ng/mL selenium induced a significant decrease of bacterial growth (p < 0.0001) and a significant increase in macrophage phagocytic activity, NO production/arginase balance and S. aureus killing (for all comparisons, p < 0.001). Conclusions Selenium acts in a dose-dependent manner on macrophage activation, phagocytosis and bacterial killing suggesting that inadequate doses may cause a loss of macrophage bactericidal activities and that selenium supplementation could enhance the in vivo control of immune response to S. aureus.	[Aribi, Mourad; Meziane, Warda; Habi, Salim; Boulatika, Yasser] Univ Tlemcen, Dept Biol, Lab Appl Mol Biol & Immunol, Tilimsen 13000, Algeria; [Marchandin, Helene] Univ Montpellier I, Equipe Pathogenes Hydr Sante Environm, UMR HydroSci Montpellier 5569, F-34093 Montpellier 5, France; [Marchandin, Helene] Ctr Hosp Reg Univ, Lab Bacteriol, F-34295 Montpellier 5, France; [Aymeric, Jean-Luc] Univ Montpellier, INRA, UM2, UMR1333,Lab Divers Genomes & Interact Microorgani, F-34095 Montpellier 05, France	Universite Abou Bekr Belkaid; Universite de Montpellier; INRAE; Universite de Montpellier	Aribi, M (corresponding author), Univ Tlemcen, Dept Biol, Lab Appl Mol Biol & Immunol, Tilimsen 13000, Algeria.	m_aribi@mail.univ-tlemcen.dz	Aribi, Mourad/M-9790-2018; Aribi, Mourad/Q-1290-2016; MARCHANDIN, Hélène/AAM-8288-2021; MEZIANE, Warda/P-7543-2016	Aribi, Mourad/0000-0002-6522-7252; Aribi, Mourad/0000-0002-6522-7252; MARCHANDIN, Hélène/0000-0003-2130-6335; MEZIANE, Warda/0000-0003-0985-8786				Akil M, 2011, BRATISL MED J, V112, P314; Amdahl H, 2013, J IMMUNOL, V191, P1775, DOI 10.4049/jimmunol.1300638; Aslam R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068993; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Chen KJ, 2014, FOOD CHEM TOXICOL, V74, P91, DOI 10.1016/j.fct.2014.09.003; Chudobova D, 2014, FEMS MICROBIOL LETT, V351, P195, DOI 10.1111/1574-6968.12353; Colleluori DM, 2001, BIOCHEMISTRY-US, V40, P9356, DOI 10.1021/bi010783g; CORRALIZA IM, 1995, BIOCHEM BIOPH RES CO, V206, P667, DOI 10.1006/bbrc.1995.1094; Dace DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003381; Dai JH, 2001, IMMUNOLOGY, V103, P235, DOI 10.1046/j.1365-2567.2001.01224.x; de Andrade D, 2000, Rev Panam Salud Publica, V7, P179; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; DING AH, 1988, J IMMUNOL, V141, P2407; DUCROS V, 2004, EMC ENDOCRINOLOGIE, V1, P19, DOI DOI 10.1016/j.emcend.2003.10.001; Erickson KL, 2000, J INFECT DIS, V182, pS5, DOI 10.1086/315922; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Fox S, 2010, ACTA BIOMATER, V6, P1515, DOI 10.1016/j.actbio.2009.10.038; Fraunholz M, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00043; Fritzsche C, 2010, IMMUNOBIOLOGY, V215, P826, DOI 10.1016/j.imbio.2010.05.022; Geissmann Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054072; Giadinis N, 2000, COMP IMMUNOL MICROB, V23, P129, DOI 10.1016/S0147-9571(99)00066-1; Gladyshev VN, 2001, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, P99; Guevara I, 1998, CLIN CHIM ACTA, V274, P177, DOI 10.1016/S0009-8981(98)00060-6; HASSALL DG, 1995, CYTOMETRY, V21, P352, DOI 10.1002/cyto.990210407; Horta Maria Fatima, 2012, J Parasitol Res, V2012, P203818, DOI 10.1155/2012/203818; Trevino-Villarreal JH, 2012, INFECT IMMUN, V80, P3587, DOI 10.1128/IAI.00446-12; Johnston MJG, 2010, INFECT IMMUN, V78, P1364, DOI 10.1128/IAI.01349-08; Karimian Parastoo, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P219, DOI 10.1016/S2221-1691(14)60235-5; Kiremidjian-Schumacher L, 1998, Z ERNAHRUNGSWISS, V37, P50; Klasen S, 2001, BRIT J PHARMACOL, V132, P1349, DOI 10.1038/sj.bjp.0703951; Kraus D, 2008, FUTURE MICROBIOL, V3, P437, DOI 10.2217/17460913.3.4.437; Krstic B, 2012, BIOL TRACE ELEM RES, V146, P68, DOI 10.1007/s12011-011-9229-0; Krut O, 2003, INFECT IMMUN, V71, P2716, DOI 10.1128/IAI.71.5.2716-2723.2003; Kubica M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001409; Lahiri A, 2010, VIRULENCE, V1, P563, DOI 10.4161/viru.1.6.13623; Li ZR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035834, 10.1371/journal.pone.0051597]; Maehira F, 2003, CLIN CHIM ACTA, V334, P163, DOI 10.1016/S0009-8981(03)00223-7; Mathews SM, 2006, CORNEA, V25, P806, DOI 10.1097/01.ico.0000224636.57062.90; Mehrzad J, 2009, VET MICROBIOL, V134, P106, DOI 10.1016/j.vetmic.2008.09.001; Meraz IM, 2014, MOL PHARMACEUT, V11, P3484, DOI 10.1021/mp5002697; More P, 2012, IMMUNOPHARM IMMUNOT, V34, P368, DOI 10.3109/08923973.2011.606324; Myers JT, 2003, J IMMUNOL, V171, P5447, DOI 10.4049/jimmunol.171.10.5447; Nair SP, 2000, RHEUMATOLOGY, V39, P821, DOI 10.1093/rheumatology/39.8.821; Nelson SM, 2011, J NUTR, V141, P1754, DOI 10.3945/jn.111.141176; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; POULSEN HD, 1989, ACTA VET SCAND, V30, P371; Prabhu KS, 2002, BIOCHEM J, V366, P203, DOI 10.1042/BJ20020256; PREDARI SC, 1991, ANTIMICROB AGENTS CH, V35, P2568, DOI 10.1128/AAC.35.12.2568; Puertollano MA, 2011, CURR TOP MED CHEM, V11, P1752; Rasigade JP, 2011, FEMS IMMUNOL MED MIC, V62, P368, DOI 10.1111/j.1574-695X.2011.00808.x; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Richardson AR, 2008, SCIENCE, V319, P1672, DOI 10.1126/science.1155207; Rotllant J, 2004, DEV COMP IMMUNOL, V28, P815, DOI 10.1016/j.dci.2003.11.001; Rutschman R, 2001, J IMMUNOL, V166, P2173, DOI 10.4049/jimmunol.166.4.2173; Safir N, 2003, CLIN CHEM LAB MED, V41, P1005, DOI 10.1515/CCLM.2003.154; Sanchez-Miranda E, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/762020; Shi C, 2008, BLOOD, V112, P4699, DOI 10.1182/blood-2008-01-137018; Shih YT, 2007, J ETHNOPHARMACOL, V112, P537, DOI 10.1016/j.jep.2007.04.015; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P93, DOI 10.1189/jlb.0809549; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; STUEHR DJ, 1991, J BIOL CHEM, V266, P6259; SZABO C, 1994, BRIT J PHARMACOL, V112, P355, DOI 10.1111/j.1476-5381.1994.tb13078.x; Teixeira FM, 2008, CLIN EXP IMMUNOL, V154, P255, DOI 10.1111/j.1365-2249.2008.03728.x; Thurlow LR, 2011, J IMMUNOL, V186, P6585, DOI 10.4049/jimmunol.1002794; Thwaites GE, 2011, NAT REV MICROBIOL, V9, P215, DOI 10.1038/nrmicro2508; Tran PL, 2012, ANTIMICROB AGENTS CH, V56, P972, DOI 10.1128/AAC.05680-11; Tran Phong A, 2011, Int J Nanomedicine, V6, P1553, DOI 10.2147/IJN.S21729; Urao N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013440; URBAN T, 1986, IMMUNOPHARMACOLOGY, V12, P167, DOI 10.1016/0162-3109(86)90042-1; Valenta J, 2011, INTENS CARE MED, V37, P808, DOI 10.1007/s00134-011-2153-0; Vanhommerig E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104561; Vatansever F, 2013, FEMS MICROBIOL REV, V37, P955, DOI 10.1111/1574-6976.12026; Vunta H, 2008, MOL NUTR FOOD RES, V52, P1316, DOI 10.1002/mnfr.200700346; Vunta H, 2007, J BIOL CHEM, V282, P17964, DOI 10.1074/jbc.M703075200; Weidenmaier C, 2012, TRENDS MICROBIOL, V20, P243, DOI 10.1016/j.tim.2012.03.004; Woods JA, 2000, IMMUNOL CELL BIOL, V78, P545, DOI 10.1046/j.1440-1711.2000.00960.x; Wrann CD, 2007, CELL IMMUNOL, V245, P63, DOI 10.1016/j.cellimm.2007.04.001; Wright AJ, 2007, MOL IMMUNOL, V44, P2507, DOI 10.1016/j.molimm.2006.12.022; Xia Y, 1997, P NATL ACAD SCI USA, V94, P6954, DOI 10.1073/pnas.94.13.6954; Youn HS, 2008, INT IMMUNOPHARMACOL, V8, P495, DOI 10.1016/j.intimp.2007.12.008; Yun CH, 2007, INT IMMUNOPHARMACOL, V7, P1192, DOI 10.1016/j.intimp.2007.05.002; Zeng HW, 2013, NUTRIENTS, V5, P97, DOI 10.3390/nu5010097; Zhang XL, 2013, INT J BIOCHEM CELL B, V45, P995, DOI 10.1016/j.biocel.2013.02.008	84	35	41	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0135515	10.1371/journal.pone.0135515	http://dx.doi.org/10.1371/journal.pone.0135515			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340099	Green Submitted, Green Published, gold			2022-12-26	WOS:000360688200004
J	Kitchen, MO; Bryan, RT; Haworth, KE; Emes, RD; Luscombe, C; Gommersall, L; Cheng, KK; Zeegers, MP; James, ND; Devall, AJ; Fryer, AA; Farrell, WE				Kitchen, Mark O.; Bryan, Richard T.; Haworth, Kim E.; Emes, Richard D.; Luscombe, Christopher; Gommersall, Lyndon; Cheng, K. K.; Zeegers, Maurice P.; James, Nicholas D.; Devall, Adam J.; Fryer, Anthony A.; Farrell, William E.			Methylation of HOXA9 and ISL1 Predicts Patient Outcome in High-Grade Non-Invasive Bladder Cancer	PLOS ONE			English	Article							DNA METHYLATION; URINE SEDIMENTS; MARKERS; PATTERNS; IDENTIFICATION; EPIGENETICS; BIOMARKERS; CARCINOMA; GENES; STAGE	Introduction Inappropriate DNA methylation is frequently associated with human tumour development, and in specific cases, is associated with clinical outcomes. Previous reports of DNA methylation in low/intermediate grade non-muscle invasive bladder cancer (NMIBC) have suggested that specific patterns of DNA methylation may have a role as diagnostic or prognostic biomarkers. In view of the aggressive and clinically unpredictable nature of high-grade (HG) NMIBC, and the current shortage of the preferred treatment option (Bacillus: Calmette-Guerin), novel methylation analyses may similarly reveal biomarkers of disease outcome that could risk-stratify patients and guide clinical management at initial diagnosis. Methods Promoter-associated CpG island methylation was determined in primary tumour tissue of 36 initial presentation high-grade NMIBCs, 12 low/intermediate-grade NMIBCs and 3 normal bladder controls. The genes HOXA9, ISL1, NKX6-2, SPAG6, ZIC1 and ZNF154 were selected for investigation on the basis of previous reports and/or prognostic utility in low/intermediate-grade NMIBC. Methylation was determined by Pyrosequencing of sodium-bisulphite converted DNA, and then correlated with gene expression using RT-qPCR. Methylation was additionally correlated with tumour behaviour, including tumour recurrence and progression to muscle invasive bladder cancer or metastases. Results The ISL1 genes' promoter-associated island was more frequently methylated in recurrent and progressive high-grade tumours than their non-recurrent counterparts (60.0% vs. 18.2%, p = 0.008). ISL1 and HOXA9 showed significantly higher mean methylation in recurrent and progressive tumours compared to non-recurrent tumours (43.3% vs. 20.9%, p = 0.016 and 34.5% vs 17.6%, p = 0.017, respectively). Concurrent ISL1/HOXA9 methylation in HG-NMIBC reliably predicted tumour recurrence and progression within one year (Positive Predictive Value 91.7%), and was associated with disease-specific mortality (DSM). Conclusions In this study we report methylation differences and similarities between clinical sub-types of high-grade NMIBC. We report the potential ability of methylation biomarkers, at initial diagnosis, to predict tumour recurrence and progression within one year of diagnosis. We found that specific biomarkers reliably predict disease outcome and therefore may help guide patient treatment despite the unpredictable clinical course and heterogeneity of high-grade NMIBC. Further investigation is required, including validation in a larger patient cohort, to confirm the clinical utility of methylation biomarkers in high-grade NMIBC.	[Kitchen, Mark O.; Haworth, Kim E.; Fryer, Anthony A.; Farrell, William E.] Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England; [Kitchen, Mark O.; Luscombe, Christopher; Gommersall, Lyndon] Univ Hosp North Midlands NHS Trust, Dept Urol, Stoke On Trent, Staffs, England; [Bryan, Richard T.; Cheng, K. K.; Devall, Adam J.] Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England; [Emes, Richard D.] Univ Nottingham, Adv Data Anal Ctr, Nottingham NG7 2RD, England; [Zeegers, Maurice P.] Maastricht Univ, Med Ctr, Dept Complex Genet, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [James, Nicholas D.] Univ Warwick, Canc Res Unit, Coventry CV4 7AL, W Midlands, England	Keele University; University of Birmingham; University of Nottingham; Maastricht University; Maastricht University Medical Centre (MUMC); University of Warwick	Kitchen, MO (corresponding author), Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England.	m.o.kitchen@keele.ac.uk	Cheng, Kar/AAL-8899-2021; Bryan, Richard T/AAJ-9325-2021; Devall, Adam/AAC-9646-2022; Emes, Richard D/C-5341-2008; Kitchen, Mark O/J-4662-2012	Cheng, Kar/0000-0002-1516-1857; Bryan, Richard T/0000-0003-2853-4293; Emes, Richard D/0000-0001-6855-5481; Haworth, Kim/0000-0002-9460-4424; Fryer, Anthony/0000-0001-8678-0404; Kitchen, Mark/0000-0002-1124-2940; Zeegers, Maurice/0000-0002-2387-083X	North Staffordshire Medical Institute; University Hospital of North Midlands NHS Trust Cancer Charitable Foundation; Cancer Research UK; University of Birmingham; Birmingham & The Black Country and West Midlands North Comprehensive Local Research Network; Birmingham Experimental Cancer Medicine Centre; Birmingham & The Black Country and West Midlands South Comprehensive Local Research Network	North Staffordshire Medical Institute; University Hospital of North Midlands NHS Trust Cancer Charitable Foundation; Cancer Research UK(Cancer Research UK); University of Birmingham; Birmingham & The Black Country and West Midlands North Comprehensive Local Research Network; Birmingham Experimental Cancer Medicine Centre; Birmingham & The Black Country and West Midlands South Comprehensive Local Research Network	This work was supported by the North Staffordshire Medical Institute, Research Awards Committee, "Pump-Prime" Grant, and The University Hospital of North Midlands NHS Trust Cancer Charitable Foundation. BCPP is funded by Cancer Research UK, the University of Birmingham and the Birmingham & The Black Country and West Midlands North and South Comprehensive Local Research Networks, and sponsored by the University of Birmingham. The BCPP biospecimen collection is supported by funding from the Birmingham Experimental Cancer Medicine Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Azzawi H, 2011, ENDOCRINOLOGY, V152, P364, DOI 10.1210/en.2010-0886; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; Boustead GB, 2014, BJU INT, V113, P924, DOI 10.1111/bju.12468; Catto JWF, 2005, J CLIN ONCOL, V23, P2903, DOI 10.1200/JCO.2005.03.163; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chung W, 2011, CANCER EPIDEM BIOMAR, V20, P1483, DOI 10.1158/1055-9965.EPI-11-0067; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; De Berardinis E, 2011, INT UROL NEPHROL, V43, P1047, DOI 10.1007/s11255-011-9941-x; Dudley KJ, 2008, MOL CANCER RES, V6, P1567, DOI 10.1158/1541-7786.MCR-08-0234; Duong Cuong V, 2012, Endocr Relat Cancer, V19, P805, DOI 10.1530/ERC-12-0251; Fryer AA, 2011, EPIGENETICS-US, V6, P86, DOI 10.4161/epi.6.1.13392; Gontero P, 2014, EUR UROL; Gyparaki MT, 2013, J MOL MED, V91, P1249, DOI 10.1007/s00109-013-1088-z; Kalari S, 2010, ADV GENET, V70, P277, DOI [10.1016/B978-0-12-380866-0.60010-1, 10.1016/S0065-2660(10)70010-9]; Kim YJ, 2013, INT J CANCER, V133, P1135, DOI 10.1002/ijc.28121; Li YS, 2014, HUM MOL GENET, V23, P5378, DOI 10.1093/hmg/ddu256; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Netto GJ, 2012, NAT REV UROL, V9, P41, DOI 10.1038/nrurol.2011.193; Raj GV, 2007, J UROLOGY, V177, P1283, DOI 10.1016/j.juro.2006.11.090; Reinert T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046297; Reinert T, 2011, CLIN CANCER RES, V17, P5582, DOI 10.1158/1078-0432.CCR-10-2659; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Tada Y, 2011, INT J ONCOL, V39, P727, DOI 10.3892/ijo.2011.1049; Tilki D, 2011, EUR UROL, V60, P484, DOI 10.1016/j.eururo.2011.05.053; Vedder MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096849; Wolff EM, 2010, CANCER RES, V70, P8169, DOI 10.1158/0008-5472.CAN-10-1335; Yu J, 2007, CLIN CANCER RES, V13, P7296, DOI 10.1158/1078-0432.CCR-07-0861; Zeegers MP, 2010, BJU INT, V105, P784, DOI 10.1111/j.1464-410X.2009.08849.x	30	33	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137003	10.1371/journal.pone.0137003	http://dx.doi.org/10.1371/journal.pone.0137003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332997	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000360613800087
J	Lei, F; Yan, X; Zhao, FS; Zhang, SF; Zhang, QL; Zhou, H; Zheng, Y				Lei, Fang; Yan, Xiang; Zhao, Fusheng; Zhang, Senfeng; Zhang, Qilan; Zhou, Hua; Zheng, Yu			Impairment of Central Chemoreception in Neonatal Rats Induced by Maternal Cigarette Smoke Exposure during Pregnancy	PLOS ONE			English	Article							INFANT-DEATH-SYNDROME; PRENATAL NICOTINE EXPOSURE; SELF-REPORTED SMOKING; BRAIN-STEM; VENTILATORY RESPONSES; CARDIORESPIRATORY RESPONSE; BREATHING AUTOMATICITY; RETROTRAPEZOID NUCLEUS; PREBOTZINGER COMPLEX; RESPIRATORY CONTROL	It has been postulated that prenatal cigarette smoke exposure (CSE) increases the risk for sudden infant death syndrome. The victims of infant death syndrome suffer from respiratory abnormalities, such as central apnea, diminished chemoreflex and alteration in respiratory pattern during sleep. However, no experimental evidence on CSE model exists to confirm whether prenatal CSE gives rise to reduction of neonatal central chemoreception in in vitro preparations in absence of peripheral sensory feedback. The aim of the present study was to test the hypothesis that maternal CSE during pregnancy depresses central chemoreception of the neonatal rats. The pregnant rats were divided into two groups, control (n = 8) and CSE (n = 8). Experiments were performed on neonatal (0-3days) rat pups. Fictive respiratory activity was monitored by recording the rhythmic discharge from the hypoglossal rootlets of the medullary slices obtained from the neonatal rats. The burst frequency (BF) and integrated amplitude (IA) of the discharge were analyzed. Their responses to acidified artificial cerebrospinal fluid (aCSF) were tested to indicate the change of the central chemosensitivity. Under condition of perfusing with standard aCSF (pH 7.4), no significant difference was detected between the two groups in either BF or IA (P>0.05). Under condition of perfusing with acidified aCSF (pH 7.0), BF was increased and IA was decreased in both groups (P<0.01). However, their change rates in the CSE group were obviously smaller than that in the control group, 66.98 +/- 10.11% vs. 143.75 +/- 15.41% for BF and -22.38 +/- 2.51% vs. -44.90 +/- 3.92% for IA (P<0.01). In conclusion, these observations, in a prenatal CSE model, provide important evidence that maternal smoking during pregnancy exerts adverse effects on central chemoreception of neonates.	[Lei, Fang; Yan, Xiang; Zhao, Fusheng; Zhang, Senfeng; Zhang, Qilan; Zhou, Hua; Zheng, Yu] Sichuan Univ, Dept Physiol, West China Sch Preclin & Forens Med, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Zheng, Y (corresponding author), Sichuan Univ, Dept Physiol, West China Sch Preclin & Forens Med, Chengdu 610064, Sichuan, Peoples R China.	yzheng@scu.edu.com			National Natural Science Foundation of China [31271233, 31471096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work received funding from the National Natural Science Foundation of China (No.: 31271233, 31471096 URL: http://www.nsfc.gov.cn/). The author who received the funding: YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamford OS, 1996, RESP PHYSIOL, V106, P1, DOI 10.1016/0034-5687(96)00051-5; Campbell AJ, 2001, ACTA PAEDIATR, V90, P793, DOI 10.1080/080352501750315726; Coddou C, 2009, PHILOS T R SOC B, V364, P2527, DOI 10.1098/rstb.2009.0078; Dubreuil V, 2008, P NATL ACAD SCI USA, V105, P1067, DOI 10.1073/pnas.0709115105; Fleming P, 2007, EARLY HUM DEV, V83, P721, DOI 10.1016/j.earlhumdev.2007.07.011; Goridis C, 2010, RESP PHYSIOL NEUROBI, V173, P312, DOI 10.1016/j.resp.2010.03.014; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Guyenet PG, 2008, J APPL PHYSIOL, V105, P404, DOI 10.1152/japplphysiol.90452.2008; Guyenet PG, 2009, RESP PHYSIOL NEUROBI, V168, P59, DOI 10.1016/j.resp.2009.02.001; Hafstrom O, 2002, AM J RESP CRIT CARE, V166, P1544, DOI 10.1164/rccm.200204-289OC; Kato I, 2001, AM J RESP CRIT CARE, V164, P1464, DOI 10.1164/ajrccm.164.8.2009001; Kinney HC, 2009, ANNU REV PATHOL-MECH, V4, P517, DOI 10.1146/annurev.pathol.4.110807.092322; Klebanoff MA, 1998, AM J EPIDEMIOL, V148, P259; Lavezzi AM, 2005, NEUROBIOL DIS, V20, P601, DOI 10.1016/j.nbd.2005.04.015; LEWIS KW, 1995, J PEDIATR-US, V127, P691, DOI 10.1016/S0022-3476(95)70155-9; LONGO LD, 1976, SCIENCE, V194, P523, DOI 10.1126/science.973133; MCLEAN HA, 1994, RESP PHYSIOL, V96, P49, DOI 10.1016/0034-5687(94)90105-8; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; Neff RA, 2004, J NEUROSCI, V24, P9261, DOI 10.1523/JNEUROSCI.1918-04.2004; Nie LH, 2013, RESP PHYSIOL NEUROBI, V188, P29, DOI 10.1016/j.resp.2013.05.001; Paine SML, 2014, NEUROPATH APPL NEURO, V40, P364, DOI 10.1111/nan.12095; Pan JG, 2010, RESP PHYSIOL NEUROBI, V171, P181, DOI 10.1016/j.resp.2010.04.006; Pendlebury JD, 2008, AM J RESP CRIT CARE, V177, P1255, DOI 10.1164/rccm.200711-1739OC; Poole KA, 2000, AM J RESP CRIT CARE, V162, P801, DOI 10.1164/ajrccm.162.3.9909071; Rekling JC, 1998, ANNU REV PHYSIOL, V60, P385, DOI 10.1146/annurev.physiol.60.1.385; Schuen JN, 1997, RESP PHYSIOL, V109, P231, DOI 10.1016/S0034-5687(97)00052-2; Shah T, 2006, AM J PUBLIC HEALTH, V96, P1757, DOI 10.2105/AJPH.2005.073213; Slotkin TA, 2005, NEUROPSYCHOPHARMACOL, V30, P129, DOI 10.1038/sj.npp.1300544; Slotkin TA, 2011, NEUROTOXICOL TERATOL, V33, P431, DOI 10.1016/j.ntt.2011.02.001; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Vasankari T, 2011, SCAND J PUBLIC HEALT, V39, P547, DOI 10.1177/1403494811401474; Zhang K, 2013, LEGAL MED-TOKYO, V15, P115, DOI 10.1016/j.legalmed.2012.10.007	32	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137362	10.1371/journal.pone.0137362	http://dx.doi.org/10.1371/journal.pone.0137362			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26333001	Green Published, gold, Green Submitted			2022-12-26	WOS:000360613800127
J	Singhal, A; Arora, G; Virmani, R; Kundu, P; Khanna, T; Sajid, A; Misra, R; Joshi, J; Yadav, V; Samanta, S; Saini, N; Pandey, AK; Visweswariah, SS; Hentschker, C; Becher, D; Gerth, U; Singh, Y				Singhal, Anshika; Arora, Gunjan; Virmani, Richa; Kundu, Parijat; Khanna, Tanya; Sajid, Andaleeb; Misra, Richa; Joshi, Jayadev; Yadav, Vikas; Samanta, Sintu; Saini, Neeru; Pandey, Amit K.; Visweswariah, Sandhya S.; Hentschker, Christian; Becher, Doerte; Gerth, Ulf; Singh, Yogendra			Systematic Analysis of Mycobacterial Acylation Reveals First Example of Acylation-mediated Regulation of Enzyme Activity of a Bacterial Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; L-HOMOCYSTEINE HYDROLASE; ACETYL-COA SYNTHETASE; X-RAY-STRUCTURE; LYSINE ACETYLATION; PROPIONATE METABOLISM; POSTTRANSLATIONAL MODIFICATIONS; FUNCTIONAL-CHARACTERIZATION; REVERSIBLE ACETYLATION; METHYLCITRATE CYCLE	Protein lysine acetylation is known to regulate multiple aspects of bacterial metabolism. However, its presence in mycobacterial signal transduction and virulence-associated proteins has not been studied. In this study, analysis of mycobacterial proteins from different cellular fractions indicated dynamic and widespread occurrence of lysine acetylation. Mycobacterium tuberculosis proteins regulating diverse physiological processes were then selected and expressed in the surrogate host Mycobacterium smegmatis. The purified proteins were analyzed for the presence of lysine acetylation, leading to the identification of 24 acetylated proteins. In addition, novel lysine succinylation and propionylation events were found to co-occur with acetylation on several proteins. Protein-tyrosine phosphatase B (PtpB), a secretory phosphatase that regulates phosphorylation of host proteins and plays a critical role in Mycobacterium infection, is modified by acetylation and succinylation at Lys-224. This residue is situated in a lid region that covers the enzyme's active site. Consequently, acetylation and succinylation negatively regulate the activity of PtpB.	[Singhal, Anshika; Arora, Gunjan; Virmani, Richa; Kundu, Parijat; Khanna, Tanya; Sajid, Andaleeb; Misra, Richa; Joshi, Jayadev; Yadav, Vikas; Saini, Neeru; Singh, Yogendra] CSIR, Inst Genom & Integrat Biol, Delhi 110007, India; [Arora, Gunjan; Pandey, Amit K.] Translat Hlth Sci & Technol Inst, Faridabad 121001, India; [Samanta, Sintu; Visweswariah, Sandhya S.] Indian Inst Sci, Bangalore 560012, Karnataka, India; [Hentschker, Christian; Becher, Doerte; Gerth, Ulf] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, D-17487 Greifswald, Germany	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); Indian Institute of Science (IISC) - Bangalore; Ernst Moritz Arndt Universitat Greifswald	Pandey, AK (corresponding author), Translat Hlth Sci & Technol Inst, Faridabad 121001, India.	amitpandey@thsti.res.in	Arora, Gunjan/AAL-3448-2020; Visweswariah, Sandhya/Q-7500-2019; yadav, vikas/AAZ-7364-2021; Misra, Richa/AAE-6257-2019; Sajid, Andaleeb/AAI-2960-2020; Joshi, Jayadev/AHD-1520-2022; Misra, Richa/B-3860-2018; Becher, Dorte/B-4454-2015	Arora, Gunjan/0000-0003-0575-6205; Visweswariah, Sandhya/0000-0003-2786-7344; yadav, vikas/0000-0003-4353-3731; Sajid, Andaleeb/0000-0001-6248-4985; Misra, Richa/0000-0003-3630-827X; Singhal, Anshika/0000-0001-7932-5809; Kundu, Parijat/0000-0003-1944-4579; Becher, Dorte/0000-0002-9630-5735	Department of Biotechnology, Government of India [BT/PR6556/GBD/27/459/2012, BT/RLF/Re-entry/45/2011]; Department of Biotechnology, Government of India; Council of Scientific and Industrial Research [BSC-0123]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by Department of Biotechnology, Government of India, Grants BT/PR6556/GBD/27/459/2012 and BT/RLF/Re-entry/45/2011 (to A. K. P.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Department of Biotechnology, Government of India.; Recipient of support from Council of Scientific and Industrial Research-funded Project BSC-0123.	Arora G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003315; Arora G, 2013, BIOMETALS, V26, P715, DOI 10.1007/s10534-013-9646-y; Arora G, 2012, J BIOL CHEM, V287, P26749, DOI 10.1074/jbc.M112.351304; Arora G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010772; Bach H, 2009, BIOCHEM J, V420, P155, DOI 10.1042/BJ20090478; Bernal V, 2014, NEW BIOTECHNOL, V31, P586, DOI 10.1016/j.nbt.2014.03.002; Beste DJV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002091; Bhaduri A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088090; Bonn F, 2014, ANAL CHEM, V86, P7421, DOI 10.1021/ac501189j; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Canova MJ, 2014, J BIOL CHEM, V289, P9473, DOI 10.1074/jbc.R113.529917; Chao J, 2010, BBA-PROTEINS PROTEOM, V1804, P620, DOI 10.1016/j.bbapap.2009.09.008; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Connor SE, 2011, ACTA CRYSTALLOGR D, V67, P1017, DOI 10.1107/S0907444911042971; COOPER JB, 1995, J MOL BIOL, V246, P531, DOI 10.1006/jmbi.1994.0105; Corrales RM, 2013, BIOCHEM BIOPH RES CO, V430, P858, DOI 10.1016/j.bbrc.2012.11.038; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Crosby HA, 2012, J BIOL CHEM, V287, P15590, DOI 10.1074/jbc.M112.352104; Ecco G, 2010, CHEM COMMUN, V46, P7501, DOI 10.1039/c0cc01704c; Ferraris DM, 2015, PROTEINS, V83, P389, DOI 10.1002/prot.24743; Festa RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008589; Gould TA, 2006, MOL MICROBIOL, V61, P940, DOI 10.1111/j.1365-2958.2006.05297.x; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Grundner C, 2005, STRUCTURE, V13, P1625, DOI 10.1016/j.str.2005.07.017; Gu J, 2009, BIOCHEMISTRY-MOSCOW+, V74, P743, DOI 10.1134/S0006297909070062; Gupta M, 2014, J BACTERIOL, V196, P2646, DOI 10.1128/JB.01625-14; Hayden JD, 2013, MICROBIOL-SGM, V159, P1986, DOI 10.1099/mic.0.068585-0; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Henriksen P, 2012, MOL CELL PROTEOMICS, V11, P1510, DOI 10.1074/mcp.M112.017251; Henriksson LM, 2004, EUR J BIOCHEM, V271, P4107, DOI 10.1111/j.1432-1033.2004.04348.x; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hu LI, 2010, MOL MICROBIOL, V77, P15, DOI 10.1111/j.1365-2958.2010.07204.x; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Jayachandran R, 2012, EXPERT REV ANTI-INFE, V10, P1007, DOI [10.1586/ERI.12.95, 10.1586/eri.12.95]; Jeffers V, 2012, EUKARYOT CELL, V11, P735, DOI 10.1128/EC.00088-12; Kim D, 2013, PROTEOMICS, V13, P1726, DOI 10.1002/pmic.201200001; Koul A, 2001, MICROBIOL-SGM, V147, P2307, DOI 10.1099/00221287-147-8-2307; Koul A, 2000, J BACTERIOL, V182, P5425, DOI 10.1128/JB.182.19.5425-5432.2000; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee DW, 2013, PROTEOMICS, V13, P2278, DOI 10.1002/pmic.201200072; Lee S, 2013, TOX RESEARCH, V29, P81, DOI 10.5487/TR.2013.29.2.081; Lee W, 2013, J BIOL CHEM, V288, P6788, DOI 10.1074/jbc.M112.445056; Liu FY, 2014, MOL CELL PROTEOMICS, V13, P3352, DOI 10.1074/mcp.M114.041962; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Miao J, 2013, MOL MICROBIOL, V89, P660, DOI 10.1111/mmi.12303; Minguez P, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.31; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; Nambi S, 2013, J BIOL CHEM, V288, P14114, DOI 10.1074/jbc.M113.463992; Nambi S, 2010, J BIOL CHEM, V285, P24313, DOI 10.1074/jbc.M110.118398; Noens EE, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-27; Norris KL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.297pe76; Noy T, 2014, ARCH BIOCHEM BIOPHYS, V550, P42, DOI 10.1016/j.abb.2014.04.004; Ojha A, 2005, CELL, V123, P861, DOI 10.1016/j.cell.2005.09.012; Okanishi H, 2013, J PROTEOME RES, V12, P3952, DOI 10.1021/pr400245k; Parandhaman DK, 2014, LIFE SCI, V109, P116, DOI 10.1016/j.lfs.2014.06.013; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Podobnik M, 2014, J BIOL CHEM, V289, P16588, DOI 10.1074/jbc.M114.560086; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Reddy MCM, 2008, PROTEIN SCI, V17, P2134, DOI 10.1110/ps.038125.108; Rhee KY, 2005, P NATL ACAD SCI USA, V102, P467, DOI 10.1073/pnas.0406133102; Sajid A, 2011, J BACTERIOL, V193, P5347, DOI 10.1128/JB.05469-11; Sajid A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017871; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Savvi S, 2008, J BACTERIOL, V190, P3886, DOI 10.1128/JB.01767-07; Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104; Sharma V, 2000, NAT STRUCT BIOL, V7, P663, DOI 10.1038/77964; Singh DK, 2014, APPL MICROBIOL BIOT, V98, P10065, DOI 10.1007/s00253-014-5859-4; Singh R, 2003, MOL MICROBIOL, V50, P751, DOI 10.1046/j.1365-2958.2003.03712.x; Singhal A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02264; Sol EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050545; Still AJ, 2013, J BIOL CHEM, V288, P26209, DOI 10.1074/jbc.M113.483396; Upton AM, 2007, MICROBIOL-SGM, V153, P3973, DOI 10.1099/mic.0.2007/011726-0; van Noort V, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.4; Vetting MW, 2008, ACTA CRYSTALLOGR F, V64, P978, DOI 10.1107/S1744309108031679; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; Wu X, 2013, J PROTEOMICS, V79, P60, DOI 10.1016/j.jprot.2012.12.001; Xie LX, 2015, INT J BIOCHEM CELL B, V59, P193, DOI 10.1016/j.biocel.2014.11.010; Xie LX, 2015, J PROTEOME RES, V14, P107, DOI 10.1021/pr500859a; Xu H, 2011, BIOCHEMISTRY-US, V50, P5883, DOI 10.1021/bi200156t; Xue B, 2013, MOL BIOSYST, V9, P645, DOI 10.1039/c3mb25517d; Yadav V, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1560-y; Yang MK, 2015, MOL CELL PROTEOMICS, V14, P796, DOI 10.1074/mcp.M114.045922; Yu BJ, 2008, J MICROBIOL BIOTECHN, V18, P1529; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang K, 2009, J PROTEOME RES, V8, P900, DOI 10.1021/pr8005155; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI [10.1038/nchembio.495, 10.1038/NCHEMBIO.495]; Zhou B, 2010, P NATL ACAD SCI USA, V107, P4573, DOI 10.1073/pnas.0909133107; Zhou PF, 2015, FEBS LETT, V589, P326, DOI 10.1016/j.febslet.2014.12.015	98	31	31	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26218	+		10.1074/jbc.M115.687269	http://dx.doi.org/10.1074/jbc.M115.687269			26	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26350458	hybrid, Green Published			2022-12-26	WOS:000363527300039
J	Cooney, S; Dignam, H; Brady, N				Cooney, Sarah; Dignam, Holly; Brady, Nuala			Heads First: Visual Aftereffects Reveal Hierarchical Integration of Cues to Social Attention	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; GAZE DIRECTION; ORIENTATION; ADAPTATION; PERCEPTION; SIZE; REPRESENTATION; MECHANISMS; RESPONSES	Determining where another person is attending is an important skill for social interaction that relies on various visual cues, including the turning direction of the head and body. This study reports a novel high-level visual aftereffect that addresses the important question of how these sources of information are combined in gauging social attention. We show that adapting to images of heads turned 25 degrees to the right or left produces a perceptual bias in judging the turning direction of subsequently presented bodies. In contrast, little to no change in the judgment of head orientation occurs after adapting to extremely oriented bodies. The unidirectional nature of the aftereffect suggests that cues from the human body signaling social attention are combined in a hierarchical fashion and is consistent with evidence from single-cell recording studies in nonhuman primates showing that information about head orientation can override information about body posture when both are visible.	[Cooney, Sarah; Brady, Nuala] Univ Coll Dublin, Sch Psychol, Dublin 2, Ireland; [Dignam, Holly] Univ Coll Dublin, Sch Bimol & Biomed Sci, Dublin 2, Ireland	University College Dublin; University College Dublin	Brady, N (corresponding author), Univ Coll Dublin, Sch Psychol, Dublin 2, Ireland.	nuala.brady@ucd.ie			Irish Research Council (IRC) [GOIPD/2013/83]	Irish Research Council (IRC)(Irish Research Council for Science, Engineering and Technology)	The research described in the authors' manuscript - Cooney, Dignam & Brady, 'Heads First: Visual Aftereffects Reveal Hierarchical Integration of Cues to Social Attention' - is funded by a postgraduate research scholarship to the first author, Sarah Cooney, from the Irish Research Council (IRC: Funding Agency Reference Number: Ref: GOIPD/2013/83). Dr. Nuala Brady is a senior lecturer in Psychology at University College Dublin (UCD), Sarah Cooney is a postgraduate researcher working under the supervision of Dr Nuala Brady, and Holly Dignam is a former undergraduate student from UCD who worked on this project as part of her final year project in Neuroscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AJ, 2001, INVEST OPHTH VIS SCI, V42, P1411; [Anonymous], 2010, R LANG ENV STAT COMP; Ashbridge E, 2000, COGN NEUROPSYCHOL, V17, P13, DOI 10.1080/026432900380463; Ashwin C, 2015, MOL AUTISM, V6, DOI 10.1186/2040-2392-6-5; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Bayliss AP, 2011, J EXP PSYCHOL HUMAN, V37, P634, DOI 10.1037/a0020559; Calder AJ, 2007, CURR BIOL, V17, P20, DOI 10.1016/j.cub.2006.10.052; Cumming G., 2013, UNDERSTANDING NEW ST; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; De Souza WC, 2005, J NEUROPHYSIOL, V94, P1252, DOI 10.1152/jn.00949.2004; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Fang F, 2005, NEURON, V45, P793, DOI 10.1016/j.neuron.2005.01.037; Ghuman AS, 2010, CURR BIOL, V20, P32, DOI 10.1016/j.cub.2009.10.077; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; Hietanen JK, 2002, PSYCHOL RES-PSYCH FO, V66, P174, DOI 10.1007/s00426-002-0091-8; Hietanen JK, 1999, NEUROREPORT, V10, P3443, DOI 10.1097/00001756-199911080-00033; Hudson M, 2009, COGNITION, V112, P423, DOI 10.1016/j.cognition.2009.06.011; Javadi AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046079; Jenkins R, 2006, PSYCHOL SCI, V17, P506, DOI 10.1111/j.1467-9280.2006.01736.x; Kessler E, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00413; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Langton SRH, 2000, Q J EXP PSYCHOL-A, V53, P825, DOI 10.1080/027249800410562; Laube I, 2011, NEUROIMAGE, V54, P1643, DOI 10.1016/j.neuroimage.2010.08.074; Lawson RP, 2011, J VISION, V11, DOI 10.1167/11.9.17; Lawson RP, 2009, PSYCHOL SCI, V20, P363, DOI 10.1111/j.1467-9280.2009.02301.x; Mareschal I, 2013, CURR BIOL, V23, P717, DOI 10.1016/j.cub.2013.03.030; Palumbo R, 2004, PSYCHOL RES, P1; PERRETT DI, 1992, PHILOS T ROY SOC B, V335, P23, DOI 10.1098/rstb.1992.0003; Re DE, 2011, J EVOLUTIONARY PSYCH, V9, P295, DOI DOI 10.1556/JEP.9.2011.4.2; Reed CL, 2003, PSYCHOL SCI, V14, P302, DOI 10.1111/1467-9280.14431; Vangeneugden J, 2014, J NEUROSCI, V34, P574, DOI 10.1523/JNEUROSCI.4032-13.2014; Webster M. A., 2005, ADV VISUAL COGNITION, V2, P241, DOI DOI 10.1093/ACPROF:OSO/9780198529699.003.0010; Webster MA, 2011, J VISION, V11, DOI 10.1167/11.5.3; Webster MA, 2011, PHILOS T R SOC B, V366, P1702, DOI 10.1098/rstb.2010.0360	35	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0135742	10.1371/journal.pone.0135742	http://dx.doi.org/10.1371/journal.pone.0135742			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CR0WB	26359866	Green Submitted, gold, Green Published			2022-12-26	WOS:000361043100004
J	Nishizawa, M; Matsuda, M; Hattori, J; Shiino, T; Matano, T; Heneine, W; Johnson, JA; Sugiura, W				Nishizawa, Masako; Matsuda, Masakazu; Hattori, Junko; Shiino, Teiichiro; Matano, Tetsuro; Heneine, Walid; Johnson, Jeffrey A.; Sugiura, Wataru			Longitudinal Detection and Persistence of Minority Drug-Resistant Populations and Their Effect on Salvage Therapy	PLOS ONE			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; SINGLE-DOSE NEVIRAPINE; TREATMENT-NAIVE; VIROLOGICAL FAILURE; INFECTED PATIENTS; TYPE-1 POL; VARIANTS; MUTATIONS; TRANSMISSION; PCR	Background Drug-resistant HIV are more prevalent and persist longer than previously demonstrated by bulk sequencing due to the ability to detect low-frequency variants. To clarify a clinical benefit to monitoring minority-level drug resistance populations as a guide to select active drugs for salvage therapy, we retrospectively analyzed the dynamics of low-frequency drug-resistant population in antiretroviral (ARV)-exposed drug resistant individuals. Materials and Methods Six HIV-infected individuals treated with ARV for more than five years were analyzed. These individuals had difficulty in controlling viremia, and treatment regimens were switched multiple times guided by standard drug resistance testing using bulk sequencing. To detect minority variant populations with drug resistance, we used a highly sensitive allele-specific PCR (AS-PCR) with detection thresholds of 0.3-2%. According to ARV used in these individuals, we focused on the following seven reverse transcriptase inhibitor-resistant mutations: M41L, K65R, K70R, K103N, Y181C, M184V, and T215F/Y. Results of AS-PCR were compared with bulk sequencing data for concordance and presence of additional mutations. To clarify the genetic relationship between low-frequency and high-frequency populations, AS-PCR amplicon sequences were compared with bulk sequences in phylogenetic analysis. Results The use of AS-PCR enabled detection of the drug-resistant mutations, M41L, K103N, Y181C, M184V and T215Y, present as low-frequency populations in five of the six individuals. These drug resistant variants persisted for several years without ARV pressure. Phylogenetic analysis indicated that pre-existing K103N and T215I variants had close genetic relationships with high-frequency K103N and T215I observed during treatment. Discussion and Conclusion Our results demonstrate the long-term persistence of drug-resistant viruses in the absence of drug pressure. The rapid virologic failures with pre-existing mutant viruses detectable by AS-PCR highlight the clinical importance of low-frequency drug-resistant viruses. Thus, our results highlight the usefulness of AS-PCR and support its expanded evaluation in ART clinical management.	[Nishizawa, Masako; Matano, Tetsuro; Sugiura, Wataru] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Matsuda, Masakazu; Hattori, Junko; Sugiura, Wataru] Natl Hosp Org, Clin Res Ctr, Nagoya Med Ctr, Nagoya, Aichi, Japan; [Shiino, Teiichiro] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan; [Heneine, Walid; Johnson, Jeffrey A.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA; [Sugiura, Wataru] Nagoya Univ, Grad Sch Med, Dept AIDS Res, Nagoya, Aichi 4648601, Japan	National Institute of Infectious Diseases (NIID); Nagoya Medical Center; National Institute of Infectious Diseases (NIID); Centers for Disease Control & Prevention - USA; Nagoya University	Sugiura, W (corresponding author), Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan.	taru1600@me.com			Ministry of Health, Labour, and Welfare of Japan [H25-AIDS-004]	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for AIDS research from the Ministry of Health, Labour, and Welfare of Japan (H25-AIDS-004) http://www.mhlw.go.jp/ to WS.	Albrecht D, 2002, J CLIN VIROL, V24, P93, DOI 10.1016/S1386-6532(01)00231-1; Avidor B, 2013, J CLIN MICROBIOL, V51, P880, DOI 10.1128/JCM.02652-12; Boltz VF, 2010, J VIROL METHODS, V164, P122, DOI 10.1016/j.jviromet.2009.11.025; Borroto-Esoda K, 2007, AIDS RES HUM RETROV, V23, P988, DOI 10.1089/aid.2006.0310; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Delobel P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021655; Dudley DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036494; Edelstein RE, 1998, J CLIN MICROBIOL, V36, P569, DOI 10.1128/JCM.36.2.569-572.1998; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; Flys T, 2005, J INFECT DIS, V192, P24, DOI 10.1086/430742; Gianella S, 2011, J VIROL, V85, P8359, DOI 10.1128/JVI.02582-10; Goodman DD, 2011, AIDS, V25, P325, DOI 10.1097/QAD.0b013e3283427dcb; Gunthard HF, 1998, AIDS RES HUM RETROV, V14, P869, DOI 10.1089/aid.1998.14.869; Halfon P, 2003, AIDS, V17, P1351, DOI 10.1097/00002030-200306130-00009; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; Hattori J, 2010, ANTIVIR RES, V88, P72, DOI 10.1016/j.antiviral.2010.07.008; Johnson JA, 2005, J INFECT DIS, V192, P16, DOI 10.1086/430741; Johnson JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000638; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Katlama C, 2012, EXPERT OPIN INV DRUG, V21, P523, DOI 10.1517/13543784.2012.661713; Kuritzkes DR, 2008, J INFECT DIS, V197, P867, DOI 10.1086/528802; Lataillade M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010952; LEITNER T, 1993, BIOTECHNIQUES, V15, P120; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; MacLeod IJ, 2010, J CLIN VIROL, V48, P162, DOI 10.1016/j.jcv.2010.03.017; Martinez-Picado J, 2008, VIRUS RES, V134, P104, DOI 10.1016/j.virusres.2007.12.021; Messiaen P, 2012, VIROLOGY, V426, P7, DOI 10.1016/j.virol.2012.01.002; Metzner KJ, 2007, AIDS, V21, P703, DOI 10.1097/QAD.0b013e3280121ac6; Metzner KJ, 2013, J INFECT DIS, V208, P1102, DOI 10.1093/infdis/jit310; Metzner KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021734; Metzner KJ, 2011, J CLIN VIROL, V50, P156, DOI 10.1016/j.jcv.2010.10.001; Metzner KJ, 2010, J INFECT DIS, V201, P1063, DOI 10.1086/651136; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Mohamed S, 2014, AIDS; Nei M., 2000, MOL EVOLUTION PHYLOG; Nishizawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083150; Palmer S, 2006, P NATL ACAD SCI USA, V103, P7094, DOI 10.1073/pnas.0602033103; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2014, GUIDELINES FOR THE U; Paredes R, 2007, J VIROL METHODS, V146, P136, DOI 10.1016/j.jviromet.2007.06.012; Peuchant O, 2008, AIDS, V22, P1417, DOI 10.1097/QAD.0b013e3283034953; Sax PE, 2005, CLIN INFECT DIS, V41, P1316, DOI 10.1086/496984; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Stekler JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028952; Stelzl E, 2011, J VIROL METHODS, V178, P94, DOI 10.1016/j.jviromet.2011.08.020; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vandenhende MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086771; Wainberg MA, 2011, J ANTIMICROB CHEMOTH, V66, P2346, DOI 10.1093/jac/dkr291	48	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0135941	10.1371/journal.pone.0135941	http://dx.doi.org/10.1371/journal.pone.0135941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360259	Green Published, gold, Green Submitted			2022-12-26	WOS:000361043100006
J	Grant, JF; Chittleborough, CR; Taylor, AW				Grant, Janet F.; Chittleborough, Catherine R.; Taylor, Anne W.			Parental Midlife Body Shape and Association with Multiple Adult Offspring Obesity Measures: North West Adelaide Health Study	PLOS ONE			English	Article							BRITISH BIRTH COHORT; TO-HEIGHT RATIO; WAIST-HIP RATIO; MASS INDEX; CARDIOVASCULAR-DISEASE; FAT DISTRIBUTION; SCREENING TOOL; RISK-FACTORS; CIRCUMFERENCE; WEIGHT	There is compelling evidence that parental weight is a strong determinant of offspring weight status. The study used cross-sectional self-reported and measured data from a longitudinal cohort of Australian adults (n = 2128) from Stage 3 (2008-10) of the North West Adelaide Health Study (1999-2003, baseline n = 4056) to investigate the association between midlife parental body shape and four indicators of obesity and fat distribution. The analysis used measured body mass index (BMI), waist circumference (WC), waist hip ratio (WHR) and waist height ratio (WHtR) of adult offspring, together with pictograms for recall of parental body shape. Compared to both parents being a healthy weight, offspring were more likely to be overweight or obese if both parents were an unhealthy weight at age 40 (OR 2.14, 95% CI 1.67-2.76) and further, those participants whose mother was an unhealthy weight were more likely to be overweight or obese themselves (OR 1.50, 95% CI 1.14-1.98). There were similar but lower results for those with an overweight/obese father (OR 1.44, 95% CI 1.08-1.93). The effect of one or both parents being overweight or obese tended to be stronger for daughters than for sons across BMI, WC and WHtR. BMI showed the strongest association with parental body shape (OR 2.14), followed by WC (OR 1.78), WHtR (OR 1.71) and WHR (OR 1.45). WHtR (42-45%) and BMI (35-36%) provided the highest positive predictive values for overweight/obesity from parental body shape. Parental obesity increases the risk of obesity for adult offspring, both for overall body shape and central adiposity, particularly for daughters. Pictograms could potentially be used as a screening tool in primary care settings to promote healthy weight among young adults.	[Grant, Janet F.; Taylor, Anne W.] Univ Adelaide, Discipline Med, Populat Res & Outcome Studies, Adelaide, SA, Australia; [Chittleborough, Catherine R.] Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia	University of Adelaide; University of Adelaide	Grant, JF (corresponding author), Univ Adelaide, Discipline Med, Populat Res & Outcome Studies, Adelaide, SA, Australia.	janet.grant@adelaide.edu.au	Grant, Janet F/B-9577-2011; Taylor, Anne w/F-5708-2010; Chittleborough, Catherine/A-7436-2011	Taylor, Anne w/0000-0002-4422-7974; Chittleborough, Catherine/0000-0003-3196-7137; Grant, Janet/0000-0002-3421-5603	South Australian Department of Human Services	South Australian Department of Human Services(Department for Environment, Food & Rural Affairs (DEFRA))	The research was internally funded by the South Australian Department of Human Services, including an allocation from the SA Health Human Services Research Initiatives (Large) Projects (HSRIP) fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Rmeileh NME, 2008, OBESITY, V16, P1388, DOI 10.1038/oby.2008.211; [Anonymous], 2005, ENCY HUMAN NUTR, P392; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Australian Bureau of Statistics, 2012, PROF HLTH AUSTR 2011; Australian Bureau of Statistics, 2006, AUSTR NZ STAND CLASS; Bhuiyan AR, 2003, AM J EPIDEMIOL, V158, P792, DOI 10.1093/aje/kwg218; Britton KA, 2013, J AM COLL CARDIOL, V62, P921, DOI 10.1016/j.jacc.2013.06.027; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Bulik CM, 2001, INT J OBESITY, V25, P1517, DOI 10.1038/sj.ijo.0801742; Choi BCK, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/875253; Cooper R, 2010, AM J CLIN NUTR, V92, P946, DOI 10.3945/ajcn.2010.29477; Flood V, 1998, RECOMMENDATIONS MONI; Fontaine KR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027692; Frayling TM, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5844; Gardner RM, 1998, PERCEPT MOTOR SKILL, V86, P387, DOI 10.2466/pms.1998.86.2.387; GARN SM, 1989, AM J CLIN NUTR, V50, P1308, DOI 10.1093/ajcn/50.6.1308; Gill T, 2003, SOZ PRAVENTIV MED, V48, P191, DOI 10.1007/s00038-003-2055-1; Grant Janet F, 2006, Epidemiol Perspect Innov, V3, P4, DOI 10.1186/1742-5573-3-4; Grant JF, 2009, INT J EPIDEMIOL, V38, P1479, DOI 10.1093/ije/dyn262; HAN TS, 1995, BRIT MED J, V311, P1401, DOI 10.1136/bmj.311.7017.1401; Jensen MD, 2008, J CLIN ENDOCR METAB, V93, pS57, DOI 10.1210/jc.2008-1585; Johnson PCD, 2012, EUR J EPIDEMIOL, V27, P53, DOI 10.1007/s10654-011-9639-5; Katzmarzyk PT, 1999, AM J EPIDEMIOL, V149, P933, DOI 10.1093/oxfordjournals.aje.a009737; Keshtkar AA, 2010, J CLIN EPIDEMIOL, V63, P655, DOI 10.1016/j.jclinepi.2009.08.014; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599; Murrin CM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-81; Overgaard D, 2006, OBESITY, V14, P458, DOI 10.1038/oby.2006.60; Power C, 2011, ANN HUM BIOL, V38, P390, DOI 10.3109/03014460.2011.591827; SORENSEN TIA, 1992, INT J OBESITY, V16, P705; SORENSEN TIA, 1983, INT J OBESITY, V7, P115; SORENSEN TIA, 1993, ACTA PSYCHIAT SCAND, V87, P67, DOI 10.1111/j.1600-0447.1993.tb05363.x; STUNKARD AJ, 1982, RES PUBL ASSOC RES N, V60, P115; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Taylor AW, 2006, AUST NZ J PUBL HEAL, V30, P238, DOI 10.1111/j.1467-842X.2006.tb00864.x; Taylor AW, 2013, J CLIN EPIDEMIOL, V66, P461, DOI 10.1016/j.jclinepi.2012.06.021; Turner LR, 2015, MED J AUSTRALIA, V202, P370, DOI 10.5694/mja14.00998; Vanltallie TB, 1998, NUTR REV, V56, P300, DOI 10.1111/j.1753-4887.1998.tb01663.x; Welborn TA, 2003, MED J AUSTRALIA, V179, P580, DOI 10.5694/j.1326-5377.2003.tb05704.x; Wilding J, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5843; World Health Organization, 2013, BMI CLASS GEN; World Health Organization, WAIST CIRC WAIST HIP	43	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137534	10.1371/journal.pone.0137534	http://dx.doi.org/10.1371/journal.pone.0137534			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355742	Green Published, Green Submitted, gold			2022-12-26	WOS:000360965800059
J	Goodall, LJ; Ovecka, M; Rycroft, D; Friel, SL; Sanderson, A; Mistry, P; Davies, ML; Stoop, AA				Goodall, Laura J.; Ovecka, Milan; Rycroft, Daniel; Friel, Sarah L.; Sanderson, Andrew; Mistry, Prafull; Davies, Marie L.; Stoop, A. Allart			Pharmacokinetic and Pharmacodynamic Characterisation of an Anti-Mouse TNF Receptor 1 Domain Antibody Formatted for In Vivo Half-Life Extension	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MONOCLONAL-ANTIBODIES; AUTOIMMUNE-DISEASES; KAPPA-B; ARTHRITIS; LIGAND; ACTIVATION; INFECTION; RESPONSES; MICE	Tumour Necrosis Factor-alpha (TNF-alpha) inhibition has been transformational in the treatment of patients with inflammatory disease, e.g. rheumatoid arthritis. Intriguingly, TNF-alpha signals through two receptors, TNFR1 and TNFR2, which have been associated with detrimental inflammatory and beneficial immune-regulatory processes, respectively. To investigate if selective TNFR1 inhibition might provide benefits over pan TNF-alpha inhibition, tools to investigate the potential impact of pharmacological intervention are needed. Receptor-deficient mice have been very insightful, but are not reversible and could distort receptor cross-talk, while inhibitory anti-TNFR1 monoclonal antibodies have a propensity to induce receptor agonism. Therefore, we set out to characterise a monovalent anti-TNFR1 domain antibody (dAb) formatted for in vivo use. The mouse TNFR1 antagonist (DMS5540) is a genetic fusion product of an anti-TNFR1 dAb with an albumin-binding dAb (AlbudAb). It bound mouse TNFR1, but not human TNFR1, and was an antagonist of TNF-alpha-mediated cytotoxicity in a L929 cell assay. Surprisingly, the dAb did not compete with TNF-alpha for TNFR1-binding. This was supported by additional data showing the anti-TNFR1 epitope mapped to a single residue in the first domain of TNFR1. Pharmacokinetic studies of DMS5540 in mice over three doses (0.1, 1.0 and 10 mg/kg) confirmed extended in vivo half-life, mediated by the AlbudAb, and demonstrated non-linear clearance of DMS5540. Target engagement was further confirmed by dose-dependent increases in total soluble TNFR1 levels. Functional in vivo activity was demonstrated in a mouse challenge study, where DMS5540 provided dose-dependent inhibition of serum IL-6 increases in response to bolus mouse TNF-alpha injections. Hence, DMS5540 is a potent mouse TNFR1 antagonist with in vivo pharmacokinetic and pharmacodynamic properties compatible with use in pre-clinical disease models and could provide a useful tool to dissect the individual contributions of TNFR1 and TNFR2 in homeostasis and disease.	[Goodall, Laura J.; Ovecka, Milan; Rycroft, Daniel; Friel, Sarah L.; Sanderson, Andrew; Davies, Marie L.; Stoop, A. Allart] GlaxoSmithKline, Biopharm Innovat Unit, Biopharm R&D, Stevenage, Herts, England; [Mistry, Prafull] GlaxoSmithKline, R&D Projects, Clin Platforms & Sci, Stevenage, Herts, England	GlaxoSmithKline; GlaxoSmithKline	Davies, ML (corresponding author), GlaxoSmithKline, Biopharm Innovat Unit, Biopharm R&D, Stevenage, Herts, England.	marie.l.davies@gsk.com			GlaxoSmithkline	GlaxoSmithkline(GlaxoSmithKline)	The work described was funded by GlaxoSmithkline. The funder provided support in the form of salaries for authors LG, MO, DR, SF, PM, AS, MD and AAS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; AGGARWAL BB, 1985, NATURE, V318, P665, DOI 10.1038/318665a0; Aggarwal BB, 2014, ARTHRITIS RHEUMATOL, V66, P2657, DOI 10.1002/art.38753; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Deng GM, 2005, NAT MED, V11, P1066, DOI 10.1038/nm1304; Dostalek M, 2013, CLIN PHARMACOKINET, V52, P83, DOI 10.1007/s40262-012-0027-4; Doyle ML, 2003, J BIOL CHEM, V278, P9426, DOI 10.1074/jbc.M209220200; ENGELMANN H, 1990, J BIOL CHEM, V265, P14497; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Evans TJ, 2000, MOL BIOTECHNOL, V15, P243, DOI 10.1385/MB:15:3:243; Faustman D, 2010, NAT REV DRUG DISCOV, V9, P482, DOI 10.1038/nrd3030; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Hamid T, 2009, CIRCULATION, V119, P1386, DOI 10.1161/CIRCULATIONAHA.108.802918; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; Holt LJ, 2008, PROTEIN ENG DES SEL, V21, P283, DOI 10.1093/protein/gzm067; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; Kim EY, 2006, J IMMUNOL, V176, P1026, DOI 10.4049/jimmunol.176.2.1026; Kudo H, 2009, J HEPATOL, V51, P168, DOI 10.1016/j.jhep.2009.02.032; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; McCann FE, 2014, ARTHRITIS RHEUMATOL, V66, P2728, DOI 10.1002/art.38755; Naude PJW, 2011, FEBS J, V278, P888, DOI 10.1111/j.1742-4658.2011.08017.x; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; SHEEHAN KCF, 1995, J EXP MED, V181, P607, DOI 10.1084/jem.181.2.607; Shibata H, 2008, J BIOL CHEM, V283, P998, DOI 10.1074/jbc.M707933200; TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292; Wajant H, 2011, FEBS J, V278, P862, DOI 10.1111/j.1742-4658.2011.08015.x; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; Zalevsky J, 2007, J IMMUNOL, V179, P1872, DOI 10.4049/jimmunol.179.3.1872	32	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137065	10.1371/journal.pone.0137065	http://dx.doi.org/10.1371/journal.pone.0137065			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352810	Green Published, gold, Green Submitted			2022-12-26	WOS:000360932800059
J	McClune, DW; Kostka, B; Delahay, RJ; Montgomery, WI; Marks, NJ; Scantlebury, DM				McClune, David W.; Kostka, Berit; Delahay, Richard J.; Montgomery, W. Ian; Marks, Nikki J.; Scantlebury, David M.			Winter Is Coming: Seasonal Variation in Resting Metabolic Rate of the European Badger (Meles meles)	PLOS ONE			English	Article							OXYGEN-CONSUMPTION; ENERGY-METABOLISM; BODY-SIZE; FAT MASS; ENERGETICS; TEMPERATURE; COSTS; MOLT; AGE; HIBERNATION	Resting metabolic rate (RMR) is a measure of the minimum energy requirements of an animal at rest, and can give an indication of the costs of somatic maintenance. We measured RMR of free-ranging European badgers (Meles meles) to determine whether differences were related to sex, age and season. Badgers were captured in live-traps and placed individually within a metabolic chamber maintained at 20 +/- 1 degrees C. Resting metabolic rate was determined using an open-circuit respirometry system. Season was significantly correlated with RMR, but no effects of age or sex were detected. Summer RMR values were significantly higher than winter values (mass-adjusted mean +/- standard error: 2366 +/- 70 kJ.d(-1); 1845 +/- 109 kJ.d(-1), respectively), with the percentage difference being 24.7%. While under the influence of anaesthesia, RMR was estimated to be 25.5% lower than the combined average value before administration, and after recovery from anaesthesia. Resting metabolic rate during the autumn and winter was not significantly different to allometric predictions of basal metabolic rate for mustelid species weighing 1 kg or greater, but badgers measured in the summer had values that were higher than predicted. Results suggest that a seasonal reduction in RMR coincides with apparent reductions in physical activity and body temperature as part of the overwintering strategy ('winter lethargy') in badgers. This study contributes to an expanding dataset on the ecophysiology of medium-sized carnivores, and emphasises the importance of considering season when making predictions of metabolic rate.	[McClune, David W.; Kostka, Berit; Montgomery, W. Ian; Marks, Nikki J.; Scantlebury, David M.] Queens Univ Belfast, Inst Global Food Secur, Sch Biol Sci, Belfast, Antrim, North Ireland; [Delahay, Richard J.] Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, Stonehouse GL10 3UJ, Glos, England	Queens University Belfast; Animal & Plant Health Agency UK	Marks, NJ (corresponding author), Queens Univ Belfast, Inst Global Food Secur, Sch Biol Sci, Belfast, Antrim, North Ireland.	n.marks@qub.ac.uk; m.scantlebury@qub.ac.uk	Delahay, Richard/J-2261-2014; Delahay, Richard/GSI-4663-2022	McClune, David/0000-0001-9629-0249	Department of Employment and Learning (DEL) NI	Department of Employment and Learning (DEL) NI	David W. McClune was supported by a PhD studentship from the Department of Employment and Learning (DEL) NI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beiglbock C, 2003, J WILDLIFE DIS, V39, P665, DOI 10.7589/0090-3558-39.3.665; Bevanger K, 1998, WILDLIFE BIOL, V4, P97, DOI 10.2981/wlb.1998.006; Bracco D, 1996, OBES RES, V4, P213, DOI 10.1002/j.1550-8528.1996.tb00539.x; BROWN JH, 1972, ECOLOGY, V53, P939, DOI 10.2307/1934312; Burton T, 2011, P ROY SOC B-BIOL SCI, V278, P3465, DOI 10.1098/rspb.2011.1778; Chamane SC, 2009, J THERM BIOL, V34, P337, DOI 10.1016/j.jtherbio.2009.06.005; CHRAIBI F, 1982, J PHYSIOL-PARIS, V78, P207; Corp N, 1997, J COMP PHYSIOL B, V167, P229, DOI 10.1007/s003600050069; de Leeuw ANS, 2004, VET J, V167, P186, DOI 10.1016/S1090-0233(03)00113-8; Delahay RJ, 2013, EPIDEMIOL INFECT, V141, P1445, DOI 10.1017/S0950268813000721; Delahay RJ, 2000, J ANIM ECOL, V69, P428, DOI 10.1046/j.1365-2656.2000.00406.x; DEPOCAS F, 1957, J APPL PHYSIOL, V10, P388, DOI 10.1152/jappl.1957.10.3.388; Elliott KH, 2015, FUNCT ECOL, V29, P219, DOI 10.1111/1365-2435.12316; FOWLER PA, 1988, J REPROD FERTIL, V84, P259; FOWLER PA, 1988, J ZOOL, V214, P635, DOI 10.1111/j.1469-7998.1988.tb03763.x; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; Goszczynski J, 2005, MAMM BIOL, V70, P1, DOI 10.1078/1616-5047-00171; HARLOW HJ, 1985, COMP BIOCHEM PHYS A, V82, P885, DOI 10.1016/0300-9629(85)90501-8; Harrington LA, 2003, J MAMMAL, V84, P497, DOI 10.1644/1545-1542(2003)084<0497:BMOTBF>2.0.CO;2; Herberich E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009788; HILL RW, 1972, J APPL PHYSIOL, V33, P261, DOI 10.1152/jappl.1972.33.2.261; HINDELL MA, 1994, POLAR BIOL, V14, P275; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; IVERSEN J A, 1972, Norwegian Journal of Zoology, V20, P317; IVERSEN JA, 1972, J COMP PHYSIOL, V81, P341, DOI 10.1007/BF00697754; Iversen JA, 1970, STOFFSKIFTE KROPSSTO; Johannsen DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040837; Johnstone AM, 2005, AM J CLIN NUTR, V82, P941, DOI 10.1093/ajcn/82.5.941; Kingma Boris, 2012, Front Biosci (Elite Ed), V4, P1975; KLAASSEN M, 1995, OECOLOGIA, V104, P424, DOI 10.1007/BF00341339; Kleiber M., 1961, FIRE LIFE INTRO ANIM; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Kowalczyk R, 2003, J BIOGEOGR, V30, P463, DOI 10.1046/j.1365-2699.2003.00804.x; KRUUK H, 1983, Z SAUGETIERKD, V48, P45; Kruuk H., 1978, BEHAV ECOL SOCIOBIOL, V4, P75, DOI [10.1007/BF00302562, DOI 10.1007/BF00302562]; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; LIGHTON JRB, 1987, PHYSIOL ZOOL, V60, P524, DOI 10.1086/physzool.60.5.30156127; Luhrmann PM, 2001, METABOLISM, V50, P972, DOI 10.1053/meta.2001.24871; MAUREL D, 1987, GEN COMP ENDOCR, V65, P317, DOI 10.1016/0016-6480(87)90179-1; MAUREL D, 1979, GEN COMP ENDOCR, V38, P207, DOI 10.1016/0016-6480(79)90208-9; MAUREL D, 1983, J INTERDISCIPL CYCLE, V14, P285, DOI 10.1080/09291018309359823; McKay WP, 2009, EUR J APPL PHYSIOL, V106, P583, DOI 10.1007/s00421-009-1054-1; McNab BK, 2000, CAN J ZOOL, V78, P2227, DOI 10.1139/cjz-78-12-2227; MCNAB BK, 1979, ECOLOGY, V60, P1010, DOI 10.2307/1936869; McNab BK, 2002, J THERM BIOL, V27, P459, DOI 10.1016/S0306-4565(02)00016-5; Mcnab BK, 2008, COMP BIOCHEM PHYS A, V151, P5, DOI 10.1016/j.cbpa.2008.05.008; Moore JAH, 2003, MAMMAL REV, V33, P308, DOI 10.1046/j.1365-2907.2003.00021.x; Munoz-Garcia A, 2005, PHYSIOL BIOCHEM ZOOL, V78, P1039, DOI 10.1086/432852; NAGY KA, 1987, ECOL MONOGR, V57, P111, DOI 10.2307/1942620; Neal E., 1996, BADGERS; Noonan MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083156; PEREL'DIK M. N., 1950, Karakulevodstvo i Zverovodstvo, V3, P29; Pinheiro J., 2015, NLME LINEAR NONLINEA, P1; POCZOPKO P, 1979, ACTA THERIOL, V24, P125, DOI 10.4098/AT.arch.79-16; R Core Team, 2013, R LANG ENV STAT COMP; Roper T, 2010, BADGER; Roper TJ, 2001, BEHAVIOUR, V138, P173, DOI 10.1163/15685390151074366; Scantlebury M, 2005, PHYSIOL BEHAV, V84, P739, DOI 10.1016/j.physbeh.2005.02.022; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; Schutz KE, 2006, J WILDLIFE MANAGE, V70, P884, DOI 10.2193/0022-541X(2006)70[884:BAPROT]2.0.CO;2; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; Speakman JR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00034; Speakman JR, 2000, ADV ECOL RES, V30, P177; Stearns S.C., 1992, pi; Stewart PD, 1997, J ZOOL, V241, P543, DOI 10.1111/j.1469-7998.1997.tb04846.x; Tanaka H, 2006, ZOOL SCI, V23, P991, DOI 10.2108/zsj.23.991; Thompson LJ, 2015, J THERM BIOL, V51, P119, DOI 10.1016/j.jtherbio.2015.04.003; TOMASI T, 1984, COMP BIOCHEM PHYS A, V78, P431, DOI 10.1016/0300-9629(84)90572-3; Tomasi TE, 1998, GEN COMP ENDOCR, V109, P192, DOI 10.1006/gcen.1997.7018; Tomlinson S, 2014, TRENDS ECOL EVOL, V29, P280, DOI 10.1016/j.tree.2014.03.003; Trewby ID, 2008, BIOL LETTERS, V4, P170, DOI 10.1098/rsbl.2007.0516; Trewby ID, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095477; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; WOODROFFE R, 1995, J ZOOL, V235, P237; Zhao ZJ, 2010, J THERM BIOL, V35, P52, DOI 10.1016/j.jtherbio.2009.10.008	75	16	16	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135920	10.1371/journal.pone.0135920	http://dx.doi.org/10.1371/journal.pone.0135920			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352150	Green Submitted, Green Published, gold			2022-12-26	WOS:000360932800018
J	Tang, X; Zhao, LN; Chen, HQ; Chen, YQ; Chen, W; Song, YD; Ratledge, C				Tang, Xin; Zhao, Lina; Chen, Haiqin; Chen, Yong Q.; Chen, Wei; Song, Yuanda; Ratledge, Colin			Complete Genome Sequence of a High Lipid-Producing Strain of Mucor circinelloides WJ11 and Comparative Genome Analysis with a Low Lipid-Producing Strain CBS 277.49	PLOS ONE			English	Article							FATTY-ACID SYNTHESIS; MALIC ENZYME; OLEAGINOUS MICROORGANISMS; OVER-EXPRESSION; ACCUMULATION; ANNOTATION; NADPH; TRIACYLGLYCEROL; OVEREXPRESSION; IDENTIFICATION	The genome of a high lipid-producing fungus Mucor circinelloides WJ11 (36% w/w lipid, cell dry weight, CDW) was sequenced and compared with that of the low lipid-producing strain, CBS 277.49 (15% w/w lipid, CDW), which had been sequenced by Joint Genome Institute. The WJ11 genome assembly size was 35.4 Mb with a G+C content of 39.7%. The general features of WJ11 and CBS 277.49 indicated that they have close similarity at the level of gene order and gene identity. Whole genome alignments with MAUVE revealed the presence of numerous blocks of homologous regions and MUMmer analysis showed that the genomes of these two strains were mostly co-linear. The central carbon and lipid metabolism pathways of these two strains were reconstructed and the numbers of genes encoding the enzymes related to lipid accumulation were compared. Many unique genes coding for proteins involved in cell growth, carbohydrate metabolism and lipid metabolism were identified for each strain. In conclusion, our study on the genome sequence of WJ11 and the comparative genomic analysis between WJ11 and CBS 277.49 elucidated the general features of the genome and the potential mechanism of high lipid accumulation in strain WJ11 at the genomic level. The different numbers of genes and unique genes involved in lipid accumulation may play a role in the high oleaginicity of strain WJ11.	[Tang, Xin; Zhao, Lina; Chen, Haiqin; Chen, Yong Q.; Chen, Wei; Song, Yuanda] Jiangnan Univ, State Key Lab Food Sci & Technol, Sch Food Sci & Technol, Wuxi, Peoples R China; [Chen, Haiqin; Chen, Yong Q.; Chen, Wei] Synergist Innovat Ctr Food Safety & Nutr, Wuxi, Peoples R China; [Ratledge, Colin] Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England	Jiangnan University; University of Hull	Song, YD (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Sch Food Sci & Technol, Wuxi, Peoples R China.	ysong@jiangnan.edu.cn	Chen, Wei/GZK-7348-2022; Chen, Yong Q/AAI-9864-2021	Chen, Yong Q/0000-0003-4747-4708	National Natural Science Foundation of China [31271812, 81071685, 21276108]; National High Technology Research and Development Program of China [2012AA022105C]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1249]; Program for New Century Excellent Talents [NCET-13-0831]; Strategic Merieux Research Grant	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Program for New Century Excellent Talents(Program for New Century Excellent Talents in University (NCET)); Strategic Merieux Research Grant	Funding: This work was supported by the National Natural Science Foundation of China (31271812, 81071685, 21276108), the National High Technology Research and Development Program of China (2012AA022105C), the Program for Changjiang Scholars and Innovative Research Team in University (IRT1249), the Program for New Century Excellent Talents (NCET-13-0831), and the Strategic Merieux Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso AP, 2010, METAB ENG, V12, P488, DOI 10.1016/j.ymben.2010.04.002; Rodriguez-Frometa RA, 2013, APPL MICROBIOL BIOT, V97, P3063, DOI 10.1007/s00253-012-4432-2; ArisanAtac I, 1996, FEMS MICROBIOL LETT, V140, P77, DOI 10.1016/0378-1097(96)00164-4; BOTHAM PA, 1979, J GEN MICROBIOL, V114, P361, DOI 10.1099/00221287-114-2-361; BOULTON CA, 1981, J GEN MICROBIOL, V127, P169; Chen YL, 2010, MOL MICROBIOL, V75, P1112, DOI 10.1111/j.1365-2958.2009.07018.x; Csernetics A, 2011, FUNGAL GENET BIOL, V48, P696, DOI 10.1016/j.fgb.2011.03.006; Delcher AL, 2003, CURR PROTOC BIOINF, DOI DOI 10.13.11-10.13.18; Fan W, 2007, INFECT IMMUN, V75, P3394, DOI 10.1128/IAI.01977-06; Germain V, 2001, PLANT J, V28, P1, DOI 10.1046/j.1365-313X.2001.01095.x; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Hao GF, 2014, APPL ENVIRON MICROB, V80, P2672, DOI 10.1128/AEM.00140-14; HOSAKA K, 1979, EUR J BIOCHEM, V93, P197, DOI 10.1111/j.1432-1033.1979.tb12811.x; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; KENDRICK A, 1992, EUR J BIOCHEM, V209, P667, DOI 10.1111/j.1432-1033.1992.tb17334.x; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li Z, 2013, APPL MICROBIOL BIOT, V97, P4927, DOI 10.1007/s00253-012-4571-5; Liang MH, 2013, PROG LIPID RES, V52, P395, DOI 10.1016/j.plipres.2013.05.002; Lim H, 2009, J MICROBIOL, V47, P225, DOI 10.1007/s12275-008-0247-3; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Navarro E, 2000, EUR J BIOCHEM, V267, P800, DOI 10.1046/j.1432-1327.2000.01058.x; Padham AK, 2007, PLANT PHYSIOL, V143, P1372, DOI 10.1104/pp.106.090811; Ratledge C, 2002, ADV APPL MICROBIOL, V51, P1, DOI 10.1016/S0065-2164(02)51000-5; Ratledge C., 2005, HDB FUNCTIONAL LIPID, P19, DOI [10.1201/9781420039184.ch2, DOI 10.1201/9781420039184.CH2]; Ratledge C, 2014, BIOTECHNOL LETT, V36, P1557, DOI 10.1007/s10529-014-1532-3; Shi YG, 2009, AM J PHYSIOL-ENDOC M, V297, pE10, DOI 10.1152/ajpendo.90949.2008; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Tamano K, 2013, APPL MICROBIOL BIOT, V97, P269, DOI 10.1007/s00253-012-4193-y; Tang X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128396; Tang X, 2014, CURR MICROBIOL, V69, P899, DOI 10.1007/s00284-014-0671-z; Vigeolas H, 2007, PLANT BIOTECHNOL J, V5, P431, DOI 10.1111/j.1467-7652.2007.00252.x; Vongsangnak W, 2012, BIOTECHNOL LETT, V34, P941, DOI 10.1007/s10529-012-0859-x; Wanasundara UN, 2005, HDB FUNCTIONAL LIPID, P47; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028319; Wasylenko TM, 2015, METAB ENG, V30, P27, DOI 10.1016/j.ymben.2015.02.007; Wynn JP, 1999, MICROBIOL-UK, V145, P1911, DOI 10.1099/13500872-145-8-1911; Wynn JP, 1997, MICROBIOL-SGM, V143, P253, DOI 10.1099/00221287-143-1-253; Wynn JP, 2001, MICROBIOL-SGM, V147, P2857, DOI 10.1099/00221287-147-10-2857; Xiong W, 2010, PLANT PHYSIOL, V154, P1001, DOI 10.1104/pp.110.158956; Yang WL, 2012, PLANT PHYSIOL, V160, P638, DOI 10.1104/pp.112.201996; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; ZHANG HB, 1995, PLANT J, V7, P175, DOI 10.1046/j.1365-313X.1995.07010175.x; Zhang HY, 2014, J BIOTECHNOL, V192, P78, DOI 10.1016/j.jbiotec.2014.10.004; Zhang Y, 2007, MICROBIOL-SGM, V153, P2013, DOI 10.1099/mic.0.2006/002683-0; Zhao GZ, 2013, J AGR FOOD CHEM, V61, P7805, DOI 10.1021/jf400080g	49	35	36	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137543	10.1371/journal.pone.0137543	http://dx.doi.org/10.1371/journal.pone.0137543			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352831	gold, Green Published, Green Submitted			2022-12-26	WOS:000360932800095
J	Kim, BS; Rongisch, R; Hager, S; Grieb, G; Nourbakhsh, M; Rennekampff, HO; Bucala, R; Bernhagen, J; Pallua, N				Kim, Bong-Sung; Rongisch, Robert; Hager, Stephan; Grieb, Gerrit; Nourbakhsh, Mahtab; Rennekampff, Hans-Oliver; Bucala, Richard; Bernhagen, Juergen; Pallua, Norbert			Macrophage Migration Inhibitory Factor in Acute Adipose Tissue Inflammation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; IN-VITRO; CELL-MIGRATION; STROMAL CELLS; ADIPOCYTES; MIF; RELEASE; FIBROBLASTS; RECRUITMENT	Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine and has been implicated in inflammatory diseases. However, little is known about the regulation of MIF in adipose tissue and its impact on wound healing. The aim of this study was to investigate MIF expression in inflamed adipose and determine its role in inflammatory cell recruitment and wound healing. Adipose tissue was harvested from subcutaneous adipose tissue layers of 24 healthy subjects and from adipose tissue adjacent to acutely inflamed wounds of 21 patients undergoing wound debridement. MIF protein and mRNA expression were measured by ELISA and RT-PCR. Cell-specific MIF expression was visualized by immunohistochemistry. The functional role of MIF in cell recruitment was investigated by a chemotaxis assay and by flow cytometry of labeled macrophages that were injected into Mif(-/-) and wildtype mice. Wound healing was evaluated by an in vitro scratch assay on human fibroblast monolayers. MIF protein levels of native adipose tissue and supernatants from acutely inflamed wounds were significantly elevated when compared to healthy controls. MIF mRNA expression was increased in acutely inflamed adipose tissue indicating the activation of MIF gene transcription in response to adipose tissue inflammation. MIF is expressed in mature adipocytes and in infiltrated macrophages. Peripheral blood mononuclear cell migration was significantly increased towards supernatants derived from inflamed adipose tissue. This effect was partially abrogated by MIF-neutralizing antibodies. Moreover, when compared to wildtype mice, Mif(-/-) mice showed reduced infiltration of labeled macrophages into LPS-stimulated epididymal fat pads in vivo. Finally, MIF antibodies partially neutralized the detrimental effect of MIF on fibroblast wound healing. Our results indicate that increased MIF expression and rapid activation of the MIF gene in fat tissue adjacent to acute wound healing disorders may play a role in cell recruitment to the site of inflammation and wound healing.	[Kim, Bong-Sung; Rongisch, Robert; Hager, Stephan; Grieb, Gerrit; Nourbakhsh, Mahtab; Rennekampff, Hans-Oliver; Pallua, Norbert] Rhein Westfal TH Aachen, Dept Plast & Reconstruct Surg, Hand Surg Burn Ctr, Aachen, Germany; [Kim, Bong-Sung; Bucala, Richard] Yale Univ, Sch Med, Dept Med, New Haven, CT USA; [Kim, Bong-Sung; Bernhagen, Juergen] Rhein Westfal TH Aachen, Inst Biochem & Mol Cell Biol, Aachen, Germany	RWTH Aachen University; Yale University; RWTH Aachen University	Kim, BS (corresponding author), Rhein Westfal TH Aachen, Dept Plast & Reconstruct Surg, Hand Surg Burn Ctr, Aachen, Germany.	bkim@ukaachen.de	Nourbakhsh, Mahtab/U-8818-2019; Kim, Bong-Sung/AAR-3802-2021	Nourbakhsh, Mahtab/0000-0003-4102-0748; Nourbakhsh, Mahtab/0000-0003-0918-1736; Kim, Bong-Sung/0000-0002-0493-3196; Rongisch, Robert/0000-0002-6494-6466	"START"-a program for young scientists of the Medical Faculty at the RWTH Aachen University [691346, START 2013-2]; German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [GZ: KI 1973/1-1]; DFG [PA 1271/5-1, SFB-TRR57/P03, BE 1977/7-1]; Interdisciplinary Center for Clinical Research (Interdisziplinare Zentrum fur Klinische Forschung, IZKF Aachen grant) [O2-2]; National Institute of Health [NIH R01 AI042310]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042310] Funding Source: NIH RePORTER	"START"-a program for young scientists of the Medical Faculty at the RWTH Aachen University; German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (Interdisziplinare Zentrum fur Klinische Forschung, IZKF Aachen grant); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Bong-Sung Kim is supported by "START"-a program for young scientists of the Medical Faculty at the RWTH Aachen University (Project number: 691346, START 2013-2, https://www.rwth-aachen.de)-and the Research Fellowship Program of the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG, GZ: KI 1973/1-1, www.dfg.de). Norbert Pallua is supported by DFG grant PA 1271/5-1. Jurgen Bernhagen is supported by DFG grants SFB-TRR57/P03 and BE 1977/7-1, and by the Interdisciplinary Center for Clinical Research (Interdisziplinare Zentrum fur Klinische Forschung, IZKF Aachen grant O2-2, www.izkf-aachen.de). Richard Bucala is supported by National Institute of Health (NIH R01 AI042310, www.nih.gov).	Aoki S, 2004, MOL BIOL CELL, V15, P4647, DOI 10.1091/mbc.E04-01-0038; Atalay S, 2014, BURNS, V40, P1375, DOI 10.1016/j.burns.2014.01.023; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Campbell CA, 2010, ANN PLAS SURG, V64, P327, DOI 10.1097/SAP.0b013e318199f82c; Chatterjee P, 2013, J BIOL CHEM, V288, P28324, DOI 10.1074/jbc.C113.495473; Cho KW, 2014, METHOD ENZYMOL, V537, P297, DOI 10.1016/B978-0-12-411619-1.00016-1; Collawn SS, 2012, ANN PLAS SURG, V68, P501, DOI 10.1097/SAP.0b013e31823b69fc; Dewor M, 2007, FEBS LETT, V581, P4734, DOI 10.1016/j.febslet.2007.08.071; Emmerson E, 2009, ENDOCRINOLOGY, V150, P2749, DOI 10.1210/en.2008-1569; Fain JN, 2006, METABOLISM, V55, P1113, DOI 10.1016/j.metabol.2006.04.008; Fan HP, 2011, J IMMUNOL, V186, P4915, DOI 10.4049/jimmunol.1003713; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Finucane OM, 2012, P NUTR SOC, V71, P622, DOI 10.1017/S0029665112000730; Gilliver SC, 2011, EXP DERMATOL, V20, P1, DOI 10.1111/j.1600-0625.2010.01194.x; Grieb G, 2012, WOUND REPAIR REGEN, V20, P707, DOI 10.1111/j.1524-475X.2012.00817.x; Hirokawa J, 1997, BIOCHEM BIOPH RES CO, V235, P94, DOI 10.1006/bbrc.1997.6745; Hirokawa J, 1998, J BIOCHEM, V123, P733; Ikeda D, 2008, ENDOCRINOLOGY, V149, P6037, DOI 10.1210/en.2008-0158; Kim BS, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.26; Kim HR, 2011, HORM METAB RES, V43, P642, DOI 10.1055/s-0031-1283150; Koska J, 2009, INT J OBESITY, V33, P842, DOI 10.1038/ijo.2009.106; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lopez YP, 2015, NEUROIMMUNOMODULAT, V22, P274, DOI 10.1159/000368554; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; NIINIKOSKI J, 1972, ANN SURG, V175, P588, DOI 10.1097/00000658-197204000-00020; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Pierpont YN, 2014, ISRN OBES, V2014, DOI [10.1155/2014/638936PMID:24701367, DOI 10.1155/2014/638936]; Schmidt BA, 2013, DEVELOPMENT, V140, P1517, DOI 10.1242/dev.087593; Siewe L, 2006, EUR J IMMUNOL, V36, P3248, DOI 10.1002/eji.200636012; Skurk T, 2005, ENDOCRINOLOGY, V146, P1006, DOI 10.1210/en.2004-0924; Sugihara H, 2001, BRIT J DERMATOL, V144, P244, DOI 10.1046/j.1365-2133.2001.04008.x; Trayhurn P, 2007, OBES REV, V8, P41, DOI 10.1111/j.1467-789X.2007.00316.x; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; Vozarova B, 2002, DIABETOLOGIA, V45, P1739, DOI 10.1007/s00125-002-0896-4	35	20	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137366	10.1371/journal.pone.0137366	http://dx.doi.org/10.1371/journal.pone.0137366			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348853	Green Published, gold			2022-12-26	WOS:000360897600041
J	Kim, YG; Alvarez, M; Suzuki, H; Hirose, S; Izui, S; Tomino, Y; Huard, B; Suzuki, Y				Kim, Yang Gyun; Alvarez, Montserrat; Suzuki, Hitoshi; Hirose, Sachiko; Izui, Shozo; Tomino, Yasuhiko; Huard, Bertrand; Suzuki, Yusuke			Pathogenic Role of a Proliferation-Inducing Ligand (APRIL) in Murine IgA Nephropathy	PLOS ONE			English	Article							HUMAN MESANGIAL CELLS; EXTRACELLULAR-MATRIX; IMMUNE-COMPLEXES; BAFF; EXPRESSION; MONOCYTES; MICE; TACI; ACCUMULATION; FRACTALKINE	A proliferation-inducing ligand (APRIL) is a member of the tumor necrosis factor (TNF) superfamily. Despite advances in clinical and genetic studies, the details of the pathological roles of APRIL in IgA nephropathy (IgAN) remain to be fully defined. The present study aimed to further assess the pathological role of APRIL using a mouse model of IgAN. Mice with IgAN designated "grouped ddY" (gddY) were intraperitoneally administered an anti-APRIL monoclonal antibody (anti-APRIL Ab) or control IgG (Control Ab) twice each week for 2 weeks starting during the early stage of IgAN (6-7 weeks of age). Urinary albumin, serum IgA, and glomerular IgA deposition were evaluated. We further assessed the inflammatory responses during treatment by measuring the levels of the chemokine fractalkine (FKN) and its receptor CX3CR1 as well as the level of peripheral blood monocytosis. Anti-APRIL Ab treatment significantly decreased albuminuria and tissue damage combined with decreases in serum IgA levels and deposition of glomerular IgA. In contrast, the abundance of IgA(+)/B220+ or CD138(+)/B220(+) B cells in the spleen and bone marrow, respectively, was unchanged. Treating gddY mice with anti-April Ab reduced the overexpression of FKN/CX3CR1 in the kidney and the increase in the population of circulating Gr1(-)/CD115(+) monocytes. The size of the population of Gr1(-)/CD115(+) monocytes correlated with renal FKN and urinary albumin levels. Moreover, mice treated with anti-APRIL Ab exhibited reduced progression of IgAN, serum IgA levels, and glomerular IgA deposition as well as an attenuated inflammatory process mediated by FKN-associated activation of monocytes. To the best of our knowledge, this is the first study to implicate the APRIL signal transduction pathway in the pathogenesis of nephrogenic IgA production. Moreover, our findings identify APRIL as a potential target of therapy.	[Kim, Yang Gyun; Alvarez, Montserrat; Suzuki, Hitoshi; Tomino, Yasuhiko; Suzuki, Yusuke] Juntendo Univ, Sch Med, Dept Internal Med, Div Nephrol, Tokyo 113, Japan; [Kim, Yang Gyun] Kyung Hee Univ, Sch Med, Dept Internal Med, Div Nephrol, Seoul, South Korea; [Alvarez, Montserrat; Izui, Shozo] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland; [Hirose, Sachiko] Juntendo Univ, Sch Med, Dept Pathol, Tokyo 113, Japan; [Huard, Bertrand] INSERMU823, Inst Albert Bonniot, La Tronche, France; [Huard, Bertrand] Grenoble Alpes Univ, La Tronche, France	Juntendo University; Kyung Hee University; University of Geneva; Juntendo University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Suzuki, Y (corresponding author), Juntendo Univ, Sch Med, Dept Internal Med, Div Nephrol, Tokyo 113, Japan.	yusuke@juntendo.ac.jp	KIM, YANG GYUN/AAI-9821-2020; huard, bertrand/L-8011-2013	KIM, YANG GYUN/0000-0002-3497-5514; huard, bertrand/0000-0003-1358-6576	Ministry of Health, Labor and Welfare of Japan; Strategic Japanese (JST)-Swiss (ETHZ) Cooperative Scientific Program; Study Group on IgAN in Japan	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Strategic Japanese (JST)-Swiss (ETHZ) Cooperative Scientific Program; Study Group on IgAN in Japan	This study was supported in part by a Grant-in-Aid for Progressive Renal Diseases Research, Research on Intractable Disease, from the Ministry of Health, Labor and Welfare of Japan, by a grant from Strategic Japanese (JST)-Swiss (ETHZ) Cooperative Scientific Program, and by a research grant from the Study Group on IgAN in Japan.	Aizawa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095365; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Barratt J, 2004, SEMIN NEPHROL, V24, P197, DOI 10.1016/j.semnephrol.2004.01.002; Batten M, 2004, J IMMUNOL, V172, P812, DOI 10.4049/jimmunol.172.2.812; BOHLE A, 1992, PATHOL RES PRACT, V188, P908, DOI 10.1016/S0344-0338(11)80252-9; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; CHEN A, 1994, J PATHOL, V173, P119, DOI 10.1002/path.1711730208; Cox SN, 2012, KIDNEY INT, V82, P548, DOI 10.1038/ki.2012.147; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; FUJII K, 1990, AM J KIDNEY DIS, V16, P207, DOI 10.1016/S0272-6386(12)81019-5; Goto T, 2008, CLIN IMMUNOL, V126, P260, DOI 10.1016/j.clim.2007.11.003; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914; Huard B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031837; Ikezumi Y, 2006, NEPHROL DIAL TRANSPL, V21, P3466, DOI 10.1093/ndt/gfl455; IWASATO T, 1992, J EXP MED, V175, P1539, DOI 10.1084/jem.175.6.1539; Joo H, 2012, J EXP MED, V209, P1335, DOI 10.1084/jem.20111644; Kajiyama T, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/819646; LAN HY, 1991, KIDNEY INT, V40, P425, DOI 10.1038/ki.1991.229; Le WB, 2012, NEPHROL DIAL TRANSPL, V27, P1479, DOI 10.1093/ndt/gfr527; Li PKT, 2002, NEPHROL DIAL TRANSPL, V17, P64, DOI 10.1093/ndt/17.1.64; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; LopezArmada MJ, 1996, J IMMUNOL, V157, P2136; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; McCarthy DD, 2006, CELL IMMUNOL, V241, P85, DOI 10.1016/j.cellimm.2006.08.002; McCarthy DD, 2011, J CLIN INVEST, V121, P3991, DOI 10.1172/JCI45563; Muso E, 1996, KIDNEY INT, V50, P1946, DOI 10.1038/ki.1996.517; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nakata J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089707; Okazaki K, 2012, J AM SOC NEPHROL, V23, P1364, DOI 10.1681/ASN.2011121160; Santiago-Raber ML, 2011, J AUTOIMMUN, V37, P171, DOI 10.1016/j.jaut.2011.05.015; Sato D, 2012, NEPHROL DIAL TRANSPL, V27, P1090, DOI 10.1093/ndt/gfr403; Song KH, 2013, DIABETOLOGIA, V56, P1661, DOI 10.1007/s00125-013-2907-z; Suzuki H, 2005, J AM SOC NEPHROL, V16, P1289, DOI 10.1681/ASN.2004030219; Suzuki H, 2009, J CLIN INVEST, V119, P1668, DOI 10.1172/JCI38468; Suzuki H, 2008, J AM SOC NEPHROL, V19, P2384, DOI 10.1681/ASN.2007121311; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; YOSHIKAWA N, 1987, KIDNEY INT, V32, P585, DOI 10.1038/ki.1987.248; Yoshimoto S, 2007, AM J KIDNEY DIS, V50, P47, DOI 10.1053/j.ajkd.2007.04.012; Yoshimura H, 2008, LIFE SCI, V82, P899, DOI 10.1016/j.lfs.2008.02.006; Zuo N, 2011, NEPHROL DIAL TRANSPL, V26, P2127, DOI 10.1093/ndt/gfq687	43	95	99	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137044	10.1371/journal.pone.0137044	http://dx.doi.org/10.1371/journal.pone.0137044			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348210	gold, Green Published, Green Submitted			2022-12-26	WOS:000360897600018
J	Liang, KC; Patil, A; Nakai, K				Liang, Kuo-ching; Patil, Ashwini; Nakai, Kenta			Discovery of Intermediary Genes between Pathways Using Sparse Regression	PLOS ONE			English	Article							DENDRITIC CELL APOPTOSIS; ANTIGEN PRESENTATION; IFN-BETA; MYD88; TRIF; TLR; REGULARIZATION; TRANSCRIPTION; MATURATION; INDUCTION	The use of pathways and gene interaction networks for the analysis of differential expression experiments has allowed us to highlight the differences in gene expression profiles between samples in a systems biology perspective. The usefulness and accuracy of pathway analysis critically depend on our understanding of how genes interact with one another. That knowledge is continuously improving due to advances in next generation sequencing technologies and in computational methods. While most approaches treat each of them as independent entities, pathways actually coordinate to perform essential functions in a cell. In this work, we propose a methodology based on a sparse regression approach to find genes that act as intermediary to and interact with two pathways. We model each gene in a pathway using a set of predictor genes, and a connection is formed between the pathway gene and a predictor gene if the sparse regression coefficient corresponding to the predictor gene is non-zero. A predictor gene is a shared neighbor gene of two pathways if it is connected to at least one gene in each pathway. We compare the sparse regression approach to Weighted Correlation Network Analysis and a correlation distance based approach using time-course RNA-Seq data for dendritic cell from wild type, MyD88-knockout, and TRIF-knockout mice, and a set of RNA-Seq data from 60 Caucasian individuals. For the sparse regression approach, we found overrepresented functions for shared neighbor genes between TLR-signaling pathway and antigen processing and presentation, apoptosis, and Jak-Stat pathways that are supported by prior research, and compares favorably to Weighted Correlation Network Analysis in cases where the gene association signals are weak.	[Liang, Kuo-ching; Patil, Ashwini; Nakai, Kenta] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan	University of Tokyo	Nakai, K (corresponding author), Univ Tokyo, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	knakai@ims.u-tokyo.ac.jp	Nakai, Kenta/B-7293-2009	Nakai, Kenta/0000-0002-8721-8883; Patil, Ashwini/0000-0002-3353-1970	Research on Regenerative Medicine for Clinical Application, Health and Labour Sciences Research Grants; Cabinet Office, Government of Japan; Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovation R&D on Science and Technology (FIRST Program); Grants-in-Aid for Scientific Research [26830135] Funding Source: KAKEN	Research on Regenerative Medicine for Clinical Application, Health and Labour Sciences Research Grants; Cabinet Office, Government of Japan; Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovation R&D on Science and Technology (FIRST Program); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research is funded in part by Research on Regenerative Medicine for Clinical Application, Health and Labour Sciences Research Grants (https://research-er.jp/projects/view/885791). This research is also funded by the Cabinet Office, Government of Japan and the Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovation R&D on Science and Technology (FIRST Program) for the Comprehensive understanding of immune dynamism: toward manipulation of immune responses (https://research-er. jp/projects/view/106146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew S., FASTQC QUALITY CONTR; Barrett DM, 2004, MOL CELL BIOL, V24, P6194, DOI 10.1128/MCB.24.14.6194-6204.2004; Brieger A, 2013, J IMMUNOL, V191, P1808, DOI 10.4049/jimmunol.1301261; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; De Trez C, 2005, J IMMUNOL, V175, P839, DOI 10.4049/jimmunol.175.2.839; Donato M, 2013, GENOME RES, V23, P1885, DOI 10.1101/gr.153551.112; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Famakin BM, 2011, BRAIN RES, V1388, P148, DOI 10.1016/j.brainres.2011.02.074; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Frazee AC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-449; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Guilbault B, 2004, J BIOL CHEM, V279, P19523, DOI 10.1074/jbc.M314273200; Han JH, 2006, NAT IMMUNOL, V7, P370, DOI 10.1038/ni0406-370; Hartuv E, 1999, P 3 ANN INT C COMP M, P188, DOI [10.1145/299432.299483, DOI 10.1145/299432.299483]; Hayashi EA, 2005, J IMMUNOL, V174, P6639, DOI 10.4049/jimmunol.174.11.6639; Hu R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-20; Huber PJ, 2009, WILEY SERIES PROBABI, P200; Jonnalagadda S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-267; Jung S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku099; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kokkonen TS, 2010, J HISTOCHEM CYTOCHEM, V58, P131, DOI 10.1369/jhc.2009.954669; Kushwah R, 2010, J IMMUNOL, V185, P795, DOI 10.4049/jimmunol.1000325; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee M-LT, 2004, ANAL MICROARRAY GENE; Leonardson AS, 2010, HUM MOL GENET, V19, P159, DOI 10.1093/hmg/ddp476; Lu LN, 1996, J IMMUNOL, V157, P3577; Ludewig B, 1998, J EXP MED, V188, P1493, DOI 10.1084/jem.188.8.1493; Marraco SAF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020189; Mentzen WI, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-601; Milacic Marija, 2012, Cancers (Basel), V4, P1180, DOI 10.3390/cancers4041180; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Patil A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003323; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Reim D, 2011, J LEUKOCYTE BIOL, V90, P613, DOI 10.1189/jlb.1110602; Roskrow MA, 1999, LEUKEMIA RES, V23, P549, DOI 10.1016/S0145-2126(99)00045-4; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Spaggiari GM, 2002, BLOOD, V100, P4098, DOI 10.1182/blood-2002-04-1284; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tang SQ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5657; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Van Der Maaten L., 2009, J MACH LEARN RES, V10, P13, DOI [10.1080/ 135062804440 0 0102, DOI 10.1080/13506280444000102]; Ye Jieping, 2012, SIGKDD Explor, V14, P4; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhao P, 2006, J MACH LEARN RES, V7, P2541; Zietara N, 2009, J IMMUNOL, V183, P1099, DOI 10.4049/jimmunol.0803214; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	58	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137222	10.1371/journal.pone.0137222	http://dx.doi.org/10.1371/journal.pone.0137222			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348038	Green Published, gold, Green Submitted			2022-12-26	WOS:000360897600026
J	Tsoneva, D; Stritzker, J; Bedenk, K; Zhang, Q; Frentzen, A; Cappello, J; Fischer, U; Szalay, AA				Tsoneva, Desislava; Stritzker, Jochen; Bedenk, Kristina; Zhang, Qian; Frentzen, Alexa; Cappello, Joseph; Fischer, Utz; Szalay, Aladar A.			Drug-Encoded Biomarkers for Monitoring Biological Therapies	PLOS ONE			English	Article							ONCOLYTIC VACCINIA VIRUS; IN-VIVO; CANCER; GLUCURONIDASE; LUCIFERASE; INSERTION; BACTERIA; TUMORS; AGENT	Blood tests are necessary, easy-to-perform and low-cost alternatives for monitoring of oncolytic virotherapy and other biological therapies in translational research. Here we assessed three candidate proteins with the potential to be used as biomarkers in biological fluids: two glucuronidases from E. coli (GusA) and Staphylococcus sp. RLH1 (GusPlus), and the luciferase from Gaussia princeps (GLuc). The three genes encoding these proteins were inserted individually into vaccinia virus GLV-1h68 genome under the control of an identical promoter. The three resulting recombinant viruses were used to infect tumor cells in cultures and human tumor xenografts in nude mice. In contrast to the actively secreted GLuc, the cytoplasmic glucuronidases GusA and GusPlus were released into the supernatants only as a result of virus-mediated oncolysis. GusPlus resulted in the most sensitive detection of enzyme activity under controlled assay conditions in samples containing as little as 1 pg/ml of GusPlus, followed by GusA (25 pg/ml) and GLuc (>= 375 pg/ml). Unexpectedly, even though GusA had a lower specific activity compared to GusPlus, the substrate conversion in the serum of tumor-bearing mice injected with the GusA-encoding virus strains was substantially higher than that of GusPlus. This was attributed to a 3.2 fold and 16.2 fold longer half-life of GusA in the blood stream compared to GusPlus and GLuc respectively, thus a more sensitive monitor of virus replication than the other two enzymes. Due to the good correlation between enzymatic activity of expressed marker gene and virus titer, we conclude that the amount of the biomarker protein in the body fluid semiquantitatively represents the amount of virus in the infected tumors which was confirmed by low light imaging. We found GusA to be the most reliable biomarker for monitoring oncolytic virotherapy among the three tested markers.	[Tsoneva, Desislava; Bedenk, Kristina; Fischer, Utz; Szalay, Aladar A.] Univ Wurzburg, Dept Biochem, Bioctr, D-97070 Wurzburg, Germany; [Stritzker, Jochen; Zhang, Qian; Frentzen, Alexa; Cappello, Joseph] Genelux Corp, San Diego Sci Ctr, San Diego, CA 92109 USA; [Stritzker, Jochen] Univ Wurzburg, Bioctr, D-97070 Wurzburg, Germany; [Fischer, Utz; Szalay, Aladar A.] Univ Calif San Diego, Dept Radiat Oncol, Moores Canc Ctr, San Diego, CA 92103 USA	University of Wurzburg; University of Wurzburg; University of California System; University of California San Diego	Stritzker, J (corresponding author), Genelux Corp, San Diego Sci Ctr, San Diego, CA 92109 USA.	js@genelux.com; szalay@biozentrum.uni-wuerzburg.de	Fischer, Utz/AAT-8422-2020; Fischer, Utz/A-4090-2016	Fischer, Utz/0000-0002-1465-6591; Fischer, Utz/0000-0002-1465-6591	Genelux Corporation; University of Wurzburg; German Research Foundation (DFG)	Genelux Corporation; University of Wurzburg; German Research Foundation (DFG)(German Research Foundation (DFG))	The work was supported by Genelux Corporation and a Service Grant awarded to the University of Wurzburg, graduate stipends from the University of Wurzburg. The publication costs were co-funded by the German Research Foundation (DFG) and the University of wurzburg in the funding program Open Access Publishing. The funder provided support in the form of salaries for authors (JS, QZ, AF, JC, UF, AAS), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arul L, 2008, BIOINFORMATION, V2, P339, DOI 10.6026/97320630002339; Broothaerts W, 2005, NATURE, V433, P629, DOI 10.1038/nature03309; Browne AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019530; Chen NH, 2009, MOL MED, V15, P144, DOI 10.2119/molmed.2009.00014; Chen NG, 2010, FUTURE VIROL, V5, P763, DOI 10.2217/FVL.10.58; Coupar BEH, 2000, J GEN VIROL, V81, P431, DOI 10.1099/0022-1317-81-2-431; FALKNER FG, 1990, J VIROL, V64, P3108, DOI 10.1128/JVI.64.6.3108-3111.1990; Haddad D, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-36; Heo J, 2013, NAT MED, V19, P329, DOI 10.1038/nm.3089; Hess M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-172; Jefferson RA, 2002, MICROBIAL BETA GLUCU; Kirn DH, 2009, NAT REV CANCER, V9, P64, DOI 10.1038/nrc2545; Mansfield D, 2013, VALIDATION BIOMARKER; Phuong LK, 2003, CANCER RES, V63, P2462; Ruiz-Hernandez E, 2014, POLYM CHEM-UK, V5, P1674, DOI [10.1039/c3py01097j, 10.1039/C3PY01097J]; Stritzker J, 2013, P NATL ACAD SCI USA, V110, P3316, DOI 10.1073/pnas.1216916110; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; Yu YA, 2004, NAT BIOTECHNOL, V22, P313, DOI 10.1038/nbt937; Zenser TV, 1999, DRUG METAB DISPOS, V27, P1064; Zhang Q, 2007, CANCER RES, V67, P10038, DOI 10.1158/0008-5472.CAN-07-0146	21	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137573	10.1371/journal.pone.0137573	http://dx.doi.org/10.1371/journal.pone.0137573			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348361	Green Published, Green Submitted, gold			2022-12-26	WOS:000360897600055
J	Yoshimura, T; Suzuki, T; Mineki, S; Ohuchi, S				Yoshimura, Takeo; Suzuki, Takamasa; Mineki, Shigeru; Ohuchi, Shokichi			Controlled Microwave Heating Accelerates Rolling Circle Amplification	PLOS ONE			English	Article							ORGANIC-SYNTHESIS; PADLOCK PROBES; REPLICATION; OLIGONUCLEOTIDES; MOLECULES	Rolling circle amplification (RCA) generates single-stranded DNAs or RNA, and the diverse applications of this isothermal technique range from the sensitive detection of nucleic acids to analysis of single nucleotide polymorphisms. Microwave chemistry is widely applied to increase reaction rate as well as product yield and purity. The objectives of the present research were to apply microwave heating to RCA and indicate factors that contribute to the microwave selective heating effect. The microwave reaction temperature was strictly controlled using a microwave applicator optimized for enzymatic-scale reactions. Here, we showed that microwave-assisted RCA reactions catalyzed by either of the four thermostable DNA polymerases were accelerated over 4-folds compared with conventional RCA. Furthermore, the temperatures of the individual buffer components were specifically influenced by microwave heating. We concluded that microwave heating accelerated isothermal RCA of DNA because of the differential heating mechanisms of microwaves on the temperatures of reaction components, although the overall reaction temperatures were the same.	[Yoshimura, Takeo; Suzuki, Takamasa; Mineki, Shigeru] Tokyo Univ Sci, Dept Appl Biol Sci, Noda, Chiba 3058506, Japan; [Ohuchi, Shokichi] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Iizuka, Fukuoka 8208502, Japan	Tokyo University of Science; Kyushu Institute of Technology	Yoshimura, T (corresponding author), Tokyo Univ Sci, Dept Appl Biol Sci, 264 Yamazaki, Noda, Chiba 3058506, Japan.	yoshimura@rs.tus.ac.jp			Japan Society of the Promotion of Science [23655146]	Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society of the Promotion of Science, a Grant-in-Aid for Challenging Exploratory Research [23655146]; http://www.jsps.go.jp/english/index.html.	Abe N, 2013, ANGEW CHEM, V125, P7142; Baghbanzadeh M, 2011, ANGEW CHEM INT EDIT, V50, P11312, DOI 10.1002/anie.201101274; Bilecka I, 2010, NANOSCALE, V2, P1358, DOI 10.1039/b9nr00377k; BRANCH AD, 1984, SCIENCE, V223, P450, DOI 10.1126/science.6197756; Cheng YQ, 2008, ANAL BIOCHEM, V378, P123, DOI 10.1016/j.ab.2008.03.040; Collins JM, 2007, ORG BIOMOL CHEM, V5, P1141, DOI 10.1039/b617084f; DAROS JA, 1994, P NATL ACAD SCI USA, V91, P12813, DOI 10.1073/pnas.91.26.12813; Fermer C, 2003, EUR J PHARM SCI, V18, P129, DOI 10.1016/S0928-0987(02)00252-X; FIRE A, 1995, P NATL ACAD SCI USA, V92, P4641, DOI 10.1073/pnas.92.10.4641; Goransson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031068; Gude V. G., 2013, SUSTAINABLE CHEM PRO, V1, P1, DOI DOI 10.1186/2043-7129-1-5; Hamblin GD, 2012, J AM CHEM SOC, V134, P2888, DOI 10.1021/ja2107492; Hutchison CA, 2005, P NATL ACAD SCI USA, V102, P17332, DOI 10.1073/pnas.0508809102; Kappe C. O., 2012, MICROWAVES ORGANIC M, V2nd; Kappe CO, 2013, CHEM SOC REV, V42, P4977, DOI 10.1039/c3cs00010a; Kappe CO, 2009, MOL DIVERS, V13, P71, DOI 10.1007/s11030-009-9138-8; Kempitiya A, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3078273; Korlach J, 2008, P NATL ACAD SCI USA, V105, P1176, DOI 10.1073/pnas.0710982105; Larsson C, 2004, NAT METHODS, V1, P227, DOI 10.1038/NMETH723; Lidstrom P, 2001, TETRAHEDRON, V57, P9225, DOI 10.1016/S0040-4020(01)00906-1; Liu DY, 1996, J AM CHEM SOC, V118, P1587, DOI 10.1021/ja952786k; Loupy A., 2006, MICROWAVES ORGANIC S; Martinez-Palou R, 2010, MOL DIVERS, V14, P3, DOI 10.1007/s11030-009-9159-3; Mochizuki D, 2011, MINI-REV ORG CHEM, V8, P294, DOI 10.2174/157019311796197409; Nagashima I, 2014, BIOSCI BIOTECH BIOCH, V78, P758, DOI 10.1080/09168451.2014.891931; NILSSON M, 1994, SCIENCE, V265, P2085, DOI 10.1126/science.7522346; Orrling K, 2004, CHEM COMMUN, P790, DOI 10.1039/b317049g; Reddy PM, 2013, J PROTEOMICS, V80, P160, DOI 10.1016/j.jprot.2013.01.005; Sandoval WN, 2008, DRUG DISCOV TODAY, V13, P1075, DOI 10.1016/j.drudis.2008.08.007; Shaw KJ, 2010, LAB CHIP, V10, P1725, DOI 10.1039/c000357n; Suzuki M, 1996, J PHYS CHEM-US, V100, P7279, DOI 10.1021/jp953331k; Thomas DC, 1999, ARCH PATHOL LAB MED, V123, P1170; Wang B, 2005, J CLIN MICROBIOL, V43, P2339, DOI 10.1128/JCM.43.5.2339-2344.2005; Yadav GD, 2012, J MOL CATAL B-ENZYM, V81, P58, DOI 10.1016/j.molcatb.2012.05.007; Yoshimura Takeo, 2006, Nucleic Acids Symp Ser (Oxf), P305; Zhao H, 2009, J MOL CATAL B-ENZYM, V57, P149, DOI 10.1016/j.molcatb.2008.08.006	36	3	4	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136532	10.1371/journal.pone.0136532	http://dx.doi.org/10.1371/journal.pone.0136532			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348227	Green Submitted, Green Published, gold			2022-12-26	WOS:000360897600009
J	Anderson, GA; Udan, RS; Dickinson, ME; Henkelman, RM				Anderson, Gregory A.; Udan, Ryan S.; Dickinson, Mary E.; Henkelman, R. Mark			Cardiovascular Patterning as Determined by Hemodynamic Forces and Blood Vessel Genetics	PLOS ONE			English	Article							EMBRYONIC LETHALITY; VASCULAR DEFECTS; MICE LACKING; TGF-BETA; MOUSE; NOTCH; ENDOGLIN; VASCULOGENESIS; MORPHOGENESIS; ANGIOGENESIS	Background Vascular patterning depends on coordinated timing of arteriovenous specification of endothelial cells and the concomitant hemodynamic forces supplied by the onset of cardiac function. Using a combination of 3D imaging by OPT and embryo registration techniques, we sought to identify structural differences between three different mouse models of cardiovascular perturbation. Results Endoglin mutant mice shared a high degree of similarity to Mlc2a mutant mice, which have been shown to have a primary developmental heart defect causing secondary vessel remodeling failures. Dll4 mutant mice, which have well-characterized arterial blood vessel specification defects, showed distinct differences in vascular patterning when compared to the disruptions seen in Mlc2a(-/-) and Eng(-/-) models. While Mlc2a(-/-) and Eng(-/-) embryos exhibited significantly larger atria than wild-type, Dll(4-/-) embryos had significantly smaller hearts than wild-type, but this quantitative volume decrease was not limited to the developing atrium. Dll4(-/-) embryos also had atretic dorsal aortae and smaller trunks, suggesting that the cardiac abnormalities were secondary to primary arterial blood vessel specification defects. Conclusions The similarities in Eng(-/-) and Mlc2a(-/-) embryos suggest that Eng(-/-) mice may suffer from a primary heart developmental defect and secondary defects in vessel patterning, while defects in Dll4(-/-) embryos are consistent with primary defects in vessel patterning.	[Anderson, Gregory A.; Henkelman, R. Mark] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Anderson, Gregory A.; Henkelman, R. Mark] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Udan, Ryan S.; Dickinson, Mary E.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Baylor College of Medicine	Anderson, GA (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	gregory.anderson@mail.utoronto.ca	HENKELMAN, MARK/W-6847-2019		National Institute of Health [U54 HG006348-S1, R01 HL095586]; American Heart Association [10POST4280097]; National Institute of Health - National Institute of General Medical Sciences [K12 GM084897]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095586] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM084897] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institute of Health - National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by: National Institute of Health, U54 HG006348-S1 (Mary E. Dickinson), National Institute of Health, R01 HL095586 (Mary E. Dickinson), American Heart Association, 10POST4280097 (Ryan S. Udan), and National Institute of Health - National Institute of General Medical Sciences, K12 GM084897, (Ryan S. Udan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GA, 2013, DEV DYNAM, V242, P527, DOI 10.1002/dvdy.23947; Argraves WS, 2005, ANAT REC PART A, V286A, P875, DOI 10.1002/ar.a.20232; Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Benedito R, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-117; Borges L, 2012, BLOOD, V119, P5417, DOI 10.1182/blood-2011-11-391896; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Carvalho RLC, 2004, DEVELOPMENT, V131, P6237, DOI 10.1242/dev.01529; Chaturvedi K, 2006, NEUROENDOCRINOLOGY, V83, P387, DOI 10.1159/000096049; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Culver JC, 2010, MICROCIRCULATION, V17, P164, DOI 10.1111/j.1549-8719.2010.00025.x; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gerety SS, 2002, DEVELOPMENT, V129, P1397; Gleave JA, 2012, PHYSIOL GENOMICS, V44, P778, DOI 10.1152/physiolgenomics.00055.2012; He C, 2008, DEVELOPMENT, V135, P2467, DOI 10.1242/dev.020131; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Huang CQ, 2003, DEVELOPMENT, V130, P6111, DOI 10.1242/dev.00831; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Kelsey L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003612; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; May SR, 2004, DEV BIOL, V270, P31, DOI 10.1016/j.ydbio.2004.02.006; Meadows SM, 2012, CIRC RES, V110, P34, DOI 10.1161/CIRCRESAHA.111.249847; Midgett M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0643; Nomura-Kitabayashi A, 2009, DEV BIOL, V335, P66, DOI 10.1016/j.ydbio.2009.08.016; Sacilotto N, 2013, P NATL ACAD SCI USA, V110, P11893, DOI 10.1073/pnas.1300805110; Schneider Juergen E., 2004, BMC Developmental Biology, V4, P1; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Slaney M., 1988, PRINCIPLES COMPUTERI; Solloway MJ, 2003, CARDIOVASC RES, V58, P264, DOI 10.1016/S0008-6363(03)00286-4; Song LY, 2007, DEV BIOL, V301, P276, DOI 10.1016/j.ydbio.2006.08.004; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Udan RS, 2013, DEVELOPMENT, V140, P4041, DOI 10.1242/dev.096255; Udan RS, 2013, WIRES DEV BIOL, V2, P327, DOI 10.1002/wdev.91; Walls JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002853; Weninger WJ, 2006, ANAT EMBRYOL, V211, P213, DOI 10.1007/s00429-005-0073-x; Wong MD, 2014, DEVELOPMENT, V141, P2533, DOI 10.1242/dev.107722; Wong MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073491; Wong MD, 2012, DEVELOPMENT, V139, P3248, DOI 10.1242/dev.082016; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723	46	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137175	10.1371/journal.pone.0137175	http://dx.doi.org/10.1371/journal.pone.0137175			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340748	Green Published, gold, Green Submitted			2022-12-26	WOS:000360688200030
J	Cao, LL; Ding, J; Dong, LG; Zhao, JY; Su, JM; Wang, LY; Sui, Y; Zhao, T; Wang, F; Jin, JJ; Cai, Y				Cao, Lingling; Ding, Jian; Dong, Liguo; Zhao, Jiayao; Su, Jiaming; Wang, Lingyao; Sui, Yi; Zhao, Tong; Wang, Fei; Jin, Jingji; Cai, Yong			Negative Regulation of p21(Waf1/Cip1) by Human INO80 Chromatin Remodeling Complex Is Implicated in Cell Cycle Phase G2/M Arrest and Abnormal Chromosome Stability	PLOS ONE			English	Article							P21; TRANSCRIPTION; REPLICATION; INHIBITOR; RECRUITMENT; SENESCENCE; PROTEINS; BIOLOGY; SITES	We previously identified an ATP-dependent human Ino80 (INO80) chromatin remodeling complex which shares a set of core subunits with yeast Ino80 complex. Although research evidence has suggested that INO80 complex functions in gene transcription and genome stability, the precise mechanism remains unclear. Herein, based on gene expression profiles from the INO80 complex-knockdown in HeLa cells, we first demonstrate that INO80 complex negatively regulates the p21(Waf1/Cip1) (p21) expression in a p53-mediated mechanism. In chromatin immunoprecipitation (ChIP) and a sequential ChIP (Re-ChIP) assays, we determined that the INO80 complex and p53 can bind to the same promoter region of p21 gene (-2.2kb and -1.0kb upstream of the p21 promoter region), and p53 is required for the recruitment of the INO80 complex to the p21 promoter. RNAi knockdown strategies of INO80 not only led to prolonged progression of cell cycle phase G2/M to G1, but it also resulted in abnormal chromosome stability. Interestingly, high expression of p21 was observed in most morphologically-changed cells, suggesting that negative regulation of p21 by INO80 complex might be implicated in maintaining the cell cycle process and chromosome stability. Together, our findings will provide a theoretical basis to further elucidate the cellular mechanisms of the INO80 complex.	[Cao, Lingling; Ding, Jian; Dong, Liguo; Zhao, Jiayao; Su, Jiaming; Wang, Lingyao; Sui, Yi; Zhao, Tong; Wang, Fei; Jin, Jingji; Cai, Yong] Jilin Univ, Sch Life Sci, Changchun 130023, Jilin, Peoples R China; [Jin, Jingji; Cai, Yong] Jilin Univ, Natl Engn Lab AIDS Vaccine, Changchun 130023, Jilin, Peoples R China; [Jin, Jingji; Cai, Yong] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University	Jin, JJ (corresponding author), Jilin Univ, Sch Life Sci, Changchun 130023, Jilin, Peoples R China.	jjjin@jlu.edu.cn; caiyong62@jlu.edu.cn	Zhao, Jiayao/HDL-8501-2022	Dong, Liguo/0000-0002-8805-7487	National Natural Science Foundation of China [31071131, 31171245]; National Laboratory of Biomacromolecules, Institue of Biophysics, Chinese Academy of Sciences [O5SY02110A, 2012kf04]; Project of Jilin Province Science and Technology Development Program [20130413002GH]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Laboratory of Biomacromolecules, Institue of Biophysics, Chinese Academy of Sciences; Project of Jilin Province Science and Technology Development Program	This work was supported by National Natural Science Foundation of China (No. 31071131&31171245, YC), National Laboratory of Biomacromolecules, Institue of Biophysics, Chinese Academy of Sciences (No. O5SY02110A, YC and 2012kf04, JJ) and the Project of Jilin Province Science and Technology Development Program (20130413002GH, YC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2014, FEBS LETT, V588, P4065, DOI 10.1016/j.febslet.2014.09.033; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bennett G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3084; Cai Y, 2007, NAT STRUCT MOL BIOL, V14, P872, DOI 10.1038/nsmb1276; Chen L, 2011, J BIOL CHEM, V286, P11283, DOI 10.1074/jbc.M111.222505; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Cmielova J, 2011, J CELL BIOCHEM, V112, P3502, DOI 10.1002/jcb.23296; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Dion V, 2010, CURR OPIN CELL BIOL, V22, P383, DOI 10.1016/j.ceb.2010.02.006; Dutto I, 2015, ARCH TOXICOL, V89, P155, DOI 10.1007/s00204-014-1430-4; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gerhold CB, 2014, TRENDS CELL BIOL, V24, P619, DOI 10.1016/j.tcb.2014.06.004; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Gorgoulis VG, 2010, CURR OPIN CELL BIOL, V22, P816, DOI 10.1016/j.ceb.2010.07.013; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hur SK, 2010, CELL MOL LIFE SCI, V67, P2283, DOI 10.1007/s00018-010-0337-3; Jin JJ, 2005, TRENDS BIOCHEM SCI, V30, P680, DOI 10.1016/j.tibs.2005.10.003; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kashiwaba S, 2010, BIOCHEM BIOPH RES CO, V402, P619, DOI 10.1016/j.bbrc.2010.10.066; Lee K, 2012, MECH AGEING DEV, V133, P686, DOI 10.1016/j.mad.2012.11.001; Li QL, 2014, ONCOTARGET, V5, P6387, DOI 10.18632/oncotarget.2201; Li W, 2010, CANCER SCI, V101, P1226, DOI 10.1111/j.1349-7006.2010.01523.x; Min JN, 2013, CELL RES, V23, P1396, DOI 10.1038/cr.2013.113; Nguyen VQ, 2013, CELL, V154, P1220, DOI 10.1016/j.cell.2013.08.018; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; Seeber A, 2013, GENE DEV, V27, P1999, DOI 10.1101/gad.222992.113; Seeber A, 2013, CURR OPIN GENET DEV, V23, P174, DOI 10.1016/j.gde.2012.12.008; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Shimada K, 2008, CURR BIOL, V18, P566, DOI 10.1016/j.cub.2008.03.049; Stark GR, 2006, MOL BIOTECHNOL, V32, P227, DOI 10.1385/MB:32:3:227; Tosi A, 2013, CELL, V154, P1207, DOI 10.1016/j.cell.2013.08.016; Truax AD, 2012, METHODS MOL BIOL, V809, P175, DOI 10.1007/978-1-61779-376-9_12; Tyson JJ, 2001, J THEOR BIOL, V210, P249, DOI 10.1006/jtbi.2001.2293; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Vassileva I, 2014, NUCLEIC ACIDS RES, V42, P9074, DOI 10.1093/nar/gku605; Wang F, 2011, APOPTOSIS, V16, P301, DOI 10.1007/s10495-010-0559-8; Wang L, 2014, CELL STEM CELL, V14, P575, DOI 10.1016/j.stem.2014.02.013; Wang YM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-8; Warfel NA, 2013, CURR OPIN ONCOL, V25, P52, DOI 10.1097/CCO.0b013e32835b639e; Watanabe S, 2010, COLD SH Q B, V75, P35, DOI 10.1101/sqb.2010.75.063; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0	45	16	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137411	10.1371/journal.pone.0137411	http://dx.doi.org/10.1371/journal.pone.0137411			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340092	Green Submitted, Green Published, gold			2022-12-26	WOS:000360688200054
J	Jakubowicz, M; Berkowski, B; Lopez Correa, M; Jarochowska, E; Joachimski, M; Belka, Z				Jakubowicz, Michal; Berkowski, Blazej; Lopez Correa, Matthias; Jarochowska, Emilia; Joachimski, Michael; Belka, Zdzislaw			Stable Isotope Signatures of Middle Palaeozoic Ahermatypic Rugose Corals - Deciphering Secondary Alteration, Vital Fractionation Effects, and Palaeoecological Implications	PLOS ONE			English	Article							EASTERN ANTI-ATLAS; PENNSYLVANIAN KENDRICK FAUNA; HOLY CROSS MOUNTAINS; DEEP-SEA CORALS; ZIGZAG MICROSTRUCTURE; BIOLOGICAL CARBONATES; SCLERACTINIAN CORALS; SKELETAL CARBONATE; MUD MOUNDS; DIAGENESIS	This study investigates stable isotope signatures of five species of Silurian and Devonian deep-water, ahermatypic rugose corals, providing new insights into isotopic fractionation effects exhibited by Palaeozoic rugosans, and possible role of diagenetic processes in modifying their original isotopic signals. To minimize the influence of intraskeletal cements on the observed signatures, the analysed specimens included unusual species either devoid of large intraskeletal open spaces ('button corals': Microcyclus, Palaeocyclus), or typified by particularly thick corallite walls (Calceola). The corals were collected at four localities in the Holy Cross Mountains (Poland), Mader Basin (Morocco) and on Gotland (Sweden), representing distinct diagenetic histories and different styles of diagenetic alteration. To evaluate the resistance of the corallites to diagenesis, we applied various microscopic and trace element preservation tests. Distinct differences between isotopic compositions of the leastaltered and most-altered skeleton portions emphasise a critical role of material selection for geochemical studies of Palaeozoic corals. The least-altered parts of the specimens show marine or near-marine stable isotope signals and lack positive correlation between delta C-13 and delta O-18. In terms of isotopic fractionation mechanisms, Palaeozoic rugosans must have differed considerably from modern deep-water scleractinians, typified by significant depletion in both O-18 and C-13, and pronounced delta C-13-delta O-18 co-variance. The fractionation effects exhibited by rugosans seem similar rather to the minor isotopic effects typical of modern non-scleractinian corals (octocorals and hydrocorals). The results of the present study add to growing evidence for significant differences between Scleractinia and Rugosa, and agree with recent studies indicating that calcification mechanisms developed independently in these two groups of cnidarians. Consequently, particular caution is needed in using scleractinians as analogues in isotopic studies of extinct coral lineages. Answering some of the pertinent palaeoecological questions, such as that of the possibility of photosymbiosis in Palaeozoic corals, may not be possible based on stable isotope data.	[Jakubowicz, Michal] Adam Mickiewicz Univ, Inst Geoecol & Geoinformat, Poznan, Poland; [Berkowski, Blazej] Adam Mickiewicz Univ, Inst Geol, Poznan, Poland; [Lopez Correa, Matthias; Jarochowska, Emilia; Joachimski, Michael] Univ Erlangen Nurnberg, GeoZentrum Nordbayern, D-91054 Erlangen, Germany; [Lopez Correa, Matthias] German Univ Technol Oman GUtech, Muscat, Oman; [Belka, Zdzislaw] Adam Mickiewicz Univ, Isotope Lab, Poznan, Poland	Adam Mickiewicz University; Adam Mickiewicz University; University of Erlangen Nuremberg; Adam Mickiewicz University	Jakubowicz, M (corresponding author), Adam Mickiewicz Univ, Inst Geoecol & Geoinformat, Poznan, Poland.	mjakub@amu.edu.pl	Belka, Zdzislaw/A-5177-2008; Joachimski, Michael M./B-9477-2011; Correa, Matthias López/A-2477-2011; Jarochowska, Emilia/AAK-1439-2021; Berkowski, Blazej/A-1244-2008; Jakubowicz, Michal/Q-6329-2016	Belka, Zdzislaw/0000-0001-9634-610X; Correa, Matthias López/0000-0002-6996-1876; Jarochowska, Emilia/0000-0001-8937-9405; Jakubowicz, Michal/0000-0001-7995-0532; Berkowski, Blazej/0000-0001-7249-0182; Joachimski, Michael/0000-0001-6088-3261	Polish Ministry of Science and Higher Education [IP2014 016373]; German Academic Exchange Service (DAAD)	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	The study was funded by a Polish Ministry of Science and Higher Education grant No. IP2014 016373. MJ was supported by German Academic Exchange Service (DAAD) during his stay at Friedrich-Alexander University. MJ is a scholarship holder of Adam Mickiewicz University Foundation for the academic year 2014-2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins JF, 2003, GEOCHIM COSMOCHIM AC, V67, P1129, DOI 10.1016/S0016-7037(02)01203-6; Ahmad SM, 2011, QUATERN INT, V238, P107, DOI 10.1016/j.quaint.2009.11.020; Allison N, 2007, GEOCHIM COSMOCHIM AC, V71, P4693, DOI 10.1016/j.gca.2007.07.026; [Anonymous], 2001, ATLAS EARTH HIST; BANNER JL, 1990, GEOCHIM COSMOCHIM AC, V54, P3123, DOI 10.1016/0016-7037(90)90128-8; Barbin Vincent, 1995, Geobios Memoire Special (Villeurbanne), V18, P39; Bathurst R.G., 1975, CARBONATE SEDIMENTS; Belka Z, 1998, J SEDIMENT RES, V68, P368, DOI 10.2110/jsr.68.368; Berkowski B, 2008, PALAEOGEOGR PALAEOCL, V265, P87, DOI 10.1016/j.palaeo.2008.04.018; Berkowski B, 2008, PALAEONTOGR ABT A, V284, P17; Black H, 2012, U ALABAMA MCNAIR J, V12, P19; BRAND U, 1981, CHEM GEOL, V32, P1, DOI 10.1016/0009-2541(81)90124-8; BRAND U, 1989, GLOBAL PLANET CHANGE, V75, P311, DOI 10.1016/0921-8181(89)90008-8; BRAND U, 1981, J SEDIMENT PETROL, V51, P987; Brand U, 2004, CHEM GEOL, V204, P23, DOI 10.1016/j.chemgeo.2003.10.013; Brand U, 2003, CHEM GEOL, V198, P305, DOI 10.1016/S0009-2541(03)00032-9; BRAND U, 1983, CHEM GEOL, V40, P167, DOI 10.1016/0009-2541(83)90097-9; BRAND U, 1981, CHEM GEOL, V32, P17, DOI 10.1016/0009-2541(81)90125-X; Brand U., 2011, ASS AUSTR PALEONTOL, V41, P9; Calner M., 2004, ERLANGER GEOLOGISCHE, V5, P113; Constantz B.R., 1986, P53; Coronado I, 2013, PALAEOGEOGR PALAEOCL, V386, P286, DOI 10.1016/j.palaeo.2013.05.030; DENISON RE, 1994, CHEM GEOL, V112, P131, DOI 10.1016/0009-2541(94)90110-4; Doring S, 2001, FACIES, V44, P137, DOI 10.1007/BF02668171; Dzik J., 1981, Przeglad Geologiczny, V29, P125; Enmar R, 2000, GEOCHIM COSMOCHIM AC, V64, P3123, DOI 10.1016/S0016-7037(00)00417-8; Ezaki Y, 1997, PALAEONTOLOGY, V40, P1; Fedorowski J, 1997, ACTA PALAEONTOL POL, V42, P446; Fedorowski J., 2003, GEOLOGOS, V6, P89; Franchi F, 2012, B GEOSCI, V87, P1, DOI 10.3140/bull.geosci.1294; Frankowiak K, 2013, PALAIOS, V28, P333, DOI 10.2110/palo.2012.p12-116r; Gagan MK, 2000, QUATERNARY SCI REV, V19, P45, DOI 10.1016/S0277-3791(99)00054-2; GIVEN RK, 1985, J SEDIMENT PETROL, V55, P430; Grottoli AG, 2007, EARTH-SCI REV, V81, P67, DOI 10.1016/j.earscirev.2006.10.001; Heikoop JM, 2000, GEOCHIM COSMOCHIM AC, V64, P975, DOI 10.1016/S0016-7037(99)00363-4; Hendy EJ, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2007PA001462; HENRICH R, 1995, FACIES, V32, P71, DOI 10.1007/BF02536865; Hill D., 1981, TREATISE INVERTEBRAT; Hill TM, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003443; Jaffres JBD, 2007, EARTH-SCI REV, V83, P83, DOI 10.1016/j.earscirev.2007.04.002; JAMES NP, 1983, GEOSCI CAN, V10, P162; Jeppsson L, 2006, GFF, V128, P109, DOI 10.1080/11035890601282109; Joachimski MM, 2005, GEOCHIM COSMOCHIM AC, V69, P4035, DOI 10.1016/j.gca.2004.11.017; Kaufmann B, 1997, J SEDIMENT RES, V67, P945; Kaufmann B., 1998, ACTA GEOL POL, V48, P43; Kaufmann Bernd, 1998, Geological Society Special Publication, V149, P417, DOI 10.1144/GSL.SP.1999.149.01.19; Knauth LP, 2009, NATURE, V460, P728, DOI 10.1038/nature08213; Lazar B, 2004, GEOCHIM COSMOCHIM AC, V68, P4583, DOI 10.1016/j.gca.2004.03.029; Lee MR, 2005, J SEDIMENT RES, V75, P313, DOI 10.2110/jsr.2005.023; LONGMAN MW, 1980, AAPG BULL, V64, P461; Lopez Correa M, 2010, DEEP-SEA RES PT II, V57, P471, DOI 10.1016/j.dsr2.2009.08.016; MACHEL HG, 1991, SEPM SHORT, V25, P9; Marali S, 2013, PALAEOGEOGR PALAEOCL, V373, P25, DOI 10.1016/j.palaeo.2012.06.017; MARSHALL JD, 1992, GEOL MAG, V129, P143, DOI 10.1017/S0016756800008244; MCCONNAUGHEY T, 1989, GEOCHIM COSMOCHIM AC, V53, P151, DOI 10.1016/0016-7037(89)90282-2; McConnaughey TA, 2003, CORAL REEFS, V22, P316, DOI 10.1007/s00338-003-0325-2; McConnaughey TA, 1997, GEOCHIM COSMOCHIM AC, V61, P611, DOI 10.1016/S0016-7037(96)00361-4; Melim LA, 2002, MAR GEOL, V185, P27, DOI 10.1016/S0025-3227(01)00289-4; Mienis F, 2008, THESIS VRIJE U AMSTE; Moore C.H., 1989, CARBONATE DIAGENESIS; Muller A, 2001, GEOPHYS RES LETT, V28, P4471, DOI 10.1029/2001GL013577; Munnecke A, 1996, FACIES, V34, P159, DOI 10.1007/BF02546162; Munnecke A, 2003, PALAEOGEOGR PALAEOCL, V195, P99, DOI 10.1016/S0031-0182(03)00304-3; NEUMAN BEE, 1988, LETHAIA, V21, P97, DOI 10.1111/j.1502-3931.1988.tb00801.x; Nothdurft Luke D., 2007, Schriftenreihe der Erdwissenschaftlichen Kommissionen, V17, P85; Nothdurft LD, 2009, FACIES, V55, P161, DOI 10.1007/s10347-008-0167-z; Oliver William A. Jr, 1996, Paleontological Society Papers, V1, P107; Pajchlowa M, 1957, B I GEOLOGICZNEGO, V122, P145; Park E, 2012, MOL PHYLOGENET EVOL, V62, P329, DOI 10.1016/j.ympev.2011.10.008; PATTERSON WP, 1994, GEOLOGY, V22, P127, DOI 10.1130/0091-7613(1994)022<0127:SDOMPC>2.3.CO;2; Perrin C, 2007, J SEDIMENT RES, V77, P495, DOI 10.2110/jsr.2007.051; Plusquellec Y., 1971, Annls Soc geol Nord, V91, P129; POPP BN, 1986, J SEDIMENT PETROL, V56, P715; Poprawa P, 1999, TECTONOPHYSICS, V314, P219, DOI 10.1016/S0040-1951(99)00245-0; Rabier C, 2008, SEDIMENT GEOL, V211, P73, DOI 10.1016/j.sedgeo.2008.08.005; Richter DK, 2003, MINER PETROL, V79, P127, DOI 10.1007/s00710-003-0237-4; Rodriguez S., 1989, Memoir of the Association of Australasian Palaeontologists, V8, P157; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; Rosales I, 2001, SEDIMENTOLOGY, V48, P1149, DOI 10.1046/j.1365-3091.2001.00412.x; Sadler J, 2014, EARTH-SCI REV, V139, P291, DOI 10.1016/j.earscirev.2014.10.002; SANDBERG PA, 1975, J PALEONTOL, V49, P587; Sayani HR, 2011, GEOCHIM COSMOCHIM AC, V75, P6361, DOI 10.1016/j.gca.2011.08.026; Scrutton Colin T., 1996, Proceedings of the Yorkshire Geological Society, V51, P1; Scrutton CT, 1998, P YORKS GEOL SOC, V52, P1, DOI 10.1144/pygs.52.1.1; Scrutton CT, 1997, P YORKS GEOL SOC, V51, P177, DOI 10.1144/pygs.51.3.177; Smith AM, 2003, EARTH-SCI REV, V63, P1, DOI 10.1016/S0012-8252(02)00164-2; Smith JE, 2000, PALAIOS, V15, P25, DOI 10.2307/3515589; Sorauf James E., 1993, Courier Forschungsinstitut Senckenberg, V164, P63; Sorauf JE, 1996, PALAIOS, V11, P64, DOI 10.2307/3515117; Sorauf JE, 2003, J PALEONTOL, V77, P16, DOI 10.1666/0022-3360(2003)077<0016:TOASOZ>2.0.CO;2; Soto F., 1978, Trabajos de Geologia, V10, P425; Spero HJ, 1997, NATURE, V390, P497, DOI 10.1038/37333; STANLEY GD, 1995, PALEOBIOLOGY, V21, P179, DOI 10.1017/S0094837300013191; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6; Stolarski J, 2007, SCIENCE, V318, P92, DOI 10.1126/science.1149237; Stolarski J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-316; Stolarski Jaroslaw, 1993, Courier Forschungsinstitut Senckenberg, V164, P169; Turnau E, 1999, REV PALAEOBOT PALYNO, V106, P237, DOI 10.1016/S0034-6667(99)00011-1; van Geldern R, 2006, PALAEOGEOGR PALAEOCL, V240, P47, DOI 10.1016/j.palaeo.2006.03.045; Veizer J, 1999, CHEM GEOL, V161, P59, DOI 10.1016/S0009-2541(99)00081-9; Webb GE, 2002, GEOLOGY, V30, P415, DOI 10.1130/0091-7613(2002)030<0415:ZMIRCA>2.0.CO;2; WEBER JN, 1970, CHEM GEOL, V6, P93, DOI 10.1016/0009-2541(70)90009-4; WEBER JN, 1972, MAR BIOL, V15, P293, DOI 10.1007/BF00401388; WEFER G, 1991, MAR GEOL, V100, P207, DOI 10.1016/0025-3227(91)90234-U; Wenzel B, 1996, PALAEOGEOGR PALAEOCL, V122, P143, DOI 10.1016/0031-0182(95)00094-1; Wisshak M, 2009, MAR ECOL PROG SER, V397, P197, DOI 10.3354/meps08165; Wood R, 2003, T GEOBIOL, V20, P33; WRIGHT AJ, 2010, MEM ASSOC AUSTRALAS, P159; Zapalski MK, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2663; Zaton M, 2011, J PALEONTOL, V85, P757, DOI 10.1666/11-005.1	110	19	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136289	10.1371/journal.pone.0136289	http://dx.doi.org/10.1371/journal.pone.0136289			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334730	gold, Green Published, Green Submitted			2022-12-26	WOS:000360615400013
J	Mao, XB; Liu, MH; Tang, J; Chen, H; Chen, DW; Yu, B; He, J; Yu, J; Zheng, P				Mao, Xiangbing; Liu, Minghui; Tang, Jun; Chen, Hao; Chen, Daiwen; Yu, Bing; He, Jun; Yu, Jie; Zheng, Ping			Dietary Leucine Supplementation Improves the Mucin Production in the Jejunal Mucosa of the Weaned Pigs Challenged by Porcine Rotavirus	PLOS ONE			English	Article							SIGNALING PATHWAY; IMMUNE-RESPONSES; BARRIER FUNCTION; INTESTINAL BARRIER; PROTEIN-METABOLISM; C2C12 MYOTUBES; WEANLING PIGS; FED PIGLETS; THREONINE; MUSCLE	The present study was mainly conducted to determine whether dietary leucine supplementation could attenuate the decrease of the mucin production in the jejunal mucosa of weaned pigs infected by porcine rotavirus (PRV). A total of 24 crossbred barrows weaned at 21 d of age were assigned randomly to 1 of 2 diets supplemented with 1.00% L-leucine or 0.68% L-alanine (isonitrogenous control) for 17 d. On day 11, all pigs were orally infused PRV or the sterile essential medium. During the first 10 d of trial, dietary leucine supplementation could improve the feed efficiency (P = 0.09). The ADG and feed efficiency were impaired by PRV infusion (P<0.05). PRV infusion also increased mean cumulative score of diarrhea, serum rotavirus antibody concentration and crypt depth of the jejunal mucosa (P<0.05), and decreased villus height: crypt depth (P = 0.07), goblet cell numbers (P<0.05), mucin 1 and 2 concentrations (P<0.05) and phosphorylated mTOR level (P<0.05) of the jejunal mucosa in weaned pigs. Dietary leucine supplementation could attenuate the effects of PRV infusion on feed efficiency (P = 0.09) and mean cumulative score of diarrhea (P = 0.09), and improve the effects of PRV infusion on villus height: crypt depth (P = 0.06), goblet cell numbers (P<0.05), mucin 1 (P = 0.08) and 2 (P = 0.07) concentrations and phosphorylated mTOR level (P = 0.08) of the jejunal mucosa in weaned pigs. These results suggest that dietary 1% leucine supplementation alleviated the decrease of mucin production and goblet cell numbers in the jejunal mucosa of weaned pigs challenged by PRV possibly via activation of the mTOR signaling.	[Mao, Xiangbing; Liu, Minghui; Tang, Jun; Chen, Hao; Chen, Daiwen; Yu, Bing; He, Jun; Yu, Jie; Zheng, Ping] Sichuan Agr Univ, Inst Anim Nutr, Yaan, Sichuan, Peoples R China; [Mao, Xiangbing; Liu, Minghui; Tang, Jun; Chen, Hao; Chen, Daiwen; Yu, Bing; He, Jun; Yu, Jie; Zheng, Ping] Minist Educ, Key Lab Anim Dis Resistance Nutr, Yaan, Sichuan, Peoples R China	Sichuan Agricultural University	Mao, XB (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Yaan, Sichuan, Peoples R China.	acatmxb2003@163.com			National Natural Science Foundation of China [31201812]; earmarked fund for the China Agriculture Research System [CARS-36]; Science and Technology Support Program of Sichuan Province [13ZC2237]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for the China Agriculture Research System; Science and Technology Support Program of Sichuan Province	This study was financially supported by the grant from National Natural Science Foundation of China (31201812), the earmarked fund for the China Agriculture Research System (CARS-36), and the grant from the Science and Technology Support Program of Sichuan Province (13ZC2237).	[Anonymous], 1998, NUTRIENT REQUIREMENT; Arnold MM, 2011, J VIROL, V85, P1970, DOI 10.1128/JVI.01801-10; Association of Official Analytical Chemists, 1995, 99003 AOAC; Balage M, 2011, J NUTR BIOCHEM, V22, P219, DOI 10.1016/j.jnutbio.2010.02.001; Bansil R, 2006, CURR OPIN COLLOID IN, V11, P164, DOI 10.1016/j.cocis.2005.11.001; BARNETT B, 1983, MED CLIN N AM, V67, P1031, DOI 10.1016/S0025-7125(16)31165-8; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Boshuizen JA, 2005, VIROLOGY, V337, P210, DOI 10.1016/j.virol.2005.03.039; Botic T, 2007, INT J FOOD MICROBIOL, V115, P227, DOI 10.1016/j.ijfoodmicro.2006.10.044; Chen H, 2015, J NUTR, V145, P51, DOI 10.3945/jn.114.201772; Chen H, 2013, BRIT J NUTR, V110, P1837, DOI 10.1017/S0007114513001293; Chu L., 2012, THESIS CHINA AGR U; Coeffier M, 2011, AM J CLIN NUTR, V93, P1255, DOI 10.3945/ajcn.111.013649; COMA J, 1995, J ANIM SCI, V73, P472; Dibner JJ, 2004, J APPL POULTRY RES, V13, P86, DOI 10.1093/japr/13.1.86; Dodd KM, 2012, AM J PHYSIOL-ENDOC M, V302, pE1329, DOI 10.1152/ajpendo.00525.2011; DONELLI GO, 1994, COMP IMMUNOL MICROB, V17, P305, DOI 10.1016/0147-9571(94)90050-7; EDMONDS MS, 1987, J ANIM SCI, V64, P1664, DOI 10.2527/jas1987.6461664x; Farhadi A, 2003, J GASTROEN HEPATOL, V18, P479, DOI 10.1046/j.1440-1746.2003.03032.x; Forstner Janet F., 1994, P1255; GATNAU R, 1995, J ANIM SCI, V73, P159; Goodman CA, 2014, REV PHYSIOL BIOCH P, V166, P43, DOI 10.1007/112_2013_17; Langkamp-Henken B, 1992, Nutr Clin Pract, V7, P100, DOI 10.1177/0115426592007003100; Liu FN, 2010, VIRAL IMMUNOL, V23, P135, DOI 10.1089/vim.2009.0088; Lopez N, 2010, PEPTIDES, V31, P1361, DOI 10.1016/j.peptides.2010.03.028; Lynch CJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE621, DOI 10.1152/ajpendo.00462.2005; Magalhaes JG, 2007, SEMIN IMMUNOL, V19, P106, DOI 10.1016/j.smim.2006.12.006; MANTLE M, 1981, BIOCHEM J, V195, P267, DOI 10.1042/bj1950267; Mao X, 2011, CHINESE J ANIM SCI, V47, P26; Mao XB, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-49; Mao XB, 2013, BRIT J NUTR, V110, P256, DOI 10.1017/S0007114512004849; Mao XB, 2011, MOL BIOL REP, V38, P3201, DOI 10.1007/s11033-010-9992-6; Mordier S, 2000, J BIOL CHEM, V275, P29900, DOI 10.1074/jbc.M003633200; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Rieu I, 2003, J NUTR, V133, P1198, DOI 10.1093/jn/133.4.1198; Roh C, 2003, AM J PHYSIOL-ENDOC M, V284, pE322, DOI 10.1152/ajpendo.00230.2002; Sasaki M, 2007, PROG HISTOCHEM CYTO, V42, P61, DOI 10.1016/j.proghi.2007.02.001; Schaart MW, 2005, J NUTR, V135, P765, DOI 10.1093/jn/135.4.765; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Sridhar S, 2012, J PATHOL, V226, P255, DOI 10.1002/path.3025; Stoll B, 1999, AM J PHYSIOL-ENDOC M, V277, pE168, DOI 10.1152/ajpendo.1999.277.1.E168; Stoll B, 1998, J NUTR, V128, P606, DOI 10.1093/jn/128.3.606; Torrazza RM, 2010, J NUTR, V140, P2145, DOI 10.3945/jn.110.128421; Wang WW, 2010, J NUTR, V140, P981, DOI 10.3945/jn.109.118497; Wu SP, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-22; Yin YL, 2010, AMINO ACIDS, V39, P1477, DOI 10.1007/s00726-010-0612-5; Yuan LJ, 1998, J VIROL, V72, P330, DOI 10.1128/JVI.72.1.330-338.1998; Zhao Y, 2014, BRIT J NUTR, V112, P381, DOI 10.1017/S000711451400097X	48	21	31	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137380	10.1371/journal.pone.0137380	http://dx.doi.org/10.1371/journal.pone.0137380			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26336074	Green Published, Green Submitted, gold			2022-12-26	WOS:000360615400056
J	Yong, CSM; Sharkey, J; Duscio, B; Venville, B; Wei, WZ; Jones, RF; Slaney, CY; Arnau, GM; Papenfuss, AT; Schroder, J; Darcy, PK; Kershaw, MH				Yong, Carmen S. M.; Sharkey, Janelle; Duscio, Belinda; Venville, Ben; Wei, Wei-Zen; Jones, Richard F.; Slaney, Clare Y.; Arnau, Gisela Mir; Papenfuss, Anthony T.; Schroeder, Jan; Darcy, Phillip K.; Kershaw, Michael H.			Embryonic Lethality in Homozygous Human Her-2 Transgenic Mice Due to Disruption of the Pds5b Gene	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; MAMMARY-TUMOR VIRUS; MODIFIED T-CELLS; CHROMOSOMAL INTEGRATION; DNA VACCINATION; COPY NUMBER; FUSION GENE; EXPRESSION; CANCER; PROTEIN	The development of antigen-targeted therapeutics is dependent on the preferential expression of tumor-associated antigens (TAA) at targetable levels on the tumor. Tumor-associated antigens can be generated de novo or can arise from altered expression of normal basal proteins, such as the up-regulation of human epidermal growth factor receptor 2 (Her2/ErbB2). To properly assess the development of Her2 therapeutics in an immune tolerant model, we previously generated a transgenic mouse model in which expression of the human Her2 protein was present in both the brain and mammary tissue. This mouse model has facilitated the development of Her2 targeted therapies in a clinically relevant and suitable model. While heterozygous Her2(+/-) mice appear to develop in a similar manner to wild type mice (Her2(-/-)), it has proven difficult to generate homozygous Her2(+/+) mice, potentially due to embryonic lethality. In this study, we performed whole genome sequencing to determine if the integration site of the Her2 transgene was responsible for this lethality. Indeed, we report that the Her2 transgene had integrated into the Pds5b (precocious dissociation of sisters) gene on chromosome 5, as a 162 copy concatemer. Furthermore, our findings demonstrate that Her2(+/+) mice, similar to Pds5b(-/-) mice, are embryonic lethal and confirm the necessity for Pds5b in embryonic development. This study confirms the value of whole genome sequencing in determining the integration site of transgenes to gain insight into associated phenotypes.	[Yong, Carmen S. M.; Sharkey, Janelle; Duscio, Belinda; Venville, Ben; Slaney, Clare Y.; Darcy, Phillip K.; Kershaw, Michael H.] Univ Melbourne, Canc Immunol Res Program, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia; [Wei, Wei-Zen; Jones, Richard F.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA; [Wei, Wei-Zen; Jones, Richard F.] Karmanos Canc Inst, Detroit, MI USA; [Arnau, Gisela Mir; Papenfuss, Anthony T.] Peter MacCallum Canc Ctr, Mol Genom Core, East Melbourne, Vic 3002, Australia; [Papenfuss, Anthony T.; Schroeder, Jan] Peter MacCallum Canc Ctr, Bioinformat & Canc Genom, East Melbourne, Vic 3002, Australia; [Papenfuss, Anthony T.; Schroeder, Jan] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3052, Australia; [Papenfuss, Anthony T.; Schroeder, Jan] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Schroeder, Jan] Univ Melbourne, Dept Comp & Informat Syst, Parkville, Vic 3010, Australia; [Darcy, Phillip K.] Monash Univ, Dept Immunol, Prahran, Vic 3181, Australia	Peter Maccallum Cancer Center; University of Melbourne; Wayne State University; Barbara Ann Karmanos Cancer Institute; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; Monash University	Kershaw, MH (corresponding author), Univ Melbourne, Canc Immunol Res Program, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia.	michael.kershaw@petermac.org	Papenfuss, Anthony T/C-6297-2008; Slaney, Clare/AHC-2382-2022	Papenfuss, Anthony T/0000-0002-1102-8506; Slaney, Clare/0000-0002-6986-6115; Mir Arnau, Gisela/0000-0002-9005-3485; SCHROEDER, JAN/0000-0001-5270-0605; Darcy, Phillip/0000-0002-5303-9561; Kershaw, Michael/0000-0002-2697-487X	Cancer Council of Victoria, Australia [1066554]; National Health and Medical Research Council (NHMRC) of Australia [1003667]; Senior Research Fellowships from the NHMRC; National Health and Medical Research Council (NHMRC) Career Development Fellowship [1003856]; NHMRC Program [1054618]; Victorian State Government Operational Infrastructure Support; Australian Government NHMRC Independent Research Institute Infrastructure Support Scheme; National Breast Cancer Foundation [PF-12-14] Funding Source: researchfish	Cancer Council of Victoria, Australia(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Senior Research Fellowships from the NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (NHMRC) Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Program(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support; Australian Government NHMRC Independent Research Institute Infrastructure Support Scheme(Australian GovernmentNational Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation	This work was supported by grants from the Cancer Council of Victoria, Australia (1066554) and the National Health and Medical Research Council (NHMRC) of Australia (1003667). MHK and PKD were supported by Senior Research Fellowships from the NHMRC. ATP was supported by a National Health and Medical Research Council (NHMRC) Career Development Fellowship (1003856), an NHMRC Program Grant (1054618) and benefitted from support by the Victorian State Government Operational Infrastructure Support and Australian Government NHMRC Independent Research Institute Infrastructure Support Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BISHOP JO, 1989, MOL BIOL MED, V6, P283; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; BRINSTER RL, 1981, CELL, V27, P223, DOI 10.1016/0092-8674(81)90376-7; Burstein HJ, 2005, NEW ENGL J MED, V353, P1652, DOI 10.1056/NEJMp058197; Carretero M, 2013, EMBO J, V32, P2938, DOI 10.1038/emboj.2013.230; Chen ZY, 2001, MOL THER, V3, P403, DOI 10.1006/mthe.2001.0278; CHOI YW, 1987, J VIROL, V61, P3013, DOI 10.1128/JVI.61.10.3013-3019.1987; De Giovanni C, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3602; Finkle D, 2004, CLIN CANCER RES, V10, P2499, DOI 10.1158/1078-0432.CCR-03-0448; FOLGER KR, 1982, MOL CELL BIOL, V2, P1372, DOI 10.1128/MCB.2.11.1372; Geck P, 2000, P NATL ACAD SCI USA, V97, P10185, DOI 10.1073/pnas.97.18.10185; HAMADA T, 1993, GENE, V128, P197, DOI 10.1016/0378-1119(93)90563-I; Hanker AB, 2013, P NATL ACAD SCI USA, V110, P14372, DOI 10.1073/pnas.1303204110; HENRARD D, 1988, J VIROL, V62, P3046, DOI 10.1128/JVI.62.8.3046-3049.1988; Jacob JB, 2010, CANCER RES, V70, P119, DOI 10.1158/0008-5472.CAN-09-2554; John LB, 2013, CLIN CANCER RES, V19, P5636, DOI 10.1158/1078-0432.CCR-13-0458; Kershaw MH, 2004, J IMMUNOL, V173, P2143, DOI 10.4049/jimmunol.173.3.2143; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Losada A, 2005, J CELL SCI, V118, P2133, DOI 10.1242/jcs.02355; Mar N, 2015, LUNG CANCER, V87, P220, DOI 10.1016/j.lungcan.2014.12.018; Matsuoka T, 2015, WORLD J CLIN CASES, V3, P42, DOI 10.12998/wjcc.v3.i1.42; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Panizza S, 2000, CURR BIOL, V10, P1557, DOI 10.1016/S0960-9822(00)00854-X; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Piechocki MP, 2003, J IMMUNOL, V171, P5787, DOI 10.4049/jimmunol.171.11.5787; PITTIUS CW, 1988, P NATL ACAD SCI USA, V85, P5874, DOI 10.1073/pnas.85.16.5874; Pollock NI, 2015, CLIN CANCER RES, V21, P526, DOI 10.1158/1078-0432.CCR-14-1432; Pupa SM, 2001, GENE THER, V8, P75, DOI 10.1038/sj.gt.3301360; Radkevich-Brown O, 2009, CANCER RES, V69, P212, DOI 10.1158/0008-5472.CAN-08-3092; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Ross JS, 1998, STEM CELLS, V16, P413, DOI 10.1002/stem.160413; Schroder J, 2014, BIOINFORMATICS; SHILONI E, 1993, CANCER IMMUNOL IMMUN, V37, P286, DOI 10.1007/BF01518450; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Singer SM, 1996, P NATL ACAD SCI USA, V93, P2947, DOI 10.1073/pnas.93.7.2947; Singer T, 2003, METH MOL B, V236, P241; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Stead K, 2003, J CELL BIOL, V163, P729, DOI 10.1083/jcb.200305080; Tessier CR, 2004, CANCER RES, V64, P209, DOI 10.1158/0008-5472.CAN-03-2927; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; WANG BP, 1994, P NATL ACAD SCI USA, V91, P9402, DOI 10.1073/pnas.91.20.9402; Wang LXJ, 2010, CANCER RES, V70, P9591, DOI 10.1158/0008-5472.CAN-10-2884; Wang SH, 2014, INT J BIOL SCI, V10, P25, DOI 10.7150/ijbs.6309; Wang SW, 2002, J CELL SCI, V115, P587; WEN JY, 1995, MOL REPROD DEV, V41, P399, DOI 10.1002/mrd.1080410402; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; Yan BW, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-58; Zerafa N, 2005, J IMMUNOL, V175, P5586, DOI 10.4049/jimmunol.175.9.5586; Zhang B, 2007, DEVELOPMENT, V134, P3191, DOI 10.1242/dev.005884; Zhang B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005232; Zhang M, 2000, ONCOGENE, V19, P6053, DOI 10.1038/sj.onc.1204006	51	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136817	10.1371/journal.pone.0136817	http://dx.doi.org/10.1371/journal.pone.0136817			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334628	Green Published, gold, Green Submitted			2022-12-26	WOS:000360615400028
J	Strom, J; Xu, BB; Tian, XQ; Chen, QM				Strom, Joshua; Xu, Beibei; Tian, Xiuqing; Chen, Qin M.			Nrf2 protects mitochondrial decay by oxidative stress	FASEB JOURNAL			English	Article						cell survival; loss of mitochondria; transcription factor; mitochondrial outer membrane	PROCEDURAL MYOCARDIAL INJURY; TRANSCRIPTION FACTOR NRF2; HEME OXYGENASE-1; CELL-DEATH; PERMEABILITY TRANSITION; BIOGENESIS; ACTIVATION; AUTOPHAGY; ANTIOXIDANT; FISSION	Sublethal levels of oxidative stress are commonly associated with various pathophysiological conditions. Cardiomyocytes have the highest content of mitochondria among all cell types, allowing the study of mitochondria in cells surviving oxidative stress and address whether nuclear factor-erythroid-derived 2-related factor 2 (Nrf2) can reverse these changes. Mitochondria normally exist in elaborated networks, which were replaced by predominately individual punctuate mitochondria 24 h after exposure to a nonlethal dose of H2O2. Electron microscopy revealed that cells surviving H2O2 show swelling of mitochondria with disorganized cristae and areas of condensation. Measurements of functional mitochondria showed a H2O2 dose-dependent decrease over a course of 5 d. At the protein and mRNA levels, cells surviving H2O2 treatment show a reduction of mitochondrial components, cytochrome c, and cytochrome b. Nrf2 overexpression prevented H2O2 from inducing mitochondria morphologic changes and reduction of cytochrome b/c. Although Nrf2 is known as a transcription factor regulating antioxidant and detoxification genes, Nrf2 overexpression did not significantly reduce the level of protein oxidation. Instead, Nrf2 was found to associate with the outer mitochondrial membrane. Mitochondria prepared from the myocardium of Nrf2 knockout mice are more sensitive to permeability transition. Our data suggest that Nrf2 protects mitochondria from oxidant injury likely through direct interaction with mitochondria.-Strom, J., Xu, B., Tian, X., Chen, Q. M. Nrf2 protects mitochondrial decay by oxidative stress. FASEB J. 30, 66-80 (2016). www.fasebj.org	[Strom, Joshua; Xu, Beibei; Tian, Xiuqing; Chen, Qin M.] Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA	University of Arizona	Chen, QM (corresponding author), Univ Arizona, Coll Med, Dept Pharmacol, 1501 N Campbell Ave, Tucson, AZ 85724 USA.	qchen@email.arizona.edu		Strom, Joshua/0000-0003-1236-1877	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [R01 HL089958]; NIH National Institute of Environmental Sciences [R21 ES017473, T32 ES007091]; NIH National Institute of General Medicine Sciences [R01 GM111337]; University of Arizona Sarver Heart Center Anonymous Award for Heart Failure Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES017473, T32ES007091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111337] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of Environmental Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of General Medicine Sciences; University of Arizona Sarver Heart Center Anonymous Award for Heart Failure Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant R01 HL089958, NIH National Institute of Environmental Sciences Grants R21 ES017473 and T32 ES007091, and NIH National Institute of General Medicine Sciences Grant R01 GM111337 and a University of Arizona Sarver Heart Center Anonymous Award for Heart Failure Research.	Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819; Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Athale J, 2012, FREE RADICAL BIO MED, V53, P1584, DOI 10.1016/j.freeradbiomed.2012.08.009; Babu GG, 2011, EUR HEART J, V32, P23, DOI 10.1093/eurheartj/ehq393; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bakhanashvili M, 2008, CELL DEATH DIFFER, V15, P1865, DOI 10.1038/cdd.2008.122; BARTH E, 1992, J MOL CELL CARDIOL, V24, P669, DOI 10.1016/0022-2828(92)93381-S; Bindu S, 2011, J BIOL CHEM, V286, P39387, DOI 10.1074/jbc.M111.279893; Bolisetty S, 2013, AM J PHYSIOL-RENAL, V305, pF255, DOI 10.1152/ajprenal.00160.2013; Borillo GA, 2010, CIRC RES, V106, P1265, DOI 10.1161/CIRCRESAHA.109.212035; Brady NR, 2006, BBA-BIOENERGETICS, V1757, P667, DOI 10.1016/j.bbabio.2006.04.011; Caballero-Caballero A, 2013, J NEUROCHEM, V124, P749, DOI 10.1111/jnc.12133; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chen QM, 2002, ONCOGENE, V21, P5313, DOI 10.1038/sj.onc.1205644; Chen QM, 2000, ARCH BIOCHEM BIOPHYS, V373, P242, DOI 10.1006/abbi.1999.1558; Chen YR, 2014, CIRC RES, V114, P524, DOI 10.1161/CIRCRESAHA.114.300559; Chung SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047299; Cooper MP, 2013, CIRCULATION, V127, P1932, DOI 10.1161/CIRCULATIONAHA.113.003177; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Darvekar SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085262; Dement GA, 2005, EXP CELL RES, V307, P388, DOI 10.1016/j.yexcr.2005.04.004; Dominic EA, 2014, HEART, V100, P611, DOI 10.1136/heartjnl-2013-304657; Dutta D, 2012, CIRC RES, V110, P1125, DOI 10.1161/CIRCRESAHA.111.246108; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Estaquier J, 2007, CELL DEATH DIFFER, V14, P1086, DOI 10.1038/sj.cdd.4402107; Goldhaber J.I., 1997, MYOCARDIUM, Vsecond, P325; He XQ, 2009, J MOL CELL CARDIOL, V46, P47, DOI 10.1016/j.yjmcc.2008.10.007; Herrmann J, 2005, EUR HEART J, V26, P2493, DOI 10.1093/eurheartj/ehi455; Holmstrom KM, 2013, BIOL OPEN, V2, P761, DOI 10.1242/bio.20134853; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Hoshino A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3308; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Jo C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4496; Joshi G, 2015, NEUROBIOL AGING, V36, P664, DOI 10.1016/j.neurobiolaging.2014.09.004; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; KLONER RA, 1989, CIRCULATION, V80, P1115, DOI 10.1161/01.CIR.80.5.1115; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kovac S, 2015, BBA-GEN SUBJECTS, V1850, P794, DOI 10.1016/j.bbagen.2014.11.021; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Kwon J, 2012, EMBO REP, V13, P150, DOI 10.1038/embor.2011.246; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Lee JM, 2003, J BIOL CHEM, V278, P37948, DOI 10.1074/jbc.M305204200; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Lo SC, 2008, EXP CELL RES, V314, P1789, DOI 10.1016/j.yexcr.2008.02.014; Ludtmann MHR, 2014, BIOCHEM J, V457, P415, DOI 10.1042/BJ20130863; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Ogita K, 2003, J NEUROSCI RES, V73, P794, DOI 10.1002/jnr.10720; Ong SB, 2010, CARDIOVASC RES, V88, P16, DOI 10.1093/cvr/cvq237; OPIE LH, 1989, CIRCULATION, V80, P1049, DOI 10.1161/01.CIR.80.4.1049; Petit PX, 1998, FEBS LETT, V426, P111, DOI 10.1016/S0014-5793(98)00318-4; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; Purdom S, 2005, J PHARMACOL EXP THER, V312, P1179, DOI 10.1124/jpet.104.077057; Purdom-Dickinson SE, 2007, MOL PHARMACOL, V72, P1074, DOI 10.1124/mol.107.035360; Purdom-Dickinson SE, 2007, J MOL CELL CARDIOL, V42, P159, DOI 10.1016/j.yjmcc.2006.09.012; Rao VA, 2010, J BIOL CHEM, V285, P34447, DOI 10.1074/jbc.M110.133579; Rasbach KA, 2007, J BIOL CHEM, V282, P2355, DOI 10.1074/jbc.M608009200; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Slebos DJ, 2007, AM J RESP CELL MOL, V36, P409, DOI 10.1165/rcmb.2006-0214OC; Tammineni P, 2013, J BIOL CHEM, V288, P4723, DOI 10.1074/jbc.M112.378984; Tu Victoria C, 2003, Cardiovasc Toxicol, V3, P119, DOI 10.1385/CT:3:2:119; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Xie LF, 2010, CARDIOVASC RES, V87, P628, DOI 10.1093/cvr/cvq138; Xu BB, 2014, BBA-MOL BASIS DIS, V1842, P1638, DOI 10.1016/j.bbadis.2014.06.002; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhang J, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010587, 10.1074/mcp.M111.015032]	69	81	85	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					66	80		10.1096/fj.14-268904	http://dx.doi.org/10.1096/fj.14-268904			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26340923	Green Published			2022-12-26	WOS:000367621000009
J	Rosenfeld, L; Shirian, J; Zur, Y; Levaot, N; Shifman, JM; Papo, N				Rosenfeld, Lior; Shirian, Jason; Zur, Yuval; Levaot, Noam; Shifman, Julia M.; Papo, Niv			Combinatorial and Computational Approaches to Identify Interactions of Macrophage Colony-stimulating Factor (M-CSF) and Its Receptor c-FMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; YEAST SURFACE DISPLAY; PICHIA-PASTORIS; GROWTH-FACTOR; CYTOKINES IL-34; EXPRESSION; ANTIBODIES; AFFINITY; CANCER; DOMAIN	The molecular interactions between macrophage colony-stimulating factor (M-CSF) and the tyrosine kinase receptor c-FMS play a key role in the immune response, bone metabolism, and the development of some cancers. Because no x-ray structure is available for the human M-CSF.c-FMS complex, the binding epitope for this complex is largely unknown. Our goal was to identify the residues that are essential for binding of the human M-CSF to c-FMS. For this purpose, we used a yeast surface display (YSD) approach. We expressed a combinatorial library of monomeric M-CSF (M-CSFM) single mutants and screened this library to isolate variants with reduced affinity for c-FMS using FACS. Sequencing yielded a number of single M-CSFM variants with mutations both in the direct binding interface and distant from the binding site. In addition, we used computational modeling to map the identified mutations onto the M-CSFM structure and to classify the mutations into three groups as follows: those that significantly decrease protein stability; those that destroy favorable intermolecular interactions; and those that decrease affinity through allosteric effects. To validate the YSD and computational data, M-CSFM and three variants were produced as soluble proteins; their affinity and structure were analyzed; and very good correlations with both YSD data and computational predictions were obtained. By identifying the M-CSFM residues critical for M-CSF.c-FMS interactions, we have laid down the basis for a deeper understanding of the M-CSF.c-FMS signaling mechanism and for the development of target-specific therapeutic agents with the ability to sterically occlude the M-CSF.c-FMS binding interface.	[Rosenfeld, Lior; Zur, Yuval; Papo, Niv] Ben Gurion Univ Negev, Dept Biotechnol Engn, 1 Ben Gurion Ave, IL-8410501 Beer Sheva, Israel; [Rosenfeld, Lior; Zur, Yuval; Papo, Niv] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-8410501 Beer Sheva, Israel; [Zur, Yuval; Levaot, Noam] Ben Gurion Univ Negev, Dept Physiol & Cell Biol, IL-8410501 Beer Sheva, Israel; [Shirian, Jason; Shifman, Julia M.] Hebrew Univ Jerusalem, Dept Biol Chem, Alexander Silberman Inst Life Sci, IL-9190401 Jerusalem, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Hebrew University of Jerusalem	Papo, N (corresponding author), Ben Gurion Univ Negev, Dept Biotechnol Engn, 1 Ben Gurion Ave, IL-8410501 Beer Sheva, Israel.	papo@bgu.ac.il	Levaot, Noam/AAA-3052-2022; Papo, Niv/R-3946-2017	Levaot, Noam/0000-0001-7747-3883; 	European Research Council [336041]; Israel Science Foundation [1372/10]	European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation)	This work was supported in part by the European Research Council "Ideas Program" ERC-2013-StG Contract Grant 336041 (to N. P.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by Israel Science Foundation Grant 1372/10.	Aizner Y, 2014, STRUCTURE, V22, P636, DOI 10.1016/j.str.2014.01.012; BARTELMEZ SH, 1989, EXP HEMATOL, V17, P240; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Brooks SA, 2004, MOL BIOTECHNOL, V28, P241, DOI 10.1385/MB:28:3:241; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Chao G, 2004, J MOL BIOL, V342, P539, DOI 10.1016/j.jmb.2004.07.053; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen XY, 2008, P NATL ACAD SCI USA, V105, P18267, DOI 10.1073/pnas.0807762105; Chockalingam S, 2014, TUMOR BIOL, V35, P10635, DOI 10.1007/s13277-014-2627-0; Cochran JR, 2004, J IMMUNOL METHODS, V287, P147, DOI 10.1016/j.jim.2004.01.024; Colby DW, 2004, METHOD ENZYMOL, V388, P348; CORTESE R, 1994, TRENDS BIOTECHNOL, V12, P262, DOI 10.1016/0167-7799(94)90137-6; Cregg JM, 2000, MOL BIOTECHNOL, V16, P23, DOI 10.1385/MB:16:1:23; CREGG JM, 1985, MOL CELL BIOL, V5, P3376, DOI 10.1128/MCB.5.12.3376; Dahiyat BI, 1997, J MOL BIOL, V273, P789, DOI 10.1006/jmbi.1997.1341; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Daly R, 2005, J MOL RECOGNIT, V18, P119, DOI 10.1002/jmr.687; DESMET J, 1992, NATURE, V356, P539, DOI 10.1038/356539a0; Doolan KM, 2015, J MOL BIOL, V427, P328, DOI 10.1016/j.jmb.2014.10.024; Douglass TG, 2008, INT IMMUNOPHARMACOL, V8, P1354, DOI 10.1016/j.intimp.2008.04.016; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; Elegheert J, 2012, NAT STRUCT MOL BIOL, V19, P938, DOI 10.1038/nsmb.2367; Erijman A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110085; Escamilla J, 2015, CANCER RES, V75, P950, DOI 10.1158/0008-5472.CAN-14-0992; Fack F, 1997, J IMMUNOL METHODS, V206, P43, DOI 10.1016/S0022-1759(97)00083-5; Filchtinski D, 2010, J MOL BIOL, V399, P422, DOI 10.1016/j.jmb.2010.03.046; Gai SA, 2007, CURR OPIN STRUC BIOL, V17, P467, DOI 10.1016/j.sbi.2007.08.012; Gordon DB, 2003, J COMPUT CHEM, V24, P232, DOI 10.1002/jcc.10121; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; GRONSKI P, 1988, Behring Institute Mitteilungen, P246; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Lefevre F, 1997, NUCLEIC ACIDS RES, V25, P447, DOI 10.1093/nar/25.2.447; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; Lin EY, 2002, J MAMMARY GLAND BIOL, V7, P147, DOI 10.1023/A:1020399802795; Liu HL, 2012, BBA-PROTEINS PROTEOM, V1824, P938, DOI 10.1016/j.bbapap.2012.04.012; Luo YX, 2008, BIOTECHNOL PROGR, V24, P214, DOI 10.1021/bp0702727; Lyskov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063906; Ma XL, 2012, STRUCTURE, V20, P676, DOI 10.1016/j.str.2012.02.010; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mata-Fink J, 2013, J MOL BIOL, V425, P444, DOI 10.1016/j.jmb.2012.11.010; Murciano-Calles J, 2014, J MOL BIOL, V426, P3500, DOI 10.1016/j.jmb.2014.05.003; Murray LJ, 2003, CLIN EXP METASTAS, V20, P757, DOI 10.1023/B:CLIN.0000006873.65590.68; Pal G, 2006, J BIOL CHEM, V281, P22378, DOI 10.1074/jbc.M603826200; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Sharabi O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093712; Sharabi O, 2013, BIOCHEM SOC T, V41, P1166, DOI 10.1042/BST20130121; Sharabi O, 2013, METHOD ENZYMOL, V523, P41, DOI 10.1016/B978-0-12-394292-0.00003-5; Sharabi O, 2011, PROTEINS, V79, P1487, DOI 10.1002/prot.22977; Shi XZ, 2003, PROTEIN EXPRES PURIF, V28, P321, DOI 10.1016/S1046-5928(02)00706-4; Sluijter M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104230; Stanley ER, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a021857; TANNER W, 1987, BIOCHIM BIOPHYS ACTA, V906, P81, DOI 10.1016/0304-4157(87)90006-2; TAYLOR EW, 1994, J BIOL CHEM, V269, P31171; Thompson LC, 2006, BIOCHEMISTRY-US, V45, P2267, DOI 10.1021/bi0519506; TUSHINSKI RJ, 1982, CELL, V28, P71, DOI 10.1016/0092-8674(82)90376-2; Van Overmeire E, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00127; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zhao YM, 1996, P NATL ACAD SCI USA, V93, P4020, DOI 10.1073/pnas.93.9.4020	64	16	17	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26180	26193		10.1074/jbc.M115.671271	http://dx.doi.org/10.1074/jbc.M115.671271			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26359491	hybrid, Green Published			2022-12-26	WOS:000363527300036
J	Wang, HY; Jin, HN; Rapraeger, AC				Wang, Haiyao; Jin, Haining; Rapraeger, Alan C.			Syndecan-1 and Syndecan-4 Capture Epidermal Growth Factor Receptor Family Members and the alpha 3 beta 1 Integrin Via Binding Sites in Their Ectodomains NOVEL SYNSTATINS PREVENT KINASE CAPTURE AND INHIBIT alpha 6 beta 4-INTEGRIN-DEPENDENT EPITHELIAL CELL MOTILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE 3-OH KINASE; FACTOR-I RECEPTOR; ALPHA-6-BETA-4 INTEGRIN; CARCINOMA INVASION; ALPHA(6)BETA(4) INTEGRIN; SURFACE PROTEOGLYCAN; ERBB-3 EXPRESSION; ACTIVATION; HEMIDESMOSOMES; DOMAIN	The alpha 6 beta 4 integrin is known to associate with receptor tyrosine kinases when engaged in epithelial wound healing and in carcinoma invasion and survival. Prior work has shown that HER2 associates with alpha 6 beta 4 integrin and syndecan-1 (Sdc1), in which Sdc1 engages the cytoplasmic domain of the beta 4 integrin subunit allowing HER2-dependent motility and carcinoma cell survival. In contrast, EGFR associates with Sdc4 and the alpha 6 beta 4 integrin, and EGFR-dependent motility depends on cytoplasmic engagement of beta 4 integrin with Sdc4. However, how HER2 and EGFR assimilate into a complex with the syndecans and integrin, and why kinase capture is syndecan-specific has remained unknown. In the present study, we demonstrate that HER2 is captured via a site, comprised of amino acids 210-240, in the extracellular domain of human Sdc1, and EGFR is captured via an extracellular site comprised of amino acids 87-131 in human Sdc4. Binding assays using purified recombinant proteins demonstrate that the interaction between the EGFR family members and the syndecans is direct. The alpha 3 beta 1 integrin, which is responsible for the motility of the cells, is captured at these sites as well. Peptides based on the interaction motifs in Sdc1 and Sdc4, called synstatins (SSTN210-240 and SSTN87-131) competitively displace the receptor tyrosine kinase and alpha 3 beta 1 integrin from the syndecan with an IC50 of 100-300 nM. The syndecans remain anchored to the alpha 6 beta 4 integrin via its cytoplasmic domain, but the activation of cell motility is disrupted. These novel SSTN peptides are potential therapeutics for carcinomas that depend on these HER2-and EGFR-coupled mechanisms for their invasion and survival.	[Wang, Haiyao; Jin, Haining; Rapraeger, Alan C.] Univ Wisconsin, Wisconsin Inst Med Res, Dept Human Oncol, Madison, WI 53705 USA; [Rapraeger, Alan C.] Univ Wisconsin, Wisconsin Inst Med Res, Carbone Canc Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Rapraeger, AC (corresponding author), Wisconsin Inst Med Res, 1111 Highland Ave, Madison, WI 53705 USA.	rapraeger@humonc.wisc.edu			National Cancer Institute [P30 CA014520]; NATIONAL CANCER INSTITUTE [P30CA014520, R01CA109010, R01CA163662] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the University of Wisconsin Carbone Cancer Center for the use of its shared services, supported by the National Cancer Institute (P30 CA014520). We are especially thankful for reagents from Filippo Giancotti, Memorial Sloan-Kettering Cancer Center, that have made this work possible.	Beauvais DM, 2010, J CELL SCI, V123, P3796, DOI 10.1242/jcs.067645; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bertotti A, 2006, J CELL BIOL, V175, P993, DOI 10.1083/jcb.200605114; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; de Pereda JM, 2009, EMBO J, V28, P1180, DOI 10.1038/emboj.2009.48; Dutta U, 2008, CANCER RES, V68, P8779, DOI 10.1158/0008-5472.CAN-08-2125; Falcioni R, 1997, EXP CELL RES, V236, P76, DOI 10.1006/excr.1997.3695; Folgiero V, 2007, CANCER RES, V67, P1645, DOI 10.1158/0008-5472.CAN-06-2980; Folgiero V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001592; Frijns E, 2012, MOL BIOL CELL, V23, P1475, DOI 10.1091/mbc.E11-11-0957; Gambaletta D, 2000, J BIOL CHEM, V275, P10604, DOI 10.1074/jbc.275.14.10604; Goldfinger LE, 1999, J CELL SCI, V112, P2615; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Koster J, 2004, MOL BIOL CELL, V15, P1211, DOI 10.1091/mbc.E03-09-0697; Langford JK, 2005, J BIOL CHEM, V280, P3467, DOI 10.1074/jbc.M412451200; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; McFall AJ, 1997, J BIOL CHEM, V272, P12901, DOI 10.1074/jbc.272.20.12901; McFall AJ, 1998, J BIOL CHEM, V273, P28270, DOI 10.1074/jbc.273.43.28270; Merdek KD, 2007, J BIOL CHEM, V282, P30322, DOI 10.1074/jbc.M703156200; Nievers MG, 1999, MATRIX BIOL, V18, P5, DOI 10.1016/S0945-053X(98)00003-1; Nikolopoulos SN, 2004, CANCER CELL, V6, P471, DOI 10.1016/j.ccr.2004.09.029; Nistico P, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0459-x; Rabinovitz I, 2004, MOL CELL BIOL, V24, P4351, DOI 10.1128/MCB.24.10.4351-4360.2004; RAPRAEGER A, 1985, J BIOL CHEM, V260, P1046; Rapraeger AC, 2013, FEBS J, V280, P2207, DOI 10.1111/febs.12160; Rapraeger AC, 2013, FEBS J, V280, P2194, DOI 10.1111/febs.12134; Russell AJ, 2003, J CELL SCI, V116, P3543, DOI 10.1242/jcs.00663; Sehgal BU, 2006, J BIOL CHEM, V281, P35487, DOI 10.1074/jbc.M606317200; Shaw LM, 2001, MOL CELL BIOL, V21, P5082, DOI 10.1128/MCB.21.15.5082-5093.2001; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Wang HY, 2014, J BIOL CHEM, V289, P30318, DOI 10.1074/jbc.M114.586438; Wang HY, 2010, J BIOL CHEM, V285, P13569, DOI 10.1074/jbc.M110.102137; Whiteford JR, 2006, J BIOL CHEM, V281, P32156, DOI 10.1074/jbc.M605553200; Wilhelmsen K, 2006, MOL CELL BIOL, V26, P2877, DOI 10.1128/MCB.26.8.2877-2886.2006; Wilhelmsen K, 2007, MOL BIOL CELL, V18, P3512, DOI 10.1091/mbc.E07-04-0306; Yang XQ, 2010, MOL CELL BIOL, V30, P5306, DOI 10.1128/MCB.00326-10; Yoshioka T, 2013, J CLIN INVEST, V123, P682, DOI 10.1172/JCI60720	40	46	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26103	26113		10.1074/jbc.M115.679084	http://dx.doi.org/10.1074/jbc.M115.679084			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26350464	Green Published, hybrid			2022-12-26	WOS:000363527300030
J	Manzanares, D; Krick, S; Baumlin, N; Dennis, JS; Tyrrell, J; Tarran, R; Salathe, M				Manzanares, Dahis; Krick, Stefanie; Baumlin, Nathalie; Dennis, John S.; Tyrrell, Jean; Tarran, Robert; Salathe, Matthias			Airway Surface Dehydration by Transforming Growth Factor beta (TGF-beta) in Cystic Fibrosis Is Due to Decreased Function of a Voltage-dependent Potassium Channel and Can Be Rescued by the Drug Pirfenidone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS; LIQUID VOLUME; LARGE-CONDUCTANCE; CFTR POTENTIATOR; LUNG-DISEASE; K+ CHANNELS; PATHOGENESIS; LAYER; ION	Transforming growth factor beta 1 (TGF-beta 1) is not only elevated in airways of cystic fibrosis (CF) patients, whose airways are characterized by abnormal ion transport and mucociliary clearance, but TGF-beta 1 is also associated with worse clinical outcomes. Effective mucociliary clearance depends on adequate airway hydration, governed by ion transport. Apically expressed, large-conductance, Ca2+- and voltage-dependent K+ (BK) channels play an important role in this process. In this study, TGF-beta 1 decreased airway surface liquid volume, ciliary beat frequency, and BK activity in fully differentiated CF bronchial epithelial cells by reducing mRNA expression of the BK gamma subunit leucine-rich repeat-containing protein 26 (LRRC26) and its function. Although LRRC26 knockdown itself reduced BK activity, LRRC26 overexpression partially reversed TGF-beta 1-induced BK dysfunction. TGF-beta 1-induced airway surface liquid volume hyper-absorption was reversed by the BK opener mallotoxin and the clinically useful TGF-beta signaling inhibitor pirfenidone. The latter increased BK activity via rescue of LRRC26. Therefore, we propose that TGF-beta 1-induced mucociliary dysfunction in CF airways is associated with BK inactivation related to a LRRC26 decrease and is amenable to treatment with clinically useful TGF-beta 1 inhibitors.	[Manzanares, Dahis; Krick, Stefanie; Baumlin, Nathalie; Dennis, John S.; Salathe, Matthias] Univ Miami, Div Pulm Allergy Crit Care & Sleep Med, Miami, FL 33136 USA; [Tyrrell, Jean; Tarran, Robert] Univ N Carolina, Cyst Fibrosis Ctr, Chapel Hill, NC 27599 USA	University of Miami; University of North Carolina; University of North Carolina Chapel Hill	Salathe, M (corresponding author), Univ Miami, Miller Sch Med, Div Pulm Allergy Crit Care & Sleep Med, 1600 N-W 10th Ave,RMSB 7061 R-47, Miami, FL 33136 USA.	msalathe@med.miami.edu		Salathe, Matthias/0000-0001-9092-4861	Cystic Fibrosis Foundation	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This work was supported by a grant from the Cystic Fibrosis Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Almassy J, 2012, MOL PHARMACOL, V81, P21, DOI 10.1124/mol.111.075234; Arkwright PD, 2000, THORAX, V55, P459, DOI 10.1136/thorax.55.6.459; Bentzen BH, 2007, MOL PHARMACOL, V72, P1033, DOI 10.1124/mol.107.038331; Boucher RC, 2003, PFLUG ARCH EUR J PHY, V445, P495, DOI 10.1007/s00424-002-0955-1; Boucher RC, 2002, ADV DRUG DELIVER REV, V54, P1359, DOI 10.1016/S0169-409X(02)00144-8; Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012; Collaco JM, 2008, CURR OPIN PULM MED, V14, P559, DOI 10.1097/MCP.0b013e3283121cdc; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Guillot L, 2014, INT J BIOCHEM CELL B, V52, P83, DOI 10.1016/j.biocel.2014.02.011; Harris WT, 2009, PEDIATR PULM, V44, P1057, DOI 10.1002/ppul.21079; Harvey PR, 2011, AM J RESP CELL MOL, V45, P592, DOI 10.1165/rcmb.2010-0484OC; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Manzanares D, 2014, AM J PHYSIOL-LUNG C, V306, pL453, DOI 10.1152/ajplung.00247.2013; Manzanares D, 2011, J BIOL CHEM, V286, P19830, DOI 10.1074/jbc.M110.185074; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Perkett EA, 2006, PEDIATR PULM, V41, P771, DOI 10.1002/ppul.20452; Peters DM, 2014, P NATL ACAD SCI USA, V111, pE374, DOI 10.1073/pnas.1306798111; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Ratjen F, 2012, J CYST FIBROS, V11, P539, DOI 10.1016/j.jcf.2012.05.003; Roomans Godfried M, 2004, J Cyst Fibros, V3 Suppl 2, P135, DOI 10.1016/j.jcf.2004.05.029; Salathe M, 1999, J PHYSIOL-LONDON, V520, P851, DOI 10.1111/j.1469-7793.1999.00851.x; Schmid A, 2006, J CELL SCI, V119, P4176, DOI 10.1242/jcs.03181; Snodgrass SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063167; Sun HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106842; Tarran Robert, 2004, Proc Am Thorac Soc, V1, P42, DOI 10.1513/pats.2306014; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Yan JS, 2012, P NATL ACAD SCI USA, V109, P7917, DOI 10.1073/pnas.1205435109; Yan JS, 2010, NATURE, V466, P513, DOI 10.1038/nature09162	29	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25710	25716		10.1074/jbc.M115.670885	http://dx.doi.org/10.1074/jbc.M115.670885			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26338706	Green Published, hybrid			2022-12-26	WOS:000362962800042
J	Miller, EV; Grandi, LN; Giannini, JA; Robinson, JD; Powell, JR				Miller, Elizabeth V.; Grandi, Leah N.; Giannini, Jennifer A.; Robinson, Joseph D.; Powell, Jennifer R.			The Conserved G-Protein Coupled Receptor FSHR-1 Regulates Protective Host Responses to Infection and Oxidative Stress	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; CAENORHABDITIS-ELEGANS; PATHOGENIC BACTERIA; CHEMOSENSORY CELLS; HYDROGEN-PEROXIDE; IMMUNE-RESPONSE; AVOIDANCE; GENES; EXPRESSION; COMPLEX	The innate immune system's ability to sense an infection is critical so that it can rapidly respond if pathogenic microorganisms threaten the host, but otherwise maintain a quiescent baseline state to avoid causing damage to the host or to commensal microorganisms. One important mechanism for discriminating between pathogenic and non-pathogenic bacteria is the recognition of cellular damage caused by a pathogen during the course of infection. In Caenorhabditis elegans, the conserved G-protein coupled receptor FSHR-1 is an important constituent of the innate immune response. FSHR-1 activates the expression of antimicrobial infection response genes in infected worms and delays accumulation of the ingested pathogen Pseudomonas aeruginosa. FSHR-1 is central not only to the worm's survival of infection by multiple pathogens, but also to the worm's survival of xenobiotic cadmium and oxidative stresses. Infected worms produce reactive oxygen species to fight off the pathogens; FSHR-1 is required at the site of infection for the expression of detoxifying genes that protect the host from collateral damage caused by this defense response. Finally, the FSHR-1 pathway is important for the ability of worms to discriminate pathogenic from benign bacteria and subsequently initiate an aversive learning program that promotes selective pathogen avoidance.	[Miller, Elizabeth V.; Grandi, Leah N.; Giannini, Jennifer A.; Robinson, Joseph D.; Powell, Jennifer R.] Gettysburg Coll, Dept Biol, Gettysburg, PA 17325 USA	Gettysburg College	Powell, JR (corresponding author), Gettysburg Coll, Dept Biol, Gettysburg, PA 17325 USA.	jpowell@gettysburg.edu	Powell, Jennifer/HFZ-8254-2022	Giannini, Jennifer/0000-0003-0034-9328; Miller, Elizabeth/0000-0001-5087-3713	Howard Hughes Medical Institute through the Precollege and Undergraduate Science Education Program	Howard Hughes Medical Institute through the Precollege and Undergraduate Science Education Program	This work was supported in part by a grant to Gettysburg College from the Howard Hughes Medical Institute through the Precollege and Undergraduate Science Education Program.	Bolm M, 2004, INFECT IMMUN, V72, P1192, DOI 10.1128/IAI.72.2.1192-1194.2004; BRENNER S, 1974, GENETICS, V77, P71; Cezairliyan B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003101; Chang HC, 2011, NATURE, V480, P525, DOI 10.1038/nature10643; Chavez V, 2007, GENETICS, V176, P1567, DOI 10.1534/genetics.107.072587; Chavez V, 2009, INFECT IMMUN, V77, P4983, DOI 10.1128/IAI.00627-09; Chmielowska-Bak J, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00245; Darby Creg, 2005, WormBook, P1; Dong J, 2005, BBA-GENE STRUCT EXPR, V1727, P16, DOI 10.1016/j.bbaexp.2004.11.007; Dunbar TL, 2012, CELL HOST MICROBE, V11, P375, DOI 10.1016/j.chom.2012.02.008; Fan QR, 2008, PROTEINS, V72, P393, DOI 10.1002/prot.21937; Fan QR, 2007, MOL CELL ENDOCRINOL, V260, P73, DOI 10.1016/j.mce.2005.12.055; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; GINSBURG I, 1993, FREE RADICAL BIO MED, V14, P495, DOI 10.1016/0891-5849(93)90106-5; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; Kirienko NV, 2014, METHODS MOL BIOL, V1149, P653, DOI 10.1007/978-1-4939-0473-0_50; Kudo M, 2000, MOL ENDOCRINOL, V14, P272, DOI 10.1210/me.14.2.272; Lee KA, 2015, CELL HOST MICROBE, V17, P191, DOI 10.1016/j.chom.2014.12.012; Lee KA, 2013, CELL, V153, P797, DOI 10.1016/j.cell.2013.04.009; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Meisel JD, 2014, TRENDS IMMUNOL, V35, P465, DOI 10.1016/j.it.2014.08.008; Meisel JD, 2014, CELL, V159, P267, DOI 10.1016/j.cell.2014.09.011; Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050; Powell JR, 2009, P NATL ACAD SCI USA, V106, P2782, DOI 10.1073/pnas.0813048106; Powell Jennifer R., 2008, V415, P403, DOI 10.1007/978-1-59745-570-1_24; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Reddy KC, 2009, SCIENCE, V323, P382, DOI 10.1126/science.1166527; Saunders CJ, 2014, P NATL ACAD SCI USA, V111, P6075, DOI 10.1073/pnas.1402251111; Schakel C, 2015, 8TH ACM INTERNATIONAL CONFERENCE ON PERVASIVE TECHNOLOGIES RELATED TO ASSISTIVE ENVIRONMENTS (PETRA 2015), DOI 10.1145/2769493.2769499; Sem X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045417; Shivers RP, 2009, CELL HOST MICROBE, V6, P321, DOI 10.1016/j.chom.2009.09.001; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Van Der Hoeven R, 2015, PLOS ONE, V10; van der Hoeven R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002453; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216; Zugasti O, 2014, NAT IMMUNOL, V15, P833, DOI 10.1038/ni.2957	42	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137403	10.1371/journal.pone.0137403	http://dx.doi.org/10.1371/journal.pone.0137403			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360906	Green Published, gold			2022-12-26	WOS:000361043100034
J	Paredes, M; Quiles, MJ				Paredes, Miriam; Quiles, Maria Jose			The Effects of Cold Stress on Photosynthesis in Hibiscus Plants	PLOS ONE			English	Article							CYCLIC ELECTRON FLOW; CHLOROPLASTIC NAD(P)H DEHYDROGENASE; HIGH LIGHT-INTENSITY; PLASTID TERMINAL OXIDASE; HIGH ROOT TEMPERATURE; PHOTOSYSTEM-I; HIGH ILLUMINATION; CHILLING STRESS; NDH COMPLEX; C-3 PLANTS	The present work studies the effects of cold on photosynthesis, as well as the involvement in the chilling stress of chlororespiratory enzymes and ferredoxin-mediated cyclic electron flow, in illuminated plants of Hibiscus rosa-sinensis. Plants were sensitive to cold stress, as indicated by a reduction in the photochemistry efficiency of PSII and in the capacity for electron transport. However, the susceptibility of leaves to cold may be modified by root temperature. When the stem, but not roots, was chilled, the quantum yield of PSII and the relative electron transport rates were much lower than when the whole plant, root and stem, was chilled at 10 degrees C. Additionally, when the whole plant was cooled, both the activity of electron donation by NADPH and ferredoxin to plastoquinone and the amount of PGR5 polypeptide, an essential component of the cyclic electron flow around PSI, increased, suggesting that in these conditions cyclic electron flow helps protect photosystems. However, when the stem, but not the root, was cooled cyclic electron flow did not increase and PSII was damaged as a result of insufficient dissipation of the excess light energy. In contrast, the chlororespiratory enzymes (NDH complex and PTOX) remained similar to control when the whole plant was cooled, but increased when only the stem was cooled, suggesting the involvement of chlororespiration in the response to chilling stress when other pathways, such as cyclic electron flow around PSI, are insufficient to protect PSII.	[Paredes, Miriam; Quiles, Maria Jose] Univ Murcia, Fac Biol, Dept Biol Vegetal, Murcia, Spain	University of Murcia	Quiles, MJ (corresponding author), Univ Murcia, Fac Biol, Dept Biol Vegetal, Murcia, Spain.	mjquiles@um.es			Spanish Ministry of Education and Science [BFU2009-00331]; University of Murcia (Spain) [E005-03]	Spanish Ministry of Education and Science(Spanish Government); University of Murcia (Spain)	This work was supported by the Spanish Ministry of Education and Science (grant BFU2009-00331) and the University of Murcia (Spain) (grant E005-03).	Allen DJ, 2001, TRENDS PLANT SCI, V6, P36, DOI 10.1016/S1360-1385(00)01808-2; Aluru MR, 2004, PHYSIOL PLANTARUM, V120, P4, DOI 10.1111/j.0031-9317.2004.0217.x; BENDALL DS, 1995, BBA-BIOENERGETICS, V1229, P23, DOI 10.1016/0005-2728(94)00195-B; BENNOUN P, 1982, P NATL ACAD SCI-BIOL, V79, P4352, DOI 10.1073/pnas.79.14.4352; BENNOUN P, 1994, BBA-BIOENERGETICS, V1186, P59, DOI 10.1016/0005-2728(94)90135-X; Bernhard Teicher H, 2000, PHOTOSYNTH RES, V64, P53, DOI 10.1023/A:1026524302191; Breyton C, 2006, BIOCHEMISTRY-US, V45, P13465, DOI 10.1021/bi061439s; Bukhov N, 2004, PHOTOSYNTH RES, V82, P17, DOI 10.1023/B:PRES.0000040442.59311.72; Casano LM, 2001, PLANT PHYSIOL, V125, P1450, DOI 10.1104/pp.125.3.1450; Catala R, 1997, PLANT CELL PHYSIOL, V38, P1382, DOI 10.1093/oxfordjournals.pcp.a029133; DalCorso G, 2008, CELL, V132, P273, DOI 10.1016/j.cell.2007.12.028; DemmigAdams B, 1996, PLANTA, V198, P460, DOI 10.1007/BF00620064; Diaz M, 2007, PLANT CELL ENVIRON, V30, P1578, DOI 10.1111/j.1365-3040.2007.01735.x; Endo T, 1999, FEBS LETT, V457, P5, DOI 10.1016/S0014-5793(99)00989-8; FORK DC, 1993, PHOTOSYNTH RES, V36, P149, DOI 10.1007/BF00033035; Gamboa J, 2009, PLANT SCI, V177, P643, DOI 10.1016/j.plantsci.2009.09.004; Golding AJ, 2004, PLANTA, V220, P356, DOI 10.1007/s00425-004-1345-z; Golding AJ, 2003, PLANTA, V218, P107, DOI 10.1007/s00425-003-1077-5; Havaux M, 2005, BBA-BIOENERGETICS, V1709, P203, DOI 10.1016/j.bbabio.2005.07.010; HAVAUX M, 1991, PLANTA, V186, P88, DOI 10.1007/BF00201502; Herbert SK, 1995, PHOTOSYNTH RES, V46, P277, DOI 10.1007/BF00020441; HERBERT SK, 1990, PLANT PHYSIOL, V94, P926, DOI 10.1104/pp.94.3.926; Ibanez H, 2010, J PLANT PHYSIOL, V167, P732, DOI 10.1016/j.jplph.2009.12.013; Ifuku K, 2011, PLANT CELL PHYSIOL, V52, P1560, DOI 10.1093/pcp/pcr098; Ivanov AG, 2012, PHOTOSYNTH RES, V113, P191, DOI 10.1007/s11120-012-9769-y; Joet T, 2002, PLANT PHYSIOL, V128, P760, DOI 10.1104/pp.010775; Joet T, 2001, PLANT PHYSIOL, V125, P1919, DOI 10.1104/pp.125.4.1919; Johnson GN, 2005, J EXP BOT, V56, P407, DOI 10.1093/jxb/eri106; Joliot P, 2002, P NATL ACAD SCI USA, V99, P10209, DOI 10.1073/pnas.102306999; Joliot P, 2006, BBA-BIOENERGETICS, V1757, P362, DOI 10.1016/j.bbabio.2006.02.018; Joliot P, 2011, P NATL ACAD SCI USA, V108, P13317, DOI 10.1073/pnas.1110189108; Kuntz M, 2004, PLANTA, V218, P896, DOI 10.1007/s00425-004-1217-6; Laureau C, 2011, PHYSIOL PLANTARUM, V143, P246, DOI 10.1111/j.1399-3054.2011.01505.x; Li XG, 2004, PLANT CELL PHYSIOL, V45, P103, DOI 10.1093/pcp/pch011; Lichtenthaler H., 1983, BIOCHEM SOC T, V11, P591, DOI [10.1042/bst0110591, 10.1042/BST0110591, DOI 10.1042/BST0110591]; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYONS JM, 1973, ANNU REV PLANT PHYS, V24, P445, DOI 10.1146/annurev.pp.24.060173.002305; Martin M, 1996, PLANT CELL PHYSIOL, V37, P293, DOI 10.1093/oxfordjournals.pcp.a028945; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X; Munoz R, 2013, INT J MOL SCI, V14, P5432, DOI 10.3390/ijms14035432; Paredes M, 2013, J PLANT PHYSIOL, V170, P165, DOI 10.1016/j.jplph.2012.09.010; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; Quiles MJ, 2006, PLANT CELL ENVIRON, V29, P1463, DOI 10.1111/j.1365-3040.2006.01510.x; Quiles MJ, 1998, PLANT PHYSIOL, V117, P235, DOI 10.1104/pp.117.1.235; Quiles MJ, 2005, PLANT SCI, V168, P1561, DOI 10.1016/j.plantsci.2005.02.005; Quiles MJ, 2004, PLANT SCI, V166, P815, DOI 10.1016/j.plantsci.2003.11.025; Quiles MJ, 2003, PLANT SCI, V164, P541, DOI 10.1016/S0168-9452(03)00003-7; Quiles MJ, 2000, PLANT PHYSIOL BIOCH, V38, P225, DOI 10.1016/S0981-9428(00)00740-3; Rizhsky L, 2002, PLANT J, V32, P329, DOI 10.1046/j.1365-313X.2002.01427.x; Rumeau D, 2005, PLANT CELL, V17, P219, DOI 10.1105/tpc.104.028282; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; Saura P., 2009, Open Plant Science Journal, V3, P7, DOI 10.2174/1874294700903010007; Sazanov LA, 1998, P NATL ACAD SCI USA, V95, P1319, DOI 10.1073/pnas.95.3.1319; Segura MV, 2015, PLANT CELL ENVIRON, V38, P525, DOI 10.1111/pce.12406; Sonoike K, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P2217; Streb P, 2005, PLANT CELL ENVIRON, V28, P1123, DOI 10.1111/j.1365-3040.2005.01350.x; Sun X, 2011, J BIOSCIENCES, V36, P951, DOI 10.1007/s12038-011-9161-7; Suzuki K, 2008, PLANT CELL PHYSIOL, V49, P433, DOI 10.1093/pcp/pcn020; Suzuki K, 2013, PLANT CELL PHYSIOL, V54, P1769, DOI 10.1093/pcp/pct120; Suzuki K, 2011, PLANT CELL PHYSIOL, V52, P1697, DOI 10.1093/pcp/pcr104; Tallon C, 2007, PLANT SCI, V173, P438, DOI 10.1016/j.plantsci.2007.07.001; Wang P, 2006, PLANT PHYSIOL, V141, P465, DOI 10.1104/pp.105.070490	63	27	30	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137472	10.1371/journal.pone.0137472	http://dx.doi.org/10.1371/journal.pone.0137472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360248	Green Published, Green Submitted, gold			2022-12-26	WOS:000361043100042
J	Dai, XF; Guo, WW; Zhan, CJ; Liu, XX; Bai, ZH; Yang, YK				Dai, Xiaofeng; Guo, Wenwen; Zhan, Chunjun; Liu, Xiuxia; Bai, Zhonghu; Yang, Yankun			WDR5 Expression Is Prognostic of Breast Cancer Outcome	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; GENE-EXPRESSION; CHROMATIN; PROSTATE; MUTATION; IDENTIFICATION; TRANSCRIPTION; METHYLATION	WDR5 is a core component of the human mixed lineage leukemia-2 complex, which plays central roles in ER positive tumour cells and is a major driver of androgen-dependent prostate cancer cell proliferation. Given the similarities between breast and prostate cancers, we explore the potential prognostic value of WDR5 gene expression on breast cancer survival. Our findings reveal that WDR5 over-expression is associated with poor breast cancer clinical outcome in three gene expression data sets and BreastMark. The eQTL analysis reveals 130 trans-eQTL SNPs whose genes mapped with statistical significance are significantly associated with patient survival. These genes together with WDR5 are enriched with "cellular development, gene expression, cell cycle" signallings. Knocking down WDR5 in MCF7 dramatically decreases cell viability, but does not alter tumour cell response to doxorubicin. Our study reveals the prognostic value of WDR5 expression in breast cancer which is under long-range regulation of genes involved in cell cycle, and anthracycline could be coupled with treatments targeting WDR5 once such a regimen is available.	[Dai, Xiaofeng; Guo, Wenwen; Zhan, Chunjun; Liu, Xiuxia; Bai, Zhonghu; Yang, Yankun] Jiangnan Univ, Sch Biotechnol, Wuxi, Peoples R China; [Dai, Xiaofeng; Guo, Wenwen; Zhan, Chunjun; Liu, Xiuxia; Bai, Zhonghu; Yang, Yankun] Jiangnan Univ, Natl Engn Lab Cereal Fermentat Technol, Wuxi, Peoples R China	Jiangnan University; Jiangnan University	Dai, XF (corresponding author), Jiangnan Univ, Sch Biotechnol, Wuxi, Peoples R China.	xiaofeng.dai@me.com; yangyankun@jiangnan.edu.cn	Bai, Zhihui/O-5303-2019; Yang, Yankun/AAJ-3032-2020	Bai, Zhihui/0000-0002-3818-527X; Yang, Yankun/0000-0003-4815-6832	National Natural Science Foundation of China [31471251]; Jiangnan University Research Support Foundation for Young Scientists [5922050205150370]; National High Technology Research and Development Program of China, 863 Program [2015AA020802]; National Basic Research Program of China, 973 Program [2013CB733602]; Fundamental Research Funds for the Central Universities [JUSRP51401A]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangnan University Research Support Foundation for Young Scientists; National High Technology Research and Development Program of China, 863 Program(National High Technology Research and Development Program of China); National Basic Research Program of China, 973 Program(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Grant No. 31471251, http://www.nsfc.gov.cn/ to XFD), the Jiangnan University Research Support Foundation for Young Scientists (Grant No. 5922050205150370, http://kjc.jiangnan.edu.cn/ to XFD), the National High Technology Research and Development Program of China, 863 Program (Grant No. 2015AA020802, http://www.863.gov.cn/ to ZHB), the National Basic Research Program of China, 973 Program (Grant No. 2013CB733602, http://www.973.gov.cn/ to ZHB) and the Fundamental Research Funds for the Central Universities (Grant No. JUSRP51401A, http://kjc.jiangnan.edu.cn/ to YKY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix I, 2008, AFF GEN WID HUM SNP; Badve S, 2007, CLIN CANCER RES, V13, P4415, DOI 10.1158/1078-0432.CCR-07-0122; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bralten LBC, 2010, GENE CHROMOSOME CANC, V49, P509, DOI 10.1002/gcc.20760; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Coffey DS, 2001, UROLOGY, V57, P31, DOI 10.1016/S0090-4295(00)00938-9; Day TK, 2013, ENDOCR-RELAT CANCER, V20, pR215, DOI 10.1530/ERC-13-0204; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fagerholm R, 2008, NAT GENET, V40, P844, DOI 10.1038/ng.155; Frommolt P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-475; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kilpivaara O, 2005, INT J CANCER, V113, P575, DOI 10.1002/ijc.20638; Kim JY, 2014, MOL CELL, V54, P613, DOI 10.1016/j.molcel.2014.03.043; Kim JW, 2009, CANCER SCI, V100, P1468, DOI 10.1111/j.1349-7006.2009.01209.x; Luscher-Firzlaff J, 2008, CANCER RES, V68, P749, DOI 10.1158/0008-5472.CAN-07-3158; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Madden SF, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3444; Magklara A, 2009, MOL ENDOCRINOL, V23, P61, DOI 10.1210/me.2008-0028; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Mo R, 2006, J BIOL CHEM, V281, P15714, DOI 10.1074/jbc.M513245200; Mungamuri SK, 2013, CELL REP, V5, P302, DOI 10.1016/j.celrep.2013.09.009; Natarajan TG, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-13; Pan YF, 2008, J BIOL CHEM, V283, P32977, DOI 10.1074/jbc.M802024200; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Riemenschneider MJ, 1999, CANCER RES, V59, P6091; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Syrjakoski K, 2000, J NATL CANCER I, V92, P1529, DOI 10.1093/jnci/92.18.1529; Tan SK, 2011, EMBO J, V30, P2569, DOI 10.1038/emboj.2011.151; Team RDC, 2009, R LANG ENV STAT COMP; Trievel RC, 2009, NAT STRUCT MOL BIOL, V16, P678, DOI 10.1038/nsmb0709-678; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Wang CY, 2011, MOL ENDOCRINOL, V25, P1527, DOI 10.1210/me.2011-1037; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yoshimaru T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3443; Yuan ZM, 1999, ONCOGENE, V18, P5714, DOI 10.1038/sj.onc.1202930; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zwart W, 2011, EMBO J, V30, P4764, DOI 10.1038/emboj.2011.368	48	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0124964	10.1371/journal.pone.0124964	http://dx.doi.org/10.1371/journal.pone.0124964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355959	gold, Green Published, Green Submitted			2022-12-26	WOS:000360965800001
J	Newkirk, GS; Hoon, M; Wong, RO; Detwiler, PB				Newkirk, G. S.; Hoon, M.; Wong, R. O.; Detwiler, P. B.			Response Properties of a Newly Identified Tristratified Narrow Field Amacrine Cell in the Mouse Retina	PLOS ONE			English	Article							INNER PLEXIFORM LAYER; MAMMALIAN RETINA; GANGLION-CELLS; BIPOLAR CELLS; KAINATE-RECEPTORS; CAT RETINA; LIGHT; PATHWAYS; SIGNALS; VISION	Amacrine cells were targeted for whole cell recording using two-photon fluorescence microscopy in a transgenic mouse line in which the promoter for dopamine receptor 2 drove expression of green fluorescent protein in a narrow field tristratified amacrine cell (TNAC) that had not been studied previously. Light evoked a multiphasic response that was the sum of hyperpolarizing and depolarization synaptic inputs consistent with distinct dendritic ramifications in the off and on sublamina of the inner plexiform layer. The amplitude and waveform of the response, which consisted of an initial brief hyperpolarization at light onset followed by recovery to a plateau potential close to dark resting potential and a hyperpolarizing response at the light offset varied little over an intensity range from 0.4 to similar to 10(boolean AND)6 Rh*/rod/s. This suggests that the cell functions as a differentiator that generates an output signal (a transient reduction in inhibitory input to downstream retina neurons) that is proportional to the derivative of light input independent of its intensity. The underlying circuitry appears to consist of rod and cone driven on and off bipolar cells that provide direct excitatory input to the cell as well as to GABAergic amacrine cells that are synaptically coupled to TNAC. Canonical reagents that blocked excitatory (glutamatergic) and inhibitory (GABA and glycine) synaptic transmission had effects on responses to scotopic stimuli consistent with the rod driven component of the proposed circuit. However, responses evoked by photopic stimuli were paradoxical and could not be interpreted on the basis of conventional thinking about the neuropharmacology of synaptic interactions in the retina.	[Newkirk, G. S.; Detwiler, P. B.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Newkirk, G. S.; Detwiler, P. B.] Univ Washington, Program Neurobiol & Behav, Seattle, WA 98195 USA; [Hoon, M.; Wong, R. O.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Newkirk, GS (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	gnewkirk@uw.edu; detwiler@uw.edu			National Eye Institute [EY02048, EY10699]; Knights Templar Eye Foundation; NATIONAL EYE INSTITUTE [R01EY010699, R01EY002048] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Knights Templar Eye Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding: The work was supported by the following: National Eye Institute EY02048 and EY10699, https://www.nei.nih.gov; and Knights Templar Eye Foundation, http://www.knightstemplar.org/ktef/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badea TC, 2004, J COMP NEUROL, V480, P331, DOI 10.1002/cne.20304; Baden T, 2013, TRENDS NEUROSCI, V36, P480, DOI 10.1016/j.tins.2013.04.006; Baden T, 2013, CURR BIOL, V23, P48, DOI 10.1016/j.cub.2012.11.006; BAYLOR DA, 1973, J PHYSIOL-LONDON, V234, P163, DOI 10.1113/jphysiol.1973.sp010340; Bleakman D, 1996, NEUROPHARMACOLOGY, V35, P1689, DOI 10.1016/S0028-3908(96)00156-6; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; Chittajallu R, 1999, TRENDS PHARMACOL SCI, V20, P26, DOI 10.1016/S0165-6147(98)01286-3; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; DACEY DM, 1990, J COMP NEUROL, V301, P461, DOI 10.1002/cne.903010310; Demb JB, 2012, VISUAL NEUROSCI, V29, P51, DOI 10.1017/S0952523811000368; Denk W, 1999, P NATL ACAD SCI USA, V96, P7035, DOI 10.1073/pnas.96.12.7035; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dong CJ, 2003, J NEUROPHYSIOL, V89, P2159, DOI 10.1152/jn.01008.2002; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Euler T, 2014, NAT REV NEUROSCI, V15, P507, DOI 10.1038/nrn3783; Euler T, 2009, PFLUG ARCH EUR J PHY, V457, P1393, DOI 10.1007/s00424-008-0603-5; FAMIGLIETTI EV, 1983, VISION RES, V23, P1265, DOI 10.1016/0042-6989(83)90102-5; Grimes WN, 2010, NEURON, V65, P873, DOI 10.1016/j.neuron.2010.02.028; Gustincich S, 1997, NEURON, V18, P723, DOI 10.1016/S0896-6273(00)80313-X; Hausselt SE, 2007, PLOS BIOL, V5, P1474, DOI 10.1371/journal.pbio.0050185; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; KOLB H, 1974, SCIENCE, V186, P47, DOI 10.1126/science.186.4158.47; LEVICK WR, 1967, J PHYSIOL-LONDON, V188, P285, DOI 10.1113/jphysiol.1967.sp008140; Lyubarsky AL, 2004, VISION RES, V44, P3235, DOI 10.1016/j.visres.2004.09.019; Macneil MA, 1999, J COMP NEUROL, V413, P305; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; Majumdar S, 2009, J PHYSIOL-LONDON, V587, P3831, DOI 10.1113/jphysiol.2009.171207; Margolis DJ, 2007, J NEUROSCI, V27, P5994, DOI 10.1523/JNEUROSCI.0130-07.2007; Masland RH, 2012, VISUAL NEUROSCI, V29, P3, DOI 10.1017/S0952523811000344; Menger N, 2000, VISUAL NEUROSCI, V17, P769, DOI 10.1017/S0952523800175108; NEHER E, 1992, METHOD ENZYMOL, V207, P123; NELSON R, 1985, J NEUROPHYSIOL, V54, P592, DOI 10.1152/jn.1985.54.3.592; Newkirk GS, 2013, J NEUROPHYSIOL, V110, P536, DOI 10.1152/jn.00118.2013; Peters BN, 1996, J NEUROPHYSIOL, V75, P469, DOI 10.1152/jn.1996.75.1.469; Russell TL, 2010, J NEUROPHYSIOL, V103, P2757, DOI 10.1152/jn.00987.2009; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; VANEY DI, 1991, NEUROSCI LETT, V125, P187, DOI 10.1016/0304-3940(91)90024-N; VANEY DI, 1986, SCIENCE, V233, P444, DOI 10.1126/science.3726538; VERSAUXBOTTERI C, 1984, BRAIN RES, V301, P192, DOI 10.1016/0006-8993(84)90423-2; WATKINS JC, 1990, TRENDS PHARMACOL SCI, V11, P25, DOI 10.1016/0165-6147(90)90038-A; Wilding TJ, 1996, MOL PHARMACOL, V49, P540; Zhang YF, 2012, P NATL ACAD SCI USA, V109, pE2391, DOI 10.1073/pnas.1211547109; ZHOU ZJ, 1995, J NEUROSCI, V15, P5334	43	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137702	10.1371/journal.pone.0137702	http://dx.doi.org/10.1371/journal.pone.0137702			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352594	Green Published, gold, Green Submitted			2022-12-26	WOS:000360932800111
J	Carter, DW; Crosson, S; Liese, C				Carter, David W.; Crosson, Scott; Liese, Christopher			Nowcasting Intraseasonal Recreational Fishing Harvest with Internet Search Volume	PLOS ONE			English	Article							FISHERIES; BEHAVIOR; TRENDS; TIME	Estimates of recreational fishing harvest are often unavailable until after a fishing season has ended. This lag in information complicates efforts to stay within the quota. The simplest way to monitor quota within the season is to use harvest information from the previous year. This works well when fishery conditions are stable, but is inaccurate when fishery conditions are changing. We develop regression-based models to "nowcast" intraseasonal recreational fishing harvest in the presence of changing fishery conditions. Our basic model accounts for seasonality, changes in the fishing season, and important events in the fishery. Our extended model uses Google Trends data on the internet search volume relevant to the fishery of interest. We demonstrate the model with the Gulf of Mexico red snapper fishery where the recreational sector has exceeded the quota nearly every year since 2007. Our results confirm that data for the previous year works well to predict intraseasonal harvest for a year (2012) where fishery conditions are consistent with historic patterns. However, for a year (2013) of unprecedented harvest and management activity our regression model using search volume for the term "red snapper season" generates intraseasonal nowcasts that are 27% more accurate than the basic model without the internet search information and 29% more accurate than the prediction based on the previous year. Reliable nowcasts of intraseasonal harvest could make in-season (or in-year) management feasible and increase the likelihood of staying within quota. Our nowcasting approach using internet search volumemight have the potential to improve quota management in other fisheries where conditions change year-to-year.	[Carter, David W.; Crosson, Scott; Liese, Christopher] NOAA, Social Sci Res Grp, Southeast Fisheries Sci Ctr, Miami, FL 33149 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Carter, DW (corresponding author), NOAA, Social Sci Res Grp, Southeast Fisheries Sci Ctr, Miami, FL 33149 USA.	david.w.carter@noaa.gov	Carter, David W/G-7472-2016	Carter, David W/0000-0001-8960-7236; Crosson, Scott/0000-0002-8126-1282				[Anonymous], [No title captured]; [Anonymous], 2014, R LANG ENV STAT COMP; Antenucci D, 2014, 20010 NBER, DOI [10.3386/w20010, DOI 10.3386/W20010]; Bordino I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040014; CANOVA F, 1995, J BUS ECON STAT, V13, P237, DOI 10.2307/1392184; Chen T, 2015, CONTEMP ECON POLICY, V33, P395, DOI 10.1111/coep.12074; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Crosson S, 2013, SCI PUBL POLICY, V40, DOI 10.1093/scipol/scs104; Farmer NA, 2015, N AM J FISH MANAGE, V35, P720, DOI 10.1080/02755947.2015.1044628; Fondeur Y, 2013, ECON MODEL, V30, P117, DOI 10.1016/j.econmod.2012.07.017; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; Hyndman RJ, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i03; Hyndman RobJ., 2018, FORECASTING PRINCIPL; Kumar S, 2011, GOOGLE CORRELATE WHI; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Martin DR, 2014, FISH RES, V157, P24, DOI 10.1016/j.fishres.2014.03.013; Martin DR, 2012, FISHERIES, V37, P458, DOI 10.1080/03632415.2012.722875; Methot RD, 2014, ICES J MAR SCI, V71, P183, DOI 10.1093/icesjms/fst119; Southeast Regional Office (SERO), 2013, SEROLAPP201305 NOAA; Wilde GR, 2013, FISHERIES MANAG ECOL, V20, P211, DOI 10.1111/fme.12009; Wu L., 2014, FUTURE PREDICTION GO	22	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137752	10.1371/journal.pone.0137752	http://dx.doi.org/10.1371/journal.pone.0137752			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ8YQ	26348645	Green Published, Green Submitted, gold			2022-12-26	WOS:000360897600057
J	Lou, LP; Yao, LD; Cheng, GH; Wang, LX; He, YF; Hu, BL				Lou, Liping; Yao, Lingdan; Cheng, Guanghuan; Wang, Lixiao; He, Yunfeng; Hu, Baolan			Application of Rice-Straw Biochar and Microorganisms in Nonylphenol Remediation: Adsorption-Biodegradation Coupling Relationship and Mechanism	PLOS ONE			English	Article							ACTIVATED CARBON; BLACK CARBON; SORPTION; BIOAVAILABILITY; DESORPTION; SOIL; PENTACHLOROPHENOL; PHENANTHRENE; DEGRADATION; AMENDMENT	Biochar adsorption presents a potential remediation method for the control of hydrophobic organic compounds (HOCs) pollution in the environment. It has been found that HOCs bound on biochar become less bioavailable, so speculations have been proposed that HOCs will persist for longer half-life periods in biochar-amended soil/sediment. To investigate how biochar application affects coupled adsorption-biodegradation, nonylphenol was selected as the target contaminant, and biochar derived from rice straw was applied as the adsorbent. The results showed that there was an optimal dosage of biochar in the presence of both adsorption and biodegradation for a given nonylphenol concentration, thus allowing the transformation of nonylphenol to be optimized. Approximately 47.6% of the nonylphenol was biodegraded in two days when 0.005 g biochar was added to 50 mg/L of nonylphenol, which was 125% higher than the relative quantity biodegraded without biochar, though the resistant desorption component of nonylphenol reached 87.1%. All adsorptive forms of nonylphenol (f(rap), f(slow), f(r)) decreased gradually during the biodegradation experiment, and the resistant desorption fraction of nonylphenol (f(r)) on biochar could also be biodegraded. It was concluded that an appropriate amount of biochar could stimulate biodegradation, not only illustrating that the dosage of biochar had an enormous influence on the half-life periods of HOCs but also alleviating concerns that enhanced HOCs binding by biochar may cause secondary pollution in biochar-modified environment.	[Lou, Liping; Yao, Lingdan; Cheng, Guanghuan; Wang, Lixiao; He, Yunfeng; Hu, Baolan] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Hu, BL (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China.	blhu@zju.edu.cn			National Natural Science Foundation of China [41371447]; National Science-technology Support Plan Projects [2013BAC16B04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science-technology Support Plan Projects	This research is financially supported by the National Natural Science Foundation of China (41371447) and the National Science-technology Support Plan Projects (2013BAC16B04), which supported the experiments of microorganisms study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander M, 2000, ENVIRON SCI TECHNOL, V34, P4259, DOI 10.1021/es001069+; Beesley L, 2011, ENVIRON POLLUT, V159, P3269, DOI 10.1016/j.envpol.2011.07.023; Mariel AC, 2014, ENVIRON TOXICOL PHAR, V38, P634, DOI 10.1016/j.etap.2014.08.014; Chai YZ, 2012, ENVIRON SCI TECHNOL, V46, P1035, DOI 10.1021/es2029697; Chen BL, 2009, CHEMOSPHERE, V76, P127, DOI 10.1016/j.chemosphere.2009.02.004; Cheng GH, 2014, J SOIL SEDIMENT, V14, P344, DOI 10.1007/s11368-013-0700-8; De Weert J, 2010, APPL MICROBIOL BIOT, V86, P761, DOI 10.1007/s00253-009-2394-9; Farrell M, 2013, SCI TOTAL ENVIRON, V465, P288, DOI 10.1016/j.scitotenv.2013.03.090; Gai XP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0113888, 10.1371/journal.pone.0097730]; Gurwick NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075932; Kong LL, 2014, REV ENVIRON CONTAM T, V228, P83, DOI 10.1007/978-3-319-01619-1_4; Kukkonen JVK, 2005, ENVIRON TOXICOL CHEM, V24, P877, DOI 10.1897/04-171R.1; Liu J, 2014, ENVIRON POLLUT, V186, P83, DOI 10.1016/j.envpol.2013.11.017; Lou LP, 2014, ENVIRON POLLUT, V190, P101, DOI 10.1016/j.envpol.2014.03.027; Luo L, 2011, J HAZARD MATER, V185, P639, DOI 10.1016/j.jhazmat.2010.09.066; Marchal G, 2013, ENVIRON POLLUT, V181, P200, DOI 10.1016/j.envpol.2013.06.026; Martin SM, 2012, J HAZARD MATER, V231, P70, DOI 10.1016/j.jhazmat.2012.06.040; Mercier A, 2014, WATER RES, V59, P304, DOI 10.1016/j.watres.2014.04.021; Mercier A, 2013, J SOIL SEDIMENT, V13, P793, DOI 10.1007/s11368-012-0647-1; Meynet P, 2012, ENVIRON SCI TECHNOL, V46, P5057, DOI 10.1021/es2043905; Muter O, 2014, ECOTOX ENVIRON SAFE, V109, P93, DOI 10.1016/j.ecoenv.2014.08.012; Park JH, 2011, PLANT SOIL, V348, P439, DOI 10.1007/s11104-011-0948-y; Ren XM, 2011, CHEM ENG J, V170, P395, DOI 10.1016/j.cej.2010.08.045; Rhodes AH, 2012, ENVIRON SCI TECHNOL, V46, P12445, DOI 10.1021/es3025098; Smith JL, 2010, SOIL BIOL BIOCHEM, V42, P2345, DOI 10.1016/j.soilbio.2010.09.013; Sopena F, 2013, CHEMOSPHERE, V91, P1525, DOI 10.1016/j.chemosphere.2012.12.031; Tanghe T, 1999, APPL ENVIRON MICROB, V65, P746; Tatarkova V, 2013, ECOTOX ENVIRON SAFE, V92, P215, DOI 10.1016/j.ecoenv.2013.02.005; Tong H, 2014, SOIL BIOL BIOCHEM, V70, P142, DOI 10.1016/j.soilbio.2013.12.012; Toyama T, 2011, ENVIRON SCI TECHNOL, V45, P6524, DOI 10.1021/es201061a; Wang Z, 2014, INT BIODETER BIODEGR, V92, P1, DOI 10.1016/j.ibiod.2014.04.004; Writer JH, 2011, ENVIRON SCI TECHNOL, V45, P4370, DOI 10.1021/es2000134; Xin J, 2014, ECOTOX ENVIRON SAFE, V106, P27, DOI 10.1016/j.ecoenv.2014.04.036; Xu RK, 2011, BIORESOURCE TECHNOL, V102, P10293, DOI 10.1016/j.biortech.2011.08.089; Yang YN, 2003, ENVIRON SCI TECHNOL, V37, P3635, DOI 10.1021/es034006a; Zhang QZ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0102062, 10.1371/journal.pone.0105500]	36	14	15	11	136	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137467	10.1371/journal.pone.0137467	http://dx.doi.org/10.1371/journal.pone.0137467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348485	Green Published, Green Submitted, gold			2022-12-26	WOS:000360897600047
J	Yip, M; Saripan, MI; Wells, K; Bradley, DA				Yip, Mary; Saripan, M. Iqbal; Wells, Kevin; Bradley, David A.			Monte Carlo Simulations for the Detection of Buried Objects Using Single Sided Backscattered Radiation	PLOS ONE			English	Article								Background Detection of buried improvised explosive devices (IEDs) is a delicate task, leading to a need to develop sensitive stand-off detection technology. The shape, composition and size of the IEDs can be expected to be revised over time in an effort to overcome increasingly sophisticated detection methods. As an example, for the most part, landmines are found through metal detection which has led to increasing use of non-ferrous materials such as wood or plastic containers for chemical based explosives being developed. Methodology Monte Carlo simulations have been undertaken considering three different commercially available detector materials (hyperpure-Ge (HPGe), lanthanum(III) bromide (LaBr) and thallium activated sodium iodide (NaI(Tl)), applied at a stand-off distance of 50 cm from the surface and burial depths of 0, 5 and 10 cm, with sand as the obfuscating medium. Target materials representing medium density wood and mild steel have been considered. Each detector has been modelled as a 10 cm thick cylinder with a 20 cm diameter. Principal Findings It appears that HPGe represents the most promising detector for this application. Although it was not the highest density material studied, its excellent energy resolving capability leads to the highest quality spectra from which detection decisions can be inferred. Conclusions The simulation work undertaken here suggests that a vehicle-born threat detection system could be envisaged using a single betatron and a series of detectors operating in parallel observing the space directly in front of the vehicle path. Furthermore, results show that non-ferrous materials such as wood can be effectively discerned in such remote-operated detection system, with the potential to apply a signature analysis template matching technique for real-time analysis of such data.	[Yip, Mary; Wells, Kevin] Univ Surrey, Fac Engn & Phys Sci, Ctr Vis Speech & Signal Proc, Guildford GU2 7XH, Surrey, England; [Yip, Mary; Bradley, David A.] Univ Surrey, Fac Engn & Phys Sci, Dept Phys, Guildford GU2 7XH, Surrey, England; [Saripan, M. Iqbal] Univ Putra Malaysia, Dept Comp & Commun Syst Engn, Fac Engn, Serdang 43400, Malaysia	University of Surrey; University of Surrey; Universiti Putra Malaysia	Wells, K (corresponding author), Univ Surrey, Fac Engn & Phys Sci, Ctr Vis Speech & Signal Proc, Guildford GU2 7XH, Surrey, England.	k.wells@surrey.ac.uk	Saripan, M Iqbal/A-9582-2010	Saripan, M Iqbal/0000-0002-3005-5331	United Kingdom Government Defence agency	United Kingdom Government Defence agency	This work was funded by a grant from a United Kingdom Government Defence agency to perform a stand-alone feasibility study in detecting buried objects with X-ray radiation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bousselham A, 2009, IEEE NUCL SCI CONF R, P2370, DOI 10.1109/NSSMIC.2009.5402210; Bradley DA, 2011, NUCL INSTRUM METH A, V652, P466, DOI 10.1016/j.nima.2011.01.142; BRADLEY DA, 1991, APPL RADIAT ISOTOPES, V42, P771; Buffler A, 2004, RADIAT PHYS CHEM, V71, P853, DOI 10.1016/j.radphyschem.2004.04.110; Chalmers A, 2003, P SOC PHOTO-OPT INS, V5199, P19; Datema CP, 2002, NUCL INSTRUM METH A, V488, P441, DOI 10.1016/S0168-9002(02)00402-3; Dunn WL, 2007, NUCL INSTRUM METH A, V580, P778, DOI 10.1016/j.nima.2007.05.188; Faust AA, 2009, IEEE T NUCL SCI, V56, P299, DOI 10.1109/TNS.2008.2009537; Harding G, 1997, NUCL INSTRUM METH A, V398, P409, DOI 10.1016/S0168-9002(97)00901-7; JME Ltd, 2011, BET RANG; Khodyuk IV, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/48/485402; Knoll, 2000, RAD DETECTION MEASUR; Menge PR, 2007, NUCL INSTRUM METH A, V579, P6, DOI 10.1016/j.nima.2007.04.002; Nuclear and Radiation Studies Board (NRSB) and Earth and Life Studies (DELS), 2008, RAD SOURC US REPL AB, P67; OWENS A, 1985, NUCL INSTRUM METH A, V238, P473, DOI 10.1016/0168-9002(85)90487-5; Qinetiq, 2009, FAST POW VERS HIGH P; Suppliersonline, 1999, CARB STEELS 1010; van Loef EVD, 2001, APPL PHYS LETT, V79, P1573, DOI 10.1063/1.1385342	18	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0135769	10.1371/journal.pone.0135769	http://dx.doi.org/10.1371/journal.pone.0135769			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348619	Green Published, gold, Green Submitted			2022-12-26	WOS:000360897600003
J	Kim, HJ; Park, JH; Lee, S; Son, HY; Hwang, J; Chae, J; Yun, JM; Kwon, H; Kim, JI; Cho, B				Kim, Hyun-Jin; Park, Jin-Ho; Lee, Seungbok; Son, Ho-Young; Hwang, Jinha; Chae, Jeesoo; Yun, Jae Moon; Kwon, Hyuktae; Kim, Jong-Il; Cho, Belong			A Common Variant of NGEF Is Associated with Abdominal Visceral Fat in Korean Men	PLOS ONE			English	Article							SUBCUTANEOUS ADIPOSE-TISSUE; BODY-MASS INDEX; METABOLIC SYNDROME; WAIST CIRCUMFERENCE; RISK-FACTORS; OBESITY; OVERWEIGHT	Central adiposity, rather than body mass index (BMI), is a key pathophysiological feature of the development of obesity-related diseases. Although genetic studies by anthropometric measures such as waist circumference have been widely conducted, genetic studies for abdominal fat deposition measured by computed tomography (CT) have been rarely performed. A total of 1,243 participants who were recruited from two health check-up centers were included in this study. We selected four and three single-nucleotide polymorphisms (SNPs) in NGEF and RGS6, respectively, and analyzed the associations between the seven SNPs and central adiposity measured by CT using an additive, dominant, or recessive model. The participants were generally healthy middle-aged men (50.7 +/- 5.3 years). In the additive model, the rs11678490 A allele of NGEF was significantly associated with total adipose tissue, visceral adipose tissue (VAT), and subcutaneous adipose tissue (all P < 0.05). The AA genotype of this SNP in the recessive model showed a more significant association with all adiposity traits, and its association with VAT remained significant even after adjustment for BMI (P = 0.005). In the overall or visceral obesity group analysis, the AA genotype of rs11678490 showed no association with overall obesity (P = 0.148), whereas it was significantly associated with visceral obesity both before (P = 0.010) and after (P = 0.029) adjustment for BMI. In particular, an AA genotype effect was conspicuous between lower and upper groups with 5% extreme VAT phenotypes (OR = 9.59, 95% CI = 1.50-61.31). However, we found no significant association between SNPs of RGS6 and central adiposity. We identified a visceral-fat-associated SNP, rs11678490 of NGEF, in Korean men. This study suggests that the genetic background of central adiposity and BMI is different, and that additional efforts should be made to find the unique genetic architecture of intra-abdominal fat accumulation.	[Kim, Hyun-Jin] Seoul Natl Univ, Sch Publ Hlth, Inst Hlth & Environm, Seoul, South Korea; [Park, Jin-Ho; Yun, Jae Moon; Cho, Belong] Seoul Natl Univ Hosp, Dept Family Med, Seoul 110744, South Korea; [Lee, Seungbok; Kim, Jong-Il] Seoul Natl Univ, Med Res Ctr, GMI, Seoul, South Korea; [Son, Ho-Young; Kim, Jong-Il] Seoul Natl Univ, Coll Med, Dept Biochem, Seoul, South Korea; [Hwang, Jinha; Chae, Jeesoo; Kim, Jong-Il] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Kwon, Hyuktae] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Inst Healthcare Res, Dept Family Med, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kim, JI (corresponding author), Seoul Natl Univ, Med Res Ctr, GMI, Seoul, South Korea.	jongil@snu.ac.kr; belong@snu.ac.kr	KIM, JONG-IL/D-1019-2011; SON, HO YOUNG/AAJ-3905-2020; Kwon, Hyuktae/C-4286-2013; Cho, Belong/GLU-3443-2022	KIM, JONG-IL/0000-0002-7240-3744; Kwon, Hyuktae/0000-0002-0312-3650; Cho, Belong/0000-0001-9558-689X; Son, Hwa-Young/0000-0003-4388-0952; Ho-young, Son/0000-0001-6326-5071; Seungbok, Lee/0000-0002-3145-8714	iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea [113032032HD020]; National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2012R1A5A2A44671346]	iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This research was supported by iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea (Grant No. 113032032HD020) and the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2012R1A5A2A44671346).	Britton KA, 2013, J AM COLL CARDIOL, V62, P921, DOI 10.1016/j.jacc.2013.06.027; Chrostowska M, 2013, BEST PRACT RES CL EN, V27, P147, DOI 10.1016/j.beem.2013.01.004; Chung SJ, 2008, GUT, V57, P1360, DOI 10.1136/gut.2007.147090; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; De Pergola G, 2013, J OBES, V2013, DOI 10.1155/2013/291546; Despres JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Fox CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002695; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004; Kadowaki T, 2006, INT J OBESITY, V30, P1163, DOI 10.1038/sj.ijo.0803248; Kim HI, 2011, J KOREAN MED SCI, V26, P906, DOI 10.3346/jkms.2011.26.7.906; Lear SA, 2007, STROKE, V38, P2422, DOI 10.1161/STROKEAHA.107.484113; Norris JM, 2009, OBESITY, V17, P1932, DOI 10.1038/oby.2009.143; Park YW, 2001, OBES RES, V9, P381, DOI 10.1038/oby.2001.49; Porter SA, 2009, DIABETES CARE, V32, P1068, DOI 10.2337/dc08-2280; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Song YM, 2004, STROKE, V35, P831, DOI 10.1161/01.STR.0000119386.22691.1C; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Xia QH, 2013, ANN NY ACAD SCI, V1281, P178, DOI 10.1111/nyas.12020; Yoshizumi T, 1999, RADIOLOGY, V211, P283, DOI 10.1148/radiology.211.1.r99ap15283	24	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137564	10.1371/journal.pone.0137564	http://dx.doi.org/10.1371/journal.pone.0137564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340433	Green Submitted, Green Published, gold			2022-12-26	WOS:000360688200067
J	Worku, N; Stich, A; Daugschies, A; Wenzel, I; Kurz, R; Thieme, R; Kurz, S; Birkenmeier, G				Worku, Netsanet; Stich, August; Daugschies, Arwid; Wenzel, Iris; Kurz, Randy; Thieme, Rene; Kurz, Susanne; Birkenmeier, Gerd			Ethyl Pyruvate Emerges as a Safe and Fast Acting Agent against Trypanosoma brucei by Targeting Pyruvate Kinase Activity	PLOS ONE			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; SLEEPING SICKNESS; IN-VITRO; TRANSPORT; DRUGS; EXPRESSION; NIFURTIMOX; INHIBITORS; PROTEIN; DESIGN	Background Human African Trypanosomiasis (HAT) also called sleeping sickness is an infectious disease in humans caused by an extracellular protozoan parasite. The disease, if left untreated, results in 100% mortality. Currently available drugs are full of severe drawbacks and fail to escape the fast development of trypanosoma resistance. Due to similarities in cell metabolism between cancerous tumors and trypanosoma cells, some of the current registered drugs against HAT have also been tested in cancer chemotherapy. Here we demonstrate for the first time that the simple ester, ethyl pyruvate, comprises such properties. Results The current study covers the efficacy and corresponding target evaluation of ethyl pyruvate on T. brucei cell lines using a combination of biochemical techniques including cell proliferation assays, enzyme kinetics, phasecontrast microscopic video imaging and ex vivo toxicity tests. We have shown that ethyl pyruvate effectively kills trypanosomes most probably by net ATP depletion through inhibition of pyruvate kinase (Ki = 3.0 +/- 0.29 mM). The potential of ethyl pyruvate as a trypanocidal compound is also strengthened by its fast acting property, killing cells within three hours post exposure. This has been demonstrated using video imaging of live cells as well as concentration and time dependency experiments. Most importantly, ethyl pyruvate produces minimal side effects in human red cells and is known to easily cross the blood-brain-barrier. This makes it a promising candidate for effective treatment of the two clinical stages of sleeping sickness. Trypanosome drug-resistance tests indicate irreversible cell death and a low incidence of resistance development under experimental conditions. Conclusion Our results present ethyl pyruvate as a safe and fast acting trypanocidal compound and show that it inhibits the enzyme pyruvate kinase. Competitive inhibition of this enzyme was found to cause ATP depletion and cell death. Due to its ability to easily cross the blood-brain-barrier, ethyl pyruvate could be considered as new candidate agent to treat the hemo-lymphatic as well as neurological stages of sleeping sickness.	[Worku, Netsanet; Kurz, Randy; Kurz, Susanne; Birkenmeier, Gerd] Univ Leipzig, Inst Biochem, Fac Med, D-04103 Leipzig, Germany; [Stich, August] Med Mission Inst, Dept Trop Med, D-97067 Wurzburg, Germany; [Daugschies, Arwid] Univ Leipzig, Dept Vet Parasitol, Fac Vet Med, D-04103 Leipzig, Germany; [Wenzel, Iris] Univ Leipzig, Dept Phys, Fac Nat Sci, D-04103 Leipzig, Germany; [Thieme, Rene] Univ Med Ctr Leipzig, Dept Visceral Transplantat Thorac & Vasc Surg, D-04103 Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University	Birkenmeier, G (corresponding author), Univ Leipzig, Inst Biochem, Fac Med, Johannisallee 30, D-04103 Leipzig, Germany.	Gerd.Birkenmeier@medizin.uni-leipzig.de			Deutscher Akademischer Austauschdienst (DAAD) [A/10/90327]	Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	NW has highly acknowledged the Deutscher Akademischer Austauschdienst (DAAD) for the support (Ref. No.: A/10/90327).	Babokhov P, 2013, PATHOG GLOB HEALTH, V107, P242, DOI 10.1179/2047773213Y.0000000105; BARNARD JP, 1993, J BIOL CHEM, V268, P3654; Barrett SV, 2000, PARASITOL TODAY, V16, P7, DOI 10.1016/S0169-4758(99)01560-4; Baunacke M, 2014, PROSTATE, V74, P48, DOI 10.1002/pros.22728; Belluti F, 2014, CHEMMEDCHEM, V9, P371, DOI 10.1002/cmdc.201300399; Bennett-Guerrero E, 2009, J CARDIOTHOR VASC AN, V23, P324, DOI 10.1053/j.jvca.2008.08.005; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bigl M, 1999, J NEURAL TRANSM, V106, P499, DOI 10.1007/s007020050174; Borges S, 2014, BREAST CANCER RES TR, V144, P79, DOI 10.1007/s10549-014-2857-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALLENS M, 1991, MOL BIOCHEM PARASIT, V47, P19, DOI 10.1016/0166-6851(91)90144-U; CALLENS M, 1992, MOL BIOCHEM PARASIT, V50, P235, DOI 10.1016/0166-6851(92)90220-E; Clayton CE, 1996, PARASITOL TODAY, V12, P465, DOI 10.1016/S0169-4758(96)10073-9; Coustou V, 2003, J BIOL CHEM, V278, P49625, DOI 10.1074/jbc.M307872200; Diaz MV, 2014, ACTA TROP, V134, P1, DOI 10.1016/j.actatropica.2014.02.012; DOCAMPO R, 1981, BIOCHEM PHARMACOL, V30, P1947, DOI 10.1016/0006-2952(81)90204-5; Franco JR, 2014, CLIN EPIDEMIOL, V6, P257, DOI 10.2147/CLEP.S39728; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Ghosh A, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1164, DOI 10.1134/S0006297911100105; Greig N, 2009, FEBS J, V276, P376, DOI 10.1111/j.1742-4658.2008.06788.x; Hall JPJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003502; Headrick DR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002772; Hollenbach M, 2008, BIOCHEM PHARMACOL, V76, P631, DOI 10.1016/j.bcp.2008.06.006; Keita M, 1997, EXP PARASITOL, V85, P183, DOI 10.1006/expr.1996.4136; Kennedy PGE, 2013, LANCET NEUROL, V12, P186, DOI 10.1016/S1474-4422(12)70296-X; KOPPERSCHLAGER G, 1993, EUR J BIOCHEM, V217, P527, DOI 10.1111/j.1432-1033.1993.tb18273.x; MANNERVIK B, 1972, EUR J BIOCHEM, V29, P276, DOI 10.1111/j.1432-1033.1972.tb01985.x; Meyskens FL, 1999, CLIN CANCER RES, V5, P945; Morgan HP, 2011, J BIOL CHEM, V286, P31232, DOI 10.1074/jbc.M110.212613; Nowicki MW, 2008, BIOORGAN MED CHEM, V16, P5050, DOI 10.1016/j.bmc.2008.03.045; Park SY, 2011, CANCER LETT, V303, P150, DOI 10.1016/j.canlet.2010.12.024; Rabbani N, 2015, BIOCHEM BIOPH RES CO, V458, P221, DOI 10.1016/j.bbrc.2015.01.140; Rigden DJ, 1999, J MOL BIOL, V291, P615, DOI 10.1006/jmbi.1999.2918; Sanchez MA, 2013, J BIOL CHEM, V288, P14428, DOI 10.1074/jbc.M113.473157; Santel T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003508; Schroeder EL, 2011, EQUINE VET J, V43, P341, DOI 10.1111/j.2042-3306.2010.00214.x; Steverding D, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-15; Stich A, 2013, LANCET INFECT DIS, V13, P733, DOI 10.1016/S1473-3099(13)70191-9; Sykes S, 2015, EUKARYOT CELL, V14, P206, DOI 10.1128/EC.00214-14; Vanderheyden N, 2000, BIOCHEM J, V346, P53, DOI 10.1042/0264-6021:3460053; Verlinde CLM, 2001, DRUG RESIST UPDATE, V4, P50, DOI 10.1054/drup.2000.0177; WARBURG O, 1956, SCIENCE, V124, P269; Watson CP, 2012, BRAIN RES, V1436, P111, DOI 10.1016/j.brainres.2011.11.053; Welburn SC, 2009, PARASITOLOGY, V136, P1943, DOI 10.1017/S0031182009006416; Wendler A, 2009, MOL BIOCHEM PARASIT, V163, P19, DOI 10.1016/j.molbiopara.2008.09.005; WIEMER EAC, 1992, BIOCHEM BIOPH RES CO, V184, P1028, DOI 10.1016/0006-291X(92)90694-G; Worku Netsanet, 2013, ISRN Biochem, V2013, P910308, DOI 10.1155/2013/910308	47	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137353	10.1371/journal.pone.0137353	http://dx.doi.org/10.1371/journal.pone.0137353			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340747	Green Published, Green Submitted, gold			2022-12-26	WOS:000360688200050
J	Wu, WY; He, Y; Lu, J; Lu, YM; Wu, JS; Liu, YX				Wu, Weiyuan; He, Yi; Lu, Jian; Lu, Yuemei; Wu, Jinsong; Liu, Yingxia			Transition of bla(OXA-58-like) to bla(OXA-23-like) in Acinetobacter baumannii Clinical Isolates in Southern China: An 8-Year Study	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; PREVALENT OXA CARBAPENEMASES; MULTIPLEX PCR; HIGH-LEVEL; RESISTANCE; GENE; EXPRESSION; SPP.; EPIDEMIOLOGY; ACQUISITION	Background The prevalence of carbapenem-resistant Acinetobacter baumannii in hospitals has been increasing worldwide. This study aims to investigate the carbapenemase genes and the clonal relatedness among A. baumannii clinical isolates in a Chinese hospital. Methods Carbapenemase genes and the upstream locations of insertion sequences were detected by polymerase chain reaction (PCR), and the clonal relatedness of isolates was determined by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing. Results A total of 231 nonduplicate carbapenemase gene-harboring A. baumannii clinical isolates recovered from Shenzhen People's Hospital, were investigated between 2002 and 2009. bla(OXA-23-like), bla(OXA-58-like), bla(OXA-40-like), and ISAba1-bla(OXA-51-like) were identified in 119, 107, 1, and 4 isolates, respectively. IS1008-Delta ISAba3, ISAba3, and ISAba1 were detected upstream of the bla(OXA-58-like) gene in 69, 35, and 3 isolates, respectively. All bla(OXA-23-like) genes but one had an upstream insertion of ISAba1. bla(OXA-58-like) was the most common carbapenemase gene in A. baumannii before 2008, thereafter bla(OXA-23-like) became rapidly prevalent and replaced blaOXA-58-like in 2009. The majority of bla(OXA-58-like)-carrying isolates showed lower level of resistance to imipenem and meropenem (minimum inhibitory concentrations (MICs), 1 mu g/ml to 16 mu g/ml), compared with the majority of bla(OXA-23-like)-carrying isolates (MICs, 16 mu g/ml to 64 mu g/ml for both imipenem and meropenem). All 231 bla(OXA) carbapenemase gene-harboring isolates belonged to 14 PFGE types (A-N), and three dominant clones A, J, and H accounted for 43.3%, 42.0%, and 8.2% of the tested isolates, respectively. Clone A (sequence type ST92/ST208) with bla(OXA-58-like) was the most prevalent before 2008. Clone H (ST229) with bla(OXA-23-like) became striking between 2007 and 2008. Clone J (ST381) with bla(OXA-23-like) rapidly spread and replaced clones A and H in 2009. Conclusion This study is the first to reveal that the distinct bla(OXA-23-like)-carrying A. baumannii ST381 displaced the previously prevalent bla(OXA-58-like)-carrying A. baumannii ST92/ST208, resulting in the rapidly increasing resistance to carbapenems in A. baumannii in Shenzhen People's Hospital in 2009.	[Wu, Weiyuan; Lu, Yuemei; Wu, Jinsong] Jinan Univ, Shenzhen Peoples Hosp, Key Lab Pathogen Microorganism & Bacterial Resist, Dept Lab Med,Clin Med Coll 2, Shenzhen, Guangdong, Peoples R China; [He, Yi; Lu, Jian; Liu, Yingxia] Third Peoples Hosp Shenzhen, Dept Infect Dis, Shenzhen, Guangdong, Peoples R China	Jinan University	Wu, WY (corresponding author), Jinan Univ, Shenzhen Peoples Hosp, Key Lab Pathogen Microorganism & Bacterial Resist, Dept Lab Med,Clin Med Coll 2, Shenzhen, Guangdong, Peoples R China.	weiywu@163.com			Natural Science Foundation of Guangdong Province, China [5009113]	Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported by Natural Science Foundation of Guangdong Province, China. (5009113) (http://www.gdstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Bertini A, 2007, ANTIMICROB AGENTS CH, V51, P2324, DOI 10.1128/AAC.01502-06; Chen TL, 2008, ANTIMICROB AGENTS CH, V52, P2573, DOI 10.1128/AAC.00393-08; Clinical and Laboratory Standards Institute, 2014, M100S24 CLIN LAB STA; Clinical and Laboratory Standards Institute, 2013, M100S23 CLIN LAB STA; Coelho J, 2006, ANTIMICROB AGENTS CH, V50, P756, DOI 10.1128/AAC.50.2.756-758.2006; Corvec S, 2007, ANTIMICROB AGENTS CH, V51, P1530, DOI 10.1128/AAC.01132-06; D'Arezzo S, 2011, J ANTIMICROB CHEMOTH, V66, P54, DOI 10.1093/jac/dkq407; Ellington MJ, 2007, J ANTIMICROB CHEMOTH, V59, P321, DOI 10.1093/jac/dkl481; Evans BA, 2010, J ANTIMICROB CHEMOTH, V65, P1586, DOI 10.1093/jac/dkq180; Fu YQ, 2010, J ANTIMICROB CHEMOTH, V65, P644, DOI 10.1093/jac/dkq027; Heritier C, 2005, ANTIMICROB AGENTS CH, V49, P3198, DOI 10.1128/AAC.49.8.3198-3202.2005; Higgins PG, 2013, ANTIMICROB AGENTS CH, V57, P2121, DOI 10.1128/AAC.02413-12; Higgins PG, 2010, INT J ANTIMICROB AG, V35, P305, DOI 10.1016/j.ijantimicag.2009.10.014; Higgins PG, 2004, J ANTIMICROB CHEMOTH, V54, P821, DOI 10.1093/jac/dkh427; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; Minandri F, 2012, J CLIN MICROBIOL, V50, P590, DOI 10.1128/JCM.05555-11; Mugnier PD, 2010, EMERG INFECT DIS, V16, P35, DOI 10.3201/eid1601.090852; Nemec A, 2008, J ANTIMICROB CHEMOTH, V62, P484, DOI 10.1093/jac/dkn205; Poirel L, 2006, CLIN MICROBIOL INFEC, V12, P826, DOI 10.1111/j.1469-0691.2006.01456.x; Poirel L, 2006, ANTIMICROB AGENTS CH, V50, P1442, DOI 10.1128/AAC.50.4.1442-1448.2006; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P24, DOI 10.1128/AAC.01512-08; Ravasi P, 2011, ANTIMICROB AGENTS CH, V55, P917, DOI 10.1128/AAC.00491-10; Robledo IE, 2010, ANTIMICROB AGENTS CH, V54, P1354, DOI 10.1128/AAC.00899-09; Seifert H, 2005, J CLIN MICROBIOL, V43, P4328, DOI 10.1128/JCM.43.9.4328-4335.2005; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Turton JF, 2006, J CLIN MICROBIOL, V44, P2974, DOI 10.1128/JCM.01021-06; Turton JF, 2010, J CLIN MICROBIOL, V48, P1445, DOI 10.1128/JCM.02467-09; Turton JF, 2006, FEMS MICROBIOL LETT, V258, P72, DOI 10.1111/j.1574-6968.2006.00195.x; Wang H, 2007, ANTIMICROB AGENTS CH, V51, P4022, DOI 10.1128/AAC.01259-06; Wang J., 2014, PLOS ONE, V9, P9, DOI DOI 10.1371/journal.pone.0104882; Wang XH, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-234; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004; Zhou H, 2007, J CLIN MICROBIOL, V45, P4054, DOI 10.1128/JCM.00343-07	34	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137174	10.1371/journal.pone.0137174	http://dx.doi.org/10.1371/journal.pone.0137174			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340666	Green Published, gold, Green Submitted			2022-12-26	WOS:000360688200029
J	Zhang, QH; Du, YJ; Zhang, JL; Xu, XJ; Xue, FQ; Guo, C; Huang, Y; Lukas, RJ; Chang, YC				Zhang, Qinhui; Du, Yingjie; Zhang, Jianliang; Xu, Xiaojun; Xue, Fenqin; Guo, Cong; Huang, Yao; Lukas, Ronald J.; Chang, Yongchang			Functional Impact of 14 Single Nucleotide Polymorphisms Causing Missense Mutations of Human alpha 7 Nicotinic Receptor	PLOS ONE			English	Article							CHOLINERGIC ANTIINFLAMMATORY PATHWAY; POSITIVE ALLOSTERIC MODULATION; GATED ION-CHANNEL; ACETYLCHOLINE-RECEPTORS; AGONIST-BINDING; INTERNATIONAL UNION; SILENT AGONIST; AMINO-ACIDS; ACTIVATION; PHARMACOLOGY	The alpha 7nicotinic receptor (nAChR) is a major subtype of the nAChRs in the central nervous system, and the receptor plays an important role in brain function. In the dbSNP database, there are 55 single nucleotide polymorphisms (SNPs) that cause missense mutations of the human alpha 7nAChR in the coding region. In this study, we tested the impact of 14 SNPs that cause missense mutations in the agonist binding site or the coupling region between binding site and channel gate on the receptor function. The wild type or mutant receptors were expressed or co-expressed in Xenopus oocytes, and the agonist-induced currents were tested using two-electrode voltage clamp. Our results demonstrated that 6 mutants were nonfunctional, 4 mutants had reduced current expression, and 1 mutants altered ACh and nicotine efficacy in the opposite direction, and one additional mutant had slightly reduced agonist sensitivity. Interestingly, the function of most of these nonfunctional mutants could be rescued by a7nAChR positive allosteric modulator PNU-120596 and agonist-PAM 4BP-TQS. Finally, when coexpressed with the wild type, the nonfunctional mutants could also influence the receptor function. These changes of the receptor properties by the mutations could potentially have an impact on the physiological function of the alpha 7nAChR-mediated cholinergic synaptic transmission and anti-inflammatory effects in the human SNP carriers. Rescuing the nonfunctional mutants could provide a novel way to treat the related disorders.	[Zhang, Qinhui; Guo, Cong] Sichuan Univ, Dept Zool, Coll Life Sci, Chengdu 610064, Sichuan Provinc, Peoples R China; [Zhang, Qinhui; Guo, Cong] Chinese Acad Sci, Chengdu Inst Biol, Chengdu 610041, Sichuan, Peoples R China; [Zhang, Qinhui; Zhang, Jianliang; Xu, Xiaojun; Xue, Fenqin; Lukas, Ronald J.; Chang, Yongchang] St Josephs Hosp, Barrow Neurol Inst, Div Neurobiol, Phoenix, AZ 85013 USA; [Du, Yingjie] Univ Calif Los Angeles, Henry Samueli Sch Engn & Appl Sci, Los Angeles, CA 90095 USA; [Zhang, Jianliang] Capital Med Univ, Beijing Key Lab Brain Major Disorders,Beijing Ins, Beijing Ctr Neural Regenerat & Repair,Dept Neurob, Key Lab Neurodegenerat Dis,Minist Educ, Beijing 100069, Peoples R China; [Zhang, Jianliang] Beijing Neurosci Disciplines, State Key Lab Incubat Base, Beijing 100069, Peoples R China; [Xue, Fenqin] Capital Med Univ, Core Facil Ctr, Core Facil Electrophysiol, Beijing 100069, Peoples R China; [Huang, Yao] St Josephs Hosp, Dept Obstet & Gynecol, Phoenix, AZ 85013 USA	Sichuan University; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; University of California System; University of California Los Angeles; Capital Medical University; Capital Medical University; St. Joseph's Hospital and Medical Center	Chang, YC (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Div Neurobiol, Phoenix, AZ 85013 USA.	yongchang.chang@dignityhealth.org			National Institute of General Medical Sciences [R01GM085237]; Barrow Neurological Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085237] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Barrow Neurological Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences (R01GM085237), and Barrow Neurological Foundation (to YC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Andersen N, 2013, P NATL ACAD SCI USA, V110, P20819, DOI 10.1073/pnas.1315775110; Bertrand D, 2008, MOL PHARMACOL, V74, P1407, DOI 10.1124/mol.107.042820; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Broide RS, 1999, MOL NEUROBIOL, V20, P1, DOI 10.1007/BF02741361; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chang YC, 2009, ACTA PHARMACOL SIN, V30, P663, DOI 10.1038/aps.2009.51; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; Chen YH, 2006, J BIOL CHEM, V281, P18184, DOI 10.1074/jbc.M600349200; Cheng XL, 2006, PLOS COMPUT BIOL, V2, P1173, DOI 10.1371/journal.pcbi.0020134; Chojnacka K, 2013, BIOORG MED CHEM LETT, V23, P4145, DOI 10.1016/j.bmcl.2013.05.039; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Criado M, 2010, BBA-BIOMEMBRANES, V1798, P654, DOI 10.1016/j.bbamem.2009.12.013; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Davies PA, 2003, J BIOL CHEM, V278, P712, DOI 10.1074/jbc.M208814200; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Elmslie F, 1997, MED GENETIK, V9, P15; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; Gay EA, 2008, J PHYSIOL-LONDON, V586, P1105, DOI 10.1113/jphysiol.2007.149492; Gill JK, 2011, P NATL ACAD SCI USA, V108, P5867, DOI 10.1073/pnas.1017975108; Horenstein NA, 2007, J BIOL CHEM, V282, P5899, DOI 10.1074/jbc.M609202200; Johnston GAR, 2003, CNS NEUROL DISORD-DR, V2, P260, DOI 10.2174/1568007033482805; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lukas RJ, 1999, PHARMACOL REV, V51, P397; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; Martelli D, 2014, AUTON NEUROSCI-BASIC, V182, P65, DOI 10.1016/j.autneu.2013.12.007; Mowrey D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064326; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; Newell JG, 2004, J NEUROSCI, V24, P11226, DOI 10.1523/JNEUROSCI.3746-04.2004; Nordman JC, 2012, J CELL SCI, V125, P5502, DOI 10.1242/jcs.110379; Northrop NA, 2011, J PHARMACOL EXP THER, V336, P900, DOI 10.1124/jpet.110.177287; Olsen JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091232; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Papke RL, 2015, NEUROPHARMACOLOGY, V91, P34, DOI 10.1016/j.neuropharm.2014.12.002; Papke RL, 2014, J BIOL CHEM, V289, P4515, DOI 10.1074/jbc.M113.524603; Purohit P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3984; Purohit P, 2012, P NATL ACAD SCI USA, V109, P9384, DOI 10.1073/pnas.1203633109; Sadis C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000469; Sedelnikova A, 2005, J BIOL CHEM, V280, P1535, DOI 10.1074/jbc.M409908200; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Shaw S, 2002, J BIOL CHEM, V277, P44920, DOI 10.1074/jbc.M204610200; Sherry ST, 1999, GENOME RES, V9, P677; Spurny R, 2015, P NATL ACAD SCI USA, V112, pE2543, DOI 10.1073/pnas.1418289112; Thompson AJ, 2007, EXPERT OPIN THER TAR, V11, P527, DOI 10.1517/14728222.11.4.527; Uteshev VV, 2014, EUR J PHARMACOL, V727, P181, DOI 10.1016/j.ejphar.2014.01.072; van Maanen MA, 2009, NAT REV RHEUMATOL, V5, P229, DOI 10.1038/nrrheum.2009.31; Vicente-Agullo F, 2001, BIOCHEMISTRY-US, V40, P8300, DOI 10.1021/bi010087g; Wang DW, 2010, J PHARMACOL EXP THER, V335, P553, DOI 10.1124/jpet.110.169961; Williams DK, 2011, MOL PHARMACOL, V80, P1013, DOI 10.1124/mol.111.074302; Williams DK, 2009, J PHARMACOL EXP THER, V330, P40, DOI 10.1124/jpet.109.151225; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105	53	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137588	10.1371/journal.pone.0137588	http://dx.doi.org/10.1371/journal.pone.0137588			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340537	gold, Green Published, Green Submitted			2022-12-26	WOS:000360688200068
J	Iqbal, J; Walsh, MT; Hammad, SM; Cuchel, M; Tarugi, P; Hegele, RA; Davidson, NO; Rader, DJ; Klein, RL; Hussain, MM				Iqbal, Jahangir; Walsh, Meghan T.; Hammad, Samar M.; Cuchel, Marina; Tarugi, Patrizia; Hegele, Robert A.; Davidson, Nicholas O.; Rader, Daniel J.; Klein, Richard L.; Hussain, M. Mahmood			Microsomal Triglyceride Transfer Protein Transfers and Determines Plasma Concentrations of Ceramide and Sphingomyelin but Not Glycosylceramide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTER TRANSFER PROTEIN; ABETALIPOPROTEINEMIA GENE; LIPID ABSORPTION; APOLIPOPROTEIN-B; SPHINGOLIPIDS; LIVER; INHIBITION; KNOCKOUT; BINDING; ATHEROSCLEROSIS	Sphingolipids, a large family of bioactive lipids, are implicated in stress responses, differentiation, proliferation, apoptosis, and other physiological processes. Aberrant plasma levels of sphingolipids contribute to metabolic disease, atherosclerosis, and insulin resistance. They are fairly evenly distributed in high density and apoB-containing lipoproteins (B-lps). Mechanisms involved in the transport of sphingolipids to the plasma are unknown. Here, we investigated the role of microsomal triglyceride transfer protein (MTP), required for B-lp assembly and secretion, in sphingolipid transport to the plasma. Abetalipoproteinemia patients with deleterious mutations in MTP and absence of B-lps had significantly lower plasma ceramide and sphingomyelin but normal hexosylceramide, lactosylceramide, and different sphingosines compared with unaffected controls. Furthermore, similar differential effects on plasma sphingolipids were seen in liver-and intestine-specific MTP knock-out (L, I-Mttp(-/-)) mice, suggesting that MTP specifically plays a role in the regulation of plasma ceramide and sphingomyelin. We hypothesized that MTP deficiency may affect either their synthesis or secretion. MTP deficiency had no effect on ceramide and sphingomyelin synthesis but reduced secretion from primary hepatocytes and hepatoma cells. Therefore, MTP is involved in ceramide and sphingomyelin secretion but not in their synthesis. We also found that MTP transferred these lipids between vesicles in vitro. Therefore, we propose that MTP might regulate plasma ceramide and sphingomyelin levels by transferring these lipids to B-lps in the liver and intestine and facilitating their secretion.	[Iqbal, Jahangir; Walsh, Meghan T.; Hussain, M. Mahmood] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Hussain, M. Mahmood] Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA; [Hammad, Samar M.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Cuchel, Marina; Rader, Daniel J.] Univ Penn, Cardiovasc Inst, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Tarugi, Patrizia] Univ Modena & Reggio Emilia, Dept Life Sci, I-41121 Modena, Italy; [Hegele, Robert A.] Robarts Res Inst, Blackburn Cardiovasc Genet Lab, London, ON N6A 5B7, Canada; [Davidson, Nicholas O.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Klein, Richard L.] Med Univ S Carolina, Dept Med, Div Endocrinol Metab & Med Genet, Charleston, SC 29425 USA; [Klein, Richard L.] Ralph H Johnson Dept Vet Affairs Med Ctr, Res Serv, Charleston, SC 29401 USA; [Hussain, M. Mahmood] New York Harbor Healthcare Syst, Dept Vet Affairs, Brooklyn, NY 11209 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Medical University of South Carolina; University of Pennsylvania; Pennsylvania Medicine; Universita di Modena e Reggio Emilia; Western University (University of Western Ontario); Washington University (WUSTL); Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Hussain, MM (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA.	mahmood.hussain@downstate.edu	Iqbal, Jahangir/B-3903-2014; Hegele, Robert/G-3301-2011; Regan, Clinton/E-6250-2012; Hegele, Robert/AAF-6482-2020	Iqbal, Jahangir/0000-0002-9021-2271; Hegele, Robert/0000-0003-2861-5325; Hammad, Samar/0000-0002-1313-2542	National Institutes of Health [HL-95924, R56DK046900-17A1, HL-38180, DK-56260, DK-52574, P20 RR017677]; Veterans Affairs Merit Award [BX001728, BX000978]; American Heart Association; Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina [P30 CA138313]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095924, R01HL038180, R37HL038180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056260, P30DK052574, R56DK046900, R01DK099177] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000978, I01BX001728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); American Heart Association(American Heart Association); Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants HL-95924 and R56DK046900-17A1 (to M. M. H.) and Grants HL-38180, DK-56260, and DK-52574 (to N. O. D.). This work was also supported by Veterans Affairs Merit Award BX001728 (to M. M. H.), American Heart Association grant-in-aid (to J. I.), and Veterans Affairs Merit Award BX000978 (to R. L. K.).; Supported in part by the Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina Grant P30 CA138313 and National Institutes of Health Grant P20 RR017677 (to the Lipidomics Core, Lipidomics and Pathobiology COBRE, Medical University of South Carolina for sphingolipid analysis).	ATZEL A, 1994, BIOCHEMISTRY-US, V33, P15382, DOI 10.1021/bi00255a019; Bakillah A, 2000, BIOCHEMISTRY-US, V39, P4892, DOI 10.1021/bi9924009; Bakillah A, 1997, LIPIDS, V32, P1113, DOI 10.1007/s11745-997-0143-8; Berriot-Varoqueaux N, 2000, ANNU REV NUTR, V20, P663, DOI 10.1146/annurev.nutr.20.1.663; Bikman BT, 2011, J CLIN INVEST, V121, P4222, DOI 10.1172/JCI57144; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boon J, 2013, DIABETES, V62, P401, DOI 10.2337/db12-0686; Chang BHJ, 1999, J BIOL CHEM, V274, P6051, DOI 10.1074/jbc.274.10.6051; Chatterjee S, 1998, ARTERIOSCL THROM VAS, V18, P1523, DOI 10.1161/01.ATV.18.10.1523; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Cuchel M, 2007, NEW ENGL J MED, V356, P148, DOI 10.1056/NEJMoa061189; DAWSON G, 1976, J LIPID RES, V17, P125; de Mello VDF, 2009, DIABETOLOGIA, V52, P2612, DOI 10.1007/s00125-009-1482-9; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Hammad SM, 2012, J LIPIDS, V2012, DOI 10.1155/2012/180705; Hammad SM, 2011, ADV EXP MED BIOL, V721, P57, DOI 10.1007/978-1-4614-0650-1_4; Hammad SM, 2010, J LIPID RES, V51, P3074, DOI 10.1194/jlr.D008532; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; Hussain MM, 2014, CURR OPIN LIPIDOL, V25, P200, DOI 10.1097/MOL.0000000000000084; Hussain MM, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-14; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; HUSSAIN MM, 1995, ARTERIOSCL THROM VAS, V15, P485, DOI 10.1161/01.ATV.15.4.485; Iqbal J, 2003, J BIOL CHEM, V278, P31610, DOI 10.1074/jbc.M301177200; Iqbal J, 2014, J LIPID RES, V55, P2261, DOI 10.1194/jlr.M047951; Iqbal J, 2013, J BIOL CHEM, V288, P30432, DOI 10.1074/jbc.M113.501247; Iqbal J, 2010, J LIPID RES, V51, P1929, DOI 10.1194/jlr.M005744; Ishibashi Y, 2013, BBA-MOL CELL BIOL L, V1831, P1475, DOI 10.1016/j.bbalip.2013.06.001; Jiang XC, 2000, ARTERIOSCL THROM VAS, V20, P2614, DOI 10.1161/01.ATV.20.12.2614; Jiang XC, 2011, ADV EXP MED BIOL, V721, P19, DOI 10.1007/978-1-4614-0650-1_2; Khatun I, 2012, HEPATOLOGY, V55, P1356, DOI 10.1002/hep.25504; Konstantynowicz-Nowicka K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116858; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; MERRILL AH, 1995, J BIOL CHEM, V270, P13834, DOI 10.1074/jbc.270.23.13834; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Raabe M, 1998, P NATL ACAD SCI USA, V95, P8686, DOI 10.1073/pnas.95.15.8686; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stiban J, 2010, ADV EXP MED BIOL, V688, P60; Tuuf J, 2014, CHEM PHYS LIPIDS, V178, P27, DOI 10.1016/j.chemphyslip.2013.10.013; WETTERAU JR, 1985, CHEM PHYS LIPIDS, V38, P205, DOI 10.1016/0009-3084(85)90068-4; WETTERAU JR, 1984, J BIOL CHEM, V259, P863; Wiesner P, 2009, J LIPID RES, V50, P574, DOI 10.1194/jlr.D800028-JLR200; Xie Y, 2006, J BIOL CHEM, V281, P4075, DOI 10.1074/jbc.M510622200	46	45	45	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25863	25875		10.1074/jbc.M115.659110	http://dx.doi.org/10.1074/jbc.M115.659110			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26350457	Green Published, hybrid			2022-12-26	WOS:000363527300011
J	Saha, PP; Srivastava, S; Kumar, SKP; Sinha, D; D'Silva, P				Saha, Prasenjit Prasad; Srivastava, Shubhi; Kumar, Praveen S. K.; Sinha, Devanjan; D'Silva, Patrick			Mapping Key Residues of ISD11 Critical for NFS1-ISD11 Subcomplex Stability IMPLICATIONS IN THE DEVELOPMENT OF MITOCHONDRIAL DISORDER, COXPD19	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTER; CYSTEINE DESULFURASE NFS1; SACCHAROMYCES-CEREVISIAE; PROTEIN MATURATION; CRYSTAL-STRUCTURE; BIOGENESIS; COMPLEX; EUKARYOTES; SCAFFOLD; METABOLISM	Biogenesis of the iron-sulfur (Fe-S) cluster is an indispensable process in living cells. In mammalian mitochondria, the initial step of the Fe-S cluster assembly process is assisted by the NFS1-ISD11 complex, which delivers sulfur to scaffold protein ISCU during Fe-S cluster synthesis. Although ISD11 is an essential protein, its cellular role in Fe-S cluster biogenesis is still not defined. Our study maps the important ISD11 amino acid residues belonging to putative helix 1 (Phe-40), helix 3 (Leu-63, Arg-68, Gln-69, Ile-72, Tyr-76), and C-terminal segment (Leu-81, Glu-84) are critical for in vivo Fe-S cluster biogenesis. Importantly, mutation of these conserved ISD11 residues into alanine leads to its compromised interaction with NFS1, resulting in reduced stability and enhanced aggregation of NFS1 in the mitochondria. Due to altered interaction with ISD11 mutants, the levels of NFS1 and Isu1 were significantly depleted, which affects Fe-S cluster biosynthesis, leading to reduced electron transport chain complex (ETC) activity and mitochondrial respiration. In humans, a clinically relevant ISD11 mutation (R68L) has been associated in the development of a mitochondrial genetic disorder, COXPD19. Our findings highlight that the ISD11 R68A/R68L mutation display reduced affinity to form a stable subcomplex with NFS1, and thereby fails to prevent NFS1 aggregation resulting in impairment of the Fe-S cluster biogenesis. The prime affected machinery is the ETC complex, which showed compromised redox properties, causing diminished mitochondrial respiration. Furthermore, the R68L ISD11 mutant displayed accumulation of mitochondrial iron and reactive oxygen species, leading to mitochondrial dysfunction, which correlates with the phenotype observed in COXPD19 patients.	[Saha, Prasenjit Prasad; Srivastava, Shubhi; Sinha, Devanjan; D'Silva, Patrick] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Kumar, Praveen S. K.] Karnatak Univ, Dept Biochem, Dharwad 580003, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Karnatak University	D'Silva, P (corresponding author), Indian Inst Sci, Dept Biochem, Biol Sci Bldg, Bangalore 560012, Karnataka, India.	patrick@biochem.iisc.ernet.in	Sinha, Devanjan/A-3953-2017; D'Silva, Patrick/L-6653-2019; Saha, Prasenjit/ABC-6481-2020; S K, Praveen Kumar/AAA-8999-2022; Srivastava, Shubhi/C-7048-2018	Sinha, Devanjan/0000-0001-5060-2075; S K, Praveen Kumar/0000-0002-9696-9734; Srivastava, Shubhi/0000-0001-9922-1943; Saha, Prasenjit/0000-0003-4679-2368	Council of Scientific and Industrial Research, India [CSIR 37(1534)/12/EMR-II]; Swarnajayanthi Fellowship from Department of Science and Technology (DST), Ministry of Science and Technology, India; DST, India INSPIRE fellowship; Department of Biotechnology for Research Associate fellowship, India	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Swarnajayanthi Fellowship from Department of Science and Technology (DST), Ministry of Science and Technology, India; DST, India INSPIRE fellowship; Department of Biotechnology for Research Associate fellowship, India	This work was supported in part by Council of Scientific and Industrial Research Grant CSIR 37(1534)/12/EMR-II, India (to P. D. S.), and Swarnajayanthi Fellowship from Department of Science and Technology (DST), Ministry of Science and Technology, India (to P. D. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Council of Scientific and Industrial Research, India for Senior Research fellowships.; Supported by a DST, India INSPIRE fellowship.; Supported by a Department of Biotechnology for Research Associate fellowship, India.	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Batandier C, 2002, J CELL MOL MED, V6, P175, DOI 10.1111/j.1582-4934.2002.tb00185.x; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; Craig EA, 1999, BIOL CHEM, V380, P1167, DOI 10.1515/BC.1999.148; Craig EA, 2002, CELL MOL LIFE SCI, V59, P1658, DOI 10.1007/PL00012493; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; de Moura MB, 2010, ENVIRON MOL MUTAGEN, V51, P391, DOI 10.1002/em.20575; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; GALLET PF, 1995, EUR J BIOCHEM, V228, P113, DOI 10.1111/j.1432-1033.1995.tb20238.x; Garland SA, 1999, J MOL BIOL, V294, P897, DOI 10.1006/jmbi.1999.3294; Goswami AV, 2012, HUM MOL GENET, V21, P3317, DOI 10.1093/hmg/dds162; GUTTERIDGE JMC, 1990, BIOCHEM J, V269, P169, DOI 10.1042/bj2690169; JOHNSON LV, 1981, J CELL BIOL, V88, P526, DOI 10.1083/jcb.88.3.526; Kaiser JT, 2000, J MOL BIOL, V297, P451, DOI 10.1006/jmbi.2000.3581; Kato S, 2002, P NATL ACAD SCI USA, V99, P5948, DOI 10.1073/pnas.082123599; Kirkinezos IG, 2001, SEMIN CELL DEV BIOL, V12, P449, DOI 10.1006/scdb.2001.0282; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; Land T, 1998, MOL CELL, V2, P807, DOI 10.1016/S1097-2765(00)80295-6; Levi S, 2009, BBA-GEN SUBJECTS, V1790, P629, DOI 10.1016/j.bbagen.2008.09.008; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2006, BBA-MOL CELL RES, V1763, P652, DOI 10.1016/j.bbamcr.2006.05.011; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Lim SC, 2013, HUM MOL GENET, V22, P4460, DOI 10.1093/hmg/ddt295; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Maio N, 2015, BBA-MOL CELL RES, V1853, P1493, DOI 10.1016/j.bbamcr.2014.09.009; Majewska J, 2013, J BIOL CHEM, V288, P29134, DOI 10.1074/jbc.M113.503524; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; Meyer J, 2008, J BIOL INORG CHEM, V13, P157, DOI 10.1007/s00775-007-0318-7; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; Pierik AJ, 2009, NAT PROTOC, V4, P753, DOI 10.1038/nprot.2009.39; Richards TA, 2006, MOL BIOL EVOL, V23, P1341, DOI 10.1093/molbev/msl001; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Saha PP, 2014, J BIOL CHEM, V289, P10359, DOI 10.1074/jbc.M113.526665; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Shan YX, 2007, HUM MOL GENET, V16, P929, DOI 10.1093/hmg/ddm038; Shi YB, 2009, HUM MOL GENET, V18, P3014, DOI 10.1093/hmg/ddp239; Song JY, 2012, P NATL ACAD SCI USA, V109, P10370, DOI 10.1073/pnas.1206945109; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Srivastava S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.355; Stehling O, 2014, BIOCHIMIE, V100, P61, DOI 10.1016/j.biochi.2014.01.010; Toyokuni S, 2002, REDOX REP, V7, P189, DOI 10.1179/135100002125000596; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; ZHENG LM, 1994, J BIOL CHEM, V269, P18723; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031	48	18	20	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25876	25890		10.1074/jbc.M115.678508	http://dx.doi.org/10.1074/jbc.M115.678508			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26342079	Green Published, hybrid			2022-12-26	WOS:000363527300012
J	Bao, H; Dalal, K; Cytrynbaum, E; Duong, F				Bao, Huan; Dalal, Kush; Cytrynbaum, Eric; Duong, Franck			Sequential Action of MalE and Maltose Allows Coupling ATP Hydrolysis to Translocation in the MalFGK(2) Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTER; ABC-TRANSPORTER; ESCHERICHIA-COLI; FUNCTIONAL-CHARACTERIZATION; CONFORMATIONAL-CHANGES; FACING CONFORMATION; ALTERNATING ACCESS; CRYSTAL-STRUCTURE; PERIPLASMIC LOOP; PROTEIN	ATP-binding cassette (ABC) transporters have evolved an ATP-dependent alternating-access mechanism to transport substrates across membranes. Despite important progress, especially in their structural analysis, it is still unknown how the substrate stimulates ATP hydrolysis, the hallmark of ABC transporters. In this study, we measure the ATP turnover cycle of MalFGK(2) in steady and pre-steady state conditions. We show that (i) the basal ATPase activity of MalFGK(2) is very low because the cleavage of ATP is rate-limiting, (ii) the binding of open-state MalE to the transporter induces ATP cleavage but leaves release of P-i limiting, and (iii) the additional presence of maltose stimulates release of P-i, and therefore increases the overall ATP turnover cycle. We conclude that open-state MalE stabilizes MalFGK(2) in the outward-facing conformation until maltose triggers return to the inward-facing state for substrate and P-i release. This concerted action explains why ATPase activity of MalFGK(2) depends on maltose, and why MalE is essential for transport.	[Bao, Huan; Dalal, Kush; Duong, Franck] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Cytrynbaum, Eric] Univ British Columbia, Dept Math, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Duong, F (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	fduong@mail.ubc.ca		Bao, Huan/0000-0002-4301-4627; Cytrynbaum, Eric/0000-0001-8789-1667; Duong Van Hoa, Franck/0000-0001-7328-6124	Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research (CIHR); Four-Year Fellowship from University of British Columbia	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Four-Year Fellowship from University of British Columbia	This work was supported by operating grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canadian Institutes of Health Research (CIHR) (to F. D. and E. C.) and a Four-Year Fellowship from the University of British Columbia (to H. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Ames GFL, 1996, J BIOL CHEM, V271, P14264, DOI 10.1074/jbc.271.24.14264; Bao H, 2014, J BIOL CHEM, V289, P9844, DOI 10.1074/jbc.M113.545525; Bao H, 2013, J BIOL CHEM, V288, P3439, DOI 10.1074/jbc.M112.431932; Bao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034836; Bohm S, 2013, P NATL ACAD SCI USA, V110, P5492, DOI 10.1073/pnas.1217745110; Bordignon E, 2010, MOL MICROBIOL, V77, P1354, DOI 10.1111/j.1365-2958.2010.07319.x; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Chen J, 2013, CURR OPIN STRUC BIOL, V23, P492, DOI 10.1016/j.sbi.2013.03.011; Chen SS, 2013, NATURE, V499, P364, DOI 10.1038/nature12232; Choudhury HG, 2014, P NATL ACAD SCI USA, V111, P9145, DOI 10.1073/pnas.1320506111; Cole SPC, 2014, J BIOL CHEM, V289, P30880, DOI 10.1074/jbc.R114.609248; COVITZ KMY, 1994, EMBO J, V13, P1752, DOI 10.1002/j.1460-2075.1994.tb06439.x; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Daus ML, 2007, J BIOL CHEM, V282, P22387, DOI 10.1074/jbc.M701979200; Daus ML, 2006, J BIOL CHEM, V281, P3856, DOI 10.1074/jbc.M511953200; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; Doshi R, 2013, J BIOL CHEM, V288, P21638, DOI 10.1074/jbc.M113.485714; Doshi R, 2013, J BIOL CHEM, V288, P6801, DOI 10.1074/jbc.M112.430074; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; Gould AD, 2009, BIOCHEMISTRY-US, V48, P8051, DOI 10.1021/bi9007066; Grossmann N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6419; Grote M, 2009, J BIOL CHEM, V284, P17521, DOI 10.1074/jbc.M109.006270; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Jacso T, 2012, J BIOL CHEM, V287, P17040, DOI 10.1074/jbc.M112.340679; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Landmesser H, 2002, BBA-BIOMEMBRANES, V1565, P64, DOI 10.1016/S0005-2736(02)00506-0; Lee JY, 2014, SCIENCE, V343, P1133, DOI 10.1126/science.1246489; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Patzlaff JS, 2003, J BIOL CHEM, V278, P29546, DOI 10.1074/jbc.M304796200; Poolman B, 2005, METHOD ENZYMOL, V400, P429, DOI 10.1016/S0076-6879(05)00025-X; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Robson A, 2009, P NATL ACAD SCI USA, V106, P5111, DOI 10.1073/pnas.0809592106; Sauna ZE, 2004, J BIOL CHEM, V279, P48855, DOI 10.1074/jbc.M408849200; Seyffer F, 2015, BBA-GEN SUBJECTS, V1850, P449, DOI 10.1016/j.bbagen.2014.05.022; Shilton BH, 2008, BBA-BIOMEMBRANES, V1778, P1772, DOI 10.1016/j.bbamem.2007.09.005; Sianidis G, 2001, EMBO J, V20, P961, DOI 10.1093/emboj/20.5.961; Syberg F, 2012, J BIOL CHEM, V287, P23923, DOI 10.1074/jbc.M112.359208; Telmer PG, 2003, J BIOL CHEM, V278, P34555, DOI 10.1074/jbc.M301004200; ter Beek J, 2014, J GEN PHYSIOL, V143, P419, DOI 10.1085/jgp.201411164; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104	48	13	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25452	25460		10.1074/jbc.M115.671826	http://dx.doi.org/10.1074/jbc.M115.671826			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26338707	Green Published, hybrid			2022-12-26	WOS:000362962800021
J	Fado, R; Soto, D; Minano-Molina, AJ; Pozo, M; Carrasco, P; Yefimenko, N; Rodriguez-Alvarez, J; Casals, N				Fado, Rut; Soto, David; Minano-Molina, Alfredo J.; Pozo, Macarena; Carrasco, Patricia; Yefimenko, Natalia; Rodriguez-Alvarez, Jose; Casals, Nuria			Novel Regulation of the Synthesis of alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Subunit GluA1 by Carnitine Palmitoyltransferase 1C (CPT1C) in the Hippocampus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM DEPRESSION; SYNAPTIC PLASTICITY; DENDRITIC SPINE; DEPENDENT REGULATION; GLUTAMATE RECEPTORS; SIGNALING PATHWAYS; BRAIN; TRANSLATION; TRAFFICKING; GHRELIN	The regulation of AMPA-type receptor (AMPAR) abundance in the postsynaptic membrane is an important mechanism involved in learning and memory formation. Recent data suggest that one of the constituents of the AMPAR complex is carnitine palmitoyltransferase 1C (CPT1C), a brain-specific isoform located in the endoplasmic reticulum of neurons. Previous results had demonstrated that CPT1C deficiency disrupted spine maturation in hippocampal neurons and impaired spatial learning, but the role of CPT1C in AMPAR physiology had remained mostly unknown. In the present study, we show that CPT1C binds GluA1 and GluA2 and that the three proteins have the same expression profile during neuronal maturation. Moreover, in hippocampal neurons of CPT1C KO mice, AMPAR-mediated miniature excitatory postsynaptic currents and synaptic levels of AMPAR subunits GluA1 and GluA2 are significantly reduced. We show that AMPAR expression is dependent on CPT1C levels because total protein levels of GluA1 and GluA2 are decreased in CPT1C KO neurons and are increased in CPT1C-overexpressing neurons, whereas other synaptic proteins remain unaltered. Notably, mRNA levels of AMPARs remained unchanged in those cultures, indicating that CPT1C is post-transcriptionally involved. We demonstrate that CPT1C is directly involved in the de novo synthesis of GluA1 and not in protein degradation. Moreover, in CPT1C KO cultured neurons, GluA1 synthesis after chemical long term depression was clearly diminished, and brain-derived neurotrophic factor treatment was unable to phosphorylate the mammalian target of rapamycin (mTOR) and stimulate GluA1 protein synthesis. These data newly identify CPT1C as a regulator of AMPAR translation efficiency and therefore also synaptic function in the hippocampus.	[Fado, Rut; Pozo, Macarena; Casals, Nuria] Univ Int Catalunya, Fac Med & Ciencies Salut, Dept Basic Sci, Sant Cugat Del Valles 08195, Spain; [Soto, David; Yefimenko, Natalia] IDIBELL, Neurobiol Lab, Lhospitalet De Llobregat 08907, Spain; [Soto, David; Yefimenko, Natalia] Univ Barcelona, Fac Med, Dept Pathol & Expt Therapeut, Lhospitalet De Llobregat 08907, Spain; [Minano-Molina, Alfredo J.; Rodriguez-Alvarez, Jose] Univ Autonoma Barcelona, Inst Neurociencies, Cerdanyola Del Valles 08193, Spain; [Minano-Molina, Alfredo J.; Rodriguez-Alvarez, Jose] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Cerdanyola Del Valles 08193, Spain; [Minano-Molina, Alfredo J.; Rodriguez-Alvarez, Jose] CIBERNED, Madrid 28031, Spain; [Carrasco, Patricia; Casals, Nuria] CIBEROBN, Santiago De Compostela 15706, Spain	Universitat Internacional de Catalunya (UIC); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; CIBERNED; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Casals, N (corresponding author), Univ Int Catalunya, Fac Med & Ciencies Salut, Dept Basic Sci, Josep Trueta S-N, Sant Cugat Del Valles 08195, Spain.	ncasals@uic.es	Soto, David/L-4403-2014; Andrés, Fadó Fadó/L-8585-2014; Miñano-Molina, Alfredo J/C-9863-2011; Rodriguez-Alvarez, Jose/F-8403-2011; Casals, Nuria/L-3378-2014	Soto, David/0000-0001-7995-3805; Andrés, Fadó Fadó/0000-0002-3293-2342; Miñano-Molina, Alfredo J/0000-0002-7761-5682; Rodriguez-Alvarez, Jose/0000-0001-8582-8082; Casals, Nuria/0000-0002-6719-4300; Pozo Ariza, Macarena/0000-0003-0723-2499	Ministerio de Ciencia e Innovacion (MICINN) Grants [SAF2011-30520-C02-02, SAF2011-30281, BFU2011-24725]; Ministerio de Economia y Competitividad (MINECO) Grants [SAF2014-52223-C2-2-R, SAF2014-59697-R]; CIBEROBN (initiatives of ISCIII); European Commission [FP7-PEOPLE-2011-CIG, 293498]; Generalitat de Catalunya [SGR2009-1231, SGR2009-152, SGR2014-0984, SGR2014-465]; Fundacio La Marato de TV3 Grant [2014-36-10]; "Ramon y Cajal" Programme [RyC-2010-05970]; Agencia de Gestio d'Ajuts Universitaris i de la Recerca (AGAUR) in Catalunya; CIBERNED (initiatives of ISCIII)	Ministerio de Ciencia e Innovacion (MICINN) Grants; Ministerio de Economia y Competitividad (MINECO) Grants; CIBEROBN (initiatives of ISCIII); European Commission(European CommissionEuropean Commission Joint Research Centre); Generalitat de Catalunya(Generalitat de Catalunya); Fundacio La Marato de TV3 Grant; "Ramon y Cajal" Programme(Spanish Government); Agencia de Gestio d'Ajuts Universitaris i de la Recerca (AGAUR) in Catalunya; CIBERNED (initiatives of ISCIII)	This work was supported by Ministerio de Ciencia e Innovacion (MICINN) Grants SAF2011-30520-C02-02 (to N. C.), SAF2011-30281 (to J. R.), and BFU2011-24725 (to D. S.) and Ministerio de Economia y Competitividad (MINECO) Grants SAF2014-52223-C2-2-R (to N. C.) and SAF2014-59697-R (to J. R.). This work was also supported by grants from CIBEROBN and CIBERNED (initiatives of ISCIII), the European Commission (FP7-PEOPLE-2011-CIG; Grant 293498 to D. S.), the Generalitat de Catalunya (Grants SGR2009-1231, SGR2009-152, SGR2014-0984, and SGR2014-465), and Fundacio La Marato de TV3 Grant 2014-36-10 (to J. R.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the "Ramon y Cajal" Programme (RyC-2010-05970).; Recipient of a fellowship from the Agencia de Gestio d'Ajuts Universitaris i de la Recerca (AGAUR) in Catalunya.	Aoto J, 2013, CELL, V154, P75, DOI 10.1016/j.cell.2013.05.060; Carlini VP, 2002, BIOCHEM BIOPH RES CO, V299, P739, DOI 10.1016/S0006-291X(02)02740-7; Carrasco P, 2013, BEHAV BRAIN RES, V256, P291, DOI 10.1016/j.bbr.2013.08.004; Carrasco P, 2012, J BIOL CHEM, V287, P21224, DOI 10.1074/jbc.M111.337493; Chen LA, 2011, EUR J NEUROSCI, V33, P266, DOI 10.1111/j.1460-9568.2010.07491.x; Chen N, 2008, FASEB J, V22, P236, DOI 10.1096/fj.07-8739com; Chen N, 2014, J PROTEOME RES, V13, P5695, DOI 10.1021/pr500697b; Dieterich DC, 2007, NAT PROTOC, V2, P532, DOI 10.1038/nprot.2007.52; Fado R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02397; Fernandez-Monreal M, 2012, J NEUROSCI, V32, P13200, DOI 10.1523/JNEUROSCI.0061-12.2012; Fortin DA, 2012, NEUROSCIENTIST, V18, P326, DOI 10.1177/1073858411407206; Fortin DA, 2012, J NEUROSCI, V32, P8127, DOI 10.1523/JNEUROSCI.6034-11.2012; Gao S, 2011, P NATL ACAD SCI USA, V108, P9691, DOI 10.1073/pnas.1103267108; Gao XF, 2009, DIABETOLOGIA, V52, P912, DOI 10.1007/s00125-009-1284-0; Gratacos-Batlle E, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00469; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Henley Jeremy M, 2013, Dialogues Clin Neurosci, V15, P11; Hu ZH, 2015, J CELL BIOL, V208, P949, DOI 10.1083/jcb.201404092; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Kudoh SN, 2002, BIOSENS BIOELECTRON, V17, P773, DOI 10.1016/S0956-5663(02)00053-2; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Lee CC, 2011, NEUROPHARMACOLOGY, V61, P867, DOI 10.1016/j.neuropharm.2011.06.003; Lissin DV, 1999, J NEUROSCI, V19, P1263; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Minano-Molina AJ, 2011, J BIOL CHEM, V286, P27311, DOI 10.1074/jbc.M111.227504; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Pavlopoulos E, 2011, CELL, V147, P1369, DOI 10.1016/j.cell.2011.09.056; Pedraza N, 2014, J NEUROSCI, V34, P13988, DOI 10.1523/JNEUROSCI.1573-14.2014; Prendergast J, 2014, J NEUROSCI, V34, P13246, DOI 10.1523/JNEUROSCI.1149-14.2014; Price NT, 2002, GENOMICS, V80, P433, DOI 10.1006/geno.2002.6845; Ramirez S, 2013, DIABETES, V62, P2329, DOI 10.2337/db12-1451; Ran I, 2013, J NEUROSCI, V33, P1872, DOI 10.1523/JNEUROSCI.3264-12.2013; Reilly PT, 2012, CLIN CANCER RES, V18, P5850, DOI 10.1158/1078-0432.CCR-11-3281; Ribeiro LF, 2014, P NATL ACAD SCI USA, V111, pE149, DOI 10.1073/pnas.1313798111; Rinaldi C, 2015, JAMA NEUROL, V72, P561, DOI 10.1001/jamaneurol.2014.4769; Schwenk J, 2014, NEURON, V84, P41, DOI 10.1016/j.neuron.2014.08.044; Schwenk J, 2012, NEURON, V74, P621, DOI 10.1016/j.neuron.2012.03.034; Shanley LJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0001.2001; Shehata M, 2012, J NEUROSCI, V32, P10413, DOI 10.1523/JNEUROSCI.4533-11.2012; Sierra AY, 2008, J BIOL CHEM, V283, P6878, DOI 10.1074/jbc.M707965200; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Tokutake Y, 2010, BIOCHEM BIOPH RES CO, V402, P158, DOI 10.1016/j.bbrc.2010.10.009; Volmer R, 2015, CURR OPIN CELL BIOL, V33, P67, DOI 10.1016/j.ceb.2014.12.002; Wang G, 2015, NEUROPHARMACOLOGY, V95, P144, DOI 10.1016/j.neuropharm.2015.03.003; Wolfgang MJ, 2008, J NEUROCHEM, V105, P1550, DOI 10.1111/j.1471-4159.2008.05255.x; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211	47	23	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25548	25560		10.1074/jbc.M115.681064	http://dx.doi.org/10.1074/jbc.M115.681064			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26338711	Green Published, hybrid			2022-12-26	WOS:000362962800029
J	Reddy, V; Wu, M; Ciavattone, N; McKenty, N; Menon, M; Barrack, ER; Reddy, GPV; Kim, SH				Reddy, Vidyavathi; Wu, Min; Ciavattone, Nicholas; McKenty, Nathan; Menon, Mani; Barrack, Evelyn R.; Reddy, G. Prem-Veer; Kim, Sahn-Ho			ATM Inhibition Potentiates Death of Androgen Receptor-inactivated Prostate Cancer Cells with Telomere Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; MAMMALIAN TELOMERES; BREAST-CANCER; REPAIR; PROTEINS; LENGTH; TRF2; P53; CHROMOSOMES; MAINTENANCE	Androgen receptor (AR) plays a role in maintaining telomere stability in prostate cancer cells, as AR inactivation induces telomere dysfunction within 3 h. Since telomere dysfunction in other systems is known to activate ATM (ataxia telangiectasia mutated)-mediated DNA damage response (DDR) signaling pathways, we investigated the role of ATM-mediated DDR signaling in AR-inactivated prostate cancer cells. Indeed, the induction of telomere dysfunction in cells treated with AR-antagonists (Casodex or MDV3100) or AR-siRNA was associated with a dramatic increase in phosphorylation (activation) of ATM and its downstream effector Chk2 and the presence of phosphorylated ATM at telomeres, indicating activation of DDR signaling at telomeres. Moreover, Casodex washout led to the reversal of telomere dysfunction, indicating repair of damaged telomeres. ATM inhibitor blocked ATM phosphorylation, induced PARP cleavage, abrogated cell cycle checkpoint activation and attenuated the formation of gamma H2AX foci at telomeres in AR-inactivated cells, suggesting that ATM inhibitor induces apoptosis in AR-inactivated cells by blocking the repair of damaged DNA at telomeres. Finally, colony formation assay revealed a dramatic decrease in the survival of cells co-treated with Casodex and ATM inhibitor as compared with those treated with either Casodex or ATM inhibitor alone. These observations indicate that inhibitors of DDR signaling pathways may offer a unique opportunity to enhance the potency of AR-targeted therapies for the treatment of androgen-sensitive as well as castration-resistant prostate cancer.	[Reddy, Vidyavathi; Wu, Min; Ciavattone, Nicholas; McKenty, Nathan; Menon, Mani; Barrack, Evelyn R.; Reddy, G. Prem-Veer; Kim, Sahn-Ho] Henry Ford Hosp, Vattikuti Urol Inst, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	Kim, SH (corresponding author), Henry Ford Hlth Syst, 1 Ford Pl, Detroit, MI 48202 USA.	skim3@hfhs.org		Ciavattone, Nicholas/0000-0001-9265-8202	Department of Defense Prostate Cancer Research Program Grant [W81XWH-10-1-0117]; Henry Ford Health System; NIH Center Grant [P30CA022455]	Department of Defense Prostate Cancer Research Program Grant(United States Department of Defense); Henry Ford Health System; NIH Center Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Department of Defense Prostate Cancer Research Program Grant W81XWH-10-1-0117 (to S. K.) and a grant from Henry Ford Health System (to S. K.). The Cytometry Resources Core is supported in part by NIH Center Grant P30CA022455 to the Karmanos Cancer Institute, Wayne State University, and the Perinatology Research Branch of the National Institutes of Child Health and Development, Wayne State University. The authors declare that they have no conflicts of interest with the contents of this article.	Angele S, 2004, AM J CLIN PATHOL, V121, P231, DOI 10.1309/JTKGGGKURFX3XMGT; Bai VU, 2005, J CELL PHYSIOL, V204, P381, DOI 10.1002/jcp.20422; Bailey SM, 1999, P NATL ACAD SCI USA, V96, P14899, DOI 10.1073/pnas.96.26.14899; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bouchal J, 2005, J PHARM PHARMACOL, V57, P83, DOI 10.1211/0022357055164; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; D'Antonio JM, 2009, ENDOCR-RELAT CANCER, V16, P325, DOI 10.1677/ERC-08-0205; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Fan C, 2006, BBA-MOL CELL RES, V1763, P1090, DOI 10.1016/j.bbamcr.2006.08.026; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Golding SE, 2009, MOL CANCER THER, V8, P2894, DOI 10.1158/1535-7163.MCT-09-0519; Gong Y, 2010, MOL CELL, V40, P377, DOI 10.1016/j.molcel.2010.10.016; Goodwin JF, 2013, CANCER DISCOV, V3, P1254, DOI 10.1158/2159-8290.CD-13-0108; Guo CH, 2003, J UROLOGY, V170, P615, DOI 10.1097/01.ju.0000074653.22766.c8; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Heaphy CM, 2013, CANCER DISCOV, V3, P1130, DOI 10.1158/2159-8290.CD-13-0135; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Jallepalli PV, 2003, J BIOL CHEM, V278, P20475, DOI 10.1074/jbc.M213159200; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Joshua AM, 2011, PROSTATE, V71, P778, DOI 10.1002/pros.21294; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Kim SH, 2010, J BIOL CHEM, V285, P10472, DOI 10.1074/jbc.M109.098798; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Liu SA, 2010, MOL CANCER THER, V9, P2016, DOI 10.1158/1535-7163.MCT-09-0924; Martinez P, 2012, J CELL BIOL, V197, P283, DOI 10.1083/jcb.201110124; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Mayeur GL, 2005, J BIOL CHEM, V280, P10827, DOI 10.1074/jbc.M413336200; Min J, 2012, J BIOL CHEM, V287, P5091, DOI 10.1074/jbc.M111.278994; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Murnane JP, 2010, CANCER RES, V70, P4255, DOI 10.1158/0008-5472.CAN-09-4357; Murthy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056692; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Polkinghorn WR, 2013, CANCER DISCOV, V3, P1245, DOI 10.1158/2159-8290.CD-13-0172; Prevo R, 2012, CANCER BIOL THER, V13, P1072, DOI 10.4161/cbt.21093; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Yamashita S, 2012, NEOPLASIA, V14, P74, DOI 10.1593/neo.111436; Zhan P, 2002, J STEROID BIOCHEM, V83, P101, DOI 10.1016/S0960-0760(02)00275-3; Zhou JY, 2013, AGING-US, V5, P3, DOI 10.18632/aging.100524	50	16	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25522	25533		10.1074/jbc.M115.671404	http://dx.doi.org/10.1074/jbc.M115.671404			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26336104	hybrid, Green Published			2022-12-26	WOS:000362962800027
J	Dickson, TL; Gross, KL				Dickson, Timothy L.; Gross, Katherine L.			Can the Results of Biodiversity-Ecosystem Productivity Studies Be Translated to Bioenergy Production?	PLOS ONE			English	Article							BIOMASS PRODUCTION; PLANT DIVERSITY; LOW-INPUT; GRASSLAND; CONSERVATION; RESTORATION; SWITCHGRASS; EVENNESS; NITROGEN; HISTORY	Biodiversity experiments show that increases in plant diversity can lead to greater biomass production, and some researchers suggest that high diversity plantings should be used for bioenergy production. However, many methods used in past biodiversity experiments are impractical for bioenergy plantings. For example, biodiversity experiments often use intensive management such as hand weeding to maintain low diversity plantings and exclude unplanted species, but this would not be done for bioenergy plantings. Also, biodiversity experiments generally use high seeding densities that would be too expensive for bioenergy plantings. Here we report the effects of biodiversity on biomass production from two studies of more realistic bioenergy crop plantings in southern Michigan, USA. One study involved comparing production between switchgrass (Panicum virgatum) monocultures and species-rich prairie plantings on private farm fields that were managed similarly to bioenergy plantings. The other study was an experiment where switchgrass was planted in monoculture and in combination with increasingly species-rich native prairie mixtures. Overall, we found that bioenergy plantings with higher species richness did not produce more biomass than switchgrass monocultures. The lack of a positive relationship between planted species richness and production in our studies may be due to several factors. Non-planted species (weeds) were not removed from our studies and these non-planted species may have competed with planted species and also prevented realized species richness from equaling planted species richness. Also, we found that low seeding density of individual species limited the biomass production of these individual species. Production in future bioenergy plantings with high species richness may be increased by using a high density of inexpensive seed from switchgrass and other highly productive species, and future efforts to translate the results of biodiversity experiments to bioenergy plantings should consider the role of seeding density.	[Dickson, Timothy L.] Univ Nebraska, Dept Biol, Omaha, NE 68182 USA; [Gross, Katherine L.] Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Gross, Katherine L.] Michigan State Univ, Dept Plant Biol, Hickory Corners, MI USA	University of Nebraska System; Michigan State University; Michigan State University	Dickson, TL (corresponding author), Univ Nebraska, Dept Biol, Omaha, NE 68182 USA.	tdickson@unomaha.edu			University of Nebraska-Omaha Office of Research and Creative Activity; Department of Energy Great Lakes Bioenergy Research Center [DE-FC02-07ER64494]; Department of Energy Office of Energy Efficiency and Renewable Energy [DE-AC05-76RL01830]; National Science Foundation [DEB 1027253]; Michigan State University; Direct For Biological Sciences [1027253] Funding Source: National Science Foundation	University of Nebraska-Omaha Office of Research and Creative Activity; Department of Energy Great Lakes Bioenergy Research Center(United States Department of Energy (DOE)); Department of Energy Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Michigan State University; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the University of Nebraska-Omaha Office of Research and Creative Activity to TLD, the Department of Energy Great Lakes Bioenergy Research Center (DE-FC02-07ER64494) to KLG, the Department of Energy Office of Energy Efficiency and Renewable Energy (DE-AC05-76RL01830) to KLG, the National Science Foundation (DEB 1027253) to KLG, and Michigan State University to KLG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PR, 2009, ECOL APPL, V19, P2202, DOI 10.1890/07-2094.1; Baer SG, 2005, RESTOR ECOL, V13, P413, DOI 10.1111/j.1526-100X.2005.00051.x; Bullock JM, 2007, J APPL ECOL, V44, P6, DOI 10.1111/j.1365-2664.2006.01252.x; Bullock JM, 2001, ECOL LETT, V4, P185, DOI 10.1046/j.1461-0248.2001.00215.x; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Craine JM, 2003, ECOL LETT, V6, P623, DOI 10.1046/j.1461-0248.2003.00467.x; Dickson TL, 2009, RESTOR ECOL, V17, P597, DOI 10.1111/j.1526-100X.2008.00427.x; ERIKSSON O, 1992, OECOLOGIA, V91, P360, DOI 10.1007/BF00317624; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Gelfand I, 2013, NATURE, V493, P514, DOI 10.1038/nature11811; Gelfand I, 2011, P NATL ACAD SCI USA, V108, P13864, DOI 10.1073/pnas.1017277108; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Henschell MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125758; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; James LK, 2010, AGRON J, V102, P675, DOI 10.2134/agronj2009.0289; Jungers JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061209; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; Lee D, 2013, GCB BIOENERGY, V5, P6, DOI 10.1111/j.1757-1707.2012.01177.x; McCoy TD, 2001, AM MIDL NAT, V145, P1, DOI 10.1674/0003-0031(2001)145[0001:GBCCVC]2.0.CO;2; Monti A, 2009, BIOMASS BIOENERG, V33, P841, DOI 10.1016/j.biombioe.2009.01.006; Natural Resources Conservation Service, 2013, NAT GRASS PLANT MICH; Petermann JS, 2010, ECOLOGY, V91, P408, DOI 10.1890/08-2304.1; Pfisterer AB, 2004, BASIC APPL ECOL, V5, P5, DOI 10.1078/1439-1791-00215; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2013, BASIC APPL ECOL, V14, P187, DOI 10.1016/j.baae.2013.01.003; Schmer MR, 2012, AGRON J, V104, P54, DOI 10.2134/agronj2011.0195; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; VOGEL KP, 1987, AGRON J, V79, P509, DOI 10.2134/agronj1987.00021962007900030021x; Wallander S., 2011, EC INFORM B; Wardle DA, 1999, OIKOS, V87, P403, DOI 10.2307/3546757; Weigelt A, 2009, BIOGEOSCIENCES, V6, P1695, DOI 10.5194/bg-6-1695-2009; Werling BP, 2014, P NATL ACAD SCI USA, V111, P1652, DOI 10.1073/pnas.1309492111; Werling BP, 2011, GCB BIOENERGY, V3, P347, DOI 10.1111/j.1757-1707.2011.01092.x; Wilsey BJ, 2000, ECOLOGY, V81, P887, DOI 10.1890/0012-9658(2000)081[0887:BAEFIO]2.0.CO;2; Wilsey BJ, 2003, ECOLOGY, V84, P920, DOI 10.1890/0012-9658(2003)084[0920:EOSAAG]2.0.CO;2; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110; Wullschleger SD, 2010, AGRON J, V102, P1158, DOI 10.2134/agronj2010.0087	41	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0135253	10.1371/journal.pone.0135253	http://dx.doi.org/10.1371/journal.pone.0135253			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26359662	Green Published, Green Submitted, gold			2022-12-26	WOS:000361043100003
J	George, AA; Paz, H; Fei, F; Kirzner, J; Kim, YM; Heisterkamp, N; Abdel-Azim, H				George, Aswathi A.; Paz, Helicia; Fei, Fei; Kirzner, Jonathan; Kim, Yong-Mi; Heisterkamp, Nora; Abdel-Azim, Hisham			Phosphoflow-Based Evaluation of Mek Inhibitors as Small-Molecule Therapeutics for B-Cell Precursor Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							RAS PATHWAY; RAS/RAF/MEK/ERK; PHOSPHORYLATION; SENSITIVITY; ACTIVATION; MUTATIONS; THERAPY; BCL6; AML	Upstream mutations that lead to constitutive activation of Erk in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) are relatively common. In the era of personalized medicine, flow cytometry could be used as a rapid method for selection of optimal therapies, which may include drugs that target the Erk pathway. Here, we evaluated the utility of phosphoflow, compared to Western blotting, to monitor Erk pathway activation and its inhibition by targeted Mek kinase inhibitors in human BCP ALL. Because the Erk pathway is not only activated endogenously, by mutations, but also by normal extracellular stimulation through stromal contact and serum growth factors, we compared Erk activation ex vivo in ALL cells in the presence and absence of stroma and serum. Phospho-flow was able to readily detect changes in the pool of pErk1/2 that had been generated by normal microenvironmental stimuli in patient-derived BCP-ALL cells passaged in NSG mice, in viably frozen primary patient samples, and in fresh patient samples. Treatment with the Mek1/2 inhibitor selumetinib resulted in a rapid, complete and persistent reduction of microenvironment-generated pErk1/2. Imaging flow cytometry confirmed reduction of nuclear pErk1/2 upon selumetinib treatment. An ALL relapsing with an activating KRasG12V mutation contained higher endogenous as well as serum/stromal-stimulated levels of pErk1/2 than the matched diagnosis sample which lacked the mutation, but selumetinib treatment reduced pErk1/2 to the same level in both samples. Selumetinib and trametinib as Mek inhibitors were mainly cytostatic, but combined treatment with the PI3K@ inhibitor CAL101 increased cytotoxicity. Thus phospho-flow cytometry could be used as a platform for rapid, individualized in vitro drug sensitivity assessment for leukemia patients at the time of diagnosis.	[George, Aswathi A.; Paz, Helicia; Fei, Fei; Kirzner, Jonathan; Kim, Yong-Mi; Heisterkamp, Nora; Abdel-Azim, Hisham] Childrens Hosp Los Angeles, Saban Res Inst, Div Hematol Oncol & Bone Marrow Transplantat, Los Angeles, CA 90027 USA; [Paz, Helicia; Fei, Fei; Heisterkamp, Nora] Childrens Hosp Los Angeles, Saban Res Inst, Sect Mol Carcinogenesis, Dept Pediat, Los Angeles, CA 90027 USA; [Heisterkamp, Nora] Univ So Calif, Norris Comprehens Canc Ctr, Leukemia & Lymphoma Program, Los Angeles, CA USA; [Heisterkamp, Nora] Univ So Calif, Dept Pathol, Los Angeles, CA 90089 USA	Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California; University of Southern California	Heisterkamp, N (corresponding author), Childrens Hosp Los Angeles, Saban Res Inst, Div Hematol Oncol & Bone Marrow Transplantat, Los Angeles, CA 90027 USA.	heisterk@hsc.usc.edu; HAbdelAzim@chla.usc.edu	kim, y/AAR-6095-2020; Heisterkamp, Nora/C-1698-2012	Heisterkamp, Nora/0000-0003-2769-2273; Kim, Yong-Mi/0000-0003-3793-6438	Alex's Lemonade Stand Foundation; Leukemia & Lymphoma Society; V-Foundation; National Institutes of Health Public Health Service [CA174020, CA172896]; NATIONAL CANCER INSTITUTE [R01CA172040, R01CA172896] Funding Source: NIH RePORTER	Alex's Lemonade Stand Foundation; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); V-Foundation; National Institutes of Health Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from Alex's Lemonade Stand Foundation [www.alexslemonade.org] (NH), the Leukemia & Lymphoma Society [http://www.lls.org/] (NH), the V-Foundation [http://www.jimmyv.org/] (NH), and National Institutes of Health Public Health Service grants CA174020 (NH) and CA172896 (YK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown R, 2015, LEUKEMIA, V29, P483, DOI 10.1038/leu.2014.204; Case M, 2008, CANCER RES, V68, P6803, DOI 10.1158/0008-5472.CAN-08-0101; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Duy C, 2011, NATURE, V473, P384, DOI 10.1038/nature09883; Fei F, 2010, LEUKEMIA, V24, P813, DOI 10.1038/leu.2009.302; Fei F, 2010, MOL CANCER THER, V9, P1318, DOI 10.1158/1535-7163.MCT-10-0069; Geng HM, 2015, CANCER CELL, V27, P409, DOI 10.1016/j.ccell.2015.02.003; Gregorj C, 2007, BLOOD, V109, P5473, DOI 10.1182/blood-2006-05-021071; Hsieh YT, 2013, BLOOD, V121, P1814, DOI 10.1182/blood-2012-01-406272; Ikeda H, 2010, BLOOD, V116, P1460, DOI 10.1182/blood-2009-06-222943; Irving J, 2014, BLOOD, V124, P3420, DOI 10.1182/blood-2014-04-531871; Knight T, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00160; Kohno M, 2006, ANN MED, V38, P200, DOI 10.1080/07853890600551037; McCubrey JA, 2012, ONCOTARGET, V3, P954, DOI 10.18632/oncotarget.652; Parameswaran R, 2010, CANCER RES, V70, P4346, DOI 10.1158/0008-5472.CAN-10-0300; Perl AE, 2012, CLIN CANCER RES, V18, P1716, DOI 10.1158/1078-0432.CCR-11-2346; Redell MS, 2013, BLOOD, V121, P1083, DOI 10.1182/blood-2012-04-421925; Shojaee S, 2015, CANCER CELL, V28, P114, DOI 10.1016/j.ccell.2015.05.008; Wang X, 2014, ONCOTARGET, V5, P10732, DOI 10.18632/oncotarget.2533	19	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137917	10.1371/journal.pone.0137917	http://dx.doi.org/10.1371/journal.pone.0137917			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360058	Green Submitted, Green Published, gold			2022-12-26	WOS:000361043100101
J	Balas, B; Conlin, C				Balas, Benjamin; Conlin, Catherine			The Visual N1 Is Sensitive to Deviations from Natural Texture Appearance	PLOS ONE			English	Article							IMAGE STATISTICS; PERCEPTION; DISCRIMINATION; RECOGNITION; REVERSAL; FACES; SHAPE	Disruptions of natural texture appearance are known to negatively impact performance in texture discrimination tasks, for example, such that contrast-negated textures, synthetic textures, and textures depicting abstract art are processed less efficiently than natural textures. Presently, we examined how visual ERP responses (the P1 and the N1 in particular) were affected by violations of natural texture appearance. We presented participants with images depicting either natural textures or synthetic textures made from the original stimuli. Both stimulus types were additionally rendered either in positive or negative contrast. These appearance manipulations (negation and texture synthesis) preserve a range of low-level features, but also disrupt higher-order aspects of texture appearance. We recorded continuous EEG while participants completed a same/different image discrimination task using these images and measured both the P1 and N1 components over occipital recording sites. While the P1 exhibited no sensitivity to either contrast polarity or real/synthetic appearance, the N1 was sensitive to both deviations from natural appearance. Polarity reversal and synthetic appearance affected the N1 latency differently, however, suggesting a differential impact on processing. Our results suggest that stages of visual processing indexed by the P1 and N1 are sensitive to high-order statistical regularities in natural textures and also suggest that distinct violations of natural appearance impact neural responses differently.	[Balas, Benjamin; Conlin, Catherine] N Dakota State Univ, Dept Psychol, Fargo, ND 58105 USA; [Balas, Benjamin] N Dakota State Univ, Ctr Visual & Cognit Neurosci, Fargo, ND 58105 USA	North Dakota State University Fargo; North Dakota State University Fargo	Balas, B (corresponding author), N Dakota State Univ, Dept Psychol, Fargo, ND 58105 USA.	Benjamin.Balas@ndsu.edu	Balas, Ben/R-4003-2019		National Institutes of Health [R15 EY024375, GM103505]; NATIONAL EYE INSTITUTE [R15EY024375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health grant R15 EY024375 awarded to BB, and the National Institutes of Health grant GM103505 awarded to Mark McCourt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balas B, 2015, P SPIE; Balas B, 2014, INFANCY, V19, P262, DOI 10.1111/infa.12050; Balas B, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00515; Balas B, 2009, J VISION, V9, DOI [10.1167/9.2.16, 10.1167/9.12.13]; Balas BJ, 2006, VISION RES, V46, P299, DOI 10.1016/j.visres.2005.04.013; Bulthoff H. H., 2004, P 1 S APPL PERC GRAP, P127; CALLAWAY E, 1982, PSYCHIAT RES, V7, P299, DOI 10.1016/0165-1781(82)90066-X; Ellemberg D, 2012, VISION RES, V67, P1, DOI 10.1016/j.visres.2012.06.018; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Fleming RW, 2014, VISION RES, V94, P62, DOI 10.1016/j.visres.2013.11.004; Fleming RW, 2011, P NATL ACAD SCI USA, V108, P20438, DOI 10.1073/pnas.1114619109; Fleming RW, 2004, J VISION, V4, P798, DOI 10.1167/4.9.10; Fleming RW, 2003, J VISION, V3, P347, DOI 10.1167/3.5.3; Fleming RW., 2005, ACM T APPL PERCEPT, V2, P346, DOI [10.1145/1077399.1077409, DOI 10.1145/1077399.1077409]; Freeman J, 2013, NAT NEUROSCI, V16, P974, DOI 10.1038/nn.3402; Freeman J, 2011, NAT NEUROSCI, V14, P1195, DOI 10.1038/nn.2889; Geisler WS, 2008, ANNU REV PSYCHOL, V59, P167, DOI 10.1146/annurev.psych.58.110405.085632; Gerhard HE, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002873; Geusebroek JM, 2005, INT J COMPUT VISION, V62, P7, DOI 10.1007/s11263-005-4632-7; Ghebreab S, 2009, ADV NEURAL INFORM PR, P629; Groen IIA, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00034; Hansen BC, 2006, J VISION, V6, P696, DOI 10.1167/6.7.3; Heeger D. J., 1995, Computer Graphics Proceedings. SIGGRAPH 95, P229, DOI 10.1145/218380.218446; Hiramatsu C, 2011, NEUROIMAGE, V57, P482, DOI 10.1016/j.neuroimage.2011.04.056; Itier RJ, 2002, NEUROIMAGE, V15, P353, DOI 10.1006/nimg.2001.0982; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Jacobs RHAH, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00146; JOHNSTON A, 1994, PERCEPTION, V23, P169, DOI 10.1068/p230169; JULESZ B, 1981, NATURE, V290, P91, DOI 10.1038/290091a0; Leung T, 2001, INT J COMPUT VISION, V43, P29, DOI 10.1023/A:1011126920638; Luck S.J., 2005, INTRO EVENT RELATED; MALIK J, 1990, J OPT SOC AM A, V7, P923, DOI 10.1364/JOSAA.7.000923; MANGUN GR, 1991, J EXP PSYCHOL HUMAN, V17, P1057, DOI 10.1037/0096-1523.17.4.1057; Nederhouser M, 2007, VISION RES, V47, P2134, DOI 10.1016/j.visres.2007.04.007; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olshausen BA, 1996, NETWORK-COMP NEURAL, V7, P333, DOI 10.1088/0954-898X/7/2/014; Portilla J, 2000, INT J COMPUT VISION, V40, P49, DOI 10.1023/A:1026553619983; Proverbio AM, 2002, NEUROPSYCHOLOGIA, V40, P479, DOI 10.1016/S0028-3932(01)00135-X; Rosenholtz R, 2011, P SPIE HVEI; Schubo A, 2001, COGNITIVE BRAIN RES, V11, P341, DOI 10.1016/S0926-6410(01)00008-8; Sharan L, 2008, J OPT SOC AM A, V25, P846, DOI 10.1364/JOSAA.25.000846; Tyler CW, 2004, VISION RES, V44, P2187, DOI 10.1016/j.visres.2004.03.032	42	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0136471	10.1371/journal.pone.0136471	http://dx.doi.org/10.1371/journal.pone.0136471			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355681	gold, Green Submitted, Green Published			2022-12-26	WOS:000360965800013
J	Schmidt, EM; Wiek, C; Parkinson, OT; Roellecke, K; Freund, M; Gombert, M; Lottmann, N; Steward, CA; Kramm, CM; Yarov-Yarovoy, V; Rettie, AE; Hanenberg, H				Schmidt, Eva M.; Wiek, Constanze; Parkinson, Oliver T.; Roellecke, Katharina; Freund, Marcel; Gombert, Michael; Lottmann, Nadine; Steward, Charles A.; Kramm, Christof M.; Yarov-Yarovoy, Vladimir; Rettie, Allan E.; Hanenberg, Helmut			Characterization of an Additional Splice Acceptor Site Introduced into CYP4B1 in Hominoidae during Evolution	PLOS ONE			English	Article							POTATOES IPOMOEA-BATATAS; TARGET ORGAN ALKYLATION; DAMAGED SWEET-POTATOES; LUNG-CANCER; FIBRONECTIN FRAGMENTS; DOSE SCHEDULE; GENE-TRANSFER; PHASE-I; 4-IPOMEANOL; CYTOCHROME-P450	CYP4B1 belongs to the cytochrome P450 family 4, one of the oldest P450 families whose members have been highly conserved throughout evolution. The CYP4 monooxygenases typically oxidize fatty acids to both inactive and active lipid mediators, although the endogenous ligand(s) is largely unknown. During evolution, at the transition of great apes to humanoids, the CYP4B1 protein acquired a serine instead of a proline at the canonical position 427 in the meander region. Although this alteration impairs P450 function related to the processing of naturally occurring lung toxins, a study in transgenic mice suggested that an additional serine insertion at position 207 in human CYP4B1 can rescue the enzyme stability and activity. Here, we report that the genomic insertion of a CAG triplet at the intron 5-exon 6 boundary in human CYP4B1 introduced an additional splice acceptor site in frame. During evolution, this change occurred presumably at the stage of Hominoidae and leads to two major isoforms of the CYP4B1 enzymes of humans and great apes, either with or without a serine 207 insertion (insSer207). We further demonstrated that the CYP4B1 enzyme with insSer207 is the dominant isoform (76%) in humans. Importantly, this amino acid insertion did not affect the 4-ipomeanol metabolizing activities or stabilities of the native rabbit or human CYP4B1 enzymes, when introduced as transgenes in human primary cells and cell lines. In our 3D modeling, this functional neutrality of insSer207 is compatible with its predicted location on the exterior surface of CYP4B1 in a flexible side chain. Therefore, the Ser207 insertion does not rescue the P450 functional activity of human CYP4B1 that has been lost during evolution.	[Schmidt, Eva M.; Gombert, Michael] Univ Dusseldorf, Childrens Hosp, Dept Pediat Hematol Oncol & Clin Immunol, D-40225 Dusseldorf, Germany; [Wiek, Constanze; Roellecke, Katharina; Freund, Marcel; Lottmann, Nadine; Hanenberg, Helmut] Univ Dusseldorf, Dept Otorhinolaryngol & Head Neck Surg, D-40225 Dusseldorf, Germany; [Parkinson, Oliver T.; Rettie, Allan E.] Univ Washington, Sch Pharm, Dept Med Chem, Seattle, WA 98195 USA; [Steward, Charles A.] Wellcome Trust Sanger Inst, Cambridge, England; [Kramm, Christof M.] Univ Gottingen, Dept Child & Adolescent Hlth, Div Pediat Hematol & Oncol, D-37099 Gottingen, Germany; [Yarov-Yarovoy, Vladimir] Univ Calif Davis, Dept Physiol, Davis, CA 95616 USA; [Yarov-Yarovoy, Vladimir] Univ Calif Davis, Dept Membrane Biol, Davis, CA 95616 USA; [Hanenberg, Helmut] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Hanenberg, Helmut] Univ Duisburg Essen, Univ Childrens Hosp Essen, Dept Pediat 3, D-45122 Essen, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Washington; University of Washington Seattle; Wellcome Trust Sanger Institute; University of Gottingen; University of California System; University of California Davis; University of California System; University of California Davis; Indiana University System; Indiana University Bloomington; University of Duisburg Essen	Hanenberg, H (corresponding author), Univ Dusseldorf, Dept Otorhinolaryngol & Head Neck Surg, D-40225 Dusseldorf, Germany.	Helmut.Hanenberg@uni-due.de	Yarov-Yarovoy, Vladimir/ABE-5454-2020	Yarov-Yarovoy, Vladimir/0000-0002-2325-4834; Steward, Charles/0000-0001-8829-5349; Wiek, Constanze/0000-0003-2214-8148	Deutsche Jose-Carreras-Leukamie-Stiftung e. V. (Munich, Germany); Deutsche Krebshilfe e. V.; NIH [R01 GM49054, R01 CA155294]; Forschungskommission of the Medical Faculty and the Strategische Forschungskommission of the Heinrich Heine University, Dusseldorf, Germany; UW School of Pharmacy Brady Fund for Natural Products Research; Lilly Foundation Physician/Scientist initiative; NATIONAL CANCER INSTITUTE [R01CA155294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049054] Funding Source: NIH RePORTER	Deutsche Jose-Carreras-Leukamie-Stiftung e. V. (Munich, Germany); Deutsche Krebshilfe e. V.(Deutsche Krebshilfe); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Forschungskommission of the Medical Faculty and the Strategische Forschungskommission of the Heinrich Heine University, Dusseldorf, Germany; UW School of Pharmacy Brady Fund for Natural Products Research; Lilly Foundation Physician/Scientist initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was initially supported by the Deutsche Jose-Carreras-Leukamie-Stiftung e. V. (Munich, Germany), the Deutsche Krebshilfe e. V. (to CMK and HH) and the NIH grant R01 GM49054 (AER). Later support was from the Forschungskommission of the Medical Faculty and the Strategische Forschungskommission of the Heinrich Heine University, Dusseldorf, Germany (to CW), the UW School of Pharmacy Brady Fund for Natural Products Research (to AER), and NIH R01 CA155294 (to HH). HH is supported by the Lilly Foundation Physician/Scientist initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer BR, 2005, CHEM RES TOXICOL, V18, P855, DOI 10.1021/tx0496993; Baer BR, 2006, DRUG METAB REV, V38, P451, DOI 10.1080/03602530600688503; BOYD MR, 1976, ENVIRON HEALTH PERSP, V16, P127, DOI 10.2307/3428593; BOYD MR, 1978, J PHARMACOL EXP THER, V207, P687; BOYD MR, 1972, J AGR FOOD CHEM, V20, P428, DOI 10.1021/jf60180a066; BOYD MR, 1975, TOXICOL APPL PHARM, V32, P147, DOI 10.1016/0041-008X(75)90205-7; BOYD MR, 1972, NATURE-NEW BIOL, V236, P158, DOI 10.1038/newbio236158a0; Bylund J, 1999, BIOCHEM BIOPH RES CO, V261, P169, DOI 10.1006/bbrc.1999.1011; Carr BA, 2003, MOL PHARMACOL, V63, P1137, DOI 10.1124/mol.63.5.1137; Chivian D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl480; Choudhary D, 2005, ARCH BIOCHEM BIOPHYS, V436, P50, DOI 10.1016/j.abb.2005.02.001; CHRISTIAN MC, 1989, J NATL CANCER I, V81, P1133, DOI 10.1093/jnci/81.15.1133; CZERWINSKI M, 1991, CANCER RES, V51, P4636; DOSTER AR, 1978, VET PATHOL, V15, P367, DOI 10.1177/030098587801500312; DUTCHER JS, 1979, BIOCHEM PHARMACOL, V28, P3367, DOI 10.1016/0006-2952(79)90074-1; Gotoh O, 2012, BIOL PHARM BULL, V35, P812; Guengerich FP, 2013, J BIOL CHEM, V288, P17065, DOI 10.1074/jbc.R113.462275; Hanenberg H, 1996, NAT MED, V2, P876, DOI 10.1038/nm0896-876; Hanenberg H, 1997, HUM GENE THER, V8, P2193, DOI 10.1089/hum.1997.8.18-2193; Hanenberg H, 2002, EXP HEMATOL, V30, P410, DOI 10.1016/S0301-472X(02)00782-8; Hiratsuka Masahiro, 2004, Drug Metab Pharmacokinet, V19, P114, DOI 10.2133/dmpk.19.114; Imaoka S, 2001, BIOCHEM BIOPH RES CO, V284, P757, DOI 10.1006/bbrc.2001.5055; Kasturi VK, 1998, CLIN CANCER RES, V4, P2095; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Lakhanpal S, 2001, INVEST NEW DRUG, V19, P69, DOI 10.1023/A:1006408803734; Lo-Guidice JM, 2002, PHARMACOGENETICS, V12, P367, DOI 10.1097/00008571-200207000-00004; Nakano M, 2012, MOL PHARMACOL, V82, P679, DOI 10.1124/mol.112.080085; Nelson David R., 2009, Human Genomics, V4, P59; NHAMBURO PT, 1989, BIOCHEMISTRY-US, V28, P8060, DOI 10.1021/bi00446a014; Omura T, 2013, BIOTECHNOL APPL BIOC, V60, P4, DOI 10.1002/bab.1099; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pollok KE, 1998, J VIROL, V72, P4882, DOI 10.1128/JVI.72.6.4882-4892.1998; ROBERTSON IGC, 1983, MOL PHARMACOL, V24, P156; ROWINSKY EK, 1993, CANCER RES, V53, P1794; SERABJITSINGH CJ, 1979, J BIOL CHEM, V254, P9901; SERABJITSINGH CJ, 1980, SCIENCE, V207, P1469, DOI 10.1126/science.6767272; SMITH PB, 1995, BIOCHEM PHARMACOL, V50, P1567, DOI 10.1016/0006-2952(95)02029-2; VERSCHOYLE RD, 1993, TOXICOL APPL PHARM, V123, P193, DOI 10.1006/taap.1993.1237; Wiek C, 2015, BIOCHEM J, V465, P103, DOI 10.1042/BJ20140813; WILSON BJ, 1970, NATURE, V227, P521, DOI 10.1038/227521a0; WILSON BJ, 1971, NATURE, V231, P52, DOI 10.1038/231052a0; WOLF CR, 1982, MOL PHARMACOL, V22, P738; YOKOTANI N, 1990, EUR J BIOCHEM, V187, P23, DOI 10.1111/j.1432-1033.1990.tb15273.x; YOST GS, 1989, TOXICOL APPL PHARM, V101, P179, DOI 10.1016/0041-008X(89)90268-8; Yu XF, 2013, BIOTECHNOL APPL BIOC, V60, P134, DOI 10.1002/bab.1074; Zheng YM, 1998, BIOCHEMISTRY-US, V37, P12847, DOI 10.1021/bi981280m	46	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2015	10	9							e0137110	10.1371/journal.pone.0137110	http://dx.doi.org/10.1371/journal.pone.0137110			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9WL	26355749	Green Published, gold			2022-12-26	WOS:000360965800029
J	Breese, EH; Buechele, C; Dawson, C; Cleary, ML; Porteus, MH				Breese, Erin H.; Buechele, Corina; Dawson, Catherine; Cleary, Michael L.; Porteus, Matthew H.			Use of Genome Engineering to Create Patient Specific MLL Translocations in Primary Human Hematopoietic Stem and Progenitor Cells	PLOS ONE			English	Article							THERAPY-RELATED LEUKEMIA; ACUTE MYELOID-LEUKEMIA; WIDE ANALYSIS; GENE; INFANT; REARRANGEMENTS; MLL-AF4; MUTATIONS; MODEL; BREAKPOINTS	One of the challenging questions in cancer biology is how a normal cell transforms into a cancer cell. There is strong evidence that specific chromosomal translocations are a key element in this transformation process. Our studies focus on understanding the developmental mechanism by which a normal stem or progenitor cell transforms into leukemia. Here we used engineered nucleases to induce simultaneous specific double strand breaks in the MLL gene and two different known translocation partners (AF4 and AF9), which resulted in specific chromosomal translocations in K562 cells as well as primary hematopoietic stem and progenitor cells (HSPCs). The initiation of a specific MLL translocation in a small number of HSPCs likely mimics the leukemia-initiating event that occurs in patients. In our studies, the creation of specific MLL translocations in CD34+ cells was not sufficient to transform cells in vitro. Rather, a variety of fates was observed for translocation positive cells including cell loss over time, a transient proliferative advantage followed by loss of the clone, or a persistent proliferative advantage. These studies highlight the application of genome engineering tools in primary human HSPCs to induce and prospectively study the consequences of initiating translocation events in leukemia pathogenesis.	[Breese, Erin H.; Dawson, Catherine] Stanford Univ, Div Pediat Hematol Oncol, Dept Pediat, Stanford, CA 94305 USA; [Buechele, Corina; Cleary, Michael L.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Porteus, Matthew H.] Stanford Univ, Div Pediat Stem Cell Transplantat & Regenerat Med, Dept Pediat, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Cleary, ML (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.	mcleary@stanford.edu; mporteus@stanford.edu			St. Baldrick's Foundation; Deutsche Krebshilfe, Germany; Children's Health Initiative of the Packard Foundation; Hyundai Hope on Wheels; Public Health Service (PHS) grant [CA116606]	St. Baldrick's Foundation; Deutsche Krebshilfe, Germany(Deutsche Krebshilfe); Children's Health Initiative of the Packard Foundation; Hyundai Hope on Wheels; Public Health Service (PHS) grant	This work was supported by the St. Baldrick's Foundation (E.B.), the Deutsche Krebshilfe, Germany (C.B.), the Children's Health Initiative of the Packard Foundation (M.P.), Hyundai Hope on Wheels (M.P.), and a Public Health Service (PHS) grant (CA116606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; Borst L, 2012, BRIT J HAEMATOL, V157, P476, DOI 10.1111/j.1365-2141.2012.09083.x; Brunet E, 2009, P NATL ACAD SCI USA, V106, P10620, DOI 10.1073/pnas.0902076106; Bursen A, 2010, BLOOD, V115, P3570, DOI 10.1182/blood-2009-06-229542; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen WL, 2006, BLOOD, V108, P669, DOI 10.1182/blood-2005-08-3498; Chen W, 2011, BLOOD, V117, P3474, DOI 10.1182/blood-2010-11-317529; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Chowdhury T, 2008, BLOOD CELL MOL DIS, V40, P192, DOI 10.1016/j.bcmd.2007.07.005; Cowell IG, 2012, INT J ENV RES PUB HE, V9, P2075, DOI 10.3390/ijerph9062075; Cowell IG, 2012, P NATL ACAD SCI USA, V109, P8989, DOI 10.1073/pnas.1204406109; Dobbins SE, 2013, GENE CHROMOSOME CANC, V52, P954, DOI 10.1002/gcc.22090; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Greaves M, 1999, EUR J CANCER, V35, P1941, DOI 10.1016/S0959-8049(99)00296-8; Greaves MF, 2003, BLOOD, V102, P2321, DOI 10.1182/blood-2002-12-3817; Howlader N, 2014, SEER CANC STAT REV; Hunger SP, 2012, J CLIN ONCOL, V30, P1663, DOI 10.1200/JCO.2011.37.8018; Iliakis G, 2004, CYTOGENET GENOME RES, V104, P14, DOI 10.1159/000077461; Jansen MWJC, 2007, LEUKEMIA, V21, P633, DOI 10.1038/sj.leu.2404578; Langer T, 2003, GENE CHROMOSOME CANC, V36, P393, DOI 10.1002/gcc.10167; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Liang DC, 2006, CANCER, V106, P950, DOI 10.1002/cncr.21687; Libura J, 2005, BLOOD, V105, P2124, DOI 10.1182/blood-2004-07-2683; Liu H, 2009, CANCER BIOL THER, V8, P1204, DOI 10.4161/cbt.8.13.8924; Meyer C, 2013, LEUKEMIA, V27, P2165, DOI 10.1038/leu.2013.135; Montes R, 2014, LEUKEMIA, V28, P666, DOI 10.1038/leu.2013.346; Montes R, 2011, BLOOD, V117, P4746, DOI 10.1182/blood-2010-12-322230; Moriya K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037892; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Piganeau M, 2013, GENOME RES, V23, P1182, DOI 10.1101/gr.147314.112; Piller GJ, 2001, BRIT J HAEMATOL, V112, P282, DOI 10.1046/j.1365-2141.2001.02411.x; Prelle C, 2013, LEUKEMIA, V27, P1425, DOI 10.1038/leu.2012.365; Qiu P, 2004, BIOTECHNIQUES, V36, P702, DOI 10.2144/04364PF01; Reichel M, 2001, ONCOGENE, V20, P2900, DOI 10.1038/sj.onc.1204401; Sam TN, 2012, PEDIATR BLOOD CANCER, V58, P836, DOI 10.1002/pbc.23274; Siraj AK, 2002, CLIN CANCER RES, V8, P3832; Stam RW, 2013, BLOOD, V121, P3780, DOI 10.1182/blood-2013-03-491738; SUPER HJG, 1993, BLOOD, V82, P3705; Taketani T, 2004, BLOOD, V103, P1085, DOI 10.1182/blood-2003-02-0418; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Weinstock David M, 2008, J Natl Cancer Inst Monogr, P20, DOI 10.1093/jncimonographs/lgn009	41	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136644	10.1371/journal.pone.0136644	http://dx.doi.org/10.1371/journal.pone.0136644			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26351841	Green Published, Green Submitted, gold			2022-12-26	WOS:000360932800044
J	Kakinuma, R; Moriyama, N; Muramatsu, Y; Gomi, S; Suzuki, M; Nagasawa, H; Kusumoto, M; Aso, T; Muramatsu, Y; Tsuchida, T; Tsuta, K; Maeshima, AM; Tochigi, N; Watanabe, S; Sugihara, N; Tsukagoshi, S; Saito, Y; Kazama, M; Ashizawa, K; Awai, K; Honda, O; Ishikawa, H; Koizumi, N; Komoto, D; Moriya, H; Oda, S; Oshiro, Y; Yanagawa, M; Tomiyama, N; Asamura, H				Kakinuma, Ryutaro; Moriyama, Noriyuki; Muramatsu, Yukio; Gomi, Shiho; Suzuki, Masahiro; Nagasawa, Hirobumi; Kusumoto, Masahiko; Aso, Tomohiko; Muramatsu, Yoshihisa; Tsuchida, Takaaki; Tsuta, Koji; Maeshima, Akiko Miyagi; Tochigi, Naobumi; Watanabe, Shun-ichi; Sugihara, Naoki; Tsukagoshi, Shinsuke; Saito, Yasuo; Kazama, Masahiro; Ashizawa, Kazuto; Awai, Kazuo; Honda, Osamu; Ishikawa, Hiroyuki; Koizumi, Naoya; Komoto, Daisuke; Moriya, Hiroshi; Oda, Seitaro; Oshiro, Yasuji; Yanagawa, Masahiro; Tomiyama, Noriyuki; Asamura, Hisao			Ultra-High-Resolution Computed Tomography of the Lung: Image Quality of a Prototype Scanner	PLOS ONE			English	Article							THIN-SECTION CT; SOLITARY PULMONARY-LESIONS; MULTIDETECTOR CT; NODULES; BENIGN; CANCER; CLASSIFICATION; FEATURES; CM; DIFFERENTIATION	Purpose The image noise and image quality of a prototype ultra-high-resolution computed tomography (U-HRCT) scanner was evaluated and compared with those of conventional high-resolution CT (C-HRCT) scanners. Materials and Methods This study was approved by the institutional review board. A U-HRCT scanner prototype with 0.25 mm x 4 rows and operating at 120 mAs was used. The C-HRCT images were obtained using a 0.5 mm x 16 or 0.5 mm x 64 detector-row CT scanner operating at 150 mAs. Images from both scanners were reconstructed at 0.1-mm intervals; the slice thickness was 0.25 mm for the U-HRCT scanner and 0.5 mm for the C-HRCT scanners. For both scanners, the display field of view was 80 mm. The image noise of each scanner was evaluated using a phantom. U-HRCT and C-HRCT images of 53 images selected from 37 lung nodules were then observed and graded using a 5-point score by 10 board-certified thoracic radiologists. The images were presented to the observers randomly and in a blinded manner. Results The image noise for U-HRCT (100.87 +/- 0.51 Hounsfield units [HU]) was greater than that for C-HRCT (40.41 +/- 0.52 HU; P < .0001). The image quality of U-HRCT was graded as superior to that of C-HRCT (P < .0001) for all of the following parameters that were examined: margins of subsolid and solid nodules, edges of solid components and pulmonary vessels in subsolid nodules, air bronchograms, pleural indentations, margins of pulmonary vessels, edges of bronchi, and interlobar fissures. Conclusion Despite a larger image noise, the prototype U-HRCT scanner had a significantly better image quality than the C-HRCT scanners.	[Kakinuma, Ryutaro; Moriyama, Noriyuki; Muramatsu, Yukio] Natl Canc Ctr, Div Canc Screening, Res Ctr Canc Prevent & Screening, Chuo Ku, Tokyo 104, Japan; [Kakinuma, Ryutaro; Gomi, Shiho; Suzuki, Masahiro; Nagasawa, Hirobumi; Kusumoto, Masahiko; Aso, Tomohiko] Natl Canc Ctr, Dept Radiol, Chuo Ku, Tokyo, Japan; [Kusumoto, Masahiko; Muramatsu, Yoshihisa] Natl Canc Ctr Hosp East, Dept Radiol, Kashiwa, Chiba, Japan; [Tsuchida, Takaaki] Natl Canc Ctr, Dept Endoscopy, Resp Endoscopy Div, Chuo Ku, Tokyo, Japan; [Tsuta, Koji; Maeshima, Akiko Miyagi; Tochigi, Naobumi] Natl Canc Ctr, Div Pathol, Chuo Ku, Tokyo, Japan; [Watanabe, Shun-ichi; Asamura, Hisao] Natl Canc Ctr, Dept Thorac Surg, Chuo Ku, Tokyo, Japan; [Sugihara, Naoki; Tsukagoshi, Shinsuke; Saito, Yasuo; Kazama, Masahiro] Toshiba Med Syst Corp, Dept CT Syst Div, Otawara, Tochigi, Japan; [Ashizawa, Kazuto] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Oncol, Nagasaki 852, Japan; [Awai, Kazuo; Komoto, Daisuke] Hiroshima Univ, Inst & Grad Sch Biomed Sci, Dept Diagnost Radiol, Hiroshima, Japan; [Honda, Osamu; Yanagawa, Masahiro; Tomiyama, Noriyuki] Osaka Univ, Grad Sch Med, Dept Radiol, Suita, Osaka, Japan; [Ishikawa, Hiroyuki] Niigata Univ, Med & Dent Hosp, Dept Radiol, Niigata, Japan; [Koizumi, Naoya] Niigata Canc Ctr Hosp, Dept Radiol, Niigata, Japan; [Moriya, Hiroshi] Ohara Gen Hosp, Dept Radiol, Fukushima, Japan; [Oda, Seitaro] Kumamoto Univ, Fac Life Sci, Dept Diagnost Radiol, Kumamoto, Japan; [Oshiro, Yasuji] Natl Hosp Org Okinawa Natl Hosp, Dept Radiol, Ginowan, Okinawa, Japan	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Toshiba Corporation; Nagasaki University; Hiroshima University; Osaka University; Niigata University; Kumamoto University	Kakinuma, R (corresponding author), Natl Canc Ctr, Div Canc Screening, Res Ctr Canc Prevent & Screening, Chuo Ku, Tokyo 104, Japan.	rkaki@ncc.go.jp	Yanagawa, Masahiro/AAD-2306-2022	Yanagawa, Masahiro/0000-0002-0911-6769; Tsuchida, Takaaki/0000-0002-4878-1956	Third-term Comprehensive Cancer Control Strategy - Ministry of Health, Labour and Welfare, Tokyo, Japan [19-1, 22-019]; Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation; National Cancer Center Research and Development Fund [48-A-12]; Toshiba Medical Systems Corporation	Third-term Comprehensive Cancer Control Strategy - Ministry of Health, Labour and Welfare, Tokyo, Japan; Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation; National Cancer Center Research and Development Fund(National Cancer Center - Japan); Toshiba Medical Systems Corporation	This research was supported in part by a Grant-in-Aid from the Third-term Comprehensive Cancer Control Strategy sponsored by the Ministry of Health, Labour and Welfare (http://www.mhlw.go.jp/english/), Tokyo, Japan (19-1, 22-019), by the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation, and by the National Cancer Center (http://www.ncc.go.jp/en/index.html) Research and Development Fund (48-A-12). Toshiba Medical Systems Corporation provided support in the form of salaries for authors NS, ST, YS & MK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akata S, 2008, CLIN IMAG, V32, P259, DOI 10.1016/j.clinimag.2007.10.002; Armato SG, 2007, ACAD RADIOL, V14, P1409, DOI 10.1016/j.acra.2007.07.008; Austin JHM, 2013, RADIOLOGY, V266, P62, DOI 10.1148/radiol.12120240; Choi JA, 2000, EUR RADIOL, V10, P1304, DOI 10.1007/s003300000315; Ehling J, 2014, AM J PATHOL, V184, P431, DOI 10.1016/j.ajpath.2013.10.014; Fan L, 2012, BRIT J RADIOL, V85, P897, DOI 10.1259/bjr/33150223; Gremse F, 2011, RADIOLOGY, V260, P709, DOI 10.1148/radiol.11110069; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hattori A, 2014, EUR J CARDIO-THORAC, V45, P699, DOI 10.1093/ejcts/ezt467; Henschke CI, 2002, AM J ROENTGENOL, V178, P1053, DOI 10.2214/ajr.178.5.1781053; International Electrotechnical Commission, 2019, EV ROUT TEST MED I 3; Ishikawa H, 2007, J COMPUT ASSIST TOMO, V31, P409, DOI 10.1097/01.rct.0000243451.25986.10; Jiang BH, 2014, ACTA RADIOL, V55, P302, DOI 10.1177/0284185113495834; Kishi K, 2004, LUNG CANCER, V44, P43, DOI 10.1016/j.lungcan.2003.09.024; KURIYAMA K, 1991, AM J ROENTGENOL, V156, P921, DOI 10.2214/ajr.156.5.2017952; KURIYAMA K, 1987, AM J ROENTGENOL, V149, P1139, DOI 10.2214/ajr.149.6.1139; Lee HJ, 2009, EUR RADIOL, V19, P552, DOI 10.1007/s00330-008-1188-2; Li F, 2004, RADIOLOGY, V233, P793, DOI 10.1148/radiol.2333031018; Li M, 2004, LUNG CANCER, V46, P349, DOI 10.1016/j.lungcan.2004.05.017; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; MORI K, 1990, RADIOLOGY, V177, P843, DOI 10.1148/radiology.177.3.2243999; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Nakata M, 2002, CHEST, V121, P1464, DOI 10.1378/chest.121.5.1464; Oda S, 2008, AM J ROENTGENOL, V190, P1363, DOI 10.2214/AJR.07.3101; Seemann MD, 1999, EUR RADIOL, V9, P409, DOI 10.1007/s003300050683; Takahashi M, 2014, J THORAC CARDIOV SUR, V147, P54, DOI 10.1016/j.jtcvs.2013.08.058; TAKANASHI N, 1995, LUNG CANCER-J IASLC, V13, P105, DOI 10.1016/0169-5002(95)00488-2; Takashima S, 2003, AM J ROENTGENOL, V180, P955, DOI 10.2214/ajr.180.4.1800955; Takashima S, 2003, AM J ROENTGENOL, V180, P1255, DOI 10.2214/ajr.180.5.1801255; Todo G, 1982, Rinsho Hoshasen, V27, P1319; TRAVIS WD, 2011, J THORAC ONCOL, V6, P244, DOI DOI 10.1097/JT0.0B013E318206A221; Tsukagoshi S, 2007, PHYS MED BIOL, V52, P791, DOI 10.1088/0031-9155/52/3/018; Yanagawa M, 2010, RADIOLOGY, V255, P944, DOI 10.1148/radiol.10091010; Yang ZG, 2001, AM J ROENTGENOL, V176, P1399, DOI 10.2214/ajr.176.6.1761399; Yoon HE, 2005, GEN THORAC CARDIOVAS, V53, P22; ZWIREWICH CV, 1991, RADIOLOGY, V179, P469, DOI 10.1148/radiology.179.2.2014294	36	70	72	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137165	10.1371/journal.pone.0137165	http://dx.doi.org/10.1371/journal.pone.0137165			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352144	gold, Green Published, Green Submitted			2022-12-26	WOS:000360932800063
J	Pilgrim, T; Heg, D; Tal, K; Erne, P; Radovanovic, D; Windecker, S; Juni, P				Pilgrim, Thomas; Heg, Dik; Tal, Kali; Erne, Paul; Radovanovic, Dragana; Windecker, Stephan; Jueni, Peter		AMIS Plus Investigators	Age- and Gender-related Disparities in Primary Percutaneous Coronary Interventions for Acute ST-segment elevation Myocardial Infarction	PLOS ONE			English	Article							IN-HOSPITAL MORTALITY; UNCONSCIOUS BIAS; DECISION-MAKING; DISEASE; CARE; QUALITY; GUIDELINES; WOMEN; MANAGEMENT; PHYSICIANS	Background Previous analyses reported age-and gender-related differences in the provision of cardiac care. The objective of the study was to compare circadian disparities in the delivery of primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) according to the patient's age and gender. Methods We investigated patients included into the Acute Myocardial Infarction in Switzerland (AMIS) registry presenting to one of 11 centers in Switzerland providing primary PCI around the clock, and stratified patients according to gender and age. Findings A total of 4723 patients presented with AMI between 2005 and 2010; 1319 (28%) were women and 2172 (54%) were >= 65 years of age. More than 90% of patients <65 years of age underwent primary PCI without differences between gender. Elderly patients and particularly women were at increased risk of being withheld primary PCI (males adj. HR 4.91, 95% CI 3.93-6.13; females adj. HR 9.31, 95% CI 7.37-11.75) as compared to males <65 years of age. An increased risk of a delay in door-to-balloon time >90 minutes was found in elderly males (adj HR 1.66 (95% CI 1.40-1.95), p < 0.001) and females (adj HR 1.57 (95% CI 1.27-1.93), p < 0.001), as well as in females <65 years (adj HR 1.47 (95% CI 1.13-1.91), p = 0.004) as compared to males <65 years of age, with significant differences in circadian patterns during on- and off-duty hours. Conclusions In a cohort of patients with AMI in Switzerland, we observed discrimination of elderly patients and females in the circadian provision of primary PCI.	[Pilgrim, Thomas; Windecker, Stephan] Univ Hosp Bern, Dept Cardiol, Swiss Cardiovasc Ctr, CH-3010 Bern, Switzerland; [Heg, Dik; Tal, Kali] Univ Bern, Dept Clin Res, ISPM, Bern, Switzerland; [Heg, Dik; Tal, Kali] Univ Bern, Dept Clin Res, Clin Trials Unit, Bern, Switzerland; [Radovanovic, Dragana] Univ Zurich, Inst Social & Prevent Med, AMIS Plus Data Ctr, CH-8006 Zurich, Switzerland; [Jueni, Peter] Univ Bern, Inst Primary Care & Clin Epidemiol, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Zurich; University of Bern	Juni, P (corresponding author), Univ Bern, Inst Primary Care & Clin Epidemiol, Bern, Switzerland.	peter.juni@biham.unibe.ch	Pilgrim, Thomas/AAS-9120-2021; Jeger, Raban/ABG-1678-2021; Radovanovic, Dragana I/F-7908-2013; Puhan, Milo/ABE-6298-2020; Juni, Peter/Q-8700-2016	Pilgrim, Thomas/0000-0001-8721-4068; Jeger, Raban/0000-0003-1290-5491; Radovanovic, Dragana I/0000-0002-9507-6272; Puhan, Milo/0000-0003-4721-1879; Juni, Peter/0000-0002-5985-0670; Heg, Dik/0000-0002-8766-7945; Maggiorini, Marco/0000-0001-8180-2117; Tal, Kali/0000-0003-2454-2560				AYANIAN JZ, 1991, NEW ENGL J MED, V325, P221, DOI 10.1056/NEJM199107253250401; Berger A, 2008, AM J CARDIOL, V101, P422, DOI 10.1016/j.amjcard.2007.09.092; Blair Irene V, 2011, Perm J, V15, P71; Burgess DJ, 2004, J GEN INTERN MED, V19, P1154, DOI 10.1111/j.1525-1497.2004.30227.x; Cabana MD, 2003, WOMEN HEALTH ISS, V13, P142, DOI 10.1016/S1049-3867(03)00034-3; Chiaramonte GR, 2006, HEALTH PSYCHOL, V25, P255, DOI 10.1037/0278-6133.25.3.255; CLARKE KW, 1994, BMJ-BRIT MED J, V309, P563, DOI 10.1136/bmj.309.6954.563; Cox NJ, 2006, STATA J, V6, P561, DOI 10.1177/1536867X0600600408; Croskerry P, 2002, ACAD EMERG MED, V9, P1184, DOI 10.1111/j.1553-2712.2002.tb01574.x; Green AR, 2007, J GEN INTERN MED, V22, P1231, DOI 10.1007/s11606-007-0258-5; Hannah SD, 2013, CULT MED PSYCHIAT, V37, P314, DOI 10.1007/s11013-013-9320-4; Hebert K, 2010, J HEALTH CARE POOR U, V21, P264, DOI 10.1353/hpu.0.0243; ject, 2003, EUR HEART J, V24, P987, DOI [DOI 10.1016/S0195-668X(02)00618-8, 10.1016/s0195-668x(03)00114-3, DOI 10.1016/S0195-668X(03)00114-3]; Kudenchuk PJ, 1996, AM J CARDIOL, V78, P9, DOI 10.1016/S0002-9149(96)00218-4; Medina HM, 2011, AM HEART J, V162, P283, DOI 10.1016/j.ahj.2011.04.017; Mejhert M, 1999, EUR J HEART FAIL, V1, P407, DOI 10.1016/S1388-9842(99)00053-7; Milcent C, 2007, CIRCULATION, V115, P833, DOI 10.1161/CIRCULATIONAHA.106.664979; Moretti C, 2015, INT J CARDIOL, V179, P552, DOI 10.1016/j.ijcard.2014.10.035; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Palmerini T, 2015, J AM COLL CARDIOL, V65, P2496, DOI 10.1016/j.jacc.2015.04.017; Peterson ED, 2008, AM HEART J, V156, P1045, DOI 10.1016/j.ahj.2008.07.028; Roger VL, 2000, JAMA-J AM MED ASSOC, V283, P646, DOI 10.1001/jama.283.5.646; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Stepanikova I, 2012, J HEALTH SOC BEHAV, V53, P329, DOI 10.1177/0022146512445807; Stock EO, 2012, CURR PROB CARDIOLOGY, V37, P450, DOI 10.1016/j.cpcardiol.2012.07.001; Stone J, 2011, MED EDUC, V45, P768, DOI 10.1111/j.1365-2923.2011.04026.x; Teal CR, 2012, MED EDUC, V46, P80, DOI 10.1111/j.1365-2923.2011.04101.x; Travis CB, 2012, WOMEN THER, V35, P207, DOI 10.1080/02703149.2012.684589; Wang TY, 2011, J AM COLL CARDIOL, V58, P637, DOI 10.1016/j.jacc.2011.05.012	29	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137047	10.1371/journal.pone.0137047	http://dx.doi.org/10.1371/journal.pone.0137047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9KG	26352574	Green Published, gold			2022-12-26	WOS:000360932800057
J	Chaparro-Garcia, A; Schwizer, S; Sklenar, J; Yoshida, K; Petre, B; Bos, JIB; Schornack, S; Jones, AME; Bozkurt, TO; Kamoun, S				Chaparro-Garcia, Angela; Schwizer, Simon; Sklenar, Jan; Yoshida, Kentaro; Petre, Benjamin; Bos, Jorunn I. B.; Schornack, Sebastian; Jones, Alexandra M. E.; Bozkurt, Tolga O.; Kamoun, Sophien			Phytophthora infestans RXLR-WY Effector AVR3a Associates with Dynamin-Related Protein 2 Required for Endocytosis of the Plant Pattern Recognition Receptor FLS2	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; INNATE IMMUNITY; NICOTIANA-BENTHAMIANA; PLASMA-MEMBRANE; CELL-DEATH; PSEUDOMONAS-SYRINGAE; ARABIDOPSIS-THALIANA; TRIGGERED IMMUNITY; DEFENSE RESPONSES; HIGH-THROUGHPUT	Pathogens utilize effectors to suppress basal plant defense known as PTI (Pathogen-associated molecular pattern-triggered immunity). However, our knowledge of PTI suppression by filamentous plant pathogens, i.e. fungi and oomycetes, remains fragmentary. Previous work revealed that the co-receptor BAK1/SERK3 contributes to basal immunity against the potato pathogen Phytophthora infestans. Moreover BAK1/SERK3 is required for the cell death induced by P. infestans elicitin INF1, a protein with characteristics of PAMPs. The P. infestans host-translocated RXLR-WY effector AVR3a is known to supress INF1-mediated cell death by binding the plant E3 ligase CMPG1. In contrast, AVR3a(KI-Y147del), a deletion mutant of the C-terminal tyrosine of AVR3a, fails to bind CMPG1 and does not suppress INF1-mediated cell death. Here, we studied the extent to which AVR3a and its variants perturb additional BAK1/SERK3-dependent PTI responses in N. benthamiana using the elicitor/receptor pair flg22/FLS2 as a model. We found that all tested variants of AVR3a suppress defense responses triggered by flg22 and reduce internalization of activated FLS2. Moreover, we discovered that AVR3a associates with the Dynamin-Related Protein 2 (DRP2), a plant GTPase implicated in receptor-mediated endocytosis. Interestingly, silencing of DRP2 impaired ligand-induced FLS2 internalization but did not affect internalization of the growth receptor BRI1. Our results suggest that AVR3a associates with a key cellular trafficking and membrane-remodeling complex involved in immune receptor-mediated endocytosis. We conclude that AVR3a is a multifunctional effector that can suppress BAK1/SERK3-mediated immunity through at least two different pathways.	[Chaparro-Garcia, Angela; Schwizer, Simon; Sklenar, Jan; Yoshida, Kentaro; Petre, Benjamin; Bos, Jorunn I. B.; Schornack, Sebastian; Jones, Alexandra M. E.; Bozkurt, Tolga O.; Kamoun, Sophien] Sainsbury Lab, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Bozkurt, TO (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England.	o.bozkurt@imperial.ac.uk; sophien.kamoun@tsl.ac.uk	Bozkurt, Tolga Osman/AAA-8014-2019; Schornack, Sebastian/A-3650-2011; Schornack, Sebastian/AAE-4897-2020; Jones, Alexandra/B-5227-2009; Kamoun, Sophien/B-3529-2009; Bozkurt, Tolga O/C-9764-2014; Bos, Jorunn IB/E-4703-2011; Petre, Benjamin/AAF-1156-2019	Bozkurt, Tolga Osman/0000-0003-0507-6875; Schornack, Sebastian/0000-0002-7836-5881; Schornack, Sebastian/0000-0002-7836-5881; Jones, Alexandra/0000-0003-2571-8708; Kamoun, Sophien/0000-0002-0290-0315; Bozkurt, Tolga O/0000-0003-0507-6875; Bos, Jorunn IB/0000-0003-3222-8643; Petre, Benjamin/0000-0002-3204-4249; Yoshida, Kentaro/0000-0002-3614-1759	Gatsby Charitable Foundation; European Research Council (ERC); Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC [BB/I020470/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I020470/1] Funding Source: researchfish	Gatsby Charitable Foundation; European Research Council (ERC)(European Research Council (ERC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded through grants by the Gatsby Charitable Foundation, European Research Council (ERC) and Biotechnology and Biological Sciences Research Council (BBSRC) to SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht C, 2012, P NATL ACAD SCI USA, V109, P303, DOI 10.1073/pnas.1109921108; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Backues SK, 2010, PLANT CELL, V22, P3218, DOI 10.1105/tpc.110.077727; Bar M, 2010, PLANT J, V63, P791, DOI 10.1111/j.1365-313X.2010.04282.x; Basquin C, 2013, J CELL SCI, V126, P1099, DOI 10.1242/jcs.110932; Beck M, 2012, PLANT CELL, V24, P4205, DOI 10.1105/tpc.112.100263; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Bos JIB, 2009, MOL PLANT MICROBE IN, V22, P269, DOI 10.1094/MPMI-22-3-0269; Boutemy LS, 2011, J BIOL CHEM, V286, P35834, DOI 10.1074/jbc.M111.262303; Bozkurt TO, 2014, REROUTING PLANT LATE; Bozkurt TO, 2012, CURR OPIN PLANT BIOL, V15, P483, DOI 10.1016/j.pbi.2012.03.008; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Caillaud MC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004496; Cao YR, 2014, ELIFE, V3, DOI 10.7554/eLife.03766; Chaparro-Garcia A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016608; Chen X, 2011, CURR OPIN PLANT BIOL, V14, P674, DOI 10.1016/j.pbi.2011.08.006; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; Chockalingam A, 2009, IMMUNOL CELL BIOL, V87, P209, DOI 10.1038/icb.2008.101; Choi SW, 2013, PLANT CELL, V25, P1174, DOI 10.1105/tpc.112.108803; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Di Rubbo S, 2013, PLANT CELL, V25, P2986, DOI 10.1105/tpc.113.114058; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engelhardt S, 2012, PLANT CELL, V24, P5142, DOI 10.1105/tpc.112.104992; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Fradin EF, 2009, PLANT PHYSIOL, V150, P320, DOI 10.1104/pp.109.136762; Fujimoto M, 2008, PLANT CELL REP, V27, P1581, DOI 10.1007/s00299-008-0583-0; Fujimoto M, 2010, P NATL ACAD SCI USA, V107, P6094, DOI 10.1073/pnas.0913562107; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; Gilroy EM, 2011, NEW PHYTOL, V190, P653, DOI 10.1111/j.1469-8137.2011.03643.x; Gimenez-Ibanez S, 2009, CURR BIOL, V19, P423, DOI 10.1016/j.cub.2009.01.054; Goehre V, 2008, CURR BIOL, V18, P1824, DOI 10.1016/j.cub.2008.10.063; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hann DR, 2007, PLANT J, V49, P607, DOI 10.1111/j.1365-313X.2006.02981.x; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Helliwell C, 2003, METHODS, V30, P289, DOI 10.1016/S1046-2023(03)00036-7; Hisata S, 2007, J CELL BIOL, V178, P843, DOI 10.1083/jcb.200610073; Hogenhout SA, 2009, MOL PLANT MICROBE IN, V22, P115, DOI 10.1094/MPMI-22-2-0115; Hong Z, 2003, PLANT MOL BIOL, V53, P261, DOI 10.1023/B:PLAN.0000007000.29697.81; Huang J, 2015, BIOCHEM BIOPH RES CO, V456, P238, DOI 10.1016/j.bbrc.2014.11.065; Irani NG, 2012, NAT CHEM BIOL, V8, P583, DOI [10.1038/nchembio.958, 10.1038/NCHEMBIO.958]; Jin JB, 2001, PLANT CELL, V13, P1511, DOI 10.1105/tpc.13.7.1511; Kamoun S, 1998, PHYTOPATHOLOGY, V88, P1315, DOI 10.1094/PHYTO.1998.88.12.1315; Larroque M, 2013, J EXP BOT, V64, P3615, DOI 10.1093/jxb/ert195; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Lu Dongping, 2010, Commun Integr Biol, V3, P80; Lu YJ, 2012, CELL MICROBIOL, V14, P682, DOI 10.1111/j.1462-5822.2012.01751.x; Macho AP, 2015, CURR OPIN MICROBIOL, V23, P14, DOI 10.1016/j.mib.2014.10.009; Macho AP, 2014, MOL CELL, V54, P263, DOI 10.1016/j.molcel.2014.03.028; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Monaghan J, 2012, CURR OPIN PLANT BIOL, V15, P349, DOI 10.1016/j.pbi.2012.05.006; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Nicaise V, 2009, PLANT PHYSIOL, V150, P1638, DOI 10.1104/pp.109.139709; Ntoukakis V, 2011, PLANT CELL, V23, P3871, DOI 10.1105/tpc.111.090779; Okmen B, 2014, CURR OPIN PLANT BIOL, V20, P19, DOI 10.1016/j.pbi.2014.03.011; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Petre B, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001801; Petutschnig EK, 2010, J BIOL CHEM, V285, P28902, DOI 10.1074/jbc.M110.116657; Platta HW, 2011, CURR OPIN CELL BIOL, V23, P393, DOI 10.1016/j.ceb.2011.03.008; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rafiqi M, 2012, CURR OPIN PLANT BIOL, V15, P477, DOI 10.1016/j.pbi.2012.05.003; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; RCore Team, 2020, R LANG ENV STAT COMP; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Robatzek S, 2014, ENDOCYTOSIS AT THE C; Robinson DG, 2008, PLANT PHYSIOL, V147, P1482, DOI 10.1104/pp.108.120105; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Rovenich H, 2014, CURR OPIN PLANT BIOL, V20, P96, DOI 10.1016/j.pbi.2014.05.001; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Salomon S, 2006, PLANT SIGNAL BEHAV, V1, P293, DOI 10.4161/psb.1.6.3594; Schafer DA, 2004, TRAFFIC, V5, P463, DOI 10.1111/j.1600-0854.2004.00199.x; Schulze B, 2010, J BIOL CHEM, V285, P9444, DOI 10.1074/jbc.M109.096842; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; Segonzac C, 2011, PLANT PHYSIOL, V156, P687, DOI 10.1104/pp.110.171249; Segonzac C, 2011, CURR OPIN MICROBIOL, V14, P54, DOI 10.1016/j.mib.2010.12.005; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; Smith JM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004578; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Sun YD, 2013, SCIENCE, V342, P624, DOI 10.1126/science.1243825; Taylor NG, 2011, PLANT MOL BIOL, V76, P117, DOI 10.1007/s11103-011-9773-1; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Vogel F, 2007, TRAFFIC, V8, P1205, DOI 10.1111/j.1600-0854.2007.00608.x; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Win J., 2012, COLD SPRING HARB SYM, V77, P235, DOI [10.1101/sqb.2012.77.015933, DOI 10.1101/SQB.2012.77.015933]; Win J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002400; Win J, 2011, METHODS MOL BIOL, V712, P181, DOI 10.1007/978-1-61737-998-7_15; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; Yaeno T, 2011, P NATL ACAD SCI USA, V108, P14682, DOI 10.1073/pnas.1106002108; Zheng XZ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004057; Zipfel C, 2014, TRENDS IMMUNOL, V35, P345, DOI 10.1016/j.it.2014.05.004; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	103	49	54	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137071	10.1371/journal.pone.0137071	http://dx.doi.org/10.1371/journal.pone.0137071			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348328	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000360897600019
J	Dragset, MS; Barczak, AK; Kannan, N; Maerk, M; Flo, TH; Valla, S; Rubin, EJ; Steigedal, M				Dragset, Marte S.; Barczak, Amy K.; Kannan, Nisha; Maerk, Mali; Flo, Trude H.; Valla, Svein; Rubin, Eric J.; Steigedal, Magnus			Benzoic Acid-Inducible Gene Expression in Mycobacteria	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; META-CLEAVAGE PATHWAY; ESCHERICHIA-COLI; PM PROMOTER; TOL PLASMID; TETRACYCLINE REPRESSORS; TUBERCULOSIS; SMEGMATIS; XYLS; PROTEIN	Conditional expression is a powerful tool to investigate the role of bacterial genes. Here, we adapt the Pseudomonas putida-derived positively regulated XylS/Pm expression system to control inducible gene expression in Mycobacterium smegmatis and Mycobacterium tuberculosis, the causative agent of human tuberculosis. By making simple changes to a Gram-negative broad-host-range XylS/Pm-regulated gene expression vector, we prove that it is possible to adapt this well-studied expression system to non-Gram-negative species. With the benzoic acid-derived inducer m-toluate, we achieve a robust, time- and dose-dependent reversible induction of Pm-mediated expression in mycobacteria, with low background expression levels. XylS/Pm is thus an important addition to existing mycobacterial expression tools, especially when low basal expression is of particular importance.	[Dragset, Marte S.; Rubin, Eric J.; Steigedal, Magnus] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Dragset, Marte S.; Kannan, Nisha; Maerk, Mali; Flo, Trude H.; Steigedal, Magnus] Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Dragset, Marte S.; Valla, Svein] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7034 Trondheim, Norway; [Barczak, Amy K.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Steigedal, Magnus] Cent Norway Reg Hlth Author, Stjordal, Norway	Harvard University; Harvard T.H. Chan School of Public Health; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Harvard University; Massachusetts General Hospital	Steigedal, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	magnus.steigedal@ntnu.no	Steigedal, Magnus/H-7053-2019; Flo, Trude Helen/E-1311-2013	Steigedal, Magnus/0000-0002-3695-3132; Flo, Trude Helen/0000-0002-2569-0381; Maerk, Mali/0000-0001-7447-0687	Research Council of Norway through its Centres of Excellence funding scheme [223255/F50]; Research Council of Norway [220836/F10, 246944/F10]; NTNU; Liaison Committee; Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007061] Funding Source: NIH RePORTER	Research Council of Norway through its Centres of Excellence funding scheme; Research Council of Norway(Research Council of Norway); NTNU; Liaison Committee; Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 223255/F50. In addition the Research Council of Norway supported the work through project numbers 220836/F10 and 246944/F10. In addition NTNU and the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU) contributed with funding to the study.	Bakke I, 2009, APPL ENVIRON MICROB, V75, P2002, DOI 10.1128/AEM.02315-08; Berg L, 2012, J BIOTECHNOL, V158, P224, DOI 10.1016/j.jbiotec.2011.07.012; Bernheim F, 1942, J BIOL CHEM, V143, P383; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Boldrin F, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq235; Brautaset T, 2009, MICROB BIOTECHNOL, V2, P15, DOI 10.1111/j.1751-7915.2008.00048.x; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Carroll P, 2005, APPL ENVIRON MICROB, V71, P3077, DOI 10.1128/AEM.71.6.3077-3084.2005; Carroll P, 2007, FEMS MICROBIOL LETT, V274, P73, DOI 10.1111/j.1574-6968.2007.00842.x; Connell ND, 1995, METHOD CELL BIOL, V45, P107, DOI DOI 10.1016/S0091-679X(08)61848-8; DEBOER HA, 1983, P NATL ACAD SCI-BIOL, V80, P21; Dragset MS, 2015, ANTIMICROB AGENTS CH, V59, P2256, DOI 10.1128/AAC.05114-14; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Forti F, 2009, J BIOTECHNOL, V140, P270, DOI 10.1016/j.jbiotec.2009.02.001; Gandotra S, 2007, NAT MED, V13, P1515, DOI 10.1038/nm1683; Grant SS, 2013, ACS CHEM BIOL, V8, P2224, DOI 10.1021/cb4004817; Guo XV, 2007, J BACTERIOL, V189, P4614, DOI 10.1128/JB.00216-07; Hernandez-Abanto SM, 2006, ARCH MICROBIOL, V186, P459, DOI 10.1007/s00203-006-0160-2; Hickey MJ, 1996, ANTIMICROB AGENTS CH, V40, P400, DOI 10.1128/AAC.40.2.400; Higgins DR, 1998, METH MOL B, V103, P41; HOWARD NS, 1995, GENE, V166, P181, DOI 10.1016/0378-1119(95)00597-X; INOUYE S, 1987, J BACTERIOL, V169, P3587, DOI 10.1128/jb.169.8.3587-3592.1987; Kaneko T, 2011, FUTURE MED CHEM, V3, P1373, DOI [10.4155/fmc.11.115, 10.4155/FMC.11.115]; Kaur P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005923; Klotzsche M, 2009, NUCLEIC ACIDS RES, V37, P1778, DOI 10.1093/nar/gkp015; Komeda H, 1996, P NATL ACAD SCI USA, V93, P10572, DOI 10.1073/pnas.93.20.10572; Lale R, 2011, APPL ENVIRON MICROB, V77, P2648, DOI 10.1128/AEM.02091-10; Lambert RJ, 1999, J APPL MICROBIOL, V86, P157, DOI 10.1046/j.1365-2672.1999.00646.x; Lim A, 2000, BIOL CHEM, V381, P517, DOI 10.1515/BC.2000.066; Medina C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023055; MERMOD N, 1986, J BACTERIOL, V167, P447, DOI 10.1128/jb.167.2.447-454.1986; Miesel L, 2003, NAT REV GENET, V4, P442, DOI 10.1038/nrg1086; Milligan DL, 2007, J BACTERIOL, V189, P8381, DOI 10.1128/JB.01201-07; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Pandey AK, 2009, TUBERCULOSIS, V89, P12, DOI 10.1016/j.tube.2008.07.007; Parish T, 1997, MICROBIOL-UK, V143, P2267, DOI 10.1099/00221287-143-7-2267; Prelich G, 2012, GENETICS, V190, P841, DOI 10.1534/genetics.111.136911; RAMOS JL, 1990, J MOL BIOL, V211, P373, DOI 10.1016/0022-2836(90)90358-S; Ramos JL, 1997, ANNU REV MICROBIOL, V51, P341, DOI 10.1146/annurev.micro.51.1.341; Ruiz R, 2003, J BACTERIOL, V185, P3036, DOI 10.1128/JB.185.10.3036-3041.2003; SCHEIN CH, 1988, BIO-TECHNOL, V6, P291, DOI 10.1038/nbt0388-291; Schleif R, 2000, TRENDS GENET, V16, P559, DOI 10.1016/S0168-9525(00)02153-3; Seeliger JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029266; Silva PEA, 2001, ANTIMICROB AGENTS CH, V45, P800, DOI 10.1128/AAC.45.3.800-804.2001; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Tabor S, 1992, Biotechnology, V24, P280; Wegerer A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-2; WHO Food Standards, 2014, CODEX AL BENZ; Wilms B, 2001, BIOTECHNOL BIOENG, V73, P95, DOI 10.1002/bit.1041; Winther-Larsen HC, 2000, METAB ENG, V2, P79, DOI 10.1006/mben.1999.0142; Yuan Y, 1998, P NATL ACAD SCI USA, V95, P9578, DOI 10.1073/pnas.95.16.9578; Zwick F, 2013, BIOENGINEERED, V4, P431, DOI 10.4161/bioe.24703; Zwick F, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-262	54	5	5	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0134544	10.1371/journal.pone.0134544	http://dx.doi.org/10.1371/journal.pone.0134544			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348349	Green Published, gold, Green Submitted			2022-12-26	WOS:000360897600001
J	Kao, LT; Lee, HC; Lin, HC; Tsai, MC; Chung, SD				Kao, Li-Ting; Lee, Hsin-Chien; Lin, Herng-Ching; Tsai, Ming-Chieh; Chung, Shiu-Dong			Healthcare Service Utilization by Patients with Obstructive Sleep Apnea: A Population-Based Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; INTERMITTENT HYPOXIA; ECONOMIC-IMPACT; ASSOCIATION; DIAGNOSIS; ACTIVATION; RESOURCES; MORBIDITY; PATHWAYS; OBESITY	Objective Although obstructive sleep apnea (OSA) is not a life-threatening disease, very few studies have compared differences in healthcare service utilization between patients with and those without OSA in an Asian population according to different age groups. This study attempted to investigate differences in healthcare service utilization between patients with and those without OSA in different age groups in Taiwan. Methods Sampled subjects and data on their health service utilization were retrieved from the Taiwan Longitudinal Health Insurance Database 2005. We included 568 patients with OSA and 2840 subjects without OSA. Each subject was followed for a 1-year period to evaluate their healthcare resource utilization. Wilcoxon-Mann-Whitney tests were performed to compare differences in healthcare utilization between patients with and those without OSA during the 1-year follow-up period. Results As to all healthcare service utilization, patients with OSA had significantly more outpatient visits (30.3 vs. 18.6), outpatient costs (US$1231.2 vs. US$764.8), inpatient days (1.8 vs. 1.2), inpatient costs (US$563.6 vs. US$276.7), and total costs (US$1794.8 vs. US$1041.5) than comparison subjects during the 1-year follow-up period. Moreover, patients with OSA aged 40 similar to 49 and 50 similar to 59 years respectively incurred 2.11- and 2.02-fold higher total costs compared to patients without OSA. However, patients with OSA aged over 70 years did not have higher total costs compared to those without OSA. Conclusions This study found that patients with OSA had greater healthcare service utilization than those without OSA. Additionally, patients with OSA in the 40 similar to 49- and 50 similar to 59-year age groups had about 2-fold higher total costs of healthcare services than those without OSA.	[Kao, Li-Ting] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Kao, Li-Ting; Lee, Hsin-Chien; Lin, Herng-Ching; Chung, Shiu-Dong] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Lee, Hsin-Chien] Taipei Med Univ, Sch Med, Dept Psychiat, Taipei, Taiwan; [Tsai, Ming-Chieh] Cathay Gen Hosp, Dept Internal Med, Taipei, Taiwan; [Chung, Shiu-Dong] Fu Jen Catholic Univ, Sch Med, Hsingchuang, Taiwan; [Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, New Taipei City, Taiwan	National Defense Medical Center; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Cathay General Hospital; Fu Jen Catholic University; Far Eastern Memorial Hospital	Chung, SD (corresponding author), Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan.	chungshiudong@gmail.com	Kao, Li-Ting/W-9287-2018	Kao, Li-Ting/0000-0003-0692-7408				Addison-Brown KJ, 2014, J SLEEP RES, V23, P69, DOI 10.1111/jsr.12086; Albarrak M, 2005, SLEEP, V28, P1306, DOI 10.1093/sleep/28.10.1306; AlGhanim N, 2008, LUNG, V186, P7, DOI 10.1007/s00408-007-9055-5; Bahammam A, 1999, SLEEP, V22, P740, DOI 10.1093/sleep/22.6.740; Baldwin CM, 2001, SLEEP, V24, P96, DOI 10.1093/sleep/24.1.96; Banno K, 2006, SLEEP, V29, P1307, DOI 10.1093/sleep/29.10.1307; Banno K, 2009, SLEEP, V32, P247, DOI 10.1093/sleep/32.2.247; Berg G, 2001, CHEST, V120, P377, DOI 10.1378/chest.120.2.377; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Diaz K, 2014, ANN THORAC MED, V9, P92, DOI 10.4103/1817-1737.128854; Dong JY, 2013, ATHEROSCLEROSIS, V229, P489, DOI 10.1016/j.atherosclerosis.2013.04.026; Greenberg-Dotan S, 2007, SLEEP, V30, P1173, DOI 10.1093/sleep/30.9.1173; Jelic S, 2008, TRENDS CARDIOVAS MED, V18, P253, DOI 10.1016/j.tcm.2008.11.008; Jennum P, 2011, THORAX, V66, P560, DOI 10.1136/thx.2010.143958; Jennum P, 2014, EUR RESPIR J, V43, P134, DOI 10.1183/09031936.00169212; Jurado-Gamez B, 2014, ARCH BRONCONEUMOL; Kapur V, 1999, SLEEP, V22, P749, DOI 10.1093/sleep/22.6.749; Kryger MH, 1996, SLEEP, V19, pS111, DOI 10.1093/sleep/19.suppl_9.S111; Lam Jamie C M, 2009, Expert Rev Respir Med, V3, P177, DOI 10.1586/ers.09.10; Lee RWW, 2010, SLEEP, V33, P1075, DOI 10.1093/sleep/33.8.1075; Mannarino MR, 2012, EUR J INTERN MED, V23, P586, DOI 10.1016/j.ejim.2012.05.013; Otake K, 2002, THORAX, V57, P417, DOI 10.1136/thorax.57.5.417; Peppard PE, 2006, ARCH INTERN MED, V166, P1709, DOI 10.1001/archinte.166.16.1709; Reuveni H, 2008, EUR RESPIR J, V31, P273, DOI 10.1183/09031936.00097907; Ronald J, 1999, SLEEP, V22, P225, DOI 10.1093/sleep/22.2.225; Ronald J, 1998, Sleep Res Online, V1, P71; Ronksley PE, 2009, THORAX, V64, P834, DOI 10.1136/thx.2009.115105; Ryan S, 2005, CIRCULATION, V112, P2660, DOI 10.1161/CIRCULATIONAHA.105.556746; Ryan Silke, 2008, Archives of Physiology and Biochemistry, V114, P261, DOI [10.1080/13813450802307337, 10.1080/13813450802307337 ]; Sharafkhaneh A, 2005, SLEEP, V28, P1405, DOI 10.1093/sleep/28.11.1405; Smith R, 2002, CHEST, V121, P164, DOI 10.1378/chest.121.1.164; Tarasiuk A, 2005, CHEST, V128, P1310, DOI 10.1378/chest.128.3.1310; Tarasiuk A, 2008, J AM GERIATR SOC, V56, P247, DOI 10.1111/j.1532-5415.2007.01544.x; Tarasiuk A, 2013, CURR OPIN PULM MED, V19, P639, DOI 10.1097/MCP.0b013e3283659e1e; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Ziegler Michael G, 2011, Drug Discov Today Dis Models, V8, P155	37	27	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137459	10.1371/journal.pone.0137459	http://dx.doi.org/10.1371/journal.pone.0137459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339792	gold, Green Published, Green Submitted			2022-12-26	WOS:000360688200061
J	Mookerjee, S; Batabyal, P; Sarkar, MH; Palit, A				Mookerjee, Subham; Batabyal, Prasenjit; Sarkar, Madhumanti Halder; Palit, Anup			Seasonal Prevalence of Enteropathogenic Vibrio and Their Phages in the Riverine Estuarine Ecosystem of South Bengal	PLOS ONE			English	Article							HOSPITALIZED DIARRHEAL PATIENTS; WEST-BENGAL; POTABLE WATER; CHOLERAE; KOLKATA; FLUVIALIS; NON-O1; IDENTIFICATION; CONTAMINATION; CYCLONE	Diarrheal disease remains an unsolved problem in developing countries. The emergence of new etiological agents (non-cholera vibrios) is a major cause of concern for health planners. We attempted to unveil the seasonal dynamics of entero-pathogenic Vibrios in Gangetic riverine- estuarine ecosystem. 120 surface water samples were collected for a period of one year from 3 sampling sites on the Hooghly river. Five enteropathogenic Vibrio species, V. cholerae (35%), V. parahaemolyticus (22.5%), V. mimicus (19.1%), V. alginolyticus (15.8%) and V. vulnificus (11.6%), were present in the water samples. The vibriophages, V. vulnificus phi (17.5%), V. alginolyticus phi (17.5%), V. parahaemolyticus phi (10%), V. cholerae non-O1/O139 phi (26.6%) and V. mimicus phi (9.1%), were also detected in these samples. The highest number of Vibrios were noted in the monsoon (20-34 degrees C), and to a lesser extent, in the summer (24-36 degrees C) seasons. Samples positive for phages for any of the identified Vibrio species were mostly devoid of that particular bacterial organism and vice versa. The detection of toxin genes and resistance to beta-lactam antibiotics in some environmental enteropathogenic Vibrio species in the aquatic niches is a significant outcome. This finding is instrumental in the south Bengal diarrhoeal incidence.	[Mookerjee, Subham; Batabyal, Prasenjit; Sarkar, Madhumanti Halder; Palit, Anup] Indian Council Med Res, Natl Inst Cholera & Enter Dis, Div Bacteriol, Scheme XM, Kolkata, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Palit, A (corresponding author), Indian Council Med Res, Natl Inst Cholera & Enter Dis, Div Bacteriol, Scheme XM, P-33,CIT Rd, Kolkata, India.	anup.palit@gmail.com						Barbieri E, 1999, APPL ENVIRON MICROB, V65, P2748; Batabyal P, 2014, INFECT GENET EVOL, V26, P359, DOI 10.1016/j.meegid.2014.06.001; Batabyal P, 2014, SCI TOTAL ENVIRON, V472, P154, DOI 10.1016/j.scitotenv.2013.10.093; Batabyal P, 2013, ACTA TROP, V127, P153, DOI 10.1016/j.actatropica.2013.04.015; Batabyal P, 2012, JPN J INFECT DIS, V65, P358, DOI 10.7883/yoken.65.358; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Bhattacharjee S, 2010, J HEALTH POPUL NUTR, V28, P311; Bross MH, 2007, AM FAM PHYSICIAN, V76, P539; Chakraborty R, 2006, J MED MICROBIOL, V55, P805, DOI 10.1099/jmm.0.46395-0; Chatterjee S, 2009, J CLIN MICROBIOL, V47, P1087, DOI 10.1128/JCM.02026-08; Chowdhury G, 2012, EMERG INFECT DIS, V18, P1868, DOI 10.3201/eid1811.120520; de Magny GC, 2008, P NATL ACAD SCI USA, V105, P17676, DOI 10.1073/pnas.0809654105; Dutta D, 2013, EMERG INFECT DIS, V19, P464, DOI 10.3201/eid1903.121156; EPSTEIN PR, 1993, LANCET, V342, P1216, DOI 10.1016/0140-6736(93)92191-U; Kanungo S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-830; Mahmud ZH, 2006, MICROBIOL RES, V161, P25, DOI 10.1016/j.micres.2005.04.005; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mookerjee S, 2014, J VIROL METHODS, V208, P115, DOI 10.1016/j.jviromet.2014.07.036; Mookerjee S, 2014, ENVIRON MONIT ASSESS, V186, P6241, DOI 10.1007/s10661-014-3851-1; Nair GB, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-4; Nhung PH, 2007, DIAGN MICR INFEC DIS, V59, P271, DOI 10.1016/j.diagmicrobio.2007.05.016; Palit A, 2010, LETT APPL MICROBIOL, V51, P241, DOI 10.1111/j.1472-765X.2010.02873.x; Palit A., 2013, ENCY FOOD SAFETY, P570; Palit A, 2012, WATER SCI TECHNOL, V66, P299, DOI 10.2166/wst.2012.177; Paul D, 2012, J MICROB BIOTEC FOOD, V2, P713; Ramamurthy T, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00091; Rhodes M., 2013, J MARINE BIOL OCEANO, V2, P2, DOI DOI 10.4172/2324-8661.1000109; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; US EPA, 2001, 821R01029 USEPA; *WHO, 2006, WKLY EPIDEMIOL REC, V81, P297; WHO, 2011, KOBE REP; [No title captured]	32	16	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137338	10.1371/journal.pone.0137338	http://dx.doi.org/10.1371/journal.pone.0137338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340543	gold, Green Published, Green Submitted			2022-12-26	WOS:000360688200048
J	Ramallal, R; Toledo, E; Martinez-Gonzalez, MA; Hernandez-Hernandez, A; Garcia-Arellano, A; Shivappa, N; Hebert, JR; Ruiz-Canela, M				Ramallal, Raul; Toledo, Estefania; Martinez-Gonzalez, Miguel A.; Hernandez-Hernandez, Aitor; Garcia-Arellano, Ana; Shivappa, Nitin; Hebert, James R.; Ruiz-Canela, Miguel			Dietary Inflammatory Index and Incidence of Cardiovascular Disease in the SUN Cohort	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MEDITERRANEAN DIET; INTERLEUKIN-1-BETA INHIBITION; PRIMARY PREVENTION; MARKERS; RISK; PATTERNS; CONSUMPTION; VALIDATION; ADHERENCE	Background Diet is known to play a key role in atherogenesis and in the development of cardiovascular events. Dietary factors may mediate these processes acting as potential modulators of inflammation. Potential Links between inflammatory properties of diet and the occurrence of cardiovascular events have not been tested previously. Objective We aimed to assess the association between the dietary inflammatory index (DII), a method to assess the inflammatory potential of the diet, and incident cardiovascular disease. Methods In the prospective, dynamic SUN cohort, 18,794 middle-aged, Spanish university graduates were followed up for 8.9 years (median). A validated 136-item food-frequency questionnaire was used to calculate the DII. The DII is based on scientific evidence about the relationship between diet and inflammatory biomarkers (C-reactive protein, IL-1 beta, IL-4, IL-6, IL-10 and TNF-alpha). Cox proportional hazard models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for the association between the DII and incident cardiovascular disease (myocardial infarction, stroke or cardiovascular death). Results The risk for cardiovascular events progressively increased with each increasing quartile of DII (p(trend) = 0.017). The multivariable-adjusted HR for participants in the highest (most pro-inflammatory) vs. the lowest quartile of the DII was 2.03 (95% CI 1.06-3.88). Conclusions A pro-inflammatory diet was associated with a significantly higher risk for developing cardiovascular events.	[Ramallal, Raul] Complejo Hosp Navarra, Serv Navarro Salud, Dept Cardiol, Pamplona, Spain; [Ramallal, Raul; Toledo, Estefania; Martinez-Gonzalez, Miguel A.; Hernandez-Hernandez, Aitor; Garcia-Arellano, Ana; Ruiz-Canela, Miguel] Navarra Inst Hlth Res, IdiSNA, Pamplona, Spain; [Ramallal, Raul; Toledo, Estefania; Martinez-Gonzalez, Miguel A.; Hernandez-Hernandez, Aitor; Garcia-Arellano, Ana; Ruiz-Canela, Miguel] Univ Navarra, Dept Prevent Med & Publ Hlth, E-31080 Pamplona, Spain; [Toledo, Estefania; Martinez-Gonzalez, Miguel A.; Garcia-Arellano, Ana; Ruiz-Canela, Miguel] Inst Salud Carlos III, Ciber Fisiopatol Obesidad & Nutr CIBERObn, Madrid, Spain; [Shivappa, Nitin] Univ S Carolina, Canc Prevent & Control Program, Columbia, SC 29208 USA; [Shivappa, Nitin; Hebert, James R.] Univ S Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA	Servicio Navarro de Salud - Osasunbidea; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Ruiz-Canela, M (corresponding author), Navarra Inst Hlth Res, IdiSNA, Pamplona, Spain.	mcanela@unav.es	Hernandez Hernandez, Aitor/AAT-6858-2020; Ruiz-Canela, Miguel/I-7738-2016; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Toledo, Estefania/H-6211-2014; Shivappa, Nitin/X-2215-2018	Hernandez Hernandez, Aitor/0000-0002-2124-6099; Ruiz-Canela, Miguel/0000-0002-7684-2787; Toledo, Estefania/0000-0002-6263-4434; Shivappa, Nitin/0000-0003-0441-8896; GARCIA ARELLANO, ANA/0000-0003-1491-9627; Hernandez- Hernandez, Aitor/0000-0001-5759-3773	Spanish Ministry of Health; European Regional Development Fund (FEDER) [PI10/02658, PI10/02293, PI13/00615, PI14/1668, PI14/01798, PI14/1754, RD06/0045, G03/140]; Navarra Regional Government [45/2011, 111/2014]; University of Navarra; United States National Institute of Diabetes and Digestive and Kidney Diseases [R44DK103377]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R44DK103377] Funding Source: NIH RePORTER	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); European Regional Development Fund (FEDER)(European Commission); Navarra Regional Government; University of Navarra; United States National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Seguimiento Universidad de Navarra (SUN) study has received funding from the Spanish Ministry of Health and European Regional Development Fund (FEDER) (current Grants PI10/02658, PI10/02293, PI13/00615, PI14/1668, PI14/01798, PI14/1754) RD06/0045, G03/140, the Navarra Regional Government (45/2011, 111/2014) and the University of Navarra. Drs. Shivappa and Hebert were supported by grant number R44DK103377 from the United States National Institute of Diabetes and Digestive and Kidney Diseases. Funding sources had no role in the design, collection, analysis, and interpretation of the data; in the writing, or in the decision to submit the paper for publication.	Akbaraly TN, 2015, AM J MED, V128, P152, DOI 10.1016/j.amjmed.2014.10.002; Akesson A, 2014, J AM COLL CARDIOL, V64, P1299, DOI 10.1016/j.jacc.2014.06.1190; Martinez-Gonzalez MA, 2014, CURR OPIN LIPIDOL, V25, P20, DOI 10.1097/MOL.0000000000000044; Barbaresko J, 2013, NUTR REV, V71, P511, DOI 10.1111/nure.12035; Bes-Rastrollo M, 2005, REV ESP OBESIDAD, V3, P352; Casas-Agustench P, 2011, NUTR METAB CARDIOVAS, V21, P126, DOI 10.1016/j.numecd.2009.08.005; Cheng JM, 2014, AM J CARDIOL, V114, P1497, DOI 10.1016/j.amjcard.2014.08.013; Cuadrado C., 2013, FOOD COMPOSITION TAB, V16th ed.; Dias JA, 2015, ATHEROSCLEROSIS, V238, P38, DOI 10.1016/j.atherosclerosis.2014.11.006; Esmaillzadeh A, 2006, AM J CLIN NUTR, V84, P1489, DOI 10.1093/ajcn/84.6.1489; Esmaillzadeh A, 2010, PUBLIC HEALTH NUTR, V13, P1395, DOI 10.1017/S1368980009992126; Esposito K, 2004, JAMA-J AM MED ASSOC, V292, P1440, DOI 10.1001/jama.292.12.1440; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Everett BM, 2013, AM HEART J, V166, P199, DOI 10.1016/j.ahj.2013.03.018; Fung TT, 2001, AM J CLIN NUTR, V73, P61; Garcia-Arellano A, 2015, NUTRIENTS, V7, P4124, DOI 10.3390/nu7064124; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Healy AM, 2006, CIRCULATION, V113, P2278, DOI 10.1161/CIRCULATIONAHA.105.607333; Hermsdorff HHM, 2011, EUR J NUTR, V50, P61, DOI 10.1007/s00394-010-0115-x; Hermsdorff HHM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-42; Imhof A, 2001, LANCET, V357, P763, DOI 10.1016/S0140-6736(00)04170-2; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Kuczmarski MF, 2013, J ACAD NUTR DIET, V113, P1620, DOI 10.1016/j.jand.2013.07.004; Lopez-Garcia E, 2004, AM J CLIN NUTR, V80, P1029, DOI 10.1093/ajcn/80.4.1029; Ma YS, 2006, AM J CLIN NUTR, V83, P760, DOI 10.1093/ajcn/83.4.760; Martinez-Gonzalez MA, 2008, BMJ-BRIT MED J, V336, P1348, DOI 10.1136/bmj.39561.501007.BE; Martinez-Gonzalez MA, 2011, NUTR METAB CARDIOVAS, V21, P237, DOI 10.1016/j.numecd.2009.10.005; Martinez-Gonzalez MA, 2005, PUBLIC HEALTH NUTR, V8, P920, DOI 10.1079/PHN2005745; MARTINMORENO JM, 1993, INT J EPIDEMIOL, V22, P512, DOI 10.1093/ije/22.3.512; Mataix J, 2009, FOOD COMPOSITION TAB; Nettleton JA, 2006, AM J CLIN NUTR, V83, P1369, DOI 10.1093/ajcn/83.6.1369; Plotnick GD, 1997, JAMA-J AM MED ASSOC, V278, P1682, DOI 10.1001/jama.278.20.1682; Ridker PM, 2012, CIRCULATION, V126, P2739, DOI 10.1161/CIRCULATIONAHA.112.122556; Ridker PM, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-012-0295-3; Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Root MM, 2012, NUTRIENTS, V4, P29, DOI 10.3390/nu4010029; Ruiz-Canela M, 2015, BRIT J NUTR, V113, P984, DOI 10.1017/S0007114514004401; Segui-Gomez M, 2006, INT J EPIDEMIOL, V35, P1417, DOI 10.1093/ije/dyl223; Shivappa N, 2014, CANCER EPIDEM BIOMAR, V23, P2383, DOI 10.1158/1055-9965.EPI-14-0537; Shivappa N, 2015, BRIT J NUTR, V113, P292, DOI 10.1017/S0007114514003626; Shivappa N, 2015, BRIT J NUTR, V113, P278, DOI 10.1017/S0007114514003572; Shivappa N, 2014, PUBLIC HEALTH NUTR, V17, P1825, DOI 10.1017/S1368980013002565; Shivappa N, 2014, PUBLIC HEALTH NUTR, V17, P1689, DOI 10.1017/S1368980013002115; Sofi F, 2014, PUBLIC HEALTH NUTR, V17, P2769, DOI 10.1017/S1368980013003169; Tabung FK, 2015, CANCER CAUSE CONTROL, V26, P399, DOI 10.1007/s10552-014-0515-y; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Willeit P, 2014, EUR J PREV CARD 1121; Willett W, 2012, NUTR EPIDEMIOLOGY, P74; Wood L, 2014, RESPIROLOGY, V19, P37, DOI 10.1111/cea.12323; World Health Organization, 2008, The global burden of disease: 2004 update; Zamora-Ros R, 2015, GENES NUTR, V10, DOI 10.1007/s12263-014-0447-x	53	102	103	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0135221	10.1371/journal.pone.0135221	http://dx.doi.org/10.1371/journal.pone.0135221			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340022	Green Published, gold			2022-12-26	WOS:000360688200003
J	Thanapirom, K; Suksawatamnuay, S; Sukeepaisarnjaroen, W; Tangkijvanich, P; Treeprasertsuk, S; Thaimai, P; Wasitthankasem, R; Poovorawan, Y; Komolmit, P				Thanapirom, Kessarin; Suksawatamnuay, Sirinporn; Sukeepaisarnjaroen, Wattana; Tangkijvanich, Pisit; Treeprasertsuk, Sombat; Thaimai, Panarat; Wasitthankasem, Rujipat; Poovorawan, Yong; Komolmit, Piyawat			Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; DIPEPTIDYL-PEPTIDASE-IV; INTERFERON-GAMMA; RIBAVIRIN THERAPY; PLUS RIBAVIRIN; VIRAL RESPONSE; IP-10 LEVELS; HCV; EXPRESSION; PROTEIN-10	Pretreatment serumlevels of interferon-.-inducible protein-10 (IP-10, CXCL10) and dipeptidyl peptidase-4 (DPP IV) predict treatment response in chronic hepatitis C (CHC). The association between functional genetic polymorphisms of CXCL10 and DPP4 and treatment outcome has not previously been studied. This study aimed to determine the association between genetic variations of CXCL10 and DPP4 and the outcome of treatment with pegylated interferon-alpha (PEG-IFN-alpha) based therapy in Thai patients with CHC. 602 Thai patients with CHC treated using a PEG-IFN-alpha based regimen were genotyped for CXCL10 rs56061981 G>A and IL28B rs12979860 C>T. In addition, in patients infected with CHC genotype 1, DPP4 (rs13015258 A>C, rs17848916 T>C, rs41268649 G>A, and rs 17574 T>C) were genotyped. Correlations between single nucleotide polymorphisms, genotype, and treatment response were analyzed. The rate of sustained virologic response (SVR) was higher for the CC genotype of IL28B rs12979860 polymorphisms than for non-CC in both genotype 1 (60.6% vs. 29.4%, P < 0.001) and non-genotype 1 (69.4% vs. 49.1%, P < 0.05) CHC. SVR was not associated with the CXCL10 gene variant in all viral genotypes or DPP4 gene polymorphisms in viral genotype1. Multivariate analysis revealed IL28B rs12979860 CC genotype (OR = 3.12; 95% CI, 1.72-5.67; P < 0.001), hepatitis C virus RNA < 400,000 IU/ml (OR = 2.21; 95% CI, 1.22-3.99, P < 0.05), age < 45 years (OR = 2.03; 95% CI, 1.11-3.68; P < 0.05), and liver fibrosis stage 0-1 (OR = 1.64; 95% CI, 1.01-2.65, P < 0.05) were independent factors for SVR. Unfavorable IL28B rs12979860 CT or TT genotypes with the CXCL10 rs56061981 non-GG genotype were associated with a higher SVR than GG genotype (66.7% vs. 33.0%, P = 0.004) in viral genotype 1. In Thai CHC genotype 1 infected patients with an unfavorable IL28B rs12979860 CT/TT genotype, the complementary CXCL10 polymorphism strongly enhances prediction of treatment response.	[Thanapirom, Kessarin; Suksawatamnuay, Sirinporn; Treeprasertsuk, Sombat; Thaimai, Panarat; Komolmit, Piyawat] Chulalongkorn Univ, Fac Med, Dept Med, Div Gastroenterol, Bangkok 10330, Thailand; [Sukeepaisarnjaroen, Wattana] Khon Kaen Univ, Fac Med, Srinagarind Hosp, Gastroenterol Unit,Dept Med, Khon Kaen, Thailand; [Tangkijvanich, Pisit] Chulalongkorn Univ, Fac Med, Dept Biochem, Bangkok 10330, Thailand; [Wasitthankasem, Rujipat; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Dept Pediat, Ctr Excellence Clin Virol, Bangkok 10330, Thailand	Chulalongkorn University; Khon Kaen University; Chulalongkorn University; Chulalongkorn University	Komolmit, P (corresponding author), Chulalongkorn Univ, Fac Med, Dept Med, Div Gastroenterol, Bangkok 10330, Thailand.	pkomolmit@yahoo.co.uk	Komolmit, Piyawat/AAD-1629-2020; treeprasertsuk, sombat/T-6855-2019; ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022; Thanapirom, Kessarin/O-6346-2015; Sukeepaisarnjaroen, Wattana/GQH-3065-2022	Komolmit, Piyawat/0000-0002-1357-9547; Treeprasertsuk, Sombat/0000-0001-6459-8329; Poovorawan, Yong/0000-0002-2337-6807	Ratchadaphiseksomphot Endowment Fund [CU's SRP_05_55_30_01]; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University [RES560530155]	Ratchadaphiseksomphot Endowment Fund; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University(Chulalongkorn University)	This work was supported by the Ratchadaphiseksomphot Endowment Fund Part of the "Grants for Junior or Terminated Executive staff" (CU's SRP_05_55_30_01) and the Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (RES560530155).	Amanzada A, 2012, DIGESTION, V86, P218, DOI 10.1159/000339879; Amanzada A, 2013, J MED VIROL, V85, P1534, DOI 10.1002/jmv.23632; Amanzada A, 2012, J MED VIROL, V84, P1208, DOI 10.1002/jmv.23323; Askarieh G, 2010, HEPATOLOGY, V51, P1523, DOI 10.1002/hep.23509; Bouchard L, 2009, ACTA DIABETOL, V46, P13, DOI 10.1007/s00592-008-0049-4; Casrouge A, 2011, J CLIN INVEST, V121, P308, DOI 10.1172/JCI40594; Charles ED, 2011, J CLIN INVEST, V121, P25, DOI 10.1172/JCI45610; Darling JM, 2011, HEPATOLOGY, V53, P14, DOI 10.1002/hep.24056; Deng GH, 2008, GASTROENTEROLOGY, V134, P716, DOI 10.1053/j.gastro.2007.12.044; Diago M, 2006, GUT, V55, P374, DOI 10.1136/gut.2005.074062; Feld JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080003; Firneisz G, 2001, SCAND J GASTROENTERO, V36, P877, DOI 10.1080/003655201750313423; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Grebely J, 2013, HEPATOLOGY, V57, P2124, DOI 10.1002/hep.26263; Grungreiff K, 2009, MOL MED REP, V2, P63, DOI 10.3892/mmr_00000062; Harvey CE, 2003, J LEUKOCYTE BIOL, V74, P360, DOI 10.1189/jlb.0303093; HEGEN M, 1990, J IMMUNOL, V144, P2908; Heydtmann M, 2009, HEPATOLOGY, V49, P676, DOI 10.1002/hep.22763; Ikura Y, 1996, AM J GASTROENTEROL, V91, P1367; Itou M, 2008, J GASTROEN HEPATOL, V23, P244, DOI 10.1111/j.1440-1746.2007.05183.x; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Lagging M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017232; Lange CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040159; Mihm S, 2003, J MED VIROL, V70, P562, DOI 10.1002/jmv.10431; Proost P, 2001, BLOOD, V98, P3554, DOI 10.1182/blood.V98.13.3554; Romero AI, 2006, J INFECT DIS, V194, P895, DOI 10.1086/507307; Soderholm J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056991; Stattermayer AF, 2011, CLIN GASTROENTEROL H, V9, P344, DOI 10.1016/j.cgh.2010.07.019; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Turcot V, 2011, OBESITY, V19, P388, DOI 10.1038/oby.2010.198; Xu ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072799; You CR, 2011, GUT LIVER, V5, P506, DOI 10.5009/gnl.2011.5.4.506	35	4	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137365	10.1371/journal.pone.0137365	http://dx.doi.org/10.1371/journal.pone.0137365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339796	Green Published, Green Submitted, gold			2022-12-26	WOS:000360688200051
J	Tatsumi, H; Nakatani, E; Kanno, T; Nariai, Y; Kagimura, T; Sekine, J				Tatsumi, Hiroto; Nakatani, Eiji; Kanno, Takahiro; Nariai, Yoshiki; Kagimura, Tatsuo; Sekine, Joji			Clinical Features and Treatment Modes of Mandibular Fracture at the Department of Oral and Maxillofacial Surgery, Shimane University Hospital, Japan	PLOS ONE			English	Article							RIGID INTERNAL-FIXATION; RECONSTRUCTION; REDUCTION	Background The number of elderly patients with maxillofacial trauma is rapidly increasing due to active lifestyles and longevity. Shimane prefecture has the fastest growing proportion of elderly individuals in Japan. The aim of this study was to reveal the distinctive features and treatment modes of mandibular fracture treatment mode in patients requiring hospitalization at the Department of Oral and Maxillofacial Surgery, Shimane University Hospital, Japan. Patients and Methods Patient age, sex, period between injury and first consultation, years since injury, cause of injury, fracture site, treatment, and duration of hospitalization were evaluated. Univariate Poisson regression, relative risk with 95% confidence interval based on the Wald test, Fisher's exact test, and Kruskal-Wallis test were used to explore associations among clinical and demographic variables. Results In total, 305 patients were diagnosed with and hospitalized for mandibular fracture from 1980 to 2010. Younger age increased the risk for mandibular fracture. Incidence was higher in males than females, particularly in the young, but the male to female ratio decreased with age. The period until first hospital consultation decreased progressively over the study period. Fall was a much more frequent cause in patients aged >= 60 than in those aged <60 years. Mandibular fracture with condyle, symphysis, and angle involvement were most common and were associated with sex, age, and treatment mode. Length of hospitalization has decreased since 1980. Conclusion In our department, patients aged >= 60 years accounted for a greater proportion of mandibular fracture cases than in many previous studies, reflecting the greater proportion of elderly residents in Shimane prefecture.	[Tatsumi, Hiroto; Kanno, Takahiro; Nariai, Yoshiki; Sekine, Joji] Shimane Univ, Fac Med, Dept Oral & Maxillofacial Surg, Izumo, Shimane, Japan; [Nakatani, Eiji; Kagimura, Tatsuo] Fdn Biomed Res & Innovat, Translat Res Informat Ctr, Kobe, Hyogo, Japan	Shimane University; Institute for Biomedical Research & Innovation (IBRI)	Sekine, J (corresponding author), Shimane Univ, Fac Med, Dept Oral & Maxillofacial Surg, Izumo, Shimane, Japan.	georges@med.shimane-u.ac.jp	Nakatani, Eiji/O-2782-2013	Nakatani, Eiji/0000-0002-4876-446X				Adeyemo WL, 2008, WORLD J SURG, V32, P2631, DOI 10.1007/s00268-008-9773-8; Atilgan S, 2010, J APPL ORAL SCI, V18, P17, DOI 10.1590/S1678-77572010000100005; Bakardjiev A, 2007, J CRANIO MAXILL SURG, V35, P147, DOI 10.1016/j.jcms.2007.01.005; Bither S, 2008, DENT TRAUMATOL, V24, P468, DOI 10.1111/j.1600-9657.2008.00606.x; Bormann KH, 2009, J ORAL MAXIL SURG, V67, P1251, DOI 10.1016/j.joms.2008.09.022; Chrcanovic BR, 2012, J CRANIO MAXILL SURG, V40, P116, DOI 10.1016/j.jcms.2011.03.012; Czerwinski M, 2008, CAN J PLAST SURG, V16, P36, DOI 10.1177/229255030801600107; de Matos FP, 2010, INT J ORAL MAX SURG, V39, P10, DOI 10.1016/j.ijom.2009.10.005; Domanski MC, 2011, J CRANIOFAC SURG, V22, P2260, DOI 10.1097/SCS.0b013e31823270e3; Eskitascioglu T, 2013, ULUS TRAVMA ACIL CER, V19, P348, DOI 10.5505/tjtes.2013.56313; Brasileiro BF, 2006, ORAL SURG ORAL MED O, V102, P28, DOI 10.1016/j.tripleo.2005.07.023; Fonceca RJ, 1991, ORAL MAXILLOFACIAL T, P238; GOLDSCHMIDT MJ, 1995, J ORAL MAXIL SURG, V53, P1145, DOI 10.1016/0278-2391(95)90620-7; Gutta R, 2014, J ORAL MAXIL SURG, V72, P550, DOI 10.1016/j.joms.2013.09.005; Iida S, 2003, J CRANIO MAXILL SURG, V31, P278, DOI 10.1016/S1010-5182(03)00069-6; Jung HW, 2014, J KOR ASSOC ORAL MAX, V40, P21, DOI 10.5125/jkaoms.2014.40.1.21; Kanno T, 2014, INT J ORAL MAX SURG, V43, P177, DOI 10.1016/j.ijom.2013.08.008; Kanno T, 2011, J ORAL MAXIL SURG, V69, pE372, DOI 10.1016/j.joms.2011.02.040; Kloss FR, 2011, INT J ORAL MAX SURG, V40, P33, DOI 10.1016/j.ijom.2010.08.006; Maliska Maximiana Cristina de Souza, 2009, Braz. oral res., V23, P268, DOI 10.1590/S1806-83242009000300008; Ministry of Internal Affairs and Communications, JAP STAT YB; Sasaki R, 2009, ORAL SCI INT, V6, P1; SEKINE J, 1995, J ORAL MAXIL SURG, V53, P1317, DOI 10.1016/0278-2391(95)90592-8; Tatsumi H, 2014, INT J ORAL MAX SURG, V43, P185, DOI 10.1016/j.ijom.2013.07.742; United Nations, WORLD POP PROSP 2008; Wang GS, 2012, OR SURG OR MED OR PA, V113, P356, DOI 10.1016/j.tripleo.2011.03.034; Wilde F, 2014, CRANIOMAX TRAUM REC, V7, P158, DOI 10.1055/s-0034-1371356; Yu H, 2013, J CRANIOMAXILLOFAC S	28	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136278	10.1371/journal.pone.0136278	http://dx.doi.org/10.1371/journal.pone.0136278			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334627	Green Submitted, gold, Green Published			2022-12-26	WOS:000360615400012
J	Theysohn, JM; Ruhlmann, M; Muller, S; Dechene, A; Best, J; Haubold, J; Umutlu, L; Gerken, G; Bockisch, A; Lauenstein, TC				Theysohn, Jens M.; Ruhlmann, Marcus; Mueller, Stefan; Dechene, Alexander; Best, Jan; Haubold, Johannes; Umutlu, Lale; Gerken, Guido; Bockisch, Andreas; Lauenstein, Thomas C.			Radioembolization with Y-90 Glass Microspheres: Do We Really Need SPECT-CT to Identify Extrahepatic Shunts?	PLOS ONE			English	Article							INTERNAL RADIATION-THERAPY; HEPATIC-TUMORS; HEPATOCELLULAR-CARCINOMA; LIVER-TUMORS; CANCER; COMPLICATIONS; RADIOTHERAPY; TC-99M-MAA; ARTERY; SIRT	Purpose Selective Internal Radiation Therapy (SIRT) with (90)yttrium (Y-90) is an increasingly used therapeutic option for unresectable liver malignancies. Nontarget embolization of extrahepatic tissue secondary to vascular shunting can lead to SIRT associated complications. Our aim was to assess whether extrahepatic shunts can reliably be diagnosed based on hepatic digital subtraction angiography (DSA) or whether subsequent SPECT/CT data can provide additional information. Materials and Methods 825 patients with hepatocellular carcinoma (n = 636), hepatic metastases (n = 158) or cholangiocellular carcinoma (n = 31) were retrospectively analyzed. During hepatic DSA 128 arteries causing shunt flow to gastrointestinal tissue were coilembolized (right gastric artery n = 63, gastroduodenal artery n = 29; branches to duodenum/pancreas n = 36). Technectium-99m-labeled human serum albumin (HSA) was injected in all 825 patients. SPECT/CT data was used to identify additional or remaining shunts to extrahepatic tissue. Results An unexpected uptake of HSA in extrahepatic tissue was found by SPECT/CT in 54/825 (6.5%) patients (located in stomach n = 13, duodenum n = 26, distal bowel segments n = 12, kidney n = 1, diaphragm n = 2). These patients underwent repeated DSA and newly identified shunt vessels were coilembolized in 22/54 patients, while in 12/54 patients a more distal catheter position for repeat injection of HSA was chosen. In 20/54 patients the repeated SPECT/CT data still revealed an extrahepatic HSA uptake. These patients did not receive SIRT. Conclusion Most extrahepatic shunts can be identified on DSA prior to Y-90 therapy. However, SPECT-CT data helps to identify additional shunts that were initially not seen on DSA.	[Theysohn, Jens M.; Haubold, Johannes; Umutlu, Lale; Lauenstein, Thomas C.] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Ruhlmann, Marcus; Mueller, Stefan; Bockisch, Andreas] Univ Hosp Essen, Dept Nucl Med, Essen, Germany; [Dechene, Alexander; Best, Jan; Gerken, Guido] Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Theysohn, JM (corresponding author), Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.	jens.theysohn@uni-due.de	Best, Jan/AAG-2350-2020	Best, Jan/0000-0003-2074-0930				Ahmadzadehfar H, 2014, EUR J NUCL MED MOL I, V41, pS115, DOI 10.1007/s00259-013-2675-5; Ahmadzadehfar H, 2010, J NUCL MED, V51, P1206, DOI 10.2967/jnumed.109.074559; Barentsz MW, 2011, CARDIOVASC INTER RAD, V34, P1074, DOI 10.1007/s00270-010-0088-4; Crowder CD, 2009, AM J SURG PATHOL, V33, P963, DOI 10.1097/PAS.0b013e31817ed787; Dudeck O, 2012, CARDIOVASC INTER RAD, V35, P1083, DOI 10.1007/s00270-011-0252-5; Floridi C, 2014, RADIOL MED, V119, P521, DOI 10.1007/s11547-014-0429-5; Gaba RC, 2014, RADIOLOGY, V271, P602, DOI 10.1148/radiol.14131969; Gates VL, 2014, J VASC INTERV RADIOL, V25, P266, DOI 10.1016/j.jvir.2013.11.005; Geisel D, 2014, ANTICANCER RES, V34, P4315; Gordon AC, 2014, J VASC INTERV RADIOL, V25, P1523, DOI 10.1016/j.jvir.2014.07.007; Hamami ME, 2009, J NUCL MED, V50, P688, DOI 10.2967/jnumed.108.058347; Heusner TA, 2010, ROFO-FORTSCHR RONTG, V182, P603, DOI 10.1055/s-0029-1245192; Hong K, 2009, J VASC INTERV RADIOL, V20, P360, DOI 10.1016/j.jvir.2008.11.019; Jakobs TF, 2007, EUR RADIOL, V17, P1320, DOI 10.1007/s00330-006-0508-7; Jiang ML, 2011, CANCER BIOTHER RADIO, V26, P511, DOI 10.1089/cbr.2010.0944; Kao YH, 2011, ANN NUCL MED, V25, P365, DOI 10.1007/s12149-010-0464-9; Konda A, 2009, GASTROINTEST ENDOSC, V70, P561, DOI 10.1016/j.gie.2009.03.015; Lam M, 2013, CARDIOVASC INTER RAD, V36, P1536, DOI 10.1007/s00270-013-0579-1; Lencioni R, 2012, RADIOLOGY, V262, P43, DOI 10.1148/radiol.11110144; Maleux G, 2013, J VASC INTERV RADIOL, V24, P797, DOI 10.1016/j.jvir.2013.01.503; Malfertheiner P, 2014, FUTURE ONCOL, V10, P17, DOI 10.2217/fon.14.218; Paprottka PM, 2012, CARDIOVASC INTER RAD, V35, P454, DOI 10.1007/s00270-011-0169-z; Pech M, 2009, CARDIOVASC INTER RAD, V32, P455, DOI 10.1007/s00270-008-9498-y; Peterson JL, 2013, BRACHYTHERAPY, V12, P573, DOI 10.1016/j.brachy.2013.05.008; Riaz A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00198; Rodriguez-Lago I, 2013, WORLD J GASTROENTERO, V19, P2935, DOI 10.3748/wjg.v19.i19.2935; Schelhorn J, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-595; Theysohn JM, 2013, CARDIOVASC INTER RAD, V36, P1015, DOI 10.1007/s00270-012-0474-1; Yu NC, 2013, INT J RADIAT ONCOL, V85, P834, DOI 10.1016/j.ijrobp.2012.06.051; Zarva A, 2014, J NUCL MED, V55, P360, DOI 10.2967/jnumed.113.127662	30	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137587	10.1371/journal.pone.0137587	http://dx.doi.org/10.1371/journal.pone.0137587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335790	Green Published, Green Submitted, gold			2022-12-26	WOS:000360615400070
J	Yang, XJ; Wu, QP; Zhang, JM; Huang, JH; Guo, WP; Cai, SZ				Yang, Xiaojuan; Wu, Qingping; Zhang, Jumei; Huang, Jiahui; Guo, Weipeng; Cai, Shuzhen			Prevalence and Characterization of Monophasic Salmonella Serovar (1) under bar,4,[5], 12: i:-of Food Origin in China	PLOS ONE			English	Article							ENTERICA SEROTYPE TYPHIMURIUM; MOLECULAR CHARACTERIZATION; PHENOTYPIC CHARACTERISTICS; INFECTIONS; RESISTANCE; STRAINS; VARIANT; SURVEILLANCE; EMERGENCE; EVOLUTION	Salmonella enterica subsp. enterica serovar (1) under bar,4,[5], 12:i:-is a monophasic variant of Salmonella Typhimurium, which has recently been recognized as an emerging cause of infection worldwide. This bacterium has also ranked among the four most frequent serovars causing human salmonellosis in China. However, there are no reports on its contamination in Chinese food. Serotyping, polymerase chain reaction, antibiotic resistance, virulotyping, and multilocus sequence typing (MLST) assays were used to investigate the prevalence of this serological variant in food products in China, and to determine phenotypic and genotypic difference of monophasic isolates and Salmonella Typhimurium isolated over the same period. Salmonella (1) under bar,4,[5], 12:i:-was prevalent in various food sources, including beef, pork, chicken, and pigeon. The study also confirmed the high prevalence (53.8%) of resistance to ampicillin, streptomycin, sulfonamides, and tetracycline in Salmonella (1) under bar,4,[5], 12:i:-, which was higher than that in Salmonella Typhimurium. Moreover, Salmonella (1) under bar,4,[5], 12:i:-isolates in our study were different from Salmonella Typhimurium isolates by the absence of three plasmid-borne genes (spvC, pefA, and rck) and the presence of gipA in all isolates. All Salmonella (1) under bar,4,[5], 12:i:-isolates demonstrated MLST pattern ST34. Genomic deletions within the fljBA operon and surrounding genes were only found in Salmonella (1) under bar,4,[5], 12:i:isolates, with all isolates containing a deletion of fljB. However, hin and iroB were identified in all Salmonella (1) under bar,4,[5], 12:i:-isolates. Three different deletion profiles were observed and two of them were different from the reported Salmonella (1) under bar,4,[5], 12:i:-clones from Spain, America, and Italy, which provided some new evidence on the independent evolution of the multiple successful monophasic clones from Salmonella Typhimurium ancestors. This study is the first report of Salmonella (1) under bar,4,[5], 12:i:-in food products from China. The data are more comprehensive and representative, providing valuable information for epidemiological studies, risk management, and public health strategies.	[Yang, Xiaojuan; Wu, Qingping; Zhang, Jumei; Huang, Jiahui; Guo, Weipeng; Cai, Shuzhen] Guangdong Inst Microbiol, State Key Lab Appl Microbiol Southern China, Guangzhou, Guangdong, Peoples R China; [Yang, Xiaojuan; Wu, Qingping; Zhang, Jumei; Huang, Jiahui; Guo, Weipeng; Cai, Shuzhen] Guangdong Open Lab Appl Microbiol, Guangdong Prov Key Lab Microbial Culture Collect, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences	Wu, QP (corresponding author), Guangdong Inst Microbiol, State Key Lab Appl Microbiol Southern China, Guangzhou, Guangdong, Peoples R China.	wuqp203@163.com	Gu, Yan/AFQ-1163-2022		Science and Technology Projects of Guangdong [2013B050800026, 2014A040401055]; Science and Technology Projects of Guangzhou [201300000074]	Science and Technology Projects of Guangdong; Science and Technology Projects of Guangzhou	The authors' study was supported by the Science and Technology Projects of Guangdong (2013B050800026, JMZ; 2014A040401055, XJY) and the Science and Technology Projects of Guangzhou (201300000074, JMZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amavisit P, 2005, J CLIN MICROBIOL, V43, P2736, DOI 10.1128/JCM.43.6.2736-2740.2005; Andreoletti O, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1826; Antunes P, 2011, J ANTIMICROB CHEMOTH, V66, P2028, DOI 10.1093/jac/dkr228; Barco L, 2012, ZOONOSES PUBLIC HLTH, V59, P505, DOI 10.1111/j.1863-2378.2012.01487.x; Barco L, 2014, FOODBORNE PATHOG DIS, V11, P138, DOI 10.1089/fpd.2013.1626; Boland C, 2014, VET MICROBIOL, V168, P447, DOI 10.1016/j.vetmic.2013.11.040; Bone A, 2010, EUROSURVEILLANCE, V15, P2; Capuano F, 2013, FOODBORNE PATHOG DIS, V10, P963, DOI 10.1089/fpd.2013.1511; Centers for Disease Control and Prevention [CDC], 2006, EM ANT RES SALM SER; Chiou CS, 2006, DIAGN MICR INFEC DIS, V54, P315, DOI 10.1016/j.diagmicrobio.2005.10.009; Clinical and Laboratory Standards Institute, 2014, CLSI DOC; de la Torre E, 2003, J CLIN MICROBIOL, V41, P2395, DOI 10.1128/JCM.41.6.2395-2400.2003; Deng XL, 2012, FOODBORNE PATHOG DIS, V9, P305, DOI 10.1089/fpd.2011.1008; Dionisi AM, 2009, FOODBORNE PATHOG DIS, V6, P711, DOI 10.1089/fpd.2008.0240; Echeita MA, 2001, J CLIN MICROBIOL, V39, P2981, DOI 10.1128/JCM.39.8.2981-2983.2001; Gallati C, 2013, FOODBORNE PATHOG DIS, V10, P549, DOI 10.1089/fpd.2012.1407; Garaizar J, 2002, J CLIN MICROBIOL, V40, P2074, DOI 10.1128/JCM.40.6.2074-2078.2002; Garcia P, 2013, J CLIN MICROBIOL, V51, P973, DOI 10.1128/JCM.02777-12; Grimont PAD, 2007, ANTIGENIC FORMULAE F; Guerra B, 2000, FEMS MICROBIOL LETT, V190, P341, DOI 10.1016/S0378-1097(00)00359-1; Hauser E, 2010, APPL ENVIRON MICROB, V76, P4601, DOI 10.1128/AEM.02991-09; Hopkins K L, 2010, Euro Surveill, V15, P19580; Hopkins KL, 2010, 2 ANT RES ZOON BACT, P13; Huehn S, 2010, FOODBORNE PATHOG DIS, V7, P523, DOI 10.1089/fpd.2009.0447; Kurosawa A, 2012, VET MICROBIOL, V160, P264, DOI 10.1016/j.vetmic.2012.05.023; Laorden L, 2010, J CLIN MICROBIOL, V48, P4563, DOI 10.1128/JCM.00337-10; Liang ZM, 2013, S CHINA J PREVENTIVE, V39, P27; Lucarelli C, 2012, J ANTIMICROB CHEMOTH, V67, P111, DOI 10.1093/jac/dkr391; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Mossong J, 2007, Euro Surveill, V12, pE11; Mulvey MR, 2013, J ANTIMICROB CHEMOTH, V68, P1982, DOI 10.1093/jac/dkt149; Soyer Y, 2009, J CLIN MICROBIOL, V47, P3546, DOI 10.1128/JCM.00546-09; Switt AIM, 2009, FOODBORNE PATHOG DIS, V6, P407, DOI 10.1089/fpd.2008.0213; Tennant SM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000621; Wasyl D, 2012, FOODBORNE PATHOG DIS, V9, P1037, DOI 10.1089/fpd.2012.1154; Zamperini K, 2007, AVIAN DIS, V51, P958, DOI 10.1637/7944-021507-REGR.1	36	81	82	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137967	10.1371/journal.pone.0137967	http://dx.doi.org/10.1371/journal.pone.0137967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360603	Green Submitted, Green Published, gold			2022-12-26	WOS:000361043100104
J	Yang, X; Zhu, CF; Gu, Y				Yang, Xue; Zhu, Chenfang; Gu, Yan			The Prognosis of Breast Cancer Patients after Mastectomy and Immediate Breast Reconstruction: A Meta-Analysis	PLOS ONE			English	Article							SKIN-SPARING MASTECTOMY; POSTMASTECTOMY RECONSTRUCTION; ONCOLOGICAL SAFETY; ADJUVANT CHEMOTHERAPY; LOCAL RECURRENCE; FOLLOW-UP; SURVIVAL; IMPACT; CONSERVATION; REVIEWS	Background An increasing number of patients with breast cancer are being offered immediate breast reconstruction (IBR). The aim of this study was to analyze the impact of IBR on the prognosis of patients with breast cancer. Methods We searched the electronic databases of Medline (Pubmed), ISI Web of Knowledge, Embase, and Google Scholar databases for studies reporting the overall recurrence, disease- free survival (DFS), and overall survival (OS) of patients after mastectomy only and mastectomy with IBR. With these data, we conducted a meta-analysis of the clinical outcomes. Results Fourteen studies, including 3641 cases and 9462 controls, matched our criteria. Relevant information was extracted from these 14 studies. There was no significant heterogeneity (P for Q-statistic > 0.10 and I-2 < 25%). Patients who underwent IBR showed no increased risk of overall recurrence of breast cancer (RR = 0.89; 95% confidence interval [CI]: 0.75, 1.04; P = 0.14). Furthermore, patients receiving IBR had similar DFS (RR = 1.04; 95% CI: 0.99, 1.08); P = 0.10) and OS (RR = 1.02; 95% CI: 0.99, 1.05; P = 0.24)) as those of control patients. Conclusion This meta-analysis provides evidence that IBR does not have an adverse effect on prognosis. These data suggest that IBR is an appropriate and safe choice for patients with breast cancer.	[Yang, Xue; Zhu, Chenfang; Gu, Yan] Shanghai Jiao Tong Univ, Shanghai Ninth Hosp, Sch Med, Dept Gen Surg, Shanghai 200011, Peoples R China	Shanghai Jiao Tong University	Gu, Y (corresponding author), Shanghai Jiao Tong Univ, Shanghai Ninth Hosp, Sch Med, Dept Gen Surg, Shanghai 200011, Peoples R China.	guyan_8@hotmail.com	Gu, Yan/AFQ-1163-2022					Agarwal J, 2012, BREAST J, V18, P226, DOI 10.1111/j.1524-4741.2012.01235.x; Agarwal S, 2010, BREAST J, V16, P503, DOI 10.1111/j.1524-4741.2010.00958.x; Alderman AK, 2002, PLAST RECONSTR SURG, V109, P2265, DOI 10.1097/00006534-200206000-00015; Barry PN, 2014, AM J CLIN ONCOL-CANC, V37, P575, DOI 10.1097/COC.0b013e318280d79f; Bezuhly M, 2009, CANCER, V115, P4648, DOI 10.1002/cncr.24511; Blettner M, 1999, INT J EPIDEMIOL, V28, P1, DOI 10.1093/ije/28.1.1; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eriksen C, 2011, BREAST CANCER RES TR, V127, P439, DOI 10.1007/s10549-011-1437-y; Gerber B, 2009, ANN SURG, V249, P461, DOI 10.1097/SLA.0b013e31819a044f; Gieni M, 2012, BREAST, V21, P230, DOI 10.1016/j.breast.2011.12.013; Goktas SB, 2011, TURK KLIN TIP BILIM, V31, P664, DOI 10.5336/medsci.2009-15488; Gomez SL, 2010, J CLIN ONCOL, V28, pE155, DOI 10.1200/JCO.2009.26.1032; Hatala R, 2005, CAN MED ASSOC J, V172, P661, DOI 10.1503/cmaj.1031920; Hoshaw SJ, 2001, PLAST RECONSTR SURG, V107, P1393, DOI 10.1097/00006534-200105000-00012; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson A, 2000, BREAST CANCER RES TR, V60, P201, DOI 10.1023/A:1006441018271; Joslyn SA, 2005, PLAST RECONSTR SURG, V115, P1289, DOI 10.1097/01.PRS.0000156974.69184.5E; Kim MK, 2014, EUROPEAN J SURG ONCO; Kontos M, 2010, EJSO-EUR J SURG ONC, V36, P745, DOI 10.1016/j.ejso.2010.06.013; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lee TJ, 2012, ARCH PLAST SURG-APS, V39, P376, DOI 10.5999/aps.2012.39.4.376; Lim W, 2010, J SURG ONCOL, V102, P39, DOI 10.1002/jso.21573; Lohrisch C, 2006, J CLIN ONCOL, V24, P4888, DOI 10.1200/JCO.2005.01.6089; McCarthy CM, 2008, PLAST RECONSTR SURG, V121, P381, DOI 10.1097/01.prs.0000298316.74743.dd; McGuire KP, 2009, ANN SURG ONCOL, V16, P2682, DOI 10.1245/s10434-009-0635-x; Min SY, 2010, BREAST J, V16, P356, DOI 10.1111/j.1524-4741.2010.00941.x; Morrow M, 2001, J AM COLL SURGEONS, V192, P1, DOI 10.1016/S1072-7515(00)00747-X; Murphy RX, 2003, ANN PLAS SURG, V50, P333, DOI 10.1097/01.SAP.0000041488.88950.A2; Nedumpara T, 2011, BREAST, V20, P437, DOI 10.1016/j.breast.2011.04.006; Neyt MJ, 2005, BRIT J PLAST SURG, V58, P493, DOI 10.1016/j.bjps.2004.12.002; Nguyen TJ, 2012, ANN SURG, V256, P326, DOI 10.1097/SLA.0b013e3182602bb7; NOGUCHI M, 1992, J SURG ONCOL, V50, P241, DOI 10.1002/jso.2930500409; Ota D, 2014, CLIN BREAST CANCER, V14, P339, DOI 10.1016/j.clbc.2013.12.014; Petit JY, 2008, BREAST CANCER RES TR, V112, P545, DOI 10.1007/s10549-008-9891-x; Reddy S, 2011, ANN PLAS SURG, V66, P466, DOI 10.1097/SAP.0b013e318214e575; Roder D, 2013, BREAST, V22, P1220, DOI 10.1016/j.breast.2013.09.011; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Ueda S, 2008, SURGERY, V143, P414, DOI 10.1016/j.surg.2007.10.006; Viera AJ, 2005, FAM MED, V37, P360; Yoshimura, 1996, Breast Cancer, V3, P47, DOI 10.1007/BF02966962	43	81	82	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0125655	10.1371/journal.pone.0125655	http://dx.doi.org/10.1371/journal.pone.0125655			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26360603	Green Published, gold, Green Submitted			2022-12-26	WOS:000355319400008
J	Geng, YQ; Zhang, JJ; Yan, YD; Yu, BW; Geng, L; Sun, T				Geng, Yanquan; Zhang, Junjie; Yan, Yongda; Yu, Bowen; Geng, Lin; Sun, Tao			Experimental and Theoretical Investigation of Crystallographic Orientation Dependence of Nanoscratching of Single Crystalline Copper	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; INDUCED DEFORMATION; SIMULATION; NANOINDENTATION; NANOSTRUCTURE; SCRATCH; FABRICATION; MICROSCOPY; EVOLUTION; ALUMINUM	In the present work, we perform experiments and molecular dynamics simulations to elucidate the underlying deformation mechanisms of single crystalline copper under the load-controlled multi-passes nanoscratching using a triangular pyramidal probe. The correlation of microscopic deformation behavior of the material with macroscopically-observed machining results is revealed. Moreover, the influence of crystallographic orientation on the nanoscratching of single crystalline copper is examined. Our simulation results indicate that the plastic deformation of single crystalline Cu under the nanoscratching is exclusively governed by dislocation mechanisms. However, there is no glissile dislocation structure formed due to the probe oscillation under the load-controlled mode. Both experiments and MD simulations demonstrate that the machined surface morphologies in terms of groove depth and surface pile-up exhibit strong crystallographic orientation dependence, because of different geometries of activated slip planes cutting with free surfaces and strain hardening abilities associated with different crystallographic orientations.	[Geng, Yanquan; Yan, Yongda] Harbin Inst Technol, Inst Robot, State Key Lab Robot & Syst, Harbin 150008, Heilongjiang, Peoples R China; [Geng, Yanquan; Zhang, Junjie; Yan, Yongda; Yu, Bowen; Sun, Tao] Harbin Inst Technol, Ctr Precis Engn, Harbin 150001, Heilongjiang, Peoples R China; [Zhang, Junjie; Geng, Lin] Harbin Inst Technol, Sch Mat Sci & Engn, Harbin 150001, Heilongjiang, Peoples R China	Harbin Institute of Technology; Harbin Institute of Technology; Harbin Institute of Technology	Zhang, JJ (corresponding author), Harbin Inst Technol, Ctr Precis Engn, Harbin 150001, Heilongjiang, Peoples R China.	zhjj505@gmail.com; yanyongda@hit.edu.cn	Yan, Yongda/M-7315-2017; Geng, Yanquan/AAD-9914-2020; Geng, Yanquan/Q-1119-2015; Feng, Li/GQQ-3764-2022; SUN, TAO/HGA-0197-2022; Lin, Geng/AAS-4901-2020; Wang, Xin/AAN-8435-2021; Wang, Xin/GYU-1129-2022	Yan, Yongda/0000-0002-9290-5362; Wang, Xin/0000-0002-4457-7376; Geng, Yanquan/0000-0003-3499-0551; Zhang, Junjie/0000-0002-9636-5551; Geng, Yanquan/0000-0003-0958-0999	National Natural Science Foundation of China [51222504, 51275114, 51405106]; Author of National Excellent Doctoral Dissertation of PR China [201031]; Program for New Century Excellent Talents in University [NCET-11-0812]; China Postdoctoral Science Foundation [2012M511463, 2013T60358]; Heilongjiang Postdoctoral Fund [LBH-Z11143]; National Program for Support of Top-notch Young Professors	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Heilongjiang Postdoctoral Fund; National Program for Support of Top-notch Young Professors	The authors gratefully acknowledge financial supports of the National Natural Science Foundation of China (51222504, 51275114 and 51405106), the Author of National Excellent Doctoral Dissertation of PR China (201031), the Program for New Century Excellent Talents in University (NCET-11-0812), the China Postdoctoral Science Foundation (2012M511463 and 2013T60358), the Heilongjiang Postdoctoral Fund (LBH-Z11143) and the the National Program for Support of Top-notch Young Professors.	Ciesielski PN, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-47; Dongmo LS, 2000, ULTRAMICROSCOPY, V85, P141, DOI 10.1016/S0304-3991(00)00051-6; Fanzio P, 2012, SCI REP-UK, V2, DOI 10.1038/srep00791; FOILES SM, 1986, PHYS REV B, V33, P7983, DOI 10.1103/PhysRevB.33.7983; Geng YQ, 2013, J VAC SCI TECHNOL B, V31, DOI 10.1116/1.4825405; Gregory JG, 2010, J MATER RES, V25, P921; HONEYCUTT JD, 1987, J PHYS CHEM-US, V91, P4950, DOI 10.1021/j100303a014; Ju SP, 2007, MOL SIMULAT, V33, P905, DOI 10.1080/08927020701392954; Komanduri R, 2000, WEAR, V240, P113, DOI 10.1016/S0043-1648(00)00358-6; Lin YC, 2014, MOL PHYS, V112, P1115, DOI 10.1080/00268976.2013.833657; Liu H, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/17/175301; Lu C, 2009, WEAR, V267, P1961, DOI 10.1016/j.wear.2009.05.006; Meyers MA, 2006, PROG MATER SCI, V51, P427, DOI 10.1016/j.pmatsci.2005.08.003; Nazirizadeh Y, 2013, OPT EXPRESS, V21, P18661, DOI 10.1364/OE.21.018661; Pitchuka SB, 2014, J THERM SPRAY TECHN, V23, P502, DOI 10.1007/s11666-013-0021-x; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Podymova NB, 2014, LASER PHYS, V24, DOI 10.1088/1054-660X/24/8/086003; Salehinia I, 2014, INT J PLASTICITY, V52, P133, DOI 10.1016/j.ijplas.2013.04.010; Salehinia I, 2013, MAT SCI ENG A-STRUCT, V588, P340, DOI 10.1016/j.msea.2013.09.059; Singh A, 2011, ACTA MATER, V59, P7311, DOI 10.1016/j.actamat.2011.08.014; Stukowski A, 2010, MODEL SIMUL MATER SC, V18, DOI 10.1088/0965-0393/18/1/015012; Suchowski H, 2013, SCIENCE, V342, P1223, DOI 10.1126/science.1244303; Tak M, 2014, BIOSENS BIOELECTRON, V59, P200, DOI 10.1016/j.bios.2014.03.036; Tschopp MA, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2715137; Tseng AA, 2011, J VAC SCI TECHNOL B, V29, DOI 10.1116/1.3609921; Tseng AA, 2010, J VAC SCI TECHNOL B, V28, P202, DOI 10.1116/1.3292944; Tseng AA, 2009, J APPL PHYS, V106, DOI 10.1063/1.3197313; Wang Y, 2004, ACTA MATER, V52, P2229, DOI 10.1016/j.actamat.2004.01.016; Wu B, 2006, NANO LETT, V6, P468, DOI 10.1021/nl052427f; Wu SL, 2013, ACS APPL MATER INTER, V5, P4769, DOI 10.1021/am400092w; Yan YD, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-212; Zhang JJ, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/19/195301; Zhang JJ, 2013, MODEL SIMUL MATER SC, V21, DOI 10.1088/0965-0393/21/6/065001; Zhang JJ, 2012, COMP MATER SCI, V59, P14, DOI 10.1016/j.commatsci.2012.02.024; Zhang JJ, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.054109; Zhang JJ, 2009, APPL PHYS A-MATER, V94, P593, DOI 10.1007/s00339-008-4903-6; Zhang P, 2013, APPL SURF SCI, V280, P751, DOI 10.1016/j.apsusc.2013.05.056; Zheng YG, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2839581	38	62	73	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131886	10.1371/journal.pone.0131886	http://dx.doi.org/10.1371/journal.pone.0131886			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147506	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600156
J	Geng, YF; Guo, DH; Li, CQ; Wang, EY; Wei, S; Wang, ZH; Yao, S; Zhao, XW; Su, MJ; Wang, XY; Wang, JF; Wu, R; Feng, L; Sun, DB				Geng, Yufei; Guo, Donghua; Li, Chunqiu; Wang, Enyu; Wei, Shan; Wang, Zhihui; Yao, Shuang; Zhao, Xiwen; Su, Mingjun; Wang, Xinyu; Wang, Jianfa; Wu, Rui; Feng, Li; Sun, Dongbo			Co-Circulation of the Rare CPV-2c with Unique Gln370Arg Substitution, New CPV-2b with Unique Thr440Ala Substitution, and New CPV-2a with High Prevalence and Variation in Heilongjiang Province, Northeast China	PLOS ONE			English	Article							CANINE PARVOVIRUS STRAINS; GENETIC-ANALYSIS; VP2 GENE; MOLECULAR CHARACTERIZATION; PHYLOGENETIC ANALYSIS; DOGS; EMERGENCE; EVOLUTION; RECOMBINATION; REVEALS	To trace evolution of canine parvovirus-2 (CPV-2), a total of 201 stool samples were collected from dogs with diarrhea in Heilongjiang province of northeast China from May 2014 to April 2015. The presence of CPV-2 in the samples was determined by PCR amplification of the VP2 gene (568 bp) of CPV-2. The results revealed that 95 samples (47.26%) were positive for CPV-2, and they showed 98.8%-100% nucleotide identity and 97.6%-100% amino acid identity. Of 95 CPV-2-positive samples, types new2a (Ser297Ala), new2b (Ser297Ala), and 2c accounted for 64.21%, 21.05%, and 14.74%, respectively. The positive rate of CPV-2 and the distribution of the new2a, new2b and 2c types exhibited differences among regions, seasons, and ages. Immunized dogs accounted for 48.42% of 95 CPV-2-positive samples. Coinfections with canine coronavirus, canine kobuvirus, and canine bocavirus were identified. Phylogenetic analysis revealed that the identified new2a, new2b, and CPV-2c strains in our study exhibited a close relationship with most of the CPV-2 strains from China; type new2a strains exhibited high variability, forming three subgroups; type new2b and CPV-2c strains formed one group with reference strains from China. Of 95 CPV-2 strains, Tyr324Ile and Thr440Ala substitutions accounted for 100% and 64.21%, respectively; all type new2b strains exhibited the Thr440Ala substitution, while the unique Gln370Arg substitution was found in all type 2c strains. Recombination analysis using entire VP2 gene indicated possible recombination events between the identified CPV-2 strains and reference strains from China. Our data revealed the co-circulation of new CPV-2a, new CPV-2b, and rare CPV-2c, as well as potential recombination events among Chinese CPV-2 strains.	[Geng, Yufei; Guo, Donghua; Li, Chunqiu; Wang, Enyu; Wei, Shan; Wang, Zhihui; Yao, Shuang; Zhao, Xiwen; Su, Mingjun; Wang, Xinyu; Wang, Jianfa; Wu, Rui; Sun, Dongbo] Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, Daqing 163319, Peoples R China; [Feng, Li] Chinese Acad Agr Sci, Harbin Vet Res Inst, Natl Key Lab Vet Biotechnol, Harbin 150001, Peoples R China	Heilongjiang Bayi Agricultural University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Sun, DB (corresponding author), Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, 2 Xinyang Rd, Daqing 163319, Peoples R China.	dongbosun@126.com	Yan, Yongda/M-7315-2017; Geng, Yanquan/AAD-9914-2020; Geng, Yanquan/Q-1119-2015; Feng, Li/GQQ-3764-2022; SUN, TAO/HGA-0197-2022; Lin, Geng/AAS-4901-2020; Wang, Xin/AAN-8435-2021; Wang, Xin/GYU-1129-2022	Yan, Yongda/0000-0002-9290-5362; Wang, Xin/0000-0002-4457-7376; Geng, Yanquan/0000-0003-3499-0551; Zhang, Junjie/0000-0002-9636-5551; Geng, Yanquan/0000-0003-0958-0999	Program for New Century Excellent Talents in Heilongjiang Provincial University [1252-NCET-016]	Program for New Century Excellent Talents in Heilongjiang Provincial University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the Program for New Century Excellent Talents in Heilongjiang Provincial University (grant no. 1252-NCET-016).	Bodewes R, 2014, VET MICROBIOL, V174, P1, DOI 10.1016/j.vetmic.2014.08.025; Buonavoglia C, 2001, J GEN VIROL, V82, P3021, DOI 10.1099/0022-1317-82-12-3021; Cavalli A, 2014, J VET DIAGN INVEST, V26, P563, DOI 10.1177/1040638714538965; Costa EM, 2014, VET MICROBIOL, V168, P8, DOI 10.1016/j.vetmic.2013.10.002; Csagola A, 2014, ARCH VIROL, V159, P2441, DOI 10.1007/s00705-014-2068-5; Decaro N, 2009, VIROLOGY, V385, P5, DOI 10.1016/j.virol.2008.12.016; Decaro N, 2007, EMERG INFECT DIS, V13, P1222, DOI 10.3201/eid1308.070505; Decaro N, 2012, VET MICROBIOL, V155, P1, DOI 10.1016/j.vetmic.2011.09.007; Decaro N, 2011, VET J, V187, P195, DOI 10.1016/j.tvjl.2009.10.027; Di Martino B, 2013, VET MICROBIOL, V166, P246, DOI 10.1016/j.vetmic.2013.05.007; Dogonyaro BB, 2013, VET MICROBIOL, V165, P460, DOI 10.1016/j.vetmic.2013.04.022; Calderon MG, 2009, J VIROL METHODS, V159, P141, DOI 10.1016/j.jviromet.2009.03.013; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gomez MM, 2011, J MED VIROL, V83, P1093, DOI 10.1002/jmv.22071; Grellet A, 2012, VET MICROBIOL, V157, P214, DOI 10.1016/j.vetmic.2011.11.012; Han SC, 2015, ARCH MICROBIOL, V197, P621, DOI 10.1007/s00203-015-1093-4; Hoelzer K, 2008, J GEN VIROL, V89, P2280, DOI 10.1099/vir.0.2008/002055-0; Hong C, 2007, J VET DIAGN INVEST, V19, P535, DOI 10.1177/104063870701900512; Hueffer K, 2003, J VIROL, V77, P1718, DOI 10.1128/JVI.77.3.1718-1726.2003; Ikeda Y, 2000, VIROLOGY, V278, P13, DOI 10.1006/viro.2000.0653; Jeoung SY, 2008, J VET MED SCI, V70, P719, DOI 10.1292/jvms.70.719; Kapil S, 2007, J CLIN MICROBIOL, V45, P4044, DOI 10.1128/JCM.01300-07; KELLY WR, 1978, AUST VET J, V54, P593, DOI 10.1111/j.1751-0813.1978.tb02426.x; Lau SKP, 2012, J GEN VIROL, V93, P1573, DOI 10.1099/vir.0.042531-0; Lin CN, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-39; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Maya L, 2013, ARCH VIROL, V158, P1133, DOI 10.1007/s00705-012-1591-5; Meers J, 2007, AUST VET J, V85, P392, DOI 10.1111/j.1751-0813.2007.00206.x; Mesquita JR, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-107; Mittal M, 2014, INFECT GENET EVOL, V23, P1, DOI 10.1016/j.meegid.2014.01.015; Mukhopadhyay HK, 2014, VIRUS GENES, V48, P89, DOI 10.1007/s11262-013-1000-5; Nandi S, 2010, RES VET SCI, V88, P169, DOI 10.1016/j.rvsc.2009.05.018; Nelson CDS, 2007, VIROLOGY, V361, P283, DOI 10.1016/j.virol.2006.11.032; Ohshima T, 2008, J VET MED SCI, V70, P769, DOI 10.1292/jvms.70.769; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; PARRISH CR, 1991, J VIROL, V65, P6544, DOI 10.1128/JVI.65.12.6544-6552.1991; PARRISH CR, 1985, SCIENCE, V230, P1046, DOI 10.1126/science.4059921; Pedroza-Roldan C, 2015, J VET DIAGN INVEST, V27, P107, DOI 10.1177/1040638714559969; Pereira CAD, 2007, INFECT GENET EVOL, V7, P399, DOI 10.1016/j.meegid.2006.03.007; Perez R, 2007, VET MICROBIOL, V124, P147, DOI 10.1016/j.vetmic.2007.04.028; Perez R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111779; Phromnoi S, 2010, VIRUS GENES, V41, P23, DOI 10.1007/s11262-010-0475-6; Pinto LD, 2012, VIRUS RES, V165, P29, DOI 10.1016/j.virusres.2012.01.001; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Raj JM, 2010, INFECT GENET EVOL, V10, P1237, DOI 10.1016/j.meegid.2010.08.005; SMITH JM, 1992, J MOL EVOL, V34, P126; Soma T, 2013, RES VET SCI, V94, P368, DOI 10.1016/j.rvsc.2012.09.013; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Timurkan MO, 2015, VET ITAL, V51, P39, DOI 10.12834/VetIt.263.908.3; Xu J, 2015, TRANSBOUND EMERG DIS, V62, P91, DOI 10.1111/tbed.12078; Yi L, 2016, TRANSBOUND EMERG DIS, V63, pE262, DOI 10.1111/tbed.12268; Zhang RZ, 2010, VIRUS GENES, V40, P397, DOI 10.1007/s11262-010-0466-7; Zhao YB, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-272; Zhong ZJ, 2014, INT J MOL SCI, V15, P12166, DOI 10.3390/ijms150712166	55	62	73	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137288	10.1371/journal.pone.0137288	http://dx.doi.org/10.1371/journal.pone.0137288			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26147506	Green Submitted, Green Published, gold			2022-12-26	WOS:000360897600031
